PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	THEILER, R; NIEDERMAN, RA				THEILER, R; NIEDERMAN, RA			LOCALIZATION OF CHROMATOPHORE PROTEINS OF RHODOBACTER-SPHAEROIDES .2. TOPOGRAPHY OF CYTOCHROME-C1 AND THE RIESKE IRON-SULFUR PROTEIN AS DETERMINED BY PROTEOLYTIC DIGESTION OF THE OUTER AND LUMINAL MEMBRANE SURFACES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST MITOCHONDRIAL-MEMBRANE; COMPLEX-III; RHODOPSEUDOMONAS-SPHAEROIDES; ELECTRON-TRANSFER; C REDUCTASE; PHOTOSYNTHETIC BACTERIA; POLYACRYLAMIDE GELS; NUCLEOTIDE-SEQUENCE; RESPIRATORY-CHAIN; BC1 COMPLEX	Proteinase K was used to degrade membrane proteins exposed at the outer (cytoplasmic) and inner (periplasmic) surface of sealed, uniformly oriented chromatophore vesicles of Rhodobacter sphaeroides. Exclusive and controlled digestion of the chromatophore interior was achieved after Ca2+-induced fusion with large unilamellar phosphatidylglycerol liposomes containing microencapsulated enzyme. Reaction center subunit H, which served as a marker for the outer surface, was degraded to a slightly smaller product in chromatophores. This protein remained intact after liposome-chromatophore fusion, suggesting that the intermixing of lipid bilayers proceeded without significant leakage of the aqueous vesicle contents. In contrast, while cytochrome c1 was not affected in chromatophores, 70-75% was degraded within 60 min after liposome-chromatophore fusion. These results support an arrangement in which the bulk of this protein, including the mesoheme component and active site residues, faces the periplasmic side of the membrane. Although current functional models for the cytochrome bc1 complex predict that the Rieske iron-sulfur center interacts with cytochrome c1 in the periplasm, the iron-sulfur protein resisted proteolytic attack in the liposome-chromatophore fusion products under conditions that caused extensive degradation of cytochrome c1. Two cleavage products of the iron-sulfur protein were observed after the digestion of chromatophores, suggesting both a heterogeneity in the population of this protein and the exposure of at least part of its molecular mass to the cytoplasm.	RUTGERS STATE UNIV,DEPT MOLEC BIOL & BIOCHEM,POB 1059,PISCATAWAY,NJ 08855	Rutgers State University New Brunswick								ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; ANDREWS KM, 1990, BIOCHEMISTRY-US, V29, P2645, DOI 10.1021/bi00463a004; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; BACHMANN RC, 1981, BIOCHEMISTRY-US, V20, P4590, DOI 10.1021/bi00519a012; BEATTIE DS, 1981, J BIOENERG BIOMEMBR, V13, P357, DOI 10.1007/BF00743210; BECKMANN JD, 1987, J BIOL CHEM, V262, P8901; BELL RL, 1979, P NATL ACAD SCI USA, V76, P741, DOI 10.1073/pnas.76.2.741; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; BLUM H, 1983, BIOCHIM BIOPHYS ACTA, V748, P418, DOI 10.1016/0167-4838(83)90188-7; BOWYER JR, 1982, J BIOL CHEM, V257, P8321; COLLINS MLP, 1980, J BACTERIOL, V143, P221, DOI 10.1128/JB.143.1.221-230.1980; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; DAVIDSON E, 1987, J MOL BIOL, V195, P13, DOI 10.1016/0022-2836(87)90323-8; DSOUZA MP, 1982, J BIOL CHEM, V257, P1760; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; FU W, 1990, J BIOL CHEM, V265, P16541; GABELLINI N, 1988, J BIOENERG BIOMEMBR, V20, P59, DOI 10.1007/BF00762138; HALL RL, 1978, PHOTOCHEM PHOTOBIOL, V28, P273, DOI 10.1111/j.1751-1097.1978.tb07708.x; HARNISCH U, 1985, EUR J BIOCHEM, V149, P95, DOI 10.1111/j.1432-1033.1985.tb08898.x; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; KONISHI K, 1991, J BIOL CHEM, V266, P14270; KUROWSKI B, 1987, J BIOL CHEM, V262, P13805; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORUSSO M, 1989, EUR J BIOCHEM, V179, P535, DOI 10.1111/j.1432-1033.1989.tb14580.x; MAJEWSKI C, 1990, MOL GEN GENET, V224, P373, DOI 10.1007/BF00262431; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; NIEDERMAN RA, 1981, PHOTOSYNTHESIS, V5, P663; OHNISHI T, 1989, J BIOL CHEM, V264, P735; PRINCE RC, 1983, BIOCHIM BIOPHYS ACTA, V723, P133, DOI 10.1016/0005-2728(83)90112-3; PURVIS DJ, 1990, J BIOL CHEM, V265, P1208; RIESKE JS, 1986, J BIOENERG BIOMEMBR, V18, P235, DOI 10.1007/BF00743466; SIDHU A, 1983, J BIOL CHEM, V258, P2308; SIDHU A, 1983, J BIOL CHEM, V258, P649; SIEDOW JN, 1978, J BIOL CHEM, V253, P2392; STURGIS JN, 1990, PHOTOSYNTH RES, V23, P241, DOI 10.1007/BF00034854; SZCZEPANIAK A, 1990, J BIOL CHEM, V265, P17720; TAKEMOTO J, 1979, ARCH BIOCHEM BIOPHYS, V195, P526, DOI 10.1016/0003-9861(79)90379-5; THEILER R, 1991, J BIOL CHEM, V266, P23157; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMPOWER BL, 1981, BIOCHIM BIOPHYS ACTA, V639, P129, DOI 10.1016/0304-4173(81)90008-2; VERBIST J, 1989, MOL GEN GENET, V219, P445, DOI 10.1007/BF00259618; WIEMKEN V, 1983, FEMS MICROBIOL LETT, V16, P297; WILLEY DL, 1984, CELL, V36, P555, DOI 10.1016/0092-8674(84)90248-4; WOOD PM, 1980, BIOCHEM J, V189, P385, DOI 10.1042/bj1890385; YUN CH, 1990, EUR J BIOCHEM, V194, P399, DOI 10.1111/j.1432-1033.1990.tb15633.x	47	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23163	23168						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660467				2022-12-25	WOS:A1991GT48300061
J	HORAK, E; SMITH, K; BROMLEY, L; LEJEUNE, S; GREENALL, M; LANE, D; HARRIS, AL				HORAK, E; SMITH, K; BROMLEY, L; LEJEUNE, S; GREENALL, M; LANE, D; HARRIS, AL			MUTANT P53, EGF-RECEPTOR AND C-ERBB-2 EXPRESSION IN HUMAN BREAST-CANCER	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTORS; CELLULAR PROTEIN P53; TRANSFORMED-CELLS; TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; COLORECTAL CARCINOMAS; MONOCLONAL-ANTIBODIES; ALLELE LOSS; GENE; ONCOGENE	p53 expression was studied in 111 primary breast cancers with a monoclonal antibody (PAb240) that reacts with an epitope in mutant p53. Epidermal growth factor receptors (EGFr) and oestrogen receptors (ER) measured by ligand binding, c-erhB-2 expression assessed by immunochemistry and lymph node status were compared with p53 staining. Fifty-nine tumours (53%) were positive for p53, and this correlated with EGFr expression (P < 0.02), which is a known poor prognostic factor. Eighteen out of 59 p53+ tumours expressed c-erbB-2 versus 4 out of 52 p53- tumours assessed on paraffin sections. However, assessing c-erhB-2 by Southern blotting and immunochemistry on frozen sections showed that 20 out of 59 p53+ tumours overexpressed or had amplified c-erbB-2 compared with 15 out of 52 p53- tumours (not significant). Mean EGFr concentration in p53+ tumours was 31 fmol per mg of membrane protein versus 14 fmol mg-1 in p53- tumours. Cytoplasmic staining was the most frequent pattern found for p53, but some cases showed cytoplasmic plus nuclear staining, or focal cells with predominantly nuclear staining. Thus, abnormal p53 is the commonest oncogene abnormality described in breast cancer. The association with EGFr expression suggests that these oncogenes interact in the pathogenesis of breast cancer.	JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,INST MOLEC MED,CLIN ONCOL UNIT,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,DEPT SURG,OXFORD OX3 9DU,ENGLAND; IMPERIAL CANC RES FUND,S MIMMS EN6 3LD,HERTS,ENGLAND	University of Oxford; University of Oxford; University of Oxford			Harris, Adrian L/ABA-3343-2020; Lane, David P/C-4920-2008	Harris, Adrian L/0000-0003-1376-8409; Lane, David/0000-0003-0551-3545				ALI IU, 1989, ONCOGENE, V4, P89; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARNES DM, 1988, BRIT J CANCER, V58, P448, DOI 10.1038/bjc.1988.238; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BOS JL, 1989, CANCER RES, V49, P4682; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; CATTORETTI G, 1988, BRIT J CANCER, V57, P353, DOI 10.1038/bjc.1988.81; CHIMCO WJ, 1988, NATURE, V332, P805; CHUMAKOV P, 1990, CELL BIOCH S14C, V106, P269; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; Crawford L V, 1984, Mol Biol Med, V2, P261; CRAWFORD LV, 1982, INT J CANCER, V30, P403, DOI 10.1002/ijc.2910300404; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GANNON JV, 1991, NATURE, V349, P802; GANNON JV, 1990, EMBO J, V9, P3927; GREEN AR, 1988, BRIT J CANCER, V58, P115, DOI 10.1038/bjc.1988.176; GRIMAUX M, 1990, INT J CANCER, V45, P255, DOI 10.1002/ijc.2910450209; GUERIN M, 1989, INT J CANCER, V43, P201, DOI 10.1002/ijc.2910430205; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HARRIS AL, 1989, J STEROID BIOCHEM, V34, P123, DOI 10.1016/0022-4731(89)90072-1; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JENKINS JR, 1988, ONCOGENE HDB, P403; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MACKAY J, 1988, LANCET, V2, P1384; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MASON DY, 1989, J CLIN PATHOL, V42, P1194, DOI 10.1136/jcp.42.11.1194; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; NICHOLSON S, 1989, LANCET, V1, P182; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PATERSON MC, 1991, CANCER RES, V51, P556; PEREZ R, 1984, BREAST CANCER RES TR, V4, P189, DOI 10.1007/BF01806484; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; PROSSER J, 1990, ONCOGENE, V5, P1563; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROTTER V, 1983, EMBO J, V2, P1041, DOI 10.1002/j.1460-2075.1983.tb01543.x; SAINSBURY JRC, 1987, LANCET, V1, P1398; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SHOHAT O, 1987, ONCOGENE, V1, P277; SLAMON DJ, 1989, CANCER CEL, V7, P371; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STURZBECHER HW, 1987, ONCOGENE, V1, P201; STURZBECHER HW, 1988, MOL CELL BIOL, V8, P3740; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; VALVERIUS EM, 1989, MOL ENDOCRINOL, V3, P203, DOI 10.1210/mend-3-1-203; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VARLEY JM, 1991, ONCOGENE, V6, P413; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WEINBERG RA, 1989, CANCER RES, V49, P3713; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WRIGHT C, 1989, CANCER RES, V49, P2087; WYSS R, 1987, ANTICANCER RES, V7, P721; YEE LD, 1989, SEMIN DIAGN PATHOL, V6, P110; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0	65	106	106	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1991	6	12					2277	2284						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX735	1685017				2022-12-25	WOS:A1991GX73500015
J	KIRSCH, J; LANGOSCH, D; PRIOR, P; LITTAUER, UZ; SCHMITT, B; BETZ, H				KIRSCH, J; LANGOSCH, D; PRIOR, P; LITTAUER, UZ; SCHMITT, B; BETZ, H			THE 93-KDA GLYCINE RECEPTOR-ASSOCIATED PROTEIN BINDS TO TUBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SPINAL-CORD; NICOTINIC ACETYLCHOLINE-RECEPTORS; GATED ION CHANNELS; IMMUNOELECTRON MICROSCOPY; POSTSYNAPTIC MEMBRANES; MONOCLONAL-ANTIBODIES; CENTRAL SYNAPSES; PURIFICATION; BRAIN; MICROTUBULES	A peripheral membrane protein with a relative molecular mass of 93,000 Da is associated with cytoplasmic domains of the inhibitory glycine receptor of mammalian spinal cord. Here, evidence is given that this 93-kDa protein hinds to polymerized tubulin. First, tubulin cofractionated with the 93-kDa protein upon affinity purification of the glycine receptor. Second, tubulin bound to the isolated 93-kDa protein in an overlay procedure. Third, in assays containing the purified glycine receptor, the 93-kDa protein as well as the glycine receptor-alpha and beta-subunits coassembled with tubulin and microtubules. The interaction of the 93-kDa protein with tubulin displayed high affinity (K(D) almost-equal-to 2.5 n-M) and significant cooperativity (Hill coefficient almost-equal-to 2.1) and approached a stoichiometry of approximately 1:4 under saturating conditions. These data suggest that the 93-kDa protein anchors the glycine receptor at postsynaptic sites via binding to subsynaptic tubulin.	MAX PLANCK INST HIRNFORSCH, NEUROCHEM ABT, DEUTSCHORDENSTR 46, W-6000 FRANKFURT 71, GERMANY; WEIZMANN INST SCI, DEPT NEUROBIOL, IL-76100 REHOVOT, ISRAEL	Max Planck Society; Weizmann Institute of Science								ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BRIDGMAN PC, 1987, J CELL BIOL, V105, P1829, DOI 10.1083/jcb.105.4.1829; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; GOZES I, 1979, FEBS LETT, V99, P86, DOI 10.1016/0014-5793(79)80255-0; GRAHAM D, 1983, EUR J BIOCHEM, V131, P519, DOI 10.1111/j.1432-1033.1983.tb07292.x; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HIROKAWA N, 1982, J NEUROCYTOL, V11, P487, DOI 10.1007/BF01257990; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; KIRSCH J, 1990, J NEUROCHEM, V55, P1031, DOI 10.1111/j.1471-4159.1990.tb04593.x; KORDELI E, 1986, J CELL BIOL, V102, P748, DOI 10.1083/jcb.102.3.748; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1990, J BIOL CHEM, V265, P22317; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LAROCHELLE WJ, 1990, J NEUROSCI, V10, P3460; MAROTTA CA, 1979, BRAIN RES, V167, P93, DOI 10.1016/0006-8993(79)90265-8; Peters A., 1976, FINE STRUCTURE NERVO; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STEPHENS RE, 1986, BIOL CELL, V57, P95, DOI 10.1111/j.1768-322X.1986.tb00467.x; TRILLER A, 1987, J CELL BIOL, V104, P947, DOI 10.1083/jcb.104.4.947; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Vallee R B, 1984, Cell Muscle Motil, V5, P289; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VALLEE RB, 1986, METHOD ENZYMOL, V134, P104; WALKER JH, 1984, EMBO J, V3, P2287, DOI 10.1002/j.1460-2075.1984.tb02127.x; WALTERS BB, 1975, NATURE, V257, P496, DOI 10.1038/257496a0; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	42	233	237	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22242	22245						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657993				2022-12-25	WOS:A1991GR56400030
J	ZHANGKECK, ZY; KIBBE, WA; MOYEROWLEY, WS; PARKER, CS				ZHANGKECK, ZY; KIBBE, WA; MOYEROWLEY, WS; PARKER, CS			THE SV40 CORE SEQUENCE FUNCTIONS AS A REPRESSOR ELEMENT IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; RECOGNITION ELEMENT; MAMMALIAN ENHANCERS; NEGATIVE REGULATION; PROTEIN; GENE; EXPRESSION; AP-2; SILENCERS	Our previous studies showed that the AP-1 recognition element (ARE) present within the SV40 72-base pair (bp) enhancer will activate transcription in yeast when placed upstream of a truncated CYC1 promoter. However, the AP-2/AP-3 recognition element (also known as the core sequence TGTGGAAAG) from the SV40 enhancer was not able to activate CYC1-dependent transcription. In this report, we show that the core sequence, when cloned next to a yeast UAS (upstream activation sequence), can inhibit the transcriptional stimulatory activity of the UAS. We refer to this sequence as the upstream repressor element (URE) in yeast. Repression occurs in an orientation-independent fashion and irrespective of the placement of the URE between the UAS and TATA box or upstream of both of these elements. Furthermore, repression is seen when the URE is separated from the UAS by up to 214 bp. Interestingly, multiple copies of an activator site can overcome this repression. Gel-shift analysis and URE-probed protein blots indicate the presence of two polypeptide chains capable of binding the URE in yeast. The experimental evidence suggests that either the repression associated with the URE sequence is mediated by a direct, one-to-one interaction between the proteins recognizing the URE and GCRE, or alternatively, that there is a direct interaction between the activator and repressor for a general transcription factor.	CALTECH,DIV CHEM,PASADENA,CA 91125	California Institute of Technology			Moye-Rowley, Scott/AFL-7135-2022; Kibbe, Warren/B-2106-2010	Moye-Rowley, Scott/0000-0002-7163-1120; Kibbe, Warren/0000-0001-5622-7659	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029430] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-29430] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; COMPANY M, 1988, MOL CELL BIOL, V8, P5299, DOI 10.1128/MCB.8.12.5299; ERREDE B, 1985, P NATL ACAD SCI USA, V82, P5423, DOI 10.1073/pnas.82.16.5423; GOEL A, 1988, MOL CELL BIOL, V8, P2572, DOI 10.1128/MCB.8.6.2572; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; KIBBE WA, 1990, THESIS CALTECH; KUHLEMEIER C, 1987, GENE DEV, V1, P247, DOI 10.1101/gad.1.3.247; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LUCHE RM, 1990, MOL CELL BIOL, V10, P3884, DOI 10.1128/MCB.10.8.3884; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Maniatis T., 1982, MOL CLONING; MERCURIO F, 1989, EMBO J, V8, P1455, DOI 10.1002/j.1460-2075.1989.tb03528.x; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; PARK HO, 1989, MOL CELL BIOL, V9, P2025, DOI 10.1128/MCB.9.5.2025; Parker CS, 1989, CURR OPIN CELL BIOL, V1, P512, DOI 10.1016/0955-0674(89)90013-6; ROEDER GS, 1985, P NATL ACAD SCI USA, V82, P5428, DOI 10.1073/pnas.82.16.5428; Sherman F., 1982, METHODS YEAST GENETI; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; SUMRADA RA, 1987, P NATL ACAD SCI USA, V84, P3997, DOI 10.1073/pnas.84.12.3997; TEEM JL, 1983, P NATL ACAD SCI-BIOL, V80, P4403, DOI 10.1073/pnas.80.14.4403; WIEDERRECHT G, 1987, CELL, V48, P507, DOI 10.1016/0092-8674(87)90201-7; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	38	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21362	21367						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657962				2022-12-25	WOS:A1991GP80400010
J	MULBERG, AE; TULK, BM; FORGAC, M				MULBERG, AE; TULK, BM; FORGAC, M			MODULATION OF COATED VESICLE CHLORIDE CHANNEL ACTIVITY AND ACIDIFICATION BY REVERSIBLE PROTEIN-KINASE A-DEPENDENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CYSTIC-FIBROSIS; ABNORMAL FUCOSYLATION; PROTON PUMP; ILEAL-MUCUS; ATP	We have previously shown that activity of a Cl- channel is required for acidification of clathrin-coated vesicles by the coated vesicle (H+)-ATPase (Arai, H., Pink, S. and Forgac, M. (1989) Biochemistry 28, 3075-3082). We demonstrate that activity of the coated vesicle Cl- channel is modulated by phosphorylation. Cl- conductance was measured in a reconstituted preparation of coated vesicle membrane proteins using the Cl--sensitive fluorescence probe, 6-methoxy-N-(3-sulfopropyl) quinolinium. Treatment of coated vesicle membranes with alkaline phosphatase resulted in a 25 +/- 5% decrease in Cl- channel activity. A parallel decrease in ATP-dependent acidification of coated vesicles was also observed. The decrease in Cl- conductance and ATP-dependent acidification was reversed by treatment with protein kinase A and MgATP; the alkaline phosphatase inhibitor, sodium orthovanadate, blocked the inhibition of acidification. These results indicate that Cl- conductance in coated vesicles is modulated by a protein kinase A-dependent phosphorylation and that this modulation in turn affects ATP-dependent acidification.	TUFTS UNIV,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,BOSTON,MA 02111; TUFTS UNIV,SCH MED,DIV PEDIAT GASTROENTEROL,BOSTON,MA 02111; NEW ENGLAND MED CTR HOSP,BOSTON,MA 02111	Tufts University; Tufts University; Tufts Medical Center			MULBERG, ANDREW/AAJ-2249-2020		NIDDK NIH HHS [DK07542-06, 2T32DK07471] Funding Source: Medline; NIGMS NIH HHS [GM 44828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007471, T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; BAE HR, 1990, NATURE, V348, P637, DOI 10.1038/348637a0; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BARZVI D, 1988, J BIOL CHEM, V263, P4408; BREUER W, 1990, BIOCHIM BIOPHYS ACTA, V1022, P229, DOI 10.1016/0005-2736(90)90118-8; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4220; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; FUCHS R, 1987, J CELL BIOL, V105, P91; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; KEEN JH, 1986, J CELL BIOL, V102, P1325, DOI 10.1083/jcb.102.4.1325; KING A, 1990, J CLIN PATHOL, V43, P1019, DOI 10.1136/jcp.43.12.1019; MARQUEZSTERLING N, 1991, IN PRESS EUR J CELL; MERESSE S, 1990, J BIOL CHEM, V265, P1833; PAULOIN A, 1982, NATURE, V298, P574, DOI 10.1038/298574a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SIPE DM, 1991, J BIOL CHEM, V266, P3469; THIRU S, 1990, J CLIN PATHOL, V43, P1014, DOI 10.1136/jcp.43.12.1014; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; VERKMAN AS, 1989, BIOCHEMISTRY-US, V28, P4240, DOI 10.1021/bi00436a018; YURKO MA, 1987, J BIOL CHEM, V262, P15770	25	69	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20590	20593						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657931				2022-12-25	WOS:A1991GN00100004
J	HEIDARAN, MA; PIERCE, JH; YU, JC; LOMBARDI, D; ARTRIP, JE; FLEMING, TP; THOMASON, A; AARONSON, SA				HEIDARAN, MA; PIERCE, JH; YU, JC; LOMBARDI, D; ARTRIP, JE; FLEMING, TP; THOMASON, A; AARONSON, SA			ROLE OF ALPHA-BETA-RECEPTOR HETERODIMER FORMATION IN BETA-PLATELET-DERIVED GROWTH-FACTOR (PDGF) RECEPTOR ACTIVATION BY PDGF-AB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; ONE B-CHAIN; SIGNAL TRANSDUCTION; CDNA CLONING; MAJOR PART; EXPRESSION; PHOSPHORYLATION; DIMERIZATION; ESTABLISHES; SEQUENCE	We investigated the ability of highly purified recombinant platelet-derived growth factor (PDGF) AB to interact with the products of alpha and beta-receptor genes expressed in cells independently or concurrently. Although PDGF-AB lacked any detectable ability to bind or activate beta-receptors in cells expressing only this receptor, efficient beta-receptor activation by this ligand was readily observed in cells coexpressing alpha-platelet-derived growth factor receptors (alpha-PDGFRs). Beta-receptor activation induced by PDGF-AB was shown to be dependent upon in vivo physical association of this receptor with alpha-PDGFRs. Moreover, cross-linking analysis established the existence of PDGF-AB-induced beta-PDGFR dimers in vivo. All of these findings argue that initial PDGF-AB interaction with the alpha-PDGFR induces conformational changes in the ligand or receptor that facilitates efficient recruitment of beta-PDGFR by this PDGF isoform.	NCI,CELLULAR & MOLEC BIOL LAB,BLDG 37,RM 1E24,BETHESDA,MD 20892; AMGEN INC,THOUSAND OAKS,CA 91320	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Amgen								BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BOWENPOPE DF, 1985, CONTROL ANIMAL CELL, V1, P281; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; ESCOBEDO JA, 1988, SCIENCE, V240, P1532, DOI 10.1126/science.2836953; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HEIDARAN MA, 1990, J BIOL CHEM, V265, P18741; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KANAKARAJ P, 1991, BIOCHEMISTRY-US, V30, P1761, DOI 10.1021/bi00221a005; LEITZEL K, 1991, CANCER RES, V51, P4149; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI T, 1989, P NATL ACAD SCI USA, V86, P8314, DOI 10.1073/pnas.86.21.8314; RAO CD, 1986, P NATL ACAD SCI USA, V83, P2392, DOI 10.1073/pnas.83.8.2392; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; STROOBANT P, 1984, EMBO J, V3, P2933; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	31	70	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20232	20237						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657917				2022-12-25	WOS:A1991GM03900055
J	CORBETT, AH; ZECHIEDRICH, EL; LLOYD, RS; OSHEROFF, N				CORBETT, AH; ZECHIEDRICH, EL; LLOYD, RS; OSHEROFF, N			INHIBITION OF EUKARYOTIC TOPOISOMERASE-II BY ULTRAVIOLET-INDUCED CYCLOBUTANE PYRIMIDINE DIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 ENDONUCLEASE-V; CLEAVAGE RELIGATION REACTION; STRAND DNA CLEAVAGE; DROSOPHILA-MELANOGASTER; ESCHERICHIA-COLI; CALF THYMUS; MITOTIC CHROMOSOMES; MAMMALIAN-CELLS; ACTIVE FORM; REPAIR	The effects of short wave ultraviolet (UV)-induced DNA lesions on the catalytic activity of Drosophila melanogaster topoisomerase II were investigated. The presence of these photoproducts impaired the enzyme's ability to relax negatively supercoiled pBR322 plasmid molecules. As determined by DNA photolyase-catalyzed photoreactivation experiments, enzyme inhibition was due to the presence of cyclobutane pyrimidine dimers in the DNA. When 10-20 cyclobutane dimers were present per plasmid, the initial velocity of topoisomerase II-catalyzed DNA relaxation was inhibited approximately 50%. Decreased relaxation activity correlated with an inhibition of the DNA strand passage step of the enzyme's catalytic cycle. In contrast, UV-induced photoproducts did not alter the prestrand passage DNA cleavage/religation equilibrium of topoisomerase II either in the absence or presence of antineoplastic agents. Results of the present study demonstrate that the repair of cyclobutane pyrimidine dimers is important for the efficient catalytic function of topoisomerase II.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,621 LIGHT HALL,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University			Corbett, Anita/AAH-6106-2021; Zechiedrich, Elizabeth Lynn/S-4720-2019	Corbett, Anita/0000-0002-0461-6895; Lloyd, R. Stephen/0000-0001-7273-372X; Zechiedrich, Lynn/0000-0003-0533-1637	NIEHS NIH HHS [ES-00267, ES-04091] Funding Source: Medline; NIGMS NIH HHS [GM-33944] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES004091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; ANDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P6237, DOI 10.1021/bi00441a015; [Anonymous], 1985, DNA REPAIR; BAE YS, 1988, P NATL ACAD SCI USA, V85, P2076, DOI 10.1073/pnas.85.7.2076; BANERJEE SK, 1990, J BACTERIOL, V172, P2105, DOI 10.1128/jb.172.4.2105-2112.1990; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; BOHR VA, 1988, J CELL SCI, V90, P175; CHRISTMAN MF, 1988, CELL, V55, P413, DOI 10.1016/0092-8674(88)90027-X; CLEAVER JE, 1987, BIOESSAYS, V6, P122, DOI 10.1002/bies.950060307; COLLINS A, 1979, NUCLEIC ACIDS RES, V7, P1311, DOI 10.1093/nar/7.5.1311; DEGRUIJL FR, 1980, J THEOR BIOL, V83, P487, DOI 10.1016/0022-5193(80)90055-7; DILLEHAY LE, 1989, MUTAT RES, V215, P15, DOI 10.1016/0027-5107(89)90213-3; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DOWD DR, 1990, J BIOL CHEM, V265, P3424; DOWNES CS, 1988, BIOESSAYS, V8, P179, DOI 10.1002/bies.950080602; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; FRANKLIN WA, 1986, MUTAT RES, V165, P1, DOI 10.1016/0167-8817(86)90002-7; GALE KC, 1990, BIOCHEMISTRY-US, V29, P9538, DOI 10.1021/bi00493a007; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; GRUSKIN EA, 1986, J BIOL CHEM, V261, P9607; HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475; HANAWALT PC, 1986, TRENDS GENET, V2, P124, DOI 10.1016/0168-9525(86)90201-5; HICKSON ID, 1990, INT J RADIAT BIOL, V58, P561, DOI 10.1080/09553009014551921; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Jagger J., 1976, PHOTOCHEM PHOTOBIOL, P147; KIM RA, 1989, CELL, V57, P975, DOI 10.1016/0092-8674(89)90336-X; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LLOYD RS, 1980, NUCLEIC ACIDS RES, V8, P5113, DOI 10.1093/nar/8.21.5113; LOCK RB, 1987, ANTI-CANCER DRUG DES, V2, P151; MANAITIS T, 1982, MOL CLONING LABORATO, P86; MATTERN MR, 1982, BIOCHIM BIOPHYS ACTA, V697, P6, DOI 10.1016/0167-4781(82)90038-0; MULLER MT, 1988, BIOCHEMISTRY-US, V27, P8369, DOI 10.1021/bi00422a012; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P4303, DOI 10.1021/bi00388a018; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P6402, DOI 10.1021/bi00394a015; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; OSHEROFF N, 1983, MECHANISMS DNA REPLI, P55; Patrick MH., 1976, PHOTOCHEM PHOTOBIOL, V2, P35, DOI [10.1016/B978-0-12-734602-1.50008-3, DOI 10.1016/B978-0-12-734602-1.50008-3]; PAYNE G, 1987, BIOCHEMISTRY-US, V26, P7121, DOI 10.1021/bi00396a038; PEDRINI AM, 1983, P NATL ACAD SCI-BIOL, V80, P1787, DOI 10.1073/pnas.80.7.1787; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROBINSON MJ, 1990, BIOCHEMISTRY-US, V29, P2511, DOI 10.1021/bi00462a012; ROSE D, 1990, CELL, V60, P1009, DOI 10.1016/0092-8674(90)90349-J; ROSENBERG M, 1990, J BIOL CHEM, V265, P20641; SANDER M, 1987, J MOL BIOL, V194, P219, DOI 10.1016/0022-2836(87)90370-6; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SANDER M, 1983, J BIOL CHEM, V258, P8421; SAUERBIER W, 1978, ANNU REV GENET, V12, P329, DOI 10.1146/annurev.ge.12.120178.001553; SCHOMBURG U, 1986, EUR J BIOCHEM, V160, P451, DOI 10.1111/j.1432-1033.1986.tb10061.x; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; STRAUSS BS, 1985, CANCER SURV, V4, P493; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P1624, DOI 10.1021/bi00458a038; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; UEMURA T, 1986, EMBO J, V5, P1003, DOI 10.1002/j.1460-2075.1986.tb04315.x; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; ZWELLING L A, 1989, Hematologic Pathology, V3, P101	68	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19666	19671						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655791				2022-12-25	WOS:A1991GK66700078
J	SCHNEIDER, R; SCHWEIGER, M				SCHNEIDER, R; SCHWEIGER, M			A NOVEL MODULAR MOSAIC OF CELL-ADHESION MOTIFS IN THE EXTRACELLULAR DOMAINS OF THE NEUROGENIC TRK AND TRKB TYROSINE KINASE RECEPTORS	ONCOGENE			English	Article							IMMUNOGLOBULIN SUPERFAMILY; PROTEIN; GENE; EXPRESSION; SEQUENCES; ONCOGENE; PROTOONCOGENE; ACTIVATION; CONTAINS; FAMILY	The extracellular domains of the human trk proto-oncogene and the closely homologous murine trkB share two highly conserved regions as well as several invariant cysteines which are supposed to be important for ligand recognition. Detailed comparative sequence analyses have now revealed the presence of a novel combination of distinct cell adhesion motifs corresponding precisely with these conserved regions. The N-terminal part consists of an array of three tandem leucine-rich motifs of 24 amino acids which is flanked by two distinct cysteine clusters. Significantly homologous structural features are found in the toll gene product of Drosophila, a transmembrane protein mediating specific cell adhesion events involved in the dorsoventral embryonic pattern formation. Directly adjacent to these structures we additionally identified two repeats of the immunoglobulin-like C2 type, which are significantly similar to repeats found in the neural cell adhesion molecules (N-CAMs) and in the platelet-derived growth factor receptor (PDGFR)-like tyrosine kinase receptor family. Our findings indicate that the trk/trkB protein tyrosine kinase receptors are involved in the transmembrane signalling of growth factor binding as well as of specific cell adhesion events during neuronal development. Additionally, we propose that the specifically expressed truncated forms of the trkB receptor, lacking the tyrosine kinase domain, are functioning as neural cell adhesion molecules. The knowledge of this domain structure will facilitate the elucidation of the molecular reasons why alterations in the extracellular region lead to oncogenic activation of the human trk proto-oncogene, which is a major cause of papillary thyroid carcinoma.			SCHNEIDER, R (corresponding author), UNIV INNSBRUCK,INST BIOCHEM,PETER MAYR STR 1A,A-6020 INNSBRUCK,AUSTRIA.							Barton D E, 1988, Oncogene Res, V3, P323; BONGARZONE I, 1989, ONCOGENE, V4, P1457; COULIER F, 1990, MOL CELL BIOL, V10, P4202, DOI 10.1128/MCB.10.8.4202; COULIER F, 1989, MOL CELL BIOL, V9, P15, DOI 10.1128/MCB.9.1.15; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERZOG H, 1989, P NATL ACAD SCI USA, V86, P3514, DOI 10.1073/pnas.86.10.3514; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; HUNDKAPILLER T, 1988, ADV IMMUNOL, V44, P1; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MIOZZO M, 1990, ONCOGENE, V5, P1411; REBSTOCK S, 1990, J BIOL CHEM, V265, P7872; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SCHNEIDER R, 1991, FEBS LETT, V283, P203, DOI 10.1016/0014-5793(91)80588-T; SCHNEIDER R, 1988, EMBO J, V7, P4151, DOI 10.1002/j.1460-2075.1988.tb03310.x; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; WILLIAMS AF, 1987, J EXP MED, V165, P368, DOI 10.1084/jem.165.2.368; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	33	180	188	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1991	6	10					1807	1811						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656363				2022-12-25	WOS:A1991GX11800013
J	CAUGHEY, B; RAYMOND, GJ				CAUGHEY, B; RAYMOND, GJ			THE SCRAPIE-ASSOCIATED FORM OF PRP IS MADE FROM A CELL-SURFACE PRECURSOR THAT IS BOTH PROTEASE-SENSITIVE AND PHOSPHOLIPASE-SENSITIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB DISEASE; NEURO-BLASTOMA CELLS; GERSTMANN-STRAUSSLER SYNDROME; PRION-PROTEIN; FIBRIL PROTEIN; INCUBATION PERIOD; EUKARYOTIC CELLS; CULTURED-CELLS; MESSENGER-RNA; MOUSE-BRAIN	A common feature of scrapie and related transmissible spongiform encephalopathies is the accumulation of an abnormal protease-resistant form of PrP which may be the major component of the infectious agent. While it is known that both the normal (protease-sensitive) PrP and protease-resistant PrP are encoded by the same endogenous gene, the nature of the disease-associated modification of PrP is not understood. To study the cellular events leading to the formation of protease-resistant PrP, we have compared its biosynthesis to that of its normal isoform in scrapie-infected mouse neuroblastoma cells. In pulse-chase labeling experiments, the protease-resistant PrP was synthesized and degraded much more slowly than the normal PrP, suggesting that protease-resistant PrP is made from a protease-sensitive precursor. More significantly, we found that the precursor of protease-resistant PrP was eliminated from intact cells by treatments with phosphatidylinositol-specific phospholipase C and trypsin. This demonstrated that, unlike the protease-resistant PrP itself, the precursor is phospholipase- and protease-sensitive and at least transiently found on the cell surface. By these criteria, the precursor of protease-resistant PrP is indistinguishable from the normal PrP isoform. These results indicate that the conversion of PrP to the protease- and phospholipase-resistant state is a post-translational event that occurs after the precursor reaches the cell surface.			CAUGHEY, B (corresponding author), NIAID,PERSISTENT VIRAL DIS LAB,ROCKY MT LABS,HAMILTON,MT 59840, USA.							ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BENDHEIM PE, 1985, P NATL ACAD SCI USA, V82, P997, DOI 10.1073/pnas.82.4.997; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BROWN P, 1986, NEW ENGL J MED, V314, P547, DOI 10.1056/NEJM198602273140904; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CAUGHEY B, 1988, J GEN VIROL, V69, P711, DOI 10.1099/0022-1317-69-3-711; Caughey B, 1991, Curr Top Microbiol Immunol, V172, P93; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; CHO HJ, 1986, J GEN VIROL, V67, P243, DOI 10.1099/0022-1317-67-2-243; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GABIZON R, 1990, BIOCHEM J, V266, P1; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskey R A, 1980, Methods Enzymol, V65, P363; LOW MG, 1988, J IMMUNOL METHODS, V113, P101, DOI 10.1016/0022-1759(88)90386-9; MANUELIDIS L, 1985, P NATL ACAD SCI USA, V82, P4263, DOI 10.1073/pnas.82.12.4263; MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MERZ PA, 1987, J VIROL, V61, P42, DOI 10.1128/JVI.61.1.42-49.1987; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PATTISON IH, 1967, VET REC, V80, P2, DOI 10.1136/vr.80.1.2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; ROBERTS GW, 1986, NEW ENGL J MED, V315, P1231; RUBENSTEIN R, 1986, J GEN VIROL, V67, P671, DOI 10.1099/0022-1317-67-4-671; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; THILO L, 1985, BIOCHIM BIOPHYS ACTA, V822, P243, DOI 10.1016/0304-4157(85)90010-3; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WILEY CA, 1987, LAB INVEST, V57, P646; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0	56	554	568	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18217	18223						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680859				2022-12-25	WOS:A1991GG55300076
J	OLSEN, J; LAUSTSEN, L; KARNSTROM, U; SJOSTROM, H; NOREN, O				OLSEN, J; LAUSTSEN, L; KARNSTROM, U; SJOSTROM, H; NOREN, O			TISSUE-SPECIFIC INTERACTIONS BETWEEN NUCLEAR PROTEINS AND THE AMINOPEPTIDASE-N PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; DNA-BINDING; TRANSCRIPTIONAL REGULATION; TATA BOX; EUKARYOTIC TRANSCRIPTION; INVITRO TRANSCRIPTION; MAMMALIAN-CELLS; TRANSGENIC MICE; GENE-EXPRESSION; ELEMENTS	Aminopeptidase N/CD13 is a metallopeptidase found in many tissues. Aminopeptidase N activity is high in the small intestinal mucosa, moderate in the liver, and low in the spleen. Using DNase I footprinting and electrophoretic mobility shift assays with nuclear extracts from these tissues, three cis elements (DF, LF-B1, UF) were identified in the aminopeptidase N promoter. The DF region (-53 to -30) interacts with the ubiquitously expressed transcription factor Sp1. The LF-B1 region (-85 to -58) interacts with the liver transcription factor LF-B1 (HNF-1) which was detected as well in nuclei from small intestinal mucosa. The UF region (-112 to -90) interacts with nuclear factors which seem to be expressed differentially in the liver and the small intestine. Transfection of promoter deletions into HepG2 cells showed that the LF-B1 region is necessary for high expression of the aminopeptidase N gene in liver cells. LF-B1 could not be detected in spleen nuclei. In accordance with this, RNA analysis demonstrated that the aminopeptidase N promoter operating in the small intestine and in the liver is inactive in the spleen. In this tissue initiation of transcription from the aminopeptidase N gene occurs from an upstream promoter.			OLSEN, J (corresponding author), UNIV COPENHAGEN,PANUM INST,DEPT BIOCHEM C,BLEGDAMSVEJ 3,DK-2200 COPENHAGEN,DENMARK.		Olsen, Jørgen/K-5355-2019	Olsen, Jørgen/0000-0003-1974-6446				BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; CORTESE R, 1990, CELL BIOL INT REP S, V14, pS2; FINNEY M, 1990, CELL, V60, P5, DOI 10.1016/0092-8674(90)90708-M; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GIL G, 1988, J BIOL CHEM, V263, P19009; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; JACKSON PD, 1989, GENE DEV, V3, P1860, DOI 10.1101/gad.3.12a.1860; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOOPMAN P, 1989, GENE DEV, V3, P16, DOI 10.1101/gad.3.1.16; LEFF T, 1989, J BIOL CHEM, V264, P16132; LICHTSTEINER S, 1989, CELL, V57, P1179, DOI 10.1016/0092-8674(89)90055-X; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MENDELZON D, 1990, NUCLEIC ACIDS RES, V18, P5717, DOI 10.1093/nar/18.19.5717; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; NOREN O, 1989, FEBS LETT, V259, P107, DOI 10.1016/0014-5793(89)81506-6; OCHOA A, 1989, NUCLEIC ACIDS RES, V17, P119, DOI 10.1093/nar/17.1.119; OGAMI K, 1990, J BIOL CHEM, V265, P9808; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; OLSEN J, 1989, FEBS LETT, V251, P275, DOI 10.1016/0014-5793(89)81470-X; OSBORNE TF, 1987, P NATL ACAD SCI USA, V84, P3614, DOI 10.1073/pnas.84.11.3614; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Sambrook J, 1989, MOL CLONING LABORATO; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SHAPIRO LH, 1991, J BIOL CHEM, V266, P11999; TYNER AL, 1990, J CELL BIOL, V110, P915, DOI 10.1083/jcb.110.4.915; [No title captured]	51	58	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18089	18096						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680856				2022-12-25	WOS:A1991GG55300059
J	HAGEN, TM; BAI, CL; JONES, DP				HAGEN, TM; BAI, CL; JONES, DP			STIMULATION OF GLUTATHIONE ABSORPTION IN RAT SMALL-INTESTINE BY ALPHA-ADRENERGIC AGONISTS	FASEB JOURNAL			English	Article						GLUTATHIONE; PHENYLEPHRINE; INTESTINAL ABSORPTION; ANTIOXIDANTS; DIETARY	BRUSH-BORDER MEMBRANES; DIETARY GLUTATHIONE; EXOGENOUS GLUTATHIONE; CELLULAR GLUTATHIONE; REDUCED GLUTATHIONE; OXIDATIVE INJURY; TRANSPORT; CELLS; BINDING; METABOLISM	The alpha-adrenergic agonist, phenylephrine (1.6-mu-M), caused a threefold stimulation of glutathione (GSH) transport from the lumen into the vasculature in isolated, vascularly perfused rat small intestine. Stimulation of GSH transport by phenylephrine was blocked by the alpha-adrenergic antagonists, prazosin or phentolamine. Norepinephrine and epinephrine (both alpha and beta-agonists) also stimulated GSH absorption but not to the same extent as phenylephrine. Isoproterenol, a strict beta-adrenergic agonist, had no effect on the rate of GSH absorption. Under physiological luminal GSH concentrations, phenylephrine stimulated GSH efflux from the lumen, accumulation in the intestinal mucosa, and transport into the mesenteric vasculature. Phenylephrine did not stimulate the transport of polyethylene glycol, a high molecular weight molecule, and stimulated uptake of cysteine and glycine by 30%. This suggests that the effect of phenylephrine on GSH transport is not due to enhanced bulk flow through paracellular pathways. Studies with isolated small intestinal epithelial cells showed that phenylephrine also stimulated the release of GSH from the cells. Oral administration of phenylephrine with GSH caused a two- to fivefold transient increase in plasma GSH concentrations in rats. Phenylephrine alone or with the amino acid constituents of GSH caused no increase in plasma GSH concentration. Thus, absorption of dietary GSH is under hormonal regulation. The physiological importance of this regulation is not known, although such regulation may function to control utilization of dietary GSH for detoxication and may have therapeutic benefits for individuals with deficient GSH or increased risk of oxidative or chemically induced injury.	EMORY UNIV, SCH MED, DEPT BIOCHEM, ATLANTA, GA 30322 USA; EMORY UNIV, SCH MED, WINSHIP CANC CTR, ATLANTA, GA 30322 USA	Emory University; Emory University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039968] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 39968] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; BAI C, 1991, FASEB J, V5, pA1489; BASTIDAS JA, 1989, J SURG RES, V46, P484, DOI 10.1016/0022-4804(89)90165-0; BEUTLER E, 1985, J LAB CLIN MED, V105, P581; BUHL R, 1989, LANCET, V2, P1294; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHANG EB, 1983, AM J PHYSIOL, V244, pG76, DOI 10.1152/ajpgi.1983.244.1.G76; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; COMPORTI M, 1985, LAB INVEST, V53, P599; CORNELL JS, 1976, P NATL ACAD SCI USA, V73, P420, DOI 10.1073/pnas.73.2.420; COTGREAVE IA, 1987, BIOCHEM PHARMACOL, V36, P2899, DOI 10.1016/0006-2952(87)90200-0; COTTERELL DJ, 1984, BIOCHEM PHARMACOL, V33, P751, DOI 10.1016/0006-2952(84)90458-1; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; DYKE RMV, 1989, GASTROINTESTINAL DIS, P1062; FURUKAWA T, 1987, MECH AGEING DEV, V38, P107, DOI 10.1016/0047-6374(87)90071-6; GRAFSTROM R, 1979, MED BIOL, V57, P287; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HAGEN TM, 1990, AM J PHYSIOL, V259, pG524; HAGEN TM, 1988, KIDNEY INT, V34, P74, DOI 10.1038/ki.1988.147; HAGEN TM, 1986, BIOCHEM PHARMACOL, V35, P4537, DOI 10.1016/0006-2952(86)90776-8; HAGEN TM, 1987, AM J PHYSIOL, V252, pG607, DOI 10.1152/ajpgi.1987.252.5.G607; HAGEN TM, 1990, AM J PHYSIOL, V259, pG530, DOI 10.1152/ajpgi.1990.259.4.G530; HAGEN TM, 1987, ADV BIOSCI, V65, P107; HAUSSINGER D, 1987, EUR J BIOCHEM, V163, P197, DOI 10.1111/j.1432-1033.1987.tb10755.x; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; JERNSTROM B, 1982, CARCINOGENESIS, V3, P861, DOI 10.1093/carcin/3.8.861; KOWALSKI DP, 1990, J NUTR, V120, P1115, DOI 10.1093/jn/120.9.1115; LASH LH, 1986, P NATL ACAD SCI USA, V83, P4641, DOI 10.1073/pnas.83.13.4641; LASH LH, 1984, AM J PHYSIOL, V247, pG394, DOI 10.1152/ajpgi.1984.247.4.G394; MERRILL AH, 1989, BIOCHEMISTRY-US, V28, P3138, DOI 10.1021/bi00434a004; NAGANUMA A, 1990, BIOCHEM PHARMACOL, V40, P693; NOBILE MT, 1989, TUMORI, V75, P257, DOI 10.1177/030089168907500313; ORIANA S, 1987, TUMORI, V73, P337, DOI 10.1177/030089168707300403; ORRENIUS S, 1984, TRENDS PHARMACOL SCI, V5, P432, DOI 10.1016/0165-6147(84)90495-4; PALLER MS, 1986, KIDNEY INT, V29, P1162, DOI 10.1038/ki.1986.122; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; REVESZ L, 1983, FUNCTIONS GLUTATHION, P163; SCHASTEEN CS, 1983, BIOCHEM BIOPH RES CO, V112, P564, DOI 10.1016/0006-291X(83)91501-2; SIES H, 1985, BIOCHEM J, V226, P545, DOI 10.1042/bj2260545; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; TIMMERMANS PBMWM, 1983, N-S ARCH PHARMACOL, V324, P239, DOI 10.1007/BF00502618; VINCENZINI MT, 1989, BIOCHIM BIOPHYS ACTA, V987, P29, DOI 10.1016/0005-2736(89)90451-3; VINCENZINI MT, 1988, BIOCHIM BIOPHYS ACTA, V942, P107, DOI 10.1016/0005-2736(88)90279-9; WEINER N, 1980, PHARMACOL BASIS THER, P138; YANG JG, 1987, J BIOL CHEM, V262, P13372	45	18	18	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	1991	5	12					2721	2727		10.1096/fasebj.5.12.1680764	http://dx.doi.org/10.1096/fasebj.5.12.1680764			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GE811	1680764				2022-12-25	WOS:A1991GE81100014
J	POTEMPSKA, A; STYLES, J; MEHTA, P; KIM, KS; MILLER, DL				POTEMPSKA, A; STYLES, J; MEHTA, P; KIM, KS; MILLER, DL			PURIFICATION AND TISSUE-LEVEL OF THE BETA-AMYLOID PEPTIDE PRECURSOR OF RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE NEXIN-II; ALZHEIMERS-DISEASE; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; SOLUBLE DERIVATIVES; PROTEINS; IDENTIFICATION; GENE; BIOGENESIS; ANTISERA	The beta-amyloid peptide precursor (beta-APP) exists in brain tissue as a membrane-associated protein extractable with 1% Triton X-100. Beta-APP has been purified to near homogeneity by the following procedures: 1) anion exchange chromatography, 2) affinity chromatography on heparin agarose, and 3) immunoaffinity adsorption on matrix-bound antibodies directed to a synthetic peptide corresponding to the last 24 amino acids of the cDNA derived amino acid sequence of beta-APP. Conditions were chosen to minimize denaturation of the protein. The identity of the protein was confirmed by its immunoreactivity with antisera directed to five subsequences derived from the cDNA sequence. The amino-terminal sequence of beta-APP was found to be Leu-Glu-Val-Pro-Thr-Asp-Gly-Asn-Ala-Gly-Leu-Leu-Ala-Glu-Pro, which commences at residue 18 of the cDNA-derived primary structure. The procedure resulted in a 2000-fold purification of beta-APP. The purified protein migrated on polyacrylamide gels as a doublet of apparent molecular mass 100-120 kDa, although the predicted molecular mass of its constituent amino acids is 76 kDa. Beta-APP clearly behaves anomalously in gel electrophoresis. The beta-APP content of rat brain amounted to 46-mu-g/g tissue. The half-life of the protein was calculated to be about 10 h, which is 30 times as long as that observed by others in transfected PC-12 cells. We conclude that transfected cell systems may not be adequate models for beta-APP processing.			POTEMPSKA, A (corresponding author), NEW YORK STATE INST BASIC RES DEV DISABILITIES,STATEN ISL,NY 10314, USA.				NINDS NIH HHS [NS25231] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025231] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUTILIOGAMBETTI L, 1988, FEBS LETT, V241, P94, DOI 10.1016/0014-5793(88)81038-X; BODMER S, 1990, BIOCHEM BIOPH RES CO, V171, P890, DOI 10.1016/0006-291X(90)91229-L; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; DREYER W, 1967, METHOD ENZYMOL, V2, P32; DUNLOP DS, 1983, HDB NEUROCHEMISTRY, V1, P25; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; HALL C, 1981, BIOCHEM J, V196, P327, DOI 10.1042/bj1960327; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDO H, 1990, BIOCHEM BIOPH RES CO, V167, P716, DOI 10.1016/0006-291X(90)92084-D; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KOO EH, 1990, P NATL ACAD SCI US; KOWAL R, 1980, ANAL BIOCHEM, V102, P72, DOI 10.1016/0003-2697(80)90319-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MITA S, 1989, AM J PATHOL, V134, P1253; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SCHUBERT D, 1988, SCIENCE, V241, P223, DOI 10.1126/science.2968652; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SHELTON ER, 1990, J NEUROCHEM, V55, P60, DOI 10.1111/j.1471-4159.1990.tb08821.x; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SINHA S, 1990, J BIOL CHEM, V265, P8983; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TAKIO K, 1989, BIOCHEM BIOPH RES CO, V160, P1296, DOI 10.1016/S0006-291X(89)80144-5; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; TANAKA S, 1988, BIOCHEM BIOPH RES CO, V157, P472, DOI 10.1016/S0006-291X(88)80273-0; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANNOSTRAND WE, 1987, J BIOL CHEM, V262, P8508; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WOLF D, 1990, EMBO J, V9, P2079, DOI 10.1002/j.1460-2075.1990.tb07375.x	45	46	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8464	8469						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673681				2022-12-25	WOS:A1991FK44100076
J	EKI, T; HURWITZ, J				EKI, T; HURWITZ, J			INFLUENCE OF POLY(ADP-RIBOSE) POLYMERASE ON THE ENZYMATIC-SYNTHESIS OF SV40 DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; LARGE TUMOR-ANTIGEN; SIMIAN VIRUS-40 ORIGIN; LARGE T-ANTIGEN; REPLICATION INVITRO; HELICASE ACTIVITY; TOPOISOMERASE-I; CDNA SEQUENCE; PROTEIN; ALPHA	The influence of poly(ADP-ribose) polymerase (PARP) on the replication of DNA containing the SV40 origin of replication has been examined. Extensive replication of SV40 DNA can be carried out in the presence of T antigen, topoisomerase I, the multimeric human single strand DNA-binding protein (HSSB), and DNA polymerase alpha-DNA primase (pol-alpha-primase) complex (the monopolymerase system). In the monopolymerase system, both small products (Okazaki fragments), arising from lagging strand synthesis, and long products, arising from leading strand synthesis, are formed. The synthesis of long products requires the presence of relatively high levels of pol-alpha-primase complex. In the presence of PARP, the synthesis of long products was blocked and only small Okazaki fragments accumulated, arising from the replication of the lagging strand template. The inhibition of leading strand synthesis by PARP can be effectively reversed by supplementing the monopolymerase system with the multimeric activator 1 protein (A1), the proliferating cell nuclear antigen (PCNA) and PCNA-dependent DNA polymerase-delta (the dipolymerase system). The inhibition of leading strand synthesis in the monopolymerase system was caused by the binding of PARP to the ends of DNA chains, which blocked their further extension by pol-alpha. The selective accumulation of Okazaki fragments was shown to be due to the coupled synthesis of primers by DNA primase and their immediate extension by pol-alpha complexed to primase. PARP had little effect on this coupled reaction, but did inhibit the subsequent elongation of products, presumably after pol-alpha dissociated from the 3'-end of the DNA fragments. PARP inhibited several other enzymatic reactions which required free ends of DNA chains. PARP inhibited exonuclease III, DNA ligase, the 5' to 3' exonuclease, and the elongation of primed DNA templates by pol-alpha. In contrast, PARP only partly competed with the elongation of primed DNA templates by the pol-delta elongation system which required SSB, A1, and PCNA. These results suggest that the binding of PARP at the ends of nascent DNA chains can be displaced by the binding of A1 and PCNA to primer ends. HSSB can be poly(ADP-ribosylated) in vivo as well as in vitro. However, the selective effect of PARP in blocking leading strand synthesis in the monopolymerase system was shown to depend primarily on its DNA binding property rather than on its ability to synthesize poly (ADP-ribose).			EKI, T (corresponding author), MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034559, R37GM034559] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34559] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BOULIKAS T, 1990, J BIOL CHEM, V265, P14638; BULLOCK PA, 1989, P NATL ACAD SCI USA, V86, P3944, DOI 10.1073/pnas.86.11.3944; BURTSCHER HJ, 1986, ANAL BIOCHEM, V152, P285, DOI 10.1016/0003-2697(86)90410-0; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; FERRO AM, 1983, J BIOL CHEM, V258, P6000; Flint S. J, 1981, DNA TUMOR VIRUSES; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; JONGSTRABILEN J, 1983, EUR J BIOCHEM, V136, P391, DOI 10.1111/j.1432-1033.1983.tb07754.x; JUMP DB, 1979, BIOCHEMISTRY-US, V18, P983, DOI 10.1021/bi00573a008; KASID UN, 1989, J BIOL CHEM, V264, P18687; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KUROSAKI T, 1987, J BIOL CHEM, V262, P15990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1988, P NATL ACAD SCI USA, V85, P9469, DOI 10.1073/pnas.85.24.9469; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1989, P NATL ACAD SCI USA, V86, P4877, DOI 10.1073/pnas.86.13.4877; LEE SH, 1991, IN PRESS J BIOL CHEM, V266; MAKOWSKE M, 1989, J BIOL CHEM, V264, P16155; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; MURCIA JM, 1989, J MOL BIOL, V210, P229; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PINES J, 1990, New Biologist, V2, P389; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; Purnell MR, 1980, BIOCHEM SOC T, V8, P215, DOI 10.1042/bst0080215; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SASTRY SS, 1989, BIOCHEMISTRY-US, V28, P5670, DOI 10.1021/bi00439a050; SCOVASSI AI, 1984, J BIOL CHEM, V259, P973; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; TANAKA Y, 1979, J BIOL CHEM, V254, P2433; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; USHIRO H, 1987, J BIOL CHEM, V262, P2352; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9752; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; YAGURA T, 1982, J BIOL CHEM, V257, P1121; YAMADA M, 1971, ARCH BIOCHEM BIOPHYS, V146, P579, DOI 10.1016/0003-9861(71)90164-0; YOSHIHARA K, 1981, J BIOL CHEM, V256, P3471; YOSHIHARA K, 1985, BIOCHEM BIOPH RES CO, V128, P61, DOI 10.1016/0006-291X(85)91644-4; ZAHRADKA P, 1984, EUR J BIOCHEM, V142, P503, DOI 10.1111/j.1432-1033.1984.tb08314.x	59	61	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3087	3100						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1671570				2022-12-25	WOS:A1991EX60000064
J	LEPAGELEZIN, A; JOSEPHBRAVO, P; DEVILLIERS, G; BENEDETTI, L; LAUNAY, JM; GOMEZ, S; COHEN, P				LEPAGELEZIN, A; JOSEPHBRAVO, P; DEVILLIERS, G; BENEDETTI, L; LAUNAY, JM; GOMEZ, S; COHEN, P			PROSOMATOSTATIN IS PROCESSED IN THE GOLGI-APPARATUS OF RAT NEURAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULES; SOMATOSTATIN-28 CONVERTASE; MULTIPLE FORMS; IMMUNOREACTIVE SOMATOSTATIN; MEDIAN-EMINENCE; AMINO TERMINUS; BRAIN CORTEX; PRECURSORS; HYPOTHALAMUS; PITUITARY	Proteolytic processing of somatostatin precursor produces several peptides including somatostatin-14 (S-14), somatostatin-28 (S-28), and somatostatin-28 (1-12) (S-28(1-12)). The subcellular sites at which these cleavages occur were identified by quantitative evaluation of these products in enriched fractions of the biosynthetic secretory apparatus of rat cortical or hypothalamic cells. Each of the major cellular compartments was obtained by discontinuous gradient centrifugation and was characterized both by specific enzyme markers and electron microscopy. The prosomatostatin-derived fragments were measured by radioimmunoassay after chromatographic separation. Two specific antibodies were used, allowing the identification of either S-28(1-12) or S-14 which results from peptide bond hydrolysis at a monobasic (arginine) and a dibasic (Arg-Lys) cleavage site, respectively. These antibodies also revealed prosomatostatin-derived forms containing at their COOH terminus the corresponding dodeca- and tetradecapeptide sequences. Whereas the reticulum-enriched fractions contained the highest levels of prosomatostatin, the proportion of precurssor was significantly lower in the Golgi apparatus. In the latter fraction, other processed forms were also present, i.e. S-14 and S-28(1-12) together with the NH2-terminal domain (1-76) of prosomatostatin (pro-S(1-76)). Inhibition of the intracelular transport either by monensin or by preincubation at reduced temperature resulted in an increase of prosomatostatin-derived peptides in the Golgi-enriched fractions. Finally, immunogold labeling using antibodies raised against S-28(1-12) and S-14 epitopes revealed the presence of these forms almost exclusively in the Golgi-enriched fraction mainly at the surface of saccules and vesicles. Together these data demonstrate that in rat neural cells, prosomatostatin proteolytic processing at both monobasic and dibasic sites is initiated at the level of the Golgi apparatus.	UNIV PARIS 06, NEUROBIOCHIM CELLULAIRE & MOLEC GRP, CNRS, UNITE RECH 554, F-75006 PARIS, FRANCE; CNRS, INST JACQUES MONOD, F-75252 PARIS 05, FRANCE; HOP ST LOUIS, ASSOC CL BERNARD NEUROCHIM COMMUN CELLULAIRES, FORMAT RECH, F-75475 PARIS 10, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite			Gomez, Sophie/N-9888-2017					ARON DC, 1986, ENDOCRINOLOGY, V118, P218, DOI 10.1210/endo-118-1-218; ARON DC, 1984, BIOCHEM BIOPH RES CO, V124, P450, DOI 10.1016/0006-291X(84)91574-2; Barnea A, 1986, Methods Enzymol, V124, P254; BEINFELD MC, 1989, J BIOL CHEM, V264, P4460; BENOIT R, 1982, BIOCHEM BIOPH RES CO, V107, P944, DOI 10.1016/0006-291X(82)90614-3; BIRKETT SD, 1983, ARCH BIOCHEM BIOPHYS, V225, P430, DOI 10.1016/0003-9861(83)90050-4; BOURDAIS J, 1990, BIOCHEM BIOPH RES CO, V170, P1263, DOI 10.1016/0006-291X(90)90530-Z; BRADFORD HF, 1972, METHODS NEUROCHEMIST, P155; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; CAMIER M, 1985, BRAIN RES, V334, P1, DOI 10.1016/0006-8993(85)90560-8; COHEN P, 1987, BIOCHIMIE, V69, P87, DOI 10.1016/0300-9084(87)90239-2; COHEN P, 1989, PEPTIDE HORMONES PRO, P83; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DEDUVE C, 1962, ADV ENZYMOL REL S BI, V24, P291; DUNIA I, 1987, J CELL BIOL, V105, P1679, DOI 10.1083/jcb.105.4.1679; ELDE R, 1988, ADV EXPT MED BIOL, P167; EPELBAUM J, 1977, ENDOCRINOLOGY, V101, P1495, DOI 10.1210/endo-101-5-1495; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; FLEISCHER B, 1970, Biochimica et Biophysica Acta, V219, P301, DOI 10.1016/0005-2736(70)90209-9; GANEM YJ, 1989, BIOGENIC AMINES, V6, P495; GLEMBOTSKI CC, 1981, J BIOL CHEM, V256, P7433; GLUSCHANKOF P, 1985, BIOCHEM BIOPH RES CO, V128, P1051, DOI 10.1016/0006-291X(85)91046-0; GLUSCHANKOF P, 1987, J BIOL CHEM, V262, P9615; GOMEZ S, 1983, BIOCHEM BIOPH RES CO, V112, P297, DOI 10.1016/0006-291X(83)91830-2; GOMEZ S, 1988, P NATL ACAD SCI USA, V85, P5468, DOI 10.1073/pnas.85.15.5468; GOODMAN RH, 1983, J BIOL CHEM, V258, P5570; GUMBINER B, 1981, P NATL ACAD SCI-BIOL, V78, P318, DOI 10.1073/pnas.78.1.318; HOBART P, 1980, NATURE, V288, P137, DOI 10.1038/288137a0; JOSEPHBRAVO P, 1980, BIOCHEM BIOPH RES CO, V94, P1004, DOI 10.1016/0006-291X(80)91334-0; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUBER M, 1979, P NATL ACAD SCI USA, V76, P6004, DOI 10.1073/pnas.76.11.6004; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; MACKIN RB, 1987, J BIOL CHEM, V262, P6453; MAINS RE, 1987, ANN NY ACAD SCI, V493, P278, DOI 10.1111/j.1749-6632.1987.tb27213.x; MOREL A, 1983, J BIOL CHEM, V258, P8273; MOREL A, 1984, FEBS LETT, V175, P21, DOI 10.1016/0014-5793(84)80561-X; MOREL A, 1988, BIOCHEM BIOPH RES CO, V151, P347, DOI 10.1016/0006-291X(88)90600-6; MORRE DJ, 1971, METHOD ENZYMOL, V22, P130; NORDMANN JJ, 1981, SCIENCE, V211, P595, DOI 10.1126/science.7455700; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; PATEL YC, 1981, ENDOCRINOLOGY, V109, P1943, DOI 10.1210/endo-109-6-1943; PIEROTTI AR, 1985, NEUROSCI LETT, V57, P215, DOI 10.1016/0304-3940(85)90493-8; PIEROTTI AR, 1985, J ENDOCRINOL, V105, P383, DOI 10.1677/joe.0.1050383; RAVAZZOLA M, 1983, P NATL ACAD SCI-BIOL, V80, P215, DOI 10.1073/pnas.80.1.215; Reichlin S., 1983, P711; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SCHMIDT WE, 1985, FEBS LETT, V192, P141, DOI 10.1016/0014-5793(85)80060-0; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; SOSSIN WS, 1990, J CELL BIOL, V110, P1, DOI 10.1083/jcb.110.1.1; SPIESS J, 1980, BIOCHEMISTRY-US, V19, P2861, DOI 10.1021/bi00554a007; STEINER DF, 1984, J CELL BIOCHEM, V24, P121, DOI 10.1002/jcb.240240204; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIFARO JM, 1976, BIOCHIM BIOPHYS ACTA, V421, P153, DOI 10.1016/0304-4165(76)90179-3; WATTIAUX R, 1956, BIOCHEM J, V63, P606, DOI 10.1042/bj0630606	57	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1679	1688						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671040				2022-12-25	WOS:A1991EU49700051
J	DISSINGER, S; HANNA, MM				DISSINGER, S; HANNA, MM			ACTIVE-SITE LABELING OF ESCHERICHIA-COLI TRANSCRIPTION ELONGATION COMPLEXES WITH 5-((4-AZIDOPHENACYL)THIO)URIDINE 5'-TRIPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF IRVINE, CALIF COLL MED, DEPT BIOL CHEM, IRVINE, CA 92717 USA; UNIV CALIF IRVINE, CALIF COLL MED, DEPT CHEM, IRVINE, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine					NIGMS NIH HHS [GM07134-14] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG VW, 1979, BIOCHEMISTRY-US, V18, P5117, DOI 10.1021/bi00590a014; ARMSTRONG VW, 1976, BIOCHEMISTRY-US, V15, P2086, DOI 10.1021/bi00655a009; ARNDT KA, 1990, IN PRESS J MOL BIOL; Bayley H, 1977, Methods Enzymol, V46, P69; BERNHARD SL, 1986, BIOCHEMISTRY-US, V25, P5914, DOI 10.1021/bi00368a012; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRIAT JF, 1984, P NATL ACAD SCI-BIOL, V81, P7373, DOI 10.1073/pnas.81.23.7373; BROSIUS J, 1984, GENE, V27, P161, DOI 10.1016/0378-1119(84)90137-9; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; BURTON Z, 1981, NUCLEIC ACIDS RES, V9, P2889, DOI 10.1093/nar/9.12.2889; DERIEMER LH, 1981, BIOCHEMISTRY-US, V20, P1612, DOI 10.1021/bi00509a031; FAERBER P, 1973, BIOCHEM BIOPH RES CO, V55, P873, DOI 10.1016/0006-291X(73)91225-4; FISHER R, 1980, J BIOL CHEM, V255, P1056; FRISCHAUF AM, 1973, BIOCHEM BIOPH RES CO, V53, P1227, DOI 10.1016/0006-291X(73)90596-2; GODOVIKOVA TS, 1987, EUR J BIOCHEM, V166, P611, DOI 10.1111/j.1432-1033.1987.tb13557.x; GOLIGER JA, 1989, J MOL BIOL, V205, P331, DOI 10.1016/0022-2836(89)90344-6; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; GRACHEV MA, 1981, FEBS LETT, V130, P23, DOI 10.1016/0014-5793(81)80657-6; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; GRACHEV MA, 1982, FEBS LETT, V137, P89, DOI 10.1016/0014-5793(82)80321-9; HANNA MM, 1983, BIOCHEMISTRY-US, V22, P3546, DOI 10.1021/bi00284a002; HANNA MM, 1989, METHOD ENZYMOL, V180, P383; HANNA MM, 1989, BIOCHEMISTRY-US, V28, P5814, DOI 10.1021/bi00440a017; HANNA MM, 1983, P NATL ACAD SCI-BIOL, V80, P4238, DOI 10.1073/pnas.80.14.4238; KNOWLES JR, 1972, ACCOUNTS CHEM RES, V5, P155, DOI 10.1021/ar50052a006; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; MILLER JA, 1980, BIOCHIM BIOPHYS ACTA, V612, P286, DOI 10.1016/0005-2744(80)90302-2; NIXON J, 1972, BIOCHEMISTRY-US, V11, P4570, DOI 10.1021/bi00774a023; OVCHINNIKOV YA, 1977, FEBS LETT, V76, P108, DOI 10.1016/0014-5793(77)80131-2; OVCHINNIKOV YA, 1982, NUCLEIC ACIDS RES, V10, P4035, DOI 10.1093/nar/10.13.4035; OVCHINNIKOV YA, 1981, EUR J BIOCHEM, V116, P621, DOI 10.1111/j.1432-1033.1981.tb05381.x; PANKA D, 1985, J BIOL CHEM, V260, P1427; RUETSCH N, 1985, J BIOL CHEM, V260, P6310; SCHROCK AK, 1984, J AM CHEM SOC, V106, P5228, DOI 10.1021/ja00330a032; SHAPIRO R, 1966, BIOCHEMISTRY-US, V5, P2358, DOI 10.1021/bi00871a026; STACKHOUSE TM, 1988, BIOCHEMISTRY-US, V27, P3038, DOI 10.1021/bi00408a056; STUDIER FW, 1981, J MOL BIOL, V153, P503, DOI 10.1016/0022-2836(81)90405-8; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; WOODY AYM, 1984, BIOCHEMISTRY-US, V23, P2843, DOI 10.1021/bi00308a001; WOODY AYM, 1988, BIOCHEM BIOPH RES CO, V150, P917, DOI 10.1016/0006-291X(88)90716-4; WU FYH, 1974, BIOCHEMISTRY-US, V13, P2562, DOI 10.1021/bi00709a014; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241	46	29	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7662	7668						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692025				2022-12-25	WOS:A1990DB30700086
J	CASCIO, M; GOGOL, E; WALLACE, BA				CASCIO, M; GOGOL, E; WALLACE, BA			THE SECONDARY STRUCTURE OF GAP-JUNCTIONS - INFLUENCE OF ISOLATION METHODS AND PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									RENSSELAER POLYTECH INST,DEPT CHEM,TROY,NY 12180; UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97402; COLUMBIA UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; RENSSELAER POLYTECH INST,CTR BIOPHYS,TROY,NY 12180	Rensselaer Polytechnic Institute; University of Oregon; Columbia University; Rensselaer Polytechnic Institute			Wallace, B A/C-3753-2008	Wallace, B A/0000-0001-9649-5092	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM030387, R01GM027292] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27292, GM30387] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett M. V. L., 1985, GAP JUNCTIONS; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; BROWN FR, 1972, J MOL BIOL, V63, P85, DOI 10.1016/0022-2836(72)90523-2; CASCIO M, 1988, PROTEINS, V4, P89, DOI 10.1002/prot.340040203; CASCIO M, 1988, BIOPHYS J, V53, P288; CASPAR DLD, 1977, J CELL BIOL, V74, P605, DOI 10.1083/jcb.74.2.605; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CHIN JJ, 1987, P NATL ACAD SCI USA, V84, P4113, DOI 10.1073/pnas.84.12.4113; CLARK BR, 1968, ANAL BIOCHEM, V24, P27, DOI 10.1016/0003-2697(68)90056-0; DUMONT ME, 1985, J MEMBRANE BIOL, V88, P233, DOI 10.1007/BF01871088; EPSTEIN ML, 1977, J CELL BIOL, V75, P769, DOI 10.1083/jcb.75.3.769; Fiske CH, 1925, J BIOL CHEM, V66, P375; FRASER SE, 1987, SCIENCE, V237, P49, DOI 10.1126/science.3037697; GOGOL E, 1988, BIOPHYS J, V54, P105, DOI 10.1016/S0006-3495(88)82935-7; GOODENOUGH DA, 1988, J CELL BIOL, V107, P1817, DOI 10.1083/jcb.107.5.1817; GOODENOUGH DA, 1972, J CELL BIOL, V54, P646, DOI 10.1083/jcb.54.3.646; GOODENOUGH DA, 1970, J CELL BIOL, V45, P272, DOI 10.1083/jcb.45.2.272; GORDON DJ, 1971, ARCH BIOCHEM BIOPHYS, V142, P481, DOI 10.1016/0003-9861(71)90511-X; HENDERSON D, 1979, J MOL BIOL, V132, P193, DOI 10.1016/0022-2836(79)90391-7; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; HERTZBERG EL, 1985, P NATL ACAD SCI USA, V82, P2412, DOI 10.1073/pnas.82.8.2412; HERTZBERG EL, 1984, J BIOL CHEM, V259, P9936; JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; MAKOWSKI L, 1984, BIOPHYS J, V45, P208, DOI 10.1016/S0006-3495(84)84149-1; MAKOWSKI L, 1982, BIOPHYS J, V37, P189, DOI 10.1016/S0006-3495(82)84663-8; MAKOWSKI L, 1984, J MOL BIOL, V174, P449, DOI 10.1016/0022-2836(84)90331-0; MANDEL R, 1973, BIOPOLYMERS, V12, P655, DOI 10.1002/bip.1973.360120317; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MIELKE DL, 1988, J BIOL CHEM, V263, P3177; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; NABEDRYK E, 1985, BIOPHYS J, V48, P873, DOI 10.1016/S0006-3495(85)83848-0; NICHOLSON BJ, 1983, METHOD ENZYMOL, V98, P193; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; REVEL JP, 1985, ANNU REV PHYSIOL, V47, P263; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHNEIDER AS, 1976, BIOCHEMISTRY-US, V15, P4158, DOI 10.1021/bi00664a004; SCHULTE TH, 1979, BIOCHEMISTRY-US, V18, P275, DOI 10.1021/bi00569a006; SOSINSKY GE, 1988, BIOPHYS J, V53, P709, DOI 10.1016/S0006-3495(88)83152-7; TIBBITTS TT, 1989, BIOPHYS J, V55, P210; UNWIN N, 1986, NATURE, V323, P12, DOI 10.1038/323012a0; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; WALLACE BA, 1982, BIOPHYS J, V39, P233, DOI 10.1016/S0006-3495(82)84513-X; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; WALLACE BA, 1984, P NATL ACAD SCI-BIOL, V81, P1406, DOI 10.1073/pnas.81.5.1406; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; WARNER AE, 1984, NATURE, V311, P127, DOI 10.1038/311127a0; YOUNG JDE, 1987, CELL, V48, P733, DOI 10.1016/0092-8674(87)90071-7; ZIMMER DB, 1987, J BIOL CHEM, V262, P7751	58	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2358	2364						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688853				2022-12-25	WOS:A1990CL02800085
J	ZHANG, HY; YOUNG, AP				ZHANG, HY; YOUNG, AP			A SINGLE UPSTREAM GLUCOCORTICOID RESPONSE ELEMENT JUXTAPOSED TO AN AP1/ATF/CRE-LIKE SITE RENDERS THE CHICKEN GLUTAMINE-SYNTHETASE GENE HORMONALLY INDUCIBLE IN TRANSFECTED RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC NEURAL RETINA; RAT SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; BETA-GALACTOSIDASE; CELL-INTERACTIONS; EXPRESSION; DNA; INDUCTION; RECEPTOR; BINDING	The cis-acting element mediating glucocorticoid inducibility of the chicken glutamine synthetase gene has been identified. Transfection studies using intact embryonic chicken retinae and L6 myoblasts demonstrate that sequences located between 1,849 and 2,120 nucleotides upstream of the glutamine synthetase transcription start site are required to achieve hormonally inducible expression of the chloramphenicol acetyltransferase gene. Moreover, a 42-nucleotide fragment from this region provides a robust hormonal induction when positioned approximately 2 kilobases from the SV40 early promoter. A sequence containing 8 nucleotides in common with the 12-nucleotide consensus glucocorticoid response element is encoded within this element. DNase I footprinting experiments confirm that this consensus sequence provides the only binding sites for the glucocorticoid receptor within the DNA required for inducibility. Removal of 8 nucleotides that map outside of the footprinting region results in attenuation of the hormonal response in L6 myoblasts and abolition of the response in embryonic retinae. This deletion eliminates the sequence 5'CAGCGTCA3', a sequence that resembles the canonical cyclic AMP response element (CRE), activating transcription factor (ATF), and AP1 binding sites. These results suggest that the glucocorticoid receptor acts in collaboration with a member of the jun/fos/ATF/CREB family of transcription factors to mediate a strong glucocorticoid induction at a site 2.1 kilobases upstream of the glutamine synthetase transcription start site.	OHIO STATE UNIV,CTR BIOTECHNOL,RIGHTMIRE HALL,1060 CARMACK RD,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL,COLUMBUS,OH 43210	Ohio State University; Ohio State University					NEI NIH HHS [EY05063] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005063] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COYLE JT, 1981, NEUROSCI RES PROG B, V19, P331; DANESCH U, 1987, EMBO J, V6, P625, DOI 10.1002/j.1460-2075.1987.tb04800.x; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; FALDUTO MT, 1989, FASEB J, V3, P2623, DOI 10.1096/fasebj.3.14.2574120; FENG B, 1990, J BIOL CHEM, V265, P18702; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GOLD EM, 1979, ANN INTERN MED, V90, P829, DOI 10.7326/0003-4819-90-5-829; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KLEIN ES, 1988, MOL ENDOCRINOL, V2, P1343, DOI 10.1210/mend-2-12-1343; KOEHLER DE, 1975, ARCH BIOCHEM BIOPHYS, V170, P102, DOI 10.1016/0003-9861(75)90101-0; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; LINSER PJ, 1987, CELL DIFFER DEV, V20, P189, DOI 10.1016/0045-6039(87)90433-7; LIPPMAN ME, 1974, J BIOL CHEM, V249, P5916; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MAGNUSON SR, 1988, DEV BIOL, V130, P536, DOI 10.1016/0012-1606(88)90348-X; Maniatis T., 1982, MOL CLONING; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; MAYER M, 1976, METABOLISM, V25, P157, DOI 10.1016/0026-0495(76)90046-9; MEISTER A, 1967, HARVEY LECT, V63, P139; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; MOSCONA AA, 1983, CURR TOP DEV BIOL, V18, P155; MOSCONA M, 1979, DIFFERENTIATION, V13, P165, DOI 10.1111/j.1432-0436.1979.tb01579.x; NORTON PA, 1985, MOL CELL BIOL, V5, P281, DOI 10.1128/MCB.5.2.281; PATEJUNAS G, 1987, J CELL BIOCHEM, V35, P205, DOI 10.1002/jcb.240350304; PATEJUNAS G, 1987, MOL CELL BIOL, V7, P1070, DOI 10.1128/MCB.7.3.1070; PATEJUNAS G, 1990, J BIOL CHEM, V265, P15280; PU HF, 1990, GENE, V89, P259, DOI 10.1016/0378-1119(90)90014-I; PU HF, 1989, GENE, V81, P169, DOI 10.1016/0378-1119(89)90348-X; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHOJI S, 1977, MOL CELL ENDOCRINOL, V6, P159, DOI 10.1016/0303-7207(77)90082-X; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; VARDIMON L, 1988, P NATL ACAD SCI USA, V85, P5981, DOI 10.1073/pnas.85.16.5981; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	45	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24332	24338						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1684791				2022-12-25	WOS:A1991GW84500018
J	JUNTTIBERGGREN, L; ARKHAMMAR, P; NILSSON, T; RORSMAN, P; BERGGREN, PO				JUNTTIBERGGREN, L; ARKHAMMAR, P; NILSSON, T; RORSMAN, P; BERGGREN, PO			GLUCOSE-INDUCED INCREASE IN CYTOPLASMIC PH IN PANCREATIC BETA-CELLS IS MEDIATED BY NA+/H+ EXCHANGE, AN EFFECT NOT DEPENDENT ON PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-ACTIVATED K+ CHANNELS; FREE CA-2+ CONCENTRATION; INTRACELLULAR PH; INSULIN RELEASE; B-CELLS; ISLET CELLS; POTASSIUM PERMEABILITY; SECRETION; ATP; CALCIUM	Glucose-induced changes in cytoplasmic pH (pH(i)) were investigated using pancreatic beta-cells isolated from obese hyperglycemic mice. Glucose, at concentrations above 3-5 mM, depolarized the beta-cell and increased pH(i), cytoplasmic free Ca2+[Ca2+]i), and insulin release. This increase in pH(i) was dependent, on the presence of extracellular Na+ and was inhibited by 5-(N-ethyl-N-isopropyl) amiloride, a blocker of Na+/H+ exchange. Stimulation of protein kinase C with phorbol ester also induced an alkalinization. However, when protein kinase C activity was down-regulated, glucose stimulation still induced alkalinization. At 20 mM glucose, 10 mM NH4Cl induced a marked rise in pH(i), paralleled by repolarization, inhibition of electrical activity, and decreases in both [Ca2+]i and insulin release. Reduction in [Ca2+]i was prevented by 200-mu-M tolbutamide, but not by 10 mM tetraethylammonium. At 4 mM glucose, NH4Cl induced a transient increase in insulin release, without changing [Ca2+]i. Exposure of beta-cells to 10 mM sodium acetate caused a persistent decrease in pH(i), an effect paralleled by a small transient increase in [Ca2+]i. Acidification per se did not change the beta-cell sensitivity to glucose, not excluding that the activity of the ATP-regulated K+ channels may be modulated by changes in pH(i).	UNIV UPPSALA,BIOMEDICUM,DEPT MED CELL BIOL,S-75123 UPPSALA,SWEDEN; KAROLINSKA INST,KAROLINSKA HOSP,DEPT ENDOCRINOL,ROLF LUFT CTR DIABET RES,S-10401 STOCKHOLM 60,SWEDEN; GOTHENBURG UNIV,DEPT MED PHYS,S-40033 GOTHENBURG,SWEDEN	Uppsala University; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	BERGGREN, PO (corresponding author), UNIV UPPSALA,BIOMEDICUM,DEPT MED CELL BIOL,S-75123 UPPSALA,SWEDEN.		Rorsman, Patrik/A-4331-2016	Rorsman, Patrik/0000-0001-7578-0767; Berggren, Per-Olof/0000-0001-8991-413X				ARKHAMMAR P, 1987, J BIOL CHEM, V262, P5448; ARKHAMMAR P, 1989, CELL CALCIUM, V10, P17, DOI 10.1016/0143-4160(89)90040-7; ARKHAMMAR P, 1986, BIOSCIENCE REP, V6, P355, DOI 10.1007/BF01116422; ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT FM, 1990, PROG BIOPHYS MOL BIO, V54, P87; ATWATER I, 1979, J PHYSIOL-LONDON, V288, P575; BOKVIST K, 1990, J PHYSIOL-LONDON, V423, P327, DOI 10.1113/jphysiol.1990.sp018025; COOK DL, 1984, NATURE, V311, P269, DOI 10.1038/311269a0; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DELEERS M, 1985, HORM METAB RES, V17, P391, DOI 10.1055/s-2007-1013555; FATHERAZI S, 1991, J MEMBRANE BIOL, V120, P105, DOI 10.1007/BF01872393; FERRER R, 1984, Q J EXP PHYSIOL CMS, V69, P831, DOI 10.1113/expphysiol.1984.sp002872; GRAPENGIESSER E, 1989, BIOCHIM BIOPHYS ACTA, V1014, P219, DOI 10.1016/0167-4889(89)90215-2; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; HELLMAN B, 1972, ENDOCRINOLOGY, V90, P335, DOI 10.1210/endo-90-1-335; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; HELLMAN B, 1975, ENDOCRINOLOGY, V97, P392, DOI 10.1210/endo-97-2-392; HENQUIN JC, 1988, BIOCHEM BIOPH RES CO, V156, P769, DOI 10.1016/S0006-291X(88)80910-0; HENQUIN JC, 1981, MOL CELL ENDOCRINOL, V21, P119, DOI 10.1016/0303-7207(81)90049-6; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HORN R, 1988, J GEN PHYSIOL, V93, P1; KANATSUNA T, 1981, DIABETES, V30, P231, DOI 10.2337/diabetes.30.3.231; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; LINDSTROM P, 1984, BIOCHEM J, V218, P887, DOI 10.1042/bj2180887; LINDSTROM P, 1986, BIOCHEM J, V239, P199, DOI 10.1042/bj2390199; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V270, P15, DOI 10.1016/0003-9861(89)90002-7; MADSHUS IH, 1988, BIOCHEM J, V250, P1, DOI 10.1042/bj2500001; MALAISSE WJ, 1980, LIFE SCI, V26, P1367, DOI 10.1016/0024-3205(80)90038-7; MALAISSE WJ, 1979, DIABETOLOGIA, V16, P331, DOI 10.1007/BF01223623; MISLER S, 1989, J MEMBRANE BIOL, V109, P135, DOI 10.1007/BF01870852; MOOLENAAR WH, 1986, TRENDS BIOCHEM SCI, V11, P141, DOI 10.1016/0968-0004(86)90069-1; NILSSON T, 1987, BIOCHEM J, V248, P329, DOI 10.1042/bj2480329; PACE CS, 1983, AM J PHYSIOL, V244, pE3, DOI 10.1152/ajpendo.1983.244.1.E3; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; RORSMAN P, 1985, PFLUG ARCH EUR J PHY, V405, P305, DOI 10.1007/BF00595682; ROSARIO LM, 1986, FEBS LETT, V200, P203, DOI 10.1016/0014-5793(86)80539-7; SEHLIN J, 1975, NATURE, V253, P635, DOI 10.1038/253635a0; SMITH PA, 1990, J GEN PHYSIOL, V95, P1041, DOI 10.1085/jgp.95.6.1041; TAPPER H, 1990, BIOCHEM J, V272, P407, DOI 10.1042/bj2720407; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; VARA F, 1985, BIOCHEM BIOPH RES CO, V130, P646, DOI 10.1016/0006-291X(85)90466-8; VIGNE P, 1983, BIOCHEM BIOPH RES CO, V116, P86, DOI 10.1016/0006-291X(83)90384-4; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	51	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23537	23541						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660875				2022-12-25	WOS:A1991GV31900005
J	PAULWEBER, B; LEVYWILSON, B				PAULWEBER, B; LEVYWILSON, B			THE MECHANISMS BY WHICH A HUMAN APOLIPOPROTEIN-B GENE ENHANCER AND REDUCER INTERACT WITH THE PROMOTER ARE DIFFERENT IN CULTURED-CELLS OF HEPATIC AND INTESTINAL ORIGIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; SILENCER; ELEMENTS	In the preceding paper (Paulweber, B., Onasch, M. A., Nagy, B. P., and Levy-Wilson, B. (1991) J. Biol. Chem. 266, 24149-24160) we demonstrated that the segment of the apolipoprotein B promoter extending from -260 to -85 is functionally different in hepatic (HepG2) and intestinal (CaCo-2) cells. These functional differences could be explained at least in part by differences in binding of three nuclear proteins to the region from -111 to -88. In this article we present further evidence suggesting that the mechanisms involved in transcriptional control of the apolipoprotein B gene in HepG2 and CaCo-2 cells are different, by demonstrating that an enhancer and a reducer can alter the activity of various apolipoprotein B promoter segments in widely differing ways in these two cell lines. Furthermore, we have localized a 329-base pair segment that is found within a negative regulatory region in the 5' distal portion of the gene. It displays a strong reducer effect upon promoter sequences that exhibit maximal transcriptional activity in CaCo-2 cells, but not in HepG2 cells.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,POB 40608,SAN FRANCISCO,CA 94140; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94140	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	LEVYWILSON, B (corresponding author), UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,POB 40608,SAN FRANCISCO,CA 94140, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANIAHMAD A, 1987, EMBO J, V6, P2297, DOI 10.1002/j.1460-2075.1987.tb02504.x; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BENLEVY R, 1989, MOL CELL BIOL, V9, P1804, DOI 10.1128/MCB.9.4.1804; BLACKHART BD, 1986, J BIOL CHEM, V261, P5364; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; CARLSSON P, 1989, GENE, V77, P113, DOI 10.1016/0378-1119(89)90365-X; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; HIGUCHI K, 1988, J BIOL CHEM, V263, P18530; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; KANE JP, 1983, ANNU REV PHYSIOL, V45, P637, DOI 10.1146/annurev.ph.45.030183.003225; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LEVYWILSON B, 1991, J LIPID RES, V32, P137; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; Locker J, 1990, DNA Seq, V1, P3, DOI 10.3109/10425179009041342; METZGER S, 1990, J BIOL CHEM, V265, P9978; PACIUCCI R, 1991, MOL CELL BIOL, V11, P1334, DOI 10.1128/MCB.11.3.1334; PAULWEBER B, 1991, J BIOL CHEM, V266, P24149; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; WINGENDER E, 1988, NUCLEIC ACIDS RES, V16, P1879, DOI 10.1093/nar/16.5.1879; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574	22	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					24161	24168						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660893				2022-12-25	WOS:A1991GV31900097
J	MORRIS, JF; MADDEN, SL; TOURNAY, OE; COOK, DM; SUKHATME, VP; RAUSCHER, FJ				MORRIS, JF; MADDEN, SL; TOURNAY, OE; COOK, DM; SUKHATME, VP; RAUSCHER, FJ			CHARACTERIZATION OF THE ZINC FINGER PROTEIN ENCODED BY THE WT1 WILMS-TUMOR LOCUS	ONCOGENE			English	Article							HUMAN CHROMOSOME-11; MAMMALIAN-CELLS; BINDING; GENE; FOS; DELETION; GROWTH; JUN; DIFFERENTIATION; PURIFICATION	We analysed the biochemical properties of the transcription factor encoded by the putative tumor-suppressor gene present at the WT1 Wilms' tumor locus. A gene containing the full-length amino acid coding sequence of human wt1 was reconstructed from synthetic oligonucleotides and cloned into expression vectors for in vitro and in vivo protein synthesis. Polyclonal rabbit antibodies specific for the WT1 protein were raised to an Escherichia coli-produced 91 amino acid N-terminal segment and to a 136 amino acid C-terminal segment, which contains the zinc finger domain. WT1 produced by in vitro translation migrated as a 52 kDa protein on sodium dodecylsulfate-polyacrylamide gels and bound to the EGR consensus sequence in gel-retardation assays. Expression of the wt1 gene via transient transfection in COS-1 cells revealed a 52 kDa protein which was immunoprecipitated by both the N-terminal- and C-terminal-specific antisera. Immunofluorescence studies of wt1-transfected COS-1 cells revealed that the WT1 protein was localized to the nucleus. Metabolic labeling with [P-32]orthophosphate failed to reveal significant phosphorylation of the WT1 protein in COS-1 cells. Two immunoreactive WT polypeptides of 52 and 54kDa were observed in murine embryonic stem cells and COS-1 kidney cells and may represent previously identified splicing variants of WT1. These antisera should be useful in characterizing the structure and function of the WT1 protein in human Wilms' tumor specimens.	WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637	The Wistar Institute; Howard Hughes Medical Institute; University of Chicago			Sukhatme, Vikas/W-2776-2019		NATIONAL CANCER INSTITUTE [P01CA047983, P01CA052009, R01CA023413] Funding Source: NIH RePORTER; NCI NIH HHS [CA-52009, CA-47983-04, CA-23413] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABATE C, 1990, CELL GROWTH DIFFER, V1, P455; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1701; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P184; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; MADDEN SL, 1991, IN PRESS SCIENCE; MATSUNAGA E, 1981, HUM GENET, V57, P231; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PATWARDHAN S, 1991, ONCOGENE, V6, P917; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0	33	125	133	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1991	6	12					2339	2348						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX735	1662794				2022-12-25	WOS:A1991GX73500024
J	GIRALT, M; PARK, EA; GURNEY, AL; LIU, J; HAKIMI, P; HANSON, RW				GIRALT, M; PARK, EA; GURNEY, AL; LIU, J; HAKIMI, P; HANSON, RW			IDENTIFICATION OF A THYROID-HORMONE RESPONSE ELEMENT IN THE PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE - EVIDENCE FOR SYNERGISTIC INTERACTION BETWEEN THYROID-HORMONE AND CAMP CIS-REGULATORY ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GROWTH-HORMONE; MALIC ENZYME GENE; NEGATIVE REGULATION; TRANSCRIPTIONAL REGULATION; DIETARY-REGULATION; TRANS-ACTIVATION; PROLACTIN GENE; RECEPTOR BINDS; PROMOTER; EXPRESSION	Transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK) in the liver is regulated by many hormones including thyroid hormone (T3). In order to identify the elements in the promoter which are required for transcriptional induction by T3, we cotransfected a T3 receptor expression vector with a PEPCK-CAT reporter gene into HepG2 cells. Using vectors with deletions in the PEPCK promoter, we identified a single T3 response element (TRE) between positions -332 and -308. This element binds [I-125]T3-labeled T3 receptor contained in nuclear extracts prepared from rat liver. Furthermore, the P3(I) element (-250 to -234), a previously described cis-sequence involved in mediating the induction of PEPCK gene transcription by cAMP, is also required for the T3 responsiveness of the promoter. In the absence of either the TRE or the P3(I) binding sites, no stimulation of transcription from the PEPCK promoter by T3 was observed, indicating that both elements are required for the T3 transcriptional regulation. Finally, a synergistic induction of PEPCK gene transcription by T3 and cAMP is described. This interaction requires both T3- and cAMP-responsive cis-acting elements.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	Case Western Reserve University			Hakimi, Parvin/AAB-1643-2021; Giralt, Marta/A-4756-2013	Giralt, Marta/0000-0001-7968-4190	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021859, R37DK021859] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-24451, DK-21859] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BAKER JA, 1988, J BIOL CHEM, V263, P19740; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BRENT GA, 1988, MOL ENDOCRINOL, V2, P792, DOI 10.1210/mend-2-9-792; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; COPP RP, 1989, MOL ENDOCRINOL, V3, P790, DOI 10.1210/mend-3-5-790; DAY RN, 1989, MOL ENDOCRINOL, V3, P931, DOI 10.1210/mend-3-6-931; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; GARCIARUIZ JP, 1983, ENZYME, V30, P265; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; HARTONG R, 1987, ENDOCRINOLOGY, V120, P2460, DOI 10.1210/endo-120-6-2460; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOPPNER W, 1986, EUR J BIOCHEM, V159, P399, DOI 10.1111/j.1432-1033.1986.tb09882.x; HORWITZ KB, 1978, J BIOL CHEM, V253, P8185; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IYNEDJIAN PB, 1984, EUR J BIOCHEM, V145, P489, DOI 10.1111/j.1432-1033.1984.tb08583.x; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LAVIN TN, 1988, J BIOL CHEM, V263, P9418; LIU J, 1991, IN PRESS J BIOL CHEM; LIU JS, 1990, BIOTECHNIQUES, V9, P738; LOOSE DS, 1985, BIOCHEMISTRY-US, V24, P4509, DOI 10.1021/bi00338a004; MCGRANE MM, 1990, J BIOL CHEM, V265, P22371; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MUNOZ A, 1990, MOL ENDOCRINOL, V4, P312, DOI 10.1210/mend-4-2-312; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; NORMAN MF, 1989, J BIOL CHEM, V264, P12063; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; Oppenheimer J. H., 1983, MOL BASIS THYROID HO; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PETTY KJ, 1989, J BIOL CHEM, V264, P11483; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHORT JM, 1986, J BIOL CHEM, V261, P9721; STANLEY F, 1989, MOL ENDOCRINOL, V3, P1627, DOI 10.1210/mend-3-10-1627; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WIGHT PA, 1988, MOL ENDOCRINOL, V2, P536, DOI 10.1210/mend-2-6-536; YE ZS, 1988, J BIOL CHEM, V263, P7821; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	53	99	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21991	21996						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657985				2022-12-25	WOS:A1991GP80400100
J	GONEN, H; SCHWARTZ, AL; CIECHANOVER, A				GONEN, H; SCHWARTZ, AL; CIECHANOVER, A			PURIFICATION AND CHARACTERIZATION OF A NOVEL PROTEIN THAT IS REQUIRED FOR DEGRADATION OF N-ALPHA-ACETYLATED PROTEINS BY THE UBIQUITIN SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT PROTEASES; RABBIT RETICULOCYTES; BINDING-SITES; AFFINITY PURIFICATION; CONJUGATING ENZYMES; PROTEOLYTIC SYSTEM; TRANSFER-RNA; 26S COMPLEX; END RULE; LIGASE	Anion exchange chromatography of reticulocyte lysates revealed that the ubiquitin cell-free system can be resolved into two essential fractions: unadsorbed material (Fraction I) that contains ubiquitin and a high salt eluate (Fraction II) that contains the conjugating enzymes and the conjugate-degrading protease. Many proteins with exposed NH2 termini are degraded in a ubiquitin-supplemented Fraction II. However, this partially purified and reconstituted system does not degrade N-alpha-acetylated proteins. These proteins are degraded in whole lysates in a ubiquitin-dependent manner (Mayer, A. Siegel, N. R., Schwartz, A. L., and Ciechanover, A. (1989) Science 244, 1480-1483). It appears that a protein factor which is specifically required for the degradation of N-alpha-acetylated proteins is removed or inactivated during the fractionation of the lysate. Here we report the purification and characterization of a novel protein that is required along with the protease for the degradation of ubiquitin conjugates of histone H2A, an N-alpha-acetylated protein. The protein is not required for the degradation of ubiquitin conjugates of proteins with free NH2 termini. The protein, which is found in crude Fraction I, was purified approximately 200-fold by (NH4)2SO4 precipitation, Sephadex G-100 gel-filtration chromatography, Mono Q anion exchange chromatography, and an additional Sephadex G-100 gel filtration chromatography step. The protein is removed from Fraction I during the purification of ubiquitin and has not been previously recognized since the majority of the protein substrates evaluated in the cell-free system have free NH2 termini. The protein has an apparent molecular mass of approximately 92 kDa. It is a homodimer that is composed of two identical 46-kDa subunits. Initial analysis of the mechanism of action of this protein revealed that it must interact with the conjugates in order to allow proteolysis to occur. We designated the protein Factor H (Factor Hedva).	TECHNION ISRAEL INST TECHNOL,FAC MED,DEPT BIOCHEM,POB 9649,IL-31096 HAIFA,ISRAEL; WASHINGTON UNIV,SCH MED,DIV HEMATOL ONCOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,MAILINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110; TECHNION ISRAEL INST TECHNOL,RAPPAPORT FAMILY INST RES MED SCI,IL-31096 HAIFA,ISRAEL; WASHINGTON UNIV,SCH MED,MALLINCKODT DEPT PHARMACOL,ST LOUIS,MO 63110	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Washington University (WUSTL); Washington University (WUSTL); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Washington University (WUSTL)			Ciechanover, Aaron J/C-9166-2017					ARMON T, 1990, J BIOL CHEM, V265, P20723; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JL, 1976, J BIOL CHEM, V251, P1009; CIECHANOVER A, 1989, TRENDS BIOCHEM SCI, V14, P483, DOI 10.1016/0968-0004(89)90180-1; CIECHANOVER A, 1988, J BIOL CHEM, V263, P11155; CIECHANOYER A, 1980, J BIOL CHEM, V255, P7525; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FERBER S, 1986, J BIOL CHEM, V261, P3128; GANOTH D, 1988, J BIOL CHEM, V263, P12412; GONDA DK, 1989, J BIOL CHEM, V264, P16700; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; PICKART CM, 1985, J BIOL CHEM, V260, P7903; RAPPOPORT SM, 1979, EUR J BIOCHEM, V96, P545; RECHSTEINER M, 1988, UBIQUITIN, P1; REISS Y, 1989, J BIOL CHEM, V264, P10378; REISS Y, 1988, J BIOL CHEM, V263, P2693; REISS Y, 1990, J BIOL CHEM, V265, P3685; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; SCHLESINGER M, 1988, UBIQUITIN SYSTEM, P1; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529	41	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19221	19231						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655778				2022-12-25	WOS:A1991GK66700020
J	KUHAR, SG; LEHMAN, JM				KUHAR, SG; LEHMAN, JM			T-ANTIGEN AND P53 IN PRECRISIS AND POSTCRISIS SIMIAN VIRUS-40-TRANSFORMED HUMAN CELL-LINES	ONCOGENE			English	Article							TUMOR-ANTIGEN; SV40-TRANSFORMED CELLS; MONOCLONAL-ANTIBODIES; TRANSFORMED-CELLS; HUMAN-FIBROBLASTS; VIRUS-40; PROTEIN; SV40; GROWTH; FORMS	Infection of normal human diploid fibroblasts (HF) with the DNA tumor virus simian virus 40 (SV) leads to an extension of lifespan and concomitant increase in' the levels of the viral large tumor antigen (T antigen) and the cellular protein p53. The intracellular localization of T antigen and p53 was mostly nuclear in both SVpre-crisis and SVpost-crisis cells, however certain population doubling (PD) of the SVpre-crisis cells exhibited some cytoplasmic staining. The DNA content of SVpre-crisis cells shifted to tetraploidy and the SVpost-crisis cells were near-tetraploid. Quantitation of T antigen and p53 in single cells by flow cytometry demonstrated that for all antibodies tested the levels of T antigen were higher in the SVpre-crisis HF than in the SVpost-crisis. The quantity of p53 increased with increasing age of SVpre-crisis HF, and the levels of p53 were higher in the SVpost-crisis HF populations. Immunoprecipitation of p53, T antigen and complexes demonstrated that all p53 was bound to T antigen in SVpre-crisis HF and SVpost-crisis HF. The SVpre-crisis HF cells showed that 33% of all T antigen was bound to p53, while 67% was free, and the SVpost-crisis HF exhibited 50% free T antigen and 50% bound to p53. The half-life of p53 was similar in all SVpre-crisis HF; however, the half-life was 2-3 times greater in SVpost-crisis HF than in SVpre-crisis HF. These results suggest that the interaction of DNA (ploidy), T antigen, p53 and complexes may be involved in formation of a stable SV40-transformed human cell line.	UNION UNIV,DEPT MICROBIOL & IMMUNOL,A-68,ALBANY,NY 12208	Union College			Lehman, John M./AAU-4849-2020		NCI NIH HHS [CA41608] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA041608, R01CA041608] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEPPERT W, 1989, ONCOGENE, V4, P1103; GIRARDI AJ, 1966, ANN MED EXP BIOL FEN, V44, P242; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HARA H, 1987, EXP CELL RES, V168, P531, DOI 10.1016/0014-4827(87)90025-5; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; JACOBBERGER JW, 1986, CYTOMETRY, V7, P356, DOI 10.1002/cyto.990070410; JENKINS JR, 1988, ONCOGENE HDB; KOPROWSKI H, 1962, J CELL COMPAR PHYSL, V59, P281, DOI 10.1002/jcp.1030590308; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LAFFIN J, 1989, CYTOMETRY, V10, P205, DOI 10.1002/cyto.990100212; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEHMAN JM, 1979, J SUPRAMOLEC STRUCT, V10, P25; LEVINE AJ, 1990, VIROLOGY, V177, P419, DOI 10.1016/0042-6822(90)90505-L; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; RADNA RL, 1989, MOL CELL BIOL, V9, P3093, DOI 10.1128/MCB.9.7.3093; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; SACK GH, 1981, EXP CELL RES, V134, P425, DOI 10.1016/0014-4827(81)90442-0; SACK GH, 1981, IN VITRO CELL DEV B, V17, P1; SCHEIDTMANN KH, 1990, J VIROL, V64, P672, DOI 10.1128/JVI.64.2.672-679.1990; SHEIN HM, 1962, P SOC EXP BIOL MED, V109, P495, DOI 10.3181/00379727-109-27246; TACK LC, 1989, J VIROL, V63, P2352, DOI 10.1128/JVI.63.5.2352-2356.1989; TACK LC, 1988, J VIROL, V62, P1028, DOI 10.1128/JVI.62.3.1028-1037.1988; Tooze J, 1981, MOL BIOL TUMOR VIRUS; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0	32	23	24	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1991	6	9					1499	1506						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX274	1656367				2022-12-25	WOS:A1991GX27400002
J	AESCHLIMANN, D; PAULSSON, M				AESCHLIMANN, D; PAULSSON, M			CROSS-LINKING OF LAMININ-NIDOGEN COMPLEXES BY TISSUE TRANSGLUTAMINASE - A NOVEL MECHANISM FOR BASEMENT-MEMBRANE STABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG LIVER; PLASMA FACTOR-XIIIA; COAGULATION FACTOR-XIII; AMINO-ACID SEQUENCE; EXTRACELLULAR-MATRIX; CELLULAR TRANSGLUTAMINASE; STRUCTURAL FEATURES; LENS TRANSGLUTAMINASE; ELECTRON-MICROSCOPY; GLUTAMINE RESIDUES	The laminin-nidogen complex, a major component of basement membranes, incorporates [H-3]putrescine and monodansylcadaverine in the presence of guinea pig liver transglutaminase. Label was detected in nidogen in the isolated, as well as in the complexed form, but not in laminin. The incorporation proceeds in a time-dependent manner at a rate similar to that achieved with N,N-dimethylcasein, a well characterized transglutaminase substrate. Saturation of incorporation site(s), as well as comparison with the incorporation level in reference proteins, indicated the presence of one high affinity amine acceptor site in nidogen. Electron microscopy of the reaction products showed that the laminin-nidogen complexes become stabilized in a head-to-head arrangement, characteristic of Ca2+-induced self-aggregation. Indirect immunofluorescence and detection of transglutaminase activity on unfixed cryosections revealed an extracellular distribution of tissue transglutaminase. Intensive staining was observed in collagen-rich connective tissue. Codistribution with nidogen was not a ubiquitous feature, but was observed in many locations.	UNIV BASEL,BIOCTR,DEPT BIOPHYS CHEM,CH-4056 BASEL,SWITZERLAND	University of Basel	AESCHLIMANN, D (corresponding author), UNIV BERN,ME MULLER INST BIOMECH,POB 30,CH-3010 BERN,SWITZERLAND.			Aeschlimann, Daniel/0000-0003-0930-7706				ACHYUTHAN KE, 1988, J BIOL CHEM, V263, P14296; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; BARLOW DP, 1984, EMBO J, V3, P2355, DOI 10.1002/j.1460-2075.1984.tb02140.x; BARRY ELR, 1989, J BIOL CHEM, V264, P4179; BARSIGIAN C, 1988, J BIOL CHEM, V263, P14015; BERBERS GAM, 1984, P NATL ACAD SCI-BIOL, V81, P7017, DOI 10.1073/pnas.81.22.7017; Birckbichler P J, 1978, Ann N Y Acad Sci, V312, P354, DOI 10.1111/j.1749-6632.1978.tb16813.x; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; BIRCKBICHLER PJ, 1977, CANCER RES, V37, P1340; BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; BOWNESS JM, 1987, J BIOL CHEM, V262, P1022; BRUCH M, 1989, EUR J BIOCHEM, V185, P271, DOI 10.1111/j.1432-1033.1989.tb15112.x; BYRD JC, 1987, J BIOL CHEM, V262, P11699; CARLIN B, 1981, J BIOL CHEM, V256, P5209; CARRELL NA, 1989, J BIOL CHEM, V264, P551; CHANG SK, 1986, J BIOL CHEM, V261, P8112; CHIQUET M, 1984, J CELL BIOL, V98, P1226; CLARKE DD, 1959, ARCH BIOCHEM BIOPHYS, V79, P338, DOI 10.1016/0003-9861(59)90413-8; COCUZZI ET, 1986, J BIOL CHEM, V261, P8122; CONNELLAN JM, 1971, J BIOL CHEM, V246, P1093; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; EDGAR D, 1989, TRENDS NEUROSCI, V12, P248, DOI 10.1016/0166-2236(89)90020-9; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; EYRE D, 1987, METHOD ENZYMOL, V144, P115; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; FOLK JE, 1966, J BIOL CHEM, V241, P5518; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; GORMAN JJ, 1984, J BIOL CHEM, V259, P9007; GORMAN JJ, 1980, J BIOL CHEM, V255, P419; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; IKURA K, 1990, FEBS LETT, V268, P203, DOI 10.1016/0014-5793(90)81008-C; IMHOF BA, 1983, EXP CELL RES, V145, P199, DOI 10.1016/S0014-4827(83)80021-4; KORNER G, 1989, BIOCHEM J, V262, P633, DOI 10.1042/bj2620633; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORAND L, 1971, ANAL BIOCHEM, V44, P207, DOI 10.1016/0003-2697(71)90362-9; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; LORAND L, 1981, P NATL ACAD SCI-BIOL, V78, P1356, DOI 10.1073/pnas.78.3.1356; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MARTINET N, 1988, J BIOL CHEM, V263, P4236; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; NARA K, 1989, J BIOL CHEM, V264, P19308; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; PAULSSON M, 1989, J BIOL CHEM, V264, P18726; PAULSSON M, 1988, J BIOL CHEM, V263, P5425; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; PAULSSON M, 1988, EUR J BIOCHEM, V177, P477, DOI 10.1111/j.1432-1033.1988.tb14397.x; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; PAULSSON M, 1986, EUR J BIOCHEM, V156, P467, DOI 10.1111/j.1432-1033.1986.tb09605.x; PIACENTINI M, 1988, BIOCHEM J, V253, P33, DOI 10.1042/bj2530033; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; SANE DC, 1988, BIOCHEM BIOPH RES CO, V157, P115, DOI 10.1016/S0006-291X(88)80020-2; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SELL DR, 1989, J BIOL CHEM, V264, P21597; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SIMON M, 1988, J BIOL CHEM, V263, P18093; TAKASHI R, 1988, BIOCHEMISTRY-US, V27, P938, DOI 10.1021/bi00403a015; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; WILLIAMSASHMAN HG, 1984, MOL CELL BIOCHEM, V58, P51, DOI 10.1007/BF00240604; YURCHENCO PD, 1986, J HISTOCHEM CYTOCHEM, V34, P93, DOI 10.1177/34.1.3510247; YURCHENCO PD, 1990, J BIOL CHEM, V265, P3981; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636	72	187	199	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15308	15317						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1678389				2022-12-25	WOS:A1991GB09700073
J	DANOFF, A; CUTLER, DF; SHIELDS, D				DANOFF, A; CUTLER, DF; SHIELDS, D			HETEROLOGOUS EXPRESSION OF PREPROSOMATOSTATIN - INTRACELLULAR DEGRADATION OF PROSOMATOSTATIN-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULES; PITUITARY-CELLS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; MESSENGER-RNAS; BREFELDIN-A; PRE-GOLGI; SOMATOSTATIN; ANGLERFISH; TRANSPORT	Somatostatin (SRIF) is a peptide hormone that is synthesized as part of a larger precursor, prepro-SRIF, consisting of a signal peptide and a proregion of 80-90 amino acids. The mature hormone exists as two different bioactive species. In addition to the most common form, which is a 14-residue peptide, there is also a 14-amino acid NH2-terminally extended form of the tetradecapeptide, SRIF-28. In mammals a single prepro-SRIF molecule undergoes tissue-specific processing to generate the mature hormone, whereas in some species of fish separate genes encode two distinct but homologous precursors, prepro-SRIF-I and -II, that give rise to SRIF-14 and -28, respectively. To investigate the molecular basis for differential processing of the prohormones, we have expressed their cDNAs in heterologous cells. Previously, we demonstrated that prepro-SRIF-I was efficiently and accurately processed in rat pituitary growth hormone (GH3) cells to generate the same hormone as synthesized in pancreatic islet D-cells, namely SRIF-14 (Stoller, T., and Shields, D. (1989) J. Biol. Chem. 264, 6922-6928). We have now compared the proteolytic processing of pro-SRIF-II to that of pro-SRIF-I in these cells. In contrast to pro-SRIF-I, pro-SRIF-II was neither processed nor secreted. Instead, greater than 70% of the precursor was degraded intracellularly in a post-trans Golgi network compartment which was inhibited by weak bases. Brefeldin A treatment prevented degradation, suggesting that turnover of the remaining pro-SRIF-II occurred after exit from the endoplasmic reticulum/intermediate compartment and prior to arrival at the trans Golgi network. The intracellular degradation of the precursor was unexpected, since heterologous cells which do not cleave prohormones generally secrete the unprocessed precursor. We speculate that unique structural domains within each precursor are recognized by the sorting apparatus in GH3 cells, thereby targeting the molecules to different intracellular organelles.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT ANAT & STRUCT BIOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT DEV BIOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT CANC,BRONX,NY 10461; UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT BIOCHEM,LONDON SW7 2AY,ENGLAND	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Imperial College London	DANOFF, A (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV ENDOCRINOL,BRONX,NY 10461, USA.			Cutler, Daniel/0000-0002-4288-7530	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021860, R37DK021860] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 21860, DK 18994] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; ANDREWS PC, 1987, J BIOL CHEM, V262, P12692; ANDREWS PC, 1984, J BIOL CHEM, V259, P5021; ARGOS P, 1983, J BIOL CHEM, V258, P8788; ARMSTRONG J, 1990, J CELL SCI, V95, P191; BEINFELD MC, 1989, J BIOL CHEM, V264, P4460; BOURBONNAIS Y, 1988, J BIOL CHEM, V263, P15342; BURGESS TL, 1985, J CELL BIOL, V101, P639, DOI 10.1083/jcb.101.2.639; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BURKE B, 1984, CELL, V36, P847, DOI 10.1016/0092-8674(84)90034-5; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; DANOFF A, 1988, J BIOL CHEM, V263, P16461; DICKERSON IM, 1987, J BIOL CHEM, V262, P13646; FAWELL SE, 1984, MOL CELL ENDOCRINOL, V37, P15, DOI 10.1016/0303-7207(84)90124-2; FRITZ LC, 1987, J BIOL CHEM, V262, P12409; FUGIWARA T, 1988, J BIOL CHEM, V263, P18545; HELLERMAN JG, 1984, P NATL ACAD SCI-BIOL, V81, P5340, DOI 10.1073/pnas.81.17.5340; HOBART P, 1980, NATURE, V288, P137, DOI 10.1038/288137a0; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MACKIN RB, 1987, J BIOL CHEM, V262, P6453; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MCDONALD JK, 1987, J HISTOCHEM CYTOCHEM, V35, P155, DOI 10.1177/35.2.2878951; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; NOE BD, 1986, J CELL BIOL, V103, P1205, DOI 10.1083/jcb.103.4.1205; NOE BD, 1983, J BIOL CHEM, V258, P1121; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; RHOLAM M, 1986, FEBS LETT, V207, P1, DOI 10.1016/0014-5793(86)80002-3; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SEVARINO KA, 1987, J BIOL CHEM, V262, P4987; SEVARINO KA, 1989, CELL, V57, P11, DOI 10.1016/0092-8674(89)90167-0; SPIESS J, 1985, P NATL ACAD SCI USA, V82, P277, DOI 10.1073/pnas.82.2.277; STOLLER TJ, 1989, J BIOL CHEM, V264, P6922; STOLLER TJ, 1988, J CELL BIOL, V107, P2087, DOI 10.1083/jcb.107.6.2087; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; THOMAS G, 1986, SCIENCE, V232, P1641, DOI 10.1126/science.3754979; THORNE BA, 1990, J BIOL CHEM, V265, P8436; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; WARREN TG, 1984, CELL, V39, P547, DOI 10.1016/0092-8674(84)90461-6	43	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					10004	10010						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1674509				2022-12-25	WOS:A1991FM45900099
J	ANDO, Y; IMAMURA, S; OWADA, MK; KANNAGI, R				ANDO, Y; IMAMURA, S; OWADA, MK; KANNAGI, R			CALCIUM-INDUCED INTRACELLULAR CROSS-LINKING OF LIPOCORTIN-I BY TISSUE TRANSGLUTAMINASE IN A431 CELLS - AUGMENTATION BY MEMBRANE PHOSPHOLIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; DEPENDENT 35-KILODALTON SUBSTRATE; PROTEIN KINASE-C; BINDING-PROTEINS; HUMAN-PLACENTA; PHOSPHORYLATION SITES; PROTEOLYTIC FRAGMENTS; PURIFICATION; INHIBITION; SEQUENCE	Covalently cross-linked multimers of lipocortin I are shown to be present in human epidermoid carcinoma A431 cells treated with epidermal growth factor or the calcium ionophore A23187. This intracellular cross-linking of lipocortin I is suggested to be mediated by the action of tissue transglutaminase, a Ca2+-dependent protein cross-linking enzyme. Cross-linking of lipocortin I competes with proteolytic digestion of the protein, and pretreatment of the cells with inhibitors for calpain (Ca2+-dependent intracellular protease) markedly enhanced the cross-linking of lipocortin I. Cross-linked lipocortin I is shown to be present in the soluble fraction of A431 cells as well as in the particulate fraction; a 34-kDa fragment of lipocortin I was solubilized successfully by plasmin digestion of the latter fraction. Immunofluorescence microscopy using specific antilipocortin-I antibody showed that cross-linked lipocortin I forms an envelope-like structure, which is not extracted with [ethylenebis(oxyethylenenitrilo)]tetra-acetic acid (EGTA) or Triton X-100. In vitro incubation of purified lipocortin I with tissue transglutaminase resulted in the formation of covalently cross-linked lipocortin I dimer, tetramer, and so on. Amine incorporation and cross-linking studies using lipocortin I and its N-terminal truncated derivatives indicated that the cross-linking site is localized within the plasmin-susceptible N-terminal 29 amino acids of lipocortin I. The cross-linking of lipocortin I is shown to be accelerated more than 10 times by the addition of phosphatidylserine vesicles, on which lipocortin I molecules are most likely aligned in a conformation suitable for cross-linking. Collectively, these findings suggest that an increase of intracellular calcium concentration results in the attachment of lipocortin I onto the plasma membrane phospholipids through the C-terminal domain of the molecule where the membrane-bound lipocortin I is cross-linked by the action of tissue transglutaminase through the N-terminal domain.	KYOTO UNIV,FAC MED,DEPT CLIN SCI,KYOTO 606,JAPAN; KYOTO PHARMACEUT UNIV,INST MOLEC & CELLULAR BIOL PHARMACEUT SCI,DEPT MOLEC BIOREGULAT,KYOTO 607,JAPAN	Kyoto University; Kyoto Pharmaceutical University	ANDO, Y (corresponding author), KYOTO UNIV,FAC MED,DEPT DERMATOL,KYOTO 606,JAPAN.		Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921				AARSMAN AJ, 1987, FEBS LETT, V219, P176, DOI 10.1016/0014-5793(87)81212-7; AHN NG, 1988, J BIOL CHEM, V263, P18657; ALKI SM, 1989, NATURE, V340, P313; ANDO Y, 1987, J BIOCHEM-TOKYO, V101, P1331, DOI 10.1093/oxfordjournals.jbchem.a122000; ANDO Y, 1989, BIOCHEM BIOPH RES CO, V163, P944, DOI 10.1016/0006-291X(89)92313-9; ANDO Y, 1989, J BIOL CHEM, V264, P6948; Birckbichler P J, 1978, Ann N Y Acad Sci, V312, P354, DOI 10.1111/j.1749-6632.1978.tb16813.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNGAY PJ, 1986, BIOCHEM J, V235, P269, DOI 10.1042/bj2350269; CHUAH SY, 1989, J BIOL CHEM, V264, P21160; CREUTZ CE, 1987, J BIOL CHEM, V262, P1860; CROMPTON MR, 1988, EMBO J, V7, P21, DOI 10.1002/j.1460-2075.1988.tb02779.x; DADABAY CY, 1989, BIOCHEM J, V264, P679, DOI 10.1042/bj2640679; DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; DE BK, 1986, J BIOL CHEM, V261, P3784; FAVA RA, 1984, J BIOL CHEM, V259, P2636; FESUS L, 1985, J BIOL CHEM, V260, P3771; FLOWER RJ, 1984, ADV INFLAMMAT RES, V7, P61; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GEISOW MJ, 1987, BIOSCIENCE REP, V7, P289, DOI 10.1007/BF01121450; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; HAIGLER HT, 1987, J BIOL CHEM, V262, P6921; HAYASHI H, 1987, BIOCHEM BIOPH RES CO, V146, P912, DOI 10.1016/0006-291X(87)90617-6; HAYASHI H, 1989, J BIOL CHEM, V264, P17222; HIRATA F, 1984, ADV INFLAMMAT RES, V7, P71; HUANG KS, 1987, J BIOL CHEM, V262, P7639; HUANG KS, 1986, CELL, V46, P191, DOI 10.1016/0092-8674(86)90736-1; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; KAETZEL MA, 1989, J BIOL CHEM, V264, P14463; KANNAGI R, 1982, BIOCHEM BIOPH RES CO, V105, P164, DOI 10.1016/S0006-291X(82)80026-0; KITAHARA A, 1987, J CLIN ENDOCR METAB, V65, P885, DOI 10.1210/jcem-65-5-885; KITAHARA A, 1984, J BIOCHEM-TOKYO, V95, P1759; KRETSINGER RH, 1986, NATURE, V320, P573, DOI 10.1038/320573a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; LORAND L, 1987, BIOCHEMISTRY-US, V26, P308, DOI 10.1021/bi00375a043; MURACHI T, 1983, TRENDS BIOCHEM SCI, V8, P167, DOI 10.1016/0968-0004(83)90165-2; PEPINSKY RB, 1988, J BIOL CHEM, V263, P10799; PEPINSKY RB, 1986, NATURE, V321, P81, DOI 10.1038/321081a0; PEPINSKY RB, 1989, BIOCHEM J, V263, P97, DOI 10.1042/bj2630097; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; SARIS CJM, 1986, CELL, V46, P201, DOI 10.1016/0092-8674(86)90737-3; SCHLAEPFER DD, 1988, BIOCHEMISTRY-US, V27, P4253, DOI 10.1021/bi00412a008; SCHLAEPFER DD, 1987, J BIOL CHEM, V262, P6931; SHOJIKASAI Y, 1988, P NATL ACAD SCI USA, V85, P146, DOI 10.1073/pnas.85.1.146; SUDHOF TC, 1988, P NATL ACAD SCI USA, V85, P664, DOI 10.1073/pnas.85.3.664; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TAIT JF, 1988, BIOCHEMISTRY-US, V27, P6268, DOI 10.1021/bi00417a011; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; TYRRELL DJ, 1988, J BIOL CHEM, V263, P1946; VALENTINEBRAUN KA, 1987, ARCH BIOCHEM BIOPHYS, V259, P262, DOI 10.1016/0003-9861(87)90494-2; VARTICOVSKI L, 1988, BIOCHEMISTRY-US, V27, P3682, DOI 10.1021/bi00410a024; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; WEBER K, 1987, EMBO J, V6, P1599, DOI 10.1002/j.1460-2075.1987.tb02406.x; YEATON RW, 1983, J BIOL CHEM, V258, P9254	58	71	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1101	1108						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1670773				2022-12-25	WOS:A1991ET17700067
J	STRADER, CD; GAFFNEY, T; SUGG, EE; CANDELORE, MR; KEYS, R; PATCHETT, AA; DIXON, RAF				STRADER, CD; GAFFNEY, T; SUGG, EE; CANDELORE, MR; KEYS, R; PATCHETT, AA; DIXON, RAF			ALLELE-SPECIFIC ACTIVATION OF GENETICALLY ENGINEERED RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-ADRENERGIC-RECEPTOR; LIGAND-BINDING; ADENYLATE-CYCLASE; IDENTIFICATION; CELLS; LOCALIZATION; PROTEINS	The binding of agonists and antagonists to the beta-adrenergic receptor (beta-AR) is postulated to involve an ionic interaction between the amine group of the ligand and the carboxylate side chain of Asp113 in the third hydrophobic domain of the receptor. To explore the importance of this interaction in the binding of ligands to the Beta-AR, a Ser residue was substituted for Asp113, and the ability of this mutant receptor to respond to compounds which could potentially interact with the hydroxyl side chain of the Ser residue was assessed. The mutant receptor was fully activated by catechol-containing esters and ketones, compounds which did not activate the wild-type beta-AR. The demonstration that the molecular substitution of a single amino acid residue can alter the ligand binding specificity of the beta-AR provides evidence that the chemical nature of this residue is a critical determinant in the recognition site of the receptor. Further, the ability to modify the specificity of a receptor by the replacement of amino acids at the binding site demonstrates the potential for the rational design of drugs which function specifically at genetically engineered receptors.	MED UNIV S CAROLINA,DEPT PHARMACOL,CHARLESTON,SC 29425; MERCK SHARP & DOHME LTD,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065; MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486	Medical University of South Carolina; Merck & Company; Merck & Company	STRADER, CD (corresponding author), MERCK SHARP & DOHME LTD,DEPT MOLEC PHARMACOL & BIOCHEM,RAHWAY,NJ 07065, USA.							BILEZIKIAN JP, 1978, BIOCHEM PHARMACOL, V27, P1445, DOI 10.1016/0006-2952(78)90100-4; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DIXON RAF, 1987, NATURE, V326, P73, DOI 10.1038/326073a0; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; MAIN BG, 1985, PROG MED CHEM, V22, P122; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SAUNDERS J, 1989, TRENDS PHARMACOL SCI, P70; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; WILLINGHAM MC, 1978, P NATL ACAD SCI USA, V75, P4359, DOI 10.1073/pnas.75.9.4359; ZEMCIK BA, 1988, BIOCHEM J, V251, P333, DOI 10.1042/bj2510333	16	179	182	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					5	8						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1670767				2022-12-25	WOS:A1991EQ33900002
J	LUO, K; HURLEY, TR; SEFTON, BM				LUO, K; HURLEY, TR; SEFTON, BM			TRANSFER OF PROTEINS TO MEMBRANES FACILITATES BOTH CYANOGEN-BROMIDE CLEAVAGE AND 2-DIMENSIONAL PROTEOLYTIC MAPPING	ONCOGENE			English	Article											LUO, K (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92138, USA.				NATIONAL CANCER INSTITUTE [R01CA042350, P30CA014195, R01CA017289] Funding Source: NIH RePORTER; NCI NIH HHS [CA 17289, CA 42350, CA 14195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BOLEN JB, 1987, ONCOGENE RES, V1, P149; GIBSON W, 1974, VIROLOGY, V62, P319, DOI 10.1016/0042-6822(74)90395-X; GLYNN JP, 1964, CANCER RES, V24, P502; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HURLEY TR, 1989, ONCOGENE, V4, P265; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; LUO K, 1990, ONCOGENE, V5, P803; NIKODEM V, 1979, ANAL BIOCHEM, V97, P382, DOI 10.1016/0003-2697(79)90089-7; VEILLETTE A, 1988, ONCOGENE RES, V2, P385	12	118	120	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					921	923						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	1688326				2022-12-25	WOS:A1990DP55300020
J	PROCHNOW, D; RIEDEL, N; AGUTTER, PS; FASOLD, H				PROCHNOW, D; RIEDEL, N; AGUTTER, PS; FASOLD, H			POLY(A) BINDING-PROTEINS LOCATED AT THE INNER SURFACE OF RESEALED NUCLEAR ENVELOPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV FRANKFURT KLINIKUM,INST BIOCHEM,HAUS 75A,THEODOR STERN KAI 7,W-6000 FRANKFURT 70,GERMANY; BOSTON UNIV,SCH MED,CTR PULM,BOSTON,MA 02118; NAPIER COLL,DEPT BIOL SCI,EDINBURGH EH10 5DT,SCOTLAND	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Boston University; Edinburgh Napier University								AGUTTER PS, 1977, BIOCHEM J, V162, P671, DOI 10.1042/bj1620671; AGUTTER PS, 1986, NUCLEAR ENVELOPE RNA, P561; ARIMA T, 1968, BIOCHEM J, V106, P609, DOI 10.1042/bj1060609; BACHMANN M, 1984, BIOCHIM BIOPHYS ACTA, V773, P308, DOI 10.1016/0005-2736(84)90095-6; BERND A, 1982, MECH AGEING DEV, V20, P331, DOI 10.1016/0047-6374(82)90100-2; BERND A, 1982, EUR J BIOCHEM, V129, P43, DOI 10.1111/j.1432-1033.1982.tb07018.x; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BLOBEL G, 1973, P NATL ACAD SCI USA, V70, P924, DOI 10.1073/pnas.70.3.924; BLOOMFIELD VA, 1974, PHYSICAL CHEM NUCLEI; BORNENS M, 1978, J CELL BIOL, V76, P191, DOI 10.1083/jcb.76.1.191; DARNELL JE, 1971, P NATL ACAD SCI USA, V68, P1321, DOI 10.1073/pnas.68.6.1321; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; DWYER N, 1976, J CELL BIOL, V70, P581, DOI 10.1083/jcb.70.3.581; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; KAY RR, 1972, EUR J BIOCHEM, V30, P145, DOI 10.1111/j.1432-1033.1972.tb02081.x; KONDORKOCH C, 1982, EUR J BIOCHEM, V127, P285, DOI 10.1111/j.1432-1033.1982.tb06868.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG A, 1982, CHEM ENZYMATIC SYNTH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; MCDONALD JR, 1980, FEBS LETT, V116, P145, DOI 10.1016/0014-5793(80)80629-6; MCLAUGHLIN LW, 1984, OLIGONUCLEOTIDE SYNT, P128; MOLLOY GR, 1972, BIOCHEMISTRY-US, V11, P3256, DOI 10.1021/bi00767a020; PAINE PL, 1988, CELL BIOL INT REP, V12, P691, DOI 10.1016/0309-1651(88)90084-7; PORSCHKE D, 1985, J BIOMOL STRUCT DYN, V2, P1173, DOI 10.1080/07391102.1985.10507631; RICHARDSON CC, 1965, P NATL ACAD SCI USA, V54, P158, DOI 10.1073/pnas.54.1.158; RIEDEL N, 1987, P NATL ACAD SCI USA, V84, P3540, DOI 10.1073/pnas.84.11.3540; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; SCHRODER HC, 1986, EUR J BIOCHEM, V159, P51, DOI 10.1111/j.1432-1033.1986.tb09832.x; SCHWEIGER A, 1985, BIOCHIM BIOPHYS ACTA, V826, P87, DOI 10.1016/0167-4781(85)90112-5; Silberklang M, 1979, Methods Enzymol, V59, P58; WRESCHNER DH, 1984, NUCLEIC ACIDS RES, V12, P1349, DOI 10.1093/nar/12.3.1349; ZEEVI M, 1982, MOL CELL BIOL, V2, P517, DOI 10.1128/MCB.2.5.517	39	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6536	6539						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691170				2022-12-25	WOS:A1990CZ67700007
J	RADER, JS; GOLUB, TR; HUDSON, JB; PATEL, D; BEDELL, MA; LAIMINS, LA				RADER, JS; GOLUB, TR; HUDSON, JB; PATEL, D; BEDELL, MA; LAIMINS, LA			INVITRO DIFFERENTIATION OF EPITHELIAL-CELLS FROM CERVICAL NEOPLASIAS RESEMBLES INVIVO LESIONS	ONCOGENE			English	Article									UNIV CHICAGO, HOWARD HUGHES MED INST, DEPT MOLEC GENET & CELL BIOL, CHICAGO, IL 60637 USA; MICHAEL REESE HOSP & MED CTR, DEPT OBSTET & GYNECOL, CHICAGO, IL 60616 USA	Howard Hughes Medical Institute; University of Chicago; Michael Reese Hospital & Medical Center								ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; BEDELL MA, 1987, J VIROL, V61, P3635, DOI 10.1128/JVI.61.11.3635-3640.1987; BEDELL MA, 1989, J VIROL, V63, P1247, DOI 10.1128/JVI.63.3.1247-1255.1989; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; CAMPION MJ, 1986, LANCET, V2, P237; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DURST M, 1987, ONCOGENE, V1, P251; FERENCZY A, 1987, BLAUSTEINS PATHOLOGY, P141; GISSMANN L, 1983, P NATL ACAD SCI-BIOL, V80, P560, DOI 10.1073/pnas.80.2.560; GRUNEBAUM AN, 1983, OBSTET GYNECOL, V62, P448; HAUSEN HZ, 1985, PROG MED VIROL, V32, P15; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; KAUR P, 1988, J VIROL, V62, P1917, DOI 10.1128/JVI.62.6.1917-1924.1988; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; KOSS LG, 1956, ANN NY ACAD SCI, V63, P1245, DOI 10.1111/j.1749-6632.1956.tb32134.x; LORINCZ AT, 1986, J VIROL, V58, P225, DOI 10.1128/JVI.58.1.225-229.1986; MACNAB JCM, 1986, NEW ENGL J MED, V315, P1052, DOI 10.1056/NEJM198610233151703; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; MCCANCE DJ, 1985, BRIT J OBSTET GYNAEC, V92, P1101, DOI 10.1111/j.1471-0528.1985.tb03019.x; MOORE KL, 1977, DEV HUMAN, P240; PIRISI L, 1987, J VIROL, V61, P1061, DOI 10.1128/JVI.61.4.1061-1066.1987; SCHLEGEL R, 1988, EMBO J, V7, P3181, DOI 10.1002/j.1460-2075.1988.tb03185.x; SILVERBERG E, 1989, CA-CANCER J CLIN, V39, P3; WAGNER D, 1984, OBSTET GYNECOL, V64, P767; WOODRUFF JD, 1980, OBSTET GYNECOL, V56, P727; WOODWORTH CD, 1989, J VIROL, V63, P159, DOI 10.1128/JVI.63.1.159-164.1989	26	56	62	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					571	576						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1691480				2022-12-25	WOS:A1990DB85300017
J	ORLOWSKI, J; LINGREL, JB				ORLOWSKI, J; LINGREL, JB			THYROID AND GLUCOCORTICOID HORMONES REGULATE THE EXPRESSION OF MULTIPLE NA,K-ATPASE GENES IN CULTURED NEONATAL RAT CARDIAC MYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CINCINNATI, COLL MED, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, DEPT BIOCHEM, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, DEPT MICROBIOL, CINCINNATI, OH 45267 USA	University of Cincinnati; University of Cincinnati; University of Cincinnati				Orlowski, John/0000-0001-7371-175X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BLONDEL B, 1971, EXPERIENTIA, V27, P356, DOI 10.1007/BF02138197; BRUTSAERT DL, 1989, ANNU REV PHYSIOL, V51, P263, DOI 10.1146/annurev.physiol.51.1.263; CHARLEMAGNE D, 1986, J BIOL CHEM, V261, P185; CHAUDHURY S, 1987, MOL ENDOCRINOL, V1, P83, DOI 10.1210/mend-1-1-83; CHIZZONITE RA, 1984, J BIOL CHEM, V259, P2628; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CURFMAN GD, 1977, J CLIN INVEST, V59, P586, DOI 10.1172/JCI108675; DANIELSEN M, 1984, MOL CELL BIOL, V4, P449, DOI 10.1128/MCB.4.3.449; DEWEER P, 1985, KIDNEY PHYSL PATHOPH, P31; ELMERNISSI G, 1983, PFLUG ARCH EUR J PHY, V399, P147; Gick G G, 1988, Prog Clin Biol Res, V268B, P277; GICK GG, 1988, J BIOL CHEM, V263, P16610; Grupp G, 1988, Prog Clin Biol Res, V258, P215; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; HABER RS, 1988, AM J PHYSIOL, V255, pE912, DOI 10.1152/ajpendo.1988.255.6.E912; HAGANE K, 1988, EUR J PHARMACOL, V146, P137, DOI 10.1016/0014-2999(88)90495-5; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; HOH JFY, 1978, J MOL CELL CARDIOL, V10, P1053, DOI 10.1016/0022-2828(78)90401-7; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; KALINYAK JE, 1987, J BIOL CHEM, V262, P10441; KENT RB, 1987, P NATL ACAD SCI USA, V84, P5369, DOI 10.1073/pnas.84.15.5369; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LANE LK, 1989, GENOMICS, V5, P445, DOI 10.1016/0888-7543(89)90008-6; LELIEVRE LG, 1986, BIOCHEM PHARMACOL, V35, P3449, DOI 10.1016/0006-2952(86)90611-8; LIN MH, 1978, J BIOL CHEM, V253, P723; LINGREL JB, 1990, IN PRESS PROG NUCLEI; LO CS, 1976, J BIOL CHEM, V251, P7826; LOMPRE AM, 1981, DEV BIOL, V84, P286, DOI 10.1016/0012-1606(81)90396-1; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; MAHDAVI V, 1982, NATURE, V297, P659, DOI 10.1038/297659a0; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; NAG AC, 1984, BIOCHEM J, V221, P21, DOI 10.1042/bj2210021; NG YC, 1987, MOL PHARMACOL, V32, P201; NORGAARD A, 1983, BIOCHEM BIOPH RES CO, V111, P319, DOI 10.1016/S0006-291X(83)80154-5; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; PHILIPSON KD, 1977, AM J PHYSIOL, V232, pC196, DOI 10.1152/ajpcell.1977.232.5.C196; RAYSON BM, 1982, AM J PHYSIOL, V243, pF463, DOI 10.1152/ajprenal.1982.243.5.F463; SAMUELS HH, 1977, J BIOL CHEM, V252, P6052; SCHMITT CA, 1988, J BIOL CHEM, V263, P17643; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; SCHWARTZ A, 1975, PHARMACOL REV, V27, P3; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; SIMONET WS, 1989, J BIOL CHEM, V264, P569; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; SINHA SK, 1981, BIOCHIM BIOPHYS ACTA, V641, P20, DOI 10.1016/0005-2736(81)90566-6; SWANN AC, 1989, J NEUROCHEM, V52, P1598, DOI 10.1111/j.1471-4159.1989.tb09214.x; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TAKEYASU K, 1989, CURR TOP MEMBR TRANS, V34, P143; WALKER P, 1980, PEDIATR RES, V14, P247, DOI 10.1203/00006450-198003000-00014; WERDAN K, 1984, BIOCHEM PHARMACOL, V33, P1873, DOI 10.1016/0006-2952(84)90542-2; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8; YOUNG RM, 1987, BIOCHEM BIOPH RES CO, V145, P52, DOI 10.1016/0006-291X(87)91286-1	58	140	140	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3462	3470						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689303				2022-12-25	WOS:A1990CP23600072
J	MARCHAND, JE; HERSHMAN, K; KUMAR, MSA; THOMPSON, ML; KREAM, RM				MARCHAND, JE; HERSHMAN, K; KUMAR, MSA; THOMPSON, ML; KREAM, RM			DISULFIRAM ADMINISTRATION AFFECTS SUBSTANCE-P-LIKE IMMUNOREACTIVE AND MONOAMINERGIC NEURAL SYSTEMS IN RODENT BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TUFTS UNIV, SCH MED, DEPT ANESTHESIOL, 136 HARRISON AVE, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT PHARMACOL, BOSTON, MA 02111 USA; TUFTS UNIV, SCH VET MED, DEPT ANAT, BOSTON, MA 02111 USA	Tufts University; Tufts University; Tufts University					NIDA NIH HHS [R01 DA 04128] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004128] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BANNON MJ, 1983, NATURE, V306, P791, DOI 10.1038/306791a0; BARABAN JM, 1978, EUR J PHARMACOL, V52, P27, DOI 10.1016/0014-2999(78)90018-3; BARUCH P, 1988, NEUROSCIENCE, V25, P889, DOI 10.1016/0306-4522(88)90042-5; BORRETT D, 1985, ANN NEUROL, V17, P396, DOI 10.1002/ana.410170416; BRADBURY AF, 1983, BIOCHEM BIOPH RES CO, V112, P372, DOI 10.1016/0006-291X(83)91473-0; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; CAVALLERI A, 1978, Scandinavian Journal of Work Environment and Health, V4, P66; CHRISTENSEN JK, 1984, BR J CLIN PRACTIC S, V38, P21; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; FAIMAN MD, 1979, BIOCH PHARMACOLOGY E, V2, P325; GLEMBOTSKI CC, 1983, J BIOL CHEM, V258, P7299; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GOLDSTEIN M, 1964, LIFE SCI, V3, P763, DOI 10.1016/0024-3205(64)90031-1; HARMAR AJ, 1984, BRAIN RES, V323, P342, DOI 10.1016/0006-8993(84)90310-X; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jancso G, 1987, CLIN J PAIN, V3, P123; JENSEN SB, 1984, ACTA PSYCHIAT SCAND, V69, P543, DOI 10.1111/j.1600-0447.1984.tb02529.x; JESSELL TM, 1978, BRAIN RES, V152, P183, DOI 10.1016/0006-8993(78)90146-4; KILPATRICK IC, 1986, J NEUROCHEM, V46, P1865; KIZER JS, 1984, P NATL ACAD SCI-BIOL, V81, P3228, DOI 10.1073/pnas.81.10.3228; KREAM RM, 1985, P NATL ACAD SCI USA, V82, P4832, DOI 10.1073/pnas.82.14.4832; KREAM RM, 1984, J COMP NEUROL, V222, P140, DOI 10.1002/cne.902220112; KREAM RM, 1987, SOC NEUR ABSTR, V13, P1257; MAINS RE, 1983, TRENDS NEUROSCI, V6, P229, DOI 10.1016/0166-2236(83)90100-5; MAINS RE, 1986, J BIOL CHEM, V261, P1938; MEFFORD IN, 1981, J NEUROSCI METH, V3, P207, DOI 10.1016/0165-0270(81)90056-X; MUSACCHIO J, 1964, LIFE SCI, V3, P769, DOI 10.1016/0024-3205(64)90032-3; NAKANISHI S, 1987, PHYSIOL REV, V67, P1117, DOI 10.1152/physrev.1987.67.4.1117; OTSUKA M, 1987, TRENDS PHARMACOL SCI, V8, P506; PANG IH, 1986, BRAIN RES, V376, P268, DOI 10.1016/0006-8993(86)90189-7; PAQUETTE TL, 1981, BIOCHEMISTRY-US, V20, P7403, DOI 10.1021/bi00529a013; PERNOW B, 1983, PHARMACOL REV, V35, P85; PLAZNIK A, 1983, PHARMACOL BIOCHEM BE, V19, P27, DOI 10.1016/0091-3057(83)90306-4; REGOLI D, 1988, TRENDS PHARMACOL SCI, V9, P290, DOI 10.1016/0165-6147(88)90013-2; SPAULDING TC, 1979, NEUROPHARMACOLOGY, V18, P103, DOI 10.1016/0028-3908(79)90015-7; SUGANO K, 1985, J BIOL CHEM, V260, P1724; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; TATEMOTO K, 1981, P NATL ACAD SCI-BIOL, V78, P6603, DOI 10.1073/pnas.78.11.6603; VOLICER L, 1984, ARCH INTERN MED, V144, P1294, DOI 10.1001/archinte.144.6.1294; YAKSH TL, 1985, PHARMACOL BIOCHEM BE, V22, P845, DOI 10.1016/0091-3057(85)90537-4; YAKSH TL, 1981, PAIN, V11, P293, DOI 10.1016/0304-3959(81)90633-3	41	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					264	273						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688429				2022-12-25	WOS:A1990CF66200042
J	ROMANI, A; DOWELL, E; SCARPA, A				ROMANI, A; DOWELL, E; SCARPA, A			CYCLIC AMP-INDUCED MG2+ RELEASE FROM RAT-LIVER HEPATOCYTES, PERMEABILIZED HEPATOCYTES, AND ISOLATED-MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC FREE MAGNESIUM; INTRACELLULAR FREE MAGNESIUM; HEPATIC CAMP ACCUMULATION; FLUORESCENT INDICATOR; ADENYLATE-CYCLASE; CALCIUM EFFLUX; MG-2+ EFFLUX; HEART; TRANSPORT; STIMULATION	The addition of norepinephrine, epinephrine, or forskolin to collagenase-dispersed rat liver hepatocytes increase cAMP and result in a 15% loss in total cell Mg2+ within 5 min. Conversely, carbachol and vasopressin induce a 10-15% increase of total cell Mg2+. Permeabilized hepatocytes also mobilize a large pool of Mg2+ when stimulated by ADP or cAMP. This stimulation is completely inhibited by atractyloside and bongkrekic acid, two different specific inhibitors of the mitochondrial adenine nucleotide translocase. cAMP directly mobilizes Mg2+ efflux from isolated rat liver mitochondria. 50 nM cAMP or 250-mu-M ADP induces in 5 min a mitochondrial loss of about 6 nmol of Mg2+/mg of protein and a stimulation of ATP efflux. The effect of cAMP is specific, is not reproduced by other cyclic or noncyclic nucleotides, and is inhibited by inhibitors of the adenine nucleotide translocase. These data indicate that cAMP is a messenger for a major mobilization of Mg2+ in hepatocytes. A major target for the effect of cAMP are mitochondria, which lose up to 20-25% of their total Mg2+ in 5 min, both within the cell and after isolation. Evidence is presented suggesting that the adenine nucleotide translocase is the target of the cAMP-dependent Mg2+ efflux and that cAMP may change the operation of the translocase. This, in turn, could change within the matrix the substrate of choice of the translocase from ATP to ATP.Mg.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA	Case Western Reserve University				Romani, Andrea/0000-0001-9864-4848	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018708] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 18708] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; ARIAS IM, 1908, LIVER BIOL PATHOBIOL, P9; BIRNBAUMER L, 1989, MOL MECHANISMS HORMO, P147; BLAIR JB, 1979, J BIOL CHEM, V254, P7579; BLATTER LA, 1990, PFLUG ARCH EUR J PHY, V416, P238, DOI 10.1007/BF00392059; BOGUCKA K, 1971, BIOCHEM BIOPH RES CO, V44, P1330, DOI 10.1016/S0006-291X(71)80231-0; BOND M, 1987, J BIOL CHEM, V262, P15630; BORLE AB, 1976, J MEMBRANE BIOL, V29, P209, DOI 10.1007/BF01868961; BORLE AB, 1974, J MEMBRANE BIOL, V16, P221, DOI 10.1007/BF01872416; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURI A, 1990, EXP PHYSIOL, V75, P751, DOI 10.1113/expphysiol.1990.sp003457; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; DEYOUNG MB, 1989, METHOD ENZYMOL, V173, P662; DOUGLAS JG, 1987, HYPERTENSION, V9, P49; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; EXTON JH, 1980, AM J PHYSIOL, V238, pE3, DOI 10.1152/ajpendo.1980.238.1.E3; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FLATMAN PW, 1984, J MEMBRANE BIOL, V80, P1, DOI 10.1007/BF01868686; Fleischer S, 1979, Methods Enzymol, V55, P32; GARFINKEL L, 1986, J MOL CELL CARDIOL, V18, P1003, DOI 10.1016/S0022-2828(86)80289-9; GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277; GRINSTEIN S, 1983, J BIOL CHEM, V258, P4774; GRUBBS RD, 1989, METHOD ENZYMOL, V173, P546; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUNTHER T, 1986, MAGNESIUM, V5, P53; HENDERSON PJ, 1970, BIOCHEMISTRY-US, V9, P3453, DOI 10.1021/bi00819a026; JAKOB A, 1989, FEBS LETT, V246, P127, DOI 10.1016/0014-5793(89)80267-4; JAKOBS KH, 1979, N-S ARCH PHARMACOL, V310, P113, DOI 10.1007/BF00500275; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; KLINGENBERG M, 1970, BIOCHEM BIOPH RES CO, V39, P344, DOI 10.1016/0006-291X(70)90582-6; KLINGENBERG M, 1977, EUR J BIOCHEM, V73, P125, DOI 10.1111/j.1432-1033.1977.tb11298.x; KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511; KLINGENBERG M, 1975, CIBA F S, V31, P105; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MAGUIRE ME, 1988, ANN NY ACAD SCI, V551, P201, DOI 10.1111/j.1749-6632.1988.tb22338.x; MORGAN NG, 1983, FEBS LETT, V153, P77, DOI 10.1016/0014-5793(83)80122-7; MORGAN NG, 1983, J BIOL CHEM, V258, P5103; MORGAN NG, 1983, FEBS LETT, V163, P277, DOI 10.1016/0014-5793(83)80835-7; MURPHY E, 1989, J BIOL CHEM, V264, P5622; MURPHY E, 1989, P NATL ACAD SCI USA, V86, P2981, DOI 10.1073/pnas.86.8.2981; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; PULLMAN ME, 1967, METHOD ENZYMOL, V10, P59; QUAMME GA, 1990, AM J PHYSIOL, V259, pC521, DOI 10.1152/ajpcell.1990.259.3.C521; QUAMME GA, 1990, BIOCHEM BIOPH RES CO, V167, P1406, DOI 10.1016/0006-291X(90)90679-H; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROMANI A, 1990, NATURE, V346, P841, DOI 10.1038/346841a0; ROMANI A, 1990, FEBS LETT, V269, P37, DOI 10.1016/0014-5793(90)81113-3; SCARPA A, 1974, BIOCHEMISTRY-US, V13, P2789, DOI 10.1021/bi00711a001; SCARPA A, 1976, J MEMBRANE BIOL, V29, P205, DOI 10.1007/BF01868960; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; STUDER RK, 1982, J BIOL CHEM, V257, P7987; VINOGRADOV A, 1972, ARCH BIOCHEM BIOPHYS, V152, P646, DOI 10.1016/0003-9861(72)90261-5; VORMANN J, 1987, MAGNESIUM, V6, P220; WALKER GM, 1986, MAGNESIUM, V5, P9; WEINER N, 1985, PHARMACOL BASIS THER, P145; WHITE RE, 1989, BIOCHEM PHARMACOL, V38, P859, DOI 10.1016/0006-2952(89)90272-4; WIENER E, 1989, J BIOL CHEM, V264, P4324; WULF R, 1978, EUR J BIOCHEM, V82, P585, DOI 10.1111/j.1432-1033.1978.tb12054.x; ZHENG JS, 1990, ANN NY ACAD SCI, V603, P448; ZHENG JS, 1992, IN PRESS AM J PHYSL	62	78	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24376	24384						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662210				2022-12-25	WOS:A1991GW84500024
J	SHEIKH, SP; HANSEN, AP; WILLIAMS, JA				SHEIKH, SP; HANSEN, AP; WILLIAMS, JA			SOLUBILIZATION AND AFFINITY PURIFICATION OF THE Y2 RECEPTOR FOR NEUROPEPTIDE-Y AND PEPTIDE-YY FROM RABBIT KIDNEY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; CROSS-LINKING; BINDING; MEMBRANES; NPY; RESPONSES; PROTEINS; HORMONE; ANIMALS; FAMILY	Neuropeptide Y (NPY) is an important neuropeptide in both central and peripheral neurones whereas peptide YY (PYY) is a gut hormone present in endocrine cells in the lower bowel. Both peptides interact with multiple binding sites that have been further classified into Y1 and Y2 receptors. We have solubilized native Y2 receptors both from basolateral membranes of proximal convoluted tubules from rabbit kidney and from rat hippocampal membranes. Solubilization of functional Y2 receptors was obtained with both 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) and digitonin and resulted in each case in a single class of high affinity binding sites. The soluble receptor retained the binding specificity for different peptides and long C-terminal fragments of NPY exhibited by membrane preparations. Gel filtration of solubilized receptors resulted in a single peak of specific PYY binding activity corresponding to M(r) = 350,000 whereas affinity labeling revealed a major band of M(r) = 60,000. Since this binding activity was inhibited by guanosine 5'-3-O-(thio)triphosphate (GTP-gamma-S) the Y2 receptor is probably solubilized as a receptor complex containing a G-protein along with the ligand binding protein. Y2 receptor binding sites from kidney tubular membranes were purified to homogeneity by a three-step procedure employing Mono S cation-exchange adsorption, affinity chromatography on wheat germ lectin-agarose beads, and affinity chromatography on NPY-Affi-Gel. Electrophoresis and silver staining of the final receptor preparation revealed a single protein with M(r) = 60,000 whereas gel filtration showed a single peak at approximately M(r) = 60,000. The purified protein can be affinity labeled with [I-125-Tyr36] PYY, indicating that the M(r) = 60,000 protein contains the ligand binding site of the Y2 receptor, and this binding is not affected by GTP-gamma-S. Scatchard transformation of binding data for the purified Y2 receptors was compatible with a single class of binding sites with K(d) = 76 pM. The purified Y2 receptors retain their binding properties with regard to affinity and specificity for different members of the pancreatic polypeptide-fold peptide family. The specific activity of purified Y2 receptors was calculated to approximately 14.7 nmol of ligand binding/mg of receptor protein, which is consistent with the theoretical value (16.6 nmol/mg) for a pure M(r) = 60,000 protein binding one PYY molecule. Purification to homogeneity thus reveals the Y2 receptor as an M(r) = 60,000 glycoprotein.	UNIV MICHIGAN,DEPT PHYSIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	SHEIKH, SP (corresponding author), UNIV COPENHAGEN,RIGSHOSP 6321,DEPT CLIN BIOCHEM,MOLEC ENDOCRINOL LAB,DK-1168 COPENHAGEN,DENMARK.			Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041225] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 41225] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHANG RSL, 1985, LIFE SCI, V37, P2111, DOI 10.1016/0024-3205(85)90583-1; COLMERS WF, 1987, J PHYSIOL-LONDON, V383, P285; GIMPL G, 1990, J BIOL CHEM, V265, P18142; GLOVER ID, 1985, EUR J BIOCHEM, V142, P379; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; INUI A, 1989, ENDOCRINOLOGY, V124, P402, DOI 10.1210/endo-124-1-402; KOPPELMAN MCS, 1982, ENDOCRINOLOGY, V111, P1350, DOI 10.1210/endo-111-4-1350; LABURTHE M, 1986, ENDOCRINOLOGY, V118, P1910, DOI 10.1210/endo-118-5-1910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V116, P477, DOI 10.1111/j.1748-1716.1982.tb07171.x; LUNDBERG JM, 1988, NEUROSCIENCE, V24, P659, DOI 10.1016/0306-4522(88)90359-4; MANNON PJ, 1989, AM J PHYSIOL, V256, pG637, DOI 10.1152/ajpgi.1989.256.3.G637; MANNON PJ, 1991, J NEUROCHEM, V56, P1804, DOI 10.1111/j.1471-4159.1991.tb02084.x; NGUYEN TD, 1990, J BIOL CHEM, V265, P6416; ODONOHUE TL, 1985, PEPTIDES, V6, P755, DOI 10.1016/0196-9781(85)90180-9; OHARE MMT, 1990, CANCER RES, V49, P7015; SCHWARTZ TW, 1987, FEBS LETT, V225, P209, DOI 10.1016/0014-5793(87)81159-6; SCHWARTZ TW, 1989, NEUROPEPTIDE Y, P143; SHEIKH MI, 1982, BIOCHEM J, V208, P377, DOI 10.1042/bj2080377; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; SHEIKH SP, 1989, AM J PHYSIOL, V257, pF978, DOI 10.1152/ajprenal.1989.257.6.F978; SHEIKH SP, 1990, J BIOL CHEM, V265, P8304; SHEIKH SP, 1991, AM J PHYSIOL, V261, P701; SHEIKH SP, 1991, AM J PHYSIOL, V260, P250; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; SZECOWKA J, 1985, REGUL PEPTIDES, V10, P71, DOI 10.1016/0167-0115(85)90001-1; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2514, DOI 10.1073/pnas.79.8.2514; UNDEN A, 1984, EUR J BIOCHEM, V145, P525, DOI 10.1111/j.1432-1033.1984.tb08588.x; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WALKER MW, 1989, MOL PHARMACOL, V34, P779	30	19	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23959	23966						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660889				2022-12-25	WOS:A1991GV31900068
J	PANDE, S; JAHN, D; SOLL, D				PANDE, S; JAHN, D; SOLL, D			HISTIDINE TRANSFER-RNA GUANYLYLTRANSFERASE FROM SACCHAROMYCES-CEREVISIAE .1. PURIFICATION AND PHYSICAL-PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-III GENES; CHLAMYDOMONAS-REINHARDTII; 5'-TERMINAL GUANYLATE; POLYMERASE-II; 5' TERMINUS; TRANSCRIPTION; PRECURSORS; CLEAVAGE; MUTANTS; COLI	Compared to other tRNAs all known histidine tRNAs have the unique feature of possessing an additional nucleotide at their 5' end. It is usually a guanosine residue but not in bacteriophage T5 tRNA which carries an additional uridine. The additional nucleotide is not encoded in eukaryotic histidine tRNA genes but is added in a post-transcriptional modification reaction (Cooley, L., Appel, B., and Soll, D. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6475-6479) by histidine tRNA guanylyltransferase (tRNA(His) guanylyltransferase). Here we report the purification of this enzyme from Saccharomyces cerevisiae and the determination of some of its physical properties. Six different steps including Polymin P precipitation, chromatography on DEAE-cellulose, phosphocellulose, heparin-agarose, ATP-agarose, and gel filtration on Superose 12 were employed for the purification of the guanylyltransferase from an S-100 extract. A Stokes radius of 46.5 +/- 0.5 angstrom and a sedimentation coefficient (s20,w) of 7.8 +/- 0.2 were determined by gel filtration and rate zonal sedimentation, respectively. A relative molecular weight (M(r)) of approximately 120,000 was calculated for the purified native enzyme. The M(r) of the denatured protein is approximately 58,000 as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These results indicate a homodimeric (alpha-2) structure for the enzyme. Among all acceptor RNAs in unfractionated tRNA only tRNA(his) is a substrate for the purified guanylyltransferase. The reaction requires ATP, a guanosine substrate, and a divalent metal ion. Treatment of guanylyltransferase with 5,5'-dithiobis(2-nitrobenzoic)acid abolishes activity; this suggests the importance of sulfhydryl groups for enzymatic activity. The enzyme shows discrimination among different histidine tRNA species; tRNA from plant and prokaryotes are better substrates than mammalian and insect tRNAs.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,POB 6666,NEW HAVEN,CT 06511	Yale University				Jahn, Dieter/0000-0002-4064-9205	NIGMS NIH HHS [R01-GM22854-16] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELSON J, 1979, ANNU REV BIOCHEM, V48, P1035, DOI 10.1146/annurev.bi.48.070179.005131; BARCISZEWSKA MZ, 1986, PLANT SCI, V47, P103, DOI 10.1016/0168-9452(86)90056-7; BOGUSLAWSKI G, 1974, BIOCHEMISTRY-US, V13, P4659, DOI 10.1021/bi00719a030; BURKARD U, 1988, J BIOL CHEM, V263, P9578; BURKARD U, 1988, J BIOL CHEM, V263, P2447; CHEN MW, 1990, J BIOL CHEM, V265, P4054; CHEN MW, 1990, J BIOL CHEM, V265, P4058; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; FRANCKLYN C, 1991, IN PRESS; GREEN CJ, 1988, J BIOL CHEM, V263, P652; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7588; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; JAHN D, 1990, J BIOL CHEM, V265, P8059; JAHN D, 1987, J MOL BIOL, V193, P303, DOI 10.1016/0022-2836(87)90221-X; JAHN D, 1991, J BIOL CHEM, V266, P22832; JENDRISAK JJ, 1975, BIOCHEMISTRY-US, V14, P4639, DOI 10.1021/bi00692a012; JONES EW, 1977, GENETICS, V85, P23; KLEKAMP MS, 1982, J BIOL CHEM, V257, P8432; KUMAR AM, 1990, THESIS INDIAN I SCI; LABBE D, 1990, J BIOL CHEM, V265, P2988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; ROSA MD, 1983, NUCLEIC ACIDS RES, V11, P853, DOI 10.1093/nar/11.3.853; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5889; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sprinzl M., 1989, Nucleic Acids Research, V17, P1; WALDSCHMIDT R, 1988, J BIOL CHEM, V263, P13350; WILLIAMS JB, 1990, METHOD ENZYMOL, V181, P665; ZILLIG W, 1970, H-S Z PHYSIOL CHEM, V351, P221, DOI 10.1515/bchm2.1970.351.1.221	32	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					22826	22831						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660461				2022-12-25	WOS:A1991GT48300011
J	ANDERSON, CM; OLEFSKY, JM				ANDERSON, CM; OLEFSKY, JM			PHORBOL ESTER-MEDIATED PROTEIN-KINASE-C INTERACTION WITH WILD-TYPE AND COOH-TERMINAL TRUNCATED INSULIN-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; RAT ADIPOCYTES; SERINE KINASE; BETA-SUBUNIT; CELLS; BINDING; INVITRO; STIMULATION; BASAL; SITE	The effects of 12-0-tetradecanoylphorbol-13-acetate (TPA) and insulin were compared in wild-type human insulin receptors (HIRc cells) and human insulin receptors lacking 43 COOH-terminal amino acid residues (HIR-DELTA-CT cells). TPA increased total phosphorylation of the wild-type insulin receptor and inhibited insulin-stimulated autophosphorylation by 32 +/- 10% in HIRc cells. TPA inhibited insulin-stimulated autophosphorylation by 46 +/- 14% in HIR-DELTA-CT cells and also caused a 65% decrease in basal phosphorylation. Insulin-stimulated tyrosine kinase activity for poly(Glu4/Tyr1) was inhibited by TPA in HIRc and HIR-DELTA-CT cells by 50 and 40%, respectively. TPA decreased insulin-stimulated glucose incorporation into glycogen by 50% in HIRc cells and to near basal levels in HIR-DELTA-CT cells; this inhibitory effect of TPA was reversed in both cell lines by staurosporine. In conclusion, 1) TPA-induced inhibition of insulin receptor tyrosine autophosphorylation was linked to concomitant inhibition of the biological effects of insulin in cells expressing either wild-type or COOH-terminal truncated insulin receptors; and 2) the inhibitory effects of TPA were not dependent upon phosphorylation of COOH-terminal residues and furthermore appeared to be independent of phosphorylation of any insulin receptor serine/threonine residues. These findings suggest a novel protein kinase C mechanism that results in altered insulin receptor function without increasing phosphorylation of the receptor.	VET ADM MED CTR,MED RES SERV,SAN DIEGO,CA 92161	US Department of Veterans Affairs; Veterans Health Administration (VHA)	ANDERSON, CM (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651, T32DK007494] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 07494, DK 33651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; COCHET C, 1984, J BIOL CHEM, V259, P2553; HACHIYA HL, 1987, J BIOL CHEM, V262, P6417; JACOBS S, 1986, J BIOL CHEM, V261, P934; JACOBS S, 1983, P NATL ACAD SCI-BIOL, V80, P6211, DOI 10.1073/pnas.80.20.6211; KASUGA M, 1982, J BIOL CHEM, V257, P9891; KASUGA M, 1983, P NATL ACAD SCI-BIOL, V80, P2137, DOI 10.1073/pnas.80.8.2137; KIRSCH D, 1985, BIOCHEM BIOPH RES CO, V128, P824, DOI 10.1016/0006-291X(85)90121-4; KOSHIO O, 1989, FEBS LETT, V254, P22, DOI 10.1016/0014-5793(89)81001-4; LEWIS RE, 1990, BIOCHEMISTRY-US, V29, P1807, DOI 10.1021/bi00459a020; LEWIS RE, 1990, J BIOL CHEM, V265, P947; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MAY WS, 1983, P NATL ACAD SCI USA, V81, P7797; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; PANG DT, 1985, J BIOL CHEM, V260, P7131; PURCHIO AF, 1985, SCIENCE, V229, P1393, DOI 10.1126/science.2994221; RAZIN A, 1978, P NATL ACAD SCI USA, V75, P4268, DOI 10.1073/pnas.75.9.4268; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; SHACKELFORD DA, 1984, J BIOL CHEM, V259, P1706; SMITH DM, 1988, BIOCHEM J, V250, P509, DOI 10.1042/bj2500509; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TAKAYAMA S, 1984, P NATL ACAD SCI-BIOL, V81, P7797, DOI 10.1073/pnas.81.24.7797; TAYLOR R, 1987, BIOCHEM J, V242, P123, DOI 10.1042/bj2420123; THEIS RS, 1989, J BIOL CHEM, V264, P12820; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VANDEWERVE G, 1985, BIOCHEM J, V225, P523, DOI 10.1042/bj2250523; WHITE MF, 1985, J BIOL CHEM, V260, P9470; YU KT, 1984, J BIOL CHEM, V259, P5277	30	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21760	21764						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657981				2022-12-25	WOS:A1991GP80400066
J	EASTON, EW; BOLSCHER, JGM; VANDENEIJNDEN, DH				EASTON, EW; BOLSCHER, JGM; VANDENEIJNDEN, DH			ENZYMATIC AMPLIFICATION INVOLVING GLYCOSYLTRANSFERASES FORMS THE BASIS FOR THE INCREASED SIZE OF ASPARAGINE-LINKED GLYCANS AT THE SURFACE OF NIH 3T3 CELLS EXPRESSING THE N-RAS PROTOONCOGENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER-KIDNEY CELLS; ACETYLGLUCOSAMINYLTRANSFERASE-V ACTIVITIES; ASCITES TUMOR-CELLS; BLOOD-GROUP-I; GLYCOPROTEIN-SYNTHESIS; BOVINE COLOSTRUM; SIALIC-ACID; UDP-GAL; MEMBRANE-GLYCOPROTEINS; LIQUID-CHROMATOGRAPHY	Expression of ras oncogenes in NIH 3T3 fibroblasts results in the acquisition by these cells of an invasive potential concomitant with the appearance of cell surface asparagine-linked complex-type glycan structures of a higher average molecular weight (Bolscher, J. G. M., van der Bijl, M. M. W., Neefjes, J. J., Hall, A., Smets, L. A., and Ploegh, H. L. (1988) EMBO J. 7, 3361-3368). We have investigated the enzymatic basis for the altered glycosylation by assessing the activities of all major Golgi glycosyltransferases involved in the synthesis of these structures. Use was made of a stable transfectant cell line (T15) containing the N-ras-protooncogene under the control of a glucocorticoid-inducible mouse mammary tumor virus promoter. Upon induction of the ras gene with dexamethasone: 1) the levels of N-acetylglucosaminyltransferase I and II were essentially unaltered, indicating an unaffected potential to synthesize complex-type glycans; 2) the activities of the branching N-acetylglucosaminyltransferase III and V were elevated 2- to 2.5-fold suggesting the formation of increased amounts of bisected glycans and of structures carrying a Gal-beta-1 --> GlcNAc-beta-1 --> 6Man-branch; 3) the levels of the elongating beta-4-galactosyltransferase and beta-3-N-acetylglucosaminyltransferase were increased 5- to 7-fold indicating a strongly enhanced capacity to synthesize polylactosaminoglycan chains; 4) the level of the major chain-terminating enzyme, alpha-3-galactosyltransferase, was slightly decreased (0.7-fold), whereas those of the alpha-3- and alpha-6-sialyltransferases were slightly elevated (1.3- and 2-fold, respectively), suggesting a shift from termination by alpha-galactosyl residues to termination by sialic acid moieties. Studies on the acceptor specificities of the different glycosyltransferases indicate that these changes occur in a coordinated manner in which the effects of altered glycosyltransferase expression levels amplify each other. Analysis of the size of cell surface complex-type glycopeptides before and after digestion with neuraminidase and endo-beta-galactosidase suggested an increased sialic acid density, an increase in the number and/or length of polylactosaminoglycan chains, and an increased branching of the glycans upon N-ras induction. The enzymatic results explain these structural changes and allow us to define the alterations in glycosylation pathways associated with ras expression.	FREE UNIV AMSTERDAM,DEPT MED CHEM,VAN DER BOECHORSTSTR 7,1081 BT AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,DIV CELLULAR BIOCHEM,1066 CX AMSTERDAM,NETHERLANDS	Vrije Universiteit Amsterdam; Netherlands Cancer Institute			Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164				ALHADEFF JA, 1989, CRIT REV ONCOL HEMAT, V9, P37, DOI 10.1016/S1040-8428(89)80014-9; ARANGO J, 1988, J CELL BIOCHEM, V37, P225, DOI 10.1002/jcb.240370209; BERGER EG, 1985, P NATL ACAD SCI USA, V82, P4736, DOI 10.1073/pnas.82.14.4736; BLANKEN WM, 1984, J BIOL CHEM, V259, P5131; BLANKEN WM, 1982, EUR J BIOCHEM, V127, P547, DOI 10.1111/j.1432-1033.1982.tb06906.x; BLANKEN WM, 1985, J BIOL CHEM, V260, P2927; BLANKEN WM, 1985, THESIS VRIJE U AMSTE; BOLSCHER JGM, 1986, CANCER RES, V46, P4080; BOLSCHER JGM, 1988, EMBO J, V7, P3361, DOI 10.1002/j.1460-2075.1988.tb03208.x; CHESTER MA, 1976, EUR J BIOCHEM, V69, P583, DOI 10.1111/j.1432-1033.1976.tb10944.x; COLLARD JG, 1986, CANCER RES, V46, P3521; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1990, GLYCOCONJUGATE J, V7, P417; DENNIS JW, 1988, CANCER SURV, V7, P573; DENNIS JW, 1989, ONCOGENE, V4, P853; DENNIS JW, 1989, CANCER RES, V49, P945; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; ELICES MJ, 1989, J BIOL CHEM, V264, P1375; GLEESON PA, 1983, J BIOL CHEM, V258, P6162; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; HARPAZ N, 1980, J BIOL CHEM, V255, P4885; HUBBARD SC, 1987, J BIOL CHEM, V262, P16403; JOZIASSE DH, 1983, CARBOHYD RES, V119, P303; KOBATA A, 1984, PURE APPL CHEM, V56, P821, DOI 10.1351/pac198456070821; Koenderman A H, 1986, Biomed Chromatogr, V1, P104, DOI 10.1002/bmc.1130010304; KOENDERMAN AHL, 1989, EUR J BIOCHEM, V181, P651, DOI 10.1111/j.1432-1033.1989.tb14772.x; MCKAY IA, 1986, EMBO J, V5, P2617, DOI 10.1002/j.1460-2075.1986.tb04542.x; NARASIMHAN S, 1985, BIOCHEMISTRY-US, V24, P1694, DOI 10.1021/bi00328a019; NARASIMHAN S, 1988, J BIOL CHEM, V263, P1273; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PIERCE M, 1986, J BIOL CHEM, V261, P772; SADEH S, 1983, FEBS LETT, V163, P104, DOI 10.1016/0014-5793(83)81173-9; SANTER UV, 1984, CANCER RES, V44, P3730; SANTER UV, 1979, BIOCHEMISTRY-US, V18, P2533, DOI 10.1021/bi00579a016; SANTER UV, 1989, EUR J BIOCHEM, V181, P249, DOI 10.1111/j.1432-1033.1989.tb14719.x; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SCHIRRMACHER V, 1982, Invasion and Metastasis, V2, P313; SCUDDER P, 1984, J BIOL CHEM, V259, P6586; SMITH DF, 1990, J BIOL CHEM, V265, P6225; TETTEROO PAT, 1987, J BIOL CHEM, V262, P15984; VANBEEK WP, 1977, BRIT J CANCER, V36, P157, DOI 10.1038/bjc.1977.172; VANBEEK WP, 1973, CANCER RES, V33, P2913; VANDENEIJNDEN DH, 1988, J BIOL CHEM, V263, P12461; VANDENEIJNDEN DH, 1981, J BIOL CHEM, V256, P3159; VANDENEIJNDEN DH, 1983, J BIOL CHEM, V258, P3435; VANDENEIJNDEN DH, 1985, 8TH P INT S GLYC, V1, P285; VANDIJK W, 1986, BIOCHEM CELL BIOL, V64, P79, DOI 10.1139/o86-014; WANG XC, 1989, J BIOL CHEM, V264, P1854; WARREN L, 1972, P NATL ACAD SCI USA, V69, P1838, DOI 10.1073/pnas.69.7.1838; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; YAMASHITA K, 1985, J BIOL CHEM, V260, P3963; YAMASHITA K, 1984, J BIOL CHEM, V259, P834	54	84	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21674	21680						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657976				2022-12-25	WOS:A1991GP80400054
J	HAKEDA, Y; HARADA, S; MATSUMOTO, T; TEZUKA, K; HIGASHINO, K; KODAMA, H; HASHIMOTOGOTO, T; OGATA, E; KUMEGAWA, M				HAKEDA, Y; HARADA, S; MATSUMOTO, T; TEZUKA, K; HIGASHINO, K; KODAMA, H; HASHIMOTOGOTO, T; OGATA, E; KUMEGAWA, M			PROSTAGLANDIN-F2-ALPHA STIMULATES PROLIFERATION OF CLONAL OSTEOBLASTIC MC3T3-E1 CELLS BY UP-REGULATION OF INSULIN-LIKE GROWTH FACTOR-I RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BINDING-PROTEINS; FACTOR IGF BINDING; CULTURED MOUSE CALVARIA; PARATHYROID-HORMONE; BONE-RESORPTION; CYCLIC-AMP; RAT BONE; ENRICHED CULTURES; CALCIUM; COLLAGEN	Prostaglandin F2-alpha (PGF2-alpha) stimulates proliferation of clonal osteoblastic MC3T3-E1 cells mainly via the stimulation of phospholipase C. These cells constitutively produced and secreted insulin-like growth factor I (IGF-I). In addition, a neutralizing anti-IGF-I antibody completely abolished DNA synthesis stimulated by PGF2-alpha in MC3T3-E1 cells, suggesting that IGF-I indeed mediates the PGF2-alpha effect. However, PGF2-alpha decreased the expression of IGF-I mRNA and the secretion of immunoreactive IGF-I into the medium, whereas progression activity in the conditioned medium was not affected by PGF2-alpha. Although IGF-I alone did not stimulate DNA synthesis in MC3T3-E1 cells, when PGF2-alpha was added to the cultures, IGF-I stimulated their proliferation. Thus, PGF2-alpha may potentiate the action of IGF-I. At the same time, PGF2-alpha increased the number of high affinity binding sites (molecular mass of 130 kDa) for IGF-I in a dose-dependent manner. The increase in IGF-I-binding site number preceded the elevation of DNA synthesis by approximately 3 h. Furthermore, MC3T3-El cells secreted at least three species of IGF-binding proteins (IGFBPs) with molecular masses of 24, 30, and 34 kDa. In the early period of PGF2-alpha exposure, PGF2-alpha attenuated the secretion of all of these IGFBPs, whereas thereafter, it markedly increased their secretion, especially that of the 34-kDa IGFBP, suggesting a modulation of metabolism and action of IGF-I. These effects of PGF2-alpha on IGF-I receptor number and IGFBP secretion may play a role in the synergism between PGF2-alpha and IGF-I that results in the stimulation of DNA synthesis in MC3T3-E1 cells.	UNIV TOKYO, SCH MED, DEPT INTERNAL MED, BUNKYO KU, TOKYO 112, JAPAN; HOECHST JAPAN LTD, PHARMA RES LABS, MOLEC BIOL LAB, KAWAGOE, SAITAMA 350, JAPAN; OHU UNIV, SCH DENT, DEPT ORAL ANAT, KORIYAMA, FUKUSHIMA 963, JAPAN	University of Tokyo	HAKEDA, Y (corresponding author), MEIKAI UNIV, SCH DENT, DEPT ORAL ANAT, SAKADO, SAITAMA 35002, JAPAN.		Tezuka, Ken-ichi/B-3836-2012					BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873; BENNETT A, 1984, ENDOCRINOLOGY, V115, P1577, DOI 10.1210/endo-115-4-1577; CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; CASCIERI MA, 1989, J CELL PHYSIOL, V139, P181, DOI 10.1002/jcp.1041390125; CLEMMONS DR, 1990, ENDOCRINOLOGY, V127, P643, DOI 10.1210/endo-127-2-643; CROZE F, 1990, ENDOCRINOLOGY, V127, P1995, DOI 10.1210/endo-127-4-1995; DZIAK R, 1979, ARCH ORAL BIOL, V24, P347, DOI 10.1016/0003-9969(79)90101-8; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; ERNST M, 1989, ENDOCRINOLOGY, V125, P825, DOI 10.1210/endo-125-2-825; ERNST M, 1990, ENDOCRINOLOGY, V127, P807, DOI 10.1210/endo-127-2-807; ERNST M, 1988, BIOCHEM BIOPH RES CO, V151, P142, DOI 10.1016/0006-291X(88)90570-0; FUKUO K, 1986, BIOCHEM BIOPH RES CO, V136, P247, DOI 10.1016/0006-291X(86)90901-0; HAKEDA Y, 1987, ENDOCRINOLOGY, V121, P1966, DOI 10.1210/endo-121-6-1966; HAKEDA Y, 1986, J CELL PHYSIOL, V128, P155, DOI 10.1002/jcp.1041280204; HAKEDA Y, 1985, BIOCHEM BIOPH RES CO, V126, P340, DOI 10.1016/0006-291X(85)90611-4; HAKEDA Y, 1988, J BONE MINER METAB, V6, P55; HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; JIMENEZDEASUA L, 1975, P NATL ACAD SCI USA, V72, P2724; KATHER H, 1979, J CLIN INVEST, V64, P609, DOI 10.1172/JCI109500; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; KOJIMA I, 1988, J BIOL CHEM, V263, P16561; KULL FC, 1983, J BIOL CHEM, V258, P6561; KUROSE H, 1990, ENDOCRINOLOGY, V126, P2088, DOI 10.1210/endo-126-4-2088; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWITT MS, 1989, J CLIN ENDOCR METAB, V69, P246, DOI 10.1210/jcem-69-2-246; Maniatis T., 1982, MOL CLONING; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; MCCARTHY TL, 1990, ENDOCRINOLOGY, V126, P1569, DOI 10.1210/endo-126-3-1569; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P301, DOI 10.1210/endo-124-1-301; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P1247, DOI 10.1210/endo-124-3-1247; MCCUSKER RH, 1990, J CELL PHYSIOL, V144, P244, DOI 10.1002/jcp.1041440210; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-69; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1076, DOI 10.1210/endo-126-2-1076; RAISZ LG, 1984, BONE MINERAL RES ANN, V2, P286; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; TAMURA K, 1990, J ENDOCRINOL, V125, P327, DOI 10.1677/joe.0.1250327; TASHJIAN AH, 1978, BIOCHEM BIOPH RES CO, V85, P966, DOI 10.1016/0006-291X(78)90638-1; TASHJIAN AH, 1982, ENDOCRINOLOGY, V111, P118, DOI 10.1210/endo-111-1-118; TASHJIAN AH, 1985, P NATL ACAD SCI USA, V82, P4535, DOI 10.1073/pnas.82.13.4535; YAMAGUCHI DT, 1988, J BIOL CHEM, V263, P10745; YAMASHITA T, 1987, J BIOL CHEM, V262, P5536; ZAPF J, 1988, BIOCHEM BIOPH RES CO, V156, P1187, DOI 10.1016/S0006-291X(88)80758-7	46	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21044	21050						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657946				2022-12-25	WOS:A1991GN00100073
J	AHLIJANIAN, MK; STRIESSNIG, J; CATTERALL, WA				AHLIJANIAN, MK; STRIESSNIG, J; CATTERALL, WA			PHOSPHORYLATION OF AN ALPHA-1-LIKE SUBUNIT OF AN OMEGA-CONOTOXIN-SENSITIVE BRAIN CALCIUM-CHANNEL BY CAMP-DEPENDENT PROTEIN-KINASE AND PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CA-2+ CHANNELS; FUNCTIONAL EXPRESSION; PERIPHERAL NEURONS; CATALYTIC SUBUNIT; CURRENT COMPONENT; ACTION-POTENTIALS; PHORBOL ESTERS; CELL-CULTURE; RECEPTOR	Antibodies that recognize the alpha-2-delta and alpha-1 subunits of skeletal muscle L-type calcium channels have been used to investigate the subunit components and phosphorylation of omega-conotoxin (omega-CgTx)-sensitive N-type calcium channels from rabbit brain. Photolabeling of the N-type channel with a photoreactive derivative of I-125-omega-CgTx results in the identification of a single polypeptide of 240 kDa. MANC-1, a monoclonal antibody recognizing alpha-2-delta subunits of L-type calcium channels from skeletal muscle, immunoprecipitates the omega-CgTx-labeled 240-kDa polypeptide and approximately 6% of the digitonin-solubilized I-125-omega-CgTx-labeled N-type channels. MANC-1 also immunoprecipitates a phosphoprotein of 240 kDa that comigrates with I-125-omega-CgTx-labeled N-type calcium channels, but not with L-type calcium channels, in sucrose gradients. Both cAMP-dependent protein kinase and protein kinase C are effective in the phosphorylation of this polypeptide. Similar to the alpha-1 subunits of skeletal muscle L-type calcium channels, the immunoprecipitation of the 240-kDa phosphoprotein by MANC-1 is prevented by the detergent Triton X-100. Anti-CP-(1382-1400), an antipeptide antibody against a highly conserved segment of the alpha-1 subunits of calcium channels, immunoprecipitates the 240-kDa phosphopeptide in Triton X-100. The 240-kDa protein is phosphorylated to a stoichiometry of approximately 1 mol of phosphate/mol of omega-CgTx-binding N-type calcium channels by both cAMP-dependent protein kinase and protein kinase C. Our results show that the 240-kDa polypeptide is an alpha-1-like subunit of an omega-CgTx-sensitive N-type calcium channel. The N-type calcium channels containing this subunit are phosphorylated by cAMP-dependent protein kinase and protein kinase C and contain noncovalently associated alpha-1-like and alpha-2-delta-like subunits as part of their oligomeric structure.			AHLIJANIAN, MK (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.		Striessnig, Joerg/S-9334-2017	Striessnig, Joerg/0000-0002-9406-7120	NINDS NIH HHS [P0-1 NS20482, R0-1 NS22625] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020482, R01NS022625] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1987, J BIOL CHEM, V262, P9877; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; BARHANIN J, 1988, BIOCHEM BIOPH RES CO, V150, P1051, DOI 10.1016/0006-291X(88)90736-X; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CRUZ LJ, 1987, BIOCHEMISTRY-US, V26, P820, DOI 10.1021/bi00377a024; CRUZ LJ, 1986, J BIOL CHEM, V261, P6230; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DOERNER D, 1990, J NEUROSCI, V10, P1699; DUBEL S J, 1990, Society for Neuroscience Abstracts, V16, P1174; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1; Glossmann H., 1988, CALCIUM CHANNEL STRU, P168, DOI [10.1007/978-3-642-73914-9_15, DOI 10.1007/978-3-642-73914-9_15]; GROSS RA, 1988, NEUROSCI LETT, V88, P50, DOI 10.1016/0304-3940(88)90314-X; GROSS RA, 1989, J NEUROPHYSIOL, V61, P97, DOI 10.1152/jn.1989.61.1.97; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; HOFMANN F, 1989, ARZNEIMITTEL-FORSCH, V39-1, P164; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KANEKO S, 1987, NEUROSCI LETT, V83, P123, DOI 10.1016/0304-3940(87)90227-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1990, J BIOL CHEM, V265, P20839; LEVITAN I, 1987, J MEMBRANE BIOL, V87, P177; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; NUNOKI K, 1989, P NATL ACAD SCI USA, V86, P6816, DOI 10.1073/pnas.86.17.6816; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; ROSENBERG RL, 1989, ANN NY ACAD SCI, V560, P39, DOI 10.1111/j.1749-6632.1989.tb24077.x; ROSSIE S, 1987, ENZYMES, V8, P335; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; STARR T V, 1990, Society for Neuroscience Abstracts, V16, P1174; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; WERZ MA, 1987, J NEUROSCI, V7, P1639; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836	48	91	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20192	20197						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657916				2022-12-25	WOS:A1991GM03900049
J	BRANDT, U; HAASE, U; SCHAGGER, H; VONJAGOW, G				BRANDT, U; HAASE, U; SCHAGGER, H; VONJAGOW, G			SIGNIFICANCE OF THE RIESKE IRON-SULFUR PROTEIN FOR FORMATION AND FUNCTION OF THE UBIQUINOL-OXIDATION POCKET OF MITOCHONDRIAL CYTOCHROME-C REDUCTASE (BC1 COMPLEX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PROTONMOTIVE Q-CYCLE; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MOLECULAR-BASIS; STROBILURIN-A; BEEF-HEART; INHIBITORS; STIGMATELLIN	The binding of specific inhibitors to the ubiquinol oxidation pocket ("Q(p) center") of cytochrome c reductase was analyzed before and after removal of bound phospholipid and the "Rieske" iron-sulfur protein using optical spectroscopy and fluorescence quench binding assays. The enzyme lacking iron-sulfur protein showed almost unchanged, tight binding of the E-beta-methoxyacrylate inhibitors oudemansin A and MOA-stilbene, whereas binding of the chromone inhibitor stigmatellin was almost completely abolished. The affinity of the weak inhibitor 3-undecyl-2-hydroxy-naphthoquinone was decreased. Oudemansin A binding to the defective pocket of the iron-sulfur protein-depleted enzyme was lowered by added phospholipid. It was deduced from these results that the Q(p) center is a spacious pocket formed by domains of cytochrome b, bearing the E-beta-methoxcyacrylate binding site, and the iron-sulfur protein, bearing the stigmatellin binding site. Moreover, removal of the iron-sulfur protein leaves this pocket defective but essentially unchanged in its remaining binding capability. The affinity of three preparations of cytochrome c reductase, the complete, the delipidated, and the iron-sulfur depleted enzyme for E-beta-methoxyacrylate-stilbene, was analyzed for different redox states of the catalytic centers of cytochrome c reductase. The apparent K(d) values for the different redox states were interpreted in terms of two conformational states. It is suggested that these changes reflect the two states of the "catalytic switch" proposed recently for the Q(p) pocket of cytochrome c reductase (Brandt, U., and von Jagow, G. (1991) Eur. J. Biochem. 195, 163-170). According to the refined model presented in this work, changeover to the "b" state is triggered by reduction of the iron-sulfur cluster, and changeover back to the "FeS" state is triggered by electron transfer from the low potential onto the high potential heme b center. Our interpretation implies that the stability of the two states is affected by the redox states of the enzyme, but that additionally changing the redox states of the two centers is required for "switching" on a catalytic time scale.	UNIV FRANKFURT,ZENTRUM BIOL CHEM,W-6000 FRANKFURT 70,GERMANY	Goethe University Frankfurt			Brandt, Ulrich/C-4406-2008	Brandt, Ulrich/0000-0003-1869-6811				BECKER WF, 1981, FEBS LETT, V132, P329, DOI 10.1016/0014-5793(81)81190-8; BOWYER JR, 1982, J BIOL CHEM, V257, P8321; BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; BRASSEUR R, 1988, J BIOL CHEM, V263, P12571; DALDAL F, 1989, EMBO J, V8, P3951, DOI 10.1002/j.1460-2075.1989.tb08578.x; DALDAL F, 1986, MICROBIAL ENERGY TRA, P113; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; DIRAGO JP, 1989, J BIOL CHEM, V264, P14543; DIRAGO JP, 1990, J BIOL CHEM, V265, P15750; EDWARDS CA, 1982, J BIOL CHEM, V257, P3705; ENGEL WD, 1980, BIOCHIM BIOPHYS ACTA, V592, P211, DOI 10.1016/0005-2728(80)90182-6; ENGEL WD, 1983, EUR J BIOCHEM, V132, P395, DOI 10.1111/j.1432-1033.1983.tb07376.x; FEE JA, 1986, BIOCHIM BIOPHYS ACTA, V853, P153, DOI 10.1016/0304-4173(86)90009-1; HOWELL N, 1987, J BIOL CHEM, V262, P2411; LJUNGDAHL PO, 1989, J BIOL CHEM, V264, P3723; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; RICH PR, 1990, FEBS LETT, V269, P139, DOI 10.1016/0014-5793(90)81139-F; RIESKE JS, 1967, J BIOL CHEM, V242, P4854; ROBRETSON DE, 1990, BIOCHEMISTRY-US, V29, P11249; SCHAGGER H, 1990, EUR J BIOCHEM, V190, P123, DOI 10.1111/j.1432-1033.1990.tb15554.x; SCHAGGER H, 1987, FEBS LETT, V219, P161, DOI 10.1016/0014-5793(87)81210-3; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; VONJAGOW G, 1981, FEBS LETT, V136, P19, DOI 10.1016/0014-5793(81)81206-9; WELLS MA, 1969, METHOD ENZYMOL, V14, P178	34	74	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19958	19964						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657909				2022-12-25	WOS:A1991GM03900017
J	MAHLBERG, FH; GLICK, JM; LUNDKATZ, S; ROTHBLAT, GH				MAHLBERG, FH; GLICK, JM; LUNDKATZ, S; ROTHBLAT, GH			INFLUENCE OF APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-AII, AND APOLIPOPROTEIN-CS ON THE METABOLISM OF MEMBRANE AND LYSOSOMAL CHOLESTEROL IN MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; LANDSCHUTZ ASCITES-CELLS; CROSS-LINKING; LIPID DROPLETS; CULTURED-CELLS; BINDING-SITES; ADIPOSE-CELLS; EFFLUX; FIBROBLASTS; TRANSPORT	We have demonstrated previously that HDL-mediated efflux of plasma membrane cholesterol is independent of specific binding of apolipoproteins to the high density lipoprotein (HDL) receptor in either control or cholesterol-enriched cells (Karlin, J. B., Johnson, W. J., Benedict, C. R., Chacko, G. K., Phillips, M. C., and Rothblat, G. H. (1987) J. Biol. Chem. 262, 12557-12564 and Johnson, W. J., Mahlberg, F. H., Chacko, G. K., Phillips, M. C., and Rothblat, G. H. (1988) J. Biol Chem. 263, 14099-14106). The present studies were conducted to determine if the process for removal of intracellular (lysosomal) cholesterol is similar to that of membrane cholesterol or if, in contrast, it is selectively regulated by specific apolipoproteins of HDL. For these reasons, we examined the influence of each of the major apolipoproteins of human HDL, apoAI, apoAII, and apoCs on the metabolism of membrane and lysosomal cholesterol in a macrophage foam cell model. We developed an experimental system which allows, for the first time, the simultaneous determination of lysosomal hydrolysis of cholesteryl ester and efflux and esterification of both lysosomal and membrane cholesterol. J774 and elicited mouse peritoneal macrophages were loaded with cholesteryl ester within lysosomes through phagocytosis of sonicated lipid droplets. Membrane and lysosomal pools of cholesterol were differentially radiolabeled. Discoidal complexes of egg phosphatidylcholine and purified apolipoproteins having a similar size and composition were used as cholesterol acceptors. Our results demonstrate that lysosomal hydrolysis of cholesteryl ester is independent of the presence of extracellular acceptors. Lysosomal production of cholesterol stimulates the esterification by acyl-CoA:cholesterol acyltransferase of membrane and lysosomal cholesterol. All the particles tested induce the efflux of both pools of cholesterol at a similar ratio. As efflux is stimulated, esterification by acyl-CoA:cholesterol acyltransferase is reduced. We conclude that none of these apolipoproteins selectively influences the efflux or the esterification of membrane or lysosomal cholesterol. In addition, we observe that particles containing apoAI are the most efficient acceptors, but this effect is not linked to specific binding to the HDL receptor.	MED COLL PENN,DEPT PHYSIOL & BIOCHEM,PHILADELPHIA,PA 19129	Drexel University					NHLBI NIH HHS [HL22633] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BERNARD DW, 1991, J BIOL CHEM, V266, P710; BERNARD DW, 1990, ARTERIOSCLEROSIS, V10, P135, DOI 10.1161/01.ATV.10.1.135; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRASAEMLE DL, 1990, J LIPID RES, V31, P103; CHACKO GK, 1987, J LIPID RES, V28, P332; CHACKO GK, 1988, J LIPID RES, V29, P319; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; FIDGE NH, 1985, J BIOL CHEM, V260, P3570; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; HOLMQUIST L, 1977, BIOCHIM BIOPHYS ACTA, V493, P400, DOI 10.1016/0005-2795(77)90196-9; ISHIKAWA TT, 1974, J LIPID RES, V15, P286; JACKSON RL, 1975, J BIOL CHEM, V250, P7204; JEROME WG, 1987, AM J PATHOL, V128, P253; JOHNSON WJ, 1988, J BIOL CHEM, V263, P14099; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; JOHNSON WJ, 1991, IN PRESS BIOCH BIOPH; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; KILSDONK EPC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P205, DOI 10.1016/0005-2760(90)90121-D; MAHLBERG FH, 1990, NUTR RES, V10, P1239, DOI 10.1016/S0271-5317(05)80162-9; MAHLBERG FH, 1990, BIOCHIM BIOPHYS ACTA, V1045, P291, DOI 10.1016/0005-2760(90)90133-I; MAHLBERG FH, 1990, ATHEROSCLEROSIS, V84, P95, DOI 10.1016/0021-9150(90)90078-W; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MENDEL CM, 1988, J LIPID RES, V29, P1171; MENDEL CM, 1988, J BIOL CHEM, V263, P1314; MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0; ORAM JF, 1991, ARTERIOSCLER THROMB, V11, P403, DOI 10.1161/01.ATV.11.2.403; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; PICARDO M, 1986, ARTERIOSCLEROSIS, V6, P434, DOI 10.1161/01.ATV.6.4.434; REICHL D, 1989, ARTERIOSCLEROSIS, V9, P785, DOI 10.1161/01.ATV.9.6.785; ROTHBLAT GH, 1982, J BIOL CHEM, V257, P4775; ROTHBLAT GH, 1967, BIOCHIM BIOPHYS ACTA, V144, P423, DOI 10.1016/0005-2760(67)90172-5; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SENAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1046, P81, DOI 10.1016/0005-2760(90)90097-H; SHIO H, 1978, LAB INVEST, V39, P390; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; STCLAIR RW, 1983, J LIPID RES, V24, P183; STEIN O, 1973, BIOCHIM BIOPHYS ACTA, V326, P232, DOI 10.1016/0005-2760(73)90249-X; STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; VANHEUSDEN GPH, 1989, J LIPID RES, V30, P1357; WERB Z, 1971, J EXP MED, V134, P1545, DOI 10.1084/jem.134.6.1545	46	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19930	19937						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657906				2022-12-25	WOS:A1991GM03900013
J	PEPPELENBOSCH, MP; TERTOOLEN, LGJ; DELAAT, SW				PEPPELENBOSCH, MP; TERTOOLEN, LGJ; DELAAT, SW			EPIDERMAL GROWTH FACTOR-ACTIVATED CALCIUM AND POTASSIUM CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONAL PITUITARY-CELLS; CYTOSOLIC FREE CALCIUM; PROTEIN KINASE-C; SIGNAL TRANSDUCTION; A431 CELLS; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-1; INOSITOL PHOSPHATES; CATALYTIC ACTIVITY; CARCINOMA-CELLS	The earliest responses to activation of the epidermal growth factor (EGF) receptor include a transient increase in calcium influx and a transient membrane hyperpolarization. The underlying mechanisms are, however, not well understood as yet. In the present study, we have applied patch clamp recording in the cell-attached and the outside-out mode, and fluorimetric cytosolic Ca2+ determinations, to identify the nature of the ion channels involved, to characterize their properties at the level of single channels, and to unravel their mechanism of activation. We provide evidence that activation of the EGF receptor results initially in the activation of voltage-independent Ca2+ channels that can be defined as direct receptor-operated channels. This in turn causes the activation of Ca2+-dependent K+ channels, which results in a (delayed) membrane hyperpolarization and then leads to the activation of a second class of Ca2+ channels that are sensitive to hyperpolarization. An autocatalytic generation of further hyperpolarization and Ca2+ influx is the predicted outcome of this ionic cascade. Based on the observed inhibitory effects of protein kinase C activation on the activity of Ca2+-dependent K+ channels, we propose that protein kinase C is involved in the negative regulation of this cascade, which explains the transient nature of these responses.	NETHERLANDS INST DEV BIOL,HUBRECHT LAB,3584 CT UTRECHT,NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)				Peppelenbosch, Maikel/0000-0001-9112-6028				BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; CAVALIE A, 1983, PFLUG ARCH EUR J PHY, V398, P284, DOI 10.1007/BF00657238; CHESNOYMARCHAIS D, 1985, J PHYSIOL-LONDON, V367, P457, DOI 10.1113/jphysiol.1985.sp015835; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P4574; ENOMOTO K, 1986, FEBS LETT, V203, P181, DOI 10.1016/0014-5793(86)80738-4; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; GONZALEZ FA, 1988, J CELL PHYSIOL, V135, P269, DOI 10.1002/jcp.1041350214; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGIWARA S, 1983, J PHYSIOL-LONDON, V336, P649, DOI 10.1113/jphysiol.1983.sp014603; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; MACARA IG, 1986, J BIOL CHEM, V261, P9321; MAHAUTSMITH MP, 1990, J PHYSIOL-LONDON, V428, P723, DOI 10.1113/jphysiol.1990.sp018237; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MOHAUTSMITH MP, 1990, J BIOL CHEM, V265, P10479; MOHR FC, 1987, J CELL BIOL, V104, P783, DOI 10.1083/jcb.104.3.783; MOOLENAAR WH, 1984, NATURE, V312, P371, DOI 10.1038/312371a0; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; MOOLENAAR WH, 1986, J BIOL CHEM, V261, P279; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; MOZHAYEVA GN, 1989, BIOCHIM BIOPHYS ACTA, V1011, P171, DOI 10.1016/0167-4889(89)90206-1; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PANDIELLA A, 1987, BIOCHEM BIOPH RES CO, V147, P145; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARKADI B, 1990, BIOCHIM BIOPHYS ACTA, V1027, P130, DOI 10.1016/0005-2736(90)90076-Z; SAVAGE AL, 1989, BIOCHEM J, V260, P821, DOI 10.1042/bj2600821; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; TILLY BC, 1987, BIOCHEM J, V244, P129, DOI 10.1042/bj2440129; TILLY BC, 1988, BIOCHEM J, V252, P857, DOI 10.1042/bj2520857; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K	38	97	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19938	19944						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657907				2022-12-25	WOS:A1991GM03900014
J	PLATT, EJ; FIRESTONE, GL				PLATT, EJ; FIRESTONE, GL			EXPRESSION OF MOUSE MAMMARY-TUMOR VIRUS GLYCOPROTEIN TRUNCATIONS DEFINES ROLES FOR THE TRANSMEMBRANE DOMAIN AND ECTODOMAIN HYDROPHOBIC REGION IN CONSTITUTIVE EXOCYTIC TRAFFICKING AND PROTEOLYTIC PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOMA-CELLS; SURFACE-ASSOCIATED GLYCOPROTEINS; CHAIN BINDING-PROTEIN; ENDOPLASMIC-RETICULUM; ENV GENE; INFLUENZA HEMAGGLUTININ; INTRACELLULAR-TRANSPORT; CYTOPLASMIC DOMAINS; GOLGI-COMPLEX; ENVELOPE GENE	A mutational analysis was used to identify structural domains that are important for exocytic transport and proteolytic cleavage of the mouse mammary tumor virus (MMTV) glycoprotein, which is expressed as a multidomain polyprotein. Rat HTC hepatoma cells were transfected with the MMTV glycoprotein gene driven by the constitutive Rous sarcoma virus promoter, with mutant genes encoding a series of polypeptide truncations or with a defective MMTV provirus containing a premature termination codon in the viral glycoprotein gene. Efficient proteolytic maturation and transport of MMTV glycoproteins to the cell surface or extracellular environment required the presence of the transmembrane domain but not the cytoplasmic tail. Two stable truncations retaining the hydrophobic region of the ectodomain in the absence of the transmembrane domain and cytoplasmic tail (trgp67 and trgp58) remained in endoglycosidase H sensitive and uncleaved forms. One of these truncations, trgp58, appeared to be tightly associated with intracellular membranes and strongly bound by heavy chain binding protein, whereas the other truncation, trgp67, was a soluble component of the lumen and persists intracellularly by a heavy chain binding protein-independent pathway. The truncated MMTV glycoprotein additionally lacking the hydrophobic region of the ectodomain was efficiently secreted. Taken together, our results demonstrate that the hydrophobic transmembrane domain of the MMTV glycoprotein is required for proper transport and proteolytic processing, whereas, in the absence of the transmembrane domain, the presence of a hydrophobic region of the ectodomain correlated with retention at an early step in the exocytic pathway.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV CELL & DEV, BOX 591 LSA, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NCI NIH HHS [CA-09041] Funding Source: Medline; NIDDK NIH HHS [DK-42799] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042799, R01DK042799] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMACHER SL, 1989, MOL ENDOCRINOL, V3, P1634, DOI 10.1210/mend-3-10-1634; BERMAN PW, 1988, J VIROL, V62, P3135, DOI 10.1128/JVI.62.9.3135-3142.1988; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; BRAVO DA, 1991, MOL ENDOCRINOL, V5, P336, DOI 10.1210/mend-5-3-336; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CARDIFF RD, 1978, VIROLOGY, V85, P157, DOI 10.1016/0042-6822(78)90420-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; EINFELD D, 1988, P NATL ACAD SCI USA, V85, P8688, DOI 10.1073/pnas.85.22.8688; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FIRESTONE GL, 1983, J BIOL CHEM, V258, P6155; FIRESTONE GL, 1986, J CELL BIOL, V103, P2323, DOI 10.1083/jcb.103.6.2323; FIRESTONE GL, 1983, MOL CELL BIOL, V3, P149, DOI 10.1128/MCB.3.2.149; FIRESTONE GL, 1982, NATURE, V300, P221, DOI 10.1038/300221a0; FIRESTONE GL, 1990, METHOD ENZYMOL, V182, P688; FIRESTONE GL, 1988, ENDOCRINE GENES ANAL, P95; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GABATHULER R, 1990, J CELL BIOL, V111, P1803, DOI 10.1083/jcb.111.5.1803; GAROFF H, 1985, ANNU REV CELL BIOL, V1, P403, DOI 10.1146/annurev.cb.01.110185.002155; GETHING MJ, 1982, NATURE, V300, P598, DOI 10.1038/300598a0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HAFFAR OK, 1987, MOL CELL BIOL, V7, P1508, DOI 10.1128/MCB.7.4.1508; HAFFAR OK, 1988, J CELL BIOL, V106, P1463, DOI 10.1083/jcb.106.5.1463; HAFFAR OK, 1986, BIOCHIM BIOPHYS ACTA, V884, P520, DOI 10.1016/0304-4165(86)90204-7; HENDERSON LE, 1983, J VIROL, V48, P314, DOI 10.1128/JVI.48.1.314-319.1983; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JOHN NJ, 1989, MOL CELL ENDOCRINOL, V61, P57, DOI 10.1016/0303-7207(89)90189-5; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KRANGEL MS, 1979, CELL, V18, P979, DOI 10.1016/0092-8674(79)90210-1; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MAJORS JE, 1983, J VIROL, V47, P495, DOI 10.1128/JVI.47.3.495-504.1983; MARSH M, 1984, BIOCHEM J, V218, P1; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; PATERSON RG, 1987, CELL, V48, P441, DOI 10.1016/0092-8674(87)90195-4; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PEREZ LG, 1987, J VIROL, V61, P2981, DOI 10.1128/JVI.61.10.2981-2988.1987; PLATT EJ, 1986, ANAL BIOCHEM, V156, P126, DOI 10.1016/0003-2697(86)90163-6; RACEVSKIS J, 1980, J VIROL, V35, P937, DOI 10.1128/JVI.35.3.937-948.1980; REDMOND SMS, 1983, EMBO J, V2, P125, DOI 10.1002/j.1460-2075.1983.tb01393.x; RICCA GA, 1982, ANN NY ACAD SCI, V389, P88, DOI 10.1111/j.1749-6632.1982.tb22127.x; RINGOLD GM, 1979, P NATL ACAD SCI USA, V76, P665, DOI 10.1073/pnas.76.2.665; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SALMONS B, 1986, VIRUS RES, V4, P377, DOI 10.1016/0168-1702(86)90084-5; SALMONS B, 1985, VIROLOGY, V144, P101, DOI 10.1016/0042-6822(85)90309-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR NH, 1983, VIROLOGY, V126, P279, DOI 10.1016/0042-6822(83)90479-8; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; WADE JB, 1986, ANNU REV PHYSIOL, V48, P213; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WHITTAKER J, 1988, J BIOL CHEM, V263, P3063; WILLS JW, 1984, J CELL BIOL, V99, P2011, DOI 10.1083/jcb.99.6.2011; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	63	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19384	19395						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655786				2022-12-25	WOS:A1991GK66700043
J	SARDET, C; FAFOURNOUX, P; POUYSSEGUR, J				SARDET, C; FAFOURNOUX, P; POUYSSEGUR, J			ALPHA-THROMBIN, EPIDERMAL GROWTH-FACTOR, AND OKADAIC ACID ACTIVATE THE NA+/H+ EXCHANGER, NHE-1, BY PHOSPHORYLATING A SET OF COMMON SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVITY; SIGNAL TRANSDUCTION; TUMOR PROMOTER; ANTIPORTER; FIBROBLASTS; CELLS; PH; PHOSPHATASES; EXPRESSION; STIMULATION	The ubiquitous and amiloride-sensitive Na+/H+ exchanger (NHE-1), a plasma membrane phosphoglycoprotein that regulates intracellular pH, is rapidly activated by growth factors. We showed previously that epidermal growth factor (EGF), alpha-thrombin, or serum stimulates Na+/H+ exchange activity in growth-arrested Chinese hamster lung fibroblasts (ER22 cells) in a time-dependent manner which correlates with increased phosphorylation of NHE-1 at serine residues (Sardet, C., Counillon, L., Franchi, A., and Pouyssegur, J. (1990) Science 247, 723-726). Here we show that the tumor promoter, okadaic acid, a potent in vivo inhibitor of serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A), stimulates Na+/H+ exchange in G0-arrested ER22 cells and in exchanger-deficient fibroblasts transfected with the human NHE-1 cDNA. Okadaic acid effects are maximal at 1-mu-M (EC50 = 500 nm), detected in 2 min, complete within 15-20 min, and are additives when combined with EGF or alpha-thrombin. Parallel to the pH(i)-induced rise, okadaic acid alone or together with growth factors stimulated the phosphorylation of NHE-1. More importantly tryptic phosphopeptide maps of NHE-1, immunoprecipitated from cells treated with EGF, alpha-thrombin, or okadaic acid, show a common pattern of phosphorylation. This pattern consists of five major P-32-labeled peptides (P1-P5) present in lower amounts in resting cells. One of them, P5, barely detectable in resting cells is increased up to 15-fold in mitogen-stimulated cells. Taken together these results reinforce the notion that phosphorylation of NHE-1 controls the set point value of the exchanger and suggest that: (i) the proximate step in Na+/H+ exchange activation is mediated by as yet unidentified growth factor-activatable serine "NHE-1 kinase(s)" and (ii) this NHE-1 kinase(s), partly active in resting cells, integrate signals from receptor tyrosine kinases and G protein-coupled receptors.			SARDET, C (corresponding author), UNIV NICE,CNRS,CTR BIOCHIM,PARC VALROSE,F-06034 NICE,FRANCE.							AHN NG, 1991, J BIOL CHEM, V266, P4220; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; CASSEL D, 1986, J BIOL CHEM, V261, P5460; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FRANCHI A, 1986, P NATL ACAD SCI USA, V83, P9388, DOI 10.1073/pnas.83.24.9388; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; GRINSTEIN S, 1988, NA PLUS H PLUS EXCHA; HAGGERTY JG, 1988, P NATL ACAD SCI USA, V85, P6797, DOI 10.1073/pnas.85.18.6797; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; KIM SJ, 1990, CELL REGUL, V1, P269, DOI 10.1091/mbc.1.3.269; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; KNICKELBEIN RG, 1988, FASEB J, V2, pA941; KOZMA SC, 1989, CELL SIGNAL, V1, P219, DOI 10.1016/0898-6568(89)90039-9; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; L'allemain G, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000255; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; MOOLENAAR WH, 1984, NATURE, V312, P371, DOI 10.1038/312371a0; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; PARIS S, 1984, J BIOL CHEM, V259, P989; PEWITT EB, 1990, J BIOL CHEM, V265, P20747; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; POUYSSEGUR J, 1990, G PROTEIN, V23, P555; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SARDET C, 1990, GASTROENTEROLOGY, V99, P565; SEIFTER JL, 1986, J CLIN INVEST, V78, P859, DOI 10.1172/JCI112671; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TSE MC, 1991, EMBO J, V10, P1957; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANOBBERGHENSCHILLING E, 1985, EMBO J, V4, P2927, DOI 10.1002/j.1460-2075.1985.tb04025.x; YAMASHITA K, 1990, EMBO J, V9, P4331, DOI 10.1002/j.1460-2075.1990.tb07882.x	42	205	205	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19166	19171						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655777				2022-12-25	WOS:A1991GK66700011
J	BALSINDE, J; MOLLINEDO, F				BALSINDE, J; MOLLINEDO, F			PLATELET-ACTIVATING-FACTOR SYNERGIZES WITH PHORBOL-MYRISTATE ACETATE IN ACTIVATING PHOSPHOLIPASE D IN THE HUMAN PROMONOCYTIC CELL-LINE U937 - EVIDENCE FOR DIFFERENT MECHANISMS OF ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; ARACHIDONIC-ACID RELEASE; CALCIUM-DEPENDENT ACTIVATION; MOUSE PERITONEAL-MACROPHAGES; HUMAN-NEUTROPHILS; CHEMOTACTIC PEPTIDE; HL-60 GRANULOCYTES; INTRACELLULAR CALCIUM; SIGNAL TRANSDUCTION; MEDIATED ACTIVATION	The activation of phospholipase D by platelet-activating factor (PAF) in the human promonocytic cell line U937 has been investigated. In cells prelabeled with [H-3]palmitic acid, addition of PAF or phorbol 12-myristate 13-acetate (PMA) induced the synthesis of [H-3]phosphatidylethanol, indicating phospholipase D activation. When U937 cells were preincubated for 5 min with PMA, and then stimulated with PAF, formation of phosphatidylethanol was greatly enhanced. In contrast, under the same experimental conditions PMA treatment blocked completely the PAF-induced inositol phosphates formation in cells prelabeled with [H-3]inositol. Thus, PMA treatment demonstrates that phospholipase D activation can occur independently from phosphoinositide-specific phospholipase C activation during PAF stimulation in U937 cells. On the other hand, the data herein presented suggest that influx of external calcium is required for phospholipase D activation by PAF, as assessed by complete inhibition of the enzyme activity by chelation of extracellular calcium or by treatment with the calcium channel blocker verapamil. Based on these findings, a hypothetical model for phospholipase D activation is discussed.			BALSINDE, J (corresponding author), CSIC,CTR INVEST BIOL,VELAZQUEZ 144,E-28006 MADRID,SPAIN.		Balsinde, Jesús/C-7833-2018	Balsinde, Jesús/0000-0002-4157-6714				ADEREM AA, 1988, CURR OPIN IMMUNOL, V1, P56, DOI 10.1016/0952-7915(88)90051-9; AGWU DE, 1989, J BIOL CHEM, V264, P1405; ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; BALSINDE J, 1990, FEBS LETT, V259, P237, DOI 10.1016/0014-5793(90)80017-D; BALSINDE J, 1990, BIOCHIM BIOPHYS ACTA, V1052, P90, DOI 10.1016/0167-4889(90)90061-H; BALSINDE J, 1988, BIOCHEM BIOPH RES CO, V151, P802, DOI 10.1016/S0006-291X(88)80352-8; BALSINDE J, 1990, J IMMUNOL, V144, P4298; BALSINDE J, 1988, J BIOL CHEM, V263, P1929; BARZAGHI G, 1989, J PHARMACOL EXP THER, V248, P559; BARZAGHI G, 1989, LIFE SCI, V44, P361, DOI 10.1016/0024-3205(89)90230-0; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; BURGOYNE RD, 1987, TRENDS BIOCHEM SCI, V12, P332, DOI 10.1016/0968-0004(87)90155-1; CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; COCKCROFT S, 1984, BIOCHIM BIOPHYS ACTA, V795, P37, DOI 10.1016/0005-2760(84)90102-4; DIEZ E, 1990, J BIOL CHEM, V265, P14654; DIVIRGILIO F, 1984, NATURE, V310, P691, DOI 10.1038/310691a0; EMILSSON A, 1986, BIOCHIM BIOPHYS ACTA, V876, P533, DOI 10.1016/0005-2760(86)90041-X; EMILSSON A, 1984, J BIOL CHEM, V259, P3111; EXTON JH, 1990, J BIOL CHEM, V256, P1; FEINSTEIN MB, 1988, EXPERIENTIA, V44, P101, DOI 10.1007/BF01952189; FERNANDEZ B, 1990, FEBS LETT, V268, P107, DOI 10.1016/0014-5793(90)80984-Q; GARCIA MD, 1991, BIOCHEM J, V273, P573, DOI 10.1042/bj2730573; GRUCHALLA RS, 1990, J IMMUNOL, V144, P2334; HALENDA SP, 1990, BIOCHEM J, V267, P479, DOI 10.1042/bj2670479; HALENDA SP, 1987, BIOCHEM J, V248, P471, DOI 10.1042/bj2480471; KOBAYASHI M, 1987, J NEUROCHEM, V48, P1597, DOI 10.1111/j.1471-4159.1987.tb05707.x; LISTER MD, 1989, J BIOL CHEM, V264, P8520; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; MARTINSON EA, 1990, J BIOL CHEM, V265, P22282; MAUDSLEY DJ, 1987, IMMUNOLOGY, V61, P189; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MULLMANN TJ, 1990, BIOCHEM BIOPH RES CO, V170, P1197, DOI 10.1016/0006-291X(90)90520-W; OFLAHERTY JT, 1987, J IMMUNOL, V138, P1889; PAI JK, 1988, BIOCHEM BIOPH RES CO, V150, P355, DOI 10.1016/0006-291X(88)90528-1; PAI JK, 1988, J BIOL CHEM, V263, P12472; PAI JK, 1987, CARCINOGENESIS, V8, P173, DOI 10.1093/carcin/8.1.173; QIAN Z, 1989, J BIOL CHEM, V264, P21720; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; ROSSI F, 1989, J IMMUNOL, V142, P1652; SANDBORG RR, 1988, LAB INVEST, V59, P300; SMITH CD, 1987, J BIOL CHEM, V262, P6121; TETTENBORN CS, 1988, BIOCHEM BIOPH RES CO, V155, P249, DOI 10.1016/S0006-291X(88)81076-3; VALONE FH, 1988, J IMMUNOL, V140, P2389; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; WINKLER JD, 1988, BIOCHEM BIOPH RES CO, V157, P521, DOI 10.1016/S0006-291X(88)80280-8; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4; ZAVOICO GB, 1985, P NATL ACAD SCI USA, V82, P3859, DOI 10.1073/pnas.82.11.3859	56	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18726	18730						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655758				2022-12-25	WOS:A1991GJ47200051
J	WU, CY; CHUNG, AE				WU, CY; CHUNG, AE			POTENTIAL ROLE OF ENTACTIN IN HEMOSTASIS - SPECIFIC INTERACTION OF ENTACTIN WITH FIBRINOGEN A-ALPHA AND B-BETA CHAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE PROTEIN; COLD-INSOLUBLE GLOBULIN; AMINO-ACID SEQUENCE; CROSS-LINKING; STABILIZING FACTOR; BINDING; FIBRONECTIN; GLYCOPROTEIN; CELLS; NIDOGEN	The interactions between the endothelial basement membrane, platelets, and coagulation factors play essential roles in hemostasis. Entactin is an integral and ubiquitous component of the basement membrane. Experiments were designed to study the interactions between entactin and blood coagulation factors. We have demonstrated, for the first time, that entactin interacts with fibrinogen in a specific manner. Entactin binding sites have been localized to the A-alpha and B-beta chains of fibrinogen. The binding of entactin to either the A-alpha chain or the B-beta chain was divalent cation-independent. The binding of S-35-labeled entactin to the immobilized fibrinogen A-alpha or B-beta chain was concentration-dependent and saturable and could be inhibited by unlabeled entactin, soluble fibrinogen, anti-entactin antiserum, or anti-fibrinogen antiserum. In addition, we have provided evidence that entactin can be cross-linked to itself, and probably also to fibrin(ogen), by transglutaminase. These novel properties, together with its cell binding, chemotactic, and phagocytic promoting activities and ubiquitous distribution in basement membranes, suggest that entactin may play important roles in hemostasis and wound healing.	UNIV PITTSBURGH,DEPT BIOL SCI,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCI NIH HHS [CA-21246] Funding Source: Medline; NIGMS NIH HHS [GM-25690] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA021246] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHYUTHAN KE, 1988, FIBRINOGEN, V3, P165; BACONBAGULEY T, 1990, J BIOL CHEM, V265, P2317; BACONBAGULEY T, 1987, J BIOL CHEM, V262, P1927; CARLIN B, 1981, J BIOL CHEM, V256, P5209; CARLIN BE, 1983, J BIOL CHEM, V258, P7729; CHAKRAVARTI S, 1990, J BIOL CHEM, V265, P10597; CHARO IF, 1991, J BIOL CHEM, V266, P1415; CHUNG AE, 1990, AM J RESP CELL MOL, V3, P275, DOI 10.1165/ajrcmb/3.4.275; CHUNG AE, 1979, CELL, V16, P277, DOI 10.1016/0092-8674(79)90005-9; COLMAN RW, 1987, HEMOSTASIS THROMBOSI, P3; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; GREENBERG CS, 1987, BLOOD, V70, P702; GREENBERG CS, 1982, J BIOL CHEM, V257, P6096; HORMANN H, 1985, PLASMA FIBRONECTIN S, P99; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; ILL CR, 1984, J CELL BIOL, V99, P2140, DOI 10.1083/jcb.99.6.2140; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; LAHAV J, 1984, EUR J BIOCHEM, V145, P151, DOI 10.1111/j.1432-1033.1984.tb08534.x; LIU CY, 1979, J BIOL CHEM, V254, P421; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MANN K, 1988, EUR J BIOCHEM, V178, P71, DOI 10.1111/j.1432-1033.1988.tb14430.x; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; McDonagh J, 1987, HEMOSTASIS THROMBOSI, P289; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1984, MOL CELL BIOCHEM, V58, P63, DOI 10.1007/BF00240605; PLOW EF, 1991, HEMATOLOGY BASIC PRI, P1165; RUOSLAHTI E, 1975, J EXP MED, V141, P497, DOI 10.1084/jem.141.2.497; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAITO H, 1991, DISORDERS HEMOSTASIS, P18; SANTORO SA, 1983, BIOCHEM BIOPH RES CO, V116, P135, DOI 10.1016/0006-291X(83)90391-1; SENIOR R, 1991, FASEB J, V5, pA1558; TAMAKI T, 1981, BIOCHIM BIOPHYS ACTA, V661, P280, DOI 10.1016/0005-2744(81)90016-4; TSAO T, 1990, J BIOL CHEM, V265, P5188; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1977, THROMB RES, V10, P213, DOI 10.1016/0049-3848(77)90003-2; WU CY, 1988, BIOCHEMISTRY-US, V27, P8780, DOI 10.1021/bi00424a014; YAMADA KM, 1990, FIBRONECTIN, P47	43	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18802	18807						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1680863				2022-12-25	WOS:A1991GJ47200062
J	DESAUVAGE, FJ; CAMERATO, TR; GOEDDEL, DV				DESAUVAGE, FJ; CAMERATO, TR; GOEDDEL, DV			PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF THE HUMAN RECEPTOR FOR ESCHERICHIA-COLI HEAT-STABLE ENTEROTOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE RECEPTOR; GUANYLATE-CYCLASE ACTIVITY; CYCLIC-GMP; DIARRHEAL DISEASE; ION-TRANSPORT; MEMBRANE FORM; TOXIN; INTESTINE; ATRIAL; DIVERSITY	Heat-stable enterotoxin (STa) produced by Escherichia coli induces intestinal secretion in mammals by binding to the brush border membrane of the small intestine and activating guanylyl cyclase. We report here the cloning and expression of a cDNA encoding the human receptor for STa. The receptor contains both an extracellular ligand binding site and a cytoplasmic guanylyl cyclase catalytic domain, making it a member of the same receptor family as the natriuretic peptide receptors. Stable mammalian cell lines over-expressing the STa receptor specifically bind I-125-STa (K(d) approximately 1.0 nM) and respond to STa by dramatically increasing (approximately 50-fold) cellular cGMP levels. Sequence comparisons between the human and the rat STa receptors show less conservation in the extracellular domain than similar comparisons of natriuretic peptide receptors. This divergence may indicate important species differences in ligand-receptor interaction.			DESAUVAGE, FJ (corresponding author), GENENTECH INC, DEPT MOLEC BIOL, San Francisco, CA 94080 USA.		de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; FORTE LR, 1989, AM J PHYSIOL, V257, pF874, DOI 10.1152/ajprenal.1989.257.5.F874; FRANTZ JC, 1984, INFECT IMMUN, V43, P622, DOI 10.1128/IAI.43.2.622-630.1984; GARIEPY J, 1987, P NATL ACAD SCI USA, V84, P8907, DOI 10.1073/pnas.84.24.8907; GIANNELLA RA, 1979, INFECT IMMUN, V24, P19, DOI 10.1128/IAI.24.1.19-23.1979; GIANNELLA RA, 1983, AM J PHYSIOL, V243, pG36; GORDON JE, 1971, ANN NY ACAD SCI, V176, P9, DOI 10.1111/j.1749-6632.1971.tb34988.x; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEIN J, 1990, METHOD ENZYMOL, V183, P626; HUGHES JM, 1978, NATURE, V271, P755, DOI 10.1038/271755a0; IVENS K, 1990, INFECT IMMUN, V58, P1817, DOI 10.1128/IAI.58.6.1817-1820.1990; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUNO T, 1986, J BIOL CHEM, V261, P1470; LEVINE MM, 1977, INFECT IMMUN, V17, P78, DOI 10.1128/IAI.17.1.78-82.1977; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MARGOLSKEE RF, 1988, MOL CELL BIOL, V8, P2837, DOI 10.1128/MCB.8.7.2837; MORRISON M, 1970, BIOCHEMISTRY-US, V9, P2995, DOI 10.1021/bi00817a010; NEWSOME PM, 1978, INFECT IMMUN, V22, P290, DOI 10.1128/IAI.22.1.290-291.1978; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; RAO MC, 1981, INFECT IMMUN, V33, P165, DOI 10.1128/IAI.33.1.165-170.1981; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SACK RB, 1975, ANNU REV MICROBIOL, V29, P333, DOI 10.1146/annurev.mi.29.100175.002001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; THOMPSON MR, 1985, ANAL BIOCHEM, V148, P26, DOI 10.1016/0003-2697(85)90623-2; THORPE DS, 1990, J BIOL CHEM, V265, P14717; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALDMAN SA, 1986, INFECT IMMUN, V51, P320, DOI 10.1128/IAI.51.1.320-326.1986; YOSHIMURA S, 1985, FEBS LETT, V181, P138, DOI 10.1016/0014-5793(85)81129-7	35	144	158	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17912	17918						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680854				2022-12-25	WOS:A1991GG55300033
J	ROONEY, TA; HAGER, R; THOMAS, AP				ROONEY, TA; HAGER, R; THOMAS, AP			BETA-ADRENERGIC RECEPTOR-MEDIATED PHOSPHOLIPASE-C ACTIVATION INDEPENDENT OF CAMP FORMATION IN TURKEY ERYTHROCYTE-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; ADENYLATE-CYCLASE ACTIVATION; PAROTID ACINAR-CELLS; P2Y-PURINERGIC RECEPTOR; GUANINE-NUCLEOTIDES; CA-2+ MOBILIZATION; CHOLERA-TOXIN; G-PROTEINS; BINDING; GTP	The effect of the beta-adrenergic receptor agonist isoproterenol on guanine nucleotide-dependent phospholipase C (PLC) activity was examined in turkey erythrocyte membranes prepared from [H-3]inositol-labeled turkey erythrocytes. In the presence of guanosine 5'-(gamma-thiotriphosphate) (GTP[S]) isoproterenol caused a dose-dependent stimulation of [H-3]inositol phosphate ([H-3]InsP) formation. The activation of PLC by GTP[S] occurred after an initial lag period of 1-2 min and was followed by a sustained rate of [H-3]InsP formation which remained linear for 4-5 min. Isoproterenol decreased the lag period for GTP[S]-induced [H-3]InsP formation and increased PLC activity at all time points following this lag. Consequently, isoproterenol shifted the dose-response curve for GTP[S] to the left (10-fold) and increased the maximal response. The EC50 value for isoproterenol-induced activation of PLC was 104 +/- 17 nM. Isoproterenol also potentiated GTP-dependent PLC activity but was ineffective in stimulating the enzyme in the presence of AlF4-. The PLC activation by isoproterenol was completely inhibited by propanolol and atenolol but was unaffected by prazosin or yohimbine. Although GTP[S] and isoproterenol could increase cAMP formation in this membrane preparation, the isoproterenol-induced stimulation of PLC occurred in the absence of ATP and was independent of cAMP formation. Furthermore, addition of cAMP, 8-bromo-cAMP, forskolin, or either the regulatory or catalytic subunits of cAMP-dependent protein kinase failed to stimulate [H-3]InsP formation and had no effect on the responses elicited by GTP[S] and isoproterenol. Isoproterenol also stimulated [H-3]InsP2 and [H-3]InsP3 production in intact erythrocytes. Cholera toxin had no effect on [H-3]InsP formation in the intact cells under conditions where it stimulated cAMP accumulation. In addition, the activation of PLC by GTP[S] and isoproterenol was unaffected in membranes prepared from cholera toxin-treated erythrocytes. These data demonstrate that stimulation of turkey erythrocyte beta-adrenergic receptors by isoproterenol results in a direct activation of guanine nucleotide-dependent PLC.	THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,1020 LOCUST ST,PHILADELPHIA,PA 19107	Jefferson University			Thomas, Andrew/C-6755-2013	Thomas, Andrew/0000-0002-9026-7467	NIAAA NIH HHS [AA07186, AA07215] Funding Source: Medline; NIDDK NIH HHS [DK38422] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038422, R29DK038422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA007186] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; BILEZIKIAN JP, 1978, BIOCHEM PHARMACOL, V27, P1445, DOI 10.1016/0006-2952(78)90100-4; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOYER JL, 1989, J BIOL CHEM, V264, P13917; BOYER JL, 1989, J BIOL CHEM, V264, P884; BROWN EM, 1976, J BIOL CHEM, V251, P1239; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P4155, DOI 10.1073/pnas.75.9.4155; CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DOWNS RW, 1980, J BIOL CHEM, V255, P949; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARDEN TK, 1983, PHARMACOL REV, V35, P5; HARDEN TK, 1987, J BIOL CHEM, V262, P9057; HARDEN TK, 1988, BIOCHEM J, V252, P583, DOI 10.1042/bj2520583; HERTEL C, 1990, J BIOL CHEM, V265, P17988; HORN VJ, 1988, J BIOL CHEM, V263, P12454; HUGHES AR, 1989, CELL CALCIUM, V10, P519, DOI 10.1016/0143-4160(89)90013-4; LAD PM, 1980, J BIOL CHEM, V255, P988; MARTIN MW, 1989, J BIOL CHEM, V264, P19535; MINNEMAN KP, 1980, MOL PHARMACOL, V17, P1; MINNEMAN KP, 1979, J PHARMACOL EXP THER, V211, P502; MORRIS AJ, 1990, J BIOL CHEM, V265, P13501; MORRIS AJ, 1990, J BIOL CHEM, V265, P13508; PIKE LJ, 1980, J BIOL CHEM, V255, P6860; ROONEY TA, 1989, J BIOL CHEM, V264, P6817; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; RUDOLPH SA, 1977, J BIOL CHEM, V252, P7132; SCHRAMM M, 1975, J BIOL CHEM, V250, P2232; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SPIEGEL AM, 1974, J BIOL CHEM, V249, P7630; STADEL JM, 1981, J CYCLIC NUCL PROT, V7, P37; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020	35	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15068	15074						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1678388				2022-12-25	WOS:A1991GB09700043
J	PARK, KR; KIM, KH				PARK, KR; KIM, KH			REGULATION OF ACETYL-COA CARBOXYLASE GENE-EXPRESSION - INSULIN INDUCTION OF ACETYL-COA CARBOXYLASE AND DIFFERENTIATION OF 30A5 PREADIPOCYTES REQUIRE PRIOR CAMP ACTION ON THE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; TUMOR NECROSIS FACTOR; RAT MAMMARY-GLAND; AMYLASE CAT GENE; MESSENGER-RNA; 5' END; TRANSCRIPTIONAL REGULATION; HOUSEKEEPING GENE; PROMOTER REGION; TRANSGENIC MICE	30A5 preadipocytes, derived from 10T1/2 mouse fibroblasts, can be induced to differentiate into adipocytes by hormone treatment. In this paper, we introduce a modified procedure to induce differentiation of 30A5 cells by pretreatment with cAMP for a brief period or by a "nutrition deprivation" pretreatment, followed by incubation in medium containing insulin. These procedures accelerate the differentiation of the preadipocytes, so that the cells are fully differentiated within 4 days instead of the 7-8 days normally required. This differentiation is accompanied by the early induction of acetyl-CoA carboxylase (ACC). ACC catalyzes the rate-limiting step in the biogenesis of long chain fatty acids. To analyze the relationship between cAMP and insulin action in the induction of ACC and cell differentiation, we identified the DNA sequences in promoter II of the ACC gene necessary for the action of insulin and cAMP. Chimeric genes between different fragments of the ACC promoter and the promoterless chloramphenicol transacetylase (CAT) gene were constructed, and stable clones containing these chimeric genes were obtained. By analyzing the CAT activities in these stable clones, we established that insulin action in inducing ACC and cell differentiation requires prior treatment of cells with cAMP and the presence of specific DNA regions in the ACC promoter for cAMP action. Stable clones containing a chimeric gene which consists of DNA sequences in promoter II that are required for insulin action, thymidine kinase promoter, and the CAT gene did not respond to insulin. However, when the DNA sequences required for cAMP action were placed in this chimeric gene, it responded to insulin upon prior treatment of 30A5 cells with cAMP. Thus, cAMP and insulin, whose physiological actions generally appear to be antagonistic, are synergistically interacting in the induction of ACC and the differentiation of 30A5 cells.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NCI NIH HHS [CA 46882] Funding Source: Medline; NIDDK NIH HHS [DK 12865] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012865] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADHYA S, 1990, J BIOL CHEM, V265, P10797; AIVARAM P, 1990, J BIOL CHEM, V265, P5774; BATENBURG JJ, 1989, BIOCHIM BIOPHYS ACTA, V1006, P329, DOI 10.1016/0005-2760(89)90020-9; BOYER TG, 1989, J BIOL CHEM, V264, P5177; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTCHER RW, 1965, J BIOL CHEM, V240, P4515; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; CRABB DW, 1989, METHOD ENZYMOL, V168, P690; FARNHAM PJ, 1985, J BIOL CHEM, V260, P7675; FOREST CD, 1990, MOL ENDOCRINOL, V4, P1302, DOI 10.1210/mend-4-9-1302; GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x; KIM KH, 1983, CURR TOP CELL REGUL, V22, P143; LEE KL, 1986, ARCH BIOCHEM BIOPHYS, V248, P597, DOI 10.1016/0003-9861(86)90513-8; LOPEZCASILLAS F, 1987, ARCH BIOCHEM BIOPHYS, V257, P63, DOI 10.1016/0003-9861(87)90543-1; LOPEZCASILLAS F, 1989, J BIOL CHEM, V264, P7176; LOPEZCASILLAS F, 1989, GENE, V83, P311, DOI 10.1016/0378-1119(89)90117-0; LUO XC, 1990, NUCLEIC ACIDS RES, V18, P3249, DOI 10.1093/nar/18.11.3249; LUO XC, 1989, P NATL ACAD SCI USA, V86, P4042, DOI 10.1073/pnas.86.11.4042; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MELTON DW, 1986, CELL, V44, P319, DOI 10.1016/0092-8674(86)90766-X; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; OSBORN L, 1988, J BIOL CHEM, V263, P16519; PAPE ME, 1988, ARCH BIOCHEM BIOPHYS, V267, P104, DOI 10.1016/0003-9861(88)90013-6; PAPE ME, 1988, MOL ENDOCRINOL, V2, P395, DOI 10.1210/mend-2-5-395; PAPE ME, 1989, MOL CELL BIOL, V9, P974, DOI 10.1128/MCB.9.3.974; PAPE ME, 1989, THESIS PURDUE U; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI K, 1988, P NATL ACAD SCI USA, V85, P2954, DOI 10.1073/pnas.85.9.2954; SIESS EA, 1976, FEBS LETT, V69, P265, DOI 10.1016/0014-5793(76)80701-6; SINGERSAM J, 1984, GENE, V32, P409, DOI 10.1016/0378-1119(84)90016-7; TAKAI T, 1988, ARCH BIOCHEM BIOPHYS, V266, P313, DOI 10.1016/0003-9861(88)90263-9; TAPAROWSKY EJ, 1987, CANCER RES, V47, P4125; TAUB R, 1987, J BIOL CHEM, V262, P10893; YUTZEY KE, 1989, MOL CELL BIOL, V9, P1397, DOI 10.1128/MCB.9.4.1397; ZHU Z, 1989, J BIOL CHEM, V264, P6550; ZUURENDONK PF, 1974, BIOCHIM BIOPHYS ACTA, V333, P393, DOI 10.1016/0005-2728(74)90022-X; 1986, CAMP 125I ASSAY SYST, P509	45	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12249	12256						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1676399				2022-12-25	WOS:A1991FV18000026
J	STROM, MS; LORY, S				STROM, MS; LORY, S			AMINO-ACID SUBSTITUTIONS IN PILIN OF PSEUDOMONAS-AERUGINOSA - EFFECT ON LEADER PEPTIDE CLEAVAGE, AMINO-TERMINAL METHYLATION, AND PILUS ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIGENIC ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; SIGNAL PEPTIDE; OUTER-MEMBRANE; MUTANT PILINS; GENE; PROTEINS; CLONING; SITE; EXPRESSION	A total of 37 separate mutants containing single and multiple amino acid substiutions in the leader and amino-terminal conserved region of the Type IV pilin from Pseudomonas aeruginosa were generated by oligonucleotide-directed mutagenesis. The effect of these substitutions on the secretion, processing, and assembly of the pilin monomers into mature pili was examined. The majority of substitutions in the highly conserved amino-terminal region of the pilin monomer had no effect of piliation. Likewise, substitution of several of the residues within the six amino acid leader sequence did not affect secretion and leader cleavage (processing), including replacement of one or both of the positively charged lysine residues with uncharged or negatively charged amino acids. One characteristic of the Type IV pili is the presence of an amino-terminal phenylalanine after leader peptide cleavage which is N-methylated prior to assembly of pilin monomers into pili. Substitution of the amino-terminal phenylalanine with a number of other amino acids, including polar, hydrophobic, and charged residues, did not affect proper leader cleavage and subsequent assembly into pili. Amino-terminal sequencing showed that the majority of substitute residues were also methylated. Substitution of the glycine residue at the -1 position to the cleavage site resulted in the inability to cleave the prepilin monomers and blocked the subsequent assembly of monomers into pili. These results indicate that despite the high degree of conservation in the amino-terminal sequences of the Type IV pili, N-methylphenylalanine at the +1 position relative to the leader peptide cleavage site is not strictly required for pilin assembly. N-Methylation of the amino acids substituted for phenylalanine was shown to have taken place in four of the five mutants tested, but it remains unclear as to whether pilin assembly in dependent on this modification. Recognition and proper cleavage of the prepilin by the leader peptidase appears to be dependent only on the glycine residue at the -1 position. Cell fractionation experiments demonstrated that pilin isolated from mutants deficient in prepilin processing and/or assembly was found in both inner and outer membrane fractions, indistinguishable from the results seen with the wild type.			STROM, MS (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MICROBIOL,SC-42,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021451, R01AI021451] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAGA M, 1984, J BACTERIOL, V157, P330; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; DODD DC, 1984, J BACTERIOL, V159, P1077, DOI 10.1128/JB.159.3.1077-1079.1984; DUFFAUD G, 1988, J BIOL CHEM, V263, P10224; FAAST R, 1989, GENE, V85, P227, DOI 10.1016/0378-1119(89)90486-1; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GAASTRA W, 1981, FEMS MICROBIOL LETT, V12, P41; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; HOSHINO T, 1980, J BACTERIOL, V141, P1055, DOI 10.1128/JB.141.3.1055-1063.1980; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; INOUYE S, 1983, SCIENCE, V221, P59, DOI 10.1126/science.6344218; JOHNSON K, 1986, J BIOL CHEM, V261, P5703; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARRS CF, 1985, J BACTERIOL, V163, P132, DOI 10.1128/JB.163.1.132-139.1985; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCKERN NM, 1983, FEBS LETT, V164, P149, DOI 10.1016/0014-5793(83)80039-8; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990; ORNDORFF PE, 1985, J BACTERIOL, V162, P454, DOI 10.1128/JB.162.1.454-457.1985; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; OSBORN MJ, 1963, P NATL ACAD SCI USA, V50, P499, DOI 10.1073/pnas.50.3.499; PASLOSKE BL, 1989, J BACTERIOL, V171, P2142, DOI 10.1128/jb.171.4.2142-2147.1989; PASLOSKE BL, 1988, MOL MICROBIOL, V2, P489, DOI 10.1111/j.1365-2958.1988.tb00055.x; POLLITT S, 1986, J BIOL CHEM, V261, P1835; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; ROOSENDAAL B, 1984, FEMS MICROBIOL LETT, V22, P253; SAIMAN L, 1990, J INFECT DIS, V161, P541, DOI 10.1093/infdis/161.3.541; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHAW CE, 1990, INFECT IMMUN, V58, P3042, DOI 10.1128/IAI.58.9.3042-3049.1990; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; STROM MS, 1986, J BACTERIOL, V165, P367, DOI 10.1128/jb.165.2.367-372.1986; STROM MS, 1987, J BACTERIOL, V169, P3181, DOI 10.1128/jb.169.7.3181-3188.1987; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VLASUK GP, 1983, J BIOL CHEM, V258, P7141; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WU HC, 1986, PROTEIN COMPARTMENTA, P46; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	44	133	140	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1656	1664						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671038				2022-12-25	WOS:A1991EU49700048
J	NAIR, BG; STEINKE, L; YU, YM; RASHED, HM; SEYER, JM; PATEL, TB				NAIR, BG; STEINKE, L; YU, YM; RASHED, HM; SEYER, JM; PATEL, TB			INCREASE IN THE NUMBER OF ATRIAL NATRIURETIC HORMONE RECEPTORS IN REGENERATING RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICULATE GUANYLATE-CYCLASE; PEPTIDE CLEARANCE RECEPTOR; CYCLIC-GMP ACCUMULATION; VASCULAR SMOOTH-MUSCLE; CELLS; BINDING; INHIBITION; PROTEINS; STIMULATION; EXPRESSION	Forty-eight hours after partial (approximately 67%) hepatectomy the activity of the particulate guanylate cyclase was increased by 2-fold in the regenerating rat liver. This increase was not an artifact of membrane isolation procedures, and as determined by I-125-labeled Tyr-28 atrial natriuretic hormone-(1-28) ANF binding, was accompanied by a 2-fold increase in the number of ANF receptors. The K(d) of the receptors in membranes of regenerating livers was not significantly different from the K(d) of the receptors in livers of sham-operated rats. The linear synthetic descysteine analog of ANF, analog I, which binds only to the 66-kDa receptors, displaced approximately 40% of the specifically bound I-125-ANF in liver membranes from both hepatectomized and sham-operated (control) animals. Affinity cross-linking studies with I-125-ANF confirmed the increase in the 116-kDa ANF receptor in membranes of regenerating livers. In perfused livers derived from control and hepatectomized animals, the basal rates of cGMP production were not significantly different. However, atriopeptin II-stimulated cGMP production was twice as great in regenerating livers as compared with controls. These data demonstrate that the increase in particulate guanylate cyclase activity observed during liver regeneration is due to an increase in the 116-kDa ANF receptor-associated activity. Additionally, our data demonstrate that the regenerating rat liver may be a valuable model with which to study the role of the hepatic ANF receptor/particulate guanylate cyclase.	UNIV TENNESSEE, CTR HLTH SCI, DEPT PHARMACOL, 874 UNION AVE, MEMPHIS, TN 38163 USA; UNIV TENNESSEE, CTR HLTH SCI, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center				nair, bipin/0000-0002-4944-8805	NHLBI NIH HHS [HL07641] Funding Source: Medline; NIDDK NIH HHS [DK 01742, DK 35713] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035713, K04DK001742] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS SP, 1987, ENDOCRIN METAB CLIN, V16, P1; ANTUNESRODRIGUES J, 1986, ENDOCRINOLOGY, V118, P1726, DOI 10.1210/endo-118-4-1726; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHRISMAN TD, 1975, J BIOL CHEM, V250, P374; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DELEAN A, 1984, ENDOCRINOLOGY, V115, P1636; EARP HS, 1981, J CLIN INVEST, V67, P1580, DOI 10.1172/JCI110190; EPSTEIN M, 1986, J HYPERTENS, V4, pS93; FULLER F, 1988, J BIOL CHEM, V263, P9395; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GIERSCHIK P, 1985, P NATL ACAD SCI USA, V82, P727, DOI 10.1073/pnas.82.3.727; HASSID A, 1987, AM J PHYSIOL, V253, pF1077; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HEMS DA, 1978, FEBS LETT, V87, P196, DOI 10.1016/0014-5793(78)80330-5; HUERTABAHENA J, 1983, BIOCHIM BIOPHYS ACTA, V763, P112, DOI 10.1016/0167-4889(83)90033-2; JOHNSON A, 1988, BIOCHEM BIOPH RES CO, V152, P893, DOI 10.1016/S0006-291X(88)80123-2; KIMURA H, 1975, P NATL ACAD SCI USA, V72, P1965, DOI 10.1073/pnas.72.5.1965; KOIDE Y, 1978, J BIOL CHEM, V253, P4439; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; KUDO T, 1984, NATURE, V312, P756, DOI 10.1038/312756a0; KUROSE H, 1987, FEBS LETT, V219, P375, DOI 10.1016/0014-5793(87)80256-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; LEITMAN DC, 1987, BIOCHEM J, V244, P69, DOI 10.1042/bj2440069; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MATSUO H, 1987, ENDOCRIN METAB CLIN, V16, P43, DOI 10.1016/S0889-8529(18)30494-8; NEEDLEMAN P, 1989, ANNU REV PHARMACOL, V29, P23, DOI 10.1146/annurev.pa.29.040189.000323; NEVILLE DM, 1968, BIOCHIM BIOPHYS ACTA, V154, P540, DOI 10.1016/0005-2795(68)90014-7; OLINS GM, 1988, J BIOL CHEM, V263, P10989; PARK CR, 1972, DIABETES, V21, P439, DOI 10.2337/diab.21.2.S439; PORTER JG, 1988, J BIOL CHEM, V263, P18827; RUBIN RA, 1982, P NATL ACAD SCI-BIOL, V79, P776, DOI 10.1073/pnas.79.3.776; SAMSON WK, 1985, NEUROENDOCRINOLOGY, V40, P77; SCARBOROUGH RM, 1986, J BIOL CHEM, V261, P2960; SCHOLZ R, 1973, EUR J BIOCHEM, V38, P64, DOI 10.1111/j.1432-1033.1973.tb03034.x; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; SCHWARTZ D, 1985, SCIENCE, V229, P397, DOI 10.1126/science.3160114; SONG CS, 1967, J BIOL CHEM, V242, P694; TAKAYANAGI R, 1987, J BIOL CHEM, V262, P12104; THIBAULT G, 1985, BIOCHEM BIOPH RES CO, V130, P981, DOI 10.1016/0006-291X(85)91711-5; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; YAMATANI K, 1987, BIOCHIM BIOPHYS ACTA, V931, P180, DOI 10.1016/0167-4889(87)90205-9	48	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					567	573						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1670770				2022-12-25	WOS:A1991EQ33900083
J	WATSON, PA				WATSON, PA			DIRECT STIMULATION OF ADENYLATE-CYCLASE BY MECHANICAL FORCES IN S49 MOUSE LYMPHOMA-CELLS DURING HYPOSMOTIC SWELLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											WATSON, PA (corresponding author), GEISINGER MED CLIN,WEIS CTR RES,DANVILLE,PA 17822, USA.							AHLIJANIAN MK, 1988, MOL PHARMACOL, V32, P127; BELL JD, 1987, AM J PHYSIOL, V252, pE783, DOI 10.1152/ajpendo.1987.252.6.E783; BELL JD, 1986, J BIOL CHEM, V261, P2036; COFFINO P, 1975, J CELL PHYSIOL, V85, P603, DOI 10.1002/jcp.1040850312; DARFLER FJ, 1981, J BIOL CHEM, V256, P8422; DARFLER FJ, 1982, J BIOL CHEM, V257, P1901; FLORIO VA, 1983, MOL PHARMACOL, V24, P195; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; GORDELADZE JO, 1989, EUR J BIOCHEM, V183, P397, DOI 10.1111/j.1432-1033.1989.tb14941.x; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; HAZEKI O, 1981, J BIOL CHEM, V256, P2856; HUDSPETH AJ, 1983, ANNU REV BIOPHYS BIO, V17, P99; HUMES JL, 1969, ANAL BIOCHEM, V32, P210, DOI 10.1016/0003-2697(69)90077-3; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; INSEL PA, 1982, J BIOL CHEM, V257, P9717; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; KENNEDY MS, 1979, MOL PHARMACOL, V16, P215; KENT RL, 1989, CIRC RES, V64, P74, DOI 10.1161/01.RES.64.1.74; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; PRENTKI M, 1987, FEBS LETT, V220, P103, DOI 10.1016/0014-5793(87)80884-0; RUSSO LA, 1989, AM J PHYSIOL, V257, pE261, DOI 10.1152/ajpendo.1989.257.2.E261; SACHS F, 1987, FASEB J, V46, P12; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SCHRAMM M, 1986, BIOCHEM PHARMACOL, V35, P2805, DOI 10.1016/0006-2952(86)90193-0; SCHULSTER D, 1978, J BIOL CHEM, V253, P1201; SCHWARTZ MA, 1989, P NATL ACAD SCI USA, V86, P4525, DOI 10.1073/pnas.86.12.4525; STALLA GK, 1988, ENDOCRINOLOGY, V122, P618; STALLA GK, 1989, ENDOCRINOLOGY, V125, P699, DOI 10.1210/endo-125-2-699; TAKUWA Y, 1988, J BIOL CHEM, V263, P762; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; WATSON PA, 1989, AM J PHYSIOL, V256, pC1257, DOI 10.1152/ajpcell.1989.256.6.C1257; WATSON PA, 1989, J BIOL CHEM, V264, P14735; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; XENOPHONTOS XP, 1989, CIRC RES, V65, P647, DOI 10.1161/01.RES.65.3.647; YATANI A, 1988, J BIOL CHEM, V263, P9887	37	87	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6569	6575						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691172				2022-12-25	WOS:A1990CZ67700014
J	WRAIGHT, CJ; VANENDERT, P; MOLLER, P; LIPP, J; LING, NR; MACLENNAN, ICM; KOCH, N; MOLDENHAUER, G				WRAIGHT, CJ; VANENDERT, P; MOLLER, P; LIPP, J; LING, NR; MACLENNAN, ICM; KOCH, N; MOLDENHAUER, G			HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INVARIANT CHAIN IS EXPRESSED ON THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									GERMAN CANC RES CTR,INST IMMUNOL & GENET,W-6900 HEIDELBERG,GERMANY; UNIV HEIDELBERG,INST PATHOL,W-6900 HEIDELBERG,GERMANY; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY; UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Birmingham			van Endert, Peter/R-4606-2017	van Endert, Peter/0000-0003-3782-0750				ACCOLLA RS, 1985, J IMMUNOL, V134, P3265; ALTMANN DM, 1989, NATURE, V338, P512, DOI 10.1038/338512a0; ANDERSSON LC, 1982, EXPRESSION DIFFERENT, P239; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHARRON DJ, 1980, J EXP MED, V152, pS18; CLAESSONWELSH L, 1986, J IMMUNOL, V136, P484; DORKEN P, 1989, IN PRESS CLUSTER REP; EPSTEIN AL, 1984, J IMMUNOL, V133, P1028; FALO LD, 1987, J IMMUNOL, V139, P3918; HARDING CV, 1989, J IMMUNOL, V142, P12; JONES PP, 1978, IMMUNOCHEMISTRY, V16, P51; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; KOCH N, 1984, J IMMUNOL, V132, P1361; KOCH N, 1989, TRENDS BIOCHEM SCI, V14, P383, DOI 10.1016/0968-0004(89)90013-3; KOCH N, 1986, J BIOL CHEM, V261, P3434; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPP J, 1986, J CELL BIOL, V102, P2169, DOI 10.1083/jcb.102.6.2169; LIPP L, 1966, CELL, V46, P1103; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOLDENHAUER G, 1987, BRIT J CANCER, V56, P714, DOI 10.1038/bjc.1987.276; MOMBURG F, 1986, J IMMUNOL, V136, P940; MOOSIC JP, 1982, J BIOL CHEM, V257, P9684; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OSULLIVAN DM, 1987, J EXP MED, V166, P444, DOI 10.1084/jem.166.2.444; QUARANTA V, 1984, J IMMUNOL, V132, P1900; ROSAMOND S, 1987, J IMMUNOL, V139, P1946; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHACKELFORD DA, 1980, J EXP MED, V151, P144, DOI 10.1084/jem.151.1.144; SIVAK LE, 1987, J IMMUNOL, V138, P1319; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025	39	125	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5787	5792						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690714				2022-12-25	WOS:A1990CW48000076
J	NORTH, TW; CRONN, RC; REMINGTON, KM; TANDBERG, RT; JUDD, RC				NORTH, TW; CRONN, RC; REMINGTON, KM; TANDBERG, RT; JUDD, RC			CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM FELINE IMMUNODEFICIENCY VIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											NORTH, TW (corresponding author), UNIV MONTANA,DIV BIOL SCI,MISSOULA,MT 59812, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028189, R01AI021236, K04AI000834, R55AI028189] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 28189, AI 00834, AI 21236] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRELL JW, 1973, J VIROL, V12, P431, DOI 10.1128/JVI.12.3.431-439.1973; CHANDRA A, 1986, FEBS LETT, V200, P327, DOI 10.1016/0014-5793(86)81162-0; CHENG YC, 1987, J BIOL CHEM, V262, P2187; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; JUDD RC, 1987, ANAL BIOCHEM, V160, P306, DOI 10.1016/0003-2697(87)90052-2; JUDD RC, 1986, INFECT IMMUN, V54, P408, DOI 10.1128/IAI.54.2.408-414.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN TS, 1987, BIOCHEM PHARMACOL, V36, P2713; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; NORTH TW, 1989, ANTIMICROB AGENTS CH, V33, P915, DOI 10.1128/AAC.33.6.915; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; SCHINAZI RF, 1989, ANTIMICROB AGENTS CH, V33, P115, DOI 10.1128/AAC.33.1.115; STARNES MC, 1989, J BIOL CHEM, V264, P7073; STARNES MC, 1988, J BIOL CHEM, V263, P5132; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; VRANG L, 1986, ANTIMICROB AGENTS CH, V29, P867, DOI 10.1128/AAC.29.5.867; YAMAMOTO JK, 1988, AM J VET RES, V49, P1246	20	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5121	5128						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690735				2022-12-25	WOS:A1990CV58700058
J	BIRD, TA; SAKLATVALA, J				BIRD, TA; SAKLATVALA, J			DOWN-MODULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AFFINITY IN FIBROBLASTS TREATED WITH INTERLEUKIN-1 OR TUMOR NECROSIS FACTOR IS ASSOCIATED WITH PHOSPHORYLATION AT A SITE OTHER THAN THREONINE-654	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BIRD, TA (corresponding author), STRANGEWAYS RES LAB,CYTOKINE BIOCHEM GRP,WORTS CAUSEWAY,CAMBRIDGE CB1 4RN,ENGLAND.							BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BIRD TA, 1989, J IMMUNOL, V142, P126; BIRD TA, 1986, NATURE, V324, P263, DOI 10.1038/324263a0; COCHET C, 1984, J BIOL CHEM, V259, P2553; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DAVIS RJ, 1984, J BIOL CHEM, V259, P8545; DIDIER M, 1988, J IMMUNOL, V141, P3078; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FRIEDMAN B, 1989, P NATL ACAD SCI USA, V86, P812, DOI 10.1073/pnas.86.3.812; GRAY GM, 1988, J BIOL CHEM, V263, P10714; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HONNEGER AM, 1989, P NATL ACAD SCI USA, V86, P925; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IWASHITA S, 1984, J BIOL CHEM, V259, P2559; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; LOVETT DH, 1988, KIDNEY INT, V34, P26, DOI 10.1038/ki.1988.141; MARTIN M, 1989, EUR J BIOCHEM, V180, P343, DOI 10.1111/j.1432-1033.1989.tb14654.x; MATSUSHIMA K, 1987, J IMMUNOL, V139, P3367; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; OLASHAW NE, 1986, P NATL ACAD SCI USA, V83, P3834, DOI 10.1073/pnas.83.11.3834; RAZ A, 1989, P NATL ACAD SCI USA, V86, P1657, DOI 10.1073/pnas.86.5.1657; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SEHGAL PB, 1987, P NATL ACAD SCI USA, V84, P3663, DOI 10.1073/pnas.84.11.3663; TAKISHIMA K, 1988, BIOCHEM BIOPH RES CO, V157, P740, DOI 10.1016/S0006-291X(88)80312-7; TATSUYA T, 1986, BIOCHEM BIOPH RES CO, V135, P397; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	38	98	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					235	240						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688428				2022-12-25	WOS:A1990CF66200038
J	MAYEUX, P; LACOMBE, C; CASADEVALL, N; CHRETIEN, S; DUSANTER, I; GISSELBRECHT, S				MAYEUX, P; LACOMBE, C; CASADEVALL, N; CHRETIEN, S; DUSANTER, I; GISSELBRECHT, S			STRUCTURE OF THE MURINE ERYTHROPOIETIN RECEPTOR COMPLEX - CHARACTERIZATION OF THE ERYTHROPOIETIN CROSS-LINKED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERLEUKIN-2 RECEPTOR; INFECTED ERYTHROID-CELLS; ERYTHROLEUKEMIA-CELLS; MOLECULAR-CLONING; ESCHERICHIA-COLI; BETA-CHAIN; ONE-STEP; BINDING; EXPRESSION; IDENTIFICATION	The structure of the murine erythropoietin receptor was studied using antibodies against the intracellular part of the cloned erythropoietin receptor chain. These antibodies precipitated erythropoietin-receptor complexes from Triton X-100-solubilized cells. When the complexes were cross-linked by disuccinimidyl suberate, the 85- and 100-kDa erythropoietin-cross-linked proteins previously described were immunoprecipitated. However, these proteins were not precipitated when the complexes were denatured and reduced before immunoprecipitation. Using 1-ethyl 3-(3-dimethylaminopropyl)carbodiimide, we observed erythropoietin cross-linking with a protein of 66 kDa in addition to the 100- and 85-kDa proteins. Only the 66-kDa erythropoietin-cross-linked protein was immunoprecipitated by anti-receptor antibodies after denaturation and reduction of the complex. Thus, our results suggest that the 85- and 100-kDa proteins previously evidenced by cross-linking are associated with the cloned chain of the receptor to form a multimeric complex but these proteins seem immunologically unrelated to the cloned chain. We observed that reducing the length of molecules able to cross-link amino groups decreased the efficiency of cross-linking with the 100-Kda protein and only the 85-kDa protein was cross-linked with erythropoietin using 1,5-difluoro-2,4-dinitrobenzene. These results suggest that the 85- and 100-kDa proteins occupy slightly different positions relative to the erythropoietin molecule bound to the receptor.	INST NATL TRANSFUS SANGUINE, INSERM, U76, F-75015 PARIS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	MAYEUX, P (corresponding author), HOP COCHIN, ICGM, INSERM, U152, 27 RUE FAUBOURG ST JACQUES, F-75674 PARIS 14, FRANCE.		Chretien, Stany/M-5166-2018; Dusanter-Fourt, Isabelle/P-4558-2017	Dusanter-Fourt, Isabelle/0000-0002-9286-1021				AKAHANE K, 1989, EXP HEMATOL, V17, P177; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; BROUDY VC, 1988, P NATL ACAD SCI USA, V85, P6513, DOI 10.1073/pnas.85.17.6513; CLEMENT JM, 1989, CR ACAD SCI III-VIE, V308, P401; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; DANDREA A, 1989, CELL, V58, P1023, DOI 10.1016/0092-8674(89)90499-6; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; de Both N J, 1978, Nature, V272, P626, DOI 10.1038/272626a0; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HOSOI T, 1991, BIOCHEMISTRY-US, V30, P329, DOI 10.1021/bi00216a004; KRANTZ SB, 1991, BLOOD, V77, P419; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ KT, 1989, BLOOD, V73, P1476; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; MANIATIS T, 1982, MOL CLONING LABORATO, P467; MAYEUX P, 1987, FEBS LETT, V211, P229, DOI 10.1016/0014-5793(87)81442-4; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; MAYEUX P, 1990, EUR J BIOCHEM, V194, P271, DOI 10.1111/j.1432-1033.1990.tb19453.x; MAYEUX P, 1990, FEBS LETT, V269, P167, DOI 10.1016/0014-5793(90)81145-E; MCCAFFERY PJ, 1989, J BIOL CHEM, V264, P10507; MUFSON RA, 1987, BLOOD, V69, P1485; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; SASAKI R, 1987, EUR J BIOCHEM, V168, P43, DOI 10.1111/j.1432-1033.1987.tb13384.x; SAWYER ST, 1987, J BIOL CHEM, V262, P5554; SAWYER ST, 1989, J BIOL CHEM, V264, P13343; SAWYER ST, 1987, P NATL ACAD SCI USA, V84, P3690, DOI 10.1073/pnas.84.11.3690; TODOKORO K, 1987, P NATL ACAD SCI USA, V84, P4126, DOI 10.1073/pnas.84.12.4126; WEISS TL, 1989, J BIOL CHEM, V264, P1804; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139	33	74	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23380	23385						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660472				2022-12-25	WOS:A1991GT48300090
J	UNEMORI, EN; BAIR, MJ; BAUER, EA; AMENTO, EP				UNEMORI, EN; BAIR, MJ; BAUER, EA; AMENTO, EP			STROMELYSIN EXPRESSION REGULATES COLLAGENASE ACTIVATION IN HUMAN FIBROBLASTS - DISSOCIABLE CONTROL OF 2 METALLOPROTEINASES BY INTERFERON-GAMMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; RABBIT SYNOVIAL FIBROBLASTS; GROWTH-FACTOR; MATRIX METALLOPROTEINASE-3; STIMULATES COLLAGENASE; ENDOGENOUS ACTIVATION; DERMAL FIBROBLASTS; INDUCIBLE GENES; MESSENGER-RNA; PROCOLLAGENASE	The expression of collagenolytic activity by cells represents the rate-limiting step in the turnover of collagen during remodeling. The collagenase gene is transcriptionally activated in normal dermal or rheumatoid synovial fibroblasts by interleukin-1-beta (IL-1-beta), resulting in secretion of trypsin-activatable procollagenase measuring in the range of 2.0-5.0 units/10(6) cells/48 h in the C-14-fibril assay. The addition of interferon-gamma (IFN-gamma; 50-100 units/ml) inhibits the expression of collagenase activity by 45-80% in these cells. The IL-1-beta induction of procollagenase protein was not altered by IFN-gamma, as judged by Western blot analysis using a monoclonal antibody to collagenase and by gelatin zymography, and procollagenase mRNA was also unaltered, as assessed by Northern blot analysis. Because collagenolytic activity is also controlled by the quantity of tissue inhibitor of metalloproteinases present, its expression was examined by Western blot analysis using a polyclonal antibody to tissue inhibitor of metalloproteinases and by reverse gelatin zymography. Tissue inhibitor of metalloproteinase protein was found to be unaltered or slightly less abundant in conditioned media from cultures treated with IL-1-beta and IFN-gamma when compared with that from cultures treated with IL-1-beta alone. However, the expression of the metalloproteinase activator of procollagenase, stromelysin, was found to be significantly inhibited by the addition of IFN-gamma. Addition of purified activated stromelysin to these conditioned media completely reconstituted collagenolytic activity. These observations demonstrate in an intact system that stromelysin is a specific activator necessary for the development of collagenolytic activity. Despite stromelysin's lack of catalytic activity against collagen, its expression can serve as a control point in the regulation of collagenolysis.	STANFORD UNIV, DEPT DERMATOL, STANFORD, CA 94305 USA	Stanford University	UNEMORI, EN (corresponding author), GENENTECH INC, DEPT DEV BIOL, INFLAMMAT BONE & CONNECT TISSUE RES, 460 PT SAN BRUNO BLVD, S SAN FRANCISCO, CA 94080 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR019537] Funding Source: NIH RePORTER; NIAMS NIH HHS [R37-AR19537] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BAUER EA, 1985, P NATL ACAD SCI USA, V82, P4132, DOI 10.1073/pnas.82.12.4132; BOSS JM, 1986, P NATL ACAD SCI USA, V83, P9139, DOI 10.1073/pnas.83.23.9139; BRINCKERHOFF CE, 1986, BIOCHEMISTRY-US, V25, P6378, DOI 10.1021/bi00369a006; CAWSTON TE, 1979, ANAL BIOCHEM, V99, P340, DOI 10.1016/S0003-2697(79)80017-2; CHIN JR, 1985, J BIOL CHEM, V260, P2367; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; ENGHILD JJ, 1989, J BIOL CHEM, V264, P8779; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; GRANT GA, 1987, J BIOL CHEM, V262, P5886; GRAY PW, 1982, NATURE, V295, P503, DOI 10.1038/295503a0; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; GROSS J, 1965, P NATL ACAD SCI USA, V54, P1197, DOI 10.1073/pnas.54.4.1197; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HERRON GS, 1986, J BIOL CHEM, V261, P2810; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; OKADA Y, 1988, BIOCHEM J, V254, P731, DOI 10.1042/bj2540731; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; SAUS J, 1988, J BIOL CHEM, V263, P6742; SHAPIRO SD, 1990, J CLIN INVEST, V86, P1204, DOI 10.1172/JCI114826; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STEPHENSON ML, 1985, FEBS LETT, V180, P43, DOI 10.1016/0014-5793(85)80227-1; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; UNEMORI EN, 1988, J BIOL CHEM, V263, P16252; VATER CA, 1983, J BIOL CHEM, V258, P9374; WERB Z, 1974, BIOCHEM J, V137, P373, DOI 10.1042/bj1370373; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; WERB Z, 1989, TXB RHEUMATOLOGY, V2, P300; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913	48	72	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23477	23482						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660474				2022-12-25	WOS:A1991GT48300105
J	YODER, BL; BURGERS, PMJ				YODER, BL; BURGERS, PMJ			SACCHAROMYCES-CEREVISIAE REPLICATION FACTOR-C .1. PURIFICATION AND CHARACTERIZATION OF ITS ATPASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; AUXILIARY PROTEIN; ESCHERICHIA-COLI; INITIATION COMPLEX; SV40 ORIGIN; CYCLIN PCNA; CALF THYMUS; CDC2 GENE; DELTA; INVITRO	Saccharomyces cerevisiae replication factor C (RF-C) was purified 25,000-fold from a protease-deficient strain of yeast. RF-C is a complex of 6 subunits of 130, 86, 41, 40, 37, and 27 kDa. None of the subunits are related through proteolysis or differential phosphorylation. The assay for RF-C used as a substrate single-stranded DNA binding protein-coated singly primed single-stranded mp18 DNA. This DNA was poorly replicated by yeast DNA polymerase-delta with or without its cofactor proliferating cell nuclear antigen (PCNA). In the presence of RF-C, however, replication of the template proceeded efficiently when both ATP and PCNA were present as well. Formation of this replication-proficient complex of DNA polymerase-delta required an input of one to two molecules of PCNA per replicated DNA molecule. DNA polymerase-epsilon also formed an ATP-dependent complex with PCNA and RF-C. RF-C has a DNA-dependent ATPase activity, equally active on single-stranded and primed single-stranded mp18 DNA. Addition of PCNA stimulated the ATPase of RF-C on primed but not on unprimed DNA, indicating that the increase in ATPase was due to PCNA-enhanced binding of RF-C to the primer terminus. Calf thymus PCNA also stimulated the ATPase activity of yeast RF-C and participated in holoenzyme formation with DNA polymerase-delta. These results attest to the structural and functional homology between yeast and mammalian cells for these components of the replication machinery.	WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,660 S EUCLID AVE,BOX 8231,ST LOUIS,MO 63110	Washington University (WUSTL)			Burgers, Peter M/AAW-6621-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32431, R01 GM032431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; BAUER GA, 1988, J BIOL CHEM, V263, P917; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BUDD ME, 1989, MOL CELL BIOL, V9, P365, DOI 10.1128/MCB.9.2.365; BURGERS PMJ, 1988, NUCLEIC ACIDS RES, V16, P6297, DOI 10.1093/nar/16.14.6297; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BURGERS PMJ, 1991, EUKARYOTIC DNA POLYM; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CONRAD MN, 1983, MOL CELL BIOL, V3, P1000, DOI 10.1128/MCB.3.6.1000; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Hartwell LH, 1981, MOL BIOL YEAST SACCH, P97; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1991, J BIOL CHEM, V266, P594; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MELENDY T, 1991, J BIOL CHEM, V266, P1942; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9742, DOI 10.1073/pnas.86.24.9742; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692	43	109	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22689	22697						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1682321				2022-12-25	WOS:A1991GR56400094
J	HELMS, JB; DEVRIES, KJ; WIRTZ, KWA				HELMS, JB; DEVRIES, KJ; WIRTZ, KWA			SYNTHESIS OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE IN THE ENDOPLASMIC-RETICULUM OF CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PROTEIN-TRANSPORT; POLYPHOSPHOINOSITIDE METABOLISM; SUBCELLULAR-DISTRIBUTION; LIPID PHOSPHORYLATION; HUMAN-ERYTHROCYTES; EXOCRINE PANCREAS; ARACHIDONIC-ACID; RAT-BRAIN; LIVER	We have investigated the intracellular localization and synthesis of phosphatidylinositol 4,5-bisphosphate (PtdInsP2) in Chinese hamster ovary (CHO) cells by analyzing membrane fractions that were obtained by sucrose density gradient centrifugation. After labeling the cells for 24 h with [H-3]inositol, the bulk of [H-3] PtdInsP2 was found in the plasma membrane fraction, yet this lipid was also distinctly present in the microsomal fraction (20% of total cellular [H-3]PtdInsP2). To determine the origin of this microsomal PtdInsP2, gradient fractions from unlabeled CHO cells were incubated with [H-3]inositol in the presence of an ATP-generating system. Under these conditions of labeling, [H-3]PtdIns was exclusively present in the microsomal fractions and found to be partially converted to [H-3] phosphatidylinositol 4-phosphate ([H-3]PtdInsP) and [H-3]PtdInsP2. The ability of microsomes to synthesize PtdInsP and PtdInsP2 was confirmed by assaying the gradient fractions for PtdIns and PtdInsP kinase activity using endogenous substrate and [gamma-P-32]ATP. In the presence of exogenous substrate and Triton X-100, PtdlnsP kinase activity was particularly high in the plasma membrane fractions. When phosphoinositide synthesis was studied in permeabilized CHO cells under conditions of sustained membrane vesicle flow (Helms, J. B., Karrenbauer, A., Wirtz, K. W. A., Rothman, J. E., and Wieland, F. T. (1990) J. Biol. Chem. 265,20027-20032), no lag-time could be detected between the synthesis of [H-3]PtdIns and the formation of [H-3]PtdInSP2. Moreover, when lipid transport pathways were blocked in these permeabilized cells either by omission of membrane-free cytosol, addition of GTP-gamma-S and brefeldin A, or temperature block, PtdInSP2 formation still occurred at normal levels. These results strongly suggest that PtdInSP2 can be formed at the site of PtdIns synthesis, i.e. the endoplasmic reticulum (ER). The relationship between PtdInSP2, generated in the ER, and PtdInSP2 present in the plasma membrane, remains to be established.	UNIV UTRECHT, CTR BIOMEMBRANES & LIPID ENZYMOL, TRANSITORIUM 3, PADUALAAN 8, 3584 CH UTRECHT, NETHERLANDS	Utrecht University								AUGERT G, 1989, J BIOL CHEM, V264, P2574; BAKER RR, 1990, BIOCH BIOPHSY ACTA, V1042, pR55; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BEHARBANNELIER M, 1980, BIOCHEM J, V187, P147, DOI 10.1042/bj1870147; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREW K, 1975, J BIOL CHEM, V250, P1434; BROCKERHOFF H, 1962, J BIOL CHEM, V237, P1764; CAMPBELL CR, 1985, J BIOL CHEM, V260, P948; CAPITANI S, 1990, CELL BIOL INT REP, V14, P783, DOI 10.1016/0309-1651(90)90005-J; CAPITANI S, 1989, FEBS LETT, V254, P194, DOI 10.1016/0014-5793(89)81037-3; COCCO L, 1987, BIOCHEM J, V248, P765, DOI 10.1042/bj2480765; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; COLLINS CA, 1983, J BIOL CHEM, V258, P2130; DIXON JF, 1984, J BIOL CHEM, V259, P4418; EVANS WH, 1979, LABORATORY TECHNIQUE, V7, P1; FAIN JN, 1979, BIOCHEM J, V180, P655, DOI 10.1042/bj1800655; FOLCH J, 1957, J BIOL CHEM, V226, P497; GASCARD P, 1989, BIOCHEM J, V264, P547, DOI 10.1042/bj2640547; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; HELMS JB, 1990, J BIOL CHEM, V265, P20027; HOKIN LE, 1965, P NATL ACAD SCI USA, V53, P1369, DOI 10.1073/pnas.53.6.1369; IMAI A, 1987, NATURE, V325, P726, DOI 10.1038/325726a0; JERGIL B, 1983, J BIOL CHEM, V258, P7968; JOLLES J, 1981, BIOCHEM J, V194, P283, DOI 10.1042/bj1940283; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; KASINATHAN C, 1989, LIPIDS, V24, P818, DOI 10.1007/BF02544590; KOREH K, 1986, J BIOL CHEM, V261, P88; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUNDBERG GA, 1988, FEBS LETT, V240, P171, DOI 10.1016/0014-5793(88)80362-4; MONACO ME, 1983, J BIOL CHEM, V258, P5125; MORITZ A, 1990, J NEUROCHEM, V54, P351, DOI 10.1111/j.1471-4159.1990.tb13322.x; MORRIS SJ, 1990, BIOCHIM BIOPHYS ACTA, V1022, P339, DOI 10.1016/0005-2736(90)90283-T; MULLER E, 1986, BIOCHEM J, V235, P775; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PALMER FBS, 1986, BIOCHEM CELL BIOL, V64, P117, DOI 10.1139/o86-019; PAULUS H, 1960, J BIOL CHEM, V235, P1303; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PHILLIPS JH, 1973, BIOCHEM J, V136, P579, DOI 10.1042/bj1360579; PUTNEY JW, 1983, BIOCHEM J, V212, P483, DOI 10.1042/bj2120483; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RANA RS, 1986, ARCH BIOCHEM BIOPHYS, V245, P411, DOI 10.1016/0003-9861(86)90232-8; RAWYLER AJ, 1982, FEBS LETT, V148, P140, DOI 10.1016/0014-5793(82)81260-X; RENKONEN O, 1972, BIOCHIM BIOPHYS ACTA, V255, P66, DOI 10.1016/0005-2736(72)90008-9; RICHMOND W, 1973, CLIN CHEM, V19, P1350; SCHMIDT SY, 1983, J CELL BIOL, V97, P832, DOI 10.1083/jcb.97.3.832; SHAIKH NA, 1976, J NEUROCHEM, V26, P597, DOI 10.1111/j.1471-4159.1976.tb01517.x; SMITH CD, 1983, J BIOL CHEM, V258, P9368; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VANPARIDON PA, 1987, BIOCHIM BIOPHYS ACTA, V903, P68, DOI 10.1016/0005-2736(87)90156-8; WARREN G, 1987, NATURE, V327, P17, DOI 10.1038/327017a0; WATTENBERG BW, 1986, J BIOL CHEM, V261, P2208; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	56	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21368	21374						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657963				2022-12-25	WOS:A1991GP80400011
J	ZHANG, A; GAO, ZY; GILON, P; NENQUIN, M; DREWS, G; HENQUIN, JC				ZHANG, A; GAO, ZY; GILON, P; NENQUIN, M; DREWS, G; HENQUIN, JC			VANADATE STIMULATION OF INSULIN RELEASE IN NORMAL MOUSE ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC B-CELLS; GLUCOSE-INDUCED OSCILLATIONS; PROTEIN KINASE-C; ENDOPLASMIC-RETICULUM; BETA-CELLS; PLASMA-MEMBRANE; RAT ISLETS; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE METABOLISM; TYROSINE PHOSPHORYLATION	The effects of vanadate (Na3VO4) on pancreatic B-cell function were studied in normal mouse islets. Vanadate did not affect basal insulin release but potentiated the effect of 7-30 mM glucose at concentrations of 0.1-1 mM. This effect was progressive and slowly reversible. It was abolished by omission of extracellular Ca2+ but unaffected by blockers of adrenergic or muscarinic receptors. Comparison of the changes in membrane potential, Rb-86 efflux and Ca-45 efflux that vanadate and ouabain produced in B-cells made it possible to exclude the hypothesis that vanadate increases insulin release by blocking the sodium pump. Vanadate was also without effect on cAMP levels. On the other hand, it markedly changed the characteristics of, the Ca2+-dependent electrical activity and of the oscillations of cytoplasmic Ca2+ recorded in B-cells stimulated by 15 mM glucose. In the steady state, Ca2+ influx was increased by vanadate, and this resulted in a rise in cytoplasmic Ca2+. The exact mechanisms underlying these changes could not be established but a blockade of K channels was excluded. In the presence of LiCl, vanadate markedly increased inositol phosphate levels in islet cells. This effect was attenuated but not suppressed by omission of Ca2+. A small increase in inositol bisphosphate was still produced by vanadate in the absence of LiCl. These results suggest that vanadate both stimulates phosphoinositide breakdown and inhibits inositol phosphate degradation. In conclusion, vanadate does not induce insulin release, but markedly potentiates the stimulation by glucose. This property is not due to an inhibition of the sodium pump or to a rise in cAMP concentration. It results from a complex interplay between changes in B-cell membrane potential, phosphoinositide metabolism and Ca2+ handling.	CATHOLIC UNIV LOUVAIN,FAC MED,UNITE DIABETOL & NUTR,UCL 5474,B-1200 BRUSSELS,BELGIUM; UNIV SAARLAND,INST PHYSIOL,W-6650 HOMBURG,GERMANY	Universite Catholique Louvain; Saarland University								AXEN KV, 1983, J CLIN INVEST, V72, P13, DOI 10.1172/JCI110951; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BIDEN TJ, 1984, BIOCHEM J, V223, P467, DOI 10.1042/bj2230467; BOZEM M, 1988, PFLUG ARCH EUR J PHY, V413, P147, DOI 10.1007/BF00582524; BOZEM M, 1987, ENDOCRINOLOGY, V121, P1025, DOI 10.1210/endo-121-3-1025; BRICHARD SM, 1989, ENDOCRINOLOGY, V125, P2510, DOI 10.1210/endo-125-5-2510; BRICHARD SM, 1990, DIABETES, V39, P1326, DOI 10.2337/diabetes.39.11.1326; BRICHARD SM, 1991, IN PRESS DIABETE MET; BROWN DJ, 1984, J BIOL CHEM, V259, P9580; CANTLEY LC, 1977, J BIOL CHEM, V252, P7421; CARONI P, 1981, J BIOL CHEM, V256, P3263; CHASTEEN ND, 1983, STRUCT BOND, V53, P105; CLEMENTS RS, 1976, J CLIN INVEST, V57, P684, DOI 10.1172/JCI108325; COLCA JR, 1983, BIOCHIM BIOPHYS ACTA, V729, P176, DOI 10.1016/0005-2736(83)90483-2; DELFERT DM, 1985, ARCH BIOCHEM BIOPHYS, V241, P665, DOI 10.1016/0003-9861(85)90593-4; DIPOLO R, 1979, NATURE, V281, P228, DOI 10.1038/281228a0; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; FAGIN JA, 1987, DIABETES, V36, P1448, DOI 10.2337/diabetes.36.12.1448; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; GAO ZY, 1991, BIOCHEM J, V276, P169, DOI 10.1042/bj2760169; GAO ZY, 1990, J BIOL CHEM, V265, P15724; GARCIA MC, 1988, BIOCHEM J, V254, P211, DOI 10.1042/bj2540211; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GRAPENGIESSER E, 1990, MOL PHARMACOL, V37, P461; GREEN A, 1986, BIOCHEM J, V238, P663, DOI 10.1042/bj2380663; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GULLAPALLI S, 1989, MOL CELL BIOCHEM, V90, P155; HACKBARTH I, 1980, BIOCHEM PHARMACOL, V29, P1429, DOI 10.1016/0006-2952(80)90439-6; HALES CN, 1988, J PHYSL, V194, P725; HENQUIN JC, 1988, BIOCHEM BIOPH RES CO, V156, P769, DOI 10.1016/S0006-291X(88)80910-0; HENQUIN JC, 1978, NATURE, V271, P271, DOI 10.1038/271271a0; HENQUIN JC, 1981, BIOCHEM J, V196, P771, DOI 10.1042/bj1960771; HENQUIN JC, 1982, BIOCHEM PHARMACOL, V31, P1407, DOI 10.1016/0006-2952(82)90036-3; HENQUIN JC, 1982, J PHYSIOL-LONDON, V332, P529, DOI 10.1113/jphysiol.1982.sp014429; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; ISAWA Y, 1982, BIOCHEM BIOPH RES CO, V105, P488; KANAHO Y, 1988, J BIOL CHEM, V263, P17584; KRAWIETZ W, 1982, BIOCHEM PHARMACOL, V31, P843, DOI 10.1016/0006-2952(82)90472-5; LEBRUN P, 1983, J MEMBRANE BIOL, V74, P67, DOI 10.1007/BF01870596; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; LICHTSTEIN D, 1982, P NATL ACAD SCI-BIOL, V79, P4202, DOI 10.1073/pnas.79.13.4202; MATHIAS PCF, 1985, BIOCHEM PHARMACOL, V34, P3451, DOI 10.1016/0006-2952(85)90717-8; MEISSNER HP, 1974, PFLUG ARCH EUR J PHY, V351, P195, DOI 10.1007/BF00586918; MEYEROVITCH J, 1987, J BIOL CHEM, V262, P6658; NECHAY BR, 1984, ANNU REV PHARMACOL, V24, P501; NEUMCKE B, 1991, EUR BIOPHYS J, V19, P119; PARIS S, 1987, J BIOL CHEM, V262, P1970; PERSAUD SJ, 1989, BIOCHEM J, V264, P753, DOI 10.1042/bj2640753; Posner B. I., 1990, NEW ANTIDIABETIC DRU, P107; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; RORSMAN P, 1988, J GEN PHYSIOL, V91, P223, DOI 10.1085/jgp.91.2.223; SCHWABE U, 1979, NATURE, V277, P143, DOI 10.1038/277143a0; SHECHTER Y, 1990, DIABETES, V39, P1, DOI 10.2337/diabetes.39.1.1; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TAMURA S, 1984, J BIOL CHEM, V259, P6650; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; VARECKA L, 1982, J BIOL CHEM, V257, P7414; VILLARPALASI C, 1989, BIOCHEM J, V262, P563, DOI 10.1042/bj2620563; VIRJI MAG, 1978, ENDOCRINOLOGY, V102, P706, DOI 10.1210/endo-102-3-706; WANG JL, 1990, BIOCHEM BIOPH RES CO, V166, P813, DOI 10.1016/0006-291X(90)90882-N; WIBO M, 1981, BIOCHIM BIOPHYS ACTA, V649, P651, DOI 10.1016/0005-2736(81)90170-X; WIERICHS R, 1980, BIOCHEM BIOPH RES CO, V92, P1124, DOI 10.1016/0006-291X(80)90403-9; WOLF BA, 1986, J BIOL CHEM, V261, P6284; ZAWALICH WS, 1988, AM J PHYSIOL, V254, pE609, DOI 10.1152/ajpendo.1988.254.5.E609; ZAWALICH WS, 1989, ENDOCRINOLOGY, V125, P2400, DOI 10.1210/endo-125-5-2400; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	68	37	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21649	21656						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657974				2022-12-25	WOS:A1991GP80400051
J	ERIKSSON, A; NISTER, M; LEVEEN, P; WESTERMARK, B; HELDIN, CH; CLAESSONWELSH, L				ERIKSSON, A; NISTER, M; LEVEEN, P; WESTERMARK, B; HELDIN, CH; CLAESSONWELSH, L			INDUCTION OF PLATELET-DERIVED GROWTH-FACTOR ALPHA-RECEPTOR AND BETA-RECEPTOR MESSENGER-RNA AND PROTEIN BY PLATELET-DERIVED GROWTH FACTOR-BB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN SARCOMA-VIRUS; MICROVASCULAR ENDOTHELIAL-CELLS; FACTOR-A-CHAIN; PDGF RECEPTOR; HUMAN-FIBROBLASTS; CDNA CLONING; ONC GENE; EXPRESSION; PROLIFERATION; SIMILARITIES	We describe that stimulation of human fibroblasts with platelet-derived growth factor BB (PDGF-BB) induces a transient up-regulation of the PDGF alpha- and beta-receptor transcript and protein levels. The effect of PDGF-BB on the receptor transcript levels was more pronounced than those seen when other cytokines were used. Regulation of transcript levels by PDGF-BB was mediated through post-transcriptional mechanisms. No induction could be observed in a nuclear run-on analysis, but cycloheximide treatment attenuated the accumulation of both alpha- and beta-receptor transcripts induced by PDGF-BB. An increase in receptor protein levels was observed using two different experimental approaches. Increased amounts of receptor precursor forms could be immunoprecipitated from metabolically labeled cells, stimulated with PDGF-BB. In a second approach, cells were exposed to different concentrations of PDGF-BB, and, in a subsequent step, ligand binding analysis was performed. In this experiment, an initial down-regulation of receptors was followed by increased levels of the cell surface forms of the receptors. In conclusion, PDGF-BB, but not PDGF-AA, induces increased synthesis of both PDGF alpha- and beta-receptor protein; this constitutes a positive feed-back mechanism, which, for example, could serve to potentiate autocrine stimulation of growth.	UNIV HOSP UPPSALA,DEPT PATHOL,S-75185 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital	ERIKSSON, A (corresponding author), BIOMED CTR,LUDWIG INST CANC RES,S-75124 UPPSALA,SWEDEN.							ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BAR RS, 1989, ENDOCRINOLOGY, V124, P1841, DOI 10.1210/endo-124-4-1841; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BECKMANN MP, 1988, SCIENCE, V241, P1346, DOI 10.1126/science.2842868; BETSHOLTZ C, 1984, J CELL PHYSIOL, V118, P203, DOI 10.1002/jcp.1041180213; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BYWATER M, 1988, MOL CELL BIOL, V8, P2753, DOI 10.1128/MCB.8.7.2753; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; EARP HS, 1986, J BIOL CHEM, V261, P4777; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; HILL DJ, 1986, J CELL PHYSIOL, V128, P322, DOI 10.1002/jcp.1041280226; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KANAKARAJ P, 1991, BIOCHEMISTRY-US, V30, P1761, DOI 10.1021/bi00221a005; KAVANAUGH WM, 1988, J BIOL CHEM, V263, P8470; Maniatis T., 1982, MOL CLONING; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; Paulsson Y, 1988, GROWTH FACTORS, V1, P19, DOI 10.3109/08977198809000243; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RAINES EW, 1990, HDB EXPT PHARM 1, V95, P173; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; RONNSTRAND L, 1987, J BIOL CHEM, V262, P2929; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; SMITS A, IN PRESS P NATL ACAD; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; STARKSEN NF, 1987, J BIOL CHEM, V262, P14381; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	50	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21138	21144						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657951				2022-12-25	WOS:A1991GN00100086
J	FEVE, B; EMORINE, LJ; LASNIER, F; BLIN, N; BAUDE, B; NAHMIAS, C; STROSBERG, AD; PAIRAULT, J				FEVE, B; EMORINE, LJ; LASNIER, F; BLIN, N; BAUDE, B; NAHMIAS, C; STROSBERG, AD; PAIRAULT, J			ATYPICAL BETA-ADRENERGIC-RECEPTOR IN 3T3-F442A ADIPOCYTES PHARMACOLOGICAL AND MOLECULAR RELATIONSHIP WITH THE HUMAN BETA-3-ADRENERGIC RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; BETA-2-ADRENERGIC RECEPTOR; MESSENGER-RNA; BETA-1-ADRENERGIC RECEPTOR; ADRENOCEPTOR AGONISTS; 3T3-L1 PREADIPOCYTES; RAT ADIPOCYTES; BINDING; EXPRESSION; CLONING	Expression of ligand binding properties for an atypical beta-adrenergic receptor (beta-AR) subtype was studied during the adipose differentiation of murine 3T3-F442A cells and compared with that of the human beta-3-AR expressed in Chinese hamster ovary cells stably transfected with the human beta-3-AR gene (CHO-beta-3 cells) Emorine, L. J., Marullo, S., Briend-Sutren, M. M., Patey, G., Tate, K., Delavier-Klutchko, C., and Strosberg, A. D. (1989) Science 245, 1118-1121). 3T3-F442A adipocytes exhibited high and low affinity binding sites for (-)-4-(3-t-butylamino-2-hydroxypropoxy)[5,7-H-3]benzimidazole-2-one ((-)-[H-3]CGP-12177) (K(D) = 1.2 and 38.3 nM) and (-)-[I-125]iodocyanopindolol([I-125]CYP) (K(D) = 47 and 1,510 pM). The high affinity sites corresponded to the classical, beta-1- and beta-2-AR subtypes whereas the K(D) values of the low affinity sites for the radioligands were similar to those measured in CHO-beta-3 cells (K(D) = 28 nM and 1,890 pM for (-)-[H-3]CGP12177 and [I-125]CYP, respectively). These low affinity sites were undetectable in preadipocytes but represented about 90% of total beta-ARs in adipocytes. The atypical beta--AR and the human beta-3-AR had similarly low affinities (K(i) = 3-5-mu-M) for (+/-)-(2-(3-carbamoyl-4-hydroxyphenoxy)ethylamino-3)-(4-(1-methyl-4-trifluormethyl-2-imidazolyl)-phenoxy)-2-propanol methane sulfonate (CGP20712A) or erythro-(+/-)1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol (ICI118551), highly selective beta-1- and beta-2-AR antagonists, respectively, in agreement with the poor inhibitory effect of the compounds on (-)-isoproterenol (IPR)-stimulated adenylate cyclase activity. Atypical beta-AR and beta-3-AR had an affinity about 10-50 times higher for sodium-4-{2-[2-hydroxy-2-(3-chlorophenyl)ethylamino]propyl}phenoxyacetate sesquihydrate (BRL37344) than the beta-1-AR subtype. This correlates with the potent lipolytic effect of BRL37344 in adipocytes. The rank order of potency of agonists in functional and binding studies was BRL37344 > IPR < (-)-norepinephrine > (-)-epinephrine both in 3T3 adipocytes and CHO-beta-3 cells. As in CHO-beta-3 cells, the classical beta-1- and beta-2-antagonists CGP12177, oxprenolol, and pindolol were partial agonists in adipocytes. Although undetectable in preadipocytes, a major mRNA species of 2.3 kilobases (kb) and a minor one of 2.8 kb were observed in adipocytes by hybridization to a human beta-3-AR specific probe. The 2.3-kb transcript was also found in mouse white adipose tissue. Polymerase chain reaction analysis of cDNA reverse-transcribed from 3T3-F442A RNA revealed the presence in adipocytes but not in preadipocytes of transcripts homologous to the human beta-3-AR gene. *The close parallelism between the pharmacological and mRNA analyses supports the existence in 3T3 adipocytes of a predominant beta-3-AR population involved in the lipolytic effect of catecholamines.	CNRS, UPR 0415, F-75005 PARIS, FRANCE; UNIV PARIS 07, INST COCHIN GENET MOLEC, F-75014 PARIS, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	FEVE, B (corresponding author), HOP HENRI MONDOR, CNRS, INSERM, U282, 51 AV MARECHAL DE LATTRE DE TASSIGNY, F-94010 CRETEIL, FRANCE.			Feve, Bruno/0000-0001-6577-9009				ARCH JRS, 1989, P NUTR SOC, V48, P215, DOI 10.1079/PNS19890032; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, P495; BAHOUTH SW, 1988, MOL PHARMACOL, V34, P318; BOJANIC D, 1985, BRIT J PHARMACOL, V84, P131; BUKOWIECKI L, 1978, EUR J BIOCHEM, V92, P189, DOI 10.1111/j.1432-1033.1978.tb12737.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG FZ, 1987, FEBS LETT, V211, P200, DOI 10.1016/0014-5793(87)81436-9; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOOLEY DJ, 1987, J PHARMACOL METHOD, V18, P131, DOI 10.1016/0160-5402(87)90005-2; EMORINE LJ, 1991, BIOCHEM PHARMACOL, V41, P853, DOI 10.1016/0006-2952(91)90188-B; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FEVE B, 1990, J BIOL CHEM, V265, P16343; FEVE B, 1989, MOL CELL ENDOCRINOL, V67, P17, DOI 10.1016/0303-7207(89)90226-8; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN K, 1979, ACTA OBSTET GYN SCAN, P15; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; HOLLENGA C, 1989, BRIT J PHARMACOL, V98, P1420, DOI 10.1111/j.1476-5381.1989.tb12692.x; HOLLENGA C, 1990, HORM METAB RES, V22, P17, DOI 10.1055/s-2007-1004839; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KENT RS, 1980, MOL PHARMACOL, V17, P14; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; LAI E, 1982, J BIOL CHEM, V257, P6691; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LANGIN D, 1991, EUR J PHARMACOL, V199, P291, DOI 10.1016/0014-2999(91)90492-9; LEVIN BE, 1986, J PHARMACOL EXP THER, V236, P681; LIN ECC, 1960, J BIOL CHEM, V235, P1820; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MOHELL N, 1989, BIOCHEM J, V261, P401, DOI 10.1042/bj2610401; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUZZIN P, 1988, BIOCHEM BIOPH RES CO, V156, P375, DOI 10.1016/S0006-291X(88)80851-9; NAHMIAS C, 1991, IN PRESS EMBO J; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; ODONNELL SR, 1980, LIFE SCI, V27, P671, DOI 10.1016/0024-3205(80)90008-9; PAIRAULT J, 1982, EUR J BIOCHEM, V127, P351, DOI 10.1111/j.1432-1033.1982.tb06879.x; ROTHWELL NJ, 1985, AM J PHYSIOL, V248, pE397, DOI 10.1152/ajpendo.1985.248.4.E397; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; TATE KM, 1991, EUR J BIOCHEM, V196, P357, DOI 10.1111/j.1432-1033.1991.tb15824.x; WILSON C, 1984, EUR J PHARMACOL, V100, P309, DOI 10.1016/0014-2999(84)90007-4; ZAAGSMA J, 1990, TRENDS PHARMACOL SCI, V11, P3, DOI 10.1016/0165-6147(90)90032-4; ZAAGSMA J, 1985, PHARM ADRENOCEPTORS, P247	49	129	132	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20329	20336						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1682311				2022-12-25	WOS:A1991GM03900068
J	LOCKYER, JM; MCCRACKEN, JB				LOCKYER, JM; MCCRACKEN, JB			IDENTIFICATION OF A TISSUE-SPECIFIC REGULATORY ELEMENT WITHIN THE HUMAN MUSCLE GLYCOGEN-PHOSPHORYLASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE GENE; CARDIAC ACTIN GENE; SEQUENCE-ANALYSIS; MESSENGER-RNA; DNA FRAGMENTS; MOUSE MUSCLE; HUMAN-LIVER; EXPRESSION; ENHANCER; PROTEIN	Northern blot analysis showed that human muscle glycogen phosphorylase is developmentally regulated in human adult and fetal skeletal muscle. Furthermore, muscle phosphorylase mRNA expression is temporally regulated in the C2C12 mouse muscle cell line. To define regulatory elements that control expression of the human muscle glycogen phosphorylase gene, the structure of the 5' end of the gene was determined, and 1,129 base pairs of the 5'-flanking region were subcloned and sequenced. Primer extension, RNase protection, and S1 nuclease protection experiments mapped the transcription start site to 76 base pairs upstream from the starting methionine. Sequential deletions of the 5'-flanking region were tested for the ability to activate chloramphenicol acetyltransferase (CAT) expression in fused or proliferating C2C12 cells. Inclusion of the 43 base pairs between -612 and -570 led to a 9-fold increase in CAT activity in fused myotubes. No increase was observed in proliferating myoblasts. This region contains a 10-base pair sequence, CTCCAAAAGG, at -592, which is also repeated at -252. Mutation of the sequence at -592 results in a 50% decrease in CAT activity compared with the amount of CAT activity observed with the normal or a control mutation. These results indicate that a regulatory element is found within -612 to -570 of the 5'-flanking DNA of the human muscle glycogen phosphorylase gene which activates transcription only in differentiated muscle cells.			LOCKYER, JM (corresponding author), TULANE UNIV,SCH MED,HUMAN GENET PROGRAM,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.							BENOIST C, 1980, NUCLEIC ACIDS RES, V8, P127, DOI 10.1093/nar/8.1.127; BERGSMA DJ, 1986, MOL CELL BIOL, V6, P2462, DOI 10.1128/MCB.6.7.2462; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BUCKINGHAM ME, 1977, BIOCH CELL DIFFERENT, V15, P269; BURKE J, 1987, PROTEINS, V2, P177, DOI 10.1002/prot.340020303; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEVLIN RB, 1979, DEV BIOL, V69, P202, DOI 10.1016/0012-1606(79)90286-0; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P539; HENION WF, 1957, J BIOL CHEM, V224, P477; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MARTINUZZI A, 1986, J CELL BIOL, V103, P1423, DOI 10.1083/jcb.103.4.1423; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MIRANDA AF, 1979, MUSCLE REGENERATION, P453; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; NAKANO K, 1986, FEBS LETT, V204, P283, DOI 10.1016/0014-5793(86)80829-8; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1986, P NATL ACAD SCI USA, V83, P8132, DOI 10.1073/pnas.83.21.8132; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRASK RV, 1988, J BIOL CHEM, V263, P17142; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WOSILAIT WD, 1956, J BIOL CHEM, V218, P469; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YUTZEY KE, 1990, MOL CELL BIOL, V10, P3934, DOI 10.1128/MCB.10.8.3934	43	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20262	20269						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657918				2022-12-25	WOS:A1991GM03900058
J	CASILLAS, A; HANEKOM, C; WILLIAMS, K; KATZ, R; NEL, AE				CASILLAS, A; HANEKOM, C; WILLIAMS, K; KATZ, R; NEL, AE			STIMULATION OF B-CELLS VIA THE MEMBRANE IMMUNOGLOBULIN RECEPTOR OR WITH PHORBOL-MYRISTATE 13-ACETATE INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF A 42-KDA MICROTUBULE-ASSOCIATED PROTEIN-2 KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; LYMPHOCYTES-B; MONOCLONAL-ANTIBODY; MAP-2 KINASE; ESTER; PROLIFERATION; INSULIN; ACID	Engagement of membrane IgM on a number of human and murine B-cell lines induced activation of a Mn2+-preferring serine/threonine kinase that phosphorylated microtubule-associated protein-2 (MAP-2) in vitro. B-cell MAP-2 kinase (MAP-2K) activity could be fractionated into two peaks by sequential DEAE and hydrophobic chromatography. Although peak I included two tyrosine phosphoproteins of molecular mass 36 and 38 kDa, peak II showed a single 42-kDa tyrosine phosphoprotein (pp42). Since all kinase activity could be removed from peak II material over an antiphosphotyrosine immune affinity column, it suggests that pp42 is identical with lymphoid MAP-2K. Although peak I activity showed a similarity to peak II with regard to its preference for Mn2+, sensitivity to phosphatase exposure, and resistance to a range of common serine kinase inhibitors, it is not clear whether these activities are related. MAP-2 kinase activity could also be induced by treatment with the phorbol ester, phorbol myristate 13-acetate, suggesting that protein kinase C may also be involved with MAP-2K regulation. Although MAP-2K activity reached a peak response within minutes of receptor ligation, there were differences in the rates of dephosphorylation of pp42 and decline of MAP-2K activity in different B-cell lines. The tyrosine phosphatase inhibitor, vanadate, transformed a rapidly reversible MAP-2K response in BAL 17.2 cells into a sustained state of activation that resembled the kinetics of activation in WEHI-231 cells. The latter findings implies involvement of a tyrosine phosphatase, which opposes the effect of an inducing tyrosine kinase.	UNIV CALIF LOS ANGELES, SCH MED,DEPT MED,DIV CLIN IMMUNOL & ALLERGY, 10833 LE CONTE AVE,52-175 CHS, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, CTR INTERDISCIPLINARY RES IMMUNOL & DIS, LOS ANGELES, CA 90024 USA; STELLENBOSCH MED SCH, DEPT INTERNAL MED, TYGERBERG 7505, SOUTH AFRICA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Stellenbosch University			Nel, Andre E/J-2808-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI015332] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 15332, AI 07126] Funding Source: Medline; NIGMS NIH HHS [GM 41576] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DENIS KA, 1985, HUMAN HYBRIDOMAS MON, P293; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; HANEKOM C, 1989, BIOCHEM J, V262, P449, DOI 10.1042/bj2620449; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; LANE PJL, 1990, J IMMUNOL, V144, P3684; LANE PJL, 1991, J IMMUNOL, V146, P715; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; NEL AE, 1985, BIOCHEM BIOPH RES CO, V128, P1364, DOI 10.1016/0006-291X(85)91091-5; NEL AE, 1985, J IMMUNOL, V135, P3448; NEL AE, 1986, BIOCHEM J, V233, P145, DOI 10.1042/bj2330145; NEL AE, 1990, J IMMUNOL, V145, P971; NEL AE, 1990, J IMMUNOL, V144, P2683; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SHERR E, 1988, J EXP MED, V168, P55, DOI 10.1084/jem.168.1.55; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435	21	99	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19088	19094						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655769				2022-12-25	WOS:A1991GJ47200104
J	MUNSON, KB; GUTIERREZ, C; BALAJI, VN; RAMNARAYAN, K; SACHS, G				MUNSON, KB; GUTIERREZ, C; BALAJI, VN; RAMNARAYAN, K; SACHS, G			IDENTIFICATION OF AN EXTRACYTOPLASMIC REGION OF H+,K+-ATPASE LABELED BY A K+-COMPETITIVE PHOTOAFFINITY INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED ADENOSINE-TRIPHOSPHATASE; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCE; (NA+ + K+)-ATPASE; SARCOPLASMIC-RETICULUM; GASTRIC (H+; CONFORMATIONAL TRANSITIONS; COMPLEMENTARY-DNA; ALPHA-POLYPEPTIDE; NUCLEIC-ACIDS	The photoaffinity reagent 8-[(4-azidophenyl)-methoxy]-1-tritiomethyl-2,3-dimethylimidazo-[1,2-a]pyridinium iodide ([H-3]mDAZIP) has been synthesized and used to photoinactivate and label purified hog gastric H+,K+-ATPase. The specific (K+-sensitive) components of both photoinactivation and labeling showed dependences on inhibitor concentration consistent with covalent modification at an extracytoplasmic site of reversible K+-competitive binding in the dark. The maximum amount of specific labeling (1.2 nmol/mg) was similar to the number of phosphorylation sites measured (1.0 +/- 0.14 nmol/mg). Specific labeling was distributed 76% on the alpha chain, 18% on the beta chain, and 6% on undefined peptides. Various digestions with trypsin, protease V8, and thermolysin were employed to fragment the labeled enzyme. Gasphase sequencing of the radioactive peptides identified the major site of specific labeling to be within a region where only two stretches of amino acids (Leu105 to Ile126 and Leu139 to Phe155, designated H1 and H2, respectively) are predicted to span the membrane. This in turn suggested that the labeling site was located within or close to the proposed loop between them (Gln127 to Asn138). A computer-driven energy minimization protocol yielded a loop structure to which SCH 28080 (the parent structure of [H-3]mDAZIP) could be docked. Conversely, modeling of the corresponding region of Na+,K+-ATPase (a homologous enzyme with much lower affinity for SCH 28080) yielded no apparent binding site. Similarities in the inhibition of H+,K+-ATPase by SCH 28080 and of Na+,K+-ATPase by ouabain lead to the hypothesis that, in each case, inhibitor binding to E2-P is associated with an increase in the hydrophobicity of the environment of the loop between H1 and H2.	UNIV CALIF LOS ANGELES, DEPT MED & PHYSIOL, LOS ANGELES, CA 90024 USA; VET ADM MED CTR, LOS ANGELES, CA 90072 USA; Scripps Res Inst, RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Scripps Research Institute					NIDDK NIH HHS [DK 40615, DK 41301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040615, P30DK041301] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRIVING C, 1988, BIOCHIM BIOPHYS ACTA, V946, P185, DOI 10.1016/0005-2736(88)90391-4; CHIN G, 1983, BIOCHEMISTRY-US, V22, P3405, DOI 10.1021/bi00283a016; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; EISENMAN G, 1987, ANNU REV BIOPHYS BIO, V16, P205; GANSER AL, 1973, BIOCHIM BIOPHYS ACTA, V307, P169, DOI 10.1016/0005-2736(73)90035-7; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; HELMICHDEJONG ML, 1987, BIOCHIM BIOPHYS ACTA, V905, P358, DOI 10.1016/0005-2736(87)90464-0; HERSEY SJ, 1988, BIOCHIM BIOPHYS ACTA, V956, P49, DOI 10.1016/0167-4838(88)90296-8; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KAMINSKI JJ, 1985, J MED CHEM, V28, P876, DOI 10.1021/jm00145a006; KAMINSKI JJ, 1991, J MED CHEM, V34, P533, DOI 10.1021/jm00106a008; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; KEELING DJ, 1989, J BIOL CHEM, V264, P5552; KEELING DJ, 1989, J BIOL CHEM, V264, P5545; KYTE J, 1987, BIOCHEMISTRY-US, V26, P8350, DOI 10.1021/bi00399a049; KYTE J, 1981, NATURE, V292, P201, DOI 10.1038/292201a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; KYTE J, 1981, J BIOL CHEM, V256, P3231; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MUNSON KB, 1988, BIOCHEMISTRY-US, V27, P3932, DOI 10.1021/bi00411a007; MUNSON KB, 1981, J BIOL CHEM, V256, P3223; NICHOLAS RA, 1984, BIOCHEMISTRY-US, V23, P888, DOI 10.1021/bi00300a015; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; PRICE EM, 1989, J BIOL CHEM, V264, P21902; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RABON E, 1985, J BIOL CHEM, V260, P200; RABON E, 1991, J BIOL CHEM, V266, P12395; RABON EC, 1990, J BIOL CHEM, V265, P19594; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SACHS G, 1976, J BIOL CHEM, V251, P7690; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHULL GE, 1986, MAEDUKM, V261, P16788; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; ULASZEWSKI S, 1987, J BIOL CHEM, V262, P223; WALLMARK B, 1987, J BIOL CHEM, V262, P2077; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	45	108	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18976	18988						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655768				2022-12-25	WOS:A1991GJ47200087
J	SU, HY; BOS, TJ; MONTECLARO, FS; VOGT, PK				SU, HY; BOS, TJ; MONTECLARO, FS; VOGT, PK			JUN INHIBITS MYOGENIC DIFFERENTIATION	ONCOGENE			English	Article							C-JUN; V-JUN; REGULATORY GENE; CELLS; ONCOGENES; MYOD1; EXPRESSION; TRANSFORMATION; TRANSCRIPTION; PROGRAM	Myoblasts from skeletal muscle of chicken or Japanese quail embryos were infected with avian sarcoma virus 17 (ASV-17), a retrovirus carrying the jun oncogene. At high multiplicities of infection ASV-17-induced morphologic transformation inhibited fusion of myoblasts into myotubes and stimulated extended replication. The expression of the muscle-specific proteins desmin, myosin and creatine phosphokinase was inhibited in ASV-17-infected cultures. Immunofluorescent staining detected strong expression of the ASV-17 Gag-Jun fusion protein in the nuclei of infected mononuclear myoblasts, but Gag-Jun was not detectable in multinucleated myotubes that occurred in clonal populations of ASV-17-infected quail myoblasts. This result suggests that the nuclear expression of viral jun and myogenic differentiation are mutually exclusive events. A mutant of ASV-17, ts jun-1, is partly temperature-sensitive in its ability to transform chicken embryo fibroblasts. At the non-permissive temperature of 41.5-degrees-C, multinucleated myotubes readily formed in ts jun-1-infected myoblast cultures and expressed muscle-specific proteins detectable by immunofluorescent staining. These myotubes also showed strong immunofluorescent staining for Gag-Jun in the cell nuclei. The nuclear expression of a Jun protein that is defective in its transforming function appears therefore to be compatible with myogenesis. Several retroviral constructs carrying various viral and cellular jun inserts, as well as jun deletion mutants and recombinants between c-jun and v-jun, were tested for their effect on myogenic differentiation. There was an approximate correlation between the ability of a construct to transform chicken embryo fibroblasts and its effectiveness in interfering with myogenic differentiation. We conclude that the expression of an oncogenic jun gene in myoblasts strongly inhibits myogenic differentiation, and that a highly transforming Jun protein cannot be expressed in the nuclei of differentiating myotubes, while the presence of transformation-defective variants of Jun is compatible with differentiation.	UNIV SO CALIF, SCH MED, NORRIS CANC CTR, LOS ANGELES, CA 90033 USA	University of Southern California	SU, HY (corresponding author), UNIV SO CALIF, SCH MED, DEPT MICROBIOL, 2011 ZONAL AVE, LOS ANGELES, CA 90033 USA.		Vogt, Peter K./R-7547-2019	Vogt, Peter K./0000-0002-4519-7500	NCI NIH HHS [CA 42564] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042564] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abate C, 1990, Semin Cancer Biol, V1, P19; ALEMA S, 1987, ADV CANCER RES, V49, P1, DOI 10.1016/S0065-230X(08)60792-7; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BISCHOFF R, 1969, J CELL BIOL, V41, P188, DOI 10.1083/jcb.41.1.188; BOETTIGER D, 1989, CURR TOP MICROBIOL, V147, P31; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; CAPLAN AI, 1976, J EMBRYOL EXP MORPH, V36, P175; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; CURRAN M, 1991, TRANSCRIPTIONAL REGU; DEGROOT RP, 1990, EMBO J, V9, P1831, DOI 10.1002/j.1460-2075.1990.tb08308.x; DELABROUSSE FC, 1990, GENE DEV, V4, P567, DOI 10.1101/gad.4.4.567; FALCONE G, 1985, P NATL ACAD SCI USA, V82, P426, DOI 10.1073/pnas.82.2.426; GROSSI M, 1991, ONCOGENE, V6, P1767; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; KONIECZNY SF, 1989, ONCOGENE, V4, P473; LAROCCA SA, 1989, CELL, V58, P123, DOI 10.1016/0092-8674(89)90409-1; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LILLIE RD, 1969, BIOL STAINS, P74; LIN ZY, 1989, GENE DEV, V3, P986, DOI 10.1101/gad.3.7.986; LOUGH J, 1977, DEV BIOL, V57, P330, DOI 10.1016/0012-1606(77)90219-6; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Rosenthal N, 1989, CURR OPIN CELL BIOL, V1, P1094, DOI 10.1016/S0955-0674(89)80056-0; TOYOSHIMA K, 1969, VIROLOGY, V39, P930, DOI 10.1016/0042-6822(69)90030-0; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; VOGT PK, 1969, FUNDAMENTAL TECHNIQU, P316; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; Yaffe D, 1969, Curr Top Dev Biol, V4, P37, DOI 10.1016/S0070-2153(08)60480-9	32	60	60	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1991	6	10					1759	1766						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656361				2022-12-25	WOS:A1991GX11800006
J	ZHANG, JT; LING, V				ZHANG, JT; LING, V			STUDY OF MEMBRANE ORIENTATION AND GLYCOSYLATED EXTRACELLULAR LOOPS OF MOUSE P-GLYCOPROTEIN BY INVITRO TRANSLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE GENE; BACTERIAL TRANSPORT PROTEINS; OVARY CELL MUTANTS; ENDOPLASMIC-RETICULUM; FREE SYSTEMS; TRANSLOCATION; VESICLES; HOMOLOGY; IDENTIFICATION; PERMEABILITY	Increased expression of P-glycoprotein (Pgp) has been demonstrated to cause multidrug resistance (MDR) in vitro, and it may be responsible for chemotherapy failure in a number of human cancers. Pgp is a plasma membrane protein thought to function as an energy-dependent drug transporter. From its deduced protein sequence the topology of Pgp was proposed to contain 12 transmembrane domains with six extracellular loops and two cytoplasmic ATP-binding sites. To investigate further the membrane orientation of Pgp, we have expressed a full length cDNA of mouse mdr1, as well as its truncated forms, in a cell-free system supplemented with dog pancreatic microsomal membranes (RM). We determined which domains of the in vitro-synthesized Pgp had transversed the RM membranes by analyzing their resistance to protease digestion and their glycosylation state. To our surprise, this system revealed that a significant portion of in vitro-synthesized Pgp molecules has an additional glycosylated domain in the C-terminal half. Previously, only the first predicted extracellular loop near the N terminus had been thought to be glycosylated. Furthermore, we discovered that Pgp has at least two functional signal recognition particle/docking protein dependent signal sequences, one at the N-terminal half and the other at the C-terminal half. These findings suggest a new topological model for in vitro synthesized P-glycoprotein which may be relevant to its in vivo topology.	UNIV TORONTO, DEPT BIOPHYS, 500 SHERBOURNE ST, TORONTO M4X 1K9, ONTARIO, CANADA; PRINCESS MARGARET HOSP, ONTARIO CANC INST, TORONTO M4X 1K9, ONTARIO, CANADA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre			Zhang, Jian-Ting/L-8334-2015		NCI NIH HHS [CA-37130] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037130] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS D, 1989, BIOTECHNIQUES, V7, P960; BELL DR, 1985, J CLIN ONCOL, V3, P311, DOI 10.1200/JCO.1985.3.3.311; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BRADLEY G, 1990, J CELL PHYSIOL, V145, P398, DOI 10.1002/jcp.1041450303; CHAN HSL, 1990, J CLIN ONCOL, V8, P689, DOI 10.1200/JCO.1990.8.4.689; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GREENBERGER LM, 1987, J BIOL CHEM, V262, P13685; GREENBERGER LM, 1988, J NATL CANCER I, V80, P506, DOI 10.1093/jnci/80.7.506; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HORIO M, 1989, J BIOL CHEM, V264, P14880; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; KAMIMOTO Y, 1989, J BIOL CHEM, V264, P11693; KAWAI K, 1990, J BIOL CHEM, V265, P13137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBERMAN DM, 1989, BIOCHEM BIOPH RES CO, V162, P244, DOI 10.1016/0006-291X(89)91988-8; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; RAPOPORT TA, 1990, TRENDS BIOCHEM SCI, V15, P355, DOI 10.1016/0968-0004(90)90076-N; RIORDAN JR, 1979, J BIOL CHEM, V254, P2701; SAFA AR, 1986, J BIOL CHEM, V261, P6137; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WEBER K, 1969, J BIOL CHEM, V244, P4406; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938	38	126	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18224	18232						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680860				2022-12-25	WOS:A1991GG55300077
J	DEVEDJIAN, JC; FARGUES, M; DENISPOUXVIEL, C; DAVIAUD, D; PRATS, H; PARIS, H				DEVEDJIAN, JC; FARGUES, M; DENISPOUXVIEL, C; DAVIAUD, D; PRATS, H; PARIS, H			REGULATION OF THE ALPHA-2A-ADRENERGIC RECEPTOR IN THE HT29 CELL-LINE - EFFECTS OF INSULIN AND GROWTH-FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2-ADRENERGIC RECEPTOR; HUMAN-COLON; ADRENERGIC RECEPTORS; ADENYLATE-CYCLASE; BINDING; TRANSCRIPTION; GENE; DESENSITIZATION; IDENTIFICATION; METABOLISM	The density of the alpha-2A-adrenergic receptor in the HT29 cell line, a human colonic adenocarcinoma, increases when the cells are placed in fetal calf serum (FCS)-free culture medium and decreases again, in a concentration-dependent manner, when they are reexposed to FCS. In an attempt to identify the FCS components responsible for this phenomenon, we examined the effect of insulin and of various growth factors on receptor expression. Incubation of HT29 cells with insulin resulted in a time- and dose-dependent lowering of the alpha-2-adrenergic receptor number. The decrease of [H-3]RX821002 binding sites after a 48-h period of treatment reached 70-75% with 170 nm insulin, and a half-maximal effect was observed at 2.6 nm. This value is in agreement with the EC50 of the hormone for stimulating the glycolytic activity of HT29 cells (8 nM) and is sufficiently low to indicate that the decrease of alpha-2-adrenergic receptor number is mediated through stimulation of insulin receptors. Direct quantification of [H-3]UK14304 binding sites and the study of the inhibition of [H-3]RX821002 binding by (-)-epinephrine indicated that the degree of receptor coupling to G(i) protein was not affected when the receptor number was decreased by insulin treatment. The reduction in receptor number did result in an attenuation of the inhibitory effect of UK14304 on forskolin-induced cAMP accumulation in a manner which was consistent with the existence of a large population of spare receptors in untreated cells. The action of insulin is not due to an accelerated rate of receptor degradation and can be mimicked by other growth factors (epidermal growth factor and insulin-like growth factors I and II) acting through stimulation of tyrosine kinase receptors. RNase mapping experiments with a 0.35-kilobase riboprobe prepared from the human alpha-2C10-adrenergic receptor gene demonstrated that the decrease of receptor number induced by the different treatments is a reflection of changes occurring at the level of its mRNA. The use of cycloheximide indicated that the effect of insulin on alpha-2-adrenergic receptor mRNA does not require protein synthesis. The half-life of the alpha-2-adrenergic receptor mRNA measured after the addition of actinomycin D was unchanged by insulin which suggests that a decrease in the transcription rate is the predominant factor responsible for the observed regulation of receptor expression.	UNIV TOULOUSE 3,INST PHYSIOL,INSERM,U317,2 RUE F MAGENDIE,F-31400 TOULOUSE,FRANCE; CNRS,CTR RECH BIOCHIM & GENET CELLULAIRES,F-31062 TOULOUSE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)			Denis, Colette/K-1571-2019; Denis, Colette/U-5267-2017	Denis, Colette/0000-0002-8376-8351; Prats, Herve/0000-0002-4861-2167				BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BOUSCAREL B, 1985, EUR J PHARMACOL, V107, P223, DOI 10.1016/0014-2999(85)90062-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPENE C, 1983, GEN PHARMACOL, V14, P701, DOI 10.1016/0306-3623(83)90173-8; CARPENE C, 1983, J LIPID RES, V24, P766; CEZARD JP, 1981, CANCER RES, V41, P1148; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853; CONVENTS A, 1989, BIOCHEM J, V262, P245, DOI 10.1042/bj2620245; DENISPOUXVIEL C, 1990, BIOCHEM J, V268, P465, DOI 10.1042/bj2680465; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FRANKLIN CC, 1988, BIOCHIM BIOPHYS ACTA, V972, P60, DOI 10.1016/S0005-2728(88)80093-8; FRASER CM, 1989, J BIOL CHEM, V264, P11754; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; LANGIN D, 1989, EUR J PHARMACOL, V167, P95, DOI 10.1016/0014-2999(89)90751-6; LORENZ W, 1990, MOL PHARMACOL, V38, P599; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MEISLER MH, 1989, ANNU REV PHYSIOL, V51, P701, DOI 10.1146/annurev.physiol.51.1.701; MOTULSKY HJ, 1986, MOL PHARMACOL, V29, P1; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; PARIS H, 1990, J PHARMACOL EXP THER, V254, P888; PARIS H, 1987, MOL PHARMACOL, V32, P646; PARIS H, 1989, MOL PHARMACOL, V35, P345; PARIS H, 1985, FEBS LETT, V184, P82, DOI 10.1016/0014-5793(85)80658-X; PFEIFER MA, 1984, J CLIN INVEST, V74, P1063, DOI 10.1172/JCI111473; RIVERA V M, 1990, New Biologist, V2, P751; Sambrook J, 1989, MOL CLONING LABORATO; SUPIANO MA, 1989, AM J PHYSIOL, V256, pE339, DOI 10.1152/ajpendo.1989.256.3.E339; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; THOMAS JM, 1986, ENDOCRINOLOGY, V119, P1305, DOI 10.1210/endo-119-3-1305; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VASSLOPEZ A, 1990, J PHARMACOL EXP THER, V253, P819; VILLENEUVE A, 1985, EUR J CLIN INVEST, V15, P403, DOI 10.1111/j.1365-2362.1985.tb00292.x; WATT PW, 1991, BIOCHEM J, V273, P39, DOI 10.1042/bj2730039; WEISS RJ, 1983, J AM COLL CARDIOL, V2, P631, DOI 10.1016/S0735-1097(83)80302-7; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575	36	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14359	14366						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1677644				2022-12-25	WOS:A1991FZ35100040
J	ZOBEL, A; KALKBRENNER, F; GUEHMANN, S; NAWRATH, M; VORBRUEGGEN, G; MOELLING, K				ZOBEL, A; KALKBRENNER, F; GUEHMANN, S; NAWRATH, M; VORBRUEGGEN, G; MOELLING, K			INTERACTION OF THE V-MYB AND C-MYB PROTEINS WITH REGULATORY SEQUENCES OF THE HUMAN C-MYC GENE	ONCOGENE			English	Article							COLI RNA-POLYMERASE; MOUSE ERYTHROLEUKEMIA-CELLS; HUMAN HEMATOPOIETIC-CELLS; AVIAN-LEUKOSIS VIRUS; DNA-BINDING DOMAIN; BURKITT-LYMPHOMA; PROTO-ONCOGENE; NUCLEOTIDE-SEQUENCE; TRANSCRIPTIONAL ACTIVATION; MONOCLONAL-ANTIBODY	Eight c-Myb-binding sites have been identified in the regulatory region of the human c-myc gene using gel retardation and DNAase I footprint assays with purified bacterially expressed full-length and carboxy-terminally truncated c-Myb proteins. These binding sites exhibit different affinities whereby strong binding correlates better with conservation of the palindromic sequences, AACXGTT or AACGTT, than the previously described consensus sequence. Flanking AT-rich sequences further increase the binding affinity. The c-Myb-binding sites are arranged in pairs consisting of one high- and one low-affinity binding site. Binding of the Myb proteins to these sites is non-cooperative. The v-Myb protein protects two nucleotides fewer than the c-Myb protein. Co-transfection of reporter CAT genes, containing upstream human c-myc sequences including exon 1, with c-Myb-expressing constructs resulted in positive transactivation, which was eightfold with full-length Myb and 14-fold with the truncated Myb. This result suggests that the Myb protein could participate in regulation of human c-myc gene expression.	MAX PLANCK INST MOLEC GENET,SCHUSTER ABT,IHNESTR 73,W-1000 BERLIN 33,GERMANY	Max Planck Society								BADING H, 1987, ONCOGENE, V1, P395; BADING H, 1988, ONCOGENE, V3, P257; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6348; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DASGUPTA P, 1990, P NATL ACAD SCI USA, V87, P8090, DOI 10.1073/pnas.87.20.8090; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HOWE KM, 1990, EMBO J, V9, P161, DOI 10.1002/j.1460-2075.1990.tb08092.x; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KALKBRENNER F, 1990, ONCOGENE, V5, P657; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KELLY K, 1988, J BIOL CHEM, V263, P4828; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RA, 1986, MOL CELL BIOL, V6, P4112, DOI 10.1128/MCB.6.11.4112; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCLINTON D, 1990, MOL CELL BIOL, V10, P705, DOI 10.1128/MCB.10.2.705; MCMAHON J, 1988, ONCOGENE, V3, P717; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; OEHLER T, 1990, NUCLEIC ACIDS RES, V18, P1703, DOI 10.1093/nar/18.7.1703; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PROCHOWNIK EV, 1988, MOL CELL BIOL, V8, P3683, DOI 10.1128/MCB.8.9.3683; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sambrook J, 1989, MOL CLONING LABORATO; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHEINESS D, 1984, MOL CELL BIOL, V4, P1206, DOI 10.1128/MCB.4.7.1206; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SHIH CK, 1984, P NATL ACAD SCI-BIOL, V81, P4697, DOI 10.1073/pnas.81.15.4697; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; WEBER BL, 1990, SCIENCE, V249, P1291, DOI 10.1126/science.2205003; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510	73	68	68	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1991	6	8					1397	1407						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX272	1679531				2022-12-25	WOS:A1991GX27200016
J	DIAZ, E; LOPEZ, R; GARCIA, JL				DIAZ, E; LOPEZ, R; GARCIA, JL			CHIMERIC PNEUMOCOCCAL CELL-WALL LYTIC ENZYMES REVEAL IMPORTANT PHYSIOLOGICAL AND EVOLUTIONARY TRAITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; MODULAR EVOLUTION; CLONING VEHICLES; TEICHOIC-ACIDS; AUTOLYSIN; AMIDASE; PURIFICATION; GENE; CONSTRUCTION	Two novel chimeric pneumococcal cell wall lytic enzymes, named LC7 and CL7, have been constructed by in vitro recombination of the lytA gene encoding the major autolysin (LYTA amidase) of Streptococcus pneumoniae, a choline-dependent enzyme, and the cpl7 gene encoding the CPL7 lysozyme of phage Cp-7, a choline-independent enzyme. In remarkable contrast with previous chimeric constructions, we fused here two genes that lack nucleotide homology. The CL7 enzyme, which contains the N-terminal domain of CPL7 and the C-terminal domain of LYTA, exhibited a choline-dependent lysozyme activity. This experimental rearrangement of domains might mimic the process that have generated the choline-dependent CPL1 lysozyme of phage Cp-1 during evolution, providing additional support to the modular theory of protein evolution. The LC7 enzyme, built up by fusion of the N-terminal domain of LYTA and the C-terminal domain of CPL7, exhibited an amidase activity capable of degrading ethanolamine-containing cell walls. The chimeric amidase behaved as an autolytic enzyme when it was cloned and expressed in S. pneumoniae. The chimeric enzymes provided new insights on the mechanisms involved in regulation of the host pneumococcal autolysins and on the participation of these enzymes in the process of cell separation. Furthermore, our experimental approach confirmed the basic role of the C-terminal domains in substrate recognition and revealed the influence of these domains on the optimal pH for catalytic activity.	CSIC,CTR INVEST BIOL,UNIDAD GENET BACTERIANA,VELAZQUEZ 144,E-28006 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consiglio Nazionale delle Ricerche (CNR)			Garcia Lopez, Jose Luis/G-9139-2015; Diaz, Eduardo/F-8605-2016	Garcia Lopez, Jose Luis/0000-0002-9238-2485; Diaz, Eduardo/0000-0002-9731-6524				ARRAJ JA, 1983, J BACTERIOL, V153, P562, DOI 10.1128/JB.153.1.562-565.1983; BALGANESH TS, 1987, EMBO J, V6, P3543, DOI 10.1002/j.1460-2075.1987.tb02681.x; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BOLIVAR F, 1978, GENE, V4, P121, DOI 10.1016/0378-1119(78)90025-2; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; Campbell A., 1988, BACTERIOPHAGES, P1; DIAZ E, 1989, J BIOL CHEM, V264, P1238; DIAZ E, 1990, GENE, V90, P157, DOI 10.1016/0378-1119(90)90454-Y; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; DUBOSE RF, 1989, P NATL ACAD SCI USA, V86, P9966, DOI 10.1073/pnas.86.24.9966; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; GARCIA JL, 1988, FEMS MICROBIOL LETT, V52, P133; GARCIA JL, 1987, J VIROL, V61, P2573; GARCIA JL, 1987, ARCH MICROBIOL, V149, P52, DOI 10.1007/BF00423136; GARCIA P, 1989, BIOCHEM BIOPH RES CO, V158, P251, DOI 10.1016/S0006-291X(89)80205-0; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; GARCIA P, 1983, J GEN MICROBIOL, V129, P489; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; HOUGHTON JE, 1989, NATURE, V338, P172, DOI 10.1038/338172a0; HUNKAPILLER TH, 1982, IMPACT MODERN GENETI, P164; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPEZ R, 1990, FEMS MICROBIOL LETT, V66, P317, DOI 10.1016/0378-1097(90)90305-A; Maniatis T., 1982, MOL CLONING; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Rogers H., 1980, MICROBIAL CELL WALLS, P437; ROMERO A, 1990, J BACTERIOL, V172, P5064, DOI 10.1128/jb.172.9.5064-5070.1990; ROMERO A, 1990, J VIROL, V64, P137, DOI 10.1128/JVI.64.1.137-142.1990; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; RONDA C, 1987, EUR J BIOCHEM, V164, P621, DOI 10.1111/j.1432-1033.1987.tb11172.x; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANZ JM, 1988, FEBS LETT, V232, P308, DOI 10.1016/0014-5793(88)80759-2; SONEA S, 1987, ANN NY ACAD SCI, V503, P251, DOI 10.1111/j.1749-6632.1987.tb40612.x; STROYNOWSKI IT, 1981, J BACTERIOL, V148, P91, DOI 10.1128/JB.148.1.91-100.1981; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1981, REV INFECT DIS, V3, P190; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TOMASZ A, 1975, J SUPRAMOL STR CELL, V3, P1, DOI 10.1002/jss.400030102; TOMASZ A, 1971, P NATL ACAD SCI USA, V68, P2627, DOI 10.1073/pnas.68.11.2627; TOMASZ A, 1984, MICROBIAL CELL WALL, P3; Tomasz A, 1970, J BACTERIOL, V101, P860, DOI 10.1128/JB.101.3.860-871.1970	48	56	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5464	5471						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1672313				2022-12-25	WOS:A1991FD37000020
J	RENFREW, CA; HUBBARD, AL				RENFREW, CA; HUBBARD, AL			SEQUENTIAL PROCESSING OF EPIDERMAL GROWTH-FACTOR IN EARLY AND LATE ENDOSOMES OF RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PROTEINASE-INHIBITORS; GOLGI FRACTIONS; HEPATOCYTES; LIGAND; LYSOSOMES; INSULIN; ASIALOGLYCOPROTEINS; ACIDIFICATION; FIBROBLASTS	We have used isolated perfused rat livers to examine the intracellular processing of I-125-epidermal growth factor (EGF) and to determine where in the endocytic pathway the hydrolases which degrade EGF are acting. Following uptake of I-125-EGF at 37 or 16-degrees-C, subcellular fractions enriched in endosomes and lysosomes were isolated, and their I-125-EGF content was examined by reverse-phase high performance liquid chromatography. Three forms of EGF processed at their carboxyl termini are generated in endosomes. At 37-degrees-C, EGF is first processed in early endosomes by a carboxypeptidase B-like protease and is further processed in late endosomes by a trypsin-like protease and then a carboxypeptidase B-like protease. At 16-degrees-C, entry of EGF into late endosomes is slowed, and only the first processed form is generated over 60 min. Longer perfusions (180 min) at 16-degrees-C result in some processing (7%) by proteases found in late endosomes. EGF-horseradish peroxidase cytochemistry confirmed that the additional processing detected at 180 min correlated with movement of EGF from tubulovesicular to multivesicular endosomes. These results, combined with in vitro incubations of EGF in isolated endosomal and lysosomal fractions, suggest that different proteases are active at selective points in the endocytic pathway and that the full complement of proteases needed for complete degradation of EGF is active only in lysosomes.	JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,725 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University					NIGMS NIH HHS [R01 GM29133] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029133, R01GM129133] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONSON NN, 1981, ACTA BIOL MED GER, V40, P1531; BARRETT AJ, 1979, PROTEINASES MAMMALIA, P181; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BERGERON JJM, 1985, ANNU REV PHYSIOL, V47, P383; BOWSER R, 1990, J CELL PHYSIOL, V143, P110, DOI 10.1002/jcp.1041430115; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CASCIOLAROSEN LAF, 1991, J BIOL CHEM, V266, P4341; COHEN S, 1962, J BIOL CHEM, V237, P1555; DIMENT S, 1989, J BIOL CHEM, V264, P13403; DOHERTY JJ, 1990, J CELL BIOL, V110, P35, DOI 10.1083/jcb.110.1.35; DUCKWORTH WC, 1987, BIOCHEM BIOPH RES CO, V147, P615, DOI 10.1016/0006-291X(87)90975-2; DUNN WA, 1983, METHOD ENZYMOL, V98, P225; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; DUNN WA, 1980, J BIOL CHEM, V255, P5971; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; EHRENREICH JH, 1973, J CELL BIOL, V59, P73; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GEUZE HJ, 1987, J CELL BIOL, V104, P1715, DOI 10.1083/jcb.104.6.1715; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GLAUMANN H, 1986, EXP CELL RES, V163, P151, DOI 10.1016/0014-4827(86)90567-7; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GUGLIARDI LE, 1990, NATURE, V343, P133; HAMEL FG, 1988, J BIOL CHEM, V263, P6703; HOWELL KE, 1978, J CELL BIOL, V79, P581, DOI 10.1083/jcb.79.2.581; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; HUBBARD AL, 1985, J CELL BIOL, V100, P1115, DOI 10.1083/jcb.100.4.1115; HUBBARD AL, 1983, J CELL BIOL, V61, P188; KHAN MN, 1986, J BIOL CHEM, V261, P8462; KHAN MN, 1989, J BIOL CHEM, V264, P12931; KUEHN L, 1984, BIOCHEM J, V218, P953, DOI 10.1042/bj2180953; MAGUN BE, 1982, BIOCHEM BIOPH RES CO, V108, P299, DOI 10.1016/0006-291X(82)91866-6; MAGUN BE, 1982, J CELL BIOCHEM, V20, P259, DOI 10.1002/jcb.240200306; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; MATRISIAN LM, 1985, BIOCHIM BIOPHYS ACTA, V839, P139, DOI 10.1016/0304-4165(85)90030-3; MATRISIAN LM, 1984, J BIOL CHEM, V259, P3047; MATRISIAN LM, 1987, J BIOL CHEM, V262, P6908; Maxfield F R, 1987, Adv Exp Med Biol, V225, P189; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; MUELLER SC, 1986, J CELL BIOL, V102, P932, DOI 10.1083/jcb.102.3.932; PLANCK SR, 1984, J BIOL CHEM, V259, P3053; RICHARD C, 1972, J BIOL CHEM, V247, P7609; SCHAUDIES RP, 1986, ENDOCRINOLOGY, V118, P875, DOI 10.1210/endo-118-2-875; SELL S, 1977, CANCER BIOL, V4, P272; SHEETZ JM, 1988, J BIOL CHEM, V263, P19210; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SMITH DG, 1967, METHOD ENZYMOL, V11, P211; SMITH J, 1982, NUCLEIC ACIDS RES, V10, P4467, DOI 10.1093/nar/10.15.4467; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WAKAMATSU N, 1982, J BIOL CHEM, V257, P4653; WALL DA, 1985, J CELL BIOL, V101, P2104, DOI 10.1083/jcb.101.6.2104; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WILEY HS, 1985, J BIOL CHEM, V260, P5290; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375	60	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4348	4356						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1671862				2022-12-25	WOS:A1991FA69400053
J	MINOTTI, AM; BARLOW, SB; CABRAL, F				MINOTTI, AM; BARLOW, SB; CABRAL, F			RESISTANCE TO ANTIMITOTIC DRUGS IN CHINESE-HAMSTER OVARY CELLS CORRELATES WITH CHANGES IN THE LEVEL OF POLYMERIZED TUBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; BETA-TUBULIN; ALPHA-TUBULIN; MAMMALIAN-CELLS; CHO CELLS; ASPERGILLUS-NIDULANS; TAXOL; MUTANTS; COLCHICINE; BINDING	A sensitive and reproducible method to measure relative levels of polymerized and soluble tubulin in cells has been developed. This method involves metabolically labeling cells with radioactive amino acids followed by lysis in a microtubule-stabilizing buffer, centrifugation to separate soluble from polymerized tubulin, resolution of the proteins in each fraction by two-dimensional gel electrophoresis, and quantitation of the tubulin by liquid scintillation counting of spots excised from the gel. Several buffers were evaluated for their reproducibility and efficacy in preserving the state of in vivo microtubule assembly at the time of cell lysis, and the ability of the technique to measure drug-induced changes in tubulin polymerization was determined. Results using this method indicate that Chinese hamster ovary cells maintain approximately 40% of the cellular tubulin in an assembled form. Dose-dependent decreases in tubulin polymerization could be measured in Colcemid-treated cells, while dose-dependent increases in assembly were measured in taxol-treated cells. The results with taxol indicate that, following the increase in microtubule polymerization, there is a time-dependent bundling of microtubules that occurs without further increases in the extent of tubulin assembly. Examination of drug-resistant Chinese hamster ovary cells reveals that Colcemid-resistant mutants maintain more tubulin in the polymerized state (approximately 50%), while taxol-resistant mutants maintain less assembled tubulin (about 28%). Similar changes occur regardless of whether the mutant cells have an alteration in alpha- or beta-tubulin. A model to explain these results is discussed.	UNIV TEXAS, SCH MED, DEPT PHARMACOL, POB 20708, HOUSTON, TX 77025 USA	University of Texas System					NATIONAL CANCER INSTITUTE [R01CA052962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029955] Funding Source: NIH RePORTER; NCI NIH HHS [CA 52962] Funding Source: Medline; NIGMS NIH HHS [GM 29955] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECHHANSEN NT, 1976, J CELL PHYSIOL, V88, P23, DOI 10.1002/jcp.1040880104; BOGGS B, 1987, MOL CELL BIOL, V7, P2700, DOI 10.1128/MCB.7.8.2700; BORISY GG, 1972, ANAL BIOCHEM, V50, P373, DOI 10.1016/0003-2697(72)90046-2; CABRAL F, 1989, FASEB J, V3, P1593, DOI 10.1096/fasebj.3.5.2646163; CABRAL F, 1983, J CELL BIOL, V97, P30, DOI 10.1083/jcb.97.1.30; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F, 1979, Methods Enzymol, V56, P602; CABRAL F, 1980, J HISTOCHEM CYTOCHEM, V28, P653, DOI 10.1177/28.7.7391554; CABRAL F, 1989, MITOSIS, P273; CABRAL FR, 1986, ANN NY ACAD SCI, V466, P745, DOI 10.1111/j.1749-6632.1986.tb38456.x; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P10, DOI 10.1016/S0955-0674(89)80030-4; CLEVELAND DW, 1985, ANNU REV BIOCHEM, V54, P331, DOI 10.1146/annurev.bi.54.070185.001555; DAVIDSE LC, 1977, J CELL BIOL, V72, P174, DOI 10.1083/jcb.72.1.174; ELLIOTT EM, 1986, MOL CELL BIOL, V6, P906, DOI 10.1128/MCB.6.3.906; ELLIOTT EM, 1985, MOL CELL BIOL, V5, P236, DOI 10.1128/MCB.5.1.236; Fulton C., 1979, MICROTUBULES, P117; GOTTESMAN MM, 1988, TRENDS PHARMACOL SCI, V9, P54, DOI 10.1016/0165-6147(88)90117-4; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HIMES RH, 1977, J BIOL CHEM, V252, P6222; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; KEATES RAB, 1980, BIOCHEM BIOPH RES CO, V97, P1163, DOI 10.1016/0006-291X(80)91497-7; KELLOGG DR, 1989, J CELL BIOL, V109, P2977, DOI 10.1083/jcb.109.6.2977; KOWIT JD, 1974, J BIOL CHEM, V249, P3638; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LING V, 1979, CELL, V18, P423, DOI 10.1016/0092-8674(79)90061-8; MINOTTI AM, 1990, ANAL BIOCHEM, V184, P28, DOI 10.1016/0003-2697(90)90006-U; OAKLEY BR, 1981, CELL, V24, P837, DOI 10.1016/0092-8674(81)90109-4; OLMSTED JB, 1973, BIOCHEMISTRY-US, V12, P4282, DOI 10.1021/bi00745a037; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; PATZELT C, 1975, J CELL BIOL, V66, P609, DOI 10.1083/jcb.66.3.609; PIPELEERS DG, 1976, SCIENCE, V191, P88, DOI 10.1126/science.1108194; PIPELEERS DG, 1977, J CELL BIOL, V74, P341, DOI 10.1083/jcb.74.2.341; RUBIN RW, 1975, J CELL BIOL, V64, P42, DOI 10.1083/jcb.64.1.42; SAWADA T, 1989, J BIOL CHEM, V264, P3013; SCHATZ PJ, 1988, GENETICS, V120, P681; SCHIBLER MJ, 1989, FASEB J, V3, P163, DOI 10.1096/fasebj.3.2.2563346; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; SCHIBLER MJ, 1987, J CELL BIOL, V105, P29; SCHIBLER MJ, 1985, MOL CELL GENETICS, P669; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; THOMAS JH, 1985, GENETICS, V111, P715; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; VALLEE RB, 1986, METHOD ENZYMOL, V134, P116	46	215	219	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3987	3994						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1671676				2022-12-25	WOS:A1991EY68200095
J	KIMBALL, SR; ANTONETTI, DA; BRAWLEY, RM; JEFFERSON, LS				KIMBALL, SR; ANTONETTI, DA; BRAWLEY, RM; JEFFERSON, LS			MECHANISM OF INHIBITION OF PEPTIDE-CHAIN INITIATION BY AMINO-ACID DEPRIVATION IN PERFUSED-RAT-LIVER - REGULATION INVOLVING INHIBITION OF EUKARYOTIC INITIATION FACTOR-2-ALPHA PHOSPHATASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RNA-SYNTHETASES; RABBIT RETICULOCYTE LYSATE; NUCLEOTIDE EXCHANGE FACTOR; ASCITES TUMOR-CELLS; DOUBLE-STRANDED-RNA; PROTEIN-SYNTHESIS; FACTOR-II; FACTOR EIF-2; MAMMALIAN-CELLS; DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE	In previous studies, initiation of protein synthesis was shown to be inhibited in perfused rat livers deprived of single essential amino acids. In the present study, histidinol, a competitive inhibitor of histidinyl-tRNA synthetase, was used to amplify the effects of histidine deprivation on protein synthesis in perfused liver to facilitate investigation of mechanisms involved in the inhibition of peptide chain initiation. Protein synthesis was reduced to 77% of the control rate in livers deprived of histidine and to 13% of the control rate in livers deprived of histidine and exposed to 2.0 mM histidinol. The inhibition of protein synthesis caused by histidine deprivation alone was accompanied by a 2-fold increase in the number of free ribosomal particles, a 29% decrease in Met-tRNA(i) binding to 43 S preinitiation complexes, and a 31% reduction in activity of eukaryotic initiation factor 2B (eIF-2B). By comparison, histidine deprivation combined with histidinol addition resulted in a 3-fold increase in free ribosomal particles, a 66% decrease in Met-tRNA(i) binding, and a 78% reduction in eIF-2B activity. The proportion of the alpha-subunit of eukaryotic initiation factor two (eIF-2) in the phosphorylated form increased from 8.9 +/- 0.8% in control livers to 52.4 +/- 5.5% in response to histidinol. The increase in the amount of eIF-2-alpha in the phosphorylated form apparently was not due to an increase in kinase activity, because there was no change in eIF-2-alpha kinase activity in extracts of livers perfused with medium containing histidinol compared to controls. Instead, the increased phosphorylation of eIF-2-alpha was associated with an inhibition of eIF-2-alpha phosphatase activity. Thus, in contrast to other systems that have been examined, the mechanism involved in the increase in the phosphorylation state of eIF-2-alpha appears to involve an inhibition of eIF-2-alpha phosphatase activity rather than activation of an eIF-2-alpha kinase.			KIMBALL, SR (corresponding author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,POB 850,HERSHEY,PA 17033, USA.			antonetti, david/0000-0003-1130-6577	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 13499] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUSTIN SA, 1982, EUR J BIOCHEM, V157, P39; BAKER JC, 1984, ANAL BIOCHEM, V141, P451, DOI 10.1016/0003-2697(84)90070-8; BALKOW D, 1973, MOL PHARMACOL, V9, P229; BLANQUET S, 1983, MOL CELL BIOCHEM, V52, P3; BREVET A, 1981, BIOCHEMISTRY-US, V20, P4654; BUISSON M, 1979, BIOCHEM BIOPH RES CO, V90, P634, DOI 10.1016/0006-291X(79)91282-8; CLEMENS MJ, 1987, J BIOL CHEM, V262, P767; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; CROUCH D, 1984, J BIOL CHEM, V259, P363; CROUCH D, 1980, J BIOL CHEM, V255, P7918; DANG CV, 1989, J BIOL CHEM, V264, P5861; DELAUNAY J, 1977, P NATL ACAD SCI USA, V74, P2264, DOI 10.1073/pnas.74.6.2264; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; FELDHOFF RC, 1977, J BIOL CHEM, V252, P3611; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; GRUMMT F, 1976, EUR J BIOCHEM, V64, P307, DOI 10.1111/j.1432-1033.1976.tb10302.x; GRUMMT F, 1988, MODERN CELL BIOL, V6, P29; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Henshaw E C, 1979, Methods Enzymol, V59, P410; HENSHAW EC, 1980, BIOCH CELLULAR REGUL, V1, P119; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HURST R, 1987, J BIOL CHEM, V262, P15939; JEFFERSON LS, 1971, EXCERPTA MED INT C S, V244, P106; KELLY FJ, 1985, J BIOL CHEM, V260, P6677; KIMBALL SR, 1990, J BIOL CHEM, V265, P16794; KIMBALL SR, 1988, J IMMUNOL METHODS, V106, P217, DOI 10.1016/0022-1759(88)90200-1; KIMBALL SR, 1987, J BIOL CHEM, V262, P2220; KIMBALL SR, 1989, AM J PHYSIOL, V256, pC28, DOI 10.1152/ajpcell.1989.256.1.C28; KNOPF PM, 1965, BIOCHIM BIOPHYS ACTA, V95, P398, DOI 10.1016/0005-2787(65)90186-3; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MORGAN HE, 1971, J BIOL CHEM, V246, P2163; PAIN VM, 1980, J BIOL CHEM, V255, P1486; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PAIN VM, 1975, EUR J BIOCHEM, V57, P335, DOI 10.1111/j.1432-1033.1975.tb02306.x; PATO MD, 1983, EUR J BIOCHEM, V132, P283, DOI 10.1111/j.1432-1033.1983.tb07360.x; PLATEAU P, 1982, BIOCHEMISTRY-US, V21, P5273, DOI 10.1021/bi00264a024; POLLARD JW, 1989, EUR J BIOCHEM, V182, P1, DOI 10.1111/j.1432-1033.1989.tb14793.x; RAPAPORT E, 1976, P NATL ACAD SCI USA, V73, P3984, DOI 10.1073/pnas.73.11.3984; SAFER B, 1979, P NATL ACAD SCI USA, V76, P1094, DOI 10.1073/pnas.76.3.1094; Safer B, 1979, Methods Enzymol, V60, P61; SCHNEIDER RJ, 1987, ANNU REV BIOCHEM, V56, P317, DOI 10.1146/annurev.biochem.56.1.317; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; TAMURA S, 1980, EUR J BIOCHEM, V104, P347, DOI 10.1111/j.1432-1033.1980.tb04435.x; THOMAS NSB, 1984, P NATL ACAD SCI-BIOL, V81, P6998, DOI 10.1073/pnas.81.22.6998; TOLMAN EL, 1973, J BIOL CHEM, V248, P4552; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWLE CA, 1984, BIOCHEM BIOPH RES CO, V121, P134, DOI 10.1016/0006-291X(84)90697-1; VAUGHAN MH, 1973, J BIOL CHEM, V248, P7087; WAHAB SZ, 1985, J BIOL CHEM, V260, P5286; WEINMANNDORSCH C, 1984, EUR J BIOCHEM, V138, P179, DOI 10.1111/j.1432-1033.1984.tb07897.x; WONG ST, 1982, J BIOL CHEM, V257, P5231; YAMAGUCHI N, 1985, GASTROENTEROLOGY, V89, P723, DOI 10.1016/0016-5085(85)90565-7	56	108	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1969	1976						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671047				2022-12-25	WOS:A1991EU49700090
J	SANE, DC; MOSER, TL; PARKER, CJ; SEIFFERT, D; LOSKUTOFF, DJ; GREENBERG, CS				SANE, DC; MOSER, TL; PARKER, CJ; SEIFFERT, D; LOSKUTOFF, DJ; GREENBERG, CS			HIGHLY SULFATED GLYCOSAMINOGLYCANS AUGMENT THE CROSS-LINKING OF VITRONECTIN BY GUINEA-PIG LIVER TRANSGLUTAMINASE - FUNCTIONAL-STUDIES OF THE CROSS-LINKED VITRONECTIN MULTIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									DUKE UNIV,MED CTR,DEPT MED,BOX 3934,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; UNIV UTAH,SCH MED,DEPT MED,SALT LAKE CITY,UT 84112; VET ADM MED CTR,SALT LAKE CITY,UT 84148; SCRIPPS CLIN & RES FDN,RES INST,LA JOLLA,CA 92037	Duke University; Duke University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Scripps Research Institute				Havener, Tammy/0000-0002-4613-0498	NHLBI NIH HHS [HL28391, HL22289, 5-T32-HL07101-14] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL028391, R01HL022289, T32HL007101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; AKAMA T, 1986, J BIOCHEM-TOKYO, V100, P1343, DOI 10.1093/oxfordjournals.jbchem.a121840; BARNES DW, 1985, J BIOL CHEM, V260, P9117; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; DAWES J, 1983, HEPARIN NEW BIOCH ME, P132; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GREENBERG CS, 1984, J BIOL CHEM, V259, P4721; HAY ED, 1981, J CELL BIOL, V91, pS205, DOI 10.1083/jcb.91.3.205s; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HOLMES R, 1967, J CELL BIOL, V32, P297, DOI 10.1083/jcb.32.2.297; JENNE D, 1985, EMBO J, V4, P3153, DOI 10.1002/j.1460-2075.1985.tb04058.x; KOLB WP, 1975, J EXP MED, V141, P724; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; MIMURO J, 1989, J BIOL CHEM, V264, P936; PODACK ER, 1979, J BIOL CHEM, V254, P9908; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; PREISSNER KT, 1987, BIOCHEM J, V243, P105, DOI 10.1042/bj2430105; PREISSNER KT, 1986, EUR J BIOCHEM, V156, P645, DOI 10.1111/j.1432-1033.1986.tb09626.x; PREISSNER KT, 1988, THROMB HAEMOSTASIS, V60, P399; PREISSNER KT, 1988, BLOOD, V70, P407; SANE DC, 1988, BIOCHEM BIOPH RES CO, V157, P115, DOI 10.1016/S0006-291X(88)80020-2; STAPRANS I, 1985, J CLIN INVEST, V76, P1984, DOI 10.1172/JCI112198; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TOMASINI BR, 1988, BLOOD, V72, P903; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029	29	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3543	3548						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689304				2022-12-25	WOS:A1990CP23600085
J	SERAFIN, WE; REYNOLDS, DS; ROGELJ, S; LANE, WS; CONDER, GA; JOHNSON, SS; AUSTEN, KF; STEVENS, RL				SERAFIN, WE; REYNOLDS, DS; ROGELJ, S; LANE, WS; CONDER, GA; JOHNSON, SS; AUSTEN, KF; STEVENS, RL			IDENTIFICATION AND MOLECULAR-CLONING OF A NOVEL MOUSE MUCOSAL MAST-CELL SERINE PROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA; HARVARD UNIV, MICROCHEM FACIL, CAMBRIDGE, MA 02138 USA; HARVARD UNIV, BIOL LABS, CAMBRIDGE, MA 02138 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; UPJOHN CO, PARASITOL RES, KALAMAZOO, MI 49001 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Pfizer					NIAID NIH HHS [AI-23483, AI-22531, AI-23401] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI023401, R01AI022531, R37AI022531, R01AI023483] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BELL GI, 1984, J BIOL CHEM, V259, P4265; BENFEY PN, 1987, J BIOL CHEM, V262, P5377; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAIK CS, 1984, J BIOL CHEM, V259, P4255; de Haen C, 1975, J Mol Biol, V92, P225, DOI 10.1016/0022-2836(75)90225-9; DUBUSKE L, 1984, J IMMUNOL, V133, P1535; ECCLESTON E, 1973, NATURE-NEW BIOL, V244, P73, DOI 10.1038/newbio244073b0; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; GIBSON S, 1987, IMMUNOLOGY, V62, P621; GUYGRAND D, 1984, J EXP MED, V160, P12, DOI 10.1084/jem.160.1.12; HARTLEY BS, 1970, PHILOS T ROY SOC B, V257, P77, DOI 10.1098/rstb.1970.0010; HOLGATE ST, 1980, J IMMUNOL, V124, P2093; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; JENNE D, 1988, P NATL ACAD SCI USA, V85, P4814, DOI 10.1073/pnas.85.13.4814; JENNE D, 1988, J IMMUNOL, V140, P318; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGUNOFF D, 1976, ARCH BIOCHEM BIOPHYS, V173, P554, DOI 10.1016/0003-9861(76)90292-7; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOBE CG, 1988, BIOCHEMISTRY-US, V27, P6941, DOI 10.1021/bi00418a040; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILLER HRP, 1988, IMMUNOLOGY, V65, P559; MITCHELL LA, 1983, PARASITE IMMUNOL, V5, P1, DOI 10.1111/j.1365-3024.1983.tb00718.x; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NEWLANDS GFJ, 1987, IMMUNOLOGY, V62, P629; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; RAND TH, 1982, CELL IMMUNOL, V71, P334, DOI 10.1016/0008-8749(82)90267-2; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; SALVESEN G, 1987, BIOCHEMISTRY-US, V26, P2289, DOI 10.1021/bi00382a032; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELDIN DC, 1985, P NATL ACAD SCI USA, V82, P3871, DOI 10.1073/pnas.82.11.3871; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; STEVENS RL, 1986, MAST CELL DIFFERENTI, P183; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRONG HL, 1987, BIOCHEMISTRY-US, V26, P6988; TRONG HL, 1989, BIOCHEMISTRY-US, V28, P391; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WOODBURY RG, 1978, P NATL ACAD SCI USA, V75, P5311, DOI 10.1073/pnas.75.11.5311; WOODBURY RG, 1978, BIOCHEMISTRY-US, V17, P4298, DOI 10.1021/bi00613a029; WOODBURY RG, 1978, BIOCHEMISTRY-US, V17, P811, DOI 10.1021/bi00598a010; WOODBURY RG, 1981, METHOD ENZYMOL, V80, P588; YURT R, 1977, J EXP MED, V146, P1405, DOI 10.1084/jem.146.5.1405; YURT RW, 1977, J BIOL CHEM, V252, P518	48	132	134	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					423	429						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688433				2022-12-25	WOS:A1990CF66200064
J	HAZUDA, DJ; PERRY, HC; NAYLOR, AM; MCCLEMENTS, WL				HAZUDA, DJ; PERRY, HC; NAYLOR, AM; MCCLEMENTS, WL			CHARACTERIZATION OF THE HERPES-SIMPLEX VIRUS ORIGIN BINDING-PROTEIN INTERACTION WITH ORIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION ORIGIN; TYPE-1 ORIGIN; IDENTIFICATION; RECOGNITION; SEQUENCE; CLONING	The origin binding protein (OBP) of herpes simplex virus (HSV), which is essential for viral DNA replication, binds specifically to sequences within the viral replication origin(s) (for a review, see Challberg, M.D., and Kelly, T. J. (1989) Annu. Rev. Biochem. 58, 671-717). Using either a COOH-terminal OBP protein A fusion or the full-length protein, each expressed in Escherichia coli, we investigated the interaction of OBP with one HSV origin, Ori(S). Binding of OBP to a set of binding site variant sequences demonstrates that the 10-base pair sequence, 5' CGTTCGCACT 3', comprises the OBP-binding site. This sequence must be presented in the context of at least 15 total base pairs for high affinity binding, K(a) = approximately 0.3 nM. Single base pair mutations in the central CGC sequence lower the affinity by several orders of magnitude, whereas a substitution at any of the other seven positions reduces the affinity by 10-fold or less. OBP binds with high affinity to duplex DNA containing mismatched base pairs. This property is exploited to analyze OBP binding to DNA heteroduplexes containing singly substituted mutant and wild-type DNA strands. For positions 2, 3, 5, 6, 7, 8, and 9, substitutions are tolerated on one or the other DNA strand, indicating that base-mediated interactions are limited to one base of each pair. For both Boxes I and II, these interactions are localized to one face of the DNA helix, forming a recognition surface in the major groove. In Ori(S), the 31 base pairs which separate Boxes I and II orient the two interaction surfaces to the same side of the DNA.	MERCK SHARP & DOHME LTD,DEPT VIRUS & CELL BIOL,W POINT,PA 19486; MERCK SHARP & DOHME LTD,DEPT MOLEC SYST,W POINT,PA 19486	Merck & Company; Merck & Company								Bellomy G R, 1990, Prog Nucleic Acid Res Mol Biol, V39, P81, DOI 10.1016/S0079-6603(08)60624-8; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; DEB S, 1989, NUCLEIC ACIDS RES, V17, P2733, DOI 10.1093/nar/17.7.2733; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; Gromova E S, 1990, Prog Nucleic Acid Res Mol Biol, V39, P1, DOI 10.1016/S0079-6603(08)60622-4; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; KOFF A, 1988, J VIROL, V62, P4096, DOI 10.1128/JVI.62.11.4096-4103.1988; LOCKSHON D, 1986, J VIROL, V58, P513, DOI 10.1128/JVI.58.2.513-521.1986; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; STOW ND, 1982, EMBO J, V1, P863, DOI 10.1002/j.1460-2075.1982.tb01261.x; STOW ND, 1985, J GEN VIROL, V66, P31, DOI 10.1099/0022-1317-66-1-31; STOW ND, 1983, VIROLOGY, V130, P427, DOI 10.1016/0042-6822(83)90097-1; STOW ND, 1986, J GEN VIROL, V67, P1613, DOI 10.1099/0022-1317-67-8-1613; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; WELLER SK, 1985, MOL CELL BIOL, V5, P930, DOI 10.1128/MCB.5.5.930	22	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24621	24626						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662213				2022-12-25	WOS:A1991GW84500059
J	WEVER, R; OERTLING, WA; HOOGLAND, H; BOLSCHER, BGJM; KIM, Y; BABCOCK, GT				WEVER, R; OERTLING, WA; HOOGLAND, H; BOLSCHER, BGJM; KIM, Y; BABCOCK, GT			DENATURATION AND RENATURATION OF MYELOPEROXIDASE - CONSEQUENCES FOR THE NATURE OF THE PROSTHETIC GROUP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; RESONANCE RAMAN-SPECTRA; STRUCTURAL-ANALYSIS; CYTOCHROME-OXIDASE; LIGAND VIBRATIONS; HEME; COMPLEXES; IRON; BINDING; LACTOPEROXIDASE	The effects of the chaotropic agent, guanidine HCl, on the chlorinating activity, optical absorption, EPR, and resonance Raman spectra of myeloperoxidase have been studied. In the presence of the agent the Soret optical absorption of the reduced enzyme (lambda(max) = 474 nm) is blue shifted to 448 nm, a position similar to heme alpha-containing enzymes. The chlorinating activity of the enzyme disappears, and EPR spectra show a loss of intensity of the rhombic high spin heme signals (g(x) = 6.9; g(y) = 5.4) and the appearance of a more axial high spin signal (g(x) = g(y) = 6.0). Surprisingly the effects of guanidine HCl are partly reversible. Upon decreasing the concentration of the chaotropic agents by dilution, both the chlorinating activity and the original optical spectrum of native reduced enzyme (lambda(max) = 474 nm) are partly restored. The resonance Raman spectra of denatured cyanomyeloperoxidase are less complicated than those of native myeloperoxidase, which have been interpreted previously to suggest an iron chlorin chromophore. The multiple lines in the oxidation state marker region are not seen in the spectra of the denatured species. The changes suggest that upon denaturation the macrocycle is converted into a more symmetric structure. Since the effects on the optical absorption spectrum are reversible we speculate that, in the native enzyme, an apparent porphyrin macrocycle undergoes a reversible interaction with amino acid residues in the protein which creates an asymmetry in the electronic distribution of the macrocycle. Comparison of the Raman spectra of denatured cyanomyeloperoxidase with those of analogous heme a model complexes suggests the presence of a formyl group in the denatured species; our data, however, demonstrate that the chromophore structure is not identical to heme-alpha and may contain a different C-beta substitution on the ring macrocycle.	MICHIGAN STATE UNIV,DEPT CHEM,E LANSING,MI 48824; MICHIGAN STATE UNIV,LASER LAB,E LANSING,MI 48824	Michigan State University; Michigan State University	WEVER, R (corresponding author), UNIV AMSTERDAM,EC SLATER INST BIOCHEM RES,PLANTAGE MUIDERGRACHT 12,1018 TV AMSTERDAM,NETHERLANDS.		Wever, Ron/AAM-4520-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025480] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25480] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; AGNER K, 1958, ACTA CHEM SCAND, V12, P89, DOI 10.3891/acta.chem.scand.12-0089; AGNER K, 1970, STRUCTURE FUNCTION O, P329; ANDERSSON LA, 1984, J BIOL CHEM, V259, P5340; ANDERSSON LA, 1989, P SPIE INT SOC OPT E, V1055, P279; BABCOCK GT, 1985, BIOCHIM BIOPHYS ACTA, V828, P58, DOI 10.1016/0167-4838(85)90009-3; BABCOCK GT, 1976, J BIOL CHEM, V251, P7907; BABCOCK GT, 1988, BIOL APPLICATIONS RA, P293; BAKKENIST ARJ, 1980, BIOCHIM BIOPHYS ACTA, V613, P337, DOI 10.1016/0005-2744(80)90088-1; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; BONDOC LL, 1986, BIOCHEMISTRY-US, V25, P8458, DOI 10.1021/bi00374a021; BONDOC LL, 1989, J BIOL CHEM, V264, P6134; CALLAHAN PM, 1981, BIOCHEMISTRY-US, V20, P952, DOI 10.1021/bi00507a048; CHANG CK, 1982, BIOL CHEM IRON, P313; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; CHOI S, 1983, J AM CHEM SOC, V105, P3692, DOI 10.1021/ja00349a057; DAVIS RC, 1981, J AM CHEM SOC, V102, P6823; DUGAD LB, 1990, J BIOL CHEM, V265, P7173; ECCLES J, 1983, P NATL ACAD SCI-BIOL, V80, P4959, DOI 10.1073/pnas.80.16.4959; EGLINTON DG, 1982, BIOCHIM BIOPHYS ACTA, V703, P187, DOI 10.1016/0167-4838(82)90047-4; GOUTERMAN M, 1961, J MOL SPECTROSC, V6, P138, DOI 10.1016/0022-2852(61)90236-3; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HARRISON JE, 1978, BIOCHIM BIOPHYS ACTA, V536, P341, DOI 10.1016/0005-2795(78)90492-0; HARRISON JE, 1979, J BIOL CHEM, V254, P4536; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; HORI H, 1990, BIOCHEMISTRY-US, V29, P7106, DOI 10.1021/bi00482a023; IKEDASAITO M, 1985, FEBS LETT, V184, P52, DOI 10.1016/0014-5793(85)80651-7; KLIBANOV AM, 1983, ADV APPL MICROBIOL, V29, P1, DOI 10.1016/S0065-2164(08)70352-6; LEMBERG R., 1961, PROC ROY SOC SER B BIOL SCI, V155, P364; LOPEZGARRIGA JJ, 1990, BIOCHEMISTRY-US, V29, P9387, DOI 10.1021/bi00492a012; NEWTON N, 1965, BIOCHIM BIOPHYS ACTA, V96, P476, DOI 10.1016/0005-2787(65)90564-2; ODAJIMA T, 1972, BIOCHIM BIOPHYS ACTA, V284, P368, DOI 10.1016/0005-2744(72)90132-5; ODAJIMA T, 1980, J BIOCHEM-TOKYO, V87, P379, DOI 10.1093/oxfordjournals.jbchem.a132758; OERTLING WA, 1988, BIOCHEMISTRY-US, V27, P5395, DOI 10.1021/bi00415a002; OERTLING WA, 1990, INORG CHEM, V29, P2633, DOI 10.1021/ic00339a021; SCHULTZ J, 1964, BIOCHEMISTRY-US, V3, P1234, DOI 10.1021/bi00897a009; SCHULTZ J, 1983, BIOCHEMISTRY-US, V22, P14; SIBBETT SS, 1984, BIOCHEMISTRY-US, V23, P3007, DOI 10.1021/bi00308a025; STUMP RF, 1987, BIOPHYS J, V51, P605, DOI 10.1016/S0006-3495(87)83385-4; TAKEMORI S, 1965, J BIOL CHEM, V240, P504; UNO T, 1988, INORG CHEM, V27, P3215, DOI 10.1021/ic00291a035; VARADARAJAN R, 1989, BIOCHEMISTRY-US, V28, P3771, DOI 10.1021/bi00435a022; WEVER R, 1980, BIOCHIM BIOPHYS ACTA, V612, P178, DOI 10.1016/0005-2744(80)90291-0; WEVER R, 1981, BIOCHIM BIOPHYS ACTA, V661, P235, DOI 10.1016/0005-2744(81)90009-7; YU NT, 1984, P NATL ACAD SCI-BIOL, V81, P5106, DOI 10.1073/pnas.81.16.5106; ZENG J, 1989, J MOL BIOL, V210, P681, DOI 10.1016/0022-2836(89)90143-5	47	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24308	24313						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662207				2022-12-25	WOS:A1991GW84500014
J	FENG, ZH; WILSON, SE; PENG, ZY; SCHLENDER, KK; REIMANN, EM; TRUMBLY, RJ				FENG, ZH; WILSON, SE; PENG, ZY; SCHLENDER, KK; REIMANN, EM; TRUMBLY, RJ			THE YEAST GLC7-GENE REQUIRED FOR GLYCOGEN ACCUMULATION ENCODES A TYPE-1 PROTEIN PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE PHOSPHATASES; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; 2 FORMS; DNA; PHOSPHORYLASE; PURIFICATION; METABOLISM; SYNTHETASE; SYNTHASE	The glc7 mutant of the yeast Saccharomyces cerevisiae does not accumulate glycogen due to a defect in glycogen synthase activation (Peng, Z., Trumbly, R. J., and Reimann, E. M. (1990) J. Biol. Chem. 265, 13871-13877) whereas wild-type strains accumulate glycogen as the cell cultures approach stationary phase. We isolated the GLC7 gene by complementation of the defect in glycogen accumulation and found that the GLC7 gene is the same as the DIS2S1 gene (Ohkura, H., Kinoshita, N., Miyatani, S., Toda, T., and Yanagida, M. (1989) Cell 57, 997-1007). The protein product predicted by the GLC7 DNA sequence has a sequence that is 81% identical with rabbit protein phosphatase 1 catalytic subunit. Protein phosphatase 1 activity was greatly diminished in extracts from glc7 mutant cells. Two forms of protein phosphatase 1 were identified after chromatography of extracts on DEAE-cellulose. Both forms were diminished in the glc7 mutant and were partly restored by transformation with a plasmid carrying the GLC7 gene. Southern blots indicate the presence of a single copy of GLC7 in S. cerevisiae, and gene disruption experiments showed that the GLC7 gene is essential for cell viability. The GLC7 mRNA was identified as a 1.4-kilobase RNA that increases 4-fold at the end of exponential growth in wild-type cells, suggesting that activation of glycogen synthase is mediated by increased expression of protein phosphatase 1 as cells reach stationary phase.	MED COLL OHIO, DEPT BIOCHEM & MOLEC BIOL, TOLEDO, OH 43699 USA; MED COLL OHIO, DEPT PHARMACOL, TOLEDO, OH 43699 USA		TRUMBLY, RJ (corresponding author), MED COLL OHIO, DEPT BIOCHEM & MOLEC BIOL, TOLEDO, OH 43699 USA.		Trumbly, Robert/AAF-6667-2020	Trumbly, Robert/0000-0001-5618-146X	NHLBI NIH HHS [HL36573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOEKE JD, 1988, MOL CELL BIOL, V8, P1432, DOI 10.1128/MCB.8.4.1432; BOOHER R, 1989, CELL, V57, P1009, DOI 10.1016/0092-8674(89)90339-5; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CANNON JF, 1986, GENETICS, V113, P247; CHESTER VF, 1967, ARCH MICROBIOL, V51, P49; CLOTET J, 1991, CURR GENET, V19, P339, DOI 10.1007/BF00309593; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, FEBS LETT, V250, P601, DOI 10.1016/0014-5793(89)80804-X; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; FOSSET M, 1971, BIOCHEMISTRY-US, V10, P4105, DOI 10.1021/bi00798a015; FRANCOIS J, 1988, EUR J BIOCHEM, V174, P561, DOI 10.1111/j.1432-1033.1988.tb14135.x; FRANCOIS J, 1988, EUR J BIOCHEM, V174, P551, DOI 10.1111/j.1432-1033.1988.tb14134.x; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUANG KP, 1974, J BIOL CHEM, V249, P3851; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KILLILEA SD, 1978, ARCH BIOCHEM BIOPHYS, V191, P638, DOI 10.1016/0003-9861(78)90402-2; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Maniatis T., 1982, MOL CLONING; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; ORGAD S, 1990, FEBS LETT, V275, P44, DOI 10.1016/0014-5793(90)81435-Q; PENG ZY, 1991, J BIOL CHEM, V266, P10925; PENG ZY, 1990, J BIOL CHEM, V265, P13871; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHMANDENES LB, 1971, BIOCHEMISTRY-US, V10, P1236; ROTHMANDENES LB, 1970, P NATL ACAD SCI USA, V66, P967, DOI 10.1073/pnas.66.3.967; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; SCHLENDER KK, 1986, BIOCHIM BIOPHYS ACTA, V889, P200, DOI 10.1016/0167-4889(86)90105-9; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHENOLIKAR S, 1991, ADV 2ND MESSENGER PH, V23, P1; Sherman F., 1982, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TRUMBLY RJ, 1986, J BACTERIOL, V166, P1123, DOI 10.1128/jb.166.3.1123-1127.1986; TUNG HYL, 1984, EUR J BIOCHEM, V138, P635, DOI 10.1111/j.1432-1033.1984.tb07962.x; WADZINSKI BE, 1990, J BIOL CHEM, V265, P21504; WEICKERT MJ, 1989, COMMENTS, V16, P5	47	125	128	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23796	23801						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660885				2022-12-25	WOS:A1991GV31900043
J	ISHIBE, N; LYNCH, SR; COPELAND, RA				ISHIBE, N; LYNCH, SR; COPELAND, RA			THE PH-DEPENDENCE OF CYTOCHROME-A CONFORMATION IN CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATION; REDUCTION; BINDING; CYANIDE; MODEL; PUMP	The pH dependence of the conformation of cytochrome a in bovine cytochrome c oxidase has been studied by second derivative absorption spectroscopy. At neutral pH, the second derivative spectra of the cyanide-inhibited fully reduced and mixed valence enzyme display two Soret electronic transitions, at 443 and 451 nm, associated with cytochrome a. As the pH is lowered these two bands collapse into a single transition at approximately 444 nm. pH titration of the cyanide-inhibited mixed valence enzyme suggests that the transition from the two-band to one-band spectrum obeys the Henderson Hasselbalch relationship for a single protonation event with a transition pK(a) of 6.6 +/- 0.1. No pH dependence is observed for the spectra of the fully reduced unliganded or CO-inhibited enzyme. Tryptophan fluorescence spectra of the enzyme indicate that no major disruption of protein structure occurs in the pH range 5.5-8.5 used in this study. Resonance Raman spectroscopy indicates that the cytochrome a3 chromophore remains in its ferric, cyanide-bound form in the mixed valence enzyme throughout the pH range used here. These data indicate that the transition observed by second derivative spectroscopy is not due simply to pH-induced protein denaturation or disruption of the cytochrome a3 iron-CN bond. The pH dependence observed here is in good agreement with those observed earlier for the midpoint reduction potential of cytochrome a and for the conformational transition associated with energy transduction in the proton pumping model of Malmstrom (Malmstrom, B. G. (1990) Arch. Biochem. Biophys. 280, 233-241). These results are discussed in terms of a model for allosteric communication between cytochrome a and the binuclear ligand binding center of the enzyme that is mediated by ionization of a single group within the protein.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637	University of Chicago	COPELAND, RA (corresponding author), UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637, USA.							ANDREEV IM, 1983, BIOORG KHIM+, V9, P216; ARTZATBANOV VY, 1978, FEBS LETT, V87, P180, DOI 10.1016/0014-5793(78)80327-5; BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; BLAIR DF, 1986, BIOPHYS J, V50, P713, DOI 10.1016/S0006-3495(86)83511-1; BLAIR DF, 1982, BIOCHEMISTRY-US, V21, P6928, DOI 10.1021/bi00269a048; BOLGIANO B, 1991, BIOCHEM J, V274, P723, DOI 10.1042/bj2740723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHING YC, 1985, BIOCHEMISTRY-US, V24, P4938, DOI 10.1021/bi00339a032; COPELAND RA, 1989, ANNU REV PHYS CHEM, V40, P671; COPELAND RA, 1991, P NATL ACAD SCI USA, V88, P7281, DOI 10.1073/pnas.88.16.7281; FABIAN M, 1989, BIOCHIM BIOPHYS ACTA, V973, P414, DOI 10.1016/S0005-2728(89)80383-4; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P155; GELLES J, 1986, BIOCHIM BIOPHYS ACTA, V853, P205, DOI 10.1016/0304-4173(87)90002-4; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; HILL BC, 1986, BIOCHEMISTRY-US, V25, P2287, DOI 10.1021/bi00356a065; MAISONPETERI B, 1989, BIOCHEMISTRY-US, V28, P3156, DOI 10.1021/bi00434a007; MALMSTROM BG, 1990, ARCH BIOCHEM BIOPHYS, V280, P233, DOI 10.1016/0003-9861(90)90325-S; MULLER M, 1988, P NATL ACAD SCI USA, V85, P6647, DOI 10.1073/pnas.85.18.6647; MULLER M, 1991, J BIOENERG BIOMEMBR, V23, P291, DOI 10.1007/BF00762223; Nicholls D.G., 1982, BIOENERGETICS INTRO; PAPADOPOULOS PG, 1991, BIOCHEMISTRY-US, V30, P840, DOI 10.1021/bi00217a038; SAARI H, 1980, J BIOENERG BIOMEMBR, V12, P325, DOI 10.1007/BF00744692; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SEGEL IH, 1976, BIOCH CALCULATIONS, P403; SHERMAN D, 1991, P NATL ACAD SCI USA, V88, P4256; SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13; THORNSTROM PE, 1988, BIOCHEMISTRY-US, V27, P5441; Wikstrom M., 1981, CYTOCHROME OXIDASE S; WIKSTROM MK, 1989, NATURE, V33, P776; YOSHIKAWA S, 1990, J BIOL CHEM, V265, P7945	30	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23916	23920						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660888				2022-12-25	WOS:A1991GV31900061
J	BENNETT, BD; BENNETT, GL; VITANGCOL, RV; JEWETT, JRS; BURNIER, J; HENZEL, W; LOWE, DG				BENNETT, BD; BENNETT, GL; VITANGCOL, RV; JEWETT, JRS; BURNIER, J; HENZEL, W; LOWE, DG			EXTRACELLULAR DOMAIN-IGG FUSION PROTEINS FOR 3 HUMAN NATRIURETIC PEPTIDE RECEPTORS - HORMONE PHARMACOLOGY AND APPLICATION TO SOLID-PHASE SCREENING OF SYNTHETIC PEPTIDE ANTISERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL ZONA GLOMERULOSA; CLEARANCE RECEPTOR; PORCINE BRAIN; SIGNAL TRANSDUCTION; POLYACRYLAMIDE GELS; GUANYLATE-CYCLASE; CD4 IMMUNOADHESIN; ATRIAL; SEQUENCE; PURIFICATION	The natriuretic peptide receptors (NPRs) are a family of three cell surface glycoproteins, each with a single transmembrane domain. Two of these receptors, designated NPR-A and NPR-B, are membrane guanylyl cyclases that synthesize cGMP in response to hormone stimulation. The third receptor, NPR-C, has been reported to function in the metabolic clearance of ligand and in guanylyl cyclase-independent signal transduction. We engineered three chimeric proteins consisting of the natriuretic peptide receptor extracellular domains fused to the Fc portion of human IgG-gamma-1. These molecules provide material for detailed studies of the human receptor's extracellular domain structure and interaction with the three human natriuretic peptides, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and type-C natriuretic peptide (CNP). The homodimeric fusion proteins, designated A-IgG, B-IgG, and C-IgG, were secreted from Chinese hamster ovary cells and purified by protein-A affinity chromatography. We present here the primary characterization of these fusion proteins as represented by the intrinsic hormone affinities measured by saturation binding and competition assays. The dissociation constant of I-125-ANP for A-IgG was 1.6 pM and for C-IgG, 1.2 pM. The dissociation constant of I-125-Y0-CNP (CNP with addition of tyrosine at the amino terminus) for B-IgG was 23 pM. The rank order of potency in competitive binding for A-IgG was ANP > BNP >> CNP, whereas for B-IgG the ranking was CNP >> ANP > BNP. For C-IgG, we observed ANP > CNP greater-than-or-equal-to BNP. These data demonstrate that the receptor-IgG fusion proteins discriminate among the natriuretic peptides in the same manner as the native receptors and provide a basis for future structural studies with these molecules. The purified fusion proteins have a variety of potential applications, one of which we illustrate by a solid phase screening assay in which rabbit sera from a series of synthetic-peptide immunizations were titered for receptor reactivity and selectivity.	GENENTECH INC,DEPT MOLEC BIOL,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT MED & ANALYT CHEM,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT BIOORGAN CHEM,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT PROT CHEM,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech				Henzel, William/0000-0003-2940-3797				ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CHAMOW SM, 1990, BIOCHEMISTRY-US, V29, P9885, DOI 10.1021/bi00494a019; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHENG YC, 1973, BIOCHEM PHARMACOL, V23, P3099; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; DAYANITHI G, 1990, J ENDOCRINOL, V125, P39, DOI 10.1677/joe.0.1250039; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; FULLER F, 1988, J BIOL CHEM, V263, P9395; Gorman CM, 1990, DNA PROTEIN ENG TECH, V2, P1; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; KAMBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P599, DOI 10.1016/S0006-291X(05)80077-4; KAMBAYASHI Y, 1990, FEBS LETT, V259, P341, DOI 10.1016/0014-5793(90)80043-I; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; LARAGH JH, 1985, NEW ENGL J MED, V313, P1330; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1990, NUCLEIC ACIDS RES, V18, P3412, DOI 10.1093/nar/18.11.3412; MELOCHE S, 1986, MOL PHARMACOL, V30, P537; MELOCHE S, 1988, BIOCHEMISTRY-US, V27, P8151, DOI 10.1021/bi00421a025; MELOCHE S, 1987, J BIOL CHEM, V262, P10252; MINAMINO N, 1990, BIOCHEM BIOPH RES CO, V170, P973, DOI 10.1016/0006-291X(90)92187-5; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V119, P524, DOI 10.1016/S0006-291X(84)80279-X; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NUSSENZVEIG DR, 1990, J BIOL CHEM, V265, P20952; PORTER JG, 1989, J BIOL CHEM, V264, P14179; PORTER JG, 1990, BIOCHEM BIOPH RES CO, V171, P796, DOI 10.1016/0006-291X(90)91216-F; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SIGEL MB, 1983, METHOD ENZYMOL, V93, P3; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; TAWARAGI Y, 1991, BIOCHEM BIOPH RES CO, V175, P645, DOI 10.1016/0006-291X(91)91614-I; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA K, 1989, BIOCHEM J, V263, P671, DOI 10.1042/bj2630671; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221; WILCOX JN, 1991, MOL CELL BIOL, V11, P3454, DOI 10.1128/MCB.11.7.3454	44	130	158	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23060	23067						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660465				2022-12-25	WOS:A1991GT48300046
J	MURAKAMI, MS; ROSEN, OM				MURAKAMI, MS; ROSEN, OM			THE ROLE OF INSULIN-RECEPTOR AUTOPHOSPHORYLATION IN SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; PROTEIN-KINASE; 3T3-L1 ADIPOCYTES; HUMAN-PLACENTA; BETA-SUBUNIT; PHOSPHORYLATION; BINDING; REPLACEMENT; ENDOCYTOSIS; ANTIBODY	We have examined the role of autophosphorylation in insulin signal transmission by oligonucleotide directed mutagenesis of seven potential tyrosine autophosphorylation sites in the human insulin receptor. Chinese hamster ovary cells transfected with these receptors were analyzed for insulin stimulated 2-deoxyglucose uptake, thymidine incorporation, endogenous substrate phosphorylation, and in vitro kinase activity. We found that phosphorylation on tyrosine residues 953, 1316, and 1322 were not necessary for receptor-mediated signal transduction. Mutation of tyrosine 960 reduced but did not abolish the signaling capabilities of the receptor. Finally, the simultaneous mutation of tyrosine residues 1146, 1150, and 1151 (the numbering system is that of Ullrich et al. (Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M., Mason, A., Seeburg, P. H., Grunfeld, C., Rosen, O. M., and Ramachandran, J. (1985) Nature 313, 756-761) resulted in a biologically inactive receptor, suggesting that the insulin receptor can be inactivated by removal of kev autophosphorylation sites.			MURAKAMI, MS (corresponding author), CORNELL UNIV,GRAD SCH MED SCI,SLOAN KETTERING INST,PROGRAM MOLEC BIOL,GRAD PROGRAM MOLEC BIOL,NEW YORK,NY 10021, USA.				NIDDK NIH HHS [DK35158] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035158, R01DK035158] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1990, J BIOL CHEM, V265, P16450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHOU CK, 1987, J BIOL CHEM, V262, P1842; DEBANT A, 1988, P NATL ACAD SCI USA, V85, P8032, DOI 10.1073/pnas.85.21.8032; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; GANGULY S, 1985, CURR TOP CELL REGUL, V27, P83; GHERZI R, 1987, J BIOL CHEM, V262, P16900; HERRERA R, 1986, J BIOL CHEM, V261, P2489; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HERRERA R, 1985, P NATL ACAD SCI USA, V82, P7899, DOI 10.1073/pnas.82.23.7899; HERRERA R, 1986, J BIOL CHEM, V261, P1980; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; Maniatis T., 1982, MOL CLONING; MCCLAIN DA, 1990, J BIOL CHEM, V265, P21363; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MYERS MG, 1991, J BIOL CHEM, V266, P10616; PETRUZZELLI L, 1984, P NATL ACAD SCI-BIOL, V81, P3327, DOI 10.1073/pnas.81.11.3327; PETRUZZELLI LM, 1982, P NATL ACAD SCI-BIOL, V79, P6792, DOI 10.1073/pnas.79.22.6792; REYNET C, 1990, MOL ENDOCRINOL, V4, P304, DOI 10.1210/mend-4-2-304; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; SMITH CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2641, DOI 10.1073/pnas.77.5.2641; STADTMAUER L, 1986, J BIOL CHEM, V261; TAKATA Y, 1991, J BIOL CHEM, V266, P9135; THIES RS, 1990, J BIOL CHEM, V265, P10132; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WHITE MF, 1985, J BIOL CHEM, V260, P9470; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; ZHANG B, 1991, J BIOL CHEM, V266, P990	40	83	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22653	22660						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658004				2022-12-25	WOS:A1991GR56400090
J	HELLER, R; BUSSOLINO, F; GHIGO, D; GARBARINO, G; PESCARMONA, G; TILL, U; BOSIA, A				HELLER, R; BUSSOLINO, F; GHIGO, D; GARBARINO, G; PESCARMONA, G; TILL, U; BOSIA, A			STIMULATION OF PLATELET-ACTIVATING-FACTOR SYNTHESIS IN HUMAN ENDOTHELIAL-CELLS BY ACTIVATION OF THE DENOVO PATHWAY - PHORBOL 12-MYRISTATE 13-ACETATE ACTIVATES 1-ALKYL-2-LYSO-SN-GLYCERO-3-PHOSPHATE-ACETYL-COA ACETYLTRANSFERASE AND DITHIOTHREITOL-INSENSITIVE 1-ALKYL-2-ACETYL-SN-GLYCEROL-CDP-CHOLINE CHOLINEPHOSPHOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN KINASE-C; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN-NEUTROPHILS; ACETYL-COA; RABBIT PLATELETS; INNER MEDULLA; BIOSYNTHESIS; 1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE; RELEASE; 1-ALKYL-2-ACYL-SN-GLYCERO-3-PHOSPHOCHOLINE	Human umbilical vein endothelial cells (HUVEC) produce platelet-activating factor (PAF) by a remodeling pathway involving a phospholipase A2 followed by an acetyl-CoA-dependent acetyltransferase which acetylates a lyso-PAF intermediate to form PAF and is stimulated by a variety of agents that generate inflammatory and allergic responses. A second route for PAF synthesis in mammalian tissues is a de novo pathway, which requires the participation of three enzymes: 1-alkyl-2-lyso-sn-glycero-3-phosphate (alkyllyso-GP): acetyl-CoA acetyltransferase, 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase, and dithiothreitol (DTT)-insensitive 1-alkyl-2-acetyl-sn-glycerol (alkylacetyl-G):CDP-choline cholinephosphotransferase. In the present study we show that protein kinase C activation by phorbol 12-myristate 13-acetate (PMA) induces PAF production in HUVEC by an increase of both alkyllyso-GP:acetyl-CoA acetyltransferase and DTT-insensitive alkylacetyl-G:CDP-choline cholinephosphotransferase. PAF synthesis, labeled precursors ([H-3]acetate and [methyl-H-3]choline) incorporation, and both enzyme activities of the de novo pathway increase concomitantly in response to different doses of PMA. PMA does not activate the enzymes of the remodeling pathway. We conclude that both remodeling and the de novo pathway for PAF synthesis are present in HUVEC and might be alternatively activated depending on the conditions of cell stimulation.	UNIV TURIN, DIPARTIMENTO GENET BIOL & CHIM MED, VIA SANTENA 5-BIS, I-10126 TURIN, ITALY; MED ACAD ERFURT, DEPT PATHOL BIOCHEM, O-5010 ERFURT, GERMANY; UNIV TURIN, INST INTERNAL MED, I-10124 TURIN, ITALY	University of Turin; University of Turin			; Bussolino, Federico/K-2500-2016	Ghigo, Dario/0000-0001-6050-1577; Bussolino, Federico/0000-0002-5348-1341; PESCARMONA, GIAN PIERO/0000-0003-2143-8901				ALBERT DH, 1983, J BIOL CHEM, V258, P97; ALONSO F, 1982, J BIOL CHEM, V257, P3376; BENVENISTE J, 1977, NATURE, V269, P170, DOI 10.1038/269170a0; BLANK ML, 1988, J BIOL CHEM, V263, P5656; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; BUSSOLINO F, 1987, BIOCHIM BIOPHYS ACTA, V927, P43, DOI 10.1016/0167-4889(87)90064-4; BUSSOLINO F, 1988, J NEUROCHEM, V51, P1755, DOI 10.1111/j.1471-4159.1988.tb01155.x; CAMUSSI G, 1983, J IMMUNOL, V131, P2397; CAMUSSI G, 1989, EUR J BIOCHEM, V182, P661, DOI 10.1111/j.1432-1033.1989.tb14876.x; CHILTON FH, 1983, J BIOL CHEM, V258, P7268; GARCIA MC, 1991, BIOCHIM BIOPHYS ACTA, V1083, P37, DOI 10.1016/0005-2760(91)90122-X; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIRAFUJI M, 1987, BIOCHIM BIOPHYS ACTA, V930, P359, DOI 10.1016/0167-4889(87)90009-7; LEE T, 1989, BIOCHEM BIOPH RES CO, V163, P1002, DOI 10.1016/0006-291X(89)92321-8; LEE TC, 1988, J BIOL CHEM, V263, P1755; LEE TC, 1986, J BIOL CHEM, V261, P5373; LEE TC, 1990, J BIOL CHEM, V265, P9181; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; MUELLER HW, 1984, J BIOL CHEM, V259, P4554; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; NIETO ML, 1988, J BIOL CHEM, V263, P2217; PRESCOTT SM, 1984, P NATL ACAD SCI-BIOL, V81, P3534, DOI 10.1073/pnas.81.11.3534; RENOOIJ W, 1981, BIOCHIM BIOPHYS ACTA, V663, P545, DOI 10.1016/0005-2760(81)90182-X; ROSENTHAL MD, 1988, J CELL PHYSIOL, V136, P333, DOI 10.1002/jcp.1041360217; SNYDER F, 1989, ANN NY ACAD SCI, V568, P35; TOUQUI L, 1985, BIOCHIM BIOPHYS ACTA, V833, P111, DOI 10.1016/0005-2760(85)90258-9; TRIGGIANI M, 1990, J IMMUNOL, V144, P4773; VALLARI DS, 1990, ARCH BIOCHEM BIOPHYS, V276, P538, DOI 10.1016/0003-9861(90)90756-O; WHATLEY RE, 1990, J BIOL CHEM, V265, P15550; WOODARD DS, 1987, J BIOL CHEM, V262, P2520; ZIMMERMAN GA, 1985, CIRCULATION, V72, P718, DOI 10.1161/01.CIR.72.4.718	34	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21358	21361						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657961				2022-12-25	WOS:A1991GP80400009
J	LUTTRELL, BM; HENNIKER, AJ				LUTTRELL, BM; HENNIKER, AJ			REACTION COUPLING OF CHELATION AND ANTIGEN-BINDING IN THE CALCIUM ION-DEPENDENT ANTIBODY-BINDING OF CYCLIC-AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G; MYELOMA PROTEIN; RADIOIMMUNOASSAY; SYSTEMS; ACIDS	Polyclonal antibodies, raised against cyclic AMP (cAMP) by the immunization of animals with a 2'-O-succinyl cAMP/bovine albumin conjugate, have been reported to be dependent upon the presence of calcium ion (Ca") for antigen binding. They also exhibit a major "bridge" effect whereby 2'-O-succinyl and 2'-O-acetyl derivatives are bound more avidly than the parent nucleotide. Since cAMP and these derivatives bind Ca2+ very weakly, they do not present substantially in the chelated form over the range of Ca2+ concentrations used. Thus direct antigen modification is excluded as an explanation for the observed ion dependence of the reaction. Instead, we propose a mechanism based on reaction coupling. The actual antigens are the Ca2+ chelates of these nucleotides, whose formation in the absence of antibody is rapid but not favored (as indicated by their weak association constants). When antibody is added, the chelates act as transient intermediates whose concentration remains low but which is replenished as they are consumed by antibody. The coupled reaction is driven by the antibody-antigen step which occurs more slowly but with a substantial gain in free energy. The reaction is limited by the availability of Ca2+. It also appears that the rabbit antibody forming cell responds preferentially to the Ca2+-bound form of the 2'-O-succinyl cAMP/bovine albumin conjugate which may appear to be more "foreign" than the unbound form of the hapten containing the ubiquitous nucleotide cAMP.			LUTTRELL, BM (corresponding author), ROYAL N SHORE HOSP,DEPT ENDOCRINOL,ENDOCRINE LAB 1A,ST LEONARDS,NSW 2065,AUSTRALIA.							CAILLA HL, 1973, ANAL BIOCHEM, V56, P383, DOI 10.1016/0003-2697(73)90204-2; CAILLA HL, 1973, ANAL BIOCHEM, V56, P394, DOI 10.1016/0003-2697(73)90205-4; CATHERWOOD BD, 1983, BONE, V6, P9; CHIANG CS, 1982, CLIN CHEM, V28, P150; COHN M, 1962, J BIOL CHEM, V237, P176; GRANT STB, 1985, CLIN ENDOCRINOL, V23, P217; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; JAFFE JP, 1979, AM J MED, V67, P343, DOI 10.1016/0002-9343(79)90412-1; LACHMANN PJ, 1970, IMMUNOLOGY, V18, P157; LIBERTI PA, 1972, BIOCHEMISTRY-US, V11, P3312, DOI 10.1021/bi00768a002; LIBERTI PA, 1971, BIOCHEMISTRY-US, V10, P1632, DOI 10.1021/bi00785a021; MARTELL AE, 1971, STABILITY CONSTANT 2, V1, P644; MARTIN RB, 1979, Q REV BIOPHYS, V12, P181, DOI 10.1017/S0033583500002754; MAURER PH, 1970, J IMMUNOL, V105, P567; MERLINI G, 1984, J CLIN IMMUNOL, V4, P185, DOI 10.1007/BF00914965; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; SPIRA G, 1980, SCAND J HAEMATOL, V24, P193; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STEINER AL, 1979, METHOD HORM RADIOIMM, V2, P3	19	18	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21626	21630						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657973				2022-12-25	WOS:A1991GP80400048
J	DAS, S; TRAYNORKAPLAN, A; REINER, DS; MENG, TC; GILLIN, FD				DAS, S; TRAYNORKAPLAN, A; REINER, DS; MENG, TC; GILLIN, FD			A SURFACE-ANTIGEN OF GIARDIA-LAMBLIA WITH A GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; PHOSPHOLIPID MEMBRANE ANCHOR; TRYPANOSOMA-BRUCEI; RIBOSOMAL-RNA; PROTEINS; GLYCOPROTEIN; INVITRO; EXPRESSION; INOSITOL; ACID	Since Giardia lamblia trophozoites are exposed to high concentrations of fatty acids in their human small intestinal milieu, we determined the pattern of incorporation of [H-3]palmitic acid and myristic acid into G. lamblia proteins. The pattern of fatty acylation was unusually simple since > 90% of the Giardia protein biosynthetically labeled with either [H-3]palmitate or myristate migrated at approximately 49 kDa (GP49) in reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis during both growth and differentiation. GP49, which partitions into the Triton X-114 detergent phase, is localized on the cell surface since it is I-125-surface-labeled. GP49 was also biosynthetically labeled with [C-14]ethanolamine and [H-3]myoinositol, suggesting that it has a glycosylphosphatidylinositol (GPI) anchor. Moreover, phospholipase A2 (PLA2) or mild alkaline treatment released free fatty acids, indicating a diacylglycerol moiety with ester linkages. Finally, a H-3- and C-14-labeled species was released by nitrous acid deamination from [C-14]palmitate- and [H-3]myoinositol-labeled GP49. The GPI anchor of GP49 is unusual, however, because purified GP49 was cleaved by Bacillus cereus phosphatidylinositol (PI)-specific PLC, but not by Staphylococcus aureus PI-PLC, or plasma PLD, and did not react with antibody against the variant surface glycoprotein cross-reactive determinant. Moreover, the double-labeled deaminated GP49 anchor migrated faster than authentic PI in TLC and produced [H-3]glycerophosphoinositol after deacylation. In contrast to the variable cysteine-rich G. lamblia surface antigens described previously, GP49 was identified in Western blots of every isolate tested, as well as in subclones of a single isolate which differ in expression of a major cysteine-rich 85/66-kDa surface antigen, which does not appear to be GPI-anchored. These observations suggest that GP49, the first common surface antigen to be described in G. lamblia, may play an important role in the interaction of this parasite with its environment.	UNIV CALIF SAN DIEGO,DEPT MED,DIV GASTROENTEROL,SAN DIEGO,CA 92103; UNIV CALIF SAN DIEGO,DIV INFECT DIS,SAN DIEGO,CA 92103	University of California System; University of California San Diego; University of California System; University of California San Diego	DAS, S (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DEPT PATHOL,8416,225 DICKINSON ST,SAN DIEGO,CA 92103, USA.		Reiner, David S./F-6106-2012	Reiner, David S./0000-0002-8289-7311	NIADDK NIH HHS [AM 35108] Funding Source: Medline; NIAID NIH HHS [AI 24285, AI 19863] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019863, R01AI024285, R21AI024285] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BINGHAM AK, 1979, EXP PARASITOL, V47, P284, DOI 10.1016/0014-4894(79)90080-8; BLAIR RJ, 1987, MOL BIOCHEM PARASIT, V25, P11, DOI 10.1016/0166-6851(87)90013-2; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Craun G. F., 1984, Giardiaand giardiasis - biology, pathogenesis, and epidemiology., P243; DAVIS CE, 1989, MICROB PATHOGENESIS, V7, P45, DOI 10.1016/0882-4010(89)90110-1; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; EDLIND TD, 1989, ANTIMICROB AGENTS CH, V33, P484, DOI 10.1128/AAC.33.4.484; FARTHING MJG, 1985, J CLIN INVEST, V76, P1727, DOI 10.1172/JCI112162; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; FERGUSON MAJ, 1988, POST TRANSLATIONAL M, P1; FRANCOEUR AM, 1986, J IMMUNOL, V136, P1648; GILLIN FD, 1988, INFECT IMMUN, V56, P705, DOI 10.1128/IAI.56.3.705-707.1988; GILLIN FD, 1989, EXP PARASITOL, V69, P164, DOI 10.1016/0014-4894(89)90185-9; GILLIN FD, 1987, SCIENCE, V235, P1040, DOI 10.1126/science.3547646; GILLIN FD, 1990, P NATL ACAD SCI USA, V87, P4463, DOI 10.1073/pnas.87.12.4463; GILLIN FD, 1986, INFECT IMMUN, V53, P641, DOI 10.1128/IAI.53.3.641-645.1986; HERELD D, 1986, J BIOL CHEM, V261, P3813; HERELD D, 1988, POST TRANSLATIONAL M, P9; JARROLL EL, 1981, MOL BIOCHEM PARASIT, V2, P187, DOI 10.1016/0166-6851(81)90099-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; LOW MG, 1987, BIOCHEM J, V241, P615, DOI 10.1042/bj2410615; NAGEL SD, 1989, J BIOL CHEM, V264, P5569; NASH TE, 1983, J IMMUNOL, V131, P2004; REINER DS, 1989, INFECT IMMUN, V57, P963, DOI 10.1128/IAI.57.3.963-968.1989; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROBERTS WL, 1988, J BIOL CHEM, V263, P18776; SCHACHT J, 1978, J LIPID RES, V19, P1063; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; TURCO SJ, 1984, J BIOL CHEM, V259, P3883; WALTER EI, 1990, J IMMUNOL, V144, P1030; WIEDER SC, 1983, J PARASITOL, V69, P1181, DOI 10.2307/3280897; WIEST PM, 1988, BIOCHEM J, V254, P419, DOI 10.1042/bj2540419	43	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21318	21325						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657957				2022-12-25	WOS:A1991GN00100113
J	HWANG, ST; WACHTER, C; SCHATZ, G				HWANG, ST; WACHTER, C; SCHATZ, G			PROTEIN IMPORT INTO THE YEAST MITOCHONDRIAL MATRIX - A NEW TRANSLOCATION INTERMEDIATE BETWEEN THE 2 MITOCHONDRIAL-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED PRECURSOR PROTEIN; OUTER-MEMBRANE; CONTACT SITES; INNER MEMBRANE	Import of authentic or artificial precursor proteins into the matrix of isolated yeast mitochondria can proceed via a translocation intermediate that is lodged between the two mitochondrial membranes. The intermediate accumulates when import is arrested by depleting mitochondria of ATP. Generation of the intermediate requires a potential across the inner membrane. The intermediate is membrane-bound, partly or completely processed (depending on the precursor), and chased into the matrix by added ATP. This chase does not require a potential across the inner membrane. The properties of this intermediate support the proposal (Hwang, S., Jascur, J., Vestweber, D., Pon, L., and Schatz, G. (1989) J. Cell Biol. 109, 487-493) that import into the matrix involves two distinct translocation systems in the outer and the inner mitochondrial membrane that are not permanently coupled to each other. Only translocation across the inner membrane requires ATP in the matrix.	UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND	University of Basel					NIGMS NIH HHS [2 R01 GM 37803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BOHNI PC, 1983, J BIOL CHEM, V258, P4937; DAUM G, 1982, J BIOL CHEM, V257, P3028; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; ENDO T, 1988, EMBO J, V7, P1153, DOI 10.1002/j.1460-2075.1988.tb02925.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GELI V, 1990, J BIOENERG BIOMEMBR, V22, P725; GLICK B, 1991, ANNU REV GENET, V25, P21; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; HAID A, 1983, METHOD ENZYMOL, V96, P192; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HURT EC, 1984, EMBO J, V3, P3149, DOI 10.1002/j.1460-2075.1984.tb02272.x; HWANG S, 1989, J CELL BIOL, V109, P487, DOI 10.1083/jcb.109.2.487; HWANG ST, 1989, P NATL ACAD SCI USA, V86, P8432, DOI 10.1073/pnas.86.21.8432; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; MANNINGKRIEG UC, 1991, IN PRESS EMBO J, V10; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; RASSOW J, 1989, J CELL BIOL, V109, P1421, DOI 10.1083/jcb.109.4.1421; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x	30	85	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21083	21089						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657948				2022-12-25	WOS:A1991GN00100078
J	PRATGAY, G; PALADINI, A; STEIN, M; WOLOSIUK, RA				PRATGAY, G; PALADINI, A; STEIN, M; WOLOSIUK, RA			THE EFFECT OF HIGH HYDROSTATIC-PRESSURE ON THE MODULATION OF REGULATORY ENZYMES FROM SPINACH-CHLOROPLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FERREDOXIN-THIOREDOXIN SYSTEM; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE-OXYGENASE; CHAOTROPIC ANIONS; HYDRATION CHANGES; ORGANIC-SOLVENTS; C-3 PLANTS; FRUCTOSE-1,6-BISPHOSPHATASE; ACTIVATION; DISSOCIATION	High hydrostatic pressure enhanced the specific activity of regulatory enzymes of the Benson-Calvin cycle (fructose-1,6-bisphosphatase, glyceraldehyde-3-P dehydrogenase, phosphoribulokinase) which are modulated by the ferredoxin-thioredoxin system. High activity of chloroplast fructose-1,6-bisphosphatase required dithiothreitol, fructose 1,6-bisphosphate, and Ca2+. At 100 bar the A0.5 for fructose 1,6-bisphosphate (0.3 mM) was lower than that at 1 bar (1.5 mM), whereas similar variations of pressure did not alter the A0.5 for Ca2+ (55-mu-M). The response of chloroplast glyceraldehyde-3-P dehydrogenase exposed to 500 bar was a 4-fold increase in the NADP-linked activity; conversely, the NAD-dependent activity remained unchanged. The concerted action of high pressure and P(i) (or ATP), both activators of chloroplast glyceraldehyde-3-P dehydrogenase, led to inactivation. On the other hand, the activity of phosphoribulokinase increased 10-fold when the enzyme was incubated at 1500 bar; the activation process was strictly dependent on the presence of dithiothreitol. At variance with these enzymes, bovine liver fructose-1,6-bisphosphatase, yeast glyceraldehyde-3-P dehydrogenase, and chloroplast ribulose 1,5-bisphosphate carboxylase, whose activities are not modulated by reduced thioredoxin, were inactivated by high pressure. The comparison of oligomeric enzymes revealed that the stimulation of specific activity by high pressure correlated with thioredoxin-mediated activation, and it did not depend on a particular subunit composition. Present results show that high pressure resembled thioredoxin, cosolvents, and chaotropic anions in its action on regulatory enzymes of the Benson-Calvin cycle. The comparison of physiological and nonphysiological modulators suggested that thioredoxin-mediated modifications of noncovalent interactions is an important event in light-dependent regulation of chloroplast enzymes.	FDN CAMPOMAR,INST INVEST BIOQUIM,ANTONIO MACHADO 151,RA-1405 BUENOS AIRES,ARGENTINA; INST INGN GENET & BIOL MOLEC,BUENOS AIRES,ARGENTINA	Leloir Institute				Prat Gay, Gonzalo/0000-0001-5748-6863				BALNY C, 1988, EUR J BIOCHEM, V176, P2733; BARCENA JA, 1983, BIOCHEM INT, V7, P755; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1979, TRENDS BIOCHEM SCI, V4, P93, DOI 10.1016/0968-0004(79)90191-9; CHEHEBAR C, 1980, BIOCHIM BIOPHYS ACTA, V613, P429, DOI 10.1016/0005-2744(80)90097-2; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; CORLEY E, 1985, J BIOL CHEM, V260, P3978; CRAWFORD NA, 1986, ARCH BIOCHEM BIOPHYS, V244, P1, DOI 10.1016/0003-9861(86)90088-3; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; GELLER AM, 1975, METHOD ENZYMOL, V43, P363; GREANEY GS, 1979, BIOCHEMISTRY-US, V18, P5322, DOI 10.1021/bi00591a010; HALL NP, 1978, FEBS LETT, V96, P167, DOI 10.1016/0014-5793(78)81085-0; HERTIG C, 1980, BIOCHEM BIOPH RES CO, V97, P325, DOI 10.1016/S0006-291X(80)80171-9; HERTIG CM, 1983, J BIOL CHEM, V258, P984; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HORECKER BL, 1975, ADV ENZYMOL RAMB, V42, P193; IADAROLA P, 1986, J CHROMATOGR, V359, P423, DOI 10.1016/0021-9673(86)80096-6; JAENICKE R, 1968, BIOCHEMISTRY-US, V7, P919, DOI 10.1021/bi00843a006; JAENICKE R, 1983, NATURWISSENSCHAFTEN, V70, P332, DOI 10.1007/BF00444207; KING L, 1986, BIOCHEMISTRY-US, V25, P3632, DOI 10.1021/bi00360a023; KORNBLATT MJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P277, DOI 10.1016/0003-9861(87)90032-4; LEA A, 1971, CHEM REV, V71, P525; LORIMER GH, 1977, ANAL BIOCHEM, V78, P66, DOI 10.1016/0003-2697(77)90009-4; LOW PS, 1975, P NATL ACAD SCI USA, V72, P3305, DOI 10.1073/pnas.72.9.3305; MAEDA K, 1986, EUR J BIOCHEM, V154, P197, DOI 10.1111/j.1432-1033.1986.tb09379.x; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; MODEL P, 1986, THIOREDOXIN GLUTARED, P323; Morild E, 1981, Adv Protein Chem, V34, P93, DOI 10.1016/S0065-3233(08)60519-7; NEMETHY G, 1981, ANNU REV BIOPHYS BIO, V10, P459, DOI 10.1146/annurev.bb.10.060181.002331; NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; PENNISTON JT, 1971, ARCH BIOCHEM BIOPHYS, V142, P322, DOI 10.1016/0003-9861(71)90290-6; PORTER MA, 1986, ARCH BIOCHEM BIOPHYS, V245, P14, DOI 10.1016/0003-9861(86)90185-2; PRATGAY G, 1992, IN PRESS J BIOL CHEM; RAINES CA, 1988, NUCLEIC ACIDS RES, V16, P7931, DOI 10.1093/nar/16.16.7931; RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026; SCHURMANN P, 1985, PHYSIOL VEG, V23, P813; SEIFERT T, 1984, FEBS LETT, V173, P381, DOI 10.1016/0014-5793(84)80809-1; STEIN M, 1987, J BIOL CHEM, V262, P16171; STEIN M, 1989, EUR J BIOCHEM, V185, P425, DOI 10.1111/j.1432-1033.1989.tb15132.x; TABOR S, 1986, THIOREDOXIN GLUTARED, P285; TENAUD M, 1987, J PLANT PHYSIOL, V130, P315, DOI 10.1016/S0176-1617(87)80198-0; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; WOLOSIUK RA, 1980, FEBS LETT, V109, P289, DOI 10.1016/0014-5793(80)81107-0; WOLOSIUK RA, 1978, ARCH BIOCHEM BIOPHYS, V189, P97, DOI 10.1016/0003-9861(78)90119-4; WOLOSIUK RA, 1985, FEBS LETT, V189, P212, DOI 10.1016/0014-5793(85)81025-5; WOLOSIUK RA, 1976, J BIOL CHEM, V251, P6456; WOLOSIUK RA, 1977, FEBS LETT, V81, P253, DOI 10.1016/0014-5793(77)80529-2; WOLOSIUK RA, 1990, ARCH BIOCHEM BIOPHYS, V279, P70, DOI 10.1016/0003-9861(90)90464-A; WOLOSIUK RA, 1986, ARCH BIOCHEM BIOPHYS, V246, P1, DOI 10.1016/0003-9861(86)90443-1; WOLOSIUK RA, 1978, PLANT PHYSIOL, V61, P669, DOI 10.1104/pp.61.4.669; WOLOSIUK RA, 1983, THIOREDOXINS STRUCTU, P167; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.pp.39.060188.002533; ZAKS A, 1988, J BIOL CHEM, V263, P8017	55	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20913	20921						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657939				2022-12-25	WOS:A1991GN00100052
J	LASSMANN, G; ODENWALLER, R; CURTIS, JF; DEGRAY, JA; MASON, RP; MARNETT, LJ; ELING, TE				LASSMANN, G; ODENWALLER, R; CURTIS, JF; DEGRAY, JA; MASON, RP; MARNETT, LJ; ELING, TE			ELECTRON-SPIN-RESONANCE INVESTIGATION OF TYROSYL RADICALS OF PROSTAGLANDIN-H SYNTHASE - RELATION TO ENZYME CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER OXIDATION-STATES; VESICULAR GLAND MICROSOMES; RIBONUCLEOTIDE REDUCTASE; ENDOPEROXIDE SYNTHETASE; PEROXIDASE-ACTIVITIES; COMPLEMENTARY-DNA; HEME; CYCLOOXYGENASE; HYDROPEROXIDE; BIOSYNTHESIS	We have examined, by low temperature ESR, the protein-derived radicals formed by reaction of purified ram seminal vesicle prostaglandin H synthase (PHS). Upon addition of arachidonic acid or 5-phenyl-4-pentenyl-1-hydroperoxide (PPHP) to PHS reconstituted with Fe(III)-protoporphyrin IX (Fe-PHS) at -12-degrees-C, an ESR spectrum was observed at -196-degrees-C containing a doublet that rapidly converted into a singlet. These protein-derived radicals were identified as tyrosyl radicals. The addition of a peroxidase substrate, phenol, completely abolished the appearance of the doublet and suppressed the formation of the singlet but did not inhibit eicosanoid formation. Incubation of arachidonic acid with PHS reconstituted with Mn(III)-protoporphyrin IX (Mn-PHS) produced only a broad singlet that exhibited different power saturation behavior than the tyrosyl radicals and decayed more rapidly. This broad singlet does not appear to be a tyrosyl radical. No ESR signals were observed on incubation of PPHP with Mn-PHS, which has cyclooxygenase but not peroxidase activity. Eicosanoid synthesis occurred very rapidly after addition of arachidonic acid and was complete within 1 min. In contrast, the protein-derived radicals appeared at a slower rate and after the addition of the substrate reached maximal levels between 1 and 2 min for Fe-PHS and 4-6 min for Mn-PHS. These results suggest that the observed protein-derived radicals are not catalytically competent intermediates in cyclooxygenase catalysis by either Fe-PHS or Mn-PHS. The peroxidase activity appears to play a major role in the formation of the tyrosyl radicals with Fe-PHS.	NIEHS, MOLEC BIOPHYS LAB, RES TRIANGLE PK, NC 27709 USA; VANDERBILT UNIV, MED CTR,SCH MED,CTR MOLEC TOXICOL,DEPT BIOCHEM, AB HANCOCK JR MEM LAB CANC RES, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT CHEM, NASHVILLE, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Vanderbilt University; Vanderbilt University			Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109	NATIONAL CANCER INSTITUTE [R35CA047479] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47479] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTHOLINE W, 1976, PHYS MED BIOL, V21, P840, DOI 10.1088/0031-9155/21/5/012; BARRY BA, 1990, J BIOL CHEM, V265, P20139; BARRY BA, 1988, CHEM SCRIPTA, V28A, P117; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; CHEN YNP, 1987, J BIOL CHEM, V262, P16892; CHEN YNP, 1989, FASEB J, V3, P2294, DOI 10.1096/fasebj.3.11.2506093; DEGRAY JA, 1987, THESIS BROWN U PROVI; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; EGAN RW, 1976, J BIOL CHEM, V251, P7329; EHRENBERG A, 1986, THIOREDOXIN GLUTARED, P209; ELING TE, 1986, J BIOL CHEM, V261, P5023; FASANELL.EL, 1969, P NATL ACAD SCI USA, V62, P299, DOI 10.1073/pnas.62.2.299; FISHEL LA, 1991, BIOCHEMISTRY-US, V30, P1986, DOI 10.1021/bi00221a036; GRASLUND A, 1985, ENVIRON HEALTH PERSP, V64, P139, DOI 10.2307/3430005; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P345, DOI 10.1073/pnas.71.2.345; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HEMLER ME, 1978, BIOCHEM BIOPH RES CO, V85, P1325, DOI 10.1016/0006-291X(78)91148-8; HSUANYU YC, 1990, BIOCHEM CELL BIOL, V68, P965, DOI 10.1139/o90-142; INGOLD KU, 1969, ACCOUNTS CHEM RES, V2, P1, DOI 10.1021/ar50013a001; KALYANARAMAN B, 1982, J BIOL CHEM, V257, P4764; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; KULMACZ RJ, 1987, J BIOL CHEM, V262, P10524; KULMACZ RJ, 1983, PROSTAGLANDINS, V25, P531, DOI 10.1016/0090-6980(83)90025-4; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; LAMBEIR AM, 1985, J BIOL CHEM, V260, P4894; LANDS W, 1971, ANN NY ACAD SCI, V180, P107, DOI 10.1111/j.1749-6632.1971.tb53190.x; Lands WE, 1984, FREE RADICAL BIO MED, P39; LASSMANN G, 1989, FREE RADICAL BIO MED, V6, P9, DOI 10.1016/0891-5849(89)90153-6; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; Marnett L. J., 1991, PEROXIDASES CHEM BIO, V1, P293; MARNETT LJ, 1988, J BIOL CHEM, V263, P16532; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; MASON RP, 1980, J BIOL CHEM, V255, P5019; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; NASTAINCZYK W, 1984, EUR J BIOCHEM, V144, P381, DOI 10.1111/j.1432-1033.1984.tb08475.x; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; NUGTEREN DH, 1973, BIOCHIM BIOPHYS ACTA, V326, P448, DOI 10.1016/0005-2760(73)90145-8; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; OGINO N, 1978, J BIOL CHEM, V253, P5061; OHKI S, 1979, J BIOL CHEM, V254, P829; PACEASCIAK CR, 1983, ENZYMES, V16, P544; PORTER NA, 1975, J ORG CHEM, V40, P3614, DOI 10.1021/jo00912a037; RAZ A, 1990, BIOCHEM J, V269, P603, DOI 10.1042/bj2690603; RIEGER PH, 1982, J MAGN RESON, V50, P485, DOI 10.1016/0022-2364(82)90013-0; ROTH GJ, 1981, J BIOL CHEM, V256, P18; SCHREIBER J, 1986, ARCH BIOCHEM BIOPHYS, V249, P126, DOI 10.1016/0003-9861(86)90567-9; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SJOBERG BM, 1983, ADV INORG BIOCHEM, V5, P87; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; VANDEROUDERAA FJ, 1979, BIOCHIM BIOPHYS ACTA, V572, P29, DOI 10.1016/0005-2760(79)90197-8; WELLER PE, 1985, ARCH BIOCHEM BIOPHYS, V243, P633, DOI 10.1016/0003-9861(85)90541-7; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0	59	95	95	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20045	20055						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657911				2022-12-25	WOS:A1991GM03900030
J	RENAUD, KJ; INMAN, EM; FAMBROUGH, DM				RENAUD, KJ; INMAN, EM; FAMBROUGH, DM			CYTOPLASMIC AND TRANSMEMBRANE DOMAIN DELETIONS OF NA,K-ATPASE BETA-SUBUNIT - EFFECTS ON SUBUNIT ASSEMBLY AND INTRACELLULAR-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; NA+-K+-ATPASE; SKELETAL-MUSCLE; SODIUM-PUMP; VIRUS GLYCOPROTEIN; MAMMALIAN-CELLS; ALPHA-SUBUNIT; EXPRESSION; MEMBRANE; SEQUENCE	cDNAs encoding Na,K-ATPase beta-subunits containing deletions in the cytoplasmic domain or in the single membrane-spanning domain of the molecule were constructed and expressed in mouse L cells to determine the effect(s) of deletions in these domains on alpha/beta-subunit assembly and intracellular targeting. Avian beta-subunits lacking some or all of the cytoplasmic domain (endodomain) assemble with the endogenous mouse alpha-subunit and are correctly transported to the plasma membrane. Mutants containing deletions in the transmembrane domain were constructed by fusing portions of cDNAs encoding the amino-terminal one-third of human beta-subunit deletion mutants with avian beta-subunit cDNA encoding the carboxyl two-thirds of the molecule. A deletion of 3 amino acids in transmembrane domain resulted in correct alpha/beta-subunit assembly and localization to the plasma membrane. In contrast, deletions of 5 or more amino acids in the transmembrane domain prevented expression of the beta-subunit at the cell surface and resulted in the accumulation of these molecules in the ER. In spite of these targeting differences, all beta-subunit mutants capable of membrane insertion were also able to assemble with the alpha-subunit. These results suggest that the specificity for alpha/beta assembly resides in the ectodomains of the subunits.	JOHNS HOPKINS UNIV, DEPT BIOL, 34TH & CHARLES ST, BALTIMORE, MD 21218 USA	Johns Hopkins University				Laderman, Elisabeth/0000-0001-9808-6241	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023241] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-070103] Funding Source: Medline; NINDS NIH HHS [NS-23241] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; DOYLE C, 1985, J CELL BIOL, V100, P704, DOI 10.1083/jcb.100.3.704; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; FAMBROUGH DM, 1983, J BIOL CHEM, V258, P3926; FAMBROUGH DM, 1988, TRENDS NEUROSCI, V11, P325, DOI 10.1016/0166-2236(88)90096-3; FAMBROUGH DM, 1983, COLD SPRING HARB SYM, V48, P297, DOI 10.1101/SQB.1983.048.01.032; GAROFF H, 1983, J CELL BIOL, V97, P652, DOI 10.1083/jcb.97.3.652; GEERING K, 1987, J CELL BIOL, V105, P2613, DOI 10.1083/jcb.105.6.2613; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HIATT A, 1984, J BIOL CHEM, V259, P2629; HOROWITZ B, 1990, J BIOL CHEM, V265, P4189; JOHNSON JD, 1988, P NATL ACAD SCI USA, V85, P7516, DOI 10.1073/pnas.85.20.7516; KAPRIELIAN Z, 1987, DEV BIOL, V124, P490, DOI 10.1016/0012-1606(87)90502-1; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; KAWAKAMI K, 1988, J BIOCHEM-TOKYO, V103, P54, DOI 10.1093/oxfordjournals.jbchem.a122239; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MURRE C, 1984, NATURE, V307, P432, DOI 10.1038/307432a0; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; NOGUCHI S, 1986, FEBS LETT, V196, P315, DOI 10.1016/0014-5793(86)80270-8; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; PUDDINGTON L, 1986, J CELL BIOL, V102, P2147, DOI 10.1083/jcb.102.6.2147; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; TAKEYASU K, 1989, CURR TOP MEMBR TRANS, V34, P143; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TAKEYASU K, 1987, J BIOL CHEM, V262, P10733; TAMKUN MM, 1986, J BIOL CHEM, V261, P1009; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VERREY F, 1989, AM J PHYSIOL, V256, pF1034, DOI 10.1152/ajprenal.1989.256.6.F1034; WILLS JW, 1984, J CELL BIOL, V99, P2011, DOI 10.1083/jcb.99.6.2011; YOUNG RM, 1987, J BIOL CHEM, V262, P4905; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; ZUNIGA MC, 1983, CELL, V34, P535, DOI 10.1016/0092-8674(83)90386-0	46	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20491	20497						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657927				2022-12-25	WOS:A1991GM03900092
J	YAMAGUCHI, K; AKAI, K; KAWANISHI, G; UEDA, M; MASUDA, S; SASAKI, R				YAMAGUCHI, K; AKAI, K; KAWANISHI, G; UEDA, M; MASUDA, S; SASAKI, R			EFFECTS OF SITE-DIRECTED REMOVAL OF N-GLYCOSYLATION SITES IN HUMAN ERYTHROPOIETIN ON ITS PRODUCTION AND BIOLOGICAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ERYTHROPOIETIN; HAMSTER OVARY CELLS; MONOCLONAL-ANTIBODIES; SUGAR CHAINS; SIALIC-ACID; CARBOHYDRATE; PURIFICATION; SURVIVAL; VECTOR; CDNA	Erythropoietin (Epo) has three N-linked sugar chains. Codons for asparagine at N-glycosylation sites in genomic human Epo DNA were replaced with those for glutamine. The wild-type Epo gene and seven mutants that lacked N-glycosylation sites in every possible combination were introduced into baby hamster-kidney cells. To study the role of the N-linked sugars in Epo biosynthesis, Epo protein expressed transiently was measured by an enzyme-linked immunoassay. The elimination of all three N-glycosylation sites decreased Epo production to 10% of that of the wild-type Epo. Wild-type and mutant Epos produced by stably transfected cells were partially purified to investigate their properties. Removal of N-glycosylation sites changed affinity of Epo to the receptor. The in vitro activity of Epo that lost all N-glycosylation sites was comparable with that of the wild-type Epo, while the in vivo activity severely decreased. These results indicate that N-linked sugars of Epo have two major functions; N-linked sugars are important for 1) proper biosynthesis and/or secretion and 2) expression of the in vivo activity probably by enhancing survival in the circulation. N-Linked sugars of Epo affect binding affinity of the ligand to the receptor but do not play a key role in expression of the in vitro activity.	SNOW BRAND MILK PROD CO LTD,LIFE SCI RES INST,TOCHIGI 32905,JAPAN; KYOTO UNIV,FAC AGR,DEPT FOOD SCI & TECHNOL,KYOTO 606,JAPAN	Snow Brand Milk Products Co., Ltd.; Kyoto University								AKAI K, 1988, EXPT HEMATOLOGY TODA, P109; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; DORDAL MS, 1985, ENDOCRINOLOGY, V116, P2293, DOI 10.1210/endo-116-6-2293; DUBE S, 1988, J BIOL CHEM, V263, P17516; FUKUDA MN, 1989, BLOOD, V73, P84; GOLDWASSER E, 1974, J BIOL CHEM, V249, P4202; Goldwasser E, 1975, Methods Enzymol, V37, P109; GOTO M, 1989, BLOOD, V74, P1415; GOTO M, 1988, BIO-TECHNOL, V6, P67, DOI 10.1038/nbt0188-67; ISCOVE NN, 1974, J CELL PHYSIOL, V83, P309, DOI 10.1002/jcp.1040830218; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KITAMURA T, 1989, BLOOD, V73, P375; KRYSTAL G, 1986, BLOOD, V67, P71; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI PH, 1986, J BIOL CHEM, V261, P3116; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; LUKOWSKY WA, 1972, CAN J BIOCHEM CELL B, V50, P909, DOI 10.1139/o72-127; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NIELSEN OJ, 1987, BLOOD, V70, P1904; Sambrook J, 1989, MOL CLONING LABORATO; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SASAKI R, 1987, EUR J BIOCHEM, V168, P43, DOI 10.1111/j.1432-1033.1987.tb13384.x; SASAKI R, 1987, METHOD ENZYMOL, V147, P328; SPIVAK JL, 1989, BLOOD, V73, P90; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; TSUDA E, 1990, ACTA HAEMATOL JAPON, V53, P1045; TSUDA E, 1988, BIOCHEMISTRY-US, V27, P5646, DOI 10.1021/bi00415a038; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WOJCHOWSKI DM, 1987, BIOCHIM BIOPHYS ACTA, V910, P224, DOI 10.1016/0167-4781(87)90114-X; YANAGAWA S, 1984, J BIOL CHEM, V259, P2707	33	117	145	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20434	20439						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657925				2022-12-25	WOS:A1991GM03900083
J	ZACCHETTI, D; CLEMENTI, E; FASOLATO, C; LORENZON, P; ZOTTINI, M; GROHOVAZ, F; FUMAGALLI, G; POZZAN, T; MELDOLESI, J				ZACCHETTI, D; CLEMENTI, E; FASOLATO, C; LORENZON, P; ZOTTINI, M; GROHOVAZ, F; FUMAGALLI, G; POZZAN, T; MELDOLESI, J			INTRACELLULAR CA2+ POOLS IN PC12 CELLS - A UNIQUE, RAPIDLY EXCHANGING POOL IS SENSITIVE TO BOTH INOSITOL 1,4,5-TRISPHOSPHATE AND CAFFEINE-RYANODINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; SARCOPLASMIC-RETICULUM; CALCIUM HOMEOSTASIS; SYMPATHETIC NEURONS; PHEOCHROMOCYTOMA CELLS; CHROMAFFIN CELLS; PLASMA-MEMBRANE; CYTOSOLIC CA-2+; TUMOR PROMOTER; 2ND MESSENGER	Release of Ca2+ from intracellular stores was studied in the parent PC12 cell line and in recently isolated clones sensitive or insensitive to caffeine. In the caffeine-sensitive cells the cytosolic free Ca2+ concentration ([Ca2+]i) responses by the xanthine drug and by stimulants of receptors coupled to inositol 1,4,5-trisphosphate (Ins-P3) generation (bradykinin, ATP) depend on separate pathways because 1) caffeine does not stimulate the hydrolysis of phosphatidylinositol 4,5-bisphosphate and 2) Ca2+-induced Ca2+ release, the process activated by caffeine, plays no major role in the Ins-P3-induced Ca2+ mobilization. Although distinct, these two mechanisms converge onto the same Ca2+ store. In fact 1) the [Ca2+]i responses by receptor agonists and caffeine were not additive; 2) either type of agent reduced (up to complete inhibition) the response to a subsequent administration of the same or the other agent; 3) all these responses were prevented by selective Ca2+ ATPase blockers; 4) ryanodine, which affects the intracellular Ca2+ channel sensitive to caffeine, also induced depletion of the receptor-sensitive Ca2+ pool; 5) in the 10 PC12 clones tested, sensitivity to caffeine paralleled ryanodine sensitivity. Therefore, PC12 cells, similar to some smooth muscle fibers but at variance with neurons and other secretory cells, express a single, rapidly exchanging Ca2+ store in which two distinct intracellular Ca2+ channels, i.e. the receptors for caffeine-ryanodine and Ins-P3, appear to be colocalized.	UNIV MILANO,SCI INST SAN RAFFAELE,CTR CYTOPHARMACOL,CNR,DEPT PHARMACOL,VIA OLGETTINA 60,I-20132 MILAN,ITALY; UNIV MILANO,SCI INST SAN RAFFAELE,CTR BRUNO CECCARELLI,I-20132 MILAN,ITALY; UNIV PADUA,CTR BIOMEMBRANE,CNR,INST GEN PATHOL,I-35100 PADUA,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); University of Padua			Zottini, Michela/Y-3763-2019; Zacchetti, Daniele/AAC-2724-2022; Fasolato, Cristina/AAE-6024-2019; Fumagalli, Guido F/Q-2469-2015; Grohovaz, Fabio/K-8226-2016	Zacchetti, Daniele/0000-0003-2724-7559; Fasolato, Cristina/0000-0002-9816-7751; Grohovaz, Fabio/0000-0003-4635-259X; LORENZON, Paola/0000-0002-9526-6471; zottini, michela/0000-0001-8930-2969				BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; CAMPBELL KP, 1986, SARCOPLASMIC RETICUL, P65; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHEEK TR, 1991, BIOCHEM J, V275, P697, DOI 10.1042/bj2750697; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; ELLISMAN MH, 1990, J CELL BIOL, V113, P1145; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; FASOLATO C, 1988, J BIOL CHEM, V263, P17350; FASOLATO C, 1990, J BIOL CHEM, V265, P20351; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FOSKETT JK, 1990, J CELL BIOL, V111, P466; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GROHOVAZ F, 1991, J CELL BIOL, V113, P1341, DOI 10.1083/jcb.113.6.1341; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HESS P, 1990, ANNU REV NEUROSCI, V13, P1337; IINO M, 1988, BIOCHEM BIOPH RES CO, V152, P417, DOI 10.1016/S0006-291X(88)80730-7; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KOMORI S, 1989, BRIT J PHARMACOL, V97, P973, DOI 10.1111/j.1476-5381.1989.tb12039.x; KUBA K, 1981, J THEOR BIOL, V93, P1009, DOI 10.1016/0022-5193(81)90352-0; LAW GJ, 1990, BIOCHEM J, V267, P359, DOI 10.1042/bj2670359; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MATSUMOTO T, 1990, J BIOL CHEM, V265, P5610; MAYER ML, 1990, TRENDS PHARMACOL SCI, V11, P254, DOI 10.1016/0165-6147(90)90254-6; MCPHERSON PS, 1990, J BIOL CHEM, V265, P18454; MELDOLESI J, 1987, EXP CELL RES, V171, P271, DOI 10.1016/0014-4827(87)90161-3; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MELDOLESI J, 1990, BIOCHIM BIOPHYS ACTA, V1055, P130, DOI 10.1016/0167-4889(90)90113-R; MICHEL AD, 1989, BRIT J PHARMACOL, V97, P914, DOI 10.1111/j.1476-5381.1989.tb12032.x; NEERING JR, 1984, NATURE, V309, P158; PIETROBON D, 1990, EUR J BIOCHEM, V193, P599, DOI 10.1111/j.1432-1033.1990.tb19378.x; POZZAN T, 1986, BIOCHEM J, V234, P547, DOI 10.1042/bj2340547; REGOLI D, 1990, TRENDS PHARMACOL SCI, V11, P156, DOI 10.1016/0165-6147(90)90067-I; ROBINSON IM, 1991, J NEUROCHEM, V56, P1587, DOI 10.1111/j.1471-4159.1991.tb02055.x; SCHWEITZER ES, 1985, J CELL BIOL, V101, P667, DOI 10.1083/jcb.101.2.667; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THAYER SA, 1988, J NEUROSCI, V8, P4089; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; VARNEY MA, 1990, BIOCHEM J, V269, P211, DOI 10.1042/bj2690211; WAKADE TD, 1990, J NEUROCHEM, V55, P1806, DOI 10.1111/j.1471-4159.1990.tb04972.x; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9	58	127	127	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20152	20158						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657914				2022-12-25	WOS:A1991GM03900044
J	BLACKMORE, RS; GREENWOOD, C; GIBSON, QH				BLACKMORE, RS; GREENWOOD, C; GIBSON, QH			STUDIES OF THE PRIMARY OXYGEN INTERMEDIATE IN THE REACTION OF FULLY REDUCED CYTOCHROME-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; ROOM-TEMPERATURE; C OXIDASE; FLOW-FLASH; COMPOUND-A; BINDING; OXIDATION; DIOXYGEN	The formation and disappearance of a photosensitive species during the reaction of reduced cytochrome c oxidase (putatively a3II.O2), EC 1.9.3.1, has been followed by (a) mixing a3II.CO with O2 in a stopped flow apparatus; (b) initiating the oxygen-oxidase reaction by removing CO with a laser flash; (c) probing the reaction mixture for photosensitivity with a second laser flash. Photosensitivity appears in the reaction mixture after the first laser flash, reaches a maximum after 50-60-mu-s ([02] > 100-mu-M), and disappears in a further 50-100-mu-s. The kinetics can be represented by the scheme [GRAPHICS] In species B, O2 is associated with the protein, possibly Cu(B), but not with the heme. Species C is the photosensitive a3II.O2 complex, and in D, a3 iron has been oxidized. The formation of species C is responsible for the rapid phase of absorbance change in the oxidase-oxygen reaction. The rate of reaction with oxygen approaches the limit of 35,000 s-1 at high oxygen. Nitric oxide, however, reacts with Fe(II) oxidase with a rate of 1 x 10(8) M-1 s-1, which is accurately maintained up to an observed rate of 10(5) s-1. In flash photolysis experiments, approximately half of the photodissociated nitric oxidase recombines in a biphasic geminate reaction with rates of 1 x 10(8) s-1 and 1 x 10(7) s-1.	CORNELL UNIV,DEPT BIOCHEM MOLEC & CELL BIOL,ITHACA,NY 14853; UNIV E ANGLIA,SCH BIOL SCI,NORWICH NR4 7TJ,NORFOLK,ENGLAND	Cornell University; University of East Anglia					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM014276] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 14276] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABCOCK GT, 1979, FEBS LETT, V97, P358, DOI 10.1016/0014-5793(79)80121-0; BABCOCK GT, 1985, J INORG BIOCHEM, V23, P243, DOI 10.1016/0162-0134(85)85031-5; BABCOCK GT, 1984, J AM CHEM SOC, V106, P8305, DOI 10.1021/ja00338a056; BELLELLI A, 1990, J BIOL CHEM, V265, P13595; CHANCE B, 1975, J BIOL CHEM, V250, P9226; DYER RB, 1989, J AM CHEM SOC, V111, P7657, DOI 10.1021/ja00201a080; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; GIBSON QH, 1964, BIOCHEM J, V91, P161, DOI 10.1042/bj0910161; GREENWOO.C, 1967, J BIOL CHEM, V242, P1782; HAN SH, 1990, BIOCHEMISTRY-US, V29, P1380, DOI 10.1021/bi00458a006; HILL BC, 1983, BIOCHEM J, V215, P659, DOI 10.1042/bj2150659; HILL BC, 1984, BIOCHEM J, V218, P913, DOI 10.1042/bj2180913; Keilin D, 1938, PROC R SOC SER B-BIO, V125, P171, DOI 10.1098/rspb.1938.0019; LUDWIG B, 1981, J BIOL CHEM, V256, P92; OGURA T, 1989, BIOCHEMISTRY-US, V28, P8022, DOI 10.1021/bi00446a008; ORII Y, 1984, J BIOL CHEM, V259, P7187; THOMSON AJ, 1981, BIOCHEM J, V193, P687, DOI 10.1042/bj1930687; WOODRUFF WH, 1991, P NATL ACAD SCI USA, V88, P2588, DOI 10.1073/pnas.88.6.2588; YONETANI T, 1960, J BIOL CHEM, V235, P845	19	141	141	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19245	19249						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655779				2022-12-25	WOS:A1991GK66700023
J	QUEST, AFG; SHAPIRO, BM				QUEST, AFG; SHAPIRO, BM			MEMBRANE ASSOCIATION OF FLAGELLAR CREATINE-KINASE IN THE SPERM PHOSPHOCREATINE SHUTTLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN SPERM; RAT-HEART MITOCHONDRIA; ENERGY-TRANSPORT; PLASMA-MEMBRANES; PHOSPHORYLCREATINE SHUTTLE; OXIDATIVE-PHOSPHORYLATION; POLYACRYLAMIDE GELS; KINETIC-PROPERTIES; GUANYLATE-CYCLASE; ADENOSINE-TRIPHOSPHATASE	The flagellar creatine kinase (TCK) of Strongylocentrotus purpuratus sperm is both a principal component of sperm tail membrane preparations and a cytosolic enzyme. An improved purification scheme identified three pools of TCK, termed TCK I, TCK II, and TCK III. TCK I and II were essentially homogeneous protein preparations, while TCK III was heavily contaminated with other flagellar proteins, predominantly guanylate cyclase, and alpha- and beta-tubulin. The three TCK species are roughly present in a 1:10:1 ratio as assessed by activity measurements. TCK I and II are similar proteins as shown by two-dimensional gel electrophoresis, partial proteolytic fragmentation, and cellulose polyacetate electrophoresis and have the same pH-dependent specific activity. However, they are functionally distinct with respect to their capacity to associate with lipids. TCK II associated readily with phospholipid liposomes and detergent micelles, while TCK I did not. Association of TCK II was as a protein monomer with an apparent K(d) of approximately 1-2 mm at a 10(4):1 lipid or detergent to protein ratio. Whereas the K(d) estimates were pH independent, the rate of association increased 2-3-fold between pH 6.5 and 8. The data are consistent with membrane-association of TCK II being a two-step process, involving a pH-dependent, intramolecular, TCK-specific step and a charge-facilitated, but pH-independent, membrane association step. Membrane association of TCK may, together with microtubule association (Tombes, R. M., Farr, A., and Shapiro, B. M. (1988) Exp. Cell Res. 178, 307-317) represent a mechanism required for specific accumulation of the enzyme within the flagellum.	UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle								BABBITT PC, 1986, J PROTEIN CHEM, V5, P1, DOI 10.1007/BF01025580; BACCETTI B, 1976, BIOL SPERM CELL, P65; BARBOUR RL, 1984, BIOCHEMISTRY-US, V23, P6053, DOI 10.1021/bi00320a024; BARBOUR RL, 1984, J BIOL CHEM, V259, P8246; BARRANTES FJ, 1985, J BIOL CHEM, V260, P3024; BARRANTES FJ, 1983, P NATL ACAD SCI-BIOL, V80, P5440, DOI 10.1073/pnas.80.17.5440; BESSMAN SP, 1980, BIOCHEM BIOPH RES CO, V96, P1414, DOI 10.1016/0006-291X(80)90108-4; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BIBRING T, 1984, DEV BIOL, V101, P425, DOI 10.1016/0012-1606(84)90157-X; BLUM HE, 1983, J BIOCHEM, V94, P1247, DOI 10.1093/oxfordjournals.jbchem.a134470; CADOUXHUDSON TA, 1989, FASEB J, V3, P2660, DOI 10.1096/fasebj.3.14.2629743; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DARSZON A, 1984, EUR J BIOCHEM, V144, P515, DOI 10.1111/j.1432-1033.1984.tb08496.x; DEGANI H, 1985, BIOCHEMISTRY-US, V24, P5510, DOI 10.1021/bi00341a035; ERICKSONVIITANEN S, 1982, ADV EXP MED BIOL, V151, P115; FOSTER DM, 1983, COMPARTMENTAL DISTRI, P73; FRIEDHOFF AJ, 1977, LIFE SCI, V20, P867, DOI 10.1016/0024-3205(77)90039-X; GARCIASOTO J, 1988, BIOCHIM BIOPHYS ACTA, V944, P1, DOI 10.1016/0005-2736(88)90310-0; GELLERICH F, 1982, BIOCHEM BIOPH RES CO, V105, P1473, DOI 10.1016/0006-291X(82)90954-8; GERSHON ND, 1985, P NATL ACAD SCI USA, V82, P5030, DOI 10.1073/pnas.82.15.5030; GIBBONS BH, 1972, J CELL BIOL, V54, P75, DOI 10.1083/jcb.54.1.75; GRACE AM, 1983, J BIOL CHEM, V258, P5346; HALL N, 1979, BIOCHEMISTRY-US, V18, P1745, DOI 10.1021/bi00576a017; Helenius A, 1979, Methods Enzymol, V56, P734; HERSHENSON S, 1986, J BIOL CHEM, V261, P3732; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; HOSSLE JP, 1988, BIOCHEM BIOPH RES CO, V151, P408, DOI 10.1016/0006-291X(88)90608-0; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; JACOBS H, 1964, BIOCHEM BIOPH RES CO, V16, P516, DOI 10.1016/0006-291X(64)90185-8; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; JACOBUS WE, 1985, ANNU REV PHYSIOL, V47, P707; JOENS OT, 1987, BIOL MEMBRANES PRACT, P139; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KAZAZOGLOU T, 1985, P NATL ACAD SCI USA, V82, P1460, DOI 10.1073/pnas.82.5.1460; KEUTEL HJ, 1972, ARCH BIOCHEM BIOPHYS, V150, P648, DOI 10.1016/0003-9861(72)90085-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE HC, 1983, DEV BIOL, V95, P31, DOI 10.1016/0012-1606(83)90004-0; LEE MYW, 1976, BIOCHIM BIOPHYS ACTA, V429, P123, DOI 10.1016/0005-2744(76)90035-8; LIM L, 1983, J NEUROCHEM, V41, P1177, DOI 10.1111/j.1471-4159.1983.tb09069.x; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; MCCLELLAN G, 1983, AM J PHYSIOL, V245, pC423, DOI 10.1152/ajpcell.1983.245.5.C423; MITA M, 1983, GAMETE RES, V7, P133, DOI 10.1002/mrd.1120070205; Mohri H., 1957, Journal of the Faculty of Science Tokyo University Zoology, V8, P51; MOREADITH RW, 1982, J BIOL CHEM, V257, P899; NUNNALLY RL, 1979, BIOCHEMISTRY-US, V18, P3642, DOI 10.1021/bi00583a032; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PERRYMAN MB, 1983, BIOCHIM BIOPHYS ACTA, V747, P284, DOI 10.1016/0167-4838(83)90107-3; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PODELL SB, 1984, BIOCHIM BIOPHYS ACTA, V778, P25, DOI 10.1016/0005-2736(84)90444-9; QUEST AFG, 1990, FEBS LETT, V262, P299, DOI 10.1016/0014-5793(90)80214-4; RADANY EW, 1983, J BIOL CHEM, V258, P8346; RAMARAO CS, 1988, J BIOL CHEM, V263, P1524; ROSSI AM, 1990, J BIOL CHEM, V265, P5258; SAKS VA, 1985, J BIOL CHEM, V260, P7757; SAKS VA, 1975, EUR J BIOCHEM, V57, P273, DOI 10.1111/j.1432-1033.1975.tb02299.x; SAKS VA, 1978, CAN J PHYSIOL PHARM, V56, P691, DOI 10.1139/y78-113; SAKS VA, 1980, J BIOL CHEM, V255, P755; SAKS VA, 1976, ARCH BIOCHEM BIOPHYS, V173, P34, DOI 10.1016/0003-9861(76)90231-9; SAVABI F, 1983, BIOCHEM BIOPH RES CO, V114, P785, DOI 10.1016/0006-291X(83)90850-1; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16963; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16954; SCHLEICHER M, 1983, ANAL BIOCHEM, V131, P312, DOI 10.1016/0003-2697(83)90175-6; SCHNYDER T, 1988, J BIOL CHEM, V263, P16954; SCHOLTE HR, 1973, BIOCHIM BIOPHYS ACTA, V291, P764, DOI 10.1016/0005-2736(73)90479-3; SHAROV VG, 1977, BIOCHIM BIOPHYS ACTA, V468, P495, DOI 10.1016/0005-2736(77)90299-1; SHIMOMURA H, 1986, J BIOL CHEM, V261, P5778; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SWARUP G, 1982, BIOL REPROD, V26, P953, DOI 10.1095/biolreprod26.5.953; TOMBES RM, 1987, BIOPHYS J, V52, P75, DOI 10.1016/S0006-3495(87)83190-9; TOMBES RM, 1987, J BIOL CHEM, V262, P16011; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; TOMBES RM, 1988, EXP CELL RES, V178, P307, DOI 10.1016/0014-4827(88)90401-6; TOOWICHARANONT P, 1988, J BIOL CHEM, V263, P6877; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VACQUIER VD, 1987, NEW HORIZONS SPERM C, P217; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; WALLIMANN T, 1985, J CELL BIOL, V100, P1063, DOI 10.1083/jcb.100.4.1063; WALLIMANN T, 1977, J CELL BIOL, V75, P297, DOI 10.1083/jcb.75.2.297; WALLIMANN T, 1984, J BIOL CHEM, V259, P5238; WALLIMANN T, 1986, J MUSCLE RES CELL M, V7, P25, DOI 10.1007/BF01756199; Wallimann T, 1985, Cell Muscle Motil, V6, P239; WALLIMANN T, 1986, P NATL ACAD SCI USA, V83, P3816, DOI 10.1073/pnas.83.11.3816; WALLIMANN T, 1989, MUSCLE ENERGETICS, P159; WANG FL, 1980, CLIN CHIM ACTA, V106, P339, DOI 10.1016/0009-8981(80)90320-4; WATTS DC, 1973, ENZYMES, V8, P383; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOTHE DD, 1990, P NATL ACAD SCI USA, V87, P5203, DOI 10.1073/pnas.87.13.5203; ZAHLER R, 1987, BIOPHYS J, V51, P883, DOI 10.1016/S0006-3495(87)83416-1; [No title captured]	92	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19803	19811						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1680867				2022-12-25	WOS:A1991GK66700097
J	SINE, SM; CLAUDIO, T				SINE, SM; CLAUDIO, T			GAMMA-SUBUNIT AND DELTA-SUBUNIT REGULATE THE AFFINITY AND THE COOPERATIVITY OF LIGAND-BINDING TO THE ACETYLCHOLINE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; FUNCTIONAL-PROPERTIES; CHOLINERGIC RECEPTOR; TORPEDO-CALIFORNICA; MEMBRANE-FRAGMENTS; MUSCLE-CELLS; AGONIST; SITES; LOCALIZATION; TRANSITIONS	The acetylcholine receptor (AChR) from vertebrate skeletal muscle is a pentamer composed of two ligand-binding alpha-subunits and one beta-, gamma-, and delta-subunit. To examine the functional roles of the non-alpha-subunits, we have expressed, in stable cell lines, AChRs lacking either a gamma- or a delta-subunit. Most previous work has examined how these changes in subunit composition affect single channel properties. Here, we take advantage of the stable expression system to produce large amounts of AChR and, for the first time, examine ligand binding to altered AChRs on intact cells. The changes in subunit composition affect both ligand affinity and cooperativity of the receptor, suggesting important roles for the gamma- and delta-subunits, both in shaping the ligand binding site and maintaining cooperative interactions between alpha-subunits.			SINE, SM (corresponding author), YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021714] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38156] Funding Source: Medline; NINDS NIH HHS [NS 21714] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1991, J MED CHEM, V34, P1798, DOI 10.1021/jm00110a007; ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; CHANGEUX JP, 1990, FIDA RES NEUROSCIENC, V4; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CLAUDIO T, 1977, ARCH BIOCHEM BIOPHYS, V181, P484, DOI 10.1016/0003-9861(77)90254-5; CLAUDIO T, 1986, TRENDS PHARMACOL SCI, V7, P308, DOI 10.1016/0165-6147(86)90367-6; CONTITRONCONI BM, 1982, SCIENCE, V218, P1227, DOI 10.1126/science.7146904; CONTITRONCONI BM, 1982, P NATL ACAD SCI-BIOL, V79, P6489, DOI 10.1073/pnas.79.21.6489; CULVER P, 1984, J BIOL CHEM, V259, P3763; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P3112, DOI 10.1021/bi00282a014; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KAO P, 1986, J BIOL CHEM, V259, P11662; KARLIN A, 1987, NATURE, V329, P286, DOI 10.1038/329286a0; KARLIN A, 1983, J BIOL CHEM, V258, P6678; KUBALEK E, 1987, J CELL BIOL, V105, P9, DOI 10.1083/jcb.105.1.9; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LO DC, 1990, NEURON, V5, P857, DOI 10.1016/0896-6273(90)90345-G; LUETJIE CW, 1990, NEUR ABSTR; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; PERUTZ MF, 1990, MECHANISMS COOPERATI; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SCHUBERT D, 1974, J CELL BIOL, V61, P398, DOI 10.1083/jcb.61.2.398; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1991, J BIOL CHEM, V266, P13679; SINE SM, 1988, J BIOL CHEM, V263, P18052; SINE SM, 1981, J BIOL CHEM, V256, P6692; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEINBACH JH, 1976, NEUROBIOLOGY FROG, P33; TZARTOS SJ, 1980, P NATL ACAD SCI-BIOL, V77, P755, DOI 10.1073/pnas.77.2.755; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WEBER M, 1974, MOL PHARMACOL, V10, P15; WEILAND G, 1977, J BIOL CHEM, V252, P7648; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; ZINGSHEIM HP, 1982, NATURE, V299, P81, DOI 10.1038/299081a0	44	168	169	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19369	19377						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1680865				2022-12-25	WOS:A1991GK66700041
J	ASHTONRICKARDT, PG; WYLLIE, AH; BIRD, CC; DUNLOP, MG; STEEL, CM; MORRIS, RG; PIRIS, J; ROMANOWSKI, P; WOOD, R; WHITE, R; NAKAMURA, Y				ASHTONRICKARDT, PG; WYLLIE, AH; BIRD, CC; DUNLOP, MG; STEEL, CM; MORRIS, RG; PIRIS, J; ROMANOWSKI, P; WOOD, R; WHITE, R; NAKAMURA, Y			MCC, A CANDIDATE FAMILIAL POLYPOSIS GENE IN 5Q.21, SHOWS FREQUENT ALLELE LOSS IN COLORECTAL AND LUNG-CANCER	ONCOGENE			English	Article							ADENOMATOUS POLYPOSIS; CHROMOSOME-5; CARCINOMAS; MUTATIONS; TUMORIGENESIS; DELETIONS; TUMORS; RFLP; COLI	MCC is a gene located within human chromosome band 5q.21 that shows somatically acquired mutations in colorectal cancer, and may be identical to the gene responsible for inheritance of familial adenomatous polyposis. Here we demonstrate that alleles contiguous with or within MCC are deleted in a high proportion of sporadic colorectal carcinomas. Of 106 carcinomas that were informative concurrently at close-flanking sites both centromeric and telomeric to MCC, 41.5% showed acquired allele loss contiguous with MCC. Evidence is presented to show that the true frequency of loss of MCC alleles is higher still. In contrast, allele losses in chromosome 5 that were incompatible with involvement of MCC were very rare (2% of a total series of 201 informative tumours). Interstitial deletion was the commonest mechanism of allele loss, and L5.71-3, a probe known to include coding sequences of MCC, marks the most consistently deleted site. Moreover mapping of chromosome break-points with six probes within 5q.21 sited the common critical deletion in a 2.5 Mb region which included L5.71-3. However use of L5.71-3 itself suggested that critical deleted regions may lie on either side of the probed sequence. The simplest explanation for this unexpected finding is that MCC itself is the essential deleted gene, the lost exons lying sometimes centromeric to, sometimes telomeric to and occasionally within the region detected by L5.71-3. Tumours in which MCC-related alleles were lost by interstitial deletion were in general larger than those with other mechanisms of acquired homozygosity (e.g. mitotic recombination), but there were no other obvious associations with clinicopathological features. Between 20% and 25% of lung cancers also showed acquired allele losses contiguous with MCC. The significance of this observation is still to be determined, as lung tumours show allele losses at many other sites, but the specificity of the probes used in this study does establish that the 5q.21 losses in these tumours are compatible with involvement of MCC.	UNIV EDINBURGH,SCH MED,DEPT PATHOL,CANC RES CAMPAIGN LABS,TEVIOT PL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; MED RES COUNCIL HUMAN GENET UNIT,EDINBURGH,SCOTLAND; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,TOKYO 170,JAPAN	University of Edinburgh; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Japanese Foundation for Cancer Research			Dunlop, Malcolm G/F-1973-2011	Dunlop, Malcolm G/0000-0002-3033-5851; Wood, Rachael/0000-0003-4453-623X				ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; CAREY FA, 1990, CANCER, V65, P2266, DOI 10.1002/1097-0142(19900515)65:10<2266::AID-CNCR2820651018>3.0.CO;2-R; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; DEVILEE P, 1991, ONCOGENE, V6, P1705; DOZIER C, 1986, NUCLEIC ACIDS RES, V14, P1928, DOI 10.1093/nar/14.4.1928; DUNLOP MG, 1990, AM J HUM GENET, V47, P982; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HAMILTON SR, 1990, HEREDITARY COLORECTA, P315; HOSHINO Y, 1991, BIOCHEM BIOPH RES CO, V174, P298, DOI 10.1016/0006-291X(91)90520-H; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; MIYAKI M, 1990, CANCER RES, V50, P7166; OKAMOTO M, 1990, HUM GENET, V85, P595; PURDIE CA, 1991, AM J PATHOL, V138, P807; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; TANAKA K, 1991, NATURE, V349, P340, DOI 10.1038/349340a0; TOPS CM, 1989, LANCET, V2, P12361; VARESCO L, 1989, P NATL ACAD SCI USA, V86, P10118, DOI 10.1073/pnas.86.24.10118; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; XIANG K, 1987, NUCLEIC ACIDS RES, V15, P7654, DOI 10.1093/nar/15.18.7654	26	75	75	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1991	6	10					1881	1886						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656365				2022-12-25	WOS:A1991GX11800022
J	RICKARD, JE; KREIS, TE				RICKARD, JE; KREIS, TE			BINDING OF PP170 TO MICROTUBULES IS REGULATED BY PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; GOLGI-APPARATUS; CYCLIC-AMP; ENDOGENOUS PHOSPHORYLATION; ORGANELLE TRANSPORT; CELLULAR-REGULATION; MAMMALIAN-CELLS; IDENTIFICATION; INVITRO; SUBUNIT	We have used a monoclonal antibody affinity column to purify from HeLa cells a protein of molecular weight 170,000 (designated pp170) which we previously identified as a nucleotide-sensitive microtubule-binding protein (Rickard, J. E., and Kreis, T. E. (1990) J. Cell Biol. 110, 1623-1633). We show here that the affinity-purified pp170 binds directly to taxol-polymerized tubulin. This association is not affected directly by MgATP. Addition of MgATP can, however, inhibit binding of pp170 to microtubules in the presence of microtubule-binding proteins from HeLa cells. This effect of MgATP correlates with phosphorylation of pp170 by a microtubule-associated kinase. Potato acid phosphatase dephosphorylates the pp170 and restores the ability of pp170 to bind to microtubules. Furthermore, binding of pp170 to microtubules in a high speed supernatant extract is inhibited by the phosphatase inhibitor okadaic acid, consistent with an inhibitory effect of pp170 phosphorylation on microtubule binding. In vivo, pp170 is phosphorylated on serine residues, with a half-life for the phosphate groups of approximately 2 h. Depolymerization of microtubules with nocodazole abolishes incorporation of P-32 into the protein, apparently by increasing the rate of its dephosphorylation. Stabilization of microtubules with taxol reduces the rate of P-32 incorporation into pp170 by approximately 50%, but has no significant effect on phosphate loss. These data establish that pp170 is a microtubule-binding protein, and that the microtubule interaction is inhibited by phosphorylation of pp170. The sensitivity of the in vivo phosphorylation state of pp170 to microtubule-active drugs suggests that this posttranslational modification may be an important regulator of the interaction of pp170 with microtubules in cells.			RICKARD, JE (corresponding author), EUROPEAN MOLEC BIOL LAB, MEYERHOFSTR 1, POSTFACH 102209, W-6900 HEIDELBERG, GERMANY.							ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BERSHADSKY AD, 1981, P NATL ACAD SCI-BIOL, V78, P3610, DOI 10.1073/pnas.78.6.3610; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNE CL, 1982, CELL BIOL INT REP, V6, P19, DOI 10.1016/0309-1651(82)90100-X; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DEBRABANDER M, 1981, COLD SPRING HARB SYM, V46, P227, DOI 10.1101/SQB.1982.046.01.026; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; DECAMILLI P, 1986, J CELL BIOL, V103, P189, DOI 10.1083/jcb.103.1.189; DEERY WJ, 1984, J CELL BIOL, V98, P904, DOI 10.1083/jcb.98.3.904; DIAZNIDO J, 1988, J CELL BIOL, V106, P2057, DOI 10.1083/jcb.106.6.2057; DUDEN R, 1990, PATHOL RES PRACT, V186, P535, DOI 10.1016/S0344-0338(11)80478-4; Dustin P., 1978, MICROTUBULES; EUTENEUER U, 1989, EUR J CELL BIOL, V50, P34; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HOSHI M, 1988, J BIOL CHEM, V263, P5396; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; KEITH C, 1983, J CELL BIOL, V97, P1918, DOI 10.1083/jcb.97.6.1918; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krebs EG, 1986, ENZYMES, V17, P3, DOI 10.1016/S1874-6047(08)60426-6; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; LAMB NJC, 1991, EMBO J, V10, P1523, DOI 10.1002/j.1460-2075.1991.tb07672.x; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; LYNCH TJ, 1986, J BIOL CHEM, V261, P4212; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MCINTOSH JR, 1989, J BIOL CHEM, V264, P6001; MILLER P, 1982, P NATL ACAD SCI-BIOL, V79, P5562, DOI 10.1073/pnas.79.18.5562; MITHIEUX G, 1989, J BIOL CHEM, V264, P4664; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; PALLAS D, 1982, CELL, V30, P407, DOI 10.1016/0092-8674(82)90238-0; PARHAM P, 1983, METHOD ENZYMOL, V92, P110; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PENNINGROTH SM, 1987, FEBS LETT, V222, P204, DOI 10.1016/0014-5793(87)80220-X; PICARD A, 1989, J CELL BIOL, V109, P3347, DOI 10.1083/jcb.109.6.3347; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PIRAS MM, 1974, EUR J BIOCHEM, V47, P443, DOI 10.1111/j.1432-1033.1974.tb03711.x; PORTER KR, 1974, CELL, V2, P145, DOI 10.1016/0092-8674(74)90089-0; RANGELALDAO R, 1979, J BIOL CHEM, V254, P2499; RICKARD JE, 1990, J CELL BIOL, V110, P1623, DOI 10.1083/jcb.110.5.1623; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schliwa M., 1984, Cell and Muscle Motility, V5, P1; SCHLIWA M, 1986, CYTOSKELETON; SCHROER TA, 1988, J CELL BIOL, V107, P1785, DOI 10.1083/jcb.107.5.1785; SCOTT CW, 1989, BIOCHEM J, V263, P207, DOI 10.1042/bj2630207; SERRANO L, 1987, J CELL BIOL, V105, P1731, DOI 10.1083/jcb.105.4.1731; SHETERLINE P, 1975, FEBS LETT, V56, P297, DOI 10.1016/0014-5793(75)81113-6; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; TASH JS, 1989, CELL MOTIL CYTOSKEL, V14, P332, DOI 10.1002/cm.970140303; THALER CD, 1990, J CELL BIOL, V111, P1939, DOI 10.1083/jcb.111.5.1939; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALLANO ML, 1985, P NATL ACAD SCI USA, V82, P3202, DOI 10.1073/pnas.82.10.3202; VALLEE RB, 1981, J CELL BIOL, V90, P568, DOI 10.1083/jcb.90.3.568; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; WICHE G, 1989, BIOCHEM J, V259, P1; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0; YUE VT, 1977, BIOCHEMISTRY-US, V16, P4678, DOI 10.1021/bi00640a023	72	98	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17597	17605						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1680130				2022-12-25	WOS:A1991GF44500092
J	RIBEIRO, P; PIGEON, D; KAUFMAN, S				RIBEIRO, P; PIGEON, D; KAUFMAN, S			THE HYDROXYLATION OF PHENYLALANINE AND TYROSINE BY TYROSINE-HYDROXYLASE FROM CULTURED PHEOCHROMOCYTOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PURIFICATION; BRAIN; ACTIVATION; SUBSTRATE; HOMOLOGY; AGENTS; LINE	Pheochromocytoma tyrosine hydroxylase was reported to have unusual catalytic properties, which might be unique to the tumor enzyme (Dix, T. A., Kuhn, D. M., and Benkovic, S. J. (1987) Biochemistry 24, 3354-3361). Two such properties, namely the apparent inability to hydroxylate phenylalanine and an unprecedented reactivity with hydrogen peroxide were investigated further in the present study. Tyrosine hydroxylase was purified to apparent homogeneity from cultured pheochromocytoma PC12 cells. The purified tumor enzyme was entirely dependent on tetrahydrobiopterin (BH4) for the hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine and hydrogen peroxide could not substitute for the natural cofactor. Indeed, in the presence of BH4, increasing concentrations of hydrogen peroxide completely inhibited enzyme activity. The PC12 hydroxylase exhibited typical kinetics of tyrosine hydroxylation, both as a function of tyrosine (s0.5 Tyr = 15-mu-M) and BH4 (apparent K(m) BH4 = 210-mu-M). In addition, the enzyme catalyzed the hydroxylation of substantial amounts of phenylalanine to tyrosine and 3,4-dihydroxyphenylalanine (apparent K(m) Phe = 100-mu-M). Phenylalanine did not inhibit the enzyme in the concentrations tested, whereas tyrosine showed typical substrate inhibition at concentrations greater-than-or-equal-to 50-mu-M. At higher substrate concentrations, the rate of phenylalanine hydroxylation was equal to or exceeded that of tyrosine. Essentially identical results were obtained with purified tyrosine hydroxylase from pheochromocytoma PC18 cells. The data suggest that the tumor enzyme has the same substrate specificity and sensitivity to hydrogen peroxide as tyrosine hydroxylase from other tissues.			RIBEIRO, P (corresponding author), NIMH,NEUROCHEM LAB,BETHESDA,MD 20892, USA.							BADAWY AAB, 1982, BIOCHEM J, V206, P165, DOI 10.1042/bj2060165; BAGCHI SP, 1970, LIFE SCI, V9, P111, DOI 10.1016/0024-3205(70)90023-8; BAGCHI SP, 1975, BIOCHEM PHARMACOL, V24, P1381, DOI 10.1016/0006-2952(75)90360-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAHL HHM, 1986, J BIOL CHEM, V261, P4148; DIX TA, 1987, BIOCHEMISTRY-US, V26, P3354, DOI 10.1021/bi00386a016; FUKAMI MH, 1990, BIOCHEM J, V268, P525, DOI 10.1042/bj2680525; IKEDA M, 1965, BIOCHEM BIOPH RES CO, V18, P482, DOI 10.1016/0006-291X(65)90778-3; IKEDA M, 1967, ARCH BIOCHEM BIOPHYS, V120, P420, DOI 10.1016/0003-9861(67)90259-7; KAPATOS G, 1977, J NEUROCHEM, V28, P1109, DOI 10.1111/j.1471-4159.1977.tb10675.x; KATZ I, 1976, BIOCHIM BIOPHYS ACTA, V445, P567, DOI 10.1016/0005-2744(76)90111-X; KAUFMAN S, 1985, FOLATES PTERINS, V2, P251; KAUFMAN S, 1974, CIBA F S, V22, P85; KAUFMAN S, 1987, ENZYMES B, V18, P217; KUHN DM, 1987, NEUROCHEM INT, V11, P463, DOI 10.1016/0197-0186(87)90036-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; MARKEY KA, 1980, MOL PHARMACOL, V17, P79; NAGATSU T, 1964, ANAL BIOCHEM, V9, P122, DOI 10.1016/0003-2697(64)90092-2; O'Neill R R, 1989, Appl Theor Electrophor, V1, P163; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; RICHTAND NM, 1985, J BIOL CHEM, V260, P8465; SHIMAN R, 1971, J BIOL CHEM, V246, P1330; TANK AW, 1986, MOL PHARMACOL, V30, P486	24	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16207	16211						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1678741				2022-12-25	WOS:A1991GB97700101
J	LEVESQUE, KS; MATTEI, MG; LEVY, LS				LEVESQUE, KS; MATTEI, MG; LEVY, LS			EVOLUTIONARY CONSERVATION AND CHROMOSOMAL LOCALIZATION OF FLVI-1	ONCOGENE			English	Article							PUTATIVE ONCOGENE SPI-1; TRANSCRIPTION FACTOR; ERYTHROLEUKEMIAS; INTEGRATION; VIRUS; PU.1	A locus in feline DNA, termed flvi-1, has been identified as harboring retroviral integrations commonly found in natural feline lymphomas induced by infection with feline leukemia virus (FeLV). Southern blot analysis of human and murine DNA using restriction fragments representing flvi-1 demonstrates its phylogenetic conservation among mammals. flvi-1 is localized to murine chromosome 2, proximal portion of band E, by in situ hybridization to metaphase chromosomes. This position is adjacent to that of another putative proto-oncogene, sfpi-1, although probes representing flvi-1 and sfpi-1 do not cross-hybridize. The repeated implication of flvi-1 in natural feline leukemogenesis, its evolutionary conservation and its chromosomal position support the hypothesis that flvi-1 may represent a previously unidentified proto-oncogene.	TULANE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,1430 TULANE AVE,NEW ORLEANS,LA 70112; HOP ENFANTS LA TIMONE,INSERM,U-242,F-13385 MARSEILLE,FRANCE	Tulane University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille					NATIONAL CANCER INSTITUTE [R01CA048801] Funding Source: NIH RePORTER; NCI NIH HHS [CA48801] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GOEBL MG, 1990, CELL, V61, P1165, DOI 10.1016/0092-8674(90)90676-6; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KUNG HJ, 1991, IN PRESS CURR TOP MI, V171; LEVESQUE KS, 1990, J VIROL, V64, P3455, DOI 10.1128/JVI.64.7.3455-3462.1990; Maniatis T., 1982, MOL CLONING; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; MOREAUGACHELIN F, 1990, ONCOGENE, V5, P941; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; Mullins J.I., 1990, RETROVIRUS BIOL HUMA, P87; PAUL R, 1991, J VIROL, V65, P464, DOI 10.1128/JVI.65.1.464-467.1991; PAUL R, 1989, J VIROL, V63, P4958, DOI 10.1128/JVI.63.11.4958-4961.1989; SPIRO C, 1988, J VIROL, V62, P4129, DOI 10.1128/JVI.62.11.4129-4135.1988	13	11	11	1	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1991	6	8					1377	1379						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX272	1679530				2022-12-25	WOS:A1991GX27200013
J	KENNEDY, BP; DIEHL, RE; BOIE, Y; ADAM, M; DIXON, RAF				KENNEDY, BP; DIEHL, RE; BOIE, Y; ADAM, M; DIXON, RAF			GENE CHARACTERIZATION AND PROMOTER ANALYSIS OF THE HUMAN 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID RECEPTOR; LEUKOTRIENE SYNTHESIS; DNA; SEQUENCES; BINDING; INDUCTION; CELLS; VIRUS	The human gene for the recently identified 5-lipoxygenase-activating protein (FLAP) has been cloned. The gene was isolated from two different genomic libraries and is contained within four overlapping bacteriophage clones. The gene spans > 31 kilobases and consists of five small exons and four large introns. Southern blot analysis of human genomic DNA suggests the presence of a single FLAP gene per haploid genome. A restriction site polymorphism was identified in intron II of the gene. This restriction fragment length polymorphism appears to be present in the normal population at a fairly high frequency. The transcription initiation site was located, at an adenine residue, 74 base pairs upstream of the ATG initiation codon. Examination of the sequence of the gene 5' to the mRNA start site revealed the presence of a possible TATA box (TGTAAT) 22 base pairs upstream and potential AP-2 and glucocorticoid receptor binding sites. Functional analysis of the FLAP gene promoter was assayed by transient transfection of mouse P388D1 cells (macrophage) and human HepG2 cells (hepatoma) with 5'-flanking sequences of the FLAP gene fused upstream of the chloramphenicol acetyltransferase reporter gene. Expression in the mouse macrophage cell line of the various FLAP gene promoter constructs revealed both tissue specificity and enhancer-like activities whereas in the hepatoma cell line only a minimum level of activity was obtained.	MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486	Merck & Company	KENNEDY, BP (corresponding author), MERCK FROST CANADA INC,MERCK FROST CTR THERAPEUT RES,DEPT MOLEC BIOL,POB 1005,POINTE CLAIRE H9R 4P8,QUEBEC,CANADA.							BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; CATHALA G, 1983, DNA NY, V3, P327; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; GILLARD JW, 1989, CAN J PHYSL PHARM, V67, P17; HABENICHT AJR, 1989, P NATL ACAD SCI USA, V86, P921, DOI 10.1073/pnas.86.3.921; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; REID GK, 1990, J BIOL CHEM, V265, P19818; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9	27	81	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8511	8516						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673682				2022-12-25	WOS:A1991FK44100083
J	CAO, HN; DECKER, S; STERN, DF				CAO, HN; DECKER, S; STERN, DF			TPA INHIBITS THE TYROSINE KINASE-ACTIVITY OF THE NEU PROTEIN INVIVO AND INVITRO	ONCOGENE			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR-RECEPTOR; EGF RECEPTOR; HUMAN-BREAST; INDEPENDENT MECHANISMS; ONCOGENE; PHOSPHORYLATION; GENE; AMPLIFICATION; C-ERBB-2	P185 is a receptor-like protein encoded by the neu/erbB-2 proto-oncogene. A point mutation in the transmembrane domain renders this protein oncogenic. We report here that incubation of cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulates the phosphorylation of the normal neu protein (p185) and the oncogenic neu protein (p185*). The increased phosphorylation occurs mainly on serine and threonine residues. Phosphate labeling experiments showed that TPA causes a reduction of basal phosphotyrosine in p185 but not p185*. Immunoblotting with antiphosphotyrosine antibody yielded similar results. TPA also inhibited tyrosine phosphorylation of p185* in an in vitro immune complex kinase assay. These data suggest that protein kinase C, the receptor for TPA, regulates p185 function through serine or threonine phosphorylation.	ROCKEFELLER UNIV,NEW YORK,NY 10021	Rockefeller University	CAO, HN (corresponding author), YALE UNIV,SCH MED,DEPT PATHOL,310 CEDAR ST,NEW HAVEN,CT 06510, USA.				NATIONAL CANCER INSTITUTE [R01CA037754, R01CA045708] Funding Source: NIH RePORTER; NCI NIH HHS [CA45708, CA37754] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BROWN KD, 1979, BIOCHEM BIOPH RES CO, V86, P1037, DOI 10.1016/0006-291X(79)90221-3; COCHET C, 1984, J BIOL CHEM, V259, P2553; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DOBASHI K, 1989, DNA-J MOLEC CELL BIO, V8, P723, DOI 10.1089/dna.1989.8.723; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FRIEDMAN BA, 1984, P NATL ACAD SCI-BIOL, V81, P3034, DOI 10.1073/pnas.81.10.3034; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; IWASHITA S, 1984, J BIOL CHEM, V259, P2559; KAMPS MP, 1988, ONCOGENE, V2, P305; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CS, 1986, J BIOL CHEM, V261, P10078; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LIVNEH E, 1988, MOL CELL BIOL, V103, P1355; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3400; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; WHITELEY B, 1986, J CELL BIOL, V103, P1355, DOI 10.1083/jcb.103.4.1355; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1989, P NATL ACAD SCI USA, V86, P3179, DOI 10.1073/pnas.86.9.3179	38	25	25	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					705	711						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	1675782				2022-12-25	WOS:A1991GT82500004
J	LIN, YZJ; CLINTON, GM				LIN, YZJ; CLINTON, GM			A SOLUBLE-PROTEIN RELATED TO THE HER-2 PROTOONCOGENE PRODUCT IS RELEASED FROM HUMAN BREAST-CARCINOMA CELLS	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE-ACTIVITY; FACTOR STIMULATE PHOSPHORYLATION; NEU ONCOGENE; EGF RECEPTOR; AMPLIFICATION; EXPRESSION; ADENOCARCINOMA; OVEREXPRESSION; MECHANISMS	Amplified expression of p185HER-2, the protein product of the HER-2/neu proto-oncogene, appears to be involved in carcinogenesis of human mammary epithelial cells. Our data suggest that an extracellular 130 Kda glycoprotein released from breast carcinoma cells may be related to the ectodomain of p185HER-2: (1) Both cellular p185HER-2 and extracellular p130, when reduced and alkylated, reacted with antipeptide antibody against the N-terminus of the HER-2 protein [alpha-N(HER-21)] and reactivity was blocked by cognate peptide; (2) Neither p130 nor other extracellular proteins reacted with antiserum against the C-terminus of p185HER-2 [alpha-C(HER-2)]; (3) Partial proteolysis of p185HER-2 generated an immunoreactive fragment of 130 kDa that was similar to extracellular p130; (4) Both p130 and p185HER-2 contained carbohydrate that bound to Con-A Sepharose; (50 The amount of p130 released from breast cells corresponded to the levels of expression of cellular p185HER-2. Release of the ectodomain of p185HER-2 from breast carcinoma cells may be involved in their malignant growth and may be a useful marker for assessing the expression of p185HER-2 in human tumors.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	Oregon Health & Science University					NATIONAL CANCER INSTITUTE [R01CA039641] Funding Source: NIH RePORTER; NCI NIH HHS [CA39641] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BERGER MS, 1988, CANCER RES, V48, P1238; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; DRYLAND A, 1986, J CHEM SOC PERK T 1, P125, DOI 10.1039/p19860000125; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YHJ, 1990, MOL CELL ENDOCRINOL, V69, P111, DOI 10.1016/0303-7207(90)90004-R; LOUGHNAN MS, 1988, P NATL ACAD SCI USA, V85, P3115, DOI 10.1073/pnas.85.9.3115; MCDONALD RG, 1989, J BIOL CHEM, V264, P3256; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; OSAWA T, 1987, ANNU REV BIOCHEM, V56, P21, DOI 10.1146/annurev.biochem.56.1.21; PETCH LA, 1990, MOL CELL BIOL, V10, P2973, DOI 10.1128/MCB.10.6.2973; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; ZHOU DJ, 1987, CANCER RES, V47, P6123	25	91	97	0	8	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					639	643						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	1674366				2022-12-25	WOS:A1991FR93900020
J	CHINKERS, M; SINGH, S; GARBERS, DL				CHINKERS, M; SINGH, S; GARBERS, DL			ADENINE-NUCLEOTIDES ARE REQUIRED FOR ACTIVATION OF RAT ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR GUANYLYL CYCLASE EXPRESSED IN A BACULOVIRUS SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP ACCUMULATION; SMOOTH-MUSCLE CELLS; CLEARANCE RECEPTOR; CROSS-LINKING; KINASE DOMAIN; BINDING; BRAIN; STIMULATION; PROTEINS; VECTORS	Atrial natriuretic peptide (ANP) binds to a transmembrane receptor having intrinsic guanylyl cyclase activity; this receptor has been designated GC-A. Binding of ANP to GC-A stimulates its catalytic activity, resulting in increased production of the second messenger, cyclic GMP. Here we show that GC-A can be expressed in insect cells using a recombinant baculovirus and that the expressed protein retained its abilities to bind ANP and to function as an ANP-activated guanylyl cyclase. In addition, GC-A produced in insect cells was absolutely dependent on the presence of adenine nucleotides for activation by ANP. Millimolar concentrations of ATP were required for optimal activation. The relative potencies of various nucleotides for activation was adenosine 5'-O-(thiotriphosphate) > ATP > ADP, adenosine 5'-(beta, gamma-imino)triphosphate > ADP-beta-S. AMP had no effect. These studies suggest that binding of an adenine nucleotide, most likely to the protein kinase-like domain of GC-A, is absolutely required for ANP activation. Regulation of guanylyl cyclase activation by adenine nucleotides represents a novel mechanism for the modulation of signal transduction, possibly analogous in some respects to the role of guanine nucleotides and G proteins in the regulation of adenylyl cyclase activity.	VANDERBILT UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT MOLEC PHYSIOL,NASHVILLE,TN 37232	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University					NIGMS NIH HHS [GM31362] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031362] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; CHANG CH, 1990, BIOCHIM BIOPHYS ACTA, V1052, P159, DOI 10.1016/0167-4889(90)90071-K; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULLER F, 1988, J BIOL CHEM, V263, P9395; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; KUROSE H, 1987, FEBS LETT, V219, P375, DOI 10.1016/0014-5793(87)80256-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; LEITMAN DC, 1986, J BIOL CHEM, V261, P1650; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; PORTER JG, 1988, J BIOL CHEM, V263, P18827; SCARBOROUGH RM, 1986, J BIOL CHEM, V261, P2960; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SONG DL, 1988, FEBS LETT, V232, P125, DOI 10.1016/0014-5793(88)80400-9; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Summers MD, 1987, TEXAS AGR EXPT STATI; THOM D, 1977, BIOCHEM J, V168, P187, DOI 10.1042/bj1680187; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346	30	140	142	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4088	4093						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1671858				2022-12-25	WOS:A1991FA69400013
J	HARAKUGE, S; AMANO, F; NISHIJIMA, M; AKAMATSU, Y				HARAKUGE, S; AMANO, F; NISHIJIMA, M; AKAMATSU, Y			ISOLATION OF A LIPOPOLYSACCHARIDE (LPS)-RESISTANT MUTANT, WITH DEFECTIVE LPS BINDING, OF CULTURED MACROPHAGE-LIKE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HARAKUGE, S (corresponding author), NATL INST HLTH,DEPT CHEM,SHINJUKU KU,TOKYO 141,JAPAN.							AMANO F, 1985, FEBS LETT, V82, P263; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROZEK KA, 1987, J BIOL CHEM, V262, P5170; Galanos C., 1979, BIOMEDICAL APPLICATI, P321; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; JOHNSTON RB, 1978, J EXP MED, V148, P115; LEI MG, 1988, J IMMUNOL, V141, P996; LEI MG, 1988, J IMMUNOL, V141, P1006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDERITZ O, 1982, CURR TOP MEMBR TRANS, V17, P79; MAINS PE, 1983, SOMAT CELL GENET, V9, P699, DOI 10.1007/BF01539475; Morrison D C, 1979, Adv Immunol, V28, P293; MORRISON DC, 1975, J BIOL CHEM, V250, P2911; NISHIJIMA M, 1985, P NATL ACAD SCI USA, V82, P282, DOI 10.1073/pnas.82.2.282; PROCTOR RA, 1984, HDB ENDOTOXIN, V1; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P600; TAKAYAMA K, 1983, J BIOL CHEM, V258, P4245; TAKAYAMA K, 1983, J BIOL CHEM, V258, P7379; ULEVITCH RJ, 1978, IMMUNOCHEMISTRY, V15, P157, DOI 10.1016/0161-5890(78)90144-X; WOLLENWEBER HW, 1985, J BIOL CHEM, V260, P5068	21	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6606	6610						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691173				2022-12-25	WOS:A1990CZ67700020
J	WILLIAMS, CA; ALLENHOFFMANN, BL				WILLIAMS, CA; ALLENHOFFMANN, BL			TRANSFORMING GROWTH FACTOR-BETA-1 STIMULATES FIBRONECTIN PRODUCTION IN BOVINE ADRENOCORTICAL-CELLS IN CULTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV WISCONSIN,DEPT PATHOL,5638 MED SCI CTR,MADISON,WI 53706; UNIV WISCONSIN,CTR ENVIRONM TOXICOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					PHS HHS [T32 E507015] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLENHOFFMANN BL, 1988, MOL CELL BIOL, V8, P4234, DOI 10.1128/MCB.8.10.4234; ASSOIAN RK, 1987, METHOD ENZYMOL, V146, P153; AVALLET O, 1987, BIOCHEM BIOPH RES CO, V146, P575, DOI 10.1016/0006-291X(87)90567-5; CARTER WG, 1984, J CELL BIOL, V99, P105, DOI 10.1083/jcb.99.1.105; CHILDS CB, 1982, P NATL ACAD SCI-BIOL, V79, P5312, DOI 10.1073/pnas.79.17.5312; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCHET C, 1988, J BIOL CHEM, V263, P5707; CRICKARD K, 1981, J CLIN ENDOCR METAB, V53, P790, DOI 10.1210/jcem-53-4-790; DIBARTOLOMEIS MJ, 1984, MOL PHARMACOL, V25, P476; DIBARTOLOMEIS MJ, 1984, J BIOL CHEM, V259, P159; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FAUSER BCJM, 1988, LIFE SCI, V43, P1363, DOI 10.1016/0024-3205(88)90302-5; FEIGE JJ, 1982, MOL CELL ENDOCRINOL, V28, P645, DOI 10.1016/0303-7207(82)90152-6; FEIGE JJ, 1986, BIOCHEM BIOPH RES CO, V139, P693, DOI 10.1016/S0006-291X(86)80046-8; FEIGE JJ, 1987, J BIOL CHEM, V262, P13491; GILL GN, 1977, P NATL ACAD SCI USA, V74, P5569, DOI 10.1073/pnas.74.12.5569; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; GOSPODAROWICZ D, 1977, ENDOCRINOLOGY, V100, P1080; GRIFFITHS K, 1970, ADV STEROID BIOCHEM, V2, P223; HORNSBY PJ, 1985, ENDOCR RES, V10, P259; HORNSBY PJ, 1983, IN VITRO CELL DEV B, V19, P863; HOTTA M, 1987, ENDOCRINOLOGY, V121, P150, DOI 10.1210/endo-121-1-150; HOTTA M, 1986, P NATL ACAD SCI USA, V83, P795; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; ILL CR, 1982, J CELL PHYSIOL, V113, P373, DOI 10.1002/jcp.1041130305; KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; LI CH, 1983, P NATL ACAD SCI-BIOL, V80, P2216, DOI 10.1073/pnas.80.8.2216; LIN T, 1987, BIOCHEM BIOPH RES CO, V146, P387, DOI 10.1016/0006-291X(87)90541-9; Maniatis T., 1982, MOL CLONING; MARGOSSIAN SS, 1981, J BIOL CHEM, V256, P7495; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MASSAGUE J, 1986, P NATL ACAD SCI USA, V79, P5312; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; OLDEN K, 1977, CELL, V11, P957, DOI 10.1016/0092-8674(77)90307-5; PEDERSEN RC, 1986, BIOCHEM ACTION HORM, V13, P129; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RAINEY WE, 1988, MOL CELL ENDOCRINOL, V60, P189, DOI 10.1016/0303-7207(88)90178-5; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROBERTS AB, 1988, ADV CANCER RES, V51, P107, DOI 10.1016/S0065-230X(08)60221-3; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; SIMONIAN MH, 1979, ENDOCRINOLOGY, V104, P588, DOI 10.1210/endo-104-3-588; SIMONIAN MH, 1982, ENDOCRINOLOGY, V111, P919, DOI 10.1210/endo-111-3-919; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; TURLEY EA, 1980, DIFFERENTIATION, V17, P93, DOI 10.1111/j.1432-0436.1980.tb01085.x; WRANA JL, 1986, EUR J BIOCHEM, V159, P69, DOI 10.1111/j.1432-1033.1986.tb09834.x	51	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6467	6472						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690727				2022-12-25	WOS:A1990CY58700087
J	JIANG, LW; MAHER, VM; MCCORMICK, JJ; SCHINDLER, M				JIANG, LW; MAHER, VM; MCCORMICK, JJ; SCHINDLER, M			ALKALINIZATION OF THE LYSOSOMES IS CORRELATED WITH RAS TRANSFORMATION OF MURINE AND HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824; MICHIGAN STATE UNIV,DEPT MICROBIOL & PUBL HLTH,CARCINOGENESIS LAB,E LANSING,MI 48824	Michigan State University; Michigan State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-30158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DAHMS NM, 1989, J BIOL CHEM, V264, P12115; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; JIANG LW, 1988, J CELL BIOL, V106, P13, DOI 10.1083/jcb.106.1.13; MARLIN MM, 1975, J LUMIN, V10, P381; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; RICHES DWH, 1980, BIOCHEM J, V188, P933, DOI 10.1042/bj1880933; SAVION N, 1980, P NATL ACAD SCI-BIOL, V77, P1466, DOI 10.1073/pnas.77.3.1466; SCHINDLER M, 1987, METHOD ENZYMOL, V141, P439; SHEPHERD VL, 1981, P NATL ACAD SCI-BIOL, V78, P1019, DOI 10.1073/pnas.78.2.1019; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; WILEY HS, 1985, J BIOL CHEM, V260, P5290; WILLCOX P, 1979, BIOCHIM BIOPHYS ACTA, V586, P442, DOI 10.1016/0304-4165(79)90034-5	15	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					4775	4777						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690732				2022-12-25	WOS:A1990CV58700002
J	CHOI, HS; BAILEY, SC; DONAHUE, KA; VANASSE, GJ; SYTKOWSKI, AJ				CHOI, HS; BAILEY, SC; DONAHUE, KA; VANASSE, GJ; SYTKOWSKI, AJ			PURIFICATION AND CHARACTERIZATION OF THE ERYTHROPOIETIN-SENSITIVE MEMBRANE PHOSPHOPROTEIN, PP43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,BOSTON,MA 02215	Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038841] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK38841] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHOI HS, 1987, J BIOL CHEM, V262, P2933; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; de Both N J, 1978, Nature, V272, P626, DOI 10.1038/272626a0; FARRELL PH, 1975, J BIOL CHEM, V250, P4007; Fleischer S, 1974, Methods Enzymol, V31, P6; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FRASER JK, 1988, BLOOD, V71, P104; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; IWAGAWA S, 1989, BLOOD, V73, P1452; LAWRENCE WD, 1987, J CLIN INVEST, V80, P586, DOI 10.1172/JCI113109; LEWIS JP, 1989, EXP HEMATOL, V17, P102; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MILLER BA, 1989, BLOOD, V73, P1188; MISITI J, 1979, J CLIN INVEST, V64, P1157; MUFSON RA, 1987, BLOOD, V69, P1485; SASAKI R, 1987, EUR J BIOCHEM, V168, P43, DOI 10.1111/j.1432-1033.1987.tb13384.x; SAWYER ST, 1984, J BIOL CHEM, V259, P2769; SAWYER ST, 1987, P NATL ACAD SCI USA, V84, P3690, DOI 10.1073/pnas.84.11.3690; SUE JM, 1983, P NATL ACAD SCI-BIOL, V80, P3651, DOI 10.1073/pnas.80.12.3651; SYTKOWSKI AJ, 1980, SCIENCE, V210, P74, DOI 10.1126/science.6932101; SYTKOWSKI AJ, 1980, BIOCHEM BIOPH RES CO, V96, P143, DOI 10.1016/0006-291X(80)91192-4; TODOKORO K, 1987, P NATL ACAD SCI USA, V84, P4126, DOI 10.1073/pnas.84.12.4126; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEBER K, 1971, J BIOL CHEM, V246, P4504	27	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					4143	4148						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689314				2022-12-25	WOS:A1990CQ48000086
J	ESPINO, PC; HARVEY, R; SCHWEICKHARDT, RL; WHITE, GA; SMITH, AE; CHENG, SH				ESPINO, PC; HARVEY, R; SCHWEICKHARDT, RL; WHITE, GA; SMITH, AE; CHENG, SH			THE AMINO-TERMINAL REGION OF PP60C-SRC HAS A MODULATORY ROLE AND CONTAINS MULTIPLE SITES OF TYROSINE PHOSPHORYLATION	ONCOGENE			English	Article									GENZYME CORP,CELLULAR REGULAT LAB,1 MT RD,FRAMINGHAM,MA 01701; GENZYME CORP,DNA CHEM LAB,FRAMINGHAM,MA 01701	Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation			Cheng, Seng H/AAC-6564-2022		NATIONAL CANCER INSTITUTE [R01CA043186] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 43186-03, N44 CP 85655] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BROWN DJ, 1984, J BIOL CHEM, V259, P9580; BRUGGE J, 1987, GENE DEV, V1, P287, DOI 10.1101/gad.1.3.287; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CHAKALAPARAMPIL I, 1988, CELL, V52, P801; CHENG SH, 1986, EMBO J, V5, P325, DOI 10.1002/j.1460-2075.1986.tb04216.x; CHENG SH, 1988, MOL CELL BIOL, V8, P1736, DOI 10.1128/MCB.8.4.1736; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLETT MS, 1984, MOL CELL BIOL, V4, P1213, DOI 10.1128/MCB.4.7.1213; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; COUSSENS PM, 1985, MOL CELL BIOL, V5, P2753, DOI 10.1128/MCB.5.10.2753; DECLUE JE, 1989, J VIROL, V63, P542, DOI 10.1128/JVI.63.2.542-554.1989; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; HARVEY R, 1989, MOL CELL BIOL, V9, P3647, DOI 10.1128/MCB.9.9.3647; HIROTA Y, 1988, MOL CELL BIOL, V8, P1826, DOI 10.1128/MCB.8.4.1826; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IBA H, 1984, P NATL ACAD SCI-BIOL, V81, P4424, DOI 10.1073/pnas.81.14.4424; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KATO JY, 1986, MOL CELL BIOL, V6, P4155, DOI 10.1128/MCB.6.12.4155; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; NEMETH SP, 1989, MOL CELL BIOL, V9, P1109, DOI 10.1128/MCB.9.3.1109; PARKER RC, 1984, CELL, V37, P131, DOI 10.1016/0092-8674(84)90308-8; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; Patchinsky T., 1986, J VIROL, V59, P73; PAWSON T, 1988, ONCOGENE, V3, P491; PIWNICAWORMS H, 1986, MOL CELL BIOL, V6, P2033, DOI 10.1128/MCB.6.6.2033; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Potts W M, 1988, Oncogene Res, V3, P343; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; RAYMOND VW, 1987, VIROLOGY, V160, P400, DOI 10.1016/0042-6822(87)90011-0; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RYDER JW, 1987, MOL CELL BIOL, V7, P1139, DOI 10.1128/MCB.7.3.1139; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SATO M, 1989, J VIROL, V63, P638; SHALLOWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P7071, DOI 10.1073/pnas.81.22.7071; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; VERDERAME MF, 1989, J VIROL, V63, P338, DOI 10.1128/JVI.63.1.338-348.1989; WANG HCR, 1989, J VIROL, V63, P291, DOI 10.1128/JVI.63.1.291-302.1989; YACIUK P, 1989, MOL CELL BIOL, V9, P2453, DOI 10.1128/MCB.9.6.2453; YONEMOTO W, 1985, P NATL ACAD SCI USA, V82, P4568, DOI 10.1073/pnas.82.14.4568	56	19	20	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					283	293						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	1690377				2022-12-25	WOS:A1990CW41500005
J	STORM, SM; CLEVELAND, JL; RAPP, UR				STORM, SM; CLEVELAND, JL; RAPP, UR			EXPRESSION OF RAF FAMILY PROTOONCOGENES IN NORMAL MOUSE-TISSUES	ONCOGENE			English	Article									NCI,VIRAL PATHOL SECT,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; CLAYCOMB WC, 1987, BIOCHEM J, V247, P701, DOI 10.1042/bj2470701; CLEVELAND JL, 1987, J IMMUNOL, V138, P3495; FREDRICKSON TN, 1988, AM J PATHOL, V131, P444; HEIDECKER G, 1989, GENES SIGNAL TRANSDU, P339; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; KESHET E, 1988, ONCOGENE, V2, P235; LEGUELLEC R, 1988, NUCLEIC ACIDS RES, V16, P10357; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; MARK GE, 1984, SCIENCE, V224, P285, DOI 10.1126/science.6324342; MARK GE, 1987, MOL CELL BIOL, V7, P2134, DOI 10.1128/MCB.7.6.2134; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORSE HC, 1986, P NATL ACAD SCI USA, V83, P6868, DOI 10.1073/pnas.83.18.6868; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788; PERRIMON N, 1984, GENETICS, V108, P559; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; PROPST F, 1988, ONCOGENE, V2, P227; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RAPP UR, 1988, HDB ONCOGENES, P213; REDDY EPA, 1988, ONCOGENE HDB; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Robaire B., 1988, P999; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; SUTRAVE P, 1984, NATURE, V309, P85, DOI 10.1038/309085a0; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x	34	197	202	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					345	351						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	1690378				2022-12-25	WOS:A1990CW41500012
J	HUDZIAK, RM; ULLRICH, A				HUDZIAK, RM; ULLRICH, A			CELL-TRANSFORMATION POTENTIAL OF A HER2 TRANSMEMBRANE DOMAIN DELETION MUTANT RETAINED IN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; TUMOR NECROSIS FACTOR; ERBB-RELATED GENE; C-ERBB-2 ONCOGENE; NEU ONCOGENE; EGF RECEPTOR; SIGNAL TRANSDUCTION; BREAST-CANCER; AMPLIFICATION; EXPRESSION	The HER2 (c-erbB-2) gene encodes a protein, p185HER2, which possesses all of the structural characteristics and functional properties of a growth factor receptor, although its ligand has not yet been well characterized. HER2 is the human homolog of the rat proto-oncogene neu and is closely related to the gene encoding the epidermal growth factor receptor. Amplification of this gene and overexpression have been found to be a prognostic criterion for a 30% subpopulation of human breast cancer patients. In this study, we investigated the role of the transmembrane-spanning sequence in the biosynthesis and localization of p185HER2. A truncation mutant lacking the cytoplasmic and transmembrane domains was glycosylated and efficiently secreted. However, a mutant lacking only the transmembrane-spanning sequence was incompletely glycosylated and failed to reach the cell surface. Unexpectedly, although this deletion mutant was retained in the endoplasmic reticulum membrane, it was still able to transform NIH 3T3 cells when expressed at high levels.	GENENTECH INC,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech	ULLRICH, A (corresponding author), MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY.							ALT FW, 1978, J BIOL CHEM, V253, P1357; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1988, P NATL ACAD SCI USA, V85, P5102, DOI 10.1073/pnas.85.14.5102; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; JOHNSON JD, 1988, P NATL ACAD SCI USA, V85, P7516, DOI 10.1073/pnas.85.20.7516; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LAX I, 1991, J BIOL CHEM, V266, P13828; LEE DC, 1990, HDB EXPT PHARM, P611; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; RETTENMIER CW, 1985, CELL, V40, P971, DOI 10.1016/0092-8674(85)90357-5; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; WALDMAN BC, 1987, J CELL PHYSIOL, V131, P302, DOI 10.1002/jcp.1041310303; WHITTAKER J, 1988, J BIOL CHEM, V263, P3063; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1988, BIOCHEMISTRY-US, V27, P3113, DOI 10.1021/bi00409a001; YOKOTA J, 1988, ONCOGENE, V2, P283; ZHOU DJ, 1987, CANCER RES, V47, P6123	36	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					24109	24115						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1684181				2022-12-25	WOS:A1991GV31900090
J	TULLOCH, AG; PATO, MD				TULLOCH, AG; PATO, MD			TURKEY GIZZARD SMOOTH-MUSCLE MYOSIN PHOSPHATASE-III IS A NOVEL PROTEIN PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; RABBIT SKELETAL-MUSCLE; CELLULAR-REGULATION; PURIFICATION; DEPHOSPHORYLATION; SPECIFICITY; BINDING; ENZYME; FORMS	Chromatography of turkey gizzard extract on Sephacryl S-300 has been shown to fractionate the various smooth muscle phosphatases. We have previously reported the purification and characterization of three of these enzymes, termed smooth muscle phosphatase (SMP)-I, -II, and -IV. Recently, we have purified SMP-III to near homogeneity. Although all of the smooth muscle phosphatases dephosphorylate the isolated myosin light chains, only SMP-III and -IV are active toward intact myosin and, therefore, are most likely to play a direct role in the muscle contraction-relaxation process. SMP-III has a higher molecular weight (390,000), as determined by gel filtration, than the other smooth muscle phosphatases and migrates as single band with a molecular weight of 40,000 in a sodium dodecyl sulfate-polyacrylamide gel. SMP-III is immunologically distinct from SMP-I and -II. It dephosphorylates heavy meromyosin and the isolated myosin light chains at a rapid rate but has low activity toward phosphorylase a. The activity of SMP-III is not affected by Ca2+ but is activated by Mn2+. Mg2+ stimulates the activity toward heavy meromyosin but inhibits the myosin light chain phosphatase activity. Attempts to classify SMP-III according to the scheme proposed by Ingebritsen and Cohen (Ingebritsen T. S., and Cohen, P. (1983) Science 221, 331-338) revealed that it is resistant to the heat stable inhibitor-2, suggesting that it is a Type 2 protein phosphatase. However, SMP-III is inhibited by concentrations of okadaic acid which are characteristic of Type 1 protein phosphatases and it binds to heparin-Sepharose like other Type 1 phosphatases. But most interestingly, SMP-III does not dephosphorylate the alpha- or beta-subunits of phosphorylase kinase, a property not reported for any Ser/Thr protein phosphatase.	UNIV SASKATCHEWAN,DEPT BIOCHEM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA	University of Saskatchewan								ADELSTEIN RS, 1987, J BIOL CHEM, V253, P5347; BIOLOJAN C, 1988, BIOCHEM J, V256, P286; CHISHOLM AAK, 1988, BIOCHIM BIOPHYS ACTA, V971, P163, DOI 10.1016/0167-4889(88)90188-7; CHISHOLM AAK, 1988, BIOCHIM BIOPHYS ACTA, V968, P392, DOI 10.1016/0167-4889(88)90032-8; COHEN P, 1990, BIOL MED SIGNAL TRAN, P230; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GANAPATHI MK, 1984, ARCH BIOCHEM BIOPHYS, V233, P19, DOI 10.1016/0003-9861(84)90597-6; GERGELY P, 1984, FEBS LETT, V169, P45, DOI 10.1016/0014-5793(84)80286-0; HOAR PE, 1985, J BIOL CHEM, V260, P8760; INGEBRITSEN TS, 1983, SCIENCE, V221, P331, DOI 10.1126/science.6306765; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; ONISHI H, 1982, J BIOCHEM, V91, P265, DOI 10.1093/oxfordjournals.jbchem.a133684; PATO MD, 1985, J BIOL CHEM, V260, P2359; PATO MD, 1986, J BIOL CHEM, V261, P3770; PATO MD, 1990, ARCH BIOCHEM BIOPHYS, V276, P116, DOI 10.1016/0003-9861(90)90017-S; PATO MD, 1983, EUR J BIOCHEM, V132, P283, DOI 10.1111/j.1432-1033.1983.tb07360.x; PATO MD, 1983, J BIOL CHEM, V258, P7047; PATO MD, 1983, J BIOL CHEM, V258, P7055; PATO MD, 1987, REGULATION CONTRACTI, P207; PATO MD, 1990, IN PRESS MOL CELL BI; SELLERS JR, 1984, J BIOL CHEM, V259, P7740; SELLERS JR, 1987, ENZYMES, V18, P382; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P3; SOBIESZEK A, 1984, SMOOTH MUSCLE CONTRA, P283; STULL JT, 1986, ENZYMES, V17, P113; WERTH DK, 1982, J BIOL CHEM, V257, P7306	28	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20168	20174						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657915				2022-12-25	WOS:A1991GM03900046
J	SWIERCZYNSKI, J; MITCHELL, DA; REINHOLD, DS; SALATI, LM; STAPLETON, SR; KLAUTKY, SA; STRUVE, AE; GOODRIDGE, AG				SWIERCZYNSKI, J; MITCHELL, DA; REINHOLD, DS; SALATI, LM; STAPLETON, SR; KLAUTKY, SA; STRUVE, AE; GOODRIDGE, AG			TRIIODOTHYRONINE-INDUCED ACCUMULATIONS OF MALIC ENZYME, FATTY-ACID SYNTHASE, ACETYL-COENZYME-A CARBOXYLASE, AND THEIR MESSENGER-RNAS ARE BLOCKED BY PROTEIN-KINASE INHIBITORS - TRANSCRIPTION IS THE AFFECTED STEP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO HEPATOCYTES; THYROID-HORMONE RECEPTOR; NEURAL CELL-CULTURES; LIVER-CELLS; NUTRITIONAL REGULATION; LIPOGENIC ENZYMES; COA CARBOXYLASE; HUMAN-PLATELETS; AVIAN LIVER; PRETRANSLATIONAL STEPS	Addition of triiodothyronine (T3) to chick-embryo hepatocytes in culture causes increased accumulations of malic enzyme, fatty acid synthase, acetyl-CoA carboxylase and their mRNAs. H-8 and other protein kinase inhibitors inhibited the T3-induced accumulations of these lipogenic enzymes and their mRNAs but had no effect on the activities of 6-phosphogluconate dehydrogenase and isocitrate dehydrogenase, enzymes not induced by T3 in chick-embryo hepatocytes. H-8 also had no effect on the activities of malic enzyme, fatty acid synthase, and acetyl-CoA carboxylase in hepatocytes not treated with T3. Synthesis of soluble protein, levels of mRNAs for beta-actin and glyceraldehyde-3-phosphate dehydrogenase, and induction of metallothionein mRNA by Zn2+ were unaffected by H-8 at concentrations that inhibited the T3-induced accumulation of lipogenic enzymes and their mRNAs. H-8 inhibited T3-induced transcription of the genes for both malic enzyme and fatty acid synthase but had little effect on transcription of the beta-actin or glyceraldehyde-3-phosphate dehydrogenase genes or on total RNA synthesis in isolated nuclei. H-8 also had no effect on binding of T3 to its nuclear receptor. In isolated nuclei, H-8 inhibited phosphorylation of total protein by 15-20%. Phosphorylation of only one major protein was consistently and substantially inhibited, indicating that the effect of H-8 was selective. These results suggest that on-going protein phosphorylation is required specifically for stimulation of transcription of the lipogenic genes by T3.	UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242	University of Iowa			Mitchell, David/A-1378-2012		NIADDK NIH HHS [AM21594] Funding Source: Medline; NIDDK NIH HHS [DK07018, DK25295] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM021594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295, T32DK007018] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACK DW, 1986, J BIOL CHEM, V261, P4190; BACK DW, 1986, J BIOL CHEM, V261, P2555; BERK AJ, 1989, BIOCHIM BIOPHYS ACTA, V1009, P103, DOI 10.1016/0167-4781(89)90087-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DAY RN, 1989, J BIOL CHEM, V264, P431; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; ELLIOTT LH, 1990, BIOCHEM BIOPH RES CO, V171, P148, DOI 10.1016/0006-291X(90)91369-4; ERNE P, 1987, BIOCHEM BIOPH RES CO, V145, P66, DOI 10.1016/0006-291X(87)91288-5; FAURE R, 1988, ENDOCRINOLOGY, V123, P1245, DOI 10.1210/endo-123-3-1245; FISCHER PWF, 1978, ARCH BIOCHEM BIOPHYS, V190, P332, DOI 10.1016/0003-9861(78)90283-7; FUGASSA E, 1977, BIOCHIM BIOPHYS ACTA, V485, P350, DOI 10.1016/0005-2744(77)90170-X; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GLINEUR C, 1989, ONCOGENE, V4, P1247; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GOLDMAN MJ, 1985, J BIOL CHEM, V260, P4404; GOODMAN HM, 1990, ENDOCRINOLOGY, V126, P441, DOI 10.1210/endo-126-1-441; GOODRIDG.AG, 1973, J BIOL CHEM, V248, P1924; GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946; GOODRIDGE AG, 1976, J BIOL CHEM, V251, P3027; GROVE JR, 1987, SCIENCE, V238, P530; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; HEPPLER JR, 1988, J BIOL CHEM, V263, P7610; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; INAGAKI M, 1984, J BIOL CHEM, V259, P4321; ITO M, 1986, BIOCHEMISTRY-US, V25, P4179, DOI 10.1021/bi00363a002; KIDO H, 1987, BIOCHEM BIOPH RES CO, V144, P152, DOI 10.1016/S0006-291X(87)80488-6; KING WG, 1989, J BIOL CHEM, V264, P6070; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHER I, 1989, BIOCHEM BIOPH RES CO, V158, P58, DOI 10.1016/S0006-291X(89)80176-7; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LI QL, 1990, J BIOCHEM-TOKYO, V107, P699, DOI 10.1093/oxfordjournals.jbchem.a123111; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA XJ, 1990, J BIOL CHEM, V265, P18435; Maniatis T., 1982, MOL CLONING; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V158, P105, DOI 10.1016/S0006-291X(89)80183-4; MCCORMICK CC, 1990, BIOCHEM J, V273, P185; MORRIS SM, 1982, J BIOL CHEM, V257, P3225; NAKANISHI S, 1988, J BIOL CHEM, V263, P6215; NIKODEM VM, 1983, HORM METAB RES, V15, P550, DOI 10.1055/s-2007-1018785; OFIR R, 1990, NATURE, V348, P80, DOI 10.1038/348080a0; PAPE ME, 1988, ARCH BIOCHEM BIOPHYS, V267, P104, DOI 10.1016/0003-9861(88)90013-6; RIEMANN EM, 1977, J BIOL CHEM, V246, P1986; RUEL J, 1986, MOL CELL ENDOCRINOL, V45, P223, DOI 10.1016/0303-7207(86)90151-6; RUEL J, 1986, MOL CELL ENDOCRINOL, V45, P233, DOI 10.1016/0303-7207(86)90152-8; SALATI LM, 1991, J BIOL CHEM, V266, P4010; SALATI LM, 1986, ARCH BIOCHEM BIOPHYS, V246, P82, DOI 10.1016/0003-9861(86)90451-0; SAMUELS HH, 1973, P NATL ACAD SCI USA, V70, P3488, DOI 10.1073/pnas.70.12.3488; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SIDDIQUI UA, 1981, J BIOL CHEM, V256, P4544; SILVA ES, 1977, J BIOL CHEM, V252, P6799; STAPLETON SR, 1990, J BIOL CHEM, V265, P18442; TAKAI T, 1988, J BIOL CHEM, V263, P2651; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; VANDERKLIS FRM, 1989, FEBS LETT, V246, P6, DOI 10.1016/0014-5793(89)80242-X; VONDERAHE D, 1990, NUCLEIC ACIDS RES, V18, P1991, DOI 10.1093/nar/18.8.1991; WIERSINGA WM, 1990, INT J BIOCHEM, V22, P269, DOI 10.1016/0020-711X(90)90339-5; WILSON SB, 1986, J BIOL CHEM, V261, P5179; WINBERRY LK, 1983, J BIOL CHEM, V258, P1337; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YAMADA K, 1987, BIOCHEM BIOPH RES CO, V144, P35, DOI 10.1016/S0006-291X(87)80471-0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YUAN ZY, 1988, P NATL ACAD SCI USA, V85, P6328, DOI 10.1073/pnas.85.17.6328	70	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17459	17466						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1680129				2022-12-25	WOS:A1991GF44500073
J	TAINSKY, MA; YIM, SO; KRIZMAN, DB; KANNAN, P; CHIAO, PJ; MUKHOPADHYAY, T; BUETTNER, R				TAINSKY, MA; YIM, SO; KRIZMAN, DB; KANNAN, P; CHIAO, PJ; MUKHOPADHYAY, T; BUETTNER, R			MODULATION OF DIFFERENTIATION IN PA-1 HUMAN TERATOCARCINOMA CELLS AFTER N-RAS ONCOGENE-INDUCED TUMORIGENICITY	ONCOGENE			English	Article							RETINOIC ACID RECEPTOR; EMBRYONAL CARCINOMA-CELLS; VITAMIN-A; MOLECULAR-CLONING; LINE; EXPRESSION; IDENTIFICATION; INDUCTION; PROTEIN; PATTERN	We have been studying the effect of oncogenes on differentiation using the human ovarian teratoma-derived cell line PA-1. From this study we have characterized variants representing four stages relevant to multistage carcinogenesis, two non-tumorigenic and two tumorigenic. The two non-tumorigenic cell variants differ in that one is resistant to transformation by ras oncogenes whereas the other can be transformed to tumorigenicity. When these non-tumorigenic PA-1 variants are treated with retinoic acid (RA), a morphogen, they stop dividing, begin to express homeobox genes, and change in morphology. Transfection of an activated N-ras oncogene into ras-resistant non-tumorigenic PA-1 cells does not alter the RA responsiveness of the cells, indicating that expression of the activated oncogene is not sufficient for blocking RA-induced differentiation. Spontaneous activation of an N-ras oncogene leading to tumorigenic transformants and gene transfer-induced N-ras transformants are resistant to these effects of RA. However, another spontaneous transformant of PA-1 cells that does not contain an activated N-ras is responsive to RA. We prepared somatic cell hybrids of the RA-non-responsive, N-ras-transformed and tumorigenic PA-1 cell and the RA-responsive, ras-resistant non-tumorigenic PA-1 cell; the hybrid cell lines continue to express the oncogene but are non-tumorigenic. These non-tumorigenic hybrids are responsive to RA with regard to morphological changes, growth arrest and induction of homeobox gene expression. Tumorigenic revertants of these hybrids arise as a result of the loss of some chromosomes; these hybrid cells express the oncogene but have lost RA responsiveness. These results indicate that tumorigenic transformation in general is not sufficient to induce RA resistance, and resistance to differentiation may be oncogene-specific. In addition, the expression of an activated N-ras oncogene alone is insufficient to induce resistance to RA and ras-induced tumorigenicity is necessary. Therefore, some feature of cellular metabolism that is altered by and discordantly segregates with tumorigenic transformation controls responsiveness to RA. This controlling element is presumably a tumor suppressor.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT THORAC SURG,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center	TAINSKY, MA (corresponding author), UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT TUMOR BIOL,BOX 79,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.			Tainsky, Michael/0000-0002-0261-831X	NCI NIH HHS [CA-09299, CA-42180] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042180, T32CA009299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BELL JC, 1986, MOL CELL BIOL, V6, P617, DOI 10.1128/MCB.6.2.617; BORASIO GD, 1989, NEURON, V2, P1087; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BUETTNER R, 1991, MOL CELL BIOL, V2, P3573; CHIAO PJ, 1991, ONCOGENE, V6, P713; CHIAO PJ, 1991, IN PRESS ONCOGENE, V6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DMITROVSKY E, 1990, ONCOGENE RES, V5, P233; EICHELE G, 1985, J CELL BIOL, V101, P1913, DOI 10.1083/jcb.101.5.1913; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRANKEL J, 1979, ADV COMP LEUKEMIA RE, P555; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GUMERLOCK PH, 1989, ANAL BIOCHEM, V180, P158, DOI 10.1016/0003-2697(89)90105-X; HARRIS H, 1990, J CELL SCI, V97, P65; HAUSSLER M, 1983, P NATL ACAD SCI-BIOL, V80, P5525, DOI 10.1073/pnas.80.18.5525; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; JETTEN AM, 1986, MOL CELL BIOL, V6, P3341, DOI 10.1128/MCB.6.10.3341; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; LAUTENBERGER JA, 1981, P NATL ACAD SCI-BIOL, V78, P1518, DOI 10.1073/pnas.78.3.1518; LEE J, 1985, J EMBRYOL EXP MORPH, V90, P139; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; LOTAN R, 1979, CANCER RES, V39, P1014; LUESCHER B, 1989, GENE DEV, V3, P1507; MILLER WH, 1990, ONCOGENE, V5, P511; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PEEHL DM, 1982, INT J CANCER, V30, P113, DOI 10.1002/ijc.2910300119; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; ROOP DR, 1987, DIFFERENTIATION, V35, P143, DOI 10.1111/j.1432-0436.1987.tb00162.x; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SEIFTER E, 1976, J NATL CANCER I, V57, P355, DOI 10.1093/jnci/57.2.355; SEIFTER E, 1973, LIFE SCI, V13, P945, DOI 10.1016/0024-3205(73)90084-2; SHERMAN MI, 1986, CURR TOP DEV BIOL, V20, P345, DOI 10.1016/S0070-2153(08)60674-2; SHUBEITA HE, 1987, P NATL ACAD SCI USA, V84, P5645, DOI 10.1073/pnas.84.16.5645; STANBRIDGE EJ, 1981, CANCER RES, V41, P573; TAINSKY MA, 1987, CANCER RES, V47, P3235; TAINSKY MA, 1984, SCIENCE, V225, P643, DOI 10.1126/science.6740333; TAINSKY MA, 1988, ANTICANCER RES, V8, P899; TAYLOR DD, 1990, DIFFERENTIATION, V43, P123, DOI 10.1111/j.1432-0436.1990.tb00438.x; TICKLE C, 1985, DEV BIOL, V109, P82, DOI 10.1016/0012-1606(85)90348-3; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; YOAKUM GH, 1984, BIOTECHNIQUES    JAN, P24; ZEUTHEN J, 1980, INT J CANCER, V25, P19, DOI 10.1002/ijc.2910250104	48	15	15	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1991	6	9					1575	1582						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX274	1681491				2022-12-25	WOS:A1991GX27400012
J	LEMOUAL, H; DEVAULT, A; ROQUES, BP; CRINE, P; BOILEAU, G				LEMOUAL, H; DEVAULT, A; ROQUES, BP; CRINE, P; BOILEAU, G			IDENTIFICATION OF GLUTAMIC-ACID 646 AS A ZINC-COORDINATING RESIDUE IN ENDOPEPTIDASE-24.11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENKEPHALIN-DEGRADING PEPTIDASE; SITE-DIRECTED MUTAGENESIS; ATRIAL NATRIURETIC FACTOR; KIDNEY BRUSH-BORDER; NEUTRAL ENDOPEPTIDASE; 24.11 ENKEPHALINASE; ACTIVE-SITE; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; LEUKEMIA ANTIGEN	Neutral endopeptidase (EC 3.4.24.11, NEP) is a membrane-bound zinc-metallopeptidase. The substrate specificity and catalytic activity of NEP resemble those of thermolysin, a bacterial zinc-metalloprotease. Comparison of the primary structure of both enzymes suggests that several amino acids present in the active site of thermolysin are also found in NEP. Using site-directed mutagenesis of the cDNA encoding the NEP sequence, we have already shown that His residues 583 and 587 are two of the three zinc ligands. In order to identify the third zinc ligand, we have substituted Val or Asp for Glu616 or Glu646. Val616 NEP showed the same kinetic parameters as the non-mutated NEP. In contrast, the mutant Val646 NEP was almost completely devoid of catalytic activity and unable to bind the tritiated inhibitor [H-3]N-[2(R,S)-3-hydroxyaminocarbonyl-2-benzyl-1-oxypropyl]glycine, the binding of which is dependent on the presence of the zinc ion. Replacing Glu for Asp at position 646 conserved the negative charge, and the mutant enzyme exhibited the same K(m) value as the non-mutated enzyme, but k(Cat) was decreased to less than 3% of the value of the non-mutated enzyme. When compared to the non-mutated enzyme Asp646 NEP showed a higher susceptibility to chelating agents, but bound the tritiated inhibitor with the same affinity. Taken together, these observations strongly suggest that Glu646 of NEP is the third zinc-coordinating residue and is equivalent to Glu166 in thermolysin.	UNIV MONTREAL,FAC MED,DEPT BIOQUIM,MONTREAL H3C 3J7,QUEBEC,CANADA; DEPT CHIM ORGAN,CNRS,UA 498,INSERM,U266,F-75006 PARIS,FRANCE	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)								ALMENOFF J, 1981, BIOCHEM BIOPH RES CO, V102, P206, DOI 10.1016/0006-291X(81)91508-4; AUBRY M, 1988, BIOCHIM BIOPHYS ACTA, V967, P56, DOI 10.1016/0304-4165(88)90188-2; AUBRY M, 1987, BIOCHEM CELL BIOL, V65, P398, DOI 10.1139/o87-050; AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, pCH3; BATEMAN RC, 1990, J BIOL CHEM, V265, P8365; BATEMAN RC, 1989, J BIOL CHEM, V264, P6151; BEAUMONT A, 1991, J BIOL CHEM, V266, P214; BENCHETRIT T, 1987, BIOCHEM BIOPH RES CO, V147, P1034, DOI 10.1016/S0006-291X(87)80174-2; BENCHETRIT T, 1988, BIOCHEMISTRY-US, V27, P592, DOI 10.1021/bi00402a014; COLMAN PM, 1972, J MOL BIOL, V70, P701, DOI 10.1016/0022-2836(72)90569-4; CRINE P, 1985, BIOCHEM BIOPH RES CO, V131, P255, DOI 10.1016/0006-291X(85)91796-6; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; FOURNIEZALUSKI MC, 1985, J MED CHEM, V28, P1158, DOI 10.1021/jm00147a007; GLUZMAN Y, 1981, CELL, V28, P51; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HERSH LB, 1986, J BIOL CHEM, V261, P6433; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; KOEHN JA, 1987, J BIOL CHEM, V262, P11623; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAY G, 1989, J BIOL CHEM, V264, P15620; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; Lipscomb W N, 1968, Brookhaven Symp Biol, V21, P24; MALFROY B, 1988, FEBS LETT, V229, P206, DOI 10.1016/0014-5793(88)80828-7; MALFROY B, 1987, BIOCHEM BIOPH RES CO, V144, P59, DOI 10.1016/S0006-291X(87)80475-8; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; MANIATIS T, 1982, MOL CLONING LABORATO, P55; MATSAS R, 1983, P NATL ACAD SCI-BIOL, V80, P3111, DOI 10.1073/pnas.80.10.3111; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; NOEL G, 1987, J BIOL CHEM, V262, P1876; RODERICK SL, 1989, BIOCHEMISTRY-US, V28, P1493, DOI 10.1021/bi00430a011; ROQUES BP, 1990, TRENDS PHARMACOL SCI, V11, P245; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1983, P NATL ACAD SCI-BIOL, V80, P3178, DOI 10.1073/pnas.80.11.3178; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; SOKOLOVSKY M, 1990, P NATL ACAD SCI USA, V87, P4702, DOI 10.1073/pnas.87.12.4702; SONNENBERG JL, 1988, PEPTIDES, V9, P173, DOI 10.1016/0196-9781(88)90024-1; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; VALLEE BL, 1989, FEBS LETT, V257, P138, DOI 10.1016/0014-5793(89)81805-8; VIJAYARAGHAVAN J, 1990, BIOCHEMISTRY-US, V29, P8052, DOI 10.1021/bi00487a009; VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150; WAGNER FW, 1988, METHOD ENZYMOL, V158, P21, DOI 10.1016/0076-6879(88)58045-X; WAKSMAN G, 1985, BIOCHEM BIOPH RES CO, V131, P262, DOI 10.1016/0006-291X(85)91797-8	50	65	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15670	15674						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1678740				2022-12-25	WOS:A1991GB97700024
J	BACHNOU, N; LAUDET, V; JAFFREDO, T; QUATANNENS, B; SAULE, S; DIETERLENLIEVRE, F				BACHNOU, N; LAUDET, V; JAFFREDO, T; QUATANNENS, B; SAULE, S; DIETERLENLIEVRE, F			COOPERATIVE EFFECT OF V-MYC AND V-ERBA IN THE CHICK-EMBRYO	ONCOGENE			English	Article							THYROID-HORMONE RECEPTOR; AVIAN ERYTHROBLASTOSIS VIRUS; TRANSGENIC MICE; NEURORETINA CELLS; ONCOGENES; INVITRO; PROTEIN; EXPRESSION; TRANSFORMATION; INVIVO	We show that a construct designated as MAHEVA, which encodes oncogenes v-myc from MH2 virus and v-erbA from AEV under the control of the LTR of MH2, induces rapidly growing heart rhabdomyosarcomas, when it is injected in E3 but not E5 chick embryos. A similar pathology has previously been observed with MC29, within the same limited time frame. The tumors, which expressed P61-63myc, P75gag-erbA and Pr76gag proteins were detectable from E14 onwards. Compared with MC29, MAHEVA induced a secondary anomaly, not detectable prior to E17. This is the appearance of cartilage nodules within the heart rhabdomyosarcomas. The constant location of these nodules inside the rhabdomyosarcomas and their delayed appearance suggests that the chondrocytes originate from myoblasts prevented from differentiating by the expression of the v-myc product. This interpretation is supported by the appearance of chondrocytes in E3 heart muscle cells infected in vitro with MAHEVA.	CNRS, INST EMBRYOL CELLULAIRE & MOLEC, 49 BIS AV BELLE GABRIELLE, F-94736 NOGENT SUR MARNE, FRANCE; COLL FRANCE, F-94736 NOGENT SUR MARNE, FRANCE; COLL FRANCE, F-94736 NOGENT SUR MARNE, FRANCE; INST PASTEUR, INSERM, U186, F-59019 LILLE, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	DIETERLENLIEVRE, F (corresponding author), CNRS, INST EMBRYOL CELLULAIRE & MOLEC, 49 BIS AV BELLE GABRIELLE, F-94736 NOGENT SUR MARNE, FRANCE.		JAFFREDO, Thierry/K-7870-2017	JAFFREDO, Thierry/0000-0002-8724-3261				ADAMSON ED, 1987, DEVELOPMENT, V99, P449; ALMOUSTAFA AE, 1988, CELL DIFFER DEV, V25, P119, DOI 10.1016/0922-3371(88)90005-6; AMOUYEL P, 1989, J VIROL, V63, P3382, DOI 10.1128/JVI.63.8.3382-3388.1989; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BECHADE C, 1985, NATURE, V316, P559, DOI 10.1038/316559a0; BETTEXGALLAND M, 1987, EXPERIENTIA, V43, P610, DOI 10.1007/BF02126349; BEUG H, 1985, MODERN TRENDS HUMAN, V4, P290; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DEHAAN RL, 1967, DEV BIOL, V16, P216, DOI 10.1016/0012-1606(67)90025-5; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; Gabe M., 1968, TECHNIQUES HISTOLOGI; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; ITOH Y, 1986, DEV BIOL, V115, P353, DOI 10.1016/0012-1606(86)90255-1; JAFFREDO T, 1989, DEVELOPMENT, V105, P679; JAFFREDO T, 1991, EXP CELL RES, V192, P481, DOI 10.1016/0014-4827(91)90067-5; KAWAMURA M, 1988, DEV BIOL, V130, P435, DOI 10.1016/0012-1606(88)90339-9; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; OHLSSON RI, 1987, EXP CELL RES, V173, P1, DOI 10.1016/0014-4827(87)90327-2; OKADA TS, 1983, CELL DIFFER DEV, V13, P177, DOI 10.1016/0045-6039(83)90087-8; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; RONG PM, 1987, DEV BIOL, V122, P338, DOI 10.1016/0012-1606(87)90299-5; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SAULE S, 1987, P NATL ACAD SCI USA, V84, P7982, DOI 10.1073/pnas.84.22.7982; SIMONS EV, 1971, ACTA MORPHOL NEER SC, V8, P281; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STIEFEL KARL, 1926, ANAT ANZEIGER, V61, P177; SUMIDA H, 1989, ANAT EMBRYOL, V180, P29, DOI 10.1007/BF00321897; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMADA K, 1970, HISTOCHEMISTRY, V23, P13, DOI 10.1007/BF00309485	42	10	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1991	6	6					1041	1047						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	1676836				2022-12-25	WOS:A1991GU62200021
J	MOY, JA; BATES, JN; FISHER, RA				MOY, JA; BATES, JN; FISHER, RA			EFFECTS OF NITRIC-OXIDE ON PLATELET-ACTIVATING FACTOR-STIMULATED AND ALPHA-ADRENERGIC-STIMULATED VASOCONSTRICTION AND GLYCOGENOLYSIS IN THE PERFUSED-RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLYCERYL ETHER PHOSPHORYLCHOLINE; HEPATIC GLYCOGENOLYSIS; ENDOTHELIAL-CELLS; RELAXING FACTOR; GLUCOSE OUTPUT; KUPFFER CELLS; METABOLISM; RELEASE; GLUCONEOGENESIS; HEPATOCYTES	Effects of nitric oxide (NO) on hemodynamic and glycogenolytic responses to platelet-activating factor (PAF) and phenylephrine were investigated in perfused livers derived from fed rats. Infusion of NO (34-mu-M) into perfused livers inhibited PAF (0.22 nM)-induced increases in hepatic glucose output and portal pressure approximately 90 and 85%, respectively, and abolished effects of PAF on hepatic oxygen consumption. NO attenuated PAF-stimulated increases in glucose output and portal pressure, the latter indicative of hepatic vasoconstriction, with a similar dose dependence with an IC50 of approximately 8-mu-M. In contrast to its effects on PAF-induced responses in the perfused liver, NO inhibited increases in hepatic portal pressure in response to phenylephrine (10-mu-M) approximately 75% without altering phenylephrine-stimulated glucose output and oxygen consumption. Similarly, infusion of NO into perfused livers significantly inhibited increases in hepatic portal pressure but not in glucose output in response to a submaximal concentration of phenylephrine (0.4-mu-M). Like NO, sodium nitroprusside (83-mu-M) significantly inhibited hemodynamic but not glycogenolytic responses to phenylephrine in perfused livers. However, PAF (0.22 nM)-stimulated alterations in hepatic portal pressure, glucose output, and oxygen consumption were unaffected by infusion of sodium nitroprusside (83-mu-M) into perfused livers. These results provide the first evidence for regulatory effects of NO in the perfused liver and support the contention that PAF, unlike phenylephrine, stimulates glycogenolysis by mechanism secondary to hepatic vasoconstriction. These observations raise the intriguing possibility that NO may act in liver to regulate hemodynamic responses to vasoactive mediators.	UNIV IOWA,COLL MED,DEPT PHARMACOL,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT ANESTHESIA,IOWA CITY,IA 52242	University of Iowa; University of Iowa				Fisher, Rory/0000-0003-3108-4836; Bates, James/0000-0002-6898-9527	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041071, R29HL041071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41071] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V3, P1196; BILLIAR TR, 1990, J SURG RES, V48, P349, DOI 10.1016/0022-4804(90)90073-B; BLACKMORE PF, 1986, J BIOL CHEM, V261, P1056; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUDAVARI S, 1989, MERCK INDEX ENCY CHE, P1041; BUXTON DB, 1984, J BIOL CHEM, V259, P1468; BUXTON DB, 1986, J BIOL CHEM, V261, P644; CHAO W, 1989, J BIOL CHEM, V264, P13591; CHAREST R, 1983, J BIOL CHEM, V258, P8769; CHAREST R, 1985, BIOCHEM J, V227, P79, DOI 10.1042/bj2270079; DUFFYKRYWICKI R, 1990, FASEB J, V4, pA1216; Exton J H, 1975, Adv Cyclic Nucleotide Res, V5, P519; EXTON JH, 1985, AM J PHYSIOL, V248, pE633, DOI 10.1152/ajpendo.1985.248.6.E633; EXTON JH, 1971, J BIOL CHEM, V246, P6166; FISHER RA, 1986, J BIOL CHEM, V261, P8817; FISHER RA, 1984, J BIOL CHEM, V259, P8685; FISHER RA, 1989, FEBS LETT, V251, P22, DOI 10.1016/0014-5793(89)81421-8; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GREENWAY CV, 1983, FED PROC, V42, P1678; HEMS DA, 1976, BIOCHEM J, V160, P367, DOI 10.1042/bj1600367; HEMS DA, 1980, PHYSIOL REV, V60, P1; HILL CE, 1987, BIOCHEM J, V247, P207, DOI 10.1042/bj2470207; HILL CE, 1988, BIOCHEM J, V253, P651, DOI 10.1042/bj2530651; HUTSON NJ, 1976, J BIOL CHEM, V251, P5200; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; LAPOINTE DS, 1989, HEPATOLOGY, V9, P278, DOI 10.1002/hep.1840090220; MCCUSKEY RS, 1966, AM J ANAT, V119, P455, DOI 10.1002/aja.1001190307; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; MYERS PR, 1989, AM J PHYSIOL, V256, pH1030, DOI 10.1152/ajpheart.1989.256.4.H1030; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RALL TW, 1957, J BIOL CHEM, V224, P463; REILLY FD, 1981, MICROVASC RES, V21, P103, DOI 10.1016/0026-2862(81)90008-X; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; SCHOLZ R, 1973, EUR J BIOCHEM, V38, P64, DOI 10.1111/j.1432-1033.1973.tb03034.x; SHERLINE P, 1972, ENDOCRINOLOGY, V91, P680, DOI 10.1210/endo-91-3-680; SHIKANO K, 1988, J PHARMACOL EXP THER, V247, P873; SHUKLA SD, 1983, J BIOL CHEM, V258, P212; TRACEY WR, 1990, J PHARMACOL EXP THER, V252, P922; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; WOOD KS, 1987, J BIOL CHEM, V262, P5020	42	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8092	8096						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673678				2022-12-25	WOS:A1991FK44100024
J	KITAZAWA, T; GAYLINN, BD; DENNEY, GH; SOMLYO, AP				KITAZAWA, T; GAYLINN, BD; DENNEY, GH; SOMLYO, AP			G-PROTEIN-MEDIATED CA2+ SENSITIZATION OF SMOOTH-MUSCLE CONTRACTION THROUGH MYOSIN LIGHT CHAIN PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG ILEUM; ALPHA-TOXIN; CALCIUM-CONCENTRATION; CA-2+ SENSITIVITY; FLASH-PHOTOLYSIS; OKADAIC ACID; ARTERY; KINASE; RELEASE; TENSION	The Ca2+ sensitivities of tonic (pulmonary and femoral artery) and phasic (portal vein and ileum) smooth muscles and the effects of guanosine 5'-O-(gamma-thiotriphosphate) (GTP-gamma-S) and norepinephrine on Ca2+ sensitivity of force development and myosin light chain (MLC20) phosphorylation were determined in permeabilized preparations that retained coupled receptors and endogenous calmodulin. The Ca2+ sensitivity of force was higher (approximately3-fold) in the tonic than in the phasic smooth muscles. The nucleotide specificity of Ca2+ sensitization was: GTP-gamma-S >> GTP > ITP >> CTP = UTP. Baseline phosphorylation (7% at pCa > 8) and maximal phosphorylation (58% at pCa 5.0) were both lower in portal vein than in femoral artery (20 and 97%). Norepinephrine and GTP-gamma-S increased phosphorylation at constant [Ca2+] (pCa 7.0-6.5). MLC20 phosphorylation induced by norepinephrine was completely inhibited by guanosine 5'-O-(beta-thiodiphosphate) (GDP-beta-S). In portal vein at pCa 5, GTP-gamma-S increased phosphorylation from 58%, the maximal Ca2+-activated value, to 75%, and at pCa > 8, from 7 to 13%. In femoral artery at pCa 5, neither phosphorylation (97%) nor force was affected by GTP-gamma-S, while at pCa > 8, GTP-gamma-S caused an increase in force (16% of maximum) with a borderline increase in MLC20 phosphorylation (from 20 to 27%). MLC20 phosphorylation (up to 100%) was positively correlated with force. The major results support the hypothesis that the G-protein coupled Ca2+-sensitizing effect of agonists on force development is secondary to increased MLC20 phosphorylation.			KITAZAWA, T (corresponding author), UNIV VIRGINIA,SCH MED,DEPT PHYSIOL,CHARLOTTESVILLE,VA 22908, USA.		Gaylinn, Bruce/AAD-4663-2020	Gaylinn, Bruce/0000-0003-1195-0864	NHLBI NIH HHS [HL15835, P01 HL19242-14] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL015835, P01HL019242] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKSOY MO, 1976, BIOCHEM BIOPH RES CO, V69, P35, DOI 10.1016/S0006-291X(76)80268-9; BADER MF, 1986, J BIOL CHEM, V261, P5777; BARANY K, 1985, J BIOL CHEM, V260, P7126; BECKER PL, 1989, SCIENCE, V244, P211, DOI 10.1126/science.2704996; BIALOJAN C, 1988, J PHYSIOL-LONDON, V398, P81, DOI 10.1113/jphysiol.1988.sp017030; BIALOJAN C, 1987, PFLUG ARCH EUR J PHY, V410, P304, DOI 10.1007/BF00580281; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; CSABINA S, 1986, BIOCHIM BIOPHYS ACTA, V871, P311, DOI 10.1016/0167-4838(86)90213-X; DRISKA SP, 1981, AM J PHYSIOL, V240, pC222, DOI 10.1152/ajpcell.1981.240.5.C222; Endo M, 1977, EXCITATION CONTRACTI, P199; FISCHER W, 1989, FEBS LETT, V258, P59, DOI 10.1016/0014-5793(89)81615-1; FUJIWARA T, 1989, J PHYSIOL-LONDON, V408, P535, DOI 10.1113/jphysiol.1989.sp017474; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GAYLINN BD, 1990, BIOPHYS J, V57, P165; GAYLINN BD, 1989, BIOPHYS J, V55, P78; HAEBERLE JR, 1985, J BIOL CHEM, V260, P9965; HAI CM, 1988, AM J PHYSIOL, V254, pC99, DOI 10.1152/ajpcell.1988.254.1.C99; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; HARTSHORNE DJ, 1989, ADV PROTEIN PHOSPHAT, V5, P219; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; HIMPENS B, 1988, J GEN PHYSIOL, V92, P713, DOI 10.1085/jgp.92.6.713; HIMPENS B, 1987, PFLUG ARCH EUR J PHY, V408, P32, DOI 10.1007/BF00581837; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; HORIUTI K, 1988, J PHYSIOL-LONDON, V398, P131, DOI 10.1113/jphysiol.1988.sp017034; HORIUTI K, 1989, J GEN PHYSIOL, V94, P769, DOI 10.1085/jgp.94.4.769; HOWELL TW, 1987, J CELL BIOL, V105, P191, DOI 10.1083/jcb.105.1.191; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1986, J BIOL CHEM, V261, P36; INAGAKI M, 1987, ARCH BIOCHEM BIOPHYS, V254, P136, DOI 10.1016/0003-9861(87)90089-0; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KENNEY RE, 1990, J BIOL CHEM, V65, P8642; KITAZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P1291, DOI 10.1016/0006-291X(90)91589-K; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; MOUGIOS V, 1986, BIOCHIM BIOPHYS ACTA, V872, P305, DOI 10.1016/0167-4838(86)90284-0; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8808; NISHIMURA J, 1988, BIOCHEM BIOPH RES CO, V157, P677, DOI 10.1016/S0006-291X(88)80303-6; PAUL RJ, 1989, ANNU REV PHYSIOL, V51, P331, DOI 10.1146/annurev.physiol.51.1.331; REMBOLD CM, 1988, CIRC RES, V63, P593, DOI 10.1161/01.RES.63.3.593; SATO K, 1988, J PHARMACOL EXP THER, V246, P294; SINGER HA, 1989, J BIOL CHEM, V264, P21215; SOMLYO A V, 1969, Microvascular Research, V1, P354, DOI 10.1016/0026-2862(69)90014-4; SOMLYO AP, 1989, FASEB J, V3, P2266, DOI 10.1096/fasebj.3.11.2506092; SOMLYO AP, 1990, ANNU REV PHYSIOL, V52, P857; SOMLYO AP, 1989, ADV PROTEIN PHOSPHAT, V5, P181; SOMLYO AV, 1981, NATURE, V294, P567, DOI 10.1038/294567a0; SOMLYO AV, 1968, J PHARMACOL EXP THER, V159, P129; SOMLYO AV, 1988, J GEN PHYSIOL, V91, P165, DOI 10.1085/jgp.91.2.165; SUTTON TA, 1990, J BIOL CHEM, V265, P2749; TAKAI A, 1989, BIOCHEM J, V262, P617, DOI 10.1042/bj2620617	51	309	312	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1708	1715						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671041				2022-12-25	WOS:A1991EU49700056
J	SORVILLO, JM; MCCORMACK, ES; YANEZ, L; VALENZUELA, D; REYNOLDS, FH				SORVILLO, JM; MCCORMACK, ES; YANEZ, L; VALENZUELA, D; REYNOLDS, FH			PREPARATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN TRANSFORMING GROWTH FACTOR-ALPHA	ONCOGENE			English	Article											SORVILLO, JM (corresponding author), ONCOGENE SCI INC,350 COMMUNITY DR,MANHASSET,NY 11030, USA.							ANZANO MA, 1983, P NATL ACAD SCI-BIOL, V80, P6264, DOI 10.1073/pnas.80.20.6264; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DEFEOJONES D, 1988, MOL CELL BIOL, V8, P2999, DOI 10.1128/MCB.8.8.2999; DEFIZE LHK, 1986, EMBO J, V5, P1187, DOI 10.1002/j.1460-2075.1986.tb04345.x; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DERYNCK R, 1987, CANCER RES, V47, P707; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GOTTLIEB AB, 1988, J EXP MED, V167, P670, DOI 10.1084/jem.167.2.670; IGNOTZ RA, 1986, P NATL ACAD SCI USA, V83, P6307, DOI 10.1073/pnas.83.17.6307; KIMBALL ES, 1984, CANCER RES, V44, P3616; KOBRIN MS, 1987, ENDOCRINOLOGY, V121, P1412, DOI 10.1210/endo-121-4-1412; KOBRIN MS, 1986, J BIOL CHEM, V261, P4414; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; KUDLOW JE, 1987, ENDOCRINOLOGY, V121, P1577, DOI 10.1210/endo-121-4-1577; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAR E, 1988, MOL CELL BIOL, V8, P1247, DOI 10.1128/MCB.8.3.1247; LEE DC, 1985, MOL CELL BIOL, V5, P3644, DOI 10.1128/MCB.5.12.3644; LINSLEY PS, 1985, P NATL ACAD SCI USA, V82, P356, DOI 10.1073/pnas.82.2.356; LUETTEKE NC, 1988, BIOCHEMISTRY-US, V27, P6487, DOI 10.1021/bi00417a043; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MARQUARDT H, 1982, J BIOL CHEM, V257, P5220; MARQUARDT H, 1984, SCIENCE, V223, P1079, DOI 10.1126/science.6320373; NESTOR JJ, 1985, BIOCHEM BIOPH RES CO, V129, P226, DOI 10.1016/0006-291X(85)91426-3; REYNOLDS FH, 1981, NATURE, V292, P259, DOI 10.1038/292259a0; TAM JP, 1986, P NATL ACAD SCI USA, V83, P8082, DOI 10.1073/pnas.83.21.8082; TEIXIDO J, 1988, J BIOL CHEM, V263, P3924; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANHEYNINGEN V, 1983, J IMMUNOL METHODS, V62, P147, DOI 10.1016/0022-1759(83)90000-5; WILCOX JN, 1988, J NEUROSCI, V8, P1901; WINKLER ME, 1986, J BIOL CHEM, V261, P3838; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	36	88	91	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					377	386						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	1690379				2022-12-25	WOS:A1990CW41500016
J	LUND, J; AHLGREN, R; WU, DH; KAGIMOTO, M; SIMPSON, ER; WATERMAN, MR				LUND, J; AHLGREN, R; WU, DH; KAGIMOTO, M; SIMPSON, ER; WATERMAN, MR			TRANSCRIPTIONAL REGULATION OF THE BOVINE CYP17 (P-45017-ALPHA) GENE - IDENTIFICATION OF 2 CAMP REGULATORY REGIONS LACKING THE CONSENSUS CAMP-RESPONSIVE ELEMENT (CRE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT OBSTET & GYNECOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,CECIL H & IDA GREEN CTR REPROD BIOL SCI,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028350] Funding Source: NIH RePORTER; NICHD NIH HHS [HD13234] Funding Source: Medline; NIDDK NIH HHS [DK28350] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BHASKER CR, 1989, ARCH BIOCHEM BIOPHYS, V271, P479, DOI 10.1016/0003-9861(89)90298-1; CHAPLIN DD, 1986, P NATL ACAD SCI USA, V83, P9601, DOI 10.1073/pnas.83.24.9601; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P475; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOSPODAROWICZ D, 1977, ENDOCRINOLOGY, V100, P1080; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HANDLER JD, 1988, J BIOL CHEM, V263, P13068; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JOHN ME, 1985, J BIOL CHEM, V260, P5760; JOHN ME, 1986, BIOCHEMISTRY-US, V25, P2846, DOI 10.1021/bi00358a016; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; JOHN ME, 1984, P NATL ACAD SCI-BIOL, V81, P5628, DOI 10.1073/pnas.81.18.5628; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LUND J, 1988, J BIOL CHEM, V263, P16195; Maniatis T., 1982, MOL CLONING; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MOUW AR, 1989, J BIOL CHEM, V264, P1305; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; OKAMURA T, 1987, J BIOL CHEM, V262, P10335; PARKER KL, 1986, J BIOL CHEM, V261, P5353; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WATERMAN MR, 1989, TRENDS ENDOCRIN MET, V1, P99, DOI 10.1016/1043-2760(89)90011-8; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; YASMURA Y, 1966, CANCER RES, V26, P529; ZUBER MX, 1985, ANN NY ACAD SCI, V458, P252, DOI 10.1111/j.1749-6632.1985.tb14610.x; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	39	141	141	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3304	3312						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689300				2022-12-25	WOS:A1990CP23600049
J	ZHANG, GH; YAMAGUCHI, M; KIMURA, S; HIGHAM, S; KRAUSFRIEDMANN, N				ZHANG, GH; YAMAGUCHI, M; KIMURA, S; HIGHAM, S; KRAUSFRIEDMANN, N			EFFECTS OF HEAVY-METAL ON RAT-LIVER MICROSOMAL CA-2+-ATPASE AND CA-2+ SEQUESTERING - RELATION TO SH-GROUPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SCH MED,DEPT PHYSIOL & CELL BIOL,HOUSTON,TX 77030	University of Texas System					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036916] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 36916] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMSON JJ, 1983, P NATL ACAD SCI-BIOL, V80, P1526, DOI 10.1073/pnas.80.6.1526; ABRAMSON JJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P245, DOI 10.1016/0003-9861(88)90633-9; AHAMMADSAHIB KI, 1989, CELL BIOCHEM FUNCT, V7, P185, DOI 10.1002/cbf.290070306; ARION WJ, 1976, J BIOL CHEM, V251, P4901; BELLOMO G, 1984, FEBS LETT, V168, P38, DOI 10.1016/0014-5793(84)80202-1; BELLOMO G, 1982, P NATL ACAD SCI-BIOL, V79, P6842, DOI 10.1073/pnas.79.22.6842; BINDOLI A, 1983, ARCH BIOCHEM BIOPHYS, V221, P458, DOI 10.1016/0003-9861(83)90164-9; BOND M, 1987, J BIOL CHEM, V262, P15630; BURGESS GM, 1983, J BIOL CHEM, V258, P5336; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHIESI M, 1984, BIOCHEMISTRY-US, V23, P3899, DOI 10.1021/bi00312a017; CHRISTIE NT, 1984, BIOL TRACE ELEM RES, V6, P139, DOI 10.1007/BF02916931; CODINA J, 1988, BIOCHEM BIOPH RES CO, V150, P848, DOI 10.1016/0006-291X(88)90469-X; FARISS MW, 1984, BIOCHEM BIOPH RES CO, V121, P102, DOI 10.1016/0006-291X(84)90693-4; FLESCHNER CR, 1985, BIOCHEM J, V226, P839, DOI 10.1042/bj2260839; FLESCHNER CR, 1987, ARCH BIOCHEM BIOPHYS, V254, P448, DOI 10.1016/0003-9861(87)90123-8; FLESCHNER CR, 1986, EUR J BIOCHEM, V154, P313, DOI 10.1111/j.1432-1033.1986.tb09399.x; GOULD GW, 1987, J BIOL CHEM, V262, P7676; GRAF P, 1984, BIOCHEM PHARMACOL, V33, P639, DOI 10.1016/0006-2952(84)90320-4; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HEILMANN C, 1984, J BIOL CHEM, V259, P1139; HOLME JA, 1984, BIOCHEM PHARMACOL, V33, P401, DOI 10.1016/0006-2952(84)90232-6; Kraus-Friedmann N, 1988, Adv Exp Med Biol, V232, P59; KRAUSFRIEDMANN N, 1984, PHYSIOL REV, V64, P170, DOI 10.1152/physrev.1984.64.1.170; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; MARTONOSI A, 1964, J BIOL CHEM, V239, P659; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MOORE L, 1975, J BIOL CHEM, V250, P4562; PALADE P, 1987, J BIOL CHEM, V262, P6142; PERRINO BA, 1989, TOXICOL IN VITRO, V3, P227, DOI 10.1016/0887-2333(89)90010-6; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; SALAMA G, 1984, J BIOL CHEM, V259, P3363; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THORLEYLAWSON DA, 1977, BIOCHEM J, V167, P739, DOI 10.1042/bj1670739; TRIMM JL, 1986, J BIOL CHEM, V261, P6092; VANSTAPEL F, 1986, EUR J BIOCHEM, V156, P73, DOI 10.1111/j.1432-1033.1986.tb09550.x; VERBOST PM, 1989, J BIOL CHEM, V264, P5613; YAMADA S, 1978, J BIOL CHEM, V253, P6801; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	40	84	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2184	2189						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688849				2022-12-25	WOS:A1990CL02800060
J	SHEMER, R; WALSH, A; EISENBERG, S; BRESLOW, JL; RAZIN, A				SHEMER, R; WALSH, A; EISENBERG, S; BRESLOW, JL; RAZIN, A			TISSUE-SPECIFIC METHYLATION PATTERNS AND EXPRESSION OF THE HUMAN APOLIPOPROTEIN AI GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT CELLULAR BIOCHEM,IL-91010 JERUSALEM,ISRAEL; ROCKEFELLER UNIV,DEPT BIOCHEM GENET & METAB,NEW YORK,NY 10021; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT INTERNAL MED B,IL-91010 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Rockefeller University; Hebrew University of Jerusalem			Breslow, Jan L/B-7544-2008					BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; EISENBERG S, 1984, J LIPID RES, V25, P1017; FIELD FJ, 1987, J LIPID RES, V28, P1057; GREENGARD O, 1972, J CELL BIOL, V52, P261, DOI 10.1083/jcb.52.2.261; HEGELE RA, 1987, GENET EPIDEMIOL, V4, P163, DOI 10.1002/gepi.1370040302; HOPKINS B, 1986, J EMBRYOL EXP MORPH, V97, P177; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; KOLSTO AB, 1986, NUCLEIC ACIDS RES, V14, P9667; LEVYWILSON B, 1989, J BIOL CHEM, V264, P9891; LOYD J, 1987, GENE DEV, V1, P594; Maniatis T., 1982, MOL CLONING; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RUIZOPAZO N, 1988, J BIOL CHEM, V263, P1739; SASTRY KN, 1988, MOL CELL BIOL, V8, P605, DOI 10.1128/MCB.8.2.605; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WALSH A, 1989, J BIOL CHEM, V264, P6488; YISRAELI J, 1984, DNA METHYLATION BIOC, P353; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	21	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1010	1015						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688547				2022-12-25	WOS:A1990CH53300060
J	GRINSTEIN, S; FURUYA, W; LU, DJ; MILLS, GB				GRINSTEIN, S; FURUYA, W; LU, DJ; MILLS, GB			VANADATE STIMULATES OXYGEN-CONSUMPTION AND TYROSINE PHOSPHORYLATION IN ELECTROPERMEABILIZED HUMAN-NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TORONTO GEN HOSP,TORONTO M5G 2C4,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	GRINSTEIN, S (corresponding author), HOSP SICK CHILDREN,DIV CELL BIOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ANDREWS PC, 1983, BLOOD, V61, P333; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; CHASTEEN ND, 1983, STRUCT BONDING BERLI, V53, P107; CLARK RA, 1987, J BIOL CHEM, V262, P4065; COHEN HJ, 1978, J CLIN INVEST, V61, P1088, DOI 10.1172/JCI109008; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COYNE MD, 1987, J CYCLIC NUCLEOTIDE, V11, P433; CURNUTTE JT, 1975, BLOOD, V45, P851; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; CZECH MP, 1988, J BIOL CHEM, V263, P11017; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P464; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; GRINSTEIN S, 1989, BIOCHEM J, V261, P755, DOI 10.1042/bj2610755; HEFFETZ D, 1989, J BIOL CHEM, V264, P10126; HUANG CK, 1988, BIOCHEM BIOPH RES CO, V151, P794, DOI 10.1016/S0006-291X(88)80351-6; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOSEPHSON L, 1977, BIOCHEMISTRY-US, V16, P4572, DOI 10.1021/bi00640a006; KRAFT AS, 1987, BLOOD, V70, P356; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGETI E, 1988, BIOCHEMISTRY-US, V27, P193, DOI 10.1021/bi00401a029; LIOCHEV S, 1988, ARCH BIOCHEM BIOPHYS, V263, P299, DOI 10.1016/0003-9861(88)90639-X; LISON D, 1988, TOXICOL LETT, V40, P29, DOI 10.1016/0378-4274(88)90180-4; NASMITH PE, 1989, BIOCHEM J, V257, P893, DOI 10.1042/bj2570893; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; PARIS S, 1987, J BIOL CHEM, V262, P1977; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TAUBER AI, 1987, BLOOD, V69, P711; WHITE JR, 1984, J BIOL CHEM, V259, P8605; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	35	108	108	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					318	327						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688431				2022-12-25	WOS:A1990CF66200049
J	CASANOVA, JE; MISHUMI, Y; IKEHARA, Y; HUBBARD, AL; MOSTOV, KE				CASANOVA, JE; MISHUMI, Y; IKEHARA, Y; HUBBARD, AL; MOSTOV, KE			DIRECT APICAL SORTING OF RAT-LIVER DIPEPTIDYLPEPTIDASE-IV EXPRESSED IN MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE PLASMA-MEMBRANE; EPITHELIAL-CELLS; MDCK CELLS; PROTEINS; PATHWAYS; CACO-2; LINE; GLYCOPROTEINS; ENDOCYTOSIS; BIOGENESIS	In Madin-Darby canine kidney (MDCK) cells, apical and basolateral membrane proteins are segregated from each other in the trans-Golgi network (TGN) and are transported to the appropriate membrane domain via separate vesicle populations. In hepatocytes, however, all plasma membrane proteins are delivered basolaterally. Apical proteins are then selectively retrieved and reach the apical surface by transcytosis. The sorting of apical proteins in different cell types may be the result of differences in the cellular sorting machinery, or alternatively, due to expression of cell-specific sorting signals on the proteins themselves. To test this directly, we have stably expressed cDNA encoding an apical protein from rat liver, dipeptidylpeptidase IV (DPPIV), in MDCK cells. We found that approximately 90% of the exogenous DPPIV is expressed on the apical cell surface at steady state. Furthermore, we demonstrate that this distribution is primarily due to vectorial transport from the TGN to the apical plasma membrane. The small pool of mis-sorted DPPIV that appears basolaterally is slowly endocytosed (t1/2 approximately 60 min) and is subsequently transcytosed. These data are consistent with the notion that both hepatocytes and MDCK cells are capable of correctly sorting rat liver DPPIV, but that this sorting occurs at different sites in the two cell types.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT ANAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205; FUKUOKA UNIV,SCH MED,DEPT BIOCHEM,FUKUOKA 81401,JAPAN	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Fukuoka University				mostov, keith/0000-0002-8123-6247	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI-25144] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACLAROVASTANDE.J, 1984, EMBO J, V3, P2687; BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BARTLES JR, 1985, J CELL BIOL, V100, P1126, DOI 10.1083/jcb.100.4.1126; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; LOW SH, 1991, J BIOL CHEM, V266, P13391; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATTER K, 1990, J BIOL CHEM, V265, P3503; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; OGATA S, 1989, J BIOL CHEM, V264, P3596; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; WESSELS HP, 1990, J CELL BIOL, V111, P2923, DOI 10.1083/jcb.111.6.2923	21	62	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24428	24432						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1684792				2022-12-25	WOS:A1991GW84500031
J	THIAGARAJAN, P; TAIT, JF				THIAGARAJAN, P; TAIT, JF			COLLAGEN-INDUCED EXPOSURE OF ANIONIC PHOSPHOLIPID IN PLATELETS AND PLATELET-DERIVED MICROPARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL ANTICOAGULANT PROTEIN; FACTOR-VA; PROTHROMBINASE ACTIVITY; PROCOAGULANT ACTIVITY; ACTIVATED PLATELETS; BLEEDING DISORDER; PLASMA-MEMBRANE; BINDING-SITES; ADP RECEPTOR; CYCLIC-AMP	We have shown recently that the calcium-dependent phospholipid-binding protein annexin V (placental anticoagulant protein I) can be used to study the exposure of anionic phospholipid after platelet activation. In this study we have further examined the mechanism of this process. Collagen-induced exposure of annexin V binding sites correlated directly with increased ability to support activity of the reconstituted prothrombinase complex. The potency of annexin V as an inhibitor of platelet prothrombinase was the same as its K(d) for platelets. Prior incubation of platelets with 5'-p-fluorosulfonylbenzoyladenosine or p-chloromercuribenzenesulfonate had no significant effect on annexin V binding. Similarly, inhibition of platelet cyclic endoperoxide synthesis by acetylsalicylic acid or indomethacin did not inhibit annexin V binding. Staurosporine inhibited collagen-induced, but not A23187-induced, annexin V binding. Agents that increase intraplatelet cyclic nucleotides partially inhibited collagen-induced annexin V binding. Thus, collagen-induced exposure of anionic phospholipid appears to depend primarily on increases in intraplatelet free calcium and may be independent of ADP- or endoperoxide-mediated pathways. Binding sites for annexin V on microparticles derived from collagen-stimulated platelets were demonstrated by flow cytometry and gel filtration. In addition, prior incubation of platelets with 100 nM annexin V inhibited factor Va binding to both platelets and platelet-derived microparticles. These results support the concept that the procoagulant effect of platelets and platelet-derived microparticles is mediated by calcium-induced exposure of anionic phospholipids.	UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT LAB MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NHLBI NIH HHS [HL-40860, HL-16919, HL-40801] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040801, R01HL016919, R01HL040860] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baenziger N L, 1974, Methods Enzymol, V31, P149; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; BODE AP, 1985, THROMB RES, V39, P49, DOI 10.1016/0049-3848(85)90121-5; CHEN CS, 1988, BIOCHEMISTRY-US, V27, P6121, DOI 10.1021/bi00416a044; COLMAN RW, 1986, BLOOD, V68, P565; COLMAN RW, 1990, HEMATOL ONCOL CLIN N, V4, P27, DOI 10.1016/S0889-8588(18)30504-5; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; CRUMPTON MJ, 1990, NATURE, V345, P212, DOI 10.1038/345212a0; DAHLBACK B, 1983, BLOOD, V62, P218; FEINSTEIN MB, 1983, BIOCHEM BIOPH RES CO, V113, P598, DOI 10.1016/0006-291X(83)91768-0; FIGURES WR, 1987, BLOOD, V70, P796; FOSTER WB, 1983, BLOOD, V61, P1060; FUNAKOSHI T, 1987, BIOCHEMISTRY-US, V26, P5572, DOI 10.1021/bi00391a053; GILBERT GE, 1989, BLOOD, V74, P36; Harlow E., 1988, ANTIBODIES LABORATOR, P341; HOLMSEN H, 1989, METHOD ENZYMOL, V169, P205; KINLOUGHRATHBONE RL, 1977, THROMB RES, V11, P567, DOI 10.1016/0049-3848(77)90016-0; LUDLAM CA, 1976, BRIT J HAEMATOL, V33, P239, DOI 10.1111/j.1365-2141.1976.tb03535.x; MARTINEZ J, 1974, J CLIN INVEST, V53, P600, DOI 10.1172/JCI107595; MILETICH JP, 1979, BLOOD, V54, P1015, DOI 10.1182/blood.V54.5.1015.1015; MILLS DCB, 1977, THROMB HAEMOSTASIS, V38, P82; MONKOVIC DD, 1990, J BIOL CHEM, V265, P17132; NAKAMURA S, 1989, J BIOL CHEM, V264, P7089; RAO AK, 1987, BLOOD, V70, P751; ROSING J, 1985, BLOOD, V65, P1557, DOI 10.1182/blood.V65.6.1557.bloodjournal6561557; ROSING J, 1985, BLOOD, V65, P319; SANDBERG H, 1982, BIOCHEM J, V203, P303, DOI 10.1042/bj2030303; SANDBERG H, 1985, THROMB RES, V39, P63, DOI 10.1016/0049-3848(85)90122-7; SEAMON KB, 1983, TRENDS PHARMACOL SCI, V4, P120, DOI 10.1016/0165-6147(83)90326-7; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; TAIT JF, 1989, J BIOL CHEM, V264, P7944; TAIT JF, 1990, PROG CLIN BIOL RES, V349, P173; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TANGEN O, 1973, SCAND J HAEMATOL, V10, P96; THIAGARAJAN P, 1987, BIOCHIM BIOPHYS ACTA, V924, P127, DOI 10.1016/0304-4165(87)90079-1; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Weiss H J, 1972, Prog Hemost Thromb, V1, P199; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9	42	164	171	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24302	24307						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662206				2022-12-25	WOS:A1991GW84500013
J	LI, ZY; LARSEN, RW; PAN, LP; CHAN, SI				LI, ZY; LARSEN, RW; PAN, LP; CHAN, SI			THE EFFECTS OF PARA-HYDROXYMERCURIBENZOIC ACID MODIFICATION AND HEAT-TREATMENT ON THE CU(A) REDUCTION POTENTIAL OF CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL MODIFICATION; BEEF-HEART; A SITE; CUA	p-Hydroxymercuribenzoic acid modification of cytochrome c oxidase converts the Cu(A) center into a type 2 copper site while heat treatment of the oxidase in lauryl maltoside can transform Cu(A) almost stoichiometrically (> 90%) to a blue type 1 copper site. These modifications of the protein have previously been shown to have a profound effect on the dioxygen reduction and proton pumping activities of the enzyme (Li, P. M., Morgan, J. E., Nilsson, T., Ma, M., and Chan, S. I. (1988) Biochemistry 27, 7538; Nilsson, T., Gelles, J., Li, P. M., and Chan, S. I. (1988) Biochemistry 27, 296; Sone, N., and Nicholls, P. (1984) Biochemistry 23, 6550). In this work, the intrinsic reduction potentials and the midpoint reduction potentials of the "Cu(A)" site in both these modified oxidases have been measured under various conditions in order to clarify the intramolecular electron transfer pathways in these systems. The study reveals that the Cu(A) intrinsic reduction potential decreases by almost 150 mV upon p-hydroxymercuribenzoic acid modification whereas it increases by 100 mV upon heat treatment. In addition, the redox interactions between Cu(A) and the remaining metal centers are perturbed upon Cu(A) modification. It is argued that these results bear on the role of Cu(A) in the proton-pumping paradigm of cytochrome c oxidase.	CALTECH,ARTHUR AMOS NOYES LAB CHEM PHYS,PASADENA,CA 91125	California Institute of Technology					NIGMS NIH HHS [GM 22432] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022432, R01GM022432] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; BLAIR DF, 1982, BIOCHEMISTRY-US, V21, P6928, DOI 10.1021/bi00269a048; BLAIR DF, 1986, J BIOL CHEM, V261, P1524; CHAN SI, 1988, OXIDASES RELATED RED, P731; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; ELLIS WR, 1986, BIOCHEMISTRY-US, V25, P161, DOI 10.1021/bi00349a023; GELLES J, 1986, BIOCHIM BIOPHYS ACTA, V853, P205, DOI 10.1016/0304-4173(87)90002-4; GELLES J, 1985, BIOCHEMISTRY-US, V24, P3963, DOI 10.1021/bi00336a025; GOODMAN G, 1984, J BIOL CHEM, V259, P5094; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; KRAB K, 1987, BIOCHIM BIOPHYS ACTA, V895, P25, DOI 10.1016/S0304-4173(87)80015-0; LARSEN RW, 1989, BIOCHEMISTRY-US, V28, P6418, DOI 10.1021/bi00441a039; LI PM, 1988, BIOCHEMISTRY-US, V27, P7538, DOI 10.1021/bi00419a054; NILSSON T, 1988, BIOCHEMISTRY-US, V27, P296, DOI 10.1021/bi00401a045; SONE N, 1984, BIOCHEMISTRY-US, V23, P6550, DOI 10.1021/bi00321a042; TSUDZUKI T, 1971, ARCH BIOCHEM BIOPHYS, V145, P149, DOI 10.1016/0003-9861(71)90021-X; WANG H, 1986, BIOCHEMISTRY-US, V25, P167, DOI 10.1021/bi00349a024; WIKSTROM M, 1985, J INORG BIOCHEM, V23, P327, DOI 10.1016/0162-0134(85)85042-X; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; Wikstrom M., 1981, CYTOCHROME OXIDASE S	20	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					22858	22865						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660463				2022-12-25	WOS:A1991GT48300016
J	PARKS, TN; MUELLER, AL; ARTMAN, LD; ALBENSI, BC; NEMETH, EF; JACKSON, H; JASYS, VJ; SACCOMANO, NA; VOLKMANN, RA				PARKS, TN; MUELLER, AL; ARTMAN, LD; ALBENSI, BC; NEMETH, EF; JACKSON, H; JASYS, VJ; SACCOMANO, NA; VOLKMANN, RA			ARYLAMINE TOXINS FROM FUNNEL-WEB SPIDER (AGELENOPSIS-APERTA) VENOM ANTAGONIZE N-METHYL-D-ASPARTATE RECEPTOR FUNCTION IN MAMMALIAN BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; AMINO-ACID RESPONSES; GLUTAMATE RECEPTOR; RAT-BRAIN; XENOPUS OOCYTES; BLOCKS; JSTX; CHANNEL; PHILANTHOTOXIN; TRANSMISSION	The venom of the North American funnel-web spider Agelenopsis aperta contains a variety of arylamine toxins (the alpha-agatoxins) that paralyze insects by blocking glutamatergic neuromuscular transmission. We have tested six synthetic alpha-agatoxins for their ability to antagonize glutamate receptor function in mammalian brain. These compounds produce, at submicromolar concentrations, noncompetitive inhibition of N-methyl-D-aspartate (NMDA) receptor-mediated elevations in the concentration of cytosolic free calcium in cultured rat cerebellar granule neurons. In contrast, the alpha-agatoxins are relatively weak antagonists of elevations in the cytosolic free calcium concentration induced by non-NMDA receptor agonists. The alpha-agatoxins also produce reversible suppression of the NMDA receptor-mediated excitatory postsynaptic potential in rat hippocampal slices at concentrations that have little effect on the non-NMDA receptor-mediated population spike. We conclude that the alpha-agatoxins are selective and reversible noncompetitive antagonists at NMDA receptors in mammalian brain.	NAT PROD SCI INC, 420 CHIPETA WAY, SALT LAKE CITY, UT 84108 USA; PFIZER INC, DIV CENT RES, GROTON, CT 06340 USA	Pfizer			Albensi, Benedict Charles/AAJ-2359-2021; Albensi, Benedict C/F-7304-2010	Albensi, Benedict Charles/0000-0002-7884-9261; 				ADAMS ME, 1989, J COMP PHYSIOL A, V164, P333, DOI 10.1007/BF00612993; ADAMS ME, 1990, J BIOL CHEM, V265, P861; ADAMS ME, 1987, BIOCHEM BIOPH RES CO, V148, P678, DOI 10.1016/0006-291X(87)90930-2; AKAIKE N, 1987, NEUROSCI LETT, V79, P326, DOI 10.1016/0304-3940(87)90453-8; ANTONOV SM, 1987, NEUROSCI LETT, V83, P179, DOI 10.1016/0304-3940(87)90237-0; ASAMI T, 1989, BIOMED RES-TOKYO, V10, P185, DOI 10.2220/biomedres.10.185; ASHE JH, 1989, BRAIN RES, V480, P234, DOI 10.1016/0006-8993(89)91587-4; BATEMAN A, 1985, BRAIN RES, V339, P237, DOI 10.1016/0006-8993(85)90088-5; BINDOKAS VP, 1989, J NEUROBIOL, V20, P171, DOI 10.1002/neu.480200402; BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; BRACKLEY P, 1990, NEUROSCI LETT, V114, P51, DOI 10.1016/0304-3940(90)90427-B; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COURTNEY MJ, 1990, J NEUROSCI, V10, P3873, DOI 10.1523/JNEUROSCI.10-12-03873.1990; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIMI T, 1990, J NEURAL TRANSM-GEN, V80, P95, DOI 10.1007/BF01257076; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; INO H, 1990, NEUROSCI RES, V8, P29, DOI 10.1016/0168-0102(90)90054-I; JACKSON H, 1989, ANNU REV NEUROSCI, V12, P405, DOI 10.1146/annurev.neuro.12.1.405; JACKSON H, 1988, TRENDS NEUROSCI, V11, P278, DOI 10.1016/0166-2236(88)90112-9; JACKSON H, 1990, BRAIN RES, V526, P338, DOI 10.1016/0006-8993(90)91243-A; JASYS VJ, 1990, J AM CHEM SOC, V112, P6696, DOI 10.1021/ja00174a037; JOHNSON G, 1991, ANNU REP MED CHEM, V26, P11; JONES MG, 1990, BRIT J PHARMACOL, V101, P968, DOI 10.1111/j.1476-5381.1990.tb14189.x; KAWAI N, 1984, J PHYSIOL-PARIS, V79, P228; KAWAI N, 1989, NEUROSCI RES, V6, P358, DOI 10.1016/0168-0102(89)90028-X; KAWAI N, 1982, BIOMED RES-TOKYO, V3, P353, DOI 10.2220/biomedres.3.353; KERRY CJ, 1988, BRAIN RES, V459, P312, DOI 10.1016/0006-8993(88)90647-6; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1988, P NATL ACAD SCI USA, V85, P9836, DOI 10.1073/pnas.85.24.9836; MONAGHAN DT, 1991, EUR J PHARMACOL, V194, P123, DOI 10.1016/0014-2999(91)90134-C; MUELLER A L, 1989, Society for Neuroscience Abstracts, V15, P945; MUELLER AL, 1991, IN PRESS SYNAPSE; PANHOU H, 1987, BRAIN RES, V418, P198, DOI 10.1016/0006-8993(87)90981-4; PANHOU H, 1987, NEUROSCI LETT, V81, P199, DOI 10.1016/0304-3940(87)90365-X; PARKS T N, 1989, Society for Neuroscience Abstracts, V15, P1169; PARKS TN, 1991, BRAIN RES, V552, P13, DOI 10.1016/0006-8993(91)90653-D; PRIESTLEY T, 1989, BRIT J PHARMACOL, V97, P1315, DOI 10.1111/j.1476-5381.1989.tb12594.x; QUISTAD GB, 1990, BIOCHEM BIOPH RES CO, V169, P51, DOI 10.1016/0006-291X(90)91431-Q; RAGSDALE D, 1989, J PHARMACOL EXP THER, V251, P156; REYNOLDS IJ, 1991, IN PRESS BR J PHARM; SACCOMANO NA, 1989, ANNU REP MED CHEM, V24, P287; SAITO M, 1989, BRAIN RES, V481, P16, DOI 10.1016/0006-8993(89)90480-0; SAITO M, 1985, BRAIN RES, V346, P397, DOI 10.1016/0006-8993(85)90878-9; SEKIGUCHI M, 1990, J NEUROSCI, V10, P2148; SEYMOUR P A, 1989, Society for Neuroscience Abstracts, V15, P1168; SHINOZAKI H, 1988, PROG NEUROBIOL, V30, P399, DOI 10.1016/0301-0082(88)90009-3; SHUDO K, 1987, NEUROSCI RES, V5, P82, DOI 10.1016/0168-0102(87)90026-5; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SKINNER WS, 1990, TOXICON, V28, P541, DOI 10.1016/0041-0101(90)90298-L; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	54	40	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21523	21529						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657970				2022-12-25	WOS:A1991GP80400035
J	OKAMURA, K; SATO, Y; MATSUDA, T; HAMANAKA, R; ONO, M; KOHNO, K; KUWANO, M				OKAMURA, K; SATO, Y; MATSUDA, T; HAMANAKA, R; ONO, M; KOHNO, K; KUWANO, M			ENDOGENOUS BASIC FIBROBLAST GROWTH FACTOR-DEPENDENT INDUCTION OF COLLAGENASE AND INTERLEUKIN-6 IN TUMOR NECROSIS FACTOR-TREATED HUMAN MICROVASCULAR ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR-ALPHA; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; MESSENGER-RNA; DNA-SYNTHESIS; C-FOS; BOVINE; ANGIOGENESIS; RELEASE; INVITRO	Tumor necrosis factor-alpha (TNF-alpha) has been shown to enhance the synthesis of interleukin-6 (IL-6) and collagenase in human omental microvascular endothelial (HOME) cell (Mawatari, M., Kohno, K., Mizoguchi, H., Matsuda, T., Asoh, K., Van Damme, J. V., Welgus, H. G., and Kuwano, M. (1989) J. Immunol. 143, 1619-1627). In the present study, we have examined whether the TNF-alpha-induced synthesis of IL-6 or collagenase in HOME cells is mediated by an inducible growth factor. Among several growth factors examined, we found that the expression of basic fibroblast growth factor (bFGF) mRNA was the one most prominently enhanced when HOME cells were treated with TNF-alpha. The increase of bFGF mRNA by TNF-alpha in HOME cells was observed in both a dose- and time-dependent manner when assayed by Northern blot analysis. The induction of bFGF mRNA was observed by 3 h after incubation with TNF-alpha, and the maximal increase of 5-fold was obtained after 12 h of incubation with 100 units/ml TNF-alpha. Western blot analysis confirmed the enhanced synthesis of bFGF by TNF-alpha. Metabolic labeling and immunoprecipitation assays of bFGF showed that exposure to TNF-alpha enhanced secretion of bFGF into culture medium and also that TNF-alpha stimulated the production of bFGF molecules with molecular masses of 18, 21, and 22.5 kDa in HOME cells. TNF-alpha induced the expression of collagenase mRNA and IL-6 mRNA in HOME cells as well, and the coadministration of neutralizing anti-bFGF antibody almost completely blocked the effects of TNF-alpha. The treatment of HOME cells with exogenous bFGF significantly stimulated the expression of collagenase mRNA and IL-6 mRNA in HOME cells. Therefore, the biological effects of TNF-alpha on HOME cells may be mediated, at least in part, by TNF-alpha-induced bFGF.	OITA MED SCH,DEPT BIOCHEM,HASAMA MACHI,OITA 87955,JAPAN; OITA MED SCH,DEPT MED,OITA 87955,JAPAN	Oita University								BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BILFALVI A, 1990, J CELL PHYSL, V144, P151; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CHEN MJ, 1987, NATURE, V330, P581, DOI 10.1038/330581a0; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DAMORE PA, 1990, CANCER METAST REV, V9, P227, DOI 10.1007/BF00046362; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; GAJDUSEK CM, 1989, J CELL PHYSIOL, V139, P570, DOI 10.1002/jcp.1041390317; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOSPDAROWICZ D, 1987, ENDOCR REV, V6, P95; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x; HAJJAR KA, 1987, J EXP MED, V166, P235, DOI 10.1084/jem.166.1.235; HANNEKEN A, 1989, J CELL PHYSIOL, V138, P115, DOI 10.1002/jcp.1041380116; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; JIRIK FR, 1989, J IMMUNOL, V142, P144; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; LIN JX, 1987, J BIOL CHEM, V262, P11908; LINDNER V, 1989, LAB INVEST, V61, P556; MAIER JAM, 1990, EXP CELL RES, V186, P354, DOI 10.1016/0014-4827(90)90316-3; MAWATARI M, 1991, EXP CELL RES, V192, P574, DOI 10.1016/0014-4827(91)90078-9; MAWATARI M, 1989, J IMMUNOL, V143, P1619; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; MIZOGUCHI H, 1990, BIOCHIM BIOPHYS ACTA, V1052, P475, DOI 10.1016/0167-4889(90)90158-A; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; MOSCATELLI D, 1986, J CELL PHYSIOL, V129, P273, DOI 10.1002/jcp.1041290220; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; MOSCATELLI DA, 1985, EXP CELL RES, V156, P379, DOI 10.1016/0014-4827(85)90545-2; MOTRO B, 1990, P NATL ACAD SCI USA, V87, P3092, DOI 10.1073/pnas.87.8.3092; MUNKER R, 1986, NATURE, V323, P79, DOI 10.1038/323079a0; PAULSSON Y, 1989, EXP CELL RES, V180, P490, DOI 10.1016/0014-4827(89)90075-X; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; SABURI Y, 1989, CANCER RES, V49, P7020; SATO N, 1986, JNCI-J NATL CANCER I, V76, P1113; SATO Y, 1989, MOL ENDOCRINOL, V3, P744, DOI 10.1210/mend-3-4-744; SATO Y, 1991, BIOCHEM BIOPH RES CO, V174, P1260, DOI 10.1016/0006-291X(91)91557-S; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P997, DOI 10.1016/0006-291X(87)90350-0; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SOMMER A, 1987, BIOCHEM BIOPH RES CO, V144, P543, DOI 10.1016/S0006-291X(87)80001-3; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; TESSLER S, 1990, J CELL PHYSIOL, V145, P310, DOI 10.1002/jcp.1041450216; TSUBOI R, 1990, J CELL BIOL, V110, P511, DOI 10.1083/jcb.110.2.511; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; WITTE L, 1989, CANCER RES, V49, P5066; YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299	54	85	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19162	19165						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655776				2022-12-25	WOS:A1991GK66700010
J	PROSTKO, CR; BROSTROM, MA; GALUSKAMALARA, EM; BROSTROM, CO				PROSTKO, CR; BROSTROM, MA; GALUSKAMALARA, EM; BROSTROM, CO			STIMULATION OF GRP78 GENE-TRANSCRIPTION BY PHORBOL ESTER AND CAMP IN GH3 PITUITARY-CELLS - THE ACCOMMODATION OF PROTEIN-SYNTHESIS TO CHRONIC DEPRIVATION OF INTRACELLULAR SEQUESTERED CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEIN; ELONGATION FACTOR-II; SIGNAL-TRANSDUCTION PATHWAYS; CHAIN BINDING-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSLATIONAL INITIATION; EUKARYOTIC CELLS; MAMMALIAN-CELLS; SECRETORY PROTEINS; RESPONSIVE GENES	GRP78/BiP resides in the lumen of the endoplasmic reticulum (ER), a major site of Ca2+ sequestration and early protein processing. Agents, such as ionophore A23187, that mobilize sequestered ER Ca2+ suppress translational initiation within minutes and induce GRP78 within 1-3 h accompanied by development of translational tolerance to the inhibitor. Accommodation is prevented by actinomycin D and reduced by antisense oligonucleotides directed against GRP78 mRNA. In GH3 cells, optimal induction of GRP78 and translational accommodation depended on cAMP elevation and phorbol ester. GRP78 mRNA was induced 3-6-fold with A23187 alone as compared with 12-20-fold with ionophore plus cAMP-elevating agent and phorbol ester, but was not markedly induced without A23187. GRP78 gene transcription in nuclei isolated from A23187-treated cells was increased 2-4-fold by cAMP and phorbol ester. A nucleotide sequence homologous to the cAMP-responsive element consensus potentially exists in the promoter region of the GRP78 gene. GRP78 mRNA in ionophore-treated cells was largely associated with mono- and polysomal fractions rather than ribonuclear protein particles, a distribution different from actin and tubulin mRNAs. While polysomal content increased in cells undergoing translational recovery, cAMP and phorbol esters did not affect GRP78 mRNA stability. Translational accommodation in ionophore-treated GH3 cells is proposed to involve enhanced transcription of GRP78 mRNA promoted by cAMP/phorbol ester in conjunction with preferential polysomal loading of the message.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHARMACOL,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center					NIDDK NIH HHS [DK 35393] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035393] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; BROSTROM CO, 1983, J BIOL CHEM, V258, P4390; BROSTROM CO, 1990, ANNU REV PHYSIOL, V52, P577; BROSTROM MA, 1987, J BIOL CHEM, V262, P16515; BROSTROM MA, 1991, J BIOL CHEM, V266, P7037; BROSTROM MA, 1990, J BIOL CHEM, V265, P20539; CELIS JE, 1990, P NATL ACAD SCI USA, V87, P4231, DOI 10.1073/pnas.87.11.4231; CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680; CHIN KV, 1987, J BIOL CHEM, V262, P16509; CHIN KV, 1988, INT J BIOCHEM, V20, P1313, DOI 10.1016/0020-711X(88)90236-4; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; FINK JS, 1991, J BIOL CHEM, V266, P3882; Gething M J, 1990, Semin Cell Biol, V1, P65; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233, DOI 10.1128/MCB.9.3.1233; KIMBALL SR, 1990, J BIOL CHEM, V265, P16794; KOCH GLE, 1987, J CELL SCI, V87, P491; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEE W, 1987, NATURE, V325, P369; LIN AY, 1986, MOL CELL BIOL, V6, P1235, DOI 10.1128/MCB.6.4.1235; LODISH HF, 1990, J BIOL CHEM, V265, P10893; MACKIE KP, 1989, J BIOL CHEM, V264, P1748; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MENAYA J, 1988, BIOCHEM J, V254, P773, DOI 10.1042/bj2540773; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAKAKI T, 1989, MOL CELL BIOL, V9, P2233, DOI 10.1128/MCB.9.5.2233; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PROSTKO CR, 1989, BIOCHEM J, V255, P295; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; Sambrook J, 1989, MOL CLONING LABORATO; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SCHUTZBACH JS, 1990, J BIOL CHEM, V265, P2546; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; TING J, 1987, GENE, V55, P147, DOI 10.1016/0378-1119(87)90258-7; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WONG WL, 1991, INT J BIOCHEM, V23, P605; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	65	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19790	19795						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655795				2022-12-25	WOS:A1991GK66700095
J	YOSHIDA, Y; SUN, HT; CAI, JQ; IMAI, S				YOSHIDA, Y; SUN, HT; CAI, JQ; IMAI, S			CYCLIC GMP-DEPENDENT PROTEIN-KINASE STIMULATES THE PLASMA-MEMBRANE CA2+ PUMP ATPASE OF VASCULAR SMOOTH-MUSCLE VIA PHOSPHORYLATION OF A 240-KDA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-PUMPING ATPASE; CA-2+ PUMP; ADENOSINE; PHOSPHATIDYLINOSITOL; RELAXATION; SUBSTRATE	The plasma membrane Ca2+ pump ATPase from porcine aorta was isolated by the calmodulin affinity chromatographic method of Kosk-Kosicka et al. (Kosk-Kosicka, D., Scaillet, S., and Inesi, G. (1986) J. Biol. Chem. 261, 3333-3338). Its activity was restored by adding either phosphatidylcholine or phosphatidylserine. Cyclic GMP-dependent protein kinase (G-kinase) stimulated the enzyme in a concentration-dependent manner. However, phosphatidylinositol kinase (PI-kinase) activity was not detected in the enzyme preparation, and the presence of phosphatidylinositol was not necessary for stimulation by G-kinase. Furthermore, adenosine, a potent PI-kinase inhibitor, did not affect the stimulation. The enzyme preparation contained three major proteins, with molecular masses of 240, 145, and 135 kDa, as assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The 240- and 135-kDa proteins were phosphorylated in association with the stimulation by G-kinase, but only the phosphorylation of the 240-kDa protein was dependent on the G-kinase concentration. A purified enzyme without the 240-kDa protein, prepared by our previous method (Imai, S., Yoshida, Y., and Sun, H.-T. (1990) J. Biochem. (Tokyo) 107, 755-76 1), was not activated by G-kinase. Immunoblotting with an antibody against the human erythrocyte Ca2+ pump revealed that the 135-kDa protein corresponded to one of the isoforms of the plasma membrane Ca2+ pump. These results suggest that the phosphorylation of the 240-kDa protein is responsible for stimulation of the plasma membrane Ca2+ pump ATPase by G-kinase.	NIIGATA UNIV,SCH MED,DEPT PHARMACOL,NIIGATA 951,JAPAN	Niigata University								BALTENSPERGER K, 1988, EUR J BIOCHEM, V172, P7, DOI 10.1111/j.1432-1033.1988.tb13848.x; BALTENSPERGER K, 1990, BIOCHEMISTRY-US, V29, P9753, DOI 10.1021/bi00493a035; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; CASNELLI.JE, 1974, P NATL ACAD SCI USA, V71, P1891, DOI 10.1073/pnas.71.5.1891; CASNELLIE JE, 1980, J BIOL CHEM, V255, P3770; DEJAEGERE S, 1990, BIOCHEM J, V271, P655, DOI 10.1042/bj2710655; DOCTROW SR, 1987, BIOCHEM PHARMACOL, V36, P2255, DOI 10.1016/0006-2952(87)90588-0; FURUKAWA KI, 1987, J BIOCHEM-TOKYO, V101, P287, DOI 10.1093/oxfordjournals.jbchem.a121904; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; IMAI S, 1990, J BIOCHEM-TOKYO, V107, P755, DOI 10.1093/oxfordjournals.jbchem.a123121; IVES HE, 1980, J BIOL CHEM, V255, P3777; JOLLES J, 1981, BIOCHEM J, V194, P283, DOI 10.1042/bj1940283; KESSLER F, 1990, J BIOL CHEM, V265, P16012; KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7; KOSKOSICKA D, 1986, J BIOL CHEM, V261, P3333; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINCOLN TM, 1983, METHOD ENZYMOL, V99, P62; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; PARKS TP, 1987, ARCH BIOCHEM BIOPHYS, V255, P361, DOI 10.1016/0003-9861(87)90404-8; RAPOPORT RM, 1982, P NATL ACAD SCI-BIOL, V79, P6470, DOI 10.1073/pnas.79.21.6470; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; SARCEVIC B, 1990, BIOCHEM J, V271, P493, DOI 10.1042/bj2710493; VROLIX M, 1988, BIOCHEM J, V255, P855, DOI 10.1042/bj2550855; WALDMAN SA, 1987, PHARMACOL REV, V39, P163	25	87	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19819	19825						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655796				2022-12-25	WOS:A1991GK66700099
J	SCOTT, GK; DODSON, JM; MONTGOMERY, PA; JOHNSON, RM; SARUP, JC; WONG, WL; ULLRICH, A; SHEPARD, HM; BENZ, CC				SCOTT, GK; DODSON, JM; MONTGOMERY, PA; JOHNSON, RM; SARUP, JC; WONG, WL; ULLRICH, A; SHEPARD, HM; BENZ, CC			P185HER2 SIGNAL TRANSDUCTION IN BREAST-CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE-ACTIVITY; TUMOR NECROSIS FACTOR; ERBB-2 PROTEIN; NEU ONCOGENE; EGF RECEPTOR; GENE-PRODUCT; EXPRESSION; PHOSPHORYLATION; OVEREXPRESSION	A partially agonistic monoclonal antibody, 4D5, known to bind to the extracellular domain of p185HER2 and shown to inhibit long term growth of p185HER2-overexpressing breast cancer cells, was used to study signal transduction and phosphotyrosyl protein substrates associated with this receptor. Normal breast epithelial cells and breast carcinoma cells expressing low levels of p185HER2 were not affected by 4D5. HER2/neu-overexpressing breast cancer cells (BT-474 and SK-Br-3) exposed to 4D5 exhibited rapid phosphorylation of both p185HER2 and an associated 56-kDa phosphotyrosyl protein (ptyr56). Paralleling the 4D5-stimulated phosphorylation of p185HER2 and ptyr56 was a 5-10-fold induction of c-fos mRNA and phosphatidylinositol 4-kinase activity and a 2-fold induction of inositol 1,4,5-trisphosphate 3'-kinase activity. The increased phosphatidylinositol 4-kinase activity immunoprecipitated with p185HER2 and also co-eluted with ptyr56 from an antiphosphotyrosine immunoaffinity column. These results indicate that short term (< 6 h) 4D5 activation of p185HER2 in overexpressing breast cancer cells produces agonistic-like signaling typical of homologous tyrosine kinase growth factor receptors such as epidermal growth factor receptor. The data also suggest that ptyr56 represents a novel phosphorylated substrate associated with 4D5-stimulated p185HER2.	UNIV CALIF SAN FRANCISCO,CANC RES INST M1282,SAN FRANCISCO,CA 94143; GENENTECH INC,DEPT DEV BIOL,SAN FRANCISCO,CA 94080; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	University of California System; University of California San Francisco; Roche Holding; Genentech; Max Planck Society					NATIONAL CANCER INSTITUTE [P01CA044768, R01CA036773] Funding Source: NIH RePORTER; NCI NIH HHS [CA-44768, CA-36773] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BENZ CC, 1989, JNCI-J NATL CANCER I, V81, P1704, DOI 10.1093/jnci/81.22.1704; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COCHET C, 1991, J BIOL CHEM, V266, P637; DIFIORE PP, 1990, SCIENCE, V248, P79, DOI 10.1126/science.2181668; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DRUKER BJ, 1989, NEW ENGL J MED, V321, P1383; EPSTEIN RJ, 1990, J BIOL CHEM, V265, P10746; FENDLY BM, 1990, CANCER RES, V50, P1550; HENNIPMAN A, 1989, CANCER RES, V49, P516; HUANG SS, 1990, J BIOL CHEM, V265, P3340; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1988, P NATL ACAD SCI USA, V85, P5102, DOI 10.1073/pnas.85.14.5102; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUHN RD, 1989, J CELL BIOCHEM, V39, P129, DOI 10.1002/jcb.240390205; JOHNSON RM, 1989, SCIENCE, V246, P121, DOI 10.1126/science.2506643; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KERN JA, 1990, CANCER RES, V50, P5184; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOSKINEN P, 1990, ONCOGENE, V5, P615; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; MAJERUS PW, 1990, CELL, V63, P459, DOI 10.1016/0092-8674(90)90442-H; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PARK JB, 1989, CANCER RES, V49, P6605; SARUP JC, 1991, IN PRESS GROWTH REG; SIAS PE, 1990, J IMMUNOL METHODS, V132, P73, DOI 10.1016/0022-1759(90)90400-P; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WADA T, 1990, ONCOGENE, V5, P489; WALKER DH, 1988, BIOCHEMISTRY-US, V27, P6504, DOI 10.1021/bi00417a046; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	38	97	137	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14300	14305						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1677643				2022-12-25	WOS:A1991FZ35100031
J	MITSUDOMI, T; VIALLET, J; MULSHINE, JL; LINNOILA, RI; MINNA, JD; GAZDAR, AF				MITSUDOMI, T; VIALLET, J; MULSHINE, JL; LINNOILA, RI; MINNA, JD; GAZDAR, AF			MUTATIONS OF RAS GENES DISTINGUISH A SUBSET OF NON-SMALL-CELL LUNG-CANCER CELL-LINES FROM SMALL-CELL LUNG-CANCER CELL-LINES	ONCOGENE			English	Article							BLADDER-CARCINOMA ONCOGENE; POINT MUTATION; TUMOR PROGRESSION; P53 GENE; ACTIVATION; ADENOCARCINOMA; CARCINOGENESIS; AMPLIFICATION; INITIATION; EXPRESSION	We screened a panel of 103 human lung cancer cell lines for the presence of point mutations at codons 12, 13 or 61 of the human K-, H- and N-ras genes, using restriction fragment length polymorphisms (RFLP), created through mismatched primers during polymerase chain reaction (PCR) of genomic DNA. We found ras mutations in 22/61 (36%) non-small-cell lung cancer (NSCLC) cell lines, predominantly in K-ras codon 12. Identical mutations were present in uncultured tumor materials corresponding to 11 cell lines containing mutated ras genes. ras mutations were found not only in adenocarcinoma cell lines (9/32, 28%), but also in cell lines derived from other types of NSCLC (13/29, 45%). In contrast, none of 37 small-cell lung cancer (SCLC) cell lines and five extrapulmonary small-cell cancer cell lines had ras mutations. ras mutations were not correlated with sex of the patients, tumor extent, prior therapy status or in vitro culture time. G to T or A to T transversions were the most common base substitutions, occurring in codons 12 and 61 respectively. We conclude that ras mutations play a role in the pathogenesis of a subset of NSCLC but are not involved in SCLC.	NATL NAVAL MED CTR, NCI NAVY MED ONCOL BRANCH, BDG 8, RM 5101, BETHESDA, MD 20889 USA; NCI, NAVY MED ONCOL BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Mitsudomi, Tetsuya/0000-0001-9860-8505; Mulshine, James/0000-0002-4648-9177				BAKER SJ, 1990, CANCER RES, V50, P7717; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Battey, 1986, BASIC METHODS MOL BI; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; BOS JL, 1989, CANCER RES, V49, P4682; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CARNEY DN, 1985, CANCER RES, V45, P2913; CHIBA I, 1990, ONCOGENE, V5, P1603; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; FALCO JP, 1990, J CLIN INVEST, V85, P1740, DOI 10.1172/JCI114630; GAZDAR AF, 1986, CANCER GENET CYTOGEN, V19, P5, DOI 10.1016/0165-4608(86)90365-1; GAZDAR AF, 1990, JNCI-J NATL CANCER I, V82, P117, DOI 10.1093/jnci/82.2.117; GAZDAR AF, 1988, CANCER RES, V48, P4078; GUERRERO I, 1984, P NATL ACAD SCI USA, V79, P2845; JIANG W, 1989, ONCOGENE, V4, P923; JOHNSON BE, 1989, J NATL CANCER I, V81, P1223, DOI 10.1093/jnci/81.16.1223; KAGIMOTO M, 1985, INT J CANCER, V35, P809, DOI 10.1002/ijc.2910350618; KUMAR R, 1989, ONCOGENE RES, V1, P235; MABRY M, 1988, P NATL ACAD SCI USA, V85, P6523, DOI 10.1073/pnas.85.17.6523; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; MILLICI A, 1986, BIOCHEM BIOPH RES CO, V140, P699; MINNA JD, 1989, CC MOL BIOL, P57; Minna JD, 1989, CANCER PRINCIPLES PR, P591; MUSCHEL RJ, 1985, AM J PATHOL, V121, P1; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PEDERSENBJERGAARD J, 1988, CANCER RES, V48, P1812; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; REMICK SC, 1987, MEDICINE, V66, P457, DOI 10.1097/00005792-198711000-00004; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; RODENHUIS S, 1988, CANCER RES, V48, P5738; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; STEVENSON H, 1990, ANN INTERN MED, V113, P764, DOI 10.7326/0003-4819-113-10-764; SUZUKI Y, 1990, ONCOGENE, V5, P1037; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; VALENZUELA DM, 1986, NUCLEIC ACIDS RES, V14, P843, DOI 10.1093/nar/14.2.843; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	47	310	316	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	1991	6	8					1353	1362						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX272	1679529				2022-12-25	WOS:A1991GX27200010
J	DEGITZ, K; LIANJIE, L; CAUGHMAN, SW				DEGITZ, K; LIANJIE, L; CAUGHMAN, SW			CLONING AND CHARACTERIZATION OF THE 5'-TRANSCRIPTIONAL REGULATORY REGION OF THE HUMAN INTERCELLULAR-ADHESION MOLECULE-1 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; DNA-BINDING PROTEINS; INTERFERON-GAMMA; MAMMALIAN-CELLS; PHORBOL ESTER; ICAM-1; EXPRESSION; RECEPTOR; IMMUNOGLOBULIN; KERATINOCYTES	Cell-cell adhesion is critical in the generation of immunologic responses and is dependent upon expression of a variety of cell surface receptors. While intercellular adhesion molecule 1 (ICAM-1), a specific receptor for lymphocyte function-associated antigen 1, is constitutively expressed by some cell types, its de novo or increased expression by various cells has been associated with the initiation of inflammatory responses and appears to be transcriptionally regulated. The 5' region of the human ICAM-1 gene has been cloned and both structurally and functionally analyzed. A 17.3-kilobase genomic clone containing three exonal regions encoding the N-terminal third of the ICAM-1 protein was isolated. A 2.05-kilobase subclone, containing the 5' most exon, was utilized to determine an interferon-gamma-induced transcription initiation site via primer extension and S1 nuclease protection assays. Analysis of the 5'-flanking region revealed consensus sequences for appropriately located basal promoter elements, as well as numerous potential cis-acting enhancer elements. When subcloned into a reporter gene construct, the putative promoter subregion functioned as a potent promoter. However, in accord with biologically observed expression of ICAM-1 in specific cell types, when additional 5'-flanking sequences were included in reporter gene constructs, tissue appropriate repression of transcription was observed.	EMORY UNIV,SCH MED,DEPT DERMATOL,201 WOODRUFF MEM BLDG,ATLANTA,GA 30322; NCI,DERMATOL BRANCH,BETHESDA,MD 20892	Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BENOIST C, 1980, NUCLEIC ACIDS RES, V8, P127, DOI 10.1093/nar/8.1.127; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BIERER BE, 1988, FASEB J, V2, P2584, DOI 10.1096/fasebj.2.10.2838364; BOYD AW, 1988, P NATL ACAD SCI USA, V85, P3095, DOI 10.1073/pnas.85.9.3095; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; CAUGHMAN SW, 1990, J INVEST DERMATOL, V94, pS22, DOI 10.1111/1523-1747.ep12875005; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; DALE TC, 1989, EMBO J, V8, P831, DOI 10.1002/j.1460-2075.1989.tb03444.x; DAVIS LG, 1989, BASIC METHODS MOL BI; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; DUSTIN ML, 1986, J IMMUNOL, V137, P245; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FAULL RJ, 1989, TRANSPLANTATION, V48, P226, DOI 10.1097/00007890-198908000-00009; GIRARD DJ, 1973, JNCI-J NATL CANCER I, V51, P1417; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; GRIFFITHS CEM, 1989, J AM ACAD DERMATOL, V20, P617, DOI 10.1016/S0190-9622(89)70073-6; GRIFFITHS CEM, 1990, BRIT J DERMATOL, V122, P333, DOI 10.1111/j.1365-2133.1990.tb08281.x; HALE LP, 1989, ARTHRITIS RHEUM, V32, P22, DOI 10.1002/anr.1780320105; HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435; JOHNSON JP, 1989, P NATL ACAD SCI USA, V86, P641, DOI 10.1073/pnas.86.2.641; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; LANE TA, 1989, BIOCHEM BIOPH RES CO, V161, P945, DOI 10.1016/0006-291X(89)91334-X; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MAKGOBA MW, 1989, IMMUNOL TODAY, V10, P417, DOI 10.1016/0167-5699(89)90039-X; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; POBER JS, 1986, J IMMUNOL, V137, P1893; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; VEJLSGAARD GL, 1989, J AM ACAD DERMATOL, V20, P782, DOI 10.1016/S0190-9622(89)70090-6; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	46	167	174	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14024	14030						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1677359				2022-12-25	WOS:A1991FY02700089
J	HIRABAYASHI, Y; FUJITA, SC; KON, K; ANDO, S				HIRABAYASHI, Y; FUJITA, SC; KON, K; ANDO, S			CHARACTERIZATION OF A NOVEL LEX-ACTIVE GANGLIOSIDE FROM CHICK INTESTINAL TISSUES RECOGNIZED BY MURINE MONOCLONAL-ANTIBODY 188C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-CONTAINING GLYCOSPHINGOLIPIDS; C-SERIES POLYSIALOGANGLIOSIDES; HANGANUTZIU-DEICHER ANTIGENS; NUCLEAR MAGNETIC-RESONANCE; THIN-LAYER CHROMATOGRAPHY; ADULT BOVINE BRAINS; N-FUCOPENTAOSE-III; HUMAN ADENOCARCINOMA; DENSITOMETRIC DETERMINATION; CONTAINING GLYCOLIPIDS	A monoclonal antibody, 188C1, raised against skin tissue from the back of bullfrogs (Rana catesbeiana) was found to recognize a common antigen in neural and intestinal tissues of chicken (Fujita, S. (1989) in Biological Transduction Mechanisms (Kasai, M., Yoshioka, T., and Suzuki, H., eds) pp. 159-177, Japan Scientific Societies Press, Tokyo Japan). The 188C1 antigen was isolated from chick intestinal tissues and characterized as a novel ganglioside by means of Q-Sepharose and Iatrobeads column chromatography, and chemical, immunochemical, and immunohistochemical analyses. The chemical structure was as follows: [GRAPHICS] This represents a novel hybrid structure of type 2 Le(x) epitope and G(M1) ganglioside core structure, designated as Le(x)-G(M1). Monoclonal antibody 188C1 reacted strongly with Le(x)-G(M1) on thin layer chromatography, but its reactivity was greatly reduced when sialic acid was removed from the antigen. This indicated that the internal sialic acid residue might participate in antigenicity of the Le(x) determinant. In addition to 188C1, a more specific antibody reacting with Le(x)-G(M1) but not with asialo-Le(x)-G(M1) was raised by immunizing a rabbit with Le(x)-G(M1). TLC/enzyme immunostaining using this specific antibody showed the presence of Le(x)-G(M1) in chick intestinal tissue, but not in chick brain.	MITSUBISHI KASEI INST LIFE SCI, NEUROCHEM LAB, MACHIDA, TOKYO 194, JAPAN; TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT MEMBRANE BIOCHEM, ITABASHI KU, TOKYO 173, JAPAN		HIRABAYASHI, Y (corresponding author), UNIV SHIZUOKA, SCH PHARMACEUT SCI, DEPT BIOCHEM, 395 YADA, OYA, SHIZUOKA 422, JAPAN.			Hirabayashi, Yoshio/0000-0002-5774-7354				ANDO S, 1983, NEUROCHEM INT, V5, P507, DOI 10.1016/0197-0186(83)90043-8; ANDO S, 1989, J BIOL CHEM, V264, P3478; ANDO S, 1979, J BIOL CHEM, V254, P2224; BHATTI T, 1970, BIOCHIM BIOPHYS ACTA, V222, P339, DOI 10.1016/0304-4165(70)90122-4; BREIMER ME, 1983, J BIOCHEM, V93, P1473, DOI 10.1093/oxfordjournals.jbchem.a134285; CHERESH DA, 1984, J BIOL CHEM, V259, P7453; DABROWSKI J, 1981, ARCH BIOCHEM BIOPHYS, V210, P405, DOI 10.1016/0003-9861(81)90203-4; DEGASPERI R, 1987, J BIOL CHEM, V262, P17149; EGGENS I, 1989, J BIOL CHEM, V264, P9476; FUJITA S, 1989, BIOSIGNAL TRANSDUCTI, P159; FUKUDA MN, 1986, J BIOL CHEM, V261, P2376; FUKUSHI Y, 1984, J BIOL CHEM, V259, P511; FUKUSHI Y, 1984, J BIOL CHEM, V259, P4681; GASA S, 1983, J LIPID RES, V24, P174; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; HIGASHI H, 1984, J BIOCHEM, V95, P785, DOI 10.1093/oxfordjournals.jbchem.a134670; HIGASHI H, 1984, J BIOCHEM-TOKYO, V95, P1517, DOI 10.1093/oxfordjournals.jbchem.a134760; HIRABAYASHI Y, 1978, BIOCHIM BIOPHYS ACTA, V529, P96; HIRABAYASHI Y, 1988, J CHROMATOGR, V445, P377, DOI 10.1016/S0021-9673(01)84550-7; HIRABAYASHI Y, 1986, BIOCHIM BIOPHYS ACTA, V876, P178; HIRABAYASHI Y, 1983, J BIOCHEM-TOKYO, V94, P327, DOI 10.1093/oxfordjournals.jbchem.a134350; HIRABAYASHI Y, 1985, J BIOL CHEM, V260, P3328; HIRABAYASHI Y, 1989, NEUROSCI LETT, V106, P193, DOI 10.1016/0304-3940(89)90225-5; HIRABAYASHI Y, 1988, J BIOCHEM, V104, P973, DOI 10.1093/oxfordjournals.jbchem.a122593; HIRABAYASHI Y, 1990, J BIOL CHEM, V265, P8144; HUANG LC, 1983, BLOOD, V61, P1020; ISHIZUKA I, 1972, BIOCHIM BIOPHYS ACTA, V260, P279, DOI 10.1016/0005-2760(72)90039-2; ITO M, 1986, J BIOL CHEM, V261, P14278; KANNAGI R, 1984, J BIOL CHEM, V259, P8444; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; LEDEEN RW, 1973, J NEUROCHEM, V21, P829, DOI 10.1111/j.1471-4159.1973.tb07527.x; LEVERY SB, 1986, CARBOHYD RES, V151, P311, DOI 10.1016/S0008-6215(00)90351-3; LEVERY SB, 1988, CARBOHYD RES, V178, P121, DOI 10.1016/0008-6215(88)80106-X; LEVINE JM, 1984, J NEUROSCI, V4, P820; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MCKIBBIN JM, 1982, J BIOL CHEM, V257, P755; NIIMURA Y, 1988, 3RD RINSH KEN C, P10; NISHIMURA K, 1987, J BIOCHEM-TOKYO, V101, P1315, DOI 10.1093/oxfordjournals.jbchem.a121997; OBATA K, 1988, NEUROSCI RES, V6, P131, DOI 10.1016/0168-0102(88)90015-6; Oi V.T., 1980, SELECTED METHODS CEL, P351; OSTRANDER GK, 1988, J BIOL CHEM, V263, P3103; RAUVALA H, 1976, J BIOL CHEM, V251, P7517; ROSNER H, 1985, DEV BRAIN RES, V18, P85, DOI 10.1016/0165-3806(85)90252-4; SCASDALE JN, 1990, BIOCHEMISTRY-US, V29, P9843; SCHLOSSHAUER B, 1988, J NEUROSCI, V8, P580; SEKINE M, 1987, J BIOCHEM-TOKYO, V101, P553, DOI 10.1093/jb/101.3.553; SLOMIANY BL, 1975, EUR J BIOCHEM, V56, P353, DOI 10.1111/j.1432-1033.1975.tb02240.x; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P21, DOI 10.1515/bchm2.1973.354.1.21; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TAKI T, 1986, J BIOL CHEM, V261, P3075; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045; YANG HJ, 1971, J BIOL CHEM, V246, P1192	55	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10268	10274						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1674743				2022-12-25	WOS:A1991FP08600044
J	CHANG, CD; PHILLIPS, P; LIPSON, KE; CRISTOFALO, VJ; BASERGA, R				CHANG, CD; PHILLIPS, P; LIPSON, KE; CRISTOFALO, VJ; BASERGA, R			SENESCENT HUMAN FIBROBLASTS HAVE A POSTTRANSCRIPTIONAL BLOCK IN THE EXPRESSION OF THE PROLIFERATING CELL NUCLEAR ANTIGEN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DNA POLYMERASE-DELTA; MESSENGER-RNA LEVELS; GROWTH-FACTORS; C-MYC; DIPLOID FIBROBLASTS; REPLICATION INVITRO; AUXILIARY PROTEIN; WI-38 CELLS; LIFE-SPAN; CYCLIN	The product of the proliferating cell nuclear antigen (PCNA) gene is the co-factor of DNA polymerase-delta, which is required for cellular and viral DNA replication. Its steady-state mRNA levels are growth-regulated in young human diploid fibroblasts (HDF) as well as in many other cell types. In senescent HDF, PCNA mRNA is not detectable. However, the PCNA gene is transcribed in senescent HDF as efficiently as in young cells. Furthermore, PCNA hnRNA is easily detectable by reverse transcriptase-polymerase chain reaction in both senescent and young HDF, and the levels are essentially similar. These results indicate that in senescent HDF which are incapable of synthesizing cellular DNA, one of the genes coding for a protein of the DNA-synthesizing apparatus is still transcribed, but the product fails to be processed into mature mRNA.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PATHOL,3400 N BROAD ST,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140; MED COLL PENN,CTR GERONTOL RES,PHILADELPHIA,PA 19129; MED COLL PENN,DEPT PHYSIOL BIOCHEM,PHILADELPHIA,PA 19129	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; Drexel University				Lipson, Kenneth/0000-0001-8847-6051	NIA NIH HHS [AG 00378] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG000378] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BASERGA R, 1985, BIOL CELL REPRODUCTI; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BROOKS KM, 1987, J CELL PHYSIOL, V133, P523, DOI 10.1002/jcp.1041330313; CALABRETTA B, 1986, J BIOL CHEM, V261, P2628; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRARI S, 1988, EXP CELL RES, V174, P25, DOI 10.1016/0014-4827(88)90138-3; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; LIU YC, 1989, BIOCHEMISTRY-US, V28, P2967, DOI 10.1021/bi00433a034; MARTIN GM, 1970, LAB INVEST, V23, P86; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; OLASHAW NE, 1983, EXP CELL RES, V149, P547, DOI 10.1016/0014-4827(83)90365-8; OTTAVIO L, 1990, MOL CELL BIOL, V10, P303, DOI 10.1128/MCB.10.1.303; PAULSSON Y, 1986, EMBO J, V5, P2157, DOI 10.1002/j.1460-2075.1986.tb04479.x; PHILLIPS PD, 1987, J CELL PHYSIOL, V133, P135, DOI 10.1002/jcp.1041330117; PHILLIPS PD, 1981, EXP CELL RES, V134, P297, DOI 10.1016/0014-4827(81)90429-8; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; RAPPOLEE DA, 1989, J CELL BIOCHEM, V29, P1; RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; TRAVALI S, 1989, J BIOL CHEM, V264, P7466; [No title captured]	37	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8663	8666						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1673967				2022-12-25	WOS:A1991FM03800005
J	BROWN, DC; COLLINS, KD				BROWN, DC; COLLINS, KD			DIHYDROOROTASE FROM ESCHERICHIA-COLI - SUBSTITUTION OF CO(II) FOR THE ACTIVE-SITE ZN(II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAMASE-II; EHRLICH ASCITES-CARCINOMA; ATOMIC-ABSORPTION SPECTROMETRY; CARBOXYPEPTIDASE-A; BACILLUS-CEREUS; METAL-ION; MULTIFUNCTIONAL PROTEIN; ALCOHOL-DEHYDROGENASE; CLOSTRIDIUM-OROTICUM; TRANSCRIPTION FACTOR	Treatment of Escherichia coli dihydroorotase (a homodimer of subunit molecular weight 38,729) containing only the 1 active site Zn(II) ion per subunit with the sulfhydryl reagent N-(ethyl)-maleimide (NEM) blocks the two external Zn(II) sites per subunit and dramatically lessens the precipitation caused by high concentrations of Zn(II); stabilizes the enzyme partially against air oxidation and dilution inactivation; makes the active site Zn(II) easier to remove; and lowers K(m) and increases k(cat). Treatment of NEM-blocked dihydroorotase ((NEM)dihydroorotase) with the chelator 2,6-pyridinedicarboxylic acid at pH 5.0 in the absence of oxygen and trace metal ions removes the active site Zn(II) with a half-life of 15 min, allowing the production of milligram amounts of moderately stable apo-(NEM)dihydroorotase in about 80% yield. Treatment of apo-(NEM)dihydroorotase with Co(II) at pH 7.0 produces (NEM)dihydroorotase completely substituted at the active site with Co(II) in 100% yield: analysis gives 0.95-1.1 g atoms of Co(II) per active site and 0.03-0.05 g atoms of Zn(II) per active site. This Co(II)-(NEM)dihydroorotase is hyperactive at pH 8. The electronic absorption spectrum of Co(II)-(NEM)dihyroorotase at pH 6.5 implicates an active site thiol group as a ligand to the metal ion. The spectrum is inconsistent with tetrahedral coordination of the active site metal ion and is most consistent with a pentacoordinate structure.	UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore								AULD DS, 1970, BIOCHEMISTRY-US, V9, P4352, DOI 10.1021/bi00824a016; AULD DS, 1988, METHOD ENZYMOL, V158, P110, DOI 10.1016/0076-6879(88)58051-5; BACKSTROM D, 1986, EUR J BIOCHEM, V160, P77, DOI 10.1111/j.1432-1033.1986.tb09942.x; Bertini I., 1986, ZINC ENZYMES; BERTINI I, 1983, COORDINATION CHEM ME, P1; BICKNELL R, 1986, BIOCHEMISTRY-US, V25, P7208, DOI 10.1021/bi00370a066; BROWN DC, 1986, J BIOL CHEM, V261, P5917; Carlin R. L., 1965, TRANSITION METAL CHE, P1; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; CHRISTIANSON DW, 1989, J AM CHEM SOC, V111, P6412, DOI 10.1021/ja00198a065; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; CHRISTOPHERSON RI, 1980, J BIOL CHEM, V255, P3358; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; CORWIN DT, 1987, INORG CHEM, V26, P3079, DOI 10.1021/ic00266a001; CORWIN DT, 1988, INORG CHIM A-BIOINOR, V151, P5, DOI 10.1016/S0020-1693(00)83473-8; Cotton F. Albert, 1988, ADV INORG CHEM, P724; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; Feiters M. C., 1986, Journal de Physique Colloque, V47, P1169, DOI 10.1051/jphyscol:19868228; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; GEOGHEGAN KF, 1983, BIOCHEMISTRY-US, V22, P1847, DOI 10.1021/bi00277a016; GIEDROC DP, 1986, P NATL ACAD SCI USA, V83, P8452, DOI 10.1073/pnas.83.22.8452; GOOD M, 1986, BIOCHEMISTRY-US, V25, P3328, DOI 10.1021/bi00359a036; Hayaishi O, 1989, MED BIOCH CHEM ASPEC, P11; KELLY RE, 1986, J BIOL CHEM, V261, P6073; KIDANI Y, 1986, ZINC ENZYMES, P59; KING SW, 1983, BIOCHEMISTRY-US, V22, P3603, DOI 10.1021/bi00284a010; KUMAMARU T, 1982, ANAL BIOCHEM, V126, P214, DOI 10.1016/0003-2697(82)90132-4; LITTLE C, 1986, BIOCHEM J, V233, P465, DOI 10.1042/bj2330465; MAKINEN MW, 1979, J BIOL CHEM, V254, P356; MAKINEN MW, 1983, P NATL ACAD SCI-BIOL, V80, P2584, DOI 10.1073/pnas.80.9.2584; MARET W, 1989, BIOCHEMISTRY-US, V28, P9944, DOI 10.1021/bi00452a011; MAY SW, 1978, BIOCHEMISTRY-US, V17, P3333, DOI 10.1021/bi00609a025; MORASSI R, 1973, COORDIN CHEM REV, V11, P343, DOI 10.1016/S0010-8545(00)80248-9; NYC IF, 1947, J AM CHEM SOC, V69, P1382; PAN T, 1989, P NATL ACAD SCI USA, V86, P3145, DOI 10.1073/pnas.86.9.3145; PETTIGREW DW, 1985, ARCH BIOCHEM BIOPHYS, V243, P447, DOI 10.1016/0003-9861(85)90521-1; SANDER EG, 1965, J BIOL CHEM, V240, P3628; SHAPIRO R, 1988, METHOD ENZYMOL, V158, P344, DOI 10.1016/0076-6879(88)58065-5; SHOAF WT, 1971, BIOCHEM BIOPH RES CO, V45, P796; SHRIVER DF, 1990, INORG CHEM, P493; SILHAVY TJ, 1975, P NATL ACAD SCI USA, V72, P2120, DOI 10.1073/pnas.72.6.2120; SILLEN LG, 1964, SPECIAL PUBLICATION, V17, P545; SIMMER JP, 1990, P NATL ACAD SCI USA, V87, P174, DOI 10.1073/pnas.87.1.174; SUTTON BJ, 1987, BIOCHEM J, V248, P181, DOI 10.1042/bj2480181; TAYLOR WH, 1976, J BACTERIOL, V127, P863, DOI 10.1128/JB.127.2.863-873.1976; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; VALLEE BL, 1989, FEBS LETT, V257, P138, DOI 10.1016/0014-5793(89)81805-8; WAGNER FW, 1988, METHOD ENZYMOL, V158, P21, DOI 10.1016/0076-6879(88)58045-X; WASHABAUGH MW, 1983, ANAL BIOCHEM, V134, P144, DOI 10.1016/0003-2697(83)90276-2; WASHABAUGH MW, 1986, J BIOL CHEM, V261, P2477; WASHABAUGH MW, 1984, J BIOL CHEM, V259, P3293; WASHABAUGH MW, 1986, J BIOL CHEM, V261, P5920; WILSON HR, 1987, J BACTERIOL, V169, P3051, DOI 10.1128/jb.169.7.3051-3058.1987; WILSON JM, 1980, J AM CHEM SOC, V102, P359, DOI 10.1021/ja00521a058; YACHANDRA V, 1983, J AM CHEM SOC, V105, P6596, DOI 10.1021/ja00360a009; ZAWORSKI PG, 1988, ANAL BIOCHEM, V173, P440, DOI 10.1016/0003-2697(88)90211-4	59	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1597	1604						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671037				2022-12-25	WOS:A1991EU49700039
J	BUSTELO, XR; OTERO, A; GOMEZMARQUEZ, J; FREIRE, M				BUSTELO, XR; OTERO, A; GOMEZMARQUEZ, J; FREIRE, M			EXPRESSION OF THE RAT PROTHYMOSIN-ALPHA GENE DURING LYMPHOCYTE-T PROLIFERATION AND LIVER-REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE MESSENGER-RNAS; CELL NUCLEAR ANTIGEN; AMINO-ACID SEQUENCE; ALPHA-GENE; PROTEIN; CYCLE; TISSUES; THYMOCYTES; ONCOGENE; THYMUS	Prothymosin alpha-(ProT-alpha) is a widely distributed acidic protein whose function has been related to cell proliferation. We have analyzed the expression of the rat ProT-alpha gene in several proliferative systems: concanavalin A (ConA)/interleukin-2-stimulated thymocytes, ConA-stimulated splenic T-lymphocytes, and hepatocytes proliferating during liver regeneration. In these systems, ProT-alpha-mRNA was detected in all stages of the cell cycle, with maximal increments (2-4-fold) at the beginning of the S phase. By contrast, the mRNAs for proliferating cell nuclear antigen/cyclin and histone H3, two cell-cycle-regulated proteins, were hardly detected in resting cells but increased notably at the G1/S boundary and in the S phase, respectively. Treatment of T-cells with the calcium ionophore A23187 increased ProT-alpha mRNA levels 2.5-fold, whereas phorbol 12-myristate 13-acetate, a protein kinase C activator, had no effect on ProT-alpha-gene expression. Incubation of ConA-stimulated T-cells with hydroxyurea, a DNA synthesis inhibitor, did not decrease the levels of ProT-alpha-mRNA, indicating that its expression is independent of DNA synthesis. These findings suggest that ProT-alpha is required throughout all the stages of the cell cycle, resembling a constitutively expressed gene rather than one strictly involved in cell proliferation.	UNIV SANTIAGO DE COMPOSTELA,FAC BIOL,DEPT BIOQUIM & BIOL MOLEC,SANTIAGO,SPAIN	Universidade de Santiago de Compostela			Bustelo, Xose R./A-9526-2010	Bustelo, Xose R./0000-0001-9398-6072				ADKINS B, 1987, ANNU REV IMMUNOL, V5, P325, DOI 10.1146/annurev.iy.05.040187.001545; ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; ALTERMAN RBM, 1984, MOL CELL BIOL, V4, P123, DOI 10.1128/MCB.4.1.123; BAXEVANIS CN, 1987, IMMUNOPHARM IMMUNOT, V9, P429, DOI 10.3109/08923978709035224; BAXEVANIS CN, 1988, IMMUNOPHARM IMMUNOT, V10, P443, DOI 10.3109/08923978809006448; BOYER PD, 1988, J IMMUNOL, V140, P2886; CARBALLO M, 1983, EMBO J, V2, P1759, DOI 10.1002/j.1460-2075.1983.tb01654.x; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLINTON M, 1989, ARCH BIOCHEM BIOPHYS, V269, P256, DOI 10.1016/0003-9861(89)90107-0; CONTEAS CN, 1990, P NATL ACAD SCI USA, V87, P3269, DOI 10.1073/pnas.87.9.3269; DISABATO G, 1987, METHOD ENZYMOL, V150, P3; DOSIL M, 1990, FEBS LETT, V269, P373, DOI 10.1016/0014-5793(90)81196-U; ECONOMOU M, 1988, FEBS LETT, V233, P342, DOI 10.1016/0014-5793(88)80456-3; ESCHENFELDT WH, 1989, J BIOL CHEM, V264, P7546; ESCHENFELDT WH, 1986, P NATL ACAD SCI USA, V83, P9403, DOI 10.1073/pnas.83.24.9403; FENG P, 1990, J BIOL CHEM, V265, P2022; Ghosa N., 1971, PRACINA PURVAVANGA G, V1; GOMEZMARQUEZ J, 1989, J BIOL CHEM, V264, P8451; GOMEZMARQUEZ J, 1988, FEBS LETT, V226, P217, DOI 10.1016/0014-5793(88)81425-X; GOYETTE M, 1983, SCIENCE, V219, P510, DOI 10.1126/science.6297003; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1391, DOI 10.1073/pnas.81.5.1391; HARITOS AA, 1985, P NATL ACAD SCI USA, V82, P1050, DOI 10.1073/pnas.82.4.1050; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; HARITOS AA, 1985, P NATL ACAD SCI USA, V82, P343, DOI 10.1073/pnas.82.2.343; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; KRAKOFF IH, 1968, CANCER RES, V28, P1559; KURKI P, 1987, J IMMUNOL, V138, P4114; MAGE MG, 1984, METHOD ENZYMOL, V108, P118; MAKAROVA T, 1989, FEBS LETT, V257, P247, DOI 10.1016/0014-5793(89)81544-3; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; PAN LX, 1986, ARCH BIOCHEM BIOPHYS, V250, P197, DOI 10.1016/0003-9861(86)90717-4; PANNEERSELVAM C, 1988, ARCH BIOCHEM BIOPHYS, V265, P454, DOI 10.1016/0003-9861(88)90149-X; PLUMB M, 1983, NUCLEIC ACIDS RES, V11, P2391, DOI 10.1093/nar/11.8.2391; RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0; RECLOS GJ, 1987, CLIN EXP IMMUNOL, V70, P336; SALVIN SB, 1987, CLIN IMMUNOL IMMUNOP, V43, P281, DOI 10.1016/0090-1229(87)90137-1; TAKACS L, 1988, J IMMUNOL, V141, P3810; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; TSITSILONI OE, 1989, EXPERIENTIA, V45, P332, DOI 10.1007/BF01957467; WALKER JM, 1982, HMG CHROMOSOMAL PROT, P69; WATTS JD, 1989, FEBS LETT, V245, P17, DOI 10.1016/0014-5793(89)80182-6; WAYNFORTH HB, 1980, EXPT SURGICAL TECHNI, P137; WOOD GW, 1990, IMMUNOLOGY, V69, P303; YIALOURIS PP, 1988, J IMMUNOL METHODS, V106, P267, DOI 10.1016/0022-1759(88)90207-4	47	70	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1443	1447						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671035				2022-12-25	WOS:A1991EU49700017
J	POLIARD, A; BAKKALI, L; POIRET, M; FOIRET, D; DANAN, JL				POLIARD, A; BAKKALI, L; POIRET, M; FOIRET, D; DANAN, JL			REGULATION OF THE RAT ALPHA-FETOPROTEIN GENE-EXPRESSION IN LIVER - BOTH THE PROMOTER REGION AND AN ENHANCER ELEMENT ARE LIVER-SPECIFIC AND NEGATIVELY MODULATED BY DEXAMETHASONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CNRS,ENZYMOL LAB,F-91198 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BELANGER L, 1975, NATURE, V256, P657, DOI 10.1038/256657a0; BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; COSTA RH, 1988, MOL CELL BIOL, V8, P81, DOI 10.1128/MCB.8.1.81; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603; FALKNER FG, 1986, NUCLEIC ACIDS RES, V14, P8819, DOI 10.1093/nar/14.22.8819; GODBOUT R, 1988, MOL CELL BIOL, V8, P1169, DOI 10.1128/MCB.8.3.1169; GODBOUT R, 1986, MOL CELL BIOL, V6, P477, DOI 10.1128/MCB.6.2.477; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HAMMER RE, 1987, SCIENCE, V235, P53, DOI 10.1126/science.2432657; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; HARPEN S, 1988, MOL CELL BIOL, V8, P5159; HEARD JM, 1987, MOL CELL BIOL, V7, P2425, DOI 10.1128/MCB.7.7.2425; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HUANG DP, 1985, NUCLEIC ACIDS RES, V13, P3873, DOI 10.1093/nar/13.11.3873; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; JOSEESTANYOL M, 1989, EUR J BIOCHEM, V181, P761, DOI 10.1111/j.1432-1033.1989.tb14789.x; JOSEESTANYOL M, 1988, J BIOL CHEM, V263, P10865; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LEEGWATER PAJ, 1986, EMBO J, V5, P381, DOI 10.1002/j.1460-2075.1986.tb04223.x; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maniatis T., 1982, MOL CLONING; MUGLIA L, 1986, P NATL ACAD SCI USA, V83, P7653, DOI 10.1073/pnas.83.20.7653; MULLER MM, 1988, EUR J BIOCHEM, V176, P485, DOI 10.1111/j.1432-1033.1988.tb14306.x; NAHON JL, 1987, P NATL ACAD SCI USA, V84, P2135, DOI 10.1073/pnas.84.8.2135; NAHON JL, 1987, J BIOL CHEM, V262, P12479; NAHON JL, 1987, BIOCHIMIE, V69, P445, DOI 10.1016/0300-9084(87)90082-4; OTT MO, 1984, EMBO J, V3, P2505, DOI 10.1002/j.1460-2075.1984.tb02164.x; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SAWADAISHI K, 1988, MOL CELL BIOL, V8, P5179, DOI 10.1128/MCB.8.12.5179; SELL S, 1976, CANCER RES, V36, P4239; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; STRAUL Y, 1987, EMBO J, V6, P1913; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; TRATNER I, 1987, MOL CELL BIOL, V7, P1856, DOI 10.1128/MCB.7.5.1856; TURCOTTE B, 1986, NUCLEIC ACIDS RES, V14, P9827, DOI 10.1093/nar/14.24.9827; VALETTE G, 1982, ACTA ENDOCRINOL-COP, V101, P442; VENETIANER A, 1986, DIFFERENTIATION, V32, P148, DOI 10.1111/j.1432-0436.1986.tb00567.x; VOGT TF, 1988, NUCLEIC ACIDS RES, V16, P487, DOI 10.1093/nar/16.2.487; WASYLYK B, 1988, BIOCHIM BIOPHYS ACTA, V951, P17, DOI 10.1016/0167-4781(88)90021-8; WATANABE K, 1987, J BIOL CHEM, V262, P4812; WIDEN SG, 1986, P NATL ACAD SCI USA, V83, P8196, DOI 10.1073/pnas.83.21.8196; WOOD TG, 1984, P NATL ACAD SCI-BIOL, V81, P7817, DOI 10.1073/pnas.81.24.7817	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2137	2141						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688847				2022-12-25	WOS:A1990CL02800052
J	SAUTERER, RA; GOYAL, A; ZIEVE, GW				SAUTERER, RA; GOYAL, A; ZIEVE, GW			CYTOPLASMIC ASSEMBLY OF SMALL NUCLEAR RIBONUCLEOPROTEIN-PARTICLES FROM 6 S AND 20 S RNA-FREE INTERMEDIATES IN L929 MOUSE FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SUNY STONY BROOK,DEPT ANAT SCI,STONY BROOK,NY 11794; SUNY STONY BROOK,PROGRAM CELLULAR & DEV BIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook								BERGER SL, 1979, BIOCHEMISTRY-US, V18, P5143, DOI 10.1021/bi00590a018; BILLINGS PB, 1985, J IMMUNOL, V135, P428; BRINGMANN P, 1986, EMBO J, V5, P3509, DOI 10.1002/j.1460-2075.1986.tb04676.x; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; CHANDRASEKHARAPPA SC, 1983, J CELL PHYSIOL, V117, P169, DOI 10.1002/jcp.1041170206; CRAFT J, 1988, J CLIN INVEST, V81, P1716, DOI 10.1172/JCI113511; ELICEIRI GL, 1974, CELL, V3, P11, DOI 10.1016/0092-8674(74)90031-2; ELICEIRI GL, 1981, CELL NUCLEUS, V8, P307; FEENEY RJ, 1989, J BIOL CHEM, V264, P5776; FEENEY RJ, 1990, IN PRESS J CELL BIOL; FISHER DE, 1985, CELL, V42, P751, DOI 10.1016/0092-8674(85)90271-5; FISHER DE, 1983, P NATL ACAD SCI-BIOL, V80, P6356, DOI 10.1073/pnas.80.20.6356; FORBES DJ, 1983, J CELL BIOL, V97, P62, DOI 10.1083/jcb.97.1.62; FRITZ A, 1984, J MOL BIOL, V178, P273, DOI 10.1016/0022-2836(84)90144-X; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; KRAMER A, 1987, P NATL ACAD SCI USA, V84, P8408, DOI 10.1073/pnas.84.23.8408; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LELAYTAHA MN, 1986, J MOL BIOL, V189, P519, DOI 10.1016/0022-2836(86)90321-9; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; MADORE SJ, 1984, J CELL BIOL, V98, P188, DOI 10.1083/jcb.98.1.188; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; MIMORI T, 1984, J BIOL CHEM, V259, P560; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P12; PETTERSSON I, 1984, J BIOL CHEM, V259, P5907; REDDY R, 1985, J BIOL CHEM, V260, P930; Reddy R., 1988, STRUCTURE FUNCTION M, P1, DOI 10.1007/978-3-642-73020-7_1; REUTER R, 1987, NUCLEIC ACIDS RES, V15, P4021, DOI 10.1093/nar/15.10.4021; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; STEITZ JA, 1988, STRUCTURE FUNCTION M, P155; ZELLER R, 1983, CELL, V32, P425, DOI 10.1016/0092-8674(83)90462-2; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1; ZIEVE GW, 1987, J CELL PHYSIOL, V131, P247, DOI 10.1002/jcp.1041310215; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9; ZIEVE GW, 1990, IN PRESS CRC CRIT RE, V25; ZIEVE GW, 1989, IN PRESS PROG MOL SU, V11	43	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1048	1058						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688550				2022-12-25	WOS:A1990CH53300066
J	LI, NQ; REDDY, PS; THYAGARAJU, K; REDDY, AP; HSU, BL; SCHOLZ, RW; TU, CPD; REDDY, CC				LI, NQ; REDDY, PS; THYAGARAJU, K; REDDY, AP; HSU, BL; SCHOLZ, RW; TU, CPD; REDDY, CC			ELEVATION OF RAT-LIVER MESSENGER-RNA FOR SELENIUM-DEPENDENT GLUTATHIONE-PEROXIDASE BY SELENIUM DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									PENN STATE UNIV, DEPT VET SCI, ENVIRONM RESOURCES RES INST, 226 FENSKE LAB, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, DEPT MOLEC & CELL BIOL, UNIVERSITY PK, PA 16802 USA; ACAD SINICA, INST MOL BIOL, TAIPEI 11529, TAIWAN	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Academia Sinica - Taiwan			Kedam, Thyagaraju/F-9934-2017; Kedam, Thyagaraju/ABE-4569-2021	Kedam, Thyagaraju/0000-0001-9877-7819; Kedam, Thyagaraju/0000-0001-9877-7819	NATIONAL CANCER INSTITUTE [R01CA037979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031245, K04HL001240] Funding Source: NIH RePORTER; NCI NIH HHS [CA37979] Funding Source: Medline; NHLBI NIH HHS [K04 HL01240, HL31245] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRYANT RW, 1982, PROG LIPID RES, V20, P189; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHING WM, 1984, P NATL ACAD SCI-BIOL, V81, P57, DOI 10.1073/pnas.81.1.57; CHRISTHAZELHOF E, 1976, BIOCHIM BIOPHYS ACTA, V450, P450, DOI 10.1016/0005-2760(76)90018-7; DIPLOCK AT, 1973, FEBS LETT, V29, P205, DOI 10.1016/0014-5793(73)80020-1; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HAWKES WC, 1983, BIOCHIM BIOPHYS ACTA, V739, P225, DOI 10.1016/0167-4781(83)90033-7; HONG Y, 1989, J BIOL CHEM, V264, P13793; KNIGHT SAB, 1988, J NUTR, V118, P853, DOI 10.1093/jn/118.7.853; KRAUS RJ, 1980, BIOCHIM BIOPHYS ACTA, V615, P19, DOI 10.1016/0005-2744(80)90004-2; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADDIPATI KR, 1987, ARCH BIOCHEM BIOPHYS, V254, P9, DOI 10.1016/0003-9861(87)90075-0; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; Ouchterlony O., 1968, HDB IMMUNODIFFUSION, P21; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; RAMANATHAN L, 1979, MOL IMMUNOL, V16, P935, DOI 10.1016/0161-5890(79)90094-4; REDDY AP, 1988, NUCLEIC ACIDS RES, V16, P5557, DOI 10.1093/nar/16.12.5557; REDDY CC, 1988, FASEB J, V2, pA765; REDDY CC, 1981, BIOCHEM BIOPH RES CO, V101, P970; REDDY CC, 1983, FUND APPL TOXICOL, V3, P431, DOI 10.1016/S0272-0590(83)80017-7; REDDY CC, 1985, ACS SYM SER, V277, P253; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SAEDI MS, 1988, BIOCHEM BIOPH RES CO, V153, P855, DOI 10.1016/S0006-291X(88)81174-4; STADTMAN TC, 1980, ANNU REV BIOCHEM, V49, P93, DOI 10.1146/annurev.bi.49.070180.000521; SUKENAGA Y, 1987, NUCLEIC ACIDS RES, V15, P7178, DOI 10.1093/nar/15.17.7178; SUNDE RA, 1987, J BIOL CHEM, V262, P933; SUNDE RA, 1980, BIOCHEM BIOPH RES CO, V93, P1181, DOI 10.1016/0006-291X(80)90614-2; Tappel A L, 1980, Ann N Y Acad Sci, V355, P18, DOI 10.1111/j.1749-6632.1980.tb21324.x; TAYLOR SL, 1976, LIPIDS, V11, P530, DOI 10.1007/BF02532898; TELAKOWSKIHOPKINS CA, 1985, J BIOL CHEM, V260, P5820; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHETTER PA, 1978, J ASSOC OFF ANA CHEM, V61, P927; WITTWER AJ, 1984, BIOCHEMISTRY-US, V23, P4650, DOI 10.1021/bi00315a021; YOSHIDA M, 1982, AGR BIOL CHEM TOKYO, V46, P41, DOI 10.1080/00021369.1982.10865023; YOSHIMURA S, 1988, BIOCHEM BIOPH RES CO, V154, P1024, DOI 10.1016/0006-291X(88)90242-2; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	40	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					108	113						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688426				2022-12-25	WOS:A1990CF66200019
J	WESTLUND, B; DAHMS, NM; KORNFELD, S				WESTLUND, B; DAHMS, NM; KORNFELD, S			THE BOVINE MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH FACTOR-II RECEPTOR - LOCALIZATION OF MANNOSE 6-PHOSPHATE BINDING-SITES TO DOMAINS 1-3 AND 7-11 OF THE EXTRACYTOPLASMIC REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND INTERACTIONS; SEQUENCE-ANALYSIS; CLONING; PROTEINS; PURIFICATION; CDNA; EXPRESSION; TESTES	The extracytoplasmic region of the 270-kDa mannose 6-phosphate/IGF-II receptor is composed of 15 repeating domains and is capable of binding 2 mol of mannose 6-phosphate (Man-6-P). To localize the Man-6-P binding domains, bovine receptor was subjected to partial proteolysis with subtilisin followed by affinity chromatography on pentamannosyl phosphate-agarose. Eleven proteolytic fragments ranging in apparent molecular mass from 53 to 206 kDa were isolated. Sequence analysis of six of the fragments localized their amino termini to either the beginning of domain 1 at the amino terminus of the molecule or the beginning of domain 7, according to the alignment of Lobel et al. (Lobel, P., Dahms, N. M., and Kornfeld, S. (1988) J. Biol. Chem. 263, 2563-2570). The smallest fragment, with an apparent molecular mass of 53 kDa, is predicted to encompass domains 1-3. Another fragment, with an apparent molecular mass of 82 kDa, is predicted to encompass domains 7-10 or 7-11. The Man-6-P binding site contained within domains 1-3 was further defined by expressing truncated forms of the receptor in Xenopus laevis oocytes and assaying their ability to bind phosphomannosyl residues. A soluble polypeptide containing domains 1-3 exhibited binding activity, whereas a polypeptide containing domains 1 and 2 did not. This indicates that domain 3 is a necessary component of one of the Man-6-P binding sites of the receptor.	WASHINGTON UNIV,SCH MED,DEPT MED,DIV HEMATOL ONCOL,660 S EUCLID AVE,BOX 8125,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)					NCI NIH HHS [CA 08759] Funding Source: Medline; NIAID NIH HHS [5-T32-AI07163] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRETTHAU.RK, 1973, BIOCHEMISTRY-US, V12, P1251, DOI 10.1021/bi00731a002; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DAHMS NM, 1989, J BIOL CHEM, V264, P11458; DAHMS NM, 1987, CELL, V50, P181, DOI 10.1016/0092-8674(87)90214-5; DISTLER JJ, 1987, METHOD ENZYMOL, V138, P504; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; GURDON JB, 1976, J EMBRYOL EXP MORPH, V36, P523; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1990, ARCH BIOCHEM BIOPHYS, V283, P150, DOI 10.1016/0003-9861(90)90625-9; LOBEL P, 1987, P NATL ACAD SCI USA, V84, P2233, DOI 10.1073/pnas.84.8.2233; LOBEL P, 1988, J BIOL CHEM, V263, P2563; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; PERDUE JF, 1983, J BIOL CHEM, V258, P7800; POHLMANN R, 1987, P NATL ACAD SCI USA, V84, P5575, DOI 10.1073/pnas.84.16.5575; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Sambrook J, 1989, MOL CLONING LABORATO; STEIN M, 1987, BIOL CHEM H-S, V368, P927, DOI 10.1515/bchm3.1987.368.2.927; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WAHEED A, 1988, BIOCHEM BIOPH RES CO, V152, P1248, DOI 10.1016/S0006-291X(88)80419-4	30	77	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23233	23239						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660469				2022-12-25	WOS:A1991GT48300070
J	KARPEL, R; ALON, T; GLASER, G; SCHULDINER, S; PADAN, E				KARPEL, R; ALON, T; GLASER, G; SCHULDINER, S; PADAN, E			EXPRESSION OF A SODIUM PROTON ANTIPORTER (NHAA) IN ESCHERICHIA-COLI IS INDUCED BY NA+ AND LI+ IONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; PH HOMEOSTASIS; GENE; BACTERIA; FRAGMENTS; TRANSPORT; PROTEINS; DELETION; SIGNALS; ANT	Regulation of expression of nhaA, the gene which encodes a Na+/H+ antiporter in Escherichia coli has been studied. Two promoters have been identified in the upstream sequence of the gene and the corresponding start point of transcription mapped by primer extension. Monitoring the beta-galactosidase activity of a chromosomal translation fusion of nhaA'-'lacZ show that at pH 7.5 the gene is induced, within 1 h, by 100 mM of either Li+ or Na+. Change of pH between 6.5 and 8.5 by itself does not increase expression of the gene but it markedly increases the sensitivity of the expression system to the ions. At pH 7.5 maximal induction is obtained by 100 mM NaCl, whereas at pH 8.6, 10 mm NaCl elicit similar response. The pattern of regulation of nhaA reflects its importance in adaptation to high salinity and alkaline pH in E. coli.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT CELLULAR BIOCHEM,IL-91904 JERUSALEM,ISRAEL	Hebrew University of Jerusalem	KARPEL, R (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,INST LIFE SCI,DIV MICROBIAL & MOLEC ECOL,IL-91904 JERUSALEM,ISRAEL.		Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237				AMBUDKER SV, 1990, BACTERIAL ENERGETICS, P247; BAKKER EP, 1990, FEMS MICROBIOL LETT, V75, P319, DOI 10.1111/j.1574-6968.1990.tb04105.x; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BORON WF, 1983, J MEMBRANE BIOL, V72, P1, DOI 10.1007/BF01870311; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CASTLE AM, 1986, J BIOL CHEM, V261, P7797; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; FURANO AV, 1976, CELL, V8, P115, DOI 10.1016/0092-8674(76)90192-6; GAFNY R, 1988, NUCLEIC ACIDS RES, V16, P61, DOI 10.1093/nar/16.1.61; GILLEN JR, 1981, J BACTERIOL, V145, P521, DOI 10.1128/JB.145.1.521-532.1981; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HAUSSINGER D, 1988, PH HOMEOSTASIS MECHA; HOOPES BC, 1987, ESCHERICHIA COLI SAL, P1231; KARPEL R, 1988, J BIOL CHEM, V263, P10408; LEBLANC G, 1987, NAPLUS H PLUS EXCHAN, P103; McKenney K, 1981, Gene Amplif Anal, V2, P383; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Miller J.H., 1972, EXPT MOL GENETICS; PADAN E, 1989, J BIOL CHEM, V264, P20297; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; PAN JW, 1990, J BIOL CHEM, V265, P9247; POULSEN LK, 1989, MOL MICROBIOL, V3, P1463, DOI 10.1111/j.1365-2958.1989.tb00131.x; POUYSSEGUR J, 1988, NAPLUS HPLUS EXCHANG, P337; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Silhavy T.J., 1984, EXPT GENE FUSIONS; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985	31	91	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21753	21759						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657980				2022-12-25	WOS:A1991GP80400065
J	CALLAHAN, HL; BEVERLEY, SM				CALLAHAN, HL; BEVERLEY, SM			HEAVY-METAL RESISTANCE - A NEW ROLE FOR P-GLYCOPROTEINS IN LEISHMANIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BACTERIAL TRANSPORT PROTEINS; DRUG-RESISTANCE; EXTRACHROMOSOMAL CIRCLES; MULTIDRUG RESISTANCE; BACILLUS-SUBTILIS; HUMAN-CELLS; H-REGION; GENE; AMPLIFICATION; TARENTOLAE	P-glycoproteins are responsible for multidrug resistance in tumor cell lines and are thought to have a physiologic role in exporting cellular metabolites. We now report that a P-glycoprotein gene in the H region of the trypanosomatid protozoan Leishmania confers resistance to heavy metals when present in multiple copies. The Leishmania H region is frequently amplified in drug-resistant lines and is associated with metal resistance. Leishmania expression vectors were used to introduce multiple copies of segments of the Leishmania major H region into wild-type L. major promastigotes. Only constructs bearing a segment of L. major DNA containing the P-glycoprotein lmpgpA conferred arsenite resistance. Deletional analysis of the arsenite-resistant construct mapped resistance to the lmpgpA protein coding region. Lines expressing lmpgpA showed resistance to arsenite and trivalent antimonials, but not to pentavalent antimonials, zinc, cadmium, or the typical multidrug-resistant P-glycoprotein substrates vinblastine and puromycin. Transfection of the Leishmania tarentolae P-glycoprotein homologue ltpgpA resulted in a similar resistance profile. Thus, these pgpAs represent a functionally distinct group of P-glycoproteins which exhibit a substrate specificity similar to prokaryotic heavy metal pumps. Additionally, several arguments suggest that pgpAs may play a role in the susceptibility of Leishmania to clinically utilized antimonials.			CALLAHAN, HL (corresponding author), HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115, USA.			Beverley, Stephen/0000-0001-5319-0811				AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BERMAN JD, 1982, J INFECT DIS, V145, P279, DOI 10.1093/infdis/145.2.279; BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHEN CM, 1986, J BIOL CHEM, V261, P5030; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; CROFT SL, 1981, COMP BIOCHEM PHYS C, V68, P95, DOI 10.1016/0306-4492(81)90043-5; DETKE S, 1989, EXP CELL RES, V180, P161, DOI 10.1016/0014-4827(89)90220-6; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094; ELLENBERGER TE, 1989, THESIS HARVARD U; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; GOODWIN LG, 1943, BIOCHEM J, V137, P198; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GROGL M, 1991, AM J TROP MED HYG, V45, P98, DOI 10.4269/ajtmh.1991.45.98; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HIGHTOWER RC, 1988, J BIOL CHEM, V263, P16970; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; LADDAGA RA, 1985, J BACTERIOL, V162, P1106, DOI 10.1128/JB.162.3.1106-1110.1985; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; MOBLEY HLT, 1982, P NATL ACAD SCI-BIOL, V79, P6119, DOI 10.1073/pnas.79.20.6119; OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; PETRILLOPEIXOTO ML, 1988, MOL CELL BIOL, V8, P5188, DOI 10.1128/MCB.8.12.5188; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; SUROWITZ KG, 1984, ARCH MICROBIOL, V140, P107, DOI 10.1007/BF00454911; TYNECKA Z, 1981, J BACTERIOL, V147, P313, DOI 10.1128/JB.147.2.313-319.1981; TYNECKA Z, 1975, ACTA MICROBIOL POL, V7, P11; WEST IC, 1990, TRENDS BIOCHEM SCI, V15, P42, DOI 10.1016/0968-0004(90)90171-7; WHITE TC, 1988, J BIOL CHEM, V263, P16977	31	193	198	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18427	18430						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1680861				2022-12-25	WOS:A1991GJ47200005
J	CHAPARIAN, MG; EVANS, DR				CHAPARIAN, MG; EVANS, DR			THE CATALYTIC MECHANISM OF THE AMIDOTRANSFERASE DOMAIN OF THE SYRIAN-HAMSTER MULTIFUNCTIONAL PROTEIN CAD - EVIDENCE FOR A CAD-GLUTAMYL COVALENT INTERMEDIATE IN THE FORMATION OF CARBAMYL-PHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-PHOSPHORIC ANHYDRIDE; REGULATED SYNTHESIS SUBUNIT; AMIDE TRANSFER-FUNCTION; ESCHERICHIA-COLI K-12; AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; REVERSIBLE DISSOCIATION; SALMONELLA-TYPHIMURIUM; ANTHRANILATE SYNTHASE; SERRATIA-MARCESCENS	The multifunctional protein CAD catalyzes the first three steps in pyrimidine biosynthesis in mammalian cells, including the synthesis of carbamyl phosphate from bicarbonate, MgATP and glutamine. The Syrian hamster CAD glutaminase (GLNase) domain, a trpG-type amidotransferase, catalyzes glutamine hydrolysis in the absence of MgATP and bicarbonate (K(m) = 95-mu-M and k(cat) = 0.14 s-1). Unlike E. coli carbamyl phosphate synthetase (Wellner, V. P., Anderson, P. M., and Meister, A. (1973) Biochemistry 12, 2061-2066), a stable thioester intermediate did not accumulate when the mammalian enzyme was incubated with glutamine. However, a covalent adduct could be isolated when the protein was denatured in acid. The steady state concentration of the intermediate increased with increasing glutamine concentration to nearly one mole per mole of enzyme with half saturation at 105-mu-M, close to the K(m) value for glutamine. The adduct formed at the active site of the glutaminase domain. The rate of breakdown of the intermediate (k4), determined directly, was 0.17 s-1 and the rate of formation (k3) was estimated as 0.52 s-1. In the absence of MgATP and bicarbonate, k4 = k(cat) indicating that the decomposition of the intermediate is the rate-limiting step. The intermediate was chemically and kinetically competent, and the glutamine dissociation constant (330-mu-M) and rate constants were consistent with steady state kinetics and accurately predicted the steady state concentration of the intermediate. These studies suggest a mechanism similar to the cysteine proteases such as recently proposed by Mei and Zalkin (Mei, B., and Zalkin, H. (1989) J. Biol. Chem. 264, 16613-16619) who identified a catalytic triad in glutamine phosphoribosyl-5'-pyrophosphate amidotransferase, a purF-type enzyme. MgATP and bicarbonate increased k(cat) of the glutaminase reaction 14-fold by accelerating both the rate of formation and the rate of breakdown of the intermediate, and prevented the accumulation of the intermediate; however, the K(m) value for glutamine was not significantly altered. The instability of the thioester intermediate leads to appreciable hydrolysis of glutamine in the absence of the other substrates. However, bicarbonate alone spares glutamine by increasing the K(m) and K(s) of glutamine to 600 and 8960-mu-M, respectively, thus reducing k(cat)/K(m) 3-fold when MgATP is limiting. In the absence of MgATP and bicarbonate, ammonia decreased the rate of hydrolysis and the accumulation of the thioester intermediate indicating that ammonia had direct access to the thioester at the GLNase domain active site. In contrast, in the presence of these substrates, the rate of glutamine hydrolysis as a function of ammonia concentration gave saturation kinetics with half saturation occurring at 80-mu-M, a value which is the same as the K(m) for ammonia. The latter result indicated that in the presence of MgATP and bicarbonate, ammonia must first bind to its site on the synthetase domain to gain access to the glutaminase domain active site.			CHAPARIAN, MG (corresponding author), WAYNE STATE UNIV, DEPT BIOCHEM, DETROIT, MI 48201 USA.				NATIONAL CANCER INSTITUTE [R01CA027674] Funding Source: NIH RePORTER; NCI NIH HHS [CA27674] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMURO N, 1985, J BIOL CHEM, V260, P4844; ANDERSON PM, 1973, BIOCHEM BIOPH RES CO, V55, P246, DOI 10.1016/S0006-291X(73)80086-5; ANDERSON PM, 1975, BIOCHEMISTRY-US, V14, P3688, DOI 10.1021/bi00687a027; ANDERSON PM, 1965, BIOCHEMISTRY-US, V4, P2803, DOI 10.1021/bi00888a034; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3157, DOI 10.1021/bi00874a012; ANDRULIS IL, 1987, MOL CELL BIOL, V7, P2435, DOI 10.1128/MCB.7.7.2435; BEIN K, 1991, IN PRESS J BIOL CHEM, V266; BEREZIN IV, 1971, FEBS LETT, V15, P121, DOI 10.1016/0014-5793(71)80037-6; CARLOMAGNO MS, 1988, J MOL BIOL, V203, P585, DOI 10.1016/0022-2836(88)90194-5; CHAPARIAN MG, 1988, FASEB J, V2, pA1549; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; FERSHT A, 1985, ENZYME STRUCTURE MEC, P135; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; GOTO Y, 1976, J BIOL CHEM, V251, P941; HAGER SE, 1967, J BIOL CHEM, V242, P5667; HARTMAN SC, 1973, ENZYMES GLUTAMINE ME, P320; HOOGENRAAD NJ, 1971, BIOCHEM BIOPH RES CO, V44, P981, DOI 10.1016/0006-291X(71)90808-4; KAPLAN JB, 1983, J MOL BIOL, V168, P451, DOI 10.1016/S0022-2836(83)80295-2; KAPLAN JB, 1985, J MOL BIOL, V183, P327, DOI 10.1016/0022-2836(85)90004-X; KAWAMURA M, 1978, J BIOL CHEM, V253, P4659; KHEDOURI E, 1966, BIOCHEMISTRY-US, V5, P3552, DOI 10.1021/bi00875a024; MEEK TD, 1987, BIOCHEMISTRY-US, V26, P2584, DOI 10.1021/bi00383a026; MEI B, 1989, J BIOL CHEM, V264, P16613; MEISTER A, 1989, ADV ENZYMOL RAMB, V62, P315; MELOCHE HP, 1967, BIOCHEMISTRY-US, V6, P2273, DOI 10.1021/bi00860a002; NICHOLS BP, 1980, J MOL BIOL, V142, P503, DOI 10.1016/0022-2836(80)90260-0; NYUNOYA H, 1983, P NATL ACAD SCI-BIOL, V80, P4629, DOI 10.1073/pnas.80.15.4629; PALUH JL, 1985, J BIOL CHEM, V260, P1889; PAUKERT JL, 1982, ARCH BIOCHEM BIOPHYS, V218, P443, DOI 10.1016/0003-9861(82)90366-6; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; Pinkus L M, 1977, Methods Enzymol, V46, P414; POWERS SG, 1976, P NATL ACAD SCI USA, V73, P3020, DOI 10.1073/pnas.73.9.3020; POWERS SG, 1978, J BIOL CHEM, V253, P1258; POWERS SG, 1978, J BIOL CHEM, V253, P800; RUBINO SD, 1986, J BIOL CHEM, V261, P1320; SCHENDEL FJ, 1989, BIOCHEMISTRY-US, V28, P2459, DOI 10.1021/bi00432a017; SHOAF WT, 1971, BIOCHEM BIOPH RES CO, V45, P796; SIMMER JP, 1990, J BIOL CHEM, V265, P10395; SURIN BP, 1988, MOL MICROBIOL, V2, P173, DOI 10.1111/j.1365-2958.1988.tb00019.x; TIEDEMAN AA, 1985, J BIOL CHEM, V260, P8676; TROTTA PP, 1971, P NATL ACAD SCI USA, V68, P2599, DOI 10.1073/pnas.68.10.2599; TROTTA PP, 1974, J BIOL CHEM, V249, P492; TSO JY, 1982, J BIOL CHEM, V257, P3525; TSO JY, 1980, J BIOL CHEM, V255, P1451; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799; WELLNER VP, 1973, BIOCHEMISTRY-US, V12, P2061, DOI 10.1021/bi00735a006; WELLNER VP, 1975, J BIOL CHEM, V250, P3261; WENG M, 1987, J BACTERIOL, V169, P3023, DOI 10.1128/jb.169.7.3023-3028.1987; WENG M, 1986, J BIOL CHEM, V261, P5568; WERNER M, 1985, EUR J BIOCHEM, V146, P371, DOI 10.1111/j.1432-1033.1985.tb08663.x; WU GY, 1988, BIOCHEM J, V255, P139, DOI 10.1042/bj2550139; ZALKIN H, 1985, J BIOL CHEM, V260, P3350; ZALKIN H, 1980, MULTIFUNCTIONAL PROT, P123	53	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3387	3395						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1671673				2022-12-25	WOS:A1991EY68200009
J	HORIO, Y; MURAD, F				HORIO, Y; MURAD, F			SOLUBILIZATION OF GUANYLYL CYCLASE FROM BOVINE ROD OUTER SEGMENTS AND EFFECTS OF LOWERING CA2+ AND NITRO-COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT ADAPTATION; RETINAL RODS; ENDOTHELIUM; CALCIUM; CGMP; GTP; PHOTORECEPTORS; RECEPTOR; OXIDE; CELLS	Guanylyl cyclase from bovine rod outer segments was solubilized using Triton X-100 and a high concentration of KCl, and its regulation was studied. The efficiency of solubilization was about 50-90% of total activity. When the Ca2+ content was lowered (< 80 nM), guanylyl cyclase was activated about 2-fold. In the presence of higher concentrations of Ca2+ (> 140 nM), the activity was decreased. The regulation by Ca2+ was also demonstrated with solubilized preparations. In the presence of 186 nM Ca2+ which inhibited guanylyl cyclase, La3+ activated the enzyme about 2-fold, suggesting that the Ca2+-binding protein similar to other Ca2+-binding proteins associates with guanylyl cyclase regulation. Sodium nitroprusside and nitric oxide which are activators of soluble guanylyl cyclase in other tissues also activated the retinal guanylyl cyclase. Maximum activation by sodium nitroprusside was 20-fold using Mg2+ as a cofactor. Activation by nitric oxide and related compounds suggests that retinal guanylyl cyclase contains a heme prosthetic group that may participate in a novel regulatory mechanism for this enzyme.	NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,CHICAGO,IL 60611; ABBOTT LABS,DIV PHARMACEUT,N CHICAGO,IL 60064	Northwestern University; Abbott Laboratories				Horio, Yoshiyuki/0000-0002-5021-5929	NIDDK NIH HHS [DK30787] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030787] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; BRANDWEIN HJ, 1982, J BIOL CHEM, V257, P1309; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; COHEN AI, 1978, J GEN PHYSIOL, V71, P595, DOI 10.1085/jgp.71.5.595; COTE RH, 1986, J BIOL CHEM, V261, P2965; COTE RH, 1989, J BIOL CHEM, V264, P15384; ELDIEB MMR, 1987, BIOCHIM BIOPHYS ACTA, V928, P83; FLEISCHMAN D, 1980, BIOCHIM BIOPHYS ACTA, V630, P176, DOI 10.1016/0304-4165(80)90419-5; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; FORSTERMANN U, 1990, MOL PHARMACOL, V38, P7; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FURCHGOTT RF, 1984, ANNU REV PHARMACOL, V24, P175, DOI 10.1146/annurev.pa.24.040184.001135; GOLDBERG ND, 1983, J BIOL CHEM, V258, P9213; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; HORIO Y, 1989, Society for Neuroscience Abstracts, V15, P205; ISHII K, 1989, J APPL CARDIOL, V4, P505; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; KUNO T, 1986, J BIOL CHEM, V261, P5817; KUNO T, 1986, J BIOL CHEM, V261, P1470; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCDONALD LJ, 1989, BIOCHEMISTRY-US, V28, P9926, DOI 10.1021/bi00452a008; MULSCH A, 1989, N-S ARCH PHARMACOL, V340, P767; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; MURAD F, 1988, COLD SPRING HARB SYM, V53, P1005, DOI 10.1101/SQB.1988.053.01.115; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WALDMAN SA, 1984, J BIOL CHEM, V259, P4038	35	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3411	3415						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1671674				2022-12-25	WOS:A1991EY68200013
J	PRIVALSKY, ML				PRIVALSKY, ML			A SUBPOPULATION OF THE V-ERB-A ONCOGENE PROTEIN, A DERIVATIVE OF A THYROID-HORMONE RECEPTOR, ASSOCIATES WITH HEAT-SHOCK PROTEIN 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIAN ERYTHROBLASTOSIS VIRUS; CHEMICAL CROSS-LINKING; ROUS-SARCOMA VIRUS; DNA-BINDING STATE; GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; STEROID-HORMONES; GENE; TRANSCRIPTION; ENCODES	The v-erb A oncogene of avian erythroblastosis virus is derived from a host gene for a thyroid hormone receptor and is able to block differentiation of erythroid cells and modify the growth properties of fibroblasts. Unlike its host cell progenitor, the v-erb A protein is found in both cytoplasmic and nuclear fractions of the cell. I report here that the cytoplasmic form of the v-erb A protein is associated in a higher molecular weight complex with heat shock protein 90, the same polypeptide found in association with the unliganded steroid receptors and with the soluble forms of the src oncogene.			PRIVALSKY, ML (corresponding author), UNIV CALIF DAVIS, DEPT MICROBIOL, DAVIS, CA 95616 USA.							ABDELLA PM, 1979, BIOCHEM BIOPH RES CO, V87, P734, DOI 10.1016/0006-291X(79)92020-5; APRILETTI JW, 1983, MOL BIOL THYROID HOR, P1; ARANYI P, 1988, BIOCHEMISTRY-US, V27, P1330, DOI 10.1021/bi00404a036; BAULIEU EE, 1987, J CELL BIOCHEM, V35, P161, DOI 10.1002/jcb.240350209; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; BOUCHER P, 1988, J VIROL, V62, P534, DOI 10.1128/JVI.62.2.534-544.1988; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CLARK CR, 1985, INTERACTION STEROID; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DENIS M, 1989, CANCER RES, V49, pS2275; DENIS M, 1987, J BIOL CHEM, V262, P11803; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRANDICS P, 1984, J BIOL CHEM, V259, P3173; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; JOAB I, 1984, NATURE, V308, P850, DOI 10.1038/308850a0; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PICARD D, 1990, IN PRESS CELL REGUL; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; PRIVALSKY ML, 1983, CELL, V32, P1257, DOI 10.1016/0092-8674(83)90307-0; PRIVALSKY ML, 1991, IN PRESS CELL; RADANYI C, 1989, J BIOL CHEM, V264, P2568; REXIN M, 1988, BIOCHEMISTRY-US, V27, P5593, DOI 10.1021/bi00415a030; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHERMAN MR, 1984, ANNU REV PHYSIOL, V46, P83; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TOFT DO, 1987, BIOCHEM ACTION HORM, V14, P293; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WRANGE O, 1986, J BIOL CHEM, V261, P1770; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1	46	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1456	1462						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671036				2022-12-25	WOS:A1991EU49700019
J	HOGREFE, HH; HOGREFE, RI; WALDER, RY; WALDER, JA				HOGREFE, HH; HOGREFE, RI; WALDER, RY; WALDER, JA			KINETIC-ANALYSIS OF ESCHERICHIA-COLI RNASE H USING DNA-RNA-DNA DNA SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242; INTEGRATED DNA TECHNOL,CORALVILLE,IA 52241	University of Iowa								ARENDES J, 1982, J BIOL CHEM, V257, P4719; BERKOWER I, 1973, J BIOL CHEM, V248, P5914; Blackburn P, 1982, ENZYMES, VXV, P317; BUSEN W, 1980, J BIOL CHEM, V255, P9434; CARUTHERS MH, 1982, GENETIC ENG, V4, P1; Crouch R. J., 1982, NUCLEASES, P211; DARLIX JL, 1975, EUR J BIOCHEM, V51, P369, DOI 10.1111/j.1432-1033.1975.tb03937.x; EADIE JS, 1987, ANAL BIOCHEM, V165, P442, DOI 10.1016/0003-2697(87)90294-6; Fasman GD., 1975, HDB BIOCH MOL BIOL N, V1, P589; Gait M. J, 1984, OLIGONUCLEOTIDE SYNT; GREENE PJ, 1975, J MOL BIOL, V99, P237, DOI 10.1016/S0022-2836(75)80143-4; Inoue H, 1987, Nucleic Acids Symp Ser, P221; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; ITOH T, 1982, NUCLEIC ACIDS RES, V10, P5949, DOI 10.1093/nar/10.19.5949; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KANAYA S, 1989, J BIOL CHEM, V264, P11546; KANAYA S, 1983, J BIOL CHEM, V258, P1276; KARWAN R, 1988, J BIOL CHEM, V263, P14970; KARWAN R, 1983, BIOCHEMISTRY-US, V22, P5500, DOI 10.1021/bi00293a008; KIERZEK R, 1986, BIOCHEMISTRY-US, V25, P7840, DOI 10.1021/bi00372a009; KOGOMA T, 1986, J BACTERIOL, V166, P361, DOI 10.1128/jb.166.2.361-363.1986; KRUG MS, 1989, P NATL ACAD SCI USA, V86, P3539, DOI 10.1073/pnas.86.10.3539; LU AL, 1981, J BIOL CHEM, V256, P3200; MANIATIS T, 1982, MOL CLONING LABORATO, P190; MARKIEWICZ WT, 1984, B POL ACAD SCI-CHEM, V32, P433; MILLER HI, 1973, J BIOL CHEM, V248, P2621; MODRICH P, 1976, J BIOL CHEM, V251, P5866; Modrich P., 1982, NUCLEASES, P109; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; RUBIN RA, 1978, NUCLEIC ACIDS RES, V5, P2991, DOI 10.1093/nar/5.8.2991; SHIBAHARA S, 1987, NUCLEIC ACIDS RES, V15, P4403, DOI 10.1093/nar/15.11.4403; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P3539; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; STAWINSKI J, 1988, NUCLEIC ACIDS RES, V16, P9285, DOI 10.1093/nar/16.19.9285; STAWINSKI J, 1988, J AM CHEM SOC, V109, P7845; SUMIDAYASUMOTO C, 1979, COLD SPRING HARB SYM, V43, P311, DOI 10.1101/SQB.1979.043.01.038; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011; WITZEL H, 1962, BIOCHEM BIOPH RES CO, V7, P295, DOI 10.1016/0006-291X(62)90194-8	39	100	106	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5561	5566						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690712				2022-12-25	WOS:A1990CW48000041
J	WEINER, FR; SMITH, PJ; WERTHEIMER, S; RUBIN, CS				WEINER, FR; SMITH, PJ; WERTHEIMER, S; RUBIN, CS			REGULATION OF GENE-EXPRESSION BY INSULIN AND TUMOR-NECROSIS-FACTOR-ALPHA IN 3T3-L1 CELLS - MODULATION OF THE TRANSCRIPTION OF GENES ENCODING ACYL-COA SYNTHETASE AND STEAROYL-COA DESATURASE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DEPENDENT PROTEIN-KINASE; GROWTH FACTOR-I; MESSENGER-RNAS; DIFFERENTIATION; ADIPOCYTES; CLONING; PREADIPOCYTES; CACHECTIN; INVITRO; SUBUNIT	Insulin and tumor necrosis factor alpha (TNF-alpha) produce potent and opposing physiological signals in adipocytes. However, genes that are co-regulated by the hormone and cytokine during and after adipocyte differentiation have not been characterized. Using 3T3-L1 cells, we have studied the regulation of the expression of genes encoding acyl-CoA synthetase (ACS), and stearoyl CoA desaturase-1 (SCD-1), two enzymes that play key roles in the metabolism of long chain fatty acids. Insulin is required for triggering the transcriptional activation of the ACS and SCD-1 genes at an early stage in adipocyte differentiation. In mature adipocytes insulin elicits a 4-fold increase in the rates of transcription of the two genes. However, when 3T3-L1 adipocytes are treated with TNF-alpha the cytokine causes a 75-90% decrease in the levels of ACS and SCD-1 mRNAs. The decline in mRNA content is associated with similar decrements in the rates of transcription of the ACS and SCD-1 genes. Thus, the ACS and SCD-1 genes are subject to stimulation and counter-regulation (at the transcriptional level) by insulin and TNF-alpha, respectively. The opposing effects of insulin and TNF-alpha are observed in developing and terminally differentiated adipocytes. Unlike the ACS and SCD-1 genes, the genes that encode the lipogenic enzymes lipoprotein lipase and malic enzyme are not subject to counter-regulation by insulin and TNF-alpha at the transcriptional level in 3T3-L1 adipocytes. These observations on the control of ACS and SCD-1 expression suggest possible mechanisms by which adipocytes can markedly adjust their capacity for long chain fatty acid metabolism in response to external stimuli.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, ATRAN LABS, DEPT MOLEC PHARMACOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	WEINER, FR (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, ATRAN LABS, DEPT MED, BRONX, NY 10461 USA.				NIDDK NIH HHS [DK38484, DK21248, DK01307] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038484, R01DK021248, K11DK001307] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; BAGCHI S, 1987, J BIOL CHEM, V262, P1558; BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; GROSS RE, 1990, J BIOL CHEM, V265, P8152; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KASTURI R, 1982, J BIOL CHEM, V257, P2224; KORNBERG A, 1953, J BIOL CHEM, V204, P329; LU XY, 1990, J BIOL CHEM, V265, P3293; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SALATI LM, 1991, J BIOL CHEM, V266, P4010; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; SUL HS, 1984, J BIOL CHEM, V259, P1201; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; WEINER FR, 1989, BIOCHEMISTRY-US, V28, P4094, DOI 10.1021/bi00435a070; ZECHNER R, 1988, MOL CELL BIOL, V8, P2394, DOI 10.1128/MCB.8.6.2394	25	80	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23525	23528						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1684180				2022-12-25	WOS:A1991GV31900003
J	MOSHIRI, F; SMITH, EG; TAORMINO, JP; MAIER, RJ				MOSHIRI, F; SMITH, EG; TAORMINO, JP; MAIER, RJ			TRANSCRIPTIONAL REGULATION OF CYTOCHROME-D IN NITROGEN-FIXING AZOTOBACTER-VINELANDII - EVIDENCE THAT UP-REGULATION DURING N2 FIXATION IS INDEPENDENT OF NIFA BUT DEPENDENT ON NTRA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL OXIDASE COMPLEX; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; MUTAGENESIS; SYSTEM; CLONING; CONSTRUCTION; PROMOTERS	Cytochrome d has been postulated to be the "respiratory protection" oxidase of Azotobacter vinelandii, allowing this organism to fix nitrogen under aerobic growth conditions. We have previously cloned and characterized the structural genes for the A. vinelandii cytochrome d (cydA and cydB). The cyd genes are cotranscribed, yielding an mRNA of approximately 3.6 kilobase pairs. The level of the cyd message was 2-3-fold higher in cells that were fixing nitrogen, as compared with non-nitrogen-fixing cells. RNase protection analysis was used to determine the transcriptional start site at 275 bases upstream of the initiator ATG of cydA, and this start site was the same for nitrogen-fixing and non-nitrogen-fixing cells. The cyd promoter has sequence similarities to the canonical Escherichia coli promoters, which are transcribed by the major sigma-70 form of RNA polymerase. Plasmid-borne lacZ transcriptional fusions were constructed, using approximately 650 base pairs of 5'-upstream sequences of the cyd structural genes. This region had a strong promoter activity which was further up-regulated 1.5-2.5-fold upon the induction of nitrogen fixation. The cyd-lacZ fusions were characterized in a nifA- as well as an ntrA- background. Mutations in neither of these nif regulatory genes affected the constitutive expression of cyd under non-nitrogen-fixing conditions. However, the up-regulation of this promoter during the induction of nitrogen fixation was abolished only in the ntrA- background. Based on these results, the cytochrome d promoter of A. vinelandii belongs to a new class of nitrogen-regulated promoters which, unlike the authentic nif genes, does not require the ntrA gene product for its expression. The up-regulation of this promoter during nitrogen fixation, however, requires the ntrA gene product.	JOHNS HOPKINS UNIV HOSP,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins Medicine					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040079] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 40079] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKRELL BAC, 1971, EUR J BIOCHEM, V20, P29, DOI 10.1111/j.1432-1033.1971.tb01358.x; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BENNETT LT, 1988, MOL MICROBIOL, V2, P315, DOI 10.1111/j.1365-2958.1988.tb00034.x; BENNETT LT, 1988, J BIOL CHEM, V263, P1364; BEYNON J, 1983, CELL, V34, P665, DOI 10.1016/0092-8674(83)90399-9; BISHOP PE, 1980, P NATL ACAD SCI-BIOL, V77, P7342, DOI 10.1073/pnas.77.12.7342; BUCK M, 1986, NATURE, V320, P374, DOI 10.1038/320374a0; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; DOWNS AJ, 1975, FEBS LETT, V60, P42, DOI 10.1016/0014-5793(75)80414-5; DROZD J, 1970, Journal of General Microbiology, V63, P63; FANG H, 1989, J BIOL CHEM, V264, P8026; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEORGIOU CD, 1988, J BACTERIOL, V170, P961, DOI 10.1128/jb.170.2.961-966.1988; GREEN GN, 1988, J BIOL CHEM, V263, P13138; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1986, J BACTERIOL, V167, P480, DOI 10.1128/jb.167.2.480-486.1986; JOERGER RD, 1990, J BACTERIOL, V172, P3400, DOI 10.1128/jb.172.6.3400-3408.1990; JONES CW, 1973, FEBS LETT, V29, P77, DOI 10.1016/0014-5793(73)80530-7; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990; KNOWLES CJ, 1968, BIOCHIM BIOPHYS ACTA, V162, P348, DOI 10.1016/0005-2728(68)90121-7; KRANZ RG, 1985, J BACTERIOL, V161, P709, DOI 10.1128/JB.161.2.709-713.1985; KROL AJM, 1982, NUCLEIC ACIDS RES, V10, P4147, DOI 10.1093/nar/10.14.4147; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; Miller J.H., 1972, EXPT MOL GENETICS; MOSHIRI F, 1991, J BACTERIOL, V173, P6230, DOI 10.1128/jb.173.19.6230-6241.1991; Postgate J. R, 1982, FUNDAMENTALS NITROGE; SANTERO E, 1988, MOL MICROBIOL, V2, P303, DOI 10.1111/j.1365-2958.1988.tb00033.x; TOUKDARIAN A, 1986, EMBO J, V5, P399, DOI 10.1002/j.1460-2075.1986.tb04225.x; TOUKDARIAN A, 1990, J BACTERIOL, V172, P6529, DOI 10.1128/jb.172.11.6529-6539.1990; YATES MG, 1988, NITROGEN SULPHUR CYC, V42, P383	34	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23169	23174						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660468				2022-12-25	WOS:A1991GT48300062
J	SONE, T; KERNER, S; PIKE, JW				SONE, T; KERNER, S; PIKE, JW			VITAMIN-D RECEPTOR INTERACTION WITH SPECIFIC DNA - ASSOCIATION AS A 1,25-DIHYDROXYVITAMIN-D3-MODULATED HETERODIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; CHICKEN INTESTINAL RECEPTOR; TARGET GENE SPECIFICITY; RETINOIC ACID RECEPTOR; HUMAN OSTEOCALCIN GENE; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; BINDING DOMAIN; RESPONSIVE ELEMENT; SACCHAROMYCES-CEREVISIAE	The vitamin D receptor (VDR) is a member of the steroid receptor gene family. In this report, we examine the nature of specific VDR DNA binding utilizing the vitamin D-responsive element derived from the human osteocalcin promoter. Association of the VDR with the human osteocalcin 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) responsive element (VDRE) in vitro was characterized on VDRE affinity columns by both weak and strong interactions. Weak interaction was a property of the VDR itself, monomeric in nature, and determined exclusively by the VDR's DNA-binding domain. Strong interaction, in contrast, was dependent upon an intact receptor molecule as well as a heterologous mammalian cell nuclear accessory factor (NAF). Heteromeric interaction between VDR and NAF was independent of the VDR DNA-binding domain, suggesting the presence of a functional dimerization domain separate from that for DNA binding. Direct association of NAF with immobilized VDR revealed that the interaction does not require the presence of DNA. Most importantly, while occupancy of the VDR by 1,25(OH)2D3 was not required for VDR interactions with either DNA or NAF, the presence of hormone increased the apparent relative affinity of the VDR for NAF approximately 10-fold. These studies suggest that high affinity association of the VDR with DNA requires both the DNA-binding domain as well as an additional independent structure located within the steroid-binding region. This protein subdomain interacts with NAF and is regulated by 1,25(OH)2D3.	LIGAND PHARMACEUT INC,9393 TOWNE CTR DR,SUITE 100,SAN DIEGO,CA 92121; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Ligand Pharmaceuticals; Baylor College of Medicine; Baylor College of Medicine					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038130] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-38130] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BROWN TA, 1990, J BIOL CHEM, V265, P10025; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; DAME K, 1989, NATURE, V339, P593; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DEANS RJ, 1984, P NATL ACAD SCI-BIOL, V81, P1292, DOI 10.1073/pnas.81.5.1292; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GLASS CK, 1990, CELL, V63, P729, DOI 10.1016/0092-8674(90)90139-6; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIAO J, 1990, P NATL ACAD SCI USA, V87, P9751, DOI 10.1073/pnas.87.24.9751; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MCDONNELL DP, 1989, MOL CELL BIOL, V9, P3517, DOI 10.1128/MCB.9.8.3517; MCDONNELL DP, 1987, SCIENCE, V235, P1214, DOI 10.1126/science.3029866; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; OZONO K, 1990, J BIOL CHEM, V265, P21881; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PIKE JW, 1984, J BIOL CHEM, V259, P1167; PIKE JW, 1985, BIOCHEM BIOPH RES CO, V131, P378, DOI 10.1016/0006-291X(85)91813-3; PIKE JW, 1979, P NATL ACAD SCI USA, V76, P5485, DOI 10.1073/pnas.76.11.5485; PIKE JW, 1987, J BIOL CHEM, V262, P1305; PIKE JW, 1988, VITAMIN D MOL CELLUL, P215; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SONE T, 1989, J BIOL CHEM, V264, P20230; SONE T, 1990, J BIOL CHEM, V265, P21997; SONE T, 1991, IN PRESS MOL ENDOCRI; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0	65	133	134	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23296	23305						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660470				2022-12-25	WOS:A1991GT48300079
J	GORST, CM; RAGSDALE, SW				GORST, CM; RAGSDALE, SW			CHARACTERIZATION OF THE NIFECO COMPLEX OF CARBON-MONOXIDE DEHYDROGENASE AS A CATALYTICALLY COMPETENT INTERMEDIATE IN THE PATHWAY OF ACETYL-COENZYME-A SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; CLOSTRIDIUM-THERMOACETICUM; CO DEHYDROGENASE; ACETOGENIC BACTERIA; AUTOTROPHIC PATHWAY; KINETIC CHARACTERIZATION; NICKEL; BINDING; GROWTH; PURIFICATION	Many anaerobic bacteria fix CO2 via the acetyl-CoA pathway. Carbon monoxide dehydrogenase (CODH), a key enzyme in the pathway, condenses a methyl group, a carbonyl group from CO, CO2, or the carboxyl group of pyruvate, and CoA to form acetyl-CoA. When treated with CO, CODH exhibits an EPR signal which results from an organometallic complex containing nickel, at least 3 iron, and CO and has been referred to as the NiFeC signal. Although this EPR signal has been presumed to be the spectroscopic signature of the enzyme-bound C-1 precursor of the carbonyl group of acetyl-CoA, its catalytic relevance had not been rigorously studied. We have demonstrated the catalytic competence of this NiFeC species by showing that the rate of formation of the NiFeC EPR signal is faster than the rate of an isotope exchange reaction between CO and acetyl-CoA, a partial reaction in the overall synthesis. Generation of the NiFeC signal in the absence of CO by acetyl-CoA has been demonstrated and requires a one-electron reduction at a midpoint potential of -541 mV versus the standard hydrogen electrode. In addition, we have observed and characterized an isotope exchange reaction between the carbonyl group of acetyl-CoA and the carbonyl group of the NiFeC complex, indicating that the C in the NiFeC complex is in the form of CO. These combined results demonstrate that the NiFeCO complex exhibits the characteristics expected of the precursor of the carbonyl group of acetyl-CoA.	UNIV WISCONSIN,DEPT CHEM,MILWAUKEE,WI 53201	University of Wisconsin System; University of Wisconsin Milwaukee								ADAMS MWW, 1987, J BIOL CHEM, V262, P15054; ALTMAN TE, 1981, THESIS U ILLINOIS UR; BELFORD RL, 1979, 21ST EPR S ROCK MOUN; DIEKERT G, 1983, FEBS LETT, V151, P41, DOI 10.1016/0014-5793(83)80338-X; DIEKERT GB, 1978, J BACTERIOL, V136, P597, DOI 10.1128/JB.136.2.597-606.1978; DULIBA EP, 1981, THESIS U ILLINOIS UR; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; FAN CL, 1991, BIOCHEMISTRY-US, V30, P431, DOI 10.1021/bi00216a018; FEE JA, 1978, METHOD ENZYMOL, V19, P512; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1111/j.1574-6968.1986.tb01859.x; HARDER SR, 1989, ANAL BIOCHEM, V181, P283, DOI 10.1016/0003-2697(89)90244-3; HU SI, 1982, J BACTERIOL, V149, P440, DOI 10.1128/JB.149.2.440-448.1982; HYMAN MR, 1989, BIOCHEMISTRY-US, V28, P6821, DOI 10.1021/bi00443a007; LENN ND, 1990, BIOCHEMISTRY-US, V29, P3709, DOI 10.1021/bi00467a017; LINDAHL PA, 1990, J BIOL CHEM, V265, P3880; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Ljungdahl L G, 1978, Methods Enzymol, V53, P360; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; LU WP, 1991, J BIOL CHEM, V266, P3554; LU WP, 1990, J BIOL CHEM, V265, P3124; MAURICE AM, 1981, THESIS U ILLINOIS UR; NILGES MJ, 1981, THESIS U ILLINOIS UR; PATEL SS, 1987, J BIOL CHEM, V262, P7132; PEZACKA E, 1986, J BIOL CHEM, V261, P1609; PEZACKA E, 1984, P NATL ACAD SCI-BIOL, V81, P6261, DOI 10.1073/pnas.81.20.6261; PEZACKA E, 1988, J BIOL CHEM, V263, P16000; RAGSDALE SW, 1982, BIOCHEM BIOPH RES CO, V108, P658, DOI 10.1016/0006-291X(82)90880-4; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1983, BIOCHEM BIOPH RES CO, V115, P658, DOI 10.1016/S0006-291X(83)80195-8; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; RAMER SE, 1989, BIOCHEMISTRY-US, V28, P4675, DOI 10.1021/bi00437a025; RAYBUCK SA, 1988, BIOCHEMISTRY-US, V27, P7698, DOI 10.1021/bi00420a019; SALMON RT, 1980, J ELECTROANAL CHEM, V112, P253, DOI 10.1016/S0022-0728(80)80407-4; SCHAUPP A, 1974, ARCH MICROBIOL, V100, P121, DOI 10.1007/BF00446312; SEGEL IH, 1975, ENZYME KINETICS, P860; SHANMUGASUNDARAM T, 1988, BIOCHEMISTRY-US, V27, P6499, DOI 10.1021/bi00417a045; STAVROPOULOS P, 1990, J AM CHEM SOC, V112, P5385, DOI 10.1021/ja00169a076; WATT GD, 1986, BIOCHEMISTRY-US, V25, P8156, DOI 10.1021/bi00373a005; WILLIAMSON JR, 1969, METHOD ENZYMOL, V13, P494; WOOD HG, 1986, BIOCHEM INT, V12, P421; WOOD HG, 1986, TRENDS BIOCHEM SCI, V11, P14, DOI 10.1016/0968-0004(86)90223-9	42	67	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20687	20693						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657934				2022-12-25	WOS:A1991GN00100018
J	HERNANDEZSOTOMAYOR, SMT; MUMBY, M; CARPENTER, G				HERNANDEZSOTOMAYOR, SMT; MUMBY, M; CARPENTER, G			OKADAIC ACID-INDUCED HYPERPHOSPHORYLATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR - COMPARISON WITH RECEPTOR PHOSPHORYLATION AND FUNCTIONS AFFECTED BY ANOTHER TUMOR PROMOTER, 12-O-TETRADECANOYLPHORBOL-13-ACETATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; HUMAN-FIBROBLASTS; PHOSPHOLIPASE-C; TYROSINE PHOSPHORYLATION; INDEPENDENT MECHANISMS; SIGNAL TRANSDUCTION; RAPID ISOLATION; FACTOR BINDING; SPONGE TOXIN; EGF RECEPTOR	Okadaic acid, a potent tumor promoter and inhibitor of phosphoserine/threonine protein phosphatases 1 and 2A, produces a large increase in epidermal growth factor (EGF) receptor phosphorylation in several cell types. The increases are limited to phosphoserine and phosphothreonine residues. 12-O-Tetradecanoylphorbol-13-acetate (TPA), a distinct tumor promoter and protein kinase C activator, also induces serine/threonine phosphorylation of the EGF receptor and is known to modulate receptor functions. Comparison of okadaic acid and TPA influences on the EGF receptor show significant differences. Okadaic acid did not promote phosphorylation of Thr-654, a major site of TPA-induced phosphorylation. However, other sites of phosphorylation were similar for the two tumor promoters. In vitro experiments with purified protein phosphatase 2A demonstrate the insensitivity of Thr-654 phosphorylation, which regulates EGF receptor function, to dephosphorylation by this okadaic acid-sensitive protein phosphatase. In contrast to TPA, okadaic acid did not attenuate the tyrosine kinase activity or ligand binding capacity of the EGF receptor. However, okadaic acid did produce a decrease in EGF-stimulated inositol phosphate formation in a manner distinct from that of TPA.	VANDERBILT UNIV, MED CTR, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA	Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					FOGARTY INTERNATIONAL CENTER [F05TW004600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA024071] Funding Source: NIH RePORTER; FIC NIH HHS [TW04600] Funding Source: Medline; NCI NIH HHS [CA24071] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; BERRIDGE MJ, 1984, BIOCHEM J, V222, P195, DOI 10.1042/bj2220195; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CARPENTER G, 1985, METHOD ENZYMOL, V109, P101; COHEN P, 1980, MOL ASPECTS CELLULAR, V1, P1; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DAVIS RJ, 1987, J BIOL CHEM, V262, P6832; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FRIEDMAN B, 1989, P NATL ACAD SCI USA, V86, P812, DOI 10.1073/pnas.86.3.812; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KING CS, 1986, J BIOL CHEM, V261, P73; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; RAY LB, 1988, J BIOL CHEM, V263, P12721; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; STOSCHECK CM, 1983, ARCH BIOCHEM BIOPHYS, V227, P457, DOI 10.1016/0003-9861(83)90476-9; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TACHIBANA K, 1981, J AM CHEM SOC, V103, P2469, DOI 10.1021/ja00399a082; TAKAI A, 1987, FEBS LETT, V217, P81, DOI 10.1016/0014-5793(87)81247-4; TAKISHIMA K, 1988, BIOCHEM BIOPH RES CO, V157, P740, DOI 10.1016/S0006-291X(88)80312-7; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WAHL M, 1988, J BIOL CHEM, V263, P7581; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1989, CANCER CELL-MON REV, V1, P101; WRANN M, 1980, SCIENCE, V210, P1363, DOI 10.1126/science.6254158; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211	49	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21281	21286						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657956				2022-12-25	WOS:A1991GN00100107
J	WERNER, S; ROTH, WK; BATES, B; GOLDFARB, M; HOFSCHNEIDER, PH				WERNER, S; ROTH, WK; BATES, B; GOLDFARB, M; HOFSCHNEIDER, PH			FIBROBLAST GROWTH-FACTOR 5 PROTOONCOGENE IS EXPRESSED IN NORMAL HUMAN FIBROBLASTS AND INDUCED BY SERUM GROWTH-FACTORS	ONCOGENE			English	Article							KAPOSIS SARCOMA-CELLS; MYC MESSENGER-RNA; C-MYC; NUCLEOTIDE-SEQUENCE; KINASE-C; GENE; INDUCTION; FAMILY; FOS; 3T3-CELLS	Fibroblast growth factor 5 (FGF-5) is a member of the fibroblast growth factor family with transforming potential. It has been found to be expressed in several human tumor cell lines, but nothing is known about expression of this growth factor in normal cells and its biological functions. Here we show that the FGF-5 gene is expressed in exponentially growing normal human fibroblasts. In quiescent fibroblasts, expression of FGF-5 is strongly induced by serum and several growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). This induction can be mediated by at least two different pathways involving protein kinase C or cAMP-dependent kinases. Since the effect is independent of de novo protein synthesis, FGF-5 represents the product of a primary response gene. In addition our data suggest that FGF-5 is mitogenic for human fibroblasts, indicating the existence of an FGF-5-mediated positive feedback in these cells which could amplify and prolong the cellular response to the initial stimulus.	MAX PLANCK INST BIOCHEM, KLOPFERSPITZ 18A, W-8033 MARTINSRIED, GERMANY; COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA	Max Planck Society; Columbia University				Werner, Sabine/0000-0001-7397-8710				ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BATES B, 1991, MOL CELL BIOL, V11, P1840, DOI 10.1128/MCB.11.4.1840; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; Bravo R., 1990, GROWTH FACTORS DIFFE, P324; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DELAPEYRIERE O, 1990, ONCOGENE, V5, P823; GOLDFARB M, 1990, CELL GROWTH DIFFER, V1, P439; HAUB O, 1990, P NATL ACAD SCI USA, V87, P8022, DOI 10.1073/pnas.87.20.8022; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; MARICS I, 1989, ONCOGENE, V4, P335; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; ROTH WK, 1989, ONCOGENE, V4, P483; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; THOMAS KA, 1987, FASEB J, V1, P434, DOI 10.1096/fasebj.1.6.3315806; WERNER S, 1989, INT J CANCER, V43, P1137, DOI 10.1002/ijc.2910430629; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	34	15	15	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1991	6	11					2137	2144						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658709				2022-12-25	WOS:A1991GX11900026
J	JAXEL, C; CAPRANICO, G; KERRIGAN, D; KOHN, KW; POMMIER, Y				JAXEL, C; CAPRANICO, G; KERRIGAN, D; KOHN, KW; POMMIER, Y			EFFECT OF LOCAL DNA-SEQUENCE ON TOPOISOMERASE-I CLEAVAGE IN THE PRESENCE OR ABSENCE OF CAMPTOTHECIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 DNA; BINDING; TRANSCRIPTION; REQUIREMENTS; DOXORUBICIN; BREAKAGE; MOBILITY; INVITRO; COMPLEX; SITES	In order to investigate the mechanism of topoisomerase I inhibition by camptothecin, we studied the induction of DNA cleavage by purified mammalian DNA topoisomerase I in a series of oligonucleotides and analyzed the DNA sequence locations of preferred cleavage sites in the SV40 genome. The oligonucleotides were derived from the sequence of the major camptothecin-induced cleavage site in SV40 DNA (Jaxel, C., Kohn, K. W., and Pommier, Y. (1988) Nucleic Acids Res. 16, 11157 to 11170) with the cleaved bond in their center. DNA length was critical since cleavage was detectable only in 30 and 20 base pair-(bp) oligonucleotides, but not in a 12-bp oligonucleotide. Cleavage was at the same position in the oligonucleotides as in SV40 DNA. Its intensity was greater in the 30- than in the 20-bp oligonucleotide, indicating that sequences more than 10 bp away from the cleavage site may influence intensity. Camptothecin-induced DNA cleavage required duplex DNA since none of the single-stranded oligonucleotides were cleaved. Analysis of base preferences around topoisomerase I cleavage sites in SV40 DNA indicated that camptothecin stabilized topoisomerase I preferentially at sites having a G immediately 3' to the cleaved bond. Experiments with 30-bp oligonucleotides showed that camptothecin produced most intense cleavage in a complementary duplex having a G immediately 3' to the cleavage site. Weaker cleavage was observed in a complementary duplex in which the 3'G was replaced with a T. The identity of the 3' base, however, did not affect topoisomerase I-induced DNA cleavage in the absence of drug. These results indicate that camptothecin traps preferentially a subset of the enzyme cleavage sites, those having a G immediately 3' to the cleaved bond. This strong preference suggests that camptothecin binds reversibly to the DNA at topoisomerase I cleavage sites, in analogy to a model previously proposed for inhibitors of topoisomerase II (Capranico, G., Kohn, K. W., and Pommier, Y. (1990) Nucleic Acids Res. 18, 6611-6619).	NCI,DEV THERAPEUT PROGRAM,MOLEC PHARMACOL LAB,BLDG 37,RM 5C27,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Capranico, Giovanni/K-1678-2014	Capranico, Giovanni/0000-0002-8708-6454				BEEN MD, 1984, NUCLEIC ACIDS RES, V12, P3097, DOI 10.1093/nar/12.7.3097; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; CASERTA M, 1989, NUCLEIC ACIDS RES, V17, P8463, DOI 10.1093/nar/17.21.8463; CHEN JH, 1988, NUCLEIC ACIDS RES, V16, P6803, DOI 10.1093/nar/16.14.6803; GARG LC, 1987, P NATL ACAD SCI USA, V84, P3185, DOI 10.1073/pnas.84.10.3185; GILMOUR DS, 1987, MOL CELL BIOL, V7, P141, DOI 10.1128/MCB.7.1.141; GROMOVA II, 1990, NUCLEIC ACIDS RES, V18, P637, DOI 10.1093/nar/18.3.637; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; JAXEL C, 1989, CANCER RES, V49, P1465; JAXEL C, 1988, NUCLEIC ACIDS RES, V16, P11157, DOI 10.1093/nar/16.23.11157; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; KROGH S, 1991, NUCLEIC ACIDS RES, V19, P1235, DOI 10.1093/nar/19.6.1235; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; MINFORD J, 1986, BIOCHEMISTRY-US, V25, P9, DOI 10.1021/bi00349a002; POMMIER Y, P AM ASSOC CANC RES, V32, P335; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; PRESS WH, 1986, ART SCI COMPUTING, P156; STEVNSNER T, 1989, J BIOL CHEM, V264, P10110; STEWART AF, 1987, CELL, V50, P1109, DOI 10.1016/0092-8674(87)90177-2; STEWART AF, 1990, CELL, V60, P141; SVEJSTRUP JQ, 1990, J BIOL CHEM, V265, P12529; TAPPER DP, 1981, NUCLEIC ACIDS RES, V9, P6787, DOI 10.1093/nar/9.24.6787; WANG JC, 1987, BIOCHIM BIOPHYS ACTA, V909, P1, DOI 10.1016/0167-4781(87)90040-6; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WASSERMANN K, 1990, MOL PHARMACOL, V38, P38	28	205	211	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20418	20423						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657924				2022-12-25	WOS:A1991GM03900080
J	WASSERMAN, SA; COZZARELLI, NR				WASSERMAN, SA; COZZARELLI, NR			SUPERCOILED DNA-DIRECTED KNOTTING BY T4 TOPOISOMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; ESCHERICHIA-COLI; DUPLEX DNA; TN3 RESOLVASE; CIRCULAR DNA; CATENATION; REPLICATION; MECHANISM; STEREOSTRUCTURE; MOLECULES	The mechanism by which the type 2 topoisomerase from bacteriophage T4 mediates knotting of negatively supercoiled DNA was deduced from an analysis of product topology. The knotted products were nicked and then subjected to electrophoresis in order to separate species on the basis of the minimum number of crossings in the knotted form. Knots with defined numbers of crossings were purified and the configuration of these crossings determined in the electron microscope by the RecA coating method. The product knots were exclusively of the twist form, in which an interwound region is entrapped by a single interlock of two looped ends. The interwound region was of negative sign in > 98% of the molecules examined, whereas the single interlock was equally likely to be positive or negative. These results are interpreted in terms of a model for knot formation in which random strand passage mediated by the topoisomerase links bent or branched portions of a superhelix that has a specific interwound geometry. Superhelix interwinding and DNA contacts stabilized by excess enzyme molecules explain the very high frequency of knotting.	UNIV CALIF BERKELEY,DEPT MOLEC BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	WASSERMAN, SA (corresponding author), UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235, USA.							ADRIAN M, 1990, EMBO J, V9, P4551, DOI 10.1002/j.1460-2075.1990.tb07907.x; BENJAMIN HW, 1985, CELL, V40, P147, DOI 10.1016/0092-8674(85)90318-6; BLISKA JB, 1991, J BIOL CHEM, V266, P2041; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; BROWN PO, 1981, P NATL ACAD SCI-BIOL, V78, P843, DOI 10.1073/pnas.78.2.843; CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; COZZARELLI NR, 1984, COLD SPRING HARB SYM, V49, P383, DOI 10.1101/SQB.1984.049.01.045; DEAN FB, 1985, J BIOL CHEM, V260, P4984; DEAN FB, 1985, J BIOL CHEM, V260, P4975; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; Frank-Kamenetskii M. D., 1981, Soviet Physics - Uspekhi, V24, P679, DOI 10.1070/PU1981v024n08ABEH004835; FRANKKAMENETSKII MD, 1975, NATURE, V258, P398, DOI 10.1038/258398a0; GREENFIELD L, 1975, BIOCHIM BIOPHYS ACTA, V407, P365, DOI 10.1016/0005-2787(75)90104-5; HIROSE S, 1988, J BIOL CHEM, V263, P3805; HSIEH T, 1983, J BIOL CHEM, V258, P8413; KANAAR R, 1990, CELL, V62, P353, DOI 10.1016/0092-8674(90)90372-L; KLENIN KV, 1988, J BIOMOL STRUCT DYN, V5, P1173, DOI 10.1080/07391102.1988.10506462; KLENIN KV, 1991, J MOL BIOL, V217, P413, DOI 10.1016/0022-2836(91)90745-R; KREUZER K, 1983, BACTERIOPHAGE T4; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; MUKHERJEE S, 1988, P NATL ACAD SCI USA, V85, P6287, DOI 10.1073/pnas.85.17.6287; REED RR, 1981, CELL, V25, P713, DOI 10.1016/0092-8674(81)90178-1; SHISHIDO K, 1989, NUCLEIC ACIDS RES, V17, P9749, DOI 10.1093/nar/17.23.9749; SHISHIDO K, 1987, J MOL BIOL, V195, P215, DOI 10.1016/0022-2836(87)90338-X; Smith H O, 1980, Methods Enzymol, V65, P371; SPENGLER SJ, 1985, CELL, V42, P325, DOI 10.1016/S0092-8674(85)80128-8; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; TSE Y, 1980, CELL, V22, P269, DOI 10.1016/0092-8674(80)90174-9; Wang J.C., 1979, MOL GENETICS, P65, DOI [10.1016/B978-0-12-684403-0.50009-5., DOI 10.1016/B978-0-12-684403-0.50009-5]; WASSERMAN SA, 1985, SCIENCE, V229, P171, DOI 10.1126/science.2990045; WASSERMAN SA, 1988, NATURE, V334, P448, DOI 10.1038/334448a0; WASSERMAN SA, 1986, SCIENCE, V232, P951, DOI 10.1126/science.3010458; WASSERMAN SA, 1985, P NATL ACAD SCI USA, V82, P1079, DOI 10.1073/pnas.82.4.1079; WHITE JH, 1991, J BIOL CHEM, V266, P20574; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	40	78	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20567	20573						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657929				2022-12-25	WOS:A1991GM03900104
J	KOSUGI, S; BAN, T; AKAMIZU, T; KOHN, LD				KOSUGI, S; BAN, T; AKAMIZU, T; KOHN, LD			SITE-DIRECTED MUTAGENESIS OF A PORTION OF THE EXTRACELLULAR DOMAIN OF THE RAT THYROTROPIN RECEPTOR IMPORTANT IN AUTOIMMUNE THYROID-DISEASE AND NONHOMOLOGOUS WITH GONADOTROPIN RECEPTORS - RELATIONSHIP OF FUNCTIONAL AND IMMUNOGENIC DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAVES-DISEASE; MONOCLONAL-ANTIBODIES; SECONDARY STRUCTURE; TSH RECEPTOR; CLONING; AUTOANTIBODIES; EXPRESSION; SEQUENCE; PROTEIN; BINDING	Residues 287 to 404 of the rat thyrotropin (TSH) receptor exhibit little homology to gonadotropin receptors. A large segment of this region, residues 303-382, has no determinants important for TSH to bind or elevate cAMP levels nor for the activity of thyroid-stimulating autoantibodies (TSAbs) from the sera of Graves' patients, i.e. deletions, substitutions, or mutations in this segment do not result in a loss of any of these activities in transfected Cos-7 cells. Critical residues for these activities do, however, flank both sides of this segment. Of particular interest, deletion or mutation of residues 299-301 and 387-395 results in a marked decrease in high affinity TSH binding but preserves the ability of a TSAb to increase cAMP levels. Tyrosine 385 is also of particular interest since its mutation to phenylalanine, alanine, threonine, or glutamine results in a receptor with a 20-fold decrease in the ability of TSH to bind or increase cAMP levels, but one whose TSAb activity is, once again, preserved. Because one activity is preserved, we can conclude that (a) the receptor must be fully integrated within the membrane of the cell without malfolding, (b) these sequences represent determinants involved in the high affinity TSH binding site, and (c) separate determinants exist for high affinity TSH binding and TSAb activity, consistent with the existence of autoantibodies in Graves' sera which inhibit TSH binding (TBIAbs) or which increase cAMP levels (TSAbs). Additionally, we show that a 16-mer peptide (residues 352-367), which reacts with the sera of > 80% of patients with Graves' disease, can induce the formation of antibodies to a peptide with no sequence homology, residues 377-397. This peptide flanks the region, residues 303-382, with no determinants important for TSH receptor binding or activity. As noted above, it contains residues involved in the high affinity TSH binding site but whose deletion or mutation has no effect on TSAb activity, i.e. residues which would appear to be required at an epitope important for TBIAb but not TSAb antibody activity.			KOSUGI, S (corresponding author), NIDDKD,BIOCHEM & METAB LAB,CELL REGULAT SECT,BETHESDA,MD 20892, USA.		KOSUGI, Shinji/GYR-2946-2022					AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677; BAKER JR, 1988, J IMMUNOL, V140, P2593; FENZI GF, 1987, THYROID AUTOIMMUNITY, P83; GASCUEL O, 1988, COMPUT APPL BIOSCI, V4, P357; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HILL BL, 1988, ENDOCRINOLOGY, V122, P2840, DOI 10.1210/endo-122-6-2840; KASAGI K, 1982, J CLIN ENDOCR METAB, V54, P108, DOI 10.1210/jcem-54-1-108; KOHN LD, 1986, ANN NY ACAD SCI, V475, P157, DOI 10.1111/j.1749-6632.1986.tb20865.x; KOHN LD, 1978, RECEPTORS RECOGNITIO, V5, P133; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MCKENZIE JM, 1987, THYROID AUTOIMMUNITY, P63; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; MITANI Y, 1989, PROGR THYROIDOLOGY 1, P143; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; NOVOTNY J, 1984, NUCLEIC ACIDS RES, V12, P243, DOI 10.1093/nar/12.1Part1.243; SMITH BR, 1985, J ENDOCRINOL INVEST, V8, P175, DOI 10.1007/BF03350678; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WINAND RJ, 1975, J BIOL CHEM, V250, P6534; YOSHIDA T, 1988, J BIOL CHEM, V263, P16341	26	117	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19413	19418						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655787				2022-12-25	WOS:A1991GK66700046
J	SCHMIDT, A; HESCHELER, J; OFFERMANNS, S; SPICHER, K; HINSCH, KD; KLINZ, FJ; CODINA, J; BIRNBAUMER, L; GAUSEPOHL, H; FRANK, R; SCHULTZ, G; ROSENTHAL, W				SCHMIDT, A; HESCHELER, J; OFFERMANNS, S; SPICHER, K; HINSCH, KD; KLINZ, FJ; CODINA, J; BIRNBAUMER, L; GAUSEPOHL, H; FRANK, R; SCHULTZ, G; ROSENTHAL, W			INVOLVEMENT OF PERTUSSIS TOXIN-SENSITIVE G-PROTEINS IN THE HORMONAL INHIBITION OF DIHYDROPYRIDINE-SENSITIVE CA2+ CURRENTS IN AN INSULIN-SECRETING CELL-LINE (RINM5F)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; ISLET-ACTIVATING PROTEIN; DEPENDENT CA-2+ CURRENTS; ADENYLATE-CYCLASE; ALPHA-SUBUNIT; K+ CHANNELS; NUCLEOTIDE; SOMATOSTATIN; MEMBRANES; IDENTIFICATION	Adrenaline inhibits insulin secretion via pertussis toxin-sensitive mechanisms. Since voltage-dependent Ca2+ currents play a key role in insulin secretion, we examined whether adrenaline modulates voltage-dependent Ca2+ currents of the rat insulinoma cell line, RINm5F. In the whole-cell configuration of the patch-clamp technique, dihydropyridine- but not omega-conotoxin-sensitive Ca2+ currents were identified. Adrenaline via alpha-2-adrenoceptors inhibited the Ca2+ currents by about 50%. Somatostatin which also inhibits insulin secretion was less efficient (inhibition by 20%). The hormonal inhibition of Ca2+ currents was not affected by intracellularly applied cAMP but blocked by the intracellularly applied cAMP but blocked by the intracellularly applied GDP analog guanosine 5'-O-(2-thiodiphosphate) and by pretreatment of cells with pertussis toxin. In contrast to adrenaline and somatostatin, galanin, another inhibitor of insulin secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner. Immunoblot experiments performed with antibodies generated against synthetic peptides revealed that membranes of RINm5F cells possess four pertussis toxin-sensitive G-proteins including G(i1), G(i2), G(o2), and another G(o) subtype, most likely representing G(o1). In membranes of control but not of pertussis toxin-treated cells, adrenaline via alpha-2-adrenoceptors stimulated incorporation of the photoreactive GTP analog [alpha-P-32]GTP azidoanilide into pertussis toxin substrates comigrating with the alpha-subunits of G(i2), G(o2), and the not further identified G(o) subtype. The present findings indicate that activated alpha-2-adrenoceptors of RINm5F cells interact with multiple G-proteins, i.e. two forms of G(o) and with G(i2). These G-proteins are likely to be involved in the adrenaline-induced inhibition of dihydropyridine-sensitive Ca2+ currents and in other signal transduction pathways contributing to the adrenaline-induced inhibition of insulin secretion.	FREE UNIV BERLIN, INST PHARMAKOL, THIELALLEE 69-73, W-1000 BERLIN 33, GERMANY; ZENTRUM MOLEK BIOL, W-6900 HEIDELBERG, GERMANY; BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA	Free University of Berlin; Ruprecht Karls University Heidelberg; Baylor College of Medicine; Baylor College of Medicine			Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				AKTORIES K, 1983, N-S ARCH PHARMACOL, V324, P196, DOI 10.1007/BF00503894; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ASANO T, 1988, J NEUROCHEM, V50, P1164, DOI 10.1111/j.1471-4159.1988.tb10588.x; BERTRAND P, 1990, J BIOL CHEM, V265, P18576; BIRNBAUMER L, 1991, BIOL REPROD, V44, P207, DOI 10.1095/biolreprod44.2.207; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CASSEL D, 1976, BIOCHIM BIOPHYS ACTA, V452, P538, DOI 10.1016/0005-2744(76)90206-0; CERIONE RA, 1986, J BIOL CHEM, V261, P3901; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FINDLAY I, 1985, FEBS LETT, V189, P281, DOI 10.1016/0014-5793(85)81040-1; FITZPATRICK FA, 1978, P NATL ACAD SCI USA, V75, P2689, DOI 10.1073/pnas.75.6.2689; FOSSET M, 1988, FEBS LETT, V242, P94, DOI 10.1016/0014-5793(88)80992-X; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GOLDSMITH P, 1988, J BIOL CHEM, V263, P6476; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; GOLLASCH M, 1991, AM J PHYSIOL, V260, pC1282, DOI 10.1152/ajpcell.1991.260.6.C1282; GOMPERTS BD, 1986, TRENDS BIOCHEM SCI, V11, P290, DOI 10.1016/0968-0004(86)90032-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON JK, 1991, TRENDS PHARMACOL SCI, V12, P62, DOI 10.1016/0165-6147(91)90499-I; HEAHEY HH, 1989, AM J PHYSIOL, V257, pC1171; HESCHELER J, 1988, EMBO J, V7, P619, DOI 10.1002/j.1460-2075.1988.tb02855.x; HINSCH KD, 1988, FEBS LETT, V238, P191, DOI 10.1016/0014-5793(88)80254-0; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; HSU WH, 1991, J BIOL CHEM, V266, P837; HSU WH, 1990, J BIOL CHEM, V265, P11220; ISOM LL, 1987, J BIOL CHEM, V262, P17504; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; KEAHEY HH, 1989, DIABETES, V38, P188, DOI 10.2337/diabetes.38.2.188; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MATTERA R, 1989, J BIOL CHEM, V264, P465; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; NILSSON T, 1989, J BIOL CHEM, V264, P973; OFFERMANNS S, 1991, J BIOL CHEM, V266, P3365; OFFERMANNS S, 1989, EUR J BIOCHEM, V180, P283, DOI 10.1111/j.1432-1033.1989.tb14645.x; OFFERMANNS S, 1991, IN PRESS MOL ENDOCRI; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; OFFERMANS S, 1990, FEBS LETT, V260, P14, DOI 10.1016/0014-5793(90)80054-M; PETERSEN O H, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS115, DOI 10.1007/BF00582259; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; ROSENTHAL W, 1986, EUR J BIOCHEM, V158, P255, DOI 10.1111/j.1432-1033.1986.tb09745.x; ROSENTHAL W, 1988, EMBO J, V7, P1627, DOI 10.1002/j.1460-2075.1988.tb02989.x; SCHMIDT A, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR31; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SIMMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809; SMITH PA, 1989, NATURE, V342, P550, DOI 10.1038/342550a0; SPICHER K, 1991, BIOCHEM BIOPH RES CO, V175, P473, DOI 10.1016/0006-291X(91)91588-4; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P433; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; ULLRICH S, 1989, FEBS LETT, V247, P401, DOI 10.1016/0014-5793(89)81379-1; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; ULLRICH S, 1990, BIOCHEM J, V270, P273, DOI 10.1042/bj2700273; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VELASCO JM, 1988, FEBS LETT, V231, P366, DOI 10.1016/0014-5793(88)80851-2; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	66	93	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18025	18033						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680855				2022-12-25	WOS:A1991GG55300051
J	BOURBONNAIS, Y; DANOFF, A; THOMAS, DY; SHIELDS, D				BOURBONNAIS, Y; DANOFF, A; THOMAS, DY; SHIELDS, D			HETEROLOGOUS EXPRESSION OF PEPTIDE-HORMONE PRECURSORS IN THE YEAST SACCHAROMYCES-CEREVISIAE - EVIDENCE FOR A NOVEL PROHORMONE ENDOPROTEASE WITH SPECIFICITY FOR MONOBASIC AMINO-ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; INTRACELLULAR-TRANSPORT; SECRETORY PATHWAY; MAMMALIAN-CELLS; MF-ALPHA; SOMATOSTATIN; PROSOMATOSTATIN; PREPROSOMATOSTATIN; BIOSYNTHESIS; CLEAVAGE	The peptide somatostatin (SRIF) exists as two different molecular species. In addition to the most common form, which is a 14-residue peptide, there is also a 14-amino acid amino-terminally extended form of the tetradecapeptide, SRIF-28. Both peptides are synthesized as larger precursors containing paired basic and monobasic amino acids at their processing sites, which, upon cleavage, generate either SRIF-14 or -28, respectively. In mammals a single prepro-SRIF molecule undergoes tissue-specific processing to generate the mature hormone whereas in some species of fish separate genes encode two distinct but homologous precursors prepro-SRIF-I and -II that give rise to SRIF-14 and -28, respectively. To investigate the molecular basis for differential processing of the prohormones we introduce their cDNAs into yeast cells (Saccharomyces cerevisiae). The signal peptides of both precursors were poorly recognized by the yeast endoplasmic reticulum translocation apparatus, consequently only low levels of SRIF peptides were synthesized. To circumvent this problem a chimeric precursor consisting of the alpha-factor signal peptide plus 30 residues of the proregion was fused to pro-SRIF-II. This fusion protein was efficiently transported through the yeast secretory pathway and processed to SRIF-28 exclusively, which is identical to the processing of the native precursor in pancreatic islet D-cells. Most significantly, cleavage of the precursor to SRIF-28 was independent of the Kex 2 endoprotease since processing occurred efficiently in a kex 2 mutant strain. We conclude that in addition to the Kex 2 protease, yeast possess a distinct prohormone converting enzyme with specificity toward monobasic processing sites.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT ANAT & STRUCT BIOL & DEV BIOL & CANC,BRONX,NY 10461; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA	Yeshiva University; Albert Einstein College of Medicine; McGill University	BOURBONNAIS, Y (corresponding author), NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,GENET SECT,MONTREAL H4P 2R2,QUEBEC,CANADA.		Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X; Bourbonnais, Yves/0000-0002-8130-6612	NIDDK NIH HHS [DK018994, DK 21860] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021860, R01DK021860] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEINFELD MC, 1989, J BIOL CHEM, V264, P4460; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BOURBONNAIS Y, 1988, J BIOL CHEM, V263, P15342; BUSSEY H, 1988, YEAST, V4, P17, DOI 10.1002/yea.320040103; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; EGELMITANI M, 1990, YEAST, V6, P127, DOI 10.1002/yea.320060206; ERNST JF, 1988, DNA-J MOLEC CELL BIO, V7, P355, DOI 10.1089/dna.1.1988.7.355; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; GOMEZ S, 1989, EMBO J, V8, P2911, DOI 10.1002/j.1460-2075.1989.tb08440.x; GREEN R, 1986, J BIOL CHEM, V261, P7558; HOBART P, 1980, NATURE, V288, P137, DOI 10.1038/288137a0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; MACKIN RB, 1987, J BIOL CHEM, V262, P6453; MAGAZIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5152, DOI 10.1073/pnas.79.17.5152; MCDONALD JK, 1987, J HISTOCHEM CYTOCHEM, V35, P155, DOI 10.1177/35.2.2878951; MEISSNER PS, 1987, P NATL ACAD SCI USA, V84, P4171, DOI 10.1073/pnas.84.12.4171; MINTH CD, 1982, J BIOL CHEM, V257, P372; NOE BD, 1983, J BIOL CHEM, V258, P1121; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PATEL YC, 1981, ENDOCRINOLOGY, V109, P1943, DOI 10.1210/endo-109-6-1943; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWARTZ TW, 1987, J BIOL CHEM, V262, P5093; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEVARINO KA, 1989, CELL, V57, P11, DOI 10.1016/0092-8674(89)90167-0; SHIELDS D, 1980, P NATL ACAD SCI-BIOL, V77, P4074, DOI 10.1073/pnas.77.7.4074; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; STOLLER TJ, 1989, J BIOL CHEM, V264, P6922; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; THOMAS G, 1988, SCIENCE, V241, P226, DOI 10.1126/science.3291117; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WARREN TG, 1984, CELL, V39, P547, DOI 10.1016/0092-8674(84)90461-6	38	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13203	13209						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1677005				2022-12-25	WOS:A1991FX13200064
J	YAN, DH; CHANG, LS; HUNG, MC				YAN, DH; CHANG, LS; HUNG, MC			REPRESSED EXPRESSION OF THE HER-2/C-ERBB-2 PROTOONCOGENE BY THE ADENOVIRUS E1A GENE-PRODUCTS	ONCOGENE			English	Note							GROWTH-FACTOR-RECEPTOR; ERBB-RELATED GENE; MESSENGER-RNAS; NEU ONCOGENE; HUMAN-BREAST; TRANSCRIPTION; AMPLIFICATION; CANCER; C-ERBB-2; PROTEINS	The E3 region of adenovirus induces down-regulation of epidermal growth factor receptor (EGFR) through endocytosis. Here we report that an EGFR-related protein, the HER-2/c-erbB-2 gene product, p185, is also down-regulated by adenovirus, but via a different mechanism. We found that the adenovirus E1a gene is responsible for the repression of HER-2/c-erbB-2 at the RNA level.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,BOX 79,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; PRINCETON UNIV,HOWARD HUGHES MED INST,DEPT BIOL,PRINCETON,NJ 08544	University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Princeton University			Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	NCI NIH HHS [CA-45265] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045265] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1979, CELL, V17, P935, DOI 10.1016/0092-8674(79)90333-7; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; CARLIN CR, 1989, CELL, V57, P135, DOI 10.1016/0092-8674(89)90179-7; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; FRIEDMAN DJ, 1988, VIROLOGY, V165, P303, DOI 10.1016/0042-6822(88)90689-7; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GAYNOR RB, 1982, J VIROL, V44, P276, DOI 10.1128/JVI.44.1.276-285.1982; HEN R, 1985, SCIENCE, V230, P1391, DOI 10.1126/science.2999984; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; NEVINS JR, 1987, MICROBIOL REV, V51, P419, DOI 10.1128/MMBR.51.4.419-430.1987; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; ROSENTHAL A, 1985, NATURE, V315, P579, DOI 10.1038/315579a0; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STEIN R, 1984, MOL CELL BIOL, V4, P2792, DOI 10.1128/MCB.4.12.2792; STEIN RW, 1987, MOL CELL BIOL, V7, P1164, DOI 10.1128/MCB.7.3.1164; VELCICH A, 1985, CELL, V40, P705, DOI 10.1016/0092-8674(85)90219-3; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YOKOTA J, 1986, LANCET, V1, P765; YOUNG KS, 1989, MOL CELL BIOL, V9, P3109, DOI 10.1128/MCB.9.7.3109; ZHANG X, 1989, ONCOGENE, V4, P985	27	74	76	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					343	345						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	1672040				2022-12-25	WOS:A1991FZ13400023
J	DIEHL, RE; WHITING, P; POTTER, J; GEE, N; RAGAN, CI; LINEMEYER, D; SCHOEPFER, R; BENNETT, C; DIXON, RAF				DIEHL, RE; WHITING, P; POTTER, J; GEE, N; RAGAN, CI; LINEMEYER, D; SCHOEPFER, R; BENNETT, C; DIXON, RAF			CLONING AND EXPRESSION OF BOVINE BRAIN INOSITOL MONOPHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,W POINT,PA 19486; MERCK SHARP & DOHME LTD,DEPT NEUROSCI,HARLOW CM20 2QR,ESSEX,ENGLAND; MERCK INST THERAPEUT RES,DEPT BIOCHEM,RAHWAY,NJ 07065; SALK INST BIOL STUDIES,RECEPTOR BIOL LAB,SAN DIEGO,CA 92138	Merck & Company; Merck & Company; Merck & Company; Salk Institute	DIEHL, RE (corresponding author), MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486, USA.			Whiting, Paul/0000-0002-4121-1379				ATTWOOD PV, 1988, BIOCHEM J, V253, P387, DOI 10.1042/bj2530387; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; GEE NS, 1989, BIOCHEM J, V264, P793, DOI 10.1042/bj2640793; GEE NS, 1988, BIOCHEM J, V249, P883, DOI 10.1042/bj2490883; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUMBER SC, 1984, PLANT PHYSIOL, V76, P40, DOI 10.1104/pp.76.1.40; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HEWIK RM, 1981, J BIOL CHEM, V256, P7790; MAJERUS PW, 1988, J BIOL CHEM, V263, P3031; Maniatis T., 1982, MOL CLONING; MEEK JL, 1988, BIOCHEM BIOPH RES CO, V156, P143, DOI 10.1016/S0006-291X(88)80816-7; RAGAN CI, 1988, BIOCHEM J, V249, P143, DOI 10.1042/bj2490143; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SHUTE JK, 1988, J CHEM SOC CHEM COMM, P626, DOI 10.1039/c39880000626; SPECTOR R, 1988, NEUROCHEM RES, V13, P785, DOI 10.1007/BF00971603; SPIESS J, 1979, P NATL ACAD SCI USA, V76, P2974, DOI 10.1073/pnas.76.6.2974; TAKIMOTO K, 1985, J BIOCHEM-TOKYO, V98, P363, DOI 10.1093/oxfordjournals.jbchem.a135290	24	99	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					5946	5949						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690719				2022-12-25	WOS:A1990CY58700008
J	MARKHAM, BE; TSIKA, RW; BAHL, JJ; ANDERSON, PG; MORKIN, E				MARKHAM, BE; TSIKA, RW; BAHL, JJ; ANDERSON, PG; MORKIN, E			AN ANTISENSE C-ERBA CLONE INHIBITS THYROID HORMONE-INDUCED EXPRESSION FROM THE ALPHA-MYOSIN HEAVY-CHAIN PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ARIZONA,UNIV HEART CTR,TUCSON,AZ 85724	University of Arizona					NHLBI NIH HHS [HL-20984, HL-35751] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020984, R01HL035751] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTIN PB, 1988, BIOTECHNIQUES, V6, P640; BANERJEE SK, 1988, CIRC RES, V63, P267, DOI 10.1161/01.RES.63.1.267; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GUSTAFSON TA, 1987, P NATL ACAD SCI USA, V84, P3122, DOI 10.1073/pnas.84.10.3122; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; GUSTAFSON TA, 1985, BIOCHEM BIOPH RES CO, V130, P1161, DOI 10.1016/0006-291X(85)91737-1; GUSTAFSON TA, 1986, CIRC RES, V59, P194, DOI 10.1161/01.RES.59.2.194; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; IZANT JG, 1985, SCIENCE, V229, P345, DOI 10.1126/science.2990048; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; KIM SK, 1985, CELL, V42, P129, DOI 10.1016/S0092-8674(85)80108-2; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEVI BZ, 1988, GENE DEV, V2, P554, DOI 10.1101/gad.2.5.554; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SMITH GH, 1986, ANAL BIOCHEM, V156, P17, DOI 10.1016/0003-2697(86)90147-8; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY, P90; TOMPSON CC, 1987, SCIENCE, V237, P1610; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	32	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6489	6493						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690729				2022-12-25	WOS:A1990CY58700090
J	ASAKURA, S; HIRATA, H; OKAZAKI, H; HASHIMOTOGOTOH, T; MATSUDA, M				ASAKURA, S; HIRATA, H; OKAZAKI, H; HASHIMOTOGOTOH, T; MATSUDA, M			HYDROPHOBIC RESIDUES 382-386 OF ANTITHROMBIN-III, ALA-ALA-ALA-SER-THR, SERVE AS THE EPITOPE FOR AN ANTIBODY WHICH FACILITATES HYDROLYSIS OF THE INHIBITOR BY THROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									JICHI MED SCH,INST HEMATOL,DIV HEMOSTASIS & THROMBOSIS RES,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; HOECHST JAPAN LTD,PHARMA RES LABS,SAITAMA 350,JAPAN	Jichi Medical University								ASAKURA S, 1988, BIOCHIM BIOPHYS ACTA, V952, P37, DOI 10.1016/0167-4838(88)90099-4; ASAKURA S, 1989, J BIOL CHEM, V264, P13736; BJORK I, 1982, J BIOL CHEM, V257, P2406; BJORK I, 1982, J BIOL CHEM, V257, P9487; BJORK I, 1981, FEBS LETT, V126, P257, DOI 10.1016/0014-5793(81)80255-4; BOCK SC, 1982, NUCLEIC ACIDS RES, V10, P8113, DOI 10.1093/nar/10.24.8113; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CHANDRA T, 1983, P NATL ACAD SCI-BIOL, V80, P1845, DOI 10.1073/pnas.80.7.1845; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; DANIELSSON A, 1980, FEBS LETT, V119, P241, DOI 10.1016/0014-5793(80)80262-6; DEGEN SJF, 1983, BIOCHEMISTRY-US, V22, P2087, DOI 10.1021/bi00278a008; DEVRAJKIZUK R, 1988, BLOOD, V72, P1518; ERICKSON BW, 1976, PROTEINS, P257; FISH WW, 1979, FEBS LETT, V98, P103, DOI 10.1016/0014-5793(79)80162-3; FISH WW, 1979, EUR J BIOCHEM, V101, P31, DOI 10.1111/j.1432-1033.1979.tb04212.x; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOYLAERTS M, 1984, J BIOL CHEM, V259, P5670; JORDAN R, 1979, J BIOL CHEM, V254, P2902; JORDAN RE, 1980, J BIOL CHEM, V255, P81; KURACHI K, 1981, P NATL ACAD SCI USA, V78, P6726; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LONGAS MO, 1980, BIOCHEM J, V189, P481, DOI 10.1042/bj1890481; MARCINIAK E, 1981, BRIT J HAEMATOL, V48, P325, DOI 10.1111/j.1365-2141.1981.tb02718.x; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOLHOSABATIER P, 1989, J CLIN INVEST, V84, P1236, DOI 10.1172/JCI114290; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; OLSON ST, 1985, J BIOL CHEM, V260, P153; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; ROSENBERG RD, 1977, FED PROC, V36, P10; SUMI Y, 1986, J BIOCHEM, V100, P1399, DOI 10.1093/oxfordjournals.jbchem.a121846; SUZUKI K, 1987, J BIOL CHEM, V262, P611; TOMA K, 1987, PROTEIN ENG, V1, P471, DOI 10.1093/protein/1.6.471; TONE M, 1987, J BIOCHEM-TOKYO, V102, P1033, DOI 10.1093/oxfordjournals.jbchem.a122141	33	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5135	5138						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690736				2022-12-25	WOS:A1990CV58700060
J	WALTON, GM; CHEN, WS; ROSENFELD, MG; GILL, GN				WALTON, GM; CHEN, WS; ROSENFELD, MG; GILL, GN			ANALYSIS OF DELETIONS OF THE CARBOXYL TERMINUS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR REVEALS SELF-PHOSPHORYLATION AT TYROSINE-992 AND ENHANCED INVIVO TYROSINE PHOSPHORYLATION OF CELL SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,M-013,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,SCH MED,HOWARD HUGHES MED INST,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego					NIDDK NIH HHS [NIDDK13149] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013149, R01DK013149] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COOPER JA, 1984, J BIOL CHEM, V259, P7835; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; GILL GN, 1984, J BIOL CHEM, V259, P7755; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GULLICK WJ, 1985, EMBO J, V4, P2869, DOI 10.1002/j.1460-2075.1985.tb04016.x; HONEGGER A, 1988, EMBO J, V7, P3053, DOI 10.1002/j.1460-2075.1988.tb03170.x; HUBLER L, 1989, J BIOL CHEM, V264, P1558; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KHAZAIE K, 1988, EMBO J, V7, P3061, DOI 10.1002/j.1460-2075.1988.tb03171.x; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIN MF, 1988, MOL CELL BIOL, V8, P5477, DOI 10.1128/MCB.8.12.5477; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; TONKS NK, 1988, J BIOL CHEM, V263, P6731; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; USHIRO H, 1980, J BIOL CHEM, V255, P8363; VELU TJ, 1989, MOL CELL BIOL, V9, P1772, DOI 10.1128/MCB.9.4.1772; WEBER W, 1984, J BIOL CHEM, V259, P4631; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373	27	192	198	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1990	265	3					1750	1754						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ676	1688559				2022-12-25	WOS:A1990CJ67600080
J	UCHIUMI, T; TRAUT, RR; KOMINAMI, R				UCHIUMI, T; TRAUT, RR; KOMINAMI, R			MONOCLONAL-ANTIBODIES AGAINST ACIDIC PHOSPHOPROTEIN-P0, PHOSPHOPROTEIN-P1, AND PHOSPHOPROTEIN-P2 OF EUKARYOTIC RIBOSOMES AS FUNCTIONAL PROBES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF DAVIS,DEPT BIOL CHEM,DAVIS,CA 95616	University of California System; University of California Davis	UCHIUMI, T (corresponding author), NIIGATA UNIV,SCH MED,DEPT BIOCHEM,NIIGATA 951,JAPAN.							AMONS R, 1982, FEBS LETT, V146, P143, DOI 10.1016/0014-5793(82)80722-9; AMONS R, 1979, FEBS LETT, V104, P85, DOI 10.1016/0014-5793(79)81089-3; BROT N, 1977, MOL MECHANISMS PROTE, P375; COLLINS JF, 1972, BIOCHEMISTRY-US, V11, P4187, DOI 10.1021/bi00772a024; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; ELKON K, 1988, P NATL ACAD SCI USA, V85, P5186, DOI 10.1073/pnas.85.14.5186; ELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419; Engvall E, 1980, Methods Enzymol, V70, P419; GUDKOV AT, 1978, FEBS LETT, V93, P215, DOI 10.1016/0014-5793(78)81106-5; HAMEL E, 1972, J BIOL CHEM, V247, P805; HARDY SJS, 1975, MOL GEN GENET, V140, P253, DOI 10.1007/BF00334270; Iwasaki K, 1979, Methods Enzymol, V60, P657; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CC, 1981, J BIOL CHEM, V256, P41; Liljas A, 1986, STRUCTURE FUNCTION G, P379; LIN A, 1982, J BIOL CHEM, V257, P9189; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; MACCONNELL WP, 1982, J BIOL CHEM, V257, P5359; MATHESON AT, 1980, RIBOSOMES STRUCTURE, P297; MILLER DL, 1977, MOL MECHANISMS PROTE, P324; MITSUI K, 1988, NUCLEIC ACIDS RES, V8, P3573; MITSUI K, 1988, NUCLEIC ACIDS RES, V8, P3574; MITSUIK, 1988, NUCLEIC ACIDS RES, V8, P3575; MOLLER W, 1983, J MOL BIOL, V163, P553, DOI 10.1016/0022-2836(83)90112-2; MOLLER W, 1975, P NATL ACAD SCI USA, V72, P4744, DOI 10.1073/pnas.72.12.4744; Monro RE., 1971, METHOD ENZYMOL, V20, P472; NAG B, 1987, BIOCHEMISTRY-US, V26, P461, DOI 10.1021/bi00376a018; NAG B, 1986, J BIOL CHEM, V261, P13892; NISHIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V142, P133, DOI 10.1016/0005-2787(67)90522-9; NOLAN RD, 1975, EUR J BIOCHEM, V50, P391, DOI 10.1111/j.1432-1033.1975.tb09815.x; NOMBELA C, 1973, P NATL ACAD SCI USA, V70, P3556, DOI 10.1073/pnas.70.12.3556; OLSON HM, 1986, J BIOL CHEM, V261, P6924; PETTERSSON I, 1976, FEBS LETT, V64, P135, DOI 10.1016/0014-5793(76)80267-0; REMACHA M, 1988, J BIOL CHEM, V263, P9094; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; RICHTER D, 1973, J BIOL CHEM, V248, P2853; SANCHEZMADRID F, 1981, BIOCHEMISTRY-US, V20, P3263, DOI 10.1021/bi00514a043; SOMMER A, 1985, J BIOL CHEM, V260, P6522; STACEY DW, 1988, ARCH BIOCHEM BIOPHYS, V267, P398; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; THOMPSON HA, 1974, BIOCHEMISTRY-US, V13, P1348, DOI 10.1021/bi00704a007; TOWBIN H, 1982, J BIOL CHEM, V257, P2709; TSURUGI K, 1978, J BIOL CHEM, V253, P946; UCHIUMI T, 1986, J BIOL CHEM, V261, P9668; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; UCHIUMI T, 1985, J BIOL CHEM, V260, P5675; VANAGTHOVEN A, 1978, EUR J BIOCHEM, V91, P553; VANAGTHOVEN AJ, 1977, BIOCHEM BIOPH RES CO, V77, P989, DOI 10.1016/S0006-291X(77)80075-2; VIDALES FJ, 1981, BIOCHIM BIOPHYS ACTA, V656, P28, DOI 10.1016/0005-2787(81)90022-8	50	67	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					89	95						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688437				2022-12-25	WOS:A1990CF66200016
J	MCABEE, DD; ESBENSEN, K				MCABEE, DD; ESBENSEN, K			BINDING AND ENDOCYTOSIS OF APO-LACTOFERRIN AND HOLO-LACTOFERRIN BY ISOLATED RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; COLONY-STIMULATING ACTIVITY; FLUID-PHASE ENDOCYTOSIS; LIVER ENDOTHELIAL-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; HEMOPHILUS-INFLUENZAE; HYALURONIC-ACID; TRANSFERRIN; PROTEIN; LACTOTRANSFERRIN	We characterized binding and endocytosis of I-125-bovine lactoferrin by isolated rat hepatocytes. Iron-depleted (apo-Lf), approximately 30% saturated (Lf), and iron-saturated (holo-Lf) lactoferrin were used. At 4-degrees-C, cells bound I-125-apo-Lf and I-125-holo-Lf with nearly identical apparent first order kinetics (t1/2, = approximately 42 min). Holo-Lf and apo-Lf competed with each other for binding. Hepatocytes bound lactoferrin optimally at pH greater-than-or-equal-to 7 but poorly at pH less-than-or-equal-to 6. Ca2+ (greater-than-to-equal-to 100-mu-M) enhanced Lf binding to cells, and holo-Lf remained monomeric with Ca2+ present as determined by gel filtration chromatography. With Ca2+, cells exhibited approximately 10(6) high affinity sites (K(d) approximately 20 nM) and approximately 10(7) low affinity sites (K(d) approximately 700 nM) for both apo- and holo-Lf. Without Ca2+, cells bound I-125-holo-Lf by the low affinity component only. EGTA and dextran sulfate together released greater-than-or-equal-to 90% I-125-Lf prebound at 4-degrees-C, but individually removed separate populations of surface-bound I-125-Lf. Cells bound I-125-Lf in a Ca2+-dependent manner with dextran sulfate present. We conclude that the high affinity but not the low affinity sites require Ca2+; only the low affinity sites are dextran sulfate-sensitive. Neither transferrin nor asialo-orosomucoid blocked lactoferrin binding to hepatocytes. Some cationic proteins but not others inhibited lactoferrin binding. At 37-degrees-C, hepatocytes endocytosed I-125-apo-Lf and I-125-holo-Lf similarly, and hyperosmolality (> 500 mmol/kg) blocked uptake by approximately 90%. These data support the proposal that hepatocytes regulate blood lactoferrin concentration by receptor-mediated endocytosis.			MCABEE, DD (corresponding author), UNIV NOTRE DAME,DEPT BIOL SCI,NOTRE DAME,IN 46556, USA.							BAKER EN, 1987, TRENDS BIOCHEM SCI, V12, P350, DOI 10.1016/0968-0004(87)90163-0; BENNETT RM, 1979, CLIN SCI, V57, P453, DOI 10.1042/cs0570453; BENNETT RM, 1981, BIOCHEM BIOPH RES CO, V101, P88, DOI 10.1016/S0006-291X(81)80014-9; BOXER LA, 1982, J LAB CLIN MED, V99, P866; BROXMEYER HE, 1978, J EXP MED, V148, P1052, DOI 10.1084/jem.148.4.1052; COURTOY PJ, 1984, LAB INVEST, V50, P329; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DEBANNE MT, 1985, AM J PHYSIOL, V248, pG463, DOI 10.1152/ajpgi.1985.248.4.G463; DERISBOURG P, 1990, BIOCHEM J, V269, P821, DOI 10.1042/bj2690821; FELIX K, 1960, ADV PROTEIN CHEM, V15, P1; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HANGOC G, 1987, LEUKEMIA, V1, P762; HASHIZUME S, 1987, METHOD ENZYMOL, V147, P302; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HU WL, 1990, BIOCHEMISTRY-US, V29, P535, DOI 10.1021/bi00454a030; HUETTINGER M, 1988, CLIN BIOCHEM, V21, P87, DOI 10.1016/S0009-9120(88)80093-6; IMBER MJ, 1982, J BIOL CHEM, V257, P5129; IMBER MJ, 1983, BIOCHEM J, V212, P249, DOI 10.1042/bj2120249; JANSEN RW, 1991, J BIOL CHEM, V266, P3343; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE GR, 1983, SEMIN HEMATOL, V20, P61; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7419; MASSON PL, 1968, EUR J BIOCHEM, V6, P579, DOI 10.1111/j.1432-1033.1968.tb00484.x; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MAZURIER J, 1989, EUR J BIOCHEM, V179, P481, DOI 10.1111/j.1432-1033.1989.tb14578.x; MCABEE DD, 1989, BIOCHEM BIOPH RES CO, V161, P261, DOI 10.1016/0006-291X(89)91589-1; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MOGUILEVSKY N, 1984, LAB INVEST, V50, P335; OKA JA, 1989, J BIOL CHEM, V264, P12016; OKA JA, 1987, J CELL PHYSIOL, V133, P243, DOI 10.1002/jcp.1041330207; PETERSON VM, 1988, J TRAUMA, V28, P1533, DOI 10.1097/00005373-198811000-00003; POLIS BD, 1955, METHOD ENZYMOL, V2, P813; PRIEELS JP, 1978, P NATL ACAD SCI USA, V75, P2215, DOI 10.1073/pnas.75.5.2215; RAJA RH, 1988, J BIOL CHEM, V263, P16661; REGOECZI E, 1985, AM J PHYSIOL, V248, pG8, DOI 10.1152/ajpgi.1985.248.1.G8; RETEGUI LA, 1984, LAB INVEST, V50, P323; ROCHARD E, 1989, FEBS LETT, V255, P201, DOI 10.1016/0014-5793(89)81091-9; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHACHTE.H, 1970, J BIOL CHEM, V245, P1090; SCHRYVERS AB, 1989, J MED MICROBIOL, V29, P121, DOI 10.1099/00222615-29-2-121; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P467, DOI 10.1111/j.1365-2958.1988.tb00052.x; SCHRYVERS AB, 1988, INFECT IMMUN, V56, P1144, DOI 10.1128/IAI.56.5.1144-1149.1988; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spector WS, 1956, HDB BIOL DATA; TOWNSEND R, 1981, BIOCHEM J, V194, P209, DOI 10.1042/bj1940209; VANSNICK JL, 1974, J EXP MED, V140, P1068, DOI 10.1084/jem.140.4.1068; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; WEIGEL PH, 1982, J BIOL CHEM, V257, P1201; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111; ZUCALI JR, 1989, BLOOD, V74, P1531; [No title captured]	56	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23624	23631						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660879				2022-12-25	WOS:A1991GV31900019
J	RIJNBOUTT, S; KAL, AJ; GEUZE, HJ; AERTS, H; STROUS, GJ				RIJNBOUTT, S; KAL, AJ; GEUZE, HJ; AERTS, H; STROUS, GJ			MANNOSE 6-PHOSPHATE-INDEPENDENT TARGETING OF CATHEPSIN-D TO LYSOSOMES IN HEPG2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOCYTES; DICTYOSTELIUM-DISCOIDEUM; SECRETORY PROTEINS; AMMONIUM-CHLORIDE; HUMAN-FIBROBLASTS; ARYLSULFATASE-A; BIOSYNTHESIS; ENZYMES; TRANSPORT; COMPARTMENTS	We have studied the role of N-linked oligosaccharides and proteolytic processing on the targeting of cathepsin D to the lysosomes in the human hepatoma cell line HepG2. In the presence of tunicamycin cathepsin D was synthesized as an unglycosylated 43-kDa proenzyme which was proteolytically processed via a 39-kDa intermediate to a 28-kDa mature form. Only a small portion was secreted into the culture medium. During intracellular transport the 43-kDa procathepsin D transiently became membrane-associated independently of binding to the mannose 6-phosphate receptor. Subcellular fractionation showed that unglycosylated cathepsin D was efficiently targeted to the lysosomes via intermediate compartments similar to the enzyme in control cells. The results show that in HepG2 cells processing and transport of cathepsin D to the lysosomes is independent of mannose 6-phosphate residues. Inhibition of the proteolytic processing of 53-kDa procathepsin D by protease inhibitors caused this form to accumulate intracellularly. Subcellular fractionation revealed that the procathepsin D was transported to lysosomes, thereby losing its membrane association. Procathepsin D taken up by the mannose 6-phosphate receptor also transiently became membrane-associated, probably in the same compartment. We conclude that the mannose 6-phosphate-independent membrane-association is a transient and compartment-specific event in the transport of procathepsin D.	UNIV UTRECHT, CELL BIOL LAB, 3584 CX UTRECHT, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, EC SLATER INST BIOCHEM RES, 1105 AZ AMSTERDAM, NETHERLANDS	Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	RIJNBOUTT, S (corresponding author), UNIV UTRECHT, AKAD ZIEKENHUIS, CELL BIOL LAB, RM H02314, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS.		Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565				AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; BARRANGER JA, 1989, METABOLIC BASIS INHE, P1589; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; CARDELLI JA, 1986, J CELL BIOL, V102, P1264, DOI 10.1083/jcb.102.4.1264; CARDELLI JA, 1989, J BIOL CHEM, V264, P3454; CROZE E, 1989, J CELL BIOL, V108, P1597, DOI 10.1083/jcb.108.5.1597; DEAN RT, 1984, BIOCHEM J, V217, P27, DOI 10.1042/bj2170027; DIMENT S, 1988, J BIOL CHEM, V263, P6901; ELFERINK RPJO, 1985, EUR J BIOCHEM, V153, P55, DOI 10.1111/j.1432-1033.1985.tb09266.x; ERICKSON AH, 1981, J BIOL CHEM, V256, P1224; GEUZE HJ, 1991, J ELECTRON MICR TECH, V17, P24, DOI 10.1002/jemt.1060170105; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HANEWINKEL H, 1987, J BIOL CHEM, V262, P12351; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HENTZE M, 1984, ARCH BIOCHEM BIOPHYS, V230, P375, DOI 10.1016/0003-9861(84)90120-6; IMORT M, 1983, BIOCHEM J, V214, P671, DOI 10.1042/bj2140671; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; Neufeld EF, 1983, METABOLIC BASIS INHE, P778; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V262, P159, DOI 10.1016/0003-9861(88)90178-6; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V263, P107, DOI 10.1016/0003-9861(88)90618-2; NOLAN CM, 1989, METABOLIC BASIS INHE, P1589; OPRESKO LK, 1987, CELL, V51, P557, DOI 10.1016/0092-8674(87)90125-5; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; RICHARDSON JM, 1988, J CELL BIOL, V107, P2097, DOI 10.1083/jcb.107.6.2097; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; ROSENFELD MG, 1982, J CELL BIOL, V93, P135, DOI 10.1083/jcb.93.1.135; SAMAREL AM, 1989, AM J PHYSIOL, V257, pC1069, DOI 10.1152/ajpcell.1989.257.6.C1069; SCHLOSSER E, 1969, Z NATURFORSCH PT B, VB 24, P1284; STECKEL F, 1985, EUR J BIOCHEM, V151, P147, DOI 10.1111/j.1432-1033.1985.tb09079.x; STROUS GJ, 1989, BIOCHEM J, V257, P159, DOI 10.1042/bj2570159; STROUS GJAM, 1982, J BIOL CHEM, V257, P7623; VONFIGURA K, 1979, EUR J BIOCHEM, V101, P103; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; VONFIGURA K, 1983, P NATL ACAD SCI-BIOL, V80, P6066; WASSLER M, 1987, BIOCHEM J, V247, P407, DOI 10.1042/bj2470407; WIESMANN UN, 1975, BIOCHEM BIOPH RES CO, V66, P1338, DOI 10.1016/0006-291X(75)90506-9	42	99	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23586	23592						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660878				2022-12-25	WOS:A1991GV31900013
J	ALBER, G; MILLER, L; JELSEMA, CL; VARINBLANK, N; METZGER, H				ALBER, G; MILLER, L; JELSEMA, CL; VARINBLANK, N; METZGER, H			STRUCTURE-FUNCTION-RELATIONSHIPS IN THE MAST-CELL HIGH-AFFINITY RECEPTOR FOR IGE - ROLE OF THE CYTOPLASMIC DOMAINS AND OF THE BETA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; IMMUNOGLOBULIN-E; HISTAMINE-RELEASE; TRANSFECTED CELLS; INSULIN-RECEPTORS; BINDING; EXPRESSION; PHOSPHORYLATION; PROTEIN	To define functionally critical regions of the high affinity receptor for IgE (Fc-epsilon-RI), we stably transfected P815 cells with mutated cDNAs coding for subunits with truncated cytoplasmic domains (CD). In addition, to examine further the role of the beta-subunit, stable transfectants expressing chimeric Fc-epsilon-RI without beta-subunits were generated. Transfectants were tested for receptor-mediated changes in intracellular Ca2+, for stimulated hydrolysis of phosphoinositides, and for protein tyrosine phosphorylation. In all cases these biochemical signals were affected coordinately, suggesting that they are coupled, possibly in a single pathway. Truncation of the alpha-subunit or of the NH2-terminal CD of the beta-subunit had no effect, but Fc-epsilon-RIs with beta-subunits missing the COOH-terminal CD were inactive. Interestingly, receptors in cells transfected only with human Fc-epsilon-RI(alpha) (which utilize the gamma-chains endogenously synthesized by the P815 cells but which contain no beta-subunits) responded normally. Therefore, the beta-subunit influences the functions studied but is not essential. Although structural analysis excluded a straightforward mechanism, truncation of the CD of the gamma-chain led to loss of signaling.	NIAMSD,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)				VARIN-BLANK, Nadine/0000-0003-2769-018X				ALBER G, 1991, FASEB J, V5, P1674; ALCARAZ G, 1987, BIOCHEMISTRY-US, V26, P2569, DOI 10.1021/bi00383a024; BANIYASH M, 1987, J IMMUNOL, V138, P2999; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BERENSTEIN EH, 1990, FASEB J, V4, pA1874; BLANK U, 1991, J BIOL CHEM, V266, P2639; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CHOU CK, 1987, J BIOL CHEM, V262, P1842; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; HOHMAN RJ, 1990, J IMMUNOL, V145, P3876; HOLOWKA D, 1982, MOL IMMUNOL, V19, P219, DOI 10.1016/0161-5890(82)90334-0; HOLOWKA D, 1984, J BIOL CHEM, V259, P3720; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; KINET JP, 1990, FC RECEPTORS ACTION, P239; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; KULCZYCKI A, 1974, J EXP MED, V139, P600, DOI 10.1084/jem.139.3.600; KUSTER H, 1990, J BIOL CHEM, V265, P6448; MAEGAWA H, 1988, J BIOL CHEM, V263, P12629; MAO SY, 1991, J IMMUNOL, V146, P958; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; METZGER H, 1983, PROG IMMUNOL P INT C, V5, P493; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; MILLER L, 1990, J BIOL CHEM, V265, P12444; PECHT I, 1989, PROGR IMMUNOLOGY, V7, P676; PEREZMONTFORT R, 1983, BIOCHEMISTRY-US, V22, P5722, DOI 10.1021/bi00294a007; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RIVNAY B, 1984, J BIOL CHEM, V259, P1212; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SAITO H, 1987, J IMMUNOL, V138, P3927; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; VANDOREN K, 1984, J VIROL, V50, P606, DOI 10.1128/JVI.50.2.606-614.1984; VANPEL A, 1985, SOMAT CELL MOLEC GEN, V11, P467; VARINBLANK N, 1990, J BIOL CHEM, V265, P15685; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844	36	180	184	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22613	22620						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658002				2022-12-25	WOS:A1991GR56400085
J	MATOZAKI, T; SAKAMOTO, C; NISHISAKI, H; SUZUKI, T; WADA, K; MATSUDA, K; NAKANO, O; KONDA, Y; NAGAO, M; KASUGA, M				MATOZAKI, T; SAKAMOTO, C; NISHISAKI, H; SUZUKI, T; WADA, K; MATSUDA, K; NAKANO, O; KONDA, Y; NAGAO, M; KASUGA, M			CHOLECYSTOKININ INHIBITS PHOSPHATIDYLCHOLINE SYNTHESIS VIA A CA2+-CALMODULIN-DEPENDENT PATHWAY IN ISOLATED RAT PANCREATIC ACINI - A POSSIBLE MECHANISM FOR DIACYLGLYCEROL ACCUMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; PHOSPHOLIPASE-D; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; INOSITOL TRISPHOSPHATE; CELLS; HEPATOCYTES; BIOSYNTHESIS; ACTIVATION; CALCIUM; LIVER	The effects of cholecystokinin (CCK) and other pancreatic secretagogues on phosphatidylcholine (PC) synthesis were studied in isolated rat pancreatic acini. When acini were incubated with [H-3]choline in the presence of 1 nm CCK-octapeptide (CCK8) for 60 min, the incorporations of [H-3]choline into both water-soluble choline metabolites and PC in acini were reduced by CCK8 to 74 and 41% of control, respectively. Pulse-chase study revealed that CCK8 reduced both the disappearance of phosphocholine and the synthesis of PC. Other Ca2+-mobilizing secretagogues such as carbamylcholine, bombesin, and Ca2+ ionophore A23187 also reduced PC synthesis to the same extent as did CCK8. When combined with 1 nM CCK8, A23187 or carbamylcholine did not further inhibit PC synthesis. Furthermore, W-7 or W-5, a calmodulin antagonist, reversed the inhibition by CCK8 of PC synthesis, suggesting that a Ca2+-calmodulin-dependent pathway may be involved in CCK-induced inhibition of PC synthesis in acini. By contrast, neither cAMP-dependent secretagogues such as secretin and dibutyryl cAMP nor a phorbol ester had any effect on PC synthesis in acini. Staurosporine or H-7, a protein kinase C inhibitor, did not affect the inhibition by CCK of PC synthesis. The analysis of enzyme activity involved in PC synthesis via CDP-choline pathway showed that CCK treatment of acini reduced CTP:phosphocholine cytidylyltransferase activity in both cytosolic and particulate fraction, a finding consistent with the delayed disappearance of phosphocholine induced by CCK in pulse-chase study. By contrast, CCK treatment of acini did not alter the activities of choline kinase and phosphocholine transferase in acini. The extent of inhibition by CCK of cytidylyltransferase activity became much larger when subcellular fractions of acini were prepared in the presence of phosphatase inhibitors. In addition, W-7 reversed the inhibitory effect of CCK treatment on cytidylyltransferase activity in acini. When acini were labeled with [H-3]myristic acid and chased, CCKS (1 nm) reduced the synthesis of [H-3] myristic acid-labeled PC to 27% of control after a 60-min chase period. This inhibition of PC synthesis induced by CCK was accompanied by a delayed disappearance of [H-3]diacylglycerol, the radioactivity of which was 225% of control at 60 min. These results indicate that CCK inhibits PC synthesis by inducing both the reduction of choline uptake into acini and the inhibition of CTP:phosphocholine cytidylyltransferase activity. Furthermore, the results suggest the possibility that the activation of Ca2+-calmodulin-dependent kinase in response to CCK may phosphorylate cytidylyltransferase thereby decreasing this enzyme activity in pancreatic acinar cells. By contrast, the activation of cAMP-dependent protein kinase or protein kinase C may not be involved in CCK-induced inhibition of PC synthesis in acini. The inhibition by CCK of PC synthesis may contribute to the sustained accumulation of diacylglycerol in pancreatic acinar cells.			MATOZAKI, T (corresponding author), KOBE UNIV,SCH MED,DEPT INTERNAL MED 2,KUSUNOKI CHO,CHUO KU,KOBE 650,JAPAN.							ADLER G, 1986, EXOCRINE PANCREAS BI, P1223; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BLUSZTAJN JK, 1989, FEBS LETT, V243, P267, DOI 10.1016/0014-5793(89)80142-5; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CABOT MC, 1988, FEBS LETT, V233, P153, DOI 10.1016/0014-5793(88)81374-7; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; GEELEN MJH, 1979, FEBS LETT, V105, P27, DOI 10.1016/0014-5793(79)80880-7; GORELICK FS, 1983, J CELL BIOL, V97, P1294, DOI 10.1083/jcb.97.4.1294; HAAGSMAN HP, 1984, J BIOL CHEM, V259, P1273; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; JOLLES J, 1981, BIOCHEM J, V194, P283, DOI 10.1042/bj1940283; KELLY KL, 1988, BIOCHEM J, V255, P693; KITAGAWA M, 1990, AM J PHYSIOL, V259, pG157, DOI 10.1152/ajpgi.1990.259.2.G157; KOLESNICK RN, 1987, J BIOL CHEM, V262, P14525; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; LISCOVITCH M, 1989, J BIOL CHEM, V264, P1450; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; MATOZAKI T, 1989, J BIOL CHEM, V264, P14729; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MATOZAKI T, 1991, IN PRESS PANCREAS; MERRITT JE, 1986, BIOCHEM J, V238, P825, DOI 10.1042/bj2380825; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NOGUCHI M, 1985, AM J PHYSIOL, V248, pG692, DOI 10.1152/ajpgi.1985.248.6.G692; PADDON HB, 1980, BIOCHIM BIOPHYS ACTA, V620, P636, DOI 10.1016/0005-2760(80)90156-3; PANDOL SJ, 1986, J BIOL CHEM, V261, P4438; PELECH SL, 1981, J BIOL CHEM, V256, P8283; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; PREISS J, 1986, J BIOL CHEM, V261, P8597; PUTNEY JW, 1987, AM J PHYSIOL, V252, pG149, DOI 10.1152/ajpgi.1987.252.2.G149; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SANGHERA JS, 1989, BIOCHIM BIOPHYS ACTA, V1003, P284, DOI 10.1016/0005-2760(89)90234-8; SKIPSKI VP, 1964, BIOCHEM J, V90, P374, DOI 10.1042/bj0900374; SLIVKA SR, 1988, J BIOL CHEM, V263, P12242; STREB H, 1985, J BIOL CHEM, V260, P7309; STUENKEL EL, 1989, BIOCHEM BIOPH RES CO, V158, P863, DOI 10.1016/0006-291X(89)92802-7; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; TIJBURG LBM, 1987, BIOCHIM BIOPHYS ACTA, V919, P49, DOI 10.1016/0005-2760(87)90216-5; TRUDEL S, 1990, BIOCHEM J, V269, P127, DOI 10.1042/bj2690127; Vance D E, 1981, Methods Enzymol, V71 Pt C, P576; VANCE DE, 1974, EUR J BIOCHEM, V43, P327, DOI 10.1111/j.1432-1033.1974.tb03416.x; VERME TB, 1989, AM J PHYSIOL, V257, pG548, DOI 10.1152/ajpgi.1989.257.4.G548; WEINHOLD PA, 1974, BIOCHEMISTRY-US, V13, P5135, DOI 10.1021/bi00722a013; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 1989, HDB PHYSL GASTROIN 6, VIII, P419	49	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22246	22253						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657994				2022-12-25	WOS:A1991GR56400031
J	CRUTE, JJ; BRUCKNER, RC; DODSON, MS; LEHMAN, IR				CRUTE, JJ; BRUCKNER, RC; DODSON, MS; LEHMAN, IR			HERPES SIMPLEX-1 HELICASE-PRIMASE - IDENTIFICATION OF 2 NUCLEOSIDE TRIPHOSPHATASE SITES THAT PROMOTE DNA HELICASE ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1; UNIQUE REGION; GENE-PRODUCTS; REPLICATION; ORIGIN; SEQUENCE; CLONING; GENOME; OVEREXPRESSION; LOCALIZATION	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase comprised of the products of the UL5, UL8, and UL52 genes (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488). A steady state kinetic analysis of the enzyme isolated from HSV-1-infected CV-1 cells or insect cells expressing the enzyme after infection with recombinant baculoviruses has shown it to possess two sites capable of hydrolyzing nucleoside triphosphates in a DNA-dependent manner. One site (Site I) hydrolyzes both ATP and GTP; the second (Site II) hydrolyzes only ATP. These two sites are contained within a subassembly of the helicase-primase formed by coexpression of the UL5 and UL52 genes in insect cells. Sites I and II are activated by separate DNA effector sites, both of which support DNA helicase action. These findings are likely to be of importance in understanding how helicases in general catalyze the unwinding of duplex DNA and, in particular, how the helicase-primase functions at the HSV-1 replication fork.			CRUTE, JJ (corresponding author), STANFORD UNIV, MED CTR, SCH MED, BECKMAN CTR, DEPT BIOCHEM, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012092] Funding Source: NIH RePORTER; NIAID NIH HHS [AI26538] Funding Source: Medline; NIGMS NIH HHS [1FO32 GM12092] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APOSHIAN HV, 1962, J BIOL CHEM, V237, P519; CHALLBERG MD, 1986, P NATL ACAD SCI USA, V83, P9094, DOI 10.1073/pnas.83.23.9094; CRUTE JJ, 1991, J BIOL CHEM, V266, P4484; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DODSON MS, 1989, J BIOL CHEM, V264, P20835; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GRAY CP, 1984, J GEN VIROL, V65, P2109, DOI 10.1099/0022-1317-65-12-2109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOCKSHON D, 1986, J VIROL, V58, P513, DOI 10.1128/JVI.58.2.513-521.1986; MCGEOCH DJ, 1985, J MOL BIOL, V181, P1, DOI 10.1016/0022-2836(85)90320-1; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; OLIVO PD, 1989, J VIROL, V63, P196, DOI 10.1128/JVI.63.1.196-204.1989; POST LE, 1981, CELL, V24, P555, DOI 10.1016/0092-8674(81)90346-9; SCHAFFER PA, 1973, VIROLOGY, V52, P57, DOI 10.1016/0042-6822(73)90398-X; SPAETE RR, 1985, P NATL ACAD SCI USA, V82, P694, DOI 10.1073/pnas.82.3.694; SPAETE RR, 1982, CELL, V30, P295, DOI 10.1016/0092-8674(82)90035-6; STOW ND, 1982, EMBO J, V1, P863, DOI 10.1002/j.1460-2075.1982.tb01261.x; VLAZNY DA, 1981, P NATL ACAD SCI-BIOL, V78, P742, DOI 10.1073/pnas.78.2.742; WELLER SK, 1985, MOL CELL BIOL, V5, P930, DOI 10.1128/MCB.5.5.930; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988	23	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21252	21256						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657954				2022-12-25	WOS:A1991GN00100103
J	BLACK, EJ; STREET, AJ; GILLESPIE, DAF				BLACK, EJ; STREET, AJ; GILLESPIE, DAF			PROTEIN PHOSPHATASE 2A REVERSES PHOSPHORYLATION OF C-JUN SPECIFIED BY THE DELTA DOMAIN INVITRO - CORRELATION WITH ONCOGENIC ACTIVATION AND DEREGULATED TRANSACTIVATION ACTIVITY OF V-JUN	ONCOGENE			English	Article							OKADAIC ACID; AP-1; FOS; TRANSFORMATION; INHIBITOR; ENCODES	Chicken c-Jun proteins synthesized in vitro in reticulocyte extract consist of several electrophoretic isoforms resulting from phosphorylation which can be specifically reversed by purified protein phosphatase 2A (PP2A). Using the phosphatase inhibitors okadaic acid and microcystin-LR, we conclude that the isoforms seen in vitro represent a balance between the action of an unidentified kinase(s) which phosphorylates c-Jun and dephosphorylation by an endogenous PP2A-like phosphatase. c-Jun proteins are also subject to phosphorylation in vivo in chick embryo fibroblasts (CEF), which can be reversed by PP2A. In contrast, the viral Jun oncoprotein encoded by ASV17 is not subject to PP2A-sensitive phosphorylation in vitro and is hypophosphorylated in comparison with c-Jun in ASV17-transformed CEF. Hybrids between c-Jun and v-Jun demonstrate that differential phosphorylation in vitro is a consequence of deletion of 27 amino acids in the N-terminal third of v-Jun. The deletion is important for oncogenic activation and lies in a domain, termed delta, which regulates c-Jun transactivation function. PP2A-sensitive phosphorylation in vitro correlates with the differential responsiveness of c-Jun and v-Jun to a recently identified cell type-specific inhibitor of transactivation function.	BEATSON INST CANC RES, CANC RES CAMPAIGN BEATSON LABS, GARSCUBE ESTATE, SWITCHBACK RD, GLASGOW G61 1BD, SCOTLAND; UNIV DUNDEE, INST MED SCI, DEPT BIOCHEM, MRC PROTEIN PHOSPHORYLAT UNIT, DUNDEE DD1 4HN, SCOTLAND	Beatson Institute; University of Dundee			Gillespie, David/R-4771-2019	Gillespie, David/0000-0002-6338-0544				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ANGEL P, 1989, New Biologist, V1, P35; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOS TJ, 1989, ONCOGENE, V4, P123; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COHEN P, 1988, METHOD ENZYMOL, V159, P390; CROUCH DH, 1990, ONCOGENE, V5, P683; CURRAN T, 1987, ONCOGENE, V2, P79; FRAME MC, 1991, ONCOGENE, V6, P205; GILLESPIE DAF, 1989, MOL CELL BIOL, V9, P865, DOI 10.1128/MCB.9.2.865; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; NISHIMURA T, 1988, ONCOGENE, V3, P659; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768	24	52	52	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1991	6	11					1949	1958						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658706				2022-12-25	WOS:A1991GX11900002
J	HANSEN, CA; YANG, LJ; WILLIAMSON, JR				HANSEN, CA; YANG, LJ; WILLIAMSON, JR			MECHANISMS OF RECEPTOR-MEDIATED CA2+ SIGNALING IN RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CEREBELLAR PURKINJE-CELLS; PAROTID ACINAR-CELLS; PLASMA-MEMBRANE; INTRACELLULAR CALCIUM; STIMULATED HEPATOCYTES; CA-2+ CONCENTRATION; RYANODINE RECEPTOR; HUMAN-PLATELETS; ENTRY	The Ca2+ signal observed in individual fura-2-loaded hepatocytes stimulated with the alpha-1-adrenergic agonist phenylephrine consisted of a variable latency period, a rapid biphasic increase in the cytosolic free Ca2+, followed by a period of maintained elevated cytosolic Ca2+ (plateau phase) that depended on the continued presence of both agonist and external Ca2+. Microinjection of guanosine-5'-O-(3-thiophosphate) elicited a Ca2+ transient with the same basic features. The Ca2+ transient resulting from microinjecting inositol 1,4,5-trisphosphate (Ins-1,4,5-P3) occurred with essentially no latency period and consisted of a rapid spike that decayed back to preinjection levels within 15 s. Microinjection of inositol 1,4,5-trisphosphorothioate (thio-IP3), a nonmetabolizable analog of Ins-1,4,5-P3, elicited a Ca2+ transient that was initially identical to that observed with Ins-1,4,5-P3, except that the cytosolic Ca2+ remained elevated. The maintained thio-IP3-induced Ca2+ increase was dependent on the presence of external Ca2+, suggesting an activation of Ca2+ influx. Reintroduction of external Ca2+ in the presence of 5-mu-M phenylephrine to Ca2+-depleted cells resulted in a 2-fold greater rate of rise in the cytosolic Ca2+ compared to the rate observed upon Ca2+ addition to cells Ca2+-depleted by preatement with thapsigargin. The rate of Ca2+ rise upon Ca2+ addition to cells microinjected with thio-IP3 was similar to that observed with phenylephrine. Coinjection of the cells with thio-IP3 plus heparin reduced the rate of Ca2+ rise upon Ca2+ addition to that observed in thapsigargin-treated cells. These data indicate that the mechanism responsible for receptor-mediated stimulation of Ca2+ entry into hepatocytes involves not only capacitative Ca2+ entry but also an additional component mediated directly by Ins-1,4,5-P3.	UNIV PENN, SCH MED, DEPT BIOCHEM & BIOPHYS, PHILADELPHIA, PA 19104 USA	University of Pennsylvania					NIDDK NIH HHS [DK 15120] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015120] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; CERDAN S, 1986, J BIOL CHEM, V261, P4676; CHALLISS RAJ, 1990, BIOCHEM J, V265, P421, DOI 10.1042/bj2650421; CHAMPEIL P, 1989, J BIOL CHEM, V264, P17665; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUILLEMETTE G, 1988, J BIOL CHEM, V263, P4541; HALLAM TJ, 1989, TRENDS PHARMACOL SCI, V10, P8, DOI 10.1016/0165-6147(89)90092-8; HANSEN CA, 1986, J BIOL CHEM, V261, P8100; HUGHES BP, 1987, BIOCHEM J, V248, P911, DOI 10.1042/bj2480911; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JACOB R, 1990, J PHYSIOL-LONDON, V421, P55, DOI 10.1113/jphysiol.1990.sp017933; JOSEPH SK, 1987, FEBS LETT, V219, P125, DOI 10.1016/0014-5793(87)81203-6; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; JOSEPH SK, 1989, ARCH BIOCHEM BIOPHYS, V273, P1, DOI 10.1016/0003-9861(89)90156-2; KASS GEN, 1990, J BIOL CHEM, V265, P17486; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KAWANISHI T, 1989, J BIOL CHEM, V264, P12859; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LLANO I, 1987, PFLUG ARCH EUR J PHY, V409, P499, DOI 10.1007/BF00583807; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MAHAUTSMITH MP, 1990, J BIOL CHEM, V265, P10479; MAUGER JP, 1989, J BIOL CHEM, V264, P8821; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MONCK JR, 1988, J BIOL CHEM, V263, P4569; MONCK JR, 1990, J NEUROCHEM, V54, P278, DOI 10.1111/j.1471-4159.1990.tb13312.x; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PIETRI F, 1990, J BIOL CHEM, V265, P17478; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RENGASAMY A, 1988, BIOCHEM BIOPH RES CO, V150, P1021, DOI 10.1016/0006-291X(88)90731-0; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SNYDER PM, 1988, J BIOL CHEM, V263, P11048; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TAYLOR CW, 1989, BIOCHEM J, V259, P645, DOI 10.1042/bj2590645; THOMAS AP, 1984, J BIOL CHEM, V259, P5574; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; UEMURA Y, 1989, BIOCHEM INT, V18, P335; VARNEY MA, 1990, BIOCHEM J, V269, P211, DOI 10.1042/bj2690211; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WILLIAMSON JR, 1989, ANNU REV PHYSIOL, V51, P107, DOI 10.1146/annurev.ph.51.030189.000543; WILLIAMSON JR, 1987, BIOCHEM ACTION HORM, V14, P29; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; YAMAMOTO H, 1989, J NEUROCHEM, V53, P917, DOI 10.1111/j.1471-4159.1989.tb11792.x	56	68	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18573	18579						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655756				2022-12-25	WOS:A1991GJ47200029
J	TAMAI, I; SAFA, AR				TAMAI, I; SAFA, AR			AZIDOPINE NONCOMPETITIVELY INTERACTS WITH VINBLASTINE AND CYCLOSPORINE-A BINDING TO P-GLYCOPROTEIN IN MULTIDRUG RESISTANT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSPORT PROTEINS; CALCIUM-CHANNEL BLOCKERS; PLASMA-MEMBRANE; PHOTOACTIVE ANALOGS; CROSS-RESISTANCE; SKELETAL-MUSCLE; K562 CELLS; VINCRISTINE; VERAPAMIL; DAUNORUBICIN	It is believed that P-glycoprotein (P-gp) is an energy-dependent drug efflux pump responsible for decreased drug accumulation in multidrug resistant (MGR) cells. In this study, we investigated whether azidopine, a photoactive dihydropyridine calcium channel blocker, is transported by P-gp in MDR Chinese hamster lung cells, DC-3F/VCRd-5L, and whether its binding site(s) on P-gp are distinct from those of Vinca alkaloids and cyclosporins. The efflux of azidopine from MDR cells was energy-dependent and inhibited by the cytotoxic agent vinblastine (VBL). Cyclosporin A (CsA), a modulator of MDR, also increased azidopine accumulation in MDR cells by decreasing the energy-dependent efflux of azidopine. P-gp in these cells was the only protein specifically bound to [H-3]azidopine in photo-affinity experiments. The specific photoaffinity labeling of P-gp by [H-3]azidopine was inhibited by CsA, SDZ 33-243, nonradioactive azidopine, and VBL with median concentrations (IC50) of 0.5, 0.62, 1.7, and 25-mu-M, respectively. The equilibrium binding of azidopine to plasma membranes of MDR variant DC-3F/VCRd-5L cells showed a single class of specific binding sites having a dissociation constant of 1.20-mu-M and a maximum binding capacity of 4.47 nmol/mg of protein. Kinetic analysis indicated that the inhibitory effect of VBL and CsA on azidopine binding to plasma membranes of MDR cells was noncompetitive, indicating that azidopine binds to P-gp at a binding site(s) different from the binding site(s) of these drugs.	UNIV CHICAGO,DEPT MED,HEMATOL ONCOL SECT,BOX 420,5841 S MARYLAND AVE,CHICAGO,IL 60637	University of Chicago			TAMAI, Ikumi/D-8412-2015		NCI NIH HHS [CA-47652] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA047652] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECK WT, 1988, BIOCHEM BIOPH RES CO, V153, P959, DOI 10.1016/S0006-291X(88)81321-4; BIEDLER JL, 1970, CANCER RES, V30, P1174; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FOSSET M, 1983, J BIOL CHEM, V258, P6086; FOXWELL BMJ, 1989, MOL PHARMACOL, V36, P543; GALIZZI JP, 1984, BIOCHEM BIOPH RES CO, V118, P239, DOI 10.1016/0006-291X(84)91092-1; GAVERIAUX C, 1989, BRIT J CANCER, V60, P867, DOI 10.1038/bjc.1989.381; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HU XF, 1990, CANCER RES, V50, P2953; HUET S, 1988, INT J CANCER, V41, P283, DOI 10.1002/ijc.2910410220; INABA M, 1979, CANCER RES, V39, P2200; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; LEE SC, 1988, P NATL ACAD SCI USA, V85, P2019, DOI 10.1073/pnas.85.6.2019; LEVER JE, 1977, J BIOL CHEM, V252, P1990; NAITO M, 1989, BIOCHEM BIOPH RES CO, V158, P1066, DOI 10.1016/0006-291X(89)92830-1; NAITO M, 1989, CANCER RES, V49, P1452; NAITO M, 1988, J BIOL CHEM, V263, P11887; PEARCE HL, 1989, P NATL ACAD SCI USA, V86, P5128, DOI 10.1073/pnas.86.13.5128; PETERSON RHF, 1983, CANCER RES, V43, P222; SAFA AR, 1990, BIOCHEM BIOPH RES CO, V166, P259; SAFA AR, 1989, BIOCHEM BIOPH RES CO, V162, P1402, DOI 10.1016/0006-291X(89)90830-9; SAFA AR, 1986, J BIOL CHEM, V261, P6137; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SAFA AR, 1990, P NATL ACAD SCI USA, V87, P7225, DOI 10.1073/pnas.87.18.7225; SAFA AR, 1987, J BIOL CHEM, V262, P1261; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SAFA AR, 1989, ANTI-CANCER DRUG, V191, P277; SAMUELS B L, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P361; SKOVSGAARD T, 1978, CANCER RES, V38, P4722; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; TAMAI I, 1990, J BIOL CHEM, V265, P16509; TSURUO T, 1982, CANCER RES, V42, P4730; TSURUO T, 1988, JPN J CANCER RES, V79, P285, DOI 10.1111/j.1349-7006.1988.tb01588.x; TWENTYMAN PR, 1988, BRIT J CANCER, V57, P254, DOI 10.1038/bjc.1988.55; YANG CPH, 1989, J BIOL CHEM, V264, P782; YUSA K, 1989, CANCER RES, V49, P5002	43	175	177	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16796	16800						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1679434				2022-12-25	WOS:A1991GD63500087
J	MARCONI, RT; LODMELL, JS; HILL, WE				MARCONI, RT; LODMELL, JS; HILL, WE			IDENTIFICATION OF A RIBOSOMAL-RNA CHLORAMPHENICOL INTERACTION SITE WITHIN THE PEPTIDYLTRANSFERASE CENTER OF THE 50-S SUBUNIT OF THE ESCHERICHIA-COLI RIBOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											MARCONI, RT (corresponding author), UNIV MONTANA,DIV BIOL SCI,MISSOULA,MT 59812, USA.			Marconi, Richard/0000-0002-6035-7306	NIGMS NIH HHS [GM35717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACK DM, 1985, NUCLEIC ACIDS RES, V13, P2433, DOI 10.1093/nar/13.7.2433; BLANC H, 1981, P NATL ACAD SCI-BIOL, V78, P3789, DOI 10.1073/pnas.78.6.3789; BRANLANT C, 1981, NUCLEIC ACIDS RES, V9, P4303, DOI 10.1093/nar/9.17.4303; Chaconas G, 1980, Methods Enzymol, V65, P75; Cundliffe E., 1981, MOL BASIS ANTIBIOTIC, V2nd, P402; DONNISKELLER H, 1979, NUCLEIC ACIDS RES, V7, P179; DUJON B, 1980, CELL, V20, P185, DOI 10.1016/0092-8674(80)90246-9; ELLIS RJ, 1969, SCIENCE, V163, P477, DOI 10.1126/science.163.3866.477; GALE EF, 1953, BIOCHEM J, V53, P493, DOI 10.1042/bj0530493; GLOTZ C, 1981, NUCLEIC ACIDS RES, V9, P3287, DOI 10.1093/nar/9.14.3287; GNIRKE A, 1986, J BIOL CHEM, V261, P4506; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; HILL WE, 1987, BIOCHIMIE, V69, P1071, DOI 10.1016/0300-9084(87)90007-1; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; KROON AM, 1965, BIOCHIM BIOPHYS ACTA, V108, P275, DOI 10.1016/0005-2787(65)90012-2; LAMBORG MR, 1960, BIOCHIM BIOPHYS ACTA, V42, P206, DOI 10.1016/0006-3002(60)90782-4; LASATER LS, 1988, BIOCHEMISTRY-US, V27, P4687, DOI 10.1021/bi00413a016; MARCONI RT, 1989, BIOCHEMISTRY-US, V28, P893, DOI 10.1021/bi00428a073; MARCONI RT, 1988, NUCLEIC ACIDS RES, V16, P1603, DOI 10.1093/nar/16.4.1603; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; POLITZ SM, 1980, BIOCHEMISTRY-US, V19, P3786, DOI 10.1021/bi00557a021; PONGS O, 1973, P NATL ACAD SCI USA, V70, P2229, DOI 10.1073/pnas.70.8.2229; SKINNER R, 1983, J BIOL CHEM, V258, P2702; SONNENBERG N, 1973, P NATL ACAD SCI USA, V70, P1423; STOFFLER G, 1980, RIBOSOMES STRUCTURE, P171; TAPPRICH WE, 1986, P NATL ACAD SCI USA, V83, P556, DOI 10.1073/pnas.83.3.556; Traub P, 1981, RNA PROTEIN SYNTHESI, P521; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; VAZQUEZ D, 1964, BIOCHEM BIOPH RES CO, V15, P464, DOI 10.1016/0006-291X(64)90487-5; VAZQUEZ D, 1966, BIOCHIM BIOPHYS ACTA, V114, P277, DOI 10.1016/0005-2787(66)90309-1; VOGEL Z, 1971, J MOL BIOL, V60, P339, DOI 10.1016/0022-2836(71)90298-1; WHITE GA, 1988, NUCLEIC ACIDS RES, V16, P10817, DOI 10.1093/nar/16.22.10817; WINTERSBERGER E, 1965, BIOCHEM Z, V341, P409; ZAMIR A, 1971, J MOL BIOL, V60, P347, DOI 10.1016/0022-2836(71)90299-3	34	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					7894	7899						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1692317				2022-12-25	WOS:A1990DC83500033
J	ERB, L; LUSTIG, KD; AHMED, AH; GONZALEZ, FA; WEISMAN, GA				ERB, L; LUSTIG, KD; AHMED, AH; GONZALEZ, FA; WEISMAN, GA			COVALENT INCORPORATION OF 3'-O-(4-BENZOYL)BENZOYL-ATP INTO A P2 PURINOCEPTOR IN TRANSFORMED MOUSE FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MISSOURI, DEPT FOOD SCI & NUTR, COLUMBIA, MO 65211 USA; CORNELL UNIV, BIOCHEM MOLEC & CELL BIOL SECT, ITHACA, NY 14853 USA	University of Missouri System; University of Missouri Columbia; Cornell University	ERB, L (corresponding author), UNIV MISSOURI, DEPT BIOCHEM, COLUMBIA, MO 65211 USA.			Erb, Laurie/0000-0001-6372-3378	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM011789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036887] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-07053] Funding Source: Medline; NIADDK NIH HHS [AM-11789] Funding Source: Medline; NIGMS NIH HHS [GM-36887] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIUCHI T, 1977, BIOCHEMISTRY-US, V16, P1626, DOI 10.1021/bi00627a016; Bayley H, 1977, Methods Enzymol, V46, P69; BORN GVR, 1984, J PHYSIOL-LONDON, V354, P419, DOI 10.1113/jphysiol.1984.sp015385; BOYER JL, 1989, J BIOL CHEM, V264, P884; BURGESS GM, 1979, NATURE, V279, P544, DOI 10.1038/279544a0; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; BURNSTOCK G, 1981, PURINERGIC RECEPTORS, P1; BURNSTOCK G, 1985, METHOD PHARMACOL, V6, P193; CABLE MB, 1984, J BIOL CHEM, V259, P3612; CHAUDRY IH, 1982, YALE J BIOL MED, V55, P1; CLEMENS MG, 1981, J PHYSIOL-LONDON, V312, P143, DOI 10.1113/jphysiol.1981.sp013621; COCKCROFT S, 1979, J PHYSIOL-LONDON, V296, P229, DOI 10.1113/jphysiol.1979.sp013002; COCKCROFT S, 1980, BIOCHEM J, V188, P789, DOI 10.1042/bj1880789; DE BK, 1984, BIOCHIM BIOPHYS ACTA, V775, P381, DOI 10.1016/0005-2736(84)90194-9; DICKER P, 1980, P NATL ACAD SCI-BIOL, V77, P2103, DOI 10.1073/pnas.77.4.2103; DIETERLE Y, 1978, CIRC RES, V42, P869, DOI 10.1161/01.RES.42.6.869; DUBYAK GR, 1985, J BIOL CHEM, V260, P653; FORRESTER T, 1972, J PHYSIOL-LONDON, V224, P611, DOI 10.1113/jphysiol.1972.sp009915; FORSBERG EJ, 1987, P NATL ACAD SCI USA, V84, P5630, DOI 10.1073/pnas.84.16.5630; FOX IH, 1978, ANNU REV BIOCHEM, V47, P655, DOI 10.1146/annurev.bi.47.070178.003255; FRIEDBERG I, 1985, J MEMBRANE BIOL, V83, P251, DOI 10.1007/BF01868699; GALLACHER DV, 1982, NATURE, V296, P83, DOI 10.1038/296083a0; GLYNN IM, 1968, BRIT MED BULL, V24, P165, DOI 10.1093/oxfordjournals.bmb.a070620; GOMPERTS BD, 1985, SECRETORY PROCESSES, P18; GONZALEZ FA, 1989, J CELL PHYSIOL, V141, P606, DOI 10.1002/jcp.1041410320; GONZALEZ FA, 1989, P NATL ACAD SCI USA, V86, P4530, DOI 10.1073/pnas.86.12.4530; GONZALEZ FA, 1989, J CELL PHYSIOL, V139, P109, DOI 10.1002/jcp.1041390116; GORDON EL, 1986, J BIOL CHEM, V261, P5496; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GORDON JL, 1983, BRIT J PHARMACOL, V79, P531, DOI 10.1111/j.1476-5381.1983.tb11028.x; GREEN HN, 1949, CLIN SCI, V8, P65; HEPPEL LA, 1985, J MEMBRANE BIOL, V86, P189, DOI 10.1007/BF01870597; KAMBOURIS NG, 1985, P NATL ACAD SCI USA, V82, P1950, DOI 10.1073/pnas.82.7.1950; KATZENELLENBOGE.JA, 1974, ANNU REP MED CHEM, V9, P222; LUSTIG KD, 1986, J GEN PHYSIOL, V88, P35; MAGNUSSON RP, 1976, ANAL BIOCHEM, V72, P653, DOI 10.1016/0003-2697(76)90580-7; MAHMOOD R, 1984, J BIOL CHEM, V259, P2956; MAKAN NR, 1981, J CELL PHYSIOL, V106, P49, DOI 10.1002/jcp.1041060107; MANOLSON MF, 1985, J BIOL CHEM, V260, P2273; ODONNELL JP, 1983, EUR J PHARMACOL, V86, P435, DOI 10.1016/0014-2999(83)90193-0; PADDLE BM, 1974, BLOOD VESSELS, V11, P110; PEARSON JD, 1985, METHOD PHARMACOL, V6, P87; PIROTTON S, 1987, J BIOL CHEM, V262, P17461; ROZENGURT E, 1975, BIOCHEM BIOPH RES CO, V67, P1581, DOI 10.1016/0006-291X(75)90207-7; ROZENGURT E, 1977, J BIOL CHEM, V252, P4584; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; STILES GL, 1985, J BIOL CHEM, V260, P806; SUNG SSJ, 1985, J BIOL CHEM, V260, P3442; TRAMS EG, 1974, NATURE, V252, P480, DOI 10.1038/252480a0; WEISMAN GA, 1984, J CELL PHYSIOL, V118, P124, DOI 10.1002/jcp.1041180204; WEISMAN GA, 1989, J CELL PHYSIOL, V138, P375, DOI 10.1002/jcp.1041380221; WEISMAN GA, 1984, J CELL PHYSIOL, V119, P211, DOI 10.1002/jcp.1041190211; WEISMAN GA, 1989, METHOD ENZYMOL, V171, P857; WILLIAMS N, 1982, J BIOL CHEM, V257, P2834; WILLIAMS N, 1986, METHOD ENZYMOL, V126, P667; WOLFF J, 1981, ADV CYCL NUCL RES<D>, V14, P199	56	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7424	7431						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692021				2022-12-25	WOS:A1990DB30700052
J	MAHONEY, CW; AZZI, A; HUANG, KP				MAHONEY, CW; AZZI, A; HUANG, KP			EFFECTS OF SURAMIN, AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AGENT, ON PROTEIN KINASE-C - DIFFERENTIAL ACTIVATION AND INHIBITION OF PROTEIN KINASE-C ISOZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NICHHD,METAB REGULAT ENDOCRINOL SECT,BLDG 10,RM BIL-400,BETHESDA,MD 20892; NICHHD,REPROD BRANCH,BETHESDA,MD 20892; UNIV BERN,INST BIOCHEM & MOLEC BIOL,CH-3012 BERN,SWITZERLAND	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Bern								ASHENDEL CL, 1983, CANCER RES, V43, P4333; BAINES DM, 1986, SCIENCE, V233, P419; COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22; DECLERCQ E, 1987, ANTIVIR RES, V7, P1, DOI 10.1016/0166-3542(87)90034-9; FIELDS AP, 1988, NATURE, V333, P278, DOI 10.1038/333278a0; HUANG FL, 1987, BIOCHEM BIOPH RES CO, V149, P946, DOI 10.1016/0006-291X(87)90500-6; HUANG FL, 1987, J BIOL CHEM, V262, P15714; HUANG FL, 1989, J BIOL CHEM, V264, P4238; HUANG KP, 1986, P NATL ACAD SCI USA, V83, P8535, DOI 10.1073/pnas.83.22.8535; HUANG KP, 1976, ANAL BIOCHEM, V72, P593, DOI 10.1016/0003-2697(76)90571-6; HUANG KP, 1988, J BIOL CHEM, V263, P14839; HUANG KP, 1986, J BIOL CHEM, V261, P2134; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; MAHONEY CW, 1988, DYNAMICS MEMBRANE PR, P2; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; NEWTON AC, 1987, J BIOL CHEM, V262, P10185; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ONO Y, 1988, J BIOL CHEM, V263, P6927; OSSIKOVSKI E, 1984, MOL BIOCHEM PARASIT, V12, P299, DOI 10.1016/0166-6851(84)90086-0; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; SAMSONOFF C, 1986, J COLLOID INTERF SCI, V109, P325, DOI 10.1016/0021-9797(86)90310-3; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHEARMAN MS, 1987, BIOCHEM BIOPH RES CO, V147, P911, DOI 10.1016/S0006-291X(87)80157-2; SHEARMAN MS, 1988, FEBS LETT, V234, P387, DOI 10.1016/0014-5793(88)80122-4; TABUSE Y, 1989, SCIENCE, V243, P1713, DOI 10.1126/science.2538925; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; WALKER JM, 1988, J BIOL CHEM, V263, P4537; WALTER RD, 1980, MOL BIOCHEM PARASIT, V1, P139, DOI 10.1016/0166-6851(80)90012-2; WISE BC, 1982, J BIOL CHEM, V257, P8489; YOSHIDA Y, 1988, J BIOL CHEM, V263, P9868	34	108	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5424	5428						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690710				2022-12-25	WOS:A1990CW48000021
J	DUEWEKE, TJ; GENNIS, RB				DUEWEKE, TJ; GENNIS, RB			EPITOPES OF MONOCLONAL-ANTIBODIES WHICH INHIBIT UBIQUINOL OXIDASE ACTIVITY OF ESCHERICHIA-COLI CYTOCHROME-D COMPLEX LOCALIZE FUNCTIONAL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801; UNIV ILLINOIS,DEPT CHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign					NHLBI NIH HHS [HL 16101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016101, R01HL016101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANRAKU Y, 1987, TRENDS BIOCHEM SCI, V12, P262, DOI 10.1016/0968-0004(87)90131-9; AU DCT, 1985, J BACTERIOL, V161, P123, DOI 10.1128/JB.161.1.123-127.1985; FANG H, 1989, J BIOL CHEM, V264, P8026; GEORGIOU CD, 1988, J BIOL CHEM, V263, P13130; GREEN GN, 1984, J BIOL CHEM, V259, P7994; GREEN GN, 1984, GENE, V32, P99, DOI 10.1016/0378-1119(84)90037-4; GREEN GN, 1986, BIOCHEMISTRY-US, V25, P2309, DOI 10.1021/bi00357a002; GREEN GN, 1988, J BIOL CHEM, V263, P13139; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KITA K, 1984, J BIOL CHEM, V259, P3375; KOLAND JG, 1984, BIOCHEMISTRY-US, V23, P1051, DOI 10.1021/bi00301a003; KOLAND JG, 1984, BIOCHEMISTRY-US, V23, P445, DOI 10.1021/bi00298a008; KRANZ RG, 1984, J BIOL CHEM, V259, P7998; KUMAR C, 1985, FEBS LETT, V190, P227, DOI 10.1016/0014-5793(85)81289-8; LORENCE RM, 1988, J BIOL CHEM, V263, P5271; LORENCE RM, 1986, BIOCHEMISTRY-US, V25, P2314, DOI 10.1021/bi00357a003; Maniatis T., 1982, MOL CLONING; MILLER MJ, 1985, J BIOL CHEM, V260, P4003; MILLER MJ, 1983, J BIOL CHEM, V258, P9159; MILLER MJ, 1988, J BIOL CHEM, V263, P5235; MINGHETTI KC, 1988, BIOCHEM BIOPH RES CO, V155, P243; POOLE RK, 1982, FEBS LETT, V150, P147, DOI 10.1016/0014-5793(82)81323-9; POOLE RK, 1984, J GEN MICROBIOL, V130, P3055; POOLE RK, 1988, FEBS LETT, V231, P243, DOI 10.1016/0014-5793(88)80740-3; POOLE RK, 1987, FEBS LETT, V217, P49, DOI 10.1016/0014-5793(87)81240-1; POOLE RK, 1983, J GEN MICROBIOL, V129, P1335; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; ROTHERY RA, 1987, J GEN MICROBIOL, V133, P3247; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SECKLER R, 1986, BIOCHEMISTRY-US, V25, P2403, DOI 10.1021/bi00357a016; WILLIAMS HD, 1987, J GEN MICROBIOL, V133, P2461; YOUNG RA, 1985, P NATL ACAD SCI USA, V82, P2583, DOI 10.1073/pnas.82.9.2583	32	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1990	265	8					4273	4277						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT101	1689724				2022-12-25	WOS:A1990CT10100020
J	WILLIAMS, RW; WEAVER, JL				WILLIAMS, RW; WEAVER, JL			SECONDARY STRUCTURE OF SUBSTANCE-P BOUND TO LIPOSOMES IN ORGANIC-SOLVENTS AND IN SOLUTION FROM RAMAN AND CD SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											WILLIAMS, RW (corresponding author), UNIFORMED SERV UNIV HLTH SCI,DEPT BIOCHEM,BETHESDA,MD 20814, USA.				NIGMS NIH HHS [GM7160] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aronin N., 1983, P783; BANDEKAR J, 1988, BIOPOLYMERS, V27, P885, DOI 10.1002/bip.360270602; BARUCH P, 1987, SUBSTANCE P NEUROKIN, P308; CANDY JM, 1981, J PHYSIOL-LONDON, V320, pP112; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; CHASSAING G, 1986, EUR J BIOCHEM, V154, P77, DOI 10.1111/j.1432-1033.1986.tb09361.x; Chassaing G., 1987, SUBSTANCE P NEUROKIN, P63; DEYOUNG LR, 1988, BIOPHYS J, V53, P497; ERNE D, 1986, HELV CHIM ACTA, V69, P1807, DOI 10.1002/hlca.19860690804; GABER BP, 1978, BIOPHYS J, V21, P161, DOI 10.1016/S0006-3495(78)85516-7; GIERASCH LM, 1982, BIOPHYS J, V37, P275, DOI 10.1016/S0006-3495(82)84676-6; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HAN SL, 1980, INT J PEPT PROT RES, V16, P173; HOLLOSI M, 1987, BIOPOLYMERS, V26, P1555, DOI 10.1002/bip.360260908; HOLLOSI M, 1985, BIOPOLYMERS, V24, P211, DOI 10.1002/bip.360240117; HOLZER P, 1987, SUBSTANCE P NEUROKIN, P187; Jardetzky O., 1981, NMR MOL BIOL; KARLE IL, 1978, ACTA CRYSTALLOGR B, V34, P3237, DOI 10.1107/S0567740878010572; KARLE IL, 1981, PERSPECTIVES PEPTIDE; KIM PS, 1982, J MOL BIOL, V162, P187, DOI 10.1016/0022-2836(82)90168-1; KOZIEJ P, 1985, Z NATURFORSCH B, V40, P1570; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; MEHLIS B, 1975, BIOCHEM BIOPH RES CO, V66, P1447, DOI 10.1016/0006-291X(75)90521-5; MEHLIS B, 1980, INT J PEPT PROT RES, V15, P20; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MINTON AP, 1987, IIGBT SCI NEWSLETTER, V2, P2; MULLER MJ, 1987, SUBSTANCE P NEUROKIN, P78; NEVSKAYA NA, 1976, BIOPOLYMERS, V15, P637, DOI 10.1002/bip.1976.360150404; OHLEN A, 1987, SUBSTANCE P NEUROKIN, P192; PLOUX O, 1987, SUBSTANCE P NEUROKIN, P60; ROLKA K, 1986, HELV CHIM ACTA, V69, P1798, DOI 10.1002/hlca.19860690803; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; RUEGER M, 1984, BIOPOLYMERS, V23, P747, DOI 10.1002/bip.360230413; RUEGER M, 1979, PEPTIDES 1978, P465; SANDBERG BEB, 1982, J MED CHEM, V25, P1009, DOI 10.1021/jm00351a001; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; SCHWYZER R, 1987, EMBO J, V6, P2255, DOI 10.1002/j.1460-2075.1987.tb02498.x; SCHWYZER R, 1986, HELV CHIM ACTA, V69, P1789, DOI 10.1002/hlca.19860690802; SEELIG A, 1989, BIOCHEMISTRY-US, V28, P2490, DOI 10.1021/bi00432a021; SHIH LB, 1986, J PHYS CHEM-US, V90, P1615, DOI 10.1021/j100399a032; SMITH GD, 1978, SCIENCE, V199, P1214, DOI 10.1126/science.204006; SUGIHARA T, 1982, BIOCHEMISTRY-US, V21, P3444, DOI 10.1021/bi00257a030; VAUGHT JL, 1987, SUBSTANCE P NEUROKIN, P176; WALLACE BA, 1983, BIOPOLYMERS, V22, P397, DOI 10.1002/bip.360220152; WATKINS DJ, 1987, SUBSTANCE P NEUROKIN, P87; WILLIAMS RW, 1983, J MOL BIOL, V166, P581, DOI 10.1016/S0022-2836(83)80285-X; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WILLIAMS RW, 1986, J BIOL CHEM, V261, P2408; WILLIAMS RW, 1986, METHOD ENZYMOL, V130, P311; WILLIAMS RW, 1981, J MOL BIOL, V152, P783, DOI 10.1016/0022-2836(81)90127-3; WOOLLEY GA, 1987, BIOPOLYMERS, V26, pS109, DOI 10.1002/bip.360260012; WU CSC, 1978, BIOCHEM BIOPH RES CO, V82, P85, DOI 10.1016/0006-291X(78)90580-6; WU CSC, 1981, MOL CELL BIOCHEM, V40, P109; WU CSC, 1982, BIOCHEMISTRY-US, V21, P4556, DOI 10.1021/bi00262a007; YANG JT, 1986, METHOD ENZYMOL, V130, P208	55	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1990	265	5					2505	2513						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM848	1689289				2022-12-25	WOS:A1990CM84800020
J	YE, J; ESMON, NL; ESMON, CT; JOHNSON, AE				YE, J; ESMON, NL; ESMON, CT; JOHNSON, AE			THE ACTIVE-SITE OF THROMBIN IS ALTERED UPON BINDING TO THROMBOMODULIN - 2 DISTINCT STRUCTURAL-CHANGES ARE DETECTED BY FLUORESCENCE, BUT ONLY ONE CORRELATES WITH PROTEIN-C ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; ELONGATION FACTOR-TU; RABBIT THROMBOMODULIN; PROTEOLYTIC FORMATION; BLOOD-COAGULATION; FACTOR-XA; COFACTOR; COMPLEX; DOMAIN; LOCALIZATION	The association of thrombin with thrombomodulin, a non-enzymatic endothelial cell surface receptor, alters the substrate specificity of thrombin. Complex formation converts thrombin from a procoagulant to an anticoagulant enzyme. Structure-function analysis of this change in specificity is facilitated by the availability of two soluble proteolytic derivatives of thrombomodulin, one consisting of the six repeated growth factor-like domains of thrombomodulin (GF1-6) and the other containing only the fifth and sixth such domains (GF5-6). Both derivatives can bind to thrombin and block fibrinogen clotting activity, though only the larger GF1-6 can stimulate the activation of protein C. To ascertain whether the substrate specificity change from fibrinogen to protein C is accompanied by structural changes in the active site of the enzyme, fluorescent dyes were positioned at different locations within the active site. A 5-dimethylaminonaphthalene-1-sulfonyl (dansyl) dye was covalently attached to the active site serine to form dansyl-thrombin, while either a fluorescein or an anilinonaphthalene-6-sulfonic acid (ANS) dye was attached covalently to the active site histidine of thrombin via a D-Phe-Pro-Arg linkage. The environment of the dansyl dye was altered in a similar fashion when either GF1-6 or GF5-6 bound to thrombin, since a similar reduction in dansyl emission intensity was elicited by these two thrombomodulin derivatives (25 and 32%, respectively). These spectral changes, and all others in this study, were saturable and reached a maximum when the ratio of thrombomodulin derivative to thrombin was close to 1. The environments of the fluorescein and ANS dyes were also altered when GF1-6 bound to thrombin because binding resulted in emission intensity changes of -13% and +18%, respectively. In contrast, no fluorescence changes were observed when the fluorescein and ANS thrombin derivatives were titrated with GF5-6. Thus, the structure of the active site was altered by thrombomodulin both immediately adjacent to the active site serine and also more than 15 angstrom away from it. However, the structural change far from Ser-195 was only elicited by thrombomodulin species that stimulate thrombin-dependent activation of protein C.	UNIV OKLAHOMA, DEPT CHEM & BIOCHEM, NORMAN, OK 73019 USA; OKLAHOMA MED RES FDN, CARDIOVASC BIOL RES PROGRAM, OKLAHOMA CITY, OK 73104 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT PATHOL, OKLAHOMA CITY, OK 73190 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CITY, OK 73190 USA; HOWARD HUGHES MED INST, OKLAHOMA CITY, OK 73104 USA	University of Oklahoma System; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute			Johnson, Arthur E/G-3457-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029807, R37HL030340, R01HL032934] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 32934, R37 HL 30340, R01 HL 29807] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADKINS HJ, 1983, BIOCHEMISTRY-US, V22, P1208, DOI 10.1021/bi00274a034; BERLINER LJ, 1978, THROMB RES, V12, P15, DOI 10.1016/0049-3848(78)90081-6; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BOURIN MC, 1988, J BIOL CHEM, V263, P8044; BOURIN MC, 1990, J BIOL CHEM, V265, P15424; EHRLICH HJ, 1990, EMBO J, V9, P2367, DOI 10.1002/j.1460-2075.1990.tb07411.x; ESMON CT, 1986, ANN NY ACAD SCI, V485, P215, DOI 10.1111/j.1749-6632.1986.tb34583.x; ESMON CT, 1991, ANN NY ACAD SCI, V614, P30, DOI 10.1111/j.1749-6632.1991.tb43689.x; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; ESMON CT, 1989, J BIOL CHEM, V264, P4743; ESMON NL, 1982, J BIOL CHEM, V257, P859; ESMON NL, 1983, J BIOL CHEM, V258, P5548; GALVIN JB, 1987, J BIOL CHEM, V262, P2199; GRINNELL BW, 1990, ADV AP BIOT, V11, P29; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; HOFSTEENGE J, 1986, BIOCHEM J, V237, P243, DOI 10.1042/bj2370243; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; JACKMAN RW, 1986, P NATL ACAD SCI USA, V83, P8834, DOI 10.1073/pnas.83.23.8834; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; JAKUBOWSKI HV, 1989, J BIOL CHEM, V264, P11117; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; JOHNSON AE, 1984, CIRCULATION, V70, P52; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4893, DOI 10.1021/bi00667a022; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; KUROSAWA S, 1987, J BIOL CHEM, V262, P2206; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LU RL, 1989, J BIOL CHEM, V264, P12956; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MERCOLA DA, 1972, BIOCHEMISTRY-US, V11, P3860, DOI 10.1021/bi00771a005; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; OWEN WG, 1974, J BIOL CHEM, V249, P594; PREISSNER KT, 1990, J BIOL CHEM, V265, P4915; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; THOMPSON AR, 1977, ARCH BIOCHEM BIOPHYS, V178, P356, DOI 10.1016/0003-9861(77)90204-1; WALZ DA, 1986, ANN NY ACAD SCI, V485, P323, DOI 10.1111/j.1749-6632.1986.tb34594.x; WEBER G, 1954, BIOCHEM J, V56, pR31; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	44	146	149	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23016	23021						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660464				2022-12-25	WOS:A1991GT48300039
J	THOMPSON, J; SACKETT, DL; DONKERSLOOT, JA				THOMPSON, J; SACKETT, DL; DONKERSLOOT, JA			PURIFICATION AND PROPERTIES OF FRUCTOKINASE-I FROM LACTOCOCCUS-LACTIS - LOCALIZATION OF SCRK ON THE SUCROSE-NISIN TRANSPOSON TN5306	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-MUTANS; PHOSPHOTRANSFERASE SYSTEM; NUCLEOTIDE-SEQUENCE; KLEBSIELLA-PNEUMONIAE; BACILLUS-SUBTILIS; ZYMOMONAS-MOBILIS; SUCRASE GENE; PHOSPHOENOLPYRUVATE; METABOLISM; ESCHERICHIA-COLI-K12	Two electrophoretically distinct proteins with fructokinase (ATP: fructose-6-phosphotransferase) activity were detected in Lactococcus lactis subsp. lactis K1. Whereas fructokinase I was induced specifically by growth of the organism on sucrose, fructokinase II was derepressed during growth on ribose, galactose, maltose, and lactulose. Fructokinase I was purified about 1000-fold to electrophoretic homogeneity (specific activity 112 units/mg). The amino acid composition, N-terminal sequence, nucleoside triphosphate, and metal requirement(s) of the enzyme are reported. Ultracentrifugal analysis showed that the enzyme was primarily dimeric with subunits of 33.5 kDa (+/- 5%). When completely reduced, fructokinase I migrated as a single protein (M(r) = 32,000) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, but in the absence of reducing agent two polypeptides (apparent M(r) = 29,000 and 3 1,000) were detected. Isoelectric focusing also revealed two polypeptides (pI 5.6 and 5.8), and both species catalyzed the phosphorylation of fructose and mannose. Hybridization studies showed that: (i) a sucrose-negative mutant lacking the fructokinase I gene (scrK) retained fructokinase II activity and (ii) scrK is closely linked to scrA and scrB which encode Enzyme II(Ser) and sucrose-6-phosphate hydrolase, respectively. In L. lactis K1, these genes and the N5-(1-carboxyethyl)-L-ornithine synthase gene (ceo) are encoded on the sucrose-nisin transposon Tn5306 in the order ceo-scrKAB.	NIADDKD,BETHESDA,MD 20892		THOMPSON, J (corresponding author), NIDR,MICROBIAL ECOL LAB,BLDG 30,RM 528,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; BEWLEY TA, 1969, INT J PROT RES, V1, P117; BLATCH GL, 1990, GENE, V95, P17, DOI 10.1016/0378-1119(90)90408-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; CHASSY BM, 1983, J BACTERIOL, V154, P1195, DOI 10.1128/JB.154.3.1195-1203.1983; CHASSY BM, 1979, BIOCHEM BIOPH RES CO, V89, P307, DOI 10.1016/0006-291X(79)90979-3; DELVALLE JA, 1978, BIOSYSTEMS, V10, P265, DOI 10.1016/0303-2647(78)90008-4; DODD HM, 1990, J GEN MICROBIOL, V136, P555, DOI 10.1099/00221287-136-3-555; DOELLE HW, 1982, EUR J APPL MICROBIOL, V15, P20, DOI 10.1007/BF01875395; DONKERSLOOT JA, 1990, J BACTERIOL, V172, P4122, DOI 10.1128/jb.172.7.4122-4126.1990; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FOUET A, 1987, P NATL ACAD SCI USA, V84, P8773, DOI 10.1073/pnas.84.24.8773; FOUET A, 1986, GENE, V45, P221, DOI 10.1016/0378-1119(86)90258-1; GABRIEL O, 1971, METHOD ENZYMOL, V22, P578; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; KELKER NE, 1970, J BIOL CHEM, V245, P2060; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; PORTER EV, 1980, INFECT IMMUN, V30, P43, DOI 10.1128/IAI.30.1.43-50.1980; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; SABATER B, 1972, BIOCHIM BIOPHYS ACTA, V284, P414, DOI 10.1016/0005-2744(72)90137-4; SACKETT DL, 1989, ANAL BIOCHEM, V180, P319, DOI 10.1016/0003-2697(89)90439-9; SAPICO V, 1967, J BIOL CHEM, V242, P5086; SATO Y, 1989, J BACTERIOL, V171, P263, DOI 10.1128/jb.171.1.263-271.1989; SATO Y, 1988, INFECT IMMUN, V56, P1956, DOI 10.1128/IAI.56.8.1956-1960.1988; Schachman H.K., 1959, ULTRACENTRIFUGATION; SCHMID K, 1988, MOL MICROBIOL, V2, P1, DOI 10.1111/j.1365-2958.1988.tb00001.x; SCHOLLE RR, 1989, GENE, V80, P49, DOI 10.1016/0378-1119(89)90249-7; SCOPES RK, 1985, BIOCHEM J, V228, P627, DOI 10.1042/bj2280627; SEBASTIAN J, 1972, ARCH BIOCHEM BIOPHYS, V151, P227, DOI 10.1016/0003-9861(72)90492-4; SLEE AM, 1979, INFECT IMMUN, V24, P821, DOI 10.1128/IAI.24.3.821-828.1979; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRENGER GA, 1988, J GEN MICROBIOL, V134, P1635; STMARTIN EJ, 1979, INFECT IMMUN, V24, P865, DOI 10.1128/IAI.24.3.865-868.1979; STMARTIN EJ, 1979, INFECT IMMUN, V26, P487, DOI 10.1128/IAI.26.2.487-491.1979; THOMPSON J, 1981, J BACTERIOL, V147, P543, DOI 10.1128/JB.147.2.543-551.1981; THOMPSON J, 1991, J BIOL CHEM, V266, P14573; THOMPSON J, 1989, J BIOL CHEM, V264, P9592; THOMPSON J, 1986, J BACTERIOL, V167, P522, DOI 10.1128/jb.167.2.522-529.1986; THOMPSON J, 1981, J BACTERIOL, V146, P885, DOI 10.1128/JB.146.3.885-894.1981; Thompson J., 1987, SUGAR TRANSPORT META, P13; WEHMEIER U, 1989, MOL GEN GENET, V215, P529, DOI 10.1007/BF00427052	43	31	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22626	22633						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658003				2022-12-25	WOS:A1991GR56400087
J	RUMYANTSEVA, GV; KENNEDY, CH; MASON, RP				RUMYANTSEVA, GV; KENNEDY, CH; MASON, RP			TRACE TRANSITION METAL-CATALYZED REACTIONS IN THE MICROSOMAL METABOLISM OF ALKYL HYDRAZINES TO CARBON-CENTERED FREE-RADICALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; NADPH-CYTOCHROME-P-450 REDUCTASE; XANTHINE-OXIDASE; HYDROXYL; MECHANISM; OXIDATION; IRON; SUPEROXIDE; ADRIAMYCIN; ETHANOL	Radical production from alkyl hydrazines (i.e. phenelzine and benzylhydrazine) in rat liver microsomes has been proposed to occur via cytochrome P-450-catalyzed one-electron oxidation followed by beta-scission of an alkyl radical. In microsomes treated with phenelzine (2-phenylethylhydrazine), NADPH, and the spin trap alpha-(4-pyridyl 1-oxide)-N-tert-butylnitrone (4-POBN), the 4-POBN/2-phenylethyl radical adduct was detected by electron paramagnetic resonance spectroscopy. The addition of catalase and superoxide dismutase resulted in a 28.5 and 24% decrease in radical production, respectively. The concentration of the 4-POBN/ 2-phenylethyl radical adduct decreased significantly in the presence of metal chelators, i.e. EDTA, diethylenetriaminepentaacetic acid (DTPA), or deferoxamine mesylate. When phenelzine was incubated with deferoxamine mesylate-washed microsomes and NADPH in Chelex-treated incubation buffer, no significant radical adduct formation was detected. Addition of iron-chelator complexes (either Fe3+-DTPA or Fe3+-EDTA) greatly stimulated production of the 4-POBN/ 2-phenylethyl radical adduct in this system. These results show that the 2-phenylethyl radical produced from phenelzine in a microsomal system arises via a trace transition metal-catalyzed reaction. This reaction may occur through oxidation of phenelzine by the hydroxyl radical, which has also been spin-trapped with 4-POBN in this system.	NIEHS,MOLEC BIOPHYS LAB,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Mason, Ronald P/G-5967-2019; Kennedy, Craig/AGH-5651-2022	Mason, Ronald P/0000-0002-1859-9109; 				ALBANO E, 1988, CHEM-BIOL INTERACT, V65, P223, DOI 10.1016/0009-2797(88)90108-1; AUGUSTO O, 1982, J BIOL CHEM, V257, P1288; BRITIGAN BE, 1990, J BIOL CHEM, V265, P17533; BUETTNER GR, 1988, J BIOCHEM BIOPH METH, V16, P27, DOI 10.1016/0165-022X(88)90100-5; DEMONTELLANO PRO, 1983, J BIOL CHEM, V258, P8623; ESTABROOK RW, 1979, ACTA BIOL MED GER, V38, P423; GUTTERIDGE JMC, 1982, FEBS LETT, V149, P228, DOI 10.1016/0014-5793(82)81106-X; HILDEBRANDT AG, 1973, BIOCHEM BIOPH RES CO, V54, P968, DOI 10.1016/0006-291X(73)90789-4; IWAHASHI H, 1991, ARCH BIOCHEM BIOPHYS, V285, P172, DOI 10.1016/0003-9861(91)90346-K; JANZEN EG, 1978, J AM CHEM SOC, V100, P2923, DOI 10.1021/ja00477a075; JUCHAU M R, 1972, Drug Metabolism Reviews, V1, P71, DOI 10.3109/03602537208993909; KENNEDY CH, 1990, J BIOL CHEM, V265, P11425; LIM PK, 1984, J PHYS CHEM-US, V88, P1136, DOI 10.1021/j150650a022; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MISRA HP, 1976, BIOCHEMISTRY-US, V15, P681, DOI 10.1021/bi00648a036; Mitchell J R, 1976, Prog Liver Dis, V5, P259; MOLONEY SJ, 1983, REV BIOCHEM TOXICOL, V5, P313; MOREHOUSE KM, 1988, J BIOL CHEM, V263, P1204; MOREHOUSE LA, 1984, ARCH BIOCHEM BIOPHYS, V232, P366, DOI 10.1016/0003-9861(84)90552-6; MUAKKASSAH SF, 1981, J PHARMACOL EXP THER, V219, P147; NELSON SD, 1978, J PHARMACOL EXP THER, V206, P574; OMURA T, 1964, J BIOL CHEM, V239, P2370; SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; TOTH B, 1976, CANCER RES, V36, P917; VILE GF, 1988, ARCH BIOCHEM BIOPHYS, V267, P606, DOI 10.1016/0003-9861(88)90068-9; WINSTON GW, 1984, ARCH BIOCHEM BIOPHYS, V232, P378, DOI 10.1016/0003-9861(84)90553-8; [No title captured]	28	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21422	21427						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657966				2022-12-25	WOS:A1991GP80400020
J	RENFREW, CA; HUBBARD, AL				RENFREW, CA; HUBBARD, AL			DEGRADATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN RAT-LIVER - MEMBRANE TOPOLOGY THROUGH THE LYSOSOMAL PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE PLASMA-MEMBRANE; PROTEIN-KINASE-ACTIVITY; MEDIATED ENDOCYTOSIS; CARCINOMA-CELLS; DOWN-REGULATION; RAPID ISOLATION; EGF RECEPTOR; CDNA; IDENTIFICATION; SEQUENCE	We have generated and characterized three rabbit polyclonal antibodies that recognize different regions of the epidermal growth factor receptor (EGF-R) and used them to study the degradation of the receptor in the isolated perfused rat liver. Quantitative immunoblot analyses of rat liver homogenates prepared from tissue biopsies collected at various times after epidermal growth factor (EGF) addition showed that both the ectoplasmic and cytoplasmic domains of rat liver EGF-Rs were degraded with similar kinetics (t1/2 = 3.5-3.8 h at 25-degrees-C with cycloheximide). No immunoreactive intermediate breakdown products were detected. EGF-stimulated degradation of both receptor domains was inhibited by the thiol protease inhibitor leupeptin, suggesting lysosome involvement in the hydrolysis of the whole molecule. To study this further, protease protection experiments were performed on endosome- and lysosome-enriched fractions isolated from leupeptin-treated livers. We found that the cytoplasmic domains of > 90% of the EGF-Rs in endosomal fractions were accessible to digestion when proteinase K was added to the intact vesicle populations, while the ectoplasmic domain was unaltered. In contrast, both the ectoplasmic and cytoplasmic domains of -55% of the EGF-Rs present in lysosome-enriched fractions were inaccessible to proteinase K digestion in the absence of detergent. These findings suggest that movement of EGF-Rs from the limiting membrane of endosomes to the lumen of lysosomes permits the degradation of the entire EGF-R molecule within lysosomes.	JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205	Johns Hopkins University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129133, R01GM029133] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM29133] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON WL, 1975, ANAL BIOCHEM, V67, P493, DOI 10.1016/0003-2697(75)90323-1; ARONSON NN, 1981, ACTA BIOL MED GER, V40, P1531; BARRETT AJ, 1979, PROTEINASES MAMMALIA, P181; BASU M, 1984, NATURE, V311, P477, DOI 10.1038/311477a0; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BEGUINOT L, 1986, J BIOL CHEM, V261, P1801; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BERGERON JJM, 1985, ANNU REV PHYSIOL, V47, P383; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CASCIOLAROSEN LAF, 1990, J BIOL CHEM, V266, P4341; CASSEL D, 1982, J BIOL CHEM, V257, P9845; CHINKERS M, 1984, J BIOL CHEM, V259, P1534; CHIVA VA, 1983, FEBS LETT, V160, P101, DOI 10.1016/0014-5793(83)80945-4; DAS M, 1978, P NATL ACAD SCI USA, V75, P2644, DOI 10.1073/pnas.75.6.2644; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DECKER SJ, 1989, J BIOL CHEM, V264, P17641; DECKER SJ, 1984, MOL CELL BIOL, V4, P571, DOI 10.1128/MCB.4.4.571; DUNN WA, 1983, METHOD ENZYMOL, V98, P225; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; ELOVSON J, 1980, J BIOL CHEM, V255, P5816; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FOX CF, 1982, FED PROC, V41, P2988; GALLIN WJ, 1985, P NATL ACAD SCI USA, V82, P2809, DOI 10.1073/pnas.82.9.2809; GLAUMANN H, 1986, EXP CELL RES, V163, P151, DOI 10.1016/0014-4827(86)90567-7; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HOWELL KE, 1978, J CELL BIOL, V79, P581, DOI 10.1083/jcb.79.2.581; HUBBARD AL, 1985, J CELL BIOL, V100, P1115, DOI 10.1083/jcb.100.4.1115; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; HUMPHREY PA, 1988, CANCER RES, V48, P2231; KHAIRALLAH EA, 1976, J BIOL CHEM, V251, P1375; KRUPP MN, 1982, J BIOL CHEM, V257, P1489; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIN SH, 1989, J BIOL CHEM, V264, P14403; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; Maxfield F R, 1987, Adv Exp Med Biol, V225, P189; MCABEE DD, 1988, BIOCHEMISTRY-US, V27, P2061, DOI 10.1021/bi00406a037; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; NEWSHOLME EA, 1961, BIOCHEM J, V80, P649; OGATA S, 1989, J BIOL CHEM, V264, P3596; RENFREW CA, 1991, J BIOL CHEM, V266, P4348; ROMAN LM, 1983, J CELL BIOL, V96, P1548, DOI 10.1083/jcb.96.6.1548; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHATZMAN RC, 1986, MOL CELL BIOL, V6, P1329, DOI 10.1128/MCB.6.4.1329; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WALL DA, 1985, J CELL BIOL, V101, P2104, DOI 10.1083/jcb.101.6.2104; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	56	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21265	21273						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1682317				2022-12-25	WOS:A1991GN00100105
J	KIRLEY, TL; MEI, P				KIRLEY, TL; MEI, P			IDENTIFICATION OF CYSTEINE RESIDUES IN LAMB KIDNEY (NA,K)-ATPASE ESSENTIAL FOR OUABAIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; NA,K-ATPASE; SUBUNIT; SEQUENCE; SODIUM; DNA	N-(1-Pyrene)maleimide is a hydrophobic, sulfhydryl-directed, chemical modification probe which, at a low concentration, inhibits the capacity of lamb kidney sodium- and potassium-activated adenosine triphosphatase ((Na,K)-ATPase; EC 3.6.1.3) to bind ouabain. This inhibition is partially blocked by preincubation of the enzyme with ouabagenin, an aglycone derivative which can be used as a reversible protecting ligand for the ouabain binding site. The kinetics of inhibition are not first order, suggesting that there may be more than one site of labeling which is responsible for the inhibition of ouabain binding. Although earlier work (Kirley, T. L., Lane, L. K., and Wallick, E. T. (1986) J. Biol. Chem. 261, 4525-4528) indicates that the inhibition is accompanied by a loss in the number of binding sites rather than a decrease in affinity of the sites for the ligand, other data (Scheiner-Bobis, G., Zimmerman, M., Kirch, V., and Schoner, W. (1987) Eur. J. Biochem. 165, 653-656) indicates that there is no cysteine residue located extracellularly in the ouabain binding site. By sequence analysis of alpha-subunit peptides labeled by N-(1-pyrene)maleimide in the absence but not in the presence of protecting ligand, it is demonstrated in this work that there are two major sites of labeling protected by the binding of ouabagenin, Cys-367 and Cys-656. Both of these sites are located in the large cytoplasmic domain of the alpha-subunit, one close to the phosphorylation site (Asp-369), and the other implicated in the binding of ATP (Cys-656). Therefore, it appears from this data that the inhibition of ouabain binding by N-(1-pyrene)maleimide is not due to modification of a site in the binding pocket for cardiac glycosides, but rather to an allosteric effect, since cardiac glycoside binding is known to be dependent on the phosphorylation state of the enzyme. The dependence of inhibition on the presence of sodium, potassium, and ATP also is consistent with this interpretation. The work reported here thus explains the apparent paradox posed by the earlier data.			KIRLEY, TL (corresponding author), UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & BIOPHYS,CINCINNATI,OH 45267, USA.			Kirley, Terence/0000-0002-6211-1414	NHLBI NIH HHS [P01-HL22619] Funding Source: Medline; NIAMS NIH HHS [R01-AR38576] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038576] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMED K, 1990, J GEN PHYSIOL, V96, pA81; GOELDNER MP, 1983, BIOCHEMISTRY-US, V22, P4685, DOI 10.1021/bi00289a012; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; KIRLEY TL, 1986, J BIOL CHEM, V261, P4525; LANE LK, 1979, PREP BIOCHEM, V9, P157, DOI 10.1080/00327487908061681; OHTA T, 1986, P NATL ACAD SCI USA, V83, P1; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PRICE EM, 1989, J BIOL CHEM, V264, P21902; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; SCHEINERBOBIS G, 1987, EUR J BIOCHEM, V165, P653, DOI 10.1111/j.1432-1033.1987.tb11490.x; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; WELINDER KG, 1988, ANAL BIOCHEM, V174, P54, DOI 10.1016/0003-2697(88)90518-0	12	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19953	19957						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657908				2022-12-25	WOS:A1991GM03900016
J	ZOU, A; LEUNG, PC; HARSHEY, RM				ZOU, A; LEUNG, PC; HARSHEY, RM			TRANSPOSASE CONTACTS WITH MU-DNA ENDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; BACTERIOPHAGE-MU; STRUCTURAL VARIATIONS; HELICAL PERIODICITY; BEND DIRECTION; PROTEIN; SITE; BINDING; SEQUENCE; PROMOTER	We have investigated the interaction between phage Mu transposase (A protein) and the ends (att sites) of Mu by chemical and nuclease protection and interference studies. These studies define a 24-base pair contact region at five of the six att sites (L1, L3 at att L and R1, R2, R3 at att R). Hydroxyl radical footprints show that the transposase binds to one face of the DNA helix and covers two consecutive major grooves. Binding specificity is achieved primarily through the major groove. Strong contacts are found with 3 guanines which are conserved at five of the sites. Two of these guanines are missing in the weakest binding site (L2) where 13 base pairs are mainly contacted. A pair of DNAase I hypersensitive sites, one on each strand, appear at the back of only one of the two contacted major grooves at most sites except at L2, and can be correlated with the degree of A protein-induced bend (Kuo, C.-F., Zou, A., Jayaram, M., Getzoff, E. D., and Harshey, R. M. (1991) EMBO J. 10, 1585-1591) at these sites. No contacts are observed for 4-5 base pairs in the vicinity of L1 and R1, where the A protein nicks DNA during transposition.	UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033247] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33247] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; BURLINGAME RP, 1986, P NATL ACAD SCI USA, V83, P6012, DOI 10.1073/pnas.83.16.6012; CRAIGIE R, 1985, J BIOL CHEM, V260, P1832; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; CRAIGIE R, 1985, P NATL ACAD SCI USA, V82, P7570, DOI 10.1073/pnas.82.22.7570; CRAIGIE R, 1987, CELL, V51, P493, DOI 10.1016/0092-8674(87)90645-3; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; FOX KR, 1984, NUCLEIC ACIDS RES, V12, P9271, DOI 10.1093/nar/12.24.9271; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; GILBERT W, 1976, CONTROL RIBOSOME SYN, P139; GROENEN MAM, 1986, J MOL BIOL, V189, P597, DOI 10.1016/0022-2836(86)90490-0; HARSHEY RM, 1985, P NATL ACAD SCI USA, V82, P7676, DOI 10.1073/pnas.82.22.7676; HATFULL GF, 1987, CELL, V49, P103, DOI 10.1016/0092-8674(87)90760-4; HEICHMAN KA, 1990, SCIENCE, V249, P511, DOI 10.1126/science.2166334; HERTZBERG RP, 1984, BIOCHEMISTRY-US, V23, P3934, DOI 10.1021/bi00312a022; JOHNSRUD L, 1978, P NATL ACAD SCI USA, V75, P5314, DOI 10.1073/pnas.75.11.5314; KAHMANN R, 1987, PHAGE MU, P297; KANAAR R, 1988, THESIS LEIDEN U NETH; KLUG A, 1981, NUCLEIC ACIDS RES, V9, P4267, DOI 10.1093/nar/9.17.4267; KNIGHT KL, 1989, J BIOL CHEM, V264, P3639; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PATO M, 1989, MOBILE DNA, P24; PRIESS H, 1987, PHAGE MU, P277; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; SALVO JJ, 1987, NUCLEIC ACIDS RES, V15, P9771, DOI 10.1093/nar/15.23.9771; SALVO JJ, 1988, EMBO J, V7, P3609, DOI 10.1002/j.1460-2075.1988.tb03239.x; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SURETTE MG, 1989, EMBO J, V8, P3483, DOI 10.1002/j.1460-2075.1989.tb08513.x; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Symonds N., 1987, PHAGE MU; TEPLOW DB, 1988, J BIOL CHEM, V263, P10851; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; VANDYKE MW, 1983, NUCLEIC ACIDS RES, V11, P5555; WIATER LA, 1991, J BIOL CHEM, V266, P1841; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0	49	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20476	20482						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657926				2022-12-25	WOS:A1991GM03900090
J	BRANDES, ME; WAKEFIELD, LM; WAHL, SM				BRANDES, ME; WAKEFIELD, LM; WAHL, SM			MODULATION OF MONOCYTE TYPE-I TRANSFORMING GROWTH-FACTOR-BETA RECEPTORS BY INFLAMMATORY STIMULI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TGF-BETA; EXPRESSION; MACROPHAGES; BINDING; CELLS	The regulatory mechanisms which control the wide array of cellular responses to transforming growth factor-beta (TGF-beta) are not understood. This report presents evidence that down-regulation of TGF-beta receptors on human monocytes may be one mechanism by which the effects of TGF-beta are regulated. Treatment of monocytes with interferon-gamma (IFN-gamma) and lipopolysaccharide for 18 h reduced monocyte receptor number (approximately 400/cell) in a dose-dependent fashion by 89 and 78%, respectively, as determined by I-125-TGF-beta binding. Incubation with other cytokines (granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor-1, interleukin-1, tumor necrosis factor-alpha) did not alter the amount of TGF-beta bound. The decrease in I-125-TGF-beta binding could not be attributed to competition for receptor sites by secreted TGF-beta. Instead, the decline in binding was due to a loss of type I TGF-beta receptors, the subtype primarily expressed by monocytes, with no decrease in receptor affinity. Lipopolysaccharide-induced receptor loss was rapid (1-4 h), in contrast to the prolonged (12 h) decline induced by IFN-gamma. Loss of receptors was accompanied by a diminished ability of the cells to respond to TGF-beta with an induction of TNF-alpha mRNA. Thus, this monocyte system is the first example of a heterologous agent causing the down-regulation of TGF-beta receptors with a concomitant decline in a TGF-beta-stimulated function.	NCI, CHEMOPREVENT LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	BRANDES, ME (corresponding author), NIDR, CELLULAR IMMUNOL SECT, IMMUNOL LAB, BLDG 30, RM 329, BETHESDA, MD 20892 USA.							ALLEN JB, 1990, J EXP MED, V171, P231, DOI 10.1084/jem.171.1.231; ALLEN JB, 1991, CYTOKINE, V3, P98, DOI 10.1016/1043-4666(91)90029-D; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BERMUDEZ LE, 1990, LYMPHOKINE RES, V9, P137; BRANDES ME, 1991, J CLIN INVEST, V87, P1108, DOI 10.1172/JCI115073; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; COCHET C, 1988, J BIOL CHEM, V263, P5707; DING AH, 1989, J BIOL CHEM, V264, P3924; ELLINGSWORTH L, 1989, J CELL BIOCHEM, V39, P489, DOI 10.1002/jcb.240390414; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; KATONA IM, 1991, J IMMUNOL, V146, P708; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KEHRL JH, 1989, J IMMUNOL, V143, P1868; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; McCartney-Francis N, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011007; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; SEGARINI PR, 1990, ANN NY ACAD SCI, V593, P73, DOI 10.1111/j.1749-6632.1990.tb16101.x; SEGARINI PR, 1989, MOL ENDOCRINOL, V3, P261, DOI 10.1210/mend-3-2-261; TSUJIMOTO M, 1986, J IMMUNOL, V136, P2441; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL SM, 1987, J IMMUNOL, V139, P1342; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAHL SM, 1990, J IMMUNOL, V145, P2514; WAHL SM, 1988, J IMMUNOL, V140, P3026; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; WAHL SM, 1989, IMMUNOL TODAY, V10, P258, DOI 10.1016/0167-5699(89)90136-9; WAHL SM, 1991, J IMMUNOL, V146, P95; WAHL SM, 1988, J EXP MED, V168, P1403, DOI 10.1084/jem.168.4.1403; WAHL SM, 1991, CURRENT PROTOCOLS IM, V1; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WAKEFIELD LM, 1987, J BIOL CHEM, V146, P167; WELCH GR, 1990, J IMMUNOL, V144, P3444; WISEMAN DM, 1988, BIOCHEM BIOPH RES CO, V157, P793, DOI 10.1016/S0006-291X(88)80319-X	38	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19697	19703						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655792				2022-12-25	WOS:A1991GK66700082
J	HAMILTON, SL; CODINA, J; HAWKES, MJ; YATANI, A; SAWADA, T; STRICKLAND, FM; FROEHNER, SC; SPIEGEL, AM; TORO, L; STEFANI, E; BIRNBAUMER, L; BROWN, AM				HAMILTON, SL; CODINA, J; HAWKES, MJ; YATANI, A; SAWADA, T; STRICKLAND, FM; FROEHNER, SC; SPIEGEL, AM; TORO, L; STEFANI, E; BIRNBAUMER, L; BROWN, AM			EVIDENCE FOR DIRECT INTERACTION OF GS-ALPHA WITH THE CA2+ CHANNEL OF SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC CALCIUM CHANNELS; BETA-ADRENERGIC-RECEPTOR; MUSCARINIC K+-CHANNEL; G-PROTEIN-GS; ADENYLYL CYCLASE; 1,4-DIHYDROPYRIDINE RECEPTOR; SUBUNIT COMPOSITION; POTASSIUM CHANNELS; TRANSVERSE TUBULES; BINDING-PROTEIN	The alpha-subunits of heterotrimeric GTP-binding (G) proteins act upon ion channels through both cytoplasmic and membrane-delimited pathways (Brown, A. M., and Birnbaumer, L. (1990) Annu. Rev. Physiol. 52, 197-213). The membrane pathway may involve either a direct interaction between G protein and ion channel or an indirect interaction involving a membrane-delimited second messenger. To distinguish between the two possibilities, we tested whether a purified G protein could interact with a purified channel protein in a defined system to produce changes in channel currents. We selected the alpha-subunit of G(s) and the dihydropyridine (DHP)-sensitive Ca2+ channel of skeletal muscle T-tubules, the DHP binding protein (DHPBP), because: 1) a membrane-delimited interaction between the two has been shown (Brown, A. M., and Birnbaumer, L. (1990) Annu. Rev. Physiol. 52, 197-213; Yatani, A., Imoto, Y., Codina, J., Hamilton, S. L., Brown, A. M., and Birnbaumer, L. (1988) J. Biol. Chem. 263, 9887-9895); and 2) at the present time, these Ca2+ channels are the only putative G protein channel effectors which, following purification, still retain channel function. We used a defined system in which purified components were studied by direct reconstitution in planar lipid bilayers. Just as we had found in crude skeletal muscle T-tubule membranes (Yatani, A., Imoto, Y., Codina, J., Hamilton, S. L., Brown, A. M., and Birnbaumer, L. (1988) J. Biol. Chem. 263,9887-9895), alpha-s* but not alpha-i-3* stimulated Ca2+ currents. However, in the reconstituted system, this probably represents a direct interaction between G(s)alpha and Ca2+ channels. To establish whether the two proteins were physically associated in the native T-tubule membrane, we examined the ability of either endogenous G proteins or exogenous alpha-s* to purify with detergent-solubilized DHPBP through a wheat germ agglutinin affinity column and a sucrose gradient. Small amounts of a labeled G protein were found to co-purify with DHPBP. In addition, partially purified DHPBP increased the sedimentation rate of purified alpha-s* but not alpha-i-3*. G proteins were immunoprecipitated with an antibody to the alpha-l subunit of the DHPBP, and, in addition, both alpha-s and the beta-subunit of G(s) were detected in Western blots of the partially purified DHPBP. The results suggest that G(s) and Ca2+ channels are closely associated in the T-tubule plasma membrane, and we conclude that skeletal muscle Ca2+ channels are direct effectors for G(s).	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT BIOCHEM,HANOVER,NH 03756; NIDDKD,MOLEC PATHOPHYSIOL BRANCH,BETHEDSA,MD 20892	Baylor College of Medicine; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	HAMILTON, SL (corresponding author), BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030, USA.			Strickland, Faith/0000-0002-6568-9801; Hamilton, Susan/0000-0003-0241-9369	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019318, R01DK019318] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37028] Funding Source: Medline; NIAMS NIH HHS [AR38970] Funding Source: Medline; NIDDK NIH HHS [DK19318] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFFOLTER H, 1985, BIOPHYS J, V48, P341, DOI 10.1016/S0006-3495(85)83789-9; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BORSOTTO M, 1985, J BIOL CHEM, V260, P4255; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN AM, 1983, J PHYSIOL-LONDON, V344, P549, DOI 10.1113/jphysiol.1983.sp014956; CANTIELLO HF, 1989, J BIOL CHEM, V264, P20867; CERIONE RA, 1984, J BIOL CHEM, V259, P9979; CODINA J, 1984, J BIOL CHEM, V259, P5871; CODONA J, 1984, J RECEPTOR RES, V4, P441; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GLOSSMANN H, 1983, N-S ARCH PHARMACOL, V323, P279, DOI 10.1007/BF00512465; HAMILTON SL, 1990, CIRCULATION, V82, P461; HAMILTON SL, 1989, BIOCHEMISTRY-US, V28, P7820, DOI 10.1021/bi00445a044; HAMILTON SL, 1989, ANAL BIOCHEM, V183, P31, DOI 10.1016/0003-2697(89)90167-X; HUNTER R, 1981, J IMMUNOL, V127, P1244; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; IMOTO Y, 1988, AM J PHYSIOL, V255, pH722, DOI 10.1152/ajpheart.1988.255.4.H722; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; LACERDA AE, 1989, J GEN PHYSIOL, V93, P1243, DOI 10.1085/jgp.93.6.1243; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MARBACH I, 1990, J BIOL CHEM, V265, P9999; MATTERA R, 1989, SCIENCE, V243, P804, DOI 10.1126/science.2536957; MAY DC, 1988, BIOCHEMISTRY-US, V27, P4888, DOI 10.1021/bi00413a045; MEJIAALVAREZ R, 1991, J GEN PHYSIOL, V97, P393, DOI 10.1085/jgp.97.2.393; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MORTON ME, 1987, J BIOL CHEM, V262, P11904; NELSON MT, 1986, J GEN PHYSIOL, V87, P201, DOI 10.1085/jgp.87.2.201; PELZER D, 1989, ANN NY ACAD SCI, V560, P1138; ROSEMBLATT M, 1981, J BIOL CHEM, V256, P8140; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; SMITH JS, 1987, BIOCHEMISTRY-US, V26, P7182, DOI 10.1021/bi00396a046; STRIESSNIG J, 1986, EUR J BIOCHEM, V161, P603, DOI 10.1111/j.1432-1033.1986.tb10484.x; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, J BIOL CHEM, V263, P9887; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YATANI A, 1990, SCIENCE, V249, P1163, DOI 10.1126/science.1697697; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660	48	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19528	19535						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655789				2022-12-25	WOS:A1991GK66700061
J	ORD, DC; ERNST, TJ; ZHOU, LJ; RAMBALDI, A; SPERTINI, O; GRIFFIN, J; TEDDER, TF				ORD, DC; ERNST, TJ; ZHOU, LJ; RAMBALDI, A; SPERTINI, O; GRIFFIN, J; TEDDER, TF			STRUCTURE OF THE GENE ENCODING THE HUMAN-LEUKOCYTE ADHESION MOLECULE-1 (TQ1, LEU-8) OF LYMPHOCYTES AND NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,44 BINNEY ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; OSPED RIUNITI BERGAMO,MARIO NEGRI INST,I-24100 BERGAMO,ITALY; OSPED RIUNITI BERGAMO,DIV HEMATOL,I-24100 BERGAMO,ITALY	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; Ospedali Riuniti di Bergamo			Rambaldi, Alessandro/P-2603-2018; Rambaldi, Alessandro/M-6172-2019	Rambaldi, Alessandro/0000-0002-3739-7502; Rambaldi, Alessandro/0000-0002-3739-7502	NATIONAL CANCER INSTITUTE [P01CA034183, R01CA036167, R37CA036167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026872] Funding Source: NIH RePORTER; NCI NIH HHS [CA-34183, CA-36167] Funding Source: Medline; NIAID NIH HHS [AI-26872] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AEBI M, 1987, TRENDS GENET, V3, P102, DOI 10.1016/0168-9525(87)90193-4; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERG EL, 1989, IMMUNOL REV, V108, P5, DOI 10.1111/j.1600-065X.1989.tb00010.x; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOWEN BR, 1989, J CELL BIOL, V109, P421, DOI 10.1083/jcb.109.1.421; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; DRICKAMER K, 1987, J BIOL CHEM, V262, P2582; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; GATENBY PA, 1982, J IMMUNOL, V129, P1997; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; GREGORY H, 1975, NATURE, V257, P325, DOI 10.1038/257325a0; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JOHNSTON GI, 1988, BLOOD, V72, pA327; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KISHIMOTO TK, 1990, IN PRESS P NATL ACAD; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEUNG JO, 1985, J BIOL CHEM, V260, P2523; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MCCORMACK RT, 1986, J IMMUNOL, V137, P1075; REINHERZ EL, 1982, J IMMUNOL, V128, P463; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Sambrook J., 1982, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELVARAJ P, 1988, NATURE, V333, P565, DOI 10.1038/333565a0; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STOOLMAN LM, 1984, J CELL BIOL, V99, P1535, DOI 10.1083/jcb.99.4.1535; SUTER U, 1987, NUCLEIC ACIDS RES, V15, P7295, DOI 10.1093/nar/15.18.7295; TEDDER TF, 1989, J IMMUNOL, V142, P2560; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1990, J IMMUNOL, V144, P532; TEDDER TF, 1990, IN PRESS EUR J IMMUN; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	41	93	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					7760	7767						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1692315				2022-12-25	WOS:A1990DC83500012
J	KUIPER, MTR; SABOURIN, JR; LAMBOWITZ, AM				KUIPER, MTR; SABOURIN, JR; LAMBOWITZ, AM			IDENTIFICATION OF THE REVERSE-TRANSCRIPTASE ENCODED BY THE MAURICEVILLE AND VARKUD MITOCHONDRIAL PLASMIDS OF NEUROSPORA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OHIO STATE UNIV, DEPT BIOCHEM, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	KUIPER, MTR (corresponding author), OHIO STATE UNIV, DEPT MOLEC GENET, COLUMBUS, OH 43210 USA.		Kuiper, Martin/AAM-7279-2020	Kuiper, Martin/0000-0002-1171-9876	NCI NIH HHS [CA24710] Funding Source: Medline; NIGMS NIH HHS [GM37949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA024710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKINS RA, 1988, J MOL BIOL, V204, P1, DOI 10.1016/0022-2836(88)90594-3; AKINS RA, 1989, MOL CELL BIOL, V9, P678, DOI 10.1128/MCB.9.2.678; AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; BIANY G, 1980, PEPTIDES, V2, P1; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; CHANG LJ, 1989, NATURE, V337, P364, DOI 10.1038/337364a0; COLLINS RA, 1981, CELL, V24, P443, DOI 10.1016/0092-8674(81)90335-4; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; FUETTERER J, 1987, TRENDS BIOCHEM SCI, V12, P92, DOI 10.1016/0968-0004(87)90044-2; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HERZOG NK, 1986, P NATL ACAD SCI USA, V83, P812, DOI 10.1073/pnas.83.3.812; INOUYE S, 1989, CELL, V56, P709, DOI 10.1016/0092-8674(89)90593-X; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KUIPER MTR, 1988, CELL, V55, P693, DOI 10.1016/0092-8674(88)90228-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambowitz A M, 1979, Methods Enzymol, V59, P421; LAMBOWITZ AM, 1989, CELL, V56, P323, DOI 10.1016/0092-8674(89)90232-8; LIU FT, 1979, BIOCHEMISTRY-US, V18, P690, DOI 10.1021/bi00571a022; LORI F, 1988, AIDS RES HUM RETROV, V4, P393, DOI 10.1089/aid.1988.4.393; MAJUMDER AL, 1989, MOL CELL BIOL, V9, P2089, DOI 10.1128/MCB.9.5.2089; Maniatis T., 1982, MOL CLONING; MICHEL F, 1985, NATURE, V316, P641, DOI 10.1038/316641a0; NARGANG FE, 1986, MOL BIOL EVOL, V3, P19; NARGANG FE, 1984, CELL, V38, P441, DOI 10.1016/0092-8674(84)90499-9; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHLICHT HJ, 1989, CELL, V56, P85, DOI 10.1016/0092-8674(89)90986-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOLTIS DA, 1988, P NATL ACAD SCI USA, V85, P3372, DOI 10.1073/pnas.85.10.3372; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; STARNES MC, 1988, J BIOL CHEM, V263, P5132; TANESE N, 1988, DNA-J MOLEC CELL BIO, V7, P407, DOI 10.1089/dna.1.1988.7.407; VARMUS H, 1989, MOBILE DNA, P53; XIONG Y, 1988, MOL CELL BIOL, V8, P114, DOI 10.1128/MCB.8.1.114; YUE X, 1988, MOL BIOL EVOL, V5, P675	37	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6936	6943						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691179				2022-12-25	WOS:A1990CZ67700069
J	HELL, JW; MAYCOX, PR; JAHN, R				HELL, JW; MAYCOX, PR; JAHN, R			ENERGY-DEPENDENCE AND FUNCTIONAL RECONSTITUTION OF THE GAMMA-AMINOBUTYRIC ACID CARRIER FROM SYNAPTIC VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HELL, JW (corresponding author), MAX PLANCK INST PSYCHIAT, DEPT NEUROCHEM, AM KLOPFERSPITZ 18A, W-8033 MARTINSRIED, GERMANY.		Hell, Johannes W./P-5085-2019	Jahn, Reinhard/0000-0003-1542-3498				ANDERSON DC, 1982, BIOCHEMISTRY-US, V21, P3037, DOI 10.1021/bi00256a001; APPS DK, 1980, FEBS LETT, V111, P386, DOI 10.1016/0014-5793(80)80833-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; CIDON S, 1989, J BIOL CHEM, V264, P8281; DECAMILLI P, 1990, IN PRESS ANN REV PHY; FISCHERBOVENKERK C, 1988, J NEUROCHEM, V51, P1054, DOI 10.1111/j.1471-4159.1988.tb03068.x; FYKSE EM, 1988, J NEUROCHEM, V50, P1237, DOI 10.1111/j.1471-4159.1988.tb10599.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; JOHNSON RG, 1979, J BIOL CHEM, V254, P3750; JOHNSON RG, 1981, J BIOL CHEM, V256, P5773; JOHNSON RG, 1979, J BIOL CHEM, V254, P963; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; KNOTH J, 1981, J BIOL CHEM, V256, P6541; MARON R, 1979, FEBS LETT, V98, P237, DOI 10.1016/0014-5793(79)80190-8; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; NAITO S, 1983, J BIOL CHEM, V258, P696; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; NELSON N, 1988, METHOD ENZYMOL, V157, P619; NJUS D, 1986, BIOCHIM BIOPHYS ACTA, V853, P237, DOI 10.1016/0304-4173(87)90003-6; REICHARDT LF, 1983, ANNU REV BIOCHEM, V52, P871, DOI 10.1146/annurev.bi.52.070183.004255; SCHERMAN D, 1981, EUR J BIOCHEM, V116, P335; VANDYKE RW, 1988, J BIOL CHEM, V263, P2603	26	96	100	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2111	2117						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688846				2022-12-25	WOS:A1990CL02800048
J	LEWIS, EJ; ALLISON, S; FADER, D; CLAFLIN, V; BAIZER, L				LEWIS, EJ; ALLISON, S; FADER, D; CLAFLIN, V; BAIZER, L			BOVINE DOPAMINE BETA-HYDROXYLASE CDNA - COMPLETE CODING SEQUENCE AND EXPRESSION IN MAMMALIAN-CELLS WITH VACCINIA VIRUS VECTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OREGON HLTH SCI UNIV, DEPT MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT PHARMACOL, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT BIOCHEM, PORTLAND, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038696, R29GM038696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026806] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38696] Funding Source: Medline; NINDS NIH HHS [NS 26806] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON AL, 1984, J NEUROSCI, V4, P1771; Battey, 1986, BASIC METHODS MOL BI; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEWOLF WE, 1988, BIOCHEMISTRY-US, V27, P9093, DOI 10.1021/bi00426a005; EIPPER BA, 1987, MOL ENDOCRINOL, V1, P777, DOI 10.1210/mend-1-11-777; FRIGON RP, 1987, METHOD ENZYMOL, V142, P603; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAMOS J, 1987, FASEB J, V1, P143, DOI 10.1096/fasebj.1.2.3609611; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JOH TH, 1987, ANN NY ACAD SCI, V493, P342, DOI 10.1111/j.1749-6632.1987.tb27217.x; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; KOLBIKA BK, 1987, P NATL ACAD SCI USA, V84, P46; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KVETANSK.R, 1971, AM J PHYSIOL, V220, P928, DOI 10.1152/ajplegacy.1971.220.4.928; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEWIS EJ, 1983, J BIOL CHEM, V258, P4632; MCCAFFERTY B, 1987, J NEUROSCI RES, V18, P289, DOI 10.1002/jnr.490180204; MCHUGH EM, 1985, J BIOL CHEM, V260, P4409; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBERTSON JG, 1990, J BIOL CHEM, V265, P1029; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; SAXENA A, 1983, J BIOL CHEM, V258, P4147; SHORR RGL, 1987, MOL PHARMACOL, V32, P195; SKOTLAND T, 1977, BIOCHEM BIOPH RES CO, V74, P1483, DOI 10.1016/0006-291X(77)90609-X; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; TAYLOR CS, 1989, J BIOL CHEM, V264, P14; THOENEN H, 1970, NATURE, V228, P861, DOI 10.1038/228861a0; THOMAS G, 1986, SCIENCE, V232, P1641, DOI 10.1126/science.3754979; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALLACE EF, 1973, P NATL ACAD SCI USA, V70, P2253, DOI 10.1073/pnas.70.8.2253; WOODWARD WR, 1987, J NEUROSCI RES, V17, P184, DOI 10.1002/jnr.490170214	38	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1021	1028						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688549				2022-12-25	WOS:A1990CH53300062
J	BIRD, TA; SLEATH, PR; DEROOS, PC; DOWER, SK; VIRCA, GD				BIRD, TA; SLEATH, PR; DEROOS, PC; DOWER, SK; VIRCA, GD			INTERLEUKIN-1 REPRESENTS A NEW MODALITY FOR THE ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASES MICROTUBULE-ASSOCIATED PROTEIN-2 KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; TUMOR NECROSIS FACTOR; SERINE-THREONINE KINASE; MYELIN BASIC-PROTEIN; HEAT-SHOCK PROTEIN; RNA POLYMERASE-II; MURINE B-CELL; HUMAN T-CELLS; FACTOR RECEPTOR; TRANSDUCTION PATHWAYS	In this study we describe the activation of a protein kinase which phosphorylates a peptide, T669, comprising amino acids 663-681 of the epidermal growth factor receptor and containing the phosphate acceptor site Pro-Leu-Thr669-Pro. In the human epidermoid carcinoma cell line KB, T669 kinase activity in cytosolic extracts peaked (up to 15-fold compared with basal levels) 15-30 min after addition of interleukin-I (IL1) and closely paralleled receptor occupancy with a half-maximally effective concentration of almost-equal-to 100 pM IL-1-alpha. IL-1 treatment elevated T669 kinase activity to a variable extent in selected fibroblast lines, the hepatoma cell line HepG2, and the murine thymoma EL4 6.1. An IL-1 receptor-negative EL4 variant and the B cell lines 70Z/3, CB23, and RPMI 1788 did not respond in this way. All of the cell lines except 70Z/3 showed increased levels of T669 kinase when treated with the protein kinase C activator phorbol myristate acetate and or with epidermal growth factor. This finding is in agreement with a previous study (Countaway, J. Northwood, I. C., and Davis, R. J. (1989) J. Biol. Chem. 264, 10828-10835). Activators of protein kinase A did not mimic the ability of IL-1 to stimulate T669 kinase activity, nor did the protein kinase C inhibitor staurosporine abrogate the effect of IL-1. T669 kinase activity from IL-1-stimulated KB cells was partially purified by ion exchange, hydrophobic interaction, and size exclusion chromatography. The partially purified enzyme phosphorylated myelin basic protein a characteristic substrate of microtubule-associated protein-2 kinase (MAP-2 kinase) and the peptide Arg-Arg-Arg-(Tyr-Ser-Pro-Thr-Ser-Pro-Ser), from RNA polymerase II. Western blotting of chromatographic fractions revealed that T669 kinase activity corresponded with two proteins of 43 and 45 kilodaltons which cross-reacted with antibodies raised against peptide sequences of rat extracellular signal-regulated kinase-1/microtubule-associated protein-2 kinase. T669 kinase activity was critically dependent on the presence of phosphatase inhibitors. Since both the 43- and 45-kDa proteins, immunoprecipitated from [P-32]phosphate-labeled cells, demonstrated a dramatic increase in their levels of serine, threonine, and tyrosine phosphorylation after brief treatment with IL-1, we conclude that IL-1 modulates the activity of these extracellular signal-regulated kinase/microtubule-associated protein-2 kinases by altering the level of their phosphorylation.	IMMUNEX CORP,DEPT PROT CHEM,SEATTLE,WA 98101	Immunex Corporation	BIRD, TA (corresponding author), IMMUNEX CORP,DEPT BIOCHEM,51 UNIV ST,SEATTLE,WA 98101, USA.			dower, steve/0000-0002-4675-4225				ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ARIAS JA, 1991, J BIOL CHEM, V266, P8055; AURON PE, 1984, P NATL ACAD SCI USA, V81, P7904; AWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BENJAMIN D, 1990, BLOOD, V75, P2017; BIRD TA, 1988, J BIOL CHEM, V263, P12063; BIRD TA, 1989, J IMMUNOL, V142, P126; BIRD TA, 1990, J BIOL CHEM, V265, P235; BOMSZTYK K, 1989, P NATL ACAD SCI USA, V86, P8034, DOI 10.1073/pnas.86.20.8034; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; BOULTON TG, 1991, BIOCHEMISTRY-US, V30, P278, DOI 10.1021/bi00215a038; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CARROLL GJ, 1986, BRIT J RHEUMATOL, V25, P359; CASE JP, 1990, J IMMUNOL, V145, P3755; CHEDID M, 1990, MOL CELL BIOL, V10, P3824, DOI 10.1128/MCB.10.7.3824; CHIZZONITE R, 1989, P NATL ACAD SCI USA, V86, P8029, DOI 10.1073/pnas.86.20.8029; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DIDIER M, 1988, J IMMUNOL, V141, P3078; DOWER SK, 1989, INTERLEUKIN 1 INFLAM, P63; DOYE V, 1989, J BIOL CHEM, V264, P12134; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; FAGARASAN MO, 1990, P NATL ACAD SCI USA, V87, P2555, DOI 10.1073/pnas.87.7.2555; FUJITAYAMAGUCHI Y, 1988, BIOCHEM BIOPH RES CO, V157, P955, DOI 10.1016/S0006-291X(88)80967-7; GALLIS B, 1989, J IMMUNOL, V143, P3235; GIUGNI TD, 1988, J BIOL CHEM, V263, P18988; GUY G R, 1990, Progress in Growth Factor Research, V2, P45, DOI 10.1016/0955-2235(90)90009-9; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; HORUK R, 1987, J BIOL CHEM, V262, P16275; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACCHIA G, 1990, MOL CELL BIOL, V10, P2731, DOI 10.1128/MCB.10.6.2731; MAGNUSON DK, 1989, SURGERY, V106, P218; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MARTENSON RE, 1983, J BIOL CHEM, V258, P930; MILLS GB, 1989, J CELL PHYSIOL, V141, P310, DOI 10.1002/jcp.1041410212; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MUNOZ E, 1990, J IMMUNOL, V144, P964; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NORTHWOOD IC, 1990, P NATL ACAD SCI USA, V87, P6107, DOI 10.1073/pnas.87.16.6107; NOVAKHOFER I, 1985, J BIOL CHEM, V260, P314; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P44; OSTROWSKI J, 1988, J BIOL CHEM, V263, P13786; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; RAY LB, 1988, J BIOL CHEM, V263, P12721; RAY LB, 1987, J BIOL CHEM, V262, P1502; RAZ A, 1989, P NATL ACAD SCI USA, V86, P1657, DOI 10.1073/pnas.86.5.1657; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; RENKONEN R, 1990, EUR J IMMUNOL, V20, P1563, DOI 10.1002/eji.1830200723; RESCH K, 1986, IMMUNOBIOLOGY, V172, P336, DOI 10.1016/S0171-2985(86)80115-2; Rosoff P M, 1990, Semin Immunol, V2, P129; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SHIROO M, 1990, Cytokine, V2, P13, DOI 10.1016/1043-4666(90)90038-U; SIMS JE, 1989, P NATL ACAD SCI USA, V86, P8946, DOI 10.1073/pnas.86.22.8946; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SOLARI R, 1990, Cytokine, V2, P21, DOI 10.1016/1043-4666(90)90039-V; SPRIGGS MK, 1990, J BIOL CHEM, V265, P22499; STANTON TH, 1986, J BIOL CHEM, V261, P5699; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; YU KT, 1987, J BIOL CHEM, V262, P16677; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802; ZU Y, 1990, BIOCHEMISTRY-US, V29, P1055, DOI 10.1021/bi00456a030; ZUCALI JR, 1990, EXP HEMATOL, V18, P888	79	110	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22661	22670						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658005				2022-12-25	WOS:A1991GR56400091
J	KOJRO, E; HACKENBERG, M; ZSIGO, J; FAHRENHOLZ, F				KOJRO, E; HACKENBERG, M; ZSIGO, J; FAHRENHOLZ, F			IDENTIFICATION AND ENZYMATIC DEGLYCOSYLATION OF THE MYOMETRIAL OXYTOCIN RECEPTOR USING A RADIOIODINATED PHOTOREACTIVE ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND MEMBRANES; VASOPRESSIN; RAT; PARTURITION; AFFINITY; ANALOGS	To identify and characterize oxytocin receptors, a I-125-labeled photoreactive oxytocin antagonist was synthesized. The specific oxytocin antagonist [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid), 2-O-methyltyrosine, 4-threonine, 8-ornithine, 9-tyrosylamide]oxytocin ([Mca, Tyr(O-Me)2, Thr4, Orn8, Tyr9-NH2] oxytocin) described by Elands et al. (Elands, J., Barberis, C., Jard, S., Tribollet, E., Dreifuss, J.-J., Bankowski, K., Manning, M., and Sawyer, W. H. (1987) Eur. J. Pharmacol. 147, 192-207) bound to the guinea pig uterine oxytocin receptor with high affinity (apparent K(d) = 0.74 nM). The introduction of a 4-azidophenylamidino group at Orn8 resulted in the photoreactive ligand [Mca1, Tyr(O-Me)2, Thr4, Orn(4-azidophenylamidino) 8, Tyr9-NH2]oxytocin, which retained the high binding affinity (K(d) = 0.69 nM) of the parent compound. The photoreactive antagonist monoiodinated at Tyr9 had approximately double (K(d) = 0.39 nM) the affinity of the photoreactive antagonist and several times that of oxytocin (K(d) = 2.6 nM) for the guinea pig uterine oxytocin receptor. In photoaffinity labeling experiments using myometrial membranes obtained from guinea pigs during late pregnancy, the I-125-labeled photoreactive antagonist specifically labeled a protein with an apparent molecular mass of between 68 and 80 kDa: the labeling of this protein was completely suppressed by a 100-fold molar excess of oxytocin and oxytocin receptor-specific agonists, but not by vasopressin analogues specific for V1 or V2 receptors or by other peptide hormones. The ability of oxytocin to suppress labeling was decreased in the presence of guanosine 5'-O-(thiotriphosphate) or in the absence of Mn2+. Digestion of the photolabeled oxytocin receptor with endoglycosidase F gave rise to a protein with an apparent molecular mass of 38 +/- 2 kDa. The endoglycosidase F effect and the lack of endoglycosidase H action show that the myometrial oxytocin receptor is highly glycosylated with asparagine-linked complex oligosaccharide chains. Our results suggest that the radioiodinated photoreactive oxytocin antagonist could be a helpful tool in the isolation and further characterization of the oxytocin receptor.	MAX PLANCK INST BIOPHYS,KENNEDYALLEE 70,W-6000 FRANKFURT 70,GERMANY	Max Planck Society								ALEXANDROVA M, 1980, ENDOCRINOLOGY, V106, P730, DOI 10.1210/endo-106-3-730; ANTONI FA, 1989, BIOCHEM J, V257, P611, DOI 10.1042/bj2570611; BOEGE F, 1987, BIOCHEMISTRY-US, V26, P2418, DOI 10.1021/bi00383a004; CARSTEN ME, 1985, BIOCHEM BIOPH RES CO, V130, P1027, DOI 10.1016/0006-291X(85)91718-8; CRANKSHAR DJ, 1979, EUR J BIOCHEM, V86, P481; DUONG LT, 1989, J BIOL CHEM, V264, P17990; ELANDS J, 1990, ENDOCRINOLOGY, V126, P2703, DOI 10.1210/endo-126-5-2703; ELANDS J, 1987, EUR J PHARMACOL, V147, P192; FAHRENHOLZ F, 1986, EUR J BIOCHEM, V161, P321, DOI 10.1111/j.1432-1033.1986.tb10450.x; FAHRENHOLZ F, 1984, EUR J PHARMACOL, V100, P47, DOI 10.1016/0014-2999(84)90314-5; FAHRENHOLZ F, 1988, EUR J BIOCHEM, V174, P81, DOI 10.1111/j.1432-1033.1988.tb14065.x; FRIMMER M, 1986, BIOCHIM BIOPHYS ACTA, V855, P143, DOI 10.1016/0005-2736(86)90198-7; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; GRZONKA Z, 1983, J MED CHEM, V26, P1786, DOI 10.1021/jm00366a028; GRZONKA Z, 1986, J MED CHEM, V29, P96, DOI 10.1021/jm00151a016; GUILLON G, 1987, J CLIN ENDOCR METAB, V64, P1129, DOI 10.1210/jcem-64-6-1129; JI TH, 1977, J BIOL CHEM, V252, P1566; KHURSHEED A, 1989, ENDOCRINOLOGY, V124, P17; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAGGI M, 1986, P NATL ACAD SCI USA, V83, P8824, DOI 10.1073/pnas.83.23.8824; MAGGI M, 1988, ENDOCRINOLOGY, V122, P2970, DOI 10.1210/endo-122-6-2970; MARC S, 1986, FEBS LETT, V201, P9, DOI 10.1016/0014-5793(86)80561-0; PEARLMUTTER AF, 1979, J BIOL CHEM, V254, P3899; PEARSON RK, 1987, J BIOL CHEM, V262, P13850; SCHREY MP, 1988, AM J OBSTET GYNECOL, V159, P964, DOI 10.1016/S0002-9378(88)80182-0; SOLOFF MS, 1986, ENDOCRINOLOGY, V119, P1564, DOI 10.1210/endo-119-4-1564; SOLOFF MS, 1987, ENDOCRINOLOGY, V120, P2474, DOI 10.1210/endo-120-6-2474; SOLOFF MS, 1974, J BIOL CHEM, V249, P1376; USUI M, 1990, J CHROMATOGR, V257, P611; WESCH D, 1984, ANAL BIOCHEM, V138, P141	30	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21416	21421						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657965				2022-12-25	WOS:A1991GP80400019
J	STEPHENS, CM; BAUERLE, R				STEPHENS, CM; BAUERLE, R			ANALYSIS OF THE METAL REQUIREMENT OF 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID 7-PHOSPHATE SYNTHETASE; SALMONELLA-TYPHIMURIUM; SENSITIVE ISOENZYME; PURIFICATION; PROTEINS; BIOSYNTHESIS; KINETICS; PATHWAY; ENZYME; GENE	The three isozymes of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Escherichia coli were overproduced, purified, and characterized with respect to their requirement for metal cofactor. The isolated isozymes contained 0.2-0.3 mol of iron/mol of enzyme monomer, variable amounts of zinc, and traces of copper. Enzymatic activity of the native enzymes was stimulated 3-4-fold by the addition of Fe2+ ions to the reaction mixture and was eliminated by treatment of the enzymes with EDTA. The chelated enzymes were reactivated by a variety of divalent metal ions, including Ca2+, Cd2+, Co2+, CU2+, Fe2+, Mn2+, Ni2+, and Zn2+. The specific activities of the reactivated enzymes varied widely with the different metals as follows: Mn2+ > Cd2+, Fe2+ > Co2+ > Ni2+, CU2+, Zn2+ >> Ca2+. Steady state kinetic analysis of the Mn2+, Fe2+, Co2+, and Zn2+ forms of the phenylalanine-sensitive isozyme (DAHPS(Phe)) revealed that metal variation significantly affected the apparent affinity for the substrate, erythrose 4-phosphate, but not for the second substrate, phosphoenolpyruvate, or for the feedback inhibitor, L-phenylalanine. The tetrameric DAHPS(Phe) exhibited positive homotropic cooperativity with respect to erythrose 4-phosphate, phosphoenolpyruvate, and phenylalanine in the presence of all metals tested.	UNIV VIRGINIA,DEPT BIOL,GILMER HALL,CHARLOTTESVILLE,VA 22901; UNIV VIRGINIA,INST MOLEC BIOL,CHARLOTTESVILLE,VA 22901	University of Virginia; University of Virginia					NIGMS NIH HHS [GM07082, GM 35889] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035889] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAASOV T, 1989, J BACTERIOL, V171, P6155, DOI 10.1128/jb.171.11.6155-6160.1989; BELASCO JG, 1983, BIOCHEMISTRY-US, V22, P122, DOI 10.1021/bi00270a018; BERTINI I, 1983, ZINC ITS ROLE BIOL, P101; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; CAMAKARIS J, 1974, J BACTERIOL, V120, P590, DOI 10.1128/JB.120.2.590-597.1974; DAVIES WD, 1982, NUCLEIC ACIDS RES, V10, P4045, DOI 10.1093/nar/10.13.4045; DELEO AB, 1973, J BIOL CHEM, V248, P2344; DOY CH, 1965, BIOCHIM BIOPHYS ACTA, V104, P377, DOI 10.1016/0304-4165(65)90343-0; DYER WE, 1990, J BIOL CHEM, V265, P1608; FERSHT A, 1985, ENZYME STRUCTURE MEC, P147; GANEM B, 1978, TETRAHEDRON, V34, P3353, DOI 10.1016/0040-4020(78)80222-1; GORISCH H, 1971, BIOCHIM BIOPHYS ACTA, V242, P630, DOI 10.1016/0005-2744(71)90155-0; HUISMAN OC, 1974, J BIOL CHEM, V249, P6842; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE H, 1971, BIOCHIM BIOPHYS ACTA, V242, P519, DOI 10.1016/0005-2744(71)90144-6; MCCANDLISS RJ, 1978, P NATL ACAD SCI USA, V75, P4810, DOI 10.1073/pnas.75.10.4810; MCCANDLISS RJ, 1978, J BIOL CHEM, V253, P4259; Mildvan A S, 1974, Annu Rev Biochem, V43, P357, DOI 10.1146/annurev.bi.43.070174.002041; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MUDAY GK, 1990, J BACTERIOL, V172, P2259, DOI 10.1128/jb.172.5.2259-2266.1990; NAGANO H, 1970, ARCH BIOCHEM BIOPHYS, V138, P58, DOI 10.1016/0003-9861(70)90284-5; NIMMO GA, 1981, BIOCHEM J, V199, P657, DOI 10.1042/bj1990657; PALUH JL, 1986, NUCLEIC ACIDS RES, V14, P7851, DOI 10.1093/nar/14.20.7851; PARAVICINI G, 1989, EUR J BIOCHEM, V186, P361, DOI 10.1111/j.1432-1033.1989.tb15217.x; RAY JM, 1988, J BACTERIOL, V170, P5500, DOI 10.1128/jb.170.12.5500-5506.1988; RAY JM, 1991, J BACTERIOL, V173, P1894, DOI 10.1128/jb.173.6.1894-1901.1991; REES DC, 1980, P NATL ACAD SCI-BIOL, V77, P3288, DOI 10.1073/pnas.77.6.3288; RUBIN JL, 1985, PLANT PHYSIOL, V79, P711, DOI 10.1104/pp.79.3.711; SCHONER R, 1976, J BIOL CHEM, V251, P5440; SCHULTZ J, 1984, J BIOL CHEM, V259, P9655; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SIMPSON RJ, 1976, EUR J BIOCHEM, V70, P501, DOI 10.1111/j.1432-1033.1976.tb11041.x; SIMPSON RJ, 1976, EUR J BIOCHEM, V70, P493, DOI 10.1111/j.1432-1033.1976.tb11040.x; SIMPSON RJ, 1971, EUR J BIOCHEM, V107, P798; Solomon E.I., 1983, STRUCT BONDING BERLI, V53, P1; SRINIVASAN PR, 1959, J BIOL CHEM, V234, P716; STAUB M, 1969, BIOCHIM BIOPHYS ACTA, V178, P599, DOI 10.1016/0005-2744(69)90228-9; STAUB M, 1969, BIOCHIM BIOPHYS ACTA, V178, P588, DOI 10.1016/0005-2744(69)90227-7; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001	40	72	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20810	20817						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1682314				2022-12-25	WOS:A1991GN00100036
J	GUTOWSKI, S; SMRCKA, A; NOWAK, L; WU, DG; SIMON, M; STERNWEIS, PC				GUTOWSKI, S; SMRCKA, A; NOWAK, L; WU, DG; SIMON, M; STERNWEIS, PC			ANTIBODIES TO THE ALPHA-Q-SUBFAMILY OF GUANINE NUCLEOTIDE-BINDING REGULATORY PROTEIN-ALPHA SUBUNITS ATTENUATE ACTIVATION OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE HYDROLYSIS BY HORMONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DECAPEPTIDE; PHOSPHOLIPASE-C; IMMUNOLOGICAL IDENTIFICATION; PERTUSSIS TOXIN; GS-ALPHA; RECEPTOR; PURIFICATION; INHIBITION; MEMBRANES; CHANNELS	The subfamily of guanine nucleotide-binding regulatory (G proteins) designated G(q) has been shown to regulate the activity of phospholipase C by reconstitution. However, the role of these proteins in hormonal regulation of this activity has not been demonstrated. Two antisera were used in attempts to interrupt this pathway. Antiserum W082, developed against a peptide representing an internal sequence in alpha-q, was specific for alpha-q by immunoblots but did not recognize the native protein. Antiserum X384 was developed against a peptide representing the 12 amino acids of the common carboxyl termini of alpha-q and alpha-11. It had a broader specificity for this subfamily of G protein alpha-subunits and recognized the native proteins. Antiserum X384 specifically immunoprecipitated alpha-q and its homologs from purified preparations and detergent extracts of membranes. Affinity-purified antibodies attenuated stimulation of phosphatidylinositide 4,5-bisphosphate hydrolysis by bradykinin, angiotensin, and histamine in membranes derived from NG10815 cells, rat liver, and 1321N1 cells, respectively. Activation of the phospholipase C activity by guanosine 5'-3-O-(thio)triphosphate alone was also inhibited. Inclusion of the peptide to which the antisera were raised blocked the effect of the antibody. In contrast, affinity-purified W082, which did not recognize native proteins, did not alter regulation of phospholipase C. This indicates that the G(q) family of signaling proteins can couple to several receptors and is responsible for the hormonal regulation of phospholipase C in these diverse systems. The further generality of this regulatory pathway remains to be established.	UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA; CALTECH, DEPT BIOL, PASADENA, CA 91125 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology					NIGMS NIH HHS [GM34236, GM31954] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034236, R37GM034236, R01GM031954] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CERIONE RA, 1988, J BIOL CHEM, V263, P9345; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GORMAN CM, 1989, VIROLOGY, V171, P377, DOI 10.1016/0042-6822(89)90605-3; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MORRIS D, 1990, BIOCHEMISTRY-US, V29, P9079, DOI 10.1021/bi00490a027; MUMBY S, 1988, J BIOL CHEM, V263, P2020; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; NEVILLE DM, 1960, J BIOPHYS BIOCHEM CY, V8, P413, DOI 10.1083/jcb.8.2.413; PANG IH, 1990, J BIOL CHEM, V265, P18707; PRPIC V, 1984, J BIOL CHEM, V259, P1382; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WANGE RL, 1991, J BIOL CHEM, V266, P11409; WEINGARTEN R, 1990, J BIOL CHEM, V265, P11044; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	37	307	307	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20519	20524						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657928				2022-12-25	WOS:A1991GM03900096
J	ROSSOMANDO, AJ; SANGHERA, JS; MARSDEN, LA; WEBER, MJ; PELECH, SL; STURGILL, TW				ROSSOMANDO, AJ; SANGHERA, JS; MARSDEN, LA; WEBER, MJ; PELECH, SL; STURGILL, TW			BIOCHEMICAL-CHARACTERIZATION OF A FAMILY OF SERINE THREONINE PROTEIN-KINASES REGULATED BY TYROSINE AND SERINE THREONINE PHOSPHORYLATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; MITOGENIC AGENTS INDUCE; CELL-CYCLE CONTROL; GROWTH-FACTOR; STIMULATED PROTEIN; MAP KINASE; IDENTIFICATION; INSULIN; ACTIVATION; FIBROBLASTS	Mitogen-activated protein kinase (p42mapk) becomes transiently activated after treatment of serum-starved murine Swiss 3T3 cells or EL4 thymocytes with a diversity of mitogens. Similarly, a meiosis-activated protein kinase (p44mpk) becomes stimulated during maturation of sea star oocytes induced by 1-methyladenine. Both p42mapk and p44mpk have been identified as protein-serine/threonine kinases that are activated as a consequence of their phosphorylation. Because homologous protein kinases may play essential roles in both mitogenesis and oogenesis, we have compared in detail the biochemical properties of these two kinases. We find that these kinases are highly related based on their in vitro substrate specificities, sensitivity to inhibitors, and immunological cross-reactivity. However, they differ in apparent molecular weight and can be separated chromatographically, indicating that the two enzymes are distinct. Furthermore, in the course of this investigation, we have identified a 44-kDa protein kinase in mitogen-stimulated Swiss mouse 3T3 cells and EL4 thymocytes that co-purifies with p44mpk and thus appears to be a closer homolog of the sea star enzyme. Analysis of these protein kinases clarifies the relationships between a set of tyrosine-phosphorylated 41-45-kDa proteins present in mitogen-stimulated cells (Martinez, R., Nakamura., K. D., and Weber, M. J. (1982) Mol Cell. Biol. 2, 653-655; Cooper, J. A., and Hunter, T. (1984) Mol. Cell. Biol. 4, 30-37), two myelin basic protein kinases identified in epidermal growth factor-treated Swiss mouse 3T3 cells (Ahn, N. G., Weiel, J. E., Chan, C. P., and Krebs, E. G. (1990) J. Biol. Chem. 265, 11487-11494), and p42mapk. Our work points to the existence of a group of related serine/threonine protein kinases, regulated by tyrosine phosphorylation and functioning at different stages of the cell cycle.	UNIV VIRGINIA,HLTH SCI CTR,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,CTR CANC,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT INTERNAL MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908; UNIV BRITISH COLUMBIA,CTR BIOMED RES,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER V6T 1W5,BC,CANADA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of British Columbia; University of British Columbia					NCI NIH HHS [CA 39076, CA 47815] Funding Source: Medline; NIDDK NIH HHS [DK 41077] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039076, R01CA047815, R37CA039076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041077] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN NG, 1990, J BIOL CHEM, V265, P11487; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BISHOP R, 1983, BIOCHEM BIOPH RES CO, V115, P536, DOI 10.1016/S0006-291X(83)80178-8; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009; COOPER JA, 1989, MOL CELL BIOL, V9, P3143, DOI 10.1128/MCB.9.7.3143; COOPER JA, 1985, MOL CELL BIOL, V5, P3304, DOI 10.1128/MCB.5.11.3304; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; ELY CM, 1990, J CELL BIOL, V110, P731, DOI 10.1083/jcb.110.3.731; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; GOMEZ N, 1990, FEBS LETT, V271, P119, DOI 10.1016/0014-5793(90)80386-W; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; HER JH, 1991, NUCLEIC ACIDS RES, V19, P3743, DOI 10.1093/nar/19.13.3743; HUNTER T, 1984, CANCER CELL, V2, P61; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KOHNO M, 1985, J BIOL CHEM, V260, P1771; LOHKA MJ, 1987, MOL CELL BIOL, V7, P760, DOI 10.1128/MCB.7.2.760; MARTINEZ R, 1982, MOL CELL BIOL, V2, P653, DOI 10.1128/MCB.2.6.653; MEIER KE, 1991, J BIOL CHEM, V266, P1914; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297, DOI 10.1139/o90-194; PELECH SL, 1988, DEV BIOL, V130, P28, DOI 10.1016/0012-1606(88)90410-1; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SANGHERA JS, 1991, J BIOL CHEM, V266, P6700; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; SANGHERA JS, 1990, FEBS LETT, V273, P223, DOI 10.1016/0014-5793(90)81090-B; VILA J, 1988, J CELL PHYSIOL, V135, P285, DOI 10.1002/jcp.1041350216; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	33	84	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20270	20275						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657919				2022-12-25	WOS:A1991GM03900059
J	LICALSI, C; CROCENZI, TS; FREIRE, E; ROSEMAN, S				LICALSI, C; CROCENZI, TS; FREIRE, E; ROSEMAN, S			SUGAR-TRANSPORT BY THE BACTERIAL PHOSPHOTRANSFERASE SYSTEM - STRUCTURAL AND THERMODYNAMIC DOMAINS OF ENZYME-I OF SALMONELLA-TYPHIMURIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI; PHOSPHOCARRIER PROTEIN; MOLECULAR-CLONING; PLASMID DNA; PHOSPHOENOLPYRUVATE; IIIGLC; PURIFICATION; SUBUNIT; HPR	Enzyme I, the first in the sequence of phosphocarrier proteins of the bacterial phosphoenolpyruvate:glycose phosphotransferase system, is a potential critical point for regulating sugar uptake. The thermal stability of Enzyme I was studied by high sensitivity differential scanning calorimetry. At pH 7.5, thermal unfolding of the protein exhibits two peaks with maxima (T(m)) at 47.6 and 55.1-degrees-C, indicating that the protein comprises two cooperative unfolding structures. Interaction between the two domains is markedly dependent on pH within the range 6.5-8.5. At pH 7.5, catalytic activity was unaffected by heating through the first transition but was lost by heating through the second. Cleavage of Enzyme I (63.5 kDa) by trypsin, chymotrypsin, or Staphylococcus aureus V8 protease yields a 30-kDa fragment, EI-N, containing the NH2 terminus and the active site, His-189. Protease and differential scanning calorimetry experiments show that EI-N is the structural domain corresponding to the cooperative region in the intact enzyme that unfolds at the higher T(m). EI-N catalyzes one activity of Enzyme I; it accepts a phosphoryl group from phosphohistidine-containing phosphocarrier protein but cannot be phosphorylated by phospho-Enzyme I or phosphoenolpyruvate. The phosphoryl transfer between EI-N and the histidine-containing phosphocarrier protein is reversible. Portions of the Salmonella typhimurium ptsI DNA sequence are known; the complete sequence is presented here and compared to Escherichia coli ptsI.	JOHNS HOPKINS UNIV,CTR BIOCALORIMETRY,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University	LICALSI, C (corresponding author), JOHNS HOPKINS UNIV,MCCOLLUM PRATT INST,BALTIMORE,MD 21218, USA.				NCRR NIH HHS [RR-04328] Funding Source: Medline; NIGMS NIH HHS [5-R37-GM38759, 5T32GM-07231] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R37GM038759] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; BENESKI DA, 1982, J BIOL CHEM, V257, P4492; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BEREZIN IV, 1970, FEBS LETT, V8, P261, DOI 10.1016/0014-5793(70)80281-2; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; CHAUVIN F, 1990, BIOPHYS J, V57, pA429; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHRAMBACH A, 1972, SEPAR SCI, V7, P663, DOI 10.1080/00372367208057977; CORDARO JC, 1972, J BACTERIOL, V112, P17, DOI 10.1128/JB.112.1.17-29.1972; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; EDMAN P, 1949, ARCH BIOCHEM, V22, P475; ERNI B, 1989, J BIOL CHEM, V264, P18733; FOX D, 1984, BIOCHEM SOC T, V12, P155, DOI 10.1042/bst0120155; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; HAN MK, 1990, J BIOL CHEM, V265, P1996; HAN MK, 1990, J BIOL CHEM, V265, P1985; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; JOVIN TM, 1973, ANN NY ACAD SCI, V209, P477, DOI 10.1111/j.1749-6632.1973.tb47551.x; KUKURUZINSKA MA, 1984, J BIOL CHEM, V259, P1679; KUKURUZINSKA MA, 1982, J BIOL CHEM, V257, P4470; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LICALSI C, 1990, BIOPHYS J, V57, pA446; MAJUMDAR A, 1984, P NATL ACAD SCI-BIOL, V81, P6100, DOI 10.1073/pnas.81.19.6100; MARTIN K, 1986, P NATL ACAD SCI USA, V83, P3564; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER H, 1987, METHOD ENZYMOL, V152, P145; MITCHELL WJ, 1987, J BIOL CHEM, V262, P16254; MYERS M, 1987, BIOCHEMISTRY-US, V26, P4309, DOI 10.1021/bi00388a019; NAVON G, 1977, P NATL ACAD SCI USA, V74, P888, DOI 10.1073/pnas.74.3.888; NELSON SO, 1984, EMBO J, V3, P1587, DOI 10.1002/j.1460-2075.1984.tb02015.x; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; PRESPER KA, 1989, P NATL ACAD SCI USA, V86, P4052, DOI 10.1073/pnas.86.11.4052; PULLEYBLANK D, 1983, MOL BIOL REP, V9, P191, DOI 10.1007/BF00775367; RAMSAY G, 1990, BIOCHEMISTRY-US, V29, P8677, DOI 10.1021/bi00489a024; ROOSIEN FF, 1983, BIOCHIM BIOPHYS ACTA, V760, P184; SAFFEN DW, 1987, J BIOL CHEM, V262, P16241; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P169; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; TUGGLE CK, 1986, EMBO J, V5, P1077, DOI 10.1002/j.1460-2075.1986.tb04325.x; WALSH K, 1970, METHOD ENZYMOL, V19, P60; WAYGOOD EB, 1980, CAN J BIOCHEM CELL B, V58, P40, DOI 10.1139/o80-006; WAYGOOD EB, 1985, BIOCHEMISTRY-US, V24, P6938, DOI 10.1021/bi00345a028; WAYGOOD EB, 1982, METHOD ENZYMOL, V90, P423; WEIGEL N, 1982, J BIOL CHEM, V257, P4461; 1986, FOCUS, V8, P9	52	78	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19519	19527						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655788				2022-12-25	WOS:A1991GK66700060
J	BARBER, DL; SANDERS, EJ; AEBERSOLD, R; SCHNEIDER, WJ				BARBER, DL; SANDERS, EJ; AEBERSOLD, R; SCHNEIDER, WJ			THE RECEPTOR FOR YOLK LIPOPROTEIN DEPOSITION IN THE CHICKEN OOCYTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-VLDL-II; HIGH-AFFINITY BINDING; RAPID GROWTH-PHASE; LDL-RECEPTOR; OVARIAN FOLLICLE; GALLUS-DOMESTICUS; EGG-YOLK; CYTOPLASMIC DOMAIN; RICH LIPOPROTEINS	The final rapid growth phase of the chicken oocyte is characterized by massive uptake of hepatically synthesized yolk precursor proteins from the plasma. The two major yolk-forming components, very low density lipoprotein (VLDL) and vitellogenin (VTG), have been shown to interact with a 95-kDa protein present in detergent extracts of ovarian membranes; this protein is absent in hens of a mutant nonlaying chicken strain (Nimpf, J., Radosavljevic, M., and Schneider, W. J. (1989) J. Biol. Chem. 264, 1393-1398). Here, we have purified the 95-kDa protein by ligand and immunoaffinity chromatography and demonstrated its role in receptor-mediated endocytosis by ultrastructural immunolocalization, structural, and functional studies. The receptor was visualized exclusively in the oocyte proper and was absent from somatic cells, in agreement with the previously reported expression of two different lipoprotein receptors in somatic cells and oocytes, respectively, of laying hens (Hayashi, K., Nimpf, J., and Schneider, W. J. (1989) J. Biol. Chem. 264, 3131-3139). Amino acid sequences of tryptic fragments of the oocyte receptor were obtained, and its kinship to somatic low density lipoprotein receptors was confirmed through the demonstration of sequence conservation in three characteristic domains. In particular, the chicken receptor's internalization sequence, Phe-Asp-Asn-Pro-Val-Tyr, is identical with that in low density lipoprotein receptors from mammals as well as Xenopus laevis. The ligand-binding properties, specificity, and kinetic parameters of the oocyte receptor were characterized in filtration assays employing pure ligands and receptor. In conjunction with ligand-blotting experiments following limited protease digestion of the receptor, the binding assay data suggest that VTG recognizes a substructure of the VLDL-binding site. These studies establish that a cell-specific receptor mediates the endocytosis of VTG and VLDL into growing chicken oocytes and thus possibly plays a key role in control of oocyte growth.	UNIV ALBERTA, LIPID & LIPOPROT RES GRP, 327 HERITAGE MED RES CTR, EDMONTON T6G 2S2, ALBERTA, CANADA; UNIV ALBERTA, DEPT BIOCHEM, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV ALBERTA, DEPT PHYSIOL, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV ALBERTA, LIPID & LIPOPROT RES GRP, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV BRITISH COLUMBIA, BIOMED RES CTR, VANCOUVER V6T 1Z3, BC, CANADA; UNIV BRITISH COLUMBIA, DEPT BIOCHEM, VANCOUVER V6T 1Z3, BC, CANADA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of British Columbia; University of British Columbia				Barber, Dwayne/0000-0001-5528-8150				AEBERSOLD R, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P71; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BELLAIRS RUTH, 1964, ADVANCE MORPHO GENESIS, V4, P217; BURLEY RW, 1984, EUR J BIOCHEM, V142, P171, DOI 10.1111/j.1432-1033.1984.tb08266.x; CAMEJO G, 1990, EUR HEART J, V11, P164, DOI 10.1093/eurheartj/11.suppl_E.164; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DEELEY RG, 1975, J BIOL CHEM, V250, P9060; EVANS AJ, 1979, BIOCHIM BIOPHYS ACTA, V573, P184, DOI 10.1016/0005-2760(79)90185-1; GEORGE R, 1987, J BIOL CHEM, V262, P16838; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GRIFFIN H, 1982, BIOCHEM J, V206, P647, DOI 10.1042/bj2060647; Griffin H. D., 1984, PHYSL BIOCH DOMESTIC, V5, P345; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAYASHI K, 1989, J BIOL CHEM, V264, P3131; HAYASHI K, 1989, J LIPID RES, V30, P1421; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HO KJ, 1974, ARCH PATHOL, V98, P161; HOLDSWORTH G, 1974, FEBS LETT, V39, P275, DOI 10.1016/0014-5793(74)80129-8; JONES DG, 1975, POULTRY SCI, V54, P1780; KRUMINS SA, 1981, BIOCHEM J, V196, P481, DOI 10.1042/bj1960481; KRUMINS SA, 1985, J CELL BIOCHEM, V28, P281, DOI 10.1002/jcb.240280406; LEE LY, 1989, NUCLEIC ACIDS RES, V17, P1259, DOI 10.1093/nar/17.3.1259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; MCGIBBON WH, 1977, GENETICS, V86, pS43; MEHTA KD, 1991, J BIOL CHEM, V266, P10406; NIMPF J, 1989, P NATL ACAD SCI USA, V86, P906, DOI 10.1073/pnas.86.3.906; NIMPF J, 1988, J LIPID RES, V29, P657; NIMPF J, 1989, J BIOL CHEM, V264, P1393; PERRY MM, 1985, J ULTRA MOL STRUCT R, V90, P313, DOI 10.1016/S0022-5320(85)80009-5; PERRY MM, 1978, J ANAT, V125, P481; PERRY MM, 1979, J CELL SCI, V39, P257; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHJEIDE OA, 1976, CELL TISSUE RES, V166, P109, DOI 10.1007/BF00215130; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; SCHNEIDER WJ, 1980, J BIOL CHEM, V255, P1442; SCHNEIDER WJ, 1985, METHOD ENZYMOL, V109, P405; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; SCHNEIDER WJ, 1990, J LIPID RES, V31, P507; STEYRER E, 1990, J BIOL CHEM, V265, P19575; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; WALLACE RA, 1986, BIOCHEM J, V240, P871, DOI 10.1042/bj2400871; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; WILEY HS, 1981, J BIOL CHEM, V256, P8626; WOODS JW, 1984, BIOCHEMISTRY-US, V23, P5774, DOI 10.1021/bi00319a016; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YUSKO S, 1981, BIOCHEM J, V200, P43, DOI 10.1042/bj2000043; 1979, AFFINITY CHROMATOGR, P15	60	120	132	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18761	18770						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655760				2022-12-25	WOS:A1991GJ47200056
J	POULAIN, B; MOCHIDA, S; WELLER, U; HOGY, B; HABERMANN, E; WADSWORTH, JDF; SHONE, CC; DOLLY, JO; TAUC, L				POULAIN, B; MOCHIDA, S; WELLER, U; HOGY, B; HABERMANN, E; WADSWORTH, JDF; SHONE, CC; DOLLY, JO; TAUC, L			HETEROLOGOUS COMBINATIONS OF HEAVY AND LIGHT-CHAINS FROM BOTULINUM NEUROTOXIN-A AND TETANUS TOXIN INHIBIT NEUROTRANSMITTER RELEASE IN APLYSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; MOTOR-NERVE TERMINALS; CLOSTRIDIAL NEUROTOXINS; TRANSMITTER RELEASE; NEUROMUSCULAR-TRANSMISSION; NORADRENALINE RELEASE; CHOLINERGIC SYNAPSE; EXOCYTOSIS; INTERNALIZATION; FRAGMENTS	The neuroparalytic activities of botulinum neurotoxin type A (BoNT A), tetanus toxin (TeTx), or homologous and heterologous combinations of their constituent polypeptides were examined at cholinergic and non-cholinergic synapses of Aplysia californica. When applied extracellularly, BoNT A or a mixture of its heavy (HC) and light (LC) chains were far more potent in blocking transmitter release at cholinergic than non-cholinergic synapses. The reverse was true for TeTx or a mixture its constituent chains. Such selectivity was assigned to differences in neuronal targetting and uptake of the neurotoxins since both exibited similar potencies when injected directly into the cell body of either cell type. When bath-applied, heterologous combinations of the toxins' HC and LC appeared as effective as the parent neurotoxins from whence each HC was derived. Moreover, targetting/internalization was attributable to the analogous N-terminal moieties, H-2 and beta-2, of the HC from BoNT A and TeTx. Thus, it may be postulated that the latter regions possess two functional domains, one being distinct and responsible for the divergent neuronal specificity, whereas the other serves a common role in translocating the LC of either toxin. Also, it was shown that the C-terminal portion of the HC of TeTx is unable to play the intracellular role of its counterpart in BoNT A.	UNIV GIESSEN, R BUCHHEIM INST PHARMAKOL, W-6300 GIESSEN, GERMANY; IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, LONDON SW7 2AY, ENGLAND; PUBL HLTH LAB SERV, SALISBURY SP4 0JG, WILTS, ENGLAND	Justus Liebig University Giessen; Imperial College London	POULAIN, B (corresponding author), CNRS, NEUROBIOL CELLULAIRE & MOLEC LAB, F-91198 GIF SUR YVETTE, FRANCE.		Dolly, Oliver/G-1532-2012; Dolly, Oliver/ABH-6677-2020	Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; Wadsworth, Jonathan/0000-0002-4797-2259				AHNERTHILGER G, 1989, FEBS LETT, V242, P245, DOI 10.1016/0014-5793(89)80478-8; BANDYOPADHYAY S, 1987, J BIOL CHEM, V262, P2660; BIGALKE H, 1981, N-S ARCH PHARMACOL, V316, P244, DOI 10.1007/BF00505657; BINZ T, 1990, J BIOL CHEM, V265, P9153; BITTNER MA, 1989, J BIOL CHEM, V264, P10354; BIZZINI B, 1988, TOXICON, V26, P309, DOI 10.1016/0041-0101(88)90222-X; DEPAIVA A, 1990, FEBS LETT, V277, P171, DOI 10.1016/0014-5793(90)80836-8; DOLLY JO, 1988, E H S BIOT, P79; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; DREYER F, 1983, PFLUG ARCH EUR J PHY, V399, P228, DOI 10.1007/BF00656720; EISEL U, 1986, EMBO J, V5, P2495, DOI 10.1002/j.1460-2075.1986.tb04527.x; FREDMAN SM, 1975, BRAIN RES, V100, P209, DOI 10.1016/0006-8993(75)90262-0; GAILLARD WD, 1986, BRAIN RES, V373, P311, DOI 10.1016/0006-8993(86)90345-8; GANSEL M, 1987, PFLUG ARCH EUR J PHY, V409, P533, DOI 10.1007/BF00583812; HABERMANN E, 1980, N-S ARCH PHARMACOL, V311, P33, DOI 10.1007/BF00500299; HABERMANN E, 1986, CURR TOP MICROBIOL, V129, P93; HABERMANN E, 1988, J NEUROCHEM, V51, P522, DOI 10.1111/j.1471-4159.1988.tb01069.x; MAISEY EA, 1988, EUR J BIOCHEM, V177, P683, DOI 10.1111/j.1432-1033.1988.tb14423.x; MCINNES C, 1990, FEBS LETT, V261, P323, DOI 10.1016/0014-5793(90)80582-4; MELLANBY J, 1981, NEUROSCIENCE, V6, P281, DOI 10.1016/0306-4522(81)90123-8; MOCHIDA S, 1990, P NATL ACAD SCI USA, V87, P7844, DOI 10.1073/pnas.87.20.7844; MOCHIDA S, 1989, FEBS LETT, V253, P47, DOI 10.1016/0014-5793(89)80926-3; PARTON RG, 1987, J NEUROCHEM, V49, P1057; PENNER R, 1986, NATURE, V324, P76, DOI 10.1038/324076a0; POULAIN B, 1989, EUR J BIOCHEM, V185, P197, DOI 10.1111/j.1432-1033.1989.tb15102.x; POULAIN B, 1988, P NATL ACAD SCI USA, V85, P4090, DOI 10.1073/pnas.85.11.4090; POULAIN B, 1986, P NATL ACAD SCI USA, V83, P170, DOI 10.1073/pnas.83.1.170; POULAIN B, 1989, J BIOL CHEM, V264, P21928; SCHMITT A, 1981, N-S ARCH PHARMACOL, V317, P326, DOI 10.1007/BF00501314; SIMPSON LL, 1985, J PHARMACOL EXP THER, V232, P223; SIMPSON LL, 1984, J PHARMACOL EXP THER, V228, P600; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SIMPSON LL, 1989, BOTULINUM NEUROTOXIN, P153; STECHER B, 1989, FEBS LETT, V255, P391, DOI 10.1016/0014-5793(89)81129-9; TAKANO K, 1989, TOXICON, V27, P385, DOI 10.1016/0041-0101(89)90185-2; TAUC L, 1974, NATURE, V250, P496, DOI 10.1038/250496a0; THOMPSON DE, 1990, EUR J BIOCHEM, V189, P73, DOI 10.1111/j.1432-1033.1990.tb15461.x; WADSWORTH JDF, 1990, BIOCHEM J, V268, P123, DOI 10.1042/bj2680123; WELLER U, 1988, N-S ARCH PHARMACOL, V338, P99; WELLER U, 1991, NEUROSCI LETT, V122, P132, DOI 10.1016/0304-3940(91)90210-K; WELLER U, 1989, EUR J BIOCHEM, V182, P649, DOI 10.1111/j.1432-1033.1989.tb14874.x; [No title captured]	42	41	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9580	9585						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1674511				2022-12-25	WOS:A1991FM45900039
J	KONNO, Y; NATSUMEDA, Y; NAGAI, M; YAMAJI, Y; OHNO, S; SUZUKI, K; WEBER, G				KONNO, Y; NATSUMEDA, Y; NAGAI, M; YAMAJI, Y; OHNO, S; SUZUKI, K; WEBER, G			EXPRESSION OF HUMAN IMP DEHYDROGENASE TYPE-I AND TYPE-II IN ESCHERICHIA-COLI AND DISTRIBUTION IN HUMAN NORMAL LYMPHOCYTES AND LEUKEMIC-CELL LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-PHOSPHATE DEHYDROGENASE; MONOPHOSPHATE DEHYDROGENASE; ERYTHROID-DIFFERENTIATION; REGULATORY PROPERTIES; HEPATOMA 3924A; ASSAY-METHOD; TIAZOFURIN; PURIFICATION; MODULATION; INHIBITORS	Two distinct cDNAs encoding proteins with 84% sequence identity have been isolated for human IMP dehydrogenase (EC 1.1.1.205) (Natsumeda, Y., Ohno, S., Kawasaki, H., Konno, Y., Weber, G., and Suzuki, K. (1990) J. Biol. Chem. 265, 5292-5295), an important target in antileukemic chemotherapy. We constructed expression plasmids containing these cDNAs in full length with pUC plasmids and produced lacZ'-IMP dehydrogenase fusion proteins in Escherichia coli. Both synthesized proteins exhibited IMP dehydrogenase activity and were partially separated from endogenous E. coli IMP dehydrogenase. By injecting the fusion proteins into mice we generated a polyclonal antibody specific to type I IMP dehydrogenase and an antibody which reacted with both types. Immunoblot analysis revealed that the total amounts of type I and II enzymes increased in human leukemic cell lines K562 and HL-60 in agreement with the increase in IMP dehydrogenase activity to 7.8- and 9.4-fold, respectively, above that of normal lymphocytes. The extent of expression of type I IMP dehydrogenase was similar in these cells, however, indicating that the increase in IMP dehydrogenase amount in leukemic cells was due to specific up-regulation of type II enzyme. Northern blot analysis also showed specific and predominant expression of type II in the leukemic cells. Thus, de novo GTP biosynthesis may be controlled differently in normal and neoplastic cells by different IMP dehydrogenase molecular species.	INDIANA UNIV, SCH MED, EXPTL ONCOL LAB, 702 BARNHILL DR, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, WALTHER ONCOL CTR, INDIANAPOLIS, IN 46202 USA; TOKYO METROPOLITAN INST MED SCI, DEPT MOLEC BIOL, TOKYO 113, JAPAN	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Tokyo Metropolitan Institute of Medical Science			Ohno, Shigeo/B-1768-2010	Ohno, Shigeo/0000-0002-1294-5269	NCI NIH HHS [CA-42510] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042510] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLART FR, 1988, J BIOL CHEM, V263, P15769; FUKUI M, 1982, CANCER RES, V42, P1098; HODGES SD, 1989, J BIOL CHEM, V264, P18137; HOLMES EW, 1974, BIOCHIM BIOPHYS ACTA, V364, P209, DOI 10.1016/0005-2744(74)90006-0; HUGGINS JW, 1984, ANTIMICROB AGENTS CH, V26, P476, DOI 10.1128/AAC.26.4.476; IKEGAMI T, 1987, LIFE SCI, V40, P2277, DOI 10.1016/0024-3205(87)90064-6; IKEGAMI T, 1985, ANAL BIOCHEM, V150, P155, DOI 10.1016/0003-2697(85)90454-3; JACKSON RC, 1977, BIOCHEM J, V166, P1; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; KNIGHT RD, 1987, BLOOD, V69, P634; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUI MS, 1984, J BIOL CHEM, V259, P5078; MANIATIS T, 1982, MOL CLONING LABORATO, P441; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; NATSUMEDA Y, 1989, CANCER RES, V49, P88; NATSUMEDA Y, 1988, CANCER RES, V48, P507; OKADA M, 1983, J BIOCHEM-TOKYO, V94, P1605; OLAH E, 1988, P NATL ACAD SCI USA, V85, P6533, DOI 10.1073/pnas.85.17.6533; SHIMURA K, 1983, J BIOCHEM, V94, P1595; SOKOLOSKI JA, 1986, CANCER RES, V46, P2314; STREETER DG, 1973, P NATL ACAD SCI USA, V70, P1174, DOI 10.1073/pnas.70.4.1174; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRICOT GJ, 1989, CANCER RES, V49, P3696; UEHARA Y, 1985, CANCER RES, V45, P5230; ULLMAN B, 1983, J BIOL CHEM, V258, P523; WEBER G, 1983, CANCER RES, V43, P3466; YAMADA Y, 1988, BIOCHEMISTRY-US, V27, P2193, DOI 10.1021/bi00406a057; YAMADA Y, 1989, LEUKEMIA RES, V13, P179, DOI 10.1016/0145-2126(89)90143-4; YAMAJI Y, 1990, LIFE SCI, V46, P435, DOI 10.1016/0024-3205(90)90087-8; YU J, 1989, CANCER RES, V49, P5555	31	119	124	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					506	509						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1670768				2022-12-25	WOS:A1991EQ33900075
J	LEE, SH; KWONG, AD; PAN, ZQ; HURWITZ, J				LEE, SH; KWONG, AD; PAN, ZQ; HURWITZ, J			STUDIES ON THE ACTIVATOR-1 PROTEIN COMPLEX, AN ACCESSORY FACTOR FOR PROLIFERATING CELL NUCLEAR ANTIGEN-DEPENDENT DNA POLYMERASE-DELTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; LARGE-TUMOR-ANTIGEN; REPLICATION INVITRO; SV40 ORIGIN; T-ANTIGEN; AUXILIARY PROTEIN; ESCHERICHIA-COLI; DELTA; ALPHA; INHIBITOR	Activator 1 (A1) is a multiprotein complex which is essential for proliferating cell nuclear antigen (PCNA)-dependent DNA polymerase-delta (pol-delta) activity and efficient in vitro DNA synthesis in the SV40 dipolymerase replication system. In this report, we describe the isolation of A1 from HeLa cytosolic extracts. A1 stimulated pol-delta activity in singly primed phi-X174 DNA or (dA)45000.oligO(dT)12-18 in reactions containing PCNA, single-stranded DNA binding protein (SSB), and ATP. Using this assay, A1 has been extensively purified. Purified preparations contained five discrete subunits of 145, 40, 38, 37, and 36.5 kDa. ATP hydrolysis to ADP and P(i) is essential for A1-dependent pol-delta activity, and we have shown that A1 contains an intrinsic ATPase which is stimulated by DNA. The DNA-dependent hydrolysis of ATP can be stimulated by PCNA and further activated by PCNA plus the human single-stranded DNA binding protein. These stimulatory effects were observed with (dA)45000/oligo(dT)12-18, but were not detected with each polydeoxynucleotide alone. Furthermore, A1 formed a complex with (dA)45000.oligo(dT)12-18 which could be measured by nitrocellulose binding. No complex with (dA)45000 or oligo(dT)12-18 alone was detected by this procedure. Data are also presented which indicate that A1, in conjunction with PCNA, functions as a primer-recognition factor for pol-delta, increasing its ability to utilize low levels of primer ends, but it does not increase the size of the DNA products. A1 also markedly reduced the amount of PCNA required for pol-delta activity on a multiply primed DNA suggesting that PCNA interacts with A1 at the primer end. The multiple effects of A1 closely resemble the properties of the multisubunit protein RF-C described by Tsurimoto and Stillman (Tsurimoto, T., and Stillman, B. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1023-1027).			LEE, SH (corresponding author), SLOAN KETTERING MEM CANC CTR,GRAD PROGRAM MOLEC BIOL,NEW YORK,NY 10021, USA.				NIGMS NIH HHS [GM 34559] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034559, R37GM034559] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DEAN FB, 1989, UCLA S MOL CELLULAR, P315; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; JARVIS TC, 1989, UCLA S MOL CELLULAR, P261; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; LEE SH, 1988, P NATL ACAD SCI USA, V85, P9469, DOI 10.1073/pnas.85.24.9469; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1989, P NATL ACAD SCI USA, V86, P4877, DOI 10.1073/pnas.86.13.4877; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643	33	223	225	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					594	602						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1670772				2022-12-25	WOS:A1991EQ33900086
J	GAROTTA, G; OZMEN, L; FOUNTOULAKIS, M; DEMBIC, Z; VANLOON, APGM; STUBER, D				GAROTTA, G; OZMEN, L; FOUNTOULAKIS, M; DEMBIC, Z; VANLOON, APGM; STUBER, D			HUMAN INTERFERON-GAMMA RECEPTOR - MAPPING OF EPITOPES RECOGNIZED BY NEUTRALIZING ANTIBODIES USING NATIVE AND RECOMBINANT RECEPTOR PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											GAROTTA, G (corresponding author), F HOFFMANN LA ROCHE & CO LTD,CENT RES UNITS,CH-4002 BASEL,SWITZERLAND.		Dembic, Zlatko/A-1833-2008	Dembic, Zlatko/0000-0002-9970-6497				AGUET M, 1987, J EXP MED, V165, P988, DOI 10.1084/jem.165.4.988; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; BILLIAU A, 1988, IMMUNOL TODAY, V9, P37, DOI 10.1016/0167-5699(88)91256-X; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; CALDERON J, 1988, P NATL ACAD SCI USA, V85, P4837, DOI 10.1073/pnas.85.13.4837; CAMPBELL IL, 1988, J IMMUNOL, V140, P1111; CEPPELLINI R, 1981, TISSUE ANTIGENS, V17, P28; CERTA U, 1986, EMBO J, V5, P3051, DOI 10.1002/j.1460-2075.1986.tb04605.x; CHANG ACY, 1978, NATURE, V275, P617, DOI 10.1038/275617a0; DEMAEYER E, 1988, INTERFERONS OTHER RE, P288; DIDLAKE RH, 1988, TRANSPLANTATION, V45, P222; DOBELI H, 1988, J BIOTECHNOL, V7, P199, DOI 10.1016/0168-1656(88)90052-1; DUSTIN ML, 1988, IMMUNOL TODAY, V9, P213, DOI 10.1016/0167-5699(88)91216-9; Familletti P C, 1981, Methods Enzymol, V78, P387; FOUNTOULAKIS M, 1989, J IMMUNOL, V143, P3266; Gallati H, 1987, J Biol Regul Homeost Agents, V1, P109; GAROTTA G, 1989, CHIMICA OGGI, V7, P41; GIOVARELLI M, 1988, J IMMUNOL, V141, P2831; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HERSHEY GKK, 1989, J BIOL CHEM, V264, P11981; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; JACOB CO, 1987, J EXP MED, V166, P798, DOI 10.1084/jem.166.3.798; KNOP J, 1987, J IMMUNOL, V138, P3684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDOLFO S, 1988, EUR J IMMUNOL, V18, P503, DOI 10.1002/eji.1830180403; LANDOLFO S, 1985, SCIENCE, V229, P176, DOI 10.1126/science.3160110; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; LEIBSON HJ, 1984, NATURE, V309, P799, DOI 10.1038/309799a0; LITTMAN SJ, 1985, J BIOL CHEM, V260, P1191; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Maniatis T., 1982, MOL CLONING; MARCOLI R, 1980, FEBS LETT, V110, P11, DOI 10.1016/0014-5793(80)80011-1; MASTERS JN, 1983, GENE, V21, P59, DOI 10.1016/0378-1119(83)90147-6; Miggiano V., 1982, RES DISCL, V217, P155; NOVICK D, 1987, J BIOL CHEM, V262, P8483; RASHIDBAIGI A, 1988, J INTERFERON RES, V8, P641, DOI 10.1089/jir.1988.8.641; RAYMOND CA, 1986, JAMA-J AM MED ASSOC, V256, P685, DOI 10.1001/jama.256.6.685; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULTZ RM, 1983, NATURE, V305, P239, DOI 10.1038/305239a0; SCHWARZ E, 1987, NATURE, V272, P410; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; SUTCLIFFE JG, 1979, COLD SPRING HARB SYM, V43, P77, DOI 10.1101/SQB.1979.043.01.013; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; TALMADGE KW, 1986, EUR J IMMUNOL, V16, P1471, DOI 10.1002/eji.1830161202; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; VILCEK J, 1985, LYMPHOKINES, V11, P1; VOGEL SN, 1983, J INTERFERON RES, V3, P153, DOI 10.1089/jir.1983.3.153	50	82	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6908	6915						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691178				2022-12-25	WOS:A1990CZ67700064
J	AJIRO, K; SHIBATA, K; NISHIKAWA, Y				AJIRO, K; SHIBATA, K; NISHIKAWA, Y			SUBTYPE-SPECIFIC CYCLIC AMP-DEPENDENT HISTONE-H1 PHOSPHORYLATION AT THE DIFFERENTIATION OF MOUSE NEUROBLASTOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NAGOYA CITY UNIV,DEPT PHARMACEUT SCI,NAGOYA 464,JAPAN	Nagoya City University	AJIRO, K (corresponding author), AICHI CANC CTR,CELL BIOL LAB,NAGOYA,AICHI 464,JAPAN.							ADLAKHA RC, 1982, J CELL SCI, V54, P193; ADLER AJ, 1971, BIOCHEMISTRY-US, V10, P909; ADLER AJ, 1972, ARCH BIOCHEM BIOPHYS, V153, P769, DOI 10.1016/0003-9861(72)90397-9; AJIRO K, 1985, J BIOL CHEM, V260, P5379; AJIRO K, 1983, J BIOL CHEM, V258, P4534; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1445, DOI 10.1021/bi00509a007; AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1454, DOI 10.1021/bi00509a008; ALLAN J, 1980, P NATL ACAD SCI-BIOL, V77, P885, DOI 10.1073/pnas.77.2.885; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BONDY SC, 1974, SCIENCE, V186, P359, DOI 10.1126/science.186.4161.359; BRADBURY EM, 1974, NATURE, V247, P257, DOI 10.1038/247257a0; COLE RD, 1984, ANAL BIOCHEM, V136, P24, DOI 10.1016/0003-2697(84)90303-8; COLE RD, 1977, MOL BIOL MAMMALIAN G, V1, P93; COMPTON JL, 1976, P NATL ACAD SCI USA, V73, P4382, DOI 10.1073/pnas.73.12.4382; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; FELSENFELD G, 1978, NATURE, V271, P115, DOI 10.1038/271115a0; FURMANSKI P, 1971, NATURE, V233, P413, DOI 10.1038/233413a0; GAZITT Y, 1978, CANCER RES, V38, P3779; GURLEY LR, 1973, BIOCHEM BIOPH RES CO, V50, P744, DOI 10.1016/0006-291X(73)91307-7; GURLEY LR, 1983, ANAL BIOCHEM, V131, P465, DOI 10.1016/0003-2697(83)90200-2; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HASHIMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6637, DOI 10.1073/pnas.81.21.6637; HUANG HC, 1984, J BIOL CHEM, V259, P4237; Johnson E M, 1977, Adv Cyclic Nucleotide Res, V8, P267; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUETTEL MR, 1985, J CELL BIOL, V101, P965, DOI 10.1083/jcb.101.3.965; KUROKAWA M, 1985, ANAL BIOCHEM, V144, P47, DOI 10.1016/0003-2697(85)90082-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKE RS, 1972, BIOCHEMISTRY-US, V11, P4817, DOI 10.1021/bi00775a027; LANGAN TA, 1971, ANN NY ACAD SCI, V185, P166; LANGAN TA, 1969, P NATL ACAD SCI USA, V64, P1276, DOI 10.1073/pnas.64.4.1276; LANGAN TA, 1971, J BIOL CHEM, V246, P1942; LANGAN TA, 1968, SCIENCE, V162, P579, DOI 10.1126/science.162.3853.579; LANGAN TA, 1975, CHROMOSOMAL PROTEINS, P113; LAZO JS, 1976, EXP CELL RES, V100, P41, DOI 10.1016/0014-4827(76)90324-4; LEITMAN DC, 1986, J CELL PHYSIOL, V127, P237, DOI 10.1002/jcp.1041270208; LENNOX RW, 1983, J BIOL CHEM, V258, P262; LENNOX RW, 1988, BIOCHEM CELL BIOL, V66, P636, DOI 10.1139/o88-073; MARKS PA, 1987, CANCER RES, V47, P659; OHBA Y, 1984, J BIOL CHEM, V259, P2942; OHE Y, 1989, J BIOCHEM-TOKYO, V106, P844, DOI 10.1093/oxfordjournals.jbchem.a122941; PEHRSON J, 1980, NATURE, V285, P43, DOI 10.1038/285043a0; PEHRSON JR, 1982, BIOCHEMISTRY-US, V21, P456, DOI 10.1021/bi00532a006; PRASAD KN, 1971, NATURE-NEW BIOL, V233, P141, DOI 10.1038/newbio233141a0; PRASAD KN, 1972, EXP CELL RES, V73, P436, DOI 10.1016/0014-4827(72)90069-9; SIKORSKA M, 1988, J BIOL CHEM, V263, P3005; TAKEDA M, 1973, J BIOCHEM-TOKYO, V73, P621, DOI 10.1093/oxfordjournals.jbchem.a130120; TAYLOR SS, 1982, J BIOL CHEM, V257, P6056; WICKS WD, 1975, J CYCLIC NUCL PROT, V1, P49	49	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6494	6500						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690730				2022-12-25	WOS:A1990CY58700091
J	MAJESKY, MW; DAEMEN, MJAP; SCHWARTZ, SM				MAJESKY, MW; DAEMEN, MJAP; SCHWARTZ, SM			ALPHA-1-ADRENERGIC STIMULATION OF PLATELET-DERIVED GROWTH FACTOR-A-CHAIN GENE-EXPRESSION IN RAT AORTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									STATE UNIV LIMBURG,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University	MAJESKY, MW (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SJ-60,SEATTLE,WA 98195, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026405, R01HL026405, T32HL007312] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-03174, HL-07312, HL-26405] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKA T, 1986, MOL CELL BIOL, V6, P2984, DOI 10.1128/MCB.6.8.2984; BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BERK BC, 1986, SCIENCE, V232, P87, DOI 10.1126/science.3485309; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Bevan J A, 1981, HDB PHYSL          2, VII, P515; BEVAN RD, 1981, CIRC RES, V49, P478, DOI 10.1161/01.RES.49.2.478; BEVAN RD, 1975, CIRC RES, V37, P14, DOI 10.1161/01.RES.37.1.14; BEVAN RD, 1979, BLOOD VESSELS, V16, P109; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; BLAES N, 1983, J CELL PHYSIOL, V116, P167, DOI 10.1002/jcp.1041160207; CAMPBELLBOSWELL M, 1981, EXP MOL PATHOL, V35, P265, DOI 10.1016/0014-4800(81)90066-6; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLOWES AW, 1988, J CELL BIOL, V107, P1939, DOI 10.1083/jcb.107.5.1939; COCHRAN BH, 1981, J CELL PHYSIOL, V109, P429, DOI 10.1002/jcp.1041090308; CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DEGEN JL, 1983, J BIOL CHEM, V258, P2153; EXTON JH, 1985, AM J PHYSIOL, V248, pE633, DOI 10.1152/ajpendo.1985.248.6.E633; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; GARCIASAINZ JA, 1985, P NATL ACAD SCI USA, V82, P6727, DOI 10.1073/pnas.82.20.6727; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIBALDI M, 1982, DRUGS PHARM SCI, P27; GUTMANN E, 1976, ANNU REV PHYSIOL, V38, P177, DOI 10.1146/annurev.ph.38.030176.001141; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART MN, 1980, HYPERTENSION, V2, P419, DOI 10.1161/01.HYP.2.4.419; HOUCK KA, 1988, J CELL PHYSIOL, V135, P551, DOI 10.1002/jcp.1041350327; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KAZLAUSKAS A, 1988, EMBO J, V7, P3727, DOI 10.1002/j.1460-2075.1988.tb03256.x; KEETON TK, 1988, N-S ARCH PHARMACOL, V338, P350; KLEINJANS JCS, 1983, CLIN SCI, V65, P111, DOI 10.1042/cs0650111; LEE HR, 1988, J BIOL CHEM, V263, P7352; LEE RMKW, 1987, HYPERTENSION, V10, P328, DOI 10.1161/01.HYP.10.3.328; LIBBY P, 1988, NEW ENGL J MED, V318, P1493, DOI 10.1056/NEJM198806093182303; MAJESKY MW, 1987, CIRC RES, V61, P296, DOI 10.1161/01.RES.61.2.296; MAJESKY MW, 1985, P NATL ACAD SCI USA, V82, P3450, DOI 10.1073/pnas.82.10.3450; MAJESKY MW, 1988, P NATL ACAD SCI USA, V85, P1524, DOI 10.1073/pnas.85.5.1524; MAJESKY MW, 1988, 8TH P INT S ATH, P564; MCCONLOGUE L, 1984, P NATL ACAD SCI-BIOL, V81, P540, DOI 10.1073/pnas.81.2.540; MEIDELL RS, 1986, AM J PHYSIOL, V251, P1076; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; NAKADA T, 1978, EUR J PHARMACOL, V48, P87, DOI 10.1016/0014-2999(78)90046-8; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; NILSSON J, 1985, P NATL ACAD SCI USA, V82, P4418, DOI 10.1073/pnas.82.13.4418; NISTER M, 1988, CELL, V52, P791, DOI 10.1016/0092-8674(88)90421-7; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RATNER L, 1985, NUCLEIC ACIDS RES, V13, P5007, DOI 10.1093/nar/13.14.5007; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SEIFERT RA, 1984, NATURE, V311, P669, DOI 10.1038/311669a0; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; SHERLINE P, 1984, J CLIN INVEST, V74, P483, DOI 10.1172/JCI111445; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SJOLUND M, 1988, J CELL BIOL, V106, P403, DOI 10.1083/jcb.106.2.403; STARKSEN NF, 1987, J BIOL CHEM, V262, P14381; STARKSEN NF, 1986, P NATL ACAD SCI USA, V83, P8348, DOI 10.1073/pnas.83.21.8348; STIMAC E, 1987, J CELL PHYSIOL, V133, P590, DOI 10.1002/jcp.1041330323; TERRACIO L, 1988, J CELL BIOL, V107, P1947, DOI 10.1083/jcb.107.5.1947; THADANI PV, 1979, LIFE SCI, V25, P1009, DOI 10.1016/0024-3205(79)90585-X; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WALKER LN, 1986, P NATL ACAD SCI USA, V83, P7311, DOI 10.1073/pnas.83.19.7311; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; YAMORI Y, 1976, EUR J PHARMACOL, V38, P349, DOI 10.1016/0014-2999(76)90339-3; YANAGISAWA M, 1988, P NATL ACAD SCI USA, V85, P6964, DOI 10.1073/pnas.85.18.6964	66	101	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1082	1088						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688551				2022-12-25	WOS:A1990CH53300070
J	SEN, I; SAMANTA, H; LIVINGSTON, W; SEN, GC				SEN, I; SAMANTA, H; LIVINGSTON, W; SEN, GC			ESTABLISHMENT OF TRANSFECTED CELL-LINES PRODUCING TESTICULAR ANGIOTENSIN-CONVERTING ENZYME - STRUCTURAL RELATIONSHIP BETWEEN ITS SECRETED AND CELLULAR-FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; MESSENGER-RNAS; RABBIT; ASSAY; EXPRESSION; ISOENZYMES; ISOZYME	Angiotensin-converting enzyme (ACE) is present in endothelial and epithelial cells of various tissues as well as in the circulating plasma. The structural relationship between the cellular and the secreted forms of ACE and the pathways to their biosynthesis have not been determined as yet mainly because of the unavailability of a natural cell line expressing ACE in tissue culture. To circumvent this problem we have permanently transfected a mouse epithelial line with an expression vector containing the recently cloned rabbit testicular ACE cDNA. Clonal derivatives of this line secreted large quantities of enzymatically active ACE. When these cells were cultured in serum-free medium, the only detectable protein in the culture medium was ACE. It has been suggested that a hydrophobic domain near the carboxyl terminus of the enzyme anchors it to the plasma membrane. To test this hypothesis we established cell lines expressing a truncated form of the active enzyme which is missing the putative anchoring domain. Pulse-chase experiments showed that the truncated ACE was secreted from the cells much faster than the native enzyme. Moreover, the secreted form of the native enzyme had a lower molecular weight than the corresponding cellular form. These results are consistent with the hypothesis that the hydrophobic domain is instrumental in keeping the enzyme cell-bound, and secretion is achieved physiologically by removal of this domain from the enzyme by a specific proteolytic cleavage.	CLEVELAND CLIN FDN,DEPT MOLEC BIOL,CLEVELAND,OH 44195; EUGENE TECH,ALLENDALE,NJ 07401	Cleveland Clinic Foundation	SEN, I (corresponding author), CLEVELAND CLIN FDN,DEPT HEART & HYPERTENS,FFB-29,9500 EUCLID AVE,CLEVELAND,OH 44195, USA.				NHLBI NIH HHS [HL-35667] Funding Source: Medline; NICHD NIH HHS [HD-22526] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022526] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035667] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERG T, 1986, J HISTOCHEM CYTOCHEM, V34, P753, DOI 10.1177/34.6.3009604; BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945; CHESTERMAN CN, 1983, J CELL PHYSIOL, V116, P45, DOI 10.1002/jcp.1041160108; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; ELDORRY HA, 1982, P NATL ACAD SCI-BIOL, V79, P4295, DOI 10.1073/pnas.79.14.4295; ELDORRY HA, 1982, J BIOL CHEM, V257, P4128; ERDOS EG, 1978, BIOCHEM PHARMACOL, V27, P843, DOI 10.1016/0006-2952(78)90542-7; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; KUMAR RS, 1989, J BIOL CHEM, V264, P16754; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Patchett A A, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P1; ROSEN EM, 1985, J CELL PHYSIOL, V122, P30, DOI 10.1002/jcp.1041220106; ROY SN, 1988, BIOCHEM BIOPH RES CO, V155, P678, DOI 10.1016/S0006-291X(88)80548-5; Safer R. L., 1981, BIOCH REGULATION BLO, P123; SAMANTA H, 1989, VACCINE, V7, P69, DOI 10.1016/0264-410X(89)90013-3; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1991, J BIOL CHEM, V266, P5540; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6	23	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21985	21990						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657984				2022-12-25	WOS:A1991GP80400099
J	RENSDOMIANO, S; REISINE, T				RENSDOMIANO, S; REISINE, T			STRUCTURAL-ANALYSIS AND FUNCTIONAL-ROLE OF THE CARBOHYDRATE COMPONENT OF SOMATOSTATIN RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHEAT-GERM-AGGLUTININ; RAT CEREBROCORTICAL MEMBRANES; RICINUS-COMMUNIS AGGLUTININ; N-LINKED OLIGOSACCHARIDES; PANCREATIC TYPE RECEPTORS; SIALIC-ACID; GLYCOPROTEIN NATURE; BETA-CELL; NEOCORTICAL NEURONS; ADENYLATE-CYCLASE	SRIF receptors are membrane-bound glycoproteins. To structurally identify the carbohydrate components of SRIF receptors, solubilized rat brain SRIF receptors were subjected to lectin affinity chromatography. Solubilized SRIF receptors specifically bound to wheat germ agglutinin-lectin affinity columns but not to succinylated wheat germ agglutinin. This finding, as well as the ability of the solubilized receptor to interact with a Sambucus nigra L. lectin affinity column suggested that sialic acid residues are associated with SRIF receptors. The inability of the receptor to bind to concanavalin A, Dolichus biflorus agglutinin, Ulex europeaus I, and Jacalin lectin affinity columns suggests that high mannose, N-acetylgalactosamine, fucose, and O-linked carbohydrates are not associated with receptor. To investigate the functional role of the carbohydrate groups in brain SRIF receptors, specific sugars were selectively cleaved from SRIF receptors and the subsequent effect on the specific high affinity binding of the agonist [I-125]MK 678 to SRIF receptors was determined. Treatment of the receptor with endoglycosidase D did not affect the specific binding of [I-125]MK 678 to the solubilized SRIF receptors, consistent with the finding from lectin affinity chromatography that high mannose-type carbohydrate structures were not associated with SRIF receptors. Treatment of solubilized SRIF receptors with peptide-N-glycosidase F and endoglycosidases H and F reduced [I-125]MK 678 binding to SRIF receptors indicating that either hybrid, or a combination of hybrid and complex N-linked carbohydrate structures, have a role in maintaining the receptor in a high affinity state for agonists. Treatment of solubilized SRIF receptors with neuraminidase from Vibrio cholera abolished high affinity agonist binding to the receptors, whereas treatment of the receptor with neuraminidase from Newcastle disease virus did not affect [I-125]MK 678 binding to the receptor. These findings suggest that sialic acid residues in an alpha-2,6-configuration have a role in maintaining the SRIF receptor in a high affinity conformation for agonists. This is further indicated by studies on SRIF receptors in the pituitary tumor cell line, AtT-20. Treatment of AtT-20 cells in culture with neuraminidase (V. cholera) greatly reduces high affinity [I-125]MK 678 binding sites, but did not alter the maximal ability of SRIF to inhibit forskolin-stimulated cAMP accumulation in intact AtT-20 cells. This finding suggests that the desialylated SRIF receptor is functionally active and remains coupled to GTP-binding proteins, but exhibits a reduced affinity for agonists. Treatment of AtT-20 cell membranes with neuraminidase from V. cholera was also able to greatly reduce the affinity of SRIF receptors for [I-125]MK 678. However, treatment of AtT-20 cell membranes with neuraminidase in the presence of MK 678 diminished the ability of the neuraminidase to affect [I-125]MK 678 binding to SRIF receptors. The protection afforded the agonist occupied SRIF receptors to the effects of neuraminidase treatment suggests that the sialic acid residues involved in maintaining the receptor in a high affinity state for agonist are closely associated with the ligand-binding site. The results of these studies demonstrate for the first time that sialic acid residues, as well as certain other carbohydrate components, maintain the SRIF receptor in a high affinity state for agonists and therefore may have an important physiological role in the functional activity of SRIF receptors.			RENSDOMIANO, S (corresponding author), UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104, USA.				NIMH NIH HHS [MH 45533] Funding Source: Medline; NINDS NIH HHS [NS 09002] Funding Source: Medline; PHS HHS [34781] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN AK, 1973, BIOCHEM J, V131, P155, DOI 10.1042/bj1310155; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P301; BARRINGTON WW, 1990, MOL PHARMACOL, V38, P177; BENOVIC JL, 1987, J RECEPTOR RES, V7, P257, DOI 10.3109/10799898709054989; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; BRAZEAU P, 1972, SCIENCE, V129, P77; BROWN M, 1976, ENDOCRINOLOGY, V98, P336, DOI 10.1210/endo-98-2-336; BROWN M, 1981, ENDOCRINOLOGY, V108, P2391, DOI 10.1210/endo-108-6-2391; CHESSELET MF, 1983, J NEUROSCI, V3, P232; COTRONEO P, 1988, EUR J BIOCHEM, V174, P219, DOI 10.1111/j.1432-1033.1988.tb14085.x; ELBATTARI A, 1987, BIOCHEM J, V242, P185, DOI 10.1042/bj2420185; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Goldstein I., 1986, LECTINS, DOI DOI 10.1016/B978-0-12-449945-4.50007-5; GOLDSTEIN IJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P53, DOI 10.1016/0005-2795(75)90313-X; GREEN ED, 1987, J BIOL CHEM, V262, P12030; GRIGORIADIS DE, 1989, ENDOCRINOLOGY, V125, P1877, DOI 10.1210/endo-125-4-1877; HE HT, 1989, P NATL ACAD SCI USA, V86, P1480, DOI 10.1073/pnas.86.5.1480; HE HT, 1990, MOL PHARMACOL, V37, P614; INOUE M, 1988, J PHYSIOL-LONDON, V407, P177, DOI 10.1113/jphysiol.1988.sp017409; JAKOBS KH, 1983, P NATL ACAD SCI-BIOL, V80, P3899, DOI 10.1073/pnas.80.13.3899; JAKOBS KH, 1983, NATURE, V303, P177, DOI 10.1038/303177a0; JARVIE KR, 1988, J BIOCHEM-TOKYO, V104, P791, DOI 10.1093/oxfordjournals.jbchem.a122551; JARVIE KR, 1988, MOL PHARMACOL, V34, P91; KLOTZ KN, 1986, BIOCHEM BIOPH RES CO, V140, P406, DOI 10.1016/0006-291X(86)91105-8; KNUHTSEN S, 1988, BIOCHEM J, V254, P641, DOI 10.1042/bj2540641; KNUHTSEN S, 1990, J BIOL CHEM, V265, P1129; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LEWIS LD, 1987, ENDOCRINOLOGY, V121, P486, DOI 10.1210/endo-121-2-486; MAHY N, 1988, J PHARMACOL EXP THER, V246, P779; MAHY N, 1988, J PHARMACOL EXP THER, V247, P390; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MANDARINO L, 1981, NATURE, V291, P76, DOI 10.1038/291076a0; MARIE JC, 1989, EUR J BIOCHEM, V186, P181, DOI 10.1111/j.1432-1033.1989.tb15193.x; MARTINIVERSON MT, 1986, PHARMACOL BIOCHEM BE, V24, P1707, DOI 10.1016/0091-3057(86)90509-5; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; PITTMAN QJ, 1981, BRAIN RES, V221, P402, DOI 10.1016/0006-8993(81)90791-5; PRESKY DH, 1988, J BIOL CHEM, V263, P714; RAUH JJ, 1986, J NEUROCHEM, V46, P23, DOI 10.1111/j.1471-4159.1986.tb12920.x; REISINE T, 1985, J PHARMACOL EXP THER, V229, P14; REYLDESMARS F, 1989, J BIOL CHEM, V264, P18789; SAKAMOTO C, 1988, J BIOL CHEM, V263, P14441; SAWUTZ DG, 1987, MOL PHARMACOL, V32, P565; SCHAUER R, 1982, SIALIC ACIDS CHEM ME, P1; SHIBUYA N, 1987, ARCH BIOCHEM BIOPHYS, V254, P1, DOI 10.1016/0003-9861(87)90074-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STILES GL, 1984, J BIOL CHEM, V259, P8655; SUSINI C, 1986, J BIOL CHEM, V261, P6738; TARENTINO AL, 1975, BIOCHEM BIOPH RES CO, V67, P455, DOI 10.1016/0006-291X(75)90337-X; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4655; THERMOS K, 1988, MOL PHARMACOL, V33, P370; THERMOS K, 1989, NEUROSCIENCE, V31, P131, DOI 10.1016/0306-4522(89)90035-3; THERMOS K, 1990, AM J PHYSIOL, V259, pE216, DOI 10.1152/ajpendo.1990.259.2.E216; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; VAYSSE N, 1981, ENDOCRINOLOGY, V108, P1843, DOI 10.1210/endo-108-5-1843; WANG HL, 1989, P NATL ACAD SCI USA, V86, P9616, DOI 10.1073/pnas.86.23.9616; WANG HL, 1990, MOL PHARMACOL, V38, P357; WARREN L, 1959, J BIOL CHEM, V234, P1971; YAMASHITA K, 1981, BIOCHEM BIOPH RES CO, V100, P226, DOI 10.1016/S0006-291X(81)80086-1; ZEGGARI M, 1987, EUR J BIOCHEM, V164, P667, DOI 10.1111/j.1432-1033.1987.tb11178.x	64	89	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20094	20102						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1682310				2022-12-25	WOS:A1991GM03900036
J	FERRACINI, R; LONGATI, P; NALDINI, L; VIGNA, E; COMOGLIO, PM				FERRACINI, R; LONGATI, P; NALDINI, L; VIGNA, E; COMOGLIO, PM			IDENTIFICATION OF THE MAJOR AUTOPHOSPHORYLATION SITE OF THE MET HEPATOCYTE GROWTH-FACTOR RECEPTOR TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; INSULIN-RECEPTOR; PROTEIN-KINASE; PHOSPHORYLATION SITES; SELF-PHOSPHORYLATION; MOLECULAR-CLONING; GENE-PRODUCT; EGF-RECEPTOR; CELL-LINE; SRC GENE	The MET proto-oncogene encodes a transmembrane tyrosine kinase receptor for HGF (pl90MET). In this work, pl90MET was immunoprecipitated, allowed to phosphorylate in the presence of [gamma-P-32]TP, and digested with trypsin. A major phosphopeptide was purified by reverse phase chromatography. The phosphorylated tyrosine was identified as residue 1235 (Tyr1235) by Edman covalent radiosequencing. A synthetic peptide derived from the corresponding MET sequence was phosphorylated by p190MET in an in vitro assay and coeluted in reverse phase chromatography. Tyr1235 lies within the tyrosine kinase domain of pl90MET, within a canonical tyrosine autophosphorylation site that shares homology with the corresponding region of the insulin, CSF-1 and platelet-derived growth factor receptors, and of p60src and p130gag-fps. The p190MET kinase is constitutively phosphorylated on tryosine in a gastric carcinoma cell line (GTL16), due to the amplification and overexpression of the MET gene. Metabolic labeling of GTL-16 cells with [P-32]orthophosphate followed by immunoprecipitation and tryptic phosphopeptide mapping of pl90MET showed that Tyr1235 is a major site of tyrosine phosphorylation in vivo as well. Since phosphorylation activates pl90MET kinase, we propose a regulatory role for Tyr1235.			FERRACINI, R (corresponding author), UNIV TURIN,SCH MED,DIPARTIMENTO SCI BIOMED & ONCOL,CORSO MASSIMO DAZEGLIO 52,I-10126 TURIN,ITALY.		Ferracini, Riccardo/AAL-4622-2020; Naldini, Luigi/E-9083-2012	NALDINI, Luigi/0000-0002-7835-527X; Vigna, Elisa/0000-0001-9787-5732; Comoglio, Paolo/0000-0002-7056-5328				ALLEN G, 1990, LABORATORY TECHNIQUE, P85; BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER JA, 1984, J BIOL CHEM, V259, P7835; CROSS FR, 1983, CELL, V34, P597, DOI 10.1016/0092-8674(83)90392-6; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FANTL WJ, 1989, MOL CELL BIOL, V9, P4473, DOI 10.1128/MCB.9.10.4473; FERGUSON B, 1985, J BIOL CHEM, V260, P3652; FERRACINI R, 1990, ONCOGENE RES, V5, P205; GANDINO L, 1991, J BIOL CHEM, V266, P16098; GANDINO L, 1990, ONCOGENE, V5, P721; GEALEN L, 1990, PEPTIDES PROTEIN PHO, P1; GIORDANO S, 1988, MOL CELL BIOL, V8, P3510, DOI 10.1128/MCB.8.8.3510; GIORDANO S, 1989, ONCOGENE, V4, P1383; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; HANAFUSA H, 1987, ONCOGENES GROWTH CON, P96; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3; HERRERA R, 1986, J BIOL CHEM, V261, P1980; HONEGGER A, 1988, EMBO J, V7, P3053, DOI 10.1002/j.1460-2075.1988.tb03170.x; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1982, J BIOL CHEM, V257, P4843; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; IBA H, 1984, P NATL ACAD SCI-BIOL, V81, P4424, DOI 10.1073/pnas.81.14.4424; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; MECKLINGHANSEN K, 1987, EMBO J, V6, P659, DOI 10.1002/j.1460-2075.1987.tb04805.x; MEYER HE, 1991, IN PRESS CHROMATOGRA; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, ONCOGENE, V11, P1793; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PATCHINSKY T, 1982, P NATL ACAD SCI USA, V79, P973; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; PONZETTO C, 1991, ONCOGENE, V6, P553; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; ROUSSEL MF, 1990, P NATL ACAD SCI USA, V87, P6738, DOI 10.1073/pnas.87.17.6738; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; TAPLEY P, 1990, MOL CELL BIOL, V10, P2528, DOI 10.1128/MCB.10.6.2528; TEMPEST PR, 1986, FEBS LETT, V209, P357, DOI 10.1016/0014-5793(86)81142-5; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TORNQVIST HE, 1988, J BIOL CHEM, V263, P4593; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERGEER P, 1990, MOL CELL BIOL, V10, P2991, DOI 10.1128/MCB.10.6.2991; VEILLETTE A, 1989, ONCOGENES; WEINMASTER G, 1984, CELL, V37, P559, DOI 10.1016/0092-8674(84)90386-6; WHITE MF, 1988, J BIOL CHEM, V263, P2969; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YU KT, 1984, J BIOL CHEM, V259, P5277; ZARNEGAR R, 1990, P NATL ACAD SCI USA, V87, P1252, DOI 10.1073/pnas.87.3.1252	66	135	144	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19558	19564						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655790				2022-12-25	WOS:A1991GK66700065
J	BALDARI, CT; MACCHIA, G; HEGUY, A; MELLI, M; TELFORD, JL				BALDARI, CT; MACCHIA, G; HEGUY, A; MELLI, M; TELFORD, JL			CYCLOSPORINE-A BLOCKS CALCIUM-DEPENDENT PATHWAYS OF GENE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; CHLORAMPHENICOL ACETYLTRANSFERASE GENE; PROTEIN KINASE-C; LYMPHOCYTES-T; SIGNAL TRANSDUCTION; INTERLEUKIN-2 GENE; ANTIGEN RECEPTOR; MAMMALIAN-CELLS; EXPRESSION; INDUCTION	We have used an interleukin-2 (IL-2) promoter-CAT fusion gene to study activation of IL-2 gene expression by IL-1, phytohemagglutinin (PHA), phorbol myristate acetate (PMA), and calcium ionophore in the murine thymoma line EL4 and the human lymphoma line Jurkat. The two cell lines respond differently to combinations of these stimuli. IL-1 in combination with sub-optimal concentration of PMA induced chloramphenicol acetyltransferase (CAT) activity in EL4. In Jurkat cells, IL-1 failed to synergize with PMA or PHA. Co-transfection with the IL-2/CAT gene and a construct capable of expressing murine T-cell type IL-1 receptors converted Jurkat cells to IL-1 responsiveness. IL-1 in combination with PHA but not with PMA resulted in induction of CAT activity in these cells. Induction of IL-2/CAT activity by all stimuli in both cell lines was blocked by the presence of EGTA in the culture medium. EGTA did not inhibit IL-1/PMA activation of an SV40 early promoter-CAT fusion gene in either EL4 or Jurkat cells; therefore, calcium was not required for IL-1 or PMA signal transduction. Jurkat cells were shown to differ from EL4 in their requirement for calcium mobilization. Two different calcium-dependent pathways of gene activation were distinguished, both of which were blocked by the immunosuppressive drug cyclosporin A.	SCLAVO RES CTR, VIA FIORENTINA 1, I-53100 SIENA, ITALY; UNIV SIENA, DEPT EVOLUT BIOL, I-53100 SIENA, ITALY	University of Siena			Telford, John Laird/ABG-8144-2020	Baldari, Cosima/0000-0002-4414-6744				ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BIRD P, 1987, J CELL BIOL, V105, P2905, DOI 10.1083/jcb.105.6.2905; BOREL JF, 1977, IMMUNOLOGY, V32, P1017; CASAGLI MC, 1989, PREP BIOCHEM, V19, P23, DOI 10.1080/10826068908544894; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DINARELLO CA, 1983, J IMMUNOL, V130, P890; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]; DONATI D, 1990, J IMMUNOL, V145, P4115; EASTMAN A, 1987, BIOTECHNIQUES, V5, P730; ELLIOTT JF, 1984, SCIENCE, V226, P1439, DOI 10.1126/science.6334364; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; ESPEL E, 1990, EMBO J, V9, P929, DOI 10.1002/j.1460-2075.1990.tb08191.x; FARRAR JJ, 1980, J IMMUNOL, V125, P2555; FARRAR WL, 1985, J IMMUNOL, V135, P1153; FUJITA T, 1986, CELL, V46, P401, DOI 10.1016/0092-8674(86)90660-4; GALLAGHER RB, 1990, IMMUNOL TODAY, V11, P187, DOI 10.1016/0167-5699(90)90078-N; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRUTERS RA, 1991, EUR J IMMUNOL, V21, P167, DOI 10.1002/eji.1830210125; HADDEN JW, 1988, IMMUNOL TODAY, V9, P235, DOI 10.1016/0167-5699(88)91222-4; HEGUY A, 1991, IN PRESS CELL GROWTH; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KRONKE M, 1984, P NATL ACAD SCI-BIOL, V81, P5214, DOI 10.1073/pnas.81.16.5214; LARSSON EL, 1980, NATURE, V283, P664, DOI 10.1038/283664a0; LICHTMAN AH, 1988, P NATL ACAD SCI USA, V85, P9699, DOI 10.1073/pnas.85.24.9699; LOWENTHAL JW, 1986, J IMMUNOL, V137, P1226; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCHIA G, 1990, MOL CELL BIOL, V10, P2731, DOI 10.1128/MCB.10.6.2731; MACCHIA G, 1990, PROGR CLIN BIOL RES, V349, P339; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OETTGEN HC, 1985, CELL, V40, P583, DOI 10.1016/0092-8674(85)90206-5; RANDAK C, 1990, EMBO J, V9, P2529, DOI 10.1002/j.1460-2075.1990.tb07433.x; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; ROSOFF PM, 1985, J BIOL CHEM, V260, P4053; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; SIMON PL, 1984, CELL IMMUNOL, V87, P720, DOI 10.1016/0008-8749(84)90042-X; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH KA, 1980, J EXP MED, V151, P1551, DOI 10.1084/jem.151.6.1551; STANTON TH, 1986, J BIOL CHEM, V261, P5699; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WILLIAMS TM, 1988, J IMMUNOL, V141, P662	49	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19103	19108						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655771				2022-12-25	WOS:A1991GJ47200106
J	SAVILAHTI, H; CALDENTEY, J; LUNDSTROM, K; SYVAOJA, JE; BAMFORD, DH				SAVILAHTI, H; CALDENTEY, J; LUNDSTROM, K; SYVAOJA, JE; BAMFORD, DH			OVEREXPRESSION, PURIFICATION, AND CHARACTERIZATION OF ESCHERICHIA-COLI BACTERIOPHAGE-PRD1 DNA-POLYMERASE - INVITRO SYNTHESIS OF FULL-LENGTH PRD1 DNA WITH PURIFIED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-CONTAINING BACTERIOPHAGE-PRD1; PHAGE PHI-29 DNA; TERMINAL PROTEIN; CHAIN-REACTION; EXONUCLEASE ACTIVITY; EARLY REGION; REPLICATION; EXPRESSION; INITIATION; SEQUENCES	The bacteriophage PRD1 DNA polymerase gene (gene I) has been cloned into the expression vector pPLH101 under the control of the lambda-p(L) promoter. Tailoring of an efficient ribosome binding site in front of the gene by polymerase chain reaction led to a high level heat-inducible expression of the corresponding gene product (P1) in Escherichia coli cells. Expression was confirmed in vivo by complementation of phage PRD1 DNA polymerase gene mutants and in vitro by formation of the genome terminal protein P8-dGMP replication initiation complex. Expressed PRD1 DNA polymerase was purified to apparent homogeneity in an active form. DNA polymerase, 3'-5'-exonuclease, and P8-dGMP replication initiation complex formation activities cosedimented in glycerol gradient with a protein of 65 kDa, the size expected for PRD1 DNA polymerase. The DNA polymerase was active on DNase I-activated calf thymus DNA, poly(dA).oligo(dT) and poly(dA-dT) primer/templates as well as on native phage PRD1 genome. The 3'-5'-exonuclease activity was specific for single-stranded DNA and released mononucleotides. No 5'-3'-exonuclease activity was detected. The inhibitor/activator spectrum of the PRD1 DNA polymerase was also studied. An in vitro replication system with purified components for bacteriophage PRD1 was established. Formation of the P8-dGMP replication initiation complex was a prerequisite for phage DNA replication, which proceeded from the initiation complex and yielded genome length replication products.	UNIV HELSINKI,DEPT GENET,ARKADIANKATU 7,SF-00100 HELSINKI 10,FINLAND; ORION CORP,MOLEC GENET LAB,SF-00380 HELSINKI,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	University of Helsinki; Orion Corporation; Finland National Institute for Health & Welfare; University of Oulu				Savilahti, Harri/0000-0002-6246-2572				BAMFORD D, 1983, J VIROL, V47, P311, DOI 10.1128/JVI.47.2.311-316.1983; BAMFORD DH, 1981, J GEN VIROL, V57, P365, DOI 10.1099/0022-1317-57-2-365; BAMFORD DH, 1984, J VIROL, V50, P309, DOI 10.1128/JVI.50.2.309-315.1984; BAMFORD JKH, 1991, VIROLOGY, V183, P658, DOI 10.1016/0042-6822(91)90995-N; BERNAD A, 1987, EMBO J, V6, P4219, DOI 10.1002/j.1460-2075.1987.tb02770.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1985, NUCLEIC ACIDS RES, V13, P1239, DOI 10.1093/nar/13.4.1239; BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1987, J VIROL, V61, P3983, DOI 10.1128/JVI.61.12.3983-3991.1987; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CALDENTEY J, 1990, J STRUCT BIOL, V104, P44, DOI 10.1016/1047-8477(90)90056-I; FIELD J, 1984, J BIOL CHEM, V259, P9487; HAY RT, 1984, J MOL BIOL, V175, P493, DOI 10.1016/0022-2836(84)90181-5; HORWITZ MS, 1986, FUNDAMENTAL VIROLOGY, P563; HSIEH JC, 1990, P NATL ACAD SCI USA, V87, P8665, DOI 10.1073/pnas.87.21.8665; HSIEH JC, 1987, NUCLEIC ACIDS RES, V15, P8999, DOI 10.1093/nar/15.21.8999; JUNG G, 1987, P NATL ACAD SCI USA, V84, P8287, DOI 10.1073/pnas.84.23.8287; Kelly T J, 1988, Adv Virus Res, V34, P1, DOI 10.1016/S0065-3527(08)60514-X; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECHNER RL, 1977, CELL, V12, P1007, DOI 10.1016/0092-8674(77)90165-9; LEEGWATER PAJ, 1988, BIOCHIM BIOPHYS ACTA, V951, P403, DOI 10.1016/0167-4781(88)90113-3; LILJESTROM P, 1988, J MOL BIOL, V201, P663, DOI 10.1016/0022-2836(88)90465-2; LIPPE R, 1989, J VIROL, V63, P5133; LYRA C, 1991, IN PRESS MOL GEN GEN; MACFERRIN KD, 1990, P NATL ACAD SCI USA, V87, P1937, DOI 10.1073/pnas.87.5.1937; Maniatis T., 1982, MOL CLONING; MCGRAW T, 1983, MOL GEN GENET, V190, P239; MINDICH L, 1976, J BACTERIOL, V126, P177, DOI 10.1128/JB.126.1.177-182.1976; MINDICH L, 1982, J VIROL, V44, P1013, DOI 10.1128/JVI.44.3.1013-1020.1982; MINDICH L, 1983, MOL GEN GENET, V190, P233, DOI 10.1007/BF00330645; MINDICH L, 1988, BACTERIOPHAGES, V2, P475; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; OLSEN RH, 1974, J VIROL, V14, P689, DOI 10.1128/JVI.14.3.689-699.1974; PAKULA TM, 1989, GENE, V85, P53, DOI 10.1016/0378-1119(89)90463-0; PANET J, 1973, BIOCHEMISTRY-US, V12, P5045; REMAUT E, 1983, GENE, V22, P103, DOI 10.1016/0378-1119(83)90069-0; SAKAGUCHI K, 1990, MICROBIOL REV, V54, P66, DOI 10.1128/MMBR.54.1.66-74.1990; SALAS M, 1988, CURR TOP MICROBIOL, V136, P71; SALAS M, 1988, BACTERIOPHAGES, V1, P169; SAMBROOK J, 1989, MOL CLON LABORATORY; SAVILAHTI H, 1986, GENE, V49, P199, DOI 10.1016/0378-1119(86)90280-5; SAVILAHTI H, 1987, GENE, V57, P121, DOI 10.1016/0378-1119(87)90183-1; SAVILAHTI H, 1989, GENE, V85, P45, DOI 10.1016/0378-1119(89)90462-9; SCHLABACH A, 1971, BIOCHEM BIOPH RES CO, V44, P879, DOI 10.1016/0006-291X(71)90793-5; STOW ND, 1982, NUCLEIC ACIDS RES, V10, P5105, DOI 10.1093/nar/10.17.5105; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P664; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAMANOI F, 1986, ADENOVIRUS DNA VIRAL, P97; VALLETTE F, 1989, NUCLEIC ACIDS RES, V17, P723, DOI 10.1093/nar/17.2.723; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOO SK, 1989, VIROLOGY, V170, P442, DOI 10.1016/0042-6822(89)90435-2	58	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18737	18744						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655759				2022-12-25	WOS:A1991GJ47200053
J	KAYASTHA, AM; SAWA, Y; NAGATA, S; MILES, EW				KAYASTHA, AM; SAWA, Y; NAGATA, S; MILES, EW			SITE-DIRECTED MUTAGENESIS OF THE BETA-SUBUNIT OF TRYPTOPHAN SYNTHASE FROM SALMONELLA-TYPHIMURIUM - ROLE OF ACTIVE-SITE GLUTAMIC ACID-350	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAVIOLET VISIBLE SPECTROSCOPY; SERINE O-SULFATE; ESCHERICHIA-COLI; ALPHA-SUBUNIT; PYRIDOXAL 5'-PHOSPHATE; CONFORMATIONAL-CHANGES; CIRCULAR-DICHROISM; CATALYTIC RESIDUE; SYNTHETASE; MECHANISM	To investigate the functional role of glutamic acid 350 in the active site of the beta-subunit of tryptophan synthase from Salmonella typhimurium, we have replaced this residue by glutamine or alanine by use of site-directed mutagenesis. The mutant-alpha-2-beta-2 complexes were expressed, purified, crystallized, and characterized by spectroscopic and kinetic studies with several substrates. We find large alterations in the substrate and reaction specificity of each mutant form of the alpha-2-beta-2 complex. Since the two mutant enzymes are virtually inactive in reactions with L-serine but are active in reactions with beta-chloro-L-alanine, glutamic acid 350 may facilitate the beta-elimination of the weak hydroxyl leaving group of L-serine. The mutant-alpha-2-beta-2 complexes are more active than the wild type enzyme in the beta-elimination reaction with beta-chloro-L-alanine. These enzymes are irreversibly inactivated by beta-chloro-L-alanine, whereas the wild type enzyme is not. These altered properties may result from a change in the conformation of the active site, from a change in the orientation of the coenzyme relative to active site residues, or from a change in the solvent accessibility of the active site. The alteration in the active site may enhance the release of amino acrylate from the Schiff base intermediate by hydrolysis or by transamination.	NIDDKD, BIOCHEM PHARMACOL LAB, BLDG 8, RM 2A-09, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Sawa, Yoshihiro/F-8295-2017	Sawa, Yoshihiro/0000-0002-2379-470X; Kayastha, Arvind M./0000-0002-5090-7159				BALK H, 1981, BIOCHEMISTRY-US, V20, P6391, DOI 10.1021/bi00525a017; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; BRZOVIC P, 1991, IN PRESS 8TH P INT S; COTTON RGH, 1972, J BIOL CHEM, V247, P1883; CRAWFORD IP, 1964, P NATL ACAD SCI USA, V51, P390, DOI 10.1073/pnas.51.3.390; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; DREWE WF, 1986, BIOCHEMISTRY-US, V25, P2494, DOI 10.1021/bi00357a032; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; DUNN MF, 1991, IN PRESS 8TH P INT S; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; HOUBEN KF, 1990, BIOCHEMISTRY-US, V29, P2421, DOI 10.1021/bi00461a028; HYDE CC, 1988, J BIOL CHEM, V263, P17857; KAWASAKI H, 1987, J BIOL CHEM, V262, P10678; KAYASTHA AM, 1991, IN PRESS 8TH P INT S; KAYASTHA AM, 1990, FASEB J, V4, pA2118; KIRSCHNER K, 1975, EUR J BIOCHEM, V60, P513, DOI 10.1111/j.1432-1033.1975.tb21030.x; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; KUMAGAI H, 1971, BIOCHEM BIOPH RES CO, V44, P1271, DOI 10.1016/S0006-291X(71)80223-1; LANE AN, 1981, EUR J BIOCHEM, V120, P379, DOI 10.1111/j.1432-1033.1981.tb05715.x; LANE AN, 1983, EUR J BIOCHEM, V129, P561; LANE AN, 1991, BIOCHEMISTRY-US, V30, P479, DOI 10.1021/bi00216a025; LANE AN, 1983, EUR J BIOCHEM, V129, P571; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; Miles E.W., 1986, PYRIDOXAL PHOSPHAT B, V1, P253; MILES EW, 1988, J BIOL CHEM, V263, P8611; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MILES EW, 1974, J BIOL CHEM, V249, P2852; MILES EW, 1978, J BIOL CHEM, V253, P6266; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1977, J BIOL CHEM, V252, P6594; MILES EW, 1968, BIOCHEMISTRY-US, V7, P2742, DOI 10.1021/bi00848a008; MILES EW, 1982, J BIOL CHEM, V257, P4203; MILES EW, 1991, IN PRESS 8TH P INT S; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; MOZZARELLI A, 1991, INT UNION B, V199, P273; NAGATA S, 1989, J BIOL CHEM, V264, P6288; SCHINZEL R, 1990, BIOCHEMISTRY-US, V29, P9956, DOI 10.1021/bi00494a028; TORCHINSKY YM, 1986, PYRIDOXAL PHOSPHATE, P170; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; WADA H, 1962, J BIOL CHEM, V237, P127; Yanofsky C., 1972, ENZYMES, P1, DOI [10.1016/s1874-6047(08)60445-x, DOI 10.1016/S1874-6047(08)60445-X]; YORK SS, 1972, BIOCHEMISTRY-US, V11, P2733, DOI 10.1021/bi00764a029; ZAKOMIRDINA LN, 1989, BIOCHIMIE, V71, P545, DOI 10.1016/0300-9084(89)90185-5	47	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7618	7625						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1673461				2022-12-25	WOS:A1991FJ34200048
J	CONAWAY, RC; CONAWAY, JW				CONAWAY, RC; CONAWAY, JW			TRANSCRIPTION INITIATED BY RNA POLYMERASE-II AND PURIFIED TRANSCRIPTION FACTORS FROM LIVER - TRANSCRIPTION FACTOR-ALPHA, FACTOR-BETA-GAMMA, AND FACTOR-DELTA PROMOTE FORMATION OF INTERMEDIATES IN ASSEMBLY OF THE FUNCTIONAL PREINITIATION COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,DEPT CHEM,AUSTIN,TX 78712; UNIV TEXAS,CLAYTON FDN BIOCHEM INST,AUSTIN,TX 78712	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin				Conaway, Joan/0000-0002-2786-0663	NIGMS NIH HHS [GM41628] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURTON ZF, 1986, EMBO J, V5, P2923, DOI 10.1002/j.1460-2075.1986.tb04588.x; CARTHEW RW, 1988, J BIOL CHEM, V263, P17128; CHAMBERLIN MJ, 1976, RNA POLYM, P7; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, J BIOL CHEM, V265, P7552; CONAWAY JW, 1987, J BIOL CHEM, V262, P8293; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; EGLY JM, 1984, EMBO J, V3, P2363, DOI 10.1002/j.1460-2075.1984.tb02141.x; FIRE A, 1984, J BIOL CHEM, V259, P2509; FLORES O, 1988, J BIOL CHEM, V263, P10812; KADESCH TR, 1982, J MOL BIOL, V155, P1, DOI 10.1016/0022-2836(82)90489-2; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; PRICE DH, 1987, J BIOL CHEM, V262, P3244; RAPPAPORT J, 1987, J BIOL CHEM, V262, P17510; REINBERG D, 1987, J BIOL CHEM, V262, P3310; REINBERG D, 1987, J BIOL CHEM, V262, P3322; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SAMUELS M, 1982, J BIOL CHEM, V257, P4419; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; TOLUNAY HE, 1984, MOL CELL BIOL, V4, P17, DOI 10.1128/MCB.4.1.17; TSAI SY, 1981, J BIOL CHEM, V256, P3055; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	36	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7559	7563						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692022				2022-12-25	WOS:A1990DB30700071
J	YONEDA, M; SUZUKI, S; KIMATA, K				YONEDA, M; SUZUKI, S; KIMATA, K			HYALURONIC-ACID ASSOCIATED WITH THE SURFACES OF CULTURED FIBROBLASTS IS LINKED TO A SERUM-DERIVED 85-KDA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN	Aichi Medical University								BALAZS EA, 1965, AMINO SUGARS       A, V2, P401; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Chaplin M.F., 1986, MASS SPECTROM, P1; COSTER L, 1979, BIOCHEM J, V183, P669; DELPECH B, 1985, ANAL BIOCHEM, V149, P555, DOI 10.1016/0003-2697(85)90613-X; DELPECH B, 1981, J NEUROCHEM, V38, P978; ELDER JH, 1977, J BIOL CHEM, V252, P6510; FORRESTER JV, 1981, J CELL SCI, V48, P315; GREEN SJ, 1988, J CELL PHYSIOL, V134, P376, DOI 10.1002/jcp.1041340308; HABUCHI H, 1986, J BIOL CHEM, V261, P1031; HAKANSSON L, 1985, J IMMUNOL, V135, P2735; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; Hascall V.C., 1981, CELL BIOL EXTRACELLU, P39; HEINEGARD D, 1974, J BIOL CHEM, V249, P4250; INOUE Y, 1982, CARBOHYD RES, V111, P113, DOI 10.1016/0008-6215(82)85012-X; ITO K, 1982, J BIOL CHEM, V257, P917; JOHNSTONE A, 1982, IMMUNOCHEMISTRY PRAC, P43; KIMATA K, 1983, CANCER RES, V43, P1347; KIMATA K, 1974, J BIOL CHEM, V249, P1646; KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4; LACY BE, 1987, J CELL BIOL, V105, P1395, DOI 10.1083/jcb.105.3.1395; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT UBG, 1981, BIOCHEM INT, V2, P195; LEBOEUF RD, 1986, J BIOL CHEM, V261, P2586; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASON RM, 1982, BIOCHEM J, V207, P445, DOI 10.1042/bj2070445; MIAN N, 1986, BIOCHEM J, V237, P343, DOI 10.1042/bj2370343; MIKUNITAKAGAKI Y, 1981, J BIOL CHEM, V256, P8463; OEGEMA TR, 1977, J BIOL CHEM, V252, P6470; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; ROSENBERG L, 1975, J BIOL CHEM, V250, P1877; ROUGHLEY PJ, 1985, BIOCHEM J, V231, P129, DOI 10.1042/bj2310129; SMEDSROD B, 1984, BIOCHEM J, V223, P617, DOI 10.1042/bj2230617; SUNDBLAD L, 1965, AMINO SUGARS       A, V2, P229; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TARONE G, 1984, J CELL BIOL, V99, P512, DOI 10.1083/jcb.99.2.512; TENGBLAD A, 1986, BIOCHEM J, V236, P521, DOI 10.1042/bj2360521; Toole BP, 1976, NEURONAL RECOGNITION, P275; TOOLE BP, 1984, ROLE EXTRACELLULAR M, P43; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSIGANOS CP, 1986, BIOCHEM J, V235, P117, DOI 10.1042/bj2350117; TURLEY EA, 1982, BIOCHEM BIOPH RES CO, V108, P1016, DOI 10.1016/0006-291X(82)92101-5; TURLEY EA, 1987, BIOCHEMISTRY-US, V26, P2997, DOI 10.1021/bi00385a007; UNDERHILL C, 1978, EXP CELL RES, V117, P155, DOI 10.1016/0014-4827(78)90438-X; UNDERHILL CB, 1982, BIOCHEM BIOPH RES CO, V108, P1488, DOI 10.1016/S0006-291X(82)80075-2; UNDERHILL CB, 1985, J BIOL CHEM, V260, P8128; URBANOWSKI JC, 1982, J BIOL CHEM, V257, P111; WIELAND OH, 1983, MOL CELL ENDOCRINOL, V29, P125, DOI 10.1016/0303-7207(83)90207-1; YONEDA M, 1988, J CELL SCI, V90, P265; YONEDA M, 1988, J CELL SCI, V90, P275	51	99	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5247	5257						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690737				2022-12-25	WOS:A1990CV58700079
J	FALCONE, DJ; MCCAFFREY, TA; VERGILIO, JA				FALCONE, DJ; MCCAFFREY, TA; VERGILIO, JA			STIMULATION OF MACROPHAGE UROKINASE EXPRESSION BY POLYANIONS IS PROTEIN KINASE-C-DEPENDENT AND REQUIRES PROTEIN AND RNA-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR; MOLECULAR MASS UROKINASE; PERITONEAL-MACROPHAGES; ENDOTHELIAL-CELLS; HEPARIN; RECEPTOR; AURANOFIN; SECRETION; BINDING	Highly charged polyanionic ligands of the scavenger receptor trigger macrophage secretion of urokinase-type plasminogen activator (uPA). In experiments reported here, we have investigated the intracellular and extracellular regulation of polyanion-induced macrophage plasminogen activation. Exposure of a macrophage cell line (RAW264.7) to either fucoidan or phorbol myristate acetate (PMA) stimulates the secretion of uPA, whereas calcium ionophore or dibutyryl cyclic AMP had no effect. Moreover, preincubation of macrophages with inhibitors of protein kinase C reduced (50-60%) the ability of both fucoidan and PMA to trigger the secretion of uPA, whereas aspirin and eicosatetraenoic acid had no effect. Both PMA and fucoidan treatment of RAW264.7 cells resulted in a rapid and transient increase in the steady state levels of uPA mRNA. However, in marked contrast to that observed with PMA, fucoidan-induced expression of RAW264.7 uPA activity was partially insensitive to cycloheximide and actinomycin D. In addition, fucoidan-induced uPA activity was detected in conditioned media in as little as 15 min, whereas PMA-induced uPA activity did not increase until 2 h. In addition to stimulating macrophage secretion of uPA, fucoidan bound uPA and had a small stimulatory affect on uPA activity. The binding does not interfere with the catalytic site on the B chain, or require the receptor binding or kringle domains on the A chain.	CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,DEPT CELL BIOL & ANAT,NEW YORK,NY 10021	Cornell University; Cornell University	FALCONE, DJ (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT PATHOL C440,NEW YORK,NY 10021, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035724, R01HL040819, P01HL046403] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-40819, HL-35724, HL-46403] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDRADEGORDON P, 1986, BIOCHEMISTRY-US, V25, P4033, DOI 10.1021/bi00362a007; APPELLA E, 1987, J BIOL CHEM, V262, P4437; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; CHAPMAN HA, 1985, BIOCHEM J, V230, P109, DOI 10.1042/bj2300109; DEGEN JL, 1985, J BIOL CHEM, V260, P2426; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P8270, DOI 10.1021/bi00399a038; FALCONE DJ, 1988, J CELL PHYSIOL, V135, P387, DOI 10.1002/jcp.1041350305; FALCONE DJ, 1988, ARTERIOSCLEROSIS, V8, P263, DOI 10.1161/01.ATV.8.3.263; FALCONE DJ, 1989, J CELL PHYSIOL, V140, P219, DOI 10.1002/jcp.1041400205; FEARS R, 1988, BIOCHEM J, V249, P77, DOI 10.1042/bj2490077; FROLIK CA, 1984, J BIOL CHEM, V259, P995; FROSCIO M, 1989, BIOCHEM PHARMACOL, V38, P2087, DOI 10.1016/0006-2952(89)90061-0; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; GILFILLAN AM, 1990, AGENTS ACTIONS, V30, P223; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; GRISWOLD DE, 1985, J RHEUMATOL, V12, P490; GUNZLER WA, 1982, H-S Z PHYSIOL CHEM, V363, P133, DOI 10.1515/bchm2.1982.363.1.133; GUNZLER WA, 1982, H-S Z PHYSIOL CHEM, V363, P1155, DOI 10.1515/bchm2.1982.363.2.1155; HAFSTROM I, 1984, J IMMUNOL, V132, P2007; HAFSTROM I, 1983, SCAND J RHEUMATOL, V12, P97, DOI 10.3109/03009748309102893; HAMILTON JA, 1991, BLOOD, V77, P616; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIDAKA H, 1987, TRENDS PHARMACOL SCI, V8, P162, DOI 10.1016/0165-6147(87)90155-6; JOHNSON WJ, 1982, SCIENCE, V218, P574, DOI 10.1126/science.6289443; KRUITHOF EKO, 1986, J BIOL CHEM, V261, P1207; LISON D, 1989, BIOCHEM PHARMACOL, V38, P2107, DOI 10.1016/0006-2952(89)90064-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441; MEISSAUER A, 1991, EXP CELL RES, V192, P453, DOI 10.1016/0014-4827(91)90064-2; MONTGOMERY RR, 1989, J LEUKOCYTE BIOL, V45, P129, DOI 10.1002/jlb.45.2.129; NAGAMINE Y, 1991, EMBO J, V10, P117, DOI 10.1002/j.1460-2075.1991.tb07927.x; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PAQUES EP, 1986, THROMB RES, V42, P797, DOI 10.1016/0049-3848(86)90116-7; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; POLLANEN J, 1988, J CELL BIOL, V106, P87, DOI 10.1083/jcb.106.1.87; SAKSELA O, 1985, J CELL PHYSIOL, V122, P125, DOI 10.1002/jcp.1041220119; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; SOEDA S, 1987, BIOCHIM BIOPHYS ACTA, V916, P279, DOI 10.1016/0167-4838(87)90171-3; STEIN PL, 1989, J BIOL CHEM, V264, P15441; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; SUNG CP, 1984, J RHEUMATOL, V11, P153; TRANQUILLE N, 1989, THROMB HAEMOSTASIS, V61, P442; UNKELESS JC, 1974, J EXP MED, V139, P834, DOI 10.1084/jem.139.4.834; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; VASSALLI JD, 1977, CELL, V11, P695, DOI 10.1016/0092-8674(77)90086-1; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; VIA DP, 1985, BIOCHIM BIOPHYS ACTA, V833, P417, DOI 10.1016/0005-2760(85)90099-2; WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801	51	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22726	22732						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658006				2022-12-25	WOS:A1991GR56400098
J	SCHLAME, M; HOSTETLER, KY				SCHLAME, M; HOSTETLER, KY			SOLUBILIZATION, PURIFICATION, AND CHARACTERIZATION OF CARDIOLIPIN SYNTHASE FROM RAT-LIVER MITOCHONDRIA - DEMONSTRATION OF ITS PHOSPHOLIPID REQUIREMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; BIOSYNTHESIS; ACTIVATION; MECHANISM; OXIDASE; BINDING	Cardiolipin is a specific and functionally important phospholipid of mitochondria, and its biosynthesis is considered to be crucial for the assembly of this organelle. However, little information is available about the enzyme cardiolipin synthase, largely because it has not vet been isolated. We solubilized cardiolipin synthase from rat liver mitochondrial membranes with Zwittergent 3-14 and purified it by Mono Q anion exchange chromatography, Superose 12 gel filtration, and Mono P chromatofocusing. Cardiolipin synthase is one of the most acidic mitochondrial proteins (isoelectric point, pH 4-5) and appears as a 50-kilodalton band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The purified enzyme requires Co2+ for activity, has an alkaline pH optimum (pH 8-9), and exhibits K(m) values of 45 and 1.6-mu-M for phosphatidylglycerol and CDP-diacylglycerol, respectively. Cardiolipin synthase loses activity during purification, and the activity can be partially reconstituted by the addition of phospholipids. The most effective phospholipid is phosphatidylethanolamine which reactivates in a cooperative manner. Cardiolipin reactivates hyperbolically at low concentrations but inhibits the enzyme at higher concentrations. In addition, cardiolipin shifts the sigmoidal reactivation curve of phosphatidylethanolamine toward lower concentrations. It is suggested that cardiolipin synthase requires interaction with several molecules of phosphatidylethanolamine and at least one molecule of cardiolipin for full enzymatic activity.	VET ADM MED CTR,SAN DIEGO,CA 92161	US Department of Veterans Affairs; Veterans Health Administration (VHA)	SCHLAME, M (corresponding author), UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92103, USA.			Hostetler, Karl/0000-0002-1155-2885	NIGMS NIH HHS [GM 24979] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024979] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DALE MP, 1988, BIOCHEMISTRY-US, V27, P8270, DOI 10.1021/bi00421a042; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; GONENNE A, 1978, ANAL BIOCHEM, V87, P28, DOI 10.1016/0003-2697(78)90565-1; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HJELMELAND LM, 1991, METHOD ENZYMOL, V30, P1731; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P380, DOI 10.1016/0005-2760(72)90052-5; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBETH JD, 1985, PHOSPHOLIPIDS CELLUL, P189; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; MCMURRAY WC, 1980, CAN J BIOCHEM CELL B, V58, P771, DOI 10.1139/o80-108; NAVARRETE R, 1983, BIOCHIM BIOPHYS ACTA, V728, P403, DOI 10.1016/0005-2736(83)90512-6; POORTHUIS BJHM, 1976, BIOCHIM BIOPHYS ACTA, V431, P408, DOI 10.1016/0005-2760(76)90207-1; POWELL GL, 1987, BIOCHEMISTRY-US, V26, P8138, DOI 10.1021/bi00399a018; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SANDERMANN H, 1982, EUR J BIOCHEM, V127, P123, DOI 10.1111/j.1432-1033.1982.tb06845.x; SANDERMANN H, 1986, PROGR PROTEIN LIPID, V2, P197; SARZALA MG, 1970, BIOCHIM BIOPHYS ACTA, V202, P105; SCHLAME M, 1991, ANAL BIOCHEM, V195, P290, DOI 10.1016/0003-2697(91)90332-N; SCHLAME M, 1992, METHOD ENZYMOL, V209, P330; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; SCHLAME M, 1991, EUR J BIOCHEM, V19, P459; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; STANACEV NZ, 1973, CAN J BIOCHEM CELL B, V51, P286, DOI 10.1139/o73-035; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z	30	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22398	22403						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657995				2022-12-25	WOS:A1991GR56400056
J	UHLINGER, DJ; BURNHAM, DN; LAMBETH, JD				UHLINGER, DJ; BURNHAM, DN; LAMBETH, JD			NUCLEOSIDE TRIPHOSPHATE REQUIREMENTS FOR SUPEROXIDE GENERATION AND PHOSPHORYLATION IN A CELL-FREE SYSTEM FROM HUMAN NEUTROPHILS - SODIUM DODECYL-SULFATE AND DIACYLGLYCEROL ACTIVATE INDEPENDENTLY OF PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; PIG POLYMORPHONUCLEAR LEUKOCYTES; ADENINE-DINUCLEOTIDE PHOSPHATE; 2 CYTOSOLIC COMPONENTS; MYRISTATE ACETATE PMA; GTP-BINDING PROTEINS; NADPH-OXIDASE; DIPHOSPHATE-KINASE; GUANINE-NUCLEOTIDES	The NADPH-oxidase of human neutrophils can be activated in a cell-free system comprised of plasma membrane, cytosol, and an anionic amphiphile such as arachidonate or sodium dodecyl sulfate (SDS). Recently, we showed that diacylglycerol acts synergistically with SDS in the cell-free system to stimulate superoxide generation, with concurrent phosphorylation of a 47-kDa cytosolic protein which is thought to be a component of the oxidase (Burnham, D. N., Uhlinger, D. J., and Lambeth, J. D. (1990) J. Biol. Chem. 265, 17550-17559). We report herein that when undialyzed cytosol is used along with either SDS alone or SDS plus diacylglycerol as activators, adenosine 5'(gamma-thio)triphosphate (ATP-gamma-S) and guanosine 5'-(gamma-thio)triphosphate (GTP-gamma-S) both stimulated superoxide generation several fold, yielding about the same maximal velocity. ATP and GTP showed lower levels of stimulation. Stimulation by ATP-gamma-S and GTP-gamma-S was nonadditive, and showed a 5-7-fold greater specificity for GTP-gamma-S. ATP-gamma-S stimulation was inhibited by the nucleoside diphosphate (NDP) kinase inhibitor UDP. In contrast, when extensively dialyzed cytosol was used, most of the stimulation by ATP-gamma-S was lost, while most of that by GTP-gamma-S was retained. Addition of GDP restored the ability of ATP-gamma-S to stimulate, consistent with NDP kinase-catalyzed formation of GTP-gamma-S from ATP-gamma-S plus GDP. This activity was demonstrated directly in both cytosol and plasma membrane. Using undialyzed cytosol, phosphorylation of p47 showed a similar nonspecificity for nucleoside triphosphates, due to NDP kinase activity, but revealed the expected ATP specificity when dialyzed cytosol was used. Neither ATP-gamma-S nor GTP-gamma-S were good substrates for protein phosphorylation. Under a variety of conditions, phosphorylation of p47 or other neutrophil proteins failed to correlate with oxidase activation. The present studies indicate that SDS and diacylglycerol stimulation of superoxide generation in the cell-free system is independent of protein kinase C or other protein kinase activity, and suggest a novel role for diacylglycerol in cell regulation.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University					NCI NIH HHS [CA46508] Funding Source: Medline; NIAID NIH HHS [AI22809] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022809] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABIOR BM, 1987, TRENDS BIOCHEM SCI, V12, P241, DOI 10.1016/0968-0004(87)90118-6; BABIOR BM, 1988, ARCH BIOCHEM BIOPHYS, V264, P361, DOI 10.1016/0003-9861(88)90300-1; BADWEY JA, 1989, J BIOL CHEM, V264, P20676; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P9317, DOI 10.1021/bi00450a011; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; BURNHAM DN, 1989, ARCH BIOCHEM BIOPHYS, V269, P345, DOI 10.1016/0003-9861(89)90116-1; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CLARK RA, 1987, J BIOL CHEM, V262, P4065; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; COX JA, 1987, J IMMUNOL, V138, P1884; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DOUSSIERE J, 1988, BIOCHEM BIOPH RES CO, V152, P993, DOI 10.1016/S0006-291X(88)80382-6; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; GABIG TG, 1987, J BIOL CHEM, V262, P1685; GRINSTEIN S, 1989, BIOCHEM J, V261, P755, DOI 10.1042/bj2610755; HONEYCUTT PJ, 1986, J BIOL CHEM, V261, P5900; ISHITOYA J, 1987, BIOCHEM BIOPH RES CO, V144, P1025, DOI 10.1016/S0006-291X(87)80066-9; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; KIMURA N, 1990, BIOCHEM BIOPH RES CO, V168, P99, DOI 10.1016/0006-291X(90)91680-Q; KIMURA N, 1988, BIOCHEM BIOPH RES CO, V151, P248, DOI 10.1016/0006-291X(88)90586-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBETH JD, 1988, J BIOENERG BIOMEMBR, V20, P709, DOI 10.1007/BF00762549; LAMBETH JD, 1988, J BIOL CHEM, V263, P3818; LIGITI E, 1988, BIOCHEMISTRY-US, V27, P193; LU DJ, 1990, J BIOL CHEM, V265, P13721; LUCAS DL, 1983, J CLIN INVEST, V72, P1889, DOI 10.1172/JCI111152; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MARONEY AC, 1989, J BIOL CHEM, V264, P2537; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; NASMITH PE, 1989, BIOCHEM J, V257, P893, DOI 10.1042/bj2570893; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; OHTSUKA T, 1986, BIOCHIM BIOPHYS ACTA, V888, P332, DOI 10.1016/0167-4889(86)90233-8; OHTSUKA T, 1990, J BIOCHEM-TOKYO, V108, P169, DOI 10.1093/oxfordjournals.jbchem.a123177; OHTSUKI K, 1987, BIOCHEM BIOPH RES CO, V148, P300, DOI 10.1016/0006-291X(87)91110-7; OKAMURA N, 1988, BLOOD, V72, P811; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; PEMBER SO, 1983, ARCH BIOCHEM BIOPHYS, V221, P391, DOI 10.1016/0003-9861(83)90158-3; RIDER LG, 1987, J BIOL CHEM, V262, P5603; RIDER LG, 1988, J IMMUNOL, V140, P200; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHONHARDT T, 1987, BIOCHEM BIOPH RES CO, V149, P769, DOI 10.1016/0006-291X(87)90434-7; SEGAL AW, 1985, NATURE, V316, P542; SEIFERT R, 1986, FEBS LETT, V205, P161, DOI 10.1016/0014-5793(86)80886-9; SEIFERT R, 1988, EUR J BIOCHEM, V175, P51, DOI 10.1111/j.1432-1033.1988.tb14165.x; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; TAMURA M, 1989, ARCH BIOCHEM BIOPHYS, V275, P23, DOI 10.1016/0003-9861(89)90345-7; TYAGI SR, 1988, J BIOL CHEM, V263, P13191; TYAGI SR, 1989, FEBS LETT, V257, P188, DOI 10.1016/0014-5793(89)81817-4; TYAGI SR, 1989, J BIOL CHEM, V264, P12977	57	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20990	20997						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657941				2022-12-25	WOS:A1991GN00100064
J	HUGHES, SJ; JOHNSTON, LH; DECARLOS, A; SMITH, GL				HUGHES, SJ; JOHNSTON, LH; DECARLOS, A; SMITH, GL			VACCINIA VIRUS ENCODES AN ACTIVE THYMIDYLATE KINASE THAT COMPLEMENTS A CDC8 MUTANT OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE GENE; CELL-FREE TRANSLATION; HERPES-SIMPLEX VIRUS; RIBONUCLEOTIDE REDUCTASE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; EXPRESSION VECTORS; DOMINANT SELECTION; DIVISION CYCLE; MESSENGER-RNA	A vaccinia virus open reading frame (ORF) previously predicted to encode thymidylate kinase (TmpK) is shown to encode an active enzyme. A copy of the ORF, generated by polymerase chain reaction, was cloned into an Escherichia coli inducible expression vector. Cell extracts of E. coli expressing the vaccinia gene contained high levels of TmpK activity, whereas extracts of cells without the TmpK gene did not. The vaccinia ORF expressed from a yeast vector complemented a Saccharomyces cerevisiae cdc8 mutant, demonstrating functional compatibility of the vaccinia virus and yeast TmpK enzymes. The gene is shown to be nonessential for the replication of vaccinia virus in cultured cells by the construction of a viable virus mutant that has the coding region of the TmpK gene interrupted by the Ecogpt gene. Synthesis of the vaccinia TmpK protein in infected cells was demonstrated by the use of a polyvalent rabbit antiserum raised against the purified TmpK enzyme expressed in E. coli to immunoprecipitate a 23-kDa early polypeptide from cells infected with wild type vaccinia but not from cells infected with the TmpK mutant. Plasmid vectors that allow the construction of recombinant viruses expressing foreign gene(s) from the nonessential TmpK locus are described.	UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,S PARKS RD,OXFORD OX1 3RE,ENGLAND; NATL INST MED RES,YEAST GENET LAB,LONDON NW7 1AA,ENGLAND	University of Oxford; MRC National Institute for Medical Research			de Carlos, Alejandro/L-5819-2014; Smith, Geoffrey L/G-2894-2012	de Carlos, Alejandro/0000-0003-0138-4918; Smith, Geoffrey L/0000-0002-3730-9955				BOYLE DB, 1988, GENE, V65, P123, DOI 10.1016/0378-1119(88)90424-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; CHEN MS, 1978, J BIOL CHEM, V253, P1325; CHEN MS, 1976, J BIOL CHEM, V251, P6555; CHILD SJ, 1990, VIROLOGY, V174, P625, DOI 10.1016/0042-6822(90)90119-C; COLINAS RJ, 1990, VIROLOGY, V179, P267, DOI 10.1016/0042-6822(90)90295-3; COOPER GM, 1973, P NATL ACAD SCI USA, V70, P3788, DOI 10.1073/pnas.70.12.3788; DUBBS DR, 1964, VIROLOGY, V22, P214, DOI 10.1016/0042-6822(64)90006-6; EARL PL, 1986, P NATL ACAD SCI USA, V83, P3659, DOI 10.1073/pnas.83.11.3659; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GUDAS JM, 1990, MOL CELL BIOL, V10, P5591, DOI 10.1128/MCB.10.10.5591; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HONESS RW, 1986, P NATL ACAD SCI USA, V83, P3604, DOI 10.1073/pnas.83.11.3604; HRUBY DE, 1982, J VIROL, V43, P403, DOI 10.1128/JVI.43.2.403-409.1982; HRUBY DE, 1983, P NATL ACAD SCI-BIOL, V80, P3411, DOI 10.1073/pnas.80.11.3411; JONES EV, 1984, J VIROL, V49, P72, DOI 10.1128/JVI.49.1.72-77.1984; JONG AYS, 1984, J BIOL CHEM, V259, P1052; KENT RK, 1988, THESIS U CAMBRIDGE; KERR SM, 1991, VIROLOGY, V180, P625, DOI 10.1016/0042-6822(91)90076-N; KERR SM, 1989, NUCLEIC ACIDS RES, V17, P9039, DOI 10.1093/nar/17.22.9039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKRITZ N, 1985, J VIROL, V53, P935, DOI 10.1128/JVI.53.3.935-943.1985; LIVINGSTON DM, 1977, J MOL BIOL, V116, P249, DOI 10.1016/0022-2836(77)90215-7; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Mackett M., 1985, DNA CLONING PRACTICA, P191; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MOSS B, 1982, J VIROL, V43, P673, DOI 10.1128/JVI.43.2.673-678.1982; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; MURRAY JAH, 1987, EMBO J, V6, P4205, DOI 10.1002/j.1460-2075.1987.tb02768.x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; NELSON DJ, 1969, J BIOL CHEM, V244, P5254; NEWLON CS, 1975, CELL, V5, P423; REDDY MK, 1989, J BIOL CHEM, V264, P443; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J, 1989, MOL CLONING LABORATO; SCHMITT JFC, 1988, J VIROL, V62, P1889, DOI 10.1128/JVI.62.6.1889-1897.1988; SCLAFANI RA, 1984, P NATL ACAD SCI-BIOL, V81, P5821, DOI 10.1073/pnas.81.18.5821; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; SLABAUGH M, 1988, J VIROL, V62, P519, DOI 10.1128/JVI.62.2.519-527.1988; SLABAUGH MB, 1984, J VIROL, V52, P501, DOI 10.1128/JVI.52.2.501-506.1984; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1989, NUCLEIC ACIDS RES, V17, P7581, DOI 10.1093/nar/17.19.7581; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; SU JY, 1991, NUCLEIC ACIDS RES, V19, P823, DOI 10.1093/nar/19.4.823; TENGELSEN LA, 1988, VIROLOGY, V164, P121, DOI 10.1016/0042-6822(88)90627-7; TRAKTMAN P, 1984, J VIROL, V49, P125, DOI 10.1128/JVI.49.1.125-131.1984; WEIR JP, 1983, J VIROL, V46, P530, DOI 10.1128/JVI.46.2.530-537.1983; WEIR JP, 1982, P NATL ACAD SCI-BIOL, V79, P1210, DOI 10.1073/pnas.79.4.1210; [No title captured]	57	75	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20103	20109						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657913				2022-12-25	WOS:A1991GM03900037
J	CHIANG, MY; CHAN, H; ZOUNES, MA; FREIER, SM; LIMA, WF; BENNETT, CF				CHIANG, MY; CHAN, H; ZOUNES, MA; FREIER, SM; LIMA, WF; BENNETT, CF			ANTISENSE OLIGONUCLEOTIDES INHIBIT INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION BY 2 DISTINCT MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE TRANSLATION; MESSENGER-RNA; GENE-EXPRESSION; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; XENOPUS OOCYTES; ICAM-1; OLIGODEOXYNUCLEOTIDES; DNA	Intercellular adhesion molecule 1 (ICAM-1) is a glycoprotein expressed on the surface of both hemopoietic and nonhemopoietic cells that mediates, in part, the emigration of leukocytes out of the vasculature. Expression of ICAM-1 on the surface of human umbilical vein endothelial cells and a human lung carcinoma cell line (A549) was increased by interleukin-1-beta, tumor necrosis factor-alpha, and interferon-gamma in a concentration-dependent manner. Phosphorothioate antisense oligonucleotides designed to hybridize to 10 target sites on the human ICAM-1 mRNA were tested for inhibition of ICAM-1 expression in both cell lines by an ICAM-1 enzyme-linked immunosorbent assay. Based upon potency and unique mRNA target sites, two oligonucleotides were studied in greater detail: ISIS 1570, which targeted the AUG translation initiation codon, and ISIS 1939, which targeted specific sequences in the 3'-untranslated region of the mRNA. Both oligonucleotides specifically inhibit expression of ICAM-1 as analyzed by immunoprecipitation of S-35-labeled proteins. Treatment of cells with ISIS 1939 promoted a reduction in ICAM-1 mRNA, whereas ISIS 1570 did not change the level of ICAM-1 mRNA, suggesting that the two oligonucleotides may be inhibiting ICAM-1 expression by two different mechanisms. The activity of both oligonucleotides was blocked by hybridization of the oligonucleotide to its complementary sense strand prior to addition to the cells. Neither ISIS 1570 nor ISIS 1939 changed the transcriptional rate of the ICAM-1 gene, demonstrating that both oligonucleotides were working through a post-transcriptional mechanism. 2'-O-Methyl phosphorothioate analogs, which do not support RNase H-mediated cleavage of target mRNA, were used to determine if the active antisense oligonucleotides inhibited ICAM-1 expression by an RNase H-dependent mechanism. The 2'-O-methyl phosphorothioate analog of ISIS 1939 did not significantly reduce interleukin-1-beta-induced ICAM-1 expression, whereas the 2'-O-methyl phosphorothioate analog of ISIS 1570 did inhibit ICAM-1 expression, suggesting that the reduction of ICAM-1 mRNA following treatment with ISIS 1939 was due, in part, to RNase H-mediated hydrolysis. Adherence of HL-60 cells to human umbilical vein cell monolayers was inhibited by ISIS 1570 and ISIS 1939, demonstrating that the reduced levels of ICAM-1 impact on ICAM-1-associated function.	ISIS PHARMACEUT,DEPT MOLEC & CELLULAR BIOL & MED CHEM,2280 FARADAY AVE,CARLSBAD,CA 92008	Isis Pharmaceuticals Inc								ADAMS DH, 1989, LANCET, V2, P1122; ALTMANN DM, 1989, NATURE, V338, P512, DOI 10.1038/338512a0; BLAKE KR, 1985, BIOCHEMISTRY-US, V24, P6139, DOI 10.1021/bi00343a016; BOYD AW, 1989, BLOOD, V73, P1896; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CAZENAVE C, 1989, NUCLEIC ACIDS RES, V17, P4255, DOI 10.1093/nar/17.11.4255; CELANO P, 1989, J BIOL CHEM, V264, P8922; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COSIMI AB, 1990, J IMMUNOL, V144, P4604; DAAKA Y, 1990, ONCOGENE RES, V5, P267; DAGLE JM, 1991, ANTISENSE RES DEV, V1, P11, DOI 10.1089/ard.1991.1.11; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; DOLNICK BJ, 1990, BIOCHEM PHARMACOL, V40, P671, DOI 10.1016/0006-2952(90)90300-A; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FAULL RJ, 1989, TRANSPLANTATION, V48, P226, DOI 10.1097/00007890-198908000-00009; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FERRARI S, 1990, CELL GROWTH DIFFER, V1, P543; GAGNOR C, 1987, NUCLEIC ACIDS RES, V15, P10419, DOI 10.1093/nar/15.24.10419; GERWITZ AM, 1988, SCIENCE, V242, P1303; GREENBERG ME, 1988, CURRENT PROTOCOLS MO; GRIFFITHS CEM, 1989, AM J PATHOL, V135, P1045; HALE LP, 1989, ARTHRITIS RHEUM, V32, P22, DOI 10.1002/anr.1780320105; HARELBELLAN A, 1988, J EXP MED, V168, P2309, DOI 10.1084/jem.168.6.2309; HARLAN JM, 1985, BLOOD, V65, P513; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; INOUE H, 1987, FEBS LETT, V215, P327, DOI 10.1016/0014-5793(87)80171-0; IYER RP, 1990, J AM CHEM SOC, V112, P1253, DOI 10.1021/ja00159a059; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS RE, 1989, J INVEST DERMATOL, V93, P672, DOI 10.1111/1523-1747.ep12319838; LISBY S, 1989, BRIT J DERMATOL, V120, P479, DOI 10.1111/j.1365-2133.1989.tb01320.x; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; MAKGOBA MW, 1988, EUR J IMMUNOL, V18, P637, DOI 10.1002/eji.1830180423; MANSON J, 1990, LYMPHOKINE RES, V9, P35; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; PATERSON BM, 1977, P NATL ACAD SCI USA, V74, P4370, DOI 10.1073/pnas.74.10.4370; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; ROBERTSON MJ, 1990, J IMMUNOL, V145, P3194; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SINGER KH, 1990, J IMMUNOL, V144, P2931; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STEIN CA, 1988, CANCER RES, V48, P2659; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; VENTURELLI D, 1990, P NATL ACAD SCI USA, V87, P5963, DOI 10.1073/pnas.87.15.5963; VOLPES R, 1990, HEPATOLOGY, V12, P59, DOI 10.1002/hep.1840120110; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WELLICOME SM, 1990, J IMMUNOL, V144, P2558; WOOLF TM, 1990, NUCLEIC ACIDS RES, V18, P1763, DOI 10.1093/nar/18.7.1763; ZON G, 1988, PHARM RES-DORDR, V5, P539, DOI 10.1023/A:1015985728434; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	64	457	613	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18162	18171						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680858				2022-12-25	WOS:A1991GG55300069
J	MORRISON, LE; BOEHMELT, G; BEUG, H; ENRIETTO, PJ				MORRISON, LE; BOEHMELT, G; BEUG, H; ENRIETTO, PJ			EXPRESSION OF V-REL IN A REPLICATION COMPETENT VIRUS - TRANSFORMATION AND BIOCHEMICAL-CHARACTERIZATION	ONCOGENE			English	Article							AVIAN RETICULOENDOTHELIOSIS VIRUS; NF-KAPPA-B; DNA-BINDING SUBUNIT; LYMPHOID-CELLS; C-REL; MONOCLONAL-ANTIBODIES; CHICKEN FIBROBLASTS; EMBRYO FIBROBLASTS; ONCOGENE ENCODES; LEUKEMIA VIRUSES	The avian reticuloendotheliosis virus strain T (REV-T) transforms bone marrow cells and may cause phenotypic changes in fibroblasts. Both events are thought to result from expression of the v-rel oncoprotein, a member of the NF-kappa-B family of transcription factors. Most REV stocks contain a cytopathic and immunosuppressive helper virus (REV-A) unrelated to standard avian retroviruses, and thus the degree to which v-rel expression alone contributes to the transformed phenotype in bone marrow cells and fibroblasts is complicated by helper virus expression. To gain a more accurate picture of how v-rel contributes to transformation, we have cloned the v-rel gene into a replication-competent avian retrovirus vector (RCAS) and have expressed it in both chick embryo fibroblasts (CEF) and bone marrow cells. Transfection of RCAS-rel into CEF readily produced a partially transformed phenotype, demonstrating that expression of the v-rel protein is sufficient for fibroblast transformation. The RCAS-rel virus also transformed bone marrow cells in vitro, but required culture conditions different from those normally required for transformation by REV-T. The v-rel protein expressed in transformed CEF was biochemically indistinguishable from that expressed in transformed bone marrow cells, being localized to the cytoplasm and the nucleus, and forming a complex with cellular proteins. We also demonstrate that the RCAS-rel-transformed hematopoietic cells exhibited a distinct differentiation phenotype.	SUNY STONY BROOK,DEPT MICROBIOL,STONY BROOK,NY 11794; INST MOLEC PATHOL,A-1030 VIENNA,AUSTRIA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)					NATIONAL CANCER INSTITUTE [R01CA051792] Funding Source: NIH RePORTER; NCI NIH HHS [CA 51792] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BARTH CF, 1988, J EXP MED, V167, P89, DOI 10.1084/jem.167.1.89; BARTH CF, 1990, J VIROL, V64, P6054, DOI 10.1128/JVI.64.12.6054-6062.1990; BAUERLE PA, 1988, CELL, V53, P211; BEUG H, 1981, VIROLOGY, V115, P295, DOI 10.1016/0042-6822(81)90112-4; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CLH, 1982, J IMMUNOL, V129, P2580; CHEN CLH, 1986, J EXP MED, V164, P375, DOI 10.1084/jem.164.1.375; DAVIS N, 1990, J VIROL, V64, P584, DOI 10.1128/JVI.64.2.584-591.1990; FRANKLIN RB, 1977, VIROLOGY, V83, P313, DOI 10.1016/0042-6822(77)90176-3; FUHRMANN U, 1989, GENE DEV, V3, P2027; GARSON K, 1990, VIROLOGY, V177, P106, DOI 10.1016/0042-6822(90)90464-3; GELINAS C, 1988, ONCOGENE, V3, P349; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; KABRUN N, 1990, P NATL ACAD SCI USA, V88, P1095; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KORNFELD S, 1983, EXP CELL RES, V143, P383, DOI 10.1016/0014-4827(83)90065-4; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS RB, 1981, CELL, V25, P421, DOI 10.1016/0092-8674(81)90060-X; MOORE BE, 1988, VIROLOGY, V162, P377, DOI 10.1016/0042-6822(88)90478-3; MORRISON LE, 1989, ONCOGENE, V4, P677; PALMERI S, 1982, VIROLOGY, V123, P209; ROYERPOKORA B, 1978, CELL, V13, P751, DOI 10.1016/0092-8674(78)90225-8; RUSJHLOW AC, 1990, CELL, V59, P1165; SCHMIDT JA, 1986, LEUKEMIA RES, V10, P257, DOI 10.1016/0145-2126(86)90023-8; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; SIMEK S, 1988, ONCOGENE RES, V2, P102; SIMEK SL, 1986, J VIROL, V59, P120, DOI 10.1128/JVI.59.1.120-126.1986; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; THEILEN GH, 1966, J NATL CANCER I, V37, P731; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUNG HYL, 1988, P NATL ACAD SCI USA, V85, P2479, DOI 10.1073/pnas.85.8.2479; Vogt PK, 1969, FUNDAMENTAL TECHNIQU, P198	44	34	35	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1991	6	9					1657	1666						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX274	1656369				2022-12-25	WOS:A1991GX27400022
J	TULL, D; WITHERS, SG; GILKES, NR; KILBURN, DG; WARREN, RAJ; AEBERSOLD, R				TULL, D; WITHERS, SG; GILKES, NR; KILBURN, DG; WARREN, RAJ; AEBERSOLD, R			GLUTAMIC-ACID 274 IS THE NUCLEOPHILE IN THE ACTIVE-SITE OF A RETAINING EXOGLUCANASE FROM CELLULOMONAS-FIMI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOPHYLLUM-COMMUNE CELLULASE; CLONED BACTERIAL GENES; NUCLEOTIDE-SEQUENCE; TRICHODERMA-REESEI; BETA-GLUCOSIDASE; XYLANASE GENE; 1,4-BETA-GLUCAN CELLOBIOHYDROLASE; CALDOCELLUM-SACCHAROLYTICUM; SUBSTRATE SPECIFICITIES; BINDING DOMAINS	In addition to its known substrate activity with p-nitrophenyl beta-cellobioside, the exoglucanase from Cellulomonas fimi has been shown to utilize substituted phenyl beta-glucosides as substrates, of which the best is 2',4'-dinitrophenyl beta-D-glucopyranoside. The enzyme can be inactivated by treatment with 2',4'-dinitrophenyl 2-deoxy-2-fluoro-beta-D-glucopyranoside, by trapping of the covalent intermediate in catalysis as has been shown for a beta-glucosidase (Withers, S. G., and Street, I. P. (1988) J. Am. Chem. Soc. 110, 8551-8553). The intermediate formed is stable but can undergo turnover in the presence of cellobiose, reactivating the enzyme by transglycosylation. Using a tritium-labeled inactivator it has been possible to isolate and sequence a radiolabeled peptide from this enzyme, and the active site nucleophile has been identified as glutamic acid residue 274. This glutamic acid residue and its sequentially proximal amino acids are absolutely conserved in the homologous family F of cellulases.	UNIV BRITISH COLUMBIA,DEPT CHEM,VANCOUVER V6T 1Y6,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT MICROBIOL,VANCOUVER V6T 1Y6,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1Y6,BC,CANADA; UNIV BRITISH COLUMBIA,BIOMED RES CTR,VANCOUVER V6T 1Y6,BC,CANADA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia			Withers, Stephen G/I-7229-2019	Withers, Stephen G/0000-0002-6722-5701; Tull, Dedreia/0000-0003-2546-6707				AEBERSOLD R, 1990, ANAL BIOCHEM, V187, P56, DOI 10.1016/0003-2697(90)90417-8; BAIRD SD, 1990, BIOCHEM BIOPH RES CO, V169, P1035, DOI 10.1016/0006-291X(90)91998-8; BEGUIN P, 1990, ANNU REV MICROBIOL, V44, P219, DOI 10.1146/annurev.mi.44.100190.001251; BERVEN LA, 1990, CAN J CHEM, V68, P1859, DOI 10.1139/v90-288; BHAT KM, 1990, BIOCHEM J, V266, P371, DOI 10.1042/bj2660371; BOIZET B, 1989, J GEN MICROBIOL, V135, P1833; BOUCHER F, 1988, NUCLEIC ACIDS RES, V16, P9874, DOI 10.1093/nar/16.20.9874; BREIDT F, 1987, APPL ENVIRON MICROB, V53, P969, DOI 10.1128/AEM.53.5.969-973.1987; CLARKE AJ, 1988, BIOCHEM CELL BIOL, V66, P871, DOI 10.1139/o88-099; CLARKE AJ, 1985, EUR J BIOCHEM, V149, P233, DOI 10.1111/j.1432-1033.1985.tb08917.x; CLARKE AJ, 1989, CARBOHYD RES, V188, P245, DOI 10.1016/0008-6215(89)84078-9; COULL JM, 1991, ANAL BIOCHEM, V194, P110, DOI 10.1016/0003-2697(91)90157-O; DAY AG, 1986, BIOCHEM CELL BIOL, V64, P914, DOI 10.1139/o86-122; FAGERSTAM LG, 1984, FEBS LETT, V167, P309, DOI 10.1016/0014-5793(84)80148-9; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GILKES NR, 1984, J BIOL CHEM, V259, P455; GILKES NR, 1988, J BIOL CHEM, V263, P10401; GONZALEZCANDELAS L, 1990, GENE, V95, P31, DOI 10.1016/0378-1119(90)90410-S; GREPINET O, 1988, J BACTERIOL, V170, P4582, DOI 10.1128/jb.170.10.4582-4588.1988; HALL J, 1989, MOL MICROBIOL, V3, P1211, DOI 10.1111/j.1365-2958.1989.tb00271.x; HAMAMOTO T, 1987, AGR BIOL CHEM TOKYO, V51, P953, DOI 10.1080/00021369.1987.10868127; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; HOJ PB, 1989, J BIOL CHEM, V264, P4939; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; LEGLER G, 1973, CARBOHYD RES, V28, P45, DOI 10.1016/S0008-6215(00)82855-4; LITTLE S, 1989, NUCLEIC ACIDS RES, V17, P7980, DOI 10.1093/nar/17.19.7980; LOVE DR, 1988, MOL GEN GENET, V213, P84, DOI 10.1007/BF00333402; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; MANNARELLI BM, 1990, J BACTERIOL, V172, P4247, DOI 10.1128/jb.172.8.4247-4254.1990; MITSUISHI Y, 1990, FEBS LETT, V275, P135, DOI 10.1016/0014-5793(90)81457-Y; ONEILL G, 1986, GENE, V44, P325, DOI 10.1016/0378-1119(86)90197-6; PORTER EV, 1988, GENE, V62, P263; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SAUL DJ, 1989, NUCLEIC ACIDS RES, V17, P439, DOI 10.1093/nar/17.1.439; SCHNETZ K, 1987, J BACTERIOL, V169, P2579, DOI 10.1128/jb.169.6.2579-2590.1987; Sinnott M. L., 1987, ENZYME MECHANISMS, P259; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SRINIVASA B R, 1990, Journal of Protein Chemistry, V9, P337; STREET IP, 1989, BIOCHEMISTRY-US, V28, P1581, DOI 10.1021/bi00430a024; TOMME P, 1989, FEBS LETT, V243, P239, DOI 10.1016/0014-5793(89)80136-X; VANTILBEURGH H, 1985, EUR J BIOCHEM, V148, P329; WAKARCHUK WW, 1988, J BACTERIOL, V170, P301, DOI 10.1128/jb.170.1.301-307.1988; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; WITHERS SG, 1988, J AM CHEM SOC, V110, P8551, DOI 10.1021/ja00233a045; WITHERS SG, 1986, BIOCHEM BIOPH RES CO, V139, P487, DOI 10.1016/S0006-291X(86)80017-1; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043	49	129	131	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15621	15625						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1678739				2022-12-25	WOS:A1991GB97700016
J	SZPIRER, C; SZPIRER, J; RIVIERE, M; INGVARSSON, S; VENNSTROM, B; ISLAM, MQ; LEVAN, G				SZPIRER, C; SZPIRER, J; RIVIERE, M; INGVARSSON, S; VENNSTROM, B; ISLAM, MQ; LEVAN, G			CHROMOSOMAL ASSIGNMENT OF 5 CANCER-ASSOCIATED RAT GENES - 2 THYROID-HORMONE RECEPTOR (ERBA) GENES, 2 ERBB GENES AND THE RETINOBLASTOMA GENE	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; AVIAN ERYTHROBLASTOSIS VIRUS; SOMATIC-CELL HYBRIDIZATION; C-ERBA; NEU ONCOGENE; LUNG-CANCER; MALIGNANT MESOTHELIOMA; DNA-SEQUENCE; AMPLIFICATION	Using a panel of somatic cell hybrids that segregate rat chromosomes, the localization of five cancer-related rat genes was determined: (i) two thyroid receptor genes, THRA1/ERBA1 and THRB/ERBA2 on chromosomes 10 and 15 respectively, (ii) two ERBB genes, namely the epidermal growth factor gene (EGFR, also called ERBB1) and the ERBB2 gene (also designated neu) on chromosomes 14 and 10 respectively, and (iii) the retinoblastoma gene, RB1, on chromosome 15. The THRA1/ERBA1 and ERBB2/neu genes are thus included in a synteny group, conserved on rat chromosomes 10 and human chromosome arm 17q.	KAROLINSKA INST,DEPT MOLEC BIOL,S-10401 STOCKHOLM 60,SWEDEN; GOTHENBURG UNIV,DEPT GENET,S-40033 GOTHENBURG,SWEDEN	Karolinska Institutet; University of Gothenburg	SZPIRER, C (corresponding author), UNIV LIBRE BRUXELLES,DEPT BIOL MOLEC,RUE CHEVAUX 67,B-1640 RHODE ST GENESE,BELGIUM.		Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714				BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BOUIZAR Z, 1989, CANCER RES, V49, P5199; BUCHBERG AM, 1989, GENETICS, V122, P153; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COOKE NE, 1986, ENDOCRINOLOGY, V119, P2451, DOI 10.1210/endo-119-6-2451; DAYTON AI, 1984, P NATL ACAD SCI-BIOL, V81, P4495, DOI 10.1073/pnas.81.14.4495; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DOBROVIC A, 1988, CANCER RES, V48, P682; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; DRABKIN H, 1988, P NATL ACAD SCI USA, V85, P9258, DOI 10.1073/pnas.85.23.9258; EHLEN T, 1990, ONCOGENE, V5, P219; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FLEJTER WL, 1989, GENE CHROMOSOME CANC, V1, P148, DOI 10.1002/gcc.2870010207; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; FULCHIGNONILATAUD MC, 1990, CYTOGENET CELL GENET, V53, P172, DOI 10.1159/000132922; GEORGE DL, 1981, HUM GENET, V57, P138; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; HAAG MM, 1984, CANCER RES, V44, P784; HAYMAN MJ, 1986, TRENDS GENET, V2, P260, DOI 10.1016/0168-9525(86)90259-3; HEIMER S, 1987, CANCER CYTOGENETICS; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; ISLAM MQ, 1987, HEREDITAS, V107, P127, DOI 10.1111/j.1601-5223.1987.tb00277.x; JACKSONGRUSBY LL, 1988, ENDOCRINOLOGY, V122, P2462, DOI 10.1210/endo-122-6-2462; KANOTANAKA K, 1982, INT J CANCER, V30, P495, DOI 10.1002/ijc.2910300417; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; KOVI J, 1978, JNCI-J NATL CANCER I, V61, P495; LALLEY PA, 1989, CYTOGENET CELL GENET, V51, P503, DOI 10.1159/000132806; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LEVAN G, 1975, HEREDITAS, V79, P161; Levan G., 1990, Genetic maps: locus of complex genomes.; LEVAN G, 1974, HEREDITAS, V77, P263; LEVAN G, 1991, GENOMICS, V10, P699, DOI 10.1016/0888-7543(91)90455-N; LIBBUS BL, 1988, CANCER RES, V48, P6455; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LOTHE RA, 1989, GENOMICS, V5, P134, DOI 10.1016/0888-7543(89)90097-9; MATTEI MG, 1991, IN PRESS GENOMICS, V10; MCMAHON G, 1990, P NATL ACAD SCI USA, V87, P1104, DOI 10.1073/pnas.87.3.1104; MITELMAN F, 1971, HEREDITAS-GENETISK A, V69, P155; MITELMAN F, 1986, CANCER GENET CYTOGEN, V22, P95, DOI 10.1016/0165-4608(86)90168-8; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; NADEAU JH, 1990, GENETIC VARIANTS STR, P506; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; POPESCU NC, 1988, CANCER RES, V48, P142; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHWAB M, 1990, GENE CHROMOSOME CANC, V1, P181, DOI 10.1002/gcc.2870010302; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHEER D, 1985, ANN HUM GENET, V49, P167, DOI 10.1111/j.1469-1809.1985.tb01690.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; SPURR NK, 1984, EMBO J, V3, P159, DOI 10.1002/j.1460-2075.1984.tb01777.x; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STONE JC, 1989, GENOMICS, V5, P70, DOI 10.1016/0888-7543(89)90088-8; SUGIYAMA T, 1978, J NATL CANCER I, V60, P153, DOI 10.1093/jnci/60.1.153; SZPIRER C, 1989, CYTOGENET CELL GENET, V50, P23, DOI 10.1159/000132712; SZPIRER C, 1988, CURR TOP MICROBIOL, V137, P33; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WHANGPENG J, 1982, CANCER GENET CYTOGEN, V6, P119, DOI 10.1016/0165-4608(82)90077-2; WIENER F, 1982, INT J CANCER, V29, P431, DOI 10.1002/ijc.2910290412; YAMAMOTO T, 1986, CANCER RES, V46, P414; YANGFENG TL, 1985, CYTOGENET CELL GENET, V40, P784; YOKOTA J, 1988, ONCOGENE, V2, P283; YOSHIDA MC, 1978, CYTOGENET CELL GENET, V22, P606, DOI 10.1159/000131034; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	79	13	13	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1991	6	8					1319	1324						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX272	1679528				2022-12-25	WOS:A1991GX27200004
J	MAEKAWA, H; YAMAZUMI, K; MURAMATSU, S; KANEKO, M; HIRATA, H; TAKAHASHI, N; DEBOSCH, NB; CARVAJAL, Z; OJEDA, A; AROCHAPINANGO, CL; MATSUDA, M				MAEKAWA, H; YAMAZUMI, K; MURAMATSU, S; KANEKO, M; HIRATA, H; TAKAHASHI, N; DEBOSCH, NB; CARVAJAL, Z; OJEDA, A; AROCHAPINANGO, CL; MATSUDA, M			AN A-ALPHA SER-434 TO N-GLYCOSYLATED ASN SUBSTITUTION IN A DYSFIBRINOGEN, FIBRINOGEN CARACAS-II, CHARACTERIZED BY IMPAIRED FIBRIN GEL FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CHAIN VARIANT; SIALIC-ACID; LINKED OLIGOSACCHARIDES; POLYMERIZATION SITES; ABNORMAL FIBRINOGEN; LIVER-DISEASE; CHROMATOGRAPHY; CLEAVAGE; THROMBIN; GAMMA-ASPARAGINE-308	We have identified a unique N-glycosylated Asn substitution for a Ser at position 434 of the Aa chain of an abnormal fibrinogen designated fibrinogen Caracas II. This dysfibrinogen was characterized by impaired fibrin monomer aggregation. Since there were 4 Thr residues immediately following the mutation, a new Asn-X-Thr/Ser-type consensus sequence, Asn-Thr-Thr arose for N-glycosylation of the Asn. The extra oligosaccharide was found to consist mainly of a disialylated biantennary structure comprising 81.9%, while a neutral and a monosialylated biantennary oligosaccharide represented only 3.6% and 14.5%, respectively. The mutation resides in the carboxyl-terminal region of the A-alpha-chain, which could fold back to form an extra small globular region located near the central region of the molecule (Erickson, H. P., and Fowler, W. E. (1983) Ann. N. Y. Acad. Sci. 408, 146-163; Weisel, H. P., Stauffacher, C. V., Bullitt, E., and Cohen, C. (1985) Science 230, 3124-3133). Therefore, the participation of this region, referred to as an additional central domain or an alpha-domain, in fibrin gel formation is strongly implicated.	JICHI MED SCH, INST HEMATOL, DIV HEMOSTASIS & THROMBOSIS RES, YAKUSHIJI 3311-1, MINAMI KAWACHI, TOCHIGI 32904, JAPAN; NAGOYA CITY UNIV, COLL NURSING, NAGOYA, AICHI 467, JAPAN; JICHI MED SCH, DEPT BIOCHEM, MINAMI KAWACHI, TOCHIGI 32904, JAPAN; BANCO SANGRE DISTRITO FED, CARACAS 1020A, VENEZUELA; INST VENEZOLANO INVEST CIENT, CARACAS 1020A, VENEZUELA	Jichi Medical University; Nagoya City University; Jichi Medical University; Venezuelan Institute Science Research			Muramatsu, Shin-ichi/K-9420-2013; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shin-ichi/0000-0002-3185-7790; Muramatsu, Shinichi/0000-0002-3185-7790				AROCHAPINANGO CL, 1990, REV IBEROAMER TROMB, V3, P110; BAILEY K, 1951, NATURE, V167, P233, DOI 10.1038/167233a0; BARLOW GH, 1969, J BIOL CHEM, V244, P1138; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; BLOMBACK B, 1973, J BIOL CHEM, V248, P5806; BLOMBACK B, 1988, FIBRINOGEN BIOCH BIO, P263; BLOMBACK M, 1968, NATURE, V218, P134, DOI 10.1038/218134a0; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Curtis C G, 1976, Methods Enzymol, V45, P177; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; DIAZMAURINO T, 1984, BIOCHIM BIOPHYS ACTA, V799, P45, DOI 10.1016/0304-4165(84)90325-8; Doolittle R F, 1973, Adv Protein Chem, V27, P1, DOI 10.1016/S0065-3233(08)60446-5; DOOLITTLE RF, 1979, CHEM PHYSL HUMAN PLA, P77; ERICKSON HP, 1983, ANN NY ACAD SCI, V408, P146, DOI 10.1111/j.1749-6632.1983.tb23242.x; FERRY JD, 1952, P NATL ACAD SCI USA, V38, P566, DOI 10.1073/pnas.38.7.566; FERRY JD, 1952, J AM CHEM SOC, V74, P5709, DOI 10.1021/ja01142a044; FOWLER WE, 1981, P NATL ACAD SCI-BIOL, V78, P4872, DOI 10.1073/pnas.78.8.4872; GALANAKIS DK, 1976, BLOOD, V48, P109; GALANAKIS DK, 1983, ANN NY ACAD SCI, V408, P640, DOI 10.1111/j.1749-6632.1983.tb23285.x; GOLLWITZER R, 1972, EUR J BIOCHEM, V28, P497, DOI 10.1111/j.1432-1033.1972.tb01937.x; HANTGAN RR, 1979, J BIOL CHEM, V254, P1272; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HIGGINS DL, 1981, J BIOL CHEM, V256, P2013; KAUDEWITZ H, 1986, FIBRINOGEN FIBRIN FO, P91; KEHL M, 1983, FIBRINOGEN STRUCTURE, P183; KUDRYK B, 1976, THROMB RES, V9, P25, DOI 10.1016/0049-3848(76)90146-8; KUDRYK BJ, 1974, J BIOL CHEM, V249, P3322; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER BG, 1988, J BIOL CHEM, V263, P15056; LORAND L, 1953, SCIENCE, V118, P515, DOI 10.1126/science.118.3070.515; LUNDBLAD RL, 1971, BIOCHEMISTRY-US, V10, P2501, DOI 10.1021/bi00789a012; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; MARTINEZ J, 1983, BLOOD, V61, P1196; MARTINEZ J, 1977, J LAB CLIN MED, V89, P367; MARTINEZ J, 1978, J CLIN INVEST, V61, P535, DOI 10.1172/JCI108964; MATSUDA M, 1990, INT CONGR SER, V892, P139; MATSUDA M, 1983, J CLIN INVEST, V72, P1034, DOI 10.1172/JCI111027; MORRIS S, 1981, THROMB HAEMOSTASIS, V46, P104; NIEUWENHUIZEN W, 1983, BIOCHIM BIOPHYS ACTA, V748, P86, DOI 10.1016/0167-4838(83)90030-4; OLEXA SA, 1980, P NATL ACAD SCI-BIOL, V77, P1374, DOI 10.1073/pnas.77.3.1374; PARK K, 1986, THROMB RES, V43, P293, DOI 10.1016/0049-3848(86)90149-0; RIXON MW, 1983, BIOCHEMISTRY-US, V22, P3237, DOI 10.1021/bi00282a031; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; SOUTHAN C, 1983, BRIT J HAEMATOL, V54, P143, DOI 10.1111/j.1365-2141.1983.tb02076.x; SOUTHAN C, 1982, FIBRINOGEN RECENT BI, P153; SOUTHAN C, 1988, FIBRINOGEN FIBRIN ST, P65; SUENSON E, 1990, J BIOL CHEM, V265, P22228; TERUKINA S, 1988, J BIOL CHEM, V263, P13579; TESCH R, 1979, THROMB RES, V16, P239, DOI 10.1016/0049-3848(79)90284-6; TOMIYA N, 1987, ANAL BIOCHEM, V163, P489, DOI 10.1016/0003-2697(87)90253-3; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; TOPFERPETERSEN E, 1979, THROMB HAEMOSTASIS, V41, P671; TOWNSEND RR, 1988, ANAL BIOCHEM, V174, P459, DOI 10.1016/0003-2697(88)90044-9; TOWNSEND RR, 1982, J BIOL CHEM, V257, P9704; WEBER K, 1969, J BIOL CHEM, V244, P4406; WEISEL JW, 1986, J ULTRA MOL STRUCT R, V96, P176, DOI 10.1016/0889-1605(86)90019-4; WEISEL JW, 1987, THROMB RES, V47, P155, DOI 10.1016/0049-3848(87)90372-0; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058; YAMAZUMI K, 1989, J CLIN INVEST, V83, P1590, DOI 10.1172/JCI114056; YAMAZUMI K, 1988, THROMB HAEMOSTASIS, V60, P476; YOSHIDA N, 1988, J BIOL CHEM, V263, P13848	62	51	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11575	11581						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1675636				2022-12-25	WOS:A1991FT76200027
J	GUEST, SJ; HADCOCK, JR; WATKINS, DC; MALBON, CC				GUEST, SJ; HADCOCK, JR; WATKINS, DC; MALBON, CC			BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTOR EXPRESSION IN DIFFERENTIATING 3T3-L1 CELLS - INDEPENDENT REGULATION AT THE LEVEL OF MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SUNY STONY BROOK,HLTH SCI CTR,DIABET & METAB DIS RES PROGRAM,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	GUEST, SJ (corresponding author), SUNY STONY BROOK,HLTH SCI CTR,DEPT PHARMACOL,STONY BROOK,NY 11794, USA.		malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK30111, DK25410] Funding Source: Medline; NIGMS NIH HHS [GM07518] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030111, R01DK025410] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN JM, 1988, EMBO J, V7, P133, DOI 10.1002/j.1460-2075.1988.tb02792.x; BAHOUTH SW, 1986, BIOCHEM BIOPH RES CO, V141, P411, DOI 10.1016/S0006-291X(86)80188-7; BAHOUTH SW, 1988, J BIOL CHEM, V263, P8822; BAHOUTH SW, 1987, BIOCHEM J, V248, P557, DOI 10.1042/bj2480557; BERK AJ, 1984, CELL, V50, P89; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS S, 1988, J BIOL CHEM, V263, P9067; CUBERO A, 1984, J BIOL CHEM, V259, P1344; DAVIES AO, 1984, ANNU REV PHYSIOL, V46, P119; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOOLEY DJ, 1986, EUR J PHARMACOL, V130, P137, DOI 10.1016/0014-2999(86)90193-7; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GRAZIANO MP, 1985, J BIOL CHEM, V260, P7665; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P8415, DOI 10.1073/pnas.85.22.8415; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HADCOCK JR, 1989, J BIOL CHEM, V264, P13956; HADCOCK JR, 1989, AM J PHYSIOL, V256, pC457, DOI 10.1152/ajpcell.1989.256.3.C457; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; LAI E, 1982, J BIOL CHEM, V257, P6691; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LINNENBACH AJ, 1986, P NATL ACAD SCI USA, V83, P2397, DOI 10.1073/pnas.83.8.2397; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALBON CC, 1988, BIOCHEM BIOPH RES CO, V154, P676, DOI 10.1016/0006-291X(88)90192-1; MALBON CC, 1978, J BIOL CHEM, V253, P671; MOXHAM CP, 1986, J BIOL CHEM, V261, P4562; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHELNESS GS, 1984, J BIOL CHEM, V259, P9929; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; STILES GL, 1984, PHYSIOL REV, V64, P661, DOI 10.1152/physrev.1984.64.2.661; WATKINS DC, 1987, J BIOL CHEM, V262, P10651; WILLIAMS DL, 1986, METHOD ENZYMOL, V128, P671	35	63	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5370	5375						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690708				2022-12-25	WOS:A1990CW48000012
J	ALBERT, PR; NEVE, KA; BUNZOW, JR; CIVELLI, O				ALBERT, PR; NEVE, KA; BUNZOW, JR; CIVELLI, O			COUPLING OF A CLONED RAT DOPAMINE-D2 RECEPTOR TO INHIBITION OF ADENYLYL CYCLASE AND PROLACTIN SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; DEPT VET AFFAIRS MED CTR,PORTLAND,OR 97201	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System			Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK007759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045614] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 F32 DK-07759] Funding Source: Medline; NIMH NIH HHS [MH 45614] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBERT PR, 1984, J BIOL CHEM, V259, P5350; BENJONATHAN N, 1977, ENDOCRINOLOGY, V100, P452, DOI 10.1210/endo-100-2-452; BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564; BOUVIER M, 1988, MOL PHARMACOL, V33, P133; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CANONICO PL, 1986, J ENDOCRINOL, V110, P389, DOI 10.1677/joe.0.1100389; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRONIN MJ, 1983, AM J PHYSIOL, V244, pE499, DOI 10.1152/ajpendo.1983.244.5.E499; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DELAESCALERA GM, 1988, ENDOCRINOLOGY, V123, P1682, DOI 10.1210/endo-123-3-1682; DELEAN A, 1982, MOL PHARMACOL, V22, P290; DORFLINGER LJ, 1983, ENDOCRINOLOGY, V113, P1541, DOI 10.1210/endo-113-5-1541; DORFLINGER LJ, 1983, ENDOCRINOLOGY, V113, P1551, DOI 10.1210/endo-113-5-1551; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2; JOURNOT L, 1987, J BIOL CHEM, V262, P15106; JUDD AM, 1988, ENDOCRINOLOGY, V123, P2341, DOI 10.1210/endo-123-5-2341; KOCH BD, 1985, J BIOL CHEM, V260, P3138; KOCH BD, 1984, ENDOCRINOLOGY, V114, P1784, DOI 10.1210/endo-114-5-1784; LAW GJ, 1988, MOL ENDOCRINOL, V2, P966, DOI 10.1210/mend-2-10-966; LOPEZ FJ, 1989, ENDOCRINOLOGY, V124, P527, DOI 10.1210/endo-124-1-527; LOPEZ FJ, 1988, ENDOCRINOLOGY, V124, P536; MARGAROLI A, 1987, J BIOL CHEM, V262, P13920; MEMO M, 1986, J NEURAL TRANSM-SUPP, V22, P19; OHARA K, 1988, MOL PHARMACOL, V33, P290; ONALI P, 1981, P NATL ACAD SCI-BIOL, V78, P6531, DOI 10.1073/pnas.78.10.6531; ONALI P, 1985, MOL PHARMACOL, V28, P138; OZAWA S, 1986, PHYSIOL REV, V66, P887, DOI 10.1152/physrev.1986.66.4.887; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHOFIELD JG, 1983, FEBS LETT, V159, P79, DOI 10.1016/0014-5793(83)80420-7; SENOGLES SE, 1987, J BIOL CHEM, V262, P4860; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; TASHJIAN AH, 1979, METHOD ENZYMOL, V58, P526; UHLER MD, 1987, J BIOL CHEM, V262, P15202; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; VALLAR L, 1988, J BIOL CHEM, V263, P10127; WINIGER BP, 1987, ENDOCRINOLOGY, V121, P2222, DOI 10.1210/endo-121-6-2222	39	155	155	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2098	2104						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688845				2022-12-25	WOS:A1990CL02800046
J	TISA, LS; ROSEN, BP				TISA, LS; ROSEN, BP			MOLECULAR CHARACTERIZATION OF AN ANION PUMP - THE ARSB PROTEIN IS THE MEMBRANE ANCHOR FOR THE ARSA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM, DETROIT, MI 48201 USA	Wayne State University				Tisa, Louis/0000-0001-5597-8477; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012187] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19793] Funding Source: Medline; NIGMS NIH HHS [GM12187] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUTLIN JD, 1971, BIOCHEM J, V124, P75, DOI 10.1042/bj1240075; CHEN CM, 1986, J BIOL CHEM, V261, P5030; CHEN CM, 1985, J BACTERIOL, V161, P758, DOI 10.1128/JB.161.2.758-763.1985; EPSTEIN W, 1985, CURR TOP MEMBR TRANS, V23, P153; FRANCISCO MJDS, 1989, MOL MICROBIOL, V3, P15, DOI 10.1111/j.1365-2958.1989.tb00098.x; HSU CM, 1989, J BIOL CHEM, V264, P17349; KANAZAWA H, 1984, ARCH BIOCHEM BIOPHYS, V228, P258, DOI 10.1016/0003-9861(84)90066-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MOBLEY HLT, 1983, MOL GEN GENET, V191, P421, DOI 10.1007/BF00425757; MOBLEY HLT, 1982, P NATL ACAD SCI-BIOL, V79, P6119, DOI 10.1073/pnas.79.20.6119; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; ROSEN BP, 1984, BIOCHEM BIOPH RES CO, V124, P760, DOI 10.1016/0006-291X(84)91023-4; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; ROSEN BP, 1989, IN PRESS T R SOC L B; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; SILVER S, 1981, J BACTERIOL, V146, P983, DOI 10.1128/JB.146.3.983-996.1981; SILVER S, 1982, P NATL ACAD SCI-BIOL, V79, P6114, DOI 10.1073/pnas.79.20.6114; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032	21	121	123	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					190	194						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688427				2022-12-25	WOS:A1990CF66200031
J	MCWHIRTER, RB; HILLE, R				MCWHIRTER, RB; HILLE, R			THE REDUCTIVE HALF-REACTION OF XANTHINE-OXIDASE - IDENTIFICATION OF SPECTRAL INTERMEDIATES IN THE HYDROXYLATION OF 2-HYDROXY-6-METHYLPURINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MOLYBDENUM CENTER; MOLYBDOENZYMES; MECHANISM; KINETICS; OXYGEN	The reaction of xanthine oxidase with 2-hydroxy-6-methylpurine (also called 2-oxo-6-methylpurine) has been studied under both anaerobic and aerobic conditions. Reaction of enzyme with substoichiometric concentrations of hydroxymethylpurine in aerobic 0.1 M 3-(cyclohexylamino)propanesulfonic acid, 0.1 N KCl, 0.3 mM EDTA, pH 10.0, exhibits two reaction intermediates detectable by UV-visible spectrophotometry. The rate constants for formation of the first intermediate, conversion of the first to the second, and the decay of the second to give oxidized enzyme are 18, 1.2, and 0.13 s-1, respectively. The difference spectra of these two intermediates relative to oxidized enzyme are characterized by absorbance maxima at 470 and 540 nm, respectively, with extinction changes (relative to oxidized enzyme) of approximately 410 M-1 cm-1. The 0.13 s-1 decay of the second intermediate agrees well with k(cat) of 0.11 s-1 determined under the same conditions. Based on a comparison of the kinetics of the reaction as monitored by UV-visible absorption and electron paramagnetic resonance spectrometry, it is concluded that these spectral intermediates arise from the molybdenum center of the enzyme in the Mo(IV) and Mo(V) valence states, respectively, the latter corresponding to the species exhibiting the "very rapid" Mo(V) EPR signal known to be formed in the course of the reaction. This conclusion is supported by the results of experiments using cytochrome c reduction to follow the formation of superoxide production in the course of the aerobic reaction of xanthine oxidase with substoichiometric hydroxymethylpurine, which demonstrate unequivocally that the species exhibiting the very rapid EPR signal is formed by one-electron oxidation of a Mo(IV) species rather than direct one-electron reduction of Mo(VI) by substrate. No evidence is found for the formation of any of the Mo(V) EPR signals designated "rapid" in the present studies, and it is concluded that this species is not a bona fide catalytic intermediate in the reductive half-reaction of xanthine oxidase.	OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210	University System of Ohio; Ohio State University	HILLE, R (corresponding author), OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038917] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38917] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AVIS PG, 1955, J CHEM SOC, P1100, DOI 10.1039/jr9550001100; Bevington PR, 1969, DATA REDUCTION ERROR; BRAY RC, 1964, J BIOL CHEM, V239, P2667; BRAY RC, 1988, Q REV BIOPHYS, V21, P299, DOI 10.1017/S0033583500004479; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; BRAY RC, 1985, BIOCHEM SOC T, V13, P560, DOI 10.1042/bst0130560; DARDENNE SC, 1990, BIOCHEMISTRY-US, V29, P9046, DOI 10.1021/bi00490a023; DAVIS MD, 1982, J BIOL CHEM, V257, P4730; DAVIS MD, 1984, J BIOL CHEM, V259, P3526; DUBOURDI.M, 1970, BIOCHEM BIOPH RES CO, V38, P965, DOI 10.1016/0006-291X(70)90816-8; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; HAWKES TR, 1984, BIOCHEM J, V218, P961, DOI 10.1042/bj2180961; Hille R., 1985, Metal Ions in Biology, V7, P443; HILLE R, 1991, J BIOL CHEM, V266, P5608; HILLE R, 1984, J BIOL CHEM, V259, P1570; HILLE R, 1981, J BIOL CHEM, V256, P8933; HILLE R, 1981, PHARMACOL THERAPEUT, V14, P249, DOI 10.1016/0163-7258(81)90063-2; HILLE R, 1981, J BIOL CHEM, V256, P9090; KOMAI H, 1969, J BIOL CHEM, V244, P1692; MASSEY V, 1970, J BIOL CHEM, V245, P2837; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MOORE JW, 1981, KINETICS MECHANISM, P290; MORRISON M, 1963, J BIOL CHEM, V238, P2847; NISHINO T, 1981, FEBS LETT, V131, P369, DOI 10.1016/0014-5793(81)80406-1; OERTLING WA, 1990, J BIOL CHEM, V265, P17446; OLSON JS, 1974, J BIOL CHEM, V249, P4350; OLSON JS, 1974, J BIOL CHEM, V249, P4363; PALMER G, 1964, J BIOL CHEM, V239, P2657; PORRAS AG, 1981, J BIOL CHEM, V256, P9096; SYMONS MCR, 1989, J CHEM SOC FARAD T 1, V85, P4063, DOI 10.1039/f19898504063; Tanner SJ, 1978, BIOCHEM SOC T, V6, P1328, DOI 10.1042/bst0061328	32	73	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23724	23731						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660883				2022-12-25	WOS:A1991GV31900033
J	VANBERKUM, MFA; MEANS, AR				VANBERKUM, MFA; MEANS, AR			3 AMINO-ACID SUBSTITUTIONS IN DOMAIN-I OF CALMODULIN PREVENT THE ACTIVATION OF CHICKEN SMOOTH-MUSCLE MYOSIN LIGHT CHAIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET ENZYMES; CENTRAL HELIX; BINDING DOMAIN; BACTERIAL EXPRESSION; TROPONIN-C; SEQUENCE; SITE; PHOSPHORYLATION; FLUORESCENT; PEPTIDES	TaM-BMI is a genetically engineered chimeric protein consisting of the first 55 amino acids of cardiac troponin C (but with the normally inactive first Ca" binding domain reactivated by site- directed mutagenesis) ligated to the last three domains of chicken calmodulin (George, S. E., VanBerkum, M. F., Ono, T., Cook, R., Hanley, R. M., Putkey, J. A., and Means, A. R. (1990) J. Biol. Chem. 265, 9228-9235). This protein binds chicken smooth muscle myosin light chain kinase (smMLCK) but fails to activate the enzyme, thus functioning as a potent competitive inhibitor (K(i) = 66 nM). We have created 29 mutants of calmodulin designed to identify the minimal number of alterations which must be introduced in the first domain to convert the protein to a competitive inhibitor of smMLCK. Alterations of three amino acids predicted to lie on the external surface of calmodulin (E14A, T34K, S38M) recapitulated the phenotype of TaM-BMI and exhibited a K(i) of 38 nM. Both the triple mutant and TaM-BMI activated phosphodiesterase and bound a synthetic peptide analog of the calmodulin binding region of smMLCK with an affinity similar to that of native calmodulin (K(act) and K(d) values of approximately 2 and 3 nM respectively). When a synthetic peptide analog of the myosin light chain phosphorylation site was used as substrate rather than the 20-kDa light chains, TaMBMI and the triple mutant were partial agonists: the K(m) for peptide substrate was increased 100- and 60-fold, and catalytic activity was 45 and 60%, respectively, relative to calmodulin. These data suggest TaMBMI and E14A/T34K/S38M may interact with the calmodulin binding domain of smMLCK in a manner similar to calmodulin. However, alterations in electrostatic and hydrophobic interactions created by the three amino acid substitutions prevent the conformational change in the enzyme usually produced by calmodulin binding. Lack of such changes results in loss of catalytic activity and light chain binding. Additionally, our results show that altering only 3 amino acids residues converts calmodulin to an enzyme-selective antagonist, thus demonstrating the ability to separate calmodulin binding to smMLCK from calmodulin-induced activation of the enzyme.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA	Baylor College of Medicine					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33976] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BAGCHI IC, 1989, J BIOL CHEM, V264, P15843; BARNETTE MS, 1983, BIOCHEM PHARMACOL, V32, P2929, DOI 10.1016/0006-2952(83)90398-2; Battey, 1986, BASIC METHODS MOL BI; BEVINGTON PR, 1969, DATA REDUCTION ERROR, P237; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; COMTE M, 1983, BIOCHEM J, V209, P269, DOI 10.1042/bj2090269; COX JA, 1985, J BIOL CHEM, V260, P2527; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; FOYT HL, 1985, J BIOL CHEM, V260, P7765; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEIDORN DB, 1989, BIOCHEMISTRY-US, V28, P6757, DOI 10.1021/bi00442a032; HERRING BP, 1990, J BIOL CHEM, V265, P16588; IKEBE M, 1987, J BIOL CHEM, V262, P13828; ITOH T, 1989, NATURE, V338, P164, DOI 10.1038/338164a0; JACKSON AE, 1987, PROTEINS, V2, P202, DOI 10.1002/prot.340020305; JACKSON AE, 1986, J BIOL CHEM, V261, P2226; JARRETT HW, 1991, J BIOL CHEM, V266, P362; JOHNSON JD, 1981, J BIOL CHEM, V256, P2194; KEMP BE, 1982, J BIOL CHEM, V257, P13349; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KINCAID RL, 1984, J BIOL CHEM, V259, P5158; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P4031, DOI 10.1021/bi00260a019; MALENCIK DA, 1986, BIOCHEMISTRY-US, V25, P709, DOI 10.1021/bi00351a031; MANN DM, 1989, J BIOL CHEM, V264, P2373; MEANS AR, 1988, RECENT PROG HORM RES, V44, P223; MILLS JS, 1988, BIOCHEMISTRY-US, V27, P991, DOI 10.1021/bi00403a023; MINOWA O, 1988, J BIOCHEM-TOKYO, V103, P531, DOI 10.1093/oxfordjournals.jbchem.a122303; NAKAMURA S, 1986, J BIOCHEM-TOKYO, V99, P1359, DOI 10.1093/oxfordjournals.jbchem.a135604; NEWTON DL, 1989, BIOCHEMISTRY-US, V28, P3750, DOI 10.1021/bi00435a019; NEWTON DL, 1983, BIOCHEMISTRY-US, V22, P5472, DOI 10.1021/bi00293a003; NEWTON DL, 1984, FEBS LETT, V165, P269, DOI 10.1016/0014-5793(84)80183-0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; OLWIN BB, 1984, J BIOL CHEM, V259, P949; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; ONEIL KT, 1989, PROTEINS, V6, P284, DOI 10.1002/prot.340060311; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; PEARSON RB, 1986, J BIOL CHEM, V261, P25; PERSECHINI A, 1989, J BIOL CHEM, V264, P8052; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; PERSECHINI A, 1988, J CARDIOVASC PHARM, V12, pS1; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; PUTKEY JA, 1988, J BIOL CHEM, V263, P11242; PUTKEY JA, 1986, J BIOL CHEM, V261, P9896; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; SEEHOLZER SH, 1989, BIOCHEMISTRY-US, V28, P4011, DOI 10.1021/bi00435a057; Segel I. H., 1975, ENZYME KINETICS, P360; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; STRYNADKA NCJ, 1990, PROTEINS, V7, P234, DOI 10.1002/prot.340070305; VANBERKUM MFA, 1990, J BIOL CHEM, V265, P3750; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; ZAVODNY PJ, 1988, NUCLEIC ACIDS RES, V16, P1214, DOI 10.1093/nar/16.3.1214; ZOT HG, 1989, J BIOL CHEM, V264, P15552; ZOT HG, 1990, J BIOL CHEM, V265, P14796	58	60	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21488	21495						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657969				2022-12-25	WOS:A1991GP80400030
J	MOROY, T; VERBEEK, S; MA, A; ACHACOSO, P; BERNS, A; ALT, F				MOROY, T; VERBEEK, S; MA, A; ACHACOSO, P; BERNS, A; ALT, F			E-MU N-MYC AND E-MU L-MYC COOPERATE WITH E-MU PIM-1 TO GENERATE LYMPHOID TUMORS AT HIGH-FREQUENCY IN DOUBLE-TRANSGENIC MICE	ONCOGENE			English	Article							MURINE LEUKEMIA-VIRUS; C-MYC; NEOPLASTIC TRANSFORMATION; EMBRYO FIBROBLASTS; CELL LYMPHOMAS; T DEVELOPMENT; EXPRESSION; ENHANCER; ONCOGENE; GENES	Transgenic mice that contain the L-myc gene under the control of the immunoglobulin heavy-chain enhancer (E-mu) express the transgene preferentially in T cells, develop thymic hyperplasia and are predisposed to T-cell lymphomas. An analogous E-mu N-myc transgene is expressed preferentially in pre-B and B cells and provokes the development of B-cell neoplasias. Animals with an E-mu pim-1 construct express the transgene in both B and T cells, but succumb to T-cell lymphomas. Complementation of the E-mu N- and L-myc transgenic mice by breeding with E-mu pim-1 animals leads to much more rapid development and a dramatically higher incidence of lymphoid malignancies, but the lineage specificity prescribed by the E-mu N- and L-myc transgenes is maintained. The different oncogenic potential of myc genes is illustrated by the average latency period of tumor manifestation in double transgenics. Whereas c-myc/pim-1 animals develop pre-B-cell leukemia prenatally, the mean latency period for N-myc/pim-1 and L-myc/pim-1 mice is 36 and 94 days respectively. The N- and L-myc transgenes are expressed at high levels in tumors from double transgenic mice, but expression of the endogenous c- and N-myc genes is undetectable, directly implicating the myc transgenes in the tumor formation process.	COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,701 W 168TH ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032; NETHERLANDS CANC INST,DIV MOLEC GENET,1066 CX AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,DEPT BIOCHEM,1066 CX AMSTERDAM,NETHERLANDS	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Netherlands Cancer Institute; University of Amsterdam			Moroy, Tarik/D-9923-2011		NCI NIH HHS [CA23767, CA42335] Funding Source: Medline; NIAID NIH HHS [AI 20047] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042335, P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; COLLUM R, 1990, CANCER CELLS, V3, P69; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; DEPINHO R, 1987, GENE DEV, V8, P1311; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; GOUGH NM, 1981, P NATL ACAD SCI-BIOL, V78, P509, DOI 10.1073/pnas.78.1.509; HOGAN B, 1986, MANIPULATION MOUSE E; IWAMOTO A, 1987, J EXP MED, V165, P591, DOI 10.1084/jem.165.3.591; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; MA A, 1991, MOL CELL BIOL, V11, P440, DOI 10.1128/MCB.11.1.440; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; MANIATIS T, 1983, MOL CLONING; MOROY T, 1990, EMBO J, V9, P3659, DOI 10.1002/j.1460-2075.1990.tb07577.x; NISEN PD, 1986, CANCER RES, V46, P6217; PERRY RP, 1980, P NATL ACAD SCI-BIOL, V77, P1937, DOI 10.1073/pnas.77.4.1937; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7202; ROSENBAUM H, 1989, EMBO J, V8, P749, DOI 10.1002/j.1460-2075.1989.tb03435.x; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; YANCOPOULOS G, 1984, P NATL ACAD SCI USA, V82, P5455; YANCOPOULOS GD, 1985, P NATL ACAD SCI USA, V82, P5455, DOI 10.1073/pnas.82.16.5455; YUKAWA K, 1989, J EXP MED, V170, P711, DOI 10.1084/jem.170.3.711; ZIMMERMAN K, 1990, Critical Reviews in Oncogenesis, V2, P75; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	39	94	96	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					1941	1948						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658705				2022-12-25	WOS:A1991GX11900001
J	DEPILLIS, GD; SISHTA, BP; MAUK, AG; DEMONTELLANO, PRO				DEPILLIS, GD; SISHTA, BP; MAUK, AG; DEMONTELLANO, PRO			SMALL SUBSTRATES AND CYTOCHROME-C ARE OXIDIZED AT DIFFERENT SITES OF CYTOCHROME-C PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER COMPLEX; HORSERADISH-PEROXIDASE; PROSTHETIC HEME; SODIUM-AZIDE; HYPOTHETICAL MODEL; BROWNIAN DYNAMICS; PHENYLHYDRAZINE; MECHANISM; INACTIVATION; ASSOCIATION	Modeling studies suggest that electrons are transferred from cytochrome c to cytochrome c peroxidase (CcP) with cytochrome c predominantly bound at a site facing the gamma-meso edge of the CcP prosthetic heme group (Poulos, T. L., and Kraut, J. (1980) J. Biol. Chem. 255, 10322-10330). As shown here, guaiacol and ferrocyanide are oxidized at a different site of CcP. Thus, the oxidations of cytochrome c and guaiacol are differentially inactivated by phenylhydrazine and sodium azide. The loss of guaiacol oxidation activity correlates with covalent binding of 1 equivalent of [C-14]phenylhydrazine to the protein, whereas the slower loss of cytochrome c activity correlates with the appearance of a 428-nm absorbance maximum attributed to the formation of a sigma-phenyl-iron heme complex. The delta-meso-phenyl and 8-hydroxymethyl derivatives of heme are formed as minor products. Catalytic oxidation of azide to the azidyl radical results in inactivation of CcP and formation of delta-meso-azidoheme. Reconstitution of apo-CcP with delta-meso-azido-, -ethyl-, and -(2-phenylethyl)heme yields holoproteins that give compound I species with H2O2 and exhibit 80, 59, and 31%, respectively, of the control k(cat) value for cytochrome c oxidation but little or no guaiacol or ferrocyanide oxidizing activity. Conversely, CcP reconstituted with gamma-meso-ethylheme is fully active in the oxidation of guaiacol and ferrocyanide but only retains 27% of the cytochrome c oxidizing activity. These results indicate that guaiacol and ferrocyanide are primarily oxidized near the delta-meso-heme edge rather than, like cytochrome c, at a surface site facing the gamma-meso edge.	UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1W5,BC,CANADA	University of California System; University of California San Francisco; University of British Columbia					NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032488] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-1081, RR-01614] Funding Source: Medline; NIGMS NIH HHS [GM32488] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKURA T, 1969, J BIOL CHEM, V244, P4573; ATOR MA, 1987, J BIOL CHEM, V262, P14954; ATOR MA, 1987, J BIOL CHEM, V262, P1542; AUGUSTO O, 1982, J BIOL CHEM, V257, P6231; BECHTOLD R, 1985, J BIOL CHEM, V260, P5191; BOSSHARD HR, 1984, J BIOL CHEM, V259, P5683; BOSSHARD HR, 1990, PEROXIDASES CHEM BIO, V2, P51; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; CHANCE B, 1951, ENZYMES ENZYME SYSTE, P93; CHOE YS, 1991, J BIOL CHEM, V266, P8523; COULSON AFW, 1971, J BIOL CHEM, V246, P917; DEMONTELLANO PRO, 1987, ACCOUNTS CHEM RES, V20, P289; DEMONTELLANO PRO, 1988, BIOCHEMISTRY-US, V27, P5470, DOI 10.1021/bi00415a013; DEPILLIS GD, 1989, BIOCHEMISTRY-US, V28, P7947, DOI 10.1021/bi00445a059; DEPILLIS GD, 1990, ARCH BIOCHEM BIOPHYS, V280, P217, DOI 10.1016/0003-9861(90)90539-B; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; GOODIN DB, 1991, BIOCHEMISTRY-US, V30, P4953, DOI 10.1021/bi00234a017; HARRIS RZ, 1991, J BIOL CHEM, V266, P8751; HAZZARD JT, 1988, BIOCHEM BIOPH RES CO, V151, P429, DOI 10.1016/0006-291X(88)90611-0; ITANO HA, 1977, P NATL ACAD SCI USA, V74, P2556, DOI 10.1073/pnas.74.6.2556; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; KAPUT J, 1982, J BIOL CHEM, V257, P5054; Klebanoff S.J., 1991, PEROXIDASES CHEM BIO, P1; MOCHAN E, 1971, BIOCHEM J, V121, P69, DOI 10.1042/bj1210069; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; NORTHRUP SH, 1987, J PHYS CHEM-US, V91, P5991, DOI 10.1021/j100307a036; POULOS TL, 1980, J BIOL CHEM, V255, P322; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5; WALDMEYER B, 1982, J BIOL CHEM, V257, P6073; WALDMEYER B, 1985, J BIOL CHEM, V260, P5184; YANDELL JK, 1983, BIOCHIM BIOPHYS ACTA, V748, P263, DOI 10.1016/0167-4838(83)90303-5; YONETANI T, 1965, J BIOL CHEM, V240, P4503; YONETANI T, 1966, BIOCHEM PREP, V11, P14	34	68	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19334	19341						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655784				2022-12-25	WOS:A1991GK66700036
J	SEVARINO, KA; STORK, P				SEVARINO, KA; STORK, P			MULTIPLE PREPROSOMATOSTATIN SORTING SIGNALS MEDIATE SECRETION VIA DISCRETE CAMP-RESPONSIVE AND TETRADECANOYLPHORBOLACETATE-RESPONSIVE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; COW ANTERIOR-PITUITARY; TRANS-GOLGI NETWORK; GROWTH-HORMONE; RAT-BRAIN; EXOCRINE PANCREAS; PROTEIN SECRETION; SEQUENCE-ANALYSIS; EUKARYOTIC CELLS; ENDOCRINE-CELLS	We have previously detected a sorting signal in the amino-terminal 78 residues of rat preprosomatostatin (rPPSS) that targets the precursor into a regulated secretory pathway or pathways allowing proteolytic maturation (Sevarino, K. A., Stork, P., Ventimiglia, R., Mandel, G., and Goodman, R. H. (1989) Cell 57, 11-19). To further localize this signal, we constructed three rPPSS expression vectors that code for substitutions or mutations spanning that portion of rPPSS implicated in sorting, and the precursors were expressed in RIN 5F cells. Fractionation of the intracellular products revealed that accurate processing to somatostatin-14 (SS-14) was not affected by any of the mutations. Examination of the secreted products showed no reduction in processing efficiency, indicating that none of the mutations blocked sorting from constitutive into regulated secretion. Finally, we examined the response to two separate secretogogues, cAMP and 12-O-tetradecanoylphorbol-13-acetate (TPA). Clones expressing two of the three mutant precursors displayed the same stimulation of SS-14 secretion by exogenously administered cAMP and TPA as cells expressing wild-type rPPSS, indicating that targeting specifically to the secretory pathway, or pathways, responsive to cAMP and TPA was not disrupted. However, cells expressing the mutant precursor containing a substitution of the amino-terminal 34 residues of rPPSS by the amino terminus of the vesicular stomatitis virus G protein displayed greatly reduced stimulation of SS-14 secretion by TPA, with a less than compensatory increase in response to cAMP, when compared to cells expressing wild-type rPPSS. In conjunction with our previous studies with anglerfish preprosomatostatins, we conclude that 1) the sorting signal(s) in rPPSS necessary for cAMP-responsive secretion are redundant and probably reside within both mature peptide regions and extrapeptide regions; 2) two or more distinct regulated secretory pathways utilized by secreted peptides can be demonstrated in transfected endocrine cells and targeting to these pathways can be separately mediated by at least two different types of sorting signals within the neuropeptide precursor itself; and 3) pro-region conformation plays little role in prosomatostatin-processing site recognition.	TUFTS UNIV, NEW ENGLAND MED CTR, DEPT MED, DIV MOLEC MED, BOSTON, MA 02111 USA	Tufts Medical Center; Tufts University					NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031400] Funding Source: NIH RePORTER; NIADDK NIH HHS [IP30AM34928] Funding Source: Medline; NIDDK NIH HHS [DK31400] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARGOS P, 1983, J BIOL CHEM, V258, P8788; ARVAN P, 1987, J BIOL CHEM, V262, P3886; ARVAN P, 1987, J CELL BIOL, V104, P243, DOI 10.1083/jcb.104.2.243; BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BLOOM SR, 1983, LANCET, V2, P1163; BRAKCH N, 1989, J BIOL CHEM, V264, P15912; BULANT M, 1990, P NATL ACAD SCI USA, V87, P4439, DOI 10.1073/pnas.87.12.4439; BURGESS TL, 1985, J CELL BIOL, V101, P639, DOI 10.1083/jcb.101.2.639; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; CHUNG KN, 1989, SCIENCE, V243, P192, DOI 10.1126/science.2911732; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; DECAMILLI P, 1987, ANN NY ACAD SCI, V493, P461; DOCHERTY K, 1989, J BIOL CHEM, V264, P18335; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; FAGARASAN MO, 1990, P NATL ACAD SCI USA, V87, P7871, DOI 10.1073/pnas.87.20.7871; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; FLORKIEWICZ RZ, 1983, J CELL BIOL, V97, P1381, DOI 10.1083/jcb.97.5.1381; FUMAGALLI G, 1985, J CELL BIOL, V100, P2019, DOI 10.1083/jcb.100.6.2019; GENNARO R, 1983, J CELL BIOL, V96, P1651, DOI 10.1083/jcb.96.6.1651; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; GOMEZ S, 1989, EMBO J, V8, P2911, DOI 10.1002/j.1460-2075.1989.tb08440.x; GORDELADZE JO, 1988, BIOCHEM PHARMACOL, V37, P3133, DOI 10.1016/0006-2952(88)90311-5; GREEN R, 1984, ENDOCRINOLOGY, V114, P1990, DOI 10.1210/endo-114-6-1990; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GUBLER U, 1982, NATURE, V295, P206, DOI 10.1038/295206a0; HASHIMOTO S, 1987, J CELL BIOL, V105, P1579, DOI 10.1083/jcb.105.4.1579; HOBART P, 1980, NATURE, V288, P137, DOI 10.1038/288137a0; INOUE K, 1984, CELL TISSUE RES, V235, P77; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; JORGENSEN MJ, 1987, CELL, V48, P185, DOI 10.1016/0092-8674(87)90422-3; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KREINER T, 1986, J CELL BIOL, V102, P769, DOI 10.1083/jcb.102.3.769; LAND H, 1982, NATURE, V295, P299, DOI 10.1038/295299a0; LECHAN RM, 1986, SCIENCE, V231, P159, DOI 10.1126/science.3079917; LECHAN RM, 1983, P NATL ACAD SCI-BIOL, V80, P2780, DOI 10.1073/pnas.80.9.2780; LEPAGELEZIN A, 1991, J BIOL CHEM, V266, P1679; LEW PD, 1986, J CELL BIOL, V102, P2197, DOI 10.1083/jcb.102.6.2197; LI GD, 1991, J BIOL CHEM, V266, P3449; LOW MJ, 1985, CELL, V41, P211, DOI 10.1016/0092-8674(85)90075-3; MONTMINY MR, 1984, P NATL ACAD SCI-BIOL, V81, P3337, DOI 10.1073/pnas.81.11.3337; MOORE HP, 1983, J CELL BIOL, V97, P810, DOI 10.1083/jcb.97.3.810; MOORE HPH, 1986, NATURE, V321, P443, DOI 10.1038/321443a0; NAKANISHI S, 1981, EUR J BIOCHEM, V115, P429; NIKOLICS K, 1985, NATURE, V316, P511, DOI 10.1038/316511a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; NOE BD, 1986, J CELL BIOL, V103, P1205, DOI 10.1083/jcb.103.4.1205; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; PASLEAU F, 1985, GENE, V38, P227, DOI 10.1016/0378-1119(85)90221-5; PATEL YC, 1978, ENDOCRINOLOGY, V102, P523, DOI 10.1210/endo-102-2-523; PATEL YC, 1988, J BIOL CHEM, V263, P745; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; POWELL SK, 1988, J CELL BIOL, V106, P1843, DOI 10.1083/jcb.106.6.1843; RAY KP, 1988, MOL CELL ENDOCRINOL, V58, P243, DOI 10.1016/0303-7207(88)90160-8; RHOLAM M, 1986, FEBS LETT, V207, P1, DOI 10.1016/0014-5793(86)80002-3; ROSE JK, 1982, CELL, V30, P753, DOI 10.1016/0092-8674(82)90280-X; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; SEVARINO KA, 1987, J BIOL CHEM, V262, P4987; SEVARINO KA, 1989, CELL, V57, P11, DOI 10.1016/0092-8674(89)90167-0; SEVARINO KA, 1989, J BIOL CHEM, V264, P21529; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; SOSSIN WS, 1990, P NATL ACAD SCI USA, V87, P4845, DOI 10.1073/pnas.87.12.4845; SPIESS J, 1985, P NATL ACAD SCI USA, V82, P277, DOI 10.1073/pnas.82.2.277; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; STEINER DF, 1986, CLIN INVEST MED, V9, P328; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; THIM L, 1986, P NATL ACAD SCI USA, V83, P6766, DOI 10.1073/pnas.83.18.6766; TOOZE J, 1987, J CELL BIOL, V105, P1215, DOI 10.1083/jcb.105.3.1215; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VONZASTROW M, 1989, J BIOL CHEM, V264, P6566; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; WARREN TG, 1984, CELL, V39, P547, DOI 10.1016/0092-8674(84)90461-6; WIREN KM, 1988, J BIOL CHEM, V263, P19771; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; WU P, 1988, REGUL PEPTIDES, V22, P347, DOI 10.1016/0167-0115(88)90111-5; WU P, 1988, BRAIN RES, V456, P22, DOI 10.1016/0006-8993(88)90342-3	84	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18507	18513						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1680862				2022-12-25	WOS:A1991GJ47200018
J	BORTH, W; CHANG, V; BISHOP, P; HARPEL, PC				BORTH, W; CHANG, V; BISHOP, P; HARPEL, PC			LIPOPROTEIN(A) IS A SUBSTRATE FOR FACTOR-XIIIA AND TISSUE TRANSGLUTAMINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIN-STABILIZING FACTOR; CROSS-LINKING; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-B; PLASMA; BINDING; PLASMINOGEN; ALPHA-2-MACROGLOBULIN; ATHEROSCLEROSIS; IDENTIFICATION	The mechanisms which mediate deposition of lipoprotein (a) (Lp(a)), an atherogenic lipoprotein particle, onto the vessel wall and cell surfaces are unknown. An irreversible deposition of Lp(a) may require the presence of enzymes that catalyze its binding to surface-oriented structures. Transglutaminases catalyze cross-linking of proteins as well as incorporation of primary amines into protein substrates. We studied whether tissue transglutaminase and/or activated Factor XIII (plasma derived or recombinant FXIIIa) incorporate primary amines into Lp(a). In the presence of Ca2+, Factor XIIIa and tissue transglutaminase catalyze incorporation of monodansylcadaverine or [C-14]putrescine into purified Lp(a) in a specific and time-dependent manner. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that monodansylcadaverine became incorporated into the apo(a) portion of Lp(a). Lp(a) purified from five different donors showing different apo(a) phenotypes were substrates for tissue transglutaminases (TG). Western blot analysis confirmed that apo(a) was the major monodansylcadaverine carrying protein moiety of Lp(a). Tissue TG also extensively cross-linked the apo(a) portion of the Lp(a) particle. Characterization of the specificity of tissue TG showed that fibronectin, alpha-2-plasmin inhibitor, and apo(a) could be readily labeled with monodansylcadaverine by tissue TG, but other proteins including low density lipoprotein, IgG, alpha-1-proteinase inhibitor, and albumin showed poor or no reactivity. Direct comparison of Lp(a) with low density lipoprotein showed that apoB 100 was a poor substrate for transglutaminases. Recombinant apolipoprotein (a) proved to be an excellent substrate for TGs in that 1 mol of recombinant apolipoprotein (a) incorporated as much as 15 mol of [C-14]putrescine, which corresponded to five times the amount of amine incorporated into Lp(a). The susceptibility of Lp(a) to transglutaminases suggests a mechanism whereby the interaction of Lp(a) with surface receptors and other surface oriented structures could be enzymatically altered.	CORNELL UNIV,MED CTR,COLL MED,SPECIALIZED CTR RES THROMBOSIS,NEW YORK,NY 10021; ZYMOGENET INC,SEATTLE,WA 98105	Cornell University; Zymogenet Inc.	BORTH, W (corresponding author), MT SINAI MED CTR,DEPT MED,DIV HEMATOL,BOX 1079,1 GUSTAVE L LEVY PL,NEW YORK,NY 10029, USA.				NHLBI NIH HHS [HL-18828] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL018828] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; BORTH W, 1989, J BIOL CHEM, V264, P5818; BROWN MS, 1987, NATURE, V330, P113, DOI 10.1038/330113a0; COCUZZI E, 1990, BIOCHEM J, V265, P707, DOI 10.1042/bj2650707; CUSHING GL, 1989, ARTERIOSCLEROSIS, V9, P593, DOI 10.1161/01.ATV.9.5.593; EATON DL, 1987, P NATL ACAD SCI USA, V84, P3224, DOI 10.1073/pnas.84.10.3224; FLESS GM, 1990, J LIPID RES, V31, P909; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FRANCIS RT, 1986, J BIOL CHEM, V261, P9787; GAUBATZ JW, 1990, J LIPID RES, V31, P603; GONZALEZGRONOW M, 1989, BIOCHEMISTRY-US, V28, P2374, DOI 10.1021/bi00432a005; GREENBERG CS, 1987, BLOOD, V70, P702; HADA M, 1986, BLOOD, V68, P95; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; HOFF HF, 1988, CIRCULATION, V77, P1238, DOI 10.1161/01.CIR.77.6.1238; KOSHINSKY ML, 1990, BIOCHEMISTRY-US, V29, P640; LAKI K, 1972, ANN NY ACAD SCI, V202, P235, DOI 10.1111/j.1749-6632.1972.tb16337.x; LORAND L, 1986, BIOCHEM BIOPH RES CO, V134, P685, DOI 10.1016/S0006-291X(86)80474-0; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; LORAND L, 1968, BIOCHEMISTRY-US, V7, P1214, DOI 10.1021/bi00843a043; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; MOSHER DF, 1976, J BIOL CHEM, V251, P1639; MOSHER DF, 1984, MOL CELL BIOCHEM, V58, P63, DOI 10.1007/BF00240605; MURAI A, 1986, ATHEROSCLEROSIS, V59, P199, DOI 10.1016/0021-9150(86)90048-1; NARA K, 1989, J BIOL CHEM, V264, P19308; RATH M, 1989, ARTERIOSCLEROSIS, V9, P579, DOI 10.1161/01.ATV.9.5.579; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; TYRELL DJ, 1988, J BIOL CHEM, V263, P8464	33	47	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18149	18153						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680857				2022-12-25	WOS:A1991GG55300067
J	SOTTILE, J; SCHWARZBAUER, J; SELEGUE, J; MOSHER, DF				SOTTILE, J; SCHWARZBAUER, J; SELEGUE, J; MOSHER, DF			5 TYPE-I MODULES OF FIBRONECTIN FORM A FUNCTIONAL UNIT THAT BINDS TO FIBROBLASTS AND STAPHYLOCOCCUS-AUREUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							IMMOBILIZED FIBRIN MONOMER; PLASMA FIBRONECTIN; AFFINITY-CHROMATOGRAPHY; CROSS-LINKING; EVOLUTION; FRAGMENT; PEPTIDES; PROTEIN; DOMAIN; GENE	Fibronectin is a cell-adhesive protein comprised of three types of repeating homologous sequences, I, II, and III (Petersen, T. E., Thogersen, H. C., Skorstengaard, K., Vibe-Pedersen, K., Sahl, P., Sottrup-Jensen, L., and Magnusson, S. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 137-141). The amino-terminal portion of fibronectin is comprised of five type I modules and mediates assembly of dimeric soluble fibronectin into insoluble fibrils by cultured fibroblasts, binding and cross-linking of fibronectin to Staphylococcus aureus, and binding and cross-linking of fibronectin to fibrin. It is not known whether these binding activities require individual type I modules, several modules, or all five modules. To answer this question, we generated recombinant truncated fibronectin molecules with deletions of or mutations in the amino-terminal type I modules. Binding to cellular fibronectin assembly sites and S. aureus required all five type I modules. In contrast, proteins with deletions of type I modules interacted well with fibrin.	UNIV WISCONSIN,DEPT PHYSIOL CHEM,MADISON,WI 53706; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	University of Wisconsin System; University of Wisconsin Madison; Princeton University	SOTTILE, J (corresponding author), UNIV WISCONSIN,DEPT MED,MADISON,WI 53706, USA.			Schwarzbauer, Jean/0000-0003-1012-7593	NATIONAL CANCER INSTITUTE [R01CA044627] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008136, R01HL021644] Funding Source: NIH RePORTER; NCI NIH HHS [CA44627] Funding Source: Medline; NHLBI NIH HHS [HL21644, HL08136] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; COLVIN RB, 1989, FIBRONECTIN, pP213; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7; HORMANN H, 1980, H-S Z PHYSIOL CHEM, V361, P1449; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUYPERS JM, 1989, INFECT IMMUN, V57, P2306, DOI 10.1128/IAI.57.8.2306-2312.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cb.04.110188.001151; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1989, FIBRONECTIN, P163; MOSHER DF, 1983, ANN NY ACAD SCI, V408, P583, DOI 10.1111/j.1749-6632.1983.tb23275.x; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; PATEL RS, 1987, EMBO J, V6, P2565, DOI 10.1002/j.1460-2075.1987.tb02545.x; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; PETERSEN TE, 1989, FIBRONECTIN, P163; PROCTOR RA, 1982, J BIOL CHEM, V257, P4788; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEIDL M, 1983, H-S Z PHYSIOL CHEM, V364, P83, DOI 10.1515/bchm2.1983.364.1.83; SEKEGUCHI K, 1983, J BIOL CHEM, V258, P3967; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Sottile J, 1990, Protein Expr Purif, V1, P104, DOI 10.1016/1046-5928(90)90002-G; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; Yamada KM, 1989, FIBRONECTIN, P47; ZOLLER MJ, 1989, RECOMBINANT DNA METH, P537	30	111	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					12840	12843						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1677003				2022-12-25	WOS:A1991FX13200009
J	KAHN, SM; JIANG, W; CULBERTSON, TA; WEINSTEIN, IB; WILLIAMS, GM; TOMITA, N; RONAI, Z				KAHN, SM; JIANG, W; CULBERTSON, TA; WEINSTEIN, IB; WILLIAMS, GM; TOMITA, N; RONAI, Z			RAPID AND SENSITIVE NONRADIOACTIVE DETECTION OF MUTANT K-RAS GENES VIA ENRICHED PCR AMPLIFICATION	ONCOGENE			English	Article							POLYMERASE CHAIN-REACTION; POINT MUTATIONS; HUMAN CANCER; ONCOGENES; ACTIVATION; DIAGNOSIS; ADENOCARCINOMA; CARCINOGENESIS; TUMORIGENESIS; ANTIONCOGENES	We have developed a rapid and highly sensitive nonradioactive method for the detection of a mutant codon 12 human c-K-ras allele in the presence of as many as 10(4) copies of the wild type codon 12 allele. This sensitivity is achieved by selective polymerase chain reaction (PCR) amplification of mutant K-ras gene sequences employing a two stage procedure. The first stage entails the amplification of both K-ras mutant and wild type codon 12 sequences, followed by a selective restriction enzyme digestion of only wild type sequences. The second stage involves a subsequent amplification of undigested amplified fragments, enriched in mutant codon 12 sequences. These products are subject to restriction length polymorphism analysis for the detection of point mutations at codon 12. This technique is rapid, nonradioactive, and eliminates the need for either oligonucleotide hybridization or DNA sequencing. Variations of this selective amplification procedure may prove promising for the detection of specific point mutations in heterogenous cell populations.	COLUMBIA UNIV COLL PHYS & SURG,CTR COMPREHENS CANC,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,INST CANC RES,NEW YORK,NY 10032; AMER HLTH FDN,MOLEC CARCINOGENESIS PROGRAM,VALHALLA,NY 10595; AMER HLTH FDN,DIV PATHOL & TOXICOL,VALHALLA,NY 10595	Columbia University; Columbia University; American Health Foundation; American Health Foundation	RONAI, Z (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR COMPREHENS CANC,NEW YORK,NY 10032, USA.			Jiang, Wei/0000-0002-2309-9571	NATIONAL CANCER INSTITUTE [P01CA021111, P30CA017613, R01CA039545] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39545, CA021111, CA17613] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1989, CANCER RES, V49, P4682; BOS JL, 1988, MUTAT RES, V195, P225; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; EHLEN T, 1989, BIOCHEM BIOPH RES CO, V160, P441, DOI 10.1016/0006-291X(89)92452-2; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; JIANG W, 1989, ONCOGENE, V4, P923; KAHN SM, 1990, AMPLIFICATIONS, V4, P22; KNUDSON AG, 1985, CANCER RES, V45, P1437; KUMAR R, 1989, CANCER CEL, V7, P151; KUMAR R, 1990, SCIENCE, V248, P1101, DOI 10.1126/science.2188364; KUMAR R, 1988, ONCOGENE, V3, P647; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; MCCORMICK F, 1989, CANCER CELL-MON REV, V1, P56; MIYAOTO S, 1990, MOL CELL BIOL, V19, P1593; NASSAL M, 1990, NUCLEIC ACIDS RES, V18, P3077, DOI 10.1093/nar/18.10.3077; PERUCHO M, 1989, CANCER CEL, V7, P137; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; TAYLORPAPADIMITRIOU J, 1982, CELL DIFFER DEV, V11, P169, DOI 10.1016/0045-6039(82)90008-2; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WEINBERG RA, 1989, CANCER RES, V49, P3713; WEINSTEIN IB, 1988, CANCER RES, V48, P4135	29	205	223	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					1079	1083						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	1676837				2022-12-25	WOS:A1991GU62200027
J	JAMES, R; KAZENWADEL, J				JAMES, R; KAZENWADEL, J			HOMEOBOX GENE-EXPRESSION IN THE INTESTINAL EPITHELIUM OF ADULT MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED DROSOPHILA CELLS; MOUSE SMALL-INTESTINE; ACID-BINDING-PROTEIN; HORMONE FUSION GENES; TRANSGENIC MICE; MESSENGER-RNA; DNA-BINDING; BOX GENE; TRANSCRIPTIONAL ACTIVATION; HOMOLOGOUS RECOMBINATION	Using a polymerase chain reaction-based strategy, we have detected the expression of nine different homeobox genes in adult mouse intestine. Included among these are the recently described intestine-specific Cdx-1 gene and a new, related gene, Cdx-2. Southern blot experiments show that Cdx-2 is present in a single copy in the mouse genome. Of several adult mouse tissues assayed, intestine was the only one that contained detectable levels of Cdx-2 mRNA. Expression of all nine homeobox genes in different regions of the intestine was quantitated by RNase protection analysis, which revealed a unique expression profile for each gene. These observations suggest that homeobox gene expression may play an important role in cellular differentiation in the adult intestine.			JAMES, R (corresponding author), ROYAL MELBOURNE HOSP, LUDWIG INST CANC RES, MELBOURNE TUMOUR BIOL BRANCH, PARKVILLE, VIC 3050, AUSTRALIA.		Kazenwadel, Jan/E-6620-2012	Kazenwadel, Jan/0000-0001-6216-3444				AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; ALTABA AR, 1989, CELL, V57, P317, DOI 10.1016/0092-8674(89)90969-0; ALTABA AR, 1989, NATURE, V341, P33; ALTABA ARI, 1989, DEVELOPMENT, V106, P173; AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; BOGARAD LD, 1989, DEV BIOL, V133, P537, DOI 10.1016/0012-1606(89)90056-0; BOOTHBY M, 1981, J BIOL CHEM, V256, P5121; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BREIER G, 1988, EMBO J, V7, P1329, DOI 10.1002/j.1460-2075.1988.tb02948.x; CHANG WWL, 1971, ANAT REC, V169, P293; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; COPSON RE, 1966, AM J ANAT, V118, P53; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; DRESSLER GR, 1989, TRENDS GENET, V5, P129, DOI 10.1016/0168-9525(89)90048-6; DRESSLER GR, 1988, TRENDS GENET, V4, P214, DOI 10.1016/S0168-9525(88)80003-9; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FIRESTEIN GS, 1987, ANAL BIOCHEM, V167, P381, DOI 10.1016/0003-2697(87)90180-1; GAUNT SJ, 1990, TRENDS GENET, V6, P208; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HAUFT SM, 1989, J BIOL CHEM, V264, P8419; HOEY T, 1986, P NATL ACAD SCI USA, V83, P4809, DOI 10.1073/pnas.83.13.4809; HOGAN B, 1985, TRENDS GENET, V1, P67, DOI 10.1016/0168-9525(85)90029-0; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; JACKSON PD, 1985, P NATL ACAD SCI USA, V82, P2296, DOI 10.1073/pnas.82.8.2296; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEWIS J, 1989, NATURE, V341, P382, DOI 10.1038/341382a0; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MEIJLINK F, 1987, NUCLEIC ACIDS RES, V15, P6773, DOI 10.1093/nar/15.17.6773; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NORTHOVER J, 1989, CANCER SURV, V8, P1; ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; Potten C, 1983, STEM CELLS THEIR IDE, V155-99; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; REGULSKI M, 1985, CELL, V43, P71, DOI 10.1016/0092-8674(85)90013-3; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; RUBIN DC, 1989, P NATL ACAD SCI USA, V86, P1278, DOI 10.1073/pnas.86.4.1278; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; RUBIN W, 1966, LAB INVEST, V15, P1720; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SHEN WF, 1989, P NATL ACAD SCI USA, V86, P8536, DOI 10.1073/pnas.86.21.8536; SJOLUND K, 1983, GASTROENTEROLOGY, V85, P1120; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; THOMPSON J, 1987, ANAL BIOCHEM, V163, P281, DOI 10.1016/0003-2697(87)90225-9; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; WILLETT W, 1989, NATURE, V338, P389, DOI 10.1038/338389a0; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WOLGEMUTH DJ, 1989, NATURE, V337, P464, DOI 10.1038/337464a0; WRIGHT N, 1984, BIOL EPITHELIAL CELL, V2, P537; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; ZIMMER A, 1989, NATURE, V338, P150, DOI 10.1038/338150a0	79	204	207	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3246	3251						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1671571				2022-12-25	WOS:A1991EX60000087
J	TSURIMOTO, T; STILLMAN, B				TSURIMOTO, T; STILLMAN, B			REPLICATION FACTORS REQUIRED FOR SV40 DNA-REPLICATION INVITRO .1. DNA STRUCTURE-SPECIFIC RECOGNITION OF A PRIMER-TEMPLATE JUNCTION BY EUKARYOTIC DNA-POLYMERASES AND THEIR ACCESSORY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; CELL NUCLEAR ANTIGEN; CEREVISIAE CDC2 GENE; ESCHERICHIA-COLI; III HOLOENZYME; SACCHAROMYCES-CEREVISIAE; CALF THYMUS; T-ANTIGEN; ORIGIN; DELTA	Eukaryotic DNA polymerase delta and its accessory proteins are essential for SV40 DNA replication in vitro. A multi-subunit protein complex, replication factor C (RF-C), which is composed of subunits with apparent molecular weights of 140,000, 41,000, and 37,000, has primer/template binding and DNA-dependent ATPase activities. UV-cross-linking experiments demonstrated that the M(r) = 140,000 subunit recognizes and binds to the primer-template DNA, whereas the M(r) = 41,000 polypeptide binds ATP. Assembly of a replication complex at a primer-template junction has been studied in detail with synthetic, hairpin DNAs. Following glutaraldehyde fixation, a gel shift assay demonstrated that RF-C alone forms a weak binding complex with the hairpin DNA. Addition of ATP or its nonhydrolyzable analogue, ATP-gamma-S, increased specific binding to the DNA. Footprinting experiments revealed that RF-C recognizes the primer-template junction, covering 15 bases of the primer DNA from the 3'-end and 20 bases of the template DNA. Another replication factor, proliferating cell nuclear antigen (PCNA) binds to RF-C and the primer-template DNA forming a primer recognition complex and extends the protected region on the duplex DNA. This RF-C.PCNA complex has significant single-stranded DNA binding activity in addition to binding to a primer-template junction. However, addition of another replication factor, RF-A, completely blocked the nonspecific, single-stranded DNA binding by the RF-C.PCNA complex. RF-A therefore functions as a specificity factor for primer recognition. In the absence of RF-C, DNA polymerase delta (pol delta) and PCNA form a complex at the primer-template junction, protecting exactly the same site as the primer recognition complex. Addition of RF-C to this complex produced a higher order complex which is unstable unless its formation is coupled with translocation of pol delta. These results suggest that the sequential binding of RF-C, PCNA, and pol delta to a primer-template junction might directly account for the initiation of leading strand DNA synthesis at a replication origin. We demonstrate this directly in an accompanying paper.			TSURIMOTO, T (corresponding author), COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724, USA.			Stillman, Bruce/0000-0002-9453-4091; Tsurimoto, Toshiki/0000-0001-7597-2216	NCI NIH HHS [CA13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTS BM, 1980, MECHANISTIC STUDIES, P449; BAUER GA, 1988, J BIOL CHEM, V263, P917; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; CHA TA, 1989, J BIOL CHEM, V264, P12220; CHA TA, 1988, EUKARYOTIC DNA REPLI, V6, P1; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DECKER RS, 1987, J BIOL CHEM, V262, P10863; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; INSDORF NF, 1989, J BIOL CHEM, V264, P21498; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; MACE DC, 1984, J MOL BIOL, V177, P313, DOI 10.1016/0022-2836(84)90459-5; MACE DC, 1984, J MOL BIOL, V177, P279, DOI 10.1016/0022-2836(84)90457-1; MAKI H, 1988, J BIOL CHEM, V263, P6570; MAKI S, 1988, J BIOL CHEM, V263, P6561; Maniatis T., 1982, MOL CLONING; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MELENDY T, 1991, J BIOL CHEM, V266, P1942; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P2869, DOI 10.1073/pnas.83.9.2869; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; PIPERNO JR, 1978, J BIOL CHEM, V253, P5174; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; ROBERTS JM, 1989, P NATL ACAD SCI USA, V86, P3939, DOI 10.1073/pnas.86.11.3939; SCHNEIDER R, 1986, NUCLEIC ACIDS RES, V14, P1303, DOI 10.1093/nar/14.3.1303; SELICK HE, 1987, UCLA S MOL CELLULAR, P183; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9742, DOI 10.1073/pnas.86.24.9742; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643	56	348	349	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1950	1960						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671045				2022-12-25	WOS:A1991EU49700088
J	ROESSER, JR; YANOFSKY, C				ROESSER, JR; YANOFSKY, C			THE RNA ANTITERMINATOR CAUSES TRANSCRIPTION PAUSING IN THE LEADER REGION OF THE TRYPTOPHAN OPERON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University					NIGMS NIH HHS [GM 12090, GM 09738] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012090, R37GM009738, R01GM009738] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHRISTIE GE, 1981, P NATL ACAD SCI-BIOL, V78, P4180, DOI 10.1073/pnas.78.7.4180; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; DAS A, 1982, J BIOL CHEM, V257, P8795; DEKELGORODETSKY L, 1986, J BACTERIOL, V165, P1046, DOI 10.1128/jb.165.3.1046-1048.1986; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; FARNHAM PJ, 1980, CELL, V20, P739, DOI 10.1016/0092-8674(80)90320-7; KOLTER R, 1984, J MOL BIOL, V175, P299, DOI 10.1016/0022-2836(84)90350-4; KOLTER R, 1982, ANNU REV GENET, V16, P113, DOI 10.1146/annurev.ge.16.120182.000553; KURODA MI, 1984, J BIOL CHEM, V259, P2838; LANDICK R, 1987, J MOL BIOL, V196, P363, DOI 10.1016/0022-2836(87)90697-8; LANDICK R, 1984, J BIOL CHEM, V259, P1550; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LEE F, 1978, J MOL BIOL, V121, P193, DOI 10.1016/S0022-2836(78)80005-9; LEE F, 1977, P NATL ACAD SCI USA, V74, P4365, DOI 10.1073/pnas.74.10.4365; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MANIATIS T, 1982, MOL CLONING LABORATO, P237; Maxam A M, 1980, Methods Enzymol, V65, P499; MIOZZARI GF, 1978, J BACTERIOL, V133, P1457, DOI 10.1128/JB.133.3.1457-1466.1978; MIOZZARI GF, 1978, J BACTERIOL, V133, P1459; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; OXENDER DL, 1979, P NATL ACAD SCI USA, V76, P5524, DOI 10.1073/pnas.76.11.5524; PLATT T, 1981, CELL, V24, P10, DOI 10.1016/0092-8674(81)90496-7; REISBIG RR, 1981, BIOCHEMISTRY-US, V20, P1907, DOI 10.1021/bi00510a029; ROESSER JR, 1989, J BIOL CHEM, V264, P12284; ROESSER JR, 1988, J BIOL CHEM, V263, P14251; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; RYAN T, 1983, J BIOL CHEM, V258, P4690; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; SOMMER H, 1978, J MOL BIOL, V123, P457; STAUFFER GV, 1978, P NATL ACAD SCI USA, V75, P4833, DOI 10.1073/pnas.75.10.4833; STROYNOWSKI I, 1982, NATURE, V298, P38, DOI 10.1038/298038a0; STROYNOWSKI I, 1983, P NATL ACAD SCI-BIOL, V80, P2206, DOI 10.1073/pnas.80.8.2206; STROYNOWSKI I, 1982, NATURE, V298, P34, DOI 10.1038/298034a0; WINKLER ME, 1981, BIOCHEMISTRY-US, V20, P3738, DOI 10.1021/bi00516a011; YANOFSKY C, 1981, J BACTERIOL, V145, P1334, DOI 10.1128/JB.145.3.1334-1341.1981; YANOFSKY C, 1984, J BACTERIOL, V158, P1018, DOI 10.1128/JB.158.3.1018-1024.1984; ZUBAY G, 1970, LACTOSE OPERON, P375; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; ZURAWSKI G, 1978, P NATL ACAD SCI USA, V75, P5988, DOI 10.1073/pnas.75.12.5988	40	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6055	6060						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690721				2022-12-25	WOS:A1990CY58700027
J	CIRCOLO, A; PIERCE, GF; KATZ, Y; STRUNK, RC				CIRCOLO, A; PIERCE, GF; KATZ, Y; STRUNK, RC			ANTIINFLAMMATORY EFFECTS OF POLYPEPTIDE GROWTH-FACTORS - PLATELET-DERIVED GROWTH-FACTOR, EPIDERMAL GROWTH-FACTOR, AND FIBROBLAST GROWTH-FACTOR INHIBIT THE CYTOKINE-INDUCED EXPRESSION OF THE ALTERNATIVE COMPLEMENT PATHWAY ACTIVATOR FACTOR-B IN HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									ST LOUIS CHILDRENS HOSP,DIV PULM MED,ST LOUIS,MO 63110; ST LOUIS CHILDRENS HOSP,DIV ALLERGY IMMUNOL,ST LOUIS,MO 63110; AMGEN INC,DEPT EXPTL PATHOL,THOUSAND OAKS,CA 91320	St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Amgen	CIRCOLO, A (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PEDIAT,400 S KINGSHIGHWAY,ST LOUIS,MO 63110, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024836, R01AI024739, R37AI024739] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37591] Funding Source: Medline; NIAID NIH HHS [AI24836, AI24739] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIRD TA, 1989, J IMMUNOL, V142, P126; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLE FS, 1985, J IMMUNOL, V134, P2610; Colten H R, 1976, Adv Immunol, V22, P67, DOI 10.1016/S0065-2776(08)60548-9; Colten H R, 1979, Ann N Y Acad Sci, V332, P482, DOI 10.1111/j.1749-6632.1979.tb47142.x; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; EK B, 1982, J BIOL CHEM, V257, P486; ESCOBEDO JA, 1988, SCIENCE, V240, P1532, DOI 10.1126/science.2836953; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; KASID A, 1988, J IMMUNOL, V141, P690; KATZ Y, 1988, J IMMUNOL, V141, P559; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KATZ Y, 1989, J IMMUNOL, V142, P3862; KATZ Y, 1988, J EXP MED, V167, P1, DOI 10.1084/jem.167.1.1; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LE JM, 1987, LAB INVEST, V56, P234; MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404; MIYAJIMA A, 1988, FASEB J, V2, P2462, DOI 10.1096/fasebj.2.9.2836253; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; PERLMUTTER DH, 1986, SCIENCE, V232, P850, DOI 10.1126/science.3010455; PIERCE GF, 1988, ONCOGENE RES, V2, P235; PIERCE GF, 1988, J EXP MED, V167, P974, DOI 10.1084/jem.167.3.974; PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429; PIERCE GF, 1989, P NATL ACAD SCI USA, V86, P2229, DOI 10.1073/pnas.86.7.2229; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; REID KBM, 1977, BIOCHEM J, V167, P647, DOI 10.1042/bj1670647; SHAWVER LK, 1989, J BIOL CHEM, V264, P1046; STRUNK RC, 1985, J CLIN INVEST, V76, P985, DOI 10.1172/JCI112099; STRUNK RC, 1985, J BIOL CHEM, V260, P5280; SUSA M, 1989, CELL, V57, P817, DOI 10.1016/0092-8674(89)90796-4; THOMAS PS, 1980, P NATL ACAD SCI USA, V77, P5102; TZENG DY, 1984, BLOOD, V64, P1123; TZENG DY, 1985, BLOOD, V66, P179; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WAHL SM, 1988, J IMMUNOL, V140, P3026; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WOODS DE, 1982, P NATL ACAD SCI-BIOL, V79, P5661, DOI 10.1073/pnas.79.18.5661	42	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5066	5071						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690734				2022-12-25	WOS:A1990CV58700050
J	CARTER, BJ; MURTY, VS; REDDY, KS; WANG, SN; HECHT, SM				CARTER, BJ; MURTY, VS; REDDY, KS; WANG, SN; HECHT, SM			A ROLE FOR THE METAL-BINDING DOMAIN IN DETERMINING THE DNA-SEQUENCE SELECTIVITY OF FE-BLEOMYCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22901; UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22901	University of Virginia; University of Virginia					NCI NIH HHS [CA38544, CA27603] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA038544, R01CA027603, R01CA038544] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOYAGI Y, 1982, J AM CHEM SOC, V104, P5237, DOI 10.1021/ja00383a045; BERRY DE, 1985, BIOCHEMISTRY-US, V24, P3207, DOI 10.1021/bi00334a020; CHIEN M, 1977, BIOCHEMISTRY-US, V16, P3641, DOI 10.1021/bi00635a021; DANDREA AD, 1978, P NATL ACAD SCI USA, V75, P3608, DOI 10.1073/pnas.75.8.3608; FISHER LM, 1985, BIOCHEMISTRY-US, V24, P3199, DOI 10.1021/bi00334a019; FRASER RDB, 1973, CONFORMATION FIBROUS, P285; HECHT SM, 1986, ACCOUNTS CHEM RES, V19, P383, DOI 10.1021/ar00132a002; HERTZBERG RP, 1988, BIOCHEMISTRY-US, V27, P3164, DOI 10.1021/bi00409a007; KILKUSKIE RE, 1985, J AM CHEM SOC, V107, P260, DOI 10.1021/ja00287a052; KROSS J, 1982, BIOCHEMISTRY-US, V21, P3711, DOI 10.1021/bi00258a029; KUWAHARA J, 1988, P NATL ACAD SCI USA, V85, P2459, DOI 10.1073/pnas.85.8.2459; LEVY MJ, 1988, BIOCHEMISTRY-US, V27, P2647, DOI 10.1021/bi00408a002; POVIRK LF, 1979, BIOCHEMISTRY-US, V18, P96, DOI 10.1021/bi00568a015; REDDY VB, 1978, SCIENCE, V200, P494, DOI 10.1126/science.205947; ROY SN, 1981, CANCER RES, V41, P4471; SAKAI TT, 1983, BIOCHIM BIOPHYS ACTA, V758, P176, DOI 10.1016/0304-4165(83)90299-4; SHIPLEY JB, 1988, CHEM RES TOXICOL, V1, P25, DOI 10.1021/tx00001a004; STUBBE J, 1987, CHEM REV, V87, P1107, DOI 10.1021/cr00081a011; SUGIYAMA H, 1985, J NAT PROD, V48, P869, DOI 10.1021/np50042a001; SUGIYAMA H, 1986, J AM CHEM SOC, V108, P3852, DOI 10.1021/ja00273a063; TAKESHITA M, 1978, P NATL ACAD SCI USA, V75, P5983, DOI 10.1073/pnas.75.12.5983; UMEZAWA H, 1977, LLOYDIA, V40, P67	22	101	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1990	265	8					4193	4196						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT101	1689722				2022-12-25	WOS:A1990CT10100006
J	SMITH, JW; CHERESH, DA				SMITH, JW; CHERESH, DA			INTEGRIN (ALPHA-V-BETA-3)-LIGAND INTERACTION - IDENTIFICATION OF A HETERODIMERIC RGD BINDING-SITE ON THE VITRONECTIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											SMITH, JW (corresponding author), SCRIPPS CLIN & RES FDN,DEPT IMMUNOL,LA JOLLA,CA 92037, USA.				NATIONAL CANCER INSTITUTE [R01CA050286, R01CA045726, R37CA050286] Funding Source: NIH RePORTER; NCI NIH HHS [CA45726, CA50286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; BOTHE D, 1985, ANAL BIOCHEM, V151, P49, DOI 10.1016/0003-2697(85)90051-X; BOUCAUT JC, 1984, NATURE, V307, P364, DOI 10.1038/307364a0; BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9; BROWN NH, 1989, CELL, V59, P185, DOI 10.1016/0092-8674(89)90880-5; BUCK CA, 1986, J CELL BIOL, V103, P2421, DOI 10.1083/jcb.103.6.2421; CHARO IF, 1986, P NATL ACAD SCI USA, V83, P8351, DOI 10.1073/pnas.83.21.8351; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; CHERESH DA, 1987, J BIOL CHEM, V262, P1434; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; FITZGERALD LA, 1987, BIOCHEMISTRY-US, V26, P8158, DOI 10.1021/bi00399a021; HUMPHRIES MJ, 1988, J CLIN INVEST, V81, P782, DOI 10.1172/JCI113384; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOOS M, 1988, J BIOL CHEM, V263, P6005; OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17249; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SMITH JW, 1988, J BIOL CHEM, V263, P18726; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; WRIGHT SD, 1987, P NATL ACAD SCI USA, V84, P1965, DOI 10.1073/pnas.84.7.1965	39	180	185	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2168	2172						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688848				2022-12-25	WOS:A1990CL02800057
J	PATEL, M; LEEVERS, SJ; BRICKELL, PM				PATEL, M; LEEVERS, SJ; BRICKELL, PM			STRUCTURE OF THE COMPLETE HUMAN C-FGR PROTOONCOGENE AND IDENTIFICATION OF MULTIPLE TRANSCRIPTIONAL START SITES	ONCOGENE			English	Article									UNIV COLL & MIDDLESEX SCH MED,DEPT BIOCHEM,MED MOLEC BIOL UNIT,WINDEYER BLDG,CLEVELAND ST,LONDON W1P 6DB,ENGLAND	University of London; University College London								Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRICKELL PM, 1988, BRIT J CANCER, V58, P704, DOI 10.1038/bjc.1988.294; CHEAH MSC, 1986, NATURE, V319, P238, DOI 10.1038/319238a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARVIN AM, 1988, MOL CELL BIOL, V8, P3058, DOI 10.1128/MCB.8.8.3058; GRIFFIN BE, 1984, NATURE, V309, P78, DOI 10.1038/309078a0; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HAMADA H, 1984, MOL CELL BIOL, V4, P2622, DOI 10.1128/MCB.4.12.2622; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; INOUE K, 1987, ONCOGENE, V1, P301; JAKOBOVITS EB, 1988, MOL CELL BIOL, V8, P5549, DOI 10.1128/MCB.8.12.5549; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KIOUSSIS D, 1987, EMBO J, V6, P355, DOI 10.1002/j.1460-2075.1987.tb04762.x; KLEIN C, 1988, INT J CANCER, V42, P29, DOI 10.1002/ijc.2910420107; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; NISHIZAWA M, 1986, MOL CELL BIOL, V6, P511, DOI 10.1128/MCB.6.2.511; PARKER RC, 1985, MOL CELL BIOL, V5, P831, DOI 10.1128/MCB.5.4.831; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; QUEEN C, 1984, NUCLEIC ACIDS RES, V12, P581, DOI 10.1093/nar/12.1Part2.581; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; ROONEY C, 1989, J VIROL, V63, P1531, DOI 10.1128/JVI.63.4.1531-1539.1989; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; TAKADERA T, 1989, MOL CELL BIOL, V9, P2173, DOI 10.1128/MCB.9.5.2173; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978	31	40	42	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					201	206						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	1690869				2022-12-25	WOS:A1990CU02900006
J	MORAN, O; SANDRI, G; PANFILI, E; STUHMER, W; SORGATO, MC				MORAN, O; SANDRI, G; PANFILI, E; STUHMER, W; SORGATO, MC			ELECTROPHYSIOLOGICAL CHARACTERIZATION OF CONTACT SITES IN BRAIN MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TRIESTE, DEPARTIMENTO BIOCHIM, I-34127 TRIESTE, ITALY; MAX PLANCK INST BIOPHYS CHEM, MEMBRANBIOPHYS ABT, W-3400 GOTTINGEN, GERMANY; SCUOLA INT SUPER SANITA, I-34014 TRIESTE, ITALY; UNIV PADUA, CNR, I-35121 PADUA, ITALY	University of Trieste; Max Planck Society; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); University of Padua	MORAN, O (corresponding author), UNIV PADUA, DIPARTIMENTO CHIM BIOL, I-35121 PADUA, ITALY.		Stuehmer, Walter/A-2176-2009; Moran, Oscar/W-4277-2019	Stuehmer, Walter/0000-0002-0642-7764; 				ADAMS V, 1989, BIOCHIM BIOPHYS ACTA, V981, P213, DOI 10.1016/0005-2736(89)90031-X; AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BENZANILLA F, 1985, BIOPHYS J, V47, P437; BIERMANS W, 1989, BIOCHIM BIOPHYS ACTA, V974, P74, DOI 10.1016/S0005-2728(89)80167-7; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; FOX JA, 1987, J MEMBRANE BIOL, V97, P1, DOI 10.1007/BF01869609; GALANTE YM, 1981, ARCH BIOCHEM BIOPHYS, V211, P643, DOI 10.1016/0003-9861(81)90500-2; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HEDRICH R, 1986, FEBS LETT, V204, P228, DOI 10.1016/0014-5793(86)80817-1; Hille B, 1984, IONIC CHANNELS EXCIT; KELLER BU, 1988, PFLUG ARCH EUR J PHY, V411, P94, DOI 10.1007/BF00581652; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; KOTTKE M, 1988, BIOCHIM BIOPHYS ACTA, V935, P87, DOI 10.1016/0005-2728(88)90111-9; LIPPE G, 1988, J BIOL CHEM, V263, P18627; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEVES H, 1989, BIOCHIM BIOPHYS ACTA, V988, P99, DOI 10.1016/0304-4157(89)90005-1; MILLER C, 1978, J MEMBRANE BIOL, V40, P1, DOI 10.1007/BF01909736; PAIN D, 1988, NATURE, V331, P232, DOI 10.1038/331232a0; PATLAK JB, 1988, J GEN PHYSIOL, V92, P413, DOI 10.1085/jgp.92.4.413; PFANNER N, 1987, EUR J BIOCHEM, V169, P289, DOI 10.1111/j.1432-1033.1987.tb13610.x; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; SANDRI G, 1988, CELL CALCIUM, V9, P159, DOI 10.1016/0143-4160(88)90020-6; SCHONKNECHT G, 1988, NATURE, V336, P589, DOI 10.1038/336589a0; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; SIGWORTH FJ, 1983, SINGLE CHANNEL RECOR, P301; SINGER SJ, 1987, P NATL ACAD SCI USA, V84, P1015, DOI 10.1073/pnas.84.4.1015; Skulachev V. P., 1988, MEMBRANE BIOENERGETI; SKULACHEV VP, 1990, IN PRESS J MEMBR BIO; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; SORGATO MC, 1989, J BIOENERG BIOMEMBR, V21, P485, DOI 10.1007/BF00762520; Stiggall D L, 1979, Methods Enzymol, V55, P308; STUHMER W, 1988, HORMONES CELL REGULA, V165, P89; THIEFFRY M, 1988, EMBO J, V7, P1449, DOI 10.1002/j.1460-2075.1988.tb02962.x; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586	41	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					908	913						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688556				2022-12-25	WOS:A1990CH53300045
J	PARK, DJ; MIN, HK; RHEE, SG				PARK, DJ; MIN, HK; RHEE, SG			IGE-INDUCED TYROSINE PHOSPHORYLATION OF PHOSPHOLIPASE C-GAMMA-1 IN RAT BASOPHILIC LEUKEMIA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MEDIATED SIGNAL TRANSDUCTION; MAST-CELLS; HISTAMINE-RELEASE; IMMUNOGLOBULIN-E; PERTUSSIS TOXIN; C-GAMMA; HIGH-AFFINITY; 2H3 CELLS; RECEPTOR; SECRETION	Stimulation of rat basophilic leukemia (RBL-2H3) cells with oligomeric IgE elicited a rapid and transient phosphorylation of phospholipase C (PLC)-gamma-1 on tyrosine residues. Prior incubation of RBL-2H3 cells with a protein tyrosine kinase inhibitor, herbimycin A, prevented the tyrosine phosphorylation of PLC-gamma-1 as well as the hydrolysis of phosphatidylinositol 4,5-bisphosphate induced by oligomeric IgE. However, 5'-(N-ethyl)carboxamidoadenosine, which is known to activate PLC through a G protein, did not elicit tyrosine phosphorylation of PLC-gamma-1. These results, together with previous findings showing that tyrosine phosphorylation of PLC-gamma-1 enhances its catalytic activity, indicate that phosphorylation of PLC-gamma-1 by a nonreceptor tyrosine kinase is the mechanism by which IgE receptor aggregation triggers PLC activation.	NHLBI,BIOCHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Park, Do-Joon/J-2736-2012					ALI H, 1990, J BIOL CHEM, V265, P745; BEAVEN MA, 1984, J BIOL CHEM, V259, P7137; BEAVEN MA, 1988, PROG ALLERGY, V42, P123; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; COCKCROFT S, 1987, J CELL BIOL, V105, P2745, DOI 10.1083/jcb.105.6.2745; COCKCROFT S, 1985, NATURE, V314, P534, DOI 10.1038/314534a0; DOWNES CP, 1986, BIOCHEM J, V238, P501, DOI 10.1042/bj2380501; ISHIZAKA T, 1984, PROG ALLERGY, V34, P188; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KIM JW, 1990, J BIOL CHEM, V265, P3940; KIM UH, 1989, J BIOL CHEM, V264, P20167; MAEYAMA K, 1986, J BIOL CHEM, V261, P2583; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MEISENHELDER J, 1989, CELL, V57, P1108; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; NAKAMURA T, 1985, J BIOL CHEM, V260, P3584; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OLIVER JM, 1988, PROG ALLERGY, V42, P185; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PRIBLUDA VS, 1987, J BIOL CHEM, V262, P11449; QUARTO R, 1986, MOL IMMUNOL, V23, P1215, DOI 10.1016/0161-5890(86)90154-9; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; RHEE SG, 1991, BIOCHEM SOC T, V19, P337, DOI 10.1042/bst0190337; SAITO H, 1989, J IMMUNOL, V143, P250; SAITO H, 1987, J IMMUNOL, V138, P3927; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SUH PG, 1988, J BIOL CHEM, V263, P14497; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WAHL MI, 1990, J BIOL CHEM, V265, P3944; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WARNER JA, 1987, J IMMUNOL, V139, P161; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484	37	192	199	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24237	24240						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662204				2022-12-25	WOS:A1991GW84500002
J	MISSALE, C; BORONI, F; CASTELLETTI, L; DALTOSO, R; GABELLINI, N; SIGALA, S; SPANO, PF				MISSALE, C; BORONI, F; CASTELLETTI, L; DALTOSO, R; GABELLINI, N; SIGALA, S; SPANO, PF			LACK OF COUPLING OF D-2 RECEPTORS TO ADENYLATE-CYCLASE IN GH-3 CELLS EXPOSED TO EPIDERMAL GROWTH-FACTOR - POSSIBLE ROLE OF A DIFFERENTIAL EXPRESSION OF GI-PROTEIN SUBTYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; NUCLEOTIDE-BINDING PROTEINS; PITUITARY TUMOR-CELLS; D2 DOPAMINE RECEPTOR; PROLACTIN SECRETION; ANTERIOR-PITUITARY; MOLECULAR-CLONING; K+ CHANNELS; SIGNAL-TRANSDUCTION; POTASSIUM CHANNELS	Exposure of GH-3 cells to epidermal growth factor for 4 consecutive days induced the expression of both D-2(415) and D-2(444) dopamine-receptor isoforms. Epidermal growth factor also promoted a remarkable increase in the content of G(i)3 protein, which is responsible for receptor-induced activation of potassium channels in GH-3 cells. D-2 receptors in this model apparently activate a specific transducing pathway, leading to opening of potassium channels and inhibition of prolactin release by cAMP-independent mechanisms. This is shown by: 1) the selective D-2 agonist quinpirole, while inactive on vasoactive intestinal peptide-induced prolactin release, strongly inhibited the hormone secretion induced by neurotensin; 2) quinpirole, up to 100-mu-M, did not inhibit cAMP production evoked by vasoactive intestinal peptide both in intact cells and in broken cell membrane preparations; and 3) quinpirole and other D-2 agonists strongly potentiated Rb+ efflux when measured in a nominally calcium-free reaction solution containing 100 mM potassium (voltage-dependent component), but did not modify Rb+ efflux if measured in a reaction solution containing 1 mM calcium and 5 mM potassium (calcium-activated, cAMP-dependent component).	FIDIA RES LABS,ABANO TERME,ITALY		MISSALE, C (corresponding author), UNIV BRESCIA,SCH MED,INST PHARMACOL & EXPTL THERAPEUT,VIA VALSABBINA 19,I-25124 BRESCIA,ITALY.		Sigala, Sandra/C-2757-2011; sigala, sandra/X-3786-2018; Spano, Pier Franco A/E-7621-2010; SPANO, PIERFRANCO/J-9944-2016	sigala, sandra/0000-0003-3294-4121; SPANO, PIERFRANCO/0000-0002-9906-0964				ALBERT PR, 1990, J BIOL CHEM, V265, P2098; BANG S, 1977, ACTA PHARMACOL TOX, V41, P317; BARTSCHAT DK, 1985, J PHYSIOL-LONDON, V361, P419, DOI 10.1113/jphysiol.1985.sp015653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY P, 1987, P NATL ACAD SCI USA, V84, P5115, DOI 10.1073/pnas.84.15.5115; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUNZOW JR, 1988, NATURE, V336, P22; CASTELLETTI L, 1989, J PHYSIOL-LONDON, V410, P251, DOI 10.1113/jphysiol.1989.sp017531; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CODINA J, 1987, FEBS LETT, V385, P611; CRONIN MJ, 1980, ENDOCRINOLOGY, V106, P718, DOI 10.1210/endo-106-3-718; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DUBINSKY JM, 1985, P NATL ACAD SCI USA, V82, P4282, DOI 10.1073/pnas.82.12.4282; ENJALBERT A, 1982, NEUROENDOCRINOLOGY, V34, P95, DOI 10.1159/000123284; FAURE N, 1980, ENDOCRINOLOGY, V107, P1022, DOI 10.1210/endo-107-4-1022; FREEDMAN JE, 1988, P NATL ACAD SCI USA, V85, P3618, DOI 10.1073/pnas.85.10.3618; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GOURDJI D, 1982, FRONT NEUROENDOCRIN, V7, P317; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; INGRAM CD, 1986, ENDOCRINOLOGY, V119, P2508, DOI 10.1210/endo-119-6-2508; ISRAEL JM, 1987, J PHYSIOL-LONDON, V390, P1, DOI 10.1113/jphysiol.1987.sp016682; ITOH H, 1986, P NATL ACAD SCI USA, V83, P3776, DOI 10.1073/pnas.83.11.3776; JONES DT, 1987, J BIOL CHEM, V262, P14241; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALARKEY WB, 1977, NATURE, V266, P640, DOI 10.1038/266640a0; Maniatis T., 1982, MOL CLONING; MATTERA R, 1989, J BIOL CHEM, V264, P465; MEMO M, 1986, J NEUROCHEM, V47, P1689, DOI 10.1111/j.1471-4159.1986.tb13075.x; MICHEL T, 1986, P NATL ACAD SCI USA, V83, P7663, DOI 10.1073/pnas.83.20.7663; MISSALE C, 1991, ENDOCRINOLOGY, V127, P13; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEVE KA, 1989, MOL PHARMACOL, V36, P446; NUKADA T, 1986, FEBS LETT, V197, P305, DOI 10.1016/0014-5793(86)80347-7; ONALI P, 1981, P NATL ACAD SCI-BIOL, V78, P6531, DOI 10.1073/pnas.78.10.6531; PIZZI M, 1990, Molecular Neuropharmacology, V1, P37; RICHTIE AK, 1987, J PHYSL, V385, P611; SCHONBRUNN A, 1980, J CELL BIOL, V85, P786, DOI 10.1083/jcb.85.3.786; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; VALLAR L, 1990, J BIOL CHEM, V265, P10320; VANMEURS KP, 1987, P NATL ACAD SCI USA, V84, P3107, DOI 10.1073/pnas.84.10.3107; WEISS ER, 1988, FASEB J, V2, P2841, DOI 10.1096/fasebj.2.13.3139484; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283	49	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23392	23398						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1683869				2022-12-25	WOS:A1991GT48300092
J	ICHIJO, H; RONNSTRAND, L; MIYAGAWA, K; OHASHI, H; HELDIN, CH; MIYAZONO, K				ICHIJO, H; RONNSTRAND, L; MIYAGAWA, K; OHASHI, H; HELDIN, CH; MIYAZONO, K			PURIFICATION OF TRANSFORMING GROWTH FACTOR-BETA-1 BINDING-PROTEINS FROM PORCINE UTERUS MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; FACTOR-BETA; RECEPTOR; INHIBITION; PROTEOGLYCAN; CHAINS	We have identified several transforming growth factor-beta-1 (TGF-beta-1) binding proteins in solubilized and glycoprotein-enriched porcine uterus membrane fractions by affinity cross-linking and in-gel ligand binding using I-125-labeled TGF-beta-1. By a ligand affinity chromatography using a column of immobilized recombinant TGF-beta-1, four components of apparent molecular weights 160,000, 80,000, 50,000, and 40,000 under reducing conditions were eluted at a pH of 3.5; the 160-, 80-, and 40-kDa components were demonstrated to bind TGF-beta-1 specifically by the I-125-TGF-beta-1 binding assays. Further purification was performed by gel chromatography using a Superose 12 column eluted in 70% formic acid. The 40-kDa component was purified to an apparently homogenous form, whereas the 160-kDa component eluted in a broad peak overlapping the peak of the 80-kDa component. It remains to be elucidated whether these TGF-beta-1 binding proteins are related to cell surface receptors for TGF-beta-s.	KIRIN BREWERY CO LTD,PHARMACEUT LAB,MAEBASHI,GUMMA 371,JAPAN; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	Kirin Brewery Company Limited; University of Tokyo	ICHIJO, H (corresponding author), BIOMED CTR,LUDWIG INST CANC RES,BOX 595,S-75124 UPPSALA,SWEDEN.		Ronnstrand, Lars/A-2429-2011	Ronnstrand, Lars/0000-0003-1275-5809; Ichijo, Hidenori/0000-0002-5005-6438				BAIRD A, 1986, BIOCHEM BIOPH RES CO, V138, P476, DOI 10.1016/0006-291X(86)90305-0; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BOYD FT, 1989, J BIOL CHEM, V264, P2272; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; FRATERSCHRODER M, 1986, BIOCHEM BIOPH RES CO, V137, P295, DOI 10.1016/0006-291X(86)91209-X; FROLIK CA, 1984, J BIOL CHEM, V259, P995; HEIMARK RL, 1986, SCIENCE, V233, P1078, DOI 10.1126/science.3461562; ICHIJO H, 1990, EXP CELL RES, V187, P263, DOI 10.1016/0014-4827(90)90090-W; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KHALIL N, 1991, CIBA F SYMP, V157, P194; LAIHO M, 1990, J BIOL CHEM, V265, P18518; MACKAY K, 1990, J BIOL CHEM, V265, P9351; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MOSES HL, 1985, CANCER CELL, V3, P65; MURPHY PR, 1990, ANAL BIOCHEM, V187, P197, DOI 10.1016/0003-2697(90)90440-K; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OGRADY P, 1991, J BIOL CHEM, V266, P8583; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; RONNSTRAND L, 1987, J BIOL CHEM, V262, P2929; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; SEGARINI PR, 1991, CIBA F SYMP, V157, P29; SLAUGHTER GR, 1987, METHOD ENZYMOL, V139, P433; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	32	56	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22459	22464						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657997				2022-12-25	WOS:A1991GR56400064
J	JOLLIE, DR; LIPSCOMB, JD				JOLLIE, DR; LIPSCOMB, JD			FORMATE DEHYDROGENASE FROM METHYLOSINUS-TRICHOSPORIUM OB3B - PURIFICATION AND SPECTROSCOPIC CHARACTERIZATION OF THE COFACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC RESONANCE; IRON-SULFUR PROTEINS; DESULFOVIBRIO-GIGAS; METHANOBACTERIUM-FORMICICUM; CLOSTRIDIUM-THERMOACETICUM; PSEUDOMONAS-OXALATICUS; ESCHERICHIA-COLI; SULFITE OXIDASE; RAT-LIVER; MOLYBDENUM	NAD+-coupled formate dehydrogenase has been purified to near-homogeneity from the obligate methanotroph Methylosinus trichosporium OB3b. The inclusion of stabilizing reagents in the purification buffers has resulted in a 3-fold increase in specific activity (98-mu-M/min/mg; turnover number 600 s-1) and as much as a 25-fold increase in yield over previously reported purification protocols. The enzyme, (molecular weight 400,000 +/- 20,000) is composed of four subunit types (alpha, 98,000; beta, 56,000; gamma, 20,000; delta, 11,500) apparently associated as 2 alpha-beta-gamma-delta protomers. The holoenzyme contains flavin (1.8 +/- 0.2), iron (46 +/- 6), inorganic sulfide (38 +/- 4), and molybdenum (1.5 +/- 0.1). The flavin is optically similar to the common flavin cofactors, but it is chromatographically distinct. Anaerobic incubation of the enzyme with formate, NADH, or sodium dithionite, resulted in approximately 50% reduction of the iron and elicited an electron paramagnetic resonance (EPR) spectrum (approximately 2.5 spins/protomer) from which the spectra of five distinct EPR-active centers could be resolved in the g = 1.94 region. Four of these spectra were characteristic of [Fe-S]x clusters. The fifth (g(ave) = 1.99; approximately 0.01 spins/protomer) was similar to that observed for the molybdenum cofactor of xanthine oxidase, and it exhibited the expected hyperfine splitting when the enzyme was enriched with Mo-95 (I = 5/2). Mossbauer spectroscopy showed that all of the iron in the enzyme became reduced upon the addition of a redox mediator, proflavin, to the dithionite reduced enzyme at pH 8.0. Nevertheless, a decrease in the EPR-active spin concentration in the g = 1.94 region of the spectrum occurred and was attributed to the reduction of the molybdenum center to the EPR-silent Mo(IV) state (S = 1). The fully reduced enzyme also exhibited a new species with an S = 3/2 ground state (1-2 spins/protomer). Addition of 50% ethylene glycol to the fully reduced enzyme revealed no new species, but caused an increase in the EPR-detectable spin quantitation to 5-6 spins/protomer. This suggests that cluster spin-spin interactions may occur in both the partially and fully reduced native enzyme.	UNIV MINNESOTA,SCH MED,DEPT BIOCHEM,4-225 MILLARD HALL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities				Lipscomb, John/0000-0002-8158-5594	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040466] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040466] Funding Source: Medline; PHS HHS [40466] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ALBRACHT S P J, 1970, Biochimica et Biophysica Acta, V223, P457, DOI 10.1016/0005-2728(70)90209-4; ANTHONY C, 1982, BIOCH METHYLOTROPHS, P1; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; ASANO Y, 1988, J BACTERIOL, V170, P3189, DOI 10.1128/jb.170.7.3189-3193.1988; AVILOVA TV, 1985, EUR J BIOCHEM, V152, P657, DOI 10.1111/j.1432-1033.1985.tb09245.x; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; BARBER MJ, 1983, J BIOL CHEM, V258, P839; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; BEVINGTON PR, 1969, DATA REDUCTION ERROR, P237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN YP, 1988, J GEN MICROBIOL, V134, P3123; CHEN YP, 1987, J BACTERIOL, V169, P4778, DOI 10.1128/jb.169.10.4778-4783.1987; DEATON JC, 1987, BIOCHEM BIOPH RES CO, V149, P424, DOI 10.1016/0006-291X(87)90384-6; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P269, DOI 10.1016/0005-2728(71)90094-6; DUDLEY KH, 1964, HELV CHIM ACTA, V47, P1354, DOI 10.1002/hlca.19640470531; EGOROV AM, 1979, EUR J BIOCHEM, V99, P569, DOI 10.1111/j.1432-1033.1979.tb13289.x; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; FOX BG, 1989, J BIOL CHEM, V264, P10023; HAUSINGER RP, 1986, METHOD ENZYMOL, V122, P199; Hille R., 1985, Metal Ions in Biology, V7, P443; IZUMI Y, 1989, EUR J BIOCHEM, V182, P333, DOI 10.1111/j.1432-1033.1989.tb14835.x; JOHNSON JL, 1976, J BIOL CHEM, V251, P5505; JOHNSON MK, 1985, J BIOL CHEM, V260, P7368; JOHNSON PA, 1964, BIOCHEM J, V93, P281, DOI 10.1042/bj0930281; JOLLIE DR, 1990, METHOD ENZYMOL, V188, P331; KING TE, 1967, METHOD ENZYMOL, V10, P634; KOWAL AT, 1986, J BIOL CHEM, V261, P9239; KRAMER SP, 1987, J BIOL CHEM, V262, P16357; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; LIU CL, 1984, J BACTERIOL, V159, P375, DOI 10.1128/JB.159.1.375-380.1984; LUNDELL DJ, 1978, J BIOL CHEM, V253, P3422; MAY HD, 1988, J BACTERIOL, V170, P3384, DOI 10.1128/jb.170.8.3384-3389.1988; MEINHARDT SW, 1990, J BIOL CHEM, V265, P1360; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; MULLER U, 1978, EUR J BIOCHEM, V83, P485, DOI 10.1111/j.1432-1033.1978.tb12115.x; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; ORMEJOHNSON WH, 1973, IRON SULFUR PROTEINS, V2, P195; Quayle JR., 1972, ADV MICROB PHYSIOL, V7, P119, DOI DOI 10.1016/S0065-2911(08)60078-8; RAGONE R, 1984, BIOCHEMISTRY-US, V23, P1871, DOI 10.1021/bi00303a044; RATTI S, 1985, J BACTERIOL, V163, P724, DOI 10.1128/JB.163.2.724-729.1985; RIEDERERHENDERSON MA, 1986, CAN J MICROBIOL, V32, P430, DOI 10.1139/m86-081; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; RUSCHIG U, 1976, EUR J BIOCHEM, V70, P325, DOI 10.1111/j.1432-1033.1976.tb11021.x; SCHOLLNHAMMER G, 1974, EUR J BIOCHEM, V44, P561, DOI 10.1111/j.1432-1033.1974.tb03514.x; SHERRY B, 1985, BIOCHEMISTRY-US, V24, P2594, DOI 10.1021/bi00332a002; STADTMAN ER, 1990, BIOCHEMISTRY-US, V29, P6323, DOI 10.1021/bi00479a001; SUELTER CH, 1960, BIOCHIM BIOPHYS ACTA, V44, P23, DOI 10.1016/0006-3002(60)91518-3; SULEIMAN SA, 1987, ARCH BIOCHEM BIOPHYS, V258, P219, DOI 10.1016/0003-9861(87)90338-9; WATT GD, 1985, BIOCHEMISTRY-US, V4, P7226; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; XAVIER AV, 1981, STRUCT BOND, V43, P187; YOCH DC, 1990, J BACTERIOL, V172, P4456, DOI 10.1128/jb.172.8.4456-4463.1990; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; ZIMMERMANN R, 1978, BIOCHIM BIOPHYS ACTA, V537, P185, DOI 10.1016/0005-2795(78)90504-4; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660; [No title captured]	60	65	66	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21853	21863						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657982				2022-12-25	WOS:A1991GP80400081
J	BURSTEN, SL; HARRIS, WE; BOMSZTYK, K; LOVETT, D				BURSTEN, SL; HARRIS, WE; BOMSZTYK, K; LOVETT, D			INTERLEUKIN-1 RAPIDLY STIMULATES LYSOPHOSPHATIDATE ACYLTRANSFERASE AND PHOSPHATIDATE PHOSPHOHYDROLASE ACTIVITIES IN HUMAN MESANGIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; GLOMERULAR MESANGIUM; SIGNAL TRANSDUCTION; PHOSPHOLIPASE-D; ADENYLATE-CYCLASE; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; GTP-BINDING; FATTY-ACIDS; G-PROTEINS	Phosphatidic acid (PA) is a cytokine in a variety of cell types, and an intermediary in cell activation. It is produced from membrane phospholipids by either lysophosphatidate acyl-CoA:acyltransferase (lyso-PA AT) or phospholipase D. Interleukin-1 (IL-1) stimulation of human mesangial cells (HMC) induced activation of lyso-PA AT, and synthesis of new PA species with significant increase in PA mass. These PA species were enriched in long-chain unsaturated acyl side chains (C18:1, C18:2, C20:5, and C22:6) in both the sn-2 and sn-1 positions, and stimulated the action of the lyso-PA AT as a positive feedback mechanism. Gas-liquid chromatography and mass spectrometry demonstrate that the acyl composition of phosphatidic acid does not resemble that of the major phospholipid fractions of this preparation and therefore is not the product of phospholipase D. The PA species were rapidly converted to 1,2-sn-diacylglycerols by phosphatidate phosphohydrolase, which also was activated by IL-1 via a separate mechanism involving a pertussis-sensitive G-protein. The activities of lyso-PA AT and phosphatidate phosphohydrolase were associated with plasma membrane enriched and refined microsomal fractions. IL-1 stimulation of a murine T cell (thymoma) line, EL-4, also caused stimulation of lyso-PA AT, resulting in PA formation. EL-4 mutants with defective IL-1 receptors did not demonstrate stimulation of lyso-PA AT, showing the necessity of intact IL-1 receptors for activation of this enzyme. We conclude that PA is a significant signaling intermediary for IL-1 via activation of lyso-PA AT and a G-protein, which activates phosphatidate phosphohydrolase. This system suggests a novel mechanism whereby a low intensity signal may be translated into cellular activation.	UNIV WASHINGTON,SCH MED,DEPT MED NEPHROL,SEATTLE,WA 98195; VET AFFAIRS MED CTR,NEUROCHEM LAB,SEATTLE,WA 98108; UNIV CALIF SAN FRANCISCO,DEPT MED NEPHROL,SAN FRANCISCO,CA 94143; VET AFFAIRS MED CTR,SAN FRANCISCO,CA 94121	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	BURSTEN, SL (corresponding author), VET AFFAIRS MED CTR,MED SERV 111A,RENAL DIALYSIS UNIT,1660 S COLUMBIAN WAY,SEATTLE,WA 98108, USA.							ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; ALTIN JG, 1987, BIOCHEM J, V247, P613, DOI 10.1042/bj2470613; BALLOU LR, 1991, J CLIN INVEST, V87, P299, DOI 10.1172/JCI114986; BERGLUND L, 1982, BIOCHEM BIOPH RES CO, V105, P288, DOI 10.1016/S0006-291X(82)80043-0; BILLAH MM, 1981, J BIOL CHEM, V256, P5399; BIRNBAUMER L, 1987, KIDNEY INT, V32, pS14; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BOMSZTYK K, 1989, P NATL ACAD SCI USA, V86, P8034, DOI 10.1073/pnas.86.20.8034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURSTEN SL, 1991, BIOCHEMISTRY-US, V30, P6195, DOI 10.1021/bi00239a017; BURSTEN SL, 1988, J CLIN INVEST, V82, P1479, DOI 10.1172/JCI113755; BURSTEN SL, 1991, AM J PATHOL, V139, P371; BURSTEN SL, 1989, CLIN RES, V37, P487; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; CASCALES C, 1988, BIOCHIM BIOPHYS ACTA, V963, P384, DOI 10.1016/0005-2760(88)90305-0; CHEDID M, 1989, J IMMUNOL, V142, P4301; DINARELLO CA, 1985, J CLIN IMMUNOL, V5, P287, DOI 10.1007/BF00918247; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; FARESE RV, 1987, SCIENCE, V236, P586, DOI 10.1126/science.3107122; FERBER E, 1977, LYMPHOCYTE STRUCTURE, P593; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOPPELT M, 1984, ANAL BIOCHEM, V140, P152, DOI 10.1016/0003-2697(84)90146-5; HARRIS WE, 1983, BIOCHIM BIOPHYS ACTA, V736, P79, DOI 10.1016/0005-2736(83)90172-4; HOSAKA K, 1975, J BIOCHEM-TOKYO, V77, P501, DOI 10.1093/oxfordjournals.jbchem.a130751; IMAGAWA W, 1989, P NATL ACAD SCI USA, V86, P4122, DOI 10.1073/pnas.86.11.4122; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; JOHNSON RS, 1990, J BIOL CHEM, V265, P8108; KATES M, 1969, METHOD ENZYMOL, V14, P197; KEENAN AW, 1968, ANAL BIOCHEM, V23, P555; KORNBERG A, 1953, J BIOL CHEM, V204, P345; LANDS WEM, 1965, J BIOL CHEM, V240, P1905; LOVETT DH, 1983, KIDNEY INT, V23, P342, DOI 10.1038/ki.1983.25; LOVETT DH, 1986, J IMMUNOL, V136, P3700; LOVETT DH, 1988, KIDNEY INT, V34, P26, DOI 10.1038/ki.1988.141; LOVETT DH, 1987, AM J PATHOL, V129, P543; LOVETT DH, 1983, J IMMUNOL, V130, P1475; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MIZEL SB, 1989, FASEB J, V3, P2379, DOI 10.1096/fasebj.3.12.2676681; MIZEL SB, 1988, CELLULAR MOL ASPECTS, P75; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; MUNOZ E, 1990, J IMMUNOL, V144, P964; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; ONEILL LAJ, 1990, J BIOL CHEM, V265, P3146; QIAN Z, 1990, J BIOL CHEM, V265, P3607; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; SOLING HD, 1989, J BIOL CHEM, V264, P10643; SZAMEL M, 1981, J BIOL CHEM, V256, P1618; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; WERBER HI, 1987, J IMMUNOL, V138, P3207; YAMASHITA S, 1975, P NATL ACAD SCI USA, V72, P600, DOI 10.1073/pnas.72.2.600; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4	55	85	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20732	20743						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657935				2022-12-25	WOS:A1991GN00100025
J	YU, DH; HUNG, MC				YU, DH; HUNG, MC			EXPRESSION OF ACTIVATED RAT NEU ONCOGENE IS SUFFICIENT TO INDUCE EXPERIMENTAL METASTASIS IN 3T3 CELLS	ONCOGENE			English	Article							TYROSINE KINASE-ACTIVITY; TUMOR EFFECTS INVIVO; HUMAN-BREAST-CANCER; MONOCLONAL-ANTIBODIES; POINT MUTATION; PROTO-ONCOGENE; INVITRO ASSAY; GENE; PHENOTYPE; AMPLIFICATION	Amplification or overexpression of the human neu oncogene has been shown to correlate with the number of lymph node metastases in breast cancer patients, suggesting that expression of the neu oncogene may be associated with increased metastatic potential. However, there has been no systematic study on the role of the neu oncogene in metastasis to support this correlation. In our study, mouse embryo fibroblast 3T3 cells transformed by the mutation-activated rat neu oncogene exhibited metastatic properties both in vitro and in vivo, while parental 3T3 cells did not. Monoclonal antibodies capable of inducing down-regulation of the neu-encoded p185 protein reduced the metastatic potential induced by neu. These data provide strong experimental evidence that neu oncogene expression is sufficient for the induction of metastasis in the 3T3 cell system and supply a molecular basis supporting the correlations found in clinical observation. The results also suggest that neu-specific monoclonal antibodies may have preventative or therapeutic potential for neu-induced metastasis.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center			Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Yu, Dihua/0000-0001-6231-9381	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA045265] Funding Source: NIH RePORTER; NCI NIH HHS [R03 CAS4989-01, CA-16672, CA-45265] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBINI A, 1987, CANCER RES, V47, P3239; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BELLONI PN, 1988, J CELL PHYSIOL, V136, P398, DOI 10.1002/jcp.1041360303; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; DREBIN JA, 1988, ONCOGENE, V2, P387; EGAN SE, 1987, SCIENCE, V238, P202, DOI 10.1126/science.3659911; HART IR, 1989, BIOCHIM BIOPHYS ACTA, V989, P65, DOI 10.1016/0304-419X(89)90035-8; HUNG M-C, 1988, Cancer Bulletin (Houston), V40, P300; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; INOKUCHI J, 1990, CANCER RES, V50, P6731; LEMOINE NR, 1990, ONCOGENE, V5, P237; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MATIN A, 1990, ONCOGENE, V5, P111; MENSING H, 1983, EUR J CELL BIOL, V29, P268; NICOLSON GL, 1982, BIOCHIM BIOPHYS ACTA, V695, P113, DOI 10.1016/0304-419X(82)90020-8; NICOLSON GL, 1987, CANCER RES, V47, P1473; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; REPESH LA, 1989, INVAS METAST, V9, P192; SAYA H, 1990, MOL CARCINOGEN, V3, P198, DOI 10.1002/mc.2940030406; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; SUEN TC, 1990, MOL CELL BIOL, V10, P6306, DOI 10.1128/MCB.10.12.6306; SUEN TC, 1991, MOL CELL BIOL, V11, P354, DOI 10.1128/MCB.11.1.354; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; Tressler R J, 1989, Cancer Commun, V1, P55; WEXLER H, 1966, JNCI-J NATL CANCER I, V36, P641, DOI 10.1093/jnci/36.4.641; YAN DH, 1991, ONCOGENE, V6, P343; YAN DH, 1991, MOL CELL BIOL, V11, P1875, DOI 10.1128/MCB.11.4.1875; YU DH, 1991, MOL CELL BIOL, V11, P1745, DOI 10.1128/MCB.11.3.1745; YU DH, 1990, P NATL ACAD SCI USA, V87, P4499, DOI 10.1073/pnas.87.12.4499; YUSA K, 1990, J NATL CANCER I, V82, P1633, DOI 10.1093/jnci/82.20.1633; ZHANG X, 1989, ONCOGENE, V4, P985	46	115	119	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					1991	1996						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1682865				2022-12-25	WOS:A1991GX11900008
J	WHITE, JH				WHITE, JH			A FORMULA FOR THE AVERAGE NUMBER OF KNOT INTERLINKS CAUSED BY TYPE-2 TOPOISOMERASE ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								During the double-stranded passage that takes place because of the topoisomerase action, a plectonemically interwound DNA often becomes knotted. In this process, a portion of the substrate supercoils are converted into interlinks that contribute to the topology of the knot formed. In this appendix, an approximate formula is derived for the average number of these interlinks in terms of the number of supercoils and branches in the substrate. This will give an indication of the complexity of the average knot obtained. When two regions of DNA come together before passage, the substrate is divided into two domains in essentially the same way as intramolecular recombination divides the substrate into two domains (Boles, T. C., White, J. H., and Cozzarelli, N. R. (1990) J. MoL Biol. 213, 931-951). Nodes formed between DNA segments from different domains are called interdomainal.			WHITE, JH (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024, USA.							BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; WASSERMAN SA, 1991, J BIOL CHEM, V266, P20567	2	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20574	20575						2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657930				2022-12-25	WOS:A1991GM03900105
J	GRIMMINGER, F; SIBELIUS, U; AKTORIES, K; JUST, I; SEEGER, W				GRIMMINGER, F; SIBELIUS, U; AKTORIES, K; JUST, I; SEEGER, W			SUPPRESSION OF CYTOSKELETAL REARRANGEMENT IN ACTIVATED HUMAN NEUTROPHILS BY BOTULINUM-C2 TOXIN - IMPACT ON CELLULAR SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATES ACTIN; RABBIT POLYMORPHONUCLEAR LEUKOCYTES; STIMULATED HUMAN-NEUTROPHILS; PROTEIN KINASE-C; CYTOCHALASIN-D; F-ACTIN; DIACYLGLYCEROL ACCUMULATION; SUPEROXIDE PRODUCTION; GUANINE-NUCLEOTIDES; INOSITOL PHOSPHATES	Botulinum C2 toxin, a binary toxin which selectively ADP-ribosylates nonmuscle G-actin, was used to evaluate the role of cytoskeletal rearrangement in ligand-evoked signal transduction and secretory processes in human neutrophils (polymorphonuclear leukocyte). Preincubation with the combined toxin components reduced the basal F-actin content and nearly completely suppressed the actin assembly initiated by the peptide and lipid chemoattractants formyl-methionyl-leucyl-phenylalanine, platelet activating factor, and leukotriene B4. Superoxide production and elastase secretion were increased markedly under these conditions. Concomitantly, ligand-elicited phosphoinositide hydrolysis was augmented with particular increase in inositol monophosphate. This was paralleled by a several-fold amplification of diacylglycerol formation and sustained elevation of cytosolic calcium. The toxin-effected amplification of postreceptor events and secretory responses was most pronounced in response to formyl-methionyl-leucyl-phenylalanine > platelet activating factor > leukotriene B4. All metabolic and secretory effects in C2 toxin-pretreated cells were sensitive to pertussis toxin inhibition. In conjunction with the recent finding of unchanged formyl-methionyl-leucyl-phenylalanine receptor binding and dissociation dynamics under influence of C2 (Norgauer, J., Just, I., Aktories, K., and Sklar, L. A. (1989) J. Cell Biol. 109, 1133-1140), the present investigation suggests amplification of postreceptor events as a major mechanism underlying C2 toxin-related increase in polymorphonuclear leukocyte secretory responses. Cytoskeletal rearrangement, putatively linked to phosphoinositide turnover and calcium transients, thus appears to be operative in temporal and/or spatial limitation of chemoattractant-evoked cellular signal transduction.	UNIV GIESSEN,RUDOLF BUCHHEIM INST PHARMACOL,W-6300 GIESSEN,GERMANY	Justus Liebig University Giessen	GRIMMINGER, F (corresponding author), UNIV GIESSEN,DEPT INTERNAL MED,W-6300 GIESSEN,GERMANY.		Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Seeger, Werner/0000-0003-1946-0894; Grimminger, Friedrich/0000-0001-8725-6276				AKTORIES K, 1986, EUR J BIOCHEM, V161, P155, DOI 10.1111/j.1432-1033.1986.tb10136.x; AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; BENDER JG, 1987, J IMMUNOL, V139, P3028; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BLIGH EG, 1959, CAN J BIOCH PHYSL, V37, P753; COHEN HJ, 1978, J CLIN INVEST, V61, P1081, DOI 10.1172/JCI109007; Collier RJ, 1982, ADP RIBOSYLATION REA, P575; EBERLE M, 1990, J BIOL CHEM, V265, P16725; FALLMAN M, 1989, EXP CELL RES, V181, P217, DOI 10.1016/0014-4827(89)90195-X; FELTNER DE, 1989, J IMMUNOL, V142, P3963; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GALLIN JI, 1984, FED PROC, V43, P2732; GENNARO R, 1984, P NATL ACAD SCI-BIOL, V81, P1416, DOI 10.1073/pnas.81.5.1416; GILL M, 1982, ADP RIBOSYLATION REA, P593; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; GOLDMAN DW, 1986, J IMMUNOL, V137, P1971; GRIMMINGER F, 1990, J IMMUNOL, V144, P1866; GRIMMINGER F, 1988, J IMMUNOL, V141, P2431; HARTIALA KT, 1985, INFECT IMMUN, V50, P527, DOI 10.1128/IAI.50.2.527-533.1985; HENSON PM, 1971, J IMMUNOL, V107, P1547; HONEYCUTT PJ, 1986, J BIOL CHEM, V261, P5900; HOWARD TH, 1987, J CLIN INVEST, V79, P1359, DOI 10.1172/JCI112962; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; IRVING HR, 1987, J BIOL CHEM, V262, P3440; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JESAITIS AJ, 1986, J BIOL CHEM, V261, P3662; KORCHAK HM, 1984, J BIOL CHEM, V259, P4076; KRAMPS JA, 1983, SCAND J CLIN LAB INV, V43, P427; MAJERUS PW, 1988, J BIOL CHEM, V263, P3051; NABI ZF, 1979, EXP CELL RES, V124, P293, DOI 10.1016/0014-4827(79)90205-2; NORGAUER J, 1988, J CLIN INVEST, V82, P1376, DOI 10.1172/JCI113741; NORGAUER J, 1989, J CELL BIOL, V109, P1133, DOI 10.1083/jcb.109.3.1133; OHISHI I, 1980, INFECT IMMUN, V30, P668; OMANN GM, 1987, J IMMUNOL, V138, P2626; OMANN GM, 1989, J BIOL CHEM, V264, P16355; OMMAN GM, 1987, PHYSIOL REV, V67, P285; PREISS J, 1986, J BIOL CHEM, V261, P8597; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RIDER LG, 1987, J BIOL CHEM, V262, P5603; SANDBORG RR, 1988, LAB INVEST, V59, P300; SEEGER W, 1986, J IMMUNOL, V137, P1286; SERRA MC, 1988, J IMMUNOL, V141, P2118; SHALIT M, 1987, BLOOD, V70, P1921; SIMPSON LL, 1984, J PHARMACOL EXP THER, V230, P665; SNYDERMAN R, 1984, FED PROC, V43, P2743; STEWART AG, 1990, P NATL ACAD SCI USA, V87, P3215, DOI 10.1073/pnas.87.8.3215; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; TREVES S, 1987, EXP CELL RES, V168, P285, DOI 10.1016/0014-4827(87)90001-2; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; TYAGI SR, 1988, J BIOL CHEM, V263, P13191; UHING RJ, 1989, J BIOL CHEM, V264, P9224; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; URBANIK E, 1989, ARCH BIOCHEM BIOPHYS, V269, P181, DOI 10.1016/0003-9861(89)90098-2; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; VERGHESE MW, 1987, J IMMUNOL, V138, P4374; WALLING EA, 1988, ARCH BIOCHEM BIOPHYS, V264, P321, DOI 10.1016/0003-9861(88)90600-5; WEGNER A, 1988, J BIOL CHEM, V263, P13739	63	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19276	19282						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655781				2022-12-25	WOS:A1991GK66700028
J	GONNEVILLE, L; MARTINS, TJ; BEDARD, PA				GONNEVILLE, L; MARTINS, TJ; BEDARD, PA			COMPLEX EXPRESSION PATTERN OF THE CEF-4 CYTOKINE IN TRANSFORMED AND MITOGENICALLY STIMULATED CELLS	ONCOGENE			English	Article							ROUS-SARCOMA VIRUS; 9E3 MESSENGER-RNA; HUMAN-FIBROBLASTS; GENOMIC STRUCTURE; PLATELET PROTEIN; GENE-EXPRESSION; GROWTH-FACTOR; SEQUENCES; PHOSPHORYLATION; TRANSCRIPTION	The transformation of chicken embryo fibroblasts (CEF) by the Rous sarcoma virus leads to the constitutive expression of the cellular gene designated CEF-4. With specific antisera, we confirmed that transformed cells actively synthesize and secrete a 6 kDa polypeptide corresponding to the CEF-4 gene product. The expression of CEF-4 was investigated by Northern and immunoprecipitation analyses. Upon activation of pp60v-src in cells infected by a ts mutant of RSV, the expression of CEF-4 was biphasic with an early transient and a late constitutive period of expression. CEF-4 was expressed in cells transformed by a variety of oncogenes, but the level of constitutive expression differed quantitatively among transformed cells. Cells transformed by v-myc alone did not express CEF-4. Unlike other members of the interleukin 8 gene family, CEF-4 was induced in response to a broad spectrum of growth factors and inflammatory agents. Dexamethasone repressed the induction of CEF-4 by liposaccharides but had little or no effect on the response to serum or pp60v-src. These data emphasize the complexity of CEF-4 expression and suggest the existence of multiple levels or pathways of CEF-4 regulation in normal and transformed cells.	UNIV MONTREAL,DEPT BIOCHEM,CP 6128 SUCC A,MONTREAL H3C 3J7,QUEBEC,CANADA; HARVARD UNIV,DEPT CELLULAR & DEV BIOL,BIOL LABS,CAMBRIDGE,MA 02138	Universite de Montreal; Harvard University								ANISOWICZ A, 1988, P NATL ACAD SCI USA, V85, P9645, DOI 10.1073/pnas.85.24.9645; ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; BARKER K, 1990, MOL CELL BIOL, V10, P3813, DOI 10.1128/MCB.10.7.3813; BARKER K, 1989, J VIROL, V63, P2929, DOI 10.1128/JVI.63.7.2929-2935.1989; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BEDARD PA, 1987, MOL CELL BIOL, V7, P1450, DOI 10.1128/MCB.7.4.1450; BEDARD PA, 1987, P NATL ACAD SCI USA, V84, P6715, DOI 10.1073/pnas.84.19.6715; BELL SM, 1990, J BIOL CHEM, V265, P1333; BLOBEL GA, 1991, P NATL ACAD SCI USA, V88, P1162, DOI 10.1073/pnas.88.4.1162; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DESJARDINS P, 1986, SOMAT CELL MOLEC GEN, V12, P133, DOI 10.1007/BF01560660; DOLBERG DS, 1985, SCIENCE, V230, P676, DOI 10.1126/science.2996144; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; KOWALSKI J, 1989, MOL CELL BIOL, V9, P1946, DOI 10.1128/MCB.9.5.1946; LANGLOIS AJ, 1976, CANCER RES, V36, P3894; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEW W, 1988, J IMMUNOL, V140, P1895; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; OBARU K, 1989, MOL IMMUNOL, V26, P423; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; SCHRODER JM, 1990, J IMMUNOL, V144, P2223; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; SPRANGLER R, 1989, P NATL ACAD SCI USA, V86, P7017; STOECKLE M Y, 1990, New Biologist, V2, P313; STOECKLE MY, 1989, MOL CELL BIOL, V9, P4738, DOI 10.1128/MCB.9.11.4738; STOECKLE MY, 1988, MOL CELL BIOL, V8, P2675, DOI 10.1128/MCB.8.7.2675; SUGANO S, 1987, CELL, V49, P321, DOI 10.1016/0092-8674(87)90284-4; Summers MD, 1987, TEXAS AGR EXPT STATI; TANABE O, 1988, J IMMUNOL, V141, P3875; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; YAMAMURA Y, 1989, J CLIN INVEST, V84, P1707, DOI 10.1172/JCI114353; YOSHIMURA T, 1989, MOL IMMUNOL, V26, P87; ZINKEWICHPOETTI K, 1991, LAB INVEST, V63, P807; ZIPFEL PF, 1989, J IMMUNOL, V142, P1582	38	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1991	6	10					1825	1833						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656364				2022-12-25	WOS:A1991GX11800015
J	SURYANARAYANA, S; DAUNT, DA; VONZASTROW, M; KOBILKA, BK				SURYANARAYANA, S; DAUNT, DA; VONZASTROW, M; KOBILKA, BK			A POINT MUTATION IN THE 7TH HYDROPHOBIC DOMAIN OF THE ALPHA-2 ADRENERGIC-RECEPTOR INCREASES ITS AFFINITY FOR A FAMILY OF BETA-RECEPTOR-ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTORS; MOLECULAR-CLONING; ALPHA-1-ADRENERGIC RECEPTOR; BETA-1-ADRENERGIC RECEPTOR; SUBTYPE SPECIFICITY; LIGAND-BINDING; EXPRESSION; GENE; CDNA	Previous studies have shown that differences in subtype-specific ligand binding between alpha-2 and beta-2 adrenergic receptors are largely determined by the seventh hydrophobic domain. Here, we report that a single amino acid substitution (Phe412 --> Asn) in the seventh hydrophobic domain of the alpha-2 adrenergic receptor reduces affinity for the alpha-2 antagonist yohimbine by 350-fold and increases affinity for beta-antagonist alprenolol by 3000-fold. The affinity of this mutant receptor alpha-2F --> N for several-alpha and beta-adrenergic receptor agonists and antagonists was determined beta-adrenergic receptor antagonists containing an oxygen atom linking the amino side chain with the aromatic ring bound to alpha-2F --> N with high affinity, while the beta-receptor antagonist sotalol, which lacks this oxygen, bound with low affinity. These data suggest that the Asn residue is involved in conferring specificity for binding to a specific class of beta-receptor antagonists.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,DIV CARDIOVASC MED,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University				Kobilka, Brian/0000-0001-5958-3990	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER; NINDS NIH HHS [5 R01 NS28471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DIXON RAF, 1989, PROTEINS, V6, P267, DOI 10.1002/prot.340060309; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; FLORDELLIS CS, 1991, P NATL ACAD SCI USA, V88, P1019, DOI 10.1073/pnas.88.3.1019; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; GUYER CA, 1990, J BIOL CHEM, V265, P17307; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KLAUSNER R D, 1989, New Biologist, V1, P3; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MARULLO S, 1990, EMBO J, V9, P1471, DOI 10.1002/j.1460-2075.1990.tb08264.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; SCHWINN DA, 1990, J BIOL CHEM, V265, P8183; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	29	136	139	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15488	15492						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1678390				2022-12-25	WOS:A1991GB09700098
J	STENMAN, G; SAHLIN, P; MARK, J; LANDYS, D				STENMAN, G; SAHLIN, P; MARK, J; LANDYS, D			STRUCTURAL ALTERATIONS OF THE C-MOS LOCUS IN BENIGN PLEOMORPHIC ADENOMAS WITH CHROMOSOME-ABNORMALITIES OF 8Q12	ONCOGENE			English	Article								Recent mapping studies have assigned the human c-mos proto-oncogene to chromosome 8, bands q11-12. This region is frequently affected by chromosomal translocations in benign pleomorphic adenomas of the salivary glands. Using Southern blot analysis we report here that the c-mos gene and its flanking sequences are structurally altered in pleomorphic adenomas with chromosomal rearrangements of 8q12. Rearrangements were detected in two out of 23 tumors. Restriction fragment analysis indicated that the rearrangements were due to multiple, subtle mutations involving the c-mos open reading frame and its flanking sequences. There was no direct evidence of translocation of mos in any of the tumors. Control DNAs from the two patients showed a normal restriction pattern for all enzymes tested, indicating that the rearrangements are tumor specific. Collectively, our cytogenetic and molecular data suggest involvement of the c-mos gene in the pathogenesis of pleomorphic adenomas.	CENT HOSP SKOVDE, DEPT PATHOL, S-54185 SKOVDE, SWEDEN		STENMAN, G (corresponding author), GOTHENBURG UNIV, DEPT ORAL PATHOL, CYTOGENET LAB, S-40033 GOTHENBURG, SWEDEN.							BLAIR DG, 1986, CELL, V46, P785, DOI 10.1016/0092-8674(86)90354-5; BLAIR DG, 1984, CANCER CELL, V2, P281; BULLERDIEK J, 1989, CYTOGENET CELL GENET, V51, P973; BULLERDIEK J, 1989, CANCER, V64, P876, DOI 10.1002/1097-0142(19890815)64:4<876::AID-CNCR2820640419>3.0.CO;2-J; CAUBET JF, 1985, EMBO J, V4, P2245, DOI 10.1002/j.1460-2075.1985.tb03921.x; DALLAFAVERA R, 1987, RECENT ADV LEUKEMIA, P165; DIAZ MO, 1985, SCIENCE, V229, P767, DOI 10.1126/science.3860954; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GROFFEN J, 1989, PROG NUCLEIC ACID RE, V36, P281; HOROWITZ M, 1984, EMBO J, V3, P2937, DOI 10.1002/j.1460-2075.1984.tb02235.x; KUFF EL, 1983, NATURE, V302, P547, DOI 10.1038/302547a0; LIDEREAU R, 1985, P NATL ACAD SCI USA, V82, P7068, DOI 10.1073/pnas.82.20.7068; MAGUIRE RT, 1983, P NATL ACAD SCI-BIOL, V80, P1947, DOI 10.1073/pnas.80.7.1947; MARK J, 1988, CANCER GENET CYTOGEN, V33, P229, DOI 10.1016/0165-4608(88)90033-7; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MORRIS CM, 1989, HUM GENET, V81, P339, DOI 10.1007/BF00283687; NEEL BG, 1982, P NATL ACAD SCI-BIOL, V79, P7842, DOI 10.1073/pnas.79.24.7842; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; RENPING Z, 1991, IN PRESS SCIENCE; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sambrook J, 1989, MOL CLONING LABORATO; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SEIFERT G, 1986, DISEASES SALIVARY GL; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STENMAN G, 1987, P NATL ACAD SCI USA, V84, P184, DOI 10.1073/pnas.84.1.184; TESTA J R, 1988, Genomics, V3, P44, DOI 10.1016/0888-7543(88)90157-7; VANDEWOUDE GF, 1987, ADV VIRAL ONCOL, V6, P71; WATSON R, 1982, P NATL ACAD SCI-BIOL, V79, P4078, DOI 10.1073/pnas.79.13.4078; WOOD TG, 1984, P NATL ACAD SCI-BIOL, V81, P7817, DOI 10.1073/pnas.81.24.7817	30	14	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1991	6	7					1105	1108						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GV260	1677749				2022-12-25	WOS:A1991GV26000002
J	PALMER, MAJ; DIFFERDING, E; GAMBONI, R; WILLIAMS, SF; PEOPLES, OP; WALSH, CT; SINSKEY, AJ; MASAMUNE, S				PALMER, MAJ; DIFFERDING, E; GAMBONI, R; WILLIAMS, SF; PEOPLES, OP; WALSH, CT; SINSKEY, AJ; MASAMUNE, S			BIOSYNTHETIC THIOLASE FROM ZOOGLOEA-RAMIGERA - EVIDENCE FOR A MECHANISM INVOLVING CYS-378 AS THE ACTIVE-SITE BASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYDECANOYL THIOESTER DEHYDRASE; ACETOACETYL-COA THIOLASE; BETA-KETOACYL THIOLASE; 3-OXOACYL-COA THIOLASE; NUCLEOTIDE-SEQUENCE; PROTON-TRANSFER; COENZYME-A; GENE; CDNA; INACTIVATION	Biosynthetic thiolase from Zoogloea ramigera was inactivated with a mechanism-based inactivator, 3-pentynoyl-S-pantetheine-11-pivalate (3-pentynoyl-SPP) where K(I) = 1.25 mM and k(inact) = 0.26 min-1, 2,3-pentadienoyl-SPP obtained from nonenzymatic rearrangement of 3-pentynoyl-SPP where K(I) = 1.54 mM and k(inact) = 1.9 min-1 and an affinity labeling reagent, acryl-SPP. The results obtained with the alkynoyl and allenoyl inactivators are taken as evidence that thiolase from Z. ramigera is able to catalyze proton abstraction uncoupled from carbon-carbon bond formation. The inactivator, 3-pentynoyl-SPP and the affinity labeling reagent, acryl-SPP, trap the same active site cysteine residue, Cys-378. To assess if Cys-378 is the active site residue involved in deprotonation of the second molecule of acetyl-CoA, a Gly-378 mutant enzyme was studied. In the thiolysis direction the Gly-378 mutant was more than 50,000-fold slower than wild type and over 100,000-fold slower in the condensation direction. However, the mutant enzyme was still capable of forming the acetyl-enzyme intermediate and incorporated 0.81 equivalents of C-14-label after incubation with [C-14]Ac-CoA for 60 min. The reversible exchange of P-32-label from [P-32]CoASH into Ac-CoA, catalyzed by the Gly-378 mutant enzyme, proceeded with a V(max) (exchange) 8,000-fold less than the wild type enzyme but at least 10-fold faster than the overall condensation reaction. These data provide evidence that Cys-378 is the active site base.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	PALMER, MAJ (corresponding author), MIT,DEPT CHEM,CAMBRIDGE,MA 02139, USA.							ALBERY WJ, 1986, BIOCHEMISTRY-US, V25, P2572, DOI 10.1021/bi00357a043; ANDERSON VE, 1990, J BIOL CHEM, V265, P6255; ARAKAWA H, 1987, EMBO J, V6, P1361, DOI 10.1002/j.1460-2075.1987.tb02376.x; Bloch K., 1971, ENZYMES, V5, P441; BOUT A, 1988, NUCLEIC ACIDS RES, V16, P10369, DOI 10.1093/nar/16.21.10369; BROCK DJH, 1967, J BIOL CHEM, V242, P4432; CHARTON M, 1964, J ORG CHEM, V29, P1222, DOI 10.1021/jo01028a057; CLARK JD, 1988, BIOCHEMISTRY-US, V27, P5961, DOI 10.1021/bi00416a020; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DAVIS JT, 1987, J BIOL CHEM, V262, P82; DAVIS JT, 1987, J BIOL CHEM, V262, P90; DEQUIN S, 1988, CURR GENET, V13, P471, DOI 10.1007/BF02427752; ENDO K, 1970, J BIOL CHEM, V245, P4293; FENDRICH G, 1982, BIOCHEMISTRY-US, V21, P6685, DOI 10.1021/bi00269a011; FUKAO T, 1989, J BIOCHEM-TOKYO, V106, P197, DOI 10.1093/oxfordjournals.jbchem.a122832; GILBERT HF, 1981, BIOCHEMISTRY-US, V20, P5643, DOI 10.1021/bi00523a001; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; HOLLAND PC, 1973, BIOCHEMISTRY-US, V12, P3309, DOI 10.1021/bi00741a024; JONES ERH, 1954, J CHEM SOC, P3201, DOI 10.1039/jr9540003201; KASS LR, 1967, P NATL ACAD SCI USA, V58, P1168, DOI 10.1073/pnas.58.3.1168; MASAMUNE S, 1989, PURE APPL CHEM, V61, P303, DOI 10.1351/pac198961030303; MIDDLETON B, 1974, BIOCHEM J, V139, P109, DOI 10.1042/bj1390109; MORISAKI M, 1972, BIOCHEMISTRY-US, V11, P309, DOI 10.1021/bi00753a001; PEOPLES OP, 1989, J BIOL CHEM, V264, P15293; PEOPLES OP, 1987, J BIOL CHEM, V262, P97; ROBINSON MS, 1983, FEBS LETT, V154, P51, DOI 10.1016/0014-5793(83)80873-4; Sambrook J, 1989, MOL CLONING LABORATO; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; YANG SY, 1990, J BIOL CHEM, V265, P10424	29	62	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8369	8375						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673680				2022-12-25	WOS:A1991FK44100064
J	HAYCOCK, JW; HAYCOCK, DA				HAYCOCK, JW; HAYCOCK, DA			TYROSINE-HYDROXYLASE IN RAT-BRAIN DOPAMINERGIC NERVE-TERMINALS - MULTIPLE-SITE PHOSPHORYLATION INVIVO AND IN SYNAPTOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SUPERIOR CERVICAL-GANGLION; ELECTRICAL-STIMULATION; CATECHOLAMINE SECRETION; STRIATAL SYNAPTOSOMES; ACTIVATOR PROTEIN; PC12 CELLS; ACETYLCHOLINE; NEURONS; CALCIUM	Tyrosine hydroxylase, which catalyzes the initial step in catecholamine biosynthesis, is phosphorylated at serines 8, 19, 31, and 40 in intact pheochromocytoma (PC12) cells (Haycock, J. W. (1990) J. Biol. Chem. 265, 11682-11691). After P-32-i labeling of rat corpus striata in vivo or rat corpus striatal synaptosomes, P-32 incorporation into tyrosine hydroxylase occurred predominantly at serines 19, 31, and 40. Electrical stimulation (30 Hz, 20 min) of the medial forebrain bundle (containing the afferent dopaminergic fibers) increased P-32 incorporation into each of the three sites. Brief depolarization of the synaptosomes with elevated [K+]o (20-60 mM, 5-30 s) or veratridine (50-mu-M, 2 min) produced a selective increase in P-32 incorporation into Ser 19. Phorbol 12, 13-dibutyrate (1-mu-M, 5 min) increased P-32 incorporation into Ser 31, and cAMP-acting agents such as forskolin (10-mu-M, 5 min) increased P-32 incorporation into Ser 40. In contrast, P-32 incorporation into Ser 8, which was usually detectable but very low, was not regulated either in vivo or in situ by any of the activators of signal transduction pathways. In synaptosomes, the only treatment found to increase Ser 8 phosphorylation was okadaic acid (a protein phosphatase inhibitor), which increased P-32 incorporation into all four phosphorylation sites. Thus, three different signal transduction systems appear to mediate the physiological regulation of tyrosine hydroxylase phosphorylation at three different sites.	STERLING DRUG CO,DIV NEUROSCI,RENSSELAER,NY 12144		HAYCOCK, JW (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,1100 FLORIDA AVE,NEW ORLEANS,LA 70119, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH043620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025134, R29NS025134] Funding Source: NIH RePORTER; NCRR NIH HHS [RR05376] Funding Source: Medline; NIMH NIH HHS [MH43620] Funding Source: Medline; NINDS NIH HHS [NS25134] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; Braun R K, 1989, Proc West Pharmacol Soc, V32, P15; BYGDEMAN S, 1958, ACTA PHYSIOL SCAND, V44, P375, DOI 10.1111/j.1748-1716.1958.tb01634.x; CAHILL AL, 1984, P NATL ACAD SCI-BIOL, V81, P7243, DOI 10.1073/pnas.81.22.7243; CAHILL AL, 1987, BIOCHIM BIOPHYS ACTA, V930, P454, DOI 10.1016/0167-4889(87)90019-X; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; COLBY KA, 1989, BRAIN RES, V478, P103, DOI 10.1016/0006-8993(89)91481-9; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; ELMESTIKAWY S, 1983, NATURE, V302, P830, DOI 10.1038/302830a0; ERIKSON E, 1988, 2ND MESSENGERS PHOSP, V12, P135; GOLDSTEIN M, 1976, BRAIN RES, V109, P563, DOI 10.1016/0006-8993(76)90035-4; GORELICK FS, 1988, J BIOL CHEM, V263, P17209; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; HAYCOCK D A, 1988, Society for Neuroscience Abstracts, V14, P1093; HAYCOCK DA, 1981, BRAIN RES, V214, P371, DOI 10.1016/0006-8993(81)91201-4; HAYCOCK J, 1990, Society for Neuroscience Abstracts, V16, P69; HAYCOCK JW, 1989, ANAL BIOCHEM, V181, P259, DOI 10.1016/0003-2697(89)90240-6; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HAYCOCK JW, 1982, J BIOL CHEM, V257, P2641; HAYCOCK JW, 1982, J BIOL CHEM, V257, P9416; HAYCOCK JW, 1978, J NEUROCHEM, V30, P1113, DOI 10.1111/j.1471-4159.1978.tb12406.x; HAYCOCK JW, 1982, J BIOL CHEM, V257, P13699; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; HAYCOCK JW, 1991, UNPUB J BIOL CHEM, V266; KAPATOS G, 1979, BRAIN RES, V170, P299, DOI 10.1016/0006-8993(79)90108-2; MALHOTRA RK, 1989, J NEUROSCI, V9, P4150; MALHOTRA RK, 1988, J BIOL CHEM, V263, P2123; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSERANO JM, 1989, CATECHOLAMINES, V2, P427; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; MURRIN LC, 1976, MOL PHARMACOL, V12, P1070; MURRIN LC, 1976, MOL PHARMACOL, V12, P463; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; ROSKOSKI R, 1989, J NEUROCHEM, V53, P1934, DOI 10.1111/j.1471-4159.1989.tb09264.x; SALAH RS, 1989, J NEUROCHEM, V52, P1517, DOI 10.1111/j.1471-4159.1989.tb09202.x; SIMON JR, 1979, MOL PHARMACOL, V16, P224; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; TASHIRO Y, 1989, NEUROSCI LETT, V97, P6, DOI 10.1016/0304-3940(89)90130-4; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; WAYMIRE JC, 1988, J BIOL CHEM, V263, P12439; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; YANAGIHARA N, 1984, MOL PHARMACOL, V26, P141; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	47	141	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5650	5657						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1672315				2022-12-25	WOS:A1991FD37000046
J	MIYAMOTO, Y; THOMPSON, YG; HOWARD, EF; GANAPATHY, V; LEIBACH, FH				MIYAMOTO, Y; THOMPSON, YG; HOWARD, EF; GANAPATHY, V; LEIBACH, FH			FUNCTIONAL EXPRESSION OF THE INTESTINAL PEPTIDE-PROTON COTRANSPORTER IN XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; MICROCLIMATE-PH; MESSENGER-RNA; RAT JEJUNUM; ABSORPTION; PROTEINS; RABBIT	The expression of the intestinal peptide-proton co-transporter was examined in Xenopus laevis oocytes by microinjection of poly(A)+ mRNA prepared from rabbit intestinal mucosal cells. The concomitant expression of the glucose-sodium co-transporter was used as the control for the effectiveness of the expression technique. There was significant endogenous activity of Gly-Sar uptake in water-injected oocytes, but the uptake activity increased nearly 3-fold in poly(A)+ mRNA-injected oocytes. The expression of the peptide transporter was time-dependent. There was no detectable expression on day 1 after injection. The expression became noticeable on day 2 and increased with time, reaching a maximum on day 4. There was no further change on days 5 and 6. The endogenous uptake rate measured in water-injected oocytes, on the contrary, showed a slight decrease during this time. The expressed peptide transporter retained its substrate specificity, having affinity for the dipeptides, Gly-Sar and Gly-Pro, and no or little affinity for the free amino acids, Gly and Sar. The expressed peptide transporter also showed a dependence on a transmembrane H+ gradient for maximal activity. These data demonstrate that the mammalian intestinal peptide-proton co-transporter can be successfully expressed in Xenopus laevis oocytes. This expression system can provide an effective assay procedure to clone the gene encoding the transporter.			MIYAMOTO, Y (corresponding author), MED COLL GEORGIA,DEPT CELL & MOLEC BIOL,AUGUSTA,GA 30912, USA.				NICHD NIH HHS [HD24451] Funding Source: Medline; NIDDK NIH HHS [DK28389] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028389] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AOSHIMA H, 1988, ARCH BIOCHEM BIOPHYS, V265, P73, DOI 10.1016/0003-9861(88)90372-4; BANNON MJ, 1990, J NEUROCHEM, V54, P706, DOI 10.1111/j.1471-4159.1990.tb01929.x; CALONGE ML, 1989, J CELL PHYSIOL, V138, P579, DOI 10.1002/jcp.1041380319; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GANAPATHY V, 1985, AM J PHYSIOL, V249, pG153, DOI 10.1152/ajpgi.1985.249.2.G153; GANAPATHY V, 1982, LIFE SCI, V30, P2137, DOI 10.1016/0024-3205(82)90287-9; GANAPATHY V, 1981, J BIOL CHEM, V256, P118; GANAPATHY V, 1987, CONTRIB INFUSION THE, V17, P54; Grimble G K, 1989, Nutr Res Rev, V2, P87, DOI 10.1079/NRR19890009; HAGENBUCH B, 1990, J BIOL CHEM, V265, P5357; HEDIGER MA, 1987, P NATL ACAD SCI USA, V84, P2634, DOI 10.1073/pnas.84.9.2634; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HOSHI T, 1985, ION GRADIENT COUPLED, P183; IWATSUBO T, 1986, J PHARM SCI, V75, P1162, DOI 10.1002/jps.2600751209; KRAMER W, 1987, BIOCHIM BIOPHYS ACTA, V905, P65, DOI 10.1016/0005-2736(87)90009-5; KRAMER W, 1988, BIOCHEM PHARMACOL, V37, P2427, DOI 10.1016/0006-2952(88)90370-X; LUCAS M, 1983, GUT, V24, P734, DOI 10.1136/gut.24.8.734; MANIATIS T, 1982, MOL CLONING LABORATO, P461; MATTHEWS DM, 1976, GASTROENTEROLOGY, V71, P151; MATTHEWS DM, 1975, PHYSIOL REV, V55, P537, DOI 10.1152/physrev.1975.55.4.537; MATTHEWS DM, 1980, CURR TOP MEMBR TRANS, V14, P331; PALACIN M, 1990, J BIOL CHEM, V265, P7142; SHIMADA T, 1987, J PHYSIOL-LONDON, V392, P113, DOI 10.1113/jphysiol.1987.sp016772; SOREQ H, 1985, CRC CR REV BIOCH MOL, V18, P199, DOI 10.3109/10409238509085134; TARNUZZER RW, 1990, J BIOL CHEM, V265, P13914; TATE SS, 1989, ARCH BIOCHEM BIOPHYS, V275, P591, DOI 10.1016/0003-9861(89)90405-0; TERAOKA H, 1981, PROTEIN NUCLEIC ACID, V26, P330; WERNER A, 1990, J BIOL CHEM, V265, P12331	28	20	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4742	4745						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1672128				2022-12-25	WOS:A1991FC21700014
J	KOBILKA, BK				KOBILKA, BK			THE ROLE OF CYTOSOLIC AND MEMBRANE FACTORS IN PROCESSING OF THE HUMAN BETA-2 ADRENERGIC-RECEPTOR FOLLOWING TRANSLOCATION AND GLYCOSYLATION IN A CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT MED CARDIOL,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute				Kobilka, Brian/0000-0001-5958-3990				BOUVIER M, 1988, MOL PHARMACOL, V33, P133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGISSER E, 1984, BRAIN RECEPTOR METHO, P299; CARON MG, 1979, J BIOL CHEM, V254, P2923; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CONTRERAS R, 1982, NUCLEIC ACIDS RES, V10, P6353, DOI 10.1093/nar/10.20.6353; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRASER CM, 1989, J BIOL CHEM, V264, P9266; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GIULIAN GG, 1985, FED PROC, V44, P686; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; KOBILKA BK, 1987, J BIOL CHEM, V262, P15796; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU JTY, 1983, J BIOL CHEM, V258, P5255; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Maniatis T., 1982, MOL CLONING; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOUS J, 1980, FEBS LETT, V122, P105, DOI 10.1016/0014-5793(80)80412-1; MOUS JM, 1982, J BIOL CHEM, V257, P1822; OLSON TS, 1987, J BIOL CHEM, V262, P6816; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; SMITH MM, 1987, J BIOL CHEM, V262, P4367; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0	36	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7610	7618						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692024				2022-12-25	WOS:A1990DB30700079
J	MCATEE, P; DAWSON, G				MCATEE, P; DAWSON, G			PHOSPHOLIPASE-C ACTIVITY IN NCB-20 CELLS IS INHIBITED BY PROTEIN KINASE-A-MEDIATED PHOSPHORYLATION OF LOW-MOLECULAR MASS GTP-BINDING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637	University of Chicago	MCATEE, P (corresponding author), UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002575] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-06426] Funding Source: Medline; NIDA NIH HHS [DA-02575] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRYKRAVIS E, 1988, J NEUROCHEM, V50, P1287, DOI 10.1111/j.1471-4159.1988.tb10606.x; BOYER JL, 1989, J BIOL CHEM, V264, P884; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; COCKCROFT S, 1987, BIOCHEM J, V241, P409, DOI 10.1042/bj2410409; COCKCROFT S, 1985, NATURE, V314, P534, DOI 10.1038/314534a0; DECOURCELLES DD, 1987, BIOCHEM J, V244, P93, DOI 10.1042/bj2440093; DOWNES CP, 1981, BIOCHEM J, V198, P133, DOI 10.1042/bj1980133; FRANCEL P, 1988, BIOCHEM BIOPH RES CO, V152, P724, DOI 10.1016/S0006-291X(88)80098-6; FRANCEL PC, 1986, BIOCHEM BIOPH RES CO, V135, P507, DOI 10.1016/0006-291X(86)90023-9; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HARDEN TK, 1987, J BIOL CHEM, V262, P9057; HIGASHIDA H, 1986, P NATL ACAD SCI USA, V83, P942, DOI 10.1073/pnas.83.4.942; HOFMANN SL, 1982, J BIOL CHEM, V257, P4359; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; INHORN RC, 1987, P NATL ACAD SCI USA, V84, P2170, DOI 10.1073/pnas.84.8.2170; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; LAPETINA EEG, 1988, J CELL BIOL, V107, P707; LAPETINA EG, 1987, P NATL ACAD SCI USA, V84, P2261, DOI 10.1073/pnas.84.8.2261; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; LAZAROWSKI ER, 1989, BIOCHEM BIOPH RES CO, V158, P440, DOI 10.1016/S0006-291X(89)80067-1; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MARTIN TFJ, 1986, J BIOL CHEM, V261, P2918; MCATEE P, 1989, J BIOL CHEM, V264, P11193; NISHIBE S, 1989, J CELL BIOL, V262, P50; PERNEY TM, 1989, J BIOL CHEM, V264, P7317; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WANG P, 1989, J BIOCHEM-TOKYO, V105, P4, DOI 10.1093/oxfordjournals.jbchem.a122615; WANG P, 1988, J BIOCHEM-TOKYO, V103, P137, DOI 10.1093/oxfordjournals.jbchem.a122219; WANG P, 1989, J BIOCHEM-TOKYO, V105, P461, DOI 10.1093/oxfordjournals.jbchem.a122687; WANG P, 1988, J BIOCHEM-TOKYO, V104, P169, DOI 10.1093/oxfordjournals.jbchem.a122435; WATSON SP, 1984, J BIOL CHEM, V259, P3199; WILSON DB, 1984, J BIOL CHEM, V259, P1718; YADA Y, 1989, FEBS LETT, V242, P368, DOI 10.1016/0014-5793(89)80503-4	35	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6788	6793						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691176				2022-12-25	WOS:A1990CZ67700047
J	CONFORTI, G; ZANETTI, A; PASQUALIRONCHETTI, I; QUAGLINO, D; NEYROZ, P; DEJANA, E				CONFORTI, G; ZANETTI, A; PASQUALIRONCHETTI, I; QUAGLINO, D; NEYROZ, P; DEJANA, E			MODULATION OF VITRONECTIN RECEPTOR-BINDING BY MEMBRANE LIPID-COMPOSITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MODENA,IST PATOL GEN,I-41100 MODENA,ITALY; UNIV PARMA,IST CHIM BIOL,I-43100 PARMA,ITALY	Universita di Modena e Reggio Emilia; University of Parma	CONFORTI, G (corresponding author), MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY.		Quaglino, Daniela/A-9381-2010	Quaglino, Daniela/0000-0002-4302-5078; adriana, zanetti/0000-0002-5825-9707; NEYROZ, PAOLO/0000-0002-9790-4027; DEJANA, ELISABETTA/0000-0002-0007-0426				ALBELDA SM, 1989, J CLIN INVEST, V83, P1992, DOI 10.1172/JCI114109; ALOJ SM, 1982, HORMONE RECEPTORS, P83; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019; BERLINER S, 1988, J BIOL CHEM, V263, P7500; CHARO IF, 1987, J BIOL CHEM, V262, P9935; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; CONFORTI G, 1989, BLOOD, V73, P1576; DEJANA E, 1989, J CELL BIOL, V109, P367, DOI 10.1083/jcb.109.1.367; DEJANA E, 1988, BLOOD, V71, P566; DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403; DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215; DEJANA E, 1990, IN PRESS BLOOD; DEMARCO L, 1981, J CLIN INVEST, V68, P321, DOI 10.1172/JCI110259; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GALVIN JB, 1987, J BIOL CHEM, V262, P2199; GINSBERG MH, 1987, J BIOL CHEM, V262, P5437; GINSBERG MH, 1986, J CLIN INVEST, V78, P1103, DOI 10.1172/JCI112667; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KANTOR RRS, 1987, J BIOL CHEM, V262, P15158; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; MARGUERIE GA, 1982, J BIOL CHEM, V257, P1872; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MULLER WA, 1983, METHOD ENZYMOL, V98, P404; MURPHYULLRICH JE, 1985, BLOOD, V66, P1098; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; PARISE LV, 1985, J BIOL CHEM, V260, P1750; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PISCHEL KD, 1987, J IMMUNOL, V138, P226; POLACK B, 1989, BLOOD, V73, P1519; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; PYTELA R, 1985, CELL, V40, P91; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SMITH JW, 1988, J CELL BIOL, V106, P153; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; WAGNER DD, 1983, J BIOL CHEM, V258, P2065; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873	48	180	181	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					4011	4019						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689312				2022-12-25	WOS:A1990CQ48000067
J	KADONAGA, JT				KADONAGA, JT			ASSEMBLY AND DISASSEMBLY OF THE DROSOPHILA RNA POLYMERASE-II COMPLEX DURING TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	KADONAGA, JT (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NIGMS NIH HHS [GM 41249] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN S, 1983, NUCLEIC ACIDS RES, V11, P6041, DOI 10.1093/nar/11.17.6041; ARIAS JA, 1989, J BIOL CHEM, V264, P3223; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; FIRE A, 1984, J BIOL CHEM, V259, P2509; FREEDMAN LP, 1989, SCIENCE, V245, P298, DOI 10.1126/science.2473529; GARIGLIO P, 1974, FEBS LETT, V44, P330, DOI 10.1016/0014-5793(74)81170-1; GAUL U, 1987, TRENDS GENET, V3, P127, DOI 10.1016/0168-9525(87)90202-2; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HEBERLEIN U, 1985, CELL, V41, P965, DOI 10.1016/S0092-8674(85)80077-5; HEIERMANN R, 1985, NUCLEIC ACIDS RES, V13, P2709, DOI 10.1093/nar/13.8.2709; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; REINBERG D, 1987, J BIOL CHEM, V262, P3310; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; SAFER B, 1985, P NATL ACAD SCI USA, V82, P2632, DOI 10.1073/pnas.82.9.2632; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SAMUELS M, 1984, J BIOL CHEM, V259, P2517; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TOLUNAY HE, 1984, P NATL ACAD SCI-BIOL, V81, P5916, DOI 10.1073/pnas.81.19.5916; WEIL PA, 1979, CELL, V18, P469	29	126	126	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1990	265	5					2624	2631						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM848	1689291				2022-12-25	WOS:A1990CM84800038
J	KRISSANSEN, GW; ELLIOTT, MJ; LUCAS, CM; STOMSKI, FC; BERNDT, MC; CHERESH, DA; LOPEZ, AF; BURNS, GF				KRISSANSEN, GW; ELLIOTT, MJ; LUCAS, CM; STOMSKI, FC; BERNDT, MC; CHERESH, DA; LOPEZ, AF; BURNS, GF			IDENTIFICATION OF A NOVEL INTEGRIN BETA-SUBUNIT EXPRESSED ON CULTURED MONOCYTES (MACROPHAGES) - EVIDENCE THAT ONE ALPHA-SUBUNIT CAN ASSOCIATE WITH MULTIPLE BETA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INST MED & VET SCI,DIV HUMAN IMMUNOL,ADELAIDE,SA 5000,AUSTRALIA; WESTMEAD HOSP,DEPT MED,WESTMEAD,NSW 2145,AUSTRALIA; SCRIPPS CLIN & RES FDN,DEPT IMMUNOL,LA JOLLA,CA 92037	Institute Medical & Veterinary Science Australia; University of Sydney; Scripps Research Institute			Berndt, Michael C/D-5580-2012; Lopez, Angel F/E-2260-2011	Lopez, Angel F/0000-0001-7430-0135	NATIONAL CANCER INSTITUTE [R01CA045726] Funding Source: NIH RePORTER; NCI NIH HHS [CA45726] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAI Y, 1984, BLOOD, V64, P139; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BROWN EJ, 1988, J EXP MED, V167, P777, DOI 10.1084/jem.167.3.777; BURNS GF, 1986, CELL, V45, P269, DOI 10.1016/0092-8674(86)90391-0; BURNS GF, 1988, J CELL BIOL, V107, P1225, DOI 10.1083/jcb.107.3.1225; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DUNN SM, 1989, TRANSPLANT P, V21, P31; FURBY FH, 1984, THROMB RES, V35, P501, DOI 10.1016/0049-3848(84)90282-2; GILTAY JC, 1987, BLOOD, V69, P809; GINSBERG MH, 1987, J BIOL CHEM, V262, P5437; GOGSTAD G, 1983, BIOCHEM J, V214, P331, DOI 10.1042/bj2140331; GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507; HEMLER ME, 1988, IMMUNOL TODAY, V9, P109, DOI 10.1016/0167-5699(88)91280-7; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; KRISSANSEN GW, 1986, EMBO J, V5, P1799, DOI 10.1002/j.1460-2075.1986.tb04429.x; LAM SCT, 1989, J BIOL CHEM, V264, P3742; METCALF D, 1986, BLOOD, V67, P37; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PARKER CJ, 1988, BLOOD, V71, P86; PHILLIPS DR, 1977, J CLIN INVEST, V60, P535, DOI 10.1172/JCI108805; PLOW EF, 1986, P NATL ACAD SCI USA, V83, P6002, DOI 10.1073/pnas.83.16.6002; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; RUAN CG, 1987, BLOOD, V69, P570; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SMITH JW, 1988, J BIOL CHEM, V263, P18726; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; WALSH FS, 1977, NATURE, V269, P307, DOI 10.1038/269307a0; WATSON DB, 1983, J IMMUNOL, V130, P2442	34	95	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					823	830						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688554				2022-12-25	WOS:A1990CH53300032
J	DAMKE, H; KLUMPERMAN, J; VONFIGURA, K; BRAULKE, T				DAMKE, H; KLUMPERMAN, J; VONFIGURA, K; BRAULKE, T			EFFECTS OF BREFELDIN-A ON THE ENDOCYTIC ROUTE - REDISTRIBUTION OF MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH FACTOR-II RECEPTORS TO THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL-ENZYMES; HUMAN-FIBROBLASTS; CATHEPSIN-D; ENDOPLASMIC-RETICULUM; SECRETORY PROTEINS; RAT HEPATOCYTES; ARYLSULFATASE-A; GOLGI PROTEINS; TRANSFERRIN; TRANSPORT	The effect of brefeldin A (BFA) on the trafficking of the mannose 6-phosphate/insulin-like growth factor II receptor within the endocytic route was analyzed. Treatment with BFA induced a redistribution of the receptor to the cell surface and increased both the binding and internalization of ligands 2-4-fold. The effect of BFA was dose- and time-dependent and reversible. Determinations of transport rates showed that BFA increases the internalization rate and the externalization rate of the receptor. This implies that the higher surface concentration is due to higher concentrations of receptor at the intracellular sites from where they recycle to the cell surface. The effect of BFA was additive to the redistribution induced by insulin-like growth factors I and II and was observed in all human and rodent cell lines analyzed. BFA increased also the cell surface expression of the M(r) 46,000 mannose 6-phosphate receptor but not of the transferrin receptor. The results indicate that BFA interferes with the transport of mannose 6-phosphate receptors and affects the endocytosis of lysosomal enzymes by increasing the number of receptors available (M for recycling to the cell surface.	UNIV GOTTINGEN, GOSSLERSTR 120, W-3400 GOTTINGEN, GERMANY; UNIV UTRECHT, DEPT CELL BIOL, 3584 CX UTRECHT, NETHERLANDS	University of Gottingen; Utrecht University			Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532				BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; BRAULKE T, 1989, EMBO J, V8, P681, DOI 10.1002/j.1460-2075.1989.tb03426.x; BRAULKE T, 1990, J BIOL CHEM, V265, P6650; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GARTUNG C, 1985, EMBO J, V4, P1725, DOI 10.1002/j.1460-2075.1985.tb03842.x; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; ODA K, 1989, BIOCHEM BIOPH RES CO, V163, P220, DOI 10.1016/0006-291X(89)92124-4; ORCI L, 1991, CELL, V64, P1183; RADONS J, 1990, BIOL CHEM H-S, V371, P567, DOI 10.1515/bchm3.1990.371.2.567; SAHAGIAN GG, 1984, BIOL CELL, V51, P207, DOI 10.1111/j.1768-322X.1984.tb00300.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; STEIN C, 1989, J BIOL CHEM, V264, P1252; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; STOORVOGEL W, 1989, J CELL BIOL, V108, P2137, DOI 10.1083/jcb.108.6.2137; ULMER JB, 1989, P NATL ACAD SCI USA, V86, P6992, DOI 10.1073/pnas.86.18.6992; ULMER JB, 1991, EUR J CELL BIOL, V54, P38; VONFIGURA K, 1984, EMBO J, V3, P1281, DOI 10.1002/j.1460-2075.1984.tb01963.x; WAHEED A, 1982, H-S Z PHYSIOL CHEM, V363, P425, DOI 10.1515/bchm2.1982.363.1.425; WILLINGHAM MC, 1984, P NATL ACAD SCI-BIOL, V81, P175, DOI 10.1073/pnas.81.1.175	34	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24829	24833						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662218				2022-12-25	WOS:A1991GW84500088
J	SABORIDO, A; MORO, G; MEGIAS, A				SABORIDO, A; MORO, G; MEGIAS, A			TRANSVERSE TUBULE MG2+-ATPASE OF SKELETAL-MUSCLE - EVIDENCE FOR EXTRACELLULAR ORIENTATION OF THE CHICKEN AND RABBIT ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROPYRIDINE RECEPTOR; BIOCHEMICAL-PROPERTIES; ADENYLATE-CYCLASE; PLASMA-MEMBRANE; PROTEIN-KINASE; MG-ATPASE; VESICLES; TRIADS; MG-2+-ATPASE; LOCALIZATION	The orientation of the enzyme Mg2+-ATPase (EC 3.6.1.3) in the transverse tubule (TT) membranes of skeletal muscle was investigated using highly purified chicken and rabbit TT vesicles. The percentage of sealed vesicles present in these preparations averaged 88 and 78%, respectively, as calculated from the detergent-induced increase in ouabain-sensitive (Na+,K+)-ATPase activity, ATP-dependent ouabain binding, and lactate dehydrogenase activity (sarcoplasmic enzyme trapped in the TT vesicles). Sidedness of the sealed vesicles, estimated from latency of 5'-nucleotidase, acetylcholinesterase, and adenylate cyclase, was predominantly right-side out (69-76%, chicken TT and 62-70%, rabbit TT). In both chicken and rabbit native vesicles, high Mg2+-ATPase activity was detected by addition of ATP to the extravesicular medium; this activity was increased 14-12% by alamethicin pointing to the external localization of the active site. Furthermore, the enzymatic activity resulted partially inhibited by treatment of the chicken TT vesicles with proteinase K or p-hydroxymercuribenzoate. Concanavalin A stimulated 4-fold the chicken TT Mg2+-ATPase activity, an effect not potentiated by detergent permeabilization of the intact vesicles, indicating that lectin-binding sites were also solvent accessible. This stimulatory effect was not observed in native or permeabilized rabbit TT vesicles. From these results we conclude that the TT Mg2+-ATPase is an ectoenzyme with its nucleotide-hydrolyzing site and glycosylated regions facing the extracellular space. Inhibitors of ion-motive ATPases did not modify the enzyme activity, suggesting a different physiological role for the TT Mg2+-ATPase which may be involved in the regulation of muscle fiber functions affected by extracellular ATP levels.	COMPLUTENSE UNIV MADRID,FAC CHEM,DEPT BIOCHEM & MOLEC BIOL,E-28040 MADRID,SPAIN	Complutense University of Madrid			Saborido, Ana/I-6248-2017	Saborido, Ana/0000-0002-9375-6215				ALLAIN CC, 1974, CLIN CHEM, V20, P470; BARRETT JN, 1978, SCIENCE, V200, P1270, DOI 10.1126/science.96524; BEELER TJ, 1983, BIOCHIM BIOPHYS ACTA, V734, P221, DOI 10.1016/0005-2736(83)90120-7; BRANDT NR, 1985, BIOCHEM BIOPH RES CO, V127, P205, DOI 10.1016/S0006-291X(85)80145-5; CASWELL AH, 1976, ARCH BIOCHEM BIOPHYS, V176, P417, DOI 10.1016/0003-9861(76)90184-3; COAN C, 1990, J BIOL CHEM, V265, P5376; CULIC O, 1990, BIOCHIM BIOPHYS ACTA, V1030, P143, DOI 10.1016/0005-2736(90)90249-N; DAMIANI E, 1987, J CELL BIOL, V104, P461, DOI 10.1083/jcb.104.3.461; DUNN SMJ, 1989, J BIOL CHEM, V264, P11053; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ERIKSSON H, 1989, BIOCHEM BIOPH RES CO, V159, P878, DOI 10.1016/0006-291X(89)92190-6; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; FORRESTER T, 1972, J PHYSIOL-LONDON, V224, P611, DOI 10.1113/jphysiol.1972.sp009915; FOSSET M, 1983, J BIOL CHEM, V258, P6086; GARCIA JL, 1981, COMP BIOCHEM PHYS C, V68, P109, DOI 10.1016/0306-4492(81)90003-4; GENTRY MK, 1975, ANAL BIOCHEM, V64, P624, DOI 10.1016/0003-2697(75)90478-9; HAMLYN JM, 1983, BIOCHEM J, V214, P59, DOI 10.1042/bj2140059; HIDALGO C, 1983, J BIOL CHEM, V258, P3937; HIDALGO C, 1986, BIOCHIM BIOPHYS ACTA, V855, P79, DOI 10.1016/0005-2736(86)90191-4; Hidalgo C., 1986, P101; HORGAN DJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P377, DOI 10.1016/0003-9861(87)90191-3; HORGAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P1, DOI 10.1016/0003-9861(88)90417-1; JONES LR, 1980, J BIOL CHEM, V255, P9971; KIRLEY TL, 1988, J BIOL CHEM, V263, P12682; KREUTZBERG GW, 1984, CELLULAR BIOL ECTOEN; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN SH, 1988, J BIOL CHEM, V263, P12253; LIN SH, 1984, J BIOL CHEM, V259, P3016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALOUF NN, 1979, EXP CELL RES, V122, P233, DOI 10.1016/0014-4827(79)90301-X; MEGIAS A, 1990, ARCH BIOCHEM BIOPHYS, V278, P113, DOI 10.1016/0003-9861(90)90238-T; MICKELSON JR, 1985, ARCH BIOCHEM BIOPHYS, V242, P112, DOI 10.1016/0003-9861(85)90485-0; Miles E W, 1977, Methods Enzymol, V47, P431; MITCHELL RD, 1983, J BIOL CHEM, V258, P9867; MOULTON MP, 1986, J BIOL CHEM, V261, P2244; OKAMOTO VR, 1985, ARCH BIOCHEM BIOPHYS, V237, P43, DOI 10.1016/0003-9861(85)90252-8; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; SABBADINI RA, 1983, ARCH BIOCHEM BIOPHYS, V223, P107, DOI 10.1016/0003-9861(83)90576-3; SABBADINI RA, 1989, J BIOENERG BIOMEMBR, V21, P163, DOI 10.1007/BF00812068; SABORIDO RA, 1991, J APPL PHYSIOL, V70, P1038; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SALVATORI S, 1990, BIOCHEM J, V267, P679, DOI 10.1042/bj2670679; ZHAO D, 1989, ARCH BIOCHEM BIOPHYS, V268, P40, DOI 10.1016/0003-9861(89)90563-8	45	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23490	23498						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660476				2022-12-25	WOS:A1991GT48300107
J	ABRAMIC, M; LEVINE, AS; PROTIC, M				ABRAMIC, M; LEVINE, AS; PROTIC, M			PURIFICATION OF AN ULTRAVIOLET-INDUCIBLE, DAMAGE-SPECIFIC DNA-BINDING PROTEIN FROM PRIMATE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM-CELLS; ESCHERICHIA-COLI; HUMAN-FIBROBLASTS; NUCLEAR EXTRACTS; APURINIC SITES; HUMAN-PLACENTA; HELA-CELLS; REPAIR; ENDONUCLEASE; EXCINUCLEASE	A UV-inducible, damage-specific DNA-binding (DDB) protein with high affinity for double-stranded UV-irradiated DNA has been identified recently in monkey kidney (CV-1) cells (Hirschfeld, S., Levine, A. S., Ozato, K., and Protic, M. (1990) Mol. Cell. Biol. 10, 2041-2048). We have now purified the DDB protein from extracts of CV-1 cells using hydroxylapatite, phosphocellulose, Mono S, and DNA-affinity column chromatography. The DDB activity, either from mock-treated or UV-induced cells, is heterodisperse in column chromatography, and separation of three forms of the protein was obtained on a phosphocellulose column. Analysis of purified preparations by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that > 90% of all three forms is a protein of approximately 126 kDa. The size of the native DDB protein was deduced from gel filtration and native polyacrylamide gel electrophoresis to be approximately 210 kDa, which suggests that the native DDB protein in solution is a homodimer. Preparations of partially purified DDB protein from UV-treated cells have enhanced levels of DDB activity and the protein when compared with similar preparations from mock-treated cells. This damage-recognition protein, alone or in conjunction with other subunits, may be of general importance for the initial recognition of DNA damage in mammals.	NICHHD, VIRUSES & CELLULAR BIOL SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								CHAO CCK, 1991, MOL CELL BIOL, V11, P2075, DOI 10.1128/MCB.11.4.2075; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; CHU G, 1990, P NATL ACAD SCI USA, V87, P3324, DOI 10.1073/pnas.87.9.3324; DEUTSCH WA, 1979, P NATL ACAD SCI USA, V76, P141, DOI 10.1073/pnas.76.1.141; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DONAHUE BA, 1990, BIOCHEMISTRY-US, V29, P5872, DOI 10.1021/bi00476a032; FELDBERG RS, 1980, NUCLEIC ACIDS RES, V8, P1133, DOI 10.1093/nar/8.5.1133; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; FELDBERG RS, 1982, J BIOL CHEM, V257, P6394; FRIEDBERG EC, 1985, DNA REPAIR, P150; GLAZER PM, 1989, P NATL ACAD SCI USA, V86, P1163, DOI 10.1073/pnas.86.4.1163; GROSSMAN L, 1990, MUTAT RES, V236, P213, DOI 10.1016/0921-8777(90)90006-Q; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HIRSCHFELD S, 1990, MOL CELL BIOL, V10, P2041, DOI 10.1128/MCB.10.5.2041; HUANG ATF, 1975, CANCER RES, V35, P981; JIRICNY J, 1988, P NATL ACAD SCI USA, V85, P8860, DOI 10.1073/pnas.85.23.8860; KANE CM, 1981, J BIOL CHEM, V256, P3405; KARRAN P, 1985, CANCER SURV, V4, P583; KARTASOVA T, 1988, EXP CELL RES, V174, P421, DOI 10.1016/0014-4827(88)90312-6; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; LENZ J, 1990, P NATL ACAD SCI USA, V87, P3396, DOI 10.1073/pnas.87.9.3396; MORANELLI F, 1980, P NATL ACAD SCI-BIOL, V77, P3201, DOI 10.1073/pnas.77.6.3201; PARRISH DD, 1990, MUTAT RES, V235, P65, DOI 10.1016/0921-8777(90)90059-E; Protic M, 1989, Mol Toxicol, V2, P255; PROTIC M, 1988, SOMAT CELL MOLEC GEN, V14, P351, DOI 10.1007/BF01534643; PROTICSABLJIC M, 1985, P NATL ACAD SCI USA, V82, P6622, DOI 10.1073/pnas.82.19.6622; PROTICSABLJIC M, 1986, PHOTOCHEM PHOTOBIOL, V43, P509, DOI 10.1111/j.1751-1097.1986.tb09528.x; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SCHORPP M, 1984, CELL, V37, P861, DOI 10.1016/0092-8674(84)90421-5; SELBY CP, 1990, MUTAT RES, V236, P203, DOI 10.1016/0921-8777(90)90005-P; SIBGHATULLAH, 1989, NUCLEIC ACIDS RES, V17, P4471, DOI 10.1093/nar/17.12.4471; TSANG SS, 1982, BIOCHIM BIOPHYS ACTA, V697, P202, DOI 10.1016/0167-4781(82)90078-1; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; 1986, 120 PHASTS SEP TECHN	39	66	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22493	22500						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657999				2022-12-25	WOS:A1991GR56400069
J	YANG, LJ; BAFFY, G; RHEE, SG; MANNING, D; HANSEN, CA; WILLIAMSON, JR				YANG, LJ; BAFFY, G; RHEE, SG; MANNING, D; HANSEN, CA; WILLIAMSON, JR			PERTUSSIS TOXIN-SENSITIVE GI PROTEIN INVOLVEMENT IN EPIDERMAL GROWTH FACTOR-INDUCED ACTIVATION OF PHOSPHOLIPASE C-GAMMA IN RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL 12-MYRISTATE 13-ACETATE; INOSITOL PHOSPHATE GENERATION; TYROSINE PHOSPHORYLATION; FACTOR RECEPTOR; PHOSPHOINOSITIDE HYDROLYSIS; KINASE-C; DIFFERENTIAL MECHANISMS; SIGNAL TRANSDUCTION; ANGIOTENSIN-II; CELLS	Treatment of rat hepatocytes with epidermal growth factor (EGF) produced an enhanced tyrosine phosphorylation of the EGF receptor and phospholipase C-gamma (PLC-gamma) in conjunction with the mobilization of Ca2+. Approximately 30% of the total PLC-gamma was tyrosine-phosphorylated with a maximum being reached after 30 s of incubation with EGF. Pretreatment of the rats with pertussis toxin prior to isolation of the hepatocytes blocked EGF-induced tyrosine phosphorylation of PLC-gamma and Ca2+ mobilization but had no effect on autophosphorylation of the EGF receptor or Ca2+ responses elicited by angiotensin II or phenylephrine. Under these conditions G(i) protein alpha-subunits were fully ADP-ribosylated. A 41-kDa G(i) protein alpha-subunit was found to be present in the anti-PLC-gamma immune complex after EGF stimulation as shown by in vitro ADP-ribosylation using [P-32]NAD+ and activated pertussis toxin. The kinetics of association between PLC-gamma with G(i)alpha protein reached a maximum after 1 min of incubation with EGF. Antibodies specific for the EGF receptor also coimmunoprecipitated a G(i) protein alpha-subunit. Treatment of hepatocytes with EGF caused first an increase and then a decrease in the amount of G(i) protein alpha-subunit associated with the EGF receptor. In contrast, studies with cultured rat liver (WB) cells, a cell line in which EGF stimulation of phosphoinositide hydrolysis is not inhibited by pertussis toxin, showed that a stable complex of G(i)alpha was not formed with either PLC-gamma or EGF receptor immunoprecipitates. These results indicate that a pertussis toxin-sensitive G(i) protein is uniquely involved in the signal transduction pathway mediating EGF-induced activation of PLC-gamma and Ca2+ mobilization in hepatocytes.	UNIV PENN,DEPT BIOCHEM & BIOPHYS,601 GODDARD LABS,37TH & HAMILTON WALK,PHILADELPHIA,PA 19104; GEISINGER MED CLIN,DANVILLE,PA 17822; UNIV PENN,DEPT PHARMACOL,PHILADELPHIA,PA 19104; NHLBI,BIOCHEM LAB,BETHESDA,MD 20892	University of Pennsylvania; Geisinger Medical Center; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Baffy, Gyorgy/P-7986-2018	Baffy, Gyorgy/0000-0002-8334-0400	NIDDK NIH HHS [DK-15120] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015120] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; CATTANEO MG, 1989, BIOCHEM J, V262, P665, DOI 10.1042/bj2620665; CHURCH JG, 1988, J BIOL CHEM, V263, P4242; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HASEGAWASASAKI H, 1988, J BIOL CHEM, V263, P12970; HEPLER JR, 1990, BIOCHEM J, V270, P337, DOI 10.1042/bj2700337; HUANG CL, 1989, J BIOL CHEM, V264, P4391; HUCKLE WR, 1990, ENDOCRINOLOGY, V127, P1697, DOI 10.1210/endo-127-4-1697; HUGHES BP, 1987, BIOCHEM J, V248, P911, DOI 10.1042/bj2480911; JOHNSON RM, 1986, P NATL ACAD SCI USA, V83, P2032, DOI 10.1073/pnas.83.7.2032; JOHNSON RM, 1987, J BIOL CHEM, V262, P17285; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; KIM JW, 1990, J BIOL CHEM, V265, P3940; KIM UH, 1990, FEBS LETT, V270, P33, DOI 10.1016/0014-5793(90)81228-G; KIM UH, 1989, J BIOL CHEM, V264, P20167; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYNCH CJ, 1985, MOL PHARMACOL, V28, P93; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MEIJER AJ, 1975, J BIOL CHEM, V250, P7728; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MONCK JR, 1988, J BIOL CHEM, V263, P4569; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; NISHIBE S, 1990, P NATL ACAD SCI USA, V87, P424, DOI 10.1073/pnas.87.1.424; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; PARIS S, 1988, J BIOL CHEM, V263, P12893; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; POBINER BF, 1985, J BIOL CHEM, V260, P6200; RASHED SM, 1991, EUR J BIOCHEM, V197, P805, DOI 10.1111/j.1432-1033.1991.tb15975.x; TAYLOR CW, 1988, BIOCHEM J, V249, P917, DOI 10.1042/bj2490917; TEITELBAUM I, 1990, J CLIN INVEST, V85, P1044, DOI 10.1172/JCI114534; TILLY BC, 1988, BIOCHEM J, V252, P857, DOI 10.1042/bj2520857; TODDERUD G, 1990, SCIENCE, V249, P296, DOI 10.1126/science.2374928; VERHEIJDEN GF, 1991, CELL REGUL, V1, P615; WAHL MI, 1990, J BIOL CHEM, V265, P3944; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1989, CANCER CELL-MON REV, V1, P101; WHITMAN M, 1988, Biochimica et Biophysica Acta, V948, P327	44	122	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22451	22458						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657996				2022-12-25	WOS:A1991GR56400063
J	LUO, JH; SMITH, CC; KULKA, M; AURELIAN, L				LUO, JH; SMITH, CC; KULKA, M; AURELIAN, L			A TRUNCATED PROTEIN-KINASE DOMAIN OF THE LARGE SUBUNIT OF HERPES-SIMPLEX VIRUS TYPE-2 RIBONUCLEOTIDE REDUCTASE (ICP10) EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BACTERIA; PROTEOLYSIS; PROMOTER; ONCOGENE; COMPLEX; REGION	The amino-terminal domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) contains a serine/threonine-specific protein kinase that has characteristics of a growth factor receptor (Chung, T. D., Wymer, J. P., Smith, C. C., Kulka, M., and Aurelian, L. (1989) J. Virol. 63, 3389-3398; Chung, T. D., Wymer, J. P., Kulka, M., Smith, C. C., and Aurelian, L. (1990) Virology 179, 168-178). To characterize this protein kinase (PK) domain further we constructed a bacterial expression vector (pJL11) containing DNA sequences encoding ICP10 amino acid residues 1-445. Bacteria containing pJL11 were induced to express a 29-kDa protein (designated pp29la1) that represents a truncated portion of the ICP10-PK domain (includes PK catalytic motifs I-V) as demonstrated by immunoprecipitation with antibodies that recognize different antigenic domains, competition studies with extracts of ICP10-positive eukaryotic cells, and peptide mapping. pp29la1 has autophosphorylating and transphosphorylating activity for calmodulin. The enzyme is activated by Mn2+ but not by Mg2+ ions, and autophosphorylation is inhibited by histone. It differs from the authentic ICP10-PK in that phosphorylation is specific only for threonine.	UNIV MARYLAND,SCH MED,DEPT PHARMACOL & EXPTL THERAPEUT,VIROL IMMUNOL LABS,10 S PINE ST,BALTIMORE,MD 21201; JOHNS HOPKINS MED INST,DEPT BIOCHEM,BALTIMORE,MD 21205	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine								ANDERSON KP, 1981, J VIROL, V37, P1011, DOI 10.1128/JVI.37.3.1011-1027.1981; AURELIAN L, 1989, CANCER CEL, V7, P187; BACCHETTI S, 1984, J VIROL, V49, P591, DOI 10.1128/JVI.49.2.591-593.1984; CHUNG TD, 1990, VIROLOGY, V179, P168, DOI 10.1016/0042-6822(90)90286-Z; CHUNG TD, 1991, J GEN VIROL, V72, P1139, DOI 10.1099/0022-1317-72-5-1139; CHUNG TD, 1989, J VIROL, V63, P3389, DOI 10.1128/JVI.63.8.3389-3398.1989; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DANIELS DL, 1983, LAMBDA, V2, P519; FARROW SN, 1989, EUR J BIOCHEM, V184, P361, DOI 10.1111/j.1432-1033.1989.tb15027.x; FERGUSON B, 1985, J BIOL CHEM, V260, P3652; FRAME MC, 1985, J GEN VIROL, V66, P1581, DOI 10.1099/0022-1317-66-7-1581; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; INGEMARSON R, 1987, VIROLOGY, V156, P417, DOI 10.1016/0042-6822(87)90422-3; MACCONNELL WP, 1983, VIROLOGY, V131, P367, DOI 10.1016/0042-6822(83)90504-4; MCLAUCHLAN J, 1983, J GEN VIROL, V64, P997, DOI 10.1099/0022-1317-64-5-997; MILMAN G, 1985, P NATL ACAD SCI USA, V82, P6300, DOI 10.1073/pnas.82.18.6300; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NIKAS I, 1986, Proteins Structure Function and Genetics, V1, P376, DOI 10.1002/prot.340010411; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLICE LW, 1989, J BIOL CHEM, V264, P20940; SMITH CC, 1991, VIRUS GENES, V5, P215, DOI 10.1007/BF00568971; SWAIN MA, 1986, J VIROL, V57, P802, DOI 10.1128/JVI.57.3.802-808.1986; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; WALDMAN AS, 1983, J BIOL CHEM, V258, P1571; WANG JYJ, 1985, J BIOL CHEM, V260, P64; WAXHAM MN, 1989, J BIOL CHEM, V264, P7477; WYMER JP, 1989, J VIROL, V63, P2773, DOI 10.1128/JVI.63.6.2773-2784.1989; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	29	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20976	20983						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657940				2022-12-25	WOS:A1991GN00100062
J	REYLAND, ME; WILLIAMS, DL				REYLAND, ME; WILLIAMS, DL			SUPPRESSION OF CAMP-MEDIATED SIGNAL TRANSDUCTION IN MOUSE ADRENOCORTICAL-CELLS WHICH EXPRESS APOLIPOPROTEIN-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN CLEAVAGE; DEPENDENT PROTEIN-KINASE; STEROL CARRIER PROTEIN-2; TUMOR-CELLS; PERIPHERAL-TISSUES; NONHUMAN-PRIMATES; ADRENAL-GLAND; CYCLIC-AMP; CHOLESTEROL; GENE	We have reported previously that expression of the human apolipoprotein E (apoE) gene in mouse Y1 adrenocortical cells suppresses basal and adrenocorticotropin (ACTH)-stimulated steroidogenesis. To understand the mechanism of this suppression, we have examined the integrity of cAMP regulated events required for adrenal steroidogenesis. Both acute and chronic responses to ACTH or cAMP are suppressed in Y1 cells which express apoE (Y1-E cells) as compared with parental Y1 cells. Acute morphologic changes in response to cAMP and acute induction of steroidogenesis by cAMP are suppressed in the Y1-E cell lines. Constitutive expression of P450-cholesterol side chain cleavage enzyme mRNA, the rate-limiting enzyme in steroid hormone synthesis, is reduced up to 11-fold in the Y1-E cell lines. The level of mRNA encoding P450-cholesterol side chain cleavage correlates directly with the reduction in basal steroid production observed in the individual Y1-E cell lines. Expression of P450-11-beta-hydroxylase mRNA, although readily detectable in Y1 parent cells, is absent or reduced in the Y1-E cell lines. Inhibition of cAMP-regulated gene expression is not restricted to genes required for steroid synthesis, since cAMP induction of ornithine decarboxylase mRNA is also inhibited in the Y1-E cell lines. These data indicate that suppression of steroidogenesis in Y1-E cells is due, at least in part, to inhibition of cAMP-regulated gene expression. These effects are not due to a defective cAMP-dependent protein kinase, since kinase activity in vitro and activation in vivo are unaltered in the Y1-E cell lines. These results suggest that expression of apoE in Y1 cells blocks cAMP-mediated signal transduction at a point distal to activation of cAMP-dependent protein kinase.	SUNY STONY BROOK,DEPT PHARMACEUT SCI,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NHLBI NIH HHS [HL32868] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032868] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAMSEN M, 1991, J CELL BIOCH B S, V15, pD600; AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BASHEERUDDIN K, 1987, P NATL ACAD SCI USA, V84, P709, DOI 10.1073/pnas.84.3.709; BENIS R, 1989, TISSUE CELL, V21, P479, DOI 10.1016/0040-8166(89)90001-3; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDERBHAN R, 1982, J BIOL CHEM, V257, P8928; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONNEELY OM, 1984, P NATL ACAD SCI-BIOL, V81, P2970, DOI 10.1073/pnas.81.10.2970; DAWSON PA, 1989, J LIPID RES, V30, P403; DIBARTOLOMEIS MJ, 1984, J BIOL CHEM, V259, P159; DYER CA, 1988, J BIOL CHEM, V263, P10965; FAUST JR, 1977, J BIOL CHEM, V252, P4861; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; HAMILTON RL, 1990, J LIPID RES, V31, P1589; ILVESMAKI V, 1991, ENDOCRINOLOGY, V128, P1450, DOI 10.1210/endo-128-3-1450; KOWAL J, 1968, ARCH BIOCHEM BIOPHYS, V128, P406, DOI 10.1016/0003-9861(68)90047-7; KUDLOW JE, 1980, P NATL ACAD SCI-BIOL, V77, P2767, DOI 10.1073/pnas.77.5.2767; MATTSON P, 1982, ENDOCRINOLOGY, V111, P1632, DOI 10.1210/endo-111-5-1632; Montminy M R, 1990, Recent Prog Horm Res, V46, P219; MOORE CCD, 1990, MOL CELL BIOL, V10, P6013, DOI 10.1128/MCB.10.11.6013; NEWMAN TC, 1985, J BIOL CHEM, V260, P2452; ORMEJOHNSON NR, 1990, BIOCHIM BIOPHYS ACTA, V1020, P213, DOI 10.1016/0005-2728(90)90151-S; PEPE MG, 1986, J IMMUNOL, V136, P3716; PRACK MM, 1991, IN PRESS J LIPID RES; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; REYLAND ME, 1991, P NATL ACAD SCI USA, V88, P2375, DOI 10.1073/pnas.88.6.2375; RICE DA, 1989, J BIOL CHEM, V264, P14011; RICE DA, 1990, J BIOL CHEM, V265, P11713; SCHIMMER BP, 1986, J CELL PHYSIOL, V126, P77, DOI 10.1002/jcp.1041260111; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; TRZECIAK WH, 1987, J BIOL CHEM, V262, P3713; TRZECIAK WH, 1987, J BIOL CHEM, V262, P15246; VOORHEES HL, 1984, CELL BIOL INT REP, V8, P483, DOI 10.1016/0309-1651(84)90169-3; WEN L, 1989, J BIOL CHEM, V264, P9016; WILLIAMS DL, 1985, J BIOL CHEM, V260, P2444; WONG M, 1989, J BIOL CHEM, V264, P12867	37	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21099	21104						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657949				2022-12-25	WOS:A1991GN00100080
J	SRIVASTAVA, SP; CHEN, NQ; LIU, YX; HOLTZMAN, JL				SRIVASTAVA, SP; CHEN, NQ; LIU, YX; HOLTZMAN, JL			PURIFICATION AND CHARACTERIZATION OF A NEW ISOZYME OF THIOL PROTEIN-DISULFIDE OXIDOREDUCTASE FROM RAT HEPATIC MICROSOMES - RELATIONSHIP OF THIS ISOZYME TO CYTOSOLIC PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C FORM 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-INSULIN TRANSHYDROGENASE; GLUCAGON DEGRADING PROTEINASE; AMINO-ACID-SEQUENCE; MONOCLONAL-ANTIBODY; DEPENDENT THIOL; CALCIUM-PUMP; LIVER; ISOMERASE; DEGRADATION; MEMBRANE	Thiol:protein-disulfide oxidoreductase catalyzes the GSH reduction of protein disulfides to sulfhydryls. Chromatography of solubilized hepatic microsomes on Mono Q yielded two peaks, Q-2 and Q-5, which contained all the thiol:protein-disulfide oxidoreductase activity. These were further purified by chromatofocusing giving specific activities of 14.4 and 45.9 nmol/mg of protein/min, respectively with purifications of 45.0- and 143.6-fold. Amino acids 1-18 of Q-5 were the same as previously reported for Thiol:protein-disulfide oxidoreductase (Edman, J. C., Ellis, L., Blacher, R. W., Roth, R. A., and Rutter, W. J. (1985) Nature 317, 267-270), except amino acid 1 was leucine instead of aspartate and amino acid 6 was asparagine instead of glutamate. The N-terminal amino acid sequence of Q-2 differed markedly from Q-5 but Q-2 showed 100% identity at amino acids 25-54, 258-269, 285-310, 347-350, 412-419, and 434-463 for the reported sequence of rat, hepatic, cytosolic phosphatidylinositol-specific phospholipase C form 1a (PLC) (Bennett, C. F., Balcarek, J. M., Varrichio, A., and Crooke, S. T. (1988) Nature 334, 268-270). PLC activity was found in the elution from the Mono Q column, but none was found in purified Q-2 or Q-5. Antibodies to Q-5 reacted with Q-2, but anti-Q-2 did not react with Q-5. Anti-Q-2 antibody showed immunoreactivity with 55- and 60-kDa microsomal proteins, whereas Q-5 antibody reacted with a number of microsomal proteins. Although Q-2 was immunoreactive with a polyclonal antibody to guinea pig, uterine cytosolic PLC, partially purified PLCs from rat liver cytosol did not react to this antibody. Our data would suggest that the published sequence for PLC form 1a may actually be the sequence for Q-2.	UNIV MINNESOTA, DEPT PHARMACOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT MED, MINNEAPOLIS, MN 55455 USA; VET ADM MED CTR, MED SERV, MINNEAPOLIS, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003731] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES03731] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANSORGE S, 1971, EUR J BIOCHEM, V19, P283, DOI 10.1111/j.1432-1033.1971.tb01316.x; ANSORGE S, 1984, BIOMED BIOCHIM ACTA, V43, P29; ANSORGE S, 1973, EUR J BIOCHEM, V32, P27, DOI 10.1111/j.1432-1033.1973.tb02574.x; ANSORGE S, 1984, BIOMED BIOCHIM ACTA, V43, P39; AXELSSON K, 1980, BIOCHIM BIOPHYS ACTA, V613, P324, DOI 10.1016/0005-2744(80)90087-X; BATTELLI MG, 1982, BIOCHEM J, V207, P133, DOI 10.1042/bj2070133; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BENNETT CF, 1987, J BIOL CHEM, V262, P13789; BJELLAND S, 1983, BIOCHIM BIOPHYS ACTA, V747, P197, DOI 10.1016/0167-4838(83)90097-3; BOADO RJ, 1988, BIOCHEM BIOPH RES CO, V155, P1297, DOI 10.1016/S0006-291X(88)81282-8; CHANDLER ML, 1972, BIOCHIM BIOPHYS ACTA, V286, P136, DOI 10.1016/0304-4165(72)90099-2; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CROOKE ST, 1989, CELL CALCIUM, V10, P309, DOI 10.1016/0143-4160(89)90057-2; DAWSON DB, 1984, BIOCHEM BIOPH RES CO, V125, P668, DOI 10.1016/0006-291X(84)90591-6; DAWSON DB, 1987, BIOCHIM BIOPHYS ACTA, V923, P389; DELLACOR.E, 1973, BIOCHEM J, V136, P597; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ERICKSON RR, 1987, J PHARMACOL EXP THER, V242, P472; FRANCIS GL, 1980, BIOCHEM J, V186, P571, DOI 10.1042/bj1860571; FREEDMAN RB, 1979, FEBS LETT, V97, P201, DOI 10.1016/0014-5793(79)80085-X; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; HILLSON DA, 1980, BIOCHEM J, V191, P373, DOI 10.1042/bj1910373; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; HILLSON DA, 1980, BIOCHEM J, V191, P389, DOI 10.1042/bj1910389; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOLTMAN JL, 1989, PHARMACOLOGIST, V31, P168; HOLTZMAN JL, 1989, DRUG METAB REV, V20, P629, DOI 10.3109/03602538909103566; HORIUCHI R, 1989, EUR J BIOCHEM, V183, P529, DOI 10.1111/j.1432-1033.1989.tb21081.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANNERVIK B, 1975, BIOCHEM J, V149, P785, DOI 10.1042/bj1490785; MCCONKEY DJ, 1986, LIFE SCI, V38, P2139, DOI 10.1016/0024-3205(86)90213-4; NARAHARA HT, 1959, J BIOL CHEM, V234, P71; OHBA H, 1981, J BIOCHEM, V89, P889, DOI 10.1093/oxfordjournals.jbchem.a133272; ROTH RA, 1981, BIOCHEMISTRY-US, V20, P6594, DOI 10.1021/bi00526a012; ROTH RA, 1984, BIOCHIM BIOPHYS ACTA, V788, P189, DOI 10.1016/0167-4838(84)90261-9; SCHOENMAKERS CHH, 1989, BIOCHEM BIOPH RES CO, V162, P857, DOI 10.1016/0006-291X(89)92389-9; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; SRIVASTAVA SP, 1990, J BIOL CHEM, V265, P8392; SRIVASTAVA SP, 1988, FASEB J, V2, pA1778; SRIVASTAVA SP, 1989, J CELL BIOL, V107, P3611; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; TAKENAWA T, 1981, J BIOL CHEM, V256, P6769; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; VARANDANI PT, 1973, BIOCHEM BIOPH RES CO, V55, P689, DOI 10.1016/0006-291X(73)91199-6; VARANDANI PT, 1978, BIOCHIM BIOPHYS ACTA, V538, P343, DOI 10.1016/0304-4165(78)90362-8; VARANDANI PT, 1973, BIOCHIM BIOPHYS ACTA, V304, P642, DOI 10.1016/0304-4165(73)90210-9; VARANDANI PT, 1968, BIOCHIM BIOPHYS ACTA, V151, P273, DOI 10.1016/0005-2744(68)90183-6; YAMAUCHI K, 1987, BIOCHEM BIOPH RES CO, V146, P1485, DOI 10.1016/0006-291X(87)90817-5; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513; ZIEGLER DM, 1979, CIBA F SYMP, V72, P191	51	84	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20337	20344						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657921				2022-12-25	WOS:A1991GM03900069
J	LAKATOS, S; MINTON, AP				LAKATOS, S; MINTON, AP			INTERACTIONS BETWEEN GLOBULAR-PROTEINS AND F-ACTIN IN ISOTONIC SALINE SOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION EQUILIBRIUM; CONTAINING-FILAMENTS; GLYCOLYTIC ENZYMES; BINDING PROTEINS; SKELETAL-MUSCLE; A-II; ALDOLASE; ASSOCIATION; METABOLISM	Solutions of each of three different globular proteins (cytochrome c, chromophorically labeled serum albumin, and chromophorically labeled aldolase), mixed with another unlabeled globular protein or with fibrous actin, were prepared in pH 8.0 Tris-HCl buffer containing 0.15 M NaCl. Each solution was centrifuged at low speed, at 5-degrees-C, until unassociated globular protein in solution achieved sedimentation equilibrium. Individual absorbance gradients of both macrosolutes in the mixtures subsequent to centrifugation were obtained via optical scans of the centrifuge tubes at two wavelengths. The gradients of each macrosolute in mixtures of two globular proteins revealed no association of globular proteins under the conditions of these experiments, but perturbation of the gradients of serum albumin, aldolase, and cytochrome c in the presence of F-actin indicated association of all three globular proteins with F-actin. Perturbation of actin gradients in the presence of serum albumin and aldolase suggested partial depolymerization of the F-actin by the globular protein. Analysis of the data with a simple phenomenological model relating free globular protein, bound globular protein, and total actin concentration provided estimates of the respective equilibrium constants for association of serum albumin and aldolase with F-actin, under the conditions of these experiments, of the order of 0.1-mu-M-1.	NIDDKD, BIOCHEM PHARMACOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Lakatos, Susan/I-9498-2019	Minton, Allen/0000-0001-8459-1247				ARNOLD H, 1971, EUR J BIOCHEM, V22, P121, DOI 10.1111/j.1432-1033.1971.tb01522.x; ARNOLD H, 1968, EUR J BIOCHEM, V6, P163, DOI 10.1111/j.1432-1033.1968.tb00434.x; ATTRI AK, 1987, ANAL BIOCHEM, V162, P409, DOI 10.1016/0003-2697(87)90412-X; ATTRI AK, 1983, ANAL BIOCHEM, V133, P142, DOI 10.1016/0003-2697(83)90235-X; BIRCHMEIER W, 1984, TRENDS BIOCHEM SCI, V9, P192, DOI 10.1016/0968-0004(84)90137-3; BROOKS SPJ, 1991, FEBS LETT, V278, P135, DOI 10.1016/0014-5793(91)80101-8; CHATELIER RC, 1988, ANAL BIOCHEM, V175, P114, DOI 10.1016/0003-2697(88)90368-5; CHATELIER RC, 1987, BIOPOLYMERS, V26, P1097, DOI 10.1002/bip.360260709; CLARKE FM, 1975, BIOCHIM BIOPHYS ACTA, V381, P37, DOI 10.1016/0304-4165(75)90187-7; CLEGG JS, 1984, AM J PHYSIOL, V246, pR133, DOI 10.1152/ajpregu.1984.246.2.R133; Connors K. A., 1987, BINDING CONSTANTS; DON M, 1988, MOL CELL BIOCHEM, V81, P145; FASMAN GD, 1976, CRC HDB BIOCH MOL BI, V1, P415; GOLDMAN M, 1968, FLUORESCENT ANTIBODY, P119; KELETI T, 1989, PROG BIOPHYS MOL BIO, V53, P105, DOI 10.1016/0079-6107(89)90016-3; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KUTER MR, 1981, ARCH BIOCHEM BIOPHYS, V212, P306, DOI 10.1016/0003-9861(81)90370-2; MASTERS CJ, 1987, MOL CELL BIOCHEM, V76, P3; MINTON AP, 1990, UCLA SYM BI, V133, P291; MINTON AP, 1990, ANAL BIOCHEM, V190, P1, DOI 10.1016/0003-2697(90)90125-S; MINTON AP, 1982, BIOPOLYMERS, V21, P451, DOI 10.1002/bip.360210215; MINTON AP, 1981, BIOPHYS CHEM, V14, P317, DOI 10.1016/0301-4622(81)85033-8; Muramatsu N, 1989, J Mol Recognit, V1, P166, DOI 10.1002/jmr.300010404; OSBORNE JC, 1980, BIOCHIM BIOPHYS ACTA, V619, P559, DOI 10.1016/0005-2760(80)90107-1; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POGLAZOV BF, 1985, ADV ENZ REGN, V25, P297; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; PORTER KR, 1984, J CELL BIOL, V99, pS3, DOI 10.1083/jcb.99.1.3s; PRESS WH, 1986, NUMERICAL RECIPES AR; ROBERTS SJ, 1987, BIOCHEMISTRY-US, V26, P3437, DOI 10.1021/bi00386a028; SERVILLO L, 1981, BIOPHYS CHEM, V13, P29, DOI 10.1016/0301-4622(81)80022-1; Smith M. H., 1968, CRC HDB BIOCH, pC3; SRERE PA, 1967, SCIENCE, V158, P936, DOI 10.1126/science.158.3803.936; SRIVASTAVA DK, 1987, ANNU REV BIOPHYS BIO, V16, P175; STEWART M, 1980, BIOCHEM J, V186, P99, DOI 10.1042/bj1860099; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; STOSSEL TP, 1984, J CELL BIOL, V99, pS15, DOI 10.1083/jcb.99.1.15s; TANFORD C, 1961, PHYSICAL CHEM MACROM, P259; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; WALSH JL, 1988, BIOCHIM BIOPHYS ACTA, V952, P83, DOI 10.1016/0167-4838(88)90104-5; WALSH TP, 1980, BIOCHEM J, V186, P89, DOI 10.1042/bj1860089	41	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18707	18713						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655757				2022-12-25	WOS:A1991GJ47200048
J	SHIN, JY; DUNBRACK, RL; LEE, SJ; STROMINGER, JL				SHIN, JY; DUNBRACK, RL; LEE, SJ; STROMINGER, JL			PHOSPHORYLATION-DEPENDENT DOWN-MODULATION OF CD4 REQUIRES A SPECIFIC STRUCTURE WITHIN THE CYTOPLASMIC DOMAIN OF CD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; PHORBOL-MYRISTATE ACETATE; TYROSINE PROTEIN-KINASE; AMINO-TERMINAL DOMAIN; EGF RECEPTOR; SECONDARY STRUCTURE; HIV INFECTION; CROSS-LINKING; ENDOCYTOSIS; INTERNALIZATION	Several structural features of the cytoplasmic domain of CD4 including phosphorylation of Ser-408 have been shown to be important in its endocytosis (Shin, J., Doyle, C., Yang, Z., Kappes, D., and Strominger, J. L. (1990) EMBO J. 9, 425-434). A series of cytoplasmic domain truncations have now indicated that the membrane proximal region of the cytoplasmic domain from Arg-396 to Lys-417 is sufficient for phorbol ester-induced internalization; this segment is predicted to be an alpha-helix. The severe impairment of endocytosis resulting from the mutation Ser-408 to Ala-408 is largely restored by a compensating mutation Ala-404 to Ser-404; phosphorylation of Ser-404 has been directly demonstrated. Furthermore, mutation of Met-407, Ile-410, Leu-413, or Leu-414 to a hydrophilic residue eliminated CD4 endocytosis as did domain truncation at Arg-412. Ser-408 was normally phosphorylated in all of these mutants, suggesting that other residues in this region, including the four hydrophobic amino acids, are also required for CD4 endocytosis. Immunofluorescence microscopy following staining of intact and permeabilized cells showed that all endocytosis defective mutants indeed remained on the cell surface even after phorbol ester treatment, while wild type CD4 was endocytosed and degraded in lysosomes. These data indicate that endocytosis requiring residues 397-417 and binding of lymphocyte tyrosine kinase at residues 417-429 are functions of independent segments of the cytoplasmic region and lead to a hypothesis regarding some features of the endocytic process.			SHIN, JY (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.		Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667	NATIONAL CANCER INSTITUTE [R35CA047554] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47554] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; BLUE ML, 1987, J IMMUNOL, V139, P3949; BLUE ML, 1989, J IMMUNOL, V142, P374; CARLIN CR, 1989, CELL, V57, P135, DOI 10.1016/0092-8674(89)90179-7; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COCHET C, 1988, J BIOL CHEM, V263, P3290; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DISANTO JP, 1989, IMMUNOGENETICS, V30, P494, DOI 10.1007/BF02421181; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HOLLEY LH, 1989, P NATL ACAD SCI USA, V86, P152, DOI 10.1073/pnas.86.1.152; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HOUSE C, 1987, J BIOL CHEM, V262, P772; HOXIE JA, 1988, J IMMUNOL, V140, P786; HOXIE JA, 1986, J IMMUNOL, V137, P1194; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LITTMAN DR, 1988, CELL, V55, P541, DOI 10.1016/0092-8674(88)90211-5; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; NEL AE, 1987, J IMMUNOL, V139, P2230; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; SLECKMAN BP, 1989, J IMMUNOL, V142, P1457; SLECKMAN BP, 1988, J IMMUNOL, V141, P49; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEGA MA, 1990, EUR J IMMUNOL, V20, P453, DOI 10.1002/eji.1830200235; WANG PTH, 1987, J IMMUNOL, V131, P2157; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEYLAND CM, 1987, J IMMUNOL, V138, P1351	40	119	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10658	10665						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1674746				2022-12-25	WOS:A1991FP08600098
J	JAKES, KS; ABRAMS, CK; FINKELSTEIN, A; SLATIN, SL				JAKES, KS; ABRAMS, CK; FINKELSTEIN, A; SLATIN, SL			ALTERATION OF THE PH-DEPENDENT ION SELECTIVITY OF THE COLICIN-E1 CHANNEL BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; ROCKEFELLER UNIV,NEW YORK,NY 10021	Yeshiva University; Albert Einstein College of Medicine; Rockefeller University	JAKES, KS (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PHYSIOL & BIOPHYS,BRONX,NY 10461, USA.				PHS HHS [29210-12] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ausuble F. M., 1987, CURRENT PROTOCOLS MO; BATY D, 1987, P NATL ACAD SCI USA, V84, P1152, DOI 10.1073/pnas.84.5.1152; BECK E, 1981, GENE, V16, P35, DOI 10.1016/0378-1119(81)90059-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHAN PT, 1985, J BIOL CHEM, V260, P8925; CLEVELAND MV, 1983, P NATL ACAD SCI-BIOL, V80, P3706, DOI 10.1073/pnas.80.12.3706; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; DANKERT JR, 1982, J BIOL CHEM, V257, P3857; ENEA V, 1982, VIROLOGY, V122, P222, DOI 10.1016/0042-6822(82)90395-6; FULFORD W, 1984, J MOL BIOL, V178, P137, DOI 10.1016/0022-2836(84)90136-0; HEITMAN J, 1989, NUCLEIC ACIDS RES, V17, P4413, DOI 10.1093/nar/17.11.4413; JAKES K, 1974, J BIOL CHEM, V249, P438; Jakes KS., 1982, MOL ACTION TOXINS VI, P131; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KALLIS GB, 1980, J BIOL CHEM, V255, P261; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; KONISKY J, 1982, ANNU REV MICROBIOL, V36, P125, DOI 10.1146/annurev.mi.36.100182.001013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU Q R, 1986, Proteins Structure Function and Genetics, V1, P218, DOI 10.1002/prot.340010304; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P55; MANKOVICH JA, 1986, J BACTERIOL, V168, P228, DOI 10.1128/jb.168.1.228-236.1986; MARTINEZ MC, 1983, EMBO J, V2, P1501, DOI 10.1002/j.1460-2075.1983.tb01614.x; Montal M, 1974, Methods Enzymol, V32, P545; MORLON J, 1983, J MOL BIOL, V170, P271, DOI 10.1016/S0022-2836(83)80148-X; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PAUL C, 1985, EMBO J, V4, P1593, DOI 10.1002/j.1460-2075.1985.tb03822.x; PUGSLEY AP, 1987, MOL MICROBIOL, V1, P317, DOI 10.1111/j.1365-2958.1987.tb01938.x; RAYMOND L, 1986, J MEMBRANE BIOL, V92, P255, DOI 10.1007/BF01869394; RAYMOND L, 1985, J MEMBRANE BIOL, V84, P173, DOI 10.1007/BF01872215; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIN SJ, 1978, NATURE, V276, P159, DOI 10.1038/276159a0; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; SHIVER JW, 1987, J BIOL CHEM, V262, P14273; SHIVER JW, 1988, BIOCHEMISTRY-US, V27, P8421, DOI 10.1021/bi00422a019; SLATIN S, 1984, BIOPHYS J, V45, pA62; SLATIN SL, 1986, J MEMBRANE BIOL, V92, P247, DOI 10.1007/BF01869393; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; WILLIAMS R J P, 1989, Biophysical Journal, V55, p495A; YAMADA M, 1982, P NATL ACAD SCI-BIOL, V79, P2827, DOI 10.1073/pnas.79.9.2827; ZINDER ND, 1982, GENE, V19, P1, DOI 10.1016/0378-1119(82)90183-4	42	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6984	6991						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691183				2022-12-25	WOS:A1990CZ67700077
J	ALLEN, GC; KORNBERG, A				ALLEN, GC; KORNBERG, A			FINE BALANCE IN THE REGULATION OF DNAB HELICASE BY DNAC PROTEIN IN REPLICATION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-DNA; CHROMOSOMAL ORIGIN; GENE-PRODUCT; INITIATION; BACTERIOPHAGE; INVITRO; MUTANTS; ASSOCIATION; MECHANISM; TEMPLATE	The DnaC protein of Escherichia coli is essential for replication in vivo and in vitro. In the initiation of replication of a minichromosome at its origin, DnaC delivers the DnaB helicase from a DnaB-DnaC complex to the future replication fork and then departs. However, if an excess of DnaC was present in subsequent steps, it severely inhibited replication by slowing the DnaB helicase at the replication fork. When DnaB was present at a level equimolar with the excess DnaC, the inhibition was relieved, implying that the ratio of DnaC to DnaB is critical for achieving optimal replication activity and avoiding inhibition by DnaC. In vivo, overproduction of DnaC slowed cell growth. This slowing was alleviated by overproducing DnaB at the same time. E. coli strains with a dnaCts gene defective in chromosomal initiation were complemented by the wild-type gene in trans. On the other hand, strains with an elongation-defective dnaCts gene were not complemented by the wild-type dnaC gene. The dominance of the mutant protein suggests that it remains tightly complexed with DnaB at the replication fork, inhibiting elongation even in the presence of the wild-type DnaC.			ALLEN, GC (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM07851] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; ARAI K, 1981, J BIOL CHEM, V256, P5267; ARAI K, 1981, J BIOL CHEM, V256, P5273; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BLINKOWA A, 1983, J BACTERIOL, V153, P535, DOI 10.1128/JB.153.1.535-538.1983; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; FULLER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5817, DOI 10.1073/pnas.80.19.5817; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOBORI JA, 1982, J BIOL CHEM, V257, P13757; KOBORI JA, 1985, J BIOL CHEM, V257, P13763; LANKA E, 1983, NUCLEIC ACIDS RES, V11, P987, DOI 10.1093/nar/11.4.987; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LEE EH, 1990, P NATL ACAD SCI USA, V87, P4620, DOI 10.1073/pnas.87.12.4620; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; Maniatis T., 1982, MOL CLONING; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; NAKAYAMA N, 1987, J BIOL CHEM, V262, P10475; NAKAYAMA N, 1984, J BIOL CHEM, V259, P97; SCHUBACH WH, 1973, J MOL BIOL, V74, P205, DOI 10.1016/0022-2836(73)90107-1; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WECHSLER JA, 1975, J BACTERIOL, V121, P594, DOI 10.1128/JB.121.2.594-599.1975; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; ZYLICZ M, 1984, MOL GEN GENET, V196, P401, DOI 10.1007/BF00436186	30	75	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22096	22101						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657989				2022-12-25	WOS:A1991GR56400008
J	RUNQUIST, EA; HAVEL, RJ				RUNQUIST, EA; HAVEL, RJ			ACID-HYDROLASES IN EARLY AND LATE ENDOSOME FRACTIONS FROM RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; LOW-DENSITY LIPOPROTEINS; CHOLESTERYL ESTER; LYSOSOMAL-ENZYMES; PHOSPHORYLATED OLIGOSACCHARIDES; MACROPHAGE ENDOSOMES; CELL-SURFACE; CATHEPSIN-D; PHOSPHATASE; MEMBRANES	We have examined the distribution of the cation-independent mannose 6-phosphate receptor and five acid hydrolases in early and late endosomes and a receptor-recycling fraction isolated from livers of estradiol-treated rats. Enrichment of mannose 6-phosphate receptor mass relative to that of crude liver membranes was comparable in membranes of early and late endosomes but was even greater in membranes of the receptor-recycling fraction. Enrichment of acid hydrolase activities (aryl sulfatase, N-acetyl-beta-glucosaminidase, tartrate-sensitive acid phosphatase, and cholesteryl ester acid hydrolase) and cathepsin D mass was also comparable in early and late endosomes but was considerably lower in the receptor-recycling fraction. The enrichment of two acid hydrolases, acid phosphatase and cholesteryl ester acid hydrolase, in endosomes was severalfold greater than that of the other three examined, about 40% of that found in lysosomes. Acid phosphatase and cholesteryl ester acid hydrolase were partially associated with endosome membranes, whereas cathepsin D was found entirely in the endosome contents. These findings raise the possibility that lysosomal enzymes traverse early endosomes during transport to lysosomes in rat hepatocytes and suggest that the greater enrichment of some acid hydrolases in endosomes is related to their association with endosome membranes. Despite the substantial enrichment of lysosomal enzymes in hepatocytic endosomes, we found that two, cholesteryl ester acid hydrolase and cathepsin D, did not degrade cholesteryl esters and apolipoprotein B-100 of endocytosed low density lipoproteins in vivo, presumably because they are inactive at the pH within endosomes.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT CHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NHLBI NIH HHS [HL 14237] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014237] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRET AJ, 1977, LYSOSOMES LAB HDB, P115; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; BRECHER P, 1976, J LIPID RES, V17, P239; CASCIOLA LAF, 1989, J CELL BIOL, V109, P328; CHAO Y, 1979, J BIOL CHEM, V254, P1360; COUDRIER E, 1983, EMBO J, V2, P469, DOI 10.1002/j.1460-2075.1983.tb01446.x; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DIMENT S, 1988, J BIOL CHEM, V263, P6901; DIMENT S, 1985, J BIOL CHEM, V260, P5311; FAUST PL, 1987, J CELL BIOL, V105, P1934; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRIFFITHS G, 1990, J CELL SCI, V95, P441; HARLOW E, 1988, ANTIBODIES LABORATOR, P301; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, P NATL ACAD SCI-BIOL, V77, P7074, DOI 10.1073/pnas.77.12.7074; HAVEL RJ, 1988, HEPATOLOGY, V8, P1689, DOI 10.1002/hep.1840080637; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIMENO M, 1989, BIOCHEM BIOPH RES CO, V162, P1044, DOI 10.1016/0006-291X(89)90779-1; HIMENO M, 1988, J BIOCHEM, V104, P773, DOI 10.1093/oxfordjournals.jbchem.a122548; HIMENO M, 1989, J BIOCHEM-TOKYO, V105, P449, DOI 10.1093/oxfordjournals.jbchem.a122685; HUANG HS, 1975, CLIN CHEM, V21, P1605; HUBSCHER G, 1965, NATURE, V205, P799, DOI 10.1038/205799a0; JACKLE S, 1991, J LIPID RES, V32, P485; JACKLE S, 1991, J BIOL CHEM, V266, P1396; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; JOSTVU E, 1986, HISTOCHEMISTRY, V85, P457, DOI 10.1007/BF00508427; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOVANEN PT, 1979, J BIOL CHEM, V254, P1367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMANSKY P, 1987, J CELL BIOL, V104, P1743, DOI 10.1083/jcb.104.6.1743; MESSNER DJ, 1989, J CELL BIOL, V108, P2149, DOI 10.1083/jcb.108.6.2149; NIMPF J, 1989, P NATL ACAD SCI USA, V86, P906, DOI 10.1073/pnas.86.3.906; OHSUMI Y, 1983, J BIOCHEM, V93, P547; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PFEFFER SR, 1988, J MEMBRANE BIOL, V103, P7, DOI 10.1007/BF01871928; RIDDLE MC, 1975, BIOCHIM BIOPHYS ACTA, V388, P339, DOI 10.1016/0005-2760(75)90092-2; ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209; RUNQUIST EA, 1989, J CELL BIOL, V109, P328; SANDO GN, 1985, J BIOL CHEM, V260, P5186; SIGURDSSON G, 1978, J LIPID RES, V19, P628; Skipski V.P., 1969, METHOD ENZYMOL, V14, P530; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; TANAKA Y, 1990, BIOCHEM BIOPH RES CO, V166, P1176, DOI 10.1016/0006-291X(90)90990-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERWESTHUYZEN DR, 1980, EUR J BIOCHEM, V112, P153; VANDYKE RW, 1988, J CELL BIOL, V107, P809; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; VONFIGURA K, 1979, EUR J BIOCHEM, V94, P347; WAHEED A, 1982, EUR J BIOCHEM, V123, P317, DOI 10.1111/j.1432-1033.1982.tb19770.x; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; YOKOTA S, 1989, CELL STRUCT FUNCT, V14, P163, DOI 10.1247/csf.14.163	56	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22557	22563						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1658000				2022-12-25	WOS:A1991GR56400078
J	DISTLER, JJ; GUO, JF; JOURDIAN, GW; SRIVASTAVA, OP; HINDSGAUL, O				DISTLER, JJ; GUO, JF; JOURDIAN, GW; SRIVASTAVA, OP; HINDSGAUL, O			THE BINDING-SPECIFICITY OF HIGH AND LOW-MOLECULAR-WEIGHT PHOSPHOMANNOSYL RECEPTORS FROM BOVINE TESTES - INHIBITION STUDIES WITH CHEMICALLY SYNTHESIZED 6-O-PHOSPHORYLATED OLIGOMANNOSIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; TESTICULAR BETA-GALACTOSIDASE; LYSOSOMAL-ENZYMES; PHOSPHORYLATED OLIGOSACCHARIDES; CARBOHYDRATE CHAINS; LIGAND INTERACTIONS; MEMBRANE-RECEPTOR; LIVER; PURIFICATION; GLUCURONIDASE	A series of chemically synthesized oligomannosides that contain mannose 6-phosphate residues were utilized as inhibitors of the binding of beta-galactosidase to high (CI-MPR, 215 kDa) and low (CD-MPR, 41-46 kDa) molecular mass mannose 6-phosphate receptor from bovine testes in order to probe the specificity of each receptor. Mannobioside phosphorylated in the terminal position and linked-alpha(1,2) was a 6-fold better inhibitor than the corresponding-alpha(1,3)- and alpha(1,6)-linked isomers. Inhibition observed with a monophosphorylated-alpha (1,2)-linked mannotrioside was approximately 6-fold greater than that with the corresponding mannobioside. Penultimate glycosidic linkages of the oligomannosides played little or no role in the inhibition of binding of ligand to the receptors. Monophosphorylated oligomannosides containing phosphomonoester groups on penultimate mannose residues were not inhibitors. Binding inhibition observed for biantennary oligomannosides with phosphate on terminal mannose residues of either alpha(1,3) or alpha(1,6) chains closely approximated the values obtained with analogous trimannosides. A biantennary oligomannoside on which each antennary chain contained a terminal phosphate exhibited approximately an 8-fold greater inhibition than monophosphorylated compounds. Although the receptors exhibited similar relative specificities for phosphomonoesters, phosphodiesters did not inhibit binding of ligand to CD-MPR and only weakly inhibited binding to CI-MPR.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alberta					NIAMS NIH HHS [AR 10531] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR010531] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALVARES K, 1983, BIOCHEM BIOPH RES CO, V112, P398, DOI 10.1016/0006-291X(83)91477-8; CREEK KE, 1982, J BIOL CHEM, V257, P9931; DISTLER JJ, 1987, METHOD ENZYMOL, V138, P504; DISTLER JJ, 1987, ANAL BIOCHEM, V166, P65, DOI 10.1016/0003-2697(87)90546-X; DISTLER JJ, 1989, ANAL BIOCHEM, V182, P432, DOI 10.1016/0003-2697(89)90619-2; FISCHER HD, 1982, J BIOL CHEM, V257, P9938; GABEL CA, 1982, J BIOL CHEM, V257, P605; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HASILIK A, 1980, P NATL ACAD SCI-BIOL, V77, P7074, DOI 10.1073/pnas.77.12.7074; HOFLACK B, 1987, J BIOL CHEM, V262, P123; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; JOURDIAN GW, 1987, PROTIDES BIOL FLUIDS, V35, P395; LENNARTZ M, 1984, THESIS U MICHIGAN; LI M, 1990, ARCH BIOCHEM BIOPHYS, V238, P150; LI M, 1989, 10TH P INT S GLYC, P168; MADIYALAKAN R, 1986, CARBOHYD RES, V152, P183, DOI 10.1016/S0008-6215(00)90298-2; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; MITCHELL DC, 1984, J CELL BIOCHEM, V24, P319, DOI 10.1002/jcb.240240403; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; SAHAGIAN GG, 1982, METHOD ENZYMOL, V83, P392; SAHAGIAN GG, 1981, P NATL ACAD SCI-BIOL, V78, P4289, DOI 10.1073/pnas.78.7.4289; SRIVASTAVA OP, 1986, CARBOHYD RES, V155, P57, DOI 10.1016/S0008-6215(00)90133-2; SRIVASTAVA OP, 1987, J ORG CHEM, V52, P2869, DOI 10.1021/jo00389a039; SRIVASTAVA OP, 1987, CARBOHYD RES, V161, P195, DOI 10.1016/S0008-6215(00)90077-6; SRIVASTAVA OP, 1987, CARBOHYD RES, V161, P324, DOI 10.1016/S0008-6215(00)90091-0; SRIVASTAVA OP, 1986, CAN J CHEM, V64, P2324, DOI 10.1139/v86-382; STEIN M, 1987, BIOL CHEM H-S, V368, P927, DOI 10.1515/bchm3.1987.368.2.927; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; STEINER AW, 1982, ARCH BIOCHEM BIOPHYS, V214, P681, DOI 10.1016/0003-9861(82)90074-1; TABAS I, 1980, J BIOL CHEM, V255, P6633; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VARKI A, 1983, J BIOL CHEM, V258, P2808; VARKI A, 1980, J BIOL CHEM, V255, P847; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167	36	67	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21687	21692						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657978				2022-12-25	WOS:A1991GP80400056
J	LU, BC; SAKAGUCHI, K				LU, BC; SAKAGUCHI, K			AN ENDO-EXONUCLEASE FROM MEIOTIC TISSUES OF THE BASIDIOMYCETE COPRINUS-CINEREUS - ITS PURIFICATION AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; GENETIC-RECOMBINATION; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; USTILAGO-MAYDIS; RAD52 GENE; DNA; REPAIR; MEIOSIS; LILIUM	An endo-exonuclease has been identified and partially purified from the basidiocarp tissues of the basidiomycete Coprinus cinereus, which include synchronous meiosis at karyogamy-pachytene stages. Its peak activity appears during the meiotic prophase. The Coprinus endo-exonuclease has a single-strand specific endonuclease activity that converts the supercoiled DNA to relaxed DNA. The endonucleolytic cleavage of single-strand DNA generates 3'-phosphomonoester termini. It is also a single-strand-specific exonuclease and it hydrolyzes linear DNA in a 3' to 5' direction, but is unable to hydrolyze single-strand DNA having a 3'-phosphomonoester terminus. It requires Mg2+ with an optimal concentration of 25 mM. It has an optimal pH of 8.3, a peak enzyme activity at 50-degrees-C, and it contains a single 43-kilodalton polypeptide. Coprinus meiotic endo-exonuclease may be involved in the substrate preparation for meiotic recombination.			LU, BC (corresponding author), UNIV GUELPH,DEPT MOLEC BIOL & GENET,GUELPH N1G 2W1,ONTARIO,CANADA.							CHOW TYK, 1988, MOL GEN GENET, V211, P41, DOI 10.1007/BF00338391; CHOW TYK, 1987, J BIOL CHEM, V262, P17659; CHOW TYK, 1983, J BIOL CHEM, V258, P2010; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLLOMAN WK, 1973, J BIOL CHEM, V248, P8107; HOLLOMAN WK, 1981, J BIOL CHEM, V256, P5087; HOTTA Y, 1974, CHROMOSOMA, V46, P279; HOTTA Y, 1976, CHROMOSOMA, V55, P171, DOI 10.1007/BF01798347; HOWELL SH, 1971, J MOL BIOL, V55, P357, DOI 10.1016/0022-2836(71)90323-8; JACOBSON GK, 1975, P NATL ACAD SCI USA, V72, P1887, DOI 10.1073/pnas.72.5.1887; KASSIR Y, 1980, CURR GENET, V2, P79, DOI 10.1007/BF00445698; KOA H, 1990, BIOCHEM CELL BIOL, V68, P387, DOI 10.1139/o90-054; KOLODKIN AL, 1986, CELL, V46, P733, DOI 10.1016/0092-8674(86)90349-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; LINN S, 1965, J BIOL CHEM, V240, P1287; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU BC, 1975, J CELL SCI, V17, P461; LU BC, 1974, GENETICS, V78, P661; LU BC, 1976, MOL GEN GENET, V147, P121, DOI 10.1007/BF00267563; LU BC, 1988, EUR J BIOCHEM, V174, P725, DOI 10.1111/j.1432-1033.1988.tb14157.x; MANIATIS T, 1982, MOL CLONING LABORATO, P113; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; MONTGOMERY GP, 1990, GENOME, V33, P101, DOI 10.1139/g90-016; RAMOTAR D, 1987, J BIOL CHEM, V262, P425; RANDERATH K, 1967, METHODS ENZYMOLOGY A, V12, P323; RESNICK MA, 1984, COLD SPRING HARB SYM, V49, P639, DOI 10.1101/SQB.1984.049.01.072; RESNICK MA, 1984, MOL CELL BIOL, V4, P2811, DOI 10.1128/MCB.4.12.2811; SADOWSKI PD, 1985, NUCLEASES, V14, P23; SMITH GR, 1988, MICROBIOL REV, V52, P1; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYMINGTON LS, 1984, COLD SPRING HARB SYM, V49, P805, DOI 10.1101/SQB.1984.049.01.091; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; UOZUMI T, 1969, AGR BIOL CHEM TOKYO, V33, P645; WALLACE DM, 1987, METHOD ENZYMOL, V152, P33	35	103	104	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21060	21066						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657947				2022-12-25	WOS:A1991GN00100075
J	ENGLER, RL; ROTH, DM; DELBALZO, U; ITO, BR				ENGLER, RL; ROTH, DM; DELBALZO, U; ITO, BR			INTRACORONARY C5A INDUCES MYOCARDIAL-ISCHEMIA BY MECHANISMS INDEPENDENT OF THE NEUTROPHIL - LEUKOCYTE FILTERS DESENSITIZE THE MYOCARDIUM TO C5A	FASEB JOURNAL			English	Article						THROMBOXANE; LEUKOTRIENE-B4; COMPLEMENT; ANAPHYLATOXIN	CORONARY-ARTERY OCCLUSION; POLYMORPHONUCLEAR LEUKOCYTES; STUNNED MYOCARDIUM; REPERFUSION INJURY; THROMBOXANE GENERATION; COMPLEMENT ACTIVATION; SUPEROXIDE-DISMUTASE; OXIDATIVE-METABOLISM; PROTAMINE REVERSAL; FREE-RADICALS	Activation of the complement cascade with the generation of anaphylatoxins accompanies the inflammatory response elicited by acute myocardial ischemia and reperfusion. Although complement is activated in the interstitium during acute myocardial ischemia, we have studied mechanisms whereby complement might exacerbate ischemia by using a model employing intracoronary injection of C5a in nonischemic hearts. Intracoronary injection of complement component C5a induces transient myocardial ischemia, mediated through the production of the coronary vasoconstrictors thromboxane A2 and peptidoleukotrienes (LTC4, LTD4), and causes sequestration of polymorphonuclear leukocytes (PMN) in the coronary vascular bed. To further investigate the role of the PMN in the C5a-induced vasoconstriction, the left anterior descending coronary artery (LAD) in pigs was perfused at constant pressure and measurements of coronary blood flow, myocardial contractile function (sonomicrometry), arterial/coronary venous blood PMN count, and thromboxane B2 (TxB2) levels were performed. The myocardial response to intracoronary C5a (500 ng) was determined before, during, and after perfusion with blood depleted of PMNs using leukocyte filters (Sepacell R-500, Pall PL-100). In additional animals, the myocardial response to the PMN chemotactic agent, LTB4, and the effects of intracoronary C5a during constant flow perfusion were measured. Control intracoronary injection of C5a decreased flow (41% of baseline) and contractile function (39% of baseline), PMNs were trapped (5.1 X 10(3) cells/mu-l), and TxB2 concentration increased in coronary venous blood. The response to C5a during coronary perfusion with arterial blood depleted of PMNs with Sepacell or Pall filters (< 0.1 X 10(3) cells/mu-l) was greatly blunted, with flow and contractile function falling by less than 14 and 8%, respectively, from baseline, and release of TxB2 was greatly attenuated. However, the myocardial ischemia and TxB2 release remained depressed in response to C5a after removal of the filters and perfusion with either arterial blood containing normal levels of PMNs or stored arterial blood never exposed to filters. In contrast, the repeat C5a challenge resulted in equivalent myocardial extraction of PMNs, thus indicating a dissociation of PMN sequestration from the acute ischemic response and release of TxB2. In separate experiments, the intracoronary injection of LTB4 also resulted in a pronounced myocardial extraction of PMNs (8.6 x 10(3) cells/mu-l) greater than during C5a, but did not depress coronary flow or function. Perfusion at constant flow greatly diminished the ischemic response to C5a, indicating that vasoconstriction and resultant ischemia is the main cause of the contractile dysfunction. These data indicate that leukocyte filters inhibit the myocardial ischemia and release of TxB2 induced by C5a via mechanisms not related to PMN depletion. These filters may directly desensitize the myocardium or may induce the release of factors that interfere with the effects of C5a in our model. These data argue against a causal role of microvascular obstruction or PMN trapping in the acute myocardial ischemic response to intravascular activated complement C5a and suggest that the acute ischemic response may have PMN-independent components. However, the longterm contribution to injury of PMNs trapped by complement activation during ischemia requires further study.	UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093	University of California System; University of California San Diego	ENGLER, RL (corresponding author), VET ADM MED CTR,RES SERV 151,DEPT MED & PATHOL,3550 LA JOLLA VILLAGE DR,SAN DIEGO,CA 92161, USA.				NHLBI NIH HHS [HL17682-16] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL017682] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARFORS KE, 1987, BLOOD, V69, P338; BJORNSSON OG, 1987, EUR J CLIN INVEST, V17, P146; BOLLI R, 1987, CIRCULATION, V76, P458, DOI 10.1161/01.CIR.76.2.458; BURKE JA, 1982, J PHARMACOL EXP THER, V221, P235; BURTON KP, 1988, FREE RADICAL BIO MED, V4, P15, DOI 10.1016/0891-5849(88)90006-8; ENGLER R, 1987, CIRC RES, V61, P20, DOI 10.1161/01.RES.61.1.20; ENGLER R, 1983, AM J PATHOL, V111, P93; ENGLER RL, 1986, AM J PHYSIOL, V251, pH314, DOI 10.1152/ajpheart.1986.251.2.H314; ENGLER RL, 1986, AM J PHYSIOL, V251, pH93, DOI 10.1152/ajpheart.1986.251.1.H93; FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466; FEINMARK SJ, 1987, BIOCHIM BIOPHYS ACTA, V922, P125, DOI 10.1016/0005-2760(87)90146-9; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; FRAME LH, 1976, CIRC RES, V39, P269, DOI 10.1161/01.RES.39.2.269; GAY JC, 1984, BLOOD, V64, P780; GIMBRONE MA, 1984, J CLIN INVEST, V74, P1552, DOI 10.1172/JCI111570; GO LO, 1988, AM J PHYSIOL, V255, pH1188, DOI 10.1152/ajpheart.1988.255.5.H1188; GOETZL EJ, 1983, FED PROC, V42, P3128; GOLDSTEIN IM, 1978, J EXP MED, V148, P787, DOI 10.1084/jem.148.3.787; GREENBERG CS, 1979, T ASSOC AM PHYSICIAN, V42, P130; GROSS GJ, 1986, AM J PHYSIOL, V250, pH372, DOI 10.1152/ajpheart.1986.250.3.H372; GUYTON RA, 1977, AM J CARDIOL, V40, P381, DOI 10.1016/0002-9149(77)90160-6; HAMMERSCHMIDT DE, 1981, AM J PATHOL, V102, P146; HARRIS TR, 1981, AM J PHYSIOL, V240, pH262, DOI 10.1152/ajpheart.1981.240.2.H262; HESS ML, 1983, ADV EXP MED BIOL, V161, P377; HILL JJH, 1970, J EXP MED, V131, P885; HUGLI TE, 1981, MOL CELL BIOCHEM, V41, P59; ITO BR, 1989, CIRC RES, V65, P1220, DOI 10.1161/01.RES.65.5.1220; ITO BR, 1990, CIRC RES, V66, P596, DOI 10.1161/01.RES.66.3.596; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; LUNDBERG C, 1987, AM J PATHOL, V128, P471; MACLOUF JA, 1988, J BIOL CHEM, V263, P174; MAROKO PR, 1978, J CLIN INVEST, V61, P661, DOI 10.1172/JCI108978; MARTIN SE, 1988, CIRC RES, V63, P483, DOI 10.1161/01.RES.63.2.483; MAZZONI MC, 1989, CIRC SHOCK, V29, P27; MCDONALD JWD, 1983, CIRC RES, V52, P1; MOREL DR, 1987, ANESTHESIOLOGY, V66, P597, DOI 10.1097/00000542-198705000-00002; MOREL DR, 1988, CIRC RES, V62, P905, DOI 10.1161/01.RES.62.5.905; MULLANE K, 1989, PROSTAGLANDINS CLIN, P39; MULLANE KM, 1984, J PHARMACOL EXP THER, V228, P510; OATES JA, 1988, NEW ENGL J MED, V319, P689, DOI 10.1056/NEJM198809153191106; OLAFSSON B, 1987, CIRCULATION, V76, P1135, DOI 10.1161/01.CIR.76.5.1135; PALMBLAD J, 1984, J IMMUNOL, V132, P3041; PINCKARD RN, 1980, J CLIN INVEST, V66, P1050, DOI 10.1172/JCI109933; POWELL WJ, 1976, CIRCULATION, V54, P603, DOI 10.1161/01.CIR.54.4.603; PRZYKLENK K, 1986, CIRC RES, V58, P148, DOI 10.1161/01.RES.58.1.148; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; ROSSEN RD, 1985, CIRC RES, V57, P119, DOI 10.1161/01.RES.57.1.119; ROSSEN RD, 1988, CIRC RES, V62, P572, DOI 10.1161/01.RES.62.3.572; SALZMAN PM, 1980, J PHARMACOL EXP THER, V215, P240; SERHAN CN, 1982, BIOCHEM BIOPH RES CO, V107, P1006, DOI 10.1016/0006-291X(82)90622-2; STAHL LD, 1988, CIRCULATION, V77, P865, DOI 10.1161/01.CIR.77.4.865; STEWART JR, 1982, SURG FORUM, V33, P317; STORRS SB, 1981, J BIOL CHEM, V256, P924; SWENSON LJ, 1987, AM J PHYSIOL, V253, pH58, DOI 10.1152/ajpheart.1987.253.1.H58; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; WESTLIN W, 1989, CIRCULATION, V80, P1828, DOI 10.1161/01.CIR.80.6.1828; YASUDA M, 1990, CIRCULATION, V81, P156, DOI 10.1161/01.CIR.81.1.156	57	19	19	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	1991	5	14					2983	2991		10.1096/fasebj.5.14.1661246	http://dx.doi.org/10.1096/fasebj.5.14.1661246			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GP269	1661246				2022-12-25	WOS:A1991GP26900015
J	PARK, JB; FAN, CL; HOFFMAN, BM; ADAMS, MWW				PARK, JB; FAN, CL; HOFFMAN, BM; ADAMS, MWW			POTENTIOMETRIC AND ELECTRON NUCLEAR DOUBLE-RESONANCE PROPERTIES OF THE 2 SPIN FORMS OF THE [4FE-4S]+ CLUSTER IN THE NOVEL FERREDOXIN FROM THE HYPERTHERMOPHILIC ARCHAEBACTERIUM PYROCOCCUS-FURIOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; AMINO-ACID-SEQUENCE; SPECTROSCOPIC CHARACTERIZATION; DESULFOVIBRIO-AFRICANUS; CLOSTRIDIUM-PASTEURIANUM; ENDOR SPECTROSCOPY; MOFE PROTEIN; FE-PROTEIN; NITROGENASE; 7FE	Pyrococcus furiosus ferredoxin contains a single [4Fe-4S] that exists in both S = 1/2 (20%) and S = 3/2 (80%) ground states in the reduced protein. We report here on the temperature-dependent potentiometric properties of the two spin forms, their stability, and on the structural features that differentiate them. The midpoint potential (E(m)) of the cluster in either spin state was determined at -365 mV (30-degrees-C, pH 8.0). By rapidly freezing samples for EPR analyses, it was shown that the E(m) values of both spin states appear to change by -1.7 mV/degrees-C over the range 20-degrees-80-degrees-C, and by -6 mV/degrees-C between 80 and 89-degrees-C. The E(m) values and the relative amounts of the S = 1/2 and S = 3/2 forms of the cluster were unaffected by pH (6.8 - 10.5), even at 85-degrees-C, and were unchanged by the presence of NaCl (1.0 M), sodium dodecyl sulfate (10%, w/v) or ethylene glycol (50%, v/v), even at 80-degrees-C. The S = 1/2 form of the [4Fe-4S]+ cluster was found to exhibit a strongly coupled H-1 ENDOR resonance (A = 22 MHz) that was exchangeable with the solvent. Such a large coupling has not been observed in any other iron-sulfur protein. Since a unique feature of this 4Fe-ferredoxin is that only 3 cysteinyl residues appear to be coordinated to the [4Fe-4S] cluster, the ENDOR data are consistent with an H2O Molecule being a ligand to the unique Fe site. The S = 3/2 form of the [4Fe-4S]+ cluster exhibited a similar, strongly coupled H-1 ENDOR resonance, but in this spin state it was not exchangeable with the solvent. This suggests that the [4Fe-4S]+ cluster exhibiting the S = 3/2, but not the S = 1/2 ground state, is "shielded" from the solvent, presumably by neighboring amino acid residues. In view of the pH dependence of the midpoint potential of the two spin states, the fourth ligand to the cluster and the source of the strongly coupled H-1 ENDOR resonance is probably an OH- rather than H2O molecule.	UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602; UNIV GEORGIA,CTR MET ENZYME STUDIES,ATHENS,GA 30602; NORTHWESTERN UNIV,DEPT CHEM,EVANSTON,IL 60208	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University				Adams, Michael/0000-0002-9796-5014	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013531, R37HL013531] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-13531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS MWW, 1990, FEMS MICROBIOL LETT, V75, P219, DOI 10.1016/0378-1097(90)90533-V; AONO S, 1989, J BACTERIOL, V171, P3433, DOI 10.1128/jb.171.6.3433-3439.1989; ARMSTRONG FA, 1989, BIOCHEM J, V264, P265, DOI 10.1042/bj2640265; ARMSTRONG FA, 1986, Q REV BIOPHYS, V18, P261; BEINERT H, 1989, EUR J BIOCHEM, V186, P5, DOI 10.1111/j.1432-1033.1989.tb15170.x; BOVIERLAPIERRE G, 1987, BIOCHIM BIOPHYS ACTA, V913, P20, DOI 10.1016/0167-4838(87)90227-5; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; CARNEY MJ, 1988, J AM CHEM SOC, V110, P6084, DOI 10.1021/ja00226a025; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; CONOVER RC, 1990, J AM CHEM SOC, V112, P4562, DOI 10.1021/ja00167a074; CONOVER RC, 1991, J AM CHEM SOC, V113, P2799, DOI 10.1021/ja00007a091; Dutton P L, 1978, Methods Enzymol, V54, P411; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; HOFFMAN BH, 1990, ADV EPR, pCH15; HOFFMAN BM, 1982, J AM CHEM SOC, V104, P860, DOI 10.1021/ja00367a042; HOWARD JB, 1989, J BIOL CHEM, V264, P11270; KOLLER KB, 1988, J ELECTROANAL CHEM, V239, P291, DOI 10.1016/0022-0728(88)80286-9; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MINAMI Y, 1983, J BIOCH, V97, P745; MORGAN TV, 1986, FEBS LETT, V206, P4, DOI 10.1016/0014-5793(86)81329-1; MUKUND S, 1990, J BIOL CHEM, V265, P11508; OKAWARA N, 1988, J BIOCHEM-TOKYO, V104, P196, DOI 10.1093/oxfordjournals.jbchem.a122441; ONATE YA, 1989, J BIOL CHEM, V264, P18386; PRINCE RC, 1981, BIOCHIM BIOPHYS ACTA, V635, P132, DOI 10.1016/0005-2728(81)90014-1; PRINCE RC, 1987, J BIOL CHEM, V262, P5125; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; SAEKI K, 1989, J BIOCHEM-TOKYO, V106, P656, DOI 10.1093/oxfordjournals.jbchem.a122912; Sands R.H., 1979, MULTIPLE ELECTRON RE, P331; SCHATT E, 1989, J BACTERIOL, V171, P6218, DOI 10.1128/jb.171.11.6218-6226.1989; SEKI Y, 1989, J GEN APPL MICROBIOL, V35, P167, DOI 10.2323/jgam.35.167; TERLESKY KC, 1988, J BIOL CHEM, V263, P4080; TROWER MK, 1990, BIOCHIM BIOPHYS ACTA, V1037, P290, DOI 10.1016/0167-4838(90)90027-D; TRUE AE, 1988, J AM CHEM SOC, V110, P1935, DOI 10.1021/ja00214a045; WAKABAYASHI S, 1983, FEBS LETT, V162, P21, DOI 10.1016/0014-5793(83)81041-2; WATT GD, 1975, BIOCHEM J, V152, P33, DOI 10.1042/bj1520033; ZAMBRANO IC, 1989, J BIOL CHEM, V264, P20974	38	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19351	19356						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655785				2022-12-25	WOS:A1991GK66700038
J	WERNERWASHBURNE, M; BROWN, D; BRAUN, E				WERNERWASHBURNE, M; BROWN, D; BRAUN, E			BCY1, THE REGULATORY SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE IN YEAST, IS DIFFERENTIALLY MODIFIED IN RESPONSE TO THE PHYSIOLOGICAL STATUS OF THE CELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING PROTEINS; S-CEREVISIAE; MUTANTS; ELECTROPHORESIS; IDENTIFICATION; SPORULATION; RESOLUTION; AFFINITY; MUSCLE	The regulatory subunit of cAMP-dependent protein kinase in yeast, encoded by the BCY1 gene, is known to be required under certain conditions such as growth on nonfermentable carbon sources and entry into stationary phase. We have identified novel isoforms of Bcy1 in cells under these conditions. The isoforms are distinguishable by their migration on one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 2-dimensional nonequilibrium pH gradient gel electrophoresis. The isoforms observed by one-dimensional SDS-PAGE bind cAMP, as determined by [P-32]8-azido-cAMP labeling (diagnostic of Bcy1 protein). Proteins isolated from cells grown to stationary phase in rich medium exhibit five antibody-reactive bands, by one-dimensional SDS-PAGE immunoblot analysis, with apparent molecular masses of 50, 52, 55, 59 and 61 kDa. Total Bcy1 protein increases at least 8-fold between exponential and stationary phase. Analysis of proteins from a variety of yeast mutants indicated that 1) many of the observed modifications of Bcy1 are dependent upon the presence of the Ser-145 phosphorylation site; 2) the appearance of the 59- and 61-kDa bands is dependent upon the presence of Yak1 kinase; and 3) Bcy1 protein is modified even in the absence of cAMP-dependent protein kinase catalytic subunits. Cells carrying the bcy1(ala145) allele exhibit non-wild type growth, indicating that these modifications may be functionally significant.			WERNERWASHBURNE, M (corresponding author), UNIV NEW MEXICO,DEPT BIOL,ALBUQUERQUE,NM 87131, USA.			Braun, Edward/0000-0003-1643-5212				BUTLEY MS, 1985, CANCER RES, V45, P3677; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; CANNON JF, 1990, J BIOL CHEM, V265, P11897; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; KURET J, 1988, J BIOL CHEM, V263, P9149; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1990, J BIOL CHEM, V265, P7814; LEE WC, 1989, P NATL ACAD SCI USA, V86, P8808, DOI 10.1073/pnas.86.22.8808; LOHMANN SM, 1988, METHOD ENZYMOL, V159, P183; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; Matsumoto K, 1985, Yeast, V1, P15, DOI 10.1002/yea.320010103; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PERCIVALSMITH A, 1984, MOL CELL BIOL, V4, P142, DOI 10.1128/MCB.4.1.142; RANGELALDAO R, 1979, J BIOL CHEM, V254, P2499; RINGHEIM GE, 1988, J BIOL CHEM, V263, P18247; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SHIN DY, 1987, MOL CELL BIOL, V7, P244, DOI 10.1128/MCB.7.1.244; SIKORSKI RS, 1989, GENETICS, V122, P19; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; UNO I, 1982, J BIOL CHEM, V257, P4110; WALTER U, 1977, J BIOL CHEM, V252, P6494; WERNERWASHBURNE M, 1989, J BACTERIOL, V171, P2680, DOI 10.1128/jb.171.5.2680-2688.1989; ZOLLER MJ, 1979, J BIOL CHEM, V254, P2408	30	41	41	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19704	19709						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655793				2022-12-25	WOS:A1991GK66700083
J	NISHIZAWA, M; TSUCHIYA, M; WATANABEFUKUNAGA, R; NAGATA, S				NISHIZAWA, M; TSUCHIYA, M; WATANABEFUKUNAGA, R; NAGATA, S			MULTIPLE ELEMENTS IN THE PROMOTER OF GRANULOCYTE COLONY-STIMULATING FACTOR GENE REGULATE ITS CONSTITUTIVE EXPRESSION IN HUMAN CARCINOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TOKYO, MINATO KU, TOKYO 108, JAPAN	University of Tokyo	NISHIZAWA, M (corresponding author), OSAKA BIOSCI INST, 6-2-4 FURUEDAI, SUITA, OSAKA 565, JAPAN.		Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426				BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; BUCHBERG AM, 1988, ONCOGENE RES, V2, P149; CHEN SJ, 1985, P NATL ACAD SCI USA, V82, P7284, DOI 10.1073/pnas.82.21.7284; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK L, 1989, NUCLEIC ACIDS RES, V17, P499, DOI 10.1093/nar/17.2.499; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; KANDA N, 1987, SOMAT CELL MOLEC GEN, V13, P679, DOI 10.1007/BF01534488; KRAMER W, 1987, METHOD ENZYMOL, V154, P350; KURIBAYASHI K, 1988, NUCLEIC ACIDS RES S, V19, P61; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MESSING J, 1983, METHOD ENZYMOL, V101, P20; METCALF D, 1985, LEUKEMIA RES, V9, P35, DOI 10.1016/0145-2126(85)90020-7; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MIYATAKE S, 1988, MOL CELL BIOL, V8, P5581, DOI 10.1128/MCB.8.12.5581; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NAGATA S, 1986, EMBO J, V5, P575, DOI 10.1002/j.1460-2075.1986.tb04249.x; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; NAGATA S, 1990, IN PRESS HDB EXPT PH; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; NIMER SD, 1988, MOL CELL BIOL, V8, P1979, DOI 10.1128/MCB.8.5.1979; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHANNON MF, 1988, P NATL ACAD SCI USA, V85, P674, DOI 10.1073/pnas.85.3.674; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TSUCHIYA M, 1986, P NATL ACAD SCI USA, V83, P7633, DOI 10.1073/pnas.83.20.7633; TSUCHIYA M, 1987, EUR J BIOCHEM, V165, P7, DOI 10.1111/j.1432-1033.1987.tb11187.x; TWEARDY DJ, 1987, ANN NY ACAD SCI, V511, P30, DOI 10.1111/j.1749-6632.1987.tb36235.x; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0	38	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5897	5902						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690717				2022-12-25	WOS:A1990CW48000091
J	ADAMKIEWICZ, J; BRULLER, HJ; GAUSEPOHL, H; FRANK, R; MULLER, R				ADAMKIEWICZ, J; BRULLER, HJ; GAUSEPOHL, H; FRANK, R; MULLER, R			MAPPING OF FUNCTIONAL DOMAINS IN FOS AND JUN PROTEINS USING EPITOPE-SPECIFIC ANTIBODIES	ONCOGENE			English	Article									EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY	European Molecular Biology Laboratory (EMBL)	ADAMKIEWICZ, J (corresponding author), UNIV MARBURG,INST MOLEK BIOL & TUMORFORSCH,EMIL MANNKOPFF STR 2,W-3550 MARBURG,GERMANY.		Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248				ADAMSON ED, 1985, EMBO J, V4, P941, DOI 10.1002/j.1460-2075.1985.tb03722.x; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CASTRO B, 1977, J CHEM RES, V182, P2118; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1982, VIROLOGY, V116, P221, DOI 10.1016/0042-6822(82)90415-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FRANK R, 1988, MODERN METHODS PROTE, V3, P42; FRANZA BR, 1987, ONCOGENE, V1, P213; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEMKE H, 1978, NATURE, V271, P249, DOI 10.1038/271249a0; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MULLER R, 1987, ONCOGENE RES, V2, P19; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RISSE G, 1989, IN PRESS EMBO J; RIVIER J, 1984, J CHROMATOGR, V288, P303, DOI 10.1016/S0021-9673(01)93709-4; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; Stewart JM, 1984, SOLID PHASE PEPTIDE; TAM JP, 1983, J AM CHEM SOC, V105, P6442, DOI 10.1021/ja00359a014; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VERRIER B, 1986, EMBO J, V5, P913, DOI 10.1002/j.1460-2075.1986.tb04303.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	45	19	20	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					525	533						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1691478				2022-12-25	WOS:A1990DB85300011
J	BOULTER, J; OSHEAGREENFIELD, A; DUVOISIN, RM; CONNOLLY, JG; WADA, E; JENSEN, A; GARDNER, PD; BALLIVET, M; DENERIS, ES; MCKINNON, D; HEINEMANN, S; PATRICK, J				BOULTER, J; OSHEAGREENFIELD, A; DUVOISIN, RM; CONNOLLY, JG; WADA, E; JENSEN, A; GARDNER, PD; BALLIVET, M; DENERIS, ES; MCKINNON, D; HEINEMANN, S; PATRICK, J			ALPHA-3, ALPHA-5, AND BETA-4 - 3 MEMBERS OF THE RAT NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR-RELATED GENE FAMILY FORM A GENE-CLUSTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV GENEVA,DEPT BIOCHEM,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva	BOULTER, J (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92138, USA.		Connolly, John/C-2862-2009					BALDWIN TJ, 1988, J CELL BIOL, V106, P469, DOI 10.1083/jcb.106.2.469; BIRDSALL NJM, 1989, TRENDS PHARMACOL SCI, V10, P50, DOI 10.1016/0165-6147(89)90073-4; BORMANN J, 1983, NEUROSCI LETT, V40, P193, DOI 10.1016/0304-3940(83)90301-4; BOULTER J, 1985, J NEUROSCI, V5, P2545; BOULTER J, 1977, BIOCHEMISTRY-US, V16, P4900, DOI 10.1021/bi00641a025; BOULTER J, 1986, J NEUROSCI RES, V16, P37, DOI 10.1002/jnr.490160106; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1989, METHODS NEUROSCI, V1, P328; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; CONNOLLY JG, 1989, COMP BIOCHEM PHYS A, V93, P221, DOI 10.1016/0300-9629(89)90210-7; CONTITRONCONI BM, 1985, P NATL ACAD SCI USA, V82, P5208, DOI 10.1073/pnas.82.15.5208; CROWDER CM, 1988, MOL CELL BIOL, V8, P5257, DOI 10.1128/MCB.8.12.5257; DANI JA, 1989, TRENDS NEUROSCI, V12, P125, DOI 10.1016/0166-2236(89)90049-0; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; EVANS S, 1987, J BIOL CHEM, V262, P4911; GOLDMAN D, 1986, P NATL ACAD SCI USA, V83, P4076, DOI 10.1073/pnas.83.11.4076; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; HEIDMANN O, 1986, SCIENCE, V234, P866, DOI 10.1126/science.3022377; HEINEMANN S, 1986, P NATO C MECHANISM A; ISENBERG KE, 1989, J NEUROCHEM, V52, P988, DOI 10.1111/j.1471-4159.1989.tb02553.x; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KAO PN, 1986, J BIOL CHEM, V261, P8085; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MARKS MJ, 1986, MOL PHARMACOL, V30, P427; MEEKER RB, 1986, J NEUROSCI, V6, P1866; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; MORLEY BJ, 1981, BRAIN RES REV, V3, P81, DOI 10.1016/0165-0173(81)90013-8; NEF P, 1984, P NATL ACAD SCI-BIOL, V81, P7975, DOI 10.1073/pnas.81.24.7975; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; OGDEN RC, 1987, METHOD ENZYMOL, V152, P61; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PATRICK J, 1977, J BIOL CHEM, V252, P8629; PATRICK J, 1977, P NATL ACAD SCI USA, V74, P4689, DOI 10.1073/pnas.74.10.4689; POPOT JL, 1984, PHYSIOL REV, V64, P1162, DOI 10.1152/physrev.1984.64.4.1162; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBAHARA S, 1985, EUR J BIOCHEM, V146, P15, DOI 10.1111/j.1432-1033.1985.tb08614.x; SMITH MA, 1983, J NEUROSCI, V3, P2395; STEINBACH JH, 1989, TRENDS NEUROSCI, V12, P3, DOI 10.1016/0166-2236(89)90145-8; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952	50	297	308	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1990	265	8					4472	4482						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT101	1689727				2022-12-25	WOS:A1990CT10100050
J	LEE, JW; MOFFITT, PG; MORLEY, KL; PETERSON, DO				LEE, JW; MOFFITT, PG; MORLEY, KL; PETERSON, DO			MULTIPARTITE STRUCTURE OF A NEGATIVE REGULATORY ELEMENT ASSOCIATED WITH A STEROID HORMONE-INDUCIBLE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; LONG TERMINAL REPEAT; GLUCOCORTICOID RESPONSE ELEMENT; SEQUENCE-SPECIFIC BINDING; SV40 ENHANCER; GEL-ELECTROPHORESIS; GENE-TRANSCRIPTION; ESCHERICHIA-COLI; CONTROL REGION; DNA	The steroid hormone-inducible promoter from mouse mammary tumor virus is associated with a distal negative regulatory element that represses its inherent basal activity. Deletion analysis localized the sequences required for repression to 64 base pairs of DNA between -427 and -364 with respect to the transcription initiation site. Transient transfection experiments with a series of linker scanning and small internal deletion mutations revealed two mutation-sensitive domains separated by a region of relative resistance to sequence alterations. DNase I footprinting and gel electrophoresis mobility shift experiments with crude nuclear extracts identified at least one protein-binding site within each of the two mutation-sensitive regions. An oligonucleotide corresponding to one of these sites is able to repress transcription, but only when linked to the promoter in multiple copies. This negative regulatory element functions synergistically with a promoter proximal negative element to mediate efficient promoter repression, selectively affecting basal relative to steroid hormone-induced transcription and thus increasing the ratio of promoter activity observed in the presence and absence of hormone.	TEXAS A&M UNIV SYST, DEPT BIOCHEM & BIOPHYS, COLLEGE STN, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	PETERSON, DO (corresponding author), TEXAS A&M UNIV SYST, DEPT BIOCHEM & BIOPHYS, COLLEGE STN, TX 77843 USA.				NATIONAL CANCER INSTITUTE [R01CA032695, R01CA048041] Funding Source: NIH RePORTER; NCI NIH HHS [CA48041, CA32695] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BALL JK, 1988, J VIROL, V62, P2985, DOI 10.1128/JVI.62.8.2985-2993.1988; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BIENZTADMOR B, 1985, EMBO J, V4, P3209, DOI 10.1002/j.1460-2075.1985.tb04067.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CATO ACB, 1987, EMBO J, V6, P363, DOI 10.1002/j.1460-2075.1987.tb04763.x; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CORDINGLEY MG, 1988, NUCLEIC ACIDS RES, V16, P609, DOI 10.1093/nar/16.2.609; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; CORTHESY B, 1989, MOL CELL BIOL, V9, P5548, DOI 10.1128/MCB.9.12.5548; DEMEDINA T, 1988, MOL CELL BIOL, V8, P2449, DOI 10.1128/MCB.8.6.2449; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GAUB MP, 1987, EMBO J, V6, P2313, DOI 10.1002/j.1460-2075.1987.tb02506.x; GEISSE S, 1982, EMBO J, V1, P1613, DOI 10.1002/j.1460-2075.1982.tb01363.x; GONZALEZ FJ, 1985, NUCLEIC ACIDS RES, V13, P7269, DOI 10.1093/nar/13.20.7269; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOVINDAN MV, 1982, P NATL ACAD SCI-BIOL, V79, P5157, DOI 10.1073/pnas.79.17.5157; HATA A, 1989, J BIOL CHEM, V264, P6404; HSU CLL, 1988, J VIROL, V62, P4644, DOI 10.1128/JVI.62.12.4644-4652.1988; HYNES N, 1983, P NATL ACAD SCI-BIOL, V80, P3637, DOI 10.1073/pnas.80.12.3637; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; KUO WL, 1988, J VIROL, V62, P2394, DOI 10.1128/JVI.62.7.2394-2402.1988; LANGER SJ, 1988, MOL CELL BIOL, V8, P3872, DOI 10.1128/MCB.8.9.3872; LARSEN PR, 1986, P NATL ACAD SCI USA, V83, P8283, DOI 10.1073/pnas.83.21.8283; LEE F, 1984, NUCLEIC ACIDS RES, V12, P4191, DOI 10.1093/nar/12.10.4191; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MAJORS J, 1983, P NATL ACAD SCI-BIOL, V80, P5866, DOI 10.1073/pnas.80.19.5866; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MICHALIDES R, 1985, MOL CELL BIOL, V5, P823, DOI 10.1128/MCB.5.4.823; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; MORLEY KL, 1987, NUCLEIC ACIDS RES, V15, P6973, DOI 10.1093/nar/15.17.6973; MUGLIA L, 1986, P NATL ACAD SCI USA, V83, P7653, DOI 10.1073/pnas.83.20.7653; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; OSTROWSKI MC, 1984, EMBO J, V3, P1891, DOI 10.1002/j.1460-2075.1984.tb02064.x; PASTORCIC M, 1989, NUCLEIC ACIDS RES, V17, P6693, DOI 10.1093/nar/17.16.6693; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; PETERSON DO, 1987, MOL CELL BIOL, V7, P1563, DOI 10.1128/MCB.7.4.1563; PONTA H, 1985, P NATL ACAD SCI USA, V82, P1020, DOI 10.1073/pnas.82.4.1020; RACEVSKIS J, 1989, J VIROL, V63, P456, DOI 10.1128/JVI.63.1.456-459.1989; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; RINGOLD GM, 1975, CELL, V6, P299, DOI 10.1016/0092-8674(75)90181-6; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; SCHIRM S, 1987, GENE DEV, V1, P65, DOI 10.1101/gad.1.1.65; TOOHEY MG, 1986, MOL CELL BIOL, V6, P4526, DOI 10.1128/MCB.6.12.4526; TOOHEY MG, 1990, J VIROL, V64, P4477, DOI 10.1128/JVI.64.9.4477-4488.1990; UCKER DS, 1984, J BIOL CHEM, V259, P7416; VONDERAHE D, 1985, NATURE, V313, P706, DOI 10.1038/313706a0; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x	61	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					24101	24108						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660891				2022-12-25	WOS:A1991GV31900089
J	YANG, FD; YU, L; HE, DY; YU, CA				YANG, FD; YU, L; HE, DY; YU, CA			PROTEIN-UBIQUINONE INTERACTION IN BOVINE HEART MITOCHONDRIAL SUCCINATE-CYTOCHROME-C REDUCTASE - SYNTHESIS AND BIOLOGICAL PROPERTIES OF FLUORINE SUBSTITUTED UBIQUINONE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; LINE-SHAPE ANALYSIS; ELECTRON-TRANSFER; FLUORINE-19-LABELED PHOSPHOLIPIDS; RESPIRATORY-CHAIN; LATERAL DIFFUSION; BINDING PROTEINS; TRANSPORT; COEFFICIENTS; COLLISION	To investigate the protein-ubiquinone interaction in the bovine heart mitochondrial succinate-cytochrome c reductase region of the respiratory chain, three fluorine substituted ubiquinone derivatives, 2,3-dimethoxy-6-(9'-fluorodecyl)-1,4-benzoquinone (9FQ), 2-methoxy-5-trifluoromethyl-6-decyl-1,4-benzoquinone (TFQ), and 2-methoxy-5-trifluoromethyl-6-(9'-fluorodecyl)1,4-benzoquinone (9FTFQ), were synthesized. 9FQ was synthesized by radical coupling of Q0 and bis(10-fluoroundecanoyl)peroxide. The latter was prepared by fluorination of undecylenic acid followed by thionylchloride treatment and peroxidation. TFQ was synthesized from 2,2,2-trifluoro-p-cresol by methylation, nitration, reduction, acetylation, nitration, reduction, oxidation, and radical alkylation. 9FTFQ was prepared by the radical alkylation of 2-methoxy-5-trifluoromethyl-1,4-benzoquinone with bis(10-fluoroundecanoyl)peroxide. All three fluoro-Q derivatives are active (> 50% the activity of 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone) when used as electron acceptors for succinate-ubiquinone reductase. However, only 9FQ is active when used as an electron donor for ubiquinol-cytochrome c reductase or as an electron mediator for succinate-cytochrome c reductase. Both TFQ and 9FTFQ are competitive inhibitors for ubiquinol-cytochrome c reductase. A F-19-NMR peak-broadening effect was observed for 9FQ when it was reconstituted with ubiquinone-depleted ubiquinol-cytochrome c reductase. A drastic up-field chemical shift was observed for TFQ when it was reconstituted with ubiquinone-depleted reductase. These results indicate that the binding environments of the benzoquinone ring and the alkyl side chain of the Q molecule are different. The strong up-field chemical shift for TFQ, and lack of significant chemical shift for 9FQ, suggest that the benzoquinone ring is bound near the paramagnetic cytochrome b heme.			YANG, FD (corresponding author), OKLAHOMA STATE UNIV,DEPT BIOCHEM,STILLWATER,OK 74078, USA.				NIGMS NIH HHS [GM-30721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAUN BS, 1986, METHOD ENZYMOL, V125, P119; CHANG YC, 1985, J BIOL CHEM, V260, P2709; CRANE FL, 1977, ANNU REV BIOCHEM, V46, P439, DOI 10.1146/annurev.bi.46.070177.002255; CRULL GB, 1989, J BIOL CHEM, V264, P2649; DOWD SR, 1984, BIOCHEMISTRY-US, V23, P6142, DOI 10.1021/bi00320a038; ENGELSBERG M, 1982, BIOCHEMISTRY-US, V21, P6985, DOI 10.1021/bi00269a056; ERNSTER L, 1969, EUR J BIOCHEM, V9, P299, DOI 10.1111/j.1432-1033.1969.tb00609.x; FABTA PE, 1955, ORG SYNTH COLL, V3, P661; FATO R, 1986, BIOCHEMISTRY-US, V25, P3378, DOI 10.1021/bi00359a043; GREEN DE, 1960, QUINONES ELECTRON TR, P130; GU LQ, 1990, BIOCHIM BIOPHYS ACTA, V1015, P482, DOI 10.1016/0005-2728(90)90082-F; GUPTE S, 1984, P NATL ACAD SCI-BIOL, V81, P2606, DOI 10.1073/pnas.81.9.2606; GUTMAN M, 1985, COENZYME, P216; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HELIN AF, 1951, J AM CHEM SOC, V73, P1189, DOI 10.1021/ja01147a093; KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x; LENAZ G, 1986, J BIOENERG BIOMEMBR, V18, P369, DOI 10.1007/BF00743011; MILLETT F, 1977, BIOMOLECULAR STRUCTU, P423; MIURA R, 1983, BIOCHEM BIOPH RES CO, V110, P406, DOI 10.1016/0006-291X(83)91163-4; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; OLAH GA, 1973, SYNTHESIS-STUTTGART, P779; ONG RL, 1984, J MEMBRANE BIOL, V78, P1, DOI 10.1007/BF01872526; POST JFM, 1984, BIOCHEMISTRY-US, V23, P6138, DOI 10.1021/bi00320a037; RAGAN CI, 1985, BIOCHIM BIOPHYS ACTA, V811, P13; SUZUKI H, 1983, J BIOL CHEM, V258, P352; SUZUKI H, 1986, BIOCHEM BIOPH RES CO, V138, P1237, DOI 10.1016/S0006-291X(86)80415-6; Vyas GN., 1963, ORGANIC SYNTHESIS CO, VIV, P836; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1981, BIOCHIM BIOPHYS ACTA, V639, P99, DOI 10.1016/0304-4173(81)90007-0; YU CA, 1980, BIOCHEMISTRY-US, V19, P3579, DOI 10.1021/bi00556a025; YU CA, 1985, BIOCHEMISTRY-US, V24, P3897, DOI 10.1021/bi00336a013; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1985, J BIOL CHEM, V260, P963; YU L, 1978, J BIOL CHEM, V253, P2657; YU L, 1982, J BIOL CHEM, V257, P2016; YU L, 1987, J BIOL CHEM, V262, P1137; YU L, 1980, BIOCHEMISTRY-US, V19, P5717	37	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20863	20869						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657937				2022-12-25	WOS:A1991GN00100044
J	FLINT, KJ; JONES, NC				FLINT, KJ; JONES, NC			DIFFERENTIAL REGULATION OF 3 MEMBERS OF THE ATF CREB FAMILY OF DNA-BINDING PROTEINS	ONCOGENE			English	Article							CELLULAR TRANSCRIPTION FACTOR; VIRUS TYPE-I; LEUCINE ZIPPER PROTEINS; CAMP-RESPONSIVE ELEMENT; ADENOVIRUS E1A PROTEIN; LONG TERMINAL REPEAT; CYCLIC-AMP; CDNA CLONES; ACTIVATION; PROMOTERS	The ATF/CRE binding site can mediate transcriptional activation by cAMP, the adenovirus EIA protein and the human T-cell leukaemia virus 1 (HTLV1) tax protein. A large number of different proteins bind specifically to this element either as homodimers or as heterodimers. Using GAL4-ATF/CREB fusions, we have investigated the regulatory functions of three members of this family. CREB1 (CREB) is strongly activated by cAMP and weakly activated by the E1A protein. In contrast, CREB2 (CRE-BP1, ATF2) is strongly activated by E1A but is insensitive to cAMP stimulation. ATF1 is weakly activated by cAMP but is not activated by E1A. All three proteins are insensitive to activation by the HTLV1 tax protein. The N-terminal region of CREB2, from amino acid residues 19 to 112, is both necessary and sufficient for E1A activation. This region contains a putative C2H2 metal-binding finger, and single amino acid substitutions of the cysteine residues severely decreased CREB2 activity. In contrast, mutations affecting a potential protein kinase A and casein kinase II phosphorylation site within this region had little effect.	IMPERIAL CANC RES FUND,GENE REGULAT LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK								BAGCHI S, 1989, P NATL ACAD SCI USA, V86, P4352, DOI 10.1073/pnas.86.12.4352; BENBROOK DM, 1990, ONCOGENE, V5, P295; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FUJISAWA J, 1989, J VIROL, V63, P3234, DOI 10.1128/JVI.63.8.3234-3239.1989; FUJISAWA J, 1985, P NATL ACAD SCI USA, V82, P2277, DOI 10.1073/pnas.82.8.2277; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOEFFLER WK, 1988, CELL, V53, P907, DOI 10.1016/S0092-8674(88)90409-6; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; HURST HC, 1987, GENE DEV, V1, P1132, DOI 10.1101/gad.1.10.1132; HURST HC, 1990, MOL CELL BIOL, V10, P6192, DOI 10.1128/MCB.10.12.6192; HURST HC, 1991, IN PRESS NUCLEIC ACI; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JAMESON JL, 1990, MOL ENDOCRINOL, V4, P1087; JEANG KT, 1988, J VIROL, V62, P4499, DOI 10.1128/JVI.62.12.4499-4509.1988; JONES RH, 1989, P NATL ACAD SCI USA, V86, P2176, DOI 10.1073/pnas.86.7.2176; KATOH I, 1989, EMBO J, V8, P497, DOI 10.1002/j.1460-2075.1989.tb03403.x; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE KAW, 1989, MOL CELL BIOL, V9, P4390, DOI 10.1128/MCB.9.10.4390; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; LIN YS, 1989, P NATL ACAD SCI USA, V86, P109, DOI 10.1073/pnas.86.1.109; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MAEKAWA T, 1991, ONCOGENE, V6, P627; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTAGNE J, 1990, EMBO J, V9, P957, DOI 10.1002/j.1460-2075.1990.tb08194.x; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; PEI R, 1989, J VIROL, V63, P3499, DOI 10.1128/JVI.63.8.3499-3506.1989; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; ROESLER WJ, 1988, J BIOL CHEM, V263, P6063; SADROWSKI J, 1989, NUCLEIC ACIDS RES, V17, P7539; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x	53	93	94	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2019	2026						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658708				2022-12-25	WOS:A1991GX11900012
J	LOW, SH; WONG, SH; TANG, BL; SUBRAMANIAM, VN; HONG, W				LOW, SH; WONG, SH; TANG, BL; SUBRAMANIAM, VN; HONG, W			APICAL CELL-SURFACE EXPRESSION OF RAT DIPEPTIDYL PEPTIDASE-IV IN TRANSFECTED MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; POLARIZED EPITHELIAL-CELLS; PLASMA-MEMBRANE PROTEINS; INFLUENZA-VIRUS HEMAGGLUTININ; VESICULAR STOMATITIS-VIRUS; CYTOPLASMIC DOMAIN; MDCK CELLS; MONOCLONAL-ANTIBODIES; VIRAL GLYCOPROTEINS; BILE CANALICULUS	Dipeptidyl peptidase IV (DPPIV) is a type II membrane glycoprotein that is predominantly localized to the apical plasma membrane in various epithelial cells. In order to understand in more detail the biogenesis and sorting of DPPIV, the cDNA for rat DPPIV was inserted into a mammalian plasmid expression vector so that DPPIV expression was driven by a control region composed of the SV40 early promoter region fused to the enhancer of the Rous sarcoma virus. Madin-Darby canine kidney cells transfected with this construct were found to express the DPPIV protein. In these transfected cells, the majority of DPPIV was present on the apical cell surface. This observation suggests that the information for apical surface localization is inherent in the DPPIV molecule itself and that this sorting information is decipherable in the epithelial cells of a different species. DPPIV is transported efficiently from the endoplasmic reticulum to the Golgi apparatus as assessed by pulse-chase experiments. Furthermore, evidence is presented which suggests that the majority of DPPIV is sorted intracellularly to the apical cell surface. The same protein has, however, been reported to be sorted by an indirect pathway through transcytosis from the basolateral to the apical cell surface in hepatocytes (Bartles, J. R., Feracci, H., M., Stinger, B., and Hubbard, A. L. (1987) J. Cell Biol. 105, 1241-1251). This study suggests that the same protein can take two different pathways in different cell types for its correct apical cell surface localization.	NATL UNIV SINGAPORE, INST MOLEC & CELL BIOL, MOLEC & CELL BIOL MEMBRANES, SINGAPORE 0511, SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore			Subramaniam, V. Nathan/A-1901-2010; Tang, Bor Luen/E-4548-2012	Subramaniam, V. Nathan/0000-0002-4583-7790; Tang, Bor Luen/0000-0002-1925-636X				ALI N, 1990, BIOCHEM J, V271, P193, DOI 10.1042/bj2710193; BARTLES JR, 1985, J BIOL CHEM, V260, P2792; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BECKER A, 1986, BIOL CHEM H-S, V367, P681, DOI 10.1515/bchm3.1986.367.2.681; BOULAN ER, 1980, CELL, V20, P45, DOI 10.1016/0092-8674(80)90233-0; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; COOK J, 1983, J CELL BIOL, V97, P1823, DOI 10.1083/jcb.97.6.1823; FUKASAWA KM, 1981, J HISTOCHEM CYTOCHEM, V29, P337, DOI 10.1177/29.3.6787113; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; GOTTLIEB TA, 1986, J CELL BIOL, V102, P1242, DOI 10.1083/jcb.102.4.1242; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; GRAEVE L, 1990, J BIOL CHEM, V265, P1216; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARTEL S, 1988, HISTOCHEMISTRY, V89, P151, DOI 10.1007/BF00489918; HIXSON DC, 1983, CANCER RES, V43, P3874; HONG WJ, 1989, EXP CELL RES, V182, P256, DOI 10.1016/0014-4827(89)90296-6; HONG WJ, 1988, J BIOL CHEM, V263, P16892; HONG WJ, 1990, J CELL BIOL, V111, P323, DOI 10.1083/jcb.111.2.323; HONG WJ, 1989, BIOCHEMISTRY-US, V28, P8474, DOI 10.1021/bi00447a030; HONG WJ, 1987, P NATL ACAD SCI USA, V84, P7962, DOI 10.1073/pnas.84.22.7962; HUBBARD AL, 1989, ANNU REV PHYSIOL, V51, P755, DOI 10.1146/annurev.physiol.51.1.755; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; JONES LV, 1985, MOL CELL BIOL, V5, P2181, DOI 10.1128/MCB.5.9.2181; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LISANTI MP, 1990, TRENDS BIOCHEM SCI, V15, P113, DOI 10.1016/0968-0004(90)90195-H; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATLIN KS, 1986, J CELL BIOL, V103, P2565, DOI 10.1083/jcb.103.6.2565; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MAURICE M, 1985, EUR J CELL BIOL, V39, P122; MENDRICK DL, 1988, KIDNEY INT, V33, P831, DOI 10.1038/ki.1988.74; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MOSTOV KE, 1987, J CELL BIOL, V105, P2031, DOI 10.1083/jcb.105.5.2031; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; OTAGA S, 1989, J BIOL CHEM, V264, P3596; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; PUDDINGTON L, 1987, P NATL ACAD SCI USA, V84, P2756; RINDLER MJ, 1985, J CELL BIOL, V100, P136, DOI 10.1083/jcb.100.1.136; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; ROMAN LM, 1986, J CELL BIOL, V103, P2607, DOI 10.1083/jcb.103.6.2607; ROTH MG, 1989, ANNU REV PHYSIOL, V51, P797; ROTH MG, 1983, CELL, V33, P435, DOI 10.1016/0092-8674(83)90425-7; Sambrook J, 1989, MOL CLONING LABORATO; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; STEPHENS EB, 1986, EMBO J, V5, P237, DOI 10.1002/j.1460-2075.1986.tb04204.x; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; WESSELS HP, 1989, J BIOL CHEM, V264, P17; WILSON JM, 1990, J CELL SCI, V96, P143	63	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13391	13396						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1677006				2022-12-25	WOS:A1991FX13200092
J	SHAPIRO, LH; ASHMUN, RA; ROBERTS, WM; LOOK, AT				SHAPIRO, LH; ASHMUN, RA; ROBERTS, WM; LOOK, AT			SEPARATE PROMOTERS CONTROL TRANSCRIPTION OF THE HUMAN AMINOPEPTIDASE-N GENE IN MYELOID AND INTESTINAL EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ANTIGEN GP150; V-MYB ONCOGENE; LEUKEMIA ANTIGEN; CHROMOSOMAL LOCALIZATION; DROSOPHILA-MELANOGASTER; NEUTRAL ENDOPEPTIDASE; MOLECULAR-CLONING; MESSENGER-RNA; B-LINEAGE; EXPRESSION	Aminopeptidase N is a membrane-bound metalloprotease expressed on the surface of normal and malignant human myeloid cells, fibroblasts, hepatocytes, and the epithelial cells that form brush borders of the small intestine and kidney. Northern blot analysis of RNA extracted from these tissues revealed two distinct aminopeptidase N transcripts: a 3.7-kilobase (kb) transcript expressed by normal monocytes, myeloid leukemia cells, and fibroblasts and a 3.4-kb transcript expressed by intestinal epithelium and kidney cells. In intestinal epithelial cells, transcripts originated 47 base pairs upstream from the initiation codon and 22 base pairs downstream from a TATA box. By contrast, the longer transcripts found in myeloid cells and fibroblasts originated from several sites clustered in an upstream exon located 8 kb from the exon containing the initiation codon. Functional promoter activity was demonstrated by fusing sequences approximately 1 kb upstream from each transcription origin to bacterial reporter genes and transfecting the resultant constructs into murine NIH-3T3 fibroblasts. A novel feature of this system is that regulatory elements of the epithelial cell promoter, including the TATA box and transcription origin, are included within the 5'-untranslated region of the longer myeloid cell transcript. Both aminopeptidase N transcripts encode the same polypeptide, indicating that the physically distinct promoters must have evolved to regulate expression of this cell-surface peptidase by cells of different tissues.	ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, 332 N LAUDERDALE, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT TUMOR CELL BIOL, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT PEDIAT, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center					NATIONAL CANCER INSTITUTE [P30CA021765, R01CA042804] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765, CA-42804] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AYER DE, 1988, MOL CELL BIOL, V8, P2021, DOI 10.1128/MCB.8.5.2021; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOWES MA, 1987, IMMUNOLOGY, V60, P247; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DANIELSEN EM, 1990, J BIOL CHEM, V265, P14566; DANIELSEN EM, 1982, BIOCHEM J, V204, P639, DOI 10.1042/bj2040639; ECONOMOU JS, 1989, J EXP MED, V170, P321, DOI 10.1084/jem.170.1.321; FINDLEY HW, 1982, BLOOD, V60, P1305; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FRASER P, 1989, MOL CELL BIOL, V9, P3308, DOI 10.1128/MCB.9.8.3308; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GOPAL TV, 1985, SCIENCE, V229, P1102, DOI 10.1126/science.2994213; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREAVES MF, 1983, BLOOD, V61, P628; GREER P, 1990, MOL CELL BIOL, V10, P2521, DOI 10.1128/MCB.10.6.2521; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; GRIFFIN JD, 1983, BLOOD, V62, P557; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; HASHINAKA K, 1988, BIOCHEMISTRY-US, V27, P5914; HOGG N, 1987, LEUCOCYTE TYPING, V3, P576; HOHN PA, 1989, J BIOL CHEM, V264, P13412; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; INGRAHAM HA, 1986, MOL CELL BIOL, V6, P2923, DOI 10.1128/MCB.6.8.2923; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JANOSSY G, 1980, BLOOD, V56, P430; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAGEYAMA R, 1988, P NATL ACAD SCI USA, V85, P5016, DOI 10.1073/pnas.85.14.5016; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; KENNY AJ, 1989, LANCET, V2, P785; Kenny AJ, 1987, MAMMALIAN ECTOENZYME, P169; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOEFFLER HP, 1980, BLOOD, V56, P265; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; LAIMINS LA, 1984, J VIROL, V49, P183, DOI 10.1128/JVI.49.1.183-189.1984; LEMONS RS, 1978, CELL, V14, P995, DOI 10.1016/0092-8674(78)90353-7; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; LOOK AT, 1985, J CLIN INVEST, V75, P569, DOI 10.1172/JCI111733; LOOK AT, 1986, J CLIN INVEST, V78, P914, DOI 10.1172/JCI112680; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; MAIRE P, 1987, J MOL BIOL, V197, P425, DOI 10.1016/0022-2836(87)90556-0; Maniatis T., 1982, MOL CLONING; MATSAS R, 1985, BIOCHEM J, V231, P445, DOI 10.1042/bj2310445; MINOWADA J, 1972, J NATL CANCER I, V49, P891; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NOREN O, 1989, FEBS LETT, V259, P107, DOI 10.1016/0014-5793(89)81506-6; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; OLSEN J, 1989, FEBS LETT, V251, P275, DOI 10.1016/0014-5793(89)81470-X; PATEL M, 1990, ONCOGENE, V5, P201; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; SAKAI K, 1987, CANCER RES, V47, P5572; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAKIS C, 1985, COLD SPRING HARB SYM, V50, P505, DOI 10.1101/SQB.1985.050.01.062; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEWART JR, 1984, BIOCHEM J, V224, P549, DOI 10.1042/bj2240549; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; STREHLER EE, 1985, MOL CELL BIOL, V5, P3168, DOI 10.1128/MCB.5.11.3168; TAKADERA T, 1989, MOL CELL BIOL, V9, P2173, DOI 10.1128/MCB.9.5.2173; TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; ULRICH MJ, 1990, BLOOD, V75, P990; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; WATT VM, 1990, HUM GENET, V85, P651; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; WU Q, 1989, J IMMUNOL, V143, P3303; WU Q, 1991, P NATL ACAD SCI USA, V88, P676, DOI 10.1073/pnas.88.2.676; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; [No title captured]	76	121	125	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11999	12007						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1675638				2022-12-25	WOS:A1991FT76200088
J	HAEFFNERGORMLEY, L; CHEN, ZD; ZALKIN, H; COLMAN, RF				HAEFFNERGORMLEY, L; CHEN, ZD; ZALKIN, H; COLMAN, RF			EVALUATION OF CYSTEINE-283 AND GLUTAMIC ACID-284 IN THE COENZYME BINDING-SITE OF SALMONELLA-TYPHIMURIUM GLUTAMATE-DEHYDROGENASE BY SITE-DIRECTED MUTAGENESIS AND REACTION WITH THE NUCLEOTIDE ANALOG 2-((4-BROMO-2,3-DIOXOBUTYL)THIO)-1,N6-ETHENOADENOSINE 2',5'-BISPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; 2-<(4-BROMO-2,3-DIOXOBUTYL)THIO>-1,N-6-ETHENOADENOSINE 2',5'-BISPHOSPHATE; ISOCITRATE DEHYDROGENASE; SEQUENCE; PEPTIDE; IDENTIFICATION; NEUROSPORA; RESIDUE; SUBUNIT; KINASE	NADP+-specific glutamate dehydrogenase of Salmonella typhimurium was previously shown to react irreversibly at the coenzyme site with the nucleotide analogue 2-((4-bromo-2,3-dioxobutyl)thio)-1,N6-ethenoadenosine 2',5'-bisphosphate (2-BDB-T-epsilon-A 2',5'-DP) yielding a partially active enzyme, and inactivation was attributed to modification of the peptide Leu282-Cys-Glu-Ile-Lys286 (Bansal, A., Dayton, M. A., Zalkin, H., and Colman, R. F. (1989) J. Biol. Chem. 264, 9827-9835). Three mutant enzymes have now been engineered, expressed in Escherichia coli, and purified: the single mutants C283I and E284Q and the double mutant C283I:E284Q. The wild-type and mutant enzymes have similar specific activities and K(m) values for alpha-ketoglutarate, ammonium ion, and NADPH, indicating that neither cysteine 283 nor glutamic acid 284 is essential for activity. The mutant enzyme E284Q, like wild-type glutamate dehydrogenase, is substantially inactivated by 2-BDB-T-epsilon-A 2',5'-DP. In contrast, the two cysteine mutant enzymes, C283I and C283I:E284Q, are not inactivated by 2-BDB-T-epsilon-A 2',5'-DP. Modified tryptic peptides with the sequence Leu-X-Glu(Gln)-Ile-Lys were isolated from wild-type or E284Q enzymes inactivated by 2-BDB-T-epsilon-A 2',5'-DP. This peptide was absent from digests of active wild-type enzyme modified in the presence of the protectant NADPH and from digests of active C283I enzyme after incubation with 2-BDB-T-epsilon-A 2',5'-DP. Although it is not required for catalytic activity, cysteine 283 is implicated by the results of the affinity labeling experiments as the reaction target of the nucleotide analogue and is located in the region of the coenzyme binding site.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	HAEFFNERGORMLEY, L (corresponding author), UNIV DELAWARE, DEPT CHEM & BIOCHEM, NEWARK, DE 19716 USA.				NIDDK NIH HHS [DK37000] Funding Source: Medline; NIGMS NIH HHS [GM24658] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024658, R01GM024658] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY JM, 1985, BIOCHEMISTRY-US, V24, P5367, DOI 10.1021/bi00341a015; BANSAL A, 1989, J BIOL CHEM, V264, P9827; BATRA SP, 1986, BIOCHEMISTRY-US, V25, P3508, DOI 10.1021/bi00360a005; BIRKTOFT JJ, 1984, PEPT PROTEIN REV, V4, P1; BLUMENTHAL KM, 1975, J BIOL CHEM, V250, P3644; BUECHLER JA, 1988, BIOCHEMISTRY-US, V27, P7356, DOI 10.1021/bi00419a027; DECAMP DL, 1989, J BIOL CHEM, V264, P8430; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; EHRLICH RS, 1987, J BIOL CHEM, V262, P12614; HAEFFNERGORMLEY L, 1990, FASEB J, V4, P1838; HOLLEMANS M, 1983, J BIOL CHEM, V258, P9307; JACOBSON MA, 1984, BIOCHEMISTRY-US, V23, P6377, DOI 10.1021/bi00321a014; JORDANSTARCK TC, 1989, J BIOL CHEM, V264, P17919; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MILLER ES, 1984, J BACTERIOL, V157, P171, DOI 10.1128/JB.157.1.171-178.1984; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PHILLIPS RS, 1989, J BIOL CHEM, V264, P10627; RICE DW, 1987, BIOCHEM J, V242, P789, DOI 10.1042/bj2420789; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VALLE F, 1984, GENE, V27, P193, DOI 10.1016/0378-1119(84)90140-9; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WEBER K, 1969, J BIOL CHEM, V244, P4406; WOOTTON JC, 1975, BIOCHEM J, V149, P739, DOI 10.1042/bj1490739	23	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5388	5394						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1672312				2022-12-25	WOS:A1991FD37000008
J	MA, LD; MARQUARDT, D; TAKEMOTO, L; CENTER, MS				MA, LD; MARQUARDT, D; TAKEMOTO, L; CENTER, MS			ANALYSIS OF P-GLYCOPROTEIN PHOSPHORYLATION IN HL60 CELLS ISOLATED FOR RESISTANCE TO VINCRISTINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVITY; MULTIDRUG-RESISTANCE; MEMBRANE GLYCOPROTEIN; TUMOR-CELLS; ADRIAMYCIN; GENE; DAUNORUBICIN; MECHANISMS; DRUG; IDENTIFICATION	In the present study we have analyzed the involvement of phosphorylation in the function of P-glycoprotein and have also examined sites of phosphorylation along the P-glycoprotein polypeptide chain. The results show that in HL60 cells isolated for resistance to vincristine the protein kinase inhibitor staurosporine induces a major inhibition in the phosphorylation of P-glycoprotein. Further studies show that under the same conditions in which staurosporine inhibits P-glycoprotein phosphorylation there is a concomitant increase in cellular drug accumulation and a major inhibition in drug efflux. Additional studies using pulse-chase experiments show that the P-glycoprotein phosphate groups are metabolically active and that the protein undergoes rapid cycles of phosphorylation and dephosphorylation in the cell. Structural analyses demonstrate that cleavage of P-32-labeled P-glycoprotein at Asp-Pro linkages with formic acid results in the formation of a major phosphorylated peptide of 35 kDa and a minor peptide of 42 kDa. Western blot analysis using site-specific antisera against P-glycoprotein suggests that P-35 represents a phosphorylated fragment containing P-glycoprotein amino acids 446-744. Analysis of tryptic peptides using site-specific antisera identifies a second major phosphorylated region of P-glycoprotein which contains amino acids 745-1088. These studies thus suggest that phosphorylation plays an important role in the biological activity of P-glycoprotein. The results also indicate that two adjacent internal regions are highly phosphorylated in the P-glycoprotein molecule.	KANSAS STATE UNIV AGR & APPL SCI,DIV BIOL,MANHATTAN,KS 66506	Kansas State University					NCI NIH HHS [CA-37585] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037585] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECK WT, 1979, CANCER RES, V39, P2070; CENTER MS, 1985, BIOCHEM PHARMACOL, V34, P1471, DOI 10.1016/0006-2952(85)90686-0; CHAMBERS TC, 1990, J BIOL CHEM, V265, P7679; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; CROOP JM, 1987, CANCER RES, V47, P5982; ELIAS L, 1985, J BIOL CHEM, V260, P7023; GARMAN D, 1982, BIOCHEM BIOPH RES CO, V105, P157, DOI 10.1016/S0006-291X(82)80025-9; GARMAN D, 1983, BIOCHEM PHARMACOL, V32, P3633, DOI 10.1016/0006-2952(83)90315-5; GROS P, 1986, NATURE, V323, P708; HAMADA H, 1987, CANCER RES, V47, P2860; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; INABA M, 1978, BIOCHEM PHARMACOL, V27, P2123, DOI 10.1016/0006-2952(78)90284-8; INABA M, 1981, BIOCHEM PHARMACOL, V30, P1863; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KLEMM DJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P496, DOI 10.1016/0003-9861(88)90154-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; MARGLIN A, 1970, ANNU REV BIOCHEM, V39, P841, DOI 10.1146/annurev.bi.39.070170.004205; MARQUARDT D, 1990, CANCER RES, V50, P1426; MCGRATH T, 1988, CANCER RES, V48, P3959; MELLADO W, 1987, BIOCHEMISTRY-US, V26, P6900, DOI 10.1021/bi00396a005; OBRIAN CA, 1989, FEBS LETT, V246, P78, DOI 10.1016/0014-5793(89)80257-1; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; PETERSON RHF, 1978, J SUPRAMOL STR CELL, V9, P289, DOI 10.1002/jss.400090302; Posada J A, 1989, Cancer Commun, V1, P285; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAFA AR, 1986, J BIOL CHEM, V261, P6137; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SKOVSGAARD T, 1978, CANCER RES, V38, P1785; STAATS J, 1990, J BIOL CHEM, V265, P4084; SUGIMOTO Y, 1987, CANCER RES, V47, P2720; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282	37	106	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5593	5599						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1672314				2022-12-25	WOS:A1991FD37000038
J	WELLHONER, HH; NEVILLE, DM; SRINIVASACHAR, K; ERDMANN, G				WELLHONER, HH; NEVILLE, DM; SRINIVASACHAR, K; ERDMANN, G			UPTAKE AND CONCENTRATION OF BIOACTIVE MACROMOLECULES BY K562 CELLS VIA THE TRANSFERRIN CYCLE UTILIZING AN ACID-LABILE TRANSFERRIN CONJUGATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN; P-GLYCOPROTEIN; RECEPTOR; TRANSPORT; INTERNALIZATION; FRAGMENT; AGENTS; ENTRY	The transferrin cycle was used to attempt the import of bioactive macromolecules into cells with the aid of an acid-labile cross-linking agent. Anti-tetanus F(ab')2 fragments were iodinated and then conjugated to transferrin with a newly developed acid-labile cleavable cross-linking reagent, bismaleimidoethoxy propane, following thiolation of both proteins. Noncleavable conjugates were also prepared. At saturating conjugate concentrations, the uptake rate for both conjugates averaged over the first 2 h is about 6.5 fmol/million cells/min. Incubation of loaded cells in fresh medium for 30 min and analysis of cell pellets and supernatants reveal that 1) of the previously cell-associated label, only intact conjugate (about 50% of the label) is returned to the medium; 2) most of the remaining cell-associated material for the cleavable conjugate is chromatographically coincident with free Fab with some contribution from free F(ab')2 fragments. In contrast, the cell pellets loaded with noncleavable conjugates contained intact transferrin-F(ab')2 conjugates. These results are consistent with transferrin receptor-mediated uptake of acid-labile conjugate followed by hydrolysis in acidified endosomes and resulting in concentration of free F(ab')2 and Fab within a prelysosomal intracellular compartment. A protein shuttle such as transferrin may therefore be used with ketal based acid-labile cross-linkers to load foreign molecules into an intracellular compartment. In addition, these data provide independent confirmation of the low pH compartment within the transferrin cycle. This new methodology is applicable to other cases of receptor/ligand trafficking to report low pH compartments independent of morphological analysis. Since transferrin receptors are overexpressed in tumors, antineoplastic agents could be targeted to tumors as transferrin acid-labile conjugates. This import system might be particularly useful in combatting the tumor cell export of antitumor agents occurring in multidrug resistance.	NIMH,MOLEC BIOL LAB,BIOPHYS CHEM SECT,BLDG 36,RM 1B-08,BETHESDA,MD 20892; MED SCH HANNOVER,DEPT TOXICOL,HANNOVER,GERMANY	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Hannover Medical School								ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Burton K., 1968, METHODS ENZYMOLOGY B, V12B, P163; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; COLOMBATTI M, 1986, J BIOL CHEM, V261, P3030; CORDES EH, 1974, CHEM REV, V74, P581, DOI 10.1021/cr60291a004; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; HUDSON TH, 1985, J BIOL CHEM, V260, P2675; HUDSON TH, 1987, J BIOL CHEM, V262, P16484; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KOLLER DM, 1989, EMBO J, V8, P3651; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MURRAY GJ, 1980, J BIOL CHEM, V255, P1942; NEVILLE DM, 1989, J BIOL CHEM, V264, P14653; NEVILLE DM, 1986, ANNU REV BIOCHEM, V55, P195, DOI 10.1146/annurev.biochem.55.1.195; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; SRINIVASACHAR K, 1989, BIOCHEMISTRY-US, V28, P2501, DOI 10.1021/bi00432a023; STEIN BS, 1986, J BIOL CHEM, V261, P319; SWORTHY RS, 1984, J BIOL CHEM, V259, P11496; YOULE RJ, 1979, J BIOL CHEM, V254, P1089; ZENKE M, 1990, P NATL ACAD SCI USA, V87, P3655, DOI 10.1073/pnas.87.10.3655	24	23	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4309	4314						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1671860				2022-12-25	WOS:A1991FA69400047
J	ICHIKAWA, M; YOSHIMURA, A; SUMIZAWA, T; SHUDO, N; KUWAZURU, Y; FURUKAWA, T; AKIYAMA, S				ICHIKAWA, M; YOSHIMURA, A; SUMIZAWA, T; SHUDO, N; KUWAZURU, Y; FURUKAWA, T; AKIYAMA, S			INTERACTION OF ORGANIC-CHEMICALS WITH P-GLYCOPROTEIN IN THE ADRENAL-GLAND, KIDNEY, AND A MULTIDRUG-RESISTANT KB CELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSPORT PROTEINS; MEMBRANE-GLYCOPROTEINS; GENE; VINBLASTINE; ADRIAMYCIN; ANTIBODIES; HOMOLOGY; LINES; PERMEABILITY; COLCHICINE	P-glycoprotein (P-gp) is thought to mediate the transport of anti-cancer drugs and to be responsible for the multidrug-resistant (MDR) phenotype in tumor cells. However, the function of P-gp in normal tissues is still not well understood. We present evidence indicating that the active efflux of several structurally unrelated organic compounds is mediated by P-gp in multidrug-resistant KB (KB-C2) cells and that these compounds interact with P-gp in the kidney and adrenal gland. The photoactive radioactive calcium channel blocker [H-3]azidopine labels a protein of approximately 140 kDa in crude membrane fractions from human kidney and adrenal gland and a 130-kDa protein from bovine adrenal gland. These photolabeled proteins are immunoprecipitated with an anti-P-gp antibody. Photolabeling is inhibited by vinblastine, reserpine, and several other organic chemicals. These data indicate that the kidney and adrenal gland express P-gp (or a protein closely related to P-gp) that can interact with several organic compounds and that the P-gp expressed in these tissues has a drug-binding site similar to that of P-gp in KB-C2 cells. Our findings thus strongly support the hypothesis that P-gp can transport a wide variety of organic chemicals as well as anti-cancer drugs and that one of the physiological functions of P-gp is the excretion of certain classes of organic compounds.	KAGOSHIMA UNIV,FAC MED,INST CANC RES,1208-1 USUKI CHO,KAGOSHIMA 890,JAPAN	Kagoshima University			Yoshimura, Akihiko/K-5515-2013	Furukawa, Tatsuhiko/0000-0003-1655-4123				AKIYAMA SI, 1988, MOL PHARMACOL, V33, P144; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; BECK WT, 1979, CANCER RES, V39, P2070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; CARMICHAEL J, 1987, CANCER RES, V47, P936; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; FOJO A, 1985, CANCER RES, V45, P3002; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; ICHIKAWA M, 1990, BIOCHEM BIOPH RES CO, V166, P74, DOI 10.1016/0006-291X(90)91913-D; IKEDA S, 1990, INT J CANCER, V45, P508, DOI 10.1002/ijc.2910450323; INABA M, 1978, BIOCHEM PHARMACOL, V27, P2123, DOI 10.1016/0006-2952(78)90284-8; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KAMIWATARI M, 1989, CANCER RES, V49, P3190; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KIOKA N, 1989, BIOCHEM BIOPH RES CO, V162, P224, DOI 10.1016/0006-291X(89)91985-2; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; LING V, 1974, J CELL PHYSIOL, V83, P103, DOI 10.1002/jcp.1040830114; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; NAYAK PK, 1969, AM J PHYSIOL, V217, P1639, DOI 10.1152/ajplegacy.1969.217.6.1639; NEYFAKH AA, 1988, EXP CELL RES, V174, P168, DOI 10.1016/0014-4827(88)90152-8; RIORDAN JR, 1989, SCIENCE, V245, P1066; SHEN DW, 1986, J BIOL CHEM, V261, P7762; SUGAWARA I, 1988, CANCER RES, V48, P1926; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; TSURUO T, 1986, JPN J CANCER RES, V77, P682; WEINER IM, 1964, AM J MED, V36, P743, DOI 10.1016/0002-9343(64)90183-4; YANG CPH, 1989, J BIOL CHEM, V264, P782; YOSHIMURA A, 1989, BIOCHIM BIOPHYS ACTA, V992, P307, DOI 10.1016/0304-4165(89)90089-5; YOSHIMURA A, 1990, CANCER LETT, V50, P45, DOI 10.1016/0304-3835(90)90177-Y; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; ZAMORA JM, 1988, MOL PHARMACOL, V33, P454; ZEHEB R, 1987, BIOCHEM BIOPH RES CO, V143, P732, DOI 10.1016/0006-291X(87)91415-X	40	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					903	908						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1670776				2022-12-25	WOS:A1991ET17700037
J	KUMAGAI, A; HADWIGER, JA; PUPILLO, M; FIRTEL, RA				KUMAGAI, A; HADWIGER, JA; PUPILLO, M; FIRTEL, RA			MOLECULAR GENETIC-ANALYSIS OF 2 G-ALPHA PROTEIN SUBUNITS IN DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE CAMP RECEPTORS; AGGREGATION-DEFICIENT MUTANTS; SIGNAL-TRANSDUCTION PATHWAYS; FOLATE CHEMOTACTIC RECEPTORS; CYCLIC-AMP RECEPTOR; GUANINE-NUCLEOTIDES; INOSITOL 1,4,5-TRISPHOSPHATE; DEVELOPMENTAL REGULATION; ADENYLATE-CYCLASE; GUANYLATE-CYCLASE	In Dictyostelium, chemotaxis to folate during growth and cAMP during aggregation is controlled via cell surface receptors. To study the role of two G-alpha proteins (G-alpha-1 and G-alpha-2) in these responses, we examined the physiological and biochemical effects of null mutations caused by antisense mutagenesis and gene disruptions. Disruption of G-alpha-2 results in an aggregation-deficient phenotype and a loss of cAMP receptor-mediated functions, including activation of adenylate cyclase, guanylate cyclase, and gene expression and in a loss of GTP-mediated decrease in receptor affinity for cAMP, but it has no effect on chemotaxis to folate or folate activation of guanylate cyclase. These phenotypes can be rescued by a vector expressing G-alpha-2, suggesting G-alpha-2 is coupled to a cAMP receptor but not to folate receptors. Loss of G-alpha-1 expression resulted in no visible growth or developmental phenotype, including cAMP- and folate-stimulated responses, suggesting G-alpha-1 function is either not essential under standard laboratory conditions or is encoded by multiple genes. Availability of null mutations provides suitable genetic backgrounds for expressing mutant G-alpha protein subunits which can then be used to examine the physiological roles of G-alpha-1 and G-alpha-2. Construction of these gene disruptions was facilitated by using the auxotrophic marker THY1, which allowed for selection of single-copy insertions into the genome.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,DEPT BIOL,M-034,LA JOLLA,CA 92093; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205	University of California System; University of California San Diego; Johns Hopkins University								BLINDER D, 1989, CELL, V56, P479, DOI 10.1016/0092-8674(89)90250-X; COUKELL MB, 1983, DEV GENET, V3, P283; DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337; DEVREOTES PN, 1982, DEV DICTYOSTELIUM DI, P117; DEWIT RJW, 1986, BIOCHIM BIOPHYS ACTA, V886, P88, DOI 10.1016/0167-4889(86)90214-4; DEWIT RJW, 1985, FEBS LETT, V179, P257, DOI 10.1016/0014-5793(85)80530-5; DEWIT RJW, 1986, DIFFERENTIATION, V32, P192, DOI 10.1111/j.1432-0436.1986.tb00573.x; DEWIT RJW, 1985, BIOCHEM BIOPH RES CO, V129, P11, DOI 10.1016/0006-291X(85)91395-6; DEWIT RJW, 1985, BIOCHIM BIOPHYS ACTA, V814, P199, DOI 10.1016/0005-2736(85)90438-9; DEWIT RJW, 1986, BIOCHIM BIOPHYS ACTA, V886, P76, DOI 10.1016/0167-4889(86)90213-2; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; EUROPEFINNER GN, 1985, BIOCHEM BIOPH RES CO, V130, P1115; EUROPEFINNER GN, 1987, J CELL SCI, V87, P513; FIRTEL RA, 1990, GENE DEV, V4, P18, DOI 10.1101/gad.4.1.18; FIRTEL RA, 1989, CELL, V58, P235, DOI 10.1016/0092-8674(89)90837-4; FOSNAUGH KL, 1989, MOL CELL BIOL, V9, P5215, DOI 10.1128/MCB.9.11.5215; GERISCH G, 1975, NATURE, V255, P547, DOI 10.1038/255547a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUNDERSEN RE, 1990, SCIENCE, V248, P591, DOI 10.1126/science.2110382; HABERSTROH L, 1990, GENE DEV, V4, P596, DOI 10.1101/gad.4.4.596; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; JANSSENS PMW, 1986, BIOCHEMISTRY-US, V25, P1314, DOI 10.1021/bi00354a019; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; KIMMEL AR, 1987, DEV BIOL, V122, P163, DOI 10.1016/0012-1606(87)90342-3; KLEIN P, 1987, J BIOL CHEM, V262, P358; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; KUMAGAI A, 1989, COLD SPRING HARB SYM, V53, P675; LO EKL, 1978, CAN J MICROBIOL, V24, P255; Loomis WF., 1975, DICTYOSTELIUM DISCOI; MANN SKO, 1988, DEV BIOL, V130, P406, DOI 10.1016/0012-1606(88)90447-2; MANN SKO, 1987, MOL CELL BIOL, V7, P458, DOI 10.1128/MCB.7.1.458; MANN SKO, 1989, P NATL ACAD SCI USA, V86, P1924, DOI 10.1073/pnas.86.6.1924; MANN SKO, 1988, DEV BIOL, V130, P294, DOI 10.1016/0012-1606(88)90435-6; MEHDY MC, 1983, CELL, V32, P761; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; NEWELL PC, 1987, MICROBIOL SCI, V4, P5; NEWELL PC, 1988, J CELL SCI, V89, P123; PODGORSKI G, 1984, MOL CELL BIOL, V4, P2784, DOI 10.1128/MCB.4.12.2784; PUPILLO M, 1989, P NATL ACAD SCI USA, V86, P4892, DOI 10.1073/pnas.86.13.4892; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; ROWEKAMP W, 1980, DEV BIOL, V79, P409, DOI 10.1016/0012-1606(80)90126-8; RUBINO S, 1989, DEV BIOL, V131, P27, DOI 10.1016/S0012-1606(89)80035-1; SEGALL JE, 1988, J CELL SCI, V91, P479; SEGALL JE, 1987, J CELL BIOL, V104, P151, DOI 10.1083/jcb.104.1.151; SNAARJAGALSKA BE, 1988, DEV GENET, V9, P215; SUN TJ, 1990, J CELL BIOL, V110, P1549, DOI 10.1083/jcb.110.5.1549; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; THEIBERT A, 1986, DEV BIOL, V114, P529, DOI 10.1016/0012-1606(86)90216-2; THEIBERT A, 1986, J BIOL CHEM, V261, P5121; VANHAASTERT PJM, 1987, BIOCHEMISTRY-US, V26, P7518, DOI 10.1021/bi00397a047; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; VANHAASTERT PJM, 1985, BIOCHIM BIOPHYS ACTA, V846, P324, DOI 10.1016/0167-4889(85)90002-3; VANHAASTERT PJM, 1989, BIOCHEM J, V258, P577, DOI 10.1042/bj2580577; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P3321; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3	58	139	140	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1220	1228						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1670774				2022-12-25	WOS:A1991ET17700083
J	MATOZAKI, T; GOKE, B; TSUNODA, Y; RODRIGUEZ, M; MARTINEZ, J; WILLIAMS, JA				MATOZAKI, T; GOKE, B; TSUNODA, Y; RODRIGUEZ, M; MARTINEZ, J; WILLIAMS, JA			2 FUNCTIONALLY DISTINCT CHOLECYSTOKININ RECEPTORS SHOW DIFFERENT MODES OF ACTIONS ON CA-2+ MOBILIZATION AND PHOSPHOLIPID HYDROLYSIS IN ISOLATED RAT PANCREATIC ACINI - STUDIES USING A NEW CHOLECYSTOKININ ANALOG, JMV-180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; CTR PHARMACOL ENDOCRINOL,F-34094 MONTPELLIER,FRANCE	University of Michigan System; University of Michigan	MATOZAKI, T (corresponding author), UNIV MICHIGAN,DEPT PHYSIOL,7744 MED SCI 2,ANN ARBOR,MI 48109, USA.		Martinez, Jean/R-9421-2019	Martinez, Jean/0000-0002-9267-4621; Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041225, R01DK041122] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 41225, DK 41122] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BURNHAM DB, 1986, BIOCHEM J, V235, P125, DOI 10.1042/bj2350125; COLLEN MJ, 1982, AM J PHYSIOL, V242, pG423, DOI 10.1152/ajpgi.1982.242.4.G423; DORMER RL, 1984, BIOCHEM BIOPH RES CO, V119, P876, DOI 10.1016/0006-291X(84)90855-6; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; FULCRAND P, 1988, INT J PEPT PROT RES, V32, P384; GAISANO HY, 1989, J CLIN INVEST, V83, P321, DOI 10.1172/JCI113877; GALAS MC, 1988, AM J PHYSIOL, V254, pG176, DOI 10.1152/ajpgi.1988.254.2.G176; GRILLONE LR, 1988, J BIOL CHEM, V263, P2658; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IRVING HR, 1987, J BIOL CHEM, V262, P3440; JENSEN RT, 1980, P NATL ACAD SCI-BIOL, V77, P2079, DOI 10.1073/pnas.77.4.2079; JUNG DH, 1980, CLIN CHIM ACTA, V100, P7, DOI 10.1016/0009-8981(80)90179-5; LIGNON MF, 1987, GASTRIN CHOLECYSTOKI, P57; MATOZAKI T, 1988, AM J PHYSIOL, V255, pE652, DOI 10.1152/ajpendo.1988.255.5.E652; MATOZAKI T, 1989, AM J PHYSIOL, V257, pG594, DOI 10.1152/ajpgi.1989.257.4.G594; MATOZAKI T, 1989, J BIOL CHEM, V264, P14729; MERRITT JE, 1986, BIOCHEM J, V236, P337, DOI 10.1042/bj2360337; MERRITT JE, 1985, BIOCHEM J, V230, P151, DOI 10.1042/bj2300151; MERRITT JE, 1986, BIOCHEM J, V238, P825, DOI 10.1042/bj2380825; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NOGUCHI M, 1985, AM J PHYSIOL, V248, pG692, DOI 10.1152/ajpgi.1985.248.6.G692; OCHS DL, 1985, AM J PHYSIOL, V249, pG389, DOI 10.1152/ajpgi.1985.249.3.G389; OTSUKI M, 1982, AM J PHYSIOL, V243, pG285, DOI 10.1152/ajpgi.1982.243.4.G285; PANDOL SJ, 1985, J BIOL CHEM, V260, P81; PANDOL SJ, 1986, J BIOL CHEM, V261, P4438; PREISS J, 1986, J BIOL CHEM, V261, P8597; SANKARAN H, 1982, AM J PHYSIOL, V242, pG250, DOI 10.1152/ajpgi.1982.242.3.G250; SANKARAN H, 1980, J BIOL CHEM, V255, P1849; SILVKA SR, 1988, J BIOL CHEM, V263, P12242; STARK HA, 1989, BIOCHIM BIOPHYS ACTA, V1010, P145, DOI 10.1016/0167-4889(89)90154-7; STREB H, 1985, J BIOL CHEM, V260, P7309; STUENKEL EL, 1989, BIOCHEM BIOPH RES CO, V158, P863, DOI 10.1016/0006-291X(89)92802-7; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSUNODA Y, 1990, AM J PHYSIOL, V258, pC147, DOI 10.1152/ajpcell.1990.258.1.C147; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WILLIAMS JA, 1987, REGUL PEPTIDES, V18, P109, DOI 10.1016/0167-0115(87)90041-3; WILLIAMS JA, 1980, AM J PHYSIOL, V238, pG269, DOI 10.1152/ajpgi.1980.238.4.G269; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; WILLIAMS JA, 1988, AM J PHYSIOL, V254, pG513, DOI 10.1152/ajpgi.1988.254.4.G513; WILLIAMS JA, 1986, EXOCRINE PANCREAS BI, P123	41	216	217	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6247	6254						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690723				2022-12-25	WOS:A1990CY58700054
J	KIZAKI, H; SUZUKI, K; TADAKUMA, T; ISHIMURA, Y				KIZAKI, H; SUZUKI, K; TADAKUMA, T; ISHIMURA, Y			ADENOSINE RECEPTOR-MEDIATED ACCUMULATION OF CYCLIC AMP-INDUCED LYMPHOCYTE-T DEATH THROUGH INTERNUCLEOSOMAL DNA CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									KEIO UNIV,SCH MED,DEPT MICROBIOL,SHINJUKU KU,TOKYO 160,JAPAN	Keio University	KIZAKI, H (corresponding author), KEIO UNIV,SCH MED,DEPT BIOCHEM,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN.							ALNEMRI ES, 1989, J BIOL CHEM, V264, P4104; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BIRCH RE, 1986, INT J IMMUNOPHARMACO, V8, P329, DOI 10.1016/0192-0561(86)90115-3; BONNAFOUS JC, 1981, J RECEPTOR RES, V2, P347, DOI 10.3109/107998981809038872; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307; COFFEY RG, 1985, FED PROC, V44, P112; COHEN JJ, 1984, J IMMUNOL, V132, P38; COMPTON MM, 1987, J BIOL CHEM, V262, P8288; FOX IH, 1978, ANNU REV BIOCHEM, V47, P655, DOI 10.1146/annurev.bi.47.070178.003255; FREDHOLM BB, 1983, BRIT J PHARMACOL, V80, P639, DOI 10.1111/j.1476-5381.1983.tb10053.x; GIBLETT ER, 1972, LANCET, V2, P1067; IKAWA H, 1984, ENDOCRINOLOGY, V114, P1686, DOI 10.1210/endo-114-5-1686; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KENNETH B, 1986, ADV CYCLIC NUCLEOTID, V20, P1; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KIZAKI H, 1988, J IMMUNOL, V141, P1652; KIZAKI H, 1989, J BIOCHEM-TOKYO, V104, P673; MARONE G, 1978, J IMMUNOL, V121, P2153; MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923; MCKONKEY DJ, 1989, FASEB J, P1843; PRATT RM, 1975, P NATL ACAD SCI USA, V72, P874, DOI 10.1073/pnas.72.3.874; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; SANDBERG G, 1983, INT J IMMUNOPHARMACO, V5, P267; SCHMALSTIEG FC, 1977, J PEDIATR-US, V91, P48, DOI 10.1016/S0022-3476(77)80442-3; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; WEISSMAN IL, 1975, ISRAEL J MED SCI, V11, P884; Whitfield J F, 1980, Ann N Y Acad Sci, V339, P216, DOI 10.1111/j.1749-6632.1980.tb15980.x; WILLIAMS M, 1987, ANNU REV PHARMACOL, V27, P315; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YOSHIHARA K, 1982, BIOCHEM BIOPH RES CO, V106, P803, DOI 10.1016/0006-291X(82)91781-8; YOUNT J, 1974, J PEDIATR-US, V84, P173, DOI 10.1016/S0022-3476(74)80597-4; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	37	141	142	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5280	5284						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690738				2022-12-25	WOS:A1990CV58700083
J	LEVINE, MA; FELDMAN, AM; ROBISHAW, JD; LADENSON, PW; AHN, TG; MORONEY, JF; SMALLWOOD, PM				LEVINE, MA; FELDMAN, AM; ROBISHAW, JD; LADENSON, PW; AHN, TG; MORONEY, JF; SMALLWOOD, PM			INFLUENCE OF THYROID-HORMONE STATUS ON EXPRESSION OF GENES ENCODING G-PROTEIN SUBUNITS IN THE RAT-HEART	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WEIS CTR RES, GEISINGER CLIN, DANVILLE, PA 17822 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV CARDIOL, BALTIMORE, MD 21205 USA	Johns Hopkins University				Levine, Michael/0000-0003-0036-7809	NCRR NIH HHS [RR0035] Funding Source: Medline; NHLBI NIH HHS [HL39719] Funding Source: Medline; NIDDK NIH HHS [DK34281] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034281] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378; BIRNBAUMER L, 1987, KIDNEY INT, V32, pS14; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; CERIONE RA, 1986, J BIOL CHEM, V261, P9514; CHANG FH, 1987, ENDOCRINOLOGY, V121, P1711, DOI 10.1210/endo-121-5-1711; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIARALDI TP, 1978, BIOCHIM BIOPHYS ACTA, V541, P334, DOI 10.1016/0304-4165(78)90193-9; DARFLER FJ, 1982, J BIOL CHEM, V257, P1901; DEBONS AF, 1961, J LIPID RES, V2, P86; DILLMANN WH, 1983, J BIOL CHEM, V258, P7738; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOSTER KA, 1989, 9TH INT WASH SPRING; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREEN DA, 1982, J CYCLIC NUCL PROT, V8, P337; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; GUARNIERI T, 1980, J CLIN INVEST, V65, P861, DOI 10.1172/JCI109738; HARRIS BA, 1985, SCIENCE, V229, P1274, DOI 10.1126/science.3839937; JONES DT, 1987, J BIOL CHEM, V262, P14241; KATADA T, 1984, J BIOL CHEM, V259, P3568; KATADA T, 1986, J BIOL CHEM, V261, P5215; KESSLER PD, 1989, J CLIN INVEST, V84, P244, DOI 10.1172/JCI114147; KRAWIETZ W, 1982, BIOCHEM PHARMACOL, V31, P2463, DOI 10.1016/0006-2952(82)90055-7; KUNOS G, 1974, NATURE, V250, P779, DOI 10.1038/250779a0; LADENSON PW, 1986, METABOLISM, V35, P5, DOI 10.1016/0026-0495(86)90088-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVIN TN, 1988, ENDOCRINOLOGY, P562; LEVEY GS, 1969, ENDOCRINOLOGY, V85, P1004, DOI 10.1210/endo-85-6-1004; LEVINE MA, 1988, P NATL ACAD SCI USA, V85, P617, DOI 10.1073/pnas.85.2.617; LEVINE MA, 1990, IN PRESS P NATL ACAD; LUETJE CW, 1988, J BIOL CHEM, V263, P13357; LUETJE CW, 1987, BIOCHEMISTRY-US, V26, P4876, DOI 10.1021/bi00389a040; MALBON CC, 1982, J CLIN INVEST, V69, P414, DOI 10.1172/JCI110465; MALBON CC, 1983, FEBS LETT, V155, P35, DOI 10.1016/0014-5793(83)80203-8; MALBON CC, 1985, J BIOL CHEM, V260, P2558; MALBON CC, 1978, J BIOL CHEM, V253, P671; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MILLIGAN G, 1987, BIOCHEM J, V247, P223, DOI 10.1042/bj2470223; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; NYBORG JK, 1984, J BIOL CHEM, V259, P2377; Oppenheimer J., 1983, MOL BASS THYROID HOR, P1; OPPENHEIMER JH, 1985, ANN INTERN MED, V102, P374, DOI 10.7326/0003-4819-102-3-374; PLUSKAL MG, 1986, BIOTECHNIQUES, V4, P272; RAPIEJKO PJ, 1989, J BIOL CHEM, V264, P16183; RONCARI DAK, 1975, J BIOL CHEM, V250, P4134; ROS M, 1988, J BIOL CHEM, V263, P4362; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SHUPNIK MA, 1985, J BIOL CHEM, V260, P2900; SHUPNIK MA, 1986, ENDOCRINOLOGY, V118, P367, DOI 10.1210/endo-118-1-367; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STILES GL, 1981, LIFE SCI, V28, P2529, DOI 10.1016/0024-3205(81)90595-6; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TSE J, 1980, ENDOCRINOLOGY, V107, P6, DOI 10.1210/endo-107-1-6; VANINWEGEN RG, 1975, J BIOL CHEM, V250, P2452; WILDENTHAL K, 1972, J CLIN INVEST, V51, P2702, DOI 10.1172/JCI107089; YAFFE BM, 1984, J BIOL CHEM, V259, P6284	56	98	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3553	3560						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689305				2022-12-25	WOS:A1990CP23600087
J	SCHNEUWLY, S; BURG, MG; LENDING, C; PERDEW, MH; PAK, WL				SCHNEUWLY, S; BURG, MG; LENDING, C; PERDEW, MH; PAK, WL			PROPERTIES OF PHOTORECEPTOR-SPECIFIC PHOSPHOLIPASE-C ENCODED BY THE NORPA GENE OF DROSOPHILA-MELANOGASTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE; BOVINE BRAIN; PHOTOTRANSDUCTION; RHODOPSIN; CASCADE; MUTANT; FORMS; IDENTIFICATION; PURIFICATION; HYDROLYSIS	Mutations in the norpA gene drastically affect the phototransduction process in Drosophila. To study the biochemical characteristics of the norpA protein and its cellular and subcellular distributions, we have generated antisera against the major gene product of norpA. The antisera recognize an eye-specific protein of 130-kDa relative molecular mass that is present in wild-type head extracts but not in those of strong norpA mutants. The protein is associated with membranes and can be extracted with high salt. Immunohistochemical analysis at the light and electron microscopic levels indicates that the protein is expressed in all adult photoreceptor cells and specifically localized within the rhabdomeres, preferentially adjacent to, but not within, the rhabdomeric membranes. The results of the present study strongly support the previous suggestion that the norpA gene encodes the major phosphoinositol-specific phospholipase C in the photoreceptors. Moreover, insofar as the rhabdomeres are specialized structures for photoreception and phototransduction, specific localization of the norpA protein within these structures, in close association with the membranes, is consistent with the proposal that it has an important role in phototransduction.	PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus				Schneuwly, Stephan/0000-0001-7711-8902	NATIONAL EYE INSTITUTE [P30EY002723, R37EY000033, R01EY000033] Funding Source: NIH RePORTER; NEI NIH HHS [EY06214, EY00033, EY02723] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BAER KM, 1988, J BIOL CHEM, V263, P17; BENNETT CF, 1987, J BIOL CHEM, V262, P13789; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Carrol SB, 1987, DNA CLONING PRACTICA, V3, P89; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; FEIN A, 1986, TRENDS NEUROSCI, V9, P110, DOI 10.1016/0166-2236(86)90037-8; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; INOUE H, 1988, J BIOCHEM-TOKYO, V103, P91, DOI 10.1093/oxfordjournals.jbchem.a122246; LEE KY, 1987, P NATL ACAD SCI USA, V84, P5540, DOI 10.1073/pnas.84.16.5540; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LENDING CR, 1988, PROTOPLASMA, V143, P51, DOI 10.1007/BF01282959; LOW MG, 1984, BIOCHEM J, V221, P813, DOI 10.1042/bj2210813; MATSUMOTO H, 1987, P NATL ACAD SCI USA, V84, P985, DOI 10.1073/pnas.84.4.985; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; O'DAY P M, 1991, Biophysical Journal, V59, p531A; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PAK WL, 1991, PHOTOCHEM PHOTOBIOL, V53, P871, DOI 10.1111/j.1751-1097.1991.tb09901.x; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; SELINGER Z, 1988, COLD SPRING HARB SYM, V53, P333, DOI 10.1101/SQB.1988.053.01.040; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOYOSHIMA S, 1990, P NATL ACAD SCI USA, V265, P14842; WANG P, 1986, J BIOCHEM-TOKYO, V100, P1015, DOI 10.1093/oxfordjournals.jbchem.a121780; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	40	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24314	24319						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662208				2022-12-25	WOS:A1991GW84500015
J	SLACK, BE; BREU, J; WURTMAN, RJ				SLACK, BE; BREU, J; WURTMAN, RJ			PRODUCTION OF DIACYLGLYCEROL BY EXOGENOUS PHOSPHOLIPASE-C STIMULATES CTP PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE ACTIVITY AND PHOSPHATIDYLCHOLINE SYNTHESIS IN HUMAN NEUROBLASTOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE-HAMSTER OVARY; PROTEIN KINASE-C; MAMMALIAN-CELLS; FATTY-ACIDS; HELA-CELLS; ENDOPLASMIC-RETICULUM; LIPID REQUIREMENTS; II PNEUMOCYTES; RAT-LIVER; BIOSYNTHESIS	The involvement of endogenous diacylglycerol production in the stimulation of phosphatidylcholine synthesis by exogenous phospholipase C was examined using a neuroblastoma (LA-N-2) cell line. Phospholipase C treatment (0.1 unit/ml) of intact cells stimulated CTP:phosphocholine cytidylyltransferase activity significantly more effectively than did maximally effective concentrations of the synthetic diacylglycerol sn-1,2-dioctanoylglycerol (1 mM). When added to cells together with phospholipase C, oleic acid, but not dioctanoylglycerol, further increased cytidylyltransferase activity with respect to phospholipase C treatment alone, indicating that the enzyme was not maximally activated by the lipase. This suggests that the lack of additivity of diacylglycerol and phospholipase C reflects a common mechanism of action. The time course of activation of cytidylyltransferase by phospholipase C paralleled that of [H-3]diacylglycerol production in cells prelabeled for 24 h with [H-3]oleic acid. Diacylglycerol mass was similarly increased. Significant elevations of [H-3]oleic acid and total fatty acids occurred later than did the increases in cytidylyltransferase activity and diacylglycerol levels. No significant reduction in total or [H-3]phosphatidylcholine was elicited by this concentration of phospholipase C, but higher concentrations (0.5 unit/ml) significantly reduced phosphatidylcholine content. The stimulation of cytidylyltransferase activity by phospholipase C or dioctanoylglycerol was also associated with enhanced incorporation of [methyl-C-14]choline into phosphatidylcholine. Dioctanoylglycerol was more effective than phospholipase C at stimulating the formation of [C-14]phosphatidylcholine, and the effects of the two treatments were additive. However, further analysis revealed that dioctanoylglycerol served as a precursor for [C-14]dioctanoylphosphatidylcholine as well as an activator of cytidylyltransferase; and when corrections were made for this effect, the apparent additivity disappeared. The results indicate that the generation of diacylglycerol by exogenous phospholipase C (and possibly the subsequent production of fatty acids via diacylglycerol metabolism) activates cytidylyltransferase activity in neuronal cells under conditions in which membrane phosphatidylcholine content is not measurably reduced.			SLACK, BE (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,BLDG E25-604,CAMBRIDGE,MA 02139, USA.		Slack, Barbara/AAU-9917-2021	Slack, Barbara/0000-0002-7619-410X	NIMH NIH HHS [MH-28783] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH028783, R01MH028783] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AEBERHARD EE, 1985, BIOCHIM BIOPHYS ACTA, V833, P473, DOI 10.1016/0005-2760(85)90105-5; BLUSZTAJN JK, 1989, FEBS LETT, V243, P267, DOI 10.1016/0014-5793(89)80142-5; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHOY PC, 1978, J BIOL CHEM, V253, P5163; CHOY PC, 1979, CAN J BIOCHEM CELL B, V57, P605, DOI 10.1139/o79-076; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; FELDMAN DA, 1985, BIOCHIM BIOPHYS ACTA, V429, P429; JAMIL H, 1990, J BIOL CHEM, V265, P4332; KOLESNICK RN, 1987, J BIOL CHEM, V262, P14525; KOLESNICK RN, 1990, J BIOL CHEM, V265, P10900; LISCOVITCH M, 1987, J BIOL CHEM, V262, P17487; MORAND JN, 1989, J BIOL CHEM, V264, P13785; MUIR JG, 1987, J CELL PHYSIOL, V130, P382, DOI 10.1002/jcp.1041300311; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROSENBERG IL, 1987, BIOCHIM BIOPHYS ACTA, V921, P473, DOI 10.1016/0005-2760(87)90074-9; SANGHERA JS, 1990, BIOCHIM BIOPHYS ACTA, V1042, P380, DOI 10.1016/0005-2760(90)90168-W; SEEGER RC, 1977, CANCER RES, V37, P1364; SLACK BE, 1989, J NEUROCHEM, V53, P472, DOI 10.1111/j.1471-4159.1989.tb07358.x; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; SLEIGHT R, 1983, J BIOL CHEM, V258, P824; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WHITLON DS, 1985, BIOCHIM BIOPHYS ACTA, V835, P369, DOI 10.1016/0005-2760(85)90293-0; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919; YAO ZM, 1990, J BIOL CHEM, V265, P4326	31	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24503	24508						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662212				2022-12-25	WOS:A1991GW84500042
J	ABO, A; PICK, E				ABO, A; PICK, E			PURIFICATION AND CHARACTERIZATION OF A 3RD CYTOSOLIC COMPONENT OF THE SUPEROXIDE-GENERATING NADPH OXIDASE OF MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; CHRONIC GRANULOMATOUS-DISEASE; SODIUM DODECYL-SULFATE; RESPIRATORY BURST OXIDASE; ADENINE-DINUCLEOTIDE PHOSPHATE; HUMAN-NEUTROPHILS; BOVINE NEUTROPHILS; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; GUANINE-NUCLEOTIDES	Activation of the superoxide (O2-)-generating NADPH oxidase of phagocytes in a cell-free system by anionic amphiphiles requires the partcipation of both membrane and cytosolic components. We reported that ammonium sulfate fractionation (Pick, E., Kroizman, T., and Abo, A. (1989) J. Immunol. 143, 4180-4187) and affinity chromatography on 2',5'-ADP-agarose (Shaag, D., and Pick, E. (1990) Biochim. Biophys. Acta 1037, 405-412) permit separation of cytosol in two fractions (sigma-1 and sigma-2) that support O2- production by solubilized membrane synergistically. We now describe the purification of sigma-1 to near homogeneity and demonstrate that it represents a cytosolic component distinct from p47-phox and p67-phox, that are both found in fraction sigma-2. Sigma-1 was absolutely required for the full expression of amphiphile-activated NADPH-oxidase activity. This requirement was evident whether sigma-1 was added to cell-free systems composed of: (a) solubilized membrane and a sigma-2-enriched cytosolic fraction, or (b) purified cytochrome b559, incorporated in liposomes, and purified sigma-2. Sigma-1 was purified by a sequence comprising ammonium sulfate fractionation, hydrophobic chromatography on phenyl-Superose, absorption with CM-Sepharose, anion exchange chromatography on DEAE-Sepharose, and gel filtration on Superose 12. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of sigma-1 of maximal purity, under both reducing and nonreducing conditions, demonstrated the presence of two proteins, of 24 and 22 kDa. On gel filtration, sigma-1 was eluted as a symmetrical peak of 46 kDa that by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis revealed the presence of both 24- and 22-kDa bands. We suggest that, in its native form, sigma-1 might represent a complex of the 24- and 22-kDa proteins. The specific roles of each molecule in NADPH oxidase function remain to be determined.	TEL AVIV UNIV, SACKLER SCH MED, DEPT HUMAN MICROBIOL, IMMUNOPHARMACOL LAB, IL-69978 TEL AVIV, ISRAEL	Tel Aviv University; Sackler Faculty of Medicine	PICK, E (corresponding author), TEL AVIV UNIV, SACKLER SCH MED, DEPT HUMAN MICROBIOL, IMMUNOPHARMACOL LAB, IL-69978 TEL AVIV, ISRAEL.		Pick, Edgar/B-1795-2008	Pick, Edgar/0000-0003-4625-3233				AHARONI I, 1990, J LEUKOCYTE BIOL, V48, P107, DOI 10.1002/jlb.48.2.107; BABIOR BM, 1988, J BIOL CHEM, V263, P1713; BABIOR BM, 1984, BLOOD, V64, P959; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; BOLSCHER BGJM, 1990, J BIOL CHEM, V265, P15782; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CLARK RA, 1987, J BIOL CHEM, V262, P4065; CURNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825, DOI 10.1073/pnas.86.3.825; CURNUTTE JT, 1988, J CLIN INVEST, V81, P606, DOI 10.1172/JCI113360; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DEWALD B, 1979, J CLIN INVEST, V63, P21, DOI 10.1172/JCI109273; DOUSSIERE J, 1990, BIOCHEMISTRY-US, V29, P2225, DOI 10.1021/bi00461a004; FUJITA I, 1987, BIOCHIM BIOPHYS ACTA, V931, P41, DOI 10.1016/0167-4889(87)90048-6; GABIG TG, 1987, J BIOL CHEM, V262, P1685; GABIG TG, 1990, J IMMUNOL, V145, P945; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HARLOW E, 1988, ANTIBODIES LABORATOR, P651; HEYMEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751; ISHIDA K, 1989, FEBS LETT, V243, P169, DOI 10.1016/0014-5793(89)80123-1; IYER S, 1991, FASEB J, V5, pA1558; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LIGETI E, 1988, BIOCHEMISTRY-US, V27, P193, DOI 10.1021/bi00401a029; LIGETI E, 1989, BIOCHEMISTRY-US, V28, P7116, DOI 10.1021/bi00443a050; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PICK E, 1987, J BIOL CHEM, V262, P16476; PICK E, 1989, J IMMUNOL, V143, P4180; PILLOUD MC, 1989, FEBS LETT, V257, P167, DOI 10.1016/0014-5793(89)81812-5; PILLOUDDAGHER MC, 1991, BIOCHEMISTRY-US, V30, P2753, DOI 10.1021/bi00225a003; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SEIFERT R, 1986, FEBS LETT, V205, P161, DOI 10.1016/0014-5793(86)80886-9; SHAAG D, 1990, BIOCHIM BIOPHYS ACTA, V1037, P405, DOI 10.1016/0167-4838(90)90044-G; SHAAG D, 1988, BIOCHIM BIOPHYS ACTA, V952, P213, DOI 10.1016/0167-4838(88)90118-5; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; STASIA MJ, 1989, BIOCHEMISTRY-US, V28, P9659, DOI 10.1021/bi00451a018; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318	49	75	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23577	23585						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660877				2022-12-25	WOS:A1991GV31900012
J	MACCARRONE, M; VELDINK, GA; VLIEGENTHART, JFG				MACCARRONE, M; VELDINK, GA; VLIEGENTHART, JFG			AN INVESTIGATION ON THE QUINOPROTEIN NATURE OF SOME FUNGAL AND PLANT OXIDOREDUCTASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-CYCLING ASSAY; PYRROLOQUINOLINE QUINONE; GALACTOSE-OXIDASE; METHYLAMINE DEHYDROGENASE; SOYBEAN LIPOXYGENASE-1; PQQ; COFACTOR; COENZYME; PROTEINS; LACCASE	The presence of pyrroloquinoline quinone (PQQ) as the organic cofactor of Dactylium dendroides galactose oxidase and lentil (Lens culinaris) seedling amine oxidase, purported PQQ-containing oxidoreductases (Van der Meer, R. A., Jongejan, J. A., and Duine, J. A. (1989) J. Biol. Chem. 264, 7792-7794; Citro, G., Verdina, A., Galati, R., Floris, G., Sabatini, S., and Finazzi-Argo', A. (1989) FEBS Lett. 247, 201-204), was reinvestigated using the nitro blue tetrazolium redoxcycling method (Paz, M. A., Gallop, P. M., Torrelio, B. M., and Fluckiger, R. (1988) Biochem. Biophys. Res. Commun. 154, 1330-1337; Paz, M. A., Fluckiger, R., Boak, A., Kagan, H. M., and Gallop, P. M. (1991) J. Biol. Chem. 266, 689-692) and the enzyme-linked immunosorbent assay with polyclonal antibodies against PQQ. The possible quinoprotein nature of the laccases from Polyporus versicolor and Rhus vernicifera was also investigated because of the similarities in spectroscopic and kinetic features of these enzymes and the laccase from Phlebia radiata, reported to be a PQQ protein (Karhunen, E., Niku-Paavola, M.-L., Viikari, L., Haltia, T., Van der Meer, R. A., and Duine, J. A. (1990) FEBS Lett. 267, 6-8). The presence of a quinonoid cofactor in lentil seedling amine oxidase is confirmed, whereas galactose oxidase and both laccases do not display any quinoprotein nature.	STATE UNIV UTRECHT, DEPT BIOORGAN CHEM, BIJVOET CTR BIOMOLEC RES, 3584 CH UTRECHT, NETHERLANDS	Utrecht University								ABDILLAHI H, 1987, FEMS MICROBIOL LETT, V48, P367, DOI 10.1016/0378-1097(87)90077-2; CITRO G, 1989, FEBS LETT, V247, P201, DOI 10.1016/0014-5793(89)81334-1; CLARK K, 1990, J AM CHEM SOC, V112, P6433, DOI 10.1021/ja00173a061; DEBIASE D, 1991, FEBS LETT, V278, P120; DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0; DOOLEY DM, 1979, J AM CHEM SOC, V101, P5038, DOI 10.1021/ja00511a039; DUINE JA, 1990, TRENDS BIOCHEM SCI, V15, P96, DOI 10.1016/0968-0004(90)90189-I; DUINE JA, 1989, ANNU REV BIOCHEM, V58, P403; DUINE JA, 1990, ANNU REV NUTR, V10, P297, DOI [10.1146/annurev.nutr.10.1.297, 10.1146/annurev.nu.10.070190.001501]; FLORIS G, 1983, PHYTOCHEMISTRY, V22, P1871, DOI 10.1016/0031-9422(83)80004-1; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; Higuchi T., 1992, BIOSYNTHESIS BIODEGR, V46; HOUCK DR, 1988, J AM CHEM SOC, V110, P6920, DOI 10.1021/ja00228a070; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; Jongejan J. A., 1989, PQQ QUINOPROTEINS; KARHUNEN E, 1990, FEBS LETT, V267, P6, DOI 10.1016/0014-5793(90)80273-L; KAWAI S, 1988, FEBS LETT, V236, P309, DOI 10.1016/0014-5793(88)80043-7; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBLANC GA, 1987, ANAL BIOCHEM, V161, P172, DOI 10.1016/0003-2697(87)90668-3; MALKIN R, 1969, EUR J BIOCHEM, V7, P253, DOI 10.1111/j.1432-1033.1969.tb19600.x; MCINTIRE WS, 1986, BIOCHEM BIOPH RES CO, V141, P562, DOI 10.1016/S0006-291X(86)80210-8; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; MICHAUDSORET I, 1990, BIOCHEM BIOPH RES CO, V172, P1122, DOI 10.1016/0006-291X(90)91563-8; MONDOVI B, 1987, LIFE CHEM REPORTS, V5, P187; NOBUTOSHI I, 1991, NATURE, V350, P87; PAZ MA, 1990, FEBS LETT, V264, P283, DOI 10.1016/0014-5793(90)80268-N; PAZ MA, 1988, BIOCHEM BIOPH RES CO, V154, P1330, DOI 10.1016/0006-291X(88)90285-9; PAZ MA, 1991, J BIOL CHEM, V266, P689; ROBERTSON JG, 1989, J BIOL CHEM, V264, P19916; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRESSEL PS, 1982, METHOD ENZYMOL, V89, P163; van Kleef M A, 1988, Biofactors, V1, P297; VANDERMEER RA, 1990, FEBS LETT, V261, P131, DOI 10.1016/0014-5793(90)80653-Z; VANDERMEER RA, 1990, FEBS LETT, V264, P284, DOI 10.1016/0014-5793(90)80269-O; VANDERMEER RA, 1989, J BIOL CHEM, V264, P7792; VANDERMEER RA, 1988, FEBS LETT, V235, P194, DOI 10.1016/0014-5793(88)81261-4; VANKLEEF MAG, 1988, FEBS LETT, V237, P91, DOI 10.1016/0014-5793(88)80178-9; Vanngard T., 1972, BIOL APPLICATIONS EL, P411; VELDINK GA, 1990, FEBS LETT, V270, P135, DOI 10.1016/0014-5793(90)81252-J; VELLIEUX FMD, 1989, EMBO J, V8, P2171, DOI 10.1002/j.1460-2075.1989.tb08339.x; VERNOOYGERRITSEN M, 1982, BIOCHIM BIOPHYS ACTA, V708, P330, DOI 10.1016/0167-4838(82)90445-9	43	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21014	21017						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657943				2022-12-25	WOS:A1991GN00100068
J	LOW, SH; WONG, SH; TANG, BL; HONG, W				LOW, SH; WONG, SH; TANG, BL; HONG, W			INVOLVEMENT OF BOTH VECTORIAL AND TRANSCYTOTIC PATHWAYS IN THE PREFERENTIAL APICAL CELL-SURFACE LOCALIZATION OF RAT DIPEPTIDYL PEPTIDASE-IV IN TRANSFECTED LLC-PK1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEINS; CANINE KIDNEY-CELLS; GLUTAMYL-TRANSFERASE TRANSPEPTIDASE; EPITHELIAL-CELLS; AMINOPEPTIDASE-N; BRUSH-BORDER; BASOLATERAL MEMBRANE; VIRAL GLYCOPROTEINS; BILE CANALICULUS; BIOGENESIS	Dipeptidyl peptidase IV (DPPIV) is a membrane glycoprotein with type II orientation. It is predominantly localized to the apical surface in epithelial cells. Previous studies (Bantles, J. P., Feracci, H. M., Shinger, B., and Hubbard, A. L. (1987) J. Cell Biol. 105, 1241-1251) using cellular fractionation and immunoprecipitation in rat liver suggest that DPPIV is targeted to the apical surface by an indirect pathway through transient appearance in the basolateral surface followed by specific transcytosis to the apical domain. In transfected Madin-Darby canine kidney (MDCK) cells using domain-selective biotinylation and streptavidin absorption, it was, however, shown that DPPIV is directly sorted to the apical surface (Low, S. H., Wong, S. H., Tang, B. L. Subramaniam, V. N., and Hong, W. (1991) J. Biol. Chem, 266,13391-13396). These studies suggest that the sorting pathway for DPPIV may be cell type-specific, but it cannot be ruled out that the observed difference in the DPPIV sorting pathway may be due to different methods employed for dissecting the sorting pathway. In this study, we have expressed rat DPPIV, using an expression system driven by the Rous sarcoma virus enhancer and the SV40 early promoter region, in another epithelial cell line, LLC-PK1. As in MDCK cells, DPPIV is preferentially (about 90%) localized to the apical surface. Employing identical methods used previously in MDCK cells, it was found that both direct and transcytotic pathways are involved in the apical surface localization of DPPIV in this epithelial cell type. These observations clearly illustrate that the sorting pathway of rat DPPIV is cell type-specific.	NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,MEMBRANE BIOL LAB,10 KENT RIDGE CRESCENT,SINGAPORE 0511,SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore			Tang, Bor Luen/E-4548-2012	Tang, Bor Luen/0000-0002-1925-636X				AHNEN DJ, 1982, J BIOL CHEM, V257, P2129; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; DANIELS PU, 1989, FEBS LETT, V244, P57, DOI 10.1016/0014-5793(89)81161-5; DENIELSEN EM, 1985, EUR J BIOCHEM, V152, P493; GORVEL JP, 1989, J CELL BIOL, V108, P2193, DOI 10.1083/jcb.108.6.2193; GOTTLIEB TA, 1986, J CELL BIOL, V102, P1242, DOI 10.1083/jcb.102.4.1242; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HANSEN GH, 1987, EUR J CELL BIOL, V43, P253; HONG WJ, 1989, EXP CELL RES, V182, P256, DOI 10.1016/0014-4827(89)90296-6; HONG WJ, 1988, J BIOL CHEM, V263, P16892; HONG WJ, 1990, J CELL BIOL, V111, P323, DOI 10.1083/jcb.111.2.323; HONG WJ, 1989, BIOCHEMISTRY-US, V28, P8474, DOI 10.1021/bi00447a030; HONG WJ, 1987, P NATL ACAD SCI USA, V84, P7962, DOI 10.1073/pnas.84.22.7962; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; KENNY AJ, 1976, BIOCHEM J, V155, P169; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; LOW SH, 1991, J BIOL CHEM, V266, P13391; MASSEY D, 1987, J MEMBRANE BIOL, V96, P19, DOI 10.1007/BF01869331; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATLIN KS, 1986, J CELL BIOL, V103, P2565, DOI 10.1083/jcb.103.6.2565; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MENDRICK DL, 1988, KIDNEY INT, V33, P831, DOI 10.1038/ki.1988.74; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MULLIN JM, 1986, AM J PHYSIOL, V251, pC597, DOI 10.1152/ajpcell.1986.251.4.C597; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; OTAGA S, 1989, J BIOL CHEM, V264, P3596; PETELL JK, 1987, J BIOL CHEM, V262, P14753; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; PUDDINGTON L, 1987, P NATL ACAD SCI USA, V84, P2756; RABITO CA, 1984, J BIOL CHEM, V259, P574; RINDLER MJ, 1985, J CELL BIOL, V100, P136, DOI 10.1083/jcb.100.1.136; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROTH MG, 1989, ANNU REV PHYSIOL, V51, P797; Sambrook J, 1989, MOL CLONING LABORATO; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; WESSELS HP, 1989, J BIOL CHEM, V264, P17; WESSELS HP, 1990, J CELL BIOL, V111, P2923, DOI 10.1083/jcb.111.6.2923; YONEYAMA Y, 1984, J CELL PHYSIOL, V121, P64, DOI 10.1002/jcp.1041210109	48	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19710	19716						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1680866				2022-12-25	WOS:A1991GK66700084
J	DOONAN, JH; MACKINTOSH, C; OSMANI, S; COHEN, P; BAI, G; LEE, EYC; MORRIS, NR				DOONAN, JH; MACKINTOSH, C; OSMANI, S; COHEN, P; BAI, G; LEE, EYC; MORRIS, NR			A CDNA-ENCODING RABBIT MUSCLE PROTEIN PHOSPHATASE 1-ALPHA COMPLEMENTS THE ASPERGILLUS CELL-CYCLE MUTATION, BIMG11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE SPECIFICITIES; CATALYTIC SUBUNIT; MAMMALIAN-TISSUES; OKADAIC ACID; NIDULANS; GENE; TYPE-1; IDENTIFICATION; YEAST; MITOSIS	The bimG11 allele causes a conditional growth defect in the fungus Aspergillus nidulans preventing both progression through mitosis and normal polar growth. Previously, we have shown that the bimG11 mutation increases the phosphorylation of nuclear proteins and that the gene encodes a protein similar to mammalian type 1 protein phosphatase. Assay of protein phosphatase activity in protein extracts of Aspergillus demonstrates directly that type 1 phosphatase activity is greatly reduced in the mutant at restrictive temperature. Expression of a muscle type 1 protein phosphatase fully complements all aspects of the bimG11 phenotype, and restores the level of PP1 activity to nearly normal. Expression of the related phosphatase, PP2A, does not complement the bimG11 mutation, showing that complementation can only be achieved by the type 1 gene. This clearly demonstrates that the phenotype of bimG11 is due to reduced PP1 activity and that the PP1 catalytic subunit is functionally conserved over a wide span of evolution.	UNIV DUNDEE,INST MED SCI,DEPT BIOCHEM,MRC,PRUT PHOSPHORYLAT UNIT,DUNDEE DD1 4HN,SCOTLAND; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,PISCATAWAY,NJ 08854; UNIV MIAMI,SCH MED,DEPT BIOCHEM & MOLEC BIOL,MIAMI,FL 33101; TEXAS MED CTR,BAYLOR SCH MED,DEPT CELL BIOL,HOUSTON,TX 77054	University of Dundee; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Miami; Baylor College of Medicine	DOONAN, JH (corresponding author), JOHN INNES INST,DEPT CELL BIOL,COLNEY LANE,NORWICH NR4 7UH,NORFOLK,ENGLAND.		Osmani, Stephen A./AAS-3904-2021; MacKintosh, Carol/B-8210-2011	MacKintosh, Carol/0000-0001-9166-589X; doonan, john/0000-0001-6027-1919	NIDDK NIH HHS [DK18512] Funding Source: Medline; NIGMS NIH HHS [GM34711] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034711] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLAKHA RC, 1982, J CELL SCI, V54, P193; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; BAI GE, 1988, FASEB J, V2, P3010, DOI 10.1096/fasebj.2.14.2846396; BOOHER R, 1989, CELL, V57, P1009, DOI 10.1016/0092-8674(89)90339-5; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, FEBS LETT, V250, P601, DOI 10.1016/0014-5793(89)80804-X; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COHEN P, 1988, METHOD ENZYMOL, V159, P390; COHEN P, 1988, METHOD ENZYMOL, V159, P421; COHEN PTW, 1988, FEBS LETT, V232, P17, DOI 10.1016/0014-5793(88)80378-8; CYERT MS, 1989, CELL, V57, P891, DOI 10.1016/0092-8674(89)90325-5; DOMBRADI V, 1990, FEBS LETT, V275, P39, DOI 10.1016/0014-5793(90)81434-P; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; ENGLE DB, 1988, CELL MOTIL CYTOSKEL, V10, P432, DOI 10.1002/cm.970100310; ENGLE DB, 1990, J BIOL CHEM, V265, P16132; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; FELIX MA, 1990, EMBO J, V9, P675, DOI 10.1002/j.1460-2075.1990.tb08159.x; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINTOSH C, 1989, BIOCHEM J, V262, P335, DOI 10.1042/bj2620335; Maniatis T., 1982, MOL CLONING; MAY GS, 1985, J CELL BIOL, V101, P712, DOI 10.1083/jcb.101.3.712; MORRIS NR, 1976, GENET RES, V26, P327; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PATEMAN JA, 1983, PROC R SOC SER B-BIO, V217, P243, DOI 10.1098/rspb.1983.0009; PONDAVEN P, 1987, EUR J BIOCHEM, V167, P135, DOI 10.1111/j.1432-1033.1987.tb13314.x; ROBINOW CF, 1969, J CELL SCI, V5, P403; SILVA OBD, 1987, FEBS LETT, V221, P415, DOI 10.1016/0014-5793(87)80966-3; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; STEWART AA, 1981, EUR J BIOCHEM, V115, P197; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8	37	46	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18889	18894						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655766				2022-12-25	WOS:A1991GJ47200075
J	MACDONALD, PN; HAUSSLER, CA; TERPENING, CM; GALLIGAN, MA; REEDER, MC; WHITFIELD, GK; HAUSSLER, MR				MACDONALD, PN; HAUSSLER, CA; TERPENING, CM; GALLIGAN, MA; REEDER, MC; WHITFIELD, GK; HAUSSLER, MR			BACULOVIRUS-MEDIATED EXPRESSION OF THE HUMAN VITAMIN-D RECEPTOR - FUNCTIONAL-CHARACTERIZATION, VITAMIN-D RESPONSE ELEMENT INTERACTIONS, AND EVIDENCE FOR A RECEPTOR AUXILIARY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; CHICKEN INTESTINAL RECEPTOR; HUMAN OSTEOCALCIN GENE; ESTROGEN-RECEPTOR; DNA-BINDING; GLUCOCORTICOID RECEPTOR; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; MONOCLONAL-ANTIBODIES; PROGESTERONE-RECEPTOR; AMINO-ACIDS	A baculovirus expression vector system (BEVS) was used to overproduce the full-length human vitamin D receptor (hVDR) in Spodoptera frugiperda ovarian cells. hVDR was expressed to a level of 0.5% of the total soluble protein in this system. Western analysis demonstrated that the baculovirus-generated protein had electrophoretic and immunologic properties equivalent to those of hVDR expressed in mammalian cells. The BEVS-derived receptor displayed specificity and high affinity (apparent K(d) = 0.7 nM) for the 1,25(OH)2D3 ligand. Recombinant hVDR generated a specific protein-DNA complex with a duplex oligomer containing a vitamin D-responsive element (VDRE) in gel mobility shift assays. The intensity of the VDR.VDRE complex was not affected by 1,25(OH)2D3. However, the complex exhibited increased mobility in the presence of hormone, possibly the result of a 1,25(OH)2D3-dependent conformational change. A nuclear extract obtained from CV-1 cells markedly enhanced the intensity of this VDR.VDRE complex and produced an additional distinct VDR-dependent complex, thus implicating a role for nuclear auxiliary factors in multiple high affinity VDR.VDRE interactions. Finally, methylation interference studies defined the guanine residues contacted when the putative VDR-auxiliary factor complex associates with the rat osteocalcin VDRE; specifically, all of the GC base pairs in the sequence GGGTGAATGAGGACA. Therefore, these results show that the BEV system elicits high level expression of hVDR with critical functional characteristics being preserved.			MACDONALD, PN (corresponding author), UNIV ARIZONA,COLL MED,DEPT BIOCHEM,TUCSON,AZ 85724, USA.			Haussler, Carol/0000-0001-8360-3066; Haussler, Mark/0000-0002-7097-1801	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR015781, R01AR015781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033351, R37DK033351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM013846] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-15781] Funding Source: Medline; NIDDK NIH HHS [DK-33351] Funding Source: Medline; NIGMS NIH HHS [1-F32-GM13846-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEGRETTO EA, 1985, J BIOL CHEM, V260, P139; ALLEGRETTO EA, 1987, J BIOL CHEM, V262, P1312; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; BAILLY A, 1986, EMBO J, V5, P3235, DOI 10.1002/j.1460-2075.1986.tb04634.x; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BEEBE JS, 1991, MOL ENDOCRINOL, V5, P85, DOI 10.1210/mend-5-1-85; BERG JM, 1990, J BIOL CHEM, V265, P6513; BROWN M, 1990, J BIOL CHEM, V265, P11238; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; COLSTON K, 1980, ENDOCRINOLOGY, V107, P1916, DOI 10.1210/endo-107-6-1916; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DOKOH S, 1981, ANAL BIOCHEM, V116, P211, DOI 10.1016/0003-2697(81)90346-8; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; GLASS CK, 1990, CELL, V63, P729, DOI 10.1016/0092-8674(90)90139-6; HAUSSLER MR, 1977, NEW ENGL J MED, V297, P974, DOI 10.1056/NEJM197711032971804; HAUSSLER MR, 1986, ANNU REV NUTR, V6, P527, DOI 10.1146/annurev.nu.06.070186.002523; HAUSSLER MR, 1982, DISORDERS MINERAL ME, V2, P359; HENDRICKSON W, 1985, P NATL ACAD SCI USA, V82, P3129, DOI 10.1073/pnas.82.10.3129; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LIAO J, 1990, P NATL ACAD SCI USA, V87, P9751, DOI 10.1073/pnas.87.24.9751; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MANGELSDORF DJ, 1987, P NATL ACAD SCI USA, V84, P354, DOI 10.1073/pnas.84.2.354; MANN SG, 1989, J GEN VIROL, V70, P3501, DOI 10.1099/0022-1317-70-12-3501; MARKOSE ER, 1990, P NATL ACAD SCI USA, V87, P1701, DOI 10.1073/pnas.87.5.1701; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; MARZLUFF WF, 1990, METHOD ENZYMOL, V181, P30; MCDONNELL DP, 1987, SCIENCE, V235, P1214, DOI 10.1126/science.3029866; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; MURDOCH FE, 1990, BIOCHEMISTRY-US, V29, P8377, DOI 10.1021/bi00488a026; OZONO K, 1990, J BIOL CHEM, V265, P21881; PEN J, 1989, NUCLEIC ACIDS RES, V17, P451, DOI 10.1093/nar/17.1.451; PIKE JW, 1982, P NATL ACAD SCI-BIOL, V79, P7719, DOI 10.1073/pnas.79.24.7719; PIKE JW, 1983, J BIOL CHEM, V258, P1289; PIKE JW, 1987, J BIOL CHEM, V262, P1305; RODRIGUEZ R, 1989, MOL ENDOCRINOL, V3, P356, DOI 10.1210/mend-3-2-356; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SABBAH M, 1991, P NATL ACAD SCI USA, V88, P390, DOI 10.1073/pnas.88.2.390; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SIMPSON RU, 1982, P NATL ACAD SCI-BIOL, V79, P16, DOI 10.1073/pnas.79.1.16; SONE T, 1990, J BIOL CHEM, V265, P21997; SRINIVASAN G, 1990, MOL ENDOCRINOL, V4, P209, DOI 10.1210/mend-4-2-209; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Summers MD, 1987, MANUAL METHODS BACUL; TERPENING CM, 1991, MOL ENDOCRINOL, V5, P373, DOI 10.1210/mend-5-3-373; TERPENING CM, 1990, BIOCHEM BIOPH RES CO, V173, P1129, DOI 10.1016/S0006-291X(05)80903-9; TSAI SY, 1987, CELL, V50, P701, DOI 10.1016/0092-8674(87)90328-X; WECKSLER WR, 1979, J CLIN ENDOCR METAB, V48, P715, DOI 10.1210/jcem-48-4-715	59	118	120	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18808	18813						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655763				2022-12-25	WOS:A1991GJ47200063
J	KOMIYAMA, T; BIGLER, TL; YOSHIDA, N; NODA, K; LASKOWSKI, M				KOMIYAMA, T; BIGLER, TL; YOSHIDA, N; NODA, K; LASKOWSKI, M			REPLACEMENT OF P1 LEU18 BY GLU18 IN THE REACTIVE SITE OF TURKEY OVOMUCOID 3RD DOMAIN CONVERTS IT INTO A STRONG INHIBITOR OF GLU-SPECIFIC STREPTOMYCES-GRISEUS PROTEINASE (GLUSGP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DERMASTERIAS-IMBRICATA TRYPSIN-1; SERINE PROTEINASES; PEPTIDE-BOND; THERMODYNAMICS; KINETICS; BINDING; ENZYME	Turkey ovomucoid third domain with P1 Leu18 at its reactive site is an excellent inhibitor of chymotrypsin and elastase and of many other serine proteinases with related specificities. Semisynthetic replacement of P1 Leu18 by Lys18 causes the expected change into a trypsin inhibitor. Strikingly, semisynthetic replacement P1 Leu18 to Glu18 changes turkey ovomucoid third domain into a powerful inhibitor of Glu-specific Streptomyces griseus proteinase, GluSGP. Of the 131 natural avian ovomucoid third domains we have sequenced none have P1 Glu18, but several avian ovomucoid first domains have P1 Glu24. They are weak to moderate inhibitors of GluSGP.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA; KYUSHU UNIV, DEPT CHEM, FUKUOKA 812, JAPAN; FUKUOKA WOMENS UNIV, DEPT HUMAN LIFE SCI, FUKUOKA 813, JAPAN	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kyushu University					NIGMS NIH HHS [GM 10831] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARDELT W, 1985, BIOCHEMISTRY-US, V24, P5313, DOI 10.1021/bi00341a007; BECKMANN J, 1989, J PROTEIN CHEM, V8, P101, DOI 10.1007/BF01025082; BODE W, 1984, EUR J BIOCHEM, V144, P185, DOI 10.1111/j.1432-1033.1984.tb08447.x; CAUGHEY GH, 1990, BIOCHEMISTRY-US, V29, P5166, DOI 10.1021/bi00473a024; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P124, DOI 10.1021/bi00542a019; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; GRAF L, 1987, BIOCHEMISTRY-US, V26, P2616, DOI 10.1021/bi00383a031; GREEN NM, 1953, BIOCHEM J, V54, P347, DOI 10.1042/bj0540347; HALL PK, 1981, BIOCHEM BIOPH RES CO, V100, P8, DOI 10.1016/S0006-291X(81)80055-1; Hutcgens T. W., 1989, PROTEIN RECOGNITION, P149; HWANG JK, 1988, NATURE, V334, P270, DOI 10.1038/334270a0; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; KATO I, 1978, P FEBS M, V47, P197; KOWALSKI D, 1974, BAYER S, V5, P311; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI M, 1987, BIOCHEMISTRY-US, V26, P202, DOI 10.1021/bi00375a028; LASKOWSKI M, 1990, J PROTEIN CHEM, V9, P715, DOI 10.1007/BF01024766; LASKOWSKI M, 1986, NUTRITIONAL TOXICOLO, P1; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; WIECZOREK M, 1987, BIOCHEM BIOPH RES CO, V144, P499, DOI 10.1016/S0006-291X(87)80537-5; WIECZOREK M, 1983, BIOCHEMISTRY-US, V22, P2630, DOI 10.1021/bi00280a006; YOSHIDA N, 1988, J BIOCHEM, V104, P451, DOI 10.1093/oxfordjournals.jbchem.a122488; YUNG BY, 1975, BIOCHEM BIOPH RES CO, V65, P927, DOI 10.1016/S0006-291X(75)80474-8; [No title captured]; [No title captured]; [No title captured]	29	24	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					10727	10730						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1674942				2022-12-25	WOS:A1991FQ77400005
J	SHAINOFF, JR; URBANIC, DA; DIBELLO, PM				SHAINOFF, JR; URBANIC, DA; DIBELLO, PM			IMMUNOELECTROPHORETIC CHARACTERIZATIONS OF THE CROSS-LINKING OF FIBRINOGEN AND FIBRIN BY FACTOR-XIIIA AND TISSUE TRANSGLUTAMINASE - IDENTIFICATION OF A RAPID MODE OF HYBRID ALPHA-CHAIN GAMMA-CHAIN CROSS-LINKING THAT IS PROMOTED BY THE GAMMA-CHAIN CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; IMMUNOCHEMICAL CHARACTERIZATION; MONOCLONAL-ANTIBODIES; STABILIZING FACTOR; CROSSLINKING; SITES; FIBRONECTIN; COAGULATION; SEQUENCE; DOMAINS	Cross-linking of human fibrin by fibrin stabilizing factor (factor XIIIa) and tissue transglutaminase (ti-TG) was examined by immunoprobing electrophoregrams for positive identification of the cross-linked chains. The immunoprobing was carried out by a new, direct staining technique employing composite gels of a porous protein immobilizing matrix (glyoxyl agarose) blended with a removable polyacrylamide filler that eliminates need for Western blotting. We find that the known rapid cross-linking of gamma-chains into gamma-2-dyads by XIIIa is accompanied by co-cross-linking of the gamma-2-dyads with alpha-chains to form hybrid alpha-gamma-2-triads. Little or no cross-linking of relatively abundant alpha- and gamma-chain monads into hybrid alpha-gamma-dyads accompanies formation of the alpha-gamma-2-triads. Thus, formation of the gamma-2-dyads accelerates the hybrid cross-linking. This acceleration is viewed as demonstrating a previously unknown mode of cooperative interaction between alpha- and gamma-chains arising from cross-linking of the D-domains of the molecules. This strengthened interaction is not critically dependent on fibrinopeptide-release, because alpha-gamma-2-triads are similarly formed when fibrinogen is cross-linked by XIIIa. Also observed in the study with XIIIa was the formation of small amounts of homologous gamma-3 and gamma-4 oligomers which had been predicted by others to contribute to branching of fibrin strands. Unlike XIIIa, ti-TG acts preferentially on alpha-chains rather than gamma-chains as known. An alpha-gamma-dyad, not seen in reactions with XIIIa, is produced concurrent with the homologous alpha-chain cross-linking. Also, three different species of alpha-2-dyads were produced by ti-TG, two of which were not seen in reactions with XIIIa. The differences in product formation revealed by the specific staining are viewed as providing criteria for distinguishing products of XIIIa and ti-TG in biologic specimens.			SHAINOFF, JR (corresponding author), CLEVELAND CLIN FDN,RES INST FF-4,9500 EUCLID AVE,CLEVELAND,OH 44195, USA.				NHLBI NIH HHS [HL-16361] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016361] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNETHEY JL, 1982, THESIS U DURHAMM; ACHYUTHAN KE, 1988, J BIOL CHEM, V263, P14296; AVRAMEAS S, 1978, SCAND J IMMUNOL   S7, V8, P7; BINI A, 1987, BLOOD, V69, P1038; BLOMBACK B, 1968, NATURE, V218, P130, DOI 10.1038/218130a0; BOORSMA DM, 1983, IMMUNOHISTOCHEMISTRY, P87; CHUNG SI, 1972, ANN NY ACAD SCI, V202, P240, DOI 10.1111/j.1749-6632.1972.tb16338.x; COLL JM, 1987, J IMMUNOL METHODS, V104, P259, DOI 10.1016/0022-1759(87)90513-8; CONNELLAN JM, 1971, J BIOL CHEM, V246, P1093; CORCORAN DH, 1980, THROMB RES, V19, P883, DOI 10.1016/0049-3848(80)90016-X; COTTRELL BA, 1979, BIOCHEMISTRY-US, V18, P5405, DOI 10.1021/bi00591a023; DARDIK BN, 1979, THROMB HAEMOSTASIS, V42, P864; DOOLITTLE RF, 1971, BIOCHEM BIOPH RES CO, V44, P94, DOI 10.1016/S0006-291X(71)80163-8; DVORAK HF, 1985, SCIENCE, V227, P1059, DOI 10.1126/science.3975602; EHRLICH PH, 1983, BIOCHEMISTRY-US, V22, P4184, DOI 10.1021/bi00287a004; FINLAYSON JS, 1963, BIOCHEMISTRY-US, V2, P42, DOI 10.1021/bi00901a010; FRETTO LJ, 1978, J BIOL CHEM, V253, P6614; GIVOL D, 1969, BIOCHEM J, V115, P371, DOI 10.1042/bj1150371; GREENBERG CS, 1987, BLOOD, V70, P702; GRON B, 1990, THROMB RES, V57, P259, DOI 10.1016/0049-3848(90)90325-7; HENSCHEN A, 1972, BIOCHIM BIOPHYS ACTA, V263, P351, DOI 10.1016/0005-2795(72)90088-8; JOVIN TM, 1970, PB259312; KANAIDE H, 1975, J LAB CLIN MED, V85, P574; LAKI K, 1972, ANN NY ACAD SCI, V202, P235, DOI 10.1111/j.1749-6632.1972.tb16337.x; LIN W, 1983, ANAL BIOCHEM, V128, P302, DOI 10.1016/0003-2697(83)90379-2; LOEWY AG, 1961, J BIOL CHEM, V236, P2625; LORAND JB, 1966, BIOCHEM BIOPH RES CO, V23, P828, DOI 10.1016/0006-291X(66)90562-6; LORAND L, 1969, BIOCHEM BIOPH RES CO, V37, P219, DOI 10.1016/0006-291X(69)90722-0; LORAND L, 1962, NATURE, V194, P1148, DOI 10.1038/1941148a0; LORAND L, 1964, ARCH BIOCHEM BIOPHYS, V105, P58, DOI 10.1016/0003-9861(64)90235-8; LOTTSPEICH F, 1977, H-S Z PHYSIOL CHEM, V358, P703; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; MCKEE PA, 1972, ANN NY ACAD SCI, V202, P127, DOI 10.1111/j.1749-6632.1972.tb16326.x; MEGA JI, 1988, FIBRINOGEN, V3, P83; MOSESSON MW, 1989, P NATL ACAD SCI USA, V86, P1113, DOI 10.1073/pnas.86.4.1113; OCONNELL PBH, 1976, ANAL BIOCHEM, V76, P63, DOI 10.1016/0003-2697(76)90264-5; OLEXA SA, 1980, P NATL ACAD SCI-BIOL, V77, P1374, DOI 10.1073/pnas.77.3.1374; PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892; PRENTICE CRM, 1970, BRIT J HAEMATOL, V13, P898; SELMAYR E, 1988, BIOPOLYMERS, V27, P1733, DOI 10.1002/bip.360271104; SELMAYR E, 1989, THROMB RES, V39, P459; Shainoff J R, 1990, Blood Coagul Fibrinolysis, V1, P479, DOI 10.1097/00001721-199010000-00021; SHAINOFF J R, 1986, Biotechniques, V4, P120; SHAINOFF JR, 1980, BIOCHEM BIOPH RES CO, V95, P690, DOI 10.1016/0006-291X(80)90840-2; SHAINOFF JR, 1972, ATHEROSCLEROSIS, V16, P287, DOI 10.1016/0021-9150(72)90079-2; SOBEL JH, 1988, THROMB HAEMOSTASIS, V60, P153; SOBEL JH, 1983, BIOCHEMISTRY-US, V22, P4175, DOI 10.1021/bi00287a003; SOBEL JH, 1988, THROMB HAEMOSTASIS, V60, P160; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; VAIDYA HC, 1985, HYBRIDOMA, V4, P271, DOI 10.1089/hyb.1985.4.271; VALENZUELA R, 1988, FIBRINOGEN, V3, P313; WEISEL JW, 1987, THROMB RES, V47, P155, DOI 10.1016/0049-3848(87)90372-0; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058	53	74	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6429	6437						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1672529				2022-12-25	WOS:A1991FE37300065
J	BODARY, SC; MCLEAN, JW				BODARY, SC; MCLEAN, JW			THE INTEGRIN BETA-1 SUBUNIT ASSOCIATES WITH THE VITRONECTIN RECEPTOR ALPHA-V SUBUNIT TO FORM A NOVEL VITRONECTIN RECEPTOR IN A HUMAN EMBRYONIC KIDNEY-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									GENENTECH INC,DEPT CARDIOVASC RES,SAN FRANCISCO,CA 94080	Roche Holding; Genentech	BODARY, SC (corresponding author), GENENTECH INC,DEPT BIOL CHEM,SAN FRANCISCO,CA 94080, USA.							BODARY SC, 1989, J BIOL CHEM, V264, P18859; BROWN DL, 1989, J CLIN INVEST, V84, P366, DOI 10.1172/JCI114166; CHERESH DA, 1987, J BIOL CHEM, V262, P1434; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; CHERESH DA, 1989, CELL, V57, P56; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; GINSBERG MH, 1988, THROMB HAEMOSTASIS, V59, P1; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; NEWMAN PJ, 1985, BLOOD, V65, P227; PHILLIPS DR, 1988, BLOOD, V71, P831; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RICCA GA, 1981, J BIOL CHEM, V256, P362; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SONNENBERG A, 1988, J BIOL CHEM, V263, P14030; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877	28	254	258	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					5938	5941						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690718				2022-12-25	WOS:A1990CY58700006
J	LABBE, D; LANG, BF; DESJARDINS, P; MORAIS, R				LABBE, D; LANG, BF; DESJARDINS, P; MORAIS, R			HISTIDINE TRANSFER-RNA FROM CHICKEN MITOCHONDRIA HAS AN UNCODED 5'-TERMINAL GUANYLATE RESIDUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MONTREAL,DEPT BIOCHIM,CP 6128,SUCCURSALE A,MONTREAL H3C 3J7,QUEBEC,CANADA	Universite de Montreal								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ATTARDI G, 1982, MITOCHONDRIAL GENES, P51; BELTZER JP, 1986, J BIOL CHEM, V261, P5160; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; BURKARD U, 1988, J BIOL CHEM, V263, P9578; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; CHANG DD, 1987, BIOCHIM BIOPHYS ACTA, V909, P85, DOI 10.1016/0167-4781(87)90029-7; CHEN JY, 1988, J BIOL CHEM, V263, P13677; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; GLAUS KR, 1980, ORG EXPRESSION MITOC, V2, P131; GRAY MW, 1989, P NATL ACAD SCI USA, V86, P2267, DOI 10.1073/pnas.86.7.2267; HOPPER AK, 1982, CELL, V28, P543, DOI 10.1016/0092-8674(82)90209-4; KEITH G, 1986, BIOCHEM BIOPH RES CO, V138, P1405, DOI 10.1016/S0006-291X(86)80439-9; LEVENS D, 1981, J BIOL CHEM, V256, P5226; MANAM S, 1987, J BIOL CHEM, V262, P10272; NAGLEY P, 1980, NUCLEIC ACIDS RES, V8, P2947, DOI 10.1093/nar/8.13.2947; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; Randerath K, 1962, ANGEW CHEM INT EDIT, V1, P435; ROE BA, 1985, J BIOL CHEM, V260, P9759; ROSA MD, 1983, NUCLEIC ACIDS RES, V11, P853, DOI 10.1093/nar/11.3.853; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9	30	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1990	265	5					2988	2992						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM848	1689297				2022-12-25	WOS:A1990CM84800090
J	HERRING, BP; STULL, JT; GALLAGHER, PJ				HERRING, BP; STULL, JT; GALLAGHER, PJ			DOMAIN CHARACTERIZATION OF RABBIT SKELETAL-MUSCLE MYOSIN LIGHT CHAIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SW MED CTR,MOSS HEART CTR,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	HERRING, BP (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235, USA.				NHLBI NIH HHS [HL06296, R01 HL026043-20, R01 HL026043, P01 HL006296] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL006296, R01HL026043] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; EDELMAN AM, 1985, J BIOL CHEM, V260, P1275; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HERRING BP, 1989, AM J PHYSIOL, V256, pC399, DOI 10.1152/ajpcell.1989.256.2.C399; ILARIA R, 1985, J NEUROSCI METH, V15, P165, DOI 10.1016/0165-0270(85)90053-6; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KENNELLY PJ, 1987, J BIOL CHEM, V262, P11958; Maniatis T., 1982, MOL CLONING; MCPHAUL MJ, 1988, J BIOL CHEM, V263, P16358; MEYER GW, 1983, FEBS LETT, V157, P225; MOORE RL, 1984, AM J PHYSIOL, V247, pC462, DOI 10.1152/ajpcell.1984.247.5.C462; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; NUNNALLY MH, 1985, J BIOL CHEM, V260, P1020; NUNNALLY MH, 1987, J BIOL CHEM, V262, P3833; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; ROUSH CL, 1988, J BIOL CHEM, V263, P10510; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHUBEITA HE, 1987, P NATL ACAD SCI USA, V84, P5645, DOI 10.1073/pnas.84.16.5645; STULL JT, 1986, ENZYMES, V17, P113; TAKIO K, 1986, BIOCHEMISTRY-US, V25, P8049, DOI 10.1021/bi00372a038; TAKIO K, 1985, BIOCHEMISTRY-US, V24, P6028, DOI 10.1021/bi00343a002; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	28	54	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1990	265	3					1724	1730						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ676	1688558				2022-12-25	WOS:A1990CJ67600076
J	DUGGAN, MJ; POLLARD, S; STEPHENSON, FA				DUGGAN, MJ; POLLARD, S; STEPHENSON, FA			IMMUNOAFFINITY PURIFICATION OF GABA-A RECEPTOR ALPHA-SUBUNIT ISO-OLIGOMERS - DEMONSTRATION OF RECEPTOR POPULATIONS CONTAINING ALPHA-1-ALPHA-2, ALPHA-1-ALPHA-3, AND ALPHA-2-ALPHA-3 SUBUNIT PAIRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACIDA-RECEPTOR; RAT-BRAIN; CEREBRAL-CORTEX; A RECEPTORS; SEQUENCE; IDENTIFICATION; ANTIBODIES; CHANNEL; SITE	Novel methods for the isolation of gamma-aminobutyric acid(A) (GABA(A)) receptor alpha-subunit iso-oligomers have been developed. Thus, populations of GABA(A) receptors containing the GABA(A) receptor alpha-1 subunit, the alpha-2 subunit, and the alpha-3 subunit have been purified from sodium deoxycholate extracts of bovine cerebral cortex with the retention of specific [H-3]flunitrazepam-binding activity by anti-alpha-1 324-341, anti-Cys alpha-2 414-424, or anti-Cys alpha-3 454-467 antibody affinity chromatography, respectively. The relative abundance of the different specificity alpha-subunits in these preparations was compared with benzodiazepine affinity chromatography-purified GABA(A) receptors by immunoblotting. In each case, it was found that although the immunoreactivity with the specific alpha-subunit antibody that was used for purification was enriched in immunoaffinity-purified receptors, reactivity with the other alpha-subunit specificity antibodies, together with anti-gamma-2 1-14 Cys immunoreactivity was found. Immunoprecipitation of GABA(A) receptors purified by anti-alpha-1 324-341 antibody affinity chromatography by all three anti-alpha-subunit antibodies employed, together with the use of anti-alpha-1 324-341 and anti-Cys alpha-2 414-424 antibody affinity columns in series, further substantiated the partial co-purification of the different Polypeptides. These results demonstrate the copurification of the gamma-2 subunit with each Population of alpha-1, alpha-2, alpha-3 subunit-enriched GABA(A) receptors. They also show the existence of minor populations of GABA(A) receptors that contain alpha-1-alpha-2, alpha-1-alpha-3, and alpha-2-alpha-3 subunit pairs within single oligomers.	UNIV LONDON,SCH PHARM,DEPT PHARMACEUT CHEM,29-3 9 BRUNSWICK SQ,LONDON WC1N 1AX,ENGLAND	University of London; University College London; University of London School of Pharmacy								ARVIEUX J, 1988, ANTIBODIES, V1, P113; BENKE D, 1991, J BIOL CHEM, V266, P4478; COSTA T, 1979, NATURE, V277, P315, DOI 10.1038/277315a0; CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; DUGGAN MJ, 1989, J NEUROCHEM, V53, P132, DOI 10.1111/j.1471-4159.1989.tb07304.x; DUGGAN MJ, 1991, IN PRESS J NEUROCHEM, V57; ENNA SJ, 1977, MOL PHARMACOL, V13, P442; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LUDDENS H, 1991, J RECEPTOR RES, V11, P535, DOI 10.3109/10799899109066426; LUDDENS H, 1991, TRENDS PHARMACOL SCI, V12, P49, DOI 10.1016/0165-6147(91)90495-E; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAMALAKI C, 1989, J NEUROCHEM, V52, P124, DOI 10.1111/j.1471-4159.1989.tb10906.x; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1983, J BIOL CHEM, V258, P6965; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; STEPHENSON FA, 1990, J BIOL CHEM, V265, P21160; STEPHENSON FA, 1989, BIOCHEM J, V264, P199, DOI 10.1042/bj2640199; STEPHENSON FA, 1989, FEBS LETT, V243, P358, DOI 10.1016/0014-5793(89)80161-9; STEPHENSON FA, 1990, CURR ASPECTS NEUROSC, V3, P177; WISDEN W, 1991, MOL BRAIN RES, V10, P179, DOI 10.1016/0169-328X(91)90109-B	25	110	110	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24778	24784						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662216				2022-12-25	WOS:A1991GW84500082
J	GUSE, AH; EMMRICH, F				GUSE, AH; EMMRICH, F			T-CELL RECEPTOR-MEDIATED METABOLISM OF INOSITOL POLYPHOSPHATES IN JURKAT LYMPHOCYTES-T - IDENTIFICATION OF A D-MYO-INOSITOL 1,2,3,4,6-PENTAKISPHOSPHATE-2-PHOSPHOMONOESTERASE ACTIVITY, A D-MYO-INOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE-1/3-PHOSPHATASE ACTIVITY AND A D/L-MYO-INOSITOL 1,2,4,5,6-PENTAKISPHOSPHATE-1/3-KINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE KINASE-ACTIVITY; ADRENAL GLOMERULOSA CELLS; AORTIC SMOOTH-MUSCLE; MYOINOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE; 1,3,4-TRISPHOSPHATE PHOSPHORYLATION; ANTIGEN RECEPTOR; RAT-LIVER; ACTIVATION; CALCIUM; TETRAKISPHOSPHATE	Stimulation of the human T-lymphocyte cell line Jurkat via the T-cell receptor/CD3 complex by an anti-CD3 antibody (OKT3) induced time-dependent changes in the intracellular concentrations of multiple inositol polyphosphate (InsP(n)) isomers. Quantitative mass analysis by anion-exchange HPLC and a recently developed postcolumn dye system (Mayr, G. W. (1988) Biochem. J. 254, 585-591) revealed basal intracellular concentrations between < 5 pmol/10(9) cells for Ins(1,3,4,5)P4 and 6380 +/- 355 pmol/10(9) cells for InsP6. Time course analysis of samples from stimulated Jurkat T-cells showed an increase of Ins(1,3,4,5)P4 to 1125 +/- 125 pmol/10(9)cells within 10 min and remained elevated over more than 30 min. Moreover, increases of the intracellular concentrations of Ins(1,3,4,6)P4, Ins(1,4,5,6)P4, and/or Ins(3,4,5,6)P4 (determined as the enantiomeric mixture), Ins(1,3,4,5,6)P5, Ins(1,2,3,4,6)P5 and InsP6 were observed. In contrast, the concentration of Ins(1,2,4,5,6)P5 and/or Ins(2,3,4,5,6)P5 (determined as the enantiomeric mixture) decreased after stimulation. Using cytosolic extracts from Jurkat T-lymphocytes incubated with purified Ins(1,3,4,5,6)P5, Ins(1,2,3,4,6)P5, or Ins(1,2,4,5,6)P5/Ins(2,3,4,5,6)P5 three enzyme activities were observed. Ins(1,3,4,5,6)P5) was dephosphorylated by a phosphatase removing a phosphate group at the 1 and/or 3 position resulting in the formation of Ins(1,4,5,6)P4 and/or Ins(3,4,5,6)P4 (determined as the enantiomeric mixture). Ins(1,2,3,4,6)P5 was metabolized by a specific phosphatase that cleaved the phosphate group at the 2 position, thereby generating the product Ins(1,3,4,6)P4. On the other hand, Ins(1,2,4,5,6)P5/Ins(2,3,4,5,6)P5 was phosphorylated by a 1/3-kinase activity to InsP6. Together novel receptor-mediated metabolic pathways of inositol polyphosphates were demonstrated in human T-lymphocytes, and corresponding enzyme activities for the inositol pentakisphosphate metabolism were found in cell lysates.			GUSE, AH (corresponding author), UNIV ERLANGEN NURNBERG,INST CLIN IMMUNOL,MAX PLANCK SOC,CLIN RES UNIT RHEUMATOL IMMUNOL,W-8520 ERLANGEN,GERMANY.							BALLA T, 1989, J BIOL CHEM, V264, P9386; BALLA T, 1987, J BIOL CHEM, V262, P9952; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIDEN TJ, 1987, J BIOL CHEM, V262, P9437; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; GUSE AH, 1992, IN PRESS J CHROMATOG; HANSEN CA, 1988, FEBS LETT, V236, P53, DOI 10.1016/0014-5793(88)80284-9; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; IMBODEN J, 1987, J IMMUNOL, V138, P1322; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; INHORN RC, 1987, P NATL ACAD SCI USA, V84, P2170, DOI 10.1073/pnas.84.8.2170; IVORRA I, 1991, BIOCHEM J, V273, P317, DOI 10.1042/bj2730317; JI H, 1989, J BIOL CHEM, V264, P20185; KOZUMBO WJ, 1987, J IMMUNOL, V138, P606; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MAYR GW, 1990, METHODS INOSITIDE RE, P83; MEEK JL, 1986, J CHROMATOGR, V351, P303, DOI 10.1016/S0021-9673(01)83500-7; MEEK JL, 1986, P NATL ACAD SCI USA, V83, P4162, DOI 10.1073/pnas.83.12.4162; MENNITI FS, 1990, J BIOL CHEM, V265, P11167; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PITTET D, 1989, J BIOL CHEM, V264, P18489; ROSSIER MF, 1987, BIOCHEM J, V245, P305, DOI 10.1042/bj2450305; SHEARS SB, 1989, J BIOL CHEM, V264, P19879; SHEARS SB, 1987, BIOCHEM J, V246, P139, DOI 10.1042/bj2460139; STEPHENS LR, 1988, BIOCHEM J, V253, P721, DOI 10.1042/bj2530721; STEPHENS LR, 1990, NATURE, V346, P580, DOI 10.1038/346580a0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; TREVES S, 1987, J EXP MED, V166, P33, DOI 10.1084/jem.166.1.33; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; YAMAGUCHI K, 1987, BIOCHEM J, V244, P787, DOI 10.1042/bj2440787	31	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24498	24502						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662211				2022-12-25	WOS:A1991GW84500041
J	KLANN, E; CHEN, SJ; SWEATT, JD				KLANN, E; CHEN, SJ; SWEATT, JD			PERSISTENT PROTEIN-KINASE ACTIVATION IN THE MAINTENANCE PHASE OF LONG-TERM POTENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXCITATORY AMINO-ACIDS; SYNAPTIC TRANSMISSION; SUBSTRATE-SPECIFICITY; AUTONOMOUS ENZYME; PHORBOL ESTERS; C ACTIVITY; AUTOPHOSPHORYLATION; PHOSPHORYLATION; HIPPOCAMPUS; CALMODULIN	Long-term potentiation (LTP) of synaptic transmission in the hippocampus is a robust form of synaptic plasticity that may contribute to mammalian memory formation. A variety of pharmacological evidence suggests that persistent kinase activation contributes to the maintenance of LTP. To determine whether persistent activation of protein kinases was associated with the maintenance phase of LTP, protein kinase activity was measured in control and LTP samples using exogenous protein kinase substrates in an in vitro assay of homogenates of the CA1 region of rat hippocampal slices. After LTP, protein kinase activity was persistently increased, and the induction of this effect was blocked by the N-methyl-D-aspartate receptor antagonist DL-2-amino-5-phosphonovaleric acid. The increased protein kinase activity was found to be significantly attenuated by PKC(19-36), a selective peptide inhibitor of protein kinase C. Thus, LTP is associated with an N-methyl-D-aspartate receptor-mediated generation of a persistently activated form of protein kinase C. These data lend strong support to the model that persistent protein kinase activation contributes to the maintenance of LTP.			KLANN, E (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.			Sweatt, J. David/0000-0003-3567-485X				AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; BAZZI MD, 1988, BIOCHEM BIOPH RES CO, V152, P336, DOI 10.1016/S0006-291X(88)80719-8; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; EICHBERG J, 1986, BIOCHEM BIOPH RES CO, V136, P1007, DOI 10.1016/0006-291X(86)90433-X; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; HOUSE C, 1987, J BIOL CHEM, V262, P772; INOUE M, 1977, J BIOL CHEM, V252, P7610; KU GY, 1987, NATURE, V328, P426; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LYNCH MA, 1989, NEUROSCIENCE, V30, P693, DOI 10.1016/0306-4522(89)90162-0; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULLER D, 1988, P NATL ACAD SCI USA, V85, P6997, DOI 10.1073/pnas.85.18.6997; MULLER D, 1990, P NATL ACAD SCI USA, V87, P4073, DOI 10.1073/pnas.87.11.4073; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; ROUTTENBERG A, 1985, BEHAV NEURAL BIOL, V43, P3, DOI 10.1016/S0163-1047(85)91426-8; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SMITH MK, 1990, J BIOL CHEM, V265, P1837; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; WOLF M, 1985, NATURE, V317, P546, DOI 10.1038/317546a0	33	125	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24253	24256						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1684790				2022-12-25	WOS:A1991GW84500006
J	CORBETT, JA; LANCASTER, JR; SWEETLAND, MA; MCDANIEL, ML				CORBETT, JA; LANCASTER, JR; SWEETLAND, MA; MCDANIEL, ML			INTERLEUKIN-1-BETA-INDUCED FORMATION OF EPR-DETECTABLE IRON-NITROSYL COMPLEXES IN ISLETS OF LANGERHANS - ROLE OF NITRIC-OXIDE IN INTERLEUKIN-BETA-INDUCED INHIBITION OF INSULIN-SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT PANCREATIC-ISLETS; TUMOR NECROSIS FACTOR; L-ARGININE; ACTIVATED MACROPHAGES; MURINE MACROPHAGES; INTERFERON-GAMMA; RELAXING FACTOR; CYTO-TOXICITY; CELLS; NITRATE	The molecular mechanism by which interleukin (IL)-1 inhibits insulin secretion and ultimately causes destruction of the pancreatic beta-cell remains unknown. Evidence is presented which suggests that IL-1-beta-induced inhibition of insulin secretion is dependent on the metabolism of L-arginine to nitric oxide. N(G)-Monomethylarginine, a competitive inhibitor of the L-arginine-dependent enzyme nitric oxide synthase, completely prevents IL-1-induced inhibition of glucose-stimulated insulin secretion as well as nitrite production by islets. It is further shown that IL-1-beta induces nitric oxide formation in islets as evidenced by an electron paramagnetic resonance feature at g = 2.04 which is similar to previously reported iron-nitrosyl complexes formed from the destruction of iron-sulfur centers by nitric oxide. Inhibition of the nitric oxide synthase by N(G)-monomethylarginine completely prevents the formation of this EPR signal in islets. These results show that IL-1-induced inhibition of insulin secretion is mediated through formation of nitric oxide and suggest that the generation of nitric oxide may represent the cellular mechanism responsible for beta-cell destruction.	WASHINGTON UNIV, SCH MED, DEPT PATHOL, BOX 8118, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA; UTAH STATE UNIV, DEPT CHEM & BIOCHEM, LOGAN, UT 84322 USA	Washington University (WUSTL); Utah System of Higher Education; Utah State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK006181, R01DK006181, T32DK007296] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK0-07296, DK-06181] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CHEN LP, 1987, J IMMUNOL, V139, P4096; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; DERVARTANIAN KV, 1973, BIOCHIM BIOPHYS ACTA, V292, P496; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; DRAPIER JC, 1988, EUR J IMMUNOL, V18, P1587, DOI 10.1002/eji.1830181018; EIZLRIK DL, 1988, ACTA ENDOCRINOL-COP, V119, P321; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GRANGER DL, 1988, J CLIN INVEST, V81, P1129, DOI 10.1172/JCI113427; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HAMMONDS P, 1990, FEBS LETT, V261, P97, DOI 10.1016/0014-5793(90)80645-Y; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1990, INT CONGR SER, V897, P189; HUGHES JH, 1990, J CLIN INVEST, V86, P856, DOI 10.1172/JCI114785; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KRORICKE KD, 1991, BIOCHEM BIOPH RES CO, V175, P752; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; MANDRUPPOULSEN T, 1986, ALLERGY, V41, P250, DOI 10.1111/j.1398-9995.1986.tb02025.x; MANDRUPPOULSEN T, 1987, DIABETES, V36, P641, DOI 10.2337/diabetes.36.5.641; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; SALERNO JC, 1976, BIOCHEM BIOPH RES CO, V73, P833, DOI 10.1016/0006-291X(76)90884-6; SANDLER S, 1987, ENDOCRINOLOGY, V121, P1424, DOI 10.1210/endo-121-4-1424; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; SUMOSKI W, 1989, DIABETOLOGIA, V32, P792; TAYEH MA, 1989, J BIOL CHEM, V264, P19654	31	291	300	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21351	21354						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657959				2022-12-25	WOS:A1991GP80400007
J	HURWITZ, DR; EMANUEL, SL; NATHAN, MH; SARVER, N; ULLRICH, A; FELDER, S; LAX, I; SCHLESSINGER, J				HURWITZ, DR; EMANUEL, SL; NATHAN, MH; SARVER, N; ULLRICH, A; FELDER, S; LAX, I; SCHLESSINGER, J			EGF INDUCES INCREASED LIGAND-BINDING AFFINITY AND DIMERIZATION OF SOLUBLE EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; BACULOVIRUS EXPRESSION VECTOR; INSECT CELLS; SIGNAL TRANSDUCTION; ALLOSTERIC ACTIVATION; SELF-PHOSPHORYLATION; POINT MUTATION; PROTEIN-KINASE; CROSS-LINKING; SITE	The binding of epidermal growth factor (EGF) to its cell surface receptor (EGF-R) results in a number of intracellular responses including the activation of the receptor intracellular tyrosine kinase. Receptor oligomerization induced by ligand binding has been suggested to play an important role in signal transduction. However, the mechanisms involved in oligomerization and signal transduction are poorly understood. We have produced and purified several milligrams of recombinant extracellular domain of the EGF receptor (EGF-Rx) using the baculovirus/insect cell expression system. The baculovirus-generated EGF-Rx is glycosylated, has had its signal peptide correctly cleaved, and exhibits a dissociation constant for EGF similar to that for solubilized full-length receptor, of about 100 nM. The binding of EGF to EGF-Rx leads to the formation of receptor dimers and higher oligomerization states which are irreversibly captured using the covalent cross-linking agent disuccinimidyl suberate. Interestingly, purified receptor monomers and dimers, stabilized by the cross-linker in the presence of EGF, exhibit increased binding affinity toward EGF as compared with receptor monomers which have not been exposed to EGF. It appears that the high affinity state of receptor can be maintained by the covalent crosslinking agent. These results indicate that in addition to ligand binding, the extracellular domain of EGF receptor possesses the inherent ability to undergo ligand-induced dimerization and that the low affinity state is converted to a high affinity state by EGF.	NIAID,DIV AIDS,DEV THERAPEUT BRANCH,ROCKVILLE,MD 20892; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY; NYU MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Max Planck Society; New York University	HURWITZ, DR (corresponding author), RHONE POULENC RORER CENT RES,KING OF PRUSSIA,PA 19406, USA.							BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COCHET C, 1988, J BIOL CHEM, V263, P3290; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FANGER BO, 1986, BIOCHEMISTRY-US, V25, P6414, DOI 10.1021/bi00369a011; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; GULLICK WJ, 1984, ANAL BIOCHEM, V141, P253, DOI 10.1016/0003-2697(84)90454-8; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JARVIS DL, 1989, MOL CELL BIOL, V9, P214, DOI 10.1128/MCB.9.1.214; KING AC, 1982, J BIOL CHEM, V257, P3053; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LAX I, 1991, J BIOL CHEM, V266, P13828; LAX I, 1985, EMBO J, V4, P3179, DOI 10.1002/j.1460-2075.1985.tb04062.x; LIEBERMAN TA, 1985, NATURE, V313, P144; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MAYES ELV, 1984, EMBO J, V3, P531, DOI 10.1002/j.1460-2075.1984.tb01842.x; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; NORTHWOOD IC, 1988, J BIOL CHEM, V263, P7450; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; SMITH GE, 1985, P NATL ACAD SCI USA, V82, P8404, DOI 10.1073/pnas.82.24.8404; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; USHIRO H, 1980, J BIOL CHEM, V255, P8363; YARDEN Y, 1985, CIBA F SYMP, V116, P23; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; ZIDOVETZKI R, 1986, EMBO J, V5, P247, DOI 10.1002/j.1460-2075.1986.tb04205.x; ZIDOVETZKI R, 1981, P NATL ACAD SCI-BIOL, V78, P6981, DOI 10.1073/pnas.78.11.6981	43	103	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					22035	22043						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657987				2022-12-25	WOS:A1991GP80400106
J	NAKAYAMA, M; NAGATA, K; KATO, A; ISHIHAMA, A				NAKAYAMA, M; NAGATA, K; KATO, A; ISHIHAMA, A			INTERFERON-INDUCIBLE MOUSE MX1 PROTEIN THAT CONFERS RESISTANCE TO INFLUENZA-VIRUS IS GTPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BINDING PROTEINS; EXPRESSION; MICE; GENE; ANTIBODIES; SEQUENCE; PROMOTER; CLONING	The murine Mx1 protein is an interferon-inducible nuclear protein and confers resistance to influenza virus infection even though the resistance mechanism is yet unclear. The Mx1 protein contains a tripartite GTP-binding domain consisting of GXXXXGKS, DXXG, and T/NKXD motifs. In the GTPase gene superfamily such as p21ras protein, signal-transducing G protein, and translation elongation factor, the GTPase activity plays a key role in each protein function. Here we show that GTPase activity is indeed associated with the intact Mx1 protein purified from Escherichia coli expressing Mx1 cDNA. Amino acid substitution within the GTP-binding motif led to significant reduction in the GTPase activity. Yeast vacuolar protein sorting (VPS1) protein and the rat microtubule-associated mechanochemical enzyme dynamin were found to be homologous to Mx1 not only in the tripartite GTP-binding motif, but also in the amino-terminal region of approximately 300 amino acids in length. The function of Mx1 is discussed in comparison with these proteins.	NATL INST GENET,DEPT MOLEC GENET,MISHIMA,SHIZUOKA 411,JAPAN; NAGOYA UNIV,FAC SCI,DEPT BIOL,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN; NIPPON INST BIOL SCI,OME,TOKYO 198,JAPAN	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nagoya University								AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; ARNHEITER H, 1988, EMBO J, V7, P1315, DOI 10.1002/j.1460-2075.1988.tb02946.x; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; HILL VM, 1990, J GEN VIROL, V71, P289, DOI 10.1099/0022-1317-71-2-289; HORISBERGER MA, 1991, VIROLOGY, V180, P185, DOI 10.1016/0042-6822(91)90022-4; HORISBERGER MA, 1990, J VIROL, V64, P1171, DOI 10.1128/JVI.64.3.1171-1181.1990; HUG H, 1988, MOL CELL BIOL, V8, P3065, DOI 10.1128/MCB.8.8.3065; MEIER E, 1990, J VIROL, V64, P6263, DOI 10.1128/JVI.64.12.6263-6269.1990; MOYER SA, 1986, P NATL ACAD SCI USA, V83, P5405, DOI 10.1073/pnas.83.15.5405; NOTEBORN M, 1987, J INTERFERON RES, V7, P657, DOI 10.1089/jir.1987.7.657; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; OBER RA, 1991, J CELL SCI, V14, P143; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; RINK H, 1984, NUCLEIC ACIDS RES, V12, P6369, DOI 10.1093/nar/12.16.6369; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; RUBINS JB, 1990, P NATL ACAD SCI USA, V87, P7080, DOI 10.1073/pnas.87.18.7080; SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAEHELI P, 1985, J BIOL CHEM, V260, P1821	24	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21404	21408						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657964				2022-12-25	WOS:A1991GP80400017
J	ROUX, P; VERRIER, B; KLEIN, B; NICCOLINO, M; MARTY, L; ALEXANDRE, C; PIECHACZYK, M				ROUX, P; VERRIER, B; KLEIN, B; NICCOLINO, M; MARTY, L; ALEXANDRE, C; PIECHACZYK, M			RETROVIRUS-MEDIATED GENE-TRANSFER OF A HUMAN C-FOS CDNA INTO MOUSE BONE-MARROW STROMAL CELLS	ONCOGENE			English	Note							STEM-CELLS; PROTO-ONCOGENE; T-ANTIGEN; V-FOS; EXPRESSION; PROTEINS; TRANSCRIPTION; CONSTRUCTION; SEQUENCE; SIGNALS	A cDNA encoding a complete human c-fos protein was isolated and inserted into two different murine MoMuLV-derived recombinant retroviruses allowing expression of c-fos protein in different cell types. One c-fos-expressing retrovirus, chosen for its ability to express high levels of proteins in fibroblast-like cells, was shown to potentiate long-term cultures of mouse bone marrow stromal cells in vitro and therefore constitutes a potential tool for immortalizing such cells. Moreover, when tested in an in vitro differentiation assay, stromal cells constitutively expressing c-fos favor the granulocyte differentiation of hematopoietic precursors. Interestingly, retroviruses expressing v-src and v-abl oncogenes, included as controls in our experiments, do not produce any detectable effects, whereas those expressing polyoma virus middle T antigen facilitate long-term growth in vitro of stromal cells that favor the macrophage differentiation pathway of bone marrow stem cells. Our observation supports the idea that constitutive expression of some oncogenes, including c-fos and polyoma virus middle T antigen, may influence cytokine production by bone marrow stromal cells.	UNIV MONTPELLIER 2,CNRS,UA 1191,PL E BATAILLON,F-34095 MONTPELLIER 05,FRANCE; FAC ALEXIS CARREL,IMMUNOVIROL MOLEC LAB,CNRS,UMR 005,F-69372 LYONS 07,FRANCE; CTR VAL AURELLE PAUL LAMARQUE,BIOCHIM LAB,F-34994 MONTPELLIER 05,FRANCE; ECOLE NATL SUPER LYON,CNRS BIOMERIEUX,UMR 103,LYONS 07,FRANCE; INSERM,U191,ZOLAD,F-34000 MONTPELLIER,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier			Roux, Pierre/D-8833-2017; PIECHACZYK, Marc/E-7896-2013; verrier, bernard/J-4094-2017	PIECHACZYK, Marc/0000-0003-1367-2597; verrier, bernard/0000-0002-8478-7095				BORELLI E, 1984, NATURE, V312, P608; BOULTER CA, 1987, NUCLEIC ACIDS RES, V15, P7194, DOI 10.1093/nar/15.17.7194; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; Curran T, 1988, ONCOGENE HDB, P307; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5567; FRANZA BR, 1987, ONCOGENE, V1, P213; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUILD BC, 1988, J VIROL, V62, P3795, DOI 10.1128/JVI.62.10.3795-3801.1988; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; JENUWEIN T, 1987, CELL, V48, P647, DOI 10.1016/0092-8674(87)90243-1; LAMB NJC, 1990, CELL, V61, P485, DOI 10.1016/0092-8674(90)90530-R; LINNEY E, 1984, NATURE, V308, P470, DOI 10.1038/308470a0; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; METCALF D, 1987, EMBO J, V6, P3703, DOI 10.1002/j.1460-2075.1987.tb02704.x; METCALF D, 1984, HEMOPOIETIC COLONIES; MOLDERS H, 1987, ONCOGENE, V1, P337; MULLER R, 1986, EMBO J, V5, P311, DOI 10.1002/j.1460-2075.1986.tb04214.x; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; RUTHER U, 1989, ONCOGENE, V4, P861; SALMON SE, 1979, CANCER RES, V39, P1133; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VELCICH A, 1985, CELL, V40, P705, DOI 10.1016/0092-8674(85)90219-3; VERRIER B, 1986, EMBO J, V5, P913, DOI 10.1002/j.1460-2075.1986.tb04303.x; WARNER NL, 1969, J NATL CANCER I, V43, P963; WEISS R, 1985, RNA TUMOR VIRUSES, V2, P893; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WILLIAMS DA, 1988, MOL CELL BIOL, V8, P3664; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	34	12	14	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2155	2160						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658710				2022-12-25	WOS:A1991GX11900029
J	NAKAMURA, M; HONDA, Z; IZUMI, T; SAKANAKA, C; MUTOH, H; MINAMI, M; BITO, H; SEYAMA, Y; MATSUMOTO, T; NOMA, M; SHIMIZU, T				NAKAMURA, M; HONDA, Z; IZUMI, T; SAKANAKA, C; MUTOH, H; MINAMI, M; BITO, H; SEYAMA, Y; MATSUMOTO, T; NOMA, M; SHIMIZU, T			MOLECULAR-CLONING AND EXPRESSION OF PLATELET-ACTIVATING-FACTOR RECEPTOR FROM HUMAN-LEUKOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG; CDNA; ANTAGONIST; PROTEIN; GENE; WEB-2086; RELEASE; BINDING	The cDNA for a platelet-activating factor (PAF) receptor was cloned from a human leukocyte cDNA library using a 0.8-kilobase pair fragment of the guinea pig lung PAF receptor cDNA (Honda, Z., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., and Shimizu, T. (1991) Nature 349, 342-346). The cDNA (1.8-kilobase pairs) had an open reading frame encoding 342 amino acid residues with a calculated M(r) of 39,203. The clone was shown to code for a PAF receptor based on the following criteria: 1) the amino acid sequence possesses seven putative membrane spanning domains with 83% identity to the guinea pig lung PAF receptor, 2) Xenopus laevis oocytes injected with the transcript of the clone showed an electrophysiological response to PAF, and 3) COS-7 cells expressing the encoded receptor showed ligand binding with the pharmacological properties of the PAF receptor. Activation of the PAF receptor yielded inositol 1,4,5-trisphosphate production in both COS-7 cells and oocytes, and guanosine 5'-O-(2-thio)bisphosphate injection into the oocytes inhibited PAF-induced Cl- current, providing an evidence that PAF stimulates phosphoinositide turnover via G-protein(s). PAF receptor mRNA was abundant in leukocytes and less so in an undifferentiated human eosinophilic cell line (EoL-1 cells) or human erythroleukemia cells (HEL cells). The production of the mRNA was prominently increased when EoL-1 cells were treated with granulocyte macrophage colony stimulating factor, interleukin-5, and n-butyrate.	UNIV TOKYO, FAC MED, DEPT BIOCHEM, 7-3-1 HONGO, BUNKYO KU, TOKYO 113, JAPAN; JAPAN TOBACCO INC, LIFE SCI RES LAB, MIDORI KU, YOKOHAMA, KANAGAWA, JAPAN; UNIV TOKYO, FAC MED, DEPT PHYSIOL CHEM & NUTR, TOKYO 113, JAPAN	University of Tokyo; Japan Tobacco Inc.; University of Tokyo			Bito, Haruhiko/A-8635-2008; Shimizu, Takao/AAV-7052-2021	Bito, Haruhiko/0000-0001-6315-9594				BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; BLANK ML, 1979, BIOCHEM BIOPH RES CO, V90, P1194, DOI 10.1016/0006-291X(79)91163-X; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DASCAL N, 1984, J PHYSIOL-LONDON, V352, P551, DOI 10.1113/jphysiol.1984.sp015310; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; DENT G, 1989, EUR J PHARMACOL, V169, P313, DOI 10.1016/0014-2999(89)90029-0; DENT G, 1989, FEBS LETT, V244, P365, DOI 10.1016/0014-5793(89)80564-2; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; OFLAHERTY JT, 1981, AM J PATHOL, V103, P70; POLONSKY J, 1980, P NATL ACAD SCI-BIOL, V77, P7019, DOI 10.1073/pnas.77.12.7019; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; SAITO H, 1985, BLOOD, V66, P1233; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHUKLA SD, 1991, IN PRESS LIPIDS, V26; SNYDER F, 1987, PLATELET ACTIVATING; STEWART AG, 1989, BRIT J PHARMACOL, V98, P141, DOI 10.1111/j.1476-5381.1989.tb16874.x; TERASAWA M, 1989, 3RD INT C PLAT ACT F, P10; TERASHITA ZI, 1987, J PHARMACOL EXP THER, V242, P263; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4	32	322	327	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20400	20405						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657923				2022-12-25	WOS:A1991GM03900077
J	LEBOURDELLES, B; HORELLOU, P; LECAER, JP; DENEFLE, P; LATTA, M; HAAVIK, J; GUIBERT, B; MAYAUX, JF; MALLET, J				LEBOURDELLES, B; HORELLOU, P; LECAER, JP; DENEFLE, P; LATTA, M; HAAVIK, J; GUIBERT, B; MAYAUX, JF; MALLET, J			PHOSPHORYLATION OF HUMAN RECOMBINANT TYROSINE-HYDROXYLASE ISOFORM-1 AND ISOFORM-2 - AN ADDITIONAL PHOSPHORYLATED RESIDUE IN ISOFORM-2, GENERATED THROUGH ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; T7 RNA-POLYMERASE; RAT PHEOCHROMOCYTOMA; ACTIVATOR PROTEIN; MESSENGER-RNA; EXPRESSION; ENZYME; CELLS; PURIFICATION; GENE	The single human tyrosine hydroxylase (TH) gene generates four different mRNA species through alternative splicing events. TH-1 and TH-2 mRNAs are expressed mostly in the brain. We have produced large amounts of the corresponding proteins in Escherichia coli to analyze their respective molecular characteristics. The polypeptides have molecular weights similar to those of TH expressed in Xenopus oocytes and react with antibodies to TH. The two isoforms were purified with a purity of 90% using a three-step procedure. The phosphorylation sites have been determined in the two isoforms after labeling with [gamma-P-32]ATP in the presence of cAMP-dependent protein kinase (PKA) or calmodulin-dependent protein kinase II (CaM-PK II). In both isoforms, Ser-40 was found to be phosphorylated by PKA, and Ser-19 and Ser-40 were found to be phosphorylated by CaM-PK II. The putative phosphorylation site generated by alternative splicing (Ser-31) was phosphorylated specifically by CaM-PK II in TH-2 only. The kinetic properties of the two isoforms in the presence of various concentrations of the substrate (tyrosine) and of the natural cofactor ((6R)-tetrahydrobiopterin) were also analyzed. TH produced in E. coli is unphosphorylated but nevertheless active. At 50-mu-M tyrosine and 300-mu-M (6R)-tetrahydrobiopterin, the specific activities of TH-1 and TH-2 are 1300 and 620 nmol of dihydroxyphenylalanine/min/mg, respectively. Phosphorylation of TH-1 and TH-2 by PKA activates both isoenzymes as shown by the increase in the affinity for the cofactor. No changes in kinetic parameters of the isoenzymes were observed after phosphorylation by CaM-PK II. Dopamine was found to inhibit both TH isoenzymes to the same extent as shown by their similar K(i) values for dopamine. These values were increased after phosphorylation of each enzyme by PKA. Unlike TH-1, phosphorylation of TH-2 by CaM-PK II resulted in an increase of the K(i) value for dopamine. This property may be related to the presence of the additional phosphorylated residue in TH-2 isoform.	CNRS,NEUROBIOL CELLULAIRE & MOLEC LAB,F-91198 GIF SUR YVETTE,FRANCE; INST BIOTECHNOL VITRY,F-94403 VITRY,FRANCE; CNRS,PHYSIOL NERVEUSE LAB,F-91198 GIF SUR YVETTE,FRANCE; UNIV BERGEN,DEPT BIOCHEM,N-5009 BERGEN,NORWAY	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Bergen			Haavik, Jan/ABE-1535-2020; Horellou, Philippe/B-4290-2019	Horellou, Philippe/0000-0003-2467-8177; Haavik, Jan/0000-0001-7865-2808				AMES MM, 1978, J BIOL CHEM, V253, P27; ANDERSSON KK, 1988, J BIOL CHEM, V263, P18621; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; BIGUET NF, 1986, EMBO J, V5, P287, DOI 10.1002/j.1460-2075.1986.tb04211.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; COCKER GT, 1988, BIOCHEM BIOPH RES CO, V157, P1341; D'MELLO SR, 1989, J NEUROSCI RES, V23, P31, DOI 10.1002/jnr.490230105; DENISDUPHIL M, 1990, EUR J BIOCHEM, V193, P581, DOI 10.1111/j.1432-1033.1990.tb19376.x; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; ELMESTIKAWY S, 1985, J NEUROCHEM, V45, P173, DOI 10.1111/j.1471-4159.1985.tb05490.x; FITZPATRICK PF, 1990, J BIOL CHEM, V265, P2042; GINNS EI, 1988, J BIOL CHEM, V263, P7406; Goldstein M, 1987, PSYCHOPHARMACOLOGY 3, P75; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HAAVIK J, 1991, EUR J BIOCHEM, V199, P371, DOI 10.1111/j.1432-1033.1991.tb16133.x; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HORELLOU P, 1988, J NEUROCHEM, V51, P652, DOI 10.1111/j.1471-4159.1988.tb01088.x; HORELLOU P, 1989, P NATL ACAD SCI USA, V86, P7233, DOI 10.1073/pnas.86.18.7233; HORELLOU P, 1986, FEBS LETT, V205, P6, DOI 10.1016/0014-5793(86)80854-7; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Kaufman S., 1974, MOL MECH OXYGEN ACTI, P285; KOBAYASHI K, 1988, FEBS LETT, V238, P431, DOI 10.1016/0014-5793(88)80526-X; LAZAR MA, 1982, J NEUROCHEM, V39, P409, DOI 10.1111/j.1471-4159.1982.tb03962.x; LEBOURDELLES B, 1988, J NEUROCHEM, V50, P988; LEBOYER M, 1990, LANCET, V335, P1219, DOI 10.1016/0140-6736(90)92738-4; LEDLEY FD, 1987, J BIOL CHEM, V262, P2228; LEVIEL V, 1989, BRAIN RES, V499, P205, DOI 10.1016/0006-8993(89)90768-3; LIU X, 1991, NEUROCHEM INT, V18, P27, DOI 10.1016/0197-0186(91)90031-8; MASSERANO JM, 1983, MOL CELL BIOCHEM, V53-4, P129; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; MITCHELL JP, 1990, J BIOL CHEM, V265, P22358; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MOGI M, 1984, ANAL BIOCHEM, V138, P125, DOI 10.1016/0003-2697(84)90779-6; OKUNO S, 1989, FEBS LETT, V253, P52, DOI 10.1016/0014-5793(89)80927-5; PARK DH, 1976, LIFE SCI, V18, P55, DOI 10.1016/0024-3205(76)90273-3; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PERLMAN RL, 1982, BIOCHIM BIOPHYS ACTA, V719, P334, DOI 10.1016/0304-4165(82)90107-6; PIGEON D, 1987, J BIOL CHEM, V262, P6155; POLLOCK RJ, 1981, J NEUROCHEM, V37, P855, DOI 10.1111/j.1471-4159.1981.tb04471.x; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOENEN H, 1974, LIFE SCI, V14, P223, DOI 10.1016/0024-3205(74)90052-6; VIGNY A, 1981, J NEUROCHEM, V36, P483, DOI 10.1111/j.1471-4159.1981.tb01618.x; VULLIET PR, 1980, P NATL ACAD SCI-BIOL, V77, P92, DOI 10.1073/pnas.77.1.92; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	52	79	80	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17124	17130						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1680128				2022-12-25	WOS:A1991GF44500026
J	MENDOZA, JA; ROGERS, E; LORIMER, GH; HOROWITZ, PM				MENDOZA, JA; ROGERS, E; LORIMER, GH; HOROWITZ, PM			CHAPERONINS FACILITATE THE INVITRO FOLDING OF MONOMERIC MITOCHONDRIAL RHODANESE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; CHLORIDE-DENATURED RHODANESE; GUANIDINIUM CHLORIDE; ATP HYDROLYSIS; PROTEINS; BINDING; INTERMEDIATE(S); PURIFICATION; DETERGENT; CATALYSTS	In vitro refolding of the monomeric mitochondrial enzyme, rhodanese (thiosulfate sulfurtransferase; EC 2.8.1.1) is facilitated by molecular chaperonins. The four components: two proteins from Escherichia coli, chaperonin 60 (groEL) and chaperonin 10 (groES), MgATP, and K+, are necessary for the in vitro folding of rhodanese. These were previously shown to be necessary for the in vitro folding of ribulose- 1,5-bisphosphate carboxylase at temperatures in excess of 25-degrees-C (Viitanen, P. V., Lubben, T. H., Reed, J., Goloubinoff, P., O'Keefe, D. P., and Lorimer, G. H. (1990) Biochemistry 29, 5665-567 1). The labile folding intermediate, rhodanese-1, which rapidly aggregates at 37-degrees-C in the absence of the chaperonins, can be stabilized by forming a binary complex with chaperonin 60. The discharge of the binary chaperonin 60-rhodanese-I complex, results in the formation of active rhodanese, and requires the presence of chaperonin 10. Optimal refolding is associated with a K+-dependent hydrolysis of ATP. At lower protein concentrations and 25-degrees-C, where aggregation is reduced, a fraction of the rhodanese refolds to an active form in the absence of the chaperonins. This spontaneous refolding can be arrested by chaperonin 60. There is some refolding (approximately equals 20%) when ATP is replaced by nonhydrolyzable analogs, but there is no refolding in the presence of ADP or AMP. ATP analogs may interfere with the interaction of rhodanese-I with the chaperonins. Nondenaturing detergents facilitate rhodanese refolding by interacting with exposed hydrophobic surfaces of folding intermediates and thereby prevent aggregation (Tandon, S., and Horowitz, P. (1986) J. Biol. Chem. 261, 15615-15618). The chaperonin proteins appear to play a similar role in as much as they can replace the detergents. Consistent with this view, chaperonin 60, but not chaperonin 10, binds 2-3 molecules of the hydrophobic fluorescent reporter, 1,1'-bi(4-anilino) naphthalene-S,5'-disulfonic acid, indicating the presence of hydrophobic surfaces on chaperonin 60. The number of bound probe molecules is reduced to 1-2 molecules when chaperonin 10 and MgATP are added. The results support a model in which chaperonins facilitate folding, at least in part, by interacting with partly folded intermediates, thus preventing the interactions of hydrophobic surfaces that lead to aggregation.	UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284; DUPONT CO,DEPT CENT RES & DEV,DIV MOLEC BIOL,EXPTL STN,WILMINGTON,DE 19880	University of Texas System; University of Texas Health San Antonio; DuPont			Rogers, Elizabeth/AAB-3643-2021; Rogers, Elizabeth E/D-2087-2009	Rogers, Elizabeth/0000-0002-0545-4744; Rogers, Elizabeth E/0000-0002-0545-4744	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ellis R J, 1990, Semin Cell Biol, V1, P1; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Georgopoulos C, 1990, Semin Cell Biol, V1, P19; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOROWITZ P, 1986, J BIOL CHEM, V261, P5652; HOROWITZ PM, 1989, J BIOL CHEM, V264, P3311; HOROWITZ PM, 1986, J BIOL CHEM, V261, P13887; HOROWITZ PM, 1985, BIOCHEMISTRY-US, V24, P2587, DOI 10.1021/bi00332a001; HOROWITZ PM, 1978, ANAL BIOCHEM, V86, P751, DOI 10.1016/0003-2697(78)90803-5; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; HORWICH AL, 1990, TRENDS BIOTECHNOL, V8, P126, DOI 10.1016/0167-7799(90)90153-O; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; OGATA K, 1989, J BIOL CHEM, V264, P2718; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Ploegman J.H., 1978, NATURE, V273, P1245; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TANDON S, 1989, J BIOL CHEM, V264, P9859; TANDON S, 1986, J BIOL CHEM, V261, P5615; TANDON S, 1990, J BIOL CHEM, V265, P5967; TANDON S, 1987, J BIOL CHEM, V262, P4486; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; WENG L, 1978, J BIOL CHEM, V253, P8109; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327	33	299	302	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13044	13049						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1677004				2022-12-25	WOS:A1991FX13200040
J	TREMBLAY, J; HUOT, C; KOCH, C; POTIER, M				TREMBLAY, J; HUOT, C; KOCH, C; POTIER, M			CHARACTERIZATION OF THE FUNCTIONAL DOMAINS OF THE NATRIURETIC PEPTIDE RECEPTOR GUANYLATE-CYCLASE BY RADIATION INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL ZONA GLOMERULOSA; SMOOTH-MUSCLE CELLS; CYCLIC-GMP; DISTINCT FORMS; PURIFICATION; ACTIVATION; PROTEINS; ENZYMES; SOLUBILIZATION; HETEROGENEITY	Radiation inactivation has been used to evaluate the molecular size of domains responsible for atrial natriuretic peptide (ANP)-binding and cyclase functions of the ANP receptor/guanylate cyclase. Two types of inactivation curves were observed for cyclase function in both adrenal cortex and aortic smooth muscle cells: 1) biphasic with enhanced guanylate cyclase activity after exposure to low radiation doses and 2) linear after preincubation of membrane proteins with 0.5-mu-M ANP or solubilization with Triton X-100. The existence of an inhibitory component was the simplest model that best explained the types of radiation curves obtained. Activation of guanylate cyclase by ANP or Triton X-100 could occur via the dissociation of this inhibitory component from the catalytic domain. On the other hand, the loss of ANP-binding activity was linear with increasing radiation exposures under basal, ANP treatment, and Triton X-100 solubilization conditions. Radiation inactivation sizes of about 30 kDa for cyclase function, 20 kDa for ANP-binding function, and 90 kDa for inhibitory function were calculated. These studies suggest that the ANP receptor/guanylate cyclase behaves as a multidomain protein. The results obtained by radiation inactivation of the various biological functions of this receptor are compatible with the hypothesis of an intramolecular inhibitory domain repressing the guanylate cyclase catalytic domain within its membrane environment.	UNIV MONTREAL, IST JUSTINE HOSP, PEDIAT RES CTR, MONTREAL H3T 1C5, QUEBEC, CANADA	Universite de Montreal	TREMBLAY, J (corresponding author), UNIV MONTREAL, HOTEL DIEU HOSP, RES CTR, CELL BIOL HYPERTENS LAB, 3840 ST URBAIN ST, MONTREAL H2W 1R8, QUEBEC, CANADA.		Cossette, Suzanne/I-8008-2016					BEAUREGARD G, 1984, ANAL BIOCHEM, V140, P403, DOI 10.1016/0003-2697(84)90185-4; BEAUREGARD G, 1983, ANAL BIOCHEM, V132, P362, DOI 10.1016/0003-2697(83)90021-0; CANTIN M, 1985, ENDOCR REV, V6, P107, DOI 10.1210/edrv-6-2-107; CARRIER F, 1985, BIOCHEM BIOPH RES CO, V132, P666, DOI 10.1016/0006-291X(85)91184-2; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; FEWTRELL C, 1981, BIOCHEMISTRY-US, V20, P6589, DOI 10.1021/bi00526a011; FULLER F, 1988, J BIOL CHEM, V263, P9395; GUTKOWSKA J, 1984, BIOCHEM BIOPH RES CO, V122, P593, DOI 10.1016/S0006-291X(84)80074-1; HADRAVA V, 1989, HYPERTENSION, V13, P589, DOI 10.1161/01.HYP.13.6.589; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; HARMON JT, 1980, J BIOL CHEM, V255, P3412; KEMPNER ES, 1982, J BIOL CHEM, V257, P13297; KEMPNER ES, 1979, ANAL BIOCHEM, V92, P2, DOI 10.1016/0003-2697(79)90617-1; KUNO T, 1986, J BIOL CHEM, V261, P5817; KUNO T, 1986, J BIOL CHEM, V261, P1470; KUROSE H, 1987, FEBS LETT, V219, P375, DOI 10.1016/0014-5793(87)80256-9; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MELOCHE S, 1986, J BIOL CHEM, V261, P1525; MELOCHE S, 1987, J BIOL CHEM, V262, P10252; OHUCHI S, 1989, BIOCHEM BIOPH RES CO, V158, P603, DOI 10.1016/S0006-291X(89)80092-0; PANDEY KN, 1987, BIOCHEM BIOPH RES CO, V147, P1146, DOI 10.1016/S0006-291X(87)80189-4; PAUL AK, 1987, SCIENCE, V235, P1224, DOI 10.1126/science.2881352; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; POTIER M, 1985, BIOCHEM J, V226, P797, DOI 10.1042/bj2260797; RICHMAN RA, 1980, J CYCLIC NUCL PROT, V6, P461; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHLEGEL W, 1987, TARGET SIZE ANAL MEM, P87; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; SHIMONAKA M, 1987, J BIOL CHEM, V262, P5510; SOLOMONSON LP, 1987, J BIOL CHEM, V262, P8934; SONG DL, 1988, FEBS LETT, V232, P125, DOI 10.1016/0014-5793(88)80400-9; TAKAYANAGI R, 1987, J BIOL CHEM, V262, P12104; TAKAYANAGI R, 1987, BIOCHEM BIOPH RES CO, V144, P244, DOI 10.1016/S0006-291X(87)80502-8; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; TREMBLAY J, 1985, FEBS LETT, V181, P17, DOI 10.1016/0014-5793(85)81105-4; VERKMAN AS, 1984, P NATL ACAD SCI-BIOL, V81, P150, DOI 10.1073/pnas.81.1.150; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; WILLENBROCK RC, 1989, J CLIN INVEST, V83, P482, DOI 10.1172/JCI113907	42	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8171	8175						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673679				2022-12-25	WOS:A1991FK44100036
J	BHANDARI, B; ROESLER, WJ; DELISIO, KD; KLEMM, DJ; ROSS, NS; MILLER, RE				BHANDARI, B; ROESLER, WJ; DELISIO, KD; KLEMM, DJ; ROSS, NS; MILLER, RE			A FUNCTIONAL PROMOTER FLANKS AN INTRONLESS GLUTAMINE-SYNTHETASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED 3T3-L1 ADIPOCYTES; DIBUTYRYL-CYCLIC-AMP; REGULATORY ELEMENTS; MAMMALIAN-CELLS; MESSENGER-RNA; INSULIN; TRANSCRIPTION; INVITRO; DNA; HYDROCORTISONE	We recently reported the 5'-flanking nucleotide sequence of a putative glutamine synthetase (GS) gene from 3T3-L1 cells (Bhandari, B., Beckwith, K. D. & Miller, R. E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5789-5793). We now find that this gene (GSr) has many, but not all, of the characteristics of a typical retroposon. It lacks introns; it contains a short poly(A) tract at its 3' end; it is flanked by 10-base pair (bp) direct repeats; and it corresponds closely at its 5' end to the transcription start site of the intron-containing GS gene (GSi) (Kuo, C. F. & Darnell, J. E., Jr. (1989) J. Mol. Biol. 208, 45-56). GSr includes a full-length, uninterrupted coding sequence that differs little (< 5%) from that of the intron-containing gene. By contrast, the 5'-flanking sequence of GSr has no similarity with that of GSi. The first 1,029 bp of the GSr 5'-flanking sequence drives expression of a promoterless bacterial chloramphenical acetyltransferase (CAT) gene in transfected HeLa cells at a level comparable to that of the Rous sarcoma virus promoter. Analysis of variably deleted GSrCAT fusions genes in both HeLa and 3T3-L1 cells indicates that full promoter activity of the 1,029-bp sequence requires > 348 bp. Moreover, nuclear extract from 3T3-L1 adipocytes as well as murine liver protects four segments in the GSr 5'-flanking sequence from DNase I digestion. Nevertheless, reverse transcription of RNA from 3T3-L1 adipocytes, mouse adipocytes, or mouse liver followed by primer-directed enzymatic amplification of the reverse transcripts reveals the presence of GSi transcripts but the absence of GSr transcripts. Thus, the 5'-flanking sequence of GSr is an active promoter that drives transcription of GSrCAT fusion genes and includes binding domains for proteins that have the potential to regulate transcription. We conclude that the intronless murine GS gene isolated from 3T3-L1 cells arose as a retroposon that was inserted into the genome downstream of a potentially active promoter.	DEPT VET AFFAIRS MED CTR,MED SERV,METAB SECT,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021145] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 07319-11, DK 21145] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRA CN, 1988, SOMAT CELL MOLEC GEN, V14, P69, DOI 10.1007/BF01535050; BHANDARI B, 1986, MOL CELL ENDOCRINOL, V47, P49, DOI 10.1016/0303-7207(86)90015-8; BHANDARI B, 1987, MOL CELL ENDOCRINOL, V51, P7, DOI 10.1016/0303-7207(87)90112-2; BHANDARI B, 1988, P NATL ACAD SCI USA, V85, P5789, DOI 10.1073/pnas.85.16.5789; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOY HA, 1989, J BIOL CHEM, V264, P1754; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRILLO M, 1990, BIOTECHNIQUES, V9, P262; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; Innis MA, 1990, PCR PROTOCOLS GUIDE; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; KUO CF, 1989, J MOL BIOL, V208, P45, DOI 10.1016/0022-2836(89)90086-7; LIN CS, 1989, DNA-J MOLEC CELL BIO, V8, P297, DOI 10.1089/dna.1.1989.8.297; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MILLER RE, 1981, ARCH BIOCHEM BIOPHYS, V209, P486, DOI 10.1016/0003-9861(81)90307-6; MILLER RE, 1985, CURR TOP CELL REGUL, V26, P65; MILLER RE, 1978, P NATL ACAD SCI USA, V75, P1418, DOI 10.1073/pnas.75.3.1418; MILLER RE, 1980, J BIOL CHEM, V255, P5490; MILLER RE, 1983, J BIOL CHEM, V258, P5405; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROGERS J, 1983, NATURE, V301, P460, DOI 10.1038/301460e0; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X	37	26	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7784	7792						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1673462				2022-12-25	WOS:A1991FJ34200075
J	WAKADE, TD; BHAVE, SV; BHAVE, AS; MALHOTRA, RK; WAKADE, AR				WAKADE, TD; BHAVE, SV; BHAVE, AS; MALHOTRA, RK; WAKADE, AR			DEPOLARIZING STIMULI AND NEUROTRANSMITTERS UTILIZE SEPARATE PATHWAYS TO ACTIVATE PROTEIN-KINASE-C IN SYMPATHETIC NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHOLIPID HYDROLYSIS; CEREBRAL CORTICAL SLICES; MEMBRANE DEPOLARIZATION; ENDOTHELIAL-CELLS; HUMAN-PLATELETS; PHOSPHATIDYLCHOLINE; DIACYLGLYCEROL; CA-2+; ACCUMULATION; HEPATOCYTES	Several types of extracellular signals affect the function of peripheral neurons. Depolarizing stimuli cause sudden increases in permeability to various ions leading to propagation of nerve impulses and release of transmitter substances. Neurons also receive external signals via neurotransmitter receptors located on the membrane. Different types of receptors present on sympathetic neurons are believed to modulate stimulation-evoked release of norepinephrine. We have investigated the effects of depolarizing stimuli and neurotransmitters on different signaling pathways in homogeneous cultures of chick sympathetic neurons. Depolarizing stimuli (35 mM KCl; electrical stimulation, 1 Hz for 5 min) and neurotransmitters (acetylcholine and 5-hydroxytryptamine) enhanced membrane binding of protein kinase C by 2-5-fold. 35 mM KCl increased formation of 1,2-diacylglycerol and hydrolysis of [H-3]phosphatidylcholine without affecting [H-3]phosphoinositide hydrolysis. Neurotransmitters increased [H-3]inositol phosphates and 1,2-diacylglycerol without affecting the hydrolysis of [H-3]phosphatidylcholine. 5-Hydroxytryptamine and acetylcholine (muscarinic component) did not increase Ca2+ concentration in the Indo-1-loaded neuronal cell body or the growth cone, but 35 mM KCl and electrical stimulation caused a marked increase in Ca2+ concentration in both regions of sympathetic neurons. We believe this to be the first demonstration of these two types of signalling mechanisms co-existing in sympathetic neurons; depolarization activate the phosphatidylcholine pathway and neurotransmitters activate the phosphatidylinositol pathway. The importance of two pathways in controlling neuronal Ca2+ concentration and the release of transmitter is discussed.	WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,540 E CANFIELD,DETROIT,MI 48201	Wayne State University			Bhave, Sanjiv/K-2398-2012					AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; AUGURT G, 1989, J BIOL CHEM, V264, P21689; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BHAVE SV, 1988, NEUROSCI LETT, V90, P234, DOI 10.1016/0304-3940(88)90818-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCCKINO SB, 1985, J BIOL CHEM, V260, P4201; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BONE EA, 1984, BIOCHEM J, V221, P803, DOI 10.1042/bj2210803; BROWN E, 1984, J NEUROCHEM, V42, P1379, DOI 10.1111/j.1471-4159.1984.tb02798.x; CABOT MC, 1988, FEBS LETT, V233, P153, DOI 10.1016/0014-5793(88)81374-7; EXTON JH, 1990, J BIOL CHEM, V265, P1; FISHER SK, 1983, J BIOL CHEM, V258, P7358; HO AK, 1988, J BIOL CHEM, V263, P9292; HORWITZ J, 1985, J PHARMACOL EXP THER, V237, P312; KENDALL DA, 1984, J NEUROCHEM, V42, P1388, DOI 10.1111/j.1471-4159.1984.tb02799.x; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P299; LINDMAR R, 1988, BIOCHEM PHARMACOL, V37, P4689, DOI 10.1016/0006-2952(88)90339-5; MALHOTRA RK, 1990, FASEB J, V4, P2492, DOI 10.1096/fasebj.4.8.1970791; MALHOTRA RK, 1988, J BIOL CHEM, V263, P2123; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; PREISS J, 1986, J BIOL CHEM, V261, P8597; RAGABTHOMAS JMF, 1987, BIOCHIM BIOPHYS ACTA, V917, P388, DOI 10.1016/0005-2760(87)90117-2; RITTENHOUSESIMMONS S, 1979, J CLIN INVEST, V63, P580, DOI 10.1172/JCI109339; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SANO K, 1985, FEBS LETT, V192, P4, DOI 10.1016/0014-5793(85)80031-4; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P645; TANDON P, 1989, J NEUROCHEM, V53, P1117, DOI 10.1111/j.1471-4159.1989.tb07404.x; WAKADE AR, 1982, J PHARMACOL EXP THER, V223, P125; WAKADE AR, 1982, EXP CELL RES, V140, P71, DOI 10.1016/0014-4827(82)90157-4; WAKADE AR, 1988, J NEUROCHEM, V51, P975, DOI 10.1111/j.1471-4159.1988.tb01835.x; WAKADE TD, 1990, J NEUROCHEM, V55, P1806, DOI 10.1111/j.1471-4159.1990.tb04972.x; White D.A., 1973, FORM FUNCTION PHOSPH; WOLF M, 1985, NATURE, V317, P546, DOI 10.1038/317546a0; WRIGHT TM, 1990, BIOCHEM J, V267, P501, DOI 10.1042/bj2670501	36	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6424	6428						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1672528				2022-12-25	WOS:A1991FE37300064
J	PEASE, RJ; MILNE, RW; JESSUP, WK; LAW, A; PROVOST, P; FRUCHART, JC; DEAN, RT; MARCEL, YL; SCOTT, J				PEASE, RJ; MILNE, RW; JESSUP, WK; LAW, A; PROVOST, P; FRUCHART, JC; DEAN, RT; MARCEL, YL; SCOTT, J			USE OF BACTERIAL EXPRESSION CLONING TO LOCALIZE THE EPITOPES FOR A SERIES OF MONOCLONAL-ANTIBODIES AGAINST APOLIPOPROTEIN-B100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MRC,CLIN RES CTR,DIV MOLEC MED,HARROW HA1 3UJ,MIDDX,ENGLAND; INST PASTEUR,SERV RECH LIPOPROT ATHEROSCLEROSE,F-59019 LILLE,FRANCE; BRUNEL UNIV,DEPT APPL BIOL,CELL BIOL RES GRP,UXBRIDGE UB8 3PH,MIDDX,ENGLAND; CLIN RES INST MONTREAL,LIPOPROT METAB LAB,MONTREAL H2W 1R7,QUEBEC,CANADA	Medical Research Council Clinical Trials Unit; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Brunel University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal				Dean, Roger Thornton/0000-0002-8859-8902				BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; Bilheimer D W, 1984, Agents Actions Suppl, V16, P191; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUTLER R, 1977, 25TH P C PROT BIOL F, P255; CARDIN AD, 1986, BIOCHEMISTRY-US, V25, P5258, DOI 10.1021/bi00366a041; CARDIN AD, 1984, J BIOL CHEM, V259, P8522; CHAPMAN MJ, 1982, EUR J BIOCHEM, V125, P479, DOI 10.1111/j.1432-1033.1982.tb06708.x; CHAPMAN MJ, 1985, DIABETES OBESITY HYP, V3, P103; CHEN PF, 1988, EUR J BIOCHEM, V175, P111, DOI 10.1111/j.1432-1033.1988.tb14172.x; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; COLLINS DR, 1988, NUCLEIC ACIDS RES, V16, P8361, DOI 10.1093/nar/16.17.8361; CURTISS LK, 1982, J BIOL CHEM, V257, P5213; Dietschy J M, 1984, Agents Actions Suppl, V16, P177; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FIEVET C, 1989, J LIPID RES, V30, P1015; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; HAHM KS, 1983, J LIPID RES, V24, P877; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOSPATTANKAR AV, 1986, BIOCHEM BIOPH RES CO, V139, P1078, DOI 10.1016/S0006-291X(86)80287-X; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; KALNINS A, 1983, EMBO J, V2, P593, DOI 10.1002/j.1460-2075.1983.tb01468.x; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P7501, DOI 10.1093/nar/14.18.7501; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; Kostner G. M., 1976, LOW DENSITY LIPOPROT, P229; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; KRUL ES, 1988, J LIPID RES, V29, P937; KRUL ES, 1985, J CLIN INVEST, V75, P361, DOI 10.1172/JCI111708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DM, 1988, CIRCULATION S2, V78, P286; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Maniatis T., 1982, MOL CLONING; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; MARCEL YL, 1987, ARTERIOSCLEROSIS, V7, P166, DOI 10.1161/01.ATV.7.2.166; MARSTON FAO, 1984, BIO-TECHNOL, V2, P800, DOI 10.1038/nbt0984-800; MILNE R, 1989, J BIOL CHEM, V264, P19754; MILNE RW, 1987, MOL IMMUNOL, V24, P435, DOI 10.1016/0161-5890(87)90017-4; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; MILNE RW, 1984, CAN J CELL BIOL, V63, P906; MYANT NB, 1981, BIOL CHOLESTEROL REL, P524; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SALMON S, 1984, BIOCHEM BIOPH RES CO, V125, P704, DOI 10.1016/0006-291X(84)90596-5; SASAKI J, 1983, EUR J BIOCHEM, V131, P535, DOI 10.1111/j.1432-1033.1983.tb07294.x; SCHLAPFER P, 1987, HYBRIDOMA, V6, P575, DOI 10.1089/hyb.1987.6.575; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; SCHONFELD G, 1986, J LIPID RES, V27, P583; SHARROCKS A, 1987, NUCLEIC ACIDS RES, V15, P8564, DOI 10.1093/nar/15.20.8564; SHOULDERS CC, 1985, ATHEROSCLEROSIS, V58, P277, DOI 10.1016/0021-9150(85)90073-5; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; TENG B, 1985, J BIOL CHEM, V260, P5067; THEOLIS R, 1984, ARTERIOSCLEROSIS, V4, P498, DOI 10.1161/01.ATV.4.5.498; THRIFT RN, 1986, J LIPID RES, V27, P236; TIKKANEN MJ, 1983, J LIPID RES, V24, P1494; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; YANISCHPERRON C, 1985, GENE, V33, P109; YOUNG SG, 1986, ARTERIOSCLEROSIS, V6, P178, DOI 10.1161/01.ATV.6.2.178; YOUNG SG, 1987, J CLIN INVEST, V79, P1831, DOI 10.1172/JCI113025; YOUNG SG, 1989, J LIPID RES, V30, P443	68	122	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					553	568						16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688435				2022-12-25	WOS:A1990CF66200083
J	IKEDASAITO, M; LUTZ, RS; SHELLEY, DA; MCKELVEY, EJ; MATTERA, R; HORI, H				IKEDASAITO, M; LUTZ, RS; SHELLEY, DA; MCKELVEY, EJ; MATTERA, R; HORI, H			EPR CHARACTERIZATION OF THE STEREOCHEMISTRY OF THE DISTAL HEME POCKET OF THE ENGINEERED HUMAN MYOGLOBIN MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; ELECTRON-PARAMAGNETIC RESONANCE; SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C PEROXIDASE; RAY CRYSTAL-STRUCTURE; COBALT MYOGLOBINS; ESCHERICHIA-COLI; REVERSIBLE OXYGENATION; 1.5-A RESOLUTION; LIGAND-BINDING	Recombinant human myoglobin mutants with the distal histidine residue replaced by Leu, Val, or Gln residues have been prepared by site-directed mutagenesis and expression in Escherichia coli. The recombinant apomyoglobin proteins have been successfully reconstituted with cobaltous protoporphyrin IX to obtain cobalt myoglobin mutant proteins, and the role of the distal histidine residue on the interaction between the bound ligand and the myoglobin molecule has been studied by EPR spectroscopy. We found that the distal histidine residue is significant in the orientation of the bound oxygen molecule. Low temperature photolysis experiments on both oxy cobalt proteins and ferric nitric oxide complexes indicated that the nature of the photolyzed form depends on the steric crowding of the distal heme pocket. To our surprise, the distal Leu mutant has a less restricted, less sterically crowded distal heme pocket than that of the distal Val mutant myoglobin, despite the fact that Leu has a larger side chain volume than Val. Our results demonstrate that the distal heme pocket steric crowding is not necessarily related to the side chain volume of the E7 residue.	OSAKA UNIV, FAC ENGN SCI, DEPT BIOPHYS ENGN, TOYONAKA, OSAKA 560, JAPAN	Osaka University	IKEDASAITO, M (corresponding author), CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA.		Ikeda-Saito, Masao/A-5992-2008; Ikeda-Saito, Masao/K-2703-2015		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR005659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039359, R01GM039492] Funding Source: NIH RePORTER; NCRR NIH HHS [RR05659] Funding Source: Medline; NIGMS NIH HHS [GM39359, GM39492] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARENTS G, 1989, J MOL BIOL, V210, P149, DOI 10.1016/0022-2836(89)90297-0; BOLOGNESI M, 1990, J MOL BIOL, V213, P621, DOI 10.1016/S0022-2836(05)80249-9; CARVER TE, 1991, BIOCHEMISTRY-US, V30, P4697, DOI 10.1021/bi00233a009; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CHANCE B, 1983, BIOCHEMISTRY-US, V22, P3820, DOI 10.1021/bi00285a017; CHIEN JCW, 1972, P NATL ACAD SCI USA, V69, P2783, DOI 10.1073/pnas.69.10.2783; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P242; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; FISHEL LA, 1987, BIOCHEMISTRY-US, V26, P351, DOI 10.1021/bi00376a004; GOODIN DB, 1986, P NATL ACAD SCI USA, V83, P1295, DOI 10.1073/pnas.83.5.1295; HENDRICH MP, 1989, BIOPHYS J, V56, P489, DOI 10.1016/S0006-3495(89)82696-7; HOFFMAN BM, 1970, J AM CHEM SOC, V92, P61, DOI 10.1021/ja00704a010; HOFFMAN BM, 1970, P NATL ACAD SCI USA, V67, P637, DOI 10.1073/pnas.67.2.637; HORI H, 1990, J BIOL CHEM, V265, P15028; HORI H, 1982, BIOCHEMISTRY-US, V21, P1431, DOI 10.1021/bi00535a050; HORI H, 1982, J BIOL CHEM, V257, P3636; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; IKEDASAITO M, 1977, J BIOL CHEM, V252, P4882; IKEDASAITO M, 1978, BIOCHIM BIOPHYS ACTA, V533, P173, DOI 10.1016/0005-2795(78)90561-5; JONGEWARD KA, 1988, J AM CHEM SOC, V110, P380, DOI 10.1021/ja00210a011; KERR EA, 1985, J BIOL CHEM, V260, P8360; KITAGAWA T, 1982, NATURE, V298, P869, DOI 10.1038/298869a0; KRISHNAMOORTHI R, 1984, J BIOL CHEM, V259, P8826; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; LAMBRIGHT DG, 1989, J MOL BIOL, V207, P289, DOI 10.1016/0022-2836(89)90456-7; MOSKIS D, 1990, J BIOL CHEM, V265, P12143; NAGAI K, 1987, METHOD ENZYMOL, V76, P667; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; PETSKO GA, 1978, FRONTIERS BIOL ENERG, P1011; PHILLIPS SEV, 1981, NATURE, V292, P81, DOI 10.1038/292081a0; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Sambrook J, 1989, MOL CLONING LABORATO; SAVICKI JP, 1984, P NATL ACAD SCI-BIOL, V81, P5417, DOI 10.1073/pnas.81.17.5417; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; STAYTON PS, 1989, MET IONS BIOL SYST, V25, P417; TEAL FWJ, 1959, BIOCHIM BIOPHYS ACTA, V45, P543; VARADARAJAN R, 1989, BIOCHEMISTRY-US, V28, P3771, DOI 10.1021/bi00435a022; VARADARAJAN R, 1985, P NATL ACAD SCI USA, V82, P5681, DOI 10.1073/pnas.82.17.5681; YONETANI T, 1974, J BIOL CHEM, V249, P682; YONETANI T, 1974, J BIOL CHEM, V249, P2168; YU LP, 1990, BIOCHEMISTRY-US, V29, P2578, DOI 10.1021/bi00462a021	41	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23641	23647						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660880				2022-12-25	WOS:A1991GV31900022
J	BARSIGIAN, C; STERN, AM; MARTINEZ, J				BARSIGIAN, C; STERN, AM; MARTINEZ, J			TISSUE (TYPE-II) TRANSGLUTAMINASE COVALENTLY INCORPORATES ITSELF, FIBRINOGEN, OR FIBRONECTIN INTO HIGH-MOLECULAR-WEIGHT COMPLEXES ON THE EXTRACELLULAR SURFACE OF ISOLATED HEPATOCYTES - USE OF 2-[(2-OXOPROPYL)THIO]IMIDAZOLIUM DERIVATIVES AS CELLULAR TRANSGLUTAMINASE INACTIVATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; MEDIATED CROSS-LINKING; AMINO-ACID SEQUENCE; HUMAN FACTOR-XIII; NORMAL RAT-LIVER; PLASMA-MEMBRANES; EPIDERMAL TRANSGLUTAMINASE; GLYCOPROTEIN IIB/IIIA; PARTIAL-PURIFICATION; MONOCLONAL-ANTIBODY	Rabbit hepatocyte surface-expressed tissue (type II) transglutaminase is shown to act as a binding site for fibrinogen or fibronectin and to covalently incorporate these glycoproteins, in addition to itself, into extracellular high molecular weight complexes. This concept is supported by the observation that a nonpeptidyl, active site-directed transglutaminase inactivator (L683685) elicited concentration-dependent (0.1-10-mu-M) decreases in the calcium-dependent binding and covalent cross-linking of I-125-fibrinogen, I-125-fibronectin, or [C-14]putrescine by hepatocyte suspensions. In corroboration with these findings, an antiserum against rabbit liver transglutaminase, which did not cross-react with rabbit factor XIII, elicited concentration-dependent decreases in the calcium-dependent binding and covalent cross-linking of I-125-fibrinogen or [C-14]putrescine by hepatocyte suspensions. Western blots of sodium dodecyl sulfate/Triton-insoluble hepatocyte fractions conducted with this antiserum, with a polyclonal antiserum against human erythrocyte transglutaminase, or with a monoclonal antibody (CUB-7401) against guinea pig liver transglutaminase detected the 80-kDa tissue transglutaminase, as well as tissue transglutaminase-immunoreactive bands of higher molecular mass (range of 90 to > 200 kDa). The higher molecular weight species were preferentially incorporated, in a time- and calcium-dependent manner, into very high molecular weight complexes which did not enter the stacking gel. Incorporation of these tissue transglutaminase-containing bands into the high molecular weight complexes was inhibited by L683685, indicating that cross-linking by the enzyme was responsible for the assembly of the complexes of which tissue transglutaminase was itself a component. Cellular integrins did not mediate ligand binding under the experimental conditions, as evidenced by the failure of the Arg-Gly-Asp-Ser tetrapeptide or anti-integrin antibodies to inhibit binding or cross-linking of I-125-fibrinogen or I-125-fibronectin, in the presence or absence of transglutaminase inactivators.	MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,W POINT,PA 19486	Merck & Company	BARSIGIAN, C (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,CARDEZA FDN HEMATOL RES,PHILADELPHIA,PA 19107, USA.			Stern, Andrew/0000-0002-8437-2957	NHLBI NIH HHS [HL-20092] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020092] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE T, 1977, BIOCHEMISTRY-US, V16, P5495, DOI 10.1021/bi00644a016; ACHYUTHAN KE, 1988, J BIOL CHEM, V263, P14296; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BARNES RN, 1985, CARCINOGENESIS, V6, P459, DOI 10.1093/carcin/6.3.459; BARSIGIAN C, 1987, J BIOL CHEM, V262, P3674; BARSIGIAN C, 1988, J BIOL CHEM, V263, P14015; BARSIGIAN C, 1989, FASEB Journal, V3, pA999; Birckbichler P J, 1978, Ann N Y Acad Sci, V312, P354, DOI 10.1111/j.1749-6632.1978.tb16813.x; BIRCKBICHLER PJ, 1976, CANCER RES, V36, P2911; BIRCKBICHLER PJ, 1985, HYBRIDOMA, V4, P179, DOI 10.1089/hyb.1985.4.179; BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; BOWNESS JM, 1987, J BIOL CHEM, V262, P1022; CARDINALI M, 1990, CANCER RES, V50, P8010; CHANG SK, 1986, J BIOL CHEM, V261, P8112; CHUNG SI, 1972, ANN NY ACAD SCI, V202, P240, DOI 10.1111/j.1749-6632.1972.tb16338.x; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Doolittle R F, 1973, Adv Protein Chem, V27, P1, DOI 10.1016/S0065-3233(08)60446-5; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FARRELL J, 1970, BLOOD-J HEMATOL, V35, P804, DOI 10.1182/blood.V35.6.804.804; FELLIN FM, 1988, J BIOL CHEM, V263, P1791; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; FESUS L, 1981, J CELL BIOL, V89, P706, DOI 10.1083/jcb.89.3.706; FLOYD EE, 1989, MOL CELL BIOL, V9, P4846, DOI 10.1128/MCB.9.11.4846; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GENTILE V, 1991, J BIOL CHEM, V266, P478; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; GREENBERG CS, 1987, BLOOD, V70, P702; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; HAND D, 1988, BIOCHIM BIOPHYS ACTA, V970, P137, DOI 10.1016/0167-4889(88)90172-3; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; IKURA K, 1987, AGR BIOL CHEM TOKYO, V51, P957, DOI 10.1080/00021369.1987.10868103; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; KANNAGI R, 1982, BIOCHEM BIOPH RES CO, V105, P164, DOI 10.1016/S0006-291X(82)80026-0; KIM HC, 1990, J BIOL CHEM, V265, P21971; KIM HC, 1991, J BIOL CHEM, V266, P536; KNIGHT CRL, 1990, FEBS LETT, V265, P93, DOI 10.1016/0014-5793(90)80891-L; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIDY EM, 1990, THROMB RES, V59, P15, DOI 10.1016/0049-3848(90)90267-G; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; MARTINET N, 1988, J BIOL CHEM, V263, P4236; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; MARTINEZHERNANDEZ A, 1985, LAB INVEST, V53, P166; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MOSESSON MW, 1963, J LAB CLIN MED, V62, P663; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; OGAWA H, 1976, J BIOL CHEM, V251, P7281; PARENTEAU NL, 1986, DIFFERENTIATION, V33, P130, DOI 10.1111/j.1432-0436.1986.tb00418.x; PEERSCHKE EIB, 1985, SEMIN HEMATOL, V22, P241; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; SCHMELL E, 1982, J BIOL CHEM, V257, P3171; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; SHEBUSKI RJ, 1990, BLOOD, V75, P1455; SLIFE CW, 1986, J BIOL CHEM, V261, P3451; SLIFE CW, 1985, ARCH BIOCHEM BIOPHYS, V241, P329, DOI 10.1016/0003-9861(85)90554-5; SLIFE CW, 1982, FED PROC, V41, P754; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; TYRRELL DJ, 1988, J BIOL CHEM, V263, P8464; TYRRELL DJ, 1988, J BIOL CHEM, V263, P1946; TYRRELL DJ, 1986, J BIOL CHEM, V2611, P14833; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29	67	105	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22501	22509						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1682320				2022-12-25	WOS:A1991GR56400070
J	GREENBERGER, LM; LISANTI, CJ; SILVA, JT; HORWITZ, SB				GREENBERGER, LM; LISANTI, CJ; SILVA, JT; HORWITZ, SB			DOMAIN MAPPING OF THE PHOTOAFFINITY DRUG-BINDING SITES IN P-GLYCOPROTEIN ENCODED BY MOUSE MDR1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE GENE; BACTERIAL TRANSPORT PROTEINS; PLASMODIUM-FALCIPARUM; CHLOROQUINE RESISTANCE; PHOTOACTIVE ANALOGS; MEMBRANE-VESICLES; ADENYLYL CYCLASE; PLASMA-MEMBRANE; CELL-LINES; EXPRESSION	P-glycoprotein is an energy-dependent drug efflux Pump with broad specificity for hydrophobic antitumor agents such as vinblastine, doxorubicin, and taxol. We have previously shown that [H-3]azidopine and [I-125] iodoaryl azidoprazosin, which are photoaffinity probes for the alpha-1-subunit of the L-type calcium channel and alpha-1-adrenergic receptor, respectively, specifically interact with P-glycoprotein, partially reverse multidrug resistance, and bind to a 6-kDa common domain in the 140-kDa P-glycoprotein molecule (Greenberger, L., Yang, C.-P. H., Gindin, E., and Horwitz, S. B. (1990) J. Biol. Chem. 265, 4394-4401). An immunological approach was used to identify the position of photoaffinity drug-binding domains in P-glycoprotein. Analysis was done with a series of site-specific rabbit polyclonal antibodies to peptides that mimic domains in the mouse mdr1b gene product. The antibodies were made against amino acid residues 269-284, 356-373, 665-682, 740-750, 907-924, and 1203-1222. Upon trypsin digestion, cleavage products of 95 and 55 kDa were obtained, which after further digestion migrated at 60 and 40 kDa, respectively. The 40-kDa fragment was recognized by the antibodies to residues 1203-1222 and 919-1276, while the 55-kDa fragment was recognized by these antibodies plus antibodies to residues 740-750 and 907-924. In contrast, the 95- and 60-kDa trypsin fragments were recognized only by the antibody to residues 269-284. The 55- and 40-kDa fragments, as well as the 95- and 60-kDa fragments, were major photolabeled species after digestion of P-glycoprotein. The previously identified 6-kDa photolabeled P-glycoprotein fragment was within the 40-kDa trypsin fragment. These data suggest that there are two photoaffinity drug-binding domains in P-glycoprotein encoded by mouse mdr1b. The C-terminal site most likely resides within or in close proximity to putative transmembrane domains 11-12.	ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,BRONX,NY 10467; ALBERT EINSTEIN COLL MED,DEPT CELL BIOL,BRONX,NY 10467	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	GREENBERGER, LM (corresponding author), AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965, USA.				NATIONAL CANCER INSTITUTE [R35CA039821, P30CA013330] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA13330, CA 39821] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483; BUSCHE R, 1989, EUR J BIOCHEM, V183, P189, DOI 10.1111/j.1432-1033.1989.tb14912.x; BUSHMAN E, 1991, MOL CELL BIOL, V11, P595; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHAN HSL, 1990, J CLIN ONCOL, V8, P689, DOI 10.1200/JCO.1990.8.4.689; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GLOSSMANN H, 1987, TRENDS PHARMACOL SCI, V8, P95, DOI 10.1016/0165-6147(87)90082-4; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GREENBERGER LM, 1987, J BIOL CHEM, V262, P13685; GREENBERGER LM, 1988, P NATL ACAD SCI USA, V85, P3762, DOI 10.1073/pnas.85.11.3762; GREENBERGER LM, 1988, J NATL CANCER I, V80, P506, DOI 10.1093/jnci/80.7.506; GREENBERGER LM, 1990, J BIOL CHEM, V265, P4394; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; HORIO M, 1989, J BIOL CHEM, V264, P12053; JENNES L, 1983, METHOD ENZYMOL, V103, P448; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; LEVER JE, 1977, J BIOL CHEM, V252, P1990; MATSUI H, 1989, BIOCHEMISTRY-US, V28, P4125, DOI 10.1021/bi00435a075; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; NAITO M, 1989, CANCER RES, V49, P1452; PARHAM P, 1990, NATURE, V348, P674, DOI 10.1038/348674a0; PRATT WB, 1990, PRINCIPLES DRUG ACTI, P595; QIAN XD, 1990, CANCER RES, V50, P1132; RIORDAN JR, 1989, SCIENCE, V245, P1066; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; SAFA AR, 1989, BIOCHEM BIOPH RES CO, V162, P1402, DOI 10.1016/0006-291X(89)90830-9; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SATO H, 1990, LEUKEMIA RES, V14, P11, DOI 10.1016/0145-2126(90)90141-U; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TANAKA S, 1990, BIOCHEM BIOPH RES CO, V166, P180, DOI 10.1016/0006-291X(90)91928-L; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; VERRELLE P, 1991, JNCI-J NATL CANCER I, V83, P111, DOI 10.1093/jnci/83.2.111; WADZINSKI BE, 1990, BIOCHEM J, V272, P151, DOI 10.1042/bj2720151; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; YANG CPH, 1988, BIOCHEM PHARMACOL, V37, P1417; YANG CPH, 1989, J BIOL CHEM, V264, P782; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; Young R. C., 1989, DRUG RESISTANCE CANC, P1; ZEHEB R, 1987, BIOCHEM BIOPH RES CO, V143, P732, DOI 10.1016/0006-291X(87)91415-X	55	109	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20744	20751						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1682313				2022-12-25	WOS:A1991GN00100026
J	KADOWAKI, T; KADOWAKI, H; ACCILI, D; YAZAKI, Y; TAYLOR, SI				KADOWAKI, T; KADOWAKI, H; ACCILI, D; YAZAKI, Y; TAYLOR, SI			SUBSTITUTION OF ARGININE FOR HISTIDINE AT POSITION 209 IN THE ALPHA-SUBUNIT OF THE HUMAN INSULIN-RECEPTOR - A MUTATION THAT IMPAIRS RECEPTOR DIMERIZATION AND TRANSPORT OF RECEPTORS TO THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; DENSITY LIPOPROTEIN RECEPTOR; FMS PROTO-ONCOGENE; TYROSINE KINASE; DEPENDENT COVALENT; RESISTANT PATIENT; STRUCTURAL BASIS; PLASMA-MEMBRANE; LIGAND-BINDING; MUTANT ALLELES	Receptors for insulin and epidermal growth factor contain cysteine-rich domains in the extracellular portion of the molecule. His209 (insulin receptor numbering system) is 1 of 2 amino acid residues that are identically conserved in the cysteine-rich domains of insulin receptors, epidermal growth factor receptors, and other homologous receptors. Previously, we have identified a patient with leprechaunism who is homozygous for a mutation substituting Arg for His209 in the insulin receptor gene (Kadowaki, T., Kadowaki, H., Rechler, M. M., Serrano-Rios, M., Roth, J., Gorden, P., and Taylor, S. 1. (1990) J. Clin. Invest. 86, 254-264). In this investigation, the Arg209 mutant receptor was expressed by transfection of mutant cDNA into NIH-3T3 cells. The mutation impairs several steps in the post-translational processing of the insulin receptor: dimerization of 190-kDa proreceptors into a disulfide linked species, proteolytic cleavage of the proreceptor into alpha- and beta-subunits, and terminal processing of the high mannose form of N-linked oligosaccharide into complex carbohydrate. In addition, the defects in post-translational processing within the endoplasmic reticulum and Golgi apparatus are associated with a marked inhibition in transport of receptors to the plasma membrane. Nevertheless, a small number (almost-equal-to 10%) of the receptors are transported to the cell surface. These receptors on the cell surface bind insulin with normal affinity and have normal tyrosine kinase activity.	NIDDKD,DIABET BRANCH,BLDG 10,RM 8S-243,BETHESDA,MD 20892; ASAHI LIFE FDN,INST DIABET CARE & RES,TOKYO 100,JAPAN; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Asahi Life Foundation; University of Tokyo								ACCILI D, 1991, J BIOL CHEM, V266, P434; ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; BACKER JM, 1989, P NATL ACAD SCI USA, V86, P3209, DOI 10.1073/pnas.86.9.3209; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; CAMA A, 1987, DIABETOLOGIA, V30, P631; CAMA A, 1988, DIABETES, V37, P982, DOI 10.2337/diabetes.37.7.982; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ESSER V, 1988, J BIOL CHEM, V263, P13282; ESSER V, 1988, J BIOL CHEM, V263, P13276; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; GOLDSTEIN BJ, 1990, MOL ENDOCRINOL, V4, P235, DOI 10.1210/mend-4-2-235; GRAY A, 1986, EMBO J, V5, P2503; HEDO JA, 1983, J BIOL CHEM, V258, P20; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; KADOWAKI T, 1990, J CLIN INVEST, V86, P254, DOI 10.1172/JCI114693; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KOBAYASHI M, 1988, DIABETES, V37, P653, DOI 10.2337/diabetes.37.5.653; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LAX I, 1988, MOL CELL BIOL, V8, P1970, DOI 10.1128/MCB.8.5.1970; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; MOMOMURA K, 1988, BIOCHEM BIOPH RES CO, V155, P1181, DOI 10.1016/S0006-291X(88)81264-6; MORRISON BD, 1988, J BIOL CHEM, V263, P7806; OLSON TS, 1988, J BIOL CHEM, V263, P7342; PAVLAKIS GN, 1983, P NATL ACAD SCI-BIOL, V80, P397, DOI 10.1073/pnas.80.2.397; PILCH PF, 1979, J BIOL CHEM, V254, P3375; ROSENBERG AM, 1980, AM J DIS CHILD, V134, P170, DOI 10.1001/archpedi.1980.02130140044014; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; SCHILLING EE, 1979, P NATL ACAD SCI USA, V76, P5877, DOI 10.1073/pnas.76.11.5877; SHIER P, 1989, J BIOL CHEM, V264, P14605; SWEET LJ, 1987, J BIOL CHEM, V262, P16730; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; WILDEN PA, 1989, BIOCHEMISTRY-US, V28, P785, DOI 10.1021/bi00428a056; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938	43	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21224	21231						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657953				2022-12-25	WOS:A1991GN00100099
J	WATKINS, JD; KENT, C				WATKINS, JD; KENT, C			REGULATION OF CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE ACTIVITY AND SUBCELLULAR LOCATION BY PHOSPHORYLATION IN CHINESE-HAMSTER OVARY CELLS - THE EFFECT OF PHOSPHOLIPASE-C TREATMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT HEPATOCYTES; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PROTEIN; ANALOGS; CHOLINE; INVITRO	The phosphorylation state of cytidylyltransferase in Chinese hamster ovary (CHO) cells was correlated with its subcellular distribution and activity in vivo. Western blot analysis of soluble and particulate fractions from control and phospholipase C-treated cells revealed slower migrating forms of cytidylyltransferase present only in the soluble fraction of control cells. These were abolished by incubating the soluble fraction at 37-degrees-C in the presence of 5 mM Mg2+ but persisted if 135 mM NaF was present in the incubation. CHO cells were labeled with P-32(i), and cytidylyltransferase was immunoprecipitated from soluble and particulate fractions from control and phospholipase C-treated cells. The slower migrating forms of cytidylyltransferase, present in the soluble fraction of control cells, were phosphorylated at multiple sites. although an equivalent amount of cytidylyltransferase was immunoprecipitated from the particulate fraction of phospholipase C-treated cells, it contained little P-32. Pretreatment of the CHO cells with okadaic acid, an inhibitor of type 1 and 2A phosphatases, prevented the stimulation of cytidylyltransferase in vivo by phospholipase C. These results demonstrate that dephosphorylation of soluble cytidylyltransferase is required for the phospholipase C-mediated translocation of cytidylyltransferase in CHO cells.	PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NICHD NIH HHS [HD 10580] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010580] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CURRAN T, 1987, ONCOGENE, V2, P79; GROSS I, 1977, BIOCHIM BIOPHYS ACTA, V488, P263, DOI 10.1016/0005-2760(77)90183-7; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; KING EL, 1979, ANAL BIOCHEM, V97, P43; KRUG EL, 1984, ARCH BIOCHEM BIOPHYS, V231, P400, DOI 10.1016/0003-9861(84)90403-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYVA A, 1974, ANAL BIOCHEM, V62, P173, DOI 10.1016/0003-2697(74)90378-9; MORAND JN, 1989, J BIOL CHEM, V264, P13785; MORAND JN, 1988, THESIS PURDUE U; NILES RM, 1979, J BIOL CHEM, V254, P4324; PELECH SL, 1982, BIOCHIM BIOPHYS ACTA, V713, P260, DOI 10.1016/0005-2760(82)90243-0; PELECH SL, 1982, J BIOL CHEM, V257, P4198; PELECH SL, 1981, J BIOL CHEM, V256, P8283; RADIKA K, 1985, BIOCHEM J, V232, P833, DOI 10.1042/bj2320833; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; STEPHENS C, 1986, CANCER CELL, V4, P429; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WATKINS JD, 1990, FASEB J, V4, pA1925; WATKINS JD, 1990, THESIS PURDUE U; WILSON JE, 1978, TRENDS BIOCHEM SCI, V3, P124, DOI 10.1016/S0968-0004(78)80029-2; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919	28	80	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21113	21117						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657950				2022-12-25	WOS:A1991GN00100082
J	LEE, B; VITALE, E; SUPERTIFURGA, A; STEINMANN, B; RAMIREZ, F				LEE, B; VITALE, E; SUPERTIFURGA, A; STEINMANN, B; RAMIREZ, F			G TO T TRANSVERSION AT POSITION +5 OF A SPLICE DONOR SITE CAUSES SKIPPING OF THE PRECEDING EXON IN THE TYPE-III PROCOLLAGEN TRANSCRIPTS OF A PATIENT WITH EHLERS-DANLOS SYNDROME TYPE-IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; SINGLE BASE MUTATION; ALPHA-1(III) CHAIN; COLLAGEN; GENE; PROTEIN; FIBROBLASTS; SECRETION; DEFECT; REGION	We identified a splicing mutation in a patient with Ehlers-Danlos syndrome type IV, a heritable connective tissue disorder associated with dysfunctions of type III collagen. The mutation was first localized in the patient's type III procollagen mRNA by amplifying the reverse transcribed product in several overlapping fragments using the polymerase chain reaction. Amplified products spanning exon 24-26 sequences displayed two distinct fragments, one of normal size and the other lacking the 99 base pairs of exon 25. Sequencing of amplified genomic products identified a G to T transversion at position +5 of the splice donor site of intron 25 in one of the patient's procollagen III genes. Expression of allelic minigene constructs correlated the T for G substitution with skipping of exon 25 sequences. Like previously characterized splicing mutations in other collagen genes, lowering the temperature at which the patient's fibroblasts were incubated nearly abolished exon skipping. As a part of this study, we also identified a highly polymorphic, intronic DNA sequence whose different allelic forms can be detected easily by the polymerase chain reaction technique.	UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8032 ZURICH,SWITZERLAND	University of Zurich	LEE, B (corresponding author), CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029, USA.		superti-furga, andrea/E-9162-2015; vitale, emilia/A-5282-2011	superti-furga, andrea/0000-0002-3543-7531; Vitale, Emilia/0000-0003-4651-3875	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR038648, R01AR038648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKLI S, 1990, J BIOL CHEM, V265, P7324; ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; BYERS PH, 1981, LAB INVEST, V44, P336; BYERS PH, 1983, PRINCIPLES PRACTICE, V2, P836; CHU ML, 1985, J BIOL CHEM, V260, P4357; COLE WG, 1990, J BIOL CHEM, V265, P17070; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; JANECZKO RA, 1989, NUCLEIC ACIDS RES, V17, P6742, DOI 10.1093/nar/17.16.6742; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; STEINMANN BU, 1982, COLLAGEN REL RES, V2, P185; STOLLE CA, 1985, J BIOL CHEM, V260, P1937; SULH HMB, 1984, CLIN GENET, V25, P278; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; SUPERTIFURGA A, 1988, BIOCHEM BIOPH RES CO, V150, P140, DOI 10.1016/0006-291X(88)90497-4; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; TEMPLETON D, 1984, MOL CELL BIOL, V4, P817, DOI 10.1128/MCB.4.5.817; TROMP G, 1989, J BIOL CHEM, V264, P1349; TROMP G, 1989, J BIOL CHEM, V264, P19313; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; [No title captured]	33	77	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5256	5259						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1672129				2022-12-25	WOS:A1991FC21700083
J	BEIN, K; SIMMER, JP; EVANS, DR				BEIN, K; SIMMER, JP; EVANS, DR			MOLECULAR-CLONING OF A CDNA-ENCODING THE AMINO END OF THE MAMMALIAN MULTIFUNCTIONAL PROTEIN CAD AND ANALYSIS OF THE 5'-FLANKING REGION OF THE CAD GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-(PHOSPHONACETYL)-L-ASPARTATE-RESISTANT HAMSTER-CELLS; 1ST 3 ENZYMES; ASPARTATE-TRANSCARBAMYLASE; PYRIMIDINE BIOSYNTHESIS; MESSENGER-RNAS; UMP SYNTHESIS; DOMAIN; SEQUENCE; STEPS	CAD is a 243-kDa multidomain polypeptide which catalyzes the first three steps in mammalian de novo pyrimidine biosynthesis. The largest cDNA clone obtained thus far, pCAD142 (Shigesada, K., Stark, G. R., Maley, J. A., Niswander, L. A., and Davidson, J. N. (1985) Mol. Cell. Biol. 5, 1735), lacks the 5' end of the mRNA which encodes the amino terminus of CAD. To clone this missing segment, a synthetic oligonucleotide complementary to pCAD142 and poly(A)+ RNA template, isolated from a Syrian hamster cell line which overproduces the CAD mRNA, were used for cDNA synthesis. The resulting clone pKB11, which has a 1369-base pair (bp) cDNA insert, overlapping pCAD142 by 781 bp, was identified by hybridization methods and sequence analysis and found to contain the entire cDNA sequence for the amino end of the CAD polypeptide. The deduced amino acid sequence is homologous to seven carbamyl phosphate synthetases. Primer extension, oligonucleotide-directed RNase H digestion, and RNA sequencing indicated that pKB11 extends to within 68 bases of the 5' end of the CAD mRNA. This conclusion was confirmed by Northern blotting analysis of the 5'-flanking region of CAD gene. The probable 3' end of an unidentified gene which codes for a 1-kilobase (kb) transcript was identified immediately upstream of the CAD gene. Northern analysis using probes complementary to the region between the CAD and the 1-kb genes detected the presence of a small transcript of less than 300 nucleotides. The sequence revealed three potential translation initiation sites raising the possibility of more than one CAD translation product. The major translation start codon was identified as the first ATG in pKB11 by sequence homology, in vitro transcription and translation, and protein studies. Starting from this ATG within pKB11, the clone encodes a 143-residue domain of unknown function. This study completes the determination of the primary structure of the CAD polypeptide. The CAD mRNA is 7.5 kb in length and has 6675 bp of coding sequence and about 200 bp and 600 bp of untranslated sequence at the 5' and 3' ends, respectively.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,DETROIT,MI 48201	Wayne State University					NCI NIH HHS [T32 CA 09531, CA 27674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027674, T32CA009531] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BERGER SL, 1987, ANAL BIOCHEM, V161, P272, DOI 10.1016/0003-2697(87)90451-9; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DAVIDSON JN, 1981, J BIOL CHEM, V256, P5220; FARNHAM PJ, 1990, CELL GROWTH DIFFER, V1, P178; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; GRAYSON DR, 1983, J BIOL CHEM, V258, P4123; KELLY RE, 1986, J BIOL CHEM, V261, P6073; KEMPE TD, 1976, CELL, V9, P541, DOI 10.1016/0092-8674(76)90036-2; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRUG MS, 1987, METHOD ENZYMOL, V152, P316; MALLY MI, 1981, P NATL ACAD SCI-BIOL, V78, P6647, DOI 10.1073/pnas.78.11.6647; MORI M, 1975, BIOCHEMISTRY-US, V14, P2622, DOI 10.1021/bi00683a010; NUSSINOV R, 1986, NUCLEIC ACIDS RES, V14, P3557, DOI 10.1093/nar/14.8.3557; PADGETT RA, 1979, J BIOL CHEM, V254, P974; PADGETT RA, 1982, MOL CELL BIOL, V2, P293, DOI 10.1128/MCB.2.3.293; PARK JH, 1986, MOL GENETICS MAMMALI, P79; PAYVAR F, 1979, J BIOL CHEM, V254, P7636; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SHIGESADA K, 1985, MOL CELL BIOL, V5, P1735, DOI 10.1128/MCB.5.7.1735; SHOAF WT, 1973, BIOCHEMISTRY-US, V12, P4039, DOI 10.1021/bi00745a004; SIMMER JP, 1990, J BIOL CHEM, V265, P10395; SIMMER JP, 1990, P NATL ACAD SCI USA, V87, P174, DOI 10.1073/pnas.87.1.174; SIMMER JP, 1989, P NATL ACAD SCI USA, V86, P4382, DOI 10.1073/pnas.86.12.4382; VINCENT BR, 1981, CELL, V27, P267, DOI 10.1016/0092-8674(81)90410-4; WAHL GM, 1979, J BIOL CHEM, V254, P8679	27	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3791	3799						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1671675				2022-12-25	WOS:A1991EY68200068
J	ZABRECKY, JR; LAM, T; MCKENZIE, SJ; CARNEY, W				ZABRECKY, JR; LAM, T; MCKENZIE, SJ; CARNEY, W			THE EXTRACELLULAR DOMAIN OF P185/NEU IS RELEASED FROM THE SURFACE OF HUMAN BREAST-CARCINOMA CELLS, SK-BR-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NEU ONCOGENE; EGF RECEPTOR; POINT MUTATION; KINASE-ACTIVITY; PROTO-ONCOGENE; ANTIBODIES; LIGAND; GENE; MECHANISMS	The human breast carcinoma cell line SK-BR-3, expresses the neu oncogene product, p185, which is a receptor tyrosine kinase. Using a double monoclonal antibody capture enzyme-linked immunosorbent assay for p185, activity was detected in conditioned media from cultures of SK-BR-3 cells. Two monoclonal antibodies specific for the extracellular domain of p185/neu immunoprecipitated a protein with a molecular mass of approximately 105 kDa. p105 was further shown to compete with p185 for binding to monoclonal antibodies and pulse-chase experiments indicate that it was generated by post-translational processing. Peptide maps showed that p105 and p185 are related polypeptides. Since p105 is close to the predicted size for the extracellular domain of p185/neu, we propose that SK-BR-3 cells specifically process and release this portion of the receptor into the medium. The release of the extracellular domain may have implications in oncogenesis and its detection could prove useful as a cancer diagnostic.	DUPONT CO,N BILLERICA,MA 01862	DuPont	ZABRECKY, JR (corresponding author), APPL BIOTECHNOL INC,80 ROGERS ST,CAMBRIDGE,MA 02142, USA.							BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; CHOU CK, 1987, J BIOL CHEM, V262, P1842; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DECKER SJ, 1989, J BIOL CHEM, V264, P17641; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; KHAZAIE K, 1988, EMBO J, V7, P3061, DOI 10.1002/j.1460-2075.1988.tb03171.x; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCKENZIE SJ, 1989, ONCOGENE, V4, P543; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; STEINBERG MJE, 1989, NATURE, V339, P587; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	25	198	215	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1716	1720						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671042				2022-12-25	WOS:A1991EU49700057
J	ITO, M; CONRAD, SE				ITO, M; CONRAD, SE			INDEPENDENT REGULATION OF THYMIDINE KINASE MESSENGER-RNA AND ENZYME LEVELS IN SERUM-STIMULATED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MICHIGAN STATE UNIV, DEPT MICROBIOL, E LANSING, MI 48824 USA	Michigan State University					NCI NIH HHS [CA37144] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037144] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARCOT SS, 1989, J BIOL CHEM, V264, P2343; BOYLE DB, 1987, VIROLOGY, V156, P355, DOI 10.1016/0042-6822(87)90415-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; Favaloro J, 1980, Methods Enzymol, V65, P718; GROSS MK, 1988, NUCLEIC ACIDS RES, V16, P11625, DOI 10.1093/nar/16.24.11625; GROSS MK, 1989, P NATL ACAD SCI USA, V86, P4987, DOI 10.1073/pnas.86.13.4987; GUDAS JM, 1988, P NATL ACAD SCI USA, V85, P4705, DOI 10.1073/pnas.85.13.4705; HOFBAUER R, 1987, NUCLEIC ACIDS RES, V15, P741, DOI 10.1093/nar/15.2.741; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; JOHNSON LF, 1982, EXP CELL RES, V138, P79, DOI 10.1016/0014-4827(82)90093-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS JA, 1986, MOL CELL BIOL, V6, P2262, DOI 10.1128/MCB.6.6.2262; LIEBERMAN HB, 1988, MOL CELL BIOL, V8, P5280, DOI 10.1128/MCB.8.12.5280; MERRILL GF, 1984, MOL CELL BIOL, V4, P1777, DOI 10.1128/MCB.4.9.1777; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; SHERLEY JL, 1988, J BIOL CHEM, V263, P375; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; STEWART CJ, 1987, MOL CELL BIOL, V7, P1156, DOI 10.1128/MCB.7.3.1156; STUART P, 1985, MOL CELL BIOL, V5, P1490, DOI 10.1128/MCB.5.6.1490; STUBBLEF.E, 1965, BIOCHEM BIOPH RES CO, V20, P535, DOI 10.1016/0006-291X(65)90613-3; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAVALI S, 1988, MOL CELL BIOL, V8, P1551, DOI 10.1128/MCB.8.4.1551; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YONG KK, 1988, P NATL ACAD SCI USA, V85, P5894, DOI 10.1073/pnas.85.16.5894	26	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6954	6960						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691180				2022-12-25	WOS:A1990CZ67700072
J	KLEBBA, PE; BENSON, SA; BALA, S; ABDULLAH, T; REID, J; SINGH, SP; NIKAIDO, H				KLEBBA, PE; BENSON, SA; BALA, S; ABDULLAH, T; REID, J; SINGH, SP; NIKAIDO, H			DETERMINANTS OF OMPF PORIN ANTIGENICITY AND STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MARYLAND,DEPT MICROBIOL,COLLEGE PK,MD 20742; UNIV CALIF BERKELEY,DEPT MICROBIOL & IMMUNOL,BERKELEY,CA 94720; ALABAMA STATE UNIV,BIOMED RES & TRAINING PROGRAMS,MONTGOMERY,AL 36195	University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley	KLEBBA, PE (corresponding author), MED COLL WISCONSIN,DEPT MICROBIOL,8701 WATERTOWN PLANK RD,MILWAUKEE,WI 53226, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009644, R01AI009644, R01AI022608] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09644, AI22608] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAVOIL P, 1977, MOL GEN GENET, V158, P23, DOI 10.1007/BF00455116; BENSON SA, 1988, J MOL BIOL, V203, P961, DOI 10.1016/0022-2836(88)90121-0; BENSON SA, 1985, J BACTERIOL, V161, P361, DOI 10.1128/JB.161.1.361-367.1985; BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; CANNON JG, 1984, INFECT IMMUN, V43, P994, DOI 10.1128/IAI.43.3.994-999.1984; CHAI TJ, 1979, J BACTERIOL, V139, P418, DOI 10.1128/JB.139.2.418-423.1979; COLEMAN WG, 1979, J BACTERIOL, V139, P899, DOI 10.1128/JB.139.3.899-910.1979; DORSET DL, 1983, J MOL BIOL, V165, P701, DOI 10.1016/S0022-2836(83)80275-7; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GABAY J, 1983, J BIOL CHEM, V258, P2410; GARTEN W, 1975, EUR J BIOCHEM, V60, P303, DOI 10.1111/j.1432-1033.1975.tb21004.x; Garvey JS, 1977, METHODS IMMUNOLOGY, V3rd; GEHRING KB, 1989, J BIOL CHEM, V264, P2810; HOFSTRA H, 1981, J GEN MICROBIOL, V125, P285; HOFSTRA H, 1980, J GEN MICROBIOL, V117, P437; INOKUCHI K, 1982, NUCLEIC ACIDS RES, V10, P6957, DOI 10.1093/nar/10.21.6957; JAP BK, 1988, J MOL BIOL, V199, P229, DOI 10.1016/0022-2836(88)90393-2; JAP BK, 1989, J MOL BIOL, V205, P407, DOI 10.1016/0022-2836(89)90351-3; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KENNEY AC, 1986, BIOTECHNIQUES, V3, P378; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; MASTUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miller J. H., 1972, EXPT MOL GENETICS, P431; MISHELL BB, 1977, SELECTED METHODS CEL; MIZUNO T, 1983, J BIOL CHEM, V258, P6932; MORONA R, 1985, EUR J BIOCHEM, V150, P161, DOI 10.1111/j.1432-1033.1985.tb09002.x; NABEDRYK E, 1988, BIOPHYS J, V53, P671, DOI 10.1016/S0006-3495(88)83148-5; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H., 1979, BACTERIAL OUTER MEMB, P361; OI VT, 1977, SELECTED METHODS CEL, P357; OVERBEEKE N, 1983, J MOL BIOL, V163, P513, DOI 10.1016/0022-2836(83)90110-9; OVERBEEKE N, 1982, EUR J BIOCHEM, V126, P113, DOI 10.1111/j.1432-1033.1982.tb06754.x; PAUL C, 1985, EMBO J, V4, P1593, DOI 10.1002/j.1460-2075.1985.tb03822.x; PUGSLEY AP, 1978, J BACTERIOL, V135, P1118, DOI 10.1128/JB.135.3.1118-1129.1978; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; REID J, 1988, J BIOL CHEM, V263, P7753; SCHENKMAN S, 1983, J BACTERIOL, V155, P1382, DOI 10.1128/JB.155.3.1382-1392.1983; SHINNICK TM, 1983, ANNU REV MICROBIOL, V37, P425, DOI 10.1146/annurev.mi.37.100183.002233; SILVERMAN JA, 1987, J BACTERIOL, V169, P4830, DOI 10.1128/jb.169.10.4830-4833.1987; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; TAPLITS M, 1979, INFECT IMMUN, V25, P943, DOI 10.1128/IAI.25.3.943-945.1979; VANDERLEY P, 1986, J BIOL CHEM, V261, P2222; VANDERLEY P, 1987, MOL GEN GENET, V209, P585, DOI 10.1007/BF00331167; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; WU HCP, 1984, P NATL ACAD SCI USA, V81, P1048; YAMADA H, 1987, J BIOCHEM-TOKYO, V102, P455, DOI 10.1093/oxfordjournals.jbchem.a122076	48	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6800	6810						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691177				2022-12-25	WOS:A1990CZ67700049
J	UNDEM, BJ; TORPHY, TJ; GOLDMAN, D; CHILTON, FH				UNDEM, BJ; TORPHY, TJ; GOLDMAN, D; CHILTON, FH			INHIBITION BY ADENOSINE 3'-5'-MONOPHOSPHATE OF EICOSANOID AND PLATELET-ACTIVATING FACTOR BIOSYNTHESIS IN THE MOUSE PT-18 MAST-CELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SK&F LABS,DEPT PHARMACOL,KING OF PRUSSIA,PA 19046		UNDEM, BJ (corresponding author), JOHNS HOPKINS ASTHMA & ALLERGY CTR,DIV CLIN IMMUNOL,301 BAYVIEW BLVD,BALTIMORE,MD 21224, USA.				NHLBI NIH HHS [HL 38095] Funding Source: Medline; NIAID NIH HHS [AI 26771, AI 29985] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038095, R01HL038095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026771] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADKINSON NF, 1977, J LAB CLIN MED, V90, P1043; AHARONY D, 1983, BIOCHEM BIOPH RES CO, V117, P574, DOI 10.1016/0006-291X(83)91239-1; ALBERT DH, 1983, J BIOL CHEM, V258, P97; ALONSO F, 1982, J BIOL CHEM, V257, P3376; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONVENTRE JV, 1988, J CLIN INVEST, V82, P168, DOI 10.1172/JCI113566; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; BUSSOLINO F, 1980, IMMUNOLOGY, V40, P367; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHERRINGTON AD, 1976, J BIOL CHEM, V251, P5209; CHILTON FH, 1988, J BIOL CHEM, V263, P5260; CHILTON FH, 1989, FASEB J, V3, P3; CLARK DA, 1980, BIOCHEM BIOPH RES CO, V94, P1133, DOI 10.1016/0006-291X(80)90537-9; FOREMAN JC, 1977, J PHYSIOL-LONDON, V271, P193, DOI 10.1113/jphysiol.1977.sp011996; FOREMAN JC, 1973, NATURE, V245, P249, DOI 10.1038/245249a0; GODFREY RW, 1987, J CELL PHYSIOL, V131, P384, DOI 10.1002/jcp.1041310310; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMBERG M, 1976, BIOCHIM BIOPHYS ACTA, V431, P651, DOI 10.1016/0005-2760(76)90232-0; KAIBUCHI K, 1982, BIOCHEM BIOPH RES CO, V104, P105, DOI 10.1016/0006-291X(82)91946-5; KENNERLY DA, 1979, J IMMUNOL, V122, P152; LAPETINA EG, 1978, P NATL ACAD SCI USA, V75, P818, DOI 10.1073/pnas.75.2.818; LERNER A, 1988, J IMMUNOL, V140, P936; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; LIEDBIG R, 1974, NAUNYNSCHMIEDEBERGS, V284, P279; MACGLASHAN D, 1987, J IMMUNOL, V139, P501; MARONE G, 1987, BIOCHEM PHARMACOL, V36, P13, DOI 10.1016/0006-2952(87)90377-7; MCINTYRE TM, 1987, J BIOL CHEM, V262, P15370; MINKES M, 1977, J CLIN INVEST, V59, P449, DOI 10.1172/JCI108659; MOSKOWITZ N, 1982, SCIENCE, V216, P305, DOI 10.1126/science.6278597; MUELLER HW, 1983, J BIOL CHEM, V258, P6213; MUSCH MW, 1987, BIOCHEM BIOPH RES CO, V144, P1243, DOI 10.1016/0006-291X(87)91444-6; NIELSON CP, 1987, J IMMUNOL, V139, P2392; NIETO ML, 1988, J BIOL CHEM, V263, P4607; ORANGE RP, 1971, J EXP MED, V134, pS136; PARKER J, 1987, J BIOL CHEM, V262, P5385; PEACHELL PT, 1988, J IMMUNOL, V140, P571; PICKETT WC, 1977, BIOCHIM BIOPHYS ACTA, V486, P209, DOI 10.1016/0005-2760(77)90086-8; PLUZNIK DH, 1982, EXP HEMATOL, V10, P211; REED PW, 1972, J BIOL CHEM, V247, P6970; RITTENHOUSESIMMONS S, 1978, BIOCHIM BIOPHYS ACTA, V543, P409, DOI 10.1016/0304-4165(78)90296-9; SCHILD H., 1936, QUART JOUR EXP PHYSIOL, V26, P165; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; TAKENAWA T, 1986, J BIOL CHEM, V261, P1092; TORPHY TJ, 1982, J BIOL CHEM, V257, P1609; UNDEM BJ, 1986, ARCH INT PHARMACOD T, V281, P110; UNDEM BJ, 1988, J PHARMACOL EXP THER, V247, P209; UNDEM BJ, 1985, J PHARMACOL EXP THER, V233, P617; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; WAKU K, 1972, J BIOCHEM-TOKYO, V72, P149, DOI 10.1093/oxfordjournals.jbchem.a129880; WHITE JR, 1984, P NATL ACAD SCI-BIOL, V81, P3978, DOI 10.1073/pnas.81.13.3978; WIGHTMAN PD, 1982, J BIOL CHEM, V257, P6650	53	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6750	6758						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691175				2022-12-25	WOS:A1990CZ67700042
J	SCHUETZ, EG; SCHUETZ, JD; MAY, B; GUZELIAN, PS				SCHUETZ, EG; SCHUETZ, JD; MAY, B; GUZELIAN, PS			REGULATION OF CYTOCHROME-P-450B/E AND P-450P GENE-EXPRESSION BY GROWTH-HORMONE IN ADULT-RAT HEPATOCYTES CULTURED ON A RECONSTITUTED BASEMENT-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MED,RICHMOND,VA 23298; UNIV ADELAIDE,DEPT BIOCHEM,ADELAIDE,SA 5001,AUSTRALIA	Virginia Commonwealth University; University of Adelaide	SCHUETZ, EG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PATHOL,MCV STN,BOX 267,RICHMOND,VA 23298, USA.		Schuetz, John D/N-2692-2018; Schuetz, Erin/N-8087-2018		NIDDK NIH HHS [DK3726] Funding Source: Medline; NIEHS NIH HHS [ES04628] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004628] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADESNIK M, 1981, J BIOL CHEM, V256, P340; ADESNIK M, 1985, CRC CRIT REV BIOCH, V19, P247; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x; BISSELL DM, 1980, J CLIN INVEST, V65, P1135, DOI 10.1172/JCI109767; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; CHIANALE J, 1988, HEPATOLOGY, V8, P327, DOI 10.1002/hep.1840080223; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; DONNER DB, 1978, J BIOL CHEM, V253, P6717; DWARKI VJ, 1987, J BIOL CHEM, V262, P16958; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; Fujita M., 1987, HEPATOLOGY, V7, p1S; GEBHARDT R, 1979, EUR J BIOCHEM, V100, P519, DOI 10.1111/j.1432-1033.1979.tb04197.x; GONZALEZ FJ, 1982, J BIOL CHEM, V257, P5962; GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969; GUZELIAN PS, 1988, P NATL ACAD SCI USA, V85, P9783, DOI 10.1073/pnas.85.24.9783; HARDWICK JP, 1983, J BIOL CHEM, V258, P8081; HARDWICK JP, 1983, J BIOL CHEM, V258, P182; JEFFERSON DM, 1984, MOL CELL BIOL, V4, P1929, DOI 10.1128/MCB.4.9.1929; KATO R, 1988, MICROSOMES DRUG OXID, P140; MACGEOCH C, 1987, BIOCHEM BIOPH RES CO, V143, P782, DOI 10.1016/0006-291X(87)91422-7; MEEHAN RR, 1988, BIOCHEM J, V254, P789, DOI 10.1042/bj2540789; MODE A, 1982, ENDOCRINOLOGY, V111, P1692, DOI 10.1210/endo-111-5-1692; MODE A, 1981, ENDOCRINOLOGY, V108, P2103, DOI 10.1210/endo-108-6-2103; MURTY CVR, 1987, ENDOCRINOLOGY, V121, P1819; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; NEWMAN SL, 1982, BIOCHEM J, V204, P281, DOI 10.1042/bj2040281; OMIECINSKI CJ, 1985, J BIOL CHEM, V260, P3247; REMMER H, 1962, CIBA F S ENZYMES DRU, P276; ROBERTS CT, 1986, J BIOL CHEM, V261, P25; SCHAFFER WT, 1985, AM J PHYSIOL, V248, pE719, DOI 10.1152/ajpendo.1985.248.6.E719; SCHUETZ EG, 1984, J BIOL CHEM, V259, P2007; SCHUETZ EG, 1986, BIOCHEMISTRY-US, V25, P1124, DOI 10.1021/bi00353a027; SCHUETZ EG, 1988, J CELL PHYSIOL, V134, P309, DOI 10.1002/jcp.1041340302; SEELIG S, 1983, BIOCHEM BIOPH RES CO, V115, P882, DOI 10.1016/S0006-291X(83)80017-5; SHINOMIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P1346, DOI 10.1073/pnas.81.5.1346; SIMMONS DL, 1987, J BIOL CHEM, V262, P326; SPENCER EM, 1979, FEBS LETT, V99, P157, DOI 10.1016/0014-5793(79)80269-0; SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202; STEINKAMPF MP, 1988, MOL CELL ENDOCRINOL, V59, P93, DOI 10.1016/0303-7207(88)90199-2; STEWARD AR, 1985, MOL PHARMACOL, V27, P125; STHILAIRE RJ, 1982, HEPATOLOGY, V2, P601; TRABER PG, 1989, J BIOL CHEM, V264, P10292; VOCKENTANZ BM, 1988, CAN J PHYSIOL PHARM, V66, P868, DOI 10.1139/y88-141; VOUTILAINEN R, 1987, P NATL ACAD SCI USA, V84, P1590, DOI 10.1073/pnas.84.6.1590; WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023; WAXMAN DJ, 1989, MOL PHARMACOL, V35, P519; WILLIAMS MT, 1988, BIOCHEM BIOPH RES CO, V155, P392, DOI 10.1016/S0006-291X(88)81098-2; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; WRIGHTON SA, 1985, MOL PHARMACOL, V28, P312; YAMAZOE Y, 1986, J BIOCHEM-TOKYO, V100, P1095, DOI 10.1093/oxfordjournals.jbchem.a121790; YAMAZOE Y, 1987, J BIOL CHEM, V262, P7423; ZAPHIROPOULOS PG, 1988, P NATL ACAD SCI USA, V85, P4214, DOI 10.1073/pnas.85.12.4214	54	131	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1188	1192						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688552				2022-12-25	WOS:A1990CH53300085
J	BECHADE, C; CALOTHY, G				BECHADE, C; CALOTHY, G			CELL-DIVISION IS REQUIRED FOR EXPRESSION OF V-MYC TRANSFORMING PROPERTIES IN CHICKEN EMBRYONIC NEURORETINA CELLS	ONCOGENE			English	Article							ROUS-SARCOMA VIRUS; AVIAN MYELOCYTOMATOSIS VIRUS; NUCLEAR-LOCALIZATION; AUTOCRINE GROWTH; DNA-BINDING; SRC GENE; ONCOGENES; PROLIFERATION; MIL; PROTEINS	We previously reported that avian retrosiruses carrying the v-myc oncogene alone fail to induce sustained proliferation and transformation of non-dividing chicken neuroretina (CNR) cells from 7-day-old embryos. However, v-myc is capable of transforming CNR cells which have been induced to multiply by the v-mil oncogene. These results suggest that entry into the cell cycle is required for the transformation of CNR cells by v-myc. To further assess the role of cell division, we investigated the transforming properties of v-myc in CNR cells conditionally induced to divide by the v-src gene or by modified culture conditions. We show that v-myc transforms CNR cells infected with Rous sarcoma virus mutants which induce cell proliferation in the absence of transformation. Expression of these transforming properties in CNR cells infected with temperature-sensitive v-src mutants depends on the continuous mitogenic activity of p60v-src. We also report that v-myc is able to transform CNR cells and to increase their growth potential under culture conditions which allow transient multiplication of uninfected cells. However, these v-myc-transformed cells rapidly cease to divide when returned to culture conditions that restrict the growth of normal cells. Taken together, these results indicate that transformation of CNR cells by the v-myc oncogene continuously depends on their ability to enter the cell Cycle.	CTR UNIV ORSAY,INST CURIE BIOL,BAT 110,F-91405 ORSAY,FRANCE	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay			Bechade, Catherine/K-5528-2017	Bechade, Catherine/0000-0003-2070-2993				ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; ADKINS B, 1984, CELL, V39, P439, DOI 10.1016/0092-8674(84)90451-3; ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; BECHADE C, 1985, NATURE, V316, P559, DOI 10.1038/316559a0; BECHADE C, 1988, J VIROL, V88, P1211; BISTER K, 1977, VIROLOGY, V82, P431, DOI 10.1016/0042-6822(77)90017-4; BUNTE T, 1983, EMBO J, V2, P1087, DOI 10.1002/j.1460-2075.1983.tb01550.x; CALOTHY G, 1978, VIROLOGY, V89, P75, DOI 10.1016/0042-6822(78)90041-7; CALOTHY G, 1980, COLD SPRING HARB SYM, V44, P983, DOI 10.1101/SQB.1980.044.01.106; CALOTHY G, 1987, J VIROL, V61, P1678, DOI 10.1128/JVI.61.5.1678-1681.1987; CASALBORE P, 1987, NATURE, V316, P188; COLL J, 1983, EMBO J, V2, P2189, DOI 10.1002/j.1460-2075.1983.tb01722.x; CRISANTICOMBES P, 1982, CELL DIFFER DEV, V11, P45, DOI 10.1016/0045-6039(82)90016-1; CRISANTICOMBES P, 1977, CELL TISSUE RES, V185, P159; CROSS FR, 1985, MOL CELL BIOL, V5, P2789, DOI 10.1128/MCB.5.10.2789; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; DUTTA A, 1990, GENE DEV, V4, P243, DOI 10.1101/gad.4.2.243; EYCHENE A, 1990, J VIROL, V64, P231; FERRE F, 1986, CR ACAD SCI III-VIE, V303, P633; GRAF T, 1986, CELL, V45, P357, DOI 10.1016/0092-8674(86)90321-1; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; KAN NC, 1984, P NATL ACAD SCI-BIOL, V81, P3000, DOI 10.1073/pnas.81.10.3000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; MARX M, 1988, J VIROL, V62, P4627, DOI 10.1128/JVI.62.12.4627-4633.1988; MAYER BJ, 1986, J VIROL, V60, P858, DOI 10.1128/JVI.60.3.858-867.1986; PESSAC B, 1974, SCIENCE, V185, P709, DOI 10.1126/science.185.4152.709; POIRIER F, 1982, J VIROL, V42, P780, DOI 10.1128/JVI.42.3.780-789.1982; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; ROYERPOKORA B, 1978, CELL, V13, P751, DOI 10.1016/0092-8674(78)90225-8; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x	38	2	2	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1991	6	12					2311	2317						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX735	1662792				2022-12-25	WOS:A1991GX73500020
J	MUNROE, SH; LAZAR, MA				MUNROE, SH; LAZAR, MA			INHIBITION OF C-ERBA MESSENGER-RNA SPLICING BY A NATURALLY-OCCURRING ANTISENSE RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							THYROID-HORMONE RECEPTOR; GENE-EXPRESSION; OPPOSITE STRAND; CDNA CLONE; IDENTIFICATION; PROTEINS; TISSUES; INVITRO; LOCUS	The rat erbA-alpha locus encodes two overlapping mRNAs, alpha-1 and alpha-2, which are identical except for their most 3' exons. Alpha-1 mRNA encodes a thyroid hormone receptor, while alpha-2 encodes an altered ligand binding domain of unknown function. Previous studies have shown that the ratio of alpha-1 to alpha-2 is highest in cells expressing a high level of a third RNA, Rev-ErbA-alpha mRNA, which is transcribed in the opposite direction and is complementary to alpha-2 but not alpha-1 mRNA. It was hypothesized that base pairing with Rev-ErbA-alpha blocks splicing of alpha-2 mRNA, thereby favoring formation of the non-overlapping alpha-1. To test this model, a system was developed in which alpha-2 pre-mRNAs were accurately spliced in vitro. Splicing was inhibited by the addition of a 5-fold excess of antisense RNAs containing the 3' end of Rev-ErbA-alpha mRNA. Both an antisense RNA extending across the 3' splice site and a shorter RNA complementary only to exon sequences efficiently blocked splicing. However, splicing was only inhibited by complementary RNAs. These observations are consistent with a mechanism in which base pairing with a complementary RNA regulates alternative processing of alpha-1 and alpha-2 mRNAs.	UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania	MUNROE, SH (corresponding author), MARQUETTE UNIV,DEPT BIOL,530 N 15TH ST,MILWAUKEE,WI 53233, USA.		Lazar, Mitchell A/AAF-3738-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM044044] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-44044] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASS CK, 1990, BIOCHIM BIOPHYS ACTA, V1032, P157, DOI 10.1016/0304-419X(90)90002-I; HODIN RA, 1990, J CLIN INVEST, V85, P101, DOI 10.1172/JCI114398; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; LAZAR MA, 1990, J BIOL CHEM, V265, P12859; LAZAR MA, 1990, J BIOL CHEM, V265, P17474; LAZAR MA, 1990, J CLIN INVEST, V86, P1777, DOI 10.1172/JCI114906; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LAZAR MA, 1989, P NATL ACAD SCI USA, V86, P7771, DOI 10.1073/pnas.86.20.7771; MANIATIS T, 1991, SCIENCE, V251, P33, DOI 10.1126/science.1824726; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MITSUHASHI T, 1989, J BIOL CHEM, V264, P8900; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MUNROE SH, 1988, EMBO J, V7, P2523, DOI 10.1002/j.1460-2075.1988.tb03100.x; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; NAKAI A, 1990, MOL CELL ENDOCRINOL, V72, P143, DOI 10.1016/0303-7207(90)90138-X; NAKAI A, 1988, MOL ENDOCRINOL, V2, P1087, DOI 10.1210/mend-2-11-1087; NAKAI A, 1988, P NATL ACAD SCI USA, V85, P2781, DOI 10.1073/pnas.85.8.2781; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	28	154	157	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22083	22086						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657988				2022-12-25	WOS:A1991GR56400005
J	MAGNANI, M; SERAFINI, G; ANTONELLI, A; MALATESTA, M; GAZZANELLI, G				MAGNANI, M; SERAFINI, G; ANTONELLI, A; MALATESTA, M; GAZZANELLI, G			EVIDENCE FOR A PARTICULATE LOCATION OF UBIQUITIN CONJUGATES AND UBIQUITIN-CONJUGATING ENZYMES IN RABBIT BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY PURIFICATION; PROTEIN-DEGRADATION; ACTIVATING ENZYME; INTRACELLULAR-LOCALIZATION; CARRIER PROTEINS; RETICULOCYTES; HEXOKINASE; MATURATION; MECHANISM; RECEPTOR	Conjugate ubiquitin was previously found in the nucleus, cytoplasm, and membranes of eukaryotic cells while the enzymes of the ubiquitin-conjugating system appear to be cytoplasmic. We have prepared the mitochondrial fraction from rabbit brain by discontinuous density gradient ultracentrifugation and by Western blotting, using a specific antibody against conjugate ubiquitin, showing that it contains ubiquitin conjugates in a very wide molecular weight range. Electron microscopy and measurement of specific enzyme markers show that this fraction not only contains mitochondria but also some endoplasmic reticulum vesicles. Immunostaining with anti-ubiquitin IgG followed by immunodecoration with colloidal gold particles provides evidence for the presence of conjugate ubiquitin both in mitochondria and in the endoplasmic reticulum. Furthermore, this "mitochondrial fraction" shows a pronounced ATP-dependent ability to conjugate I-125-ubiquitin into a number of endogenous proteins as evidenced by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. Addition of E1, E2, and E3, the enzymes of the ubiquitin conjugating system purified from rabbit reticulocytes, does not further increase this ubiquitination nor incorporate I-125-ubiquitin into additional protein bands. The same mitochondrial fraction is not able to carry out any ATP-dependent degradation of I-125-albumin; however, it contains an isopeptidase activity able to release the covalently incorporated I-125-ubiquitin and is also able to conjugate I-125-ubiquitin to exogenous proteins as oxidized RNase. By affinity chromatography on ubiquitin-agarose of fraction H of a crude Triton X-100 extract of the mitochondrial fraction, several proteins corresponding in M, to the E1 and E2. enzymes were obtained. These proteins were also able to form specific ubiquitin-thiol ester bounds on sodium dodecyl sulfate-polyacrylamide gels and to support I-125-ubiquitin conjugation to oxidized RNase. Detergent fractionation of the mitochondrial fraction provided evidence for a possible localization of the ubiquitin conjugating activity in the mitochondrial external membrane and endoplasmic reticulum. The presence of an active ubiquitin protein conjugating system in mitochondria and endoplasmic reticulum may be related to the turnover of organelle proteins as well as to specific cell functions such as import of proteins into mitochondria and ubiquitination of externally oriented membrane-bound proteins.	UNIV URBINO,IST ISTOL,I-61029 URBINO,ITALY	University of Urbino	MAGNANI, M (corresponding author), UNIV URBINO,IST CHIM BIOL G FORNAINI,VIA SAFFI 2,I-61029 URBINO,ITALY.		Magnani, Mauro/A-1919-2008	MALATESTA, Manuela/0000-0001-8196-9232; Magnani, Mauro/0000-0001-6456-6626				BEUTLER E, 1975, RED CELL METABOLISM, P65; BOND U, 1988, J BIOL CHEM, V263, P2384; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; COOK JC, 1991, BIOCHEM BIOPH RES CO, V174, P564, DOI 10.1016/0006-291X(91)91454-K; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GALLO JM, 1989, NATURE, V337, P687, DOI 10.1038/337687a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HUNT LT, 1977, BIOCHEM BIOPH RES CO, V74, P650, DOI 10.1016/0006-291X(77)90352-7; JEUTSCH S, 1987, NATURE, V329, P131; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai J C, 1979, Methods Enzymol, V55, P51; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; MAGNANI M, 1986, J BIOL CHEM, V261, P8327; MAGNANI M, 1989, MOL CELL BIOCHEM, V85, P3; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; PARRY DM, 1983, J BIOL CHEM, V258, P904; PARRY DM, 1990, J BIOL CHEM, V265, P1059; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PICCKART CM, 1988, UBIQUITIN, P77; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1988, J BIOL CHEM, V263, P12028; RAPOPORT S, 1985, FEBS LETT, V180, P249, DOI 10.1016/0014-5793(85)81080-2; Rechsteiner M., 1988, UBIQUITIN; REISS Y, 1990, J BIOL CHEM, V265, P3685; SIEGELMAN M, 1988, UBIQUITIN, P239; SMIDT E, 1974, METHOD ENZYMAT AN, P650; STJOHN T, 1986, SCIENCE, V231, P845, DOI 10.1126/science.3003914; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZHAUNG ZP, 1989, J BIOL CHEM, V264, P14594; [No title captured]	46	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21018	21024						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657944				2022-12-25	WOS:A1991GN00100069
J	CHANG, Y; SPICER, DB; SONENSHEIN, GE				CHANG, Y; SPICER, DB; SONENSHEIN, GE			EFFECTS OF IL-3 ON PROMOTER USAGE, ATTENUATION AND ANTISENSE TRANSCRIPTION OF THE C-MYC ONCOGENE IN THE IL-3-DEPENDENT BA F3 EARLY PRE-B CELL-LINE	ONCOGENE			English	Article							INTERLEUKIN-3 DEPENDENCE; GENE; TRANSLOCATION; LYMPHOCYTES; ACTIVATION; ABROGATION; ELEMENT	The c-myc gene uses two major promoters, P1 and P2, for production of mRNA. In most proliferating normal cells, transcripts initiated from P2 predominate over the ones from P1. Furthermore, transcription of normal and translocated c-myc genes is bidirectional and overlapping. In this study, we have measured the effects of interleukin 3 (IL-3) deprivation and restimulation on c-myc promoter usage in the IL-3-dependent pre-B cell line Ba/F3. The rapid drop in c-myc mRNA expression observed in Ba/F3 cells upon IL-3 deprivation is reversible upon restimulation with interleukin. The use of P1 and P2 promoters, as judged by P1/P2 ratio, shifted from 0.2 in cells in exponential growth or in quiescence to 1.3 following IL-3 stimulation. This change was not due to selective instability of one of the two myc transcripts. In vitro nuclear run-on experiments indicated that IL-3 addition resulted in a large release of transcriptional attenuation, as well as a significant increase in transcriptional initiation. These results are consistent with the hypothesis that P1/P2 promoter usage is involved in the control of transcriptional elongation. Furthermore, deprivation of IL-3 resulted in a dramatic increase in antisense transcription, whereas little change was observed in the rate of initiation or elongation of c-myc mRNA precursors. This correlation suggests a negative role for antisense transcription in expression of c-myc mRNA levels in IL-3-deprived Ba/F3 cells.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,80 E CONCORD ST,BOSTON,MA 02118	Boston University					NATIONAL CANCER INSTITUTE [R01CA036355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007429] Funding Source: NIH RePORTER; NCI NIH HHS [CA 36355] Funding Source: Medline; NHLBI NIH HHS [T32 HL07429] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROOME HE, 1987, MOL CELL BIOL, V7, P2988, DOI 10.1128/MCB.7.8.2988; CLEVELAND JL, 1989, MOL CELL BIOL, V9, P5685, DOI 10.1128/MCB.9.12.5685; DEAN M, 1983, NATURE, V305, P443, DOI 10.1038/305443a0; DEAN M, 1987, ONCOGENE RES, V1, P279; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALL DJ, 1990, ONCOGENE, V5, P47; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KINDY MS, 1987, MOL CELL BIOL, V7, P2857, DOI 10.1128/MCB.7.8.2857; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; Maniatis T., 1982, MOL CLONING; MATHEYPREVOT B, 1986, MOL CELL BIOL, V6, P4133, DOI 10.1128/MCB.6.11.4133; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; REICIN A, 1986, MOL CELL BIOL, V6, P4088, DOI 10.1128/MCB.6.11.4088; SPENCER C, 1990, IN PRESS ADV CANCER; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STEWART TA, 1984, SCIENCE, V226, P707, DOI 10.1126/science.6494906; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; YANG JQ, 1985, EMBO J, V4, P1441, DOI 10.1002/j.1460-2075.1985.tb03800.x	22	20	20	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					1979	1982						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1682864				2022-12-25	WOS:A1991GX11900006
J	MAYER, RJ; ADAMS, JL; BOSSARD, MJ; BERKHOUT, TA				MAYER, RJ; ADAMS, JL; BOSSARD, MJ; BERKHOUT, TA			EFFECTS OF A NOVEL LANOSTEROL 14-ALPHA-DEMETHYLASE INHIBITOR ON THE REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE IN HEP G2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; MEVALONATE-DERIVED PRODUCT; HAMSTER OVARY CELLS; CHOLESTEROL-BIOSYNTHESIS; RAT-LIVER; COORDINATE REGULATION; RECEPTOR ACTIVITY; CULTURED-CELLS	A 32-carboxylic acid derivative of lanosterol (SKF 104976) was found to be a potent inhibitor of lanosterol 14-alpha-demethylase (14-alpha-DM). 14-alpha-DM activity in a Hep G2 cell extract was inhibited 50% by 2 nM SKF 104976. Exposure of intact cells to similar concentrations of the compound resulted in the inhibition of incorporation of [C-14]acetate into cholesterol with concomitant accumulation of lanosterol as well as a 40-70% decrease in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) activity. SKF 104976 did not effect low density lipoprotein uptake and degradation in Hep G2 cells, suggesting that HMGR and low density lipoprotein receptor activity were not coordinately regulated under these conditions. Reduction of the flux of carbon units in the sterol synthetic pathway by as much as 80% did not alter the suppressing effect of SKF 104976 on HMGR activity. However, under conditions where sterol synthesis was almost completely blocked by lovastatin, HMGR activity was not suppressed by SKF 104976. Mevalonate, at concentrations that did not decrease HMGR activity, was able to restore the inhibiting effect of SKF 104976 on HMGR activity. The rapid inhibition (2-3 h) of HMGR activity by SKF 104976 to 30-60% of the level in controls was not dependent on the initial amount of HMGR enzyme present. These findings suggest that upon inhibition of 14-alpha-DM by SKF 104976, a mevalonate-derived precursor regulates HMGR activity, even when the sterol synthetic rate is considerably reduced and when HMGR protein levels are very high. In Hep G2 cells, formation of oxylanostenols from [H-3]mevalonate reached a maximum between 1 and 10 nM SKF 104976 and was negligible at higher concentrations. This result suggests that oxylanostenols are not the key mediators of the modulation of HMGR in Hep G2 cells upon 14-alpha-DM inhibition.	SMITHKLINE BEECHAM PHARMACEUT,THE FRYTHE,WELWYN GARDEN CIT AL6 9AR,HERTS,ENGLAND; SMITHKLINE BEECHAM PHARMACEUT,DEPT MED CHEM,KING OF PRUSSIA,PA 19406	GlaxoSmithKline; GlaxoSmithKline								BERG D, 1981, Z NATURFORSCH C, V36, P798; BERKHOUT TA, 1990, BIOCHEM J, V272, P181, DOI 10.1042/bj2720181; BOOGAARD A, 1987, BIOCHEM J, V241, P345, DOI 10.1042/bj2410345; BOSSARD MJ, 1989, BIOORG CHEM, V17, P385, DOI 10.1016/0045-2068(89)90040-0; CHEN HW, 1988, J BIOL CHEM, V263, P1248; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; CLARKE CF, 1985, J BIOL CHEM, V260, P4363; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; DAVIS RA, 1989, PHARMACOL THERAPEUT, V43, P221, DOI 10.1016/0163-7258(89)90119-8; DELACALLE CM, 1988, BIOCHEM J, V250, P33, DOI 10.1042/bj2500033; EDWARDS PA, 1983, J BIOL CHEM, V258, P219; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; FAVATA MF, 1987, J BIOL CHEM, V262, P12254; FISHER RT, 1991, J BIOL CHEM, V266, P6124; GIBBONS GF, 1980, J BIOL CHEM, V255, P395; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GUPTA A, 1986, J BIOL CHEM, V261, P8348; GUPTA AK, 1990, J LIPID RES, V31, P203; HAVEKES LM, 1986, BIOCHIM BIOPHYS ACTA, V875, P236, DOI 10.1016/0005-2760(86)90173-6; HAVEKES LM, 1987, BIOCHEM J, V247, P739, DOI 10.1042/bj2470739; HAVEL C, 1979, J BIOL CHEM, V254, P9573; IGLESIAS J, 1989, BIOCHEM J, V264, P495, DOI 10.1042/bj2640495; KEMPEN HJ, 1987, BIOCHEM PHARMACOL, V36, P1245, DOI 10.1016/0006-2952(87)90077-3; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MIETTINEN TA, 1988, J LIPID RES, V29, P43; MOLOWA DT, 1989, BIOCHEM J, V260, P731, DOI 10.1042/bj2600731; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; OSBORNE TF, 1985, CELL, V42, P203, DOI 10.1016/S0092-8674(85)80116-1; PANINI SR, 1989, J BIOL CHEM, V264, P11044; PEFFLEY D, 1985, J BIOL CHEM, V260, P9949; ROSSER DSE, 1989, J BIOL CHEM, V264, P12653; RUDNEY H, 1986, ANNU REV NUTR, V6, P245, DOI 10.1146/annurev.nu.06.070186.001333; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; TAKAGI K, 1989, J BIOL CHEM, V264, P12352; TRZASKOS J, 1986, J BIOL CHEM, V261, P4651; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; TRZASKOS JM, 1987, J BIOL CHEM, V262, P12261	40	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20070	20078						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657912				2022-12-25	WOS:A1991GM03900033
J	TEMSAMANI, J; RHOADHOUSE, M; PEDERSON, T				TEMSAMANI, J; RHOADHOUSE, M; PEDERSON, T			THE U2 SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE ASSOCIATES WITH NUCLEAR FACTORS IN A PRE-MESSENGER-RNA INDEPENDENT REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L929 MOUSE FIBROBLASTS; SNRNP BINDING; U1 RNA; PROTEINS; SITE; INVITRO; CELL	Northern blot analysis of HeLa cell nuclear extract following electrophoresis in nondenaturing gels revealed that a small proportion of U2 small nuclear ribonucleoprotein (snRNP) displays a low mobility, in confirmation of previous reports. This low mobility form of U2 snRNP (termed LMC, for low mobility complex) also formed in vitro when U2 snRNP present in HeLa cytoplasmic S100 was added to a micrococcal nuclease-treated nuclear extract. Of greater experimental value, we found that the LMC also formed when a T7 U2 RNA transcript was assembled into U2 snRNP in a HeLa cytoplasmic S100 system, followed by its incubation in micrococcal nuclease-treated nuclear extract. LMC formation was ATP-dependent and was specific for U2 snRNP since it was not observed with S100-assembled U1 or U4 snRNPs. RNase H cleavage of U2 snRNP in the nuclear extract with an oligonucleotide complementary to nucleotides 28-42 of U2 RNA, as opposed to micrococcal nuclease treatment, rendered the extract competent to form the LMC, indicating that the nuclear factors responsible for LMC formation reside on endogenous U2 snRNP. LMC formation was not competed by excess U2 RNA but was competed by partially purified native U2 snRNP, providing further evidence that the LMC represents an interaction of nuclear factors with already assembled U2 snRNP. LMC formation did not take place on a mutant U2 snRNP lacking the binding site for the two U2-specific proteins, A' and B", nor on mutant U2 snRNPs lacking nucleotides 34-37 or nucleotides 46-49. Further results revealed that nucleotides 35 and 36 of U2 RNA, but not 34 and 37, are required for LMC formation. These experiments demonstrate a nucleotide sequence-specific interaction of U2 snRNP with nuclear factors in the absence of pre-mRNA. Among the U2 RNA nucleotides involved in the formation of this complex are ones previously implicated in base pairing between U2 RNA and the pre-mRNA lariat branch site. These findings are discussed in the context of the possibility that the LMC is on the spliceosome assembly pathway.	WORCESTER FDN EXPTL BIOL INC,CELL BIOL GRP,SHREWSBURY,MA 01545	Worcester Foundation for Biomedical Research					NIGMS NIH HHS [GM-21595] Funding Source: Medline; PHS HHS [P30-12708-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021595] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOVICH N, 1990, MOL CELL BIOL, V10, P6417, DOI 10.1128/MCB.10.12.6417; AGRAWAL S, 1990, P NATL ACAD SCI USA, V87, P1401, DOI 10.1073/pnas.87.4.1401; BARK C, 1986, GENE, V50, P333, DOI 10.1016/0378-1119(86)90337-9; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELICEIRI GL, 1980, J CELL PHYSIOL, V102, P199, DOI 10.1002/jcp.1041020211; ELICEIRI GL, 1974, CELL, V3, P11, DOI 10.1016/0092-8674(74)90031-2; HAMM J, 1989, CELL, V59, P159, DOI 10.1016/0092-8674(89)90878-7; KLEINSCHMIDT AM, 1989, NUCLEIC ACIDS RES, V17, P4817, DOI 10.1093/nar/17.12.4817; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; KRAMER A, 1988, GENE DEV, V2, P1155, DOI 10.1101/gad.2.9.1155; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; LUHRMANN R, 1988, STRUCTURE FUNCTION M, P71; MADORE SJ, 1984, J CELL BIOL, V98, P188, DOI 10.1083/jcb.98.1.188; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; MAYRAND SH, 1990, NUCLEIC ACIDS RES, V18, P3307, DOI 10.1093/nar/18.11.3307; NELSON KK, 1989, GENE DEV, V3, P1562, DOI 10.1101/gad.3.10.1562; PAN ZQ, 1989, GENE DEV, V3, P1887, DOI 10.1101/gad.3.12a.1887; PATTON JR, 1987, MOL CELL BIOL, V7, P4030, DOI 10.1128/MCB.7.11.4030; PATTON JR, 1988, P NATL ACAD SCI USA, V85, P747, DOI 10.1073/pnas.85.3.747; PATTON JR, 1989, MOL CELL BIOL, V9, P3360, DOI 10.1128/MCB.9.8.3360; PEDERSON T, 1972, P NATL ACAD SCI USA, V69, P2224, DOI 10.1073/pnas.69.8.2224; PIEKIELNY CW, 1989, GENE DEV, V3, P479; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; SAUTERER RA, 1990, J BIOL CHEM, V265, P1048; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; STEITZ JA, SMALL NUCLEAR RIBONU, P115; TAZI J, 1989, NUCLEIC ACIDS RES, V17, P5223, DOI 10.1093/nar/17.13.5223; TEMSAMANI J, 1991, J BIOL CHEM, V266, P468; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1; ZIEVE GW, 1987, J CELL PHYSIOL, V131, P247, DOI 10.1002/jcp.1041310215; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	37	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20356	20362						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657922				2022-12-25	WOS:A1991GM03900071
J	FUNAKOSHI, H; OKUNO, S; FUJISAWA, H				FUNAKOSHI, H; OKUNO, S; FUJISAWA, H			DIFFERENT EFFECTS ON ACTIVITY CAUSED BY PHOSPHORYLATION OF TYROSINE-HYDROXYLASE AT SERINE-40 BY 3 MULTIFUNCTIONAL PROTEIN-KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENAL-MEDULLA; ACTIVATOR PROTEIN; TRYPTOPHAN 5-MONOOXYGENASE; PURIFICATION; 3-MONOOXYGENASE; CALMODULIN; IDENTIFICATION; SITES; ACID; PHOSPHATASE	Tyrosine hydroxylase was maximally phosphorylated by protein kinase C, with a stoichiometry of 0.43 mol of phosphate/mol of tyrosine hydroxylase subunit at Ser40, and by calmodulin-dependent protein kinase 11, with stoichiometries of 0.43 mol/mol at Ser40 and 0.76 mol/mol at Ser19, respectively, without undergoing any significant direct activation. In contrast, the enzyme was maximally phosphorylated with a stoichiometry of 0.78 mol of phosphate/mol of subunit at Ser40 by cAMP-dependent protein kinase, which resulted in a large activation of the enzyme (about 3-fold activation under the assay conditions). Incubation of the enzyme, which had previously been maximally phosphorylated by calmodulin-dependent protein kinase II, with protein kinase C under phosphorylating conditions resulted in no additional incorporation of phosphate into the enzyme, suggesting that both protein kinases phosphorylated Ser40 of the same subunits of the enzyme. Since tyrosine hydroxylase is thought to be composed of four identical subunits, the results may indicate that calmodulin-dependent protein kinase II or protein kinase C phosphorylates only two of the four subunits of the enzyme at Ser40 without affecting the enzyme activity and that cAMP-dependent protein kinase phosphorylates Ser40 of all four subunits of the enzyme molecule, causing a marked activation. Based on a linear relationship between phosphorylation and the resulting activation of the enzyme by cAMP-dependent protein kinase, possible mechanisms for the activation of the enzyme by the protein kinase are discussed.	ASAHIKAWA MED COLL, DEPT BIOCHEM, ASAHIKAWA, HOKKAIDO 078, JAPAN	Asahikawa Medical College								ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; BROWN ER, 1987, BIOCHEMISTRY-US, V26, P5208, DOI 10.1021/bi00390a046; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; Corbin J D, 1974, Methods Enzymol, V38, P287; FUJISAWA H, 1989, ADV ENZYME REGUL, V28, P93, DOI 10.1016/0065-2571(89)90066-6; FUJISAWA H, 1987, METHOD ENZYMOL, V142, P63; FUJISAWA H, 1990, BIOESSAYS, V12, P27, DOI 10.1002/bies.950120106; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HAAVIK J, 1988, BIOCHIM BIOPHYS ACTA, V953, P142, DOI 10.1016/0167-4838(88)90019-2; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; JOHNS EW, 1967, BIOCHEM J, V104, P78, DOI 10.1042/bj1040078; KATOH T, 1991, BIOCHIM BIOPHYS ACTA, V1091, P205, DOI 10.1016/0167-4889(91)90063-4; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURRAY KJ, 1984, J BIOL CHEM, V259, P7673; MUSACCHIO JM, 1971, MOL PHARMACOL, V7, P136; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; OKUNO S, 1989, FEBS LETT, V253, P52, DOI 10.1016/0014-5793(89)80927-5; OKUNO S, 1990, BIOCHIM BIOPHYS ACTA, V1038, P204, DOI 10.1016/0167-4838(90)90206-U; OKUNO S, 1985, J BIOL CHEM, V260, P2633; OKUNO S, 1983, ANAL BIOCHEM, V129, P405, DOI 10.1016/0003-2697(83)90569-9; OKUNO S, 1982, EUR J BIOCHEM, V122, P49, DOI 10.1111/j.1432-1033.1982.tb05846.x; OLIVER D, 1972, BIOCHEM J, V129, P349, DOI 10.1042/bj1290349; OMALLEY KL, 1987, BIOCHEMISTRY-US, V26, P6910, DOI 10.1021/bi00396a007; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PROUD CG, 1977, FEBS LETT, V80, P435, DOI 10.1016/0014-5793(77)80493-6; RICHTAND NM, 1985, J BIOL CHEM, V260, P8465; ROSKOSKI R, 1987, J NEUROCHEM, V48, P840, DOI 10.1111/j.1471-4159.1987.tb05593.x; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; SHIMAN R, 1971, J BIOL CHEM, V246, P1330; VULLIET PR, 1980, P NATL ACAD SCI-BIOL, V77, P92, DOI 10.1073/pnas.77.1.92; VULLIET PR, 1985, FEBS LETT, V182, P335, DOI 10.1016/0014-5793(85)80328-8; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; Warburg O, 1942, BIOCHEM Z, V310, P384; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836; YAMAUCHI T, 1983, EUR J BIOCHEM, V132, P15, DOI 10.1111/j.1432-1033.1983.tb07319.x; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YAMAUCHI T, 1979, J BIOL CHEM, V254, P503; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404	42	59	59	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15614	15620						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1678738				2022-12-25	WOS:A1991GB97700015
J	MATTS, RL; SCHATZ, JR; HURST, R; KAGEN, R				MATTS, RL; SCHATZ, JR; HURST, R; KAGEN, R			TOXIC HEAVY-METAL IONS ACTIVATE THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR-2-ALPHA KINASE BY INHIBITING THE CAPACITY OF HEMIN-SUPPLEMENTED RETICULOCYTE LYSATES TO REDUCE DISULFIDE BONDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; STABILIZED TRANSLATIONAL INHIBITOR; FACTOR-II; ALPHA-SUBUNIT; DOMAIN-SPECIFICITY; SHOCK PROTEIN; OXIDIZED GLUTATHIONE; EIF-2-ALPHA KINASE; GLOBIN SYNTHESIS; METALLOTHIONEIN	Addition of toxic heavy metal ions (Cd2+, Hg2+, and Pb2+) to hemin-supplemented rabbit reticulocyte lysate brings about the activation of the heme-regulated eukaryotic initiation factor 2-alpha kinase (HRI) and the inhibition of protein chain initiation. In this report we examined the effects of monothiol and dithiol compounds, metal ion-chelating agents, and metallothioneins (MT) on metal ion-induced inhibition of protein synthesis. The dithiol compounds dithiothreitol and 2,3-dimercaptopropane sulfonic acid prevented and relieved the inhibition of protein synthesis caused by Cd2+ and Hg2+ in hemin-supplemented lysates, but the monothiol compounds 2-mercaptoethanol, cysteamine, D-(-)penicillamine, and glutathione had no effect. The inhibition of protein synthesis caused by Cd2+ was reversed by the addition of excess EDTA but not by the addition of excess nitrilotriacetic acid. Toxic heavy metal ions inhibited the capacity of hemin-supplemented lysate to reduce disulfide bonds. Addition of excess EDTA to Cd2+-inhibited lysates restored the capacity of the lysate to reduce disulfide bonds and inhibited the phosphorylation of eukaryotic initiation factor eIF-2. MTs and their apoproteins (apoMTs) inhibited the activation of HRI and protected protein synthesis from inhibition by Cd2+, Hg2+, and Pb2+. Addition of apoMTs to heavy metal ion-inhibited lysates restored the capacity of lysates to reduce disulfide bonds. The restoration of the lysate's thioredoxin/thioredoxin reductase activity was accompanied by the inactivation of HRI and the resumption of protein synthesis, indicating that apoMTs can "detoxify" metal ions already bound to proteins. Several observations presented in this report suggest that the binding of metal ions to the alpha-domain of MT is responsible for the ability of MT to sequester bound metal in a non-toxic form. Addition of glucose 6-phosphate or NADPH had no effect on protein synthesis in metal ion-inhibited lysates, and NADPH concentrations in Cd2+-inhibited and hemin-supplemented control lysates were equivalent. The data suggest that the metal ions cause the inhibition of protein synthesis by binding to vicinal sulfhydryl groups present in some critical protein(s), possibly the dithiols present in the active site of thioredoxin and (or) thioredoxin reductase, which leads to the activation of HRI.	OKLAHOMA STATE UNIV, OKLAHOMA AGR EXPT STN, STILLWATER, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	MATTS, RL (corresponding author), OKLAHOMA STATE UNIV, DEPT BIOCHEM, 454 PS II, STILLWATER, OK 74078 USA.				NIEHS NIH HHS [R29ES-04299] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004299] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALMISKANIGUR G, 1982, FEBS LETT, V145, P143, DOI 10.1016/0014-5793(82)81223-4; BELTRAMINI M, 1982, FEBS LETT, V142, P219, DOI 10.1016/0014-5793(82)80138-5; BERNHARD WR, 1986, BIOCHEMISTRY-US, V25, P1975, DOI 10.1021/bi00356a021; BONANOUTZEDAKI SA, 1978, EUR J BIOCHEM, V84, P601, DOI 10.1111/j.1432-1033.1978.tb12203.x; BRADY FO, 1982, TRENDS BIOCHEM SCI, V7, P143, DOI 10.1016/0968-0004(82)90206-7; CHEN JJ, 1989, J BIOL CHEM, V264, P9559; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7; CULLEN WR, 1984, J INORG BIOCHEM, V21, P179, DOI 10.1016/0162-0134(84)83002-0; DEBENEDETTI A, 1986, J BIOL CHEM, V261, P338; DEHERREROS AG, 1985, P NATL ACAD SCI USA, V82, P3119, DOI 10.1073/pnas.82.10.3119; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ERNST V, 1978, P NATL ACAD SCI USA, V75, P4110, DOI 10.1073/pnas.75.9.4110; ERNST V, 1978, J BIOL CHEM, V253, P7163; ERNST V, 1976, P NATL ACAD SCI USA, V73, P1112, DOI 10.1073/pnas.73.4.1112; ERNST V, 1982, HEAT SHOCK BACTERIA, P215; FAGARD R, 1981, P NATL ACAD SCI-BIOL, V78, P866, DOI 10.1073/pnas.78.2.866; GABER BP, 1968, Q REP SULFUR CHEM, V3, P317; GABER BP, 1972, BIOINORG CHEM, V2, P135; GELLER BL, 1982, ARCH BIOCHEM BIOPHYS, V213, P109, DOI 10.1016/0003-9861(82)90445-3; GROSS M, 1972, BIOCHIM BIOPHYS ACTA, V287, P340, DOI 10.1016/0005-2787(72)90383-8; GROSS M, 1978, BIOCHIM BIOPHYS ACTA, V520, P642, DOI 10.1016/0005-2787(78)90149-1; GURD FRN, 1956, ADV PROTEIN CHEM, V11, P311, DOI 10.1016/S0065-3233(08)60424-6; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; HILLSON DA, 1980, BIOCHEM J, V191, P373, DOI 10.1042/bj1910373; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HUNT T, 1983, EUR J BIOCHEM, V131, P303, DOI 10.1111/j.1432-1033.1983.tb07263.x; HUNT T, 1972, J MOL BIOL, V66, P471, DOI 10.1016/0022-2836(72)90427-5; HUNT T, 1979, WIN MIAM S GEN PROT, V16, P321; HURST R, 1987, J BIOL CHEM, V262, P15939; JACKSON RJ, 1983, EUR J BIOCHEM, V131, P289, DOI 10.1111/j.1432-1033.1983.tb07262.x; JACKSON RJ, 1983, EUR J BIOCHEM, V131, P313, DOI 10.1111/j.1432-1033.1983.tb07264.x; JACOBS EE, 1956, J BIOL CHEM, V223, P147; JAKOBY WB, 1958, J BIOL CHEM, V232, P75; JOSHI S, 1981, J BIOL CHEM, V256, P1112; KAEGI JH, 1961, J BIOL CHEM, V236, P2435; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Klotz IM, 1954, MECHANISM ENZYME ACT, P257; KNOWLES FC, 1983, TRENDS BIOCHEM SCI, V8, P178, DOI 10.1016/0968-0004(83)90168-8; KOSOWER NS, 1972, BIOCHIM BIOPHYS ACTA, V272, P623, DOI 10.1016/0005-2787(72)90518-7; LANKS KW, 1986, EXP CELL RES, V165, P1, DOI 10.1016/0014-4827(86)90528-8; LEVIN DH, 1976, P NATL ACAD SCI USA, V73, P3112, DOI 10.1073/pnas.73.9.3112; LI TY, 1980, P NATL ACAD SCI-BIOL, V77, P6334, DOI 10.1073/pnas.77.11.6334; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LONDON IM, 1987, ENZYMES, V18, P359; LONDON IM, 1981, COLD SPRING HARBOR C, V8, P941; Martell A. E., 1974, CRITICAL STABILITY C; MATTS RL, 1989, J BIOL CHEM, V264, P15542; MATTS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2559, DOI 10.1073/pnas.80.9.2559; MICHELSON AM, 1984, J BIOL CHEM, V259, P8529; MOORE EC, 1964, J BIOL CHEM, V239, P3453; NETTESHEIM DG, 1985, BIOCHEMISTRY-US, V24, P6744, DOI 10.1021/bi00345a003; NIELSON KB, 1985, J BIOL CHEM, V260, P5342; NIELSON KB, 1984, J BIOL CHEM, V259, P4941; NIELSON KB, 1983, J BIOL CHEM, V258, P3063; Nordberg M, 1987, Experientia Suppl, V52, P669; OCHOA S, 1983, ARCH BIOCHEM BIOPHYS, V223, P325, DOI 10.1016/0003-9861(83)90598-2; PALOMO C, 1985, ARCH BIOCHEM BIOPHYS, V239, P497, DOI 10.1016/0003-9861(85)90718-0; PIGIET VP, 1986, P NATL ACAD SCI USA, V83, P7643, DOI 10.1073/pnas.83.20.7643; ROSE DW, 1989, J BIOL CHEM, V264, P6239; SANADI DR, 1959, J BIOL CHEM, V234, P183; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; SIEKIERKA J, 1984, P NATL ACAD SCI-BIOL, V81, P352, DOI 10.1073/pnas.81.2.352; SILLEN LG, 1964, CHEM SOC SPECIAL PUB, V17; SPIEGEL AM, 1976, J CYCLIC NUCL PROT, V2, P393; Squibb K.S., 1983, BIOL ENV EFFECTS ARS, V233; STILLMAN MJ, 1987, J BIOL CHEM, V262, P4538; STILLMAN MJ, 1988, J BIOL CHEM, V263, P6128; STILLMAN MJ, 1989, BIOCHEM J, V262, P181, DOI 10.1042/bj2620181; STRICKS W, 1953, J AM CHEM SOC, V75, P5673, DOI 10.1021/ja01118a060; SZYSZKA R, 1989, BIOCHEMISTRY-US, V28, P1435, DOI 10.1021/bi00430a001; TRACHSEL H, 1978, P NATL ACAD SCI USA, V75, P3654, DOI 10.1073/pnas.75.8.3654; UDOM AO, 1980, BIOCHEM J, V187, P329, DOI 10.1042/bj1870329; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; WU JM, 1981, J BIOL CHEM, V256, P4164; ZAHLER WL, 1968, J BIOL CHEM, V243, P716	80	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12695	12702						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1676400				2022-12-25	WOS:A1991FV18000092
J	SELMI, S; SAMUELS, HH				SELMI, S; SAMUELS, HH			THYROID-HORMONE RECEPTOR AND V-ERBA - A SINGLE AMINO-ACID DIFFERENCE IN THE C-TERMINAL REGION INFLUENCES DOMINANT NEGATIVE ACTIVITY AND RECEPTOR DIMER FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; GENE-EXPRESSION; ONCOGENE; PROTEIN; DOMAIN; TRANSCRIPTION; ACTIVATION; MEDIATE; ELEMENT	Thyroid hormone receptors are cellular homologues (c-erbAs) of the v-erbA oncoprotein of the avian erythroblastosis virus. Exclusive of the viral gag region, v-erbA differs from the chick c-erbA-alpha receptor by two amino acid changes N-terminal of the DNA binding domain, two amino acid changes in the DNA binding domain, nine amino acid changes in the C-terminal region corresponding to the ligand binding domain of c-erbA, and a nine-amino acid deletion near the C terminus. v-erbA does not bind thyroid hormone and when expressed in cells inhibits the activity of wild-type thyroid hormone receptors. We reported previously that mutants of chick c-erbA/thyroid hormone receptor which lack the DNA binding domain (DBD-) inhibit transcriptional activation by wild-type thyroid hormone and retinoic acid receptors (Forman, B. M., Yang, C.-R., Au, M., Casanova, J., Ghysdael, J., and Samuels, H. H. (1989) Mol. Endocrinol. 3, 1610-1626). This dominant negative activity mapped to a series of hydrophobic heptad motifs which are conserved in the C terminus of these receptors and have been suggested to play a role in receptor dimerization. In this study we show that unlike DBD- c-erbA, DBD-v-erbA does not block receptor activity, suggesting that v-erbA acts by competing for DNA response elements rather than by formation of nonfunctional v-erbA/c-erbA heterodimers. This difference in activity was localized to a single Pro to Ser change in v-erbA just N-terminal of the last heptad motif. Introduction of this Pro to Ser change into DBD- c-erbA resulted in a protein which was inactive both functionally and in blocking receptor dimer formation in vitro.	NYU MED CTR,SCH MED,DEPT PHARMACOL,550 1ST AVE,RM TH 454,NEW YORK,NY 10016; NYU,SCH MED,DEPT MED,NEW YORK,NY 10016; NYU,SCH MED,DIV MOLEC ENDOCRINOL,NEW YORK,NY 10016	New York University; New York University; New York University			RUBY, Samia/T-1131-2019	RUBY, Samia/0000-0001-9491-9285	NIDDK NIH HHS [DK16636] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016636, R37DK016636] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; FORMAN BM, 1991, IN PRESS GENE AMST; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; HOROWITZ ZD, 1989, MOL ENDOCRINOL, V3, P148, DOI 10.1210/mend-3-1-148; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SPURR NK, 1984, EMBO J, V3, P159, DOI 10.1002/j.1460-2075.1984.tb01777.x; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	23	59	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11589	11593						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1675637				2022-12-25	WOS:A1991FT76200029
J	PONZETTO, C; GIORDANO, S; PEVERALI, F; DELLAVALLE, G; ABATE, ML; VAULA, G; COMOGLIO, PM				PONZETTO, C; GIORDANO, S; PEVERALI, F; DELLAVALLE, G; ABATE, ML; VAULA, G; COMOGLIO, PM			C-MET IS AMPLIFIED BUT NOT MUTATED IN A CELL-LINE WITH AN ACTIVATED MET TYROSINE KINASE	ONCOGENE			English	Article							CYSTIC-FIBROSIS GENE; PROTO-ONCOGENE; AMPLIFICATION; PROTOONCOGENE; EXPRESSION; RECEPTOR; SEQUENCE; OVEREXPRESSION; IDENTIFICATION; FIBROBLASTS	The putative tyrosine kinase receptor encoded by the oncogene c-met is activated (tyrosine-phosphorylated in vivo) in the human gastric carcinoma cell line GTL-16. The corresponding gene is amplified and over-expressed. In this study we show that c-met is part of an amplification unit measuring more than 3000 kb. The multiple copies of the amplicon are located on a novel chromosome different from chromosome 7. We have previously shown that the c-met protein present in GTL-16 cells is indistinguishable from that found in other cells. Kinase activation could be due to over-expression of the normal c-met protein or to the presence of activating mutation(s). To verify the primary structure of the c-met protein in GTL-16 cells we sequenced a series of overlapping cDNAs obtained from GTL-16 cell RNA by reverse transcription and polymerase chain reaction. Two differences were found in the c-met coding region with respect to the published human c-met cDNA: (1) the lack of 54 nucleotides corresponding to a stretch of 18 amino acids located in the extracellular domain of the receptor, and (2) the substitution of the codon specifying alanine 1209 (located in the tyrosine kinase domain) with one coding for glycine. However, we also obtained cDNAs identical to that just described from a number of control cell lines. These results suggest: (1) that the present c-met cDNA presumably reflects the sequence of the most abundant transcript in several cell types, and (2) that overexpression of the normal c-met protein, alone or in combination with an autocrine loop, is most probably responsible for the activation of the c-met kinase in GTL-16 cells.	UNIV PAVIA,DEPT GENET & MICROBIOL,I-27100 PAVIA,ITALY	University of Pavia	PONZETTO, C (corresponding author), UNIV TURIN,DEPT BIOMED SCI & ONCOL,C SO M DAZEGLIO 52,I-10126 TURIN,ITALY.		Giordano, Silvia/J-9858-2018; Peverali, Fiorenzo/J-2660-2012	Giordano, Silvia/0000-0003-1854-1086; Peverali, Fiorenzo/0000-0001-6717-6586; Comoglio, Paolo/0000-0002-7056-5328				AMBROOK J, 1989, MOL CLONING LABORATO; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAN AML, 1988, ONCOGENE, V2, P593; COOPER CS, 1986, EMBO J, V5, P2623, DOI 10.1002/j.1460-2075.1986.tb04543.x; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; CORNAGLIAFERRARIS P, 1990, PEDIATR RES, V27, P1, DOI 10.1203/00006450-199001000-00001; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1988, AM J HUM GENET, V43, P471; GIORDANO S, 1988, J CELL BIOCHEM, V38, P229, DOI 10.1002/jcb.240380402; GIORDANO S, 1989, ONCOGENE, V4, P1383; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; HUDZIAK RM, 1990, CELL GROWTH DIFFER, V1, P129; IYER A, 1990, CELL GROWTH DIFFER, V1, P87; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LAWRENCE JB, 1988, CELL, V52, P51; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; PARK M, 1986, COLD SPRING HARB SYM, V51, P967, DOI 10.1101/SQB.1986.051.01.110; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SOMAN NR, 1990, P NATL ACAD SCI USA, V87, P738, DOI 10.1073/pnas.87.2.738; TEMPEST PR, 1986, FEBS LETT, V209, P357, DOI 10.1016/0014-5793(86)81142-5; TRENT JM, 1987, CANCER GENET CYTOGEN, V26, P187, DOI 10.1016/0165-4608(87)90150-6; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x	32	175	187	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					553	559						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	1674365				2022-12-25	WOS:A1991FR93900008
J	SCHLENDER, KK; BEAN, LJ				SCHLENDER, KK; BEAN, LJ			PHOSPHORYLATION OF CHICKEN CARDIAC C-PROTEIN BY CALCIUM CALMODULIN-DEPENDENT PROTEIN KINASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE; RABBIT SKELETAL-MUSCLE; MYOFIBRILLAR PROTEIN; CATALYTIC SUBUNIT; PURIFICATION; IDENTIFICATION; INHIBITION; MYOSIN; HEART	Chicken cardiac C-protein was readily phosphorylated by purified calcium/calmodulin-dependent protein kinase II (CaM-kinase II). Maximum incorporation was about 4 mol of P-32/mol C-protein subunit. Peptide mapping indicated that some of the sites phosphorylated by CaM-kinase II were located on the same phosphopeptides obtained when C-Protein was phosphorylated by the cAMP-dependent protein kinase (peptides T1, T2, and T3). There was a fourth peptide (T3a) which was unique to CaM-kinase II phosphorylation. P-32-Amino acid analysis showed that essentially all of the P-32 of peptides T1, T2, and T3a was in phosphoserine. cAMP-dependent protein kinase incorporated P-32 only into threonine of peptide T3. Threonine was the preferred site of phosphorylation by CaM-kinase II, but there was significant phosphorylation of a serine in peptide T3. Partially purified C-protein preparations contained an associated calcium/calmodulin-dependent protein kinase. Peptide maps obtained from C-protein phosphorylated by the endogenous kinase were similar to those obtained from C-protein phosphorylated by CaM-kinase II. However, the ratio of phosphothreonine to phosphoserine in peptide T3 was lower. This was due to a contaminating phosphatase in the partially purified C-protein which preferentially dephosphorylated the phosphothreonine of peptide T3. It is suggested that the calcium/calmodulin-dependent protein kinase associated with C-protein is similar or identical to CaM-kinase II and that CaM-kinase II may play a role in the phosphorylation of C-protein in the heart.			SCHLENDER, KK (corresponding author), MED COLL OHIO,DEPT PHARMACOL,POB 10008,TOLEDO,OH 43699, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 36573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALDWIN SW, 1989, ADV PROTEIN PHOSPHAT, V5, P507; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER RH, 1980, J BIOL CHEM, V255, P1794; CRIMMINS DL, 1988, J CHROMATOGR, V443, P63, DOI 10.1016/S0021-9673(00)94783-6; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HARTZELL HC, 1984, J GEN PHYSIOL, V83, P563, DOI 10.1085/jgp.83.4.563; HARTZELL HC, 1982, J BIOL CHEM, V257, P2111; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; JEACOCKE SA, 1980, FEBS LETT, V122, P129, DOI 10.1016/0014-5793(80)80418-2; JETT MF, 1987, ARCH BIOCHEM BIOPHYS, V255, P354, DOI 10.1016/0003-9861(87)90403-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM MS, 1986, BIOCHEM CELL BIOL, V64, P622, DOI 10.1139/o86-086; LIM MS, 1985, BIOCHEM BIOPH RES CO, V132, P1187, DOI 10.1016/0006-291X(85)91932-1; MELLGREN RL, 1983, BIOCHEM BIOPH RES CO, V114, P148, DOI 10.1016/0006-291X(83)91606-6; MOOS C, 1975, J MOL BIOL, V97, P1, DOI 10.1016/S0022-2836(75)80017-9; PAYNE ME, 1983, J BIOL CHEM, V258, P2376; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; SCHLENDER KK, 1987, BIOCHIM BIOPHYS ACTA, V928, P312, DOI 10.1016/0167-4889(87)90191-1; SCHLENDER KK, 1980, BIOCHIM BIOPHYS ACTA, V615, P324, DOI 10.1016/0005-2744(80)90500-8; SCHLENDER KK, 1988, BIOCHEM BIOPH RES CO, V155, P45, DOI 10.1016/S0006-291X(88)81047-7; SCHLENDER KK, 1989, ADV PROTEIN PHOSPHAT, V5, P37; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; SHEORAIN VS, 1985, J BIOL CHEM, V260, P1567; SOLARO RJ, 1986, PROTEIN PHOSPHORYLAT, P129; WALSH MP, 1979, J BIOL CHEM, V254, P2136; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x	29	78	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2811	2817						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1671569				2022-12-25	WOS:A1991EX60000025
J	TSURIMOTO, T; STILLMAN, B				TSURIMOTO, T; STILLMAN, B			REPLICATION FACTORS REQUIRED FOR SV40 DNA-REPLICATION INVITRO .2. SWITCHING OF DNA POLYMERASE-ALPHA AND POLYMERASE-DELTA DURING INITIATION OF LEADING AND LAGGING STRAND SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; CELL NUCLEAR ANTIGEN; T-ANTIGEN; AUXILIARY PROTEIN; MULTIPLE STAGES; ORIGIN; DELTA; ALPHA; IDENTIFICATION; PURIFICATION	Replication factors A and C (RF-A and RF-C) and the proliferating cell nuclear antigen (PCNA) differentially augment the activities of DNA polymerases alpha and delta. The mechanism of stimulation by these replication factors was investigated using a limiting concentration of primed, single-stranded template DNA. RF-A stimulated polymerase alpha activity in a concentration-dependent manner, but also suppressed nonspecific initiation of DNA synthesis by both polymerases alpha and delta. The primer recognition complex, RF-C.PCNA.ATP, stimulated pol delta activity in cooperation with RF-A, but also functioned to prevent abnormal initiation of DNA synthesis by polymerase alpha. Reconstitution of DNA replication with purified factors and a plasmid containing the SV40 origin sequences directly demonstrated DNA polymerase alpha dependent synthesis of lagging strands and DNA polymerase delta/PCNA/RF-C dependent synthesis of leading strands. RF-A and the primer recognition complex both affected the relative levels of leading and lagging strands. These results, in addition to results in an accompanying paper (Tsurimoto, T., and Stillman, B. (1991) J. Biol. Chem. 266, 1950-1960), suggest that an exchange of DNA polymerase complexes occurs during initiation of bidirectional DNA replication at the SV40 origin.			TSURIMOTO, T (corresponding author), COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724, USA.			Tsurimoto, Toshiki/0000-0001-7597-2216; Stillman, Bruce/0000-0002-9453-4091	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; GOETZ GS, 1988, J BIOL CHEM, V263, P383; HUANG CC, 1981, J BIOL CHEM, V256, P4087; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Kornberg A., 1982, DNA REPLICATION S; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; MACE DC, 1984, J MOL BIOL, V177, P313, DOI 10.1016/0022-2836(84)90459-5; Maniatis T., 1982, MOL CLONING; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MELENDY T, 1991, J BIOL CHEM, V266, P1942; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; ROBERTS JM, 1989, P NATL ACAD SCI USA, V86, P3939, DOI 10.1073/pnas.86.11.3939; SELICK HE, 1987, UCLA S MOL CELLULAR, P183; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9742, DOI 10.1073/pnas.86.24.9742; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	38	254	255	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1961	1968						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671046				2022-12-25	WOS:A1991EU49700089
J	DANIELPOUR, D; SPORN, MB				DANIELPOUR, D; SPORN, MB			DIFFERENTIAL INHIBITION OF TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-BETA-2 ACTIVITY BY ALPHA-2-MACROGLOBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											DANIELPOUR, D (corresponding author), NCI,CHEMOPREVENT LAB,BLDG 41,RM 1115,BETHESDA,MD 20892, USA.							BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; Bauer J, 1988, Adv Exp Med Biol, V240, P199; BORTH W, 1986, IMMUNOLOGY, V57, P367; COFFEY RJ, 1987, J CLIN INVEST, V80, P750, DOI 10.1172/JCI113130; CORVERA S, 1989, J BIOL CHEM, V264, P10133; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; FELDMAN SR, 1985, BIOCHEM BIOPH RES CO, V128, P795, DOI 10.1016/0006-291X(85)90117-2; FLETCHER S, 1988, EUR J BIOCHEM, V171, P703, DOI 10.1111/j.1432-1033.1988.tb13842.x; FROLIK CA, 1984, J BIOL CHEM, V259, P995; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; GLICK AB, 1990, MOL ENDOCRINOL, V4, P46, DOI 10.1210/mend-4-1-46; GONIAS SL, 1983, BIOCHEM J, V209, P99, DOI 10.1042/bj2090099; HUANG JS, 1983, J CELL BIOL, V97, P383, DOI 10.1083/jcb.97.2.383; HUANG SS, 1988, J BIOL CHEM, V263, P1535; JENNINGS JC, 1988, J CELL PHYSIOL, V137, P167, DOI 10.1002/jcp.1041370120; JENSEN PH, 1988, PLACENTA, V9, P463, DOI 10.1016/0143-4004(88)90019-7; KIRSHNER N, 1989, AM J PHYSIOL, V256, pC779, DOI 10.1152/ajpcell.1989.256.4.C779; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PIRCHER R, 1986, BIOCHEM BIOPH RES CO, V136, P30, DOI 10.1016/0006-291X(86)90872-7; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SPORN M B, 1988, Biofactors, V1, P89; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; THOMAS T, 1989, DEV BIOL, V134, P38, DOI 10.1016/0012-1606(89)90076-6; VANLEUVEN F, 1978, EXP CELL RES, V117, P273, DOI 10.1016/0014-4827(78)90141-6; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646	33	153	157	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6973	6977						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691181				2022-12-25	WOS:A1990CZ67700075
J	COLOMA, TAS; REICHERT, LE				COLOMA, TAS; REICHERT, LE			IDENTIFICATION OF A FOLLICLE-STIMULATING-HORMONE RECEPTOR-BINDING REGION IN HFSH-BETA-(81-95) USING SYNTHETIC PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNION UNIV,DEPT BIOCHEM,A-10,ALBANY,NY 12208	Union College			Santa-Coloma, Tomas/I-1254-2019	Santa-Coloma, Tomas/0000-0002-3266-1095	NICHD NIH HHS [HD-21388] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021388] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSEN T T, 1987, Biology of Reproduction, V36, P125; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BLACK J, 1989, SCIENCE, V245, P486, DOI 10.1126/science.2569237; CHOU DY, 1978, ANNU REV BIOCHEM, V47, P251; COLOMA TAS, 1990, IN PRESS BIOCHEMISTR; DATTATREYAMURTY B, 1987, J BIOL CHEM, V262, P11737; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRASSO P, 1989, ENDOCRINOLOGY, V125, P3029, DOI 10.1210/endo-125-6-3029; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KEUTMANN HT, 1987, P NATL ACAD SCI USA, V84, P2038, DOI 10.1073/pnas.84.7.2038; KEUTMANN HT, 1989, MOL ENDOCRINOL, V3, P526, DOI 10.1210/mend-3-3-526; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PIERCE JG, 1971, STRUCTURE ACTIVITY R, P91; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SCHNEYER AL, 1988, BIOCHEMISTRY-US, V27, P666, DOI 10.1021/bi00402a026; SCHNEYER AL, 1986, ENDOCRINOLOGY, V119, P1446, DOI 10.1210/endo-119-4-1446; SLUSS PM, 1986, BIOCHEMISTRY-US, V25, P2644, DOI 10.1021/bi00357a053; STEWART M, 1977, J MOL BIOL, V116, P175, DOI 10.1016/0022-2836(77)90126-7; Ward D.N., 1979, ANIMAL MODELS RES FE, P151; WARD DN, 1978, STRUCTURE FUNCTION G, P31	27	80	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1990	265	9					5037	5042						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CV587	1690733				2022-12-25	WOS:A1990CV58700045
J	PEDERSEN, SE; BRIDGMAN, PC; SHARP, SD; COHEN, JB				PEDERSEN, SE; BRIDGMAN, PC; SHARP, SD; COHEN, JB			IDENTIFICATION OF A CYTOPLASMIC REGION OF THE TORPEDO NICOTINIC ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT BY EPITOPE MAPPING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,660 S EUCLID AVE,ST LOUIS,MO 63110	Washington University (WUSTL)				Pedersen, Steen E./0000-0001-8755-8899	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS022828, R01NS019522] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19522, NS 22828] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1982, J CELL BIOL, V93, P501, DOI 10.1083/jcb.93.2.501; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; BRIDGMAN PC, 1987, J CELL BIOL, V105, P1829, DOI 10.1083/jcb.105.4.1829; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; CARR C, 1987, BIOCHEMISTRY-US, V26, P7090, DOI 10.1021/bi00396a034; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CRIADO M, 1985, P NATL ACAD SCI USA, V82, P2004, DOI 10.1073/pnas.82.7.2004; CURTIS CAM, 1989, J BIOL CHEM, V264, P489; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; DUNN SMJ, 1986, BIOCHEM BIOPH RES CO, V139, P830, DOI 10.1016/S0006-291X(86)80065-1; DWYER BP, 1988, BIOCHEMISTRY-US, V27, P5586, DOI 10.1021/bi00415a029; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GUY HR, 1984, BIOPHYS J, V45, P249, DOI 10.1016/S0006-3495(84)84152-1; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KAO PN, 1984, J BIOL CHEM, V259, P1662; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCHELLE WJ, 1985, J CELL BIOL, V100, P684, DOI 10.1083/jcb.100.3.684; LODISH HF, 1988, TRENDS BIOCHEM SCI, V13, P332, DOI 10.1016/0968-0004(88)90101-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAELICKE A, 1989, BIOCHEMISTRY-US, V28, P1396, DOI 10.1021/bi00429a068; MCCARTHY MP, 1986, ANNU REV NEUROSCI, V9, P383; MCCREA PD, 1987, EMBO J, V6, P1619; MERLIE JP, 1981, J BIOL CHEM, V256, P3605; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NODA M, 1983, NATURE, V301, P251, DOI 10.1038/301251a0; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2633, DOI 10.1021/bi00357a052; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SMITH MM, 1986, J BIOL CHEM, V261, P4825; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; Stewart JM, 1984, SOLID PHASE PEPTIDE; STJOHN PA, 1982, J CELL BIOL, V92, P333, DOI 10.1083/jcb.92.2.333; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; VANDLEN RL, 1979, BIOCHEMISTRY-US, V18, P1845, DOI 10.1021/bi00577a001; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WONG SKF, 1988, J BIOL CHEM, V263, P7925; WRAY BE, 1984, J HISTOCHEM CYTOCHEM, V31, P1117; YOUNG EF, 1985, P NATL ACAD SCI USA, V82, P626, DOI 10.1073/pnas.82.2.626	57	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					569	581						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688436				2022-12-25	WOS:A1990CF66200084
J	LONGLEY, MJ; MOSBAUGH, DW				LONGLEY, MJ; MOSBAUGH, DW			PROPERTIES OF THE 3' TO 5' EXONUCLEASE ASSOCIATED WITH PORCINE LIVER DNA POLYMERASE-GAMMA - SUBSTRATE-SPECIFICITY, PRODUCT ANALYSIS, INHIBITION, AND KINETICS OF TERMINAL EXCISION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID POLYMERASE; DROSOPHILA-MELANOGASTER EMBRYOS; VIRUS REVERSE-TRANSCRIPTASE; AVIAN-MYELOBLASTOSIS VIRUS; ESCHERICHIA-COLI; 3'->5' EXONUCLEASE; RAT-LIVER; CATALYTIC SUBUNIT; NOVIKOFF HEPATOMA; NEUROSPORA-CRASSA	Porcine liver DNA polymerase-gamma was shown previously to copurify with an associated 3' to 5' exonuclease activity (Kunkel, T. A., and Mosbaugh, D. W. (1989) Biochemistry 28, 988-995). The 3' to 5' exonuclease has now been characterized, and like the DNA polymerase activity, it has an absolute requirement for a divalent metal cation (Mg2+ or Mn2+), a relatively high NaCl and KCl optimum (150-200 mM), and an alkaline pH optimum between 7 and 10. The exonuclease has a 7.5-fold preference for single-stranded over double-stranded DNA, but it cannot excise 3'-terminal dideoxy-NMP residues from either substrate. Excision of 3'-terminally mismatched nucleotides was preferred approximately 5-fold over matched 3' termini, and the hydrolysis product from both was a deoxyribonucleoside 5'-monophosphate. The kinetics of 3'-terminal excision were measured at a single site on M13mp2 DNA for each of the 16 possible matched and mismatched primer template combinations. As defined by the substrate specificity constant (V(max)/K(m)), each of the 12 mismatched substrates was preferred over the four matched substrates (A.T, T.A, C.G, G.C). Furthermore, the exonuclease could efficiently excise internally mismatched nucleotides up to 4 residues from the 3' end. DNA polymerase-gamma was not found to possess detectable DNA primase, endonuclease, 5' to 3' exonuclease, RNase, or RNase H activities. The DNA polymerase and exonuclease activities exhibited dissimilar rates of heat inactivation and sensitivity to N-ethylmaleimide. After nondenaturing activity gel electrophoresis, the DNA polymerase and 3' to 5' exonuclease activities were partially resolved and detected in situ as separate species. A similar analysis on a denaturing activity gel identified catalytic polypeptides with molecular weights of 127,000, 60,000, and 32,000 which possessed only DNA polymerase-gamma activity. Collectively, these results suggest that the polymerase and exonuclease activities reside in separate polypeptides, which could be derived from separate gene products or from proteolysis of a single gene product.	OREGON STATE UNIV,DEPT AGR CHEM,CORVALLIS,OR 97331; OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; OREGON STATE UNIV,CTR ENVIRONM HLTH SCI,CORVALLIS,OR 97331	Oregon State University; Oregon State University; Oregon State University					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032823] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [GM32823] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEBENEK K, 1990, J BIOL CHEM, V265, P13878; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BOLDEN A, 1977, J BIOL CHEM, V252, P3351; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BRENOWITZ S, 1991, J BIOL CHEM, V266, P7888; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; CHAMPOUX JJ, 1984, J VIROL, V49, P686, DOI 10.1128/JVI.49.3.686-691.1984; CHOW TYK, 1983, J BIOL CHEM, V258, P2010; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; COTTERILL SM, 1987, P NATL ACAD SCI USA, V84, P5635, DOI 10.1073/pnas.84.16.5635; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; DOMENA JD, 1988, BIOCHEMISTRY-US, V27, P6742, DOI 10.1021/bi00418a015; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; FARMERIE WG, 1987, SCIENCE, V236, P305, DOI 10.1126/science.2436298; FOURY F, 1989, J BIOL CHEM, V264, P20552; FRASER MJ, 1983, J BACTERIOL, V154, P460, DOI 10.1128/JB.154.1.460-470.1983; FRY M, 1986, ANIMAL CELL DNA POLY, P91; GRANDGENETT DP, 1973, P NATL ACAD SCI USA, V70, P230, DOI 10.1073/pnas.70.1.230; HUBER HE, 1989, J BIOL CHEM, V264, P4669; INSDORF NF, 1989, J BIOL CHEM, V264, P21498; INSDORF NF, 1989, J BIOL CHEM, V264, P21491; ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716; JOYCE CM, 1989, J BIOL CHEM, V264, P10858; KAGUNI LS, 1989, P NATL ACAD SCI USA, V86, P6469, DOI 10.1073/pnas.86.17.6469; KALF GF, 1968, J BIOL CHEM, V243, P4904; KNOPF KW, 1976, BIOCHEMISTRY-US, V15, P4540, DOI 10.1021/bi00665a032; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1989, BIOCHEMISTRY-US, V28, P988, DOI 10.1021/bi00429a011; LEDWITH BJ, 1986, J BIOL CHEM, V261, P6571; LONGLEY M J, 1989, Methods in Molecular and Cellular Biology, V1, P79; LONGLEY MJ, 1990, NUCLEIC ACIDS RES, V18, P7317, DOI 10.1093/nar/18.24.7317; LONGLEY MJ, 1991, BIOCHEMISTRY-US, V30, P2655, DOI 10.1021/bi00224a014; LONGLEY MJ, 1992, IN PRESS METHODS E 1; MAKI H, 1987, P NATL ACAD SCI USA, V84, P4389, DOI 10.1073/pnas.84.13.4389; MATSUKAGE A, 1981, BIOCHIM BIOPHYS ACTA, V655, P269, DOI 10.1016/0005-2787(81)90037-X; MATSUKAGE A, 1975, BIOCHEMISTRY-US, V14, P1006, DOI 10.1021/bi00676a020; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130; MEYER RR, 1970, J BIOL CHEM, V245, P3426; MORRISON A, 1991, IN PRESS P NATL ACAD; MOSBAUGH DW, 1980, J BIOL CHEM, V255, P239; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113; ROBERTGUROFF M, 1977, BIOCHEMISTRY-US, V16, P2866, DOI 10.1021/bi00632a010; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2266, DOI 10.1021/bi00407a003; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STALKER DM, 1976, BIOCHEMISTRY-US, V15, P3114, DOI 10.1021/bi00659a027; WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WONG TW, 1985, J BIOL CHEM, V260, P1530; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P7002	57	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24702	24711						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662214				2022-12-25	WOS:A1991GW84500072
J	THOMPSON, AK; MOSTAFAPOUR, SP; DENLINGER, LC; BLEASDALE, JE; FISHER, SK				THOMPSON, AK; MOSTAFAPOUR, SP; DENLINGER, LC; BLEASDALE, JE; FISHER, SK			THE AMINOSTEROID U-73122 INHIBITS MUSCARINIC RECEPTOR SEQUESTRATION AND PHOSPHOINOSITIDE HYDROLYSIS IN SK-N-SH NEUROBLASTOMA-CELLS - A ROLE FOR GP IN RECEPTOR COMPARTMENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURO-BLASTOMA CELLS; BETA-ADRENERGIC-RECEPTOR; C-DEPENDENT PROCESSES; POLYMORPHONUCLEAR NEUTROPHILS; CHOLINERGIC RECEPTORS; REQUIREMENTS; STIMULATION; TURNOVER; AGONISTS; BRAIN	The relationship between muscarinic receptor activation of phosphoinositide hydrolysis and the sequestration of cell surface muscarinic receptors has been examined for both intact and digitonin-permeabilized human SK-N-SH neuroblastoma cells. Addition of the aminosteroid 1-[6-[[17-beta-3-methoxyestra-1,3,5(10)trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) to intact cells resulted in the inhibition of oxotremorine-M-stimulated inositol phosphate release and of Ca2+ signaling by > 75%. In contrast, when phospholipase C was directly activated by the addition of the calcium ionophore ionomycin, inclusion of U-73122 had little inhibitory effect. Addition of U-73122 to intact cells also inhibited the agonist-induced sequestration of cell surface muscarinic receptors and their subsequent down-regulation with an IC50 value (4.1-mu-M) similar to that observed for inhibition of inositol phosphate release (3.7-mu-M). In contrast, when oxotremorine-M-stimulated phosphoinositide hydrolysis was inhibited by depletion of extracellular Ca2+, no reduction in the extent of receptor sequestration was observed. When introduced into digitonin-permeabilized cells, U-73122 more markedly inhibited inositol phosphate release elicited by either oxotremorine-M or guanosine-5'-O-(3-thiotriphosphate) than that induced by added Ca2+. Addition of oxotremorine-M to permeabilized cells resulted in muscarinic receptor sequestration and down-regulation. Both the loss of muscarinic acetylcholine receptors and activation of phosphoinositide hydrolysis in permeabilized cells were inhibited by the inclusion of guanosine-5'-O-(2-thiodiphosphate). The results indicate that the agonist-induced sequestration of muscarinic acetylcholine receptor in SK-N-SH cells requires the involvement of a GTP-binding protein but not the production of phosphoinositide-derived second messenger molecules.	UNIV MICHIGAN, NEUROSCI LAB, 1103 E HURON ST, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, DEPT PHARMACOL, ANN ARBOR, MI 48104 USA; UPJOHN CO, DEPT CELL BIOL, KALAMAZOO, MI 49001 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pfizer	FISHER, SK (corresponding author), UNIV MICHIGAN, NEUROSCI LAB, 1103 E HURON ST, ANN ARBOR, MI 48104 USA.				NIGMS NIH HHS [5T32 GM 07767-10] Funding Source: Medline; NIMH NIH HHS [MH 42652] Funding Source: Medline; NINDS NIH HHS [NS 23831] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH042652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIL M, 1989, J NEUROCHEM, V53, P1479, DOI 10.1111/j.1471-4159.1989.tb08541.x; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CHEUNG AH, 1989, MOL PHARMACOL, V35, P132; CHEUNG AH, 1990, MOL PHARMACOL, V37, P775; EVANS T, 1985, BIOCHEM J, V232, P751, DOI 10.1042/bj2320751; FISHER SK, 1989, MOL PHARMACOL, V35, P195; FISHER SK, 1990, MOL PHARMACOL, V38, P54; FISHER SK, 1987, MOL PHARMACOL, V32, P81; FISHER SK, 1988, J NEUROCHEM, V50, P984, DOI 10.1111/j.1471-4159.1988.tb03008.x; FISHER SK, 1988, MOL PHARMACOL, V33, P414; GEIGER PJ, 1972, ANAL BIOCHEM, V49, P467, DOI 10.1016/0003-2697(72)90450-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HONEGGER P, 1976, BRAIN RES, V109, P335, DOI 10.1016/0006-8993(76)90534-5; LEE CH, 1991, IN PRESS J BIOL CHEM, V266; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P129, DOI 10.1073/pnas.82.1.129; MCKERNAN RM, 1987, MOL PHARMACOL, V32, P258; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; THOMPSON AK, 1990, J PHARMACOL EXP THER, V252, P744; THOMPSON AK, 1991, J BIOL CHEM, V266, P5004; THOMPSON AK, 1909, FASEB J, V5, pA480; YU VC, 1986, J BIOL CHEM, V261, P1065	25	480	481	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23856	23862						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660886				2022-12-25	WOS:A1991GV31900052
J	RAY, MK; YANG, J; SUNDARAM, S; STANLEY, P				RAY, MK; YANG, J; SUNDARAM, S; STANLEY, P			A NOVEL GLYCOSYLATION PHENOTYPE EXPRESSED BY LEC23, A CHINESE-HAMSTER OVARY MUTANT DEFICIENT IN ALPHA-GLUCOSIDASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; N-ACETYLGLUCOSAMINYLTRANSFERASE-I; D-MANNOSIDASE; PROCESSING GLUCOSIDASES; H-1-NMR SPECTROSCOPY; MAMMALIAN-CELL; G-GLYCOPROTEIN; MAMMARY-GLAND; HUMAN-GENE; CHO CELLS	Lec23 Chinese hamster ovary (CHO) cells have been shown to possess a unique lectin resistance phenotype and genotype compared with previously isolated CHO glycosylation mutants (Stanley, P., Sallustio, S., Krag, S. S., and Dunn, B. (1990) Somatic Cell Mol. Genet. 16, 211-223). In this paper, a biochemical basis for the lec23 mutation is identified. The carbohydrates associated with the G glycoprotein of vesicular stomatitis virus (VSV) grown in Lec23 cells (Lec23/VSV) were found to possess predominantly oligomannosyl carbohydrates that bound strongly to concanavalin A-Sepharose, eluted 3 sugar eq beyond a Man9GlcNAc marker oligosaccharide on ion suppression high pressure liquid chromatography, and were susceptible to digestion with jack bean alpha-mannosidase. Monosaccharide analyses revealed that the oligomannosyl carbohydrates contained glucose, indicating a defect in alpha-glucosidase activity. This was confirmed by further structural characterization of the Lec23/VSV oligomannosyl carbohydrates using purified rat mammary gland alpha-glucosidase I, jack bean alpha-mannosidase, and H-1 NMR spectroscopy at 500 MHz. [H-3]Glucose-labeled Glc3Man9GlcNAc was prepared from CHO/VSV labeled with [H-3]galactose in the presence of the processing inhibitors castanospermine and deoxymannojirimycin. Subsequently, [H-3]Glc2Man9GlcNAc was prepared by purified alpha-glucosidase I digestion of [H-3] Glc3Man9GlcNAc. When these oligosaccharides were used as alpha-glucosidase substrates it was revealed that Lec23 cells are specifically defective in alpha-glucosidase I, a deficiency not previously identified among mammalian cell glycosylation mutants.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT CELL BIOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine				Stanley, Pamela/0000-0001-5704-3747	PHS HHS [P01 13330, R01 36434] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRILES EB, 1982, INT REV CYTOL, V75, P101, DOI 10.1016/S0074-7696(08)61003-7; BYRD JC, 1982, J BIOL CHEM, V257, P4657; CARVER JP, 1981, BIOCHEMISTRY-US, V20, P6600, DOI 10.1021/bi00526a013; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; ESMON B, 1984, J BIOL CHEM, V259, P322; FODDY L, 1988, EUR J BIOCHEM, V175, P291, DOI 10.1111/j.1432-1033.1988.tb14196.x; FUJIMOTO K, 1991, J BIOL CHEM, V266, P3571; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; HUGHES RC, 1987, BIOCHEM J, V247, P537, DOI 10.1042/bj2470537; HUGHES RC, 1986, EUR J BIOCHEM, V158, P227, DOI 10.1111/j.1432-1033.1986.tb09742.x; KINGSLEY DM, 1986, MOL CELL BIOL, V6, P2734, DOI 10.1128/MCB.6.7.2734; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; KUMAR R, 1990, MOL CELL BIOL, V10, P3857; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; LEHRMAN MA, 1989, J BIOL CHEM, V264, P1584; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; MARTINIUK F, 1985, J BIOL CHEM, V260, P4351; MELLIS SJ, 1981, ANAL BIOCHEM, V114, P276, DOI 10.1016/0003-2697(81)90480-2; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; REITMAN ML, 1982, J BIOL CHEM, V257, P357; ROMERO PA, 1986, CARBOHYD RES, V151, P21, DOI 10.1016/S0008-6215(00)90326-4; ROMERO PA, 1986, J BIOL CHEM, V261, P5936; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; SHAILUBHAI K, 1990, J BIOL CHEM, V265, P9701; SHAILUBHAI K, 1987, BIOCHEM J, V247, P555, DOI 10.1042/bj2470555; STANLEY P, 1985, MOL CELL BIOL, V5, P1204, DOI 10.1128/MCB.5.6.1204; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1984, ARCH BIOCHEM BIOPHYS, V230, P363, DOI 10.1016/0003-9861(84)90119-X; STANLEY P, 1990, SOMAT CELL MOLEC GEN, V16, P211, DOI 10.1007/BF01233357; STANLEY P, 1987, TRENDS GENET, V3, P77, DOI 10.1016/0168-9525(87)90180-6; STANLEY P, 1987, METHOD ENZYMOL, V138, P443; STANLEY P, 1982, ARCH BIOCHEM BIOPHYS, V219, P128, DOI 10.1016/0003-9861(82)90141-2; STOLL J, 1982, P NATL ACAD SCI-BIOL, V79, P2296, DOI 10.1073/pnas.79.7.2296; TABAS I, 1978, J BIOL CHEM, V253, P7779; TRIMBLE RB, 1986, J BIOL CHEM, V261, P9815; TSAI PK, 1984, P NATL ACAD SCI-BIOL, V81, P6340, DOI 10.1073/pnas.81.20.6340; TULSIANI DRP, 1990, ARCH BIOCHEM BIOPHYS, V277, P114, DOI 10.1016/0003-9861(90)90558-G; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7636; VEROSTEK MF, 1991, J BIOL CHEM, V266, P5547	43	51	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					22818	22825						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660460				2022-12-25	WOS:A1991GT48300010
J	SAITO, Y; MIZUNO, T; ITAKURA, M; SUZUKI, Y; ITO, T; HAGIWARA, H; HIROSE, S				SAITO, Y; MIZUNO, T; ITAKURA, M; SUZUKI, Y; ITO, T; HAGIWARA, H; HIROSE, S			PRIMARY STRUCTURE OF BOVINE ENDOTHELIN ETB RECEPTOR AND IDENTIFICATION OF SIGNAL PEPTIDASE AND METAL PROTEINASE CLEAVAGE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONING; EXPRESSION; GENE; CDNA; FAMILY	A cDNA clone corresponding to the entire coding region of the bovine ET(B) endothelin receptor mRNA was isolated from a lung cDNA library and sequenced. The cDNA encodes 441 amino acids: 26 constituting an NH2-terminal signal peptide and 415 constituting the mature receptor. The signal peptidase cleavage site was determined by direct amino acid sequencing of purified receptor. A comparison of the predicted amino acid sequence with the available bovine ET(A) and rat ET(B) endothelin receptor sequences revealed 63 and 85% homology, respectively. Endothelin receptors of various species are known to be very sensitive to a certain metal proteinase(s) and have been shown to be converted to a lower M(r) form in the absence of EDTA. The metal proteinase cleavage site was also determined by direct protein sequencing of the proteolysis product. The amino acid sequence (Ala-Gly-X-Pro-Pro-Arg) surrounding the cleavage site (between Ala-79 and Gly-80) is conserved among the ET(B) endothelin receptors, explaining the above mentioned proteolytic conversion from the higher to lower M(r) forms observed in various species.			SAITO, Y (corresponding author), TOKYO INST TECHNOL,DEPT BIOL SCI,MEGURO KU,TOKYO 152,JAPAN.							ALBERT PR, 1990, J BIOL CHEM, V265, P5825; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BOLGER GT, 1990, J CARDIOVASC PHARM, V15, P946, DOI 10.1097/00005344-199006000-00013; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BORGES R, 1989, EUR J PHARMACOL, V165, P223, DOI 10.1016/0014-2999(89)90716-4; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; EGUCHI S, 1991, BIOMED RES-TOKYO, V12, P35, DOI 10.2220/biomedres.12.35; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; HAGIWARA H, 1990, BIOMED RES-TOKYO, V11, P93, DOI 10.2220/biomedres.11.93; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOZUKA M, 1991, J BIOL CHEM, V266, P16892; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHVARTZ I, 1991, ENDOCRINOLOGY, V128, P126, DOI 10.1210/endo-128-1-126; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V162, P1396, DOI 10.1016/0006-291X(89)90829-2; SUNAHARA RK, 1990, NATURE, V347, P80, DOI 10.1038/347080a0; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; TAKAYANAGI R, 1991, REGUL PEPTIDES, V32, P23, DOI 10.1016/0167-0115(91)90004-Z; TSAIMORRIS CH, 1990, J BIOL CHEM, V265, P19385; VANE J, 1990, NATURE, V348, P673, DOI 10.1038/348673a0; WATANABE H, 1989, BIOCHEM BIOPH RES CO, V161, P1252, DOI 10.1016/0006-291X(89)91377-6; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	29	70	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23433	23437						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660473				2022-12-25	WOS:A1991GT48300098
J	SHORT, S; SHORT, ML; MILKOWSKI, DM; JUNGMANN, RA				SHORT, S; SHORT, ML; MILKOWSKI, DM; JUNGMANN, RA			FUNCTIONAL-ANALYSIS OF CIS-REGULATORY AND TRANSREGULATORY ELEMENTS OF THE LACTATE DEHYDROGENASE-A SUBUNIT PROMOTER BY INVITRO TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP REGULATION; C6 GLIOMA-CELLS; RNA POLYMERASE-II; DNA-BINDING PROTEIN; NUCLEAR FACTOR CREB; MESSENGER-RNA; GENE-TRANSCRIPTION; RESPONSIVE ELEMENT; SOMATOSTATIN GENE	Using a transcription system from nuclear extracts of rat C6 glioma cells we have investigated the mechanism by which transcription from the lactate dehydrogenase A subunit (LDH) promoter is regulated via the cAMP-activated pathway. We demonstrated that the system accurately initiates transcription from the LDH promoter. Analysis of the competitive effects of linker-scanning mutants showed that the wild-type LDH promoter exhibited the highest competitive effect and reduced the rate of basal transcription, whereas LDH promoter fragments with a mutated cAMP-responsive element had little competitive activity. Cyclic AMP and the catalytic subunit of cAMP-dependent protein kinase stimulated the rate of transcription from the wild-type promoter, an effect which was inhibited by the catalytic subunit inhibitor protein. A beta-galactosidase-cAMP-responsive element binding protein fusion protein had no effect on the basal rate of transcription. Addition of beta-galactosidase-cAMP-responsive element binding protein together with cAMP or the catalytic subunit, however, enhanced the rate of transcription. The demonstrated regulatory effects indicate that the sensitivity of the transcription system makes it suitable for the functional analysis of homologous LDH and possibly heterologous transcription regulatory elements.	NORTHWESTERN UNIV, SCH MED, DEPT CELLULAR MOLEC & STRUCT BIOL, 303 E CHICAGO AVE, CHICAGO, IL 60611 USA; NORTHWESTERN UNIV, SCH MED, CTR CANC, CHICAGO, IL 60611 USA	Northwestern University; Northwestern University								AHLGREN R, 1990, J BIOL CHEM, V265, P3313; ANDRISANI OM, 1989, P NATL ACAD SCI USA, V86, P2181, DOI 10.1073/pnas.86.7.2181; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; CHENG HC, 1986, J BIOL CHEM, V261, P989; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DERDA DF, 1980, J BIOL CHEM, V255, P1112; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FUKASAWA KM, 1986, BIOCHEM J, V235, P435, DOI 10.1042/bj2350435; GLASS DB, 1989, J BIOL CHEM, V264, P8802; GLASS DB, 1983, J BIOL CHEM, V258, P4797; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HARRISON JJ, 1982, J BIOL CHEM, V257, P13602; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HOU EW, 1987, BIOCHEM BIOPH RES CO, V147, P501, DOI 10.1016/S0006-291X(87)80149-3; HURST HC, 1987, GENE DEV, V1, P1132, DOI 10.1101/gad.1.10.1132; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAMESON JL, 1988, J BIOL CHEM, V263, P9879; Jungmann R A, 1975, Adv Cyclic Nucleotide Res, V5, P281; JUNGMANN RA, 1977, INT J BIOCHEM, V8, P819, DOI 10.1016/0020-711X(77)90049-0; JUNGMANN RA, 1983, J BIOL CHEM, V258, P5312; JUNGMANN RA, 1982, PROG BRAIN RES, V56, P163; JUNGMANN RA, 1981, COLD SPRING HARBOR C, V8, P1109; JUNGMANN RA, 1979, EFFECTS DRUGS CELL N, P507; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; KANEIISHII C, 1989, NUCLEIC ACIDS RES, V17, P1521, DOI 10.1093/nar/17.4.1521; KIRSCHMEIER PT, 1988, DNA-J MOLEC CELL BIO, V7, P219, DOI 10.1089/dna.1988.7.219; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KUETTEL MR, 1985, J CELL BIOL, V101, P965, DOI 10.1083/jcb.101.3.965; KUETTEL MR, 1984, CELL BIOL INT REP, V8, P949, DOI 10.1016/0309-1651(84)90193-0; KUMAR S, 1980, J BIOL CHEM, V255, P2315; KWASTWELFELD J, 1989, J BIOL CHEM, V264, P6941; KWASTWELFELD J, 1988, J BIOL CHEM, V263, P14343; LAKS MS, 1981, J BIOL CHEM, V256, P8775; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LEE SK, 1984, J BIOL CHEM, V259, P4695; LI Y, 1988, MOL CELL BIOL, V8, P4362, DOI 10.1128/MCB.8.10.4362; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; MATTHES HWD, 1987, METHOD ENZYMOL, V154, P250; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILES MF, 1981, J BIOL CHEM, V256, P2545; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NAKAGAWA J, 1988, J BIOL CHEM, V263, P2460; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; REINBERG D, 1987, J BIOL CHEM, V262, P3322; RICE DA, 1990, J BIOL CHEM, V265, P11713; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; SASSONECORSI P, 1988, P NATL ACAD SCI USA, V85, P7192, DOI 10.1073/pnas.85.19.7192; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SIVARAMAN L, 1986, P NATL ACAD SCI USA, V83, P5914, DOI 10.1073/pnas.83.16.5914; SQUINTO SP, 1989, BIOCHEM J, V260, P673, DOI 10.1042/bj2600673; TSUKADA T, 1985, DNA-J MOLEC CELL BIO, V4, P293, DOI 10.1089/dna.1985.4.293; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WEAVER CA, 1984, GENE, V28, P319, DOI 10.1016/0378-1119(84)90149-5; WEEKS DL, 1985, NUCLEIC ACIDS RES, V13, P5389, DOI 10.1093/nar/13.14.5389; WHITEHOUSE S, 1983, METHOD ENZYMOL, V99, P80; WHITT GS, 1984, CELL BIOCHEM FUNCT, V2, P134, DOI 10.1002/cbf.290020303; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; WILLIAMS JG, 1987, NUCL ACID HYBRIDISAT, P139; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	74	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22164	22172						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657991				2022-12-25	WOS:A1991GR56400019
J	MORI, S; CLAESSONWELSH, L; HELDIN, CH				MORI, S; CLAESSONWELSH, L; HELDIN, CH			IDENTIFICATION OF A HYDROPHOBIC REGION IN THE CARBOXYL TERMINUS OF THE PLATELET-DERIVED GROWTH-FACTOR BETA-RECEPTOR WHICH IS IMPORTANT FOR LIGAND-MEDIATED ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-TYPE RECEPTOR; PDGF RECEPTOR; CYTOPLASMIC DOMAIN; HUMAN-FIBROBLASTS; CDNA CLONING; COATED PITS; BINDING; PHOSPHORYLATION; INTERNALIZATION; PURIFICATION	The functional properties of carboxyl terminally truncated mutants of the platelet-derived growth factor beta-receptor were compared with those of the wild-type receptor and a receptor mutant made kinase negative by a point mutation. A mutant in which 98 amino acids were deleted retained kinase activity and mediated a mitogenic signal, whereas deletion of 141 or 155 amino acids led to loss of kinase activity and ability to mediate a mitogenic signal. The mutant with 155 amino acids deleted, i.e. the entire carboxyl-terminal tail downstream of the kinase domain, did not undergo ligand-mediated internalization and down-regulation, whereas the mutant with 141 amino acids deleted was internalized at a relatively high rate. This indicates that the 14 amino acids immediately downstream of the kinase domain is of importance for the internalization of the platelet-derived growth factor beta-receptor. This region is hydrophobic and shares no similarity to other sequences postulated to mediate endocytotic signals.	BIOMED CTR,LUDWIG INST CANC RES,BOX 595,S-75124 UPPSALA,SWEDEN	Ludwig Institute for Cancer Research								BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BOWENPOPE DF, 1985, METHOD ENZYMOL, V109, P69; Breitfeld PP, 1989, CURR OPIN CELL BIOL, V1, P617, DOI 10.1016/0955-0674(89)90024-0; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; CULLEN SE, 1976, J IMMUNOL, V117, P136; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; EK B, 1984, J BIOL CHEM, V259, P1145; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1982, J BIOL CHEM, V257, P4216; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; MIYAZONO K, 1987, J BIOL CHEM, V262, P4098; NILSSON J, 1983, P NATL ACAD SCI-BIOL, V80, P5592, DOI 10.1073/pnas.80.18.5592; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; RAINES EW, 1990, HDB EXPT PHARM 1, V95, P173; RONNSTRAND L, 1987, J BIOL CHEM, V262, P2929; ROSENFELD ME, 1984, J CELL PHYSIOL, V121, P263, DOI 10.1002/jcp.1041210202; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SEVERINSSON L, 1989, EUR J BIOCHEM, V182, P679, DOI 10.1111/j.1432-1033.1989.tb14879.x; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; STROOBANT P, 1984, EMBO J, V3, P2963, DOI 10.1002/j.1460-2075.1984.tb02241.x; VALIQUETTE M, 1990, P NATL ACAD SCI USA, V87, P5089, DOI 10.1073/pnas.87.13.5089; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; WILEY HS, 1982, J BIOL CHEM, V257, P4222; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	44	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21158	21164						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657952				2022-12-25	WOS:A1991GN00100089
J	TAKAHASHI, S; ITO, A; NAGINO, M; MORI, Y; BEI, X; NAGASE, H				TAKAHASHI, S; ITO, A; NAGINO, M; MORI, Y; BEI, X; NAGASE, H			CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE SUPPRESSES INTERLEUKIN-1-INDUCED SYNTHESIS OF MATRIX METALLOPROTEINASES BUT NOT OF TISSUE INHIBITOR OF METALLOPROTEINASES IN HUMAN UTERINE CERVICAL FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ONCOGENE-INDUCED TRANSIN; BRAIN ADENYLATE-CYCLASE; INTERSTITIAL COLLAGENASE; SYNOVIAL FIBROBLASTS; BINDING PROTEIN; 2ND MESSENGER; PHOSPHORYLATION; EXPRESSION; STROMELYSIN	Interleukin 1 (IL-1) mediates many cellular functions, but the signal transduction mechanisms of its actions are not clearly understood. Here, we have examined the exact participation of cAMP in the IL-1-induced production of the precursors of matrix metalloproteinase (MMPs) and their specific inhibitor, tissue inhibitor of metalloproteinases (TIMP) in human uterine cervical fibroblasts. IL-1 significantly augmented the production of proMMP-1 (vertebrate procollagenase), proMMP-3 (prostromelysin), and TIMP without detectable changes in the intracellular level of cAMP. Dibutyryl cAMP (Bt2cAMP) and the cAMP elevating agent (forskolin) did not replace IL-1 as MMP inducers. On the contrary, the IL-1-mediated induction of proMMP-1 and proMMP-3 was significantly suppressed by treatment of the cells with Bt2cAMP, forskolin, or theophylline. The suppressive effect of Bt2cAMP on the IL-1-induced production of proMMP-1 and -3 was not due to the inhibition of zymogen secretion, but resulted from the decrease in the steady-state levels of proMMP-1 and proMMP-3 mRNAs. In contrast, Bt2cAMP slightly enhanced the IL-1-induced production of TIMP. The synthesis of proMMP-2 (72-kDa progelatinase/type IV procollagenase) was not altered by IL-1 and/or Bt2cAMP. These results suggest, first, that induction of proMMP-1 and -3 synthesis may share similar transduction pathways but they are distinct from those for proMMP-2 and TIMP synthesis and, second, that cAMP does not function as a second messenger in the MMPs' induction upon IL-1 stimulation in human uterine cervical fibroblasts. Thus, it is further suggested that the system that increases the intracellular cAMP level may be involved in negative regulation of proMMP-1 and -3 production.	TOKYO COLL PHARM,DEPT BIOCHEM,HACHIOJI,TOKYO 19203,JAPAN; UNIV KANSAS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,KANSAS CITY,KS 66103	Tokyo University of Pharmacy & Life Sciences; University of Kansas; University of Kansas Medical Center					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039189] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 39189] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BREATHNACH R, 1987, NUCLEIC ACIDS RES, V15, P1139, DOI 10.1093/nar/15.3.1139; BROSTROM CO, 1975, P NATL ACAD SCI USA, V72, P64, DOI 10.1073/pnas.72.1.64; BROWN PD, 1990, CANCER RES, V50, P6184; CARROLL GJ, 1986, BRIT J RHEUMATOL, V25, P359; CHEDID M, 1989, J IMMUNOL, V142, P4301; CIVITELLI R, 1989, ENDOCRINOLOGY, V124, P2928, DOI 10.1210/endo-124-6-2928; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; EMONARD H, 1989, MATRIX, V9, P382, DOI 10.1016/S0934-8832(89)80043-5; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; FUKUOKA M, 1989, ENDOCRINOLOGY, V125, P136, DOI 10.1210/endo-125-1-136; FURUTANI Y, 1985, NUCLEIC ACIDS RES, V13, P5869, DOI 10.1093/nar/13.16.5869; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; GOWEN M, 1984, BIOCHIM BIOPHYS ACTA, V797, P186, DOI 10.1016/0304-4165(84)90121-1; GRAY PW, 1986, J IMMUNOL, V137, P3644; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HIRO D, 1986, BIOCHEM BIOPH RES CO, V140, P715, DOI 10.1016/0006-291X(86)90790-4; HUYBRECHTSGODIN G, 1985, BIOCHIM BIOPHYS ACTA, V846, P51, DOI 10.1016/0167-4889(85)90109-0; ITO A, 1988, AM J OBSTET GYNECOL, V159, P261, DOI 10.1016/0002-9378(88)90532-7; ITO A, 1990, FEBS LETT, V269, P93, DOI 10.1016/0014-5793(90)81127-A; ITO A, 1991, J BIOL CHEM, V266, P13598; ITO A, 1987, BIOL REPROD, V37, P511, DOI 10.1095/biolreprod37.3.511; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; KERR LD, 1988, J BIOL CHEM, V263, P16999; KILIAN PL, 1986, J IMMUNOL, V136, P4509; KITAMURA K, 1979, BIOCHEM MED METAB B, V22, P332, DOI 10.1016/0006-2944(79)90020-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LE JM, 1987, LAB INVEST, V56, P234; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MATSUSHIMA K, 1987, J IMMUNOL, V139, P3367; MATSUSHIMA K, 1986, J IMMUNOL, V136, P4496; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; MCATEE P, 1989, J BIOL CHEM, V264, P11193; MCCARTHY JB, 1980, J IMMUNOL, V124, P2405; MIZEL SB, 1982, IMMUNOL REV, V63, P51, DOI 10.1111/j.1600-065X.1982.tb00411.x; MIZEL SB, 1979, J IMMUNOL, V122, P2167; MURPHY G, 1985, J BIOL CHEM, V260, P3079; OJIMA Y, 1989, BIOCHIM BIOPHYS ACTA, V1011, P61, DOI 10.1016/0167-4889(89)90079-7; OKADA Y, 1986, J BIOL CHEM, V261, P14245; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; PIASCIK MT, 1980, J BIOL CHEM, V255, P4176; SAKLATVALA J, 1984, BIOCHEM J, V224, P461, DOI 10.1042/bj2240461; SATO T, 1990, BIOCHEM BIOPH RES CO, V170, P824, DOI 10.1016/0006-291X(90)92165-V; SATO T, 1991, BIOCHEM J, V275, P645, DOI 10.1042/bj2750645; SAUS J, 1988, J BIOL CHEM, V263, P6742; SCHETTINI G, 1988, BIOCHEM BIOPH RES CO, V155, P1089, DOI 10.1016/S0006-291X(88)81252-X; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; ULMER JB, 1987, J BIOL CHEM, V262, P1748; VARTANIAN T, 1986, SCIENCE, V234, P1395, DOI 10.1126/science.2431483; VATER CA, 1986, BIOCHEM J, V237, P853, DOI 10.1042/bj2370853; WAHL G, 1981, SCHLEICHER SCHUELL S, V371; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	56	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19894	19899						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657905				2022-12-25	WOS:A1991GM03900008
J	WANG, XM; MOORE, TS				WANG, XM; MOORE, TS			PHOSPHATIDYLETHANOLAMINE SYNTHESIS BY CASTOR BEAN ENDOSPERM - INTRACELLULAR-DISTRIBUTION AND CHARACTERISTICS OF CTP-ETHANOLAMINEPHOSPHATE CYTIDYLYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; SUB-MITOCHONDRIAL SITES; RAT-LIVER; PHOSPHATIDYLCHOLINE SYNTHESIS; PLANT-MITOCHONDRIA; PHOSPHOLIPID-METABOLISM; SPINACH LEAVES; BIOSYNTHESIS; PURIFICATION; ENZYME	The intracellular distribution and catalytic properties of CTP:ethanolaminephosphate cytidylyltransferase from endosperm of castor bean (Ricinus communis L. var. Hale) have been studied. This enzyme was confined to membranes, with about 80% of the activity occurring in mitochondria and the rest in endoplasmic reticulum (ER) following sucrose density gradient centrifugation. The mitochondrial location of this enzyme was supported by further purifying mitochondria on Percoll density gradients. The mitochondrial cytidylyltransferase was detected largely in outer membrane fractions, and lost its activity after trypsin treatment, indicating that the active sites are exposed to the cytoplasm. Both mitochondrial and ER cytidylyltransferase required cations for activity; Mg2+ was preferred over Mn2+ and Ca2+. The pH optima both were 6.5. The apparent K(m) values for ethanolamine phosphate were 143 and 83-mu-M and those for CTP were 125 and 1010-mu-M, respectively, for the mitochondrial and ER activities. The mitochondrial cytidylyltransferase reached a maximal velocity of 3.0 nmol/min/mg protein, whereas ER cytidylyltransferase was 0.424 nmol/min/mg protein. These findings reveal that the majority of the cytidylyltransferase activity in castor bean endosperm is not closely associated with ethanolaminephosphotransferase (predominately in ER) which catalyzes the subsequent reaction in the synthesis of phosphatidylethanolamine by a nucleotide pathway. The possible roles of these enzymes in phosphatidylethanolamine synthesis in plants are discussed.			WANG, XM (corresponding author), LOUISIANA STATE UNIV, DEPT BOT, BATON ROUGE, LA 70803 USA.		Wang, Xuemin/M-2853-2013	wang, xuemin/0000-0002-6251-6745				BJERVE KS, 1973, BIOCHIM BIOPHYS ACTA, V296, P549, DOI 10.1016/0005-2760(73)90115-X; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISKIN DP, 1987, METHOD ENZYMOL, V148, P542; DEPIERRE JW, 1977, ANNU REV BIOCHEM, V46, P201, DOI 10.1146/annurev.bi.46.070177.001221; DOUCE R, 1973, BIOCHIM BIOPHYS ACTA, V292, P105, DOI 10.1016/0005-2728(73)90255-7; DYKES CW, 1976, BIOCHEM J, V158, P575, DOI 10.1042/bj1580575; FAROOQUI JZ, 1983, BIOCHIM BIOPHYS ACTA, V757, P342; GEORGE TP, 1989, BIOCHIM BIOPHYS ACTA, V1004, P283, DOI 10.1016/0005-2760(89)90075-1; HACKETT DP, 1964, MOD METHOD PLANT, V7, P675; HUBSCHER G, 1959, BIOCHIM BIOPHYS ACTA, V36, P518, DOI 10.1016/0006-3002(59)90194-5; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KINNEY AJ, 1987, PLANT PHYSIOL, V84, P78, DOI 10.1104/pp.84.1.78; KINNEY AJ, 1987, ARCH BIOCHEM BIOPHYS, V259, P15, DOI 10.1016/0003-9861(87)90464-4; Luck H, 1963, METHODS ENZYMATIC AN, P885; MACHER BA, 1974, PLANT PHYSIOL, V53, P171, DOI 10.1104/pp.53.2.171; MAISTERRENA B, 1974, BIOCHIM BIOPHYS ACTA, V367, P115, DOI 10.1016/0005-2736(74)90036-4; MARSHALL MO, 1974, CAN J BIOCHEM CELL B, V52, P469, DOI 10.1139/o74-071; MARSHALL MO, 1973, FEBS LETT, V31, P199, DOI 10.1016/0014-5793(73)80102-4; MOORE TS, 1982, ANNU REV PLANT PHYS, V33, P235, DOI 10.1146/annurev.pp.33.060182.001315; MOORE TS, 1981, METHOD ENZYMOL, V71, P579; MUDD JB, 1980, BIOCH PLANTS, V4, P249; MUDD SH, 1989, PLANT PHYSIOL, V91, P587, DOI 10.1104/pp.91.2.587; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; PRICEJONES MJ, 1983, BIOCHEM J, V216, P627, DOI 10.1042/bj2160627; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; RUDHOOME MP, 1989, PLANT PHYSL S, V89, P75; SHIN SH, 1990, PLANT PHYSIOL, V93, P148, DOI 10.1104/pp.93.1.148; SPARACE SA, 1981, PLANT PHYSIOL, V67, P922, DOI 10.1104/pp.67.5.922; SPARACE SA, 1981, PLANT PHYSIOL, V67, P261, DOI 10.1104/pp.67.2.261; SPARACE SA, 1979, PLANT PHYSIOL, V63, P963, DOI 10.1104/pp.63.5.963; STUMPF PK, 1976, ENZYMES BIOL MEMBR, V2, P145; SUNDLER R, 1975, J BIOL CHEM, V250, P8585; SUNDLER R, 1973, BIOCHIM BIOPHYS ACTA, V306, P218, DOI 10.1016/0005-2760(73)90227-0; SUNDLER R, 1975, BIOCHEM J, V146, P309, DOI 10.1042/bj1460309; VANCE DE, 1985, BIOCH LIPIDS MEMBRAN, P242; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WANG XM, 1990, PLANT PHYSIOL, V93, P250, DOI 10.1104/pp.93.1.250; WANG XM, 1989, ARCH BIOCHEM BIOPHYS, V274, P338, DOI 10.1016/0003-9861(89)90447-5; WHARFE J, 1979, BIOCHIM BIOPHYS ACTA, V575, P102, DOI 10.1016/0005-2760(79)90135-8	40	20	20	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19981	19987						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657910				2022-12-25	WOS:A1991GM03900021
J	SCHUMACHER, R; MOSTHAF, L; SCHLESSINGER, J; BRANDENBURG, D; ULLRICH, A				SCHUMACHER, R; MOSTHAF, L; SCHLESSINGER, J; BRANDENBURG, D; ULLRICH, A			INSULIN AND INSULIN-LIKE GROWTH FACTOR-I BINDING-SPECIFICITY IS DETERMINED BY DISTINCT REGIONS OF THEIR COGNATE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; MONOCLONAL-ANTIBODIES; EGF-RECEPTOR; SITE; DNA; IDENTIFICATION; DOMAINS; GENE	Chimeric insulin/insulin-like growth factor-1 receptors and insulin receptor alpha-subunit point mutants were characterized with respect to their binding properties for insulin and insulin-like growth factor-1 (IGF-1) and their ability to translate ligand interaction into tyrosine kinase activation in intact cells. We found that replacement of the amino-terminal 137 amino acids of the insulin receptor (IR) with the corresponding 131 amino acids of the IGF-1 receptor (IGF-1R) resulted in loss of affinity for both ligands. Further replacement of the adjacent cysteine region with IGF-1R sequences fully reconstituted affinity for IGF-1, but only marginally for insulin. Unexpectedly, replacement of the IR cysteine-rich domain alone by IGF-1R sequences created a high affinity receptor for both insulin and IGF-1. The binding characteristics of all receptor chimeras reflected the potential of both ligands to regulate the receptor tyrosine kinase activity in intact cells. Our chimeric receptor data, in conjunction with IR amino-terminal domain point mutants, strongly suggest major contributions of structural determinants in both amino- and carboxyl-terminal IR alpha-subunit regions for the formation of the insulin-binding pocket, whereas, surprisingly, the residues defining IGF-1 binding are present predominantly in the cysteine-rich domain of the IGF-1R.	MAX PLANCK INST BIOCHEM,DEPT MOLEC BIOL,KLOPFERSPITZ 18A,W-8033 MARTINSRIED,GERMANY; DEUTSCH WOLFORSCHUNGINST,W-5100 AACHEN,GERMANY; NYU MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016	Max Planck Society; New York University								ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DINTZIS SM, 1990, EMBO J, V9, P77, DOI 10.1002/j.1460-2075.1990.tb08082.x; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; FENDLY BM, 1990, CANCER RES, V50, P1550; GORMAN CM, 1989, VIROLOGY, V171, P377, DOI 10.1016/0042-6822(89)90605-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; PRIGENT SA, 1990, J BIOL CHEM, V265, P9970; RAFAELOFF R, 1989, J BIOL CHEM, V264, P15900; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHAEFER EM, 1990, J BIOL CHEM, V265, P13248; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; YARDEN Y, 1988, BIOCHEMISTRY-US, V27, P3113, DOI 10.1021/bi00409a001; YIP CC, 1988, BIOCHEM BIOPH RES CO, V157, P321, DOI 10.1016/S0006-291X(88)80050-0; YIP CC, 1991, BIOCHEMISTRY-US, V30, P695, DOI 10.1021/bi00217a016	28	125	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19288	19295						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655782				2022-12-25	WOS:A1991GK66700030
J	VALDIVIA, HH; FUENTES, O; ELHAYEK, R; MORRISSETTE, J; CORONADO, R				VALDIVIA, HH; FUENTES, O; ELHAYEK, R; MORRISSETTE, J; CORONADO, R			ACTIVATION OF THE RYANODINE RECEPTOR CA2+ RELEASE CHANNEL OF SARCOPLASMIC-RETICULUM BY A NOVEL SCORPION-VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SKELETAL-MUSCLE; CALCIUM-RELEASE; CA-2+ RELEASE; CARDIAC-MUSCLE; PURIFICATION; MECHANISM; CAFFEINE	We identified a peptide fraction from the venom of the scorpion Buthotus hottentota that stimulated binding of [H-3]ryanodine to ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum and brain microsomes in a highly specific manner. Activity was concentrated in a peptide fraction of M(r) 5,000-8,000. Assuming a single active peptide in this fraction, we estimated a dissociation constant of 20-30 nM for the interaction of the peptide with the ryanodine receptor. The whole venom and the purified fraction activated skeletal ryanodine receptor Ca2+ release channels incorporated into planar lipid bilayers. The venom produced a 10-fold increase in the mean open time and induced the appearance of a long lasting subconductance state not seen in controls. Changes were reversible and could be induced by the partially purified venom fraction. This novel scorpion venom should be helpful in establishing the role of ryanodine receptors in the initiation of intracellular Ca2+ release in striated muscle and in nonmuscle cells containing functional ryanodine receptors such as neurons and secretory cells.			VALDIVIA, HH (corresponding author), UNIV WISCONSIN,SCH MED,DEPT PHYSIOL,1300 UNIV AVE,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036852] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 36852] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEUCKELMANN DJ, 1988, J PHYSIOL-LONDON, V405, P233, DOI 10.1113/jphysiol.1988.sp017331; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CALVIELLO G, 1989, BIOCHEMISTRY-US, V28, P1301, DOI 10.1021/bi00429a053; CORONADO R, 1990, J GEN PHYSIOL, V96, P443; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; Fabiato A., 1988, METHOD ENZYMOL, V157, P387; HILGEMANN DW, 1987, BIOPHYS J, V51, pA550; IKEMOTO N, 1985, J BIOL CHEM, V260, P4096; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; INUI M, 1987, J BIOL CHEM, V262, P1740; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; MARBAN E, 1985, CIRC RES, V56, P133, DOI 10.1161/01.RES.56.1.133; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MICHALAK M, 1988, BIOCHIM BIOPHYS ACTA, V96, P1008; OTSU K, 1990, J BIOL CHEM, V265, P13472; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; POSSANI L, 1985, HDB NATURAL TOXINS, V2, P513; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SUTKO JL, 1990, J GEN PHYSIOL, V96, P439, DOI 10.1085/jgp.96.2.439; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TOTH PT, 1990, CELL CALCIUM, V11, P557, DOI 10.1016/0143-4160(90)90009-J; VALDIVIA H, 1991, IN PRESS AM J PHYSL; VALDIVIA H H, 1991, Biophysical Journal, V59, p63A	27	59	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19135	19138						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655775				2022-12-25	WOS:A1991GK66700003
J	BARKER, PA; MILLER, FD; LARGE, TH; MURPHY, RA				BARKER, PA; MILLER, FD; LARGE, TH; MURPHY, RA			GENERATION OF THE TRUNCATED FORM OF THE NERVE GROWTH-FACTOR RECEPTOR BY RAT SCHWANN-CELLS - EVIDENCE FOR POSTTRANSLATIONAL PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NGF RECEPTOR; PHEOCHROMOCYTOMA CELLS; PC12 PHEOCHROMOCYTOMA; MOLECULAR-CLONING; HIGH-AFFINITY; GENE-TRANSFER; SOLUBLE FORM; EXPRESSION; BINDING; PURIFICATION	These studies were initiated to determine whether the soluble, truncated form of the nerve growth factor (NGF) receptor arises from post-translational processing of the intact, membrane-bound receptor or from an alternatively spliced mRNA. Pulse-chase analysis of cultured primary rat Schwann cells coupled with immunoprecipitations using antibodies to the intracellular and extracellular domains of the receptor were used to monitor receptor production. Three forms of the NGF receptor (80, 83, and 85 kDa) displaying a precursor product relationship were detected over the 2-h chase period; only the 85-kDa species was detected on the cell surface. Truncated receptors (50 and 52 kDa) were detected in conditioned media 5 h after cell labeling but were never observed intracellularly. Polymerase chain reaction and RNase protection analyses of NGF receptor mRNA targeted toward the coding region of the transmembrane domain detected no splice variants that could generate truncated receptor, and media conditioned by fibroblasts transfected with rat receptor cDNA, in which splicing cannot occur, nonetheless contained the truncated receptor protein. Taken together, these results suggest that the truncated NGF receptor does not arise as a distinct translation product but rather from a post-translational modification of the intact, surface-bound form of the protein.	UNIV ALBERTA,DEPT ANAT & CELL BIOL,EDMONTON T6G 2H7,ALBERTA,CANADA; CASE WESTERN RESERVE UNIV,CTR NEUROSCI,CLEVELAND,OH 44106	University of Alberta; Case Western Reserve University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021824] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21824] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHWORTH A, 1990, NUCLEIC ACIDS RES, V18, P1718; BERND P, 1984, J BIOL CHEM, V259, P5509; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUCK CR, 1988, DEV BRAIN RES, V44, P259, DOI 10.1016/0165-3806(88)90224-6; BUXSER SE, 1983, J CELL BIOCHEM, V22, P219, DOI 10.1002/jcb.240220404; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; GAGE FH, 1990, TROPHIC FACTORS CENT; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GROB PM, 1985, J BIOL CHEM, V260, P8044; HARLOW E, 1989, ANTIBODIES LABORATOR, P434; HEMPSTEAD B, 1988, COLD SPRING HARB SYM, V53, P477, DOI 10.1101/SQB.1988.053.01.055; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; LOUGHNAN MS, 1988, P NATL ACAD SCI USA, V85, P3115, DOI 10.1073/pnas.85.9.3115; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMINOSKI K, 1987, BRAIN RES, V435, P273, DOI 10.1016/0006-8993(87)91610-6; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VISSAVAJJHALA P, 1990, J BIOL CHEM, V265, P4746; WATSON AY, 1985, ANAT REC, V213, P365, DOI 10.1002/ar.1092130302; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P159, DOI 10.1073/pnas.88.1.159; ZUPAN AA, 1989, J BIOL CHEM, V264, P11714	41	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19113	19119						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655773				2022-12-25	WOS:A1991GJ47200108
J	LIU, JS; PARK, EA; GURNEY, AL; ROESLER, WJ; HANSON, RW				LIU, JS; PARK, EA; GURNEY, AL; ROESLER, WJ; HANSON, RW			CYCLIC-AMP INDUCTION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE-TRANSCRIPTION IS MEDIATED BY MULTIPLE PROMOTER ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR CREB; PROTEIN-KINASE-C; PHORBOL ESTER; DNA ELEMENTS; SIGNAL-TRANSDUCTION; INDUCIBLE ENHANCER; RESPONSIVE ELEMENT; SEQUENCE ELEMENTS; REGULATORY REGION; ALPHA-SUBUNIT	The cis elements involved in the cAMP regulation of transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK) were studied by introducing a series of block mutations (10-15 base pairs of random sequence) into eight of the protein binding domains in a region of the promoter between -490 and +73. Each mutant promoter was ligated to the structural gene for chloramphenicol acetyltransferase (CAT) and transfected into HepG2 cells. Transcription of PEPCK-CAT was stimulated 4-fold by the addition of 8-bromo-cAMP (8-Br-cAMP), whereas overexpression of the catalytic subunit of protein kinase A in these cells increased transcription from the PEPCK promoter 30-fold. Several elements within the PEPCK promoter acted synergistically to mediate this effect. These include CRE-1 (-92 to -82) and a complex unit from -220 to -280 composed of multiple binding sites termed P3(I) (-250 to -234), P3(II) (-260 to -250), and P4 (-286 to -270). Mutation of both CRE-1 and P3(I) resulted in the complete elimination of transcriptional induction by either 8-Br-cAMP or the catalytic subunit of protein kinase A. To examine the proteins involved in this response, we replaced CRE-1, which binds both C/EBP and cAMP-responsive element binding protein (CREB), with an optimal C/EBP binding sequence which significantly decreased the binding of CREB, but maintained the affinity for C/EBP. Transcription from this modified promoter was induced by 8-Br-cAMP and the catalytic subunit of protein kinase A (PKA) to a similar extent as noted with the native PEPCK promoter. However, the results of experiments involving cotransfection of PEPCK-CAT with expression vectors for PKA and either C/EBP or CREB suggest that CREB is capable of mediating a greater responsiveness to PKA than C/EBP. Our results indicate that multiple cis elements are involved in the cAMP induction of PEPCK gene transcription and that C/EBP and CREB are potentially involved in this response.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	Case Western Reserve University					NIDDK NIH HHS [DK 24951, DK-07319, DK 21859] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021859, R37DK021859] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Battey, 1986, BASIC METHODS MOL BI; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BOKAR JA, 1988, J BIOL CHEM, V263, P19740; BOSCH F, 1990, J BIOL CHEM, V265, P13677; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO Z, 1991, IN PRESS GENES DEV; CHU DTW, 1986, J BIOL CHEM, V261, P6848; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; GIRALT M, 1991, IN PRESS J BIOL CHEM, V266; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HYMAN SE, 1989, MOL CELL BIOL, V9, P321, DOI 10.1128/MCB.9.1.321; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; KLEMM DJ, 1990, MOL CELL BIOL, V10, P390; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMARS WH, 1982, P NATL ACAD SCI USA, V79, P5137; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LIU J, 1991, IN PRESS MOL CELL BI; LIU JS, 1990, BIOTECHNIQUES, V9, P738; LOOSE DS, 1985, BIOCHEMISTRY-US, V24, P4509, DOI 10.1021/bi00338a004; MAGNUSON MA, 1987, J BIOL CHEM, V262, P14917; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MCGRANE MM, 1990, J BIOL CHEM, V265, P22372; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; Miller JH., 1972, EXPT MOL GENETICS; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAYLOR SS, 1989, J BIOL CHEM, V264, P8843; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; TRUS M, 1990, MOL CELL BIOL, V10, P2418, DOI 10.1128/MCB.10.5.2418; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9414; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	55	198	201	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19095	19102						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655770				2022-12-25	WOS:A1991GJ47200105
J	PORTEU, F; BROCKHAUS, M; WALLACH, D; ENGELMANN, H; NATHAN, CF				PORTEU, F; BROCKHAUS, M; WALLACH, D; ENGELMANN, H; NATHAN, CF			HUMAN NEUTROPHIL ELASTASE RELEASES A LIGAND-BINDING FRAGMENT FROM THE 75-KDA TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR - COMPARISON WITH THE PROTEOLYTIC ACTIVITY RESPONSIBLE FOR SHEDDING OF TNF RECEPTORS FROM STIMULATED NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL CROSS-REACTIVITY; FACTOR-ALPHA; GROWTH-FACTOR; SOLUBLE FORM; ALPHA-1-PROTEINASE INHIBITOR; MONOCLONAL-ANTIBODIES; LEUKOCYTE ELASTASE; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; CATHEPSIN-G	To localize the protease(s) involved in shedding of tumor necrosis factor receptors (TNF-R) from activated neutrophils (PMN) (Porteu, F., and C. Nathan (1990) J. Exp. Med. 172, 599-607), we tested subcellular fractions from PMN for their ability to cause loss of TNF-R from intact cells. Exposure of PMN to sonicated azurophil granules at 37-degrees-C resulted in inhibition of I-125-TNF binding; 50% inhibition ensued when PMN were treated for approximately 1 min with azurophil granules equivalent to 2-3 PMN per indicator cell. The TNF-R-degrading activity in azurophil granules was identified as elastase by its sensitivity to diisopropyl fluorophosphate (DFP), alpha-1-antitrypsin and N-methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone (MSAAPV-CK), and by the ability of purified elastase to reproduce the effect of azurophil granules. Elastase preferentially acted on the 75-kDa TNF-R, reducing by 85-96% the binding of I-125-TNF to mononuclear cells expressing predominantly this receptor, while having no effect on endothelial cells expressing almost exclusively the 55-kDa TNF-R. Elastase-treated PMN released a 32-kDa soluble fragment of p75 TNF-R that bound TNF and reacted with anti-TNF-R monoclonal antibodies. In contrast, fMet-Leu-Phe-activated PMN shed a 42-kDa fragment from p75 TNF-R, along with similar amounts of a 28-kDa fragment from p55 TNF-R. Shedding of both TNF-Rs by intact activated PMN was more extensive than shedding caused by elastase and was completely resistant to DFP and MSAAPV-CK. Thus, the TNF-R-releasing activity of azurophil granules is distinct from that operative in intact stimulated PMN and could provide an additional mechanism for the control of cellular responses to TNF at sites of inflammation.	F HOFFMANN LA ROCHE & CO LTD,CENT RES UNIT,CH-4002 BASEL,SWITZERLAND; WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL	Roche Holding; Weizmann Institute of Science	PORTEU, F (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT MED,DIV HEMATOL ONCOL,BEATRICE & SAMUEL A SEAVER LAB,BOX 57,NEW YORK,NY 10021, USA.		PORTEU, Françoise/I-8445-2016	PORTEU, Françoise/0000-0002-2403-4163	NATIONAL CANCER INSTITUTE [R01CA045218] Funding Source: NIH RePORTER; NCI NIH HHS [CA45218] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrews P C, 1986, Methods Enzymol, V132, P369; ASCH AS, 1986, J EXP MED, V163, P221, DOI 10.1084/jem.163.1.221; Barrett A.J., 1997, PROTEINASES MAMMALIA, P240; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BLACK RA, 1988, J BIOL CHEM, V263, P9437; BLOW AMJ, 1977, BIOCHEM J, V161, P13, DOI 10.1042/bj1610013; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; DAHINDEN C, 1983, J IMMUNOL, V130, P863; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; DING AH, 1990, J EXP MED, V171, P715, DOI 10.1084/jem.171.3.715; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; DUBRAVEC DB, 1990, P NATL ACAD SCI USA, V87, P6758, DOI 10.1073/pnas.87.17.6758; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; GABAY JE, 1986, J EXP MED, V164, P1407, DOI 10.1084/jem.164.5.1407; GAMBLE JR, 1985, P NATL ACAD SCI USA, V82, P8667, DOI 10.1073/pnas.82.24.8667; GATANAGA T, 1990, P NATL ACAD SCI USA, V87, P8781, DOI 10.1073/pnas.87.22.8781; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; HELLER RA, 1990, P NATL ACAD SCI USA, V87, P6151, DOI 10.1073/pnas.87.16.6151; HENSON PM, 1988, INFLAMMATION BASIC P, P363; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; IGNOTZ RA, 1986, P NATL ACAD SCI USA, V83, P6307, DOI 10.1073/pnas.83.17.6307; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220; KLEBANOFF SJ, 1978, NEUTROPHIL FUNCTION, P35; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P5331; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; LOETSCHER H, 1990, J BIOL CHEM, V265, P20131; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; PICHYANGKUL S, 1987, EXP HEMATOL, V15, P1055; PORTEU F, 1990, J EXP MED, V172, P599, DOI 10.1084/jem.172.2.599; POWERS JC, 1977, BIOCHIM BIOPHYS ACTA, V485, P156, DOI 10.1016/0005-2744(77)90203-0; RICHTER J, 1990, P NATL ACAD SCI USA, V87, P9472, DOI 10.1073/pnas.87.23.9472; ROBB RJ, 1987, J IMMUNOL, V139, P855; SAKLATVALA J, 1980, BIOCHIM BIOPHYS ACTA, V615, P167, DOI 10.1016/0005-2744(80)90020-0; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCUDERI P, 1989, J IMMUNOL, V143, P168; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; SECKINGER P, 1990, P NATL ACAD SCI USA, V87, P5188, DOI 10.1073/pnas.87.13.5188; SENIOR RM, 1985, J CELL BIOL, V100, P351, DOI 10.1083/jcb.100.2.351; SHALABY MR, 1985, J IMMUNOL, V135, P2069; SHALABY MR, 1990, J EXP MED, V172, P1517, DOI 10.1084/jem.172.5.1517; SHALABY MR, 1987, J LEUKOCYTE BIOL, V41, P196, DOI 10.1002/jlb.41.3.196; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SYMONS JA, 1990, FEBS LETT, V272, P133, DOI 10.1016/0014-5793(90)80466-V; TOSI MF, 1990, J CLIN INVEST, V86, P300, DOI 10.1172/JCI114699; TRAVIS J, 1981, METHOD ENZYMOL, V80, P754; WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	57	212	221	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18846	18853						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655765				2022-12-25	WOS:A1991GJ47200069
J	MENDOZA, JA; LORIMER, GH; HOROWITZ, PM				MENDOZA, JA; LORIMER, GH; HOROWITZ, PM			INTERMEDIATES IN THE CHAPERONIN-ASSISTED REFOLDING OF RHODANESE ARE TRAPPED AT LOW-TEMPERATURE AND SHOW A SMALL STOICHIOMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RIBULOSE BISPHOSPHATE CARBOXYLASE; CHLORIDE-DENATURED RHODANESE; ATP HYDROLYSIS; PROTEIN; PURIFICATION; ASSOCIATION; DETERGENT; GROEL	In vitro refolding of the urea-unfolded, monomeric, mitochondrial enzyme rhodanese (thiosulfate sulfur-transferase; EC 2.8.1.1) is facilitated by the chaperonin proteins cpn60 and cpn10 from Escherichia coli at 37-degrees-C, but the refolding is strongly inhibited at 10-degrees-C. In contrast, the unassisted refolding of rhodanese is efficient at 10-degrees-C, but the refolding efficiency decreases as the temperature is raised. These observations provided two measures of the cpn60-rhodanese complex. Thus, we monitored either 1) the cpn60-dependent inhibition of spontaneous folding at 10-degrees-C or 2) the recovery of active rhodanese in the complete chaperonin system at 25-degrees-C, after first forming a cpn60-rhodanese complex at 10-degrees-C. These procedures minimized the aggregation of interactive folding intermediates that tend to overestimate the apparent number of cpn60 14-mers in determining the stoichiometry of protein-cpn60 14-mer interactions. Both procedures used here gave results that were consistent with there being 1 rhodanese binding site/cpn60 tetradecamer. This stoichiometry is significantly less than might be expected from the fact that cpn60 is composed of 14 identical subunits, and it may indicate that rhodanese interacts with a restricted region that is formed when the cpn60 tetradecamer is assembled. The ability to stabilize chaperonin-protein complexes that can subsequently be reactivated will aid studies of the mode of action of the ubiquitous chaperonin proteins.	UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284; DUPONT CO,DEPT CENT RES & DEV,DIV MOLEC BIOL,EXPTL STN,WILMINGTON,DE 19880	University of Texas System; University of Texas Health San Antonio; DuPont					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; Ellis R J, 1990, Semin Cell Biol, V1, P1; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; Georgopoulos C, 1990, Semin Cell Biol, V1, P19; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOROWITZ PM, 1989, J BIOL CHEM, V264, P3311; HOROWITZ PM, 1978, ANAL BIOCHEM, V86, P751, DOI 10.1016/0003-2697(78)90803-5; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; HOROWITZ PM, 1986, J BIOL CHEM, V261; HORWICH AL, 1990, TRENDS BIOTECHNOL, V8, P126, DOI 10.1016/0167-7799(90)90153-O; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; LANDRY SJ, 1991, J CELL BIOCH SG, V15, P197; LEMIRE BD, 1989, J BIOL CHEM, V264; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Ploegman J.H., 1978, NATURE, V273, P1245; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TANDON S, 1989, J BIOL CHEM, V264, P9859; TANDON S, 1986, J BIOL CHEM, V261, P5615; TANDON S, 1990, J BIOL CHEM, V265, P5967; TANDON S, 1987, J BIOL CHEM, V262, P4486; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327	29	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					16973	16976						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1680127				2022-12-25	WOS:A1991GF44500003
J	BAMEZAI, A; ROCK, KL				BAMEZAI, A; ROCK, KL			EFFECT OF RAS-ACTIVATION ON THE EXPRESSION OF GLYCOSYL-PHOSPHATIDYLINOSITOL-ANCHORED PROTEINS ON THE PLASMA-MEMBRANE	ONCOGENE			English	Article							T-CELL ACTIVATION; EPIDERMAL GROWTH-FACTOR; KINASE-C; MONOCLONAL-ANTIBODY; TRANSFORMED-CELLS; DOWN-REGULATION; INSULIN ACTION; LYMPHOCYTES-T; LY-6 LOCUS; STIMULATION	NIH3T3 cells were transfected with a vector containing c-H-ras under the transcriptional control of the mouse metallothionein-I promoter. When c-H-ras expression was induced with heavy metal ions there was a marked reduction in the expression of two glycosyl-phosphatidylinositol (GPI) anchored proteins, TAP/Ly-6A.2 and Thy-1, on the plasma membrane of the transformed cells. In contrast the cell-surface expression of other non-GPI-anchored proteins was unaltered. The major loss of Thy-1 induced by ras activation occurred from the pool of molecules expressed on the cell surface. The Thy-1 molecules that were preferentially lost from the surface of the ras-transformed cells could not be recovered from the extracellular fluid by immunoprecipitation. In contrast, the rate of internalization of Thy-1 was increased approximately 69% subsequent to ras activation. The possible significance of these findings to the function of c-H-ras is discussed.	HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV LYMPHOCYTE BIOL, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	BAMEZAI, A (corresponding author), HARVARD UNIV, SCH MED, DEPT PATHOL, 44 BINNEY ST, BOSTON, MA 02115 USA.			Bamezai, Anil/0000-0002-2447-7706	NIGMS NIH HHS [5 RO1 GM 38535] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAMEZAI A, 1988, J IMMUNOL, V141, P1423; BAMEZAI A, 1989, J IMMUNOL, V143, P3107; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; CHIARUGI VP, 1989, FEBS LETT, V252, P129, DOI 10.1016/0014-5793(89)80904-4; DAVIGNON D, 1981, P NATL ACAD SCI-BIOL, V78, P4535, DOI 10.1073/pnas.78.7.4535; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; ESPINAL J, 1987, NATURE, V328, P574, DOI 10.1038/328574a0; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUNTER KC, 1984, J EXP MED, V159, P716, DOI 10.1084/jem.159.3.716; HAGAG N, 1987, MOL CELL BIOL, V7, P1984, DOI 10.1128/MCB.7.5.1984; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HSIAO WLW, 1990, ONCOGENE, V5, P417; IVANYI D, 1986, INT J CANCER, V38, P575, DOI 10.1002/ijc.2910380418; KAMATA T, 1987, ONCOGENE, V1, P37; KAMATA T, 1984, NATURE, V310, P147, DOI 10.1038/310147a0; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LLOYD AC, 1989, EMBO J, V8, P1099, DOI 10.1002/j.1460-2075.1989.tb03479.x; MALEK TR, 1986, J EXP MED, V164, P709, DOI 10.1084/jem.164.3.709; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROBINSON PJ, 1989, NATURE, V342, P85, DOI 10.1038/342085a0; ROCK KL, 1982, J IMMUNOL, V129, P1360; ROCK KL, 1986, J EXP MED, V163, P315, DOI 10.1084/jem.163.2.315; ROCK KL, 1989, IMMUNOL REV, V111, P195, DOI 10.1111/j.1600-065X.1989.tb00547.x; SALTIEL AR, 1986, P NATL ACAD SCI USA, V83, P5793, DOI 10.1073/pnas.83.16.5793; SANDRIGOLDIN RM, 1981, MOL CELL BIOL, V1, P743, DOI 10.1128/MCB.1.8.743; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; STACEY DW, 1987, MOL CELL BIOL, V7, P523, DOI 10.1128/MCB.7.1.523; STALLCUP KC, 1981, J IMMUNOL, V127, P923; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520; TRIMBLE WS, 1986, NATURE, V321, P782, DOI 10.1038/321782a0; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; WEYMAN CM, 1988, CANCER RES, V48, P6535; WILKISON WO, 1989, ONCOGENE, V4, P625; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7; YEH ETH, 1987, J IMMUNOL, V138, P91	46	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	1991	6	8					1445	1451						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX272	1679532				2022-12-25	WOS:A1991GX27200022
J	CASCIOLAROSEN, LAF; HUBBARD, AL				CASCIOLAROSEN, LAF; HUBBARD, AL			HYDROLASES IN INTRACELLULAR COMPARTMENTS OF RAT-LIVER CELLS - EVIDENCE FOR SELECTIVE ACTIVATION AND OR DELIVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE; PARATHYROID-HORMONE; RECOGNITION SYSTEM; MAMMALIAN LIVER; KUPFFER CELLS; HEPATOCYTES; RECEPTOR; ENDOCYTOSIS; FIBROBLASTS; ENDOSOMES	We used perfused rat livers to investigate the role of endosomes versus lysosomes in the hydrolysis of endocytosed material. When perfusions were performed at 37-degrees-C with I-125-asialoorosomucoid, I-125-galactosylated albumin, or I-125-mannosylated albumin, there was a 15-min lag before trichloroacetic acid-soluble degradation products were detected. Furthermore, no hydrolysis was detected at 16-degrees-C, indicating that there was no significant prelysosomal degradation of these proteins. Since detection by this method depends on extensive hydrolysis, we subsequently used three small synthetic molecules from which fluorescent products are generated by a single cleavage. These were 4-methylumbelliferyl sulfate, 4-methylumbelliferyl phosphate, and 4-methylumbelliferyl-beta-D-glucosaminide, which are substrates for aryl sulfatase, acid phosphatase, and beta-hexosaminidase, respectively. Using the first two compounds, hydrolysis was detected after 3 min at 37-degrees-C and still occurred, albeit to a reduced extent, at 16 and 4-degrees-C. This indicates that aryl sulfatase and acid phosphatase are active prelysosomally. We found a different result with 4-methylumbelliferyl-beta-D-glucosaminide. At 37-degrees-C, there was a > 15-min lag before hydrolysis products were measured; furthermore, hydrolysis ceased at 16-degrees-C, indicating that beta-hexosaminidase is active lysosomally. Taken together, these findings show that there is selective activation and/or delivery of hydrolases along the endocytic pathway.	JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,725 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129133, R01GM029133] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM29133] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARBORGH B, 1973, FEBS LETT, V35, P51, DOI 10.1016/0014-5793(73)80574-5; ARIAS I, 1982, LIVER BIOL PATHOBIOL, pR29; BERG T, 1985, EXP CELL RES, V156, P570, DOI 10.1016/0014-4827(85)90565-8; BERGERON JJM, 1985, ANNU REV PHYSIOL, V47, P383; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BOWSER R, 1990, J CELL PHYSIOL, V143, P110, DOI 10.1002/jcp.1041430115; BRAUN M, 1989, WMBO J, V8, P3633; CALDWELL J, 1984, FALK S, V40, P7; CASCIOLA LAF, 1989, J CELL BIOL, V109, P328; CHANG PL, 1984, J HISTOCHEM CYTOCHEM, V32, P617, DOI 10.1177/32.6.6202736; CLARKE BL, 1985, J BIOL CHEM, V260, P128; DAMOUR P, 1979, J CLIN INVEST, V63, P89, DOI 10.1172/JCI109283; DIMENT S, 1989, J BIOL CHEM, V264, P13403; DIMENT S, 1985, J BIOL CHEM, V260, P5311; DOHERTY JJ, 1990, J CELL BIOL, V110, P35, DOI 10.1083/jcb.110.1.35; DUNN WA, 1983, METHOD ENZYMOL, V98, P225; DUNN WA, 1980, J BIOL CHEM, V255, P5971; EMMELOT P, 1964, BIOCHIM BIOPHYS ACTA, V90, P126, DOI 10.1016/0304-4165(64)90125-4; FAHIMI HD, 1982, LIVER BIOL PATHOBIOL, P495; GIESELMANN V, 1984, H-S Z PHYSIOL CHEM, V365, P651, DOI 10.1515/bchm2.1984.365.1.651; GOTTLIEB M, 1981, SCIENCE, V212, P939, DOI 10.1126/science.7233189; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; JONES EA, 1982, LIVER BIOL PATHOBIOL, P507; Krebs H.A., 1974, REGULATION HEPATIC M, P726; LEAKE DS, 1982, EUR J BIOCHEM, V128, P557; MATRISIAN LM, 1984, J BIOL CHEM, V259, P3047; MULDER GJ, 1985, BIOCHEM PHARMACOL, V34, P1325, DOI 10.1016/0006-2952(85)90513-1; MULDER GJ, 1984, FALK S, V40, P21; MUNTHEKAAS AC, 1976, EXP CELL RES, V99, P146, DOI 10.1016/0014-4827(76)90689-3; MUPHY RF, 1988, ADV CELL BIOL, V2, P159; RENFREW CA, 1991, J BIOL CHEM, V266, P4348; ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209; SEGRE GV, 1981, J CLIN INVEST, V67, P449, DOI 10.1172/JCI110053; SENESI S, 1987, J IMMUNOL METHODS, V100, P197, DOI 10.1016/0022-1759(87)90190-6; SHAPIRO LJ, 1989, METABOLIC BASIS INHE, V48, P71; STEINMAN RM, 1974, J CELL BIOL, V63, P949, DOI 10.1083/jcb.63.3.949; TOMODA H, 1989, J BIOL CHEM, V264, P15445; WALL DA, 1981, J CELL BIOL, V90, P687, DOI 10.1083/jcb.90.3.687; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; ZEITLIN PL, 1982, J CELL BIOL, V92, P634, DOI 10.1083/jcb.92.3.634	41	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4341	4347						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1671861				2022-12-25	WOS:A1991FA69400052
J	BORG, A; BALDETORP, B; FERNO, M; KILLANDER, D; OLSSON, H; SIGURDSSON, H				BORG, A; BALDETORP, B; FERNO, M; KILLANDER, D; OLSSON, H; SIGURDSSON, H			ERBB2 AMPLIFICATION IN BREAST-CANCER WITH A HIGH-RATE OF PROLIFERATION	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; HER-2 NEU ONCOGENE; TYROSINE PHOSPHORYLATION; BIOPSY SAMPLES; CARCINOMA; PROTEIN; GENE; DNA; EXPRESSION; SURVIVAL	The ERBB2 proto-oncogene was studied in 539 invasive primary breast tumors and was found amplified (2- > 30 copies) in 19%. Amplification was correlated to most known risk factors, including; large tumor size, lymph node positivity and many tumor involved nodes, advanced stage, low patient age (< 40 years), non-diploidy and hypertetraploidy, and most significantly (P < 0.00001) to the absence of steroid receptors and to a high rate of proliferation (flow cytometric determined S phase fraction). ERBB2 amplification was strongly associated (P < 0.0001) with early recurrence and death in breast cancer among node-positive patients. This connection did not, however, remain in multivariate analyses. No correlations to clinical outcome were seen among node-negative patients. Similarly, non-diploid, but not diploid, amplified tumors were particularly aggressive. Furthermore, ERBB2 amplification was associated with a high rate of proliferation and poor prognosis in steroid receptor positive, but not receptor negative tumors. In progesterone receptor positive breast cancer, amplification was an independent and with node status equally powerful (P < 0.0001) predictor of poor survival. It is concluded that ERBB2 activity is related to an increased tumor growth rate but not directly to metastasizing ability. Its clinical relevance as a prognostic factor may be in selecting a high risk subgroup of breast cancer, in general considered as being of good prognosis.			BORG, A (corresponding author), UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN.		Baldetorp, Bo/HDM-9924-2022	Olsson, Hakan/0000-0002-8794-9635				ALLRED D, 1990, P ASCO, V9, P23; BAISCH H, 1975, RADIAT ENVIRON BIOPH, V12, P31, DOI 10.1007/BF02339807; BALDETORP B, 1989, CYTOMETRY, V10, P695, DOI 10.1002/cyto.990100605; BERGER MS, 1988, CANCER RES, V48, P1238; BORG A, 1990, CANCER RES, V50, P4332; BORG A, 1989, LANCET, V1, P1268; BRESLOW NE, 1975, INT STAT REV, V43, P45, DOI 10.2307/1402659; CALLAHAN R, 1989, BREAST CANCER RES TR, V13, P191, DOI 10.1007/BF02106570; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; COX DR, 1972, J R STAT SOC B, V34, P187; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FERNO M, 1989, ACTA ONCOL, V28, P19, DOI 10.3109/02841868909111175; FERNO M, 1986, ACTA ONCOL, V25, P171, DOI 10.3109/02841868609136398; GUERIN M, 1989, INT J CANCER, V43, P201, DOI 10.1002/ijc.2910430205; GUSTERSON BA, 1988, INT J CANCER, V42, P842, DOI 10.1002/ijc.2910420608; HIDDEMANN W, 1984, CYTOMETRY, V5, P445, DOI 10.1002/cyto.990050502; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LEE GM, 1984, ANAL BIOCHEM, V137, P221, DOI 10.1016/0003-2697(84)90374-9; LIPPMAN ME, 1990, P ASCO, V9, P24; MANGEL WF, 1988, J STEROID BIOCHEM, V30, P79, DOI 10.1016/0022-4731(88)90079-9; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARX D, 1990, J CANCER RES CLIN, V116, P15, DOI 10.1007/BF01612634; NORGREN A, 1982, ANTICANCER RES, V2, P315; NOWELL PC, 1986, CANCER RES, V46, P2203; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; RICHNER J, 1990, ANN ONCOL, V1, P263, DOI 10.1093/oxfordjournals.annonc.a057745; ROCHEFORT H, 1988, BIOCHIMIE, V70, P943, DOI 10.1016/0300-9084(88)90236-2; SAINSBURY JRC, 1987, LANCET, V1, P1398; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SIGURDSSON H, 1990, NEW ENGL J MED, V322, P1045, DOI 10.1056/NEJM199004123221505; SIGURDSSON H, 1990, BRIT J CANCER, V62, P786, DOI 10.1038/bjc.1990.380; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; THORNTHWAITE JT, 1980, CYTOMETRY, V1, P229, DOI 10.1002/cyto.990010309; TSUDA H, 1989, CANCER RES, V49, P3104; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VOGELSTEIN B, 1989, CC MOL BIOL, P73; WRIGHT C, 1989, CANCER RES, V49, P2087; ZEILLINGER R, 1989, ONCOGENE, V4, P109	47	222	226	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					137	143						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1671531				2022-12-25	WOS:A1991EY03900019
J	PASH, JM; BHORJEE, JS; PATTERSON, BM; BUSTIN, M				PASH, JM; BHORJEE, JS; PATTERSON, BM; BUSTIN, M			PERSISTENCE OF CHROMOSOMAL-PROTEINS HMG-14/-17 IN MYOTUBES FOLLOWING DIFFERENTIATION-DEPENDENT REDUCTION OF HMG MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									NCI, MOLEC CARCINOGENESIS LAB, BETHESDA, MD 20892 USA; MEHARRY MED COLL, DEPT BIOMED SCI, NASHVILLE, TN 37208 USA; NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Meharry Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K14HL001979] Funding Source: NIH RePORTER; NHLBI NIH HHS [K14HL01979] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROTHERTON TW, 1986, BIOCHEMISTRY-US, V25, P3447, DOI 10.1021/bi00359a053; BUSTIN M, 1989, METHOD ENZYMOL, V170, P214; DORBIC T, 1987, EMBO J, V6, P2393, DOI 10.1002/j.1460-2075.1987.tb02517.x; DORBIC T, 1986, NUCLEIC ACIDS RES, V14, P3363, DOI 10.1093/nar/14.8.3363; DRUCKMANN S, 1986, EXP CELL RES, V166, P486, DOI 10.1016/0014-4827(86)90493-3; EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7; EINCK L, 1983, P NATL ACAD SCI-BIOL, V80, P6735, DOI 10.1073/pnas.80.22.6735; EMERSON C, 1986, MOL BIOL MUSCLE DEV; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOODWIN GH, 1982, HMG CHROMOSOMAL PROT, P193; KRAUTER KS, 1979, J MOL BIOL, V134, P727, DOI 10.1016/0022-2836(79)90482-0; KUEHL L, 1979, J BIOL CHEM, V254, P7276; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSMAN D, 1986, J BIOL CHEM, V261, P6082; LANDSMAN D, 1986, J BIOL CHEM, V261, P7479; SANDEEN G, 1980, NUCLEIC ACIDS RES, V8, P3757, DOI 10.1093/nar/8.17.3757; SEALE RL, 1983, BIOCHEMISTRY-US, V22, P5008, DOI 10.1021/bi00290a020; SHICK VV, 1985, J MOL BIOL, V185, P329, DOI 10.1016/0022-2836(85)90407-3; TAHOURDIN CSM, 1981, BIOCHEMISTRY-US, V20, P910, DOI 10.1021/bi00507a040; WEISBROD S, 1980, CELL, V19, P289, DOI 10.1016/0092-8674(80)90410-9; WEISBROD S, 1982, NATURE, V297, P289, DOI 10.1038/297289a0; WESTERMANN R, 1984, CHROMOSOMA, V90, P355, DOI 10.1007/BF00294162; WINTER E, 1985, J CELL BIOL, V101, P175, DOI 10.1083/jcb.101.1.175; WINTER E, 1985, J CELL BIOL, V101, P167, DOI 10.1083/jcb.101.1.167	24	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1990	265	8					4197	4199						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT101	1689723				2022-12-25	WOS:A1990CT10100007
J	BOITEUX, S; OCONNOR, TR; LEDERER, F; GOUYETTE, A; LAVAL, J				BOITEUX, S; OCONNOR, TR; LEDERER, F; GOUYETTE, A; LAVAL, J			HOMOGENEOUS ESCHERICHIA-COLI FPG PROTEIN - A DNA GLYCOSYLASE WHICH EXCISES IMIDAZOLE RING-OPENED PURINES AND NICKS DNA AT APURINIC APYRIMIDINIC SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INST GUSTAVE ROUSSY,REPARAT LES RADIO & CHIMIOINDUITES LAB,CNRS,UA 147,F-94800 VILLEJUIF,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U25,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,CNRS,LA 122,F-75743 PARIS 15,FRANCE; INST GUSTAVE ROUSSY,INSERM,U140,F-94800 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy				O'Connor, Timothy/0000-0001-5848-3592				ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581; BELFORT M, 1985, CELL, V41, P375, DOI 10.1016/S0092-8674(85)80010-6; BJELLAND S, 1987, NUCLEIC ACIDS RES, V15, P2787, DOI 10.1093/nar/15.7.2787; BOITEUX S, 1983, BIOCHEM BIOPH RES CO, V110, P552, DOI 10.1016/0006-291X(83)91185-3; BOITEUX S, 1984, EMBO J, V3, P2569, DOI 10.1002/j.1460-2075.1984.tb02175.x; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; BOITEUX S, 1989, MOL GEN GENET, V215, P300, DOI 10.1007/BF00339732; BOITEUX S, 1984, NUCLEIC ACIDS RES, V13, P5429; BOITEUX S, 1989, IN PRESS P NATO WORK; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIMER LH, 1984, NUCLEIC ACIDS RES, V12, P6359, DOI 10.1093/nar/12.16.6359; BREIMER LH, 1984, J BIOL CHEM, V259, P5543; CHETSANGA CJ, 1979, NUCLEIC ACIDS RES, V6, P3673, DOI 10.1093/nar/6.11.3673; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; CUNNINGHAM RP, 1985, P NATL ACAD SCI USA, V82, P474, DOI 10.1073/pnas.82.2.474; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Grunberger D., 1983, MOL BIOL MUTAGENS CA, P55; HAINES JA, 1962, J CHEM SOC, P5281, DOI 10.1039/jr9620005281; HASELTINE WA, 1980, NATURE, V285, P634, DOI 10.1038/285634a0; IDE H, 1985, NUCLEIC ACIDS RES, V13, P8035, DOI 10.1093/nar/13.22.8035; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; KARRAN P, 1982, NATURE, V296, P770, DOI 10.1038/296770a0; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGRAVERE C, 1984, NATURE, V310, P798, DOI 10.1038/310798a0; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LAVAL J, 1977, NATURE, V269, P829, DOI 10.1038/269829a0; LAVAL J, 1989, IN PRESS P NATO WORK; LAWLEY P D, 1970, Chemico-Biological Interactions, V2, P154, DOI 10.1016/0009-2797(70)90047-5; LEE JS, 1981, MOL GEN GENET, V184, P218, DOI 10.1007/BF00272908; LEVIN JD, 1988, J BIOL CHEM, V263, P8066; Maniatis T., 1982, MOL CLONING; MARGISON GP, 1981, P NATL ACAD SCI-BIOL, V78, P861, DOI 10.1073/pnas.78.2.861; Miller J.H., 1972, EXPT MOL GENETICS; MOORE P, 1979, NATURE, V278, P664, DOI 10.1038/278664a0; NAKABEPPU Y, 1984, J BIOL CHEM, V259, P3730; OCONNOR TR, 1988, NUCLEIC ACIDS RES, V16, P5879, DOI 10.1093/nar/16.13.5879; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; RADANY EH, 1980, NATURE, V286, P182, DOI 10.1038/286182a0; RADMAN M, 1976, J BIOL CHEM, V251, P1438; ROBINS RK, 1963, J AM CHEM SOC, V85, P252; SAKUMI K, 1986, J BIOL CHEM, V261, P5761; SAPORITO SM, 1988, J BACTERIOL, V170, P4542, DOI 10.1128/jb.170.10.4542-4547.1988; SAPORITO SM, 1988, J BACTERIOL, V170, P5141, DOI 10.1128/jb.170.11.5141-5145.1988; SUMMERS WC, 1970, ANAL BIOCHEM, V33, P459; VARSHNEY U, 1988, J BIOL CHEM, V263, P7776; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411	49	335	339	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					3916	3922						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689309				2022-12-25	WOS:A1990CQ48000052
J	PARENT, JB				PARENT, JB			MEMBRANE-RECEPTORS ON RAT HEPATOCYTES FOR THE INNER CORE REGION OF BACTERIAL LIPOPOLYSACCHARIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											PARENT, JB (corresponding author), USN,MED RES INST,DIV METAB RES,CASUALTY CARE RES DEPT,BETHESDA,MD 20814, USA.							BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BRADE H, 1983, INFECT IMMUN, V42, P250, DOI 10.1128/IAI.42.1.250-256.1983; BRADE L, 1985, INFECT IMMUN, V50, P687, DOI 10.1128/IAI.50.3.687-694.1985; BRAUDE AI, 1955, J CLIN INVEST, V34, P858, DOI 10.1172/JCI103141; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; ELSBACH P, 1983, REV INFECT DIS, V5, P843; FREUDENBERG MA, 1982, BRIT J EXP PATHOL, V63, P56; GALANOS C, 1975, EUR J BIOCHEM, V54, P603, DOI 10.1111/j.1432-1033.1975.tb04172.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GEY GEORGE 0., 1936, AMER JOUR CANCER, V27, P45; HAEFFNERCAVAILLON N, 1984, MOL IMMUNOL, V21, P389, DOI 10.1016/0161-5890(84)90036-1; HAEFFNERCAVAILLON N, 1982, J IMMUNOL, V128, P1950; HALE DJ, 1986, HDB ENDOTOXIN, V4, P1; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; HINSHAW LB, 1982, PATHOPHYSIOLOGY SHOC, P219; HITCHCOCK PJ, 1986, J BACTERIOL, V166, P699, DOI 10.1128/jb.166.3.699-705.1986; HOPF U, 1983, AM J EMERG MED, V2, P13; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; LEBBAR S, 1986, EUR J IMMUNOL, V16, P87, DOI 10.1002/eji.1830160117; LEI MG, 1988, J IMMUNOL, V141, P1006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDERITZ O, 1982, CURR TOP MEMBR TRANS, V17, P79; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; MAITRA SK, 1981, HEPATOLOGY, V1, P401, DOI 10.1002/hep.1840010506; Makela P. H., 1984, HDB ENDOTOXIN, P59; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MATHISON JC, 1979, J IMMUNOL, V123, P2133; MORSE PA, 1965, CANCER RES, V25, P499; PAGANI R, 1981, FEBS LETT, V131, P103, DOI 10.1016/0014-5793(81)80897-6; PARENT JB, 1988, PROTEIN TRANSFER ORG, P51; PARENT JB, 1989, J CELL BIOCH A S, V13, pB121; PORTER WH, 1975, ANAL BIOCHEM, V63, P27, DOI 10.1016/0003-2697(75)90186-4; PRAANINGVANDALEN DP, 1981, GASTROENTEROLOGY, V81, P1036; RAMADORI G, 1979, ACTA HEPATO-GASTRO, V26, P368; ROMEO D, 1970, J MOL BIOL, V53, P475, DOI 10.1016/0022-2836(70)90078-1; RUITER DJ, 1981, LAB INVEST, V45, P38; SHAFER WM, 1986, INFECT IMMUN, V53, P651, DOI 10.1128/IAI.53.3.651-655.1986; SKARNES RC, 1985, HDB ENDOTOXIN, V3, P56; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; ULEVITCH RJ, 1978, IMMUNOCHEMISTRY, V15, P157, DOI 10.1016/0161-5890(78)90144-X; VANBOSSUYT H, 1988, J HEPATOL, V7, P325, DOI 10.1016/S0168-8278(88)80005-9; WEIGEL PH, 1984, J BIOL CHEM, V259, P1150; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WILLERSON J T, 1970, Infection and Immunity, V1, P440; WISSE E, 1979, PROGR LIVER DISEASES, V6, P1253; WOLLENWEBER HW, 1985, J BIOL CHEM, V260, P5068; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; YAMAGUCHI Y, 1982, J RETICULOENDOTH SOC, V32, P409; ZLYDASZYK JC, 1976, INFECT IMMUN, V14, P100, DOI 10.1128/IAI.14.1.100-105.1976; [No title captured]	51	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3455	3461						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689302				2022-12-25	WOS:A1990CP23600071
J	VAIRO, G; ARGYRIOU, S; BORDUN, AM; WHITTY, G; HAMILTON, JA				VAIRO, G; ARGYRIOU, S; BORDUN, AM; WHITTY, G; HAMILTON, JA			INHIBITION OF THE SIGNALING PATHWAYS FOR MACROPHAGE PROLIFERATION BY CYCLIC-AMP - LACK OF EFFECT ON EARLY RESPONSES TO COLONY STIMULATING FACTOR-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT MED,PARKVILLE 3050,AUSTRALIA	Royal Melbourne Hospital; University of Melbourne				Hamilton, John A/0000-0002-9493-9224				ALBERT DA, 1989, J CELL PHYSIOL, V138, P129, DOI 10.1002/jcp.1041380118; BECKNER SK, 1986, J BIOL CHEM, V261, P3043; BESTERMAN JM, 1986, J BIOL CHEM, V261, P723; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COFFEY RG, 1988, J IMMUNOL, V140, P2695; DIEZ J, 1985, EXPERIENTIA, V41, P666, DOI 10.1007/BF02007710; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; FARRAR WL, 1987, J IMMUNOL, V139, P2075; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRINSTEIN S, 1987, J BIOL CHEM, V262, P15277; HAMILTON JA, 1988, BLOOD, V71, P1574; HAMILTON JA, 1988, J CELL PHYSIOL, V134, P405, DOI 10.1002/jcp.1041340311; HAMILTON JA, 1989, IN PRESS J CELL PHYS; HARELBELLAN A, 1988, J CELL BIOCHEM, V38, P145, DOI 10.1002/jcb.240380302; HELDIN NE, 1989, J CELL PHYSIOL, V138, P17, DOI 10.1002/jcp.1041380104; HOLLENBERG MD, 1973, P NATL ACAD SCI USA, V70, P2964, DOI 10.1073/pnas.70.10.2964; HUME DA, 1984, EXP CELL RES, V150, P347, DOI 10.1016/0014-4827(84)90578-0; HUME DA, 1987, LYMPHOKINE RES, V6, P127; HUNT NH, 1980, CLIN SCI, V58, P463, DOI 10.1042/cs0580463; INOUYE L K, 1986, Journal of Leukocyte Biology, V39, P657; ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982; JUSTEMENT LB, 1986, J IMMUNOL, V136, P270; KNUDSEN PJ, 1986, J IMMUNOL, V137, P3189; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; KURLAND JI, 1977, CANCER RES, V37, P4534; LAPPIN D, 1984, BIOCHEM J, V222, P477, DOI 10.1042/bj2220477; LIM LK, 1983, BIOCHEM BIOPH RES CO, V114, P549, DOI 10.1016/0006-291X(83)90815-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MELMED RN, 1986, J CELL PHYSIOL, V126, P430, DOI 10.1002/jcp.1041260314; METCALF D, 1984, HEMOPOIETIC COLONIES; MICHELL RH, 1989, LANCET, V1, P765; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; MULLER R, 1984, CURR TOP MICROBIOL I, V112, P74; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; ODORISIO MS, 1984, J LEUKOCYTE BIOL, V35, P617; OLSSON IL, 1982, CANCER RES, V42, P3928; PARK LS, 1989, J BIOL CHEM, V264, P5420; RALPH RP, 1986, COLD SPRING HABOR S, V551, P679; REUSE S, 1986, BIOCHEM BIOPH RES CO, V141, P1066, DOI 10.1016/S0006-291X(86)80152-8; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SNYDER DS, 1982, NATURE, V299, P163, DOI 10.1038/299163a0; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; TUSHINSKI RJ, 1983, J CELL PHYSIOL, V116, P67, DOI 10.1002/jcp.1041160111; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; VAIRO G, 1988, J CELL PHYSIOL, V134, P13, DOI 10.1002/jcp.1041340103; VASSALLI JD, 1976, CELL, V8, P271, DOI 10.1016/0092-8674(76)90011-8; WENGER GD, 1985, J IMMUNOL, V134, P1836; WHETTON AD, 1986, EMBO J, V5, P3281, DOI 10.1002/j.1460-2075.1986.tb04640.x	54	87	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1990	265	5					2692	2701						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM848	1689293				2022-12-25	WOS:A1990CM84800048
J	JOIS, M; HALL, B; BROSNAN, JT				JOIS, M; HALL, B; BROSNAN, JT			STIMULATION OF GLYCINE CATABOLISM IN ISOLATED PERFUSED-RAT-LIVER BY CALCIUM MOBILIZING HORMONES AND IN ISOLATED RAT-LIVER MITOCHONDRIA BY SUBMICROMOLAR CONCENTRATIONS OF CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									MEM UNIV NEWFOUNDLAND,DEPT BIOCHEM,ST JOHNS A1B 3X9,NEWFOUNDLAND,CANADA	Memorial University Newfoundland			Jois, Markandeya/Y-8445-2019	Jois, Markandeya/0000-0002-0636-066X				BLACKMORE PF, 1978, J BIOL CHEM, V253, P4851; CAMPBELL AK, 1976, BIOCHEM J, V158, P211, DOI 10.1042/bj1580211; CHAREST R, 1983, J BIOL CHEM, V258, P8769; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; DENTON RM, 1978, BIOCHEM J, V176, P899, DOI 10.1042/bj1760899; Eriksson G., 1979, Analytica Chimica Acta, Computer Techniques and Optimization, V112, P375, DOI 10.1016/S0003-2670(01)85035-2; EXTON JH, 1985, J CLIN INVEST, V75, P1753, DOI 10.1172/JCI111886; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; HAMPSON RK, 1984, J BIOL CHEM, V259, P1180; HAMPSON RK, 1983, J BIOL CHEM, V258, P2993; HETENYI G, 1988, BIOCHEM J, V253, P27, DOI 10.1042/bj2530027; JOIS M, 1989, J BIOL CHEM, V264, P3347; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KOCHI H, 1986, ARCH BIOCHEM BIOPHYS, V249, P263, DOI 10.1016/0003-9861(86)90002-0; MURPHY E, 1980, J BIOL CHEM, V255, P6600; OBRIEN WE, 1978, ARCH BIOCHEM BIOPHYS, V189, P291, DOI 10.1016/0003-9861(78)90215-1; Sies H, 1978, Methods Enzymol, V52, P48; SISTARE FD, 1985, J BIOL CHEM, V260, P2744; THOMAS AP, 1984, J BIOL CHEM, V259, P5574; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; WILLIAMSON JR, 1981, BIOCHIM BIOPHYS ACTA, V639, P243, DOI 10.1016/0304-4173(81)90012-4; YOSHIDA T, 1970, ARCH BIOCHEM BIOPHYS, V139, P380, DOI 10.1016/0003-9861(70)90490-X; YUDKOFF M, 1981, METABOLISM, V30, P1096, DOI 10.1016/0026-0495(81)90054-8	25	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1990	265	3					1246	1248						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ676	1688557				2022-12-25	WOS:A1990CJ67600004
J	OEMAR, BS; LAW, NM; ROSENZWEIG, SA				OEMAR, BS; LAW, NM; ROSENZWEIG, SA			INSULIN-LIKE GROWTH FACTOR-I INDUCES TYROSYL PHOSPHORYLATION OF NUCLEAR PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GLOMERULAR MESANGIAL CELLS; FACTOR-I; TRANSCRIPTIONAL ACTIVATION; INTACT-CELLS; VASOPRESSIN; KINASE; ANTIBODIES; CULTURE; DNA; JUN	Stimulation of mesangial cells with insulin-like growth factor-1 (IGF-1) resulted in the rapid tyrosyl phosphorylation of nuclear proteins as indicated by fluorescence microscopy of cells stained with anti-phosphotyrosine antibodies. Immunoprecipitation of nuclear extracts with anti-phosphotyrosine antibodies revealed that IGF-1 induced a transient increase in immunoreactive phosphotyrosine in nuclear proteins of 43, 95, and 160 kDa. Using a double immunoprecipitation protocol, the transcription factor c-Jun was also found to increase in immunoreactive phosphotyrosine in response to IGF-1. A similar pattern of tyrosyl phosphorylation of nuclear proteins was observed in the epidermoid carcinoma cell line CaSki. These data suggest that tyrosyl phosphorylation of nuclear proteins may be a step in the transduction of mitogenic signals.	MED UNIV S CAROLINA,DEPT CELL & MOLEC PHARMACOL & EXPTL THERAPEUT,171 ASHLEY AVE,CHARLESTON,SC 29425; YALE UNIV,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510	Medical University of South Carolina; Yale University; Yale University; Yale University			Rosenzweig, Steven A/O-5062-2018	Rosenzweig, Steven/0000-0002-7022-6086; Oemar, Barry/0000-0003-1996-5817	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK034389, R01DK034389] Funding Source: NIH RePORTER; NEI NIH HHS [EY-06581] Funding Source: Medline; NIDDK NIH HHS [DK-34389] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BELL JC, 1987, NATURE, V325, P552, DOI 10.1038/325552a0; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; GANZ MB, 1989, NATURE, V337, P648, DOI 10.1038/337648a0; GANZ MB, 1988, AM J PHYSIOL, V254, pF787, DOI 10.1152/ajprenal.1988.254.6.F787; GANZ MB, 1988, AM J PHYSIOL, V255, pF898, DOI 10.1152/ajprenal.1988.255.5.F898; HUNTER T, 1988, COLD SPRING HARB SYM, V53, P131, DOI 10.1101/SQB.1988.053.01.019; IZUMI T, 1987, J BIOL CHEM, V262, P1282; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; Nigg E A, 1990, Adv Cancer Res, V55, P271, DOI 10.1016/S0065-230X(08)60471-6; OEMAR BS, 1991, J BIOL CHEM, V266, P2369; PANG DT, 1985, ARCH BIOCHEM BIOPHYS, V242, P176, DOI 10.1016/0003-9861(85)90491-6; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; ROSENZWEIG SA, 1990, J BIOL CHEM, V265, P18030; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; STERZEL RB, 1986, AM J PATHOL, V125, P130; TAKASU N, 1990, J ENDOCRINOL, V127, P305, DOI 10.1677/joe.0.1270305; TAKASU N, 1991, BIOCHEM BIOPH RES CO, V177, P113, DOI 10.1016/0006-291X(91)91955-C; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0	30	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24241	24244						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662205				2022-12-25	WOS:A1991GW84500003
J	SHABB, JB; BUZZEO, BD; NG, L; CORBIN, JD				SHABB, JB; BUZZEO, BD; NG, L; CORBIN, JD			MUTATING PROTEIN-KINASE CAMP-BINDING SITES INTO CGMP-BINDING SITES - MECHANISM OF CGMP SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE-BINDING; GENE ACTIVATOR PROTEIN; AMINO-ACID-SEQUENCE; DRUG RECEPTOR INTERACTIONS; REGULATORY SUBUNIT; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; PREDICTED STRUCTURES; POINT MUTATION; GATED CHANNEL	The cAMP-dependent protein kinase contains two different cAMP-binding sites referred to as the slow and fast sites. Mutation of Ala-334 to a threonine in the slow site of the bovine type I regulatory subunit created a site with marked increase in cGMP affinity without changing cAMP affinity (Shabb, J. B., Ng, L., Corbin, J. D. (1990) J. Biol. Chem. 265, 16031-16034). The corresponding fast site residue (Ala-210) was changed to a threonine by oligonucleotide-directed mutagenesis, and a double mutant containing a threonine in each site was also made. Holoenzymes were formed from native catalytic subunit and each recombinant regulatory subunit. The fast site mutant holoenzyme exhibited an improved cGMP activation constant and an impaired cAMP activation constant. The double mutant cGMP/cAMP selectivity was 200-fold greater than that of wild-type holoenzyme, making it as responsive to cGMP as native cGMP-dependent protein kinase. The increased intrinsic binding energies of mutated sites for cGMP were 2.7-3.0 kcal mol-1, consistent with the presence of an extra hydrogen bond. Cyclic nucleotide analog studies implied that this hydrogen bond was between the threonine hydroxyl and the 2-amino of cGMP. Comparisons of amino acid sequences and cyclic nucleotide specificities suggested that the Ala/Thr difference may also impart cAMP/cGMP binding selectivity to related proteins such as cyclic nucleotide-gated ion channels.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232	Vanderbilt University					NIDDK NIH HHS [T35DK07383, DK40029] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007383, R01DK040029] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON WB, 1972, J BIOL CHEM, V247, P2717; ANDREWS P, 1986, TRENDS PHARMACOL SCI, V7, P148, DOI 10.1016/0165-6147(86)90292-0; ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; BEEBE SJ, 1986, ENZYMES, V17, P43; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BUBIS J, 1987, BIOCHEMISTRY-US, V26, P3478, DOI 10.1021/bi00386a035; BUBIS J, 1988, BIOCHEMISTRY-US, V27, P1570, DOI 10.1021/bi00405a026; Charbonneau H., 1990, CYCLIC NUCLEOTIDE PH, P267; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; DEWIT RJW, 1984, EUR J BIOCHEM, V142, P255; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DOSKELAND SO, 1983, BIOCHEMISTRY-US, V22, P1094; DOSKELAND SO, 1987, J BIOL CHEM, V262, P3534; DOSKELAND SO, 1981, INT J BIOCHEM, V13, P1, DOI 10.1016/0020-711X(81)90131-2; EBRIGHT RH, 1985, J MOL BIOL, V182, P91, DOI 10.1016/0022-2836(85)90030-0; FLOCKHART DA, 1984, BRAIN RECEPTOR MET A, P209; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; FRANCIS SH, 1990, CYCLIC NUCLEOTIDE PH, P117; GRONENBORN AM, 1988, BIOCHEM J, V253, P801, DOI 10.1042/bj2530801; GRONENBORN AM, 1982, BIOCHEMISTRY-US, V21, P4040, DOI 10.1021/bi00260a020; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KAUPP UB, 1991, TRENDS NEUROSCI, V14, P150; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KUNO T, 1989, EUR J PHARM-MOLEC PH, V172, P263, DOI 10.1016/0922-4106(89)90056-4; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; MILLER JP, 1981, BIOCHEM PHARMACOL, V30, P509, DOI 10.1016/0006-2952(81)90637-7; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; OGREID D, 1989, EUR J BIOCHEM, V181, P19; OGREID D, 1982, FEBS LETT, V150, P161, DOI 10.1016/0014-5793(82)81326-4; OGREID D, 1988, J BIOL CHEM, V263, P17397; OGREID D, 1983, J BIOL CHEM, V258, P1041; OTTEN AD, 1989, J BIOL CHEM, V264, P20255; RANNELS SR, 1983, METHOD ENZYMOL, V99, P168; RANNELS SR, 1980, J BIOL CHEM, V255, P7085; RINGHEIM GE, 1990, J BIOL CHEM, V265, P19472; ROBINSONSTEINER AM, 1983, J BIOL CHEM, V258, P1032; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SCHOLUBBERS HG, 1984, EUR J BIOCHEM, V138, P101, DOI 10.1111/j.1432-1033.1984.tb07887.x; SHABB JB, 1990, J BIOL CHEM, V265, P16031; SHABB JB, 1991, HEART CARDIOVASCULAR, P1539; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4200, DOI 10.1021/bi00313a029; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; TANAKA JC, 1989, BIOCHEMISTRY-US, V28, P2776, DOI 10.1021/bi00433a006; THIEBART A, 1986, DEV BIOL, V114, P529; TITANI K, 1984, BIOCHEMISTRY-US, V23, P4193, DOI 10.1021/bi00313a028; TOPIOL S, 1990, J AM CHEM SOC, V112, P1452, DOI 10.1021/ja00160a024; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; WEBER IT, 1987, BIOCHEMISTRY-US, V26, P343, DOI 10.1021/bi00376a003; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WEBER IT, 1982, P NATL ACAD SCI-BIOL, V79, P7679, DOI 10.1073/pnas.79.24.7679; WOLFE L, 1990, NATO ASI SERIES H, V44, P133; WOODFORD TA, 1989, J BIOL CHEM, V264, P13321	55	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24320	24326						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662209				2022-12-25	WOS:A1991GW84500016
J	LIU, YF; ALBERT, PR				LIU, YF; ALBERT, PR			CELL-SPECIFIC SIGNALING OF THE 5-HT1A RECEPTOR - MODULATION BY PROTEIN-KINASE-C AND KINASE-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; ADENYLATE-CYCLASE ACTIVITY; FREE CA-2+ CONCENTRATION; SMOOTH-MUSCLE CELLS; PHOSPHOLIPASE-C; PITUITARY-CELLS; PHORBOL ESTERS; MEDIATED INHIBITION; HUMAN-PLATELETS; FREE CALCIUM	Heterologous expression of the rat 5-HT1A receptor in stably transfected GH4C1 rat pituitary cells (clone GH4ZD10) and mouse Ltk- fibroblast cells (clone LZD-7) (Albert, P. R., Zhou, Q.-Y., VanTol, H. H. M., Bunzow, J. R., and Civelli, O. (1990) J. Biol. Chem. 265, 5825-5832) was used to characterize the cellular specificity of signal transduction by the 5-HT1A receptor. We demonstrate that the 5-HT1A receptor, acting via pertussis toxin-sensitive G proteins, can change its inhibitory signaling phenotype and become a stimulatory receptor, depending on the cell type, differentiation state, or intracellular milieu of the cell in which it is expressed. When expressed in pituitary GH4ZD10 cells, activation of 5-HT1A receptors decreased both basal and vasoactive intestinal peptide-enhanced cAMP accumulation and blocked (+/-)-Bay K8644-induced influx of calcium, inhibitory responses which are typical of neurons which endogenously express this receptor. Similarly, 5-hydroxytryptamine (5-HT) also inhibited adenylyl cyclase in fibroblast LZD-7 cells, reducing the forskolin-induced enhancement of cAMP levels by 50%, but did not alter basal cAMP levels. In contrast to GH4ZD10 cells, where 5-HT had no effect on basal or thyrotropin-releasing hormone-induced phosphatidylinositol turnover, 5-HT enhanced the accumulation of inositol phosphates and induced a biphasic increase in [Ca2+]i in LZD-7 cells. These dominant stimulatory actions of 5-HT, as well as the inhibitory effects, were absent in untransfected cells and displayed the potency and pharmacological specificity of the 5-HT1A receptor, indicating that the 5-HT1A subtype coupled to both inhibitory and stimulatory pathways in the fibroblast cell. The actions of 5-HT in GH and L cells were blocked by 24-h pretreatment with pertussis toxin, suggesting that inhibitory G proteins (G(i)/G(o)) mediate both inhibitory and stimulatory signal transduction of the 5-HT1A receptor. However, the 5-HT-induced stimulatory pathway in fibroblasts was blocked selectively by acute (2-min) pretreatment with TPA, an activator of protein kinase C. This action of protein kinase C was potentiated by activation of protein kinase A, indicating that the expression of the stimulatory pathway of the 5-HT1A receptor in LZD-7 cells is modulated by second messengers.	MCGILL UNIV,DEPT PHARMACOL,MONTREAL H3G 1Y6,QUEBEC,CANADA	McGill University	ALBERT, PR (corresponding author), MCGILL UNIV,DEPT PHARMACOL,MONTREAL H3G 1Y6,QUEBEC,CANADA.		Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554				ALBERT PR, 1990, J BIOL CHEM, V265, P5825; ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ALBERT PR, 1986, AM J PHYSIOL, V251, pC887, DOI 10.1152/ajpcell.1986.251.6.C887; BELL JD, 1985, J BIOL CHEM, V260, P2625; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BROCK TA, 1985, J BIOL CHEM, V260, P4158; BROWN KD, 1987, BIOCHEM J, V245, P631, DOI 10.1042/bj2450631; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHUANG DM, 1989, ANNU REV PHARMACOL, V29, P71; CLARK WP, 1987, BRAIN RES, V410, P361; COLINO A, 1987, NATURE, V328, P73, DOI 10.1038/328073a0; CRONIN MJ, 1985, BIOCHEM BIOPH RES CO, V129, P404, DOI 10.1016/0006-291X(85)90165-2; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DRUMMOND AH, 1985, NATURE, V315, P752, DOI 10.1038/315752a0; DUMUIS A, 1988, MOL PHARMACOL, V33, P178; ENYEART JJ, 1987, J BIOL CHEM, V262, P3154; ENYEART JJ, 1990, MOL ENDOCRINOL, V4, P727, DOI 10.1210/mend-4-5-727; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; FARGIN A, 1989, J BIOL CHEM, V264, P14848; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOYER D, 1986, BRAIN RES, V376, P85, DOI 10.1016/0006-8993(86)90902-9; INNIS RB, 1987, EUR J PHARMACOL, V143, P195, DOI 10.1016/0014-2999(87)90533-4; KAVANAUGH WM, 1988, MOL ENDOCRINOL, V2, P599, DOI 10.1210/mend-2-7-599; LIAO CF, 1990, J BIOL CHEM, V265, P11273; MCATEE P, 1989, J BIOL CHEM, V264, P11193; MENDOZA SA, 1986, EXP CELL RES, V164, P536, DOI 10.1016/0014-4827(86)90051-0; MORIARTY TM, 1990, NATURE, V343, P79, DOI 10.1038/343079a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P306; OKADA F, 1989, J NEUROCHEM, V52, P1566, DOI 10.1111/j.1471-4159.1989.tb09209.x; PENNINGTON NJ, 1990, NEURON, V4, P751; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PRENTKI M, 1984, J BIOL CHEM, V259, P118; RAYMOND JR, 1989, J BIOL CHEM, V264, P21943; RINK TJ, 1983, NATURE, V305, P317, DOI 10.1038/305317a0; RITTENHOUSE SE, 1985, J BIOL CHEM, V260, P8657; ROPERT N, 1988, NEUROSCIENCE, V26, P69, DOI 10.1016/0306-4522(88)90128-5; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; RYU SH, 1990, J BIOL CHEM, V265, P17941; SCHULZ I, 1989, CELL CALCIUM, V10, P325, DOI 10.1016/0143-4160(89)90058-4; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; SILBERT S, 1990, J BIOL CHEM, V265, P3102; SMITH CD, 1987, J BIOL CHEM, V262, P6121; SPROUSE JS, 1988, NEUROPHARMACOLOGY, V27, P707, DOI 10.1016/0028-3908(88)90079-2; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; TRIGGLE DJ, 1987, ANNU REV PHARMACOL, V27, P347; UEDA H, 1989, J BIOL CHEM, V264, P3732; VALLAR L, 1990, J BIOL CHEM, V265, P10320; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; WALKER JW, 1987, NATURE, V327, P249, DOI 10.1038/327249a0; WEINSTEIN IB, 1988, MUTAT RES, V202, P413; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283; ZGOMBICK JM, 1989, MOL PHARMACOL, V35, P484	60	97	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					23689	23697						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660881				2022-12-25	WOS:A1991GV31900029
J	IVEY, DM; GUFFANTI, AA; BOSSEWITCH, JS; PADAN, E; KRULWICH, TA				IVEY, DM; GUFFANTI, AA; BOSSEWITCH, JS; PADAN, E; KRULWICH, TA			MOLECULAR-CLONING AND SEQUENCING OF A GENE FROM ALKALIPHILIC BACILLUS-FIRMUS OF4 THAT FUNCTIONALLY COMPLEMENTS AN ESCHERICHIA-COLI STRAIN CARRYING A DELETION IN THE NHAA NA+/H+ ANTIPORTER GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALOPHILIC BACILLUS; SYSTEMS; DNA; EXPRESSION; LLC-PK1; EFFLUX; CELLS; ANT; PH	A gene has been cloned from a DNA library from alkaliphilic Bacillus firmus OF4 that functionally complements a mutant strain of Escherichia coli, NM81, that carries a deletion for one of that strain's Na+/H+ antiporter genes (DELTA-nhaA). The cloned alkaliphile gene restored to NM81 the ability to grow at pH 7.5 in the presence of 0.6 M NaCl and on 100 mM Li+ in the presence of melibiose, and concomitantly led to an increase in the membrane associated Na+/H+ antiport activity. The biologically active alkaliphile DNA was identified as an incomplete open reading frame, the sequence of which would encode a hydrophobic protein. The insert was used to isolate clones containing the complete open reading frame, which would be predicted to encode a protein with a molecular weight of 42,960 and multiple membrane spanning regions. When the open reading frame was expressed under the control of the T7 promoter, the gene product was localized in the membrane. Southern analysis indicated no homology between the alkaliphile gene, which we propose to call nhaC, and the nhaA gene of Escherichia coli, nor with other genes in digests of DNA from E. coli, Bacillus subtilis, or Bacillus alcalophilus. Although there was also no significant similarity between the deduced protein products of the alkaliphile gene and the nhaA gene of E. coli, there was a small region of significant similarity between the deduced alkaliphile gene product and the protein encoded by a human Na+/H+ antiporter gene (Sardet, C., Franchi, A., and Pouyssegur, J. (1989) Cell 56, 271-280).	CUNY MT SINAI SCH MED, DEPT BIOCHEM, 1 GUSTAVE LEVY PL, NEW YORK, NY 10029 USA; HEBREW UNIV JERUSALEM, INST LIFE SCI, DEPT MICROBIAL & MOLEC ECOL, IL-91904 JERUSALEM, ISRAEL	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Hebrew University of Jerusalem								AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; ARONSON PS, 1986, CURRENT TOPICS MEMBR, V26, P1; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FRIEDRICH T, 1987, BIOCHEM BIOPH RES CO, V144, P869, DOI 10.1016/S0006-291X(87)80045-1; GARCIA ML, 1983, J BACTERIOL, V156, P1151, DOI 10.1128/JB.156.3.1151-1157.1983; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; GUFFANTI AA, 1986, J BACTERIOL, V167, P766, DOI 10.1128/jb.167.3.766-773.1986; GUFFANTI AA, 1991, IN PRESS J GEN MICRO; HAGGERTY JG, 1985, BIOCHEM BIOPH RES CO, V127, P759, DOI 10.1016/S0006-291X(85)80008-5; HAGGERTY JG, 1988, P NATL ACAD SCI USA, V85, P6797, DOI 10.1073/pnas.85.18.6797; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KRULWICH TA, 1989, J BIOENERG BIOMEMBR, V21, P663, DOI 10.1007/BF00762685; KRULWICH TA, 1989, ANNU REV MICROBIOL, V43, P435; KRULWICH TA, 1983, BIOCHIM BIOPHYS ACTA, V726, P245, DOI 10.1016/0304-4173(83)90011-3; KRULWICH TA, 1985, J BIOL CHEM, V260, P4055; KRULWICH TA, 1988, CRIT REV MICROBIOL, V16, P15, DOI 10.3109/10408418809104466; KRULWICH TA, 1986, J BACTERIOL, V165, P884, DOI 10.1128/jb.165.3.884-889.1986; KUDO T, 1990, J BACTERIOL, V172, P7282, DOI 10.1128/jb.172.12.7282-7283.1990; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; PADAN E, 1987, J MEMBRANE BIOL, V95, P189, DOI 10.1007/BF01869481; PADAN E, 1989, J BIOL CHEM, V264, P20297; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Sambrook J, 1989, MOL CLONING LABORATO; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SNAVELY MD, 1989, J BACTERIOL, V171, P4752, DOI 10.1128/jb.171.9.4752-4760.1989; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; ZHANG B, 1989, J CLIN INVEST, V83, P1425, DOI 10.1172/JCI114033	37	59	62	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23483	23489						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660475				2022-12-25	WOS:A1991GT48300106
J	RADI, R; TURRENS, JF; CHANG, LY; BUSH, KM; CRAPO, JD; FREEMAN, BA				RADI, R; TURRENS, JF; CHANG, LY; BUSH, KM; CRAPO, JD; FREEMAN, BA			DETECTION OF CATALASE IN RAT-HEART MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH DEHYDROGENASE; HYDROGEN-PEROXIDE; CYTOCHROME-C; INJURY; HYDROPEROXIDE; METABOLISM; TRANSPORT; MYOGLOBIN; RADICALS; OXIDASE	The presence of heme-containing catalase in rat heart mitochondria (20 +/- 5 units/mg) was demonstrated by biochemical and immunocytochemical analysis. Intact rat heart mitochondria efficiently consumed exogenously added H2O2. The rate of H2O2 consumption was not influenced by succinate, glutamate/malate, or N-ethylmaleimide but was significantly inhibited by cyanide. Hydrogen peroxide decomposition by mitochondria yielded molecular oxygen in a 2:1 stoichiometry, consistent with a catalatic mechanism. Mitochondrial fractionation studies and quantitative electron microscopic immunocytochemistry revealed that most catalase was matrix-associated. Electrophoretic analysis and Western blotting of the mitochondrial matrix fraction indicated the presence of a protein with similar electrophoretic mobility to bovine and rat liver catalase and immunoreactive to anti-catalase antibody. Myocardial tissue has a lower catalase-specific activity and a greater mitochondrial H2O2 production/g of tissue than most organs. Thus catalase, representing 0.025% of heart mitochondrial protein, is important for detoxifying mitochondrial derived H2O2 and represents a key antioxidant defense mechanism for myocardial tissue.	UNIV ALABAMA,DEPT ANESTHESIOL,619 19TH ST S,BIRMINGHAM,AL 35233; UNIV ALABAMA,DEPT BIOCHEM,BIRMINGHAM,AL 35233; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35233; UNIV SO ALABAMA,DEPT BIOMED SCI,MOBILE,AL 36688; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; Duke University			Freeman, Bruce A/H-9342-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042609, R01HL040458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024275] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40458, HL42609] Funding Source: Medline; NINDS NIH HHS [NS24275] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BINDOLI A, 1982, BIOCHIM BIOPHYS ACTA, V681, P496, DOI 10.1016/0005-2728(82)90192-X; BORS W, 1985, CRC HDB METHODS OXYG, P181; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CLAIBORNE A, 1985, HDB METHODS OXYGEN R, P181; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DOCAMPO R, 1976, EXPERIENTIA, V32, P971; FREEMAN BA, 1982, LAB INVEST, V47, P412; Fridovich, 1976, FREE RADICALS BIOLOG, V1, P239; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; GALARIS D, 1989, BIOCHEM BIOPH RES CO, V160, P1162, DOI 10.1016/S0006-291X(89)80125-1; GRIFFITHS G, 1982, J CELL BIOL, V95, P781, DOI 10.1083/jcb.95.3.781; KONNO N, 1990, Free Radical Biology and Medicine, V9, P96, DOI 10.1016/0891-5849(90)90513-I; Malis C D, 1988, Prog Clin Biol Res, V282, P235; MARRES CAM, 1985, EUR J BIOCHEM, V147, P153, DOI 10.1111/j.1432-1033.1985.tb08731.x; NOHL H, 1978, FEBS LETT, V89, P126, DOI 10.1016/0014-5793(78)80537-7; ORII Y, 1982, J BIOL CHEM, V257, P9246; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P112, DOI 10.1016/0003-9861(91)90171-E; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; RITZMANN M, 1986, EUR J BIOCHEM, V159, P493, DOI 10.1111/j.1432-1033.1986.tb09913.x; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SLOT JW, 1984, IMMUNOLABELLING ELEC, P129; THAYER WS, 1986, FEBS LETT, V202, P137, DOI 10.1016/0014-5793(86)80664-0; Tokuyasu K. T., 1984, IMMUNOLABELLING ELEC, P71; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; ZHANG Y, 1990, J BIOL CHEM, V265, P16330	33	414	423	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					22028	22034						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657986				2022-12-25	WOS:A1991GP80400105
J	CHEIFETZ, S; MASSAGUE, J				CHEIFETZ, S; MASSAGUE, J			ISOFORM-SPECIFIC TRANSFORMING GROWTH-FACTOR-BETA BINDING-PROTEINS WITH MEMBRANE ATTACHMENTS SENSITIVE TO PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSAMINOGLYCAN CHAINS; 2 FORMS; RECEPTOR; PROTEOGLYCAN; CELLS; ALPHA-2-MACROGLOBULIN; DIFFERENTIATION; IDENTIFICATION; FACTOR-BETA-2; INHIBITION	We report the identification of cell surface glycoproteins that bind transforming growth factor-beta (TGF-beta) in an isoform-specific manner, and are distinct from TGF-beta receptors I and II or the TGF-beta binding proteoglycan betaglycan. The novel TGF-beta binding proteins have been identified in various cell lines including fetal bovine heart endothelial cells and MG-63 human osteosarcoma cells. They include proteins of 90-100 and 180 kDa that preferentially bind TGF-beta-1 (K(D) 0.1-0.2 nM) and proteins of 60 and 140 kDa that preferentially bind TGF-beta-2 (K(D) 0.5-1 nM). The 180-kDa TGF-beta-1 binding protein and the 60- and 140-kDa TGF-beta-2 binding proteins can be released from the cell surface by treatment with phosphatidylinositol-specific phospholipase C, suggesting that these proteins are attached to the plasma membrane through a phosphatidylinositol anchor. The expression of these three proteins as well as their sensitivity to phosphatidylinositol-specific phospholipase C is cell line-dependent. The 90-100-kDa TGF-beta-1 binding proteins are components of a 190-kDa disulfide-linked complex. The structural properties of these proteins and their high affinity and selectivity for different TGF-beta isoforms defines them as a novel class of cell surface TGF-beta binding proteins.	MEM SLOAN KETTERING CANC CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10021	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	CHEIFETZ, S (corresponding author), MEM SLOAN KETTERING CANC CTR,CELL BIOL & GENET PROGRAM,NEW YORK,NY 10021, USA.			Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [R01CA034610, R37CA034610] Funding Source: NIH RePORTER; NCI NIH HHS [CA-34610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRES JL, 1989, J CELL BIOL, V109, P31317; BODMER S, 1990, BIOCHEM BIOPH RES CO, V171, P890, DOI 10.1016/0006-291X(90)91229-L; BOYD FT, 1989, J BIOL CHEM, V264, P2272; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; FAFEUR B, 1990, GROWTH FACTORS, V3, P237; FAVA RA, 1987, J CELL PHYSIOL, V131, P184, DOI 10.1002/jcp.1041310207; JENNINGS JC, 1988, J CELL PHYSIOL, V137, P167, DOI 10.1002/jcp.1041370120; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LAMARRE J, 1990, LAB INVEST, V62, P545; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MACKAY K, 1990, J BIOL CHEM, V265, P9351; MACKAY K, 1991, J BIOL CHEM, V266, P9907; MASSAGUE J, 1987, METHOD ENZYMOL, V146, P174; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MURPHY-ULLRICH J E, 1990, Journal of Cell Biology, V111, p148A; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OGRADY P, 1991, J BIOL CHEM, V266, P8583; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; OTTMANN OG, 1988, J IMMUNOL, V140, P2661; PARALKAR MV, 1991, DEV BIOL, V143, P303; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SEGARINI PR, 1988, J BIOL CHEM, V263, P10783; SEGARINI PR, 1989, MOL ENDOCRINOL, V3, P2611; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	36	78	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20767	20772						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657936				2022-12-25	WOS:A1991GN00100029
J	GILMOUR, BP; FANGER, GR; NEWTON, C; EVANS, SM; GARDNER, PD				GILMOUR, BP; FANGER, GR; NEWTON, C; EVANS, SM; GARDNER, PD			MULTIPLE BINDING-SITES FOR MYOGENIC REGULATORY FACTORS ARE REQUIRED FOR EXPRESSION OF THE ACETYLCHOLINE-RECEPTOR GAMMA-SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CREATINE-KINASE GENE; TRANSCRIPTIONAL REGULATION; SKELETAL-MUSCLE; ACTIN GENE; CELLS; IDENTIFICATION; REGION; DIFFERENTIATION; MYOBLASTS; PROMOTERS	The nicotinic acetylcholine receptor (AChR) is a critical component of the mechanism responsible for signal transduction between nerve and muscle. Induction of AChR gene expression occurs during myogenesis when myoblasts exit the cell cycle and fuse to form myotubes. Induction of muscle-specific genes during differentiation is believed to be mediated through the activities of members of the MyoD family of myogenic regulatory factors. At least two of the factors, MyoD and myogenin, function as transcriptional activators. Here we present evidence that MyoD is capable of activating transcription of the mouse AChR gamma-subunit gene. We have identified seven potential MyoD-binding sites (E-boxes) within the 5'-flanking DNA of the gamma-subunit gene. We demonstrate that two small regions of the 5'-flanking DNA, one containing a pair of E-boxes and the other containing a single E-box, are required for gamma-subunit expression in mouse muscle cells. DNase I footprinting indicates that the E-box proximal to the transcriptional initiation site is capable of interacting directly with MyoD. Furthermore, site-directed mutational analysis indicates that the single E-box is necessary for transactivation by MyoD and expression of the gamma-subunit promoter region in muscle cells.	DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,PROGRAM MOLEC & CELLULAR NEUROSCI,HANOVER,NH 03756; DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT BIOCHEM,HANOVER,NH 03756; UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093	Dartmouth College; Dartmouth College; University of California System; University of California San Diego			Evans, Sylvia/G-1980-2015		NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005392] Funding Source: NIH RePORTER; NCRR NIH HHS [S07RR05392] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; BRUETTI A, 1990, J BIOL CHEM, V265, P5960; BUCKINGHAM ME, 1977, INT REV BIOCHEM, V15, P269; DAUBAS P, 1988, NUCLEIC ACIDS RES, V16, P1251, DOI 10.1093/nar/16.4.1251; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; GARDNER PD, 1987, MOL BRAIN RES, V3, P69, DOI 10.1016/0169-328X(87)90046-5; HASTINGS KEM, 1982, P NATL ACAD SCI-BIOL, V79, P1553, DOI 10.1073/pnas.79.5.1553; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KLARSFELD A, 1987, MOL CELL BIOL, V7, P951, DOI 10.1128/MCB.7.2.951; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; MERLIE JP, 1989, NEURON, V2, P1295, DOI 10.1016/0896-6273(89)90067-6; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MIWA T, 1987, P NATL ACAD SCI USA, V84, P6702, DOI 10.1073/pnas.84.19.6702; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PATRICK J, 1972, P NATL ACAD SCI USA, V69, P2762, DOI 10.1073/pnas.69.10.2762; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; WANG Y, 1988, NEURON, V1, P527, DOI 10.1016/0896-6273(88)90183-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242	25	62	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19871	19874						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657903				2022-12-25	WOS:A1991GM03900002
J	HEERDT, BG; AUGENLICHT, LH				HEERDT, BG; AUGENLICHT, LH			EFFECTS OF FATTY-ACIDS ON EXPRESSION OF GENES ENCODING SUBUNITS OF CYTOCHROME-C-OXIDASE AND CYTOCHROME-C-OXIDASE ACTIVITY IN HT29 HUMAN COLONIC ADENOCARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIAL GENOME; HUMAN LARGE-INTESTINE; SODIUM-BUTYRATE; ALKALINE-PHOSPHATASE; TRANSLATION PRODUCTS; PROTEIN-DEGRADATION; ULCERATIVE-COLITIS; RETINOIC ACID; MEMBRANE; CULTURE	As the primary and preferred energy source of normal colonic epithelial cells, fatty acids may play a unique role in the differentiation and physiology of these cells. We have shown that expression levels of COXIII, a mitochondrial gene encoding one of the 13 subunits of cytochrome c oxidase, are abnormally low in colon tumors and colonic tissue at genetic risk for developing tumors but increase following in vitro treatment of HT29 human colonic adenocarcinoma cells with the fatty acid butyrate. The present studies investigate the specificity of fatty acids in effecting cytochrome c oxidase subunit expression and enzymatic activity in HT29 cells. The data demonstrate that, depending upon their chain length, metabolizable unbranched fatty acids increase expression of two subunits encoded by mitochondrial genes (I and III) and enhance cytochrome c oxidase activity. However, none of the fatty acids had an effect on expression of two subunits encoded by nuclear genes (IV and Va). These findings suggest that the low levels of COXIII expression exhibited in colonic tumors may represent a limiting factor in the assembly of functional cytochrome c oxidase and contribute to the depressed enzyme activity reported in these tumors. By elevating expression of subunits I and III and enzymatic activity, fatty acids may enhance the potential for cellular respiration. The more differentiated phenotype which is reported in colorectal carcinoma cell lines treated with fatty acids in vitro may be, therefore, associated with correction of metabolic abnormalities in transformed cells.	ALBERT EINSTEIN MED CTR,DEPT ONCOL,BRONX,NY 10467	Yeshiva University	HEERDT, BG (corresponding author), MONTEFIORE MED CTR,DEPT ONCOL,HOFHEIMER 509,111 E 210TH ST,BRONX,NY 10467, USA.				NCI NIH HHS [P30-CA-1330, CA-41372, CA-40558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K04CA001330, R01CA040558, R01CA041372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Battey, 1986, BASIC METHODS MOL BI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN SHP, 1983, FEBS LETT, V162, P344, DOI 10.1016/0014-5793(83)80785-6; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CHUNG YS, 1985, CANCER RES, V45, P2976; CLARKSON GHD, 1989, J BIOL CHEM, V264, P10114; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; COTE C, 1990, J BIOL CHEM, V265, P7532; COTE C, 1989, J BIOL CHEM, V264, P8487; CUMMINGS JH, 1983, LANCET, V1, P1206; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; EILERS M, 1987, EMBO J, V6, P1073, DOI 10.1002/j.1460-2075.1987.tb04860.x; FRIEND C, 1987, CANCER RES, V47, P378; GLOTZER DJ, 1981, GASTROENTEROLOGY, V80, P438; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; GOLDMAN P, 1969, SCIENCE, V164, P1123, DOI 10.1126/science.164.3884.1123; GUM JR, 1987, J BIOL CHEM, V262, P1092; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; HEERDT BG, 1990, CANCER COMMUN, V2, P109, DOI 10.3727/095535490820874623; HEERDT BG, 1990, EXP CELL RES, V186, P54, DOI 10.1016/0014-4827(90)90209-S; HEERDT BG, 1991, ONCOGENE, V6, P125; HERTZ F, 1983, BIOCHIM BIOPHYS ACTA, V762, P289; HERTZ F, 1981, ARCH BIOCHEM BIOPHYS, V210, P581; KADENBACH B, 1987, CURR TOP BIOENERG, V15, P113; KIM YS, 1980, CANCER-AM CANCER SOC, V45, P1185, DOI 10.1002/1097-0142(19800315)45:5+<1185::AID-CNCR2820451324>3.0.CO;2-W; Knox W E, 1967, Adv Cancer Res, V10, P117, DOI 10.1016/S0065-230X(08)60078-0; KOUDSTAAL J, 1975, EUR J CANCER, V11, P105, DOI 10.1016/0014-2964(75)90187-5; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; LENTNER C, 1981, GEIGY SCI TABLES, V1, P155; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; MALATESTA F, 1986, BIOCHEM J, V234, P569, DOI 10.1042/bj2340569; MCGINTY F, 1973, GUT, V14, P502, DOI 10.1136/gut.14.6.502; MERELE P, 1980, EUR J BIOCHEM, V105, P499; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; MORITA A, 1982, CANCER RES, V42, P4540; NISHIMUNE Y, 1983, EXP CELL RES, V146, P439, DOI 10.1016/0014-4827(83)90147-7; PHILIPPE J, 1987, MOL CELL BIOL, V7, P560, DOI 10.1128/MCB.7.1.560; PRASAD KN, 1976, IN VITRO CELL DEV B, V12, P125; RIZZUTO R, 1988, GENE, V69, P245, DOI 10.1016/0378-1119(88)90435-0; ROEDIGER WEW, 1986, LANCET, V1, P1082; ROEDIGER WEW, 1986, BRIT J EXP PATHOL, V67, P773; ROEDIGER WEW, 1980, LANCET, V2, P712; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; ROEDIGER WEW, 1988, BRIT J SURG, V75, P346, DOI 10.1002/bjs.1800750417; SCHATZ G, 1974, ANNU REV BIOCHEM, V43, P51, DOI 10.1146/annurev.bi.43.070174.000411; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; SIDDIQUI B, 1984, CANCER RES, V44, P1648; SUN AS, 1981, LAB INVEST, V44, P13; TOSCANI A, 1988, ONCOGENE RES, V3, P223; TSAO D, 1983, CANCER RES, V43, P1217; TSAO D, 1982, CANCER RES, V42, P1052; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; WALLACE DC, 1987, GENETIC MAPS 1987, V4, P642; WELCH JT, 1987, TETRAHEDRON, V43, P3123, DOI 10.1016/S0040-4020(01)90286-8; WHITEHEAD RH, 1986, GUT, V27, P1457, DOI 10.1136/gut.27.12.1457; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WRONG OM, 1981, LARGE INTESTINE ITS, P113; ZEVIANI M, 1987, GENE, V55, P205, DOI 10.1016/0378-1119(87)90281-2	62	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19120	19126						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655774				2022-12-25	WOS:A1991GJ47200109
J	LUCIUS, R; MENTLEIN, R				LUCIUS, R; MENTLEIN, R			DEGRADATION OF THE NEUROPEPTIDE SOMATOSTATIN BY CULTIVATED NEURONAL AND GLIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; AMINOPEPTIDASE-M; MEMBRANE; BINDING; PURIFICATION; ENZYME; ENDOPEPTIDASE-24.11; INACTIVATION; ENDOPROTEASE; PEPTIDASE	The enzymatic degradation of the neuropeptide somatostatin was investigated in cultivated cells and subcellular fractions from rat brain. Dissociated neurones, astrocytes, and oligodendrocytes obtained from rat cerebral cortex were of more than 85-98% purity as evidenced by immunostaining with antisera to cell specific markers. All of these cell types were able to cleave radiolabeled somatostatin to smaller fragments, especially cultivated astrocytes with the highest specific activity. The neuroblastoma cell line N1E-115 did not measureably cleave somatostatin. The somatostatin-degrading proteases of the cultivated brain cells could be differentiated by their sensitivity to protease inhibitors and by the fragments produced: astrocytes contain a metallo-endoprotease sensitive to phenanthroline which cleaves somatostatin at the Phe6-Phe7 and Thr10-Phe11 bonds, whereas the endoprotease(s) of neurones and oligodendrocytes was insensitive to chelating agents but strongly inhibited by the antibiotic bacitracin. In accordance with this, the bacitracin-sensitive activity was mainly recovered in the synaptic plasma membrane and myelin subcellular fractions obtained by differential centrifugation of rat cerebral cortex homogenate. However, the highest total and specific somatostatin-degrading activity was detected in the cytosolic fraction.	UNIV KIEL,INST ANAT,OLSHAUSENSTR 40,W-2300 KIEL 1,GERMANY	University of Kiel			Mentlein, Rolf/B-1613-2010; Lucius, Ralph/B-1614-2010	Mentlein, Rolf/0000-0002-6350-3911; 				BARNES K, 1988, NEUROSCI LETT, V94, P64, DOI 10.1016/0304-3940(88)90271-6; BAUER K, 1985, NEUROBIOCHEMISTRY, P43; BEINFELD MC, 1989, BIOCHEM BIOPH RES CO, V160, P968, DOI 10.1016/0006-291X(89)92530-8; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHECLER F, 1986, J BIOL CHEM, V261, P1274; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; FANGER BO, 1987, ANAL BIOCHEM, V162, P11, DOI 10.1016/0003-2697(87)90004-2; GLUSCHANKOF P, 1987, J BIOL CHEM, V262, P9615; GORDONWEEKS PR, 1987, NEUROCHEMISTRY PRACT, P1; GROS C, 1985, BIOCHEMISTRY-US, V24, P2179, DOI 10.1021/bi00330a011; HE HT, 1989, P NATL ACAD SCI USA, V86, P1480, DOI 10.1073/pnas.86.5.1480; HENDIL KB, 1990, BIOCHEM J, V272, P577, DOI 10.1042/bj2720577; HERSH LB, 1987, PEPTIDES, V8, P523, DOI 10.1016/0196-9781(87)90019-2; HORSTHEMKE B, 1984, BIOCHEM BIOPH RES CO, V125, P728, DOI 10.1016/0006-291X(84)90599-0; HORSTHEMKE B, 1983, BIOCHEM BIOPH RES CO, V115, P423, DOI 10.1016/S0006-291X(83)80161-2; INGRAHAM CA, 1989, J NEUROSCI, V9, P63; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; KRISCH B, 1978, CELL TISSUE RES, V195, P499; LYNCH DR, 1986, ANNU REV BIOCHEM, V55, P773, DOI 10.1146/annurev.bi.55.070186.004013; MARKS N, 1975, FEBS LETT, V55, P220, DOI 10.1016/0014-5793(75)80996-3; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MENTLEIN R, 1990, CELL TISSUE RES, V262, P431, DOI 10.1007/BF00305240; MENTLEIN R, 1989, CELL TISSUE RES, V258, P309; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; REID KH, 1988, PROG NEUROBIOL, V31, P1, DOI 10.1016/0301-0082(88)90020-2; RICHELSON E, 1978, BIOCHEM PHARMACOL, V27, P2039, DOI 10.1016/0006-2952(78)90064-3; ROSE C, 1988, P NATL ACAD SCI USA, V85, P8326, DOI 10.1073/pnas.85.21.8326; SAKURADA C, 1990, PEPTIDES, V11, P287, DOI 10.1016/0196-9781(90)90084-I; STOCCHI V, 1985, J CHROMATOGR, V349, P77, DOI 10.1016/S0021-9673(00)90635-6; TAVIANINI MA, 1984, J BIOL CHEM, V259, P1798; TURNER AJ, 1987, MAMMALIAN ECTOENZYME, P211; VANCALKER D, 1980, P NATL ACAD SCI-BIOL, V77, P6907; VEBER DF, 1981, NATURE, V292, P55, DOI 10.1038/292055a0; VECSEI L, 1988, ACTA PSYCHIAT SCAND, V78, P657, DOI 10.1111/j.1600-0447.1988.tb06401.x; WEBER M, 1986, AM J PHYSIOL, V250, pG679, DOI 10.1152/ajpgi.1986.250.5.G679; WITTMANNLIEBOLD B, 1986, ADV METHODS PROTEIN, P77	37	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18907	18913						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1680864				2022-12-25	WOS:A1991GJ47200077
J	SAKAMOTO, J; CAMPBELL, KP				SAKAMOTO, J; CAMPBELL, KP			A MONOCLONAL-ANTIBODY TO THE BETA-SUBUNIT OF THE SKELETAL-MUSCLE DIHYDROPYRIDINE RECEPTOR IMMUNOPRECIPITATES THE BRAIN OMEGA-CONOTOXIN GVIA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; DEPENDENT CA-2+ CHANNEL; H-3 RYANODINE RECEPTOR; HIGH-AFFINITY RECEPTOR; 1,4-DIHYDROPYRIDINE RECEPTOR; RAT-BRAIN; SARCOPLASMIC-RETICULUM; MAMMALIAN BRAIN; RELEASE CHANNEL; SODIUM-CHANNEL	Antibodies against the subunits of the dihydropyridine-sensitive L-type calcium channel of skeletal muscle were tested for their ability to immunoprecipitate the high affinity (K(d) = 0.13 nM) I-125-omega-conotoxin GVIA receptor from rabbit brain membranes. Monoclonal antibody VD21 against the beta subunit of the dihydropyridine receptor from skeletal muscle specifically immunoprecipitated up to 86% of the I-125-omega-conotoxin receptor solubilized from brain membranes whereas specific antibodies against the alpha-1, alpha-2, and gamma-subunits did not precipitate the brain receptor. Purified skeletal muscle dihydropyridine receptor inhibited the immunoprecipitation of the brain omega-conotoxin receptor by monoclonal antibody VD2(1). The dihydropyridine receptor from rabbit brain membranes was also precipitated by monoclonal antibody VD2(1). However, neither the neuronal ryanodine receptor nor the sodium channel was precipitated by monoclonal antibody VD2(1). The omega-conotoxin receptor immunoprecipitated by monoclonal antibody VD2(1) showed high affinity I-125-omega-conotoxin binding, which was inhibited by unlabeled omega-conotoxin and by CaCl2 but not by nitrendipine or by diltiazem. An antibody against the beta-subunit of the skeletal muscle dihydropyridine receptor stained 58- and 78-kDa proteins on immunoblot of the omega-conotoxin receptor, partially purified through heparinagarose chromatography and VD2(1)-Sepharose chromatography. These results suggest that the brain omega-conotoxin-sensitive calcium channel contains a component homologous to the beta-subunit of the dihydropyridine-sensitive calcium channel of skeletal muscle and brain.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa				Campbell, Kevin/0000-0003-2066-5889	NHLBI NIH HHS [HL39265, HL14388] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039265] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE T, 1986, NEUROSCI LETT, V71, P203, DOI 10.1016/0304-3940(86)90559-8; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BARCHI RL, 1980, P NATL ACAD SCI-BIOL, V77, P1306, DOI 10.1073/pnas.77.3.1306; BARHANIN J, 1988, BIOCHEM BIOPH RES CO, V150, P1051, DOI 10.1016/0006-291X(88)90736-X; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6460; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CRUZ LJ, 1986, J BIOL CHEM, V261, P6230; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; HAYAKAWA N, 1990, BIOCHEM BIOPH RES CO, V173, P483, DOI 10.1016/S0006-291X(05)80059-2; HORNE W A, 1990, Society for Neuroscience Abstracts, V16, P957; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; IMAGAWA T, 1987, J BIOL CHEM, V262, P8333; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; LEUNG AT, 1988, J BIOL CHEM, V263, P994; LEVINSON SR, 1979, ANAL BIOCHEM, V99, P72, DOI 10.1016/0003-2697(79)90045-9; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MCPHERSON PS, 1990, J BIOL CHEM, V265, P18454; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MUNDINAWEILENMANN C, 1991, J BIOL CHEM, V266, P4067; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRAGNELL M, 1989, BIOPHYS J, V59, P390; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROSENBERG RL, 1989, ANN NY ACAD SCI, V560, P39, DOI 10.1111/j.1749-6632.1989.tb24077.x; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; TAKAHASHI M, 1989, BIOCHEM BIOPH RES CO, V163, P1182, DOI 10.1016/0006-291X(89)92345-0; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TAKEMURA M, 1989, NEUROSCIENCE, V32, P405, DOI 10.1016/0306-4522(89)90089-4; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WAGNER JA, 1988, J NEUROSCI, V8, P3354; YAMAGUCHI T, 1988, J BIOL CHEM, V263, P9491	46	69	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18914	18919						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655767				2022-12-25	WOS:A1991GJ47200078
J	OFFERMANNS, S; SCHULTZ, G; ROSENTHAL, W				OFFERMANNS, S; SCHULTZ, G; ROSENTHAL, W			EVIDENCE FOR OPIOID RECEPTOR-MEDIATED ACTIVATION OF THE G-PROTEINS, G0 AND GI2, IN MEMBRANES OF NEUROBLASTOMA-X GLIOMA (NG108-15) HYBRID-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING-PROTEIN; RECONSTITUTED PHOSPHOLIPID-VESICLES; GUANINE-NUCLEOTIDE; ADENYLATE-CYCLASE; CALCIUM CHANNELS; PERTUSSIS TOXIN; ADRENERGIC RECEPTORS; SIGNAL TRANSDUCTION; HL-60 CELLS; INHIBITION	In membranes of neuroblastoma x glioma (NG108-15) hybrid cells, the photoreactive GTP analog, [alpha-P-32] GTP azidoanilide, was incorporated into 39-41-kDa proteins comigrating in urea-containing sodium dodecyl sulfate-polyacrylamide gels with immunologically identified G-protein alpha-subunits, i.e. a 39-kDa G(o) alpha-subunit, a 40-kDa G(i2) alpha-subunit, and a 41-kDa G(i) alpha-subunit of an unknown subtype. The synthetic opioid, D-Ala2, D-Leu5-enkephalin (DADLE), stimulated photolabeling of the 39-41-kDa proteins. In the presence of GDP, which increased the ratio of agonist-stimulated to basal photolabeling, DADLE at a maximally effective concentration stimulated photolabeling of the 39- and the 40-kDa protein 2-3-fold. Somatostatin, adrenaline, and bradykinin were less potent than DADLE and, to varying degrees, stimulated photolabeling of the 40-kDa protein more than that of the 39-kDa protein. Prostaglandin E1 was inactive. The present data represent direct evidence for an activation of endogenous G(o) and G(i2) via opioid receptors and other receptors in the native membrane milieu.	FREE UNIV BERLIN,INST PHARMAKOL,THIELALLEE 69-73,W-1000 BERLIN 33,GERMANY	Free University of Berlin			Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				ASANO T, 1984, J BIOL CHEM, V259, P9351; ASANO T, 1988, J NEUROCHEM, V50, P1164, DOI 10.1111/j.1471-4159.1988.tb10588.x; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; COSTA T, 1988, MOL PHARMACOL, V34, P744; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GORDON JH, 1988, FEBS LETT, V235, P201, DOI 10.1016/0014-5793(88)81262-6; GREINER C, 1988, BIOCHEM J, V254, P27, DOI 10.1042/bj2540027; HAGA K, 1986, J BIOL CHEM, V261, P133; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; HATTA S, 1986, P NATL ACAD SCI USA, V83, P5439, DOI 10.1073/pnas.83.15.5439; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIGASHIDA H, 1986, P NATL ACAD SCI USA, V83, P942, DOI 10.1073/pnas.83.4.942; JAKOBS KH, 1985, ADV CYCLIC NUCL PROT, V19, P137; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARBACH I, 1988, EUR J BIOCHEM, V172, P239, DOI 10.1111/j.1432-1033.1988.tb13879.x; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; MCLEISH KR, 1989, BIOCHEM J, V260, P427, DOI 10.1042/bj2600427; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OFFERMANNS S, 1991, IN PRESS METHODS ENZ; OFFERMANS S, 1990, FEBS LETT, V260, P14, DOI 10.1016/0014-5793(90)80054-M; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; ROSENTHAL W, 1986, EUR J BIOCHEM, V158, P255, DOI 10.1111/j.1432-1033.1986.tb09745.x; ROSENTHAL W, 1988, EMBO J, V7, P1627, DOI 10.1002/j.1460-2075.1988.tb02989.x; SABOL SL, 1979, J BIOL CHEM, V254, P1913; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P590, DOI 10.1073/pnas.72.2.590; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V415, P255, DOI 10.1007/BF00370874; TRABER J, 1977, FEBS LETT, V81, P351, DOI 10.1016/0014-5793(77)80552-8; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; VANDONGEN AM, 1989, SCIENCE, V242, P1433; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	37	80	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3365	3368						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1671672				2022-12-25	WOS:A1991EY68200003
J	JACKLE, S; RUNQUIST, EA; MIRANDABRADY, S; HAVEL, RJ				JACKLE, S; RUNQUIST, EA; MIRANDABRADY, S; HAVEL, RJ			TRAFFICKING OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFERRIN IN 3 HEPATOCYTIC ENDOSOMAL FRACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; LOW-DENSITY LIPOPROTEINS; MEDIATED ENDOCYTOSIS; IRON UPTAKE; K562 CELLS; MULTIVESICULAR BODIES; HUMAN FIBROBLASTS; DOWN-REGULATION; TREATED RATS; EGF RECEPTOR	Hepatocytes rapidly internalize epidermal growth factor (EGF) and transferrin by receptor-mediated endocytosis. Both EGF and its receptor are thought to be targeted for destruction in lysosomes, leading to downregulation of the receptor, whereas transferrin, after unloading iron within the cell, is thought to recycle to the cell surface bound to its receptor. Previously, we isolated three endosomal fractions from livers of estradiol-treated rats and examined their roles in cellular trafficking of low density lipoproteins (LDL) and the LDL receptor, which cycles constitutively (Belcher, J. D., Hamilton, R. L., Brady, S. E., Hornick, C. A., Jackle, S., Schneider, W. J., and Havel, R. J., Proc. Natl. Acad. Sci. U. S. A. (1987) 84, 6785-6789). In the current study we have taken advantage of the distinct trafficking of the EGF receptor and transferrin to evaluate further the functions of these endosome fractions. Intravenous injection of a saturating amount of EGF into estradiol-treated rats induced internalization of a single population of EGF receptors, which rapidly accumulated in the endosome fraction of intermediate density ("compartment of uncoupling of receptor and ligand" (CURL)) and subsequently in the low density endosome fraction (multivesicular bodies (MVBs)). The high density endosome fraction, whose membranes contain a high concentration of recycling receptors (designated receptor-recycling compartment (RRC)), failed to accumulate EGF receptors after injection of EGF. In livers of rats not given exogenous EGF, EGF receptors were found in small but comparable concentrations in RRC, CURL, and MVB membranes, consistent with other evidence that targeting of the EGF receptor to lysosomes is mediated by ligand-induced phosphorylation. Transferrin also accumulated first in CURL and later in MVBs, but it also accumulated rapidly in the RRC fraction, consistent with the proposed function of this fraction in receptor recycling. Since transferrin is not degraded during its endocytic cycle, these observations indicate that apotransferrin and its receptor recycle from late endosomes (MVBs) located at the apical pole of hepatocytes, as well as from early endosomes near the sinusoidal pole.	UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014237] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-14237] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKKEREN DL, 1987, INT J BIOCHEM, V19, P179, DOI 10.1016/0020-711X(87)90329-6; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; BURWEN SJ, 1984, J CELL BIOL, V99, P1259, DOI 10.1083/jcb.99.4.1259; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHAO Y, 1979, J BIOL CHEM, V254, P1360; CHAO YS, 1981, P NATL ACAD SCI-BIOL, V78, P597, DOI 10.1073/pnas.78.1.597; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; COHEN S, 1985, J BIOL CHEM, V260, P2351; COLE ES, 1983, BIOCHIM BIOPHYS ACTA, V762, P102, DOI 10.1016/0167-4889(83)90122-2; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GLADHAUG IP, 1988, J BIOL CHEM, V263, P12199; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRIFFITHS G, 1989, J CELL SCI, P139; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOATH SB, 1987, BIOCHIM BIOPHYS ACTA, V930, P107, DOI 10.1016/0167-4889(87)90162-5; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; JAECKLE S, 1989, P NATL ACAD SCI USA, V86, P1880, DOI 10.1073/pnas.86.6.1880; JOSTVU E, 1986, HISTOCHEMISTRY, V85, P457, DOI 10.1007/BF00508427; KARIN M, 1981, J BIOL CHEM, V256, P3245; KAY DG, 1986, J BIOL CHEM, V261, P8473; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KOVANEN PT, 1979, J BIOL CHEM, V254, P1367; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; MILSOM JP, 1979, BIOCHEM J, V182, P117, DOI 10.1042/bj1820117; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; MORIARITY DM, 1980, ARCH BIOCHEM BIOPHYS, V203, P506, DOI 10.1016/0003-9861(80)90208-8; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; OKEEFE E, 1974, ARCH BIOCHEM BIOPHYS, V164, P518, DOI 10.1016/0003-9861(74)90062-9; PAGE MA, 1984, AM J PHYSIOL, V246, pG26, DOI 10.1152/ajpgi.1984.246.1.G26; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pittman R C, 1986, Methods Enzymol, V129, P612; RUSH GF, 1987, LIFE SCI, V40, P679, DOI 10.1016/0024-3205(87)90270-0; SALZMAN NH, 1988, J CELL BIOL, V106, P1083, DOI 10.1083/jcb.106.4.1083; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SIBILLE JC, 1986, EUR J BIOCHEM, V155, P47, DOI 10.1111/j.1432-1033.1986.tb09457.x; SIGURDSSON G, 1978, J LIPID RES, V19, P628; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; STEIN BS, 1984, J BIOL CHEM, V259, P4762; STEIN BS, 1986, J BIOL CHEM, V261, P319; STOORVOGEL W, 1988, J CELL BIOL, V106, P1821, DOI 10.1083/jcb.106.6.1821; THORSTENSEN K, 1984, BIOCHIM BIOPHYS ACTA, V804, P393, DOI 10.1016/0167-4889(84)90065-X; THORSTENSEN K, 1988, J BIOL CHEM, V263, P8844; VANDYKE RW, 1985, J BIOL CHEM, V260, P1021; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WILLINGHAM MC, 1984, P NATL ACAD SCI-BIOL, V81, P175, DOI 10.1073/pnas.81.1.175; YAMASHIRO DJ, 1988, TRENDS PHARMACOL SCI, V9, P190, DOI 10.1016/0165-6147(88)90078-8; YOUNG SP, 1981, HEPATOLOGY, V1, P114, DOI 10.1002/hep.1840010205; YOUNG SP, 1985, BIOCHEM J, V232, P819, DOI 10.1042/bj2320819	70	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1396	1402						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671034				2022-12-25	WOS:A1991EU49700010
J	ADANG, AEP; BRUSSEE, J; VANDERGEN, A; MULDER, GJ				ADANG, AEP; BRUSSEE, J; VANDERGEN, A; MULDER, GJ			INHIBITION OF RAT-LIVER GLUTATHIONE-S-TRANSFERASE ISOENZYMES BY PEPTIDES STABILIZED AGAINST DEGRADATION BY GAMMA-GLUTAMYL TRANSPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; AMINO-ACIDS; ANALOGS; DIPEPTIDES; SUBSTRATE; CONJUGATE; REDUCTASE; BINDING; SERIES; MOIETY	Inhibitors for glutathione S-transferase (GST) isoenzymes from rat liver with high affinity for the glutathione-binding site (G-site) have been developed. In previous studies, a model was described for the G-site of GST (Adang, A. E. P., Brussee, J., van der Gen, A., and Mulder, G. J. (1990) Biochem. J. 269, 47-54) in terms of essential and nonessential interactions between groups in glutathione (GSH) and the G-site. Based on this model, compounds were designed that have high affinity for the G-site but cannot be conjugated. In the dipeptide gamma-L-glutamyl-D-alpha-aminoadipic acid (gamma-L-Glu-D-Aad), the L-cysteinylglycine moiety is replaced by D-aminoadipic acid. This dipeptide is an efficient competitive inhibitor (toward GSH) of mu class GST isoenzymes with K(i) values of 34-mu-M for GST isoenzyme 3-3 and 8-mu-M for GST isoenzyme 4-4. Other GSH-dependent enzymes, such as gamma-glutamyl transpeptidase (gamma-GT), glutathione reductase, and glutathione peroxidase, were not inhibited by 1 mM of gamma-L-Glu-D-Aad. Inhibition is also highly stereospecific since gamma-L-Glu-L-Aad is only a poor inhibitor (K(i) = 430-mu-M for GST 3-3). gamma-L-Glutamyl-D-norleucine also had a much higher K(i) value for GST 3-3. Thus, the presence of a delta-carboxylate group in D-Aad appears to be essential for a high affinity inhibitor. An additional hydrophobic group did not result in increased inhibitory potency. In a different approach, the gamma-L-glutamyl moiety in GSH was replaced by delta-L-aminoadipic acid; delta-L-Aad-L-Cys-Gly is an efficient cosubstrate analogue for GSTs with K(m) values comparable to GSH and V(max) values ranging from 0.24 to 57-mu-mol/min/mg for the different GSTs. The structures of the efficient inhibitor and the consubstrate analogue were combined in delta-L-Aad-D-Aad, which had a K(i) value of 68-mu-M with GST 3-3. In order to investigate their possible use in in vivo studies, the degradation of gamma-L-Glu-D-Aad and delta-L-Aad-L-Cys-Gly by gamma-GT was investigated. The peptides showed no measurable hydrolysis rates under conditions where GSH was rapidly hydrolyzed. Thus, an efficient, mu class-specific GST inhibitor and a gamma-glutamyl-modified cosubstrate analogue of GSH were developed. Their gamma-GT stability offers the possibility to use these peptides in in vivo experiments.	LEIDEN STATE UNIV,CTR BIOPHARMACEUT SCI,DIV TOXICOL,POB 9503,2312 AV LEIDEN,NETHERLANDS; LEIDEN STATE UNIV,DEPT ORGAN CHEM,2312 AV LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC								ADANG AEP, 1988, BIOCHEM J, V255, P715; ADANG AEP, 1990, BIOCHEM J, V269, P47, DOI 10.1042/bj2690047; ADANG AEP, 1988, BIOCHEM J, V255, P721; ADANG AEP, 1989, BIOCHEM J, V264, P759, DOI 10.1042/bj2640759; ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4; ASKELOF P, 1975, BIOCHEM J, V147, P513, DOI 10.1042/bj1470513; BARNES MM, 1959, BIOCHEM J, V71, P680, DOI 10.1042/bj0710680; BEALE D, 1983, EUR J BIOCHEM, V137, P125, DOI 10.1111/j.1432-1033.1983.tb07805.x; BILZER M, 1984, EUR J BIOCHEM, V138, P373, DOI 10.1111/j.1432-1033.1984.tb07925.x; BRAY HG, 1959, BIOCHEM J, V73, P465, DOI 10.1042/bj0730465; CARNE T, 1979, BIOCHEM J, V177, P433, DOI 10.1042/bj1770433; DETERMANN H, 1962, LIEBIGS ANN CHEM, V651, P172; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P268, DOI 10.1073/pnas.76.1.268; GUTTMANN S, 1958, HELV CHIM ACTA, V41, P1852; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Ketterer B., 1990, CONJUGATION REACTION, V1st ed., P307; KONIG W, 1970, CHEM BER-RECL, V103, P788, DOI 10.1002/cber.19701030319; MANNERVIK B, 1988, CRC CRIT REV BIOCH, V23, P281; MCINTYRE TM, 1979, J BIOL CHEM, V254, P6499; MEISTER A, 1976, ANNU REV BIOCHEM, V45, P559, DOI 10.1146/annurev.bi.45.070176.003015; Meister A, 1981, Methods Enzymol, V77, P237; MINATO S, 1979, ARCH BIOCHEM BIOPHYS, V192, P235, DOI 10.1016/0003-9861(79)90088-2; MULDER GJ, 1990, GLUTATHIONE S-TRANSFERASES AND DRUG RESISTANCE, P75; NEFKENS GHL, 1964, RECL TRAV CHIM PAY B, V83, P199; Sies H, 1988, GLUTATHIONE CONJUGAT; SUGIMOTO M, 1985, BIOCHEM PHARMACOL, V34, P3643; TATE SS, 1974, J BIOL CHEM, V249, P7593; THOMPSON GA, 1977, J BIOL CHEM, V252, P6792; VANOMMEN B, 1988, J BIOL CHEM, V263, P12939; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; ZERVAS L, 1957, J ORG CHEM, V22, P1515, DOI 10.1021/jo01362a052	36	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					830	836						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1670775				2022-12-25	WOS:A1991ET17700027
J	BURNSTEIN, KL; JEWELL, CM; CIDLOWSKI, JA				BURNSTEIN, KL; JEWELL, CM; CIDLOWSKI, JA			HUMAN GLUCOCORTICOID RECEPTOR CDNA CONTAINS SEQUENCES SUFFICIENT FOR RECEPTOR DOWN-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV N CAROLINA,DEPT PHYSIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	BURNSTEIN, KL (corresponding author), UNIV N CAROLINA,LINEBERGER CANC RES CTR,CHAPEL HILL,NC 27599, USA.		Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012686] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09156] Funding Source: Medline; NIDDK NIH HHS [DK32460] Funding Source: Medline; NIGMS NIH HHS [F32-GM12686] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BOURGEOIS S, 1979, CANCER RES, V39, P4749; BURNSTEIN KL, 1989, ANNU REV PHYSIOL, V51, P683, DOI 10.1146/annurev.ph.51.030189.003343; CAMPER SA, 1985, J BIOL CHEM, V260, P2246; CHARRON J, 1986, P NATL ACAD SCI USA, V83, P8903, DOI 10.1073/pnas.83.23.8903; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIDLOWSKI JA, 1981, ENDOCRINOLOGY, V109, P1975; DISTELHORST CW, 1989, J BIOL CHEM, V264, P13080; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GEHRING U, 1984, MOL CELL ENDOCRINOL, V36, P107, DOI 10.1016/0303-7207(84)90089-3; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRONER B, 1983, NUCLEIC ACIDS RES, V11, P4713, DOI 10.1093/nar/11.14.4713; HOECK W, 1989, J BIOL CHEM, V264, P14396; KALINYAK JE, 1987, J BIOL CHEM, V262, P10441; LEFKOWITZ RJ, 1981, RECEPTOR REGULATION; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTTGE WG, 1989, ENDOCRINOLOGY, V125, P1194, DOI 10.1210/endo-125-3-1194; MAJORS J, 1983, P NATL ACAD SCI-BIOL, V80, P5866, DOI 10.1073/pnas.80.19.5866; Maniatis T., 1982, MOL CLONING; MCINTYRE WR, 1985, J BIOL CHEM, V260, P418; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MUNCK A, 1984, J BIOL CHEM, V259, P820; MUNCK A, 1977, RECENT ADV STEROID B, P1109; OFARRELL PH, 1980, MOL GEN GENET, V179, P421, DOI 10.1007/BF00425473; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; PHILIBERT D, 1984, ADRENAL STEROID ANTA, P77; PRATT WB, 1988, J BIOL CHEM, V263, P267; RAJPERT EJ, 1987, J STEROID BIOCHEM, V26, P513, DOI 10.1016/0022-4731(87)90001-X; RINGOLD GM, 1975, CELL, V6, P299, DOI 10.1016/0092-8674(75)90181-6; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SILVA CM, 1987, P NATL ACAD SCI USA, V84, P1744, DOI 10.1073/pnas.84.7.1744; SIMONS SS, 1981, P NATL ACAD SCI-BIOL, V78, P3541, DOI 10.1073/pnas.78.6.3541; SLATER EP, 1985, MOL CELL BIOL, V5, P2984, DOI 10.1128/MCB.5.11.2984; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SVEC F, 1981, J BIOL CHEM, V256, P5984; TORNELLO S, 1982, NEUROENDOCRINOLOGY, V35, P411, DOI 10.1159/000123429; TULLY DB, 1987, BIOCHEM BIOPH RES CO, V144, P1, DOI 10.1016/S0006-291X(87)80467-9; WEINER FR, 1987, J BIOL CHEM, V262, P6955; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	51	124	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7284	7291						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692020				2022-12-25	WOS:A1990DB30700033
J	KENNEDY, GC; ANDERSEN, B; NILSON, JH				KENNEDY, GC; ANDERSEN, B; NILSON, JH			THE HUMAN ALPHA-SUBUNIT GLYCOPROTEIN HORMONE GENE UTILIZES A UNIQUE CCAAT BINDING-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHARMACOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106; CLEVELAND METROPOLITAN GEN HOSP,CLEVELAND,OH 44109	Case Western Reserve University; Case Western Reserve University; MetroHealth System					NCI NIH HHS [P30 CA 43703] Funding Source: Medline; NIDDK NIH HHS [DK 08132, DK28559] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008132, R01DK028559] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDWIN ASJ, 1987, CURRENT PROTOCOLS MO, V2; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BOKAR JA, 1988, J BIOL CHEM, V263, P19740; BOKAR JA, 1989, MOL CELL BIOL, V9, P5113, DOI 10.1128/MCB.9.11.5113; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHODOSH LA, 1987, CURRENT PROTOCOLS MO, V2; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GRUNDSTROM T, 1985, NUCLEIC ACIDS RES, V13, P3305, DOI 10.1093/nar/13.9.3305; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; JAMESON JL, 1988, J BIOL CHEM, V263, P9879; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; KOCH W, 1989, MOL CELL BIOL, V9, P303, DOI 10.1128/MCB.9.1.303; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; Maniatis T., 1982, MOL CLONING; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	26	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6279	6285						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690724				2022-12-25	WOS:A1990CY58700059
J	SAITTA, B; STOKES, DG; VISSING, H; TIMPL, R; CHU, ML				SAITTA, B; STOKES, DG; VISSING, H; TIMPL, R; CHU, ML			ALTERNATIVE SPLICING OF THE HUMAN ALPHA-2(VI) COLLAGEN GENE GENERATES MULTIPLE MESSENGER-RNA TRANSCRIPTS WHICH PREDICT 3 PROTEIN VARIANTS WITH DISTINCT CARBOXYL TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,1020 LOCUST ST,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL,PHILADELPHIA,PA 19107; CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	Jefferson University; Jefferson University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Max Planck Society					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, P01AR038188, R01AR038912] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38188, AR-38912, AR-38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARGRAVES WS, 1987, P NATL ACAD SCI USA, V84, P464, DOI 10.1073/pnas.84.2.464; AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENNETT VD, 1989, J BIOL CHEM, V264, P8402; BENTLEY DR, 1986, BIOCHEM J, V239, P339, DOI 10.1042/bj2390339; BERK AJ, 1978, P NATL ACAD SCI USA, V75, P1274, DOI 10.1073/pnas.75.3.1274; BERNSTEIN SI, 1986, MOL CELL BIOL, V6, P2511, DOI 10.1128/MCB.6.7.2511; BINGHAM PM, 1988, TRENDS GENET, V4, P134, DOI 10.1016/0168-9525(88)90136-9; BROWN JWS, 1986, NUCLEIC ACIDS RES, V14, P9549, DOI 10.1093/nar/14.24.9549; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, P156; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; COLMBATTI A, 1987, J BIOL CHEM, V263, P14454; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; FESSLER LI, 1981, J BIOL CHEM, V256, P2531; JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; KILLER E, 1989, EMBO J, V8, P1073; KISS I, 1989, J BIOL CHEM, V264, P8126; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; LOZANO G, 1985, P NATL ACAD SCI USA, V82, P4050, DOI 10.1073/pnas.82.12.4050; LUVALLE P, 1988, J BIOL CHEM, V263, P18378; Maxam A M, 1980, Methods Enzymol, V65, P499; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; RAMIREZ F, 1985, ANN NY ACAD SCI, V460, P117, DOI 10.1111/j.1749-6632.1985.tb51160.x; SADLER JE, 1986, COLD SPRING HARB SYM, V51, P515, DOI 10.1101/SQB.1986.051.01.063; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V208, P4563; SETZER DR, 1980, CELL, V22, P361, DOI 10.1016/0092-8674(80)90346-3; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SVOBODA KK, 1988, P NATL ACAD SCI USA, V85, P7496, DOI 10.1073/pnas.85.20.7496; SWIMMER C, 1985, NUCLEIC ACIDS RES, V13, P8053, DOI 10.1093/nar/13.22.8053; TIKKA L, 1988, P NATL ACAD SCI USA, V85, P7491, DOI 10.1073/pnas.85.20.7491; Timpl R., 1987, STRUCTURE FUNCTION C, P105, DOI [10.1016/B978--0--12--481280-2.50008---8, DOI 10.1016/B978--0--12--481280-2.50008---8]; TITANI K, 1988, TRENDS BIOCHEM SCI, V13, P94, DOI 10.1016/0968-0004(88)90048-5; TRUEB B, 1986, EMBO J, V5, P2815, DOI 10.1002/j.1460-2075.1986.tb04573.x; VANKUPPEVELT THMSM, 1989, P NATL ACAD SCI USA, V86, P5415; VISSING H, 1987, NUCLEIC ACIDS RES, V15, P1363, DOI 10.1093/nar/15.4.1363; WEIL D, 1988, AM J HUM GENET, V42, P435	41	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6473	6480						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690728				2022-12-25	WOS:A1990CY58700088
J	CAMPAGNE, MMV; WU, E; FLEISCHMANN, RD; GOTTESMAN, MM; CHASON, KW; KESSIN, RH				CAMPAGNE, MMV; WU, E; FLEISCHMANN, RD; GOTTESMAN, MM; CHASON, KW; KESSIN, RH			CYCLIC-AMP RESPONSES ARE SUPPRESSED IN MAMMALIAN-CELLS EXPRESSING THE YEAST LOW-KM CAMP-PHOSPHODIESTERASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NCI,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	CAMPAGNE, MMV (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032, USA.		van Lookeren Campagne, Michiel Maurits/AAX-6436-2021	van Lookeren Campagne, Michiel Maurits/0000-0002-8312-5946	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024240] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-24240] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM I, 1982, SOMAT CELL GENET, V8, P23, DOI 10.1007/BF01538648; ABRAHAM I, 1986, J CELL PHYSIOL, V127, P89, DOI 10.1002/jcp.1041270112; ANDERSON WB, 1973, P NATL ACAD SCI USA, V70, P1055, DOI 10.1073/pnas.70.4.1055; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISTOL JA, 1983, MED RES REV, V3, P259, DOI 10.1002/med.2610030304; BULGAKOV R, 1983, BIOCHIM BIOPHYS ACTA, V756, P56, DOI 10.1016/0304-4165(83)90024-7; CAMPAGNE MMV, 1990, J BIOL CHEM, V265, P5847; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; COLICELLI J, 1989, P NATL ACAD SCI USA, V86, P3599, DOI 10.1073/pnas.86.10.3599; CORBIN JD, 1988, ENZYMOLOGY; DAVIS RL, 1989, P NATL ACAD SCI USA, V86, P3604, DOI 10.1073/pnas.86.10.3604; DAY RN, 1989, J BIOL CHEM, V264, P431; EVAIN D, 1979, J BIOL CHEM, V254, P6931; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOTESMAN MM, 1985, MOL CELL GENETICS; GOTTESMAN MM, 1980, SOMAT CELL GENET, V6, P45, DOI 10.1007/BF01538695; GROVE JR, 1987, SCIENCE, V238, P530; HASHIMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6637, DOI 10.1073/pnas.81.21.6637; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LONDESBOROUGH J, 1977, BIOCHEM J, V163, P467, DOI 10.1042/bj1630467; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCGEADY ML, 1986, DNA-J MOLEC CELL BIO, V5, P289, DOI 10.1089/dna.1986.5.289; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; NIKAWA J, 1987, MOL CELL BIOL, V11, P3629; OCONNOR NE, 1984, SOFT HARD TISSUE REP, V2, P283; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; SCHWARZBAUER JE, 1987, P NATL ACAD SCI USA, V84, P754, DOI 10.1073/pnas.84.3.754; SHINOMIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P1346, DOI 10.1073/pnas.81.5.1346; SINGH TJ, 1988, J BIOL CHEM, V260, P13927; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUORANTA K, 1984, J BIOL CHEM, V259, P6964; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P5326; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WILSON RB, 1988, MOL CELL BIOL, V8, P505, DOI 10.1128/MCB.8.1.505	39	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5840	5846						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690715				2022-12-25	WOS:A1990CW48000083
J	BENNETT, VD; ADAMS, SL				BENNETT, VD; ADAMS, SL			IDENTIFICATION OF A CARTILAGE-SPECIFIC PROMOTER WITHIN INTRON-2 OF THE CHICK ALPHA-2(I) COLLAGEN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BENNETT, VD (corresponding author), UNIV PENN, SCH DENT MED, DEPT ANAT & HISTOL, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR007937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028840] Funding Source: NIH RePORTER; NIAMS NIH HHS [F32 AR07937] Funding Source: Medline; NIGMS NIH HHS [R01 GM28840] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SL, 1977, P NATL ACAD SCI USA, V74, P3399, DOI 10.1073/pnas.74.8.3399; ALLEBACH ES, 1985, MOL CELL BIOL, V5, P1002, DOI 10.1128/MCB.5.5.1002; BAKER CC, 1979, CELL, V18, P569, DOI 10.1016/0092-8674(79)90073-4; BARKER RF, 1983, PLANT MOL BIOL, V2, P335, DOI 10.1007/BF01578595; BENNETT VD, 1989, J BIOL CHEM, V264, P8402; BENNETT VD, 1987, J BIOL CHEM, V262, P14806; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; BOEDTKER H, 1985, ANN NY ACAD SCI, V460, P85, DOI 10.1111/j.1749-6632.1985.tb51159.x; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURNETT W, 1979, BIOCHEM BIOPH RES CO, V86, P478, DOI 10.1016/0006-291X(79)91739-X; CHACKO S, 1969, J EXP MED, V130, P417, DOI 10.1084/jem.130.2.417; FINER MH, 1985, MOL CELL BIOL, V5, P1415, DOI 10.1128/MCB.5.6.1415; FLAVELL AJ, 1979, CELL, V16, P357, DOI 10.1016/0092-8674(79)90012-6; FOCHT RJ, 1984, MOL CELL BIOL, V4, P1843, DOI 10.1128/MCB.4.9.1843; FRASER P, 1989, MOL CELL BIOL, V9, P3308, DOI 10.1128/MCB.9.8.3308; GANNON F, 1979, NATURE, V278, P428, DOI 10.1038/278428a0; GHOSH PK, 1978, J MOL BIOL, V126, P813, DOI 10.1016/0022-2836(78)90022-0; GHOSH PK, 1981, P NATL ACAD SCI-BIOL, V78, P100, DOI 10.1073/pnas.78.1.100; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P1432, DOI 10.1073/pnas.77.3.1432; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HANKE PD, 1988, MOL CELL BIOL, V8, P3591, DOI 10.1128/MCB.8.9.3591; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1980, CELL, V22, P7, DOI 10.1016/0092-8674(80)90148-8; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LODISH HF, 1971, J BIOL CHEM, V246, P7131; LUO XC, 1989, P NATL ACAD SCI USA, V86, P4042, DOI 10.1073/pnas.86.11.4042; MARINI JC, 1988, BIOCHEMISTRY-US, V27, P3351, DOI 10.1021/bi00409a035; Maxam A M, 1980, Methods Enzymol, V65, P499; MCGROGAN M, 1985, J BIOL CHEM, V260, P2307; NEVINS JR, 1983, ANNU REV BIOCHEM, V52, P441, DOI 10.1146/annurev.bi.52.070183.002301; NISHIMURA I, 1988, J CELL BIOL, V107, P232; OHKUBO H, 1980, P NATL ACAD SCI-BIOL, V77, P7059, DOI 10.1073/pnas.77.12.7059; PACIFICI M, 1977, CELL, V11, P891, DOI 10.1016/0092-8674(77)90300-2; PAWLOWSKI PJ, 1981, J BIOL CHEM, V256, P7695; ROSS AM, 1988, NUCLEIC ACIDS RES, V16, P1801; SAMPLE J, 1986, P NATL ACAD SCI USA, V83, P5096, DOI 10.1073/pnas.83.14.5096; SAXE SA, 1985, J BIOL CHEM, V260, P3812; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; STREHLER EE, 1985, MOL CELL BIOL, V5, P3168, DOI 10.1128/MCB.5.11.3168; STROHMAN RC, 1977, CELL, V10, P265, DOI 10.1016/0092-8674(77)90220-3; SVOBODA KK, 1988, P NATL ACAD SCI USA, V85, P7496, DOI 10.1073/pnas.85.20.7496; VOGELI G, 1981, P NATL ACAD SCI-BIOL, V78, P5334, DOI 10.1073/pnas.78.9.5334; von der Mark K, 1980, Curr Top Dev Biol, V14, P199; WANG F, 1987, J VIROL, V61, P945, DOI 10.1128/JVI.61.4.945-954.1987; YAMADA Y, 1983, J BIOL CHEM, V258, P4914; YOUNG RA, 1981, CELL, V23, P451, DOI 10.1016/0092-8674(81)90140-9	50	56	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1990	265	4					2223	2230						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL028	1688851				2022-12-25	WOS:A1990CL02800066
J	TOBE, K; KADOWAKI, T; TAMEMOTO, H; UEKI, K; HARA, K; KOSHIO, O; MOMOMURA, K; GOTOH, Y; NISHIDA, E; AKANUMA, Y; YAZAKI, Y; KASUGA, M				TOBE, K; KADOWAKI, T; TAMEMOTO, H; UEKI, K; HARA, K; KOSHIO, O; MOMOMURA, K; GOTOH, Y; NISHIDA, E; AKANUMA, Y; YAZAKI, Y; KASUGA, M			INSULIN AND 12-O-TETRADECANOYLPHORBOL-13-ACETATE ACTIVATION OF 2 IMMUNOLOGICALLY DISTINCT MYELIN BASIC-PROTEIN MICROTUBULE-ASSOCIATED PROTEIN-2 (MBP/MAP2) KINASES VIA DENOVO PHOSPHORYLATION OF THREONINE AND TYROSINE RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; FIBROBLASTIC CELLS; 3T3-L1 ADIPOCYTES; RECEPTOR KINASE; INTACT CELL; MAP KINASE; INVITRO; SITE; PHOSPHOTYROSINE; IDENTIFICATION	Two site-specific antibodies have been prepared by immunizing rabbits with chemically synthesized peptides derived from the partial cDNA-predicted amino acid sequence of extracellular signal-regulated kinase 1 (ERK1), which has been proposed to encode the microtubule-associated protein 2 (MAP2) kinase (Boulton, T. G., Yancopoulos, G. D., Gregory, J. S., Slauer, C., Moomaw, C., Hsu, J., and Cobb, M. H. (1990) Science 249, 64-67). With immunoprecipitation in the presence of sodium dodecyl sulfate (SDS) and Western blotting, an antibody to the peptide containing triple tyrosine residues (alpha-Y91) resembling one of the insulin receptor autophosphorylation sites specifically recognized 42- and 44-kDa proteins. On the other hand, an antibody to the peptide corresponding to the COOH terminus portions (alpha-C92) of the ERK1 cDNA gene product recognized the 44-kDa protein much more efficiently than the 42-kDa protein. With immunoprecipitation in the absence of SDS, alpha-Y91 could barely recognize these two proteins and alpha-C92 recognized the 44-kDa protein but failed to recognize the 42-kDa protein. Kinase assays in myelin basic protein (MBP)-containing gel, after SDS-polyacrylamide gel electrophoresis, revealed that insulin or 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated MBP kinase activity in alpha-Y91 immunoprecipitates comigrated at molecular mass 42 and 44 kDa. On the other hand, the stimulated MBP kinase activity in alpha-C92 immunoprecipitates comigrated only at molecular mass 44 kDa. Insulin stimulated the MBP kinase activity in gels and phosphorylation of these two proteins by greater than 10-fold with a maximal level at 5 min. Insulin and TPA rapidly stimulate the phosphorylation of the 42- and 44-kDa proteins via de novo threonine and tyrosine phosphorylation. Tryptic phosphopeptide mapping analysis of the 42- and 44-kDa proteins, respectively, revealed a single major phosphopeptide containing phosphothreonine and phosphotyrosine, which was common to both insulin- and TPA-stimulated phosphoproteins. Protein phosphatase 2A treatment of these two phosphoproteins caused a complete loss of kinase activity with selective dephosphorylation of phosphothreonine. These data strongly suggest that these two proteins are highly related to the mitogen-activated protein (MAP) kinase with an apparent molecular mass of 42 kDa (Ray, L. B., and Sturgill, T. W. (1988) Proc. Natl. Acad. Sci. U. S. A. 85,3753-3757) and that these two immunologically similar but distinct MBP/MAP2 kinases may represent isozymic forms of MBP/MAP2 kinases. These data also demonstrate that insulin and TPA activate MBP/MAP2 kinase activity by de novo phosphorylation of threonine and tyrosine residues via a very similar pathway.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; ASAHI LIFE FDN,INST DIABET CARE & RES,CHIYODA KU,TOKYO 100,JAPAN; UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN; KOBE UNIV,SCH MED,DEPT INTERNAL MED 2,CHUO KU,KOBE 650,JAPAN	University of Tokyo; Asahi Life Foundation; University of Tokyo; Kobe University								AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11495; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BERNIER M, 1987, P NATL ACAD SCI USA, V84, P1844, DOI 10.1073/pnas.84.7.1844; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRANDT H, 1975, J BIOL CHEM, V250, P8038; CHOU CK, 1987, J BIOL CHEM, V262, P1842; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DENTON RM, 1986, ADV CYCLIC NUCL PROT, V20, P293; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; GOTOH Y, 1990, EUR J BIOCHEM, V193, P671, DOI 10.1111/j.1432-1033.1990.tb19385.x; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HOSHI M, 1988, J BIOL CHEM, V263, P5396; HOSHI M, 1989, EUR J BIOCHEM, V184, P477, DOI 10.1111/j.1432-1033.1989.tb15040.x; IZUMI T, 1988, J BIOL CHEM, V263, P10386; KABURAGI Y, 1991, 73RD ANN M END SOC W, P309; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KASUGA M, 1983, P NATL ACAD SCI-BIOL, V80, P2137, DOI 10.1073/pnas.80.8.2137; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KOSHIO O, 1989, FEBS LETT, V254, P22, DOI 10.1016/0014-5793(89)81001-4; MARGLIN A, 1970, ANNU REV BIOCHEM, V39, P841, DOI 10.1146/annurev.bi.39.070170.004205; MEIER KE, 1990, J BIOL CHEM, V265, P4635; MEIER KE, 1991, J BIOL CHEM, V266, P1914; MOMOMURA K, 1988, BIOCHEM BIOPH RES CO, V155, P1181, DOI 10.1016/S0006-291X(88)81264-6; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1987, INSULIN INSULIN LIKE, P27; PERROTTI N, 1987, P NATL ACAD SCI USA, V84, P1844; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TASHIROHASHIMOTO Y, 1989, J BIOL CHEM, V264, P6879; TOBE K, 1990, DIABETES, V39, P528, DOI 10.2337/diabetes.39.5.528; WALTER G, 1980, P NATL ACAD SCI-BIOL, V77, P5197, DOI 10.1073/pnas.77.9.5197; WEIEL JE, 1991, IN PRESS ADV 2ND MES; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; YAMAMOTOHONDA R, 1990, J BIOL CHEM, V265, P14777	47	85	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24793	24803						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662217				2022-12-25	WOS:A1991GW84500084
J	JIN, JP; WANG, K				JIN, JP; WANG, K			CLONING, EXPRESSION, AND PROTEIN-INTERACTION OF HUMAN NEBULIN FRAGMENTS COMPOSED OF VARYING NUMBERS OF SEQUENCE MODULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-T; IMMUNOELECTRON MICROSCOPY; SKELETAL-MUSCLE; Z-LINE; TITIN; ORGANIZATION; FILAMENTS; CONNECTIN; BINDING	Nebulin, a family of giant myofibrillar proteins of 600-900 kDa, contains a large number of highly conserved sequence repeats of 31-38 amino acids. To investigate the significance of this repeat, human skeletal muscle nebulin cDNA fragments encoding two, six, seven, eight, or fifteen repeat modules were expressed in high yield as nonfusion proteins in Escherichia coli with the pET3d plasmid vector. F-actin cosedimentation and solid phase binding assays demonstrated that all nebulin fragments, except the smallest two-module 67-mer, bound to muscle actin with high affinity under physiological ionic conditions. Solid phase binding assays also revealed that a six-module fragment, NB5, binds to myosin and C-terminal protein but fails to bind to tropomyosin, troponin, and tubulin. Furthermore, the binding of NB5 to actin was inhibited by both tropomyosin and troponin. Immunoelectron microscopic localization of NB5 indicated that this N-terminal region fragment is situated near the distal end of thin filaments in the sarcomere. These results indicate that nebulin is a giant protein with an unprecedently large number of actin-binding sites along its length and is anchored at the C terminus to the Z line in the sarcomere. Nebulin may function as a multifunctional template protein that regulates the length of thin filaments and participates in muscle activities by interacting with actin and myosin filaments in the sarcomere of skeletal muscles.	UNIV TEXAS,DEPT CHEM & BIOCHEM,CLAYTON FDN BIOCHEM INST,AUSTIN,TX 78712	University of Texas System; University of Texas Austin				Jin, JP/0000-0001-9932-1063	NIDDK NIH HHS [DK20270] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020270] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; JIN JP, 1988, J BIOL CHEM, V263, P7309; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; JIN JP, 1989, J BIOL CHEM, V264, P14471; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; JIN JP, 1989, J CELL BIOL, V109, P261; KRUGER J, 1991, IN PRESS J CELL BIOL; MARUYAMA K, 1989, J MUSCLE RES CELL M, V10, P350, DOI 10.1007/BF01758431; NAVE R, 1990, FEBS LETT, V269, P163, DOI 10.1016/0014-5793(90)81144-D; NOWAK E, 1991, FEBS LETT, V281, P51, DOI 10.1016/0014-5793(91)80356-8; PIEROBONBORMIOLI S, 1989, J MUSCLE RES CELL M, V10, P446, DOI 10.1007/BF01771820; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STEDMAN H, 1988, UCLA S MOL CELLULAR, V93, P181; Stedman H, 1988, GENOMICS, V2, P1, DOI 10.1016/0888-7543(88)90102-4; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Wang K, 1985, Cell Muscle Motil, V6, P315; WANG K, 1988, J CELL BIOL, V107, P2199, DOI 10.1083/jcb.107.6.2199; WANG K, 1990, BIOPHYS J, V57, P555; ZEVIANI M, 1988, Genomics, V2, P249, DOI 10.1016/0888-7543(88)90009-2	23	83	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21215	21223						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1682316				2022-12-25	WOS:A1991GN00100098
J	RADEKE, HH; CROSS, AR; HANCOCK, JT; JONES, OTG; NAKAMURA, M; KAEVER, V; RESCH, K				RADEKE, HH; CROSS, AR; HANCOCK, JT; JONES, OTG; NAKAMURA, M; KAEVER, V; RESCH, K			FUNCTIONAL EXPRESSION OF NADPH OXIDASE COMPONENTS (ALPHA-SUBUNITS AND BETA-SUBUNITS OF CYTOCHROME-B558 AND 45-KDA FLAVOPROTEIN) BY INTRINSIC HUMAN GLOMERULAR MESANGIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SUPEROXIDE-GENERATING-SYSTEM; REACTIVE OXYGEN METABOLITES; NECROSIS FACTOR-ALPHA; PROSTAGLANDIN PRODUCTION; RESPIRATORY BURST; HUMAN-NEUTROPHILS; PHAGOCYTIC-CELLS; PLASMA-MEMBRANE; FREE-RADICALS	Recently, we have shown that human glomerular mesangial cells (HMCs) release oxygen radicals from the plasma membrane in response to cytokines. Now we have used diphenylene iodonium, a covalent binding inhibitor of activated 45-kDa flavoprotein, in neutrophils radiolabeled with I-125 and could identify a 45-kDa protein band in a separated HMC plasma membrane fraction. Low temperature difference spectroscopy showed a peak absorbance at 428 and 558 nm. Direct potentiometry of HMC membranes (-340 to -160 mV) showed the presence of a low potential cytochrome (76 pmol/mg to HMC membrane protein) identified as cytochrome b558. In slot blots, mouse monoclonal antibody (mAb) 7D5, specific for the extracellular domain of the alpha-subunit, showed a positive reaction with HMCs. In Western blots, mAb 449, directed against the cytoplasmic epitope of the alpha-subunit, identified a 23-kDa protein; and mAb 48, raised against the large (beta) subunit of cytochrome b558 of human neutrophils (Verhoeven, A. J., Bolscher, B. G. J. M., Meerhof, L. J., van Zwieten, R., Keijer, J., Weening, R. S., and Roos, D. (1980) Blood 73, 1686-1694), detected a smear between 75 and 100 kDa in denatured HMC membrane protein. These data determined with HMCs, suggest for the first time the expression of three essential components of NADPH:O2- oxidoreductase in mesenchymal cells.	UNIV TOKYO,INST MED SCI,TOKYO 108,JAPAN; UNIV BRISTOL,SCH MED,DEPT BIOCHEM,BRISTOL BS8 1TD,AVON,ENGLAND	University of Tokyo; University of Bristol	RADEKE, HH (corresponding author), MED SCH HANNOVER,INST MOLEC PHARMACOL,W-3000 HANNOVER 61,GERMANY.		Kaever, Volkhard/G-3280-2013; Radeke, Heinfried H/E-3772-2013	Radeke, Heinfried H/0000-0002-4499-2510				ADLER S, 1986, J CLIN INVEST, V77, P762, DOI 10.1172/JCI112372; ADLER S, 1987, AM J PHYSIOL, V252, pF743, DOI 10.1152/ajprenal.1987.252.4.F743; BABIOR BM, 1988, ANN INTERN MED, V109, P127; BAUD L, 1983, J EXP MED, V158, P1836, DOI 10.1084/jem.158.6.1836; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1984, BIOCHEM J, V223, P337, DOI 10.1042/bj2230337; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; CROSS AR, 1987, BIOCHEM PHARMACOL, V36, P489, DOI 10.1016/0006-2952(87)90356-X; CURNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825, DOI 10.1073/pnas.86.3.825; FLOEGE J, 1990, KIDNEY INT, V37, P859, DOI 10.1038/ki.1990.59; FREEMAN BA, 1982, LAB INVEST, V47, P412; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Harber M J, 1986, J Biolumin Chemilumin, V1, P15, DOI 10.1002/bio.1170010105; KLEINBERG ME, 1989, J IMMUNOL, V143, P4152; MALY FE, 1989, J IMMUNOL, V142, P1260; MEIER B, 1990, FREE RADICAL RES COM, V8, P149, DOI 10.3109/10715769009087988; MEIER B, 1991, BIOCHEM J, V275, P241, DOI 10.1042/bj2750241; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; NAKAMURA M, 1988, BLOOD, V72, P1550; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; RADEKE HH, 1990, KIDNEY INT, V37, P767, DOI 10.1038/ki.1990.44; RADEKE HH, 1991, AGENTS ACTIONS, V32, P109, DOI 10.1007/BF01983331; REDINBAUGH MG, 1985, ANAL BIOCHEM, V147, P144, DOI 10.1016/0003-2697(85)90020-X; REHAN A, 1984, LAB INVEST, V51, P396; SEDOR JR, 1987, J IMMUNOL, V138, P3751; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SEVANIAN A, 1988, BIOCHIM BIOPHYS ACTA, V961, P316, DOI 10.1016/0005-2760(88)90079-3; SHAH SV, 1989, KIDNEY INT, V35, P1093, DOI 10.1038/ki.1989.96; THELEN M, 1988, J CLIN INVEST, V81, P1889, DOI 10.1172/JCI113535; TOPLEY N, 1989, J IMMUNOL, V143, P1989; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; VOGT W, 1990, Immunobiology, V181, P203; WHORTON AR, 1985, J CLIN INVEST, V76, P295, DOI 10.1172/JCI111960	37	133	134	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21025	21029						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657945				2022-12-25	WOS:A1991GN00100070
J	SAKANO, KI; ENJOH, T; NUMATA, F; FUJIWARA, H; MARUMOTO, Y; HIGASHIHASHI, N; SATO, Y; PERDUE, JF; FUJITAYAMAGUCHI, Y				SAKANO, KI; ENJOH, T; NUMATA, F; FUJIWARA, H; MARUMOTO, Y; HIGASHIHASHI, N; SATO, Y; PERDUE, JF; FUJITAYAMAGUCHI, Y			THE DESIGN, EXPRESSION, AND CHARACTERIZATION OF HUMAN INSULIN-LIKE GROWTH FACTOR-II (IGF-II) MUTANTS SPECIFIC FOR EITHER THE IGF-II CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR OR IGF-I RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; SOMATOMEDIN-C; BETA-SUBUNIT; PURIFICATION; IDENTIFICATION; MEMBRANES; SEQUENCE; CDNA; GENE	Five mutants of recombinant insulin-like growth factor-II (rIGF-II) that bound with high affinity to either the IGF-II/cation-independent mannose 6-phosphate (IGF-II/CIM6-P) or the IGF-I receptor were prepared by site-directed mutagenic procedures, expressed as fusion proteins in the larva of Bombyx mori or Escherichia coli, purified to homogeneity, renatured, and characterized in terms of their receptor binding affinities and specificities as well as their biological activities. Class I mutants in which Phe26, Tyr27, and Val43 were substituted with Ser, Leu, and Leu, respectively, bound to enriched preperations of rat placental IGF-II/CIM6-P receptors with apparent equilibrium dissociation constants (K(d)(app)) that were only slightly greater, i.e. 0.10, 0.05, and 0.06 nM, than that of rIGF-II (0.04 nM) or hIGF-II (0.03 nM). In contrast, replacing Phe26 with Ser resulted in 5- and 20-fold decreases in the affinities of this mutant for highly purified human placental IGF-I and insulin receptors, respectively. The affinities of the two other Class I mutants, [Leu27]- and [Leu43]rIGF-IIs, for these two receptors were reduced 80- to 220-fold. The affinities of Class II mutants, i.e. [Thr48,Ser49,Ile50]- and [Arg54, Arg55] rIGF-IIs, for IGF-I receptors were as potent as rIGF-II; however, they bound very poorly or not at all to the IGF-II/CIM6-P receptor. In the binding study of those mutant rIGF-IIs, IGF-II was observed to have an unexpectedly high affinity for pure human placental insulin receptor preperations. For example, the affinities of hIGF-II, rIGF-II, and two Class II rIGF-II mutants for the insulin receptor were only 3-, 9-, and 5-fold less, respectively, than that of porcine insulin. In two biological assay systems, i.e. the stimulation of DNA synthesis in Balb/c 3T3 cells and glycogen synthesis in HepG2 cells, the K(d)(app)) of the rIGF-II mutants for the IGF-I receptor but not the IGF-II/CIM6-P receptor correlated with their abilities to produce biological responses.	AMER RED CROSS,JEROME H HOLLAND LAB,MOLEC BIOL LAB,ROCKVILLE,MD 20855; CITY HOPE NATL MED CTR,BECKMAN RES INT,DEPT MOLEC GENET,DUARTE,CA 91010	American Red Cross; City of Hope; Beckman Research Institute of City of Hope	SAKANO, KI (corresponding author), DAIICHI PHARMACEUT CO LTD,MOLEC BIOL RES LAB,16-13 KITAKASAI 1 CHOME,EDOGAWA KU,TOKYO 134,JAPAN.				NATIONAL CANCER INSTITUTE [R01CA047150, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034427] Funding Source: NIH RePORTER; NCI NIH HHS [CA47150, CA 33572] Funding Source: Medline; NIDDK NIH HHS [DK34427] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAYNE ML, 1990, J BIOL CHEM, V265, P15648; BEUKERS MW, 1991, ENDOCRINOLOGY, V128, P1201, DOI 10.1210/endo-128-2-1201; BLUNDELL TL, 1978, P NATL ACAD SCI USA, V75, P180, DOI 10.1073/pnas.75.1.180; BURGISSER DM, 1991, J BIOL CHEM, V266, P1029; CARA JF, 1990, J BIOL CHEM, V265, P17820; CASCIERI MA, 1988, BIOCHEMISTRY-US, V27, P3229, DOI 10.1021/bi00409a016; CASCIERI MA, 1989, J BIOL CHEM, V264, P2199; CASELLA SJ, 1986, J BIOL CHEM, V261, P9268; CLEMMONS DR, 1989, BRIT MED BULL, V45, P465, DOI 10.1093/oxfordjournals.bmb.a072335; DAUGHADAY WH, 1989, P NATL ACAD SCI USA, V86, P6778, DOI 10.1073/pnas.86.17.6778; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FUJITAYAMAGUCHI Y, 1983, J BIOL CHEM, V258, P5045; GOWAN LK, 1987, ENDOCRINOLOGY, V121, P449, DOI 10.1210/endo-121-2-449; HANEDA M, 1983, P NATL ACAD SCI-BIOL, V80, P6366, DOI 10.1073/pnas.80.20.6366; HARI J, 1987, EMBO J, V6, P3367, DOI 10.1002/j.1460-2075.1987.tb02658.x; JACOBS S, 1983, J BIOL CHEM, V258, P9581; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P444; KWOK SCM, 1983, DIABETES, V32, P872, DOI 10.2337/diabetes.32.9.872; LEBON TR, 1986, J BIOL CHEM, V261, P7685; LEBOUC Y, 1987, FEBS LETT, V222, P181, DOI 10.1016/0014-5793(87)80216-8; MARUMOTO Y, 1987, J GEN VIROL, V68, P2599, DOI 10.1099/0022-1317-68-10-2599; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; NISHIDA T, 1989, J BIOCHEM-TOKYO, V105, P351, DOI 10.1093/oxfordjournals.jbchem.a122667; PERDUE JF, 1983, J BIOL CHEM, V258, P7800; PERDUE JF, 1991, IND INT S INS LIK GR, P78; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; SAITO Y, 1987, J BIOCHEM-TOKYO, V101, P123, DOI 10.1093/oxfordjournals.jbchem.a121883; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI N, 1985, J BIOL CHEM, V260, P9793; SMITH MC, 1989, J BIOL CHEM, V264, P9314; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7962; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0	35	136	152	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20626	20635						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657932				2022-12-25	WOS:A1991GN00100010
J	EPSTEIN, LF; ORMEJOHNSON, NR				EPSTEIN, LF; ORMEJOHNSON, NR			REGULATION OF STEROID-HORMONE BIOSYNTHESIS - IDENTIFICATION OF PRECURSORS OF A PHOSPHOPROTEIN TARGETED TO THE MITOCHONDRION IN STIMULATED RAT ADRENAL-CORTEX CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN CLEAVAGE; ADRENOCORTICOTROPIC HORMONE; CORPUS-LUTEUM; CORTICOSTERONE SYNTHESIS; PROTEOLYTIC CLEAVAGE; INTERMEMBRANE SPACE; GEL-ELECTROPHORESIS; RAPID ACCUMULATION; ADENYLATE-CYCLASE; NEUROSPORA-CRASSA	Two short-lived precursor proteins, pp37 and pp32, of the mitochondrial phosphoprotein pp30 (formerly denoted as i(b)) have been detected in Bt2cAMP-stimulated rat adrenal cortex cells, incubated at 25-degrees-C or with 1,10-orthophenanthroline at 37-degrees-C. Subsequently, these two precursor proteins were also identified in cells incubated at 37-degrees-C, where they are present only at low levels due to their short half-life. pp30 is produced in several steroidogenic tissues in response to trophic hormone or second messenger analogue. pp37 and pp32 are also phosphoproteins located in the mitochondrion that are produced in response to cAMP analogue and give rise to proteolytic peptide maps similar to that of pp30. As for pp30, inhibition of cytosolic translation prevents the production of pp37 and pp32. The larger precursor protein pp37 has an apparent molecular mass of 37 kDa, an isoelectric point of approximately 7.1, and a half-life at 37-degrees-C of 3-4 min. Pulse-chase studies indicate that this protein is processed into the smaller protein, pp32, which has an apparent molecular mass of 32 kDa, an isoelectric point of approximately 6.4, and a half-life at 37-degrees-C of 3-4 min. This latter protein is the immediate precursor of pp30. Since orthophenanthroline inhibits the mitochondrial processing protease, while the lower incubation temperature slows both protein import and protease processing, the experimental conditions necessary to detect these proteins are consistent with pp37 being a precursor protein that contains two cleavable presequences and is imported into the mitochondrion. The sequential removal of these sequences produces the mature protein pp30.			EPSTEIN, LF (corresponding author), TUFTS UNIV,DEPT BIOCHEM,HLTH SCI CAMPUS,BOSTON,MA 02111, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032455] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32455] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTA JA, 1989, J BIOL CHEM, V264, P2368; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BOEHNI P, 1979, ORG EXPRESSION MITOC, P423; BUCKLEY DI, 1981, P NATL ACAD SCI-BIOL, V78, P7431, DOI 10.1073/pnas.78.12.7431; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CRIVELLO JF, 1978, BIOCHIM BIOPHYS ACTA, V542, P315, DOI 10.1016/0304-4165(78)90027-2; DAVIS WW, 1968, J BIOL CHEM, V243, P5153; DELUCA HF, 1964, MANOMETRIC TECHNIQUE, P131; DIBARTOLOMEIS MJ, 1984, J BIOL CHEM, V259, P159; DORFMAN R I, 1957, Cancer Res, V17, P535; FARESE RV, 1971, ENDOCRINOLOGY, V89, P958, DOI 10.1210/endo-89-4-958; FARKASH Y, 1986, ENDOCRINOLOGY, V118, P1353, DOI 10.1210/endo-118-4-1353; FERGUSON JJ, 1963, J BIOL CHEM, V238, P2754; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; Garren L D, 1971, Recent Prog Horm Res, V27, P433; GARREN LD, 1965, P NATL ACAD SCI USA, V53, P1443, DOI 10.1073/pnas.53.6.1443; GRAHAMES.DG, 1967, J BIOL CHEM, V242, P5535; HARMEY MA, 1979, FEBS LETT, V108, P385, DOI 10.1016/0014-5793(79)80569-4; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HAYNES RC, 1959, J BIOL CHEM, V234, P1421; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; ILAN J, 1981, J BIOL CHEM, V256, P2830; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KARABOYAS GC, 1965, BIOCHEMISTRY-US, V4, P462, DOI 10.1021/bi00879a014; KLOPPENB.PW, 1968, ENDOCRINOLOGY, V82, P1053, DOI 10.1210/endo-82-5-1053; KORITZ SB, 1970, J BIOL CHEM, V245, P152; KRUEGER RJ, 1983, J BIOL CHEM, V258, P159; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFKOWITZ RJ, 1970, P NATL ACAD SCI USA, V65, P745, DOI 10.1073/pnas.65.3.745; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; MICHEL R, 1979, FEBS LETT, V101, P373, DOI 10.1016/0014-5793(79)81047-9; MITANI F, 1982, J HISTOCHEM CYTOCHEM, V30, P1066, DOI 10.1177/30.10.6813370; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PFANNER N, 1988, EUR J BIOCHEM, V175, P205, DOI 10.1111/j.1432-1033.1988.tb14185.x; PODESTA EJ, 1979, P NATL ACAD SCI USA, V76, P5187, DOI 10.1073/pnas.76.10.5187; PON LA, 1988, ENDOCRINOLOGY, V123, P1942, DOI 10.1210/endo-123-4-1942; PON LA, 1986, J BIOL CHEM, V261, P3309; PON LA, 1986, ENDOCR RES, V12, P429, DOI 10.3109/07435808609035449; PON LA, 1986, J BIOL CHEM, V261, P6594; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; RAY P, 1978, ENDOCRINOLOGY, V103, P1281, DOI 10.1210/endo-103-4-1281; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; SALA GB, 1979, J BIOL CHEM, V254, P3861; SCHIMMER BP, 1972, J BIOL CHEM, V247, P3134; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SIMBENI R, 1991, IN PRESS J BIOL CHEM; SIMPSON ER, 1978, J BIOL CHEM, V253, P3135; SOLOMON S, 1956, REV CAN BIOL, V15, P282; STONE D, 1954, ARCH BIOCHEM BIOPHYS, V51, P457, DOI 10.1016/0003-9861(54)90501-9; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; VANLOON APGM, 1987, EMBO J, V6, P2441, DOI 10.1002/j.1460-2075.1987.tb02523.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WATT VM, 1982, J BIOL CHEM, V257, P1684; ZWIZINSKI C, 1983, J BIOL CHEM, V258, P3340	57	224	231	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19739	19745						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655794				2022-12-25	WOS:A1991GK66700088
J	YU, FX; ZHOU, DM; YIN, HL				YU, FX; ZHOU, DM; YIN, HL			CHIMERIC AND TRUNCATED GCAP39 ELUCIDATE THE REQUIREMENTS FOR ACTIN FILAMENT SEVERING AND END CAPPING BY THE GELSOLIN FAMILY OF PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; PLASMA GELSOLIN; BINDING-SITES; MODULATING PROTEIN; REGULATORY DOMAINS; ESCHERICHIA-COLI; VILLIN; IDENTIFICATION; SEQUENCE; CALCIUM	gCap39 is an actin filament end-capping protein which has a threefold repeated domain structure similar to the N-terminal half of gelsolin. However, unlike gelsolin, gCap39 does not sever actin filaments and dissociates completely from filament ends after calcium removal. We have capitalized on these differences to explore the structural basis for actin filament capping, severing, and their regulation. Using truncated gCap39, generated by limited proteolysis or deletion mutagenesis, we found that actin filament capping requires multiple gCap domains, and almost the entire molecule is necessary for optimal activity. gCap39 domain I, like the equivalent domain in gelsolin, contains an actin monomer binding site. gCap39 domains II-III are, however, different from gelsolin in that they do not bind to the side of actin filaments. Since filament side binding is hypothesized to be the first step in severing, lack of side binding may explain why gCap39 does not sever. This is confirmed directly by swapping gCap39 domains II-III for the side-binding gelsolin domains to generate a chimera which severs actin filaments. The chimera is Ca2+ independent in actin filament severing and capping, although gCap39 domain I itself is regulated by Ca2+.	UNIV TEXAS,HLTH SCI CTR,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NHLBI NIH HHS [HL 29113] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029113] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMPE C, 1987, EMBO J, V6, P4149, DOI 10.1002/j.1460-2075.1987.tb02761.x; ANDRE E, 1988, J BIOL CHEM, V263, P722; ARPIN M, 1988, J CELL BIOL, V107, P1759, DOI 10.1083/jcb.107.5.1759; ASHINO N, 1987, J BIOCHEM-TOKYO, V101, P609, DOI 10.1093/jb/101.3.609; BADER MF, 1986, J CELL BIOL, V102, P636, DOI 10.1083/jcb.102.2.636; BAZARI WL, 1988, P NATL ACAD SCI USA, V85, P4986, DOI 10.1073/pnas.85.14.4986; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; BROWN SS, 1982, J CELL BIOL, V93, P205, DOI 10.1083/jcb.93.1.205; BRYAN J, 1984, J BIOL CHEM, V259, P7480; BRYAN J, 1988, J CELL BIOL, V106, P1553, DOI 10.1083/jcb.106.5.1553; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; COOPER JA, 1984, J CELL BIOL, V217, P225; EICHINGER L, 1991, J CELL BIOL, V112, P665, DOI 10.1083/jcb.112.4.665; FRANKEL S, 1990, J BIOL CHEM, V265, P17980; JANMEY PA, 1988, J BIOL CHEM, V263, P16738; JANMEY PA, 1986, J MUSCLE RES CELL M, V7, P446, DOI 10.1007/BF01753587; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; JOHNSTON PA, 1990, J BIOL CHEM, V265, P17946; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KURTH MC, 1983, J BIOL CHEM, V258, P895; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1985, J BIOL CHEM, V260, P5232; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1985, P NATL ACAD SCI USA, V82, P6788, DOI 10.1073/pnas.82.20.6788; MATSUDAIRA P, 1985, NATURE, V315, P248, DOI 10.1038/315248a0; MATSUDAIRA P, 1988, CELL, V54, P139, DOI 10.1016/0092-8674(88)90542-9; PRENDERGAST GC, 1991, EMBO J, V10, P757, DOI 10.1002/j.1460-2075.1991.tb08007.x; SAKURAI T, 1991, J BIOL CHEM, V266, P4581; Sambrook J, 1989, MOL CLONING LABORATO; SOUTHWICK FS, 1986, J BIOL CHEM, V261, P14191; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vandekerckhove J, 1990, CURR OPIN CELL BIOL, V2, P41, DOI 10.1016/S0955-0674(05)80029-8; WALSH TP, 1984, BIOCHEMISTRY-US, V23, P2613, DOI 10.1021/bi00307a012; WANG YL, 1983, CELL MOTIL CYTOSKEL, V3, P151, DOI 10.1002/cm.970030205; WAY M, 1988, J MOL BIOL, V203, P1127, DOI 10.1016/0022-2836(88)90132-5; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; YIN HL, 1980, NATURE, V218, P583; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912	46	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19269	19275						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655780				2022-12-25	WOS:A1991GK66700027
J	YOO, J; JI, I; JI, TH				YOO, J; JI, I; JI, TH			CONVERSION OF LYSINE-91 TO METHIONINE OR GLUTAMIC-ACID IN HUMAN CHORIOGONADOTROPIN-ALPHA RESULTS IN THE LOSS OF CAMP INDUCIBILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN CHORIONIC-GONADOTROPIN; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN HORMONES; SUBUNIT ASSOCIATION; LUTEINIZING-HORMONE; LUTROPIN RECEPTOR; TETRANITROMETHANE	Human choriogonadotropin (hCG) is a heterodimeric glycoprotein hormone. The alpha-subunit comprises 92 amino acids, of which 6 are Lys residues (Morgan, F. G., Birken, S., and Canfield, R. E. (1975) J. Biol. Chem. 250, 5247-5258). Our photoaffinity-labeling studies indicate that several of these Lys residues make contact with the lutropin receptor and are covalently cross-linked to the receptor. Lys-91 of the alpha-subunit is of interest because deletion of the two alpha-C-terminal residues, Lys-91 and Ser-92, results in a significant reduction in the bioactivity of lutropin and thyrotropin (Cheng, K.-W., Glazer, A. N., and Pierce, J. G. (1973) J. Biol. Chem. 248, 7930-7937). To determine the importance of Lys-alpha-91, we substituted it with Arg, Met, or Glu. The resulting mutant alpha-cDNA constructs were co-transfected into CHO cells with the wild type hCG-beta cDNA construct. Secreted hCG dimers were assayed for binding to receptors on porcine granulosa cells and stimulation of cAMP synthesis in a murine Leydig tumor cell line. The natural hCG, wild type hCG, and all mutant hCGs recognized the receptor, although with somewhat divergent affinities. However, there was a striking difference in the ability of cAMP induction. The natural hCG, wild type hCG, and Lys-91 --> Arg mutant hCG induced cAMP synthesis, whereas the Lys-91 --> Met and Lys-91 --> Glu mutants did not. These results demonstrate that Lys-91 is important for receptor modulation in the stimulation of cAMP synthesis.			YOO, J (corresponding author), UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018702] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-18702] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BURLEIGH BD, 1976, J BIOL CHEM, V251, P308; CHENG KW, 1973, J BIOL CHEM, V248, P7930; CHENG KW, 1972, J BIOL CHEM, V247, P7163; COLOMA TAS, 1990, J BIOL CHEM, V265, P5037; COMBARNOUS Y, 1974, EUR J BIOCHEM, V42, P13, DOI 10.1111/j.1432-1033.1974.tb03308.x; JI I, 1981, J BIOL CHEM, V256, P853; JI I, 1981, P NATL ACAD SCI-BIOL, V78, P5465, DOI 10.1073/pnas.78.9.5465; JI IH, 1985, J BIOL CHEM, V260, P2815; LIU WK, 1976, J BIOL CHEM, V251, P316; LIU WK, 1974, J BIOL CHEM, V249, P5544; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; MERZ WE, 1979, EUR J BIOCHEM, V101, P541, DOI 10.1111/j.1432-1033.1979.tb19749.x; MORGAN FJ, 1975, J BIOL CHEM, V250, P5247; MORI KF, 1978, MOL CELL ENDOCRINOL, V11, P285, DOI 10.1016/0303-7207(78)90014-X; MOYLE WR, 1982, P NATL ACAD SCI-BIOL, V79, P2245, DOI 10.1073/pnas.79.7.2245; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SAMBROOK J, 1989, MOL CLONING LABORATO, P1639; SHIN J, 1986, J BIOL CHEM, V261, P7501	20	43	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17741	17743						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680852				2022-12-25	WOS:A1991GG55300006
J	WESSELSREIKER, M; HAYCOCK, JW; HOWLETT, AC; STRONG, R				WESSELSREIKER, M; HAYCOCK, JW; HOWLETT, AC; STRONG, R			VASOACTIVE INTESTINAL POLYPEPTIDE INDUCES TYROSINE-HYDROXYLASE IN PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT ADRENAL-MEDULLA; TRANS-SYNAPTIC INDUCTION; NERVE GROWTH-FACTOR; CYCLIC-AMP; MESSENGER-RNA; PHEOCHROMOCYTOMA CELLS; CATECHOLAMINE SECRETION; SYMPATHETIC-GANGLIA; CHROMAFFIN CELLS; GENE-EXPRESSION	Physiological stress induces tyrosine hydroxylase, the rate-limiting enzyme for catecholamine biosynthesis, via trans-synaptic mechanisms within the adrenal medulla. Previous studies have implicated cAMP as a second messenger capable of inducing tyrosine hydroxylase;however, it is unclear whether any receptor coupled to adenylate cyclase mediates tyrosine hydroxylase induction. Recently, vasoactive intestinal polypeptide, whose receptor is coupled to adenylate cyclase in many tissues, has been shown to meet many of the criteria for a neuromodulator within the adrenal medulla. We therefore undertook a series of studies to determine whether vasoactive intestinal polypeptide may induce tyrosine hydroxylase in PC12 cells, a cell line derived from rat adrenal medulla. Here we report that vasoactive intestinal polypeptide produces a transient, time- and concentration-dependent increase in tyrosine hydroxylase mRNA levels which is followed by a stable increase in tyrosine hydroxylase protein. The increase in tyrosine hydroxylase mRNA does not occur in a mutant PC12 cell line deficient in cAMP-dependent protein kinase activity, indicating that the effect of vasoactive intestinal polypeptide is mediated through the cAMP second messenger pathway. This is the first report demonstrating that a neuromodulator which acts on an adenylate cyclase-coupled receptor can induce tyrosine hydroxylase.	VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,ST LOUIS,MO 63125; ST LOUIS UNIV,SCH MED,DEPT PHARMACOL & PHYSIOL SCI,ST LOUIS,MO 63104; ST LOUIS UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63104; LOUISIANA STATE UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,NEW ORLEANS,LA 70119	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Saint Louis University; Saint Louis University; Louisiana State University System				Howlett, Allyn/0000-0002-2810-0164	NIA NIH HHS [AG09557] Funding Source: Medline; NIDA NIH HHS [DA03690] Funding Source: Medline; NINDS NIH HHS [NS25134] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025134, R29NS025134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003690] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLACK IB, 1987, SCIENCE, V236, P1263, DOI 10.1126/science.2884727; BRICK PL, 1985, PEPTIDES, V6, P1075, DOI 10.1016/0196-9781(85)90430-9; BROWN ER, 1987, BIOCHEMISTRY-US, V26, P5208, DOI 10.1021/bi00390a046; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSTA E, 1974, LIFE SCI, V14, P1169, DOI 10.1016/0024-3205(74)90425-1; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; FLUHARTY SJ, 1983, BRAIN RES, V267, P384, DOI 10.1016/0006-8993(83)90895-8; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUIDOTTI A, 1977, BIOCHEM PHARMACOL, V26, P817, DOI 10.1016/0006-2952(77)90393-8; HANBAUER I, 1973, N-S ARCH PHARMACOL, V280, P39, DOI 10.1007/BF00505353; HANBAUER I, 1975, BRAIN RES, V967, P197; HAYCOCK JW, 1989, ANAL BIOCHEM, V181, P259, DOI 10.1016/0003-2697(89)90240-6; KILBOURNE EJ, 1990, MOL BRAIN RES, V8, P121, DOI 10.1016/0169-328X(90)90056-J; KRUKOFF TL, 1986, BRAIN RES, V382, P153, DOI 10.1016/0006-8993(86)90124-1; KUMAKURA K, 1979, MOL PHARMACOL, V16, P865; LEWIS EJ, 1983, J BIOL CHEM, V258, P4632; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; MALHOTRA RK, 1987, J PHYSIOL-LONDON, V388, P285, DOI 10.1113/jphysiol.1987.sp016615; MALHOTRA RK, 1988, J BIOL CHEM, V263, P2123; MALHOTRA RK, 1989, REGUL PEPTIDES, V26, P168, DOI 10.1016/0167-0115(89)90059-1; MALLET J, 1983, COLD SPRING HARB SYM, V48, P305, DOI 10.1101/SQB.1983.048.01.033; MISBAHUDDIN M, 1988, NEUROSCI LETT, V92, P202, DOI 10.1016/0304-3940(88)90061-4; MUELLER RA, 1970, EUR J PHARMACOL, V10, P51, DOI 10.1016/0014-2999(70)90156-1; OTTEN U, 1973, N-S ARCH PHARMACOL, V280, P117, DOI 10.1007/BF00499173; QUIK M, 1978, BIOCHEM PHARMACOL, V27, P2209, DOI 10.1016/0006-2952(78)90079-5; REINMANN EM, 1971, J BIOL CHEM, V246, P1988; ROSKOSKI R, 1989, MOL PHARMACOL, V36, P925; SASEK CA, 1989, J COMP NEUROL, V280, P522, DOI 10.1002/cne.902800403; SCHALLING M, 1989, P NATL ACAD SCI USA, V86, P4302, DOI 10.1073/pnas.86.11.4302; SCHOEFFTER P, 1985, EUR J PHARMACOL, V109, P275, DOI 10.1016/0014-2999(85)90430-3; SCHWARZSCHILD MA, 1989, J NEUROSCI, V9, P160; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STACHOWIAK M, 1988, MOL BRAIN RES, V3, P193, DOI 10.1016/0169-328X(88)90066-6; STRONG R, 1990, NEUROSCI LETT, V117, P175, DOI 10.1016/0304-3940(90)90140-5; STRONG R, 1990, BRAIN RES, V525, P126, DOI 10.1016/0006-8993(90)91327-D; TANK AW, 1986, MOL PHARMACOL, V30, P497; TANK AW, 1986, MOL PHARMACOL, V30, P486; THEONEN H, 1970, NATURE, V228, P861; THOENEN H, 1969, J PHARMACOL EXP THER, V169, P249; VANBUSKIRK R, 1985, MOL CELL BIOL, V5, P1984, DOI 10.1128/MCB.5.8.1984; VOLLE RL, 1982, J NEUROCHEM, V39, P1195, DOI 10.1111/j.1471-4159.1982.tb11516.x; WASHEK JA, 1987, ANN NY ACAD SCI, V493, P308; WESSELSREIKER M, 1990, END SOC ABSTR, V72, P336; WITT JJ, 1975, ANAL BIOCHEM, V66, P253, DOI 10.1016/0003-2697(75)90743-5; YOSHIKAWA M, 1990, NEUROSCI LETT, V111, P75, DOI 10.1016/0304-3940(90)90347-C; ZIGMOND RE, 1988, J PHYSIOL-PARIS, V83, P267; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	47	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9347	9350						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1674510				2022-12-25	WOS:A1991FM45900003
J	KOCH, KW				KOCH, KW			PURIFICATION AND IDENTIFICATION OF PHOTORECEPTOR GUANYLATE-CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; FREE CALCIUM; SALAMANDER RODS; PROTEINS; LIGHT; FROG; RECEPTOR; MEMBRANE; CASCADE	Photoreceptor guanylate cyclase was solubilized and purified from bovine rod outer segments with 50-150-fold increase in specific activity using the nonionic detergent n-dodecyl-beta-D-maltoside. Guanylate cyclase activities correlated with the enrichment of a protein with an apparent M(r) = 112,000. The purified enzyme showed specific activities of 100-700 nmol of cGMP produced/min/mg protein and exhibited positive cooperativity with respect to MnGTP (Hill coefficient n = 1.6 +/- 0.1). The apparent K(m) was 274 +/- 67-mu-M, and the turnover number was determined to be 0.2-1.3 cGMP produced/s. The molar ratio of the 112-kDa protein to rhodopsin corresponds to 1:104. This indicates that the amount of guanylate cyclase in rod photoreceptors is nearly equimolar to the amount of the phosphodiesterase.			KOCH, KW (corresponding author), FORSCHUNGSZENTRUM JULICH,INST BIOL INFORMAT VERARBEITUNG,POSTFACH 1913,W-5170 JULICH,GERMANY.		Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044				CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; FLEISCHMAN D, 1980, BIOCHIM BIOPHYS ACTA, V630, P176, DOI 10.1016/0304-4165(80)90419-5; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; HAYASHI F, 1990, Investigative Ophthalmology and Visual Science, V31, P216; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; KAKIUCHI S, 1981, J BIOL CHEM, V256, P19; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KAUPP UB, 1988, COLD SPRING HARB SYM, V53, P407, DOI 10.1101/SQB.1988.053.01.048; KAWAMURA S, 1989, J GEN PHYSIOL, V94, P649, DOI 10.1085/jgp.94.4.649; KLUMPP S, 1982, EUR J BIOCHEM, V124, P317; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; MOLDAY RS, 1979, J BIOL CHEM, V254, P4653; NICOLL DA, 1989, J BIOL CHEM, V264, P16207; OCOK NJ, 1988, J BIOL CHEM, V263, P11382; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; RATTO GM, 1988, J NEUROSCI, V8, P3240; SCHNETKAMP PPM, 1982, METHOD ENZYMOL, V81, P110; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; Segel I.H., 1975, ENZYME KINETICS; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YAU KW, 1985, NATURE, V313, P579, DOI 10.1038/313579a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	29	105	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8634	8637						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1673683				2022-12-25	WOS:A1991FK44100100
J	AVNI, A; AVITAL, S; GROMETELHANAN, Z				AVNI, A; AVITAL, S; GROMETELHANAN, Z			REACTIVATION OF THE CHLOROPLAST CF1-ATPASE BETA-SUBUNIT BY TRACE AMOUNTS OF THE CF1-ALPHA SUBUNIT SUGGESTS A CHAPERONIN-LIKE ACTIVITY FOR CF1-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOSPIRILLUM-RUBRUM; COUPLING FACTOR; ATP SYNTHESIS; ALPHA-3-BETA-3 COMPLEX; ESCHERICHIA-COLI; GAMMA-SUBUNIT; H+-ATPASE; PROTEINS; HYDROLYSIS; RECONSTITUTION	Incubation of tobacco and lettuce thylakoids with 2 M LiCl in the presence of MgATP removes the beta-subunit from their CF1-ATPase (CF1-beta) together with varying amounts of the CF1 alpha-subunit (CF1-alpha). These 2 M LiCl extracts, as with the one obtained from spinach thylakoids (Avital, S., and Gromet-Elhanan, Z. (1991) J. Biol. Chem. 266, 7067-7072), could form active hybrid ATPases when reconstituted into inactive beta-less Rhodospirillum rubrum chromatophores. Pure CF1-beta fractions that have been isolated from these extracts could not form such active hybrids by themselves, but could do so when supplemented with trace amounts (less than 5%) of CF1-alpha. A mitochondrial F1-ATPase alpha-subunit was recently reported to be a heat-shock protein, having two amino acid sequences that show a highly conserved identity with sequences found in molecular chaperones (Luis, A. M., Alconada, A., and Cuezva, J. M. (1990) J. Biol. Chem. 265, 7713-7716). These sequences are also conserved in CF1-alpha isolated from various plants, but not in F1-beta subunits. The above described reactivation of CF1-beta by trace amounts of CF1-alpha could thus be due to a chaperonin-like function of CF1-alpha, which involves the correct, active folding of isolated pure CF1-beta.	WEIZMANN INST SCI,DEPT BIOCHEM,IL-76100 REHOVOT,ISRAEL; WEIZMANN INST SCI,DEPT PLANT GENET,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science; Weizmann Institute of Science								AMZEL LM, 1983, ANNU REV BIOCHEM, V52, P801, DOI 10.1146/annurev.bi.52.070183.004101; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; AVITAL S, 1991, J BIOL CHEM, V266, P7067; AVITAL S, 1990, CURRENT RES PHOTOSYN, V3, P45; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clayton R. K., 1963, BACTERIAL PHOTOSYNTH, P495; CROSS RL, 1981, ANNU REV BIOCHEM, V50, P681, DOI 10.1146/annurev.bi.50.070181.003341; CUEZVA JM, 1990, FEBS LETT, V270, P71, DOI 10.1016/0014-5793(90)81237-I; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; FLUHR R, 1984, THEOR APPL GENET, V67, P491, DOI 10.1007/BF00264891; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; FUTAI M, 1977, BIOCHEM BIOPH RES CO, V79, P1231, DOI 10.1016/0006-291X(77)91138-X; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GROMETELHANAN Z, 1985, J BIOL CHEM, V260, P2635; GROMETELHANAN Z, 1986, METHOD ENZYMOL, V126, P528; GROMETELHANAN Z, 1974, J BIOL CHEM, V249, P2522; HARRIS DA, 1985, BIOCHEMISTRY-US, V24, P3876, DOI 10.1021/bi00336a010; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; KAGAWA Y, 1989, FEBS LETT, V249, P67, DOI 10.1016/0014-5793(89)80017-1; KHANANSHVILI D, 1982, J BIOL CHEM, V257, P1377; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUIS AM, 1990, J BIOL CHEM, V265, P7713; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PHILOSOPH S, 1977, J BIOL CHEM, V252, P8747; PHILOSOPH S, 1981, PHOTOSYNTHESIS, V2, P741; RICHTER ML, 1986, J BIOL CHEM, V261, P2109; TOUSSKY H, 1953, J BIOL CHEM, V202, P675; VIGNAIS PV, 1985, ANNU REV BIOCHEM, V54, P977, DOI 10.1146/annurev.biochem.54.1.977	32	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7317	7320						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1673460				2022-12-25	WOS:A1991FJ34200002
J	COHEN, D; PIEKARZ, RL; HSU, SIH; DEPINHO, RA; CARRASCO, N; HORWITZ, SB				COHEN, D; PIEKARZ, RL; HSU, SIH; DEPINHO, RA; CARRASCO, N; HORWITZ, SB			STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE MOUSE MDR1B GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN PRECURSORS; CELL-LINES; TRANSCRIPTION INVITRO; NEGATIVE REGULATION; MAMMALIAN-CELLS; CYCLIC-AMP; EXPRESSION; SEQUENCE; ELEMENTS	The overproduction of P-glycoprotein, an integral membrane protein thought to function as a drug efflux pump, is the hallmark of the multidrug resistance phenotype. In murine multidrug resistant J774.2 cell lines, distinct mdr genes, mdr1a and mdr1b, encode unique P-glycoprotein isoforms. To examine the transcriptional regulation of the mdr1b gene, its promoter was isolated and characterized. The transcription initiation site was mapped by primer extension, and the 5'-flanking region was sequenced. Several potential regulatory elements were identified in this region. A transient expression vector was constructed by fusion of 540 base pairs of 5'-flanking sequence and part of the first untranslated exon to the chloramphenicol acetyltransferase (CAT) gene. When transfected into monkey kidney COS-1, rat pituitary GH3 or T47D human breast cells, the mdr1b 5'-flanking sequences were capable of driving CAT expression. Transient transfection studies using deletion subclones of the mdr1b-CAT construct were done to locate potential cis-acting sequences. The studies indicate the presence of cis-acting elements in the 5'-flanking region of the mdr1b gene. The implications of these findings for expression and regulation of the mdr1b gene are discussed.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, CELL BIOL, BRONX, NY 10461 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MICROBIOL & IMMUNOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	COHEN, D (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, BRONX, NY 10461 USA.		Piekarz, Richard/GXH-9978-2022	DePinho, Ronald/0000-0002-5625-577X	NCI NIH HHS [CA39821] Funding Source: Medline; NIGMS NIH HHS [T32 GM7288] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA039821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANN DK, 1988, J BIOL CHEM, V263, P10887; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; ARCECI RJ, 1990, MOL REPROD DEV, V25, P101, DOI 10.1002/mrd.1080250202; BANCROFT FC, 1981, FUNCTIONALLY DIFFERE, P47; BENOIST C, 1980, NUCLEIC ACIDS RES, V8, P127, DOI 10.1093/nar/8.1.127; BRADLEY G, 1989, CANCER RES, V49, P2790; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BREWER AC, 1988, J MOL BIOL, V199, P575, DOI 10.1016/0022-2836(88)90302-6; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BURT RK, 1988, J NCI, V80, P1382; CARR BI, 1987, CANCER RES, V47, P5577; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FURANO AV, 1986, NUCLEIC ACIDS RES, V14, P3717, DOI 10.1093/nar/14.9.3717; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERGER LM, 1988, P NATL ACAD SCI USA, V85, P3762, DOI 10.1073/pnas.85.11.3762; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; GUILD BC, 1988, P NATL ACAD SCI USA, V85, P1595, DOI 10.1073/pnas.85.5.1595; HAMADA H, 1987, CANCER RES, V47, P2860; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HSU SIH, 1990, MOL CELL BIOL, V10, P3596, DOI 10.1128/MCB.10.7.3596; HSU SIH, 1989, J BIOL CHEM, V264, P12053; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KINGSTON RE, 1988, PRIMER EXTENSION CUR; LANGER SJ, 1988, MOL CELL BIOL, V8, P3872, DOI 10.1128/MCB.8.9.3872; LOTHSTEIN L, 1989, J BIOL CHEM, V264, P16054; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; RAYMOND M, 1989, P NATL ACAD SCI USA, V86, P6488, DOI 10.1073/pnas.86.17.6488; RICKLES RJ, 1989, MOL CELL BIOL, V9, P1691, DOI 10.1128/MCB.9.4.1691; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROY SN, 1985, CANCER RES, V45, P3856; SAKAI M, 1989, CANCER RES, V49, P5633; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; STRAHLE U, 1989, NATURE, V339, P629, DOI 10.1038/339629a0; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; THORGEIRSSON SS, 1987, SCIENCE, V236, P1120, DOI 10.1126/science.3576227; UEDA K, 1987, J BIOL CHEM, V262, P17432; VANDERBLIEK AM, 1989, ADV CANCER RES, V52, P165; YANG CPH, 1989, J BIOL CHEM, V264, P782	45	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2239	2244						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1671222				2022-12-25	WOS:A1991EV51500036
J	BRUNETTI, A; GOLDFINE, ID				BRUNETTI, A; GOLDFINE, ID			ROLE OF MYOGENIN IN MYOBLAST DIFFERENTIATION AND ITS REGULATION BY FIBROBLAST GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; MT ZION HOSP & MED CTR,DEPT MED,SAN FRANCISCO,CA 94115; MT ZION HOSP & MED CTR,DIABET & ENDOCRINE RES LAB,SAN FRANCISCO,CA 94115	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion			Brunetti, Antonio/K-7756-2016		NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM026667] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM26667] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRUNETTI A, 1989, J CLIN INVEST, V83, P192, DOI 10.1172/JCI113858; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; GOODCHILD J, 1988, P NATL ACAD SCI USA, V85, P5507, DOI 10.1073/pnas.85.15.5507; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LATHROP B, 1985, J CELL BIOL, V100, P1540, DOI 10.1083/jcb.100.5.1540; LATHROP B, 1985, J CELL BIOL, V101, P2194, DOI 10.1083/jcb.101.6.2194; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; OLSON EN, 1986, MOL CELL BIOL, V6, P2792, DOI 10.1128/MCB.6.8.2792; OLSON EN, 1983, J BIOL CHEM, V258, P3946; OLSON EN, 1983, J BIOL CHEM, V258, P2644; SCHNEIDER MD, 1987, MOL CELL BIOL, V7, P1973, DOI 10.1128/MCB.7.5.1973; SCHUBERT D, 1974, J CELL BIOL, V61, P398, DOI 10.1083/jcb.61.2.398; SHAW DJ, 1985, NUCLEIC ACIDS RES, V13, P8659; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; SPIZZ G, 1987, DEV BIOL, V123, P500, DOI 10.1016/0012-1606(87)90408-8; STANDAERT ML, 1984, J BIOL CHEM, V259, P2337; STRAUCH AR, 1984, J BIOL CHEM, V259, P3152; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; WICE B, 1987, J BIOL CHEM, V262, P1810; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZEMECNIK PC, 1986, P NATL ACAD SCI USA, V83, P4143	32	157	160	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					5960	5963						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690720				2022-12-25	WOS:A1990CY58700012
J	JAHROUDI, N; FOSTER, R; PRICEHAUGHEY, J; BEITEL, G; GEDAMU, L				JAHROUDI, N; FOSTER, R; PRICEHAUGHEY, J; BEITEL, G; GEDAMU, L			CELL-TYPE SPECIFIC AND DIFFERENTIAL REGULATION OF THE HUMAN METALLOTHIONEIN GENES - CORRELATION WITH DNA METHYLATION AND CHROMATIN STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALGARY,DEPT BIOL SCI,CALGARY T2N 1N4,ALBERTA,CANADA	University of Calgary								CARTER AD, 1984, P NATL ACAD SCI-BIOL, V81, P7392, DOI 10.1073/pnas.81.23.7392; CHIN CP, 1985, CELL, V40, P417; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; DURNAM DM, 1984, P NATL ACAD SCI-BIOL, V81, P1053, DOI 10.1073/pnas.81.4.1053; FOSTER R, 1988, J BIOL CHEM, V263, P11528; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAGER LJ, 1981, NATURE, V291, P340, DOI 10.1038/291340a0; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HASLINGER A, 1985, P NATL ACAD SCI USA, V82, P8572, DOI 10.1073/pnas.82.24.8572; HEGUY A, 1986, MOL CELL BIOL, V6, P2149, DOI 10.1128/MCB.6.6.2149; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; IMBRA RJ, 1986, NATURE, V323, P555, DOI 10.1038/323555a0; JAENISCH R, 1984, BIOCHIM BIOPHYS ACTA, V782, P1, DOI 10.1016/0167-4781(84)90099-X; KAGI JHR, 1984, ENVIRON HEALTH PERSP, V54, P93, DOI 10.2307/3429795; KAPLAN BB, 1979, BIOCHEM J, V183, P1812; KARIN M, 1981, J CELL PHYSIOL, V106, P63, DOI 10.1002/jcp.1041060108; KARIN M, 1982, NATURE, V299, P797, DOI 10.1038/299797a0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KARIN M, 1985, MOL CELL BIOL, V5, P2866, DOI 10.1128/MCB.5.10.2866; KARIN M, 1981, EUR J BIOCHEM, V118, P527, DOI 10.1111/j.1432-1033.1981.tb05551.x; KNOWLES BB, 1984, ADV HEPATITIS RES; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; LIEBERMAN MW, 1983, CELL, V35, P207, DOI 10.1016/0092-8674(83)90223-4; PRICEHAUGHEY J, 1987, BIOCHIM BIOPHYS ACTA, V908, P158, DOI 10.1016/0167-4781(87)90055-8; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1984, DNA METHYLATION BIOC; RICHARDS RI, 1984, CELL, V37, P263, DOI 10.1016/0092-8674(84)90322-2; SADHU C, 1988, J BIOL CHEM, V263, P2679; SADHU C, 1988, NUCLEIC ACIDS RES, V15, P5491; SCHMIDT CJ, 1986, P NATL ACAD SCI USA, V83, P3346, DOI 10.1073/pnas.83.10.3346; SCHMIDT CJ, 1985, J BIOL CHEM, V260, P7731; SCHOLER H, 1986, SCIENCE, V232, P76, DOI 10.1126/science.3006253; SHWORAK NW, 1983, BIOCHIM BIOPHYS ACTA, V763, P332, DOI 10.1016/0167-4889(83)90094-0; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; VARSHNEY U, 1986, MOL CELL BIOL, V6, P26, DOI 10.1128/MCB.6.1.26; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136	42	111	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1990	265	11					6506	6511						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY587	1690731				2022-12-25	WOS:A1990CY58700093
J	CHANG, M; BURGESS, JR; SCHOLZ, RW; REDDY, CC				CHANG, M; BURGESS, JR; SCHOLZ, RW; REDDY, CC			THE INDUCTION OF SPECIFIC RAT-LIVER GLUTATHIONE S-TRANSFERASE SUBUNITS UNDER INADEQUATE SELENIUM NUTRITION CAUSES AN INCREASE IN PROSTAGLANDIN-F2-ALPHA FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									PENN STATE UNIV, DEPT VET SCI, 226 FENSKE LAB, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, ENVIRONM RESOURCES RES INST, UNIVERSITY PK, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park					NCI NIH HHS [CA37979] Funding Source: Medline; NHLBI NIH HHS [HL31245, KO4-HL01240] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031245, K04HL001240] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 1986, TECHNICAL MANUAL; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BURGESS JR, 1987, BIOCHEM BIOPH RES CO, V142, P441, DOI 10.1016/0006-291X(87)90294-4; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTHAZELHOF E, 1976, BIOCHIM BIOPHYS ACTA, V450, P450, DOI 10.1016/0005-2760(76)90018-7; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DING GJF, 1985, J BIOL CHEM, V260, P3268; DING VDH, 1985, ARCH BIOCHEM BIOPHYS, V240, P553, DOI 10.1016/0003-9861(85)90062-1; FREY AB, 1983, J BIOL CHEM, V258, P1321; GOTO T, 1987, SELECTED RECIPES MOL; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HONG Y, 1989, J BIOL CHEM, V264, P13793; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI HCJ, 1986, J BIOL CHEM, V261, P3793; LAI HCJ, 1984, J BIOL CHEM, V259, P5536; LAI HCJ, 1986, NUCLEIC ACIDS RES, V14, P6101, DOI 10.1093/nar/14.15.6101; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LI NQ, 1990, J BIOL CHEM, V265, P108; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MEI C, 1987, ARCH BIOCHEM BIOPHYS, V259, P548, DOI 10.1016/0003-9861(87)90521-2; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PICKETT CB, 1984, J BIOL CHEM, V259, P5182; PICKETT CB, 1982, ARCH BIOCHEM BIOPHYS, V215, P539, DOI 10.1016/0003-9861(82)90113-8; RAMANATHAN L, 1979, MOL IMMUNOL, V16, P935, DOI 10.1016/0161-5890(79)90094-4; REDDY CC, 1983, ARCH BIOCHEM BIOPHYS, V224, P87, DOI 10.1016/0003-9861(83)90192-3; REDDY CC, 1982, PROSTAGLANDINS CANCE, P149; REDDY CC, 1983, ADV MOD ENV TOXICOL, V5, P395; ROHRBAUGH ML, 1985, MOL CELL BIOL, V5, P147, DOI 10.1128/MCB.5.1.147; TELAKOWSKIHOPKINS CA, 1985, J BIOL CHEM, V260, P5820; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TU CPD, 1982, NUCLEIC ACIDS RES, V10, P5407, DOI 10.1093/nar/10.18.5407; TU CPD, 1984, J BIOL CHEM, V259, P9434; TU CPD, 1985, J BIOL CHEM, V260, P9961; URICH A, 1977, SCIENCE, V198, P1313; VANDERJAGT DL, 1985, J BIOL CHEM, V260, P1603; WHETTER PA, 1978, J ASSOC OFF ANA CHEM, V61, P927	44	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5418	5423						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690709				2022-12-25	WOS:A1990CW48000020
J	IWAMOTO, T; TAKAHASHI, M; ITO, M; HAMAGUCHI, M; ISOBE, K; MISAWA, N; ASAI, JP; YOSHIDA, T; NAKASHIMA, I				IWAMOTO, T; TAKAHASHI, M; ITO, M; HAMAGUCHI, M; ISOBE, K; MISAWA, N; ASAI, JP; YOSHIDA, T; NAKASHIMA, I			ONCOGENICITY OF THE RET TRANSFORMING GENE IN MMTV/RET TRANSGENIC MICE	ONCOGENE			English	Article									NAGOYA UNIV,SCH MED,DEPT PATHOL 1,SHOWA KU,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,SCH MED,DIS MECHANISM & CONTROL RES INST,SHOWA KU,NAGOYA,AICHI 466,JAPAN; AICHI CANC CTR,RES CTR,EXPTL PATHOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN	Nagoya University; Nagoya University; Aichi Cancer Center	IWAMOTO, T (corresponding author), NAGOYA UNIV,SCH MED,DEPT IMMUNOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN.		TAKAHASHI, Masahide/I-7244-2014; isobe, ken-ichi/A-6685-2011; Takahashi, Masahide/AAN-4770-2020	isobe, ken-ichi/0000-0002-8150-2496; Takahashi, Masahide/0000-0002-2803-2683				ANDERSON MLM, 1985, NUCLEIC ACID HYBRIDI, P73; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; Davis LG, 1986, BASIC METHODS MOL BI, P42; HAMAGUCHI M, 1988, MOL CELL BIOL, V8, P3035, DOI 10.1128/MCB.8.8.3035; HOGAN B, 1986, MANIPULATING MOUSE E, P79; ISHIZAKA Y, 1989, ONCOGENE, V4, P789; LAND H, 1986, ONCOGENES GROWTH CON, P304; MAJORS JE, 1981, NATURE, V289, P253, DOI 10.1038/289253a0; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; TREMBLAY PJ, 1989, MOL CELL BIOL, V9, P854, DOI 10.1128/MCB.9.2.854; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6	23	47	47	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					535	542						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1691479				2022-12-25	WOS:A1990DB85300012
J	PODUSLO, JF				PODUSLO, JF			GOLGI SULFATION OF THE OLIGOSACCHARIDE CHAIN OF P0 OCCURS IN THE PRESENCE OF MYELIN ASSEMBLY BUT NOT IN ITS ABSENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MAYO CLIN & MAYO FDN,DEPT BIOCHEM MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic	PODUSLO, JF (corresponding author), MAYO CLIN & MAYO FDN,DEPT NEUROL,MOLEC NEUROBIOL LAB,ROCHESTER,MN 55905, USA.							AGRAWAL HC, 1983, J BIOL CHEM, V258, P6556; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BRAULKE T, 1987, BIOCHEM BIOPH RES CO, V143, P178, DOI 10.1016/0006-291X(87)90647-4; BRUNDEN KR, 1987, ANAL BIOCHEM, V164, P474, DOI 10.1016/0003-2697(87)90521-5; BRUNDEN KR, 1987, J CELL BIOL, V104, P661, DOI 10.1083/jcb.104.3.661; BRUNDEN KR, 1987, J NEUROCHEM, V49, P1863, DOI 10.1111/j.1471-4159.1987.tb02448.x; DURIEUX C, 1983, BIOCHEM BIOPH RES CO, V114, P705, DOI 10.1016/0006-291X(83)90838-0; DYCK PJ, 1970, MAYO CLIN PROC, V45, P286; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; GARDNER JD, 1975, J CLIN INVEST, V56, P366, DOI 10.1172/JCI108101; GUPTA SK, 1988, MOL BRAIN RES, V4, P133, DOI 10.1016/0169-328X(88)90005-8; HILLE A, 1984, FEBS LETT, V177, P129, DOI 10.1016/0014-5793(84)80996-5; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V150, P342, DOI 10.1016/0006-291X(88)90526-8; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; LEBLANC AC, 1987, MOL BRAIN RES, V2, P57, DOI 10.1016/0169-328X(87)90021-0; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; MATTHIEU JM, 1975, BIOCHIM BIOPHYS ACTA, V392, P167, DOI 10.1016/0304-4165(75)90177-4; MERKLE RK, 1985, J BIOL CHEM, V260, P1083; PODUSLO JF, 1985, BIOCHEM J, V228, P43, DOI 10.1042/bj2280043; PODUSLO JF, 1985, J NEUROCHEM, V44, P1194, DOI 10.1111/j.1471-4159.1985.tb08743.x; PODUSLO JF, 1984, J NEUROCHEM, V42, P493, DOI 10.1111/j.1471-4159.1984.tb02705.x; PODUSLO JF, 1985, J NEUROCHEM, V44, P388, DOI 10.1111/j.1471-4159.1985.tb05428.x; PODUSLO JF, 1984, P NATL ACAD SCI-BIOL, V81, P1864, DOI 10.1073/pnas.81.6.1864; PODUSLO JF, 1981, ANAL BIOCHEM, V114, P131, DOI 10.1016/0003-2697(81)90463-2; PULLEYBLANK DE, 1981, J BIOCHEM BIOPH METH, V4, P339, DOI 10.1016/0165-022X(81)90074-9; RAPAPORT RN, 1981, J NEUROCHEM, V37, P164, DOI 10.1111/j.1471-4159.1981.tb05304.x; ROSA P, 1985, J CELL BIOL, V100, P928, DOI 10.1083/jcb.100.3.928; SAKAMOTO Y, 1986, BIOMED RES-TOKYO, V7, P261; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SMITH ME, 1989, T AM SOC NEUROCHEM, V20, P283; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TARENTINO AL, 1982, J BIOL CHEM, V257, P776; TOEWS AD, 1982, J NEUROCHEM, V39, P1348, DOI 10.1111/j.1471-4159.1982.tb12577.x; TOEWS AD, 1987, J NEUROCHEM, V48, P883, DOI 10.1111/j.1471-4159.1987.tb05599.x; VONWURTEMBERG MM, 1989, BIOCHEMISTRY-US, V28, P4088; WIGGINS RC, 1980, J NEUROCHEM, V34, P627, DOI 10.1111/j.1471-4159.1980.tb11190.x	39	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					3719	3725						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689308				2022-12-25	WOS:A1990CQ48000025
J	CIARDIELLO, F; TORTORA, G; KIM, N; CLAIR, T; ALLY, S; SALOMON, DS; CHOCHUNG, YS				CIARDIELLO, F; TORTORA, G; KIM, N; CLAIR, T; ALLY, S; SALOMON, DS; CHOCHUNG, YS			8-CHLORO-CAMP INHIBITS TRANSFORMING GROWTH FACTOR-ALPHA TRANSFORMATION OF MAMMARY EPITHELIAL-CELLS BY RESTORATION OF THE NORMAL MESSENGER-RNA PATTERNS FOR CAMP-DEPENDENT PROTEIN-KINASE REGULATORY SUBUNIT ISOFORMS WHICH SHOW DISRUPTION UPON TRANSFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NCI,TUMOR IMMUNOL & BIOL LAB,BLDG 10,RM 5B38,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Tortora, Giampaolo/AAA-1252-2019	Tortora, Giampaolo/0000-0002-1378-4962; Ciardiello, Fortunato/0000-0002-3369-4841				ALLY S, 1988, P NATL ACAD SCI USA, V85, P6319, DOI 10.1073/pnas.85.17.6319; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOCHUNG YS, 1989, JNCI-J NATL CANCER I, V81, P982, DOI 10.1093/jnci/81.13.982; CIARDIELLO F, 1988, CANCER RES, V48, P2483; CIARDIELLO F, 1988, MOL ENDOCRINOL, V2, P1202, DOI 10.1210/mend-2-12-1202; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; CORBIN JD, 1975, J BIOL CHEM, V250, P218; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; HOFFMAN F, 1975, J BIOL CHEM, V250, P7795; HYNES NE, 1985, MOL CELL BIOL, V5, P268, DOI 10.1128/MCB.5.1.268; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAHSEN T, 1986, J BIOL CHEM, V261, P12352; KATSAROS D, 1987, FEBS LETT, V223, P97, DOI 10.1016/0014-5793(87)80517-3; Krebs E G, 1972, Curr Top Cell Regul, V5, P99; KUO JF, 1969, P NATL ACAD SCI USA, V64, P1349, DOI 10.1073/pnas.64.4.1349; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; LEWKO WM, 1981, CANCER RES, V41, P2855; LIU SC, 1987, MOL ENDOCRINOL, V1, P683, DOI 10.1210/mend-1-10-683; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; OGREID D, 1985, EUR J BIOCHEM, V150, P219, DOI 10.1111/j.1432-1033.1985.tb09010.x; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; OYEN O, 1988, FEBS LETT, V229, P391, DOI 10.1016/0014-5793(88)81163-3; PERROTEAU I, 1986, BREAST CANCER RES TR, V7, P201, DOI 10.1007/BF01806251; REDMOND SMS, 1988, ONCOGENE, V2, P259; ROBINSONSTEINER AM, 1983, J BIOL CHEM, V258, P1032; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHANKAR V, 1989, MOL CARCINOGEN, V2, P1, DOI 10.1002/mc.2940020102; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; TAGLIAFERRI P, 1988, J BIOL CHEM, V263, P409; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TORTORA G, 1988, BLOOD, V71, P230; TORTORA G, 1989, FEBS LETT, V242, P363, DOI 10.1016/0014-5793(89)80502-2; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1987, J BIOL CHEM, V262, P15202; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300	41	73	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					1016	1020						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688548				2022-12-25	WOS:A1990CH53300061
J	BEEBE, JS; MOUNTJOY, K; KRZESICKI, RF; PERINI, F; RUDDON, RW				BEEBE, JS; MOUNTJOY, K; KRZESICKI, RF; PERINI, F; RUDDON, RW			ROLE OF DISULFIDE BOND FORMATION IN THE FOLDING OF HUMAN CHORIONIC-GONADOTROPIN BETA-SUBUNIT INTO AN ALPHA-BETA-DIMER ASSEMBLY-COMPETENT FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,M6322 MED SCI 1,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL CANCER INSTITUTE [R01CA032949] Funding Source: NIH RePORTER; NCI NIH HHS [CA-32949] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEEBE JS, 1989, ENDOCRINOLOGY, V124, P1613, DOI 10.1210/endo-124-4-1613; BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; COLE LA, 1983, ENDOCRINOLOGY, V113, P1176, DOI 10.1210/endo-113-3-1176; CORLESS CL, 1987, J CELL BIOL, V104, P1173, DOI 10.1083/jcb.104.5.1173; FREEDMAN RB, 1984, TRENDS BIOCHEM SCI, V9, P438, DOI 10.1016/0968-0004(84)90152-X; KAETZEL DM, 1988, J BIOL CHEM, V263, P6344; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTBADER J, 1989, 3RD PROT SOC S SEATT, pS89; MISE T, 1981, J BIOL CHEM, V256, P6587; PETERS BP, 1984, J BIOL CHEM, V259, P5123; PETERS T, 1982, J BIOL CHEM, V257, P8847; RUDDON RW, 1989, ENDOCRINOLOGY, V124, P862, DOI 10.1210/endo-124-2-862; RUDDON RW, 1987, J BIOL CHEM, V262, P12533; RUDDON RW, 1988, PLACENTAL PROTEIN HO, P75; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SUGANUMA N, 1989, J BIOL CHEM, V264, P19302	17	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					312	317						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688430				2022-12-25	WOS:A1990CF66200048
J	UTAL, AK; JAMIL, H; VANCE, DE				UTAL, AK; JAMIL, H; VANCE, DE			DIACYLGLYCEROL SIGNALS THE TRANSLOCATION OF CTP - CHOLINE-PHOSPHATE CYTIDYLTRANSFERASE IN HELA-CELLS TREATED WITH 12-O-TETRADECANOYLPHORBOL-13-ACETATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GH3 PITUITARY-CELLS; PROTEIN KINASE-C; STIMULATE PHOSPHATIDYLCHOLINE METABOLISM; CHINESE-HAMSTER OVARY; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; FATTY-ACIDS; RAT-LIVER; PHOSPHORYLCHOLINE CYTIDYLYLTRANSFERASE; ENDOPLASMIC-RETICULUM; SEPARATE MECHANISMS	The mechanism of 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated phosphatidylcholine biosynthesis in HeLa cells was investigated. TPA caused a 3-fold increase in particulate CTP:phosphocholine cytidylyltransferase activity in HeLa cells which correlated with decreased cytidylyltransferase activity in the cytosol. The increase in membrane-associated cytidylyltransferase was confirmed by immunoblotting. Immunoprecipitation studies suggested that TPA had no effect on the phosphorylation state of cytidylyltransferase. Enhanced binding of cytidylyltransferase to diacylglycerol-enriched membranes has previously been shown. Diacylglycerol levels in TPA-treated HeLa cells increased approximately 2-fold (2.29 to 4.02 nmol/mg of protein) after 1 h of TPA treatment. A time course experiment showed a temporal relationship in which production of diacylglycerol appeared to signal translocation of cytidylyltransferase to membranes followed by a stimulation of phosphatidylcholine biosynthesis. Diacylglycerol was further evaluated as a translocator of cytidylyltransferase by depleting HeLa cells of protein kinase C and incubating with dioctanoylglycerol. This treatment increased both membrane-associated cytidylyltransferase activity and the rate of phosphatidylcholine biosynthesis approximately 2-fold. A time course experiment with dioctanoylglycerol showed a strong positive correlation (r2 = 0.89) between the amount of particulate cytidylyltransferase activity and the rate of phosphatidylcholine biosynthesis. Therefore, TPA stimulates phosphatidylcholine biosynthesis by causing a translocation of cytidylyltransferase from the cytosol to membranes, which appears to be mediated by increased diacylglycerol.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2E1,ALBERTA,CANADA	University of Alberta	UTAL, AK (corresponding author), UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,ALBERTA,CANADA.							AEBERHARD EE, 1986, BIOCHIM BIOPHYS ACTA, V875, P6, DOI 10.1016/0005-2760(86)90004-4; ANDERSON KE, 1985, BIOCHIM BIOPHYS ACTA, V835, P360, DOI 10.1016/0005-2760(85)90292-9; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDER A, 1988, BIOCHIM BIOPHYS ACTA, V958, P343, DOI 10.1016/0005-2760(88)90219-6; CHOY PC, 1979, CAN J BIOCHEM CELL B, V57, P605, DOI 10.1139/o79-076; COOK HW, 1985, CAN J BIOCHEM CELL B, V63, P145, DOI 10.1139/o85-021; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P26, DOI 10.1016/0005-2760(87)90214-1; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P37, DOI 10.1016/0005-2760(87)90215-3; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; DANIEL LW, 1986, J BIOL CHEM, V261, P9128; GLATZ JA, 1987, CARCINOGENESIS, V8, P943; HII CST, 1990, BIOCHIM BIOPHYS ACTA, V1052, P327, DOI 10.1016/0167-4889(90)90229-7; JAMIL H, 1990, J BIOL CHEM, V265, P4332; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; KOLESNICK RN, 1990, J BIOL CHEM, V265, P10900; KOLESNICK RN, 1987, J BIOL CHEM, V262, P9204; KOLESNICK RN, 1990, BIOCHEM J, V267, P17, DOI 10.1042/bj2670017; KOLESNICK RN, 1989, J BIOL CHEM, V264, P11688; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPETINA EG, 1985, J BIOL CHEM, V260, P1358; LISCOVITCH M, 1987, J BIOL CHEM, V262, P17487; MOCK T, 1986, BIOCHEM CELL BIOL, V64, P413, DOI 10.1139/o86-058; PADDON HB, 1980, BIOCHIM BIOPHYS ACTA, V620, P636, DOI 10.1016/0005-2760(80)90156-3; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P447, DOI 10.1016/0005-2760(84)90171-1; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PELECH SL, 1981, J BIOL CHEM, V256, P8283; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; TERCE F, 1991, BIOCHIM BIOPHYS ACTA, V1084, P67; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P167, DOI 10.1016/0005-2760(91)90091-U; Vance D E, 1981, Methods Enzymol, V71 Pt C, P576; VANCE DE, 1980, J BIOL CHEM, V255, P1064; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; VANCE DE, 1984, TRENDS BIOCHEM SCI, V9, P12; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1984, J BIOL CHEM, V259, P315; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374; YAO ZM, 1990, J BIOL CHEM, V265, P4326	49	95	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1991	266	35					24084	24091						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV319	1660890				2022-12-25	WOS:A1991GV31900086
J	SORKIN, A; CARPENTER, G				SORKIN, A; CARPENTER, G			DIMERIZATION OF INTERNALIZED EPIDERMAL GROWTH-FACTOR RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TYROSINE KINASE; EGF RECEPTOR; A431 CELLS; A-431 CELLS; DIRECT VISUALIZATION; HUMAN-FIBROBLASTS; CROSS-LINKING; LIGAND; PHOSPHORYLATION; DEGRADATION	Binding of epidermal growth factor (EGF) to cell surface EGF receptors initiates the formation of the receptor homodimers that can be detected by covalent cross-linking in intact cells or in detergent-solubilized cell extracts. Low pH dissociation of EGF from surface receptors results in immediate monomerization of receptor dimers. Using chemical cross-linking during mild permeabilization or cell solubilization, we have detected dimers of internalized EGF receptors in human carcinoma A-431 cells and transfected NIH 3T3 cells that express human EGF receptors. The percent-age of internalized cross-linked receptor dimers was similar to that observed for surface EGF receptors. Furthermore, at the time of maximal accumulation of EGF-receptor complexes within the endosomal compartment (10-15 min of incubation at 37-degrees-C), both the dimeric and monomeric forms of the EGF receptor are tyrosine-phosphorylated to the same extent as surface dimer and monomer species. In transfected NIH 3T3 cells, the level of dimerized and internalized kinase-negative EGF receptors was not different from that observed for wild-type receptors. These data suggest that for some time after internalization EGF does not dissociate from its receptor and indicate that a receptor conformation is preserved intracellularly that allows maintenance of receptor-receptor interactions and tyrosine kinase activity.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232	Vanderbilt University	SORKIN, A (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.			Sorkin, Alexander/0000-0002-4446-1920	NCI NIH HHS [CA24071] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA024071] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; BOONSTRA J, 1985, EUR J CELL BIOL, V36, P209; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CARPENTER G, 1976, J CELL PHYSIOL, V88, P227, DOI 10.1002/jcp.1040880212; CARPENTIER JL, 1987, J CELL BIOL, V105, P2751, DOI 10.1083/jcb.105.6.2751; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COCHET C, 1988, J BIOL CHEM, V263, P3290; COHEN S, 1985, J BIOL CHEM, V260, P2351; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; FAGNER BO, 1986, BIOCHEMISTRY-US, V25, P6414; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; GILL GN, 1987, MOL CELL ENDOCRINOL, V51, P169, DOI 10.1016/0303-7207(87)90027-X; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HELIN K, 1991, J BIOL CHEM, V266, P8363; HELIN K, 1990, ONCOGENE, V6, P825; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HONNEGER AM, 1987, CELL, V51, P199; HONNEGER AM, 1990, J CELL BIOL, V110, P1541; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; NESTEROV A, 1990, MOL CELL BIOL, V10, P5011, DOI 10.1128/MCB.10.9.5011; NORTHWOOD IC, 1988, J BIOL CHEM, V263, P7450; RUBIN RA, 1983, J BIOL CHEM, V258, P5177; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SORKIN A, 1991, J BIOL CHEM, V266, P8355; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; STAROS JV, 1989, RECEPTOR PHOSPHORYLA, P227; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; STOSCHECK CM, 1983, ARCH BIOCHEM BIOPHYS, V227, P457, DOI 10.1016/0003-9861(83)90476-9; STURANI E, 1990, EXP CELL RES, V191, P323, DOI 10.1016/0014-4827(90)90022-3; STURANI E, 1988, MOL CELL BIOL, V8, P1345, DOI 10.1128/MCB.8.3.1345; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VERHEIJDEN GF, 1990, BIOCHEM J, V271, P215, DOI 10.1042/bj2710215; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	47	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23453	23460						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1683870				2022-12-25	WOS:A1991GT48300101
J	RAYSON, BM				RAYSON, BM			[CA2+]I REGULATES TRANSCRIPTION RATE OF THE NA+/K+-ATPASE-ALPHA-1 SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TISSUE-SPECIFIC EXPRESSION; MESSENGER-RNAS; ALPHA-SUBUNIT; 5'-FLANKING REGION; MOLECULAR-CLONING; CALCIUM IONOPHORE; PROTO-ONCOGENE; GROWTH-FACTOR; BETA-SUBUNIT; NA,K-ATPASE	The Na+/K+-ATPase enzyme is a pivotal regulator of intracellular electrolyte levels in animal cells. Changes in the rate of its synthesis have been demonstrated to mediate a number of physiological responses. The cellular mechanisms implicated in such regulatory responses though remain poorly defined. Specifically, no intracellular mediators have previously been established. We now describe for the first time, one putative mediator: [Ca2+]i. Elevations in [Ca2+]i stimulate levels of mRNA-alpha-1 and mRNA-beta-1, sequences which encode both the catalytic subunit of the enzyme, the alpha-subunit, and the glycosylated subunit, the beta-subunit. These results suggest that elevations in [Ca2+]i modulate the synthetic rate of the active enzyme, and consequently changes in [Ca2+]i may mediate the regulation of its synthetic rate in a range of physiological settings. The mRNA-alpha-1 response to the elevation of [Ca2+]i appears, at least partly, to reflect an increase in transcription rate. However, no such increase in transcription rate of the beta-1 subunit gene was detectable. Thus the mRNA-beta-1 response, under conditions of elevated [Ca2+]i, may be explained by a decrease in specific mRNA degradation rate.			RAYSON, BM (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT PHYSIOL,1300 YORK AVE,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033352] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33352] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; CURRAN T, 1987, ONCOGENE, V2, P79; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; GICK GG, 1988, J BIOL CHEM, V263, P16610; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARA Y, 1987, J BIOCHEM-TOKYO, V102, P43, DOI 10.1093/oxfordjournals.jbchem.a122039; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; LIU CM, 1978, J BIOL CHEM, V253, P5892; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MERCER RW, 1986, MOL CELL BIOL, V6, P3884, DOI 10.1128/MCB.6.11.3884; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; PETZEL D, 1989, P AM SOC NEPHROL; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RAYSON BM, 1984, AM J PHYSIOL, V243, pF463; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; SCHNEIDER JW, 1985, P NATL ACAD SCI USA, V82, P6357, DOI 10.1073/pnas.82.18.6357; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHULL MM, 1990, GENOMICS, V6, P451, DOI 10.1016/0888-7543(90)90475-A; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; TAORMINO JP, 1990, J BIOL CHEM, V265, P4116; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; YAGAWA Y, 1990, BIOCHIM BIOPHYS ACTA, V1049, P286, DOI 10.1016/0167-4781(90)90099-N	31	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21335	21338						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657958				2022-12-25	WOS:A1991GP80400003
J	PUOTI, A; DESPONDS, C; FANKHAUSER, C; CONZELMANN, A				PUOTI, A; DESPONDS, C; FANKHAUSER, C; CONZELMANN, A			CHARACTERIZATION OF A GLYCOPHOSPHOLIPID INTERMEDIATE IN THE BIOSYNTHESIS OF GLYCOPHOSPHATIDYLINOSITOL ANCHORS ACCUMULATING IN THE THY-1-NEGATIVE LYMPHOMA LINE SIA-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEINS; PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; PHOSPHATE-MANNOSE SYNTHASE; GLYCOSYL-PHOSPHATIDYLINOSITOL; THY-1 GLYCOPROTEIN; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPASE-C; STRUCTURAL CHARACTERIZATION; GLYCOLIPID PRECURSORS	Several mammalian mutant cell lines are deficient in the biosynthesis of glycophosphatidylinositol anchors for membrane proteins. When metabolically labeled with (H-3]myo-inositol or [H-3]mannose, two out of five mutant lines (SIA-b and EL4-f) accumulated abnormal lipids which remained undetectable in the corresponding parental cell lines. The most abundant glycolipid of SIA-b cells (named lipid X) was isolated and partially characterized using hydrofluoric acid, nitrous acid deamination, acetolysis, and exoglycosidase treatments alone or in combination. The partial structure for the carbohydrate moiety of lipid X is Man-alpha-(X --> )Man-alpha-GlcN-inositol, X being a charged, HF-sensitive substituent (possibly phosphoethanolamine). Lipid X is largely resistant to phosphatidylinositol-specific phospholipase C treatment but can be rendered sensitive to the enzyme by treatment with methanolic NH3, which suggests the presence of an acyl chain on the inositol moiety. The lipid moieties of lipid X are heterogenous in that about 50% of headgroups remain bound to a lipid moiety after mild alkaline hydrolysis. Similarly, about 50% of the lipid moieties of Thy-1, a glycophosphatidylinositol-anchored surface glycoprotein, isolated from SIA, the parent of SIA-b cells or from EL4 lymphoma cells, are resistant to mild alkaline hydrolysis. Altogether the data suggest that the SIA-b mutant line lacks an enzyme acting late in the anchor glycolipid biosynthesis pathway.	UNIV LAUSANNE,INST BIOCHEM,CH-1066 EPALINGES,SWITZERLAND	University of Lausanne			Puoti, Alessandro/E-5700-2012; Puoti, Alessandro/ABE-9963-2021	Puoti, Alessandro/0000-0002-1396-7662				BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; CONZELMANN A, 1988, MOL CELL BIOL, V8, P674, DOI 10.1128/MCB.8.2.674; CONZELMANN A, 1987, BIOCHEM J, V246, P605, DOI 10.1042/bj2460605; CONZELMANN A, 1990, EMBO J, V9, P653, DOI 10.1002/j.1460-2075.1990.tb08157.x; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DAVITZ MA, 1987, SCIENCE, V238, P81, DOI 10.1126/science.2443973; DEGASPERI R, 1990, SCIENCE, V250, P988, DOI 10.1126/science.1978413; DOERING TL, 1990, J BIOL CHEM, V265, P611; FATEMI SH, 1986, CELL, V46, P653, DOI 10.1016/0092-8674(86)90340-5; FATEMI SH, 1988, J BIOL CHEM, V263, P1288; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; HOLLANDER N, 1988, J IMMUNOL, V141, P4283; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; LUESCHER B, 1985, J IMMUNOL, V134, P1084; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; MACDONALD HR, 1985, EUR J IMMUNOL, V15, P495, DOI 10.1002/eji.1830150514; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MAYOR S, 1990, J BIOL CHEM, V265, P6174; MENON AK, 1988, J BIOL CHEM, V263, P1970; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROBERTS WL, 1988, J BIOL CHEM, V263, P18776; SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955; STEVENS VL, 1990, J BIOL CHEM, V265, P15653; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001; TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0; TROWBRIDGE IS, 1978, CELL, V14, P21, DOI 10.1016/0092-8674(78)90297-0; TSE AGD, 1985, SCIENCE, V230, P1003, DOI 10.1126/science.2865810; WELLS GB, 1983, J BIOL CHEM, V258, P200	44	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21051	21059						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1682315				2022-12-25	WOS:A1991GN00100074
J	ASKEW, DS; BARTHOLOMEW, C; BUCHBERG, AM; VALENTINE, MB; JENKINS, NA; COPELAND, NG; IHLE, JN				ASKEW, DS; BARTHOLOMEW, C; BUCHBERG, AM; VALENTINE, MB; JENKINS, NA; COPELAND, NG; IHLE, JN			HIS-1 AND HIS-2 - IDENTIFICATION AND CHROMOSOMAL MAPPING OF 2 COMMONLY REARRANGED SITES OF VIRAL INTEGRATION IN A MYELOID-LEUKEMIA	ONCOGENE			English	Article							T-CELL LYMPHOMAS; C-MYB LOCUS; PROVIRAL INSERTION; PROMOTER INSERTION; RETROVIRAL INSERTION; TRANSCRIPTIONAL ACTIVATION; HOMEOBOX GENE; N-MYC; VIRUS; LINE	To identify genes that contribute to myeloid leukemogenesis we have cloned viral integration sites from a CasBrM-MuLV-induced interleukin 3-independent myeloid leukemia cell line. Genomic probes derived from cellular sequences flanking two integrated proviruses were used to screen restriction digests of DNAs from a panel of 52 hematopoietic cell lines, 30 of which were established from CasBrM-MuLV- or MoMuLV-induced mouse leukemias. Probes from one integration site (His-1) defined a region that was rearranged in 3/52 cell lines, and probes from a second integration site (His-2) identified a rearrangement in 2/52 cell lines. Both cases of His-2 rearrangements occurred in concert with viral insertions in the His-1 locus. Genetic mapping of these loci using interspecific backcross analysis assigned the His-1 locus to mouse chromosome 2 and the His-2 locus to mouse chromosome 19. In situ hybridization with a probe from the human homologous region mapped the His-1 locus to human chromosome 2q14-q21. No recombinants were observed between His-2 and Gin-1, a common site of provirus integration in Gross passage A MuLV-induced T-cell leukemias, in 131 backcross animals, suggesting that these loci are tightly linked. The His-1 locus maps to mouse chromosome 2 distinct from any known oncogene or common site of integration but near the proximal breakpoint for a deletion that is observed in over 90% of radiation-induced leukemias.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; NCI, FREDERICK CANC RES & DEV CTR, MAMMALIAN GENET LAB, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA; ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38105 USA	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; St Jude Children's Research Hospital				Buchberg, Arthur/0000-0002-0543-5631; Askew, David/0000-0002-6477-2515	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, N01-CO-74101, CA 51020] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER HT, 1988, J VIROL, V62, P4113, DOI 10.1128/JVI.62.11.4113-4122.1988; BARTHOLOMEW C, 1989, ONCOGENE, V4, P529; BAUMBACH WR, 1988, J VIROL, V62, P3151, DOI 10.1128/JVI.62.9.3151-3155.1988; BERNS A, 1988, ARCH VIROL, V102, P1, DOI 10.1007/BF01315558; BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; BRECKON G, 1988, KEY CHROMOSOME C, V3; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; CANAANI E, 1983, P NATL ACAD SCI USA, V80, P7110; CHEN SJ, 1985, P NATL ACAD SCI USA, V82, P7284, DOI 10.1073/pnas.82.21.7284; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; CUYPERS HT, 1984, CELL, V37, P141; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DOLCETTI R, 1989, ONCOGENE, V4, P1009; GEORGE DL, 1986, P NATL ACAD SCI USA, V83, P1651, DOI 10.1073/pnas.83.6.1651; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987; Green EL, 1981, GENETICS PROBABILITY, P77; HAYATA I, 1983, CANCER RES, V43, P367; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P6687, DOI 10.1073/pnas.82.19.6687; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; IHLE JN, 1989, INT J CELL CLONING, V7, P68, DOI 10.1002/stem.5530070202; IHLE JN, 1982, J IMMUNOL, V129, P2431; IHLE JN, 1989, J VIROL, V63, P2959, DOI 10.1128/JVI.63.7.2959-2966.1989; IHLE JN, 1984, ADV VIRAL ONCOL, V4, P95; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KONO T, 1990, P NATL ACAD SCI USA, V87, P1806, DOI 10.1073/pnas.87.5.1806; LACOMBE C, 1991, J BIOL CHEM, V266, P6952; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; LEBEAU MM, 1984, NATURE, V312, P70, DOI 10.1038/312070a0; LI Y, 1984, P NATL ACAD SCI-BIOL, V81, P6808, DOI 10.1073/pnas.81.21.6808; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; PALMER CG, 1990, AM J MED GENET, V36, P214, DOI 10.1002/ajmg.1320360215; PETERS G, 1989, P NATL ACAD SCI USA, V86, P5678, DOI 10.1073/pnas.86.15.5678; PIZER E, 1989, J VIROL, V63, P1630, DOI 10.1128/JVI.63.4.1630-1640.1989; ROCCHI M, 1986, HUM GENET, V74, P30; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; Sambrook J, 1989, MOL CLONING LABORATO; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380; SIRACUSA LD, 1990, GENOMICS, V6, P491, DOI 10.1016/0888-7543(90)90479-E; SIRACUSA LD, 1991, IN PRESS GENETICS; TRAKHTENBROT L, 1988, LEUKEMIA, V2, P545; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; VANLOHUIZEN M, 1989, EMBO J, V8, P133, DOI 10.1002/j.1460-2075.1989.tb03357.x; VILLEMUR R, 1987, MOL CELL BIOL, V7, P512, DOI 10.1128/MCB.7.1.512; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WEINSTEIN Y, 1987, J VIROL, V61, P2339, DOI 10.1128/JVI.61.7.2339-2343.1987; WEISS R, 1985, RNA TUMOR VIRUSES, V2; WESTAWAY D, 1986, EMBO J, V5, P301, DOI 10.1002/j.1460-2075.1986.tb04213.x; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	59	40	40	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2041	2047						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1682866				2022-12-25	WOS:A1991GX11900015
J	HIEBSCH, RR; RAUB, TJ; WATTENBERG, BW				HIEBSCH, RR; RAUB, TJ; WATTENBERG, BW			PRIMAQUINE BLOCKS TRANSPORT BY INHIBITING THE FORMATION OF FUNCTIONAL TRANSPORT VESICLES - STUDIES IN A CELL-FREE ASSAY OF PROTEIN-TRANSPORT THROUGH THE GOLGI-APPARATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; FREE SYSTEM; HEPATOMA-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; SUCCESSIVE COMPARTMENTS; LYSOSOMOTROPIC AMINES; N-ACETYLGLUCOSAMINE; MEMBRANE-FUSION; STACK; CISTERNAE	The lysosomotropic amine primaquine has previously been shown to inhibit both secretory and recycling processes of cells in culture. We have used a cell-free assay that reconstitutes glycoprotein transport through the Golgi apparatus to investigate the mechanism of action of primaquine. In this assay, primaquine inhibits protein transport at a half-maximal concentration of 50-mu-M, similar to the concentration previously reported to disrupt protein secretion in cultured cells. Kinetic analysis of primaquine inhibition indicates that its point of action is at an early step in the vesicular transport mechanism. Primaquine does not inhibit the fusion of vesicles already attached to their target membranes. Primaquine irreversibly inactivates the membranes that form transport vesicles (donor), but not the membranes that are the destination of those vesicles (acceptor). Morphological data indicate that primaquine inhibits the budding of vesicles from the donor membranes. Once formed, the vesicles are refractile to primaquine action, and their attachment to and fusion with acceptor membranes proceeds unimpeded. In addition to illuminating the mechanism of action of primaquine, this study suggests that the selective action of this agent will make it a useful tool in the study of the formation of transport vesicles.	UPJOHN CO, DRUG DELIVERY RES UNIT, KALAMAZOO, MI 49001 USA	Pfizer								BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; BALCH WE, 1983, METHOD ENZYMOL, V98, P37; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DEAN RT, 1984, BIOCHEM J, V217, P27, DOI 10.1042/bj2170027; DEUTICKE B, 1968, BIOCHIM BIOPHYS ACTA, V163, P494, DOI 10.1016/0005-2736(68)90078-3; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; LEHMANN EL, 1975, NONPARAMETRICS STAT, P6; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; ODA K, 1986, BIOCHEM J, V240, P739, DOI 10.1042/bj2400739; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SCHWARTZ AL, 1984, J CELL BIOL, V98, P732, DOI 10.1083/jcb.98.2.732; SCHWARTZ AL, 1985, EMBO J, V4, P899, DOI 10.1002/j.1460-2075.1985.tb03716.x; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SIMIONESCU N, 1976, J CELL BIOL, V70, P608, DOI 10.1083/jcb.70.3.608; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; STROUS GJ, 1985, J CELL BIOL, V101, P531, DOI 10.1083/jcb.101.2.531; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WATTENBERG BW, 1986, J BIOL CHEM, V261, P2208; WATTENBERG BW, 1986, J BIOL CHEM, V261, P2202; WEIDMAN PJ, 1989, J CELL BIOL, V110, P947	33	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					20323	20328						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657920				2022-12-25	WOS:A1991GM03900067
J	CORJAY, MH; DOBRZANSKI, DJ; WAY, JM; VIALLET, J; SHAPIRA, H; WORLAND, P; SAUSVILLE, EA; BATTEY, JF				CORJAY, MH; DOBRZANSKI, DJ; WAY, JM; VIALLET, J; SHAPIRA, H; WORLAND, P; SAUSVILLE, EA; BATTEY, JF			2 DISTINCT BOMBESIN RECEPTOR SUBTYPES ARE EXPRESSED AND FUNCTIONAL IN HUMAN LUNG-CARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIN-RELEASING PEPTIDE; PROTEIN-KINASE-C; SWISS 3T3 CELLS; SEQUENCE-ANALYSIS; GROWTH-FACTORS; CANCER; GENE; CALCIUM; GUANINE; LINES	Bombesin-like peptides have been implicated as autocrine growth factors influencing the pathogenesis and progression of some human lung carcinoma cells. To determine the pharmacologic and structural properties of the bombesin receptors expressed in human lung carcinoma cells, cDNA clones encoding a human gastrin-releasing peptide receptor (GRP-R) and a pharmacologically distinct neuromedin-B preferring bombesin-receptor (NMB-R) were isolated from a human small cell lung carcinoma cell line (NCI-H345). After expression in Xenopus oocytes, a GRP-R-specific antagonist was effective in blocking responses elicited from the cloned GRP-R, but not the NMB-R. Both GRP-R and NMB-R mRNA expression was detected at varying levels in a panel of human lung cancer cell lines. These results indicate heterogeneity of bombesin receptor subtypes exists in human lung carcinoma cells and should be considered in the design of bombesin receptor antagonists intended to inhibit tumor cell growth.	NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20892; MONTREAL GEN HOSP,DIV ONCOL,MONTREAL H3G 1A4,QUEBEC,CANADA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); McGill University	CORJAY, MH (corresponding author), NINCDS,NEUROCHEM LAB,BLDG 36,ROOM 4D20,BETHESDA,MD 20892, USA.							AGUAYO SM, 1989, J CLIN INVEST, V84, P1105, DOI 10.1172/JCI114273; ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BROWER M, 1986, CANCER RES, V46, P798; BUNN PA, 1990, P NATL ACAD SCI USA, V87, P2162, DOI 10.1073/pnas.87.6.2162; CARMICHAEL J, 1988, BRIT J CANCER, V58, P437, DOI 10.1038/bjc.1988.236; CARNEY DN, 1987, CANCER RES, V47, P821; CARNEY DN, 1985, CANCER RES, V45, P2913; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAVIS LG, 1986, BASIC METHODS MOL BI, P1; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; FISCHER JB, 1988, J BIOL CHEM, V263, P2808; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HEIKKILA R, 1987, J BIOL CHEM, V262, P16456; HERSHEY AD, 1991, J BIOL CHEM, V266, P4366; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; LUPUMEIRI M, 1989, PFLUG ARCH EUR J PHY, V413, P498, DOI 10.1007/BF00594180; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; MINNA JD, 1986, COLD SPRING HARB SYM, V51, P843, DOI 10.1101/SQB.1986.051.01.098; MOODY TW, 1985, LIFE SCI, V37, P105, DOI 10.1016/0024-3205(85)90413-8; MOODY TW, 1981, SCIENCE, V214, P1246, DOI 10.1126/science.6272398; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; SAUSVILLE EA, 1986, J BIOL CHEM, V261, P2451; SHARONI Y, 1990, CANCER RES, V50, P5257; SINNETTSMITH J, 1990, BIOCHEM J, V265, P485, DOI 10.1042/bj2650485; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TREPEL JB, 1988, BIOCHEM J, V255, P403, DOI 10.1042/bj2550403; TREPEL JB, 1988, BIOCHEM BIOPH RES CO, V156, P1383, DOI 10.1016/S0006-291X(88)80785-X; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; VONSCHRENCK T, 1990, AM J PHYSIOL, V259, pG468, DOI 10.1152/ajpgi.1990.259.3.G468; VONSCHRENCK T, 1989, AM J PHYSIOL, V256, pG747, DOI 10.1152/ajpgi.1989.256.4.G747; WADA E, 1991, NEURON, V6, P421, DOI 10.1016/0896-6273(91)90250-4; WANG LH, 1990, J BIOL CHEM, V265, P15695; WEBER S, 1985, J CLIN INVEST, V75, P306, DOI 10.1172/JCI111690; WILLEY JC, 1984, EXP CELL RES, V153, P245, DOI 10.1016/0014-4827(84)90466-X; WOLL PJ, 1989, BIOCHEM BIOPH RES CO, V164, P66, DOI 10.1016/0006-291X(89)91683-5; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211	44	223	232	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18771	18779						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655761				2022-12-25	WOS:A1991GJ47200057
J	MORRISON, J; FIDGE, NH; TOZUKA, M				MORRISON, J; FIDGE, NH; TOZUKA, M			DETERMINATION OF THE STRUCTURAL DOMAIN OF APOAI RECOGNIZED BY HIGH-DENSITY-LIPOPROTEIN RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; HUMAN-SKIN FIBROBLASTS; SMOOTH-MUSCLE CELLS; CHOLESTEROL ACYLTRANSFERASE; POLYACRYLAMIDE GELS; ENDOTHELIAL-CELLS; RAT-LIVER; BINDING; IDENTIFICATION; PROTEINS	There is good evidence that high density lipoprotein (HDL) interacts with high affinity sites present on hepatocytes. The precise nature of the ligand recognized by putative HDL receptors remains controversial, although there is a consensus that apolipoprotein AI (apoAI) is involved. This suggestion would be strengthened if a biologically active site demonstrating a high affinity for the receptor could be isolated. Cyanogen bromide fragments (CF) of apoAI (CF1-CF4) were complexed with phospholipid, and their ability to associate with the receptor was compared in various binding studies. Careful analysis of the concentration-dependent association of I-125-labeled dimyristoyl phosphatidylcholine (DMPC) recombinants to rat liver plasma membranes revealed high and low affinity binding components. As all DMPC recombinants displayed the low affinity binding component, it was postulated that this interaction was independent of the protein present in the particle and may well represent a lipid-lipid or lipid-protein association with the membranes. Only I-125-labeled CF4.DMPC displayed a high affinity binding component with similar K(d) and B(max) (8 x 10(-9) M, 1.6 x 10(-12) mol/mg plasma membrane protein) to that of I-125-labeled AI.DMPC (7 x 10(-9), 1.4 x 10(-12) mol/mg plasma membrane protein). Similarly, egg yolk phosphatidylcholine complexes containing CF4 (CF4.egg PC) showed higher affinity binding than CF1-egg yolk phosphatidylcholine complexes confirming the results obtained with DMPC complexes. Furthermore, ligand blotting studies showed that only I-125-labeled CF4.DMPC associated specifically with HB1 and HB2, two HDL binding proteins recently identified in rat liver plasma membranes. We conclude that a region within the carboxyl-terminus of apoAI is responsible for the interaction with putative HDL receptors present in rat liver plasma membranes.	BAKER MED RES INST,PROT CHEM & MOLEC BIOL UNIT,POB 348,PRAHRAN,VIC 3181,AUSTRALIA	Baker Heart and Diabetes Institute								ANDERSEN JM, 1978, J BIOL CHEM, V253, P9024; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V149, P545, DOI 10.1016/0006-291X(87)90402-5; BIESBROECK R, 1983, J CLIN INVEST, V71, P525, DOI 10.1172/JCI110797; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHACKO GK, 1984, BIOCHIM BIOPHYS ACTA, V795, P417, DOI 10.1016/0005-2760(84)90093-6; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; DASHTI N, 1985, BIOCHIM BIOPHYS ACTA, V833, P100, DOI 10.1016/0005-2760(85)90257-7; FIDGE NH, 1985, J BIOL CHEM, V260, P3570; FIDGE NH, 1974, CLIN CHIM ACTA, V52, P15, DOI 10.1016/0009-8981(74)90383-0; FIDGE NH, 1983, BIOCHIM BIOPHYS ACTA, V753, P14, DOI 10.1016/0005-2760(83)90092-9; FITCH WM, 1977, GENETICS, V86, P623; Fleischer S, 1974, Methods Enzymol, V31, P6; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; HAVEKES L, 1984, BIOCHEM BIOPH RES CO, V122, P785, DOI 10.1016/S0006-291X(84)80102-3; HOPKINS GJ, 1984, BIOCHIM BIOPHYS ACTA, V794, P31, DOI 10.1016/0005-2760(84)90294-7; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; HWANG JL, 1985, J BIOL CHEM, V260, P5660; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KYTE J, 1983, ANAL BIOCHEM, V133, P515, DOI 10.1016/0003-2697(83)90118-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON M, 1986, J BIOL CHEM, V261, P2548; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MENZEL HJ, 1984, J BIOL CHEM, V259, P3070; MORRISON JR, 1990, ANAL BIOCHEM, V186, P145, DOI 10.1016/0003-2697(90)90588-Z; ORAM JF, 1987, J BIOL CHEM, V262, P2405; OSE L, 1981, SCAND J CLIN LAB INV, V41, P63, DOI 10.3109/00365518109092016; PICARDO M, 1986, ARTERIOSCLEROSIS, V6, P434, DOI 10.1161/01.ATV.6.4.434; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; RAY TK, 1970, BIOCHIM BIOPHYS ACTA, V196, P1, DOI 10.1016/0005-2736(70)90159-8; RIFICI VA, 1984, J BIOL CHEM, V259, P3814; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMITZ G, 1985, EMBO J, V4, P2773, DOI 10.1002/j.1460-2075.1985.tb04003.x; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; SWANEY JB, 1980, J BIOL CHEM, V255, P8798; TABAS I, 1984, J BIOL CHEM, V259, P3897; TOZUKA M, 1989, BIOCHEM J, V261, P239, DOI 10.1042/bj2610239; Weber K., 1975, PROTEINS, VI, P179; 1983, POLYACRYLAMIDE GEL E, P26	40	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18780	18785						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655762				2022-12-25	WOS:A1991GJ47200058
J	STOLE, E; MEISTER, A				STOLE, E; MEISTER, A			INTERACTION OF GAMMA-GLUTAMYL TRANSPEPTIDASE WITH GLUTATHIONE INVOLVES SPECIFIC ARGININE AND LYSINE RESIDUES OF THE HEAVY SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE TRANSPEPTIDASE; BINDING-SITE; REAGENT PHENYLGLYOXAL; CHEMICAL MODIFICATION; ACTIVE-SITE; GLUTAMYLTRANSFERASE; MECHANISM; SEQUENCE; ENZYME; MODULATION	Gamma-glutamyl transpeptidase, an enzyme of importance in glutathione metabolism, consists of two subunits, one of which (the light subunit, M(r) 22,000; residues 380-568; rat kidney) contains residue Thr-523, which selectively interacts with the substrate analog acivicin to form an adduct that is apparently analogous to the gamma-glutamyl enzyme intermediate formed in the normal reaction (Stole, E., Seddon, A. P., Wellner, D., and Meister, A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1706-1709). The present studies indicate that specific arginine and lysine residues of the heavy subunit (M(r) 51,000; residues 31-379) participate in catalysis by binding the substrates. Selective labeling studies of the enzyme with [C-14]phenylglyoxal showed that Lys-99 and Arg-111 were modified. This appears to be the first instance in which phenylglyoxal was found to react with an enzyme lysine residue. Incorporation of [C-14]phenylglyoxal into Lys-99 was decreased in the presence of acceptor site selective compounds. Incorporation into both Lys-99 and Arg-111 was decreased in the presence of glutathione. The findings suggest that Lys-99 and Arg-111 interact, respectively, with the omega- and alpha-carboxyl groups of glutathione. That these putative electrostatic binding sites are on the heavy subunit indicates that both subunits contribute to the active center. Two additional heavy subunit arginine residues become accessible to modification by phenylglyoxal when acivicin is bound, suggesting that interaction with acivicin is associated with a conformational change.			STOLE, E (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021, USA.				NIDDK NIH HHS [2 R37 DK 12034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012034] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; COLE SCJ, 1986, BIOCHEM J, V233, P303, DOI 10.1042/bj2330303; COLOMA J, 1986, NUCLEIC ACIDS RES, V14, P1393, DOI 10.1093/nar/14.3.1393; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; ELCE JS, 1980, BIOCHEM J, V185, P473, DOI 10.1042/bj1850473; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; FUSHIKI T, 1983, J BIOCHEM-TOKYO, V93, P795, DOI 10.1093/jb/93.3.795; GARDELL SJ, 1981, J BIOL CHEM, V256, P4799; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P268, DOI 10.1073/pnas.76.1.268; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; JACKSON DG, 1986, J BIOL CHEM, V261, P8649; JACKSON RG, 1989, BIOCHEM J, V264, P419, DOI 10.1042/bj2640419; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; KARPLUS PA, 1989, EUR J BIOCHEM, V178, P693, DOI 10.1111/j.1432-1033.1989.tb14500.x; KONISHI K, 1987, BIOCHEMISTRY-US, V26, P8496, DOI 10.1021/bi00399a069; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Meister A, 1976, ENZYMES BIOL MEMBR, Vv3, P315; Meister A, 1989, GLUTATHIONE CHEM BIO, P367; MUKHERJI S, 1986, J BIOL CHEM, V261, P4519; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; SAKAMURO D, 1988, GENE, V73, P1; SCHASTEEN CS, 1983, BIOCHEM BIOPH RES CO, V112, P564, DOI 10.1016/0006-291X(83)91501-2; SOKOL PP, 1988, J BIOL CHEM, V263, P7118; STOLE E, 1990, P NATL ACAD SCI USA, V87, P1706, DOI 10.1073/pnas.87.5.1706; SZEWCZUK A, 1965, BIOCHIM BIOPHYS ACTA, V105, P352, DOI 10.1016/S0926-6593(65)80159-X; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; TAKAHASHI K, 1977, J BIOCHEM-TOKYO, V81, P395, DOI 10.1093/oxfordjournals.jbchem.a131471; TAKAHASHI K, 1977, J BIOCHEM-TOKYO, V81, P403, DOI 10.1093/oxfordjournals.jbchem.a131472; Tate S.S., 1980, ENZYMATIC BASIS DETO, VII, P95; TATE SS, 1977, P NATL ACAD SCI USA, V74, P931, DOI 10.1073/pnas.74.3.931; TATE SS, 1985, METHOD ENZYMOL, V113, P400; THOMPSON GA, 1979, J BIOL CHEM, V254, P2956; THOMPSON GA, 1980, J BIOL CHEM, V255, P2109; WHITSON PA, 1987, BIOCHEMISTRY-US, V26, P6502, DOI 10.1021/bi00394a032; WRIGHT WB, 1958, ACTA CRYSTALLOGR, V11, P632, DOI 10.1107/S0365110X58001699	40	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17850	17857						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1680853				2022-12-25	WOS:A1991GG55300025
J	DEVILEE, P; VANVLIET, M; VANSLOUN, P; DIJKSHOORN, NK; HERMANS, J; PEARSON, PL; CORNELISSE, CJ				DEVILEE, P; VANVLIET, M; VANSLOUN, P; DIJKSHOORN, NK; HERMANS, J; PEARSON, PL; CORNELISSE, CJ			ALLELOTYPE OF HUMAN BREAST-CARCINOMA - A 2ND MAJOR SITE FOR LOSS OF HETEROZYGOSITY IS ON CHROMOSOME-6Q	ONCOGENE			English	Article							RECESSIVE MUTATION; CANCER; GENE; TUMORS; RETINOBLASTOMA; EXPRESSION; HOMOZYGOSITY; DELETION; REGIONS	Loss of heterozygosity (LOH), which is detected with polymorphic DNA markers by comparing constitutional and tumor genotypes, has been observed at a number of different chromosome arms in primary breast tumors. These include 1p, 1q, 3p, 11p, 13q, 17p and 18q. We present here the results of a screening of all nonacrocentric chromosome arms, including those of the X chromosome, with at least one polymorphic marker per arm, in a total of 86 breast carcinomas. This dataset, termed an allelotype, indicates that in addition to the chromosome regions listed above, allelic loss may be observed in more than 30% of informative cases on 6q, 8q, 9q, 15q, and 16q. Multiple LOH involving at least two different chromosomes in a single tumor was observed in approximately 75% of the investigated tumors, and revealed complex chromosome involvement. Six different combinations of concurrent LOH at two different chromosome arms were found to be significantly correlated (r > 0.45; P < 0.01). Tumors showing LOH at 3p or 17p were preferentially aneuploid, while LOH at 6q and 17q was inversely correlated with the number of positive lymph nodes and age respectively.	LEIDEN UNIV,FAC MED,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,FAC MED,DEPT MED STAT,2333 AL LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	DEVILEE, P (corresponding author), LEIDEN UNIV,FAC MED,DEPT HUMAN GENET,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS.		DEVILEE, PETER/ABR-2140-2022					ALI IU, 1989, J NATL CANCER I, V81, P1815, DOI 10.1093/jnci/81.23.1815; ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BEERMAN H, 1990, INT J CANCER, V45, P34, DOI 10.1002/ijc.2910450108; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; CROPP CS, 1990, P NATL ACAD SCI USA, V87, P7737, DOI 10.1073/pnas.87.19.7737; DEVILEE P, 1990, CYTOGENET CELL GENET, V53, P52, DOI 10.1159/000132893; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DEVILEE P, 1991, CANCER RES, V51, P1020; DEVILEE P, 1991, ONCOGENE, V6, P311; DEVILEE P, 1991, CANCER SURV, V9, P605; DUTRILLAUX B, 1990, CANCER GENET CYTOGEN, V49, P203, DOI 10.1016/0165-4608(90)90143-X; EHLEN T, 1990, ONCOGENE, V5, P219; FULTS D, 1990, CANCER RES, V50, P5784; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GENUARDI M, 1989, AM J HUM GENET, V45, P73; GERBAULTSEUREAU M, 1987, ANN GENET-PARIS, V30, P138; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KIDD KJ, 1989, CYTOGENET CELL GENET, V51; LARSSON C, 1990, GENE CHROMOSOME CANC, V2, P191, DOI 10.1002/gcc.2870020305; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MACKAY J, 1988, LANCET, V2, P1384; MARS WM, 1990, CANCER METAST REV, V9, P35, DOI 10.1007/BF00047587; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MITCHELL ELD, 1990, GENE CHROMOSOME CANC, V2, P278, DOI 10.1002/gcc.2870020405; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PROSSER J, 1990, ONCOGENE, V5, P1573; RODGERS CS, 1984, CANCER GENET CYTOGEN, V13, P95, DOI 10.1016/0165-4608(84)90052-9; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SATO T, 1990, CANCER RES, V50, P7184; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SUZUKI T, 1989, CANCER RES, V49, P1095; THOMAS GA, 1991, CANCER RES, V51, P639; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; TRENT JM, 1987, ONCOGENES HORMONES B, P142; VANDERVIJER MJ, 1991, BIOCHIM BIOPHYS ACTA, V1072, P35; VARLEY JM, 1989, ONCOGENE, V4, P725; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; YAMADA H, 1990, ONCOGENE, V5, P1141; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	42	246	246	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1991	6	9					1705	1711						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX274	1681492				2022-12-25	WOS:A1991GX27400030
J	WILLARD, JM; ZIEGRA, CJ; OSWALD, RE				WILLARD, JM; ZIEGRA, CJ; OSWALD, RE			THE INTERACTION OF A KAINATE RECEPTOR FROM GOLDFISH BRAIN WITH A PERTUSSIS TOXIN-SENSITIVE GTP-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-ACTIVATING PROTEIN; GLUTAMATE RECEPTOR; ADP-RIBOSYLATION; FUNCTIONAL EXPRESSION; QUISQUALATE; SUBUNIT; CELLS; SITES; IDENTIFICATION; ANTAGONISTS	Kainate receptors are present in high concentrations in goldfish brain (Henley and Oswald, 1988a and b; Ziegra et al., 1990), possibly in neuronal and glial cells. In a number of systems, the kainate receptor has been assumed to be an integral ion channel (Watkins and Evans, 1981); but, for some kainate receptors, ion channel activity has not been demonstrated (Wada et al., 1989). This study presents evidence that a portion of the [H-3]kainate-binding sites in goldfish brain is sensitive to guanine nucleotides, with a loss of high affinity binding in the presence of nonhydrolyzable GTP analogs. Pertussis toxin pretreatment of membranes causes a loss of high affinity [H-3]kainate binding and of the guanine nucleotide-sensitive binding. Pertussis toxin catalyzes the specific [P-32]ADP-ribosylation of a 40-kDa substrate in a kainate-sensitive manner. In addition, incorporation of [alpha-P-32]GTP-gamma-azidoanilide by photoaffinity labeling was enhanced in the presence of kainate. These results indicate that a subpopulation of [H-3]kainate-binding sites in goldfish brain may be coupled to G proteins.	CORNELL UNIV,NEW YORK STATE COLL VET MED,DEPT PHARMACOL,ITHACA,NY 14853	Cornell University								BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; FAIN JN, 1988, FASEB J, V2, P2569, DOI 10.1096/fasebj.2.10.2838362; GARTHWAITE J, 1989, J NEUROCHEM, V53, P1952, DOI 10.1111/j.1471-4159.1989.tb09266.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; HENLEY JM, 1988, J NEUROSCI, V8, P2101; HENLEY JM, 1988, BIOCHIM BIOPHYS ACTA, V937, P102; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORNE WA, 1988, P NATL ACAD SCI USA, V85, P3718, DOI 10.1073/pnas.85.11.3718; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KESSLER M, 1989, BRAIN RES, V489, P377, DOI 10.1016/0006-8993(89)90875-5; KOH JY, 1990, J NEUROSCI, V10, P693; KUROSE H, 1986, J BIOL CHEM, V261, P6423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIGANI P, 1985, BRAIN RES, V361, P36, DOI 10.1016/0006-8993(85)91272-7; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLETTI F, 1988, NEUROPHARMACOLOGY, V27, P551, DOI 10.1016/0028-3908(88)90174-8; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; PATEL J, 1990, J NEUROCHEM, V54, P1461, DOI 10.1111/j.1471-4159.1990.tb01192.x; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; ROTHENBERG PL, 1988, J BIOL CHEM, V263, P15546; ROVIRA C, 1990, PFLUG ARCH EUR J PHY, V415, P471, DOI 10.1007/BF00373625; SCHAFER R, 1988, BIOCHEM BIOPH RES CO, V155, P1051, DOI 10.1016/S0006-291X(88)80603-X; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; STEVENS CF, 1989, NATURE, V342, P620, DOI 10.1038/342620a0; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; SULLIVAN KA, 1987, NATURE, V330, P758, DOI 10.1038/330758a0; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; TSAI SC, 1984, J BIOL CHEM, V259, P5320; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WATSON S, 1990, TRENDS PHARM SCI S, V11, P13; ZIEGRA C J, 1989, Society for Neuroscience Abstracts, V15, P532; ZIEGRA CJ, 1990, BRAIN RES, V527, P308, DOI 10.1016/0006-8993(90)91151-6	43	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10196	10200						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1674742				2022-12-25	WOS:A1991FP08600033
J	CLINE, GW; SHULMAN, GI				CLINE, GW; SHULMAN, GI			QUANTITATIVE-ANALYSIS OF THE PATHWAYS OF GLYCOGEN REPLETION IN PERIPORTAL AND PERIVENOUS HEPATOCYTES INVIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; RAT-LIVER; GLUTAMINE-SYNTHETASE; HETEROGENEITY; GLUCOSE; PERFUSION; MECHANISM; ZONATION	In order to examine the pathways of hepatic glycogen repletion in the periportal and perivenous zones of the liver, [1-C-13]glucose (99% enriched) was infused intraduodenally into conscious, 24-h fasted rats for 3 h. The liver was then quickly perfused in situ, and the cytoplasmic contents of the periportal and perivenous hepatocytes were selectively sampled by modification of the dual-digitonin-pulse technique (Quistorff, B., and Grunnet, N. (1987) Biochem. J. 243, 87-95). The C-13 isotopic enrichment at each carbon position of the glucosyl units of hepatic glycogen was determined by C-13 NMR and that of the C-1 position by gas chromatography-mass spectroscopy. From comparison of hepatic glycogen repleted by direct incorporation of plasma glucose (glucose --> glucose-6-P --> glucose-1-P --> UDP-glucose --> glycogen) was calculated to be 29% in the periportal zone and 35% in the perivenous zone, assuming equal glycogen synthetic rates within the two zones. Thus, the majority of glycogen is derived by an indirect route (glucose --> --> 3-carbon unit --> --> glucose --> --> UDP-glucose --> --> glycogen) in both the periportal zone and in the perivenous zone. In conclusion, in a 24-h fasted rat there does not appear to be a major difference between the periportal and perivenous hepatocytes in the percent of glycogen synthesized by the direct pathway following a glucose load.	YALE UNIV,SCH MED,DEPT INTERNAL MED,FMP 104,333 CEDAR ST,PO 3333,NEW HAVEN,CT 06510	Yale University			Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, P30DK034989] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03475] Funding Source: Medline; NIDDK NIH HHS [DK34989, DK40936, R01 DK040936] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGIUS L, 1990, BIOCHEM J, V266, P91, DOI 10.1042/bj2660091; BARTELS H, 1987, FEBS LETT, V221, P277, DOI 10.1016/0014-5793(87)80940-7; BERGMAYER HU, 1979, METHOD ENZYMAT AN, P574; CAPRIOLI RM, 1973, BIOCHIM BIOPHYS ACTA, V297, P213, DOI 10.1016/0304-4165(73)90067-6; CHEN KS, 1988, BIOCHEM J, V255, P99, DOI 10.1042/bj2550099; GEBHARDT R, 1983, EMBO J, V2, P567, DOI 10.1002/j.1460-2075.1983.tb01464.x; GUMUCIO JJ, 1981, GASTROENTEROLOGY, V80, P393; HOGG AM, 1972, TETRAHEDRON LETT, V47, P4827; JUNGERMANN K, 1982, HEPATOLOGY, V2, P385; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; NEWGARD CB, 1984, J BIOL CHEM, V259, P6958; QUISTORFF B, 1985, BIOCHEM J, V226, P289, DOI 10.1042/bj2260289; QUISTORFF B, 1987, BIOCHEM J, V243, P87, DOI 10.1042/bj2430087; SHULMAN GI, 1985, J CLIN INVEST, V76, P1229, DOI 10.1172/JCI112078; SHULMAN GI, 1990, AM J PHYSIOL, V259, pE335, DOI 10.1152/ajpendo.1990.259.3.E335; SHULMAN GI, 1987, J CLIN INVEST, V80, P387, DOI 10.1172/JCI113084; VORHABEN JE, 1973, BIOCHEM J, V135, P893, DOI 10.1042/bj1350893; WALS PA, 1988, J BIOL CHEM, V263, P4876	20	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4094	4098						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1671859				2022-12-25	WOS:A1991FA69400014
J	BERMAN, PAM; HUMAN, L				BERMAN, PAM; HUMAN, L			REGULATION OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE AND OF HYPOXANTHINE UPTAKE AND RELEASE IN HUMAN ERYTHROCYTES BY OXYPURINE CYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BERMAN, PAM (corresponding author), UNIV CAPE TOWN,SCH MED,DEPT CHEM PATHOL,CAPE TOWN 7925,SOUTH AFRICA.							BERMAN PA, 1988, J CLIN INVEST, V82, P980, DOI 10.1172/JCI113707; Van den Berghe G, 1986, Adv Exp Med Biol, V195 Pt A, P27; BONTEMPS F, 1986, J CLIN INVEST, V77, P824, DOI 10.1172/JCI112379; BUNGENER W, 1974, TROPENMED PARASITOL, V25, P464; BUNN HF, 1971, J BIOL CHEM, V246, P5273; DOMIN BA, 1988, J BIOL CHEM, V263, P9276; FOX IH, 1971, J BIOL CHEM, V246, P5739; FOX IH, 1971, ANN INTERN MED, V74, P424, DOI 10.7326/0003-4819-74-3-424; GIACOMELLO A, 1979, FEBS LETT, V107, P203, DOI 10.1016/0014-5793(79)80495-0; GREENE ML, 1970, SCIENCE, V167, P887, DOI 10.1126/science.167.3919.887; HENDERSON JF, 1959, J BIOL CHEM, V234, P3219; HERSHKO A, 1969, BIOCHIM BIOPHYS ACTA, V184, P64, DOI 10.1016/0304-4165(69)90099-3; MANSELL MA, 1981, CLIN SCI, V61, P757, DOI 10.1042/cs0610757; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Newsholme E A, 1978, Biochem Soc Symp, P183; PLAGEMANN PGW, 1986, J CELL PHYSIOL, V128, P491, DOI 10.1002/jcp.1041280319; ROTH EF, 1986, J CLIN INVEST, V77, P1129, DOI 10.1172/JCI112412; SALERNO C, 1987, KLIN WOCHENSCHR S10, V65, P28; SCIAKY N, 1974, ADV EXP MED BIOL, V41, P87; STEYN LM, 1984, J BIOL CHEM, V259, P338; TAX WJM, 1978, COMP BIOCHEM PHYS B, V59, P219, DOI 10.1016/0305-0491(78)90250-X; WHELAN JM, 1979, BIOCHIM BIOPHYS ACTA, V563, P466, DOI 10.1016/0005-2787(79)90065-0; Wohlhueter R M, 1978, Methods Cell Biol, V20, P211, DOI 10.1016/S0091-679X(08)62020-8; YEH GC, 1983, J BIOL CHEM, V258, P9774; 1987, WHO TECH REP SER, V743, P125	25	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1990	265	12					6562	6568						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ677	1691171				2022-12-25	WOS:A1990CZ67700013
J	KIM, JW; SIM, SS; KIM, UH; NISHIBE, S; WAHL, MI; CARPENTER, G; RHEE, SG				KIM, JW; SIM, SS; KIM, UH; NISHIBE, S; WAHL, MI; CARPENTER, G; RHEE, SG			TYROSINE RESIDUES IN BOVINE PHOSPHOLIPASE C-GAMMA PHOSPHORYLATED BY THE EPIDERMAL GROWTH-FACTOR RECEPTOR INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NHLBI,BIOCHEM LAB,BETHESDA,MD 20892; VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University				Kim, Uh-Hyun/0000-0003-3304-7190				CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; ESCOBEDO JA, 1988, MOL CELL BIOL, V8, P5126, DOI 10.1128/MCB.8.12.5126; HOFMANN SL, 1982, J BIOL CHEM, V257, P4359; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HUANG KP, 1976, ANAL BIOCHEM, V72, P593, DOI 10.1016/0003-2697(76)90571-6; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; IRVINE RF, 1984, BIOCHEM J, V218, P177, DOI 10.1042/bj2180177; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WILSON DB, 1984, J BIOL CHEM, V259, P1718; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	26	158	161	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					3940	3943						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689310				2022-12-25	WOS:A1990CQ48000056
J	TAORMINO, JP; FAMBROUGH, DM				TAORMINO, JP; FAMBROUGH, DM			PRETRANSLATIONAL REGULATION OF THE (NA+ + K+)-ATPASE IN RESPONSE TO DEMAND FOR ION-TRANSPORT IN CULTURED CHICKEN SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA	Johns Hopkins University								BARLETBAS C, 1988, P NATL ACAD SCI USA, V85, P1707, DOI 10.1073/pnas.85.5.1707; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BONNER WM, 1974, EUR J BIOCHEM, V252, pC179; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; CHAUDHURY S, 1987, MOL ENDOCRINOL, V1, P83, DOI 10.1210/mend-1-1-83; CLAUSEN T, 1986, PHYSIOL REV, V66, P542, DOI 10.1152/physrev.1986.66.3.542; COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94; FAMBROUGH DM, 1987, KIDNEY INT, V32, pS97; FAMBROUGH DM, 1988, TRENDS NEUROSCI, V11, P325, DOI 10.1016/0166-2236(88)90096-3; GEERING K, 1987, J CELL BIOL, V105, P2613, DOI 10.1083/jcb.105.6.2613; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HARA Y, 1987, J BIOCHEM-TOKYO, V102, P43, DOI 10.1093/oxfordjournals.jbchem.a122039; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; HERRERA VLM, 1988, SCIENCE, V241, P221, DOI 10.1126/science.2838907; HIATT A, 1984, J BIOL CHEM, V259, P2629; KIM D, 1984, CIRC RES, V55, P39, DOI 10.1161/01.RES.55.1.39; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LO CS, 1980, J BIOL CHEM, V255, P2131; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; POLLACK LR, 1981, J CELL PHYSIOL, V106, P85, DOI 10.1002/jcp.1041060110; PRESSLEY TA, 1988, J MEMBRANE BIOL, V105, P187, DOI 10.1007/BF01870996; PRESSLEY TA, 1986, J GEN PHYSIOL, V87, P591, DOI 10.1085/jgp.87.4.591; PRESSLEY TA, 1988, AM J PHYSIOL, V255, pC252, DOI 10.1152/ajpcell.1988.255.2.C252; RAYSON BM, 1985, J BIOL CHEM, V260, P2740; ROSSIER BC, 1987, TRENDS BIOCHEM SCI, V12, P483, DOI 10.1016/0968-0004(87)90235-0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TAKEYASU K, 1989, CURR TOP MEMBR TRANS, V34, P143; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TAKEYASU K, 1987, J BIOL CHEM, V262, P10733; TAMKUN MM, 1986, J BIOL CHEM, V261, P1009; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; WOLITZKY BA, 1986, J BIOL CHEM, V261, P9990; ZEHNER ZE, 1983, NUCLEIC ACIDS RES, V11, P8317, DOI 10.1093/nar/11.23.8317	38	83	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1990	265	7					4116	4123						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ480	1689313				2022-12-25	WOS:A1990CQ48000082
J	GAY, CG; WINKLES, JA				GAY, CG; WINKLES, JA			HEPARIN-BINDING GROWTH FACTOR-I STIMULATION OF HUMAN ENDOTHELIAL-CELLS INDUCES PLATELET-DERIVED GROWTH-FACTOR A-CHAIN GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									AMER RED CROSS,JEROME H HOLLAND LAB BIOMED SCI,MOLEC BIOL LAB,ROCKVILLE,MD 20855	American Red Cross				gay, cyril/0000-0002-1685-9114	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039727, R29HL039727] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39727] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BAIRD A, 1985, BIOCHEMISTRY-US, V24, P7855, DOI 10.1021/bi00348a001; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; BARRETT TB, 1984, P NATL ACAD SCI-BIOL, V81, P6772, DOI 10.1073/pnas.81.21.6772; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BOWENPOPE DF, 1989, J BIOL CHEM, V264, P2502; BRONZERT DA, 1987, P NATL ACAD SCI USA, V84, P5763, DOI 10.1073/pnas.84.16.5763; BURGESS WH, 1986, P NATL ACAD SCI USA, V83, P7216, DOI 10.1073/pnas.83.19.7216; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P4415, DOI 10.1073/pnas.74.10.4415; CLOWES AW, 1983, LAB INVEST, V49, P327; COLLINS T, 1985, NATURE, V316, P748, DOI 10.1038/316748a0; COLLINS T, 1987, AM J PATHOL, V127, P7; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; DEVARE SG, 1983, P NATL ACAD SCI-BIOL, V80, P731, DOI 10.1073/pnas.80.3.731; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; ENGERMAN RL, 1967, LAB INVEST, V17, P738; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRIESEL R, 1989, MOL CELL BIOL, V9, P1857, DOI 10.1128/MCB.9.5.1857; GAUTSCHISOVA P, 1987, BIOCHEMISTRY-US, V26, P5844, DOI 10.1021/bi00392a039; GIMINEZGALLEGO G, 1985, SCIENCE, V230, P1385; HAJJAR KA, 1987, J EXP MED, V166, P235, DOI 10.1084/jem.166.1.235; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HAMMACHER A, 1988, EUR J BIOCHEM, V176, P179, DOI 10.1111/j.1432-1033.1988.tb14266.x; Hannan RL, 1988, GROWTH FACTORS, V1, P7, DOI 10.3109/08977198809000242; HELDIN CH, 1981, P NATL ACAD SCI-BIOL, V78, P3664, DOI 10.1073/pnas.78.6.3664; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; HOSHI H, 1988, FASEB J, V2, P2797, DOI 10.1096/fasebj.2.12.2457532; HUANG JS, 1986, J BIOL CHEM, V261, P1600; HUANG SS, 1986, J BIOL CHEM, V261, P9568; JAYE M, 1987, J BIOL CHEM, V262, P16612; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; JAYE M, 1985, SCIENCE, V228, P882, DOI 10.1126/science.3890179; JOHNSSON A, 1984, EMBO J, V3, P921, DOI 10.1002/j.1460-2075.1984.tb01908.x; JOSEPHS SF, 1984, SCIENCE, V223, P487, DOI 10.1126/science.6318322; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KAIBUCHI K, 1986, J BIOL CHEM, V261, P1187; KAVANAUGH WM, 1988, J BIOL CHEM, V263, P8470; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KNAUER DJ, 1983, J CELL PHYSIOL, V117, P397, DOI 10.1002/jcp.1041170315; KOUREMBANAS S, 1989, J BIOL CHEM, V264, P4456; LASSAM N, 1989, J IMMUNOL, V143, P3792; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LIBBY P, 1988, NEW ENGL J MED, V318, P1493, DOI 10.1056/NEJM198806093182303; LIBBY P, 1986, AM J PATHOL, V124, P179; LIBERMANN TA, 1987, EMBO J, V6, P1627, DOI 10.1002/j.1460-2075.1987.tb02410.x; LOBB RR, 1985, BIOCHEMISTRY-US, V24, P4969, DOI 10.1021/bi00340a001; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; MAJESKY MW, 1988, P NATL ACAD SCI USA, V85, P1524, DOI 10.1073/pnas.85.5.1524; MANSSON PE, 1989, CANCER RES, V49, P2485; MAY LT, 1989, BIOCHEM BIOPH RES CO, V159, P991, DOI 10.1016/0006-291X(89)92206-7; MILLER AD, 1984, CELL, V36, P51; MIOH H, 1987, BIOCHEM BIOPH RES CO, V146, P771; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTESANO R, 1987, J CELL PHYSIOL, V130, P284, DOI 10.1002/jcp.1041300215; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; NISTER M, 1988, CANCER RES, V48, P3910; NORIOKA K, 1987, BIOCHEM BIOPH RES CO, V145, P969, DOI 10.1016/0006-291X(87)91060-6; OHTAKI T, 1989, BIOCHEM BIOPH RES CO, V161, P169, DOI 10.1016/0006-291X(89)91576-3; OLWIN BB, 1989, J CELL BIOCHEM, V39, P443, DOI 10.1002/jcb.240390410; PANTAZIS P, 1986, P NATL ACAD SCI USA, V83, P6455, DOI 10.1073/pnas.83.17.6455; PAULSSON Y, 1989, EXP CELL RES, V180, P490, DOI 10.1016/0014-4827(89)90075-X; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; PRESS RD, 1989, CANCER RES, V49, P2914; QUINKLER W, 1989, EUR J BIOCHEM, V181, P67, DOI 10.1111/j.1432-1033.1989.tb14694.x; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; RYBAK SM, 1988, J CELL PHYSIOL, V136, P312, DOI 10.1002/jcp.1041360214; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; SARIBAN E, 1988, CANCER RES, V48, P4498; SCHREIBER AB, 1985, P NATL ACAD SCI USA, V82, P6138, DOI 10.1073/pnas.82.18.6138; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; SCHWARTZ SM, 1977, CIRC RES, V41, P248, DOI 10.1161/01.RES.41.2.248; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SENIOR RM, 1986, BIOCHEM BIOPH RES CO, V141, P67, DOI 10.1016/S0006-291X(86)80335-7; SIRONI M, 1989, J IMMUNOL, V142, P549; SITARAS NM, 1988, CANCER RES, V48, P1930; SITARAS NM, 1987, J CELL PHYSIOL, V132, P376, DOI 10.1002/jcp.1041320228; SJOLUND M, 1988, J CELL BIOL, V106, P403, DOI 10.1083/jcb.106.2.403; SOMA Y, 1989, J CELL PHYSIOL, V140, P246, DOI 10.1002/jcp.1041400209; STARKSEN NF, 1987, J BIOL CHEM, V262, P14381; Stein G H, 1979, Methods Enzymol, V58, P279; STOLPEN AH, 1986, AM J PATHOL, V123, P16; STROOBANT P, 1984, EMBO J, V3, P2963, DOI 10.1002/j.1460-2075.1984.tb02241.x; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; THOMAS K, 1987, ANGIOGENESIS MECHANI, P9; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; VLODAVSKY I, 1987, J CELL PHYSIOL, V131, P402, DOI 10.1002/jcp.1041310312; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WARNER SJC, 1987, J IMMUNOL, V139, P1911; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WESTERMARK B, 1986, P NATL ACAD SCI USA, V83, P7197, DOI 10.1073/pnas.83.19.7197; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WINKLES JA, 1987, P NATL ACAD SCI USA, V84, P7124, DOI 10.1073/pnas.84.20.7124	108	66	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3284	3292						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689299				2022-12-25	WOS:A1990CP23600047
J	ZHANG, DE; HOYT, PR; PAPACONSTANTINOU, J				ZHANG, DE; HOYT, PR; PAPACONSTANTINOU, J			LOCALIZATION OF DNA PROTEIN-BINDING SITES IN THE PROXIMAL AND DISTAL PROMOTER REGIONS OF THE MOUSE ALPHA-FETOPROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,F-43,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston			Papaconstantinou, John/E-3312-2010	Hoyt, Peter/0000-0002-2767-0923	NATIONAL CANCER INSTITUTE [P30CA017701, R01CA031472] Funding Source: NIH RePORTER; NCI NIH HHS [CA17701-09, CA31472-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABELEV GI, 1974, TRANSPLANT REV-DENMA, V20, P3; BABISS LE, 1986, MOL CELL BIOL, V6, P3798, DOI 10.1128/MCB.6.11.3798; Battey, 1986, BASIC METHODS MOL BI; BAUMHUETER S, 1988, EMBO J, V7, P2485, DOI 10.1002/j.1460-2075.1988.tb03095.x; BELANGER L, 1975, NATURE, V256, P657, DOI 10.1038/256657a0; BELAYEW A, 1982, MOL CELL BIOL, V2, P1427, DOI 10.1128/MCB.2.11.1427; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; COMMER P, 1979, BIOCHEM BIOPH RES CO, V89, P1264; COSTA RH, 1986, MOL CELL BIOL, V6, P4697, DOI 10.1128/MCB.6.12.4697; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; COTE GJ, 1984, BIOCHEM BIOPH RES CO, V120, P677, DOI 10.1016/0006-291X(84)91309-3; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; FRIEDMAN JM, 1986, MOL CELL BIOL, V6, P3791, DOI 10.1128/MCB.6.11.3791; GODBOUT R, 1986, MOL CELL BIOL, V6, P477, DOI 10.1128/MCB.6.2.477; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GUERTIN M, 1983, BIOCHEMISTRY-US, V22, P4296, DOI 10.1021/bi00287a021; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; HEARD JM, 1987, MOL CELL BIOL, V7, P2425, DOI 10.1128/MCB.7.7.2425; IZBAN MG, 1989, J BIOL CHEM, V264, P9171; JALANKO H, 1979, INT J CANCER, V24, P394, DOI 10.1002/ijc.2910240403; JANZEN RG, 1982, DEV BIOL, V90, P18, DOI 10.1016/0012-1606(82)90207-X; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; JOSEESTANYOL M, 1989, EUR J BIOCHEM, V181, P761, DOI 10.1111/j.1432-1033.1989.tb14789.x; JOSEESTANYOL M, 1988, J BIOL CHEM, V263, P10865; KELSEY GD, 1987, GENE DEV, V1, P161, DOI 10.1101/gad.1.2.161; KRUMLAUF R, 1985, MOL CELL BIOL, V5, P1639, DOI 10.1128/MCB.5.7.1639; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; Maniatis T., 1982, MOL CLONING; MIFFLIN RC, 1988, SOMAT CELL MOLEC GEN, V14, P553, DOI 10.1007/BF01535310; MOLNE M, 1989, NUCLEIC ACIDS RES, V17, P3447, DOI 10.1093/nar/17.9.3447; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; MUGLIA L, 1986, P NATL ACAD SCI USA, V85, P2548; NAHON JL, 1988, J BIOL CHEM, V263, P11436; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; OTT MO, 1984, EMBO J, V3, P2505, DOI 10.1002/j.1460-2075.1984.tb02164.x; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; Ruoslahti E, 1979, Adv Cancer Res, V29, P275, DOI 10.1016/S0065-230X(08)60849-0; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCOTT RW, 1984, NATURE, V310, P562, DOI 10.1038/310562a0; SELLEM CH, 1984, DEV BIOL, V102, P51, DOI 10.1016/0012-1606(84)90174-X; SELTEN GCM, 1982, BIOCHIM BIOPHYS ACTA, V699, P131, DOI 10.1016/0167-4781(82)90146-4; SHAUL Y, 1987, EMBO J, V6, P1913, DOI 10.1002/j.1460-2075.1987.tb02451.x; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; Tilghman S M, 1985, Oxf Surv Eukaryot Genes, V2, P160; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; WATANABE A, 1976, INT J CANCER, V17, P518, DOI 10.1002/ijc.2910170415; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005; WIDEN SG, 1987, MOL CELL BIOL, V7, P2606, DOI 10.1128/MCB.7.7.2606; WIDEN SG, 1986, P NATL ACAD SCI USA, V83, P8196, DOI 10.1073/pnas.83.21.8196	66	97	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1990	265	6					3382	3391						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP236	1689301				2022-12-25	WOS:A1990CP23600061
J	ENDEMANN, G; YONEZAWA, K; ROTH, RA				ENDEMANN, G; YONEZAWA, K; ROTH, RA			PHOSPHATIDYLINOSITOL KINASE OR AN ASSOCIATED PROTEIN IS A SUBSTRATE FOR THE INSULIN-RECEPTOR TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305	Stanford University; Stanford University					NIDDK NIH HHS [DK34926] Funding Source: Medline; NIGMS NIH HHS [GM24032] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034926, R37DK034926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024032, R37GM024032] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BERNIER M, 1987, P NATL ACAD SCI USA, V84, P1844, DOI 10.1073/pnas.84.7.1844; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; CARRASCOSA JM, 1988, BIOCHIM BIOPHYS ACTA, V971, P170, DOI 10.1016/0167-4889(88)90189-9; COUGHLIN SR, 1989, SCIENCE, V243, P1191; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; ENDEMANN G, 1987, BIOCHEMISTRY-US, V26, P6845, DOI 10.1021/bi00395a039; FUKUI Y, 1989, MOL CELL BIOL, V9, P1651, DOI 10.1128/MCB.9.4.1651; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; KAHN CR, 1985, ANNU REV MED, V36, P429; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPS DL, 1989, J BIOL CHEM, V264, P8759; MACARA IG, 1984, P NATL ACAD SCI-BIOL, V81, P2728, DOI 10.1073/pnas.81.9.2728; MARGOLIS RN, 1988, P NATL ACAD SCI USA, V85, P7256, DOI 10.1073/pnas.85.19.7256; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; MORGAN DO, 1986, BIOCHEMISTRY-US, V25, P1364, DOI 10.1021/bi00354a026; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROTH RA, 1986, J BIOL CHEM, V261, P3753; RUDERMAN NB, 1990, IN PRESS P NATL ACAD; SALE GJ, 1986, EUR J BIOCHEM, V155, P347; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0	28	265	268	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1990	265	1					396	400						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF662	1688432				2022-12-25	WOS:A1990CF66200060
J	BALLA, T; SIM, SS; IIDA, T; CHOI, KY; CATT, KJ; RHEE, SG				BALLA, T; SIM, SS; IIDA, T; CHOI, KY; CATT, KJ; RHEE, SG			AGONIST-INDUCED CALCIUM SIGNALING IS IMPAIRED IN FIBROBLASTS OVERPRODUCING INOSITOL 1,3,4,5-TETRAKISPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CELLS; 1,4,5-TRISPHOSPHATE 3-KINASE; INTRACELLULAR CA-2+; BINDING-SITES; TETRAKISPHOSPHATE; RELEASE; BRAIN; TRISPHOSPHATE; PURIFICATION; KINASE	The proposed Ca2+-signaling actions of inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4), formed by phosphorylation of the primary Ca2+-mobilizing messenger, inositol 1,4,5-trisphosphate (Ins(1,4,5)P3), were analyzed in NIH 3T3 and CCL39 fibroblasts transfected with rat brain Ins(1,4,5)P3 3-kinase. In such kinase-transfected cells, the conversion of Ins(1,4,5)P3 to Ins(1,3,4,5)P4 during agonist stimulation was greatly increased, with a concomitant reduction in Ins(1,4,5)P3 levels and attenuation of both the cytoplasmic Ca2+ increase and the Ca2+ influx response. This reduction in Ca2+ signaling was observed during activation of receptors coupled to guanine nucleotide-binding proteins (thrombin and bradykinin), as well as with those possessing tyrosine kinase activity. Single-cell Ca2+ measurements in CCL39 cells revealed that the smaller averaged Ca2+ response of enzyme-transfected cells was due to a marked increase in the number of cells expressing small and slow Ca2+ increases, in contrast to the predominantly large and rapid Ca2+ responses of vector-transfected controls. There was no evidence that high Ins(1,3,4,5)P4 levels promote Ca2+ mobilization, Ca2+ entry, or Ca2+ sequestration. These data indicate that Ins(1,4,5)P3 is the major determinant of the agonist-induced Ca2+ signal in fibroblasts and that Ins(1,3,4,5)P4 does not appear to contribute significantly to this process. Instead, Ins(1,4,5)3 3-kinase may serve as a negative regulator of the Ca2+-phosphoinositide signal transduction mechanism.	NHLBI, BIOCHIM & GENET MICROBIENNE LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	BALLA, T (corresponding author), NICHHD, ENDOCRINOL & REPROD RES BRANCH, BLDG 10, RM B1-L-400, BETHESDA, MD 20892 USA.			Balla, Tamas/0000-0002-9077-3335				BALLA T, 1988, J BIOL CHEM, V263, P4083; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIDEN TJ, 1987, J BIOL CHEM, V262, P9437; BLAKELEY DM, 1989, BIOCHEM J, V258, P177, DOI 10.1042/bj2580177; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADFORD PG, 1987, BIOCHEM BIOPH RES CO, V149, P680, DOI 10.1016/0006-291X(87)90421-9; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; CULLEN PJ, 1989, BIOCHEM J, V259, P931, DOI 10.1042/bj2590931; ELY JA, 1990, BIOCHEM J, V268, P333, DOI 10.1042/bj2680333; ENYEDI P, 1988, J BIOL CHEM, V263, P7940; GAWLER DJ, 1990, BIOCHEM J, V272, P519, DOI 10.1042/bj2720519; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUILLEMETTE G, 1988, J BIOL CHEM, V263, P4541; HEPLER JR, 1990, BIOCHEM J, V270, P337, DOI 10.1042/bj2700337; HILL TD, 1989, J CELL PHYSIOL, V140, P403, DOI 10.1002/jcp.1041400227; HILL TD, 1988, SCIENCE, V242, P1176, DOI 10.1126/science.2847317; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JOHANSON RA, 1988, J BIOL CHEM, V263, P7465; JOHNSON RM, 1989, SCIENCE, V246, P121, DOI 10.1126/science.2506643; JOSEPH SK, 1989, MOL PHARMACOL, V36, P391; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE SY, 1990, J BIOL CHEM, V265, P9434; LU CY, 1989, J MEMBRANE BIOL, V109, P85, DOI 10.1007/BF01870793; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; MUALLEM S, 1989, J BIOL CHEM, V264, P205; PALMER S, 1989, CELL SIGNAL, V1, P147, DOI 10.1016/0898-6568(89)90004-1; PARKER I, 1987, PROC R SOC SER B-BIO, V232, P59, DOI 10.1098/rspb.1987.0061; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; RYU SH, 1987, FASEB J, V1, P388, DOI 10.1096/fasebj.1.5.2824270; SHEARS SB, 1989, BIOCHEM J, V260, P313, DOI 10.1042/bj2600313; SIM SS, 1990, J BIOL CHEM, V265, P10367; TAKAZAWA K, 1990, BIOCHEM J, V268, P213, DOI 10.1042/bj2680213; TAKAZAWA K, 1989, BIOCHEM J, V261, P483, DOI 10.1042/bj2610483; TAYLOR CW, 1990, BIOCHEM J, V266, P189, DOI 10.1042/bj2660189; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; ZWILLER J, 1988, BIOCHEM BIOPH RES CO, V155, P767, DOI 10.1016/S0006-291X(88)80561-8	42	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1991	266	36					24719	24726						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW845	1662215				2022-12-25	WOS:A1991GW84500074
J	BARANSKI, TJ; KOELSCH, G; HARTSUCK, JA; KORNFELD, S				BARANSKI, TJ; KOELSCH, G; HARTSUCK, JA; KORNFELD, S			MAPPING AND MOLECULAR MODELING OF A RECOGNITION DOMAIN FOR LYSOSOMAL-ENZYME TARGETING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; HUMAN CATHEPSIN-D; ENDOPLASMIC-RETICULUM; PROTEIN; PHOSPHORYLATION; GLYCOPROTEINS; GENERATION; PEPSINOGEN; RESOLUTION; RECEPTOR	Lysosomal enzymes contain a common protein determinant that is recognized by UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase, the initial enzyme in the biosynthesis of mannose-6-P residues. Previously, we generated a lysosomal enzyme recognition domain by substituting two regions (lysine 203 and amino acids 265-292) of the lysosomal hydrolase cathepsin D into a related secretory protein glycopepsinogen. When expressed in Xenopus oocytes, the oligosaccharides of the chimeric protein were efficiently phosphorylated (Baranski, T. J., Faust, P. L., and Kornfeld, S. (1990) Cell 63, 281-291). In the current study, incremental substitutions of cathepsin D residues into glycopepsinogen and alanine-scanning mutagenesis were utilized to define the recognition domain more precisely. A computer-generated model of the cathepsin D/pepsinogen chimeric molecule served as a guide for mutagenesis and for the interpretation of results. These studies indicate that the recognition domain is a surface patch that contains multiple interacting sites. There is a strict positional requirement for the lysine residue at position 203.	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110; OKLAHOMA MED RES FDN,PROT STUDIES LAB,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73104	Washington University (WUSTL); Washington University (WUSTL); Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center					NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NCI NIH HHS [CA 08759] Funding Source: Medline; NIGMS NIH HHS [GM-07200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; COLMAN A, 1984, TRANSCRIPTION TRANSL, P271; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; LANG L, 1984, J BIOL CHEM, V259, P4663; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LODISH HF, 1988, J BIOL CHEM, V263, P2107; Maniatis T., 1982, MOL CLONING; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINGH UC, 1986, AMBER 30 SOFTWARE; SOGAWA K, 1983, J BIOL CHEM, V258, P5306; TAKAHASHI T, 1981, METHOD ENZYMOL, V80, P565; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; VARKI A, 1983, J BIOL CHEM, V258, P2808; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4; WENDOLOSKI JJ, 1989, PROTEINS, V5, P313, DOI 10.1002/prot.340050407; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	33	73	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					23365	23372						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660471				2022-12-25	WOS:A1991GT48300088
J	WOJCIKIEWICZ, RJH; NAHORSKI, SR				WOJCIKIEWICZ, RJH; NAHORSKI, SR			CHRONIC MUSCARINIC STIMULATION OF SH-SY5Y NEUROBLASTOMA-CELLS SUPPRESSES INOSITOL 1,4,5-TRISPHOSPHATE ACTION - PARALLEL INHIBITION OF INOSITOL 1,4,5-TRISPHOSPHATE-INDUCED CA2+ MOBILIZATION AND INOSITOL 1,4,5-TRISPHOSPHATE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURO-BLASTOMA CELLS; INTRACELLULAR CA-2+ STORES; PANCREATIC ACINAR-CELLS; PROTEIN-KINASE-C; SK-N-SH; TRISPHOSPHATE RECEPTOR; CALCIUM RELEASE; GUANINE-NUCLEOTIDES; CYCLIC-AMP; BRAIN	The possibility that chronic activation of the phosphoinositide-mediated Signaling pathway modifies the Ca2+-mobilizing action of inositol 1,4,5-trisphosphate (InsP3) was examined. SH-SY5Y human neuroblastoma cells were exposed to carbachol, permeabilized electrically, loaded with Ca-45(2+), and Ca-45(2+) mobilization in response to exogenous InsP3 was assessed. In control permeabilized cells, InsP3 released 65 +/- 2% of sequestered Ca-45(2+) (EC50) = 0.32 +/- 0.05-mu-M). Pretreatment with carbachol reduced both maximal InsP3-induced Ca-45(2+) release (to 34 +/- 3%, with half-maximal and maximal inhibition at approximately 3 and 6 h, respectively) and the potency of InsP3 (EC50) = 0.92 +/- 0.13-mu-M). This inhibitory effect of carbachol was half-maximal at approximately 5-mu-M, was mediated by muscarinic receptors, and was reversible following withdrawal of agonist. Pretreatment with phorbol 12,13-dibutyrate did not alter the maximal effect of InsP3 but doubled its EC50. Evidence suggesting that the inhibitory effects of carbachol pretreatment resulted from altered Ca2+ homeostasis was not forthcoming; both Ca-45(2+) uptake and release induced by ionomycin and thapsigargin were identical in control and pretreated permeabilized cells, as were the characteristics of reuptake of released Ca2+. In contrast, carbachol pretreatment, without altering the affinity of InsP3 (K(d) = 64 +/- 7 nM), reduced the density of [P-32]InsP3-binding sites from 2.0 +/- 0.1 to 1.0 +/- 0.1 pmol/mg protein with a time course essentially identical to that for the reduction in responsiveness to InsP3. This effect was not mimicked by pretreatment of cells with phorbol 12,13-dibutyrate. These data indicate that chronic activation of phosphoinositide hydrolysis can reduce the abundance of InsP3 receptors and that this causes a reduction in size of the InsP3-sensitive Ca2+ store. This modification, possibly in conjunction with a protein kinase C-mediated event, appears to account for the carbachol-induced suppression of InsP3 action. As intracellular InsP3 mass remained elevated above basal for at least 24 h after addition of carbachol, suppression of the Ca2+-mobilizing activity of InsP3 represents an important adaptive response to cell stimulation that can limit the extent to which intracellular Ca2+ is mobilized.			WOJCIKIEWICZ, RJH (corresponding author), UNIV LEICESTER,DEPT PHARMACOL & THERAPEUT,POB 138,UNIV RD,LEICESTER LE1 9HN,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKERMAN KEO, 1989, FEBS LETT, V242, P337, DOI 10.1016/0014-5793(89)80497-1; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BATTY IH, 1989, BIOCHEM J, V258, P23, DOI 10.1042/bj2580023; BAUMGOLD J, 1988, BIOCHEM BIOPH RES CO, V154, P1137, DOI 10.1016/0006-291X(88)90259-8; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETT DM, 1990, MOL PHARMACOL, V37, P566; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CHALLISS RAJ, 1990, BIOCHEM J, V265, P421, DOI 10.1042/bj2650421; CHAMPEIL P, 1989, J BIOL CHEM, V264, P17665; CIOFFI CL, 1990, J NEUROCHEM, V54, P1725, DOI 10.1111/j.1471-4159.1990.tb01227.x; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GILL DL, 1988, J EXP BIOL, V139, P105; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KANBA S, 1990, BIOCHEM PHARMACOL, V40, P1005, DOI 10.1016/0006-2952(90)90486-5; KOPP R, 1990, BIOCHEM J, V269, P73, DOI 10.1042/bj2690073; LAMBERT DG, 1990, BIOCHEM J, V265, P555, DOI 10.1042/bj2650555; LAMBERT DG, 1991, BIOCHEM J, V273, P791, DOI 10.1042/bj2730791; LAMBERT DG, 1989, EUR J PHARMACOL, V165, P71, DOI 10.1016/0014-2999(89)90771-1; MAUGER JP, 1989, J BIOL CHEM, V264, P8821; MELDOLESI J, 1990, BIOCHIM BIOPHYS ACTA, V1055, P130, DOI 10.1016/0167-4889(90)90113-R; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MUALLEM S, 1989, J BIOL CHEM, V264, P205; NUNN DL, 1990, BIOCHEM J, V270, P227, DOI 10.1042/bj2700227; OBERHUBER H, 1991, J BIOL CHEM, V266, P1437; SAFRANY ST, 1991, MOL PHARMACOL, V39, P754; SERRA M, 1988, J NEUROCHEM, V50, P1513, DOI 10.1111/j.1471-4159.1988.tb03038.x; SPAT A, 1986, NATURE, V319, P514, DOI 10.1038/319514a0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STRUPISH J, 1988, BIOCHEM J, V253, P901, DOI 10.1042/bj2530901; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR CW, 1990, BIOCHEM J, V266, P189, DOI 10.1042/bj2660189; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMPSON AK, 1991, J BIOL CHEM, V266, P5004; VARNEY MA, 1990, BIOCHEM J, V269, P211, DOI 10.1042/bj2690211; VERMA A, 1990, BIOCHEM BIOPH RES CO, V172, P811, DOI 10.1016/0006-291X(90)90747-B; WANG SZ, 1990, FEBS LETT, V276, P185, DOI 10.1016/0014-5793(90)80538-T; WILLCOCKS AL, 1987, BIOCHEM BIOPH RES CO, V146, P1071, DOI 10.1016/0006-291X(87)90756-X; WILLEMS PHGM, 1989, J BIOL CHEM, V264, P9762; WOJCIKIEWICZ RJH, 1990, EUR J BIOCHEM, V192, P459, DOI 10.1111/j.1432-1033.1990.tb19248.x; WOJCIKIEWICZ RJH, 1990, BIOCHEM J, V272, P269, DOI 10.1042/bj2720269; WOJCIKIEWICZ RJH, 1990, J NEUROCHEM, V54, P676, DOI 10.1111/j.1471-4159.1990.tb01924.x; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; YU VC, 1988, J NEUROCHEM, V51, P1892, DOI 10.1111/j.1471-4159.1988.tb01174.x	52	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22234	22241						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657992				2022-12-25	WOS:A1991GR56400029
J	BODENNER, DL; MROCZYNSKI, MA; WEINTRAUB, BD; RADOVICK, S; WONDISFORD, FE				BODENNER, DL; MROCZYNSKI, MA; WEINTRAUB, BD; RADOVICK, S; WONDISFORD, FE			A DETAILED FUNCTIONAL AND STRUCTURAL-ANALYSIS OF A MAJOR THYROID-HORMONE INHIBITORY ELEMENT IN THE HUMAN THYROTROPIN BETA-SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE ELEMENTS; RECEPTOR; BINDING; EXPRESSION; PROMOTER; MEDIATE; DOMAIN; SITE; JUN	The first exon of the human thyrotropin-beta (hTSH-beta) gene has been demonstrated in our laboratory to contain a major thyroid hormone inhibitory element. In order to characterize fully this element, we have performed a detailed functional and structural scanning mutational analysis of this element. Various -1192 to +37 (base pairs) bp fragments of the hTSH-beta-gene containing consecutive five deoxythymidine substitution mutations of the first exon were inserted into a luciferase reporter plasmid and transiently transfected into human embryonal cells (293) and stably transfected into rat pituitary cells (GH3). Two domains (domain 1 and 2) were identified by scanning mutations that were essential for function of the thyroid hormone inhibitory element: +3 to +13 bp and +28 to +37 bp. Biotinylated DNA fragments containing -12 to +43 bp of the hTSH-beta-gene and the identical scanning mutations demonstrate that in vitro synthesized c-erbA-beta-binding is disrupted as much as 95% by mutations from -3 to +17 bp and to a lesser extent (20-30%) by mutations from +23 to +27 bp and from +33 to +43 bp. Domain 1 displayed a higher affinity for c-erbA-beta than domain 2 in avidin-biotin complex DNA-binding and gel-mobility assays. Using increasing amounts of in vitro synthesized c-erbA-beta, we were unable to demonstrate more than one protein-DNA complex in gel-mobility assays. However, using the avidin-biotin complex DNA-binding assay and the cross-linking reagent, 1,6-bismaleimidohexane, we were able to demonstrate thyroid hormone receptor dimer formation on domain 1 but not to any significant extent on domain 2. In conclusion, functional and DNA-binding studies suggest that the thyroid hormone receptor binds to two distinct regions in the first exon of the hTSH-beta gene. The upstream site (domain 1) binds c-erbA-beta with higher affinity and is capable of binding c-erbA-beta as a dimer under some conditions, while the downstream site (domain 2) appears to bind a single molecule of c-erbA-beta with lower affinity. These results suggest that thyroid hormone receptor, binding to at least two sites in the first exon, act in conjunction to mediate T3 inhibition of hTSH-beta expression.	UNIV HOSP CLEVELAND,DIV PEDIAT,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,DIV ADULT ENDOCRINOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	BODENNER, DL (corresponding author), NIDDKD,MOLEC CELLULAR & NUTR ENDOCRINOL BRANCH,BETHESDA,MD 20892, USA.							BEEBE JS, 1991, MOL ENDOCRINOL, V5, P85, DOI 10.1210/mend-5-1-85; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; BURNSIDE J, 1989, J BIOL CHEM, V264, P6886; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Dahlquist F W, 1978, Methods Enzymol, V48, P270; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; FLUG F, 1987, J BIOL CHEM, V262, P6373; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; GARNER MM, 1981, NUCLEIC ACIDS RES, V11, P1474; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; HOLLOWAY JM, 1990, P NATL ACAD SCI USA, V87, P8160, DOI 10.1073/pnas.87.20.8160; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Maxam A M, 1980, Methods Enzymol, V65, P499; MROCZYNSKI MA, 1991, 73RD ANN END SOC M W; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NARAYAN P, 1984, P NATL ACAD SCI-BIOL, V81, P4687, DOI 10.1073/pnas.81.15.4687; NORMAN MF, 1989, J BIOL CHEM, V264, P12063; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3134; WET JR, 1987, MOL CELL BIOL, V7, P725; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WOOD WM, 1989, J BIOL CHEM, V264, P14840; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YE ZS, 1988, J BIOL CHEM, V263, P7821	32	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21666	21673						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657975				2022-12-25	WOS:A1991GP80400053
J	ONRUST, R; STUKENBERG, PT; ODONNELL, M				ONRUST, R; STUKENBERG, PT; ODONNELL, M			ANALYSIS OF THE ATPASE SUBASSEMBLY WHICH INITIATES PROCESSIVE DNA-SYNTHESIS BY DNA POLYMERASE-III HOLOENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; ACCESSORY PROTEINS; PRIMED TEMPLATE; REPLICATION; SUBUNIT; PURIFICATION; COMPLEX; GAMMA; ACTIVATION	The gamma-complex (gamma-delta-delta'-chi-psi) subassembly of DNA polymerase III holoenzyme transfers the beta-subunit onto primed DNA in a reaction which requires ATP hydrolysis. Once on DNA, beta is a "sliding clamp" which tethers the polymerase to DNA for highly processive synthesis. We have examined-beta and the gamma-complex to identify which subunit(s) hydrolyzes ATP. We find the gamma-complex is a DNA dependent ATPase. The beta-subunit, which lacks ATPase activity, enhances the gamma-complex ATPase when primed DNA is used as an effector. Hence, the gamma-complex recognizes DNA and couples ATP hydrolysis to clamp-beta onto primed DNA. Study of gamma-complex subunits showed no single subunit contained significant ATPase activity. However, the heterodimers, gamma-delta and gamma-delta', were both DNA-dependent ATPases. Only the gamma-delta ATPase was stimulated by beta and was functional in transferring the beta from solution to primed DNA. Similarity in ATPase activity of DNA polymerase III holoenzyme accessory proteins to accessory proteins of phage T4 DNA polymerase and mammalian DNA polymerase delta-suggests the basic strategy of chromosome duplication has been conserved throughout evolution.			ONRUST, R (corresponding author), CORNELL UNIV,MED CTR,COLL MED,HOWARD HUGHES MED INST,DEPT MICROBIOL,NEW YORK,NY 10021, USA.			Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISWAL SB, 1989, J BIOL CHEM, V259, P7990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; FAY PJ, 1981, J BIOL CHEM, V256, P976; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; KORNBERG A, 1982, DNA REPLICATION S, P5122; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1991, J BIOL CHEM, V266, P594; MACE DC, 1984, J MOL BIOL, V177, P279, DOI 10.1016/0022-2836(84)90457-1; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI H, 1986, MECHANISMS REPLICATI, V47, P63; MAKI S, 1988, J BIOL CHEM, V263, P6547; MAKI S, 1988, J BIOL CHEM, V263, P6555; MAKI S, 1988, J BIOL CHEM, V263, P6561; MANIATIS T, 1982, MOL CLONING LABORATO, P90; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; NOSSAL NG, 1984, BACTERIOPHAGE T4, P71; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL ME, 1985, J BIOL CHEM, V260, P2875; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; RAY DS, 1969, J MOL BIOL, V43, P631, DOI 10.1016/0022-2836(69)90364-7; ROWEN L, 1978, J BIOL CHEM, V253, P758; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STUDWELL PS, 1990, UCLA SYM BI, V127, P153; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; WEINER JH, 1975, J BIOL CHEM, V250, P1972; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511	31	92	96	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1991	266	32					21681	21686						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP804	1657977				2022-12-25	WOS:A1991GP80400055
J	KRAHENBUHL, S; CHANG, M; BRASS, EP; HOPPEL, CL				KRAHENBUHL, S; CHANG, M; BRASS, EP; HOPPEL, CL			DECREASED ACTIVITIES OF UBIQUINOL-FERRICYTOCHROME-C OXIDOREDUCTASE (COMPLEX-III) AND FERROCYTOCHROME-C-OXYGEN OXIDOREDUCTASE (COMPLEX-IV) IN LIVER-MITOCHONDRIA FROM RATS WITH HYDROXYCOBALAMIN[C-LACTAM]-INDUCED METHYLMALONIC ACIDURIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; LACTIC-ACIDOSIS; OXIDATIVE-PHOSPHORYLATION; CARNITINE METABOLISM; ELECTRON-TRANSPORT; DEFICIENCY; MYOPATHY	Rats treated with hydroxycobalamin[c-lactam] (HCCL), a cobalamin analogue that induces methylmalonic aciduria, have increased hepatic mitochondrial content and increased oxidative metabolism of pyruvate and palmitate per hepatocyte. The present studies were undertaken to characterize oxidative metabolism in isolated liver mitochondria from rats treated with HCCL. After 5-6 weeks, state 3 oxidation rates for diverse substrates are reduced in mitochondria from HCCL-treated rats. Similar reductions of mitochondrial oxidation rates are obtained with dinitrophenol-uncoupled mitochondria excluding defective phosphorylation as a cause for the observed decrease in mitochondrial oxidation. The activities of mitochondrial oxidases are reduced in HCCL-treated rats and demonstrate a defect in complex IV. Investigation of the complexes of the respiratory chain reveals a 32% decrease of ubiquinol:ferricytochrome c oxidoreductase (complex III) activity and a 72% decrease of ferrocytochrome c:oxygen oxidoreductase (complex IV) activity in mitochondria from 5-6-week HCCL-treated rats as compared with controls. Liver mitochondria from HCCL-treated rats also demonstrate decreased cytochrome content per mg of mitochondrial protein (25% decrease of cytochrome b and 52% decrease of cytochrome a + a3 as compared with control rats). The HCCL-treated rat represents an animal model for the study of the consequences of respiratory chain defects in liver mitochondria.	CASE WESTERN RESERVE UNIV,VET ADM MED CTR,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,VET ADM MED CTR,DEPT PHARMACOL,CLEVELAND,OH 44106	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Krähenbühl, Stephan/Z-4744-2019		NIDDK NIH HHS [DK-36069] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK036069, R01DK036069] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMITAGE P, 1987, STATISTICAL METHODS; BECK WS, 1957, J BIOL CHEM, V229, P997; BINDER M, 1982, ANAL BIOCHEM, V125, P253, DOI 10.1016/0003-2697(82)90003-3; BLAIR PV, 1963, BIOCHEMISTRY-US, V2, P756, DOI 10.1021/bi00904a023; BRASS EP, 1990, BIOCHEM J, V266, P809; BRASS EP, 1990, J NUTR, V120, P290, DOI 10.1093/jn/120.3.290; BRASS EP, 1988, BIOCHEM J, V255, P153, DOI 10.1042/bj2550153; CABRINI L, 1981, ARCH BIOCHEM BIOPHYS, V208, P11, DOI 10.1016/0003-9861(81)90117-X; CHANCE B, 1955, J BIOL CHEM, V217, P429; CHANCE B, 1959, CIBA F S REGULATION, P91; COOPER JM, 1990, BIOCHEM SOC T, V18, P517, DOI 10.1042/bst0180517; Dolphin D., 1971, METHOD ENZYMOL, V18, P34; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; FRENKEL EP, 1973, LAB INVEST, V29, P614; GIUDITTA A, 1959, J BIOL CHEM, V234, P662; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hatefi Y, 1978, Methods Enzymol, V53, P11; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; HAYES DJ, 1984, BRAIN, V107, P1165, DOI 10.1093/brain/107.4.1165; HOPPEL C, 1968, BIOCHEM J, V107, P367, DOI 10.1042/bj1070367; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL C, 1969, ARCH BIOCHEM BIOPHYS, V135, P173, DOI 10.1016/0003-9861(69)90528-1; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; KENNAWAY NG, 1984, PEDIATR RES, V18, P991; KRAHENBUHL S, 1990, J CLIN INVEST, V86, P2054, DOI 10.1172/JCI114942; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MORGANHUGHES JA, 1990, BIOCHEM SOC T, V18, P523, DOI 10.1042/bst0180523; Ragan C. I., 1987, MITOCHONDRIA PRACTIC, P96; ROSENBERG LE, 1989, METABOLIC BASIS INHE, P821; SATAV JG, 1982, MOL CELL ENDOCRINOL, V28, P173, DOI 10.1016/0303-7207(82)90030-2; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; STABLER SP, 1984, BLOOD S, V64, pA42; TAKEMORI S, 1964, SCIENCE, V144, P852, DOI 10.1126/science.144.3620.852; Wharton DC., 1967, METHOD ENZYMOL, P245; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; ZIEGLER DM, 1962, ARCH BIOCHEM BIOPHYS, V97, P41, DOI 10.1016/0003-9861(62)90042-5	38	153	161	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20998	21003						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657942				2022-12-25	WOS:A1991GN00100065
J	WAINWRIGHT, SL; POWELL, WS				WAINWRIGHT, SL; POWELL, WS			MECHANISM FOR THE FORMATION OF DIHYDRO METABOLITES OF 12-HYDROXYEICOSANOIDS - CONVERSION OF LEUKOTRIENE-B4 AND 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID TO 12-OXO INTERMEDIATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PRESSURE LIQUID-CHROMATOGRAPHY; OMEGA-OXIDIZED METABOLITES; GUINEA PIG LIVER; ARACHIDONIC-ACID; FATTY-ACIDS; 12-KETOEICOSATETRAENOIC ACID; LIPOXYGENASE-PRODUCTS; BIOLOGICAL-ACTIVITY; PORCINE LEUKOCYTES	Eicosanoids containing a 12-hydroxyl group preceded by at least two conjugated double bonds are metabolized to 10,11-dihydro and 10,11-dihydro-12-oxo products by porcine polymorphonuclear leukocytes (PMNL) (Wainwright, S. L., Falck, J. R., Yadagiri, P., and Powell, W. S. (1990) Biochemistry 29, 10126-10135). These 10,11-dihydro metabolites could either have been formed by the direct reduction of the 10,11-double bond of the substrate, as previous evidence suggested, or via an initially formed 12-oxo intermediate. To gain some insight into the mechanism for the formation of dihydro products by this pathway, we investigated the metabolism of leukotriene B4 (LTB4), 12(S)-hydroxy-5,8,10,14-eicosatetraenoicacid(12(S)-HETE), and 12(R)-HETE by subcellular fractions from porcine PMNL. In the presence of NAD+ and a microsomal fraction from PMNL, each of the above 12-hydroxyeicosanoids was converted to a single product with a lambda-max approximately 40 nm higher than that of the substrate, indicating that the conjugated diene or triene chromophore had been extended by one double bond, presumably by oxidation of the 12-hydroxyl group to an oxo group. In the case of LTB4, this was confirmed by mass spectrometry, which indicated that the product was identical to 12-oxo-LTB4. LTB4 was not converted to any products by a cytosolic fraction from PMNL, but was converted to both 10,11-dihydro-LTB4 and 10,11-dihydro-12-oxo-LTB4 by the 1500 x g supernatant in the presence of NAD+. Negligible amounts of dihydro products were formed in the presence of NADH or NADPH, suggesting that initial oxidation of the 12-hydroxyl group is a requirement for reduction of the 10,11-double bond. Consistent with this hypothesis, 12-oxo-LTB4 was rapidly metabolized to 10,11-dihydro-12-oxo-LTB4 by the cytosolic fraction in the presence of NADH. Only small amounts of this product, along with some LTB4, were formed by the microsomal fraction. These results indicate that the initial step in the formation of 10,11-dihydro products from 12-hydroxyeicosanoids is oxidation of the 12-hydroxyl group by a microsomal 12-hydroxyeicosanoid dehydrogenase in the presence of NAD+, which is followed by reduction of the olefinic double bond by a cytosolic DELTA-10-reductase in the presence of NADH.	MCGILL UNIV,DEPT MED,MEAKINS CHRISTIE LABS,RESP HLTH NETWORK CTR EXCELLENCE,3626 ST URBAIN ST,MONTREAL H2X 2P2,QUEBEC,CANADA; ROYAL VICTORIA HOSP,ENDOCRINE LAB,MONTREAL H3A 1A1,QUEBEC,CANADA	McGill University; McGill University; Royal Victoria Hospital			Powell, William/AAE-9000-2020	Powell, William/0000-0002-8507-4038				Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; BERGHOLTE JM, 1987, ARCH BIOCHEM BIOPHYS, V257, P444, DOI 10.1016/0003-9861(87)90589-3; BORGEAT P, 1981, PROSTAG LEUKOTR ESS, V6, P557, DOI 10.1016/0161-4630(81)90117-8; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P2148, DOI 10.1073/pnas.76.5.2148; BORGEAT P, 1979, J BIOL CHEM, V254, P2643; BRAITHWAITE SS, 1975, J BIOL CHEM, V250, P2315; BRITTINGER G, 1968, J CELL BIOL, V37, P394, DOI 10.1083/jcb.37.2.394; BULL AW, 1988, CANCER RES, V48, P1771; CAPDEVILA J, 1982, P NATL ACAD SCI-BIOL, V79, P767, DOI 10.1073/pnas.79.3.767; CUNNINGHAM FM, 1987, PROSTAGLANDINS, V34, P71, DOI 10.1016/0090-6980(87)90264-4; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DELACLOS BF, 1987, PROSTAGLANDINS, V33, P315, DOI 10.1016/0090-6980(87)90016-5; EARLES SM, 1991, BIOCHIM BIOPHYS ACTA, V1081, P174, DOI 10.1016/0005-2760(91)90023-B; FALGUEYRET JP, 1988, BIOCHEM BIOPH RES CO, V156, P1083, DOI 10.1016/S0006-291X(88)80743-5; FALGUEYRET JP, 1990, FEBS LETT, V262, P197, DOI 10.1016/0014-5793(90)80188-O; FAULER J, 1989, PROSTAG LEUKOTR ESS, V37, P193, DOI 10.1016/0952-3278(89)90085-9; FEINMARK SJ, 1981, FEBS LETT, V136, P141, DOI 10.1016/0014-5793(81)81233-1; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; FUNK CD, 1983, BIOCHIM BIOPHYS ACTA, V754, P57; GOLDMAN DW, 1984, J EXP MED, V159, P1027, DOI 10.1084/jem.159.4.1027; HAMBERG M, 1971, J BIOL CHEM, V246, P1073; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HANSSON G, 1981, FEBS LETT, V130, P107, DOI 10.1016/0014-5793(81)80676-X; HAWKINS DJ, 1987, J BIOL CHEM, V262, P7629; KAEVER V, 1987, BIOCHIM BIOPHYS ACTA, V922, P337, DOI 10.1016/0005-2760(87)90056-7; KAEVER V, 1988, FEBS LETT, V231, P385, DOI 10.1016/0014-5793(88)80855-X; KAEVER V, 1990, LIFE SCI, V46, P1465, DOI 10.1016/0024-3205(90)90463-2; KLEBANOF.SJ, 1965, ENDOCRINOLOGY, V76, P301, DOI 10.1210/endo-76-2-301; KUMLIN M, 1990, BIOCHEM BIOPH RES CO, V170, P23, DOI 10.1016/0006-291X(90)91235-K; LINDGREN JA, 1981, FEBS LETT, V128, P329, DOI 10.1016/0014-5793(81)80110-X; MAAS RL, 1982, ADV PROSTAG THROMB L, V9, P29; MURPHY RC, 1988, J BIOL CHEM, V263, P17197; OFLAHERTY JT, 1981, AM J PATHOL, V105, P264; PALMER RMJ, 1980, PROSTAGLANDINS, V20, P411, DOI 10.1016/S0090-6980(80)80058-X; POWELL WS, 1984, J BIOL CHEM, V259, P3082; POWELL WS, 1983, ANAL BIOCHEM, V128, P93, DOI 10.1016/0003-2697(83)90349-4; POWELL WS, 1982, METHOD ENZYMOL, V86, P467; POWELL WS, 1988, J BIOL CHEM, V263, P2170; POWELL WS, 1990, J BIOL CHEM, V265, P9131; POWELL WS, 1990, BIOCHIM BIOPHYS ACTA, V1044, P147, DOI 10.1016/0005-2760(90)90230-U; POWELL WS, 1987, BIOCHEM BIOPH RES CO, V145, P991, DOI 10.1016/0006-291X(87)91533-6; POWELL WS, 1986, BIOCHEM BIOPH RES CO, V136, P707, DOI 10.1016/0006-291X(86)90497-3; POWELL WS, 1989, J BIOL CHEM, V264, P5364; POWELL WS, 1987, ANAL BIOCHEM, V164, P117, DOI 10.1016/0003-2697(87)90375-7; RIMARACHIN J A, 1989, FASEB Journal, V3, pA913; ROMANO MC, 1987, J BIOL CHEM, V262, P1590; SCHONFELD W, 1988, IMMUNOLOGY, V65, P529; SHAAFI RI, 1976, BIOCHIM BIOPHYS ACTA, V448, P638, DOI 10.1016/0005-2736(76)90121-8; Tai H H, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P159; WAINWRIGHT S, 1990, BIOCHEMISTRY-US, V29, P10126, DOI 10.1021/bi00495a017; WAINWRIGHT S, 1990, BIOCHEMISTRY-US, V29, P1180, DOI 10.1021/bi00457a013; WESTBROOK C, 1978, ARCH BIOCHEM BIOPHYS, V185, P429, DOI 10.1016/0003-9861(78)90186-8; WOOLLARD PM, 1986, BIOCHEM BIOPH RES CO, V136, P169, DOI 10.1016/0006-291X(86)90891-0	54	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					20899	20906						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657938				2022-12-25	WOS:A1991GN00100050
J	WYATT, TA; LINCOLN, TM; PRYZWANSKY, KB				WYATT, TA; LINCOLN, TM; PRYZWANSKY, KB			VIMENTIN IS TRANSIENTLY CO-LOCALIZED WITH AND PHOSPHORYLATED BY CYCLIC GMP-DEPENDENT PROTEIN-KINASE IN FORMYL-PEPTIDE-STIMULATED NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GUANOSINE 3',5'-MONOPHOSPHATE; POLYMORPHONUCLEAR LEUKOCYTES; HORMONE ACTION; L-ARGININE; CELLS; COMPARTMENTALIZATION; MEMBRANE; ENZYME; ADENOSINE-3',5'-MONOPHOSPHATE	The effects of cGMP-dependent protein kinase (G-kinase), a major cellular receptor of cGMP, were investigated in activated human neutrophils. Immunocytochemistry demonstrated that G-kinase translocated from a diffuse localization in the cytoplasm to the cytoskeleton and nucleus after stimulation with N-formyl-methionyl-leucyl-phenylalanine (fMLP), and transiently co-localized with the intermediate filament protein, vimentin. During this time period, the most remarkable co-localization of G-kinase and vimentin was observed between 1-2.5 min stimulation with fMLP. At that time co-localization of G-kinase and vimentin was predominantly confined to filaments which extended from regions adjacent to the nucleus into the uropod. Distinctive localization for only G-kinase was observed at the microtubule organizing center and euchromatin of the nucleus. The filamentous staining pattern for G-kinase and vimentin was enhanced in the presence of 8-Br-cGMP. Coincident with co-localization of G-kinase and vimentin in adherent neutrophils was a transient increase in cGMP levels and an increase in the phosphorylation of vimentin in fMLP-stimulated cells. The increase in cGMP levels was dependent upon cell adherence, was enhanced by preincubating neutrophils with L-arginine (the precursor for nitric oxide synthesis), and attenuated with the nitric oxide synthase inhibitor, N(G)-monomethyl-L-arginine. Phosphorylation of vimentin in the fMLP-stimulated neutrophil was observed in the presence or absence of exogenous cGMP, although in the presence of low concentrations of 8-Br-cGMP a more rapid phosphorylation of vimentin was observed that correlated with the enhanced co-localization of G-kinase and vimentin. Phosphorylation of vimentin was not observed in non-activated cells treated with 8-Br-cGMP, suggesting that phosphorylation only occurs when G-kinase is co-localized with vimentin. The presence of the protein kinase C inhibitors, staurosporine or H-7, did not inhibit vimentin phosphorylation during fMLP stimulation, while 8-Br-cGMP enhanced phosphorylation in fMLP-treated cells. This suggests that neither protein kinase C nor cAMP-dependent protein kinase catalyze the phosphorylation of vimentin in neutrophils activated by fMLP. These results indicate that vimentin and G-kinase are co-localized in neutrophils and that vimentin is phosphorylated by G-kinase in response to the co-localization of the two proteins. A model for the targeting of G-kinase and vimentin is presented which hypothesizes that the transient redistribution of G-kinase may regulate neutrophil activation.	UNIV SO ALABAMA,DEPT PHARMACOL,MOBILE,AL 36688	University of South Alabama	WYATT, TA (corresponding author), UNIV N CAROLINA,DEPT PATHOL,BRINKHOUS BULLITT BLDG,CHAPEL HILL,NC 27599, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034646] Funding Source: NIH RePORTER; NCI NIH HHS [CA-07017] Funding Source: Medline; NHLBI NIH HHS [HL-34646] Funding Source: Medline; PHS HHS [5-S01-FR-05406] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSSON T, 1986, MOL PHARMACOL, V30, P437; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; CORNWELL TL, 1991, IN PRESS MOL PHARM; EARP HS, 1978, ANNU REV PHARMACOL, V18, P431, DOI 10.1146/annurev.pa.18.040178.002243; ESTENSEN RD, 1973, NATURE, V245, P458, DOI 10.1038/245458a0; GALLIN JI, 1984, BLOOD, V63, P977; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HAYES JS, 1982, J CYCLIC NUCL PROT, V8, P1; HELFMAN DM, 1983, BIOCHEM BIOPH RES CO, V111, P847, DOI 10.1016/0006-291X(83)91376-1; HOFFSTEIN ST, 1982, J CELL BIOL, V95, P234, DOI 10.1083/jcb.95.1.234; HOFFSTEIN ST, 1980, CELL BIOL INFLAMMATI, P387; HUANG CK, 1984, J BIOL CHEM, V259, P1386; HUANG CK, 1988, BIOCHEM BIOPH RES CO, V150, P1006, DOI 10.1016/0006-291X(88)90728-0; IGNARRO LJ, 1976, P SOC EXP BIOL MED, V151, P448; IGNARRO LJ, 1975, LYSOSOMES BIOLOGY PA, V4, P481; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; KAPLAN SS, 1989, BLOOD, V74, P1885; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KUO JF, 1970, J BIOL CHEM, V245, P2493; LEW DP, 1989, EUR J CLIN INVEST, V19, P338, DOI 10.1111/j.1365-2362.1989.tb00240.x; LINCOLN TM, 1983, ADV CYCL NUCL RES<D>, V15, P139; LINCOLN TM, 1984, ADV CYCLIC NUCL PROT, V17, P285; LINCOLN TM, 1977, J BIOL CHEM, V252, P4269; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; NACCACHE PH, 1984, SURV IMMUNOL RES, V3, P288; Naef A, 1983, Agents Actions Suppl, V12, P360; NEWMAN S L, 1984, Complement, V1, P213; OCONNOR CM, 1981, CELL, V23, P135, DOI 10.1016/0092-8674(81)90278-6; OLIVER JM, 1978, AM J PATHOL, V93, P221; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PARYSEK LM, 1984, CELL TISSUE RES, V235, P575; PRYZWANSKY KB, 1981, SCIENCE, V211, P407, DOI 10.1126/science.6261328; PRYZWANSKY KB, 1990, BLOOD, V76, P612; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; SCHMIDT HHHW, 1989, FEBS LETT, V244, P357, DOI 10.1016/0014-5793(89)80562-9; Schmitt-Graff A, 1987, Haematol Blood Transfus, V30, P302; SELIGMANN B, 1984, J IMMUNOL, V133, P2641; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; Sklar L A, 1984, Contemp Top Immunobiol, V14, P29; SKLAR LA, 1986, ADV IMMUNOL, V39, P95; SMOLEN JE, 1980, J CLIN INVEST, V65, P1077, DOI 10.1172/JCI109760; SMOLEN JE, 1981, BIOCHIM BIOPHYS ACTA, V672, P197, DOI 10.1016/0304-4165(81)90393-7; STOSSEL TP, 1977, DEV HOST DEFENSES, P187; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; WALTER U, 1984, ADV CYCLIC NUCL PROT, V17, P249; WALTER U, 1981, EUR J BIOCHEM, V118, P339; WEISSMANN G, 1975, ANN NY ACAD SCI, V256, P222, DOI 10.1111/j.1749-6632.1975.tb36049.x	49	112	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1991	266	31					21274	21280						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN001	1657955				2022-12-25	WOS:A1991GN00100106
J	GARDNER, PR; FRIDOVICH, I				GARDNER, PR; FRIDOVICH, I			SUPEROXIDE SENSITIVITY OF THE ESCHERICHIA-COLI ACONITASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-RESONANCE CHARACTERIZATION; IRON-SULFUR CLUSTER; ACTIVATED ACONITASE; <4FE-4S>+ CLUSTER; SUBSTRATE BINDING; PULSE RADIOLYSIS; 4FE-4S CLUSTER; DISMUTASE; OXYGEN; O-17	Mutants of Escherichia coli lacking superoxide dismutase (SOD) activity were used to explore the sensitivity of aconitase toward O2 and O2-. The aconitase activity in SOD-free extracts was rapidly lost under aerobic conditions and exogenous SOD afforded a concentration-dependent protection. The rate of the inactivating reaction between O2- and aconitase was estimated to be of the order of 10(9) M-1 s-1. The competitive inhibitors fluorocitrate and tricarballylate provided some protection, and at saturating concentrations, they decreased the rate of the inactivating reaction by 100- and 10-fold, respectively. Aconitase was markedly less sensitive to O2 than it was to O2-. Aerobic growth on succinate involves a greater dependence upon aconitase than does growth on glucose and, as expected, the deleterious consequences of SOD deficiency were more pronounced on succinate than on glucose. Moreover, aconitase activity was lower in extracts of aerobically grown SOD mutants, than it was in the parental strain. We suppose that inactivation of aconitase by O2- involves oxidative attack on the prosthetic iron-sulfur cluster. The extreme sensitivity of aconitase to inactivation by O2- suggests that its inactivation will be an early event in the oxidative stress imposed by hyperoxia, ultraviolet irradiation or redox-cycling agents, such as viologens or quinones.	DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA	Duke University				Gardner, Paul/0000-0001-8189-0903				ANDRES V, 1990, J BIOL CHEM, V265, P21441; BEAN JW, 1945, PHYSIOL REV, V25, P1, DOI 10.1152/physrev.1945.25.1.1; BEERS RF, 1952, J BIOL CHEM, V195, P133; BELL PJ, 1989, J BACTERIOL, V171, P3494, DOI 10.1128/jb.171.6.3494-3503.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; DINGMAN DW, 1987, J BACTERIOL, V169, P3062, DOI 10.1128/jb.169.7.3062-3067.1987; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; FLINT D H, 1990, P285; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; FRIDOVICH I, 1985, HARVEY LECT, V79, P51; GAHAN LR, 1985, J AM CHEM SOC, V107, P6231, DOI 10.1021/ja00308a015; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GAWRON O, 1977, BIOCHIM BIOPHYS ACTA, V484, P453, DOI 10.1016/0005-2744(77)90101-2; GILLIES NE, 1959, NATURE, V183, P237, DOI 10.1038/183237a0; GRAY CT, 1966, BIOCHIM BIOPHYS ACTA, V117, P33, DOI 10.1016/0304-4165(66)90149-8; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; HASSAN HM, 1977, J BACTERIOL, V132, P505, DOI 10.1128/JB.132.2.505-510.1977; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; HAUGAARD N, 1968, PHYSIOL REV, V48, P311, DOI 10.1152/physrev.1968.48.2.311; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; KENNEDY MC, 1987, P NATL ACAD SCI USA, V84, P8854, DOI 10.1073/pnas.84.24.8854; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KLUG D, 1972, J BIOL CHEM, V247, P4839; KOVACHEVICH R, 1955, J BIOL CHEM, V213, P745; KUBICEK CP, 1985, APPL ENVIRON MICROB, V50, P1336, DOI 10.1128/AEM.50.5.1336-1338.1985; KUO CF, 1987, J BIOL CHEM, V262, P4724; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; MAGER J, 1955, J BACTERIOL, V70, P320, DOI 10.1128/JB.70.3.320-325.1955; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; MINAKAMI H, 1990, FASEB J, V4, P3239, DOI 10.1096/fasebj.4.14.2172063; MYERS JW, 1961, J BIOL CHEM, V236, P1414; RAMSAY RR, 1981, BIOCHEMISTRY-US, V20, P7476, DOI 10.1021/bi00529a023; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; ROTILIO G, 1972, BIOCHIM BIOPHYS ACTA, V268, P605, DOI 10.1016/0005-2744(72)90359-2; RYDEN L, 1984, J BIOL CHEM, V259, P3141; STALLINGS WC, 1980, ARCH BIOCHEM BIOPHYS, V203, P65, DOI 10.1016/0003-9861(80)90154-X; SZWEDA LI, 1990, J BIOL CHEM, V265, P20869; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x; TELSER J, 1986, J BIOL CHEM, V261, P4840; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; WERST MM, 1990, BIOCHEMISTRY-US, V29, P10526, DOI 10.1021/bi00498a015	50	428	435	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19328	19333						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1655783				2022-12-25	WOS:A1991GK66700035
J	TAKAHASHI, T; TAKAHASHI, T; SUZUKI, H; HIDA, T; SEKIDO, Y; ARIYOSHI, Y; UEDA, R				TAKAHASHI, T; TAKAHASHI, T; SUZUKI, H; HIDA, T; SEKIDO, Y; ARIYOSHI, Y; UEDA, R			THE P53 GENE IS VERY FREQUENTLY MUTATED IN SMALL-CELL LUNG-CANCER WITH A DISTINCT NUCLEOTIDE SUBSTITUTION PATTERN	ONCOGENE			English	Article							MUTATIONS; EXPRESSION	The p53 gene has been implicated as a tumor-suppressor gene whose disruption is involved in the pathogenesis of common human cancers. The results of extensive analysis of p53 mutations in non-small cell lung cancers (NSCLCs) have revealed that p53 is mutated in 45% of NSCLC with base changes different from those of colon cancer. In this study, we examined 17 SCLC tumor samples taken directly from 15 patients as well as the corresponding nine tumor cell lines. Mutations changing the p53 coding sequence were found in 11 of 15 patients (73.3%) and showed a similar but distinct nucleotide substitution pattern compared with NSCLC, suggesting that a different mutagenic process is involved. In addition, a strong correlation was seen between the presence of p53 mutations in tumors and the successful establishment of the corresponding cell lines, suggesting that p53 mutations can confer a selective growth advantage in vitro (and probably also in vivo).	AICHI CANC CTR,DEPT INTERNAL MED,NAGOYA,AICHI 464,JAPAN; AICHI CANC CTR,IMMUNOL LAB,NAGOYA,AICHI 464,JAPAN; NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 1,NAGOYA,AICHI 466,JAPAN	Aichi Cancer Center; Aichi Cancer Center; Nagoya University	TAKAHASHI, T (corresponding author), AICHI CANC CTR,CHEMOTHERAPY LAB,NAGOYA,AICHI 464,JAPAN.		Sekido, Yoshitaka/P-9756-2015; Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Sekido, Yoshitaka/0000-0002-2428-3848				BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BAKER SJ, 1990, SCIENCE, V249, P1912; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; CHIBA I, 1990, ONCOGENE, V5, P1603; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JOHNSON P, 1991, MOL CELL BIOL, V11, P1; LAWLEY P, 1990, N NITROSO COMPOUNDS, V1, P409; MAZUR M, 1988, SOMAT CELL MOLEC GEN, V14, P393, DOI 10.1007/BF01534647; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; Minna JD, 1989, CANCER PRINCIPLES PR, P591; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; SINGER B, 1982, ANNU REV BIOCHEM, V52, P655; SOUSSI T, 1990, ONCOGENE, V5, P945; TAKAHASHI T, 1989, CANCER RES, V49, P2683; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAHASHI T, 1986, CANCER RES, V46, P4770; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; WATANABE S, 1987, JPN J CANCER RES, V78, P460; 1990, VITAL STATISTICS 198, V1, P252	23	215	216	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1991	6	10					1775	1778						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656362				2022-12-25	WOS:A1991GX11800008
J	WHEELER, TT; XIAO, JP; DOWDY, SF; STANBRIDGE, EJ; YOUNG, DA				WHEELER, TT; XIAO, JP; DOWDY, SF; STANBRIDGE, EJ; YOUNG, DA			SUPPRESSION OF TUMORIGENICITY OF A WILMS-TUMOR CELL-LINE IS ASSOCIATED WITH A DECREASE IN SYNTHESIS OF 2 PROTEINS	ONCOGENE			English	Note							FAMILIAL PREDISPOSITION; HUMAN CHROMOSOME-11; SHORT ARM; GENE; 11P13; MAP; EXPRESSION; DELETION; LOCUS; ACID	Wilms' tumor has been associated with deletions in two loci on chromosome 11, and the introduction of a translocated human chromosome [t(X;11)] into a Wilms' tumor cell line (G401.6TG.6) by microcell hybridization suppresses tumor formation in nude mice. The tumorigenic phenotype is restored in segregants of these microcell hybrids, in which the introduced chromosome is lost. We have used ultrahigh-resolution 'giant' two-dimensional gel electrophoresis of metabolically labeled cellular proteins and in vitro translation products of isolated mRNA to identify changes in cellular gene expression that occur in these cell lines. The changes in gene expression associated with these chromosomal manipulations per se are quite minimal. However, we have identified two proteins (p16 and p28) whose synthesis is consistently decreased in three non-tumorigenic (suppressed) microcell hybrid clones relative to parental and segregant tumorigenic lines. They are also decreased at the level of mRNA in at least two of the non-tumorigenic clones. The decrease of these proteins represents markers of the suppressed phenotype, and their down-regulation may conceivably mediate the suppression of tumorigenicity.	E HENRY KEUTMANN LAB,DEPT MED,ENDOCRINE METAB UNIT,ROCHESTER,NY 14642; E HENRY KEUTMANN LAB,DEPT RADIAT BIOL & BIOPHYS,ENDOCRINE METAB UNIT,ROCHESTER,NY 14642; UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717	University of California System; University of California Irvine					NATIONAL CANCER INSTITUTE [R01CA047650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016177] Funding Source: NIH RePORTER; NCI NIH HHS [CA194104, CA47650] Funding Source: Medline; NIDDK NIH HHS [DK16177] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLBERT RA, 1989, J BIOL CHEM, V261, P14733; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LEVENSON RM, 1989, VIROLOGY, V172, P170, DOI 10.1016/0042-6822(89)90118-9; LEVENSON RM, 1987, CANCER CELLS, V5, P137; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICCARDI VM, 1978, PEDIATRICS, V61, P604; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; VANKEUREN ML, 1982, ANN NY ACAD SCI, V396, P55; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; YOUNG DA, 1983, METHOD ENZYMOL, V91, P190; YOUNG DA, 1984, CLIN CHEM, V30, P2104	17	6	6	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1991	6	10					1903	1907						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX118	1656366				2022-12-25	WOS:A1991GX11800026
J	WEISER, T; GASSMANN, M; THOMMES, P; FERRARI, E; HAFKEMEYER, P; HUBSCHER, U				WEISER, T; GASSMANN, M; THOMMES, P; FERRARI, E; HAFKEMEYER, P; HUBSCHER, U			BIOCHEMICAL AND FUNCTIONAL COMPARISON OF DNA POLYMERASE-ALPHA, POLYMERASE-DELTA, AND POLYMERASE-EPSILON FROM CALF THYMUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; SIMIAN VIRUS-40 DNA; CEREVISIAE CDC2 GENE; SACCHAROMYCES-CEREVISIAE; REPLICATION INVITRO; AUXILIARY PROTEIN; LAGGING STRAND; POLYACRYLAMIDE GELS; HOLOENZYME FORM; HELA-CELLS	DNA polymerases-alpha, delta, and epsilon can be isolated simultaneously from calf thymus. DNA polymerase-delta was purified to apparent homogeneity by a four-column procedure including DEAE-Sephacel, phenyl-Sepharose, phosphocellulose, and hydroxylapatite, yielding two polypeptides of 125 and 48 kDa, respectively. On hydroxylapatite DNA polymerase-delta can completely be separated from DNA polymerase-epsilon. By KCl DNA polymerase-delta is eluted first, while addition of potassium phosphate elutes DNA polymerase-epsilon. DNA polymerases-delta and epsilon could be distinguished from DNA polymerase-alpha by their (i) resistance to the monoclonal antibody SJK 132-20, (ii) relative resistance to N2-[p-(n-butyl)phenyl]-2-deoxyguanosine triphosphate and 2-[p-(n-butyl)anilino]-2-deoxyadenosine triphosphate, (iii) presence of a 3' --> 5' exonuclease, (iv) polypeptide composition, (v) template requirements, (vi) processivities on the homopolymer poly(dA)/oligo(dT12-18), and (vii) lack of a primase. The following differences of DNA polymerase-delta to DNA polymerase-epsilon were evident: (i) the independence of DNA polymerase-epsilon to proliferating cell nuclear antigen for processivity, (ii) utilization of deoxy- and ribonucleotide primers, (iii) template requirements in the absence of proliferating cell nuclear antigen, (iv) mode of elution from hydroxylapatite, and (v) sensitivity to d2TTP and to dimethyl sulfoxide. Both enzymes contain a 3' --> 5' exonuclease, but are devoid of endonuclease, RNase H, DNA helicase, DNA dependent ATPase, DNA primase, and poly(ADP-ribose) polymerase. DNA polymerase-delta is 100-150-fold dependent on proliferating cell nuclear antigen for activity and processivity on poly(dA)/oligo(dT12-18) at base ratios between 1:1 to 100:1. The activity of DNA polymerase-delta requires an acidic pH of 6.5 and is also found on poly(dT)/oligo(dA12-18) and on poly(dT)/oligo(A12-18) but not on 10 other templates tested. All three DNA polymerases can be classified according to the revised nomenclature for eukaryotic DNA polymerases (Burgers, P. M. J., Bambara, R. A., Campbell, J. L., Chang, L. M. S., Downey, K. M., Hubscher, U., Lee, M. Y. W. T., Linn, S. M., So, A. G., and Spadari, S. (1990) Eur. J. Biochem. 191, 617-618).			WEISER, T (corresponding author), UNIV ZURICH,DEPT PHARMACOL & BIOCHEM,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.							AREZZO F, 1987, ANAL BIOCHEM, V167, P387, DOI 10.1016/0003-2697(87)90181-3; BAMBARA RA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P11, DOI 10.1016/0167-4781(91)90147-E; BAUER GA, 1988, J BIOL CHEM, V263, P917; BAUER LS, 1989, ENVIRON ENTOMOL, V18, P261, DOI 10.1093/ee/18.2.261; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BURGERS PMJ, 1991, IN PRESS EUKARYOTIC; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; CRUTE JJ, 1986, BIOCHEMISTRY-US, V25, P26, DOI 10.1021/bi00349a005; DOWNEY KM, 1988, CANCER CELLS EUKARYO, V6, P403; FOCHER F, 1989, NUCLEIC ACIDS RES, V17, P1805, DOI 10.1093/nar/17.5.1805; FOCHER F, 1988, NUCLEIC ACIDS RES, V16, P6279, DOI 10.1093/nar/16.14.6279; FOCHER F, 1988, FEBS LETT, V229, P6, DOI 10.1016/0014-5793(88)80786-5; FRY M, 1986, ANIMAL CELL DNA POLY; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; GASSMANN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P280, DOI 10.1016/0167-4781(88)90098-X; GOULIAN M, 1990, J BIOL CHEM, V265, P16402; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; HOLMES AM, 1986, J BIOL CHEM, V261, P1924; HUBSCHER U, 1979, P NATL ACAD SCI USA, V76, P6284, DOI 10.1073/pnas.76.12.6284; HUBSCHER U, 1977, NUCLEIC ACIDS RES, V4, P4917; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; KAGUNI LS, 1988, BIOCHIM BIOPHYS ACTA, V950, P87, DOI 10.1016/0167-4781(88)90001-2; KHAN NN, 1985, NUCLEIC ACIDS RES, V13, P6331, DOI 10.1093/nar/13.17.6331; KHAN NN, 1984, NUCLEIC ACIDS RES, V12, P3695, DOI 10.1093/nar/12.8.3695; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1987, BIOCHEMISTRY-US, V26, P1076, DOI 10.1021/bi00378a014; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NISHIDA C, 1988, J BIOL CHEM, V263, P501; NOWAK R, 1990, EXP CELL RES, V191, P51, DOI 10.1016/0014-4827(90)90034-8; OTTIGER H, 1987, NUCLEIC ACIDS RES, V15, P4789, DOI 10.1093/nar/15.12.4789; OTTIGER HP, 1984, P NATL ACAD SCI-BIOL, V81, P3993, DOI 10.1073/pnas.81.13.3993; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2998, DOI 10.1021/bi00408a050; Sambrook J, 1989, MOL CLONING LABORATO; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; TALANIAN RV, 1989, BIOCHEMISTRY-US, V28, P8270, DOI 10.1021/bi00447a002; TAN CK, 1986, J BIOL CHEM, V261, P2310; TANAKA S, 1982, J BIOL CHEM, V257, P8386; THOMMES P, 1990, J BIOL CHEM, V265, P14347; THOMMES P, 1990, FEBS LETT, V268, P325, DOI 10.1016/0014-5793(90)81279-W; THOMMES P, 1990, EUR J BIOCHEM, V194, P699, DOI 10.1111/j.1432-1033.1990.tb19460.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; WAHL AF, 1986, BIOCHEMISTRY-US, V25, P7821, DOI 10.1021/bi00372a006; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; WILSON S, 1988, BIOCHIM BIOPHYS ACTA, V949, P149, DOI 10.1016/0167-4781(88)90078-4; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x	64	142	142	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10420	10428						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1674744				2022-12-25	WOS:A1991FP08600066
J	DAWSON, PA; METHERALL, JE; RIDGWAY, ND; BROWN, MS; GOLDSTEIN, JL				DAWSON, PA; METHERALL, JE; RIDGWAY, ND; BROWN, MS; GOLDSTEIN, JL			GENETIC DISTINCTION BETWEEN STEROL-MEDIATED TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL CONTROL OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; LOW-DENSITY LIPOPROTEIN; HMG COA REDUCTASE; CRYSTALLOID ENDOPLASMIC-RETICULUM; REGULATED DEGRADATION; MESSENGER-RNA; RECEPTOR GENE; HAMSTER; CHOLESTEROL; SYNTHASE	Sterols reduce the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) transcriptionally by inhibiting the synthesis of reductase mRNA and posttranscriptionally by accelerating degradation of the enzyme. We and others have described mutant lines of Chinese hamster fibroblasts that are completely resistant to sterol-mediated repression of transcription of HMG-CoA reductase as well as two other sterol-regulated genes, HMG-CoA synthase and the low density lipoprotein (LDL) receptor. In the current studies, we show that one line of sterol-resistant mutant cells (SRD-3 cells) retains the ability to slow the degradation of HMG-CoA reductase by 7-fold in response to treatment with compactin, an inhibitor of reductase that blocks sterol synthesis. The compactin effect is reversed by exogenous sterols. Similar results were obtained with another mutant line of sterol-resistant cells (SRD-2 cells) whose defective transcriptional regulation is attributable to a different gene than that in the SRD-3 cells, as determined by complementation analysis. These data indicate that the gene products that are defective in the SRD-3 and SRD-2 cells are not required for the sterol-mediated regulation of degradation of HMG-CoA reductase. Thus, mammalian cells possess at least two genetically distinct mechanisms, one transcriptional and the other posttranscriptional, for sensing and responding to the intracellular level of sterols.			DAWSON, PA (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Ridgway, Neale/0000-0002-0441-6228	NATIONAL CANCER INSTITUTE [F32CA008398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, F32HL007524] Funding Source: NIH RePORTER; NCI NIH HHS [CA 08398] Funding Source: Medline; NHLBI NIH HHS [HL 07524, HL 20948] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1980, J LIPID RES, V21, P505; CHANG TY, 1982, BIOCHEMISTRY-US, V21, P5316, DOI 10.1021/bi00264a030; CHANG TY, 1980, J BIOL CHEM, V255, P7787; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; CHUN KT, 1990, J BIOL CHEM, V265, P22004; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; GIL G, 1986, J BIOL CHEM, V261, P3710; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; LACHMANN PJ, 1986, CIBA F SYMP, V119, P25; LEONARD S, 1988, BIOCHIM BIOPHYS ACTA, V947, P101, DOI 10.1016/0304-4157(88)90021-4; LISCUM L, 1983, J BIOL CHEM, V258, P8450; LUSKEY KL, 1985, J BIOL CHEM, V260, P271; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; SKALNIK DG, 1985, J BIOL CHEM, V260, P1991; SMITH JR, 1990, J BIOL CHEM, V265, P2306; SMITH JR, 1988, J BIOL CHEM, V263, P18480; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127	27	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9128	9134						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1673968				2022-12-25	WOS:A1991FM03800071
J	PATTHY, L				PATTHY, L			HOMOLOGY OF THE PRECURSOR OF PULMONARY SURFACTANT-ASSOCIATED PROTEIN SP-B WITH PROSAPOSIN AND SULFATED GLYCOPROTEIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ACTIVATOR PROTEIN; CDNA; NUCLEOTIDE; DISEASE; BINDING; SAP-1	The precursor of pulmonary surfactant-associated protein, SP-B, is composed of an NH2-terminal domain of 30 residues (a-type domain) and three tandem repeats of about 90 residues (b-type domain); biophysically active mature SP-B corresponds to the second b-type repeat. Consensus sequences constructed for the b-type repeats were used to search the data base for homologous sequences, and the search has revealed that prosaposin and sulfated glycoprotein 1 show a remarkable homology with these repeats. The domain organizations of the latter proteins, however, differ from that of SP-B precursor inasmuch as they contain four tandem copies of the b-type domain and a-type domains are present both in the NH2-terminal and COOH-terminal parts of the proteins. The implications of the homology of saposins and SP-B for their structure and function are discussed.			PATTHY, L (corresponding author), HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1518 BUDAPEST,HUNGARY.		Patthy, Laszlo/A-2353-2013; Patthy, Laszlo/Q-6058-2019					BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; CURSTEDT T, 1988, EUR J BIOCHEM, V172, P521, DOI 10.1111/j.1432-1033.1988.tb13918.x; DEWJI NN, 1987, P NATL ACAD SCI USA, V84, P8652, DOI 10.1073/pnas.84.23.8652; EMRIE PA, 1989, BIOCHIM BIOPHYS ACTA, V994, P215, DOI 10.1016/0167-4838(89)90296-3; FURST W, 1988, BIOL CHEM H-S, V369, P317, DOI 10.1515/bchm3.1988.369.1.317; GLASSER SW, 1987, P NATL ACAD SCI USA, V84, P4007, DOI 10.1073/pnas.84.12.4007; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; JACOBS KA, 1987, J BIOL CHEM, V262, P9808; KING RJ, 1982, J APPL PHYSIOL, V53, P1; KLEINSCHMIDT T, 1987, BIOL CHEM H-S, V368, P1571, DOI 10.1515/bchm3.1987.368.2.1571; KWONG MS, 1985, PEDIATRICS, V76, P585; MORIMOTO S, 1988, BIOCHEM BIOPH RES CO, V156, P403, DOI 10.1016/S0006-291X(88)80855-6; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PATTHY L, 1988, J MOL BIOL, V202, P689, DOI 10.1016/0022-2836(88)90550-5; PATTHY L, 1987, J MOL BIOL, V198, P567, DOI 10.1016/0022-2836(87)90200-2; ROSS GF, 1986, J BIOL CHEM, V261, P14283; SHEH L, 1985, BIOCHEMISTRY-US, V24, P6645, DOI 10.1021/bi00344a052; WYNN CH, 1986, BIOCHEM J, V240, P921, DOI 10.1042/bj2400921; XU JJ, 1989, BIOCHEM BIOPH RES CO, V160, P325, DOI 10.1016/0006-291X(89)91659-8	23	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6035	6037						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1688355				2022-12-25	WOS:A1991FE37300008
J	MELENDY, T; STILLMAN, B				MELENDY, T; STILLMAN, B			PURIFICATION OF DNA POLYMERASE-DELTA AS AN ESSENTIAL SIMIAN VIRUS-40 DNA-REPLICATION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; LARGE TUMOR-ANTIGEN; CEREVISIAE CDC2 GENE; LARGE T-ANTIGEN; SV40 ORIGIN; AUXILIARY PROTEIN; CALF THYMUS; INVITRO REPLICATION; MULTIPLE STAGES; DELTA	DNA replication from the SV40 origin can be reconstituted in vitro using purified SV40 large T antigen, cellular topoisomerases I and II, replication factor A (RF-A), proliferating cell nuclear antigen (PCNA), replication factor C (RF-C), and a phosphocellulose fraction (IIA) made from human cell extracts (S100). Fraction IIA contains all DNA polymerase activity required for replication in vitro in addition to other factors. A newly identified factor has been purified from fraction IIA. This factor is required for complete reconstitution of SV40 DNA replication and co-purifies with a PCNA-stimulated DNA polymerase activity. This DNA polymerase activity is sensitive to aphidicolin, but is not inhibited by butylanilinodeoxyadenosine triphosphate or by monoclonal antibodies which block synthesis by DNA polymerase alpha. The polymerase activity is synergistically stimulated by the combination of RF-A, PCNA, and RF-C in an ATP-dependent manner. Purified calf thymus polymerase delta can fully replace the purified factor in DNA replication assays. We conclude that this factor, required for reconstitution of SV40 DNA replication in vitro, corresponds to human DNA polymerase delta.			MELENDY, T (corresponding author), COLD SPRING HARBOR LAB, COLD SPRING HARBOR, NY 11724 USA.			Stillman, Bruce/0000-0002-9453-4091	NCI NIH HHS [CA13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BURGERS PMJ, 1989, PROG NUCLEIC ACID RE, V37, P235; BYRNES JJ, 1985, BIOCHEM BIOPH RES CO, V132, P628, DOI 10.1016/0006-291X(85)91179-9; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; CHA TA, 1989, J BIOL CHEM, V264, P12220; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DECKER RS, 1986, MOL CELL BIOL, V6, P3815, DOI 10.1128/MCB.6.11.3815; DEPAMPHILIS ML, 1986, PAPOVAVIRIDAE, P99; DRESLER SL, 1986, NUCLEIC ACIDS RES, V14, P7093, DOI 10.1093/nar/14.17.7093; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; HAMMOND RA, 1987, BIOCHEMISTRY-US, V26, P6817, DOI 10.1021/bi00395a035; HARLOW E, 1988, ANTIBODIES LABORATOR, P311; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Kelly T J, 1988, Adv Virus Res, V34, P1, DOI 10.1016/S0065-3527(08)60514-X; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1985, NUCLEIC ACIDS RES, V13, P8623, DOI 10.1093/nar/13.23.8623; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; Maniatis T., 1982, MOL CLONING; MELENDY T, 1989, J BIOL CHEM, V264, P1870; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P2869, DOI 10.1073/pnas.83.9.2869; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SCHOMBURG U, 1986, EUR J BIOCHEM, V160, P451, DOI 10.1111/j.1432-1033.1986.tb10061.x; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; TAN CK, 1986, J BIOL CHEM, V261, P2310; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9742, DOI 10.1073/pnas.86.24.9742; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950	62	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1942	1949						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1671044				2022-12-25	WOS:A1991EU49700087
J	KARKARIA, CE; CHEN, CM; ROSEN, BP				KARKARIA, CE; CHEN, CM; ROSEN, BP			MUTAGENESIS OF A NUCLEOTIDE-BINDING SITE OF AN ANION-TRANSLOCATING ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM, DETROIT, MI 48201 USA	Wayne State University				Rosen, Barry P./0000-0002-5230-4271	NIAID NIH HHS [AI19793] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019793] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNES WM, 1983, METHOD ENZYMOL, V101, P98; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN CM, 1986, J BIOL CHEM, V261, P5030; CHEN CM, 1985, J BACTERIOL, V161, P758, DOI 10.1128/JB.161.2.758-763.1985; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; FRANCISCO MJDS, 1989, MOL MICROBIOL, V3, P15, DOI 10.1111/j.1365-2958.1989.tb00098.x; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; HSU CM, 1989, HIGHLIGHTS OF MODERN BIOCHEMISTRY, VOLS 1-2, P743; HSU CM, 1989, J BIOL CHEM, V264, P17349; HSU SY, 1987, FEBS LETT, V218, P222, DOI 10.1016/0014-5793(87)81050-5; JONES IG, 1985, FEMS MICROBIOL LETT, V28, P355, DOI 10.1016/0378-1097(85)90110-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVY SB, 1978, NATURE, V276, P90, DOI 10.1038/276090a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maverech M., 1980, P NATL ACAD SCI USA, V77, P6476; MOBLEY HLT, 1983, MOL GEN GENET, V191, P421, DOI 10.1007/BF00425757; MOBLEY HLT, 1982, P NATL ACAD SCI-BIOL, V79, P6119, DOI 10.1073/pnas.79.20.6119; MOBLEY HLT, 1987, BACTERIAL ION TRANSP, P305; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; PARSONAGE D, 1988, J BIOL CHEM, V263, P4740; RAO R, 1988, J BIOL CHEM, V263, P15957; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; ROSEN BP, 1984, BIOCHEM BIOPH RES CO, V124, P760, DOI 10.1016/0006-291X(84)91023-4; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHORTLE D, 1983, METHOD ENZYMOL, V100, P457; SILVER S, 1981, J BACTERIOL, V146, P983, DOI 10.1128/JB.146.3.983-996.1981; SILVER S, 1982, P NATL ACAD SCI-BIOL, V79, P6114, DOI 10.1073/pnas.79.20.6114; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; TRISLER P, 1984, J BACTERIOL, V160, P184, DOI 10.1128/JB.160.1.184-191.1984; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YOHDA M, 1988, BIOCHIM BIOPHYS ACTA, V933, P156, DOI 10.1016/0005-2728(88)90065-5; YUE VT, 1977, BIOCHEMISTRY-US, V16, P4678, DOI 10.1021/bi00640a023; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	38	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					7832	7836						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1692316				2022-12-25	WOS:A1990DC83500023
J	GETTINS, P; SOTTRUPJENSEN, L				GETTINS, P; SOTTRUPJENSEN, L			NMR AND ESR STUDIES ON HUMAN-PREGNANCY ZONE PROTEIN - COMPARISON WITH HUMAN ALPHA-2-MACROGLOBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232; AARHUS UNIV,DEPT MOLEC BIOL,DK-8000 AARHUS C,DENMARK	Vanderbilt University; Aarhus University	GETTINS, P (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES 00267] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CHRISTENSEN U, 1989, BIOCHEMISTRY-US, V28, P9324, DOI 10.1021/bi00450a012; CREWS BC, 1987, BIOCHEMISTRY-US, V26, P5963, DOI 10.1021/bi00393a003; FOLKERSEN J, 1981, CLIN CHIM ACTA, V110, P139, DOI 10.1016/0009-8981(81)90343-0; GETTINS P, 1986, BIOCHEMISTRY-US, V25, P5011, DOI 10.1021/bi00366a007; GETTINS P, 1986, BIOCHEMISTRY-US, V25, P5004, DOI 10.1021/bi00366a006; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P2905, DOI 10.1021/bi00408a036; GLIEMANN J, 1986, BIOCHIM BIOPHYS ACTA, V883, P440; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MOESTRUP SK, 1987, BIOCHIM BIOPHYS ACTA, V930, P297, DOI 10.1016/0167-4889(87)90002-4; PARISI AF, 1970, BIOCHEMISTRY-US, V9, P2421, DOI 10.1021/bi00814a005; PETERSEN CM, 1988, EUR J CLIN INVEST, V18, P184, DOI 10.1111/j.1365-2362.1988.tb02411.x; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SAND O, 1985, J BIOL CHEM, V260, P5723; SINOSICH MJ, 1983, BIOCHEM INT, V7, P33; SOTTRUPJENSEN L, 1984, P NATL ACAD SCI-BIOL, V81, P7353, DOI 10.1073/pnas.81.23.7353; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P127, DOI 10.1016/0014-5793(81)81097-6; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P393; THIERS RE, 1957, METHOD BIOCHEM ANAL, V5, P310; VALLEE BL, 1960, J BIOL CHEM, V235, P64; VANLEUVEN F, 1986, J BIOL CHEM, V261, P6622; von Schoultz B, 1974, Am J Obstet Gynecol, V119, P792; WARD RL, 1967, BIOCHEM BIOPH RES CO, V28, P785, DOI 10.1016/0006-291X(67)90386-5	25	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7268	7272						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1692019				2022-12-25	WOS:A1990DB30700030
J	HOROWITZ, B; EAKLE, KA; SCHEINERBOBIS, G; RANDOLPH, GR; CHEN, CY; HITZEMAN, RA; FARLEY, RA				HOROWITZ, B; EAKLE, KA; SCHEINERBOBIS, G; RANDOLPH, GR; CHEN, CY; HITZEMAN, RA; FARLEY, RA			SYNTHESIS AND ASSEMBLY OF FUNCTIONAL MAMMALIAN NA,K-ATPASE IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV SO CALIF,SCH MED,DEPT PHYSIOL & BIOPHYS,LOS ANGELES,CA 90033; GENENTECH INC,S SAN FRANCISCO,CA 94080	University of Southern California; Roche Holding; Genentech					NHLBI NIH HHS [HL39295] Funding Source: Medline; NIGMS NIH HHS [GM28673] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028673] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; BORSTPAUWELS GWFH, 1981, BIOCHIM BIOPHYS ACTA, V650, P88, DOI 10.1016/0304-4157(81)90002-2; BROWN TA, 1987, BIOCHIM BIOPHYS ACTA, V912, P244, DOI 10.1016/0167-4838(87)90095-1; CHEN CY, 1987, NUCLEIC ACIDS RES, V15, P643, DOI 10.1093/nar/15.2.643; COLLINS JH, 1982, BIOCHIM BIOPHYS ACTA, V686, P7, DOI 10.1016/0005-2736(82)90145-6; DEE E, 1968, BIOCHEM J, V107, P265, DOI 10.1042/bj1070265; ETCHEVERRY T, 1986, BIO-TECHNOL, V4, P726, DOI 10.1038/nbt0886-726; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; HITZEMAN RA, 1983, SCIENCE, V219, P620, DOI 10.1126/science.6186023; HOROWITZ B, 1988, NA PLUS K PLUS PUM B, P85; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KENT RB, 1987, SCIENCE, V237, P901, DOI 10.1126/science.3039660; MATSUI H, 1977, BIOCHEM BIOPH RES CO, V75, P373, DOI 10.1016/0006-291X(77)91052-X; MATSUI H, 1982, J BIOCHEM-TOKYO, V92, P193, DOI 10.1093/oxfordjournals.jbchem.a133916; MATSUI H, 1983, CURR TOP MEMBR TRANS, V19, P145; MILLER RP, 1988, BIOCHIM BIOPHYS ACTA, V954, P50, DOI 10.1016/0167-4838(88)90054-4; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; ROGERS TB, 1979, BIOCHEMISTRY-US, V18, P135, DOI 10.1021/bi00568a021; ROGERS TB, 1979, FEBS LETT, V98, P373, DOI 10.1016/0014-5793(79)80220-3; SCHEINERBOBIS G, 1989, EUR J BIOCHEM, V183, P173, DOI 10.1111/j.1432-1033.1989.tb14910.x; SCHEINERBOBIS G, 1985, EUR J BIOCHEM, V152, P739, DOI 10.1111/j.1432-1033.1985.tb09255.x; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TOBIN T, 1972, BIOCHEM PHARMACOL, V21, P1553, DOI 10.1016/0006-2952(72)90305-X	26	142	151	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1990	265	8					4189	4192						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT101	1689721				2022-12-25	WOS:A1990CT10100005
J	GHOSH, S; FREITAG, AC; MARTINVASALLO, P; COCAPRADOS, M				GHOSH, S; FREITAG, AC; MARTINVASALLO, P; COCAPRADOS, M			CELLULAR-DISTRIBUTION AND DIFFERENTIAL GENE-EXPRESSION OF THE 3 ALPHA-SUBUNIT ISOFORMS OF THE NA,K-ATPASE IN THE OCULAR CILIARY EPITHELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									YALE UNIV,SCH MED,DEPT OPHTHALMOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510	Yale University; Yale University			Martin-Vasallo, Pablo/P-5046-2019		NATIONAL EYE INSTITUTE [P30EY000785, R01EY004873] Funding Source: NIH RePORTER; NEI NIH HHS [EY-00785, EY-04873] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHARLEMAGNE D, 1987, J BIOL CHEM, V262, P8941; CHAYEN J, 1981, HISTOCHEMISTRY, V71, P533, DOI 10.1007/BF00508379; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCAPRADOS M, 1987, BIOCHEM BIOPH RES CO, V145, P460, DOI 10.1016/0006-291X(87)91343-X; COCAPRADOS M, 1986, EXP EYE RES, V43, P617, DOI 10.1016/S0014-4835(86)80028-8; COCAPRADOS M, 1985, EXP EYE RES, V40, P731, DOI 10.1016/0014-4835(85)90142-3; COCAPRADOS M, 1986, P NATL ACAD SCI USA, V83, P8754, DOI 10.1073/pnas.83.22.8754; EMANUEL JR, 1987, P NATL ACAD SCI USA, V84, P9030, DOI 10.1073/pnas.84.24.9030; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; FLUGEL C, 1988, HISTOCHEMISTRY, V88, P613; HARA K, 1977, INVEST OPHTH VIS SCI, V16, P912; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; KENT RB, 1987, P NATL ACAD SCI USA, V84, P5369, DOI 10.1073/pnas.84.15.5369; KRUPIN T, 1984, EXP EYE RES, V38, P115, DOI 10.1016/0014-4835(84)90096-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MCGRAIL KM, 1986, J NEUROSCI, V6, P1272; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; RAVIOLA G, 1978, INVEST OPHTH VIS SCI, V17, P958; RILEY MV, 1986, EXP EYE RES, V42, P559, DOI 10.1016/0014-4835(86)90046-1; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHULL MM, 1987, P NATL ACAD SCI USA, V84, P4039, DOI 10.1073/pnas.84.12.4039; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; SWEADNER KJ, 1978, BIOCHIM BIOPHYS ACTA, V508, P486, DOI 10.1016/0005-2736(78)90094-9; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; VALENTICH JD, 1982, COLD SPRING HARBOR C, V9, P567; WEGNER KARSTEN, 1967, INVEST OPHTHALMOL, V6, P177; YOUNG RM, 1987, BIOCHEM BIOPH RES CO, V145, P52, DOI 10.1016/0006-291X(87)91286-1	37	93	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1990	265	5					2935	2940						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM848	1689295				2022-12-25	WOS:A1990CM84800082
J	KIM, YH; OLIVER, DJ				KIM, YH; OLIVER, DJ			MOLECULAR-CLONING, TRANSCRIPTIONAL CHARACTERIZATION, AND SEQUENCING OF CDNA-ENCODING THE H-PROTEIN OF THE MITOCHONDRIAL GLYCINE DECARBOXYLASE COMPLEX IN PEAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											KIM, YH (corresponding author), UNIV IDAHO, DEPT BACTERIOL & BIOCHEM, MOSCOW, ID 83843 USA.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOEHNI P, 1980, ORG EXPRESSION MITOC, P423; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BOURGUIGNON J, 1988, BIOCHEM J, V255, P169, DOI 10.1042/bj2550169; BOUTRY M, 1985, EMBO J, V4, P2159, DOI 10.1002/j.1460-2075.1985.tb03910.x; DAVIS LG, 1986, BASIC METHODS MOL BI, P130; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Douce R., 1985, MITOCHONDRIA HIGHER; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; FUJIWARA K, 1983, J BIOL CHEM, V258, P8156; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; GARDESTROM P, 1983, PLANT SCI LETT, V31, P173, DOI 10.1016/0304-4211(83)90054-8; GARDESTROM P, 1980, PLANT PHYSIOL, V65, P389, DOI 10.1104/pp.65.2.389; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIRAGA K, 1988, BIOCHEM BIOPH RES CO, V151, P758, DOI 10.1016/S0006-291X(88)80345-0; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KIKUCHI G, 1982, MOL CELL BIOCHEM, V45, P137; KLEIN SM, 1967, J BIOL CHEM, V242, P297; KLEIN SM, 1966, J BIOL CHEM, V241, P206; KOCHI H, 1974, J BIOCHEM, V75, P1113, DOI 10.1093/oxfordjournals.jbchem.a130483; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUME A, 1988, BIOCHEM BIOPH RES CO, V154, P292, DOI 10.1016/0006-291X(88)90683-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MOROHASHI Y, 1987, PHYSIOL PLANTARUM, V70, P46, DOI 10.1111/j.1399-3054.1987.tb08694.x; MOTOKAWA Y, 1974, ARCH BIOCHEM BIOPHYS, V164, P624, DOI 10.1016/0003-9861(74)90074-5; OLIVER DJ, 1987, PLANT MITOCHONDRIA S, P181; ROBINSON JR, 1973, J BIOL CHEM, V248, P5319; ROISE D, 1988, J BIOL CHEM, V263, P4509; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIH DS, 1979, J VIROL, V30, P472, DOI 10.1128/JVI.30.2.472-480.1979; THOMPSON WF, 1983, PLANTA, V158, P487, DOI 10.1007/BF00397240; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; WALKER JL, 1986, ARCH BIOCHEM BIOPHYS, V248, P626, DOI 10.1016/0003-9861(86)90517-5; WALKER JL, 1986, J BIOL CHEM, V261, P2214; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79	40	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					848	853						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688555				2022-12-25	WOS:A1990CH53300036
J	JAHN, D; PANDE, S				JAHN, D; PANDE, S			HISTIDINE TRANSFER-RNA GUANYLYLTRANSFERASE FROM SACCHAROMYCES-CEREVISIAE .2. CATALYTIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION	Yeast histidine tRNA guanylyltransferase (TGT) catalyzes in the presence of ATP the addition of GTP to the 5' end of eukaryotic cytoplasmic tRNA(His) species. A study of the enzyme mechanism with purified protein showed that during the first step ATP is cleaved to AMP and PP(i) creating adenylylated TGT. In a second step the activated enzyme forms a stable complex with its cognate tRNA substrate. The 5'-phosphate of the tRNA is adenylylated by nucleotide transfer from the adenylylated guanylyltransferase to form A(5')pp(5')N at the 5'-end of the tRNA. Finally, the 3'-hydroxyl of GTP adds to the activated 5' terminus of the tRNA with the release of AMP. This mechanism of tRNA(His) guanylyltransferase is very similar to that of RNA ligases. dATP can substitute for ATP in this reaction. Since among several guanosine compounds active in this reaction GTP is most efficiently added we believe that it is the natural substrate of TGT.			JAHN, D (corresponding author), YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,POB 6666,NEW HAVEN,CT 06511, USA.			Jahn, Dieter/0000-0002-4064-9205				ABBE DL, 1990, J BIOL CHEM, V265, P2988; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; ITOH N, 1987, J BIOL CHEM, V262, P1989; JAHN D, 1990, J BIOL CHEM, V265, P8059; JAHN D, 1987, J MOL BIOL, V193, P303, DOI 10.1016/0022-2836(87)90221-X; KHYSEANDERSON J, 1984, J BIOCHEM BIOPH METH, V10, P203; PANDE S, 1991, J BIOL CHEM, V266, P22826; PICK L, 1990, METHOD ENZYMOL, V181, P480; Randerath K, 1980, Methods Enzymol, V65, P638; SCHNEIDER HR, 1989, NUCLEIC ACIDS RES, V17, P5003, DOI 10.1093/nar/17.13.5003; SCHWARTZ RC, 1983, J BIOL CHEM, V258, P8374; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SHUMAN S, 1990, METHOD ENZYMOL, V181, P170; SHUMAN S, 1982, ENZYMES, V15, P246; Silberklang M, 1979, Methods Enzymol, V59, P58; Uhlenbeck O.C., 1982, ENZYMES, V15, P31, DOI [10.1016/s1874-6047(08)60274-7, DOI 10.1016/S1874-6047(08)60274-7]; WILLIAMS JB, 1990, METHOD ENZYMOL, V181, P665; XU Q, 1990, METHOD ENZYMOL, V181, P463	19	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					22832	22836						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660462				2022-12-25	WOS:A1991GT48300012
J	NAGAIKE, M; HIRAO, S; TAJIMA, H; NOJI, S; TANIGUCHI, S; MATSUMOTO, K; NAKAMURA, T				NAGAIKE, M; HIRAO, S; TAJIMA, H; NOJI, S; TANIGUCHI, S; MATSUMOTO, K; NAKAMURA, T			RENOTROPIC FUNCTIONS OF HEPATOCYTE GROWTH-FACTOR IN RENAL REGENERATION AFTER UNILATERAL NEPHRECTOMY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MESSENGER-RNA; FACTOR-I; INSITU HYBRIDIZATION; RAT PLATELETS; TUBULAR CELLS; EXPRESSION; PURIFICATION; HYPERTROPHY; CULTURES; INCREASE	Hepatocyte growth factor (HGF), a most potent growth factor for mature hepatocytes may act as a trigger for liver regeneration. We reported that HGF strongly stimulates DNA synthesis of rabbit renal tubular cells in secondary culture (Igawa, T., Kanda, S., Kanetake, H., Saitoh, Y., Ichihara, A., Tomita, Y., and Nakamura, T. (1991) Biochem. Biophys. Res. Commun. 174, 831-838). To investigate whether or not HGF is involved in renal regeneration, we examined changes in HGF mRNA, HGF activity, and HGF receptor in the rat kidney following unilateral nephrectomy or treatment with carbon tetrachloride (CCl4). In the intact kidney, the HGF mRNA increased markedly reaching a maximum 6 h after unilateral nephrectomy, followed by an increase of HGF activity at 12 h after the surgery. The marked increase in HGF mRNA and HGF activity was also found in the kidney of rats treated with CCl4. Results of in situ hybridization suggested that cells producing HGF in the kidney are endothelial cells. The number of HGF receptors on renal plasma membranes decreased to 30% of the normal value 12 h after unilateral nephrectomy, with no change in the K(d) value. The HGF receptor was greatly diminished 24 h after the operation, and recovery to 60% of the normal level was evident 1 week after the operation. Because the decrease in HGF binding may result from internalization of the HGF receptor, the HGF may bind to its receptor in vivo and act as a mitogen for renal epithelial cells. HGF may function as a renotropic factor during renal regeneration after kidney injury.	KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN; OKAYAMA UNIV,SCH DENT,DEPT BIOCHEM,OKAYAMA 700,JAPAN	Kyushu University; Okayama University								ASAMI O, 1991, J BIOCHEM-TOKYO, V109, P8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FAGIN JA, 1987, ENDOCRINOLOGY, V120, P718, DOI 10.1210/endo-120-2-718; HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8; IGAWA T, 1991, BIOCHEM BIOPH RES CO, V174, P831, DOI 10.1016/0006-291X(91)91493-V; JENNISCHE E, 1987, ACTA PHYSIOL SCAND, V129, P449, DOI 10.1111/j.1365-201X.1987.tb10616.x; JOHNSON HA, 1966, AM J PATHOL, V49, P1; KANDA S, 1989, CELL BIOL INT REP, V13, P687; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; LAJARA R, 1989, AM J PHYSIOL, V257, pF252, DOI 10.1152/ajprenal.1989.257.2.F252; LOWENSTEIN LM, 1963, SCIENCE, V142, P1479, DOI 10.1126/science.142.3598.1479; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NAKAMURA T, 1983, J BIOL CHEM, V258, P9283; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; NOJI S, 1990, BIOCHEM BIOPH RES CO, V173, P42, DOI 10.1016/S0006-291X(05)81018-6; NOJI S, 1990, ACTA HISTOCHEM CYTOC, V23, P353, DOI 10.1267/ahc.23.353; NOMURA K, 1985, NEPHRON, V39, P255, DOI 10.1159/000183381; NORMAN J, 1987, AM J PHYSIOL, V253, pF299, DOI 10.1152/ajprenal.1987.253.2.F299; PREUSS HG, 1970, NEPHRON, V7, P459, DOI 10.1159/000179845; ROLLASON HD, 1949, ANAT REC, V104, P263, DOI 10.1002/ar.1091040302; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SALIDO EC, 1988, CLIN RES, V36, pA245; SELDEN C, 1990, FEBS LETT, V270, P81, DOI 10.1016/0014-5793(90)81239-K; SINICROPE RA, 1984, AM J KIDNEY DIS, V3, P362, DOI 10.1016/S0272-6386(84)80084-0; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; YAMAMOTO N, 1983, KIDNEY INT, V23, P624, DOI 10.1038/ki.1983.68	30	208	208	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1991	266	34					22781	22784						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT483	1660459				2022-12-25	WOS:A1991GT48300002
J	KEEGAN, K; MEYER, S; HAYMAN, MJ				KEEGAN, K; MEYER, S; HAYMAN, MJ			STRUCTURAL AND BIOSYNTHETIC CHARACTERIZATION OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR-3 (FGFR-3) PROTEIN	ONCOGENE			English	Article							EARLY XENOPUS EMBRYOS; TYROSINE KINASE; MAMMALIAN-CELLS; MESSENGER-RNAS; EXPRESSION; GENE; PHOSPHOTYROSINE; DIFFERENTIATION; IDENTIFICATION; TRANSLOCATION	Recently an additional member of the fibroblast growth factor receptor family, FGFR-3, was isolated. In this report, the structure and biosynthesis of the FGFR-3 protein product are investigated. In vitro transcription and translation of the three immunoglobulin-like domain form of FGFR-3 demonstrated the primary translation product to be approximately 97 kDa. However when analysed in COS-1 cells, this form of the receptor directed the expression of three polypeptides with apparent molecular weights of 97 kDa, 125 kDa and 135 kDa. Pulse-chase analysis, treatment of the cells with N-linked glycosylation inhibitors and digestion of these proteins with endoglycosidases demonstrated that the difference in molecular weights was the result of varying degrees of glycosylation. The 97 kDa protein was determined to be a non-glycosylated, cytoplasmic protein, whereas the 125-kDa protein was found to be a membrane-associated glycoprotein that is the biosynthetic precursor of the mature 135 kDa glycoprotein.	SUNY STONY BROOK, DEPT MICROBIOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NCI NIH HHS [R01 CA-42573, P01 CA-28146] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146, R01CA042573] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BAIRD A, 1986, RECENT PROG HORM RES, V42, P143; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRIESEL R, 1991, MOL CELL BIOL, V11, P2481, DOI 10.1128/MCB.11.5.2481; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; HATTORI Y, 1990, P NATL ACAD SCI USA, V87, P5983, DOI 10.1073/pnas.87.15.5983; HAYMAN MJ, 1978, VIROLOGY, V85, P241, DOI 10.1016/0042-6822(78)90428-2; HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; HUYLEBROECK D, 1988, GENE, V66, P163, DOI 10.1016/0378-1119(88)90354-X; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; KAMPS MP, 1988, ONCOGENE, V2, P305; KAUFMAN RJ, 1987, EMBO J, V6, P187, DOI 10.1002/j.1460-2075.1987.tb04737.x; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KIMMELMAN D, 1988, SCIENCE, V242, P1053; KNIGHT J, 1988, ONCOGENE, V2, P317; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHROP B, 1985, J CELL BIOL, V100, P1540, DOI 10.1083/jcb.100.5.1540; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LINKHART TA, 1981, DEV BIOL, V86, P18; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MARICS I, 1989, ONCOGENE, V4, P335; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MUSCI TJ, 1990, P NATL ACAD SCI USA, V87, P8365, DOI 10.1073/pnas.87.21.8365; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; RUTA M, 1988, ONCOGENE, V3, P9; SAFRAN A, 1990, ONCOGENE, V5, P635; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; TARENTINO A, 1985, BIOCHEMISTRY-US, V261, P4465; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TIARA M, 1987, P NATL ACAD SCI USA, V84, P2980; TOGARI A, 1985, J NEUROSCI, V5, P307; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012	45	28	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1991	6	12					2229	2236						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX735	1662791				2022-12-25	WOS:A1991GX73500008
J	TARAKHOVSKY, A; ZAICHUK, T; PRASSOLOV, V; BUTENKO, ZA				TARAKHOVSKY, A; ZAICHUK, T; PRASSOLOV, V; BUTENKO, ZA			A 25-KDA POLYPEPTIDE IS THE LIGAND FOR P185NEU AND IS SECRETED BY ACTIVATED MACROPHAGES	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE-ACTIVITY; NEU PROTO-ONCOGENE; POINT MUTATION; EGF RECEPTOR; HUMAN-BREAST; C-ERBB-2 ONCOGENE; TUMOR-ANTIGEN; GENE; EXPRESSION	Medium conditioned by mouse peritoneal macrophages, activated by muramyl dipeptide (MDP), was used as a possible source of p185neu-specific ligand. MDP-activated macrophage-conditioned medium (MDP-CM) was shown to induce p185neu down-regulation in NEU-expressing NIH3T3 cells in a dose-dependent and temperature-sensitive manner. To exclude the possibility of an indirect action of proteins/metabolites present in MDP-CM on p185neu turnover, a ligand-trapping approach was used. Secreted NEU protein possessing only the extracellular domain but lacking transmembrane and protein kinase domains was expressed in HeLa cells and then purified from conditioned medium, using affinity chromatography on WGA-Sepharose. Co-incubation of the truncated, soluble NEU protein preparation with MDP-CM abolished MDP-CM-induced p185neu down-regulation and reduced self-phosphorylation. It is concluded that a putative p185neu-specific ligand is produced by macrophages activated by MDP. Using MDP-CM, the presence of a 25 kDa polypeptide, distinct from EGF, PDGF, FGF, IGF, TGF-alpha and TGF-beta and TNF-alpha, could be demonstrated by decorating a Western blot with soluble NEU and anti-NEU antibodies. Thus, a 25kDa (non-reduced) p185neu ligand has been described.	ACAD SCI UKSSR,INST ONCOL PROBLEMS,DEPT LEUKEMIAGENESIS,KIEV,UKRAINE,USSR; ACAD SCI USSR,INST MOLEC BIOL,MOSCOW V-71,USSR	National Academy of Sciences Ukraine								AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; ALAN A, 1981, MOL CELL BIOCHEM, V41, P27; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BAHR GM, 1986, FASEB J, V45, P2541; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BERGER MS, 1988, CANCER RES, V48, P1238; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; JALANKO A, 1988, BIOCHIM BIOPHYS ACTA, V949, P206, DOI 10.1016/0167-4781(88)90084-X; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; NECKAMEYER WS, 1986, MOL CELL BIOL, V6, P1478, DOI 10.1128/MCB.6.5.1478; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; PRASSOLOV VS, 1988, P ACAD SCI USSR, V300, P1498; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TALBOT PJ, 1984, J IMMUNOL METHODS, V73, P177, DOI 10.1016/0022-1759(84)90043-7; TARAKHOVSKY AM, 1990, ONCOGENE, V5, P405; TARAKHOVSKYA, 1990, ONCOGENES GROWTH CON, P207; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; WIEDERMANN CJ, 1988, J IMMUNOL, V137, P3928; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1991, BIOCHEMISTRY-US, V30, P3543, DOI 10.1021/bi00228a027; YARDEN Y, 1989, P NATL ACAD SCI USA, V86, P3179, DOI 10.1073/pnas.86.9.3179; ZHOU DJ, 1987, CANCER RES, V47, P6123	59	38	43	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1991	6	12					2187	2196						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX735	1685016				2022-12-25	WOS:A1991GX73500003
J	BURGERS, PMJ				BURGERS, PMJ			SACCHAROMYCES-CEREVISIAE REPLICATION FACTOR-C .2. FORMATION AND ACTIVITY OF COMPLEXES WITH THE PROLIFERATING CELL NUCLEAR ANTIGEN AND WITH DNA POLYMERASE-DELTA AND POLYMERASE-EPSILON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST; PURIFICATION; ACTIVATION; HOLOENZYME; STRAND	Lag times in DNA synthesis by DNA polymerase-delta holoenzyme were due to ATP-mediated formation of an initiation complex on the primed DNA by the polymerase with the proliferating cell nuclear antigen (PCNA) and replication factor C (RF-C). Lag time analysis showed that high affinity binding of RF-C to the primer terminus required PCNA and that this complex was recognized by the polymerase. The formation of stable complexes was investigated through their isolation by Bio-Gel A-5m filtration. A stable complex of RF-C and PCNA on primed single-stranded mp18 DNA was isolated when these factors were preincubated with the DNA and with ATP, or, less efficiently with ATP-gamma-S. These and additional experiments suggest that ATP binding promotes the formation of a labile complex of RF-C with PCNA at the primer terminus, whereas its hydrolysis is required to form a stable complex. Subsequently, DNA polymerase-delta binds to either complex in a replication competent fashion without further energy requirement. DNA polymerase-epsilon did not associate stably with RF-C and PCNA onto the DNA, but its transient participation with these cofactors into a holoenzyme-like initiation complex was inferred from its kinetic properties and replication product analysis. The kinetics of the elongation phase at 30-degrees, 110 nucleotides/s by DNA polymerase-delta holoenzyme and 50 nucleotides/s by DNA polymerase-epsilon holoenzyme, are in agreement with in vivo rates of replication fork movement in yeast. A model for the eukaryotic replication fork involving both DNA polymerase-delta and epsilon is proposed.			BURGERS, PMJ (corresponding author), WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, 660 S EUCLID AVE, BOX 8231, ST LOUIS, MO 63110 USA.		Burgers, Peter M/AAW-6621-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32431, R01 GM032431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAMBARA RA, 1991, BIOCHIM BIOPHYS ACTA, V1088, P11, DOI 10.1016/0167-4781(91)90147-E; BAUER GA, 1988, BIOCHIM BIOPHYS ACTA, V951, P274, DOI 10.1016/0167-4781(88)90097-8; BAUER GA, 1988, J BIOL CHEM, V263, P917; BROOKE RG, 1991, J BIOL CHEM, V266, P3005; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Burgers P M, 1989, Prog Nucleic Acid Res Mol Biol, V37, P235; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; BURGERS PMJ, IN PRESS EUKARYOTIC; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; HORIUCHI T, 1978, MOL GEN GENET, V163, P277, DOI 10.1007/BF00271956; KUNKEL TA, 1989, MOL CELL BIOL, V9, P4447, DOI 10.1128/MCB.9.10.4447; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1991, J BIOL CHEM, V266, P594; LEE SH, 1991, J BIOL CHEM, V266; LUCCHINI G, 1988, MOL GEN GENET, V212, P459, DOI 10.1007/BF00330850; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NETHANEL T, 1990, J VIROL, V64, P5912, DOI 10.1128/JVI.64.12.5912-5918.1990; NEWLON CS, 1988, MICROBIOL REV, V52, P568, DOI 10.1128/MMBR.52.4.568-601.1988; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; YODER BL, 1991, J BIOL CHEM, V266, P22689	26	256	256	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22698	22706						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1682322				2022-12-25	WOS:A1991GR56400095
J	GAYER, GG; GORDON, A; MILES, MF				GAYER, GG; GORDON, A; MILES, MF			ETHANOL INCREASES TYROSINE-HYDROXYLASE GENE-EXPRESSION IN N1E-115 NEUROBLASTOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; NEURO-BLASTOMA CLONE; CYCLIC-AMP; MESSENGER-RNA; ADENYLATE-CYCLASE; GROWTH-FACTOR; C-FOS; ACTIVATION; TRANSCRIPTION; DEPENDENCE	Catecholamines appear to be involved in behavioral responses to acute and chronic ethanol consumption. Since tyrosine hydroxylase (TH) is the rate-limiting enzyme for catecholamine biosynthesis and is regulated by second messenger systems known to be modulated by ethanol, we studied ethanol-induced changes in TH gene expression. In the N1E-115 neural cell line, Northern and Western blot analyses showed that treatment with 25-200 mm ethanol for 3 days caused a dose-dependent increase in TH mRNA and protein levels. N1E-115 cells were also stably transfected with pTH5' CAT, a plasmid containing 773 base pairs of the TH promoter fused to a chloramphenicol acetyltransferase (CAT) reporter gene. Subclones expressing pTH5' CAT showed ethanol-induced increases in CAT activity, suggesting that ethanol modulates TH gene transcription. Furthermore, simultaneous treatment of transfected cells with 100 mM ethanol and 1 nM to 1-mu-M prostaglandin E1 increased prostaglandin E1-mediated stimulation of TH-promoter activity. Similarly, simultaneous treatment of transfected cells with 100 mM ethanol and either 10 mM (-)-N6-(R-phenylisopropyl) adenosine or 0.5 mM 8-bromo-cAMP also resulted in increased TH-promoter activity compared to treatment with these agents without ethanol. These results suggest that ethanol treatment of N1E-115 cells has a prominent effect on both basal and cAMP-regulated TH expression. Ethanol-induced changes in TH expression may be a critical molecular event in adaptation of the central nervous system to ethanol.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,ERNEST GALLO CLIN & RES CTR,BLDG 1,ROOM 101,SAN FRANCISCO,CA 94110; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT PHARMACOL,SAN FRANCISCO,CA 94110; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT NEUROL,SAN FRANCISCO,CA 94110	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco								ACHESON A, 1986, J CELL BIOL, V102, P151, DOI 10.1083/jcb.102.1.151; AHTEE L, 1975, ACTA PHARMACOL TOX, V36, P289; AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BLACK IB, 1985, BRAIN RES, V339, P151, DOI 10.1016/0006-8993(85)90635-3; CAMBI F, 1989, J NEUROCHEM, V53, P1656, DOI 10.1111/j.1471-4159.1989.tb08567.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHARNESS ME, 1988, BIOCHEM BIOPH RES CO, V155, P138, DOI 10.1016/S0006-291X(88)81060-X; COHEN LB, 1980, J PHARMACOL EXP THER, V212, P425; DIAMOND I, 1987, P NATL ACAD SCI USA, V84, P1413, DOI 10.1073/pnas.84.5.1413; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRENCH TA, 1985, J PHARMACOL EXP THER, V232, P315; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOLDSTEI.DB, 1971, SCIENCE, V172, P288, DOI 10.1126/science.172.3980.288; GOLDSTEIN DB, 1973, J PHARMACOL EXP THER, V186, P1; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; GREENBERG DA, 1988, CALCIUM CHANNEL STRU, P541; HALL JL, 1983, MOL CELL BIOL, V3, P854, DOI 10.1128/MCB.3.5.854; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; HOEK JB, 1987, J BIOL CHEM, V262, P682; HOFFMAN PL, 1986, MOL PHARMACOL, V30, P13; HOLLANDER MC, 1990, BIOTECHNIQUES, V9, P174; HUNT WA, 1979, BIOCH PHARM ETHANOL, P167; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; KUROSAWA A, 1976, SCIENCE, V193, P691, DOI 10.1126/science.7836; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LEWIS EJ, 1987, MOL CELL BIOL, V7, P3332, DOI 10.1128/MCB.7.9.3332; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LINDBLAD B, 1976, JAMA-J AM MED ASSOC, V236, P1600, DOI 10.1001/jama.236.14.1600; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSERANO JM, 1979, MOL PHARMACOL, V16, P513; MESSING RO, 1986, P NATL ACAD SCI USA, V83, P6213, DOI 10.1073/pnas.83.16.6213; MILES MF, 1981, J BIOL CHEM, V256, P2545; MILES MF, 1991, J BIOL CHEM, V266, P2409; MOCHLYROSEN D, 1988, NATURE, V333, P848, DOI 10.1038/333848a0; MORGENROTH VH, 1974, P NATL ACAD SCI USA, V71, P4283, DOI 10.1073/pnas.71.11.4283; ORTIZ A, 1974, J PHARM PHARMACOL, V26, P249, DOI 10.1111/j.2042-7158.1974.tb09266.x; PARENT LJ, 1987, FASEB J, V1, P469, DOI 10.1096/fasebj.1.6.3678702; POHORECKY LA, 1974, J PHARMACOL EXP THER, V189, P380; RABE CS, 1988, J PHARMACOL EXP THER, V244, P417; RABIN RA, 1981, J PHARMACOL EXP THER, V216, P129; RABIN RA, 1983, J PHARMACOL EXP THER, V227, P551; RICHELSON E, 1986, J PHARMACOL EXP THER, V239, P687; RITZMANN RF, 1976, NATURE, V263, P418, DOI 10.1038/263418a0; ROHRER H, 1986, J NEUROSCI, V6, P2616; SAITO T, 1987, J NEUROCHEM, V48, P1817, DOI 10.1111/j.1471-4159.1987.tb05741.x; SAMBROON J, 1989, MOL CLONING LABORATO; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STENSTROM S, 1982, J PHARMACOL EXP THER, V221, P334; SUMMERHILL EM, 1987, MOL BRAIN RES, V2, P99, DOI 10.1016/0169-328X(87)90002-7; TANK AW, 1986, MOL PHARMACOL, V30, P497; TANK AW, 1985, J NEUROCHEM, V45, P1030, DOI 10.1111/j.1471-4159.1985.tb05519.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YAMANAKA Y, 1982, JPN J PHARMACOL, V32, P599, DOI 10.1254/jjp.32.599; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215; ZIVKOVIC B, 1974, MOL PHARMACOL, V10, P727	62	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22279	22284						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1682318				2022-12-25	WOS:A1991GR56400036
J	NAKANO, H; MCCORMICK, DB				NAKANO, H; MCCORMICK, DB			STEREOSPECIFICITY OF THE METAL.ATP COMPLEX IN FLAVOKINASE FROM RAT SMALL-INTESTINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMIUM(III) ADENOSINE 5'-TRIPHOSPHATE; NUCLEOTIDE BINDING-SITE; NUCLEOSIDE PHOSPHOROTHIOATES; KINASE REACTION; DEPENDENT STEREOSPECIFICITY; THIOPHOSPHATE-ANALOGS; YEAST HEXOKINASE; PYRUVATE-KINASE; ATP; 5'-O-(2-THIOTRIPHOSPHATE)	Transfer of the gamma-phosphoryl group of ATP to riboflavin is catalyzed by flavokinase, which prefers Zn(II), and is essential in the biosynthesis of the flavocoenzyme, FMN. To study the mechanism and steric disposition of ATP binding, adenosine 5'-O-(2-thiotriphosphate) (ATP-beta-S) and adenosine 5'-O-(3-thiotriphosphate) (ATP-gamma-S) were tested in comparison to ATP with representative divalent metal ions. Activities with 0.1 mm Zn(II) for 1 mM ATP thio analogues compared to ATP with flavokinase were 60% for the S-isomer of ATP-beta-S, 312% for the R-isomer of ATP-beta-S, and 14% for ATP-gamma-S. With Mg(II), flavokinase showed stereospecificity for the R-isomer of ATP-beta-S with a V(max) ratio, S/R = 0.125. With Cd(II), the enzyme showed preference for the S-isomer of ATP-beta-S with a V(max) ratio, S/R = 1.261. The V(max) ratio progressively increases from Mg(II) to Cd(II) in the order of affinity for sulfur. The ratios, (V(max)/K(m))Mg/(V(max)/K(m))Cd, for the diastereomers of ATP-beta-S were expectedly > 1 for one diastereomer (R = 6.597) and < 1 for the other (S = 0.292). Activities with ATP-gamma-S were much lower than with ATP or ATP-beta-S. With Mg(II), the gamma-analogue was a good substrate; however, with Cd(II), it was hardly active. Altogether these results indicate that flavokinase uses the LAMBDA,beta,gamma-bidentate Zn.ATP as a substrate.	EMORY UNIV,SCH MED,ROLLINS RES CTR,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University					NIDDK NIH HHS [DK 38940] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038940] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUCHBINDER JL, 1990, BIOCHEMISTRY-US, V29, P1799, DOI 10.1021/bi00459a019; BURGERS PMJ, 1980, J BIOL CHEM, V255, P8229; CHURCHICH JE, 1982, J BIOL CHEM, V257, P2136; CLELAND WW, 1979, ADV INORG BIOCHEM, V1, P163; CORNELIUS RD, 1978, BIOCHEMISTRY-US, V17, P3279, DOI 10.1021/bi00609a016; Cotton F. A., 1972, ADV INORGANIC CHEM; CULLIS PM, 1987, ENZYME MECH, P179; DUNAWAYMARIANO D, 1980, BIOCHEMISTRY-US, V19, P1496, DOI 10.1021/bi00548a037; DUNAWAYMARIANO D, 1980, BIOCHEMISTRY-US, V19, P1506, DOI 10.1021/bi00548a038; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; GOODY RS, 1972, BIOCHIM BIOPHYS ACTA, V276, P155, DOI 10.1016/0005-2744(72)90016-2; JAFFE EK, 1979, J BIOL CHEM, V254, P839; JAFFE EK, 1978, J BIOL CHEM, V253, P4823; JAFFE EK, 1982, J BIOL CHEM, V257, P7650; KASAI S, 1990, J BIOCHEM-TOKYO, V107, P298, DOI 10.1093/oxfordjournals.jbchem.a123042; MCCORMICK D, 1961, J BIOL CHEM, V236, P2076; MCCORMICK DB, 1960, J BIOL CHEM, V237, P959; MERRILL AH, 1980, J BIOL CHEM, V255, P1335; MERRITT EA, 1978, BIOCHEMISTRY-US, V17, P3274, DOI 10.1021/bi00609a015; NAKANO H, 1991, FLAVINS AND FLAVOPROTEINS 1990, P89; NEOC LD, 1979, FEBS LETT, V96, P65; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; ROMANIUK PJ, 1981, J BIOL CHEM, V256, P7322; ROSSOMANDO EF, 1979, BIOCHEMISTRY-US, V18, P5670, DOI 10.1021/bi00592a023; SCHLIMME E, 1973, EUR J BIOCHEM, V40, P485, DOI 10.1111/j.1432-1033.1973.tb03217.x; STINGELIN J, 1980, J BIOL CHEM, V255, P2022	26	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1991	266	33					22125	22128						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR564	1657990				2022-12-25	WOS:A1991GR56400012
J	DESBOIS, C; PAIN, B; GUILHOT, C; BENCHAIBI, M; FFRENCH, M; GHYSDAEL, J; MADJAR, JJ; SAMARUT, J				DESBOIS, C; PAIN, B; GUILHOT, C; BENCHAIBI, M; FFRENCH, M; GHYSDAEL, J; MADJAR, JJ; SAMARUT, J			V-ERBA ONCOGENE ABROGATES GROWTH-INHIBITION OF CHICKEN-EMBRYO FIBROBLASTS INDUCED BY RETINOIC ACID	ONCOGENE			English	Article							THYROID-HORMONE RECEPTOR; RESPONSIVE ELEMENT; GLUCOCORTICOID RECEPTOR; GENE-TRANSCRIPTION; BINDING DOMAIN; DNA-BINDING; VITAMIN-A; C-ERBA; JUN; CELLS	Retinoic acid inhibits chicken embryo fibroblast (CEF) proliferation by altering the G1 phase of the cell cycle with induction of a strong increase in the generation time. This growth-inhibitory response to retinoic acid is abrogated by expression of the v-erbA oncogene, suggesting an interference between retinoic acid receptors and the v-ErbA oncoprotein. Moreover, CEF expressing either the v-src, v-jun or v-fos oncogenes are also insensitive to retinoic acid treatment. In contrast, CEF expressing either the v-myc, v-myb-ets, v-mil, v-sea or v-erbB oncogenes are still sensitive to retinoic acid. These data strongly suggest functional interferences between the retinoic acid receptors and the AP-1 transcription factor complex in the control of expression of genes involved in CEF proliferation.	FAC MED GRANGE BLANCHE,CYTOL ANALYT LAB,F-69373 LYONS 08,FRANCE; CTR UNIV ORSAY,INST CURIE,BIOL SECT,LABS 110-111-112,F-91405 ORSAY,FRANCE; ECOLE NORMALE SUPER LYON,INRA,CNRS,BIOL MOLEC & CELLULAIRE LAB,UMR 49,F-69364 LYONS 07,FRANCE	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE	DESBOIS, C (corresponding author), UNIV CLAUDE BERNARD LYON 1,FAC MED ALEXIS CARREL,CNRS,UMR 30,RUE GUILLAUME PARADIN,F-69372 LYONS 08,FRANCE.		Samarut, Jacques/AAD-2587-2019; GHYSDAEL, Jacques/F-3377-2013; Morris, Christelle/M-8168-2014; Pain, Bertrand/A-7686-2015	Morris, Christelle/0000-0003-1575-4609; Pain, Bertrand/0000-0002-1210-8444				BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECHADE C, 1985, NATURE, V316, P559, DOI 10.1038/316559a0; BENCHAIBI M, 1989, VIROLOGY, V169, P15, DOI 10.1016/0042-6822(89)90036-6; BEUG H, 1977, EXP CELL RES, V107, P417, DOI 10.1016/0014-4827(77)90363-9; CORDELL J, 1984, J HISTOCHEM CYTOCHEM, V31, P219; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DIAZ JJ, 1989, ONCOL RES, V1, P163; DION LD, 1980, P SOC EXP BIOL MED, V163, P510; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GARCIA M, 1990, J VIROL, V64, P4684, DOI 10.1128/JVI.64.10.4684-4690.1990; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0; HADDOX MK, 1979, CANCER RES, V39, P2476; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JANSSON M, 1987, ONCOGENE, V1, P167; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KHAZAIE K, 1991, ONCOGENE, V6, P21; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; LI RP, 1989, ONCOGENE RES, V5, P137; MAGAUD JP, 1988, J IMMUNOL METHODS, V106, P95, DOI 10.1016/0022-1759(88)90276-1; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; PAIN B, 1990, New Biologist, V2, P284; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHRODER EW, 1982, P NATL ACAD SCI-BIOL, V79, P1549, DOI 10.1073/pnas.79.5.1549; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	46	30	30	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2129	2135						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1682867				2022-12-25	WOS:A1991GX11900025
J	VERSNEL, MA; CLAESSONWELSH, L; HAMMACHER, A; BOUTS, MJ; VANDERKWAST, TH; ERIKSSON, A; WILLEMSEN, R; WEIMA, SM; HOOGSTEDEN, HC; HAGEMEIJER, A; HELDIN, CH				VERSNEL, MA; CLAESSONWELSH, L; HAMMACHER, A; BOUTS, MJ; VANDERKWAST, TH; ERIKSSON, A; WILLEMSEN, R; WEIMA, SM; HOOGSTEDEN, HC; HAGEMEIJER, A; HELDIN, CH			HUMAN-MALIGNANT MESOTHELIOMA CELL-LINES EXPRESS PDGF BETA-RECEPTORS WHEREAS CULTURED NORMAL MESOTHELIAL CELLS EXPRESS PREDOMINANTLY PDGF ALPHA-RECEPTORS	ONCOGENE			English	Article							GROWTH-FACTOR PDGF; SIMIAN SARCOMA-VIRUS; B-CHAIN; CDNA CLONING; A-CHAIN; GENES; IDENTIFICATION; SIS; DIMERIZATION; COEXPRESSION	In human malignant mesothelioma cell lines elevated expression of the platelet-derived growth factor (PDGF) beta-chain (c-sis) gene was previously reported, while normal mesothelial cells barely express this gene. Expression of the PDGF A-chain gene was only slightly elevated in these cell lines compared with normal mesothelial cells. For a putative autocrine function of the produced PDGF, in these cells expression of PDGF receptors is a prerequisite. In this paper we report on the expression of PDGF alpha- and beta-receptors in normal and malignant mesothelial cells. Cultured normal mesothelial cells expressed PDGF alpha-receptor mRNA and protein and had weak to undetectable levels of the PDGF beta-receptor mRNA and protein. In contrast, malignant mesothelioma cell lines were found to express PDGF beta-receptor mRNA and protein, while PDGF alpha-receptor expression was not detectable by Northern blotting and immunoprecipitation. Binding experiments with [I-125]-PDGF-AA and [I-125]PDGF-BB to normal and malignant mesothelial cell lines confirmed these observations. These results suggest that autocrine stimulation of growth may occur both in cultured normal mesothelial cells (PDGF-AA acting via the alpha-receptor) and in malignant mesothelioma cell lines (PDGF-BB acting via the beta-receptor).	ERASMUS UNIV,DEPT PATHOL,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT PULM MED,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; ACAD HOSP ROTTERDAM DIJKZIGT,ROTTERDAM,NETHERLANDS; LUDWIG INST CANC RES,UPPSALA,SWEDEN; HUBRECHT LAB,UTRECHT,NETHERLANDS	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Ludwig Institute for Cancer Research; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	VERSNEL, MA (corresponding author), ERASMUS UNIV,DEPT IMMUNOL,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.			Van der Kwast, Theodorus/0000-0001-8640-5786				BENHAM FJ, 1984, EMBO J, V3, P2635, DOI 10.1002/j.1460-2075.1984.tb02186.x; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BLOBEL G, 1975, J CELL BIOL, V67, P837; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; GERWIN BI, 1987, CANCER RES, V47, P6180; GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MAXWELL M, 1990, J CLIN INVEST, V86, P131, DOI 10.1172/JCI114675; MAXWELL M, 1990, INT J CANCER, V46, P16, DOI 10.1002/ijc.2910460106; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; RAINES EW, 1990, HDB EXPT PHARM 1, V95, P173; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STENMAN G, 1989, GENE CHROMOSOME CANC, V1, P155, DOI 10.1002/gcc.2870010208; STROOBANT P, 1984, EMBO J, V3, P2963, DOI 10.1002/j.1460-2075.1984.tb02241.x; TERRACIO L, 1988, J CELL BIOL, V107, P1947, DOI 10.1083/jcb.107.5.1947; VANDENOUWELAND AMW, 1985, BIOCHIM BIOPHYS ACTA, V825, P140, DOI 10.1016/0167-4781(85)90097-1; VERSNEL MA, 1989, INT J CANCER, V44, P256, DOI 10.1002/ijc.2910440212; VERSNEL MA, 1988, ONCOGENE, V2, P601; WAGNER J C, 1960, Br J Ind Med, V17, P260; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WEIMA SM, 1990, EXP CELL RES, V186, P324, DOI 10.1016/0014-4827(90)90312-X; WILLEMSEN R, 1988, ULTRASTRUCT PATHOL, V12, P471, DOI 10.3109/01913128809032232; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	39	78	78	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2005	2011						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1658707				2022-12-25	WOS:A1991GX11900010
J	ZUSHI, M; GOMI, K; HONDA, G; KONDO, S; YAMAMOTO, S; HAYASHI, T; SUZUKI, K				ZUSHI, M; GOMI, K; HONDA, G; KONDO, S; YAMAMOTO, S; HAYASHI, T; SUZUKI, K			ASPARTIC ACID-349 IN THE 4TH EPIDERMAL GROWTH FACTOR-LIKE STRUCTURE OF HUMAN THROMBOMODULIN PLAYS A ROLE IN ITS CA2+-MEDIATED BINDING TO PROTEIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RECOMBINANT HUMAN THROMBOMODULIN; GAMMA-CARBOXYGLUTAMIC ACID; PROTEOLYTIC FORMATION; THROMBIN; ACTIVATION; COFACTOR; BOVINE; EXPRESSION; RECEPTOR; DOMAIN	The last three consecutive epidermal growth factor (EGF)-like structures of human thrombomodulin constitute the functional domain for protein C-activating cofactor activity and anticoagulant activity. Using site-directed deletion mutagenesis, we found that amino acid Asp349 Of TME456, a recombinantly produced protein consisting of EGF-like structures 4, 5, and 6, is essential for retaining full protein C-activating cofactor activity. To investigate the role of Asp349 in the protein C-activating cofactor activity of human thrombomodulin, we have constructed two mutants of TMD123, a recombinantly produced protein consisting of domains D1, D2, and D3 of thrombomodulin, using site-directed point mutagenesis of the thrombomodulin coding sequence. In mutant TMD123A, the Asp349 codon was replaced with an Ala codon and in mutant TMD123E, the Asp349 codon was replaced with a Glu codon. The partially purified mutant proteins were assayed for their protein C-activating cofactor activity at various Ca2+ concentrations. TMD123 and TMD123E protein showed similar high levels of cofactor activity and similar patterns of Ca2+ dependence, while TMD123A had lower cofactor activity and did not show any Ca2+ dependence. We concluded that Asp349 in the fourth EGF-like structure of human thrombomodulin plays a role in its Ca2+-mediated binding to protein C.	ASAHI CHEM IND CO LTD,LIFE SCI RES LABS,PHARMACEUT LAB,FUJI,SHIZUOKA 416,JAPAN; MIE UNIV,SCH MED GENET DIS,DEPT MOLEC BIOL,TSU,MIE 514,JAPAN	Mie University	ZUSHI, M (corresponding author), ASAHI CHEM IND CO LTD,LIFE SCI RES LABS,BIOSCI LABS,FUJI,SHIZUOKA 416,JAPAN.							BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DITTMAN WA, 1988, J BIOL CHEM, V263, P15815; ESMON NL, 1982, J BIOL CHEM, V257, P859; ESMON NL, 1983, J BIOL CHEM, V258, P5548; GOMI K, 1990, BLOOD, V75, P1396; HAYASHI T, 1990, J BIOCHEM-TOKYO, V108, P874, DOI 10.1093/oxfordjournals.jbchem.a123295; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; JACKMAN RW, 1986, P NATL ACAD SCI USA, V83, P8834, DOI 10.1073/pnas.83.23.8834; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KURACHI K, 1976, BIOCHEMISTRY-US, V15, P368, DOI 10.1021/bi00647a020; KUROSAWA S, 1987, J BIOL CHEM, V262, P2206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OHNO Y, 1981, J BIOCHEM, V90, P1387, DOI 10.1093/oxfordjournals.jbchem.a133604; PARKINSON JF, 1990, J BIOL CHEM, V265, P12602; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STENFLO J, 1976, J BIOL CHEM, V251, P355; SUZUKI K, 1989, J BIOL CHEM, V264, P4872; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	19	48	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1991	266	30					19886	19889						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM039	1657904				2022-12-25	WOS:A1991GM03900006
J	LIAU, G; CHAN, LM; FENG, P				LIAU, G; CHAN, LM; FENG, P			INCREASED FERRITIN GENE-EXPRESSION IS BOTH PROMOTED BY CAMP AND A MARKER OF GROWTH ARREST IN RABBIT VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; CDNA CLONES; HEAVY-CHAIN; CYCLIC-AMP; TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; FIBROBLASTS; DNA; SEQUENCE; ACTIN	To facilitate an understanding of the molecular events associated with vascular smooth muscle cells (SMC) growth arrest and differentiation, we have isolated a number of cDNAs encoding mRNAs that are more abundantly expressed in high density growth-arrested SMC. From 40,000 recombinant plaques, we identified 6 cDNA clones which encoded genes more highly expressed in density-arrested SMC. DNA sequence analysis of a cDNA clone which hybridized to a 5.5-kilobase mRNA revealed a 96% sequence homology to the carboxy-terminal propeptide region of the human alpha-2(I) collagen gene. Sequence analysis of 3 other cDNA clones which all recognized a 1-kilobase mRNA, indicated that they encode the ferritin H-chain subunit gene. The large increase in ferritin H-chain mRNA expression was both growth arrest and high density-dependent, but did not appear to be cell-cell contact-dependent. The increase in H-chain was partially accounted for by an increase in the transcription of this gene, but a post-transcriptional mechanism likely accounts for the majority of the observed difference in mRNA level. A greater than 3-fold higher expression of ferritin H-chain mRNA was also observed in BC3H1s (a nonfusing myogenic cell line) during the process of differentiation, but no elevation in ferritin H-chain mRNA was associated with density-dependent growth arrest in fibroblasts. Hemin (an intracellular iron donor) induced an elevation in ferritin H-chain mRNA expression in both preconfluent and postconfluent SMC, but was unable to elevate the preconfluent mRNA level to an untreated postconfluent level. In addition, deferoxamine (an intracellular iron chelator) was unable to reduce the ferritin mRNA level in postconfluent SMC. These results suggest that high density growth arrest-mediated elevation in ferritin H-chain occurs by a mechanism distinct from that induced by an increase in intracellular iron. cAMP was also a powerful modulator of the expression of ferritin H-chain gene since cells treated with forskolin or dibutyryl cAMP had a 5-7-fold higher level of ferritin H-chain mRNA. We propose that the increase in the ferritin H-chain mRNA level in postconfluent SMC may occur through a cAMP-dependent pathway and may be associated with an enhanced differentiated phenotype.			LIAU, G (corresponding author), AMER RED CROSS, JEROME H HOLLAND LAB BIOMED SCI, MOLEC BIOL LAB, ROCKVILLE, MD 20855 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037510, K04HL002449] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-37510, HL-02449] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEAUMONT C, 1987, J BIOL CHEM, V262, P10619; BEDARD PA, 1989, MOL CELL BIOL, V9, P1371, DOI 10.1128/MCB.9.3.1371; BOYD D, 1985, J BIOL CHEM, V260, P1755; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; BROWN AJP, 1983, P NATL ACAD SCI-BIOL, V80, P1265, DOI 10.1073/pnas.80.5.1265; BUSSE R, 1990, FEBS LETT, V275, P87, DOI 10.1016/0014-5793(90)81445-T; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; CHAMLEY JH, 1975, CELL TISSUE RES, V161, P497; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P666; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOU CC, 1986, MOL CELL BIOL, V6, P566, DOI 10.1128/MCB.6.2.566; DANIELSMCQUEEN S, 1988, NUCLEIC ACIDS RES, V16, P7741, DOI 10.1093/nar/16.15.7741; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FRIEDMAN DL, 1976, PHYSIOL REV, V56, P652, DOI 10.1152/physrev.1976.56.4.652; FRITZE LMS, 1985, J CELL BIOL, V100, P1041, DOI 10.1083/jcb.100.4.1041; FULLER F, 1981, BIOCHEMISTRY-US, V20, P996, DOI 10.1021/bi00507a054; GAY CG, 1991, P NATL ACAD SCI USA, V88, P296, DOI 10.1073/pnas.88.1.296; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; GREENBERG ME, 1989, CURRENT PROTOCOLS MO; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; JONZON B, 1985, J CELL PHYSIOL, V124, P451, DOI 10.1002/jcp.1041240314; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; LIAU G, 1989, J BIOL CHEM, V264, P10315; LIAU G, 1985, J BIOL CHEM, V260, P531; LIAU G, 1990, J CELL PHYSIOL, V142, P236, DOI 10.1002/jcp.1041420204; LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407; MAJACK RA, 1988, J CELL BIOL, V107, P1207, DOI 10.1083/jcb.107.3.1207; MATTIA E, 1989, P NATL ACAD SCI USA, V86, P1801, DOI 10.1073/pnas.86.6.1801; MUNRO HN, 1988, ANN NY ACAD SCI, V526, P113, DOI 10.1111/j.1749-6632.1988.tb55497.x; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; PADMANABHAN R, 1987, MOL CELL BIOL, V7, P1894, DOI 10.1128/MCB.7.5.1894; PASTAN IH, 1975, ANNU REV BIOCHEM, V44, P491, DOI 10.1146/annurev.bi.44.070175.002423; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROVNER AS, 1986, J BIOL CHEM, V261, P4740; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SANDELL LJ, 1984, J BIOL CHEM, V259, P7826; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI Y, 1989, J BIOCHEM-TOKYO, V106, P1009, DOI 10.1093/oxfordjournals.jbchem.a122956; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SCHUBERT D, 1974, J CELL BIOL, V61, P398, DOI 10.1083/jcb.61.2.398; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; STEIN GH, 1981, P NATL ACAD SCI-BIOL, V78, P3025, DOI 10.1073/pnas.78.5.3025; STRAUCH AR, 1986, J BIOL CHEM, V261, P849; TAGAMI M, 1986, CELL TISSUE RES, V245, P261; TAUBMAN MB, 1989, J CELL BIOL, V108, P1799, DOI 10.1083/jcb.108.5.1799; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; TORTI SV, 1988, J BIOL CHEM, V263, P12638; URSINI MV, 1988, BIOCHEM BIOPH RES CO, V150, P287, DOI 10.1016/0006-291X(88)90518-9; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WEI Y, 1990, BIOCHEM BIOPH RES CO, V169, P289, DOI 10.1016/0006-291X(90)91466-6; WHITE K, 1988, J BIOL CHEM, V263, P8938; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	58	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18819	18826						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655764				2022-12-25	WOS:A1991GJ47200065
J	PAN, LP; HE, QH; CHAN, SI				PAN, LP; HE, QH; CHAN, SI			THE NATURE OF ZINC IN CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCEIN MERCURIC ACETATE; X-RAY ABSORPTION; PARTIAL INACTIVATION; SUBUNIT-III; COPPER; HEME	The zinc ion in bovine heart cytochrome c oxidase can be completely depleted from the enzyme with mercuric chloride without denaturing the protein. The metal atom stoichiometry of 5Cu/4Fe/0Zn/2Mg obtained for the enzyme following HgCl2 treatment indicates that this depletion is highly selective. Zinc depletion exposes one cysteine on subunit VIa and one cysteine on subunit VIb for N-iodoacetyl-N'-(5-sulfo-1-napthyl)ethylene-diamine (1,5-I-AEDANS) labeling, suggesting that the zinc plays a structural role in the protein by providing a bridge between these two subunits. Although the treatment of cytochrome c oxidase with mercuric chloride inhibits the steady-state activity of the enzyme, subsequent removal of the Hg2+ bound to cysteine residues by 1,5-I-AEDANS significantly reverses the inhibition. This latter result indicates that the removal of the zinc itself does not alter the steady-state activity of the enzyme.	CALTECH,ARTHUR AMOS NOYES LAB CHEM PHYS,PASADENA,CA 91125	California Institute of Technology					NIGMS NIH HHS [GM 22432] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022432, R37GM022432] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUSE G, 1985, J INORG BIOCHEM, V23, P149, DOI 10.1016/0162-0134(85)85019-4; DARLEYUSMAR VM, 1984, FEBS LETT, V166, P131, DOI 10.1016/0014-5793(84)80058-7; DOWNER NW, 1976, BIOCHEMISTRY-US, V15, P2930, DOI 10.1021/bi00658a036; EINARSDOTTIR O, 1984, BIOCHEM BIOPH RES CO, V124, P836, DOI 10.1016/0006-291X(84)91033-7; EINARSDOTTIR O, 1985, BIOCHEM BIOPH RES CO, V129, P840, DOI 10.1016/0006-291X(85)91968-0; HALL J, 1988, J BIOL CHEM, V263, P8142; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; KADENBACH B, 1981, FEBS LETT, V135, P1, DOI 10.1016/0014-5793(81)80932-5; KADENBACH B, 1986, METHOD ENZYMOL, V126, P32; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; LUDWIG B, 1980, BIOCHIM BIOPHYS ACTA, V594, P177, DOI 10.1016/0304-4173(80)90008-7; MANN AJ, 1980, J BIOL CHEM, V255, P454; MARTIN CT, 1988, J BIOL CHEM, V263, P8420; MOUBARAK A, 1987, BIOCHEM BIOPH RES CO, V143, P1030, DOI 10.1016/0006-291X(87)90355-X; NAQUI A, 1988, J BIOL CHEM, V263, P12342; PAN LP, 1991, J BIOL CHEM, V266, P1367; PENTTILA T, 1983, EUR J BIOCHEM, V133, P355, DOI 10.1111/j.1432-1033.1983.tb07470.x; SCOTT RA, 1989, ANNU REV BIOPHYS BIO, V18, P137, DOI 10.1146/annurev.bb.18.060189.001033; STONEHUERNER J, 1985, J BIOL CHEM, V260, P1456; WIKSTROM M, 1981, CYTOCHROME OXIDASE S, P2; WINTER DB, 1980, J BIOL CHEM, V255, P1408; YEWEY GL, 1987, BIOCHEM BIOPH RES CO, V148, P1520, DOI 10.1016/S0006-291X(87)80304-2; YOSHIKAWA S, 1988, P NATL ACAD SCI USA, V85, P1354, DOI 10.1073/pnas.85.5.1354	23	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19109	19112						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1655772				2022-12-25	WOS:A1991GJ47200107
J	MERIDA, I; GAULTON, GN				MERIDA, I; GAULTON, GN			PROTEIN TYROSINE PHOSPHORYLATION ASSOCIATED WITH ACTIVATION OF THE INTERLEUKIN-2 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,DIV IMMUNOBIOL,PHILADELPHIA,PA 19104	University of Pennsylvania			Merida, Isabel/A-9713-2014	Merida, Isabel/0000-0003-2762-6241	PHS HHS [R01-25535-01A] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		COOPER JA, 1983, METHOD ENZYMOL, V99, P387; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; FARRAR WL, 1985, NATURE, V315, P233, DOI 10.1038/315233a0; FARRAR WL, 1986, IMMUNOL REV, V92, P49, DOI 10.1111/j.1600-065X.1986.tb01493.x; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FERRIS DK, 1989, J IMMUNOL, V143, P870; FORSAYETH JR, 1987, P NATL ACAD SCI USA, V84, P3448, DOI 10.1073/pnas.84.10.3448; GAULTON GN, 1986, J IMMUNOL, V136, P2470; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KONDO S, 1986, P NATL ACAD SCI USA, V83, P9026, DOI 10.1073/pnas.83.23.9026; KOZUMBO WJ, 1987, J IMMUNOL, V138, P606; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MILLER J, 1985, J IMMUNOL, V134, P4212; MILLS GB, 1986, J IMMUNOL, V136, P3019; MILLS GB, 1985, J BIOL CHEM, V260, P2500; MILLS GB, 1985, J IMMUNOL, V134, P2431; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; PETRUZZELLI L, 1984, P NATL ACAD SCI USA, V81, P3227; ROBB RJ, 1981, MOL IMMUNOL, V18, P1087, DOI 10.1016/0161-5890(81)90024-9; ROBB RJ, 1983, J EXP MED, V158, P1332, DOI 10.1084/jem.158.4.1332; SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; USHIRO H, 1980, J BIOL CHEM, V255, P8363	31	91	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1990	265	10					5690	5694						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW480	1690713				2022-12-25	WOS:A1990CW48000062
J	DIXON, BS; BRECKON, R; KAEHNY, MM; DILLINGHAM, MA; ANDERSON, RJ				DIXON, BS; BRECKON, R; KAEHNY, MM; DILLINGHAM, MA; ANDERSON, RJ			HISTIDINE REGULATION OF CYCLIC-AMP METABOLISM IN CULTURED RENAL EPITHELIAL LLC-PK1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VET ADM MED CTR,DEPT MED,MED SERV,1055 CLERMONT ST,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80220	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Dixon, Bradley/0000-0002-2534-3259				AUSIELLO DA, 1987, KIDNEY INT, V31, P521, DOI 10.1038/ki.1987.31; BURCH RM, 1979, J PHARMACOL EXP THER, V210, P344; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; CARVOUNIS CP, 1985, J CLIN INVEST, V76, P779, DOI 10.1172/JCI112035; CARVOUNIS CP, 1988, AM J PHYSIOL, V255, pF685, DOI 10.1152/ajprenal.1988.255.4.F685; Chasin M, 1976, Adv Cyclic Nucleotide Res, V7, P225; DALY JW, 1985, ADV CYCLIC NUCL PROT, V19, P29; DALY JW, 1982, J MED CHEM, V25, P197, DOI 10.1021/jm00345a001; DEFUNDIS FV, 1975, ANNU REV PHARMACOL, V15, P105; DIXON BS, 1988, AM J PHYSIOL, V254, pC183, DOI 10.1152/ajpcell.1988.254.1.C183; HASEGAWA T, 1989, FEBS LETT, V244, P283, DOI 10.1016/0014-5793(89)80546-0; HENDIL KB, 1974, J CELL PHYSIOL, V84, P115, DOI 10.1002/jcp.1040840113; KENIMER JG, 1981, MOL PHARMACOL, V20, P585; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; LONDOS C, 1977, P NATL ACAD SCI USA, V74, P5482, DOI 10.1073/pnas.74.12.5482; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANGANIELLO VC, 1984, ADV CYCLIC NUCL PROT, V16, P291; NEWMAN ME, 1983, BIOCHEM PHARMACOL, V32, P137, DOI 10.1016/0006-2952(83)90665-2; OLNEY JW, 1976, BRAIN RES, V112, P420, DOI 10.1016/0006-8993(76)90298-5; Rall T, 1982, PHARMACOLOGIST, V24, P277; ROY C, 1984, EUR J BIOCHEM, V143, P243, DOI 10.1111/j.1432-1033.1984.tb08365.x; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHMIDT MJ, 1977, BRAIN RES, V121, P182, DOI 10.1016/0006-8993(77)90450-4; SCHMIDT MJ, 1976, BRAIN RES, V112, P113, DOI 10.1016/0006-8993(76)90338-3; SHIMIZU H, 1975, MOL PHARMACOL, V11, P866; SHIMIZU H, 1975, MOL PHARMACOL, V11, P223; SHIMIZU H, 1974, J BIOL CHEM, V249, P5955; TEITELBAUM I, 1986, J CLIN INVEST, V77, P1574, DOI 10.1172/JCI112473; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; WILSON PD, 1986, J BIOL CHEM, V261, P1503	30	7	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1990	265	2					760	766						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH533	1688553				2022-12-25	WOS:A1990CH53300024
